{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "doc processing / chunking classes for storing in vector database (folder_path=\"/data/user_data/vidhij2/medical_db/rag\", embeddings=\"google/muril-base-cased\")\n",
    "( heirarchical and semantic)\n",
    "trying to preprocess and a few document and test a bit  \n",
    "reasning based rag models\n",
    "hybrid chunking ( v.v. long class def) \n",
    "making vector store and testing a bit hybrid rag - answeing as well \n",
    "Enhanced RAG class for maternal health with multilingual support, stage-aware retrieval, and cross-encoder reranking. [ class for retrieval afer final vector store is done]\n",
    "testing with different models the enhanced rag class and storing the answers [ mp used this for last results ]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Storing data for rag database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# 1.1: Load the Excel file\n",
    "df = pd.read_excel(\"/home/vidhij2/nivi/eSaathi Resources_ANC_PNC_CMU.xlsx\", sheet_name=\"Sheet1\")\n",
    "\n",
    "# 1.2: Assume there’s a column named \"resource_link\" with PDF or webpage URLs\n",
    "pairs = df[[\"Title\", \"Link\"]].dropna(subset=[\"Link\"]).to_dict(orient=\"records\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Link</th>\n",
       "      <th>Used for what part of MH journey</th>\n",
       "      <th>Document Category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>WHO recommendations on antenatal care for a po...</td>\n",
       "      <td>https://www.who.int/publications/i/item/978924...</td>\n",
       "      <td>ANC</td>\n",
       "      <td>Clinical Guidelines and Recommendations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>WHO recommendations on maternal and newborn ca...</td>\n",
       "      <td>https://www.who.int/publications/i/item/978924...</td>\n",
       "      <td>PNC</td>\n",
       "      <td>Clinical Guidelines and Recommendations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Maternal Health</td>\n",
       "      <td>https://nhm.gov.in/index1.php?lang=1&amp;level=2&amp;l...</td>\n",
       "      <td>ANC/PNC</td>\n",
       "      <td>Government Policy and Programs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IEC Materials (might not be accessible in US)</td>\n",
       "      <td>https://nhm.gov.in/index1.php?lang=1&amp;level=3&amp;s...</td>\n",
       "      <td>Audio/Visuals</td>\n",
       "      <td>Visual and Educational Resources</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>MH Guidelines (might not be accessible in US)</td>\n",
       "      <td>https://nhm.gov.in/index1.php?lang=1&amp;level=3&amp;s...</td>\n",
       "      <td>ANC/PNC</td>\n",
       "      <td>Clinical Guidelines and Recommendations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>Medicover Hospitals</td>\n",
       "      <td>https://www.medicoverhospitals.in/articles/pre...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>Renew Healthcare India</td>\n",
       "      <td>https://renewhealthcare.in/double-the-trouble-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>Matri Women's Health</td>\n",
       "      <td>https://maitriwoman.com/planning-a-pregnancy-a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>Motherhood Hospitals</td>\n",
       "      <td>https://www.motherhoodindia.com/pregnancy-afte...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>Tweak India</td>\n",
       "      <td>https://tweakindia.com/wellness/health/getting...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>252 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 Title  \\\n",
       "0    WHO recommendations on antenatal care for a po...   \n",
       "1    WHO recommendations on maternal and newborn ca...   \n",
       "2                                      Maternal Health   \n",
       "3        IEC Materials (might not be accessible in US)   \n",
       "4        MH Guidelines (might not be accessible in US)   \n",
       "..                                                 ...   \n",
       "247                                Medicover Hospitals   \n",
       "248                             Renew Healthcare India   \n",
       "249                               Matri Women's Health   \n",
       "250                               Motherhood Hospitals   \n",
       "251                                        Tweak India   \n",
       "\n",
       "                                                  Link  \\\n",
       "0    https://www.who.int/publications/i/item/978924...   \n",
       "1    https://www.who.int/publications/i/item/978924...   \n",
       "2    https://nhm.gov.in/index1.php?lang=1&level=2&l...   \n",
       "3    https://nhm.gov.in/index1.php?lang=1&level=3&s...   \n",
       "4    https://nhm.gov.in/index1.php?lang=1&level=3&s...   \n",
       "..                                                 ...   \n",
       "247  https://www.medicoverhospitals.in/articles/pre...   \n",
       "248  https://renewhealthcare.in/double-the-trouble-...   \n",
       "249  https://maitriwoman.com/planning-a-pregnancy-a...   \n",
       "250  https://www.motherhoodindia.com/pregnancy-afte...   \n",
       "251  https://tweakindia.com/wellness/health/getting...   \n",
       "\n",
       "    Used for what part of MH journey                        Document Category  \n",
       "0                                ANC  Clinical Guidelines and Recommendations  \n",
       "1                                PNC  Clinical Guidelines and Recommendations  \n",
       "2                            ANC/PNC           Government Policy and Programs  \n",
       "3                      Audio/Visuals         Visual and Educational Resources  \n",
       "4                            ANC/PNC  Clinical Guidelines and Recommendations  \n",
       "..                               ...                                      ...  \n",
       "247                              NaN                                      NaN  \n",
       "248                              NaN                                      NaN  \n",
       "249                              NaN                                      NaN  \n",
       "250                              NaN                                      NaN  \n",
       "251                              NaN                                      NaN  \n",
       "\n",
       "[252 rows x 4 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "os.makedirs(\"/data/user_data/vidhij2/medical/pdfs\", exist_ok=True)\n",
    "os.makedirs(\"/data/user_data/vidhij2/medical/html\", exist_ok=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved HTML → /data/user_data/vidhij2/medical/html/WHO_recommendations_on_antenatal_care_for_a_positive_pregnancy_experience.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/WHO_recommendations_on_maternal_and_newborn_care_for_a_positive_postnatal_experience.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Maternal_Health.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/IEC_Materials_(might_not_be_accessible_in_US).html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/MH_Guidelines_(might_not_be_accessible_in_US).html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Digital_Adaptation_Kit_for_Antenatal_Care_Operational_requirements_for_implementing_WHO_recommendations_in_digital_systems.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Pregnant_now_or_within_the_last_year.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Maternal_nutrition_for_safe_motherhood_(Flipbook).pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Maternal_nutrition_for_safe_motherhood._Messages_By-gestational_month.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Wheel_of_balanced_dietary_intake.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Maternal_Child_Protection_(MCP)_card.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Antenatal_Care_and_Skilled_Attendance_at_Birth_by_ANMsLHVsSNs.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Training_Manual_on_care_during_pregnancy_and_childbirth.pdf\n",
      "⚠️ Failed to fetch “Internal ANC/PNC notes: eSaathi team” (https://docs.google.com/spreadsheets/d/14yp7krzI9XcKAXyKgXhB50y5SCbUrWEj/edit?gid=1199340278#gid=1199340278): 401 Client Error: Unauthorized for url: https://docs.google.com/spreadsheets/d/14yp7krzI9XcKAXyKgXhB50y5SCbUrWEj/edit?gid=1199340278#gid=1199340278\n",
      "⚠️ Failed to fetch “The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions” (https://academic.oup.com/abm/article-abstract/46/1/81/4563254?redirectedFrom=fulltext): 403 Client Error: Forbidden for url: https://academic.oup.com/abm/article-abstract/46/1/81/4563254?redirectedFrom=fulltext\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/The_Behaviour_Change_Technique_Ontology_Transforming_the_Behaviour_Change_Technique_Taxonomy_v1.html\n",
      "⚠️ Failed to fetch “The effectiveness of nudging: A meta-analysis of choice architecture interventions across behavioral domains” (https://www.pnas.org/doi/full/10.1073/pnas.2107346118): 403 Client Error: Forbidden for url: https://www.pnas.org/doi/full/10.1073/pnas.2107346118\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Human_Behavior_Change_tool.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Human_Behavior_Change_summary.html\n",
      "⚠️ Failed to fetch “Human Behavior Change list of relevant publications” (https://docs.google.com/document/d/109Ph2ITl4xsJt0boc9rQgGWBdd2mn8zgD4BDA1xY7GM/edit?tab=t.0): 401 Client Error: Unauthorized for url: https://docs.google.com/document/d/109Ph2ITl4xsJt0boc9rQgGWBdd2mn8zgD4BDA1xY7GM/edit?tab=t.0\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Human_Behavior_Change_resources.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Extracted_from_Guidelines_for_Pregnancy_Care,_Maternal_Health_Division,_Dpt._of_Family_Welfare,_MOHFW,_GoI_2005.pdf\n",
      "⚠️ Failed to fetch “Development of a Comprehensive Antenatal Risk Assessment Tool to Predict Adverse Maternal and Perinatal Outcomes in Rural Areas: An Exploratory Study” (https://pmc.ncbi.nlm.nih.gov/articles/PMC8144483/): 403 Client Error: Forbidden for url: https://pmc.ncbi.nlm.nih.gov/articles/PMC8144483/\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Digital_Health_Interventions_for_Healthcare_Providers_(WHO_&_JHU_resource).html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/JSSK_Guidelines.pdf\n",
      "⚠️ Failed to fetch “National Family Health Survey - 5 (2019-20) Assam\n",
      "” (https://nhm.assam.gov.in/documents-detail/national-family-health-survey-5-2019-20): HTTPSConnectionPool(host='nhm.assam.gov.in', port=443): Max retries exceeded with url: /documents-detail/national-family-health-survey-5-2019-20 (Caused by ConnectTimeoutError(<urllib3.connection.HTTPSConnection object at 0x7f8a1b54d4c0>, 'Connection to nhm.assam.gov.in timed out. (connect timeout=15)'))\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/PMMVY_Guidelines.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Where_There_is_No_Doctor_handbook-_Hesperian.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Where_There_is_No_Doctor_handbook-_Hesperian_(Hindi).html\n",
      "⚠️ Failed to fetch “RMC White Ribbon alliance” (https://www.healthpolicyproject.com/pubs/46_FinalRespectfulCareCharter.pdf): HTTPSConnectionPool(host='www.healthpolicyproject.com', port=443): Max retries exceeded with url: /pubs/46_FinalRespectfulCareCharter.pdf (Caused by SSLError(SSLCertVerificationError(1, '[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: certificate has expired (_ssl.c:1147)')))\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Danger_Signs_of_Childbirth.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/LaQshya_Labor_room_quality_improvement_initiative.pdf\n",
      "⚠️ Failed to fetch “PMSMA guidelines: adequate, appropriate, and quality antenatal care” (https://pmsma.mohfw.gov.in/wp-content/uploads/2016/09/PMSMA_Operational_Framework.pdf): HTTPSConnectionPool(host='pmsma.mohfw.gov.in', port=443): Max retries exceeded with url: /wp-content/uploads/2016/09/PMSMA_Operational_Framework.pdf (Caused by SSLError(SSLCertVerificationError(1, '[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: unable to get local issuer certificate (_ssl.c:1147)')))\n",
      "⚠️ Failed to fetch “Pradhan Mantri Surakshit Matritva Abhiyan program guide” (https://pmsma.nhp.gov.in/wp-content/uploads/2016/09/Pradhan_Mantri_Surakshit_Matritva_Abhiyan-2.pdf): HTTPSConnectionPool(host='pmsma.nhp.gov.in', port=443): Max retries exceeded with url: /wp-content/uploads/2016/09/Pradhan_Mantri_Surakshit_Matritva_Abhiyan-2.pdf (Caused by SSLError(SSLCertVerificationError(1, '[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: certificate has expired (_ssl.c:1147)')))\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_to_be_reasonably_certain_that_a_patient_is_pregnantnot_pregnant.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/WHO_recommendations_on_Postnatal_care_of_the_mother_and_newborn.html\n",
      "⚠️ Failed to fetch “A Review on Risk Factors of Postpartum Depression in India and Its Management” (https://pmc.ncbi.nlm.nih.gov/articles/PMC9573019/): 403 Client Error: Forbidden for url: https://pmc.ncbi.nlm.nih.gov/articles/PMC9573019/\n",
      "⚠️ Failed to fetch “Postpartum depression in India: a systematic review and meta-analysis” (https://pmc.ncbi.nlm.nih.gov/articles/PMC5689195/): 403 Client Error: Forbidden for url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5689195/\n",
      "⚠️ Failed to fetch “India’s Silent Struggle: A Scoping Review on Postpartum Depression in the Land of a Billion Mothers” (https://journals.sagepub.com/doi/10.1177/02537176241245773?icid=int.sj-abstract.citing-articles.2): 403 Client Error: Forbidden for url: https://journals.sagepub.com/doi/10.1177/02537176241245773?icid=int.sj-abstract.citing-articles.2\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Prevalence_and_Correlates_of_Postpartum_Depression_(PPD)_In_India_Literature_Review-Based_Study.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Dietary_Norms_by_NHM_for_pregnant_women_(for_state_program_managers).pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidance_Note_on_Optimizing_Post-Natal_Care.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/GUIDANCE_BOOKLET_ON_maternal_health_for_COMMUNITY_HEALTH_OFFICERS.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Local_guidance_notes_on_PNC_MH.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Training_Manual_on_Care_During_Pregnancy_and_Child_Birth.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Commodity_and_service\n",
      "delivery_innovations_for\n",
      "detection_and_management\n",
      "of_pre-eclampsia\n",
      "Landscape_report.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Hyperglycemia_in_Pregnancy_(HIP)_FIGO\n",
      "offers_a_pragmatic_guide_to_diagnosis,\n",
      "management_and_care.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_Perspectives_from_Assam.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Dietary_Guidelines_for_Indians_-_A_Manual.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_perspectives_from_Assam.html\n",
      "⚠️ Failed to fetch “Comprehensive Pregnancy FAQs for Indian Mothers” (https://docs.google.com/document/d/1FrM86A9L4RWFEzSLtk2jCXqpWMql6N0FXrbe_Jyr1AQ/edit?tab=t.0): 401 Client Error: Unauthorized for url: https://docs.google.com/document/d/1FrM86A9L4RWFEzSLtk2jCXqpWMql6N0FXrbe_Jyr1AQ/edit?tab=t.0\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Healthy_Eating_and_Junk_Food.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Normal_Sleep_and_Physical_Activity.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Dental_Care,_Diapers,_and_Clothing.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Prevention_of_Accidents_and_Injuries.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Screentime_Guidelines_for_Parents.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_School_and_My_Child_Parental_Concerns_Regarding_Schooling.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Toys,_Plays,_And_Sports.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Early_Childhood_Development.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Studies,_Coaching,_and_Vocational_Counseling.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Traveling_with_children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Vaccination.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Dealing_with_Adverse_Events_Following_Immunization.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Prepare_Your_Child_to_Deal_with_Bullying.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Thumb-sucking,_Temper_Tantrums_and_PICA.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Enuresis_and_Encopresis.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Stammering_and_Stuttering.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_and_How_Do_I_Suspect_and_Prevent_Abuse_in_My_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_AUTISM.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_an_InattentiveHyperactive_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Specific_Learning_Disability_in_Your_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Intellectual_Disability.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_How_My_Child_Grows.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Normal_Development_and_When_to_Suspect_Abnormal_Development.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Visual_Impairment_and_Care_of_a_Child_with_Visual_Impairment.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Hearing_Impairment_and_Care_of_a_Child_with_Hearing_Impairment.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Normal_Psychosocial_Development_in_Adolescents.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Attainment_of_Puberty.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Mental_Health_Issues_in_Adolescents.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Eating_Disorders__Anorexia_and_Bulimia.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Fever.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_My_Child_has_a_Fever_with_Rash.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Typhoid.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Viral_Hepatitis.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Suspecting_a_Serious_Bacterial_Illness.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Tuberculosis_in_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_HIVChild_Born_to_HIV_Positive_Mother.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Immune_Deficiency.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Preventing_Mosquito-borne_Illnesses.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Breastfeeding.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Complementary_Feeding.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Vitamins_and_Minerals_for_My_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_Between_1_and_2_Years_of_Age.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_for_Preschoolers_(2–5_Years).pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_for_Children_Between_5–12_Years.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_of_Adolescents_(10–19_Years).pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Which_Nutritional_Supplements_are_Needed_for_My_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Prevention_and_Care_of_Malnutrition_in_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_obesity.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_How_Do_I_Prepare_for_Arrival_of_My_Newborn_Baby.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Physiological_Variations_in_a_Newborn.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_the_Low_Birthweight_Newborn.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Identifying_a_Sick_Newborn.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Neonatal_Jaundice.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Birth_Defects.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Congenital_Heart_Disease.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Importance_of_Checking_Blood_Pressure_in_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Taking_Care_of_My_Child_After_Heart_Surgery.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_My_Child_is_Not_Growing_Well__How_to_Monitor_and_Manage.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Early_and_Late_Puberty.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Hypothyroidism_Congenital_and_Acquired.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Diarrhea.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Care_of_a_child_with_Diabetes_Mellitus.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Caring_for_a_Child_with_Celiac_Disease.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_The_Constipated_Kid.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_How_to_Deal_with_Recurrent_Abdominal_Pain.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Chronic_Liver_Disease.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Thalassemia_What_Parents_Need_to_Know.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Hemophilia.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Anemia.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Leukemia.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_Children_with_Cancer.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Post_Bone_Marrow_TransplantStem_Cell_Transplant_Care.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_Childhood_Cancer_Survivors.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_a_Paralytic_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_a_Child_with_Cerebral_Palsy.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Duchenne_Muscular_Dystrophy.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Epilepsy.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Acute_Episodes_of_Seizures_What_to_Do.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_Children_with_Febrile_Seizure.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_My_Child_is_having_Fever_with_Cough_What_to_Do.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Cystic_Fibrosis.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Allergic_Rhinitis.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Acute_Attack_of_Asthma_What_to_Do.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_Chronic_Asthma.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_Child_on_Oxygen_and_Ventilation.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Recurrent_Cough.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Care_of_a_Child_with_Nephrotic_Syndrome.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Recurrent_Urinary_Tract_Infection.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Congenital_Anomalies_of_Kidney_and_Urinary_Tract.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Chronic_Kidney_Disease.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Skin_Allergies.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Environmental_Pollution.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_a_Dog_Bites_My_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Drug_and_Substance_Abuse.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Genetic_Disorders_How_to_Prevent_Recurrence.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Down_Syndrome.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Rheumatic_Disorders.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Child_Labor_and_Rights_of_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_I_Want_to_Adopt_a_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Chronic_Disease_in_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Terminally_Ill_Child.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guidelines_for_First_Aid.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Corona_virus_Disease-2019_in_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Yoga_for_Children.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Guideline_for_Psychosocial_Concerns_during_Pandemic.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_can_I_confirm_I_am_pregnant_What_are_the_early_signs_-_World_Health_Organization_(WHO).html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/When_should_I_first_visit_a_doctor_after_finding_out_I'm_pregnant_-_National_Health_Mission.html\n",
      "⚠️ Failed to fetch “What government schemes are available for maternity care in India? - Ministry of Health & Family Welfare” (https://pmsma.mohfw.gov.in/): HTTPSConnectionPool(host='pmsma.mohfw.gov.in', port=443): Max retries exceeded with url: / (Caused by SSLError(SSLCertVerificationError(1, '[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: unable to get local issuer certificate (_ssl.c:1147)')))\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Is_spotting_or_light_bleeding_normal_in_early_pregnancy_-_Cleveland_Clinic.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_can_I_manage_morning_sickness_What_remedies_work_best_-_CIMS_Hospital_&_1mg.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/1mg.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Which_prenatal_vitamins_should_I_take_and_when_should_I_start_-_Cleveland_Clinic.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/I_haven't_experienced_any_morning_sickness_-_is_this_normal_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html\n",
      "⚠️ Failed to fetch “What foods should I avoid during pregnancy? Any specific Indian foods to be cautious about? - National Health Portal of India” (https://www.nhp.gov.in/healthlyliving/diet-during-pregnancy): HTTPSConnectionPool(host='www.nhp.gov.in', port=443): Max retries exceeded with url: /healthlyliving/diet-during-pregnancy (Caused by NewConnectionError('<urllib3.connection.HTTPSConnection object at 0x7f8a1b506f10>: Failed to establish a new connection: [Errno -2] Name or service not known'))\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Can_I_eat_mangoespapayapineapple_during_pregnancy_-_Apollo_Pharmacy.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/How_much_weight_should_I_gain_during_pregnancy_-_Indian_Council_of_Medical_Research_(ICMR).pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Is_it_safe_to_consume_caffeine_(teacoffee)_during_pregnancy_How_much_-_World_Health_Organization_(WHO).html\n",
      "⚠️ Failed to fetch “Can I continue working during pregnancy? Until when? - Pampers India” (https://www.in.pampers.com/pregnancy/healthy-pregnancy/article/weight-gain-during-pregnancy-month-by-month): 403 Client Error: Forbidden for url: https://www.in.pampers.com/pregnancy/healthy-pregnancy/article/weight-gain-during-pregnancy-month-by-month\n",
      "⚠️ Failed to fetch “Is it safe to travel during pregnancy? When should I stop? - Pampers India” (https://www.in.pampers.com/pregnancy/healthy-pregnancy/article/flying-while-pregnant-and-other-travel-considerations): 403 Client Error: Forbidden for url: https://www.in.pampers.com/pregnancy/healthy-pregnancy/article/flying-while-pregnant-and-other-travel-considerations\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_exercises_are_safe_during_pregnancy_Can_I_do_yoga_-_CloudNine.html\n",
      "⚠️ Failed to fetch “Can I continue with religious fasting during pregnancy? - Indian Journal of Endocrinology and Metabolism” (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105573/): 403 Client Error: Forbidden for url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5105573/\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/Which_tests_are_necessary_during_pregnancy_and_when_-_National_Health_Mission.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Times_of_India.html\n",
      "⚠️ Failed to fetch “Apollo Hospitals” (https://www.apollohospitals.com/departments/obstetrics-and-gynaecology/treatments/maternity): 403 Client Error: Forbidden for url: https://www.apollohospitals.com/departments/obstetrics-and-gynaecology/treatments/maternity\n",
      "⚠️ Failed to fetch “What is anemia and why is it a concern during pregnancy? - Cureus” (https://pmc.ncbi.nlm.nih.gov/articles/PMC10484469/): 403 Client Error: Forbidden for url: https://pmc.ncbi.nlm.nih.gov/articles/PMC10484469/\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_are_the_signs_of_pregnancy_complications_I_should_watch_for_-_World_Health_Organization.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/National_Health_Mission.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Is_it_normal_to_have_swelling_in_hands_and_feet_during_pregnancy_-_CloudNineCare.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/What_are_the_risks_of_gestational_diabetes_How_is_it_managed_-_Government_of_India.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_is_preeclampsia_and_how_can_it_be_detected_-_Preeclampsia_Foundation.html\n",
      "⚠️ Failed to fetch “Max Healthcare” (https://www.maxhealthcare.in/our-specialities/obstetrics-and-gynaecology/conditions-treatments/preeclampsia): 403 Client Error: Forbidden for url: https://www.maxhealthcare.in/our-specialities/obstetrics-and-gynaecology/conditions-treatments/preeclampsia\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_often_should_I_have_ultrasound_scans_during_my_pregnancy_-_Apollo_Cradle.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_should_I_do_if_I_feel_reduced_fetal_movement_-_CloudNineCare.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_can_I_manage_thyroid_issues_during_pregnancy_-_Apollo_Cradle.html\n",
      "⚠️ Failed to fetch “How do I manage traditional advice from family that contradicts medical advice? - The Royal Society” (https://royalsocietypublishing.org/doi/10.1098/rstb.2019.0433): 403 Client Error: Forbidden for url: https://royalsocietypublishing.org/doi/10.1098/rstb.2019.0433\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Apollo_Cradle.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Should_I_follow_specific_traditional_practices_during_pregnancy_-_WorldPulse.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Can_I_attend_religious_ceremonies_and_festivals_during_pregnancy_-_Stem_Cyte_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_can_I_involve_my_husbandpartner_in_the_pregnancy_journey_-_CloudNineCare.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/StemCyte_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Medicover_Hospitals.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_prepare_my_older_child(ren)_for_a_new_sibling_-_CloudNineCare.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_are_the_signs_of_labor_When_should_I_go_to_the_hospital_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Apollo_Cradle.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_is_the_difference_between_normal_delivery_and_cesarean_section_-_CloudNineCare.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_pain_relief_options_are_available_during_labor_-_Baby_Center.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_long_does_labor_typically_last_for_first-time_mothers_-_Cord_Life_India.html\n",
      "⚠️ Failed to fetch “What is an episiotomy and when is it necessary? - Apollo Hospitals” (https://www.apollohospitals.com/procedures/is-an-episiotomy-necessary-for-all-deliveries): 403 Client Error: Forbidden for url: https://www.apollohospitals.com/procedures/is-an-episiotomy-necessary-for-all-deliveries\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_is_a_birth_plan_and_how_do_I_create_one_-_First_Cry_Parenting.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Can_I_choose_who_will_be_present_during_my_delivery_-_MOHFW_Press_Release.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_should_I_pack_in_my_hospital_bag_-_Baby_Center_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_long_will_it_take_to_recover_after_delivery_-_Motherhood_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_care_for_my_stitches_after_delivery_-_BabyCenter_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/When_will_my_menstrual_cycle_return_after_delivery_-_Apollo_Cradle.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_can_I_manage_postpartum_depression_or_mood_changes_-_Motherhood_India.html\n",
      "⚠️ Failed to fetch “What is postpartum bleeding or lochia and how long does it last? - Pampers India” (https://www.in.pampers.com/pregnancy/giving-birth/article/lochia-postpartum-bleeding-normal): 403 Client Error: Forbidden for url: https://www.in.pampers.com/pregnancy/giving-birth/article/lochia-postpartum-bleeding-normal\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/When_can_I_resume_sexual_activity_after_childbirth_-_Times_of_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_soon_can_I_get_pregnant_again_after_having_a_baby_-_World_Health_Organization.html\n",
      "⚠️ Failed to fetch “HDFC Ergo ” (https://www.hdfcergo.com/health-insurance/wellness-corner/how-soon-can-you-get-pregnant-after-giving-birth): 406 Client Error: Not Acceptable for url: https://www.hdfcergo.com/health-insurance/wellness-corner/how-soon-can-you-get-pregnant-after-giving-birth\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Times_of_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_know_if_my_baby_is_getting_enough_breast_milk_-_World_Health_Organization.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/R_is_for_Rabbit.html\n",
      "⚠️ Failed to fetch “How can I increase my milk supply? - Breastfeeding Promotion Network of India & BabyCenter India” (https://www.bpni.org/breastfeeding-myth-vs-fact/): 406 Client Error: Not Acceptable for url: https://www.bpni.org/breastfeeding-myth-vs-fact/\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/BabyCenter_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_manage_breastfeeding_if_I_need_to_return_to_work_-_CloudNineCare.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_should_I_eat_to_produce_healthy_breast_milk_-_National_Institute_of_Nutrition_&_Teddyy_Baby_Diaper.html\n",
      "⚠️ Failed to fetch “Teddyy Diaper India” (https://teddyydiaper.in/blog/perfect-diet-plan-for-breastfeeding-moms-in-india): HTTPSConnectionPool(host='teddyydiaper.in', port=443): Max retries exceeded with url: /blog/perfect-diet-plan-for-breastfeeding-moms-in-india (Caused by SSLError(SSLCertVerificationError(1, '[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: unable to get local issuer certificate (_ssl.c:1147)')))\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Can_I_take_medications_while_breastfeeding_-_Apollo_Hospitals.html\n",
      "⚠️ Failed to fetch “How can I manage breast engorgement and pain? - Pampers India ” (https://www.in.pampers.com/baby/feeding/article/breast-engorgement): 403 Client Error: Forbidden for url: https://www.in.pampers.com/baby/feeding/article/breast-engorgement\n",
      "⚠️ Failed to fetch “ Ministry of Health and Family Welfare” (https://mohfw.gov.in/sites/default/files/308320517NATIONAL%20GUIDELINES%20ON%20INFANT%20AND%20YOUNG%20CHILD%20FEEDING.pdf): ('Connection aborted.', ConnectionResetError(104, 'Connection reset by peer'))\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Does_my_diet_affect_my_breast_milk_quality_and_baby's_health_-_Academy_of_Breastfeeding_Medicine.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Danone_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_vaccinations_does_my_baby_need_and_when_-_Indian_Academy_of_Pediatrics_&_National_Health_Mission.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/National_Health_Mission.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_care_for_my_baby's_umbilical_cord_stump_-_BabyCenter_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_often_should_my_newborn_feed_-_India_MOHFW_&_EuroKids_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/EuroKids_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_is_normal_newborn_stool_and_urine_pattern_-_BabyCenter_India.html\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/How_do_I_know_if_my_baby_is_sick_What_signs_should_I_watch_for_-_Indian_Academy_of_Pediatrics.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/When_should_I_start_bathing_my_newborn_-_Times_of_India.html\n",
      "⚠️ Failed to fetch “How do I manage my baby's sleep schedule? - Pampers India & Indian Academy of Pediatrics” (https://www.in.pampers.com/newborn-baby/sleep/article/newborn-sleep-how-much-should-a-newborn-sleep): 403 Client Error: Forbidden for url: https://www.in.pampers.com/newborn-baby/sleep/article/newborn-sleep-how-much-should-a-newborn-sleep\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/IAP.pdf\n",
      "Downloaded PDF → /data/user_data/vidhij2/medical/pdfs/What_is_jaundice_and_when_should_I_be_concerned_-_Indian_Academy_of_Pediatrics.pdf\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_manage_pregnancy_with_pre-existing_conditions_like_diabetes_or_hypertension_-_Indian_Journal_of_Cardiovascular_Disease_in_Women.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Frontiers_in_Endocrinology.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_special_care_is_needed_for_high-risk_pregnancies_-_Kangaroo_Care_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Dr._Rita_Bakshi.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_do_I_cope_with_pregnancy_loss_or_previous_miscarriage_-_The_International_Stillbirth_Alliance.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Journal_of_Obstetrics_and_Gynecology_of_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Times_of_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Times_of_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/What_additional_care_is_needed_for_twinmultiple_pregnancies_-_Apollo_Cradle.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Dr._Madhu_Goel.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/India_Express.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/How_is_pregnancy_different_for_women_over_35_years_-_Hans_India.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Medicover_Hospitals.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Renew_Healthcare_India.html\n",
      "⚠️ Failed to fetch “Matri Women's Health” (https://maitriwoman.com/planning-a-pregnancy-after-35-dos-donts): HTTPSConnectionPool(host='maitriwoman.com', port=443): Max retries exceeded with url: /planning-a-pregnancy-after-35-dos-donts (Caused by ConnectTimeoutError(<urllib3.connection.HTTPSConnection object at 0x7f8a1b54d550>, 'Connection to maitriwoman.com timed out. (connect timeout=15)'))\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Motherhood_Hospitals.html\n",
      "Saved HTML → /data/user_data/vidhij2/medical/html/Tweak_India.html\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import re\n",
    "import pandas as pd\n",
    "import requests\n",
    "def sanitize_filename(name: str) -> str:\n",
    "    \"\"\"\n",
    "    Replace or remove characters that are invalid in filenames.\n",
    "    Here we:\n",
    "      - Strip leading/trailing whitespace\n",
    "      - Replace spaces with underscores\n",
    "      - Remove any characters in <>:\"/\\\\|?*  \n",
    "    \"\"\"\n",
    "    name = name.strip()\n",
    "    name = name.replace(\" \", \"_\")\n",
    "    # remove any character not in [a-zA-Z0-9_.-]\n",
    "    name = re.sub(r'[<>:\"/\\\\|?*]', \"\", name)\n",
    "    return name\n",
    "\n",
    "for item in pairs:\n",
    "    raw_title = str(item[\"Title\"])\n",
    "    url       = item[\"Link\"]\n",
    "\n",
    "    # 2.3.1: sanitize the title so we can safely use it as a filename\n",
    "    safe_title = sanitize_filename(raw_title)\n",
    "\n",
    "    try:\n",
    "        if url.lower().endswith(\".pdf\"):\n",
    "            resp = requests.get(url, timeout=15)\n",
    "            resp.raise_for_status()\n",
    "            outpath = f\"/data/user_data/vidhij2/medical/pdfs/{safe_title}.pdf\"\n",
    "            with open(outpath, \"wb\") as f:\n",
    "                f.write(resp.content)\n",
    "            print(f\"Downloaded PDF → {outpath}\")\n",
    "\n",
    "        else:\n",
    "            resp = requests.get(url, timeout=15)\n",
    "            resp.raise_for_status()\n",
    "            outpath = f\"/data/user_data/vidhij2/medical/html/{safe_title}.html\"\n",
    "            with open(outpath, \"w\", encoding=\"utf-8\") as f:\n",
    "                f.write(resp.text)\n",
    "            print(f\"Saved HTML → {outpath}\")\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"⚠️ Failed to fetch “{raw_title}” ({url}): {e}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Hierarchical chunking- Hierarchical, header‑aware splitter for clinical PDFs/Markdown with table extracter and max count split or paragraph based."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import re\n",
    "import json\n",
    "from typing import List, Dict, Any, Optional\n",
    "from dataclasses import dataclass\n",
    "import argparse\n",
    "from tqdm import tqdm\n",
    "\n",
    "# LangChain imports\n",
    "from langchain.document_loaders import TextLoader, PyPDFLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter, MarkdownHeaderTextSplitter\n",
    "from langchain.docstore.document import Document\n",
    "from langchain.schema import BaseDocumentTransformer\n",
    "from langchain.vectorstores import Chroma\n",
    "from langchain.embeddings import OpenAIEmbeddings\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "from langchain.chains import RetrievalQA\n",
    "from langchain.prompts import PromptTemplate\n",
    "import os\n",
    "import uuid\n",
    "from langchain.vectorstores import FAISS\n",
    "class MedicalHeaderTextSplitter(MarkdownHeaderTextSplitter):\n",
    "    \"\"\"Custom text splitter for medical documents that respects section headers.\"\"\"\n",
    "    \n",
    "    def __init__(self):\n",
    "        headers_to_split_on = [\n",
    "            (\"#\", \"chapter\"),\n",
    "            (\"##\", \"section\"),\n",
    "            (\"###\", \"subsection\"),\n",
    "            (\"####\", \"recommendation\"),\n",
    "            (\"#####\", \"remarks\")\n",
    "        ]\n",
    "        super().__init__(headers_to_split_on=headers_to_split_on)\n",
    "        \n",
    "    def _add_md_header(self, text):\n",
    "        \"\"\"Convert medical document headers to markdown format.\"\"\"\n",
    "        # Convert chapter headers\n",
    "        text = re.sub(r'(?m)^(?:Chapter|CHAPTER)\\s+(\\d+)[\\.:]?\\s+(.+)$', r'# \\1 \\2', text)\n",
    "        \n",
    "        # Convert section headers\n",
    "        text = re.sub(r'(?m)^(?:\\d+\\.\\d+\\.?\\s+|\\d+\\.\\s+)([A-Z][A-Za-z\\s\\-:]+)$', r'## \\1', text)\n",
    "        \n",
    "        # Convert subsection headers\n",
    "        text = re.sub(r'(?m)^(?:[A-Z]\\.\\d+\\.?\\s+|[A-Z]\\.\\s+)([A-Za-z][A-Za-z\\s\\-:]+)$', r'### \\1', text)\n",
    "        \n",
    "        # Convert recommendation headers\n",
    "        text = re.sub(\n",
    "            r'(?m)^RECOMMENDATION\\s+([A-Z0-9\\.]+):\\s+(.+?)(?:\\((?:Recommended|Context-specific|Not recommended).*?\\))?$', \n",
    "            r'#### RECOMMENDATION \\1: \\2', \n",
    "            text\n",
    "        )\n",
    "        \n",
    "        # Convert remarks sections\n",
    "        text = re.sub(r'(?m)^Remarks:$', r'##### Remarks:', text)\n",
    "        \n",
    "        return text\n",
    "\n",
    "class MedicalEvidenceExtractor(BaseDocumentTransformer):\n",
    "    \"\"\"Extract evidence levels and recommendation types from medical text.\"\"\"\n",
    "    \n",
    "    def __init__(self):\n",
    "        self.evidence_pattern = re.compile(r'(?:high|moderate|low|very\\s+low)(?:-|\\s+)(?:quality|certainty)\\s+evidence', re.IGNORECASE)\n",
    "        self.recommendation_type_pattern = re.compile(r'\\((Recommended|Context-specific recommendation|Not recommended).*?\\)')\n",
    "    \n",
    "    def transform_documents(\n",
    "        self, documents: List[Document], **kwargs\n",
    "    ) -> List[Document]:\n",
    "        \"\"\"Extract evidence levels and enhance document metadata.\"\"\"\n",
    "        for doc in documents:\n",
    "            # Only process if it's a recommendation\n",
    "            if doc.metadata.get('heading_type') == 'recommendation':\n",
    "                # Extract evidence level\n",
    "                evidence_match = self.evidence_pattern.search(doc.page_content)\n",
    "                if evidence_match:\n",
    "                    doc.metadata['evidence_level'] = evidence_match.group(0)\n",
    "                \n",
    "                # Extract recommendation type\n",
    "                rec_type_match = self.recommendation_type_pattern.search(doc.page_content)\n",
    "                if rec_type_match:\n",
    "                    doc.metadata['recommendation_type'] = rec_type_match.group(1)\n",
    "                \n",
    "                # Extract recommendation ID\n",
    "                rec_id_match = re.search(r'RECOMMENDATION\\s+([A-Z0-9\\.]+):', doc.page_content)\n",
    "                if rec_id_match:\n",
    "                    doc.metadata['recommendation_id'] = rec_id_match.group(1)\n",
    "        \n",
    "        return documents\n",
    "\n",
    "class TableExtractor(BaseDocumentTransformer):\n",
    "    \"\"\"Extract tables as separate documents with metadata.\"\"\"\n",
    "    \n",
    "    def transform_documents(\n",
    "        self, documents: List[Document], **kwargs\n",
    "    ) -> List[Document]:\n",
    "        \"\"\"Identify and mark table content.\"\"\"\n",
    "        table_pattern = re.compile(r'(Table\\s+\\d+[\\.:]?\\s+.*?)(?:\\n\\n|\\Z)', re.DOTALL)\n",
    "        \n",
    "        result_docs = []\n",
    "        for doc in documents:\n",
    "            # Find tables in the document\n",
    "            tables = table_pattern.findall(doc.page_content)\n",
    "            \n",
    "            # If tables found, create separate documents for them\n",
    "            if tables:\n",
    "                # Create a copy of the original document with tables removed\n",
    "                modified_content = doc.page_content\n",
    "                for table in tables:\n",
    "                    modified_content = modified_content.replace(table, \"\")\n",
    "                \n",
    "                # Add the modified document if it still has significant content\n",
    "                if len(modified_content.strip()) > 100:\n",
    "                    modified_doc = Document(\n",
    "                        page_content=modified_content,\n",
    "                        metadata=doc.metadata.copy()\n",
    "                    )\n",
    "                    result_docs.append(modified_doc)\n",
    "                \n",
    "                # Add each table as a separate document\n",
    "                for table in tables:\n",
    "                    if len(table.strip()) > 50:  # Skip very small tables\n",
    "                        table_doc = Document(\n",
    "                            page_content=table,\n",
    "                            metadata={\n",
    "                                **doc.metadata.copy(),\n",
    "                                \"chunk_type\": \"table\",\n",
    "                                \"parent_section_path\": doc.metadata.get(\"section_path\", [])\n",
    "                            }\n",
    "                        )\n",
    "                        result_docs.append(table_doc)\n",
    "            else:\n",
    "                # No tables, keep the original document\n",
    "                result_docs.append(doc)\n",
    "                \n",
    "        return result_docs\n",
    "\n",
    "class MedicalDocumentProcessor:\n",
    "    \"\"\"Process medical documents into semantically meaningful chunks.\"\"\"\n",
    "    \n",
    "    def __init__(\n",
    "        self, \n",
    "        chunk_size: int = 1000, \n",
    "        chunk_overlap: int = 200,\n",
    "        embedding_model_name: str = \"text-embedding-ada-002\",\n",
    "        db_directory: str = \"/data/user_data/vidhij2/medical_db/heirchical_chunking_rag\"\n",
    "    ):\n",
    "        self.chunk_size = chunk_size\n",
    "        self.chunk_overlap = chunk_overlap\n",
    "        self.embedding_model_name = embedding_model_name\n",
    "        self.db_directory = db_directory\n",
    "        # Initialize document processing pipeline\n",
    "        self.header_splitter = MedicalHeaderTextSplitter()\n",
    "        self.paragraph_splitter = RecursiveCharacterTextSplitter(\n",
    "            chunk_size=chunk_size,\n",
    "            chunk_overlap=chunk_overlap,\n",
    "            separators=[\"\\n\\n\", \"\\n\", \". \", \" \", \"\"]\n",
    "        )\n",
    "        self.evidence_extractor = MedicalEvidenceExtractor()\n",
    "        self.table_extractor = TableExtractor()\n",
    "        \n",
    "        # Initialize embedding model\n",
    "        self.embeddings = OpenAIEmbeddings(model=embedding_model_name)\n",
    "        index_path = os.path.join(db_directory, \"index.faiss\")\n",
    "        if os.path.exists(index_path):\n",
    "            self.db = FAISS.load_local(\n",
    "                folder_path=db_directory,\n",
    "                embeddings=self.embeddings,\n",
    "                allow_dangerous_deserialization=True\n",
    "            )\n",
    "        else:\n",
    "            self.db = None\n",
    "    \n",
    "    def _extract_document_metadata(self, text: str) -> Dict[str, str]:\n",
    "        \"\"\"Extract document-level metadata.\"\"\"\n",
    "        title = \"\"\n",
    "        doc_type = \"\"\n",
    "        \n",
    "        # Extract title from WHO document\n",
    "        title_match = re.search(r'(?:WHO|World Health Organization)\\s+(?:recommendations|guidelines)\\s+(?:on|for)\\s+([A-Za-z\\s\\-,]+)', text[:3000])\n",
    "        if title_match:\n",
    "            title = title_match.group(1).strip()\n",
    "            doc_type = \"WHO Guidelines\"\n",
    "            \n",
    "        # If no specific match, try to extract a general title\n",
    "        if not title:\n",
    "            title_match = re.search(r'^([A-Z][A-Za-z\\s\\-:,]+(?:Guidelines|Recommendations|Guidance))', text[:1000])\n",
    "            if title_match:\n",
    "                title = title_match.group(1).strip()\n",
    "                doc_type = \"Medical Guidelines\"\n",
    "        \n",
    "        return {\n",
    "            \"title\": title,\n",
    "            \"document_type\": doc_type\n",
    "        }\n",
    "    \n",
    "    def _build_section_path(self, doc: Document) -> List[str]:\n",
    "        \"\"\"Build the hierarchical section path for a document.\"\"\"\n",
    "        path = []\n",
    "        \n",
    "        # Add chapter if available\n",
    "        if 'chapter' in doc.metadata:\n",
    "            path.append(doc.metadata['chapter'])\n",
    "            \n",
    "        # Add section if available\n",
    "        if 'section' in doc.metadata:\n",
    "            path.append(doc.metadata['section'])\n",
    "            \n",
    "        # Add subsection if available\n",
    "        if 'subsection' in doc.metadata:\n",
    "            path.append(doc.metadata['subsection'])\n",
    "        \n",
    "        return path\n",
    "    \n",
    "    def process_text(self, text: str, source_name: str = \"\") -> List[Document]:\n",
    "        \"\"\"Process text into hierarchical chunks.\"\"\"\n",
    "        # Extract document metadata\n",
    "        doc_metadata = self._extract_document_metadata(text)\n",
    "        \n",
    "        # Add source information to metadata\n",
    "        if source_name:\n",
    "            doc_metadata[\"source\"] = source_name\n",
    "        \n",
    "        # Convert headers to markdown format for the splitter\n",
    "        md_text = self.header_splitter._add_md_header(text)\n",
    "        \n",
    "        # Split on headers\n",
    "        docs = self.header_splitter.split_text(md_text)\n",
    "        \n",
    "        # Extract evidence levels and recommendation metadata\n",
    "        docs = self.evidence_extractor.transform_documents(docs)\n",
    "        \n",
    "        # Extract tables\n",
    "        docs = self.table_extractor.transform_documents(docs)\n",
    "        \n",
    "        # Build section paths for each document\n",
    "        for doc in docs:\n",
    "            section_path = self._build_section_path(doc)\n",
    "            doc.metadata['section_path'] = section_path\n",
    "            \n",
    "            # Add document metadata\n",
    "            doc.metadata['document_title'] = doc_metadata.get('title', '')\n",
    "            doc.metadata['document_type'] = doc_metadata.get('document_type', '')\n",
    "            \n",
    "            # Determine chunk type if not already set\n",
    "            if 'chunk_type' not in doc.metadata:\n",
    "                if doc.metadata.get('heading_type') == 'recommendation':\n",
    "                    doc.metadata['chunk_type'] = 'recommendation'\n",
    "                elif doc.metadata.get('heading_type') == 'remarks':\n",
    "                    doc.metadata['chunk_type'] = 'remarks'\n",
    "                else:\n",
    "                    doc.metadata['chunk_type'] = 'text'\n",
    "        \n",
    "        # Further split large chunks while preserving metadata\n",
    "        final_docs = []\n",
    "        for doc in docs:\n",
    "            # Don't split recommendation or remarks sections\n",
    "            if doc.metadata.get('chunk_type') in ['recommendation', 'remarks', 'table']:\n",
    "                final_docs.append(doc)\n",
    "            else:\n",
    "                # Split text sections into smaller chunks\n",
    "                if len(doc.page_content) > self.chunk_size:\n",
    "                    smaller_chunks = self.paragraph_splitter.split_text(doc.page_content)\n",
    "                    for i, chunk in enumerate(smaller_chunks):\n",
    "                        chunk_doc = Document(\n",
    "                            page_content=chunk,\n",
    "                            metadata={\n",
    "                                **doc.metadata,\n",
    "                                'chunk_index': i,\n",
    "                                'total_chunks': len(smaller_chunks)\n",
    "                            }\n",
    "                        )\n",
    "                        final_docs.append(chunk_doc)\n",
    "                else:\n",
    "                    final_docs.append(doc)\n",
    "        \n",
    "        return final_docs\n",
    "    \n",
    "    def load_documents(self, input_path: str) -> List[Document]:\n",
    "        \"\"\"Load documents from file or directory.\"\"\"\n",
    "        documents = []\n",
    "        \n",
    "        if os.path.isdir(input_path):\n",
    "            # Process all files in directory\n",
    "            for filename in os.listdir(input_path):\n",
    "                file_path = os.path.join(input_path, filename)\n",
    "                if os.path.isfile(file_path):\n",
    "                    documents.extend(self._load_single_document(file_path))\n",
    "        else:\n",
    "            # Process single file\n",
    "            documents = self._load_single_document(input_path)\n",
    "        \n",
    "        return documents\n",
    "    \n",
    "    def _load_single_document(self, file_path: str) -> List[Document]:\n",
    "        \"\"\"Load and process a single document.\"\"\"\n",
    "        print(f\"Processing {file_path}...\")\n",
    "        \n",
    "        # Load the document\n",
    "        if file_path.lower().endswith('.pdf'):\n",
    "            loader = PyPDFLoader(file_path)\n",
    "            pages = loader.load()\n",
    "            text = \"\\n\\n\".join([page.page_content for page in pages])\n",
    "        else:\n",
    "            with open(file_path, 'r', encoding='utf-8') as f:\n",
    "                text = f.read()\n",
    "        \n",
    "        # Process the text\n",
    "        source_name = os.path.basename(file_path)\n",
    "        return self.process_text(text, source_name)\n",
    "    \n",
    "    def create_vector_store(self, documents: List[Document], collection_name: Optional[str] = None) :\n",
    "        \"\"\"Create a vector store from processed documents.\"\"\"\n",
    "        # Create Chroma DB with metadata\n",
    "        if collection_name is None:\n",
    "            collection_name = f\"medical_{uuid.uuid4().hex[:8]}\"\n",
    "        \n",
    "        # Create database directory if it doesn't exist\n",
    "        index_path = os.path.join(self.db_directory, collection_name)\n",
    "        os.makedirs(index_path, exist_ok=True)\n",
    "        \n",
    "        # Initialize FAISS index from documents\n",
    "        self.db = FAISS.from_documents(\n",
    "            documents=documents,\n",
    "            embedding=self.embeddings\n",
    "        )\n",
    "        \n",
    "        self.db.save_local(index_path)\n",
    "        # print(f\"Stored {len()} chunks in collection '{collection_name}'\")\n",
    "        \n",
    "        \n",
    "        return self.db\n",
    "\n",
    "    \n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Defaulting to user installation because normal site-packages is not writeable\n",
      "Collecting spacy\n",
      "  Using cached spacy-3.8.3-cp39-cp39-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (29.4 MB)\n",
      "Collecting weasel<0.5.0,>=0.1.0\n",
      "  Using cached weasel-0.4.1-py3-none-any.whl (50 kB)\n",
      "Collecting langcodes<4.0.0,>=3.2.0\n",
      "  Using cached langcodes-3.5.0-py3-none-any.whl (182 kB)\n",
      "Collecting thinc<8.4.0,>=8.3.0\n",
      "  Using cached thinc-8.3.4-cp39-cp39-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (3.7 MB)\n",
      "Collecting spacy-legacy<3.1.0,>=3.0.11\n",
      "  Using cached spacy_legacy-3.0.12-py2.py3-none-any.whl (29 kB)\n",
      "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from spacy) (4.67.1)\n",
      "Collecting cymem<2.1.0,>=2.0.2\n",
      "  Using cached cymem-2.0.11-cp39-cp39-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (208 kB)\n",
      "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from spacy) (0.15.2)\n",
      "Requirement already satisfied: setuptools in /usr/lib/python3.9/site-packages (from spacy) (53.0.0)\n",
      "Collecting spacy-loggers<2.0.0,>=1.0.0\n",
      "  Using cached spacy_loggers-1.0.5-py3-none-any.whl (22 kB)\n",
      "Collecting murmurhash<1.1.0,>=0.28.0\n",
      "  Using cached murmurhash-1.0.12-cp39-cp39-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl (124 kB)\n",
      "Requirement already satisfied: numpy>=1.19.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from spacy) (1.26.4)\n",
      "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from spacy) (2.32.3)\n",
      "Requirement already satisfied: packaging>=20.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from spacy) (24.2)\n",
      "Collecting wasabi<1.2.0,>=0.9.1\n",
      "  Using cached wasabi-1.1.3-py3-none-any.whl (27 kB)\n",
      "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /home/vidhij2/.local/lib/python3.9/site-packages (from spacy) (2.10.6)\n",
      "Collecting catalogue<2.1.0,>=2.0.6\n",
      "  Using cached catalogue-2.0.10-py3-none-any.whl (17 kB)\n",
      "Requirement already satisfied: jinja2 in /usr/local/lib/python3.9/site-packages (from spacy) (3.1.4)\n",
      "Collecting srsly<3.0.0,>=2.4.3\n",
      "  Using cached srsly-2.5.1-cp39-cp39-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (1.1 MB)\n",
      "Collecting preshed<3.1.0,>=3.0.2\n",
      "  Using cached preshed-3.0.9-cp39-cp39-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl (157 kB)\n",
      "Collecting language-data>=1.2\n",
      "  Using cached language_data-1.3.0-py3-none-any.whl (5.4 MB)\n",
      "Collecting marisa-trie>=1.1.0\n",
      "  Using cached marisa_trie-1.2.1-cp39-cp39-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (1.3 MB)\n",
      "Requirement already satisfied: pydantic-core==2.27.2 in /home/vidhij2/.local/lib/python3.9/site-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (2.27.2)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (0.7.0)\n",
      "Requirement already satisfied: typing-extensions>=4.12.2 in /home/vidhij2/.local/lib/python3.9/site-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (4.12.2)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/lib/python3.9/site-packages (from requests<3.0.0,>=2.13.0->spacy) (1.26.5)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/vidhij2/.local/lib/python3.9/site-packages (from requests<3.0.0,>=2.13.0->spacy) (2024.12.14)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/vidhij2/.local/lib/python3.9/site-packages (from requests<3.0.0,>=2.13.0->spacy) (3.4.1)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /usr/lib/python3.9/site-packages (from requests<3.0.0,>=2.13.0->spacy) (2.10)\n",
      "Collecting confection<1.0.0,>=0.0.1\n",
      "  Using cached confection-0.1.5-py3-none-any.whl (35 kB)\n",
      "Collecting blis<1.3.0,>=1.2.0\n",
      "  Using cached blis-1.2.0-cp39-cp39-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (11.5 MB)\n",
      "Requirement already satisfied: rich>=10.11.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from typer<1.0.0,>=0.3.0->spacy) (13.9.4)\n",
      "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.9/site-packages (from typer<1.0.0,>=0.3.0->spacy) (8.1.7)\n",
      "Requirement already satisfied: shellingham>=1.3.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from typer<1.0.0,>=0.3.0->spacy) (1.5.4)\n",
      "Requirement already satisfied: markdown-it-py>=2.2.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (3.0.0)\n",
      "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /home/vidhij2/.local/lib/python3.9/site-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (2.18.0)\n",
      "Requirement already satisfied: mdurl~=0.1 in /home/vidhij2/.local/lib/python3.9/site-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (0.1.2)\n",
      "Collecting cloudpathlib<1.0.0,>=0.7.0\n",
      "  Using cached cloudpathlib-0.21.0-py3-none-any.whl (52 kB)\n",
      "Collecting smart-open<8.0.0,>=5.2.1\n",
      "  Using cached smart_open-7.1.0-py3-none-any.whl (61 kB)\n",
      "Requirement already satisfied: wrapt in /home/vidhij2/.local/lib/python3.9/site-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy) (1.17.2)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib64/python3.9/site-packages (from jinja2->spacy) (3.0.2)\n",
      "Installing collected packages: catalogue, srsly, murmurhash, marisa-trie, cymem, wasabi, smart-open, preshed, language-data, confection, cloudpathlib, blis, weasel, thinc, spacy-loggers, spacy-legacy, langcodes, spacy\n",
      "\u001b[33m  WARNING: Value for scheme.platlib does not match. Please report this to <https://github.com/pypa/pip/issues/10151>\n",
      "  distutils: /home/vidhij2/.local/lib/python3.9/site-packages\n",
      "  sysconfig: /home/vidhij2/.local/lib64/python3.9/site-packages\u001b[0m\n",
      "\u001b[33m  WARNING: Additional context:\n",
      "  user = True\n",
      "  home = None\n",
      "  root = None\n",
      "  prefix = None\u001b[0m\n",
      "Successfully installed blis-1.2.0 catalogue-2.0.10 cloudpathlib-0.21.0 confection-0.1.5 cymem-2.0.11 langcodes-3.5.0 language-data-1.3.0 marisa-trie-1.2.1 murmurhash-1.0.12 preshed-3.0.9 smart-open-7.1.0 spacy-3.8.3 spacy-legacy-3.0.12 spacy-loggers-1.0.5 srsly-2.5.1 thinc-8.3.4 wasabi-1.1.3 weasel-0.4.1\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Semantic chunker"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List, Dict, Any, Optional, Tuple\n",
    "class SemanticMaternalHealthChunker:\n",
    "    \"\"\"Creates semantically meaningful chunks for maternal health documents.\"\"\"\n",
    "    \n",
    "    def __init__(self, spacy_model=\"en_core_web_md\"):\n",
    "        import spacy\n",
    "        # Load SpaCy for text processing\n",
    "        self.nlp = spacy.load(spacy_model)\n",
    "        \n",
    "        # Semantic boundary patterns\n",
    "        self.section_patterns = [\n",
    "            r'^(?:[0-9]+\\.){1,3}\\s+[A-Z]',           # Numbered sections (1.2.3 Title)\n",
    "            r'^[A-Z][A-Za-z\\s]+:',                    # Title with colon (Pregnancy Symptoms:)\n",
    "            r'^[A-Z][A-Za-z\\s]+ during [A-Za-z\\s]+',  # \"X during Y\" patterns\n",
    "            r'^(?:Table|Figure|Box)\\s+[0-9]+:',       # Tables and figures\n",
    "            r'^WARNING:',                              # Warning sections\n",
    "            r'^NOTE:'                                  # Note sections\n",
    "        ]\n",
    "        self.section_regex = re.compile('|'.join(f'({pattern})' for pattern in self.section_patterns), \n",
    "                                       re.MULTILINE)\n",
    "        \n",
    "        # Define semantic units we want to preserve\n",
    "        self.preservation_patterns = [\n",
    "            # Lists\n",
    "            r'(?:^[•\\-\\*]\\s+.+\\n){2,}',  \n",
    "            # Tables with multiple columns\n",
    "            r'(?:\\|.+\\|.+\\|.+\\n){2,}',\n",
    "            # Structured recommendations\n",
    "            r'Recommendation:[\\s\\S]+?(?:Evidence quality|Strength of recommendation)',\n",
    "            # Numbered steps/procedures\n",
    "            r'(?:^[0-9]+\\.\\s+.+\\n){2,}',\n",
    "            # Warning blocks\n",
    "            r'(?:Warning|Caution|Alert):[\\s\\S]+?(?:\\n\\n|\\Z)'\n",
    "        ]\n",
    "        self.preservation_regex = re.compile('|'.join(f'({pattern})' for pattern in self.preservation_patterns), \n",
    "                                            re.MULTILINE)\n",
    "        \n",
    "        # Topic keywords for maternal health\n",
    "        self.topic_keywords = {\n",
    "            'fetal_development': ['development', 'growth', 'fetal', 'foetal', 'baby', 'fetus'],\n",
    "            'maternal_changes': ['mother', 'maternal', 'body', 'changes', 'symptoms'],\n",
    "            'nutrition': ['diet', 'food', 'nutrition', 'eat', 'meal', 'vitamin'],\n",
    "            'warning_signs': ['danger', 'warning', 'risk', 'emergency', 'complication'],\n",
    "            'normal_variations': ['normal', 'common', 'usual', 'typical', 'variant', 'variation'],\n",
    "            'medical_tests': ['test', 'scan', 'ultrasound', 'screening', 'monitor'],\n",
    "            'delivery': ['birth', 'labor', 'labour', 'delivery', 'contractions'],\n",
    "            'postpartum': ['after birth', 'post-delivery', 'postpartum', 'post-natal', 'breastfeeding']\n",
    "        }\n",
    "    \n",
    "    def split_text_into_sections(self, text: str) -> List[str]:\n",
    "        \"\"\"Split text into semantically meaningful sections.\"\"\"\n",
    "        # Find all semantic boundaries\n",
    "        section_boundaries = [match.start() for match in self.section_regex.finditer(text)]\n",
    "        \n",
    "        if not section_boundaries:\n",
    "            # If no sections detected, return the whole text\n",
    "            return [text]\n",
    "        \n",
    "        # Add the start and end of text to boundaries\n",
    "        section_boundaries = [0] + section_boundaries + [len(text)]\n",
    "        \n",
    "        # Create sections based on boundaries\n",
    "        sections = []\n",
    "        for i in range(len(section_boundaries) - 1):\n",
    "            section_text = text[section_boundaries[i]:section_boundaries[i+1]].strip()\n",
    "            if section_text:\n",
    "                sections.append(section_text)\n",
    "        \n",
    "        return sections\n",
    "    \n",
    "    def find_preservation_blocks(self, text: str) -> List[Tuple[int, int, str]]:\n",
    "        \"\"\"Find blocks of text that should be preserved.\"\"\"\n",
    "        preserved_blocks = []\n",
    "        \n",
    "        for match in self.preservation_regex.finditer(text):\n",
    "            preserved_blocks.append((match.start(), match.end(), match.group(0)))\n",
    "        \n",
    "        return preserved_blocks\n",
    "    \n",
    "    def segment_by_semantic_boundaries(self, section: str, max_chunk_size: int = 1000) -> List[str]:\n",
    "        \"\"\"Split a section into semantic chunks respecting preserved blocks.\"\"\"\n",
    "        # Find blocks that should be preserved\n",
    "        preserved_blocks = self.find_preservation_blocks(section)\n",
    "        \n",
    "        # If section is short enough, return it as-is\n",
    "        if len(section) <= max_chunk_size and not preserved_blocks:\n",
    "            return [section]\n",
    "        \n",
    "        # Process text with SpaCy for sentence boundaries\n",
    "        doc = self.nlp(section)\n",
    "        sentences = list(doc.sents)\n",
    "        \n",
    "        # Create chunks respecting sentence boundaries and preserved blocks\n",
    "        chunks = []\n",
    "        current_chunk = []\n",
    "        current_length = 0\n",
    "        \n",
    "        i = 0\n",
    "        while i < len(sentences):\n",
    "            sentence = sentences[i]\n",
    "            # Check if this sentence is within a preserved block\n",
    "            in_preserved_block = False\n",
    "            for start, end, block_text in preserved_blocks:\n",
    "                if start <= sentence.start_char < end:\n",
    "                    # This sentence is part of a preserved block\n",
    "                    # Add the entire block as a chunk\n",
    "                    chunks.append(block_text)\n",
    "                    # Skip all sentences in this block\n",
    "                    while i < len(sentences) and sentences[i].start_char < end:\n",
    "                        i += 1\n",
    "                    in_preserved_block = True\n",
    "                    break\n",
    "            \n",
    "            if in_preserved_block:\n",
    "                # Continue to next sentence\n",
    "                continue\n",
    "            \n",
    "            # If not in a preserved block, process normally\n",
    "            sentence_text = sentence.text.strip()\n",
    "            \n",
    "            # If adding this sentence would exceed max size, create a new chunk\n",
    "            if current_length + len(sentence_text) > max_chunk_size and current_chunk:\n",
    "                chunks.append('\\n'.join(current_chunk))\n",
    "                current_chunk = []\n",
    "                current_length = 0\n",
    "            \n",
    "            # Add sentence to current chunk\n",
    "            current_chunk.append(sentence_text)\n",
    "            current_length += len(sentence_text)\n",
    "            i += 1\n",
    "        \n",
    "        # Add final chunk\n",
    "        if current_chunk:\n",
    "            chunks.append('\\n'.join(current_chunk))\n",
    "        \n",
    "        return chunks\n",
    "    \n",
    "    def identify_topics(self, text: str) -> List[str]:\n",
    "        \"\"\"Identify maternal health topics in the text.\"\"\"\n",
    "        text_lower = text.lower()\n",
    "        identified_topics = []\n",
    "        \n",
    "        for topic, keywords in self.topic_keywords.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                identified_topics.append(topic)\n",
    "        \n",
    "        return identified_topics\n",
    "    \n",
    "    def extract_pregnancy_stage(self, text: str) -> Dict[str, List]:\n",
    "        \"\"\"Extract pregnancy stages mentioned in the text.\"\"\"\n",
    "        # Week pattern (e.g., \"week 12\", \"12th week\", \"weeks 12-14\")\n",
    "        week_pattern = re.compile(r'(?:week|weeks)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+week', re.IGNORECASE)\n",
    "        \n",
    "        # Month pattern (e.g., \"month 3\", \"3rd month\", \"months 4-6\")\n",
    "        month_pattern = re.compile(r'(?:month|months)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+month', re.IGNORECASE)\n",
    "        \n",
    "        # Trimester pattern\n",
    "        trimester_pattern = re.compile(r'(first|second|third)\\s+trimester', re.IGNORECASE)\n",
    "        \n",
    "        stages = {\n",
    "            \"weeks\": [],\n",
    "            \"months\": [],\n",
    "            \"trimesters\": []\n",
    "        }\n",
    "        \n",
    "        # Extract weeks\n",
    "        for match in week_pattern.finditer(text):\n",
    "            week_str = match.group(1) or match.group(2)\n",
    "            if '-' in week_str:\n",
    "                start, end = map(int, week_str.split('-'))\n",
    "                stages[\"weeks\"].extend(list(range(start, end + 1)))\n",
    "            else:\n",
    "                stages[\"weeks\"].append(int(week_str))\n",
    "        \n",
    "        # Extract months\n",
    "        for match in month_pattern.finditer(text):\n",
    "            month_str = match.group(1) or match.group(2)\n",
    "            if '-' in month_str:\n",
    "                start, end = map(int, month_str.split('-'))\n",
    "                stages[\"months\"].extend(list(range(start, end + 1)))\n",
    "            else:\n",
    "                stages[\"months\"].append(int(month_str))\n",
    "        \n",
    "        # Extract trimesters\n",
    "        for match in trimester_pattern.finditer(text):\n",
    "            trimester = match.group(1).lower()\n",
    "            stages[\"trimesters\"].append(trimester)\n",
    "        \n",
    "        # Remove duplicates\n",
    "        for key in stages:\n",
    "            stages[key] = list(set(stages[key]))\n",
    "        \n",
    "        return stages\n",
    "    \n",
    "    def extract_medical_entities(self, text: str) -> Dict[str, List[str]]:\n",
    "        \"\"\"Extract medical entities from text using SpaCy.\"\"\"\n",
    "        doc = self.nlp(text)\n",
    "        \n",
    "        entities = {\n",
    "            \"conditions\": [],\n",
    "            \"medications\": [],\n",
    "            \"procedures\": [],\n",
    "            \"measurements\": []\n",
    "        }\n",
    "        \n",
    "        # Simple matching for common maternal health entities\n",
    "        condition_keywords = [\"preeclampsia\", \"eclampsia\", \"gestational diabetes\", \n",
    "                              \"anemia\", \"anaemia\", \"hypertension\", \"nausea\", \"vomiting\"]\n",
    "        \n",
    "        medication_keywords = [\"iron\", \"folate\", \"folic acid\", \"vitamin\", \"supplement\"]\n",
    "        \n",
    "        procedure_keywords = [\"ultrasound\", \"scan\", \"test\", \"screening\", \"amniocentesis\", \n",
    "                             \"delivery\", \"c-section\", \"cesarean\", \"caesarean\"]\n",
    "        \n",
    "        measurement_keywords = [\"weight\", \"blood pressure\", \"fundal height\", \"bp\", \"heart rate\"]\n",
    "        \n",
    "        # Extract entities using simple keyword matching\n",
    "        text_lower = text.lower()\n",
    "        \n",
    "        for condition in condition_keywords:\n",
    "            if condition in text_lower:\n",
    "                entities[\"conditions\"].append(condition)\n",
    "        \n",
    "        for medication in medication_keywords:\n",
    "            if medication in text_lower:\n",
    "                entities[\"medications\"].append(medication)\n",
    "        \n",
    "        for procedure in procedure_keywords:\n",
    "            if procedure in text_lower:\n",
    "                entities[\"procedures\"].append(procedure)\n",
    "        \n",
    "        for measurement in measurement_keywords:\n",
    "            if measurement in text_lower:\n",
    "                entities[\"measurements\"].append(measurement)\n",
    "        \n",
    "        # Extract named entities from SpaCy\n",
    "        for ent in doc.ents:\n",
    "            if ent.label_ == \"CONDITION\" and ent.text.lower() not in entities[\"conditions\"]:\n",
    "                entities[\"conditions\"].append(ent.text.lower())\n",
    "            elif ent.label_ == \"MEDICATION\" and ent.text.lower() not in entities[\"medications\"]:\n",
    "                entities[\"medications\"].append(ent.text.lower())\n",
    "            elif ent.label_ == \"PROCEDURE\" and ent.text.lower() not in entities[\"procedures\"]:\n",
    "                entities[\"procedures\"].append(ent.text.lower())\n",
    "        \n",
    "        return entities\n",
    "    \n",
    "    def create_semantic_chunks(self, text: str, metadata: Dict = None) -> List[Document]:\n",
    "        \"\"\"Create semantically meaningful chunks from text.\"\"\"\n",
    "        if metadata is None:\n",
    "            metadata = {}\n",
    "        \n",
    "        # Split text into sections\n",
    "        sections = self.split_text_into_sections(text)\n",
    "        \n",
    "        # Process each section into chunks\n",
    "        documents = []\n",
    "        \n",
    "        for section in sections:\n",
    "            # Extract section title\n",
    "            section_title = \"\"\n",
    "            first_line = section.split('\\n')[0].strip()\n",
    "            if re.match(r'^[0-9\\.]+\\s+|^[A-Z][A-Za-z\\s]+:', first_line):\n",
    "                section_title = first_line\n",
    "            \n",
    "            # Create semantic chunks from section\n",
    "            chunks = self.segment_by_semantic_boundaries(section)\n",
    "            \n",
    "            for i, chunk in enumerate(chunks):\n",
    "                # Skip empty chunks\n",
    "                if not chunk.strip():\n",
    "                    continue\n",
    "                \n",
    "                # Extract semantic metadata\n",
    "                topics = self.identify_topics(chunk)\n",
    "                pregnancy_stages = self.extract_pregnancy_stage(chunk)\n",
    "                medical_entities = self.extract_medical_entities(chunk)\n",
    "                \n",
    "                # Determine chunk type\n",
    "                chunk_type = \"general_text\"\n",
    "                if any(marker in chunk.lower() for marker in [\"warning\", \"caution\", \"danger\"]):\n",
    "                    chunk_type = \"warning\"\n",
    "                elif any(marker in chunk.lower() for marker in [\"recommendation\", \"advised\", \"should\"]):\n",
    "                    chunk_type = \"recommendation\"\n",
    "                elif re.search(r'(?:\\|.+\\|.+\\|.+\\n){2,}', chunk) or re.search(r'Table\\s+[0-9]+:', chunk):\n",
    "                    chunk_type = \"table\"\n",
    "                elif re.search(r'(?:^[•\\-\\*]\\s+.+\\n){2,}', chunk):\n",
    "                    chunk_type = \"list\"\n",
    "                \n",
    "                # Create document with metadata\n",
    "                chunk_metadata = {\n",
    "                    **metadata,\n",
    "                    \"section_title\": section_title,\n",
    "                    \"chunk_index\": i,\n",
    "                    \"total_chunks_in_section\": len(chunks),\n",
    "                    \"chunk_type\": chunk_type,\n",
    "                    \"topics\": topics,\n",
    "                    \"pregnancy_stages\": pregnancy_stages,\n",
    "                    \"medical_entities\": medical_entities,\n",
    "                    \"contains_warning\": \"warning\" in chunk_type or any(warning in chunk.lower() \n",
    "                                                                     for warning in [\"warning\", \"caution\", \"danger\"]),\n",
    "                    \"contains_recommendation\": \"recommendation\" in chunk_type or any(rec in chunk.lower() \n",
    "                                                                                   for rec in [\"recommend\", \"advised\", \"should\"])\n",
    "                }\n",
    "                \n",
    "                # Create document\n",
    "                doc = Document(\n",
    "                    page_content=chunk,\n",
    "                    metadata=chunk_metadata\n",
    "                )\n",
    "                \n",
    "                documents.append(doc)\n",
    "        \n",
    "        return documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "class MaternalHealthDocumentProcessor(MedicalDocumentProcessor):\n",
    "    \"\"\"Enhanced processor specifically for maternal health documents.\"\"\"\n",
    "    \n",
    "    def __init__(\n",
    "        self,\n",
    "        chunk_size: int = 1000, \n",
    "        chunk_overlap: int = 200,\n",
    "        embedding_model_name: str = \"text-embedding-ada-002\",\n",
    "        db_directory: str = \"maternal_health_db\"\n",
    "    ):\n",
    "        super().__init__(chunk_size, chunk_overlap, embedding_model_name, db_directory)\n",
    "        self.semantic_chunker = SemanticMaternalHealthChunker()\n",
    "        # Pregnancy stage detection\n",
    "        self.stage_patterns = {\n",
    "            'weeks': re.compile(r'(?:week|weeks)\\s+(\\d+(?:-\\d+)?)', re.IGNORECASE),\n",
    "            'months': re.compile(r'(?:month|months)\\s+(\\d+(?:-\\d+)?)', re.IGNORECASE),\n",
    "            'trimesters': re.compile(r'(first|second|third)\\s+trimester', re.IGNORECASE)\n",
    "        }\n",
    "        \n",
    "        # Key maternal health topics\n",
    "        self.topic_keywords = {\n",
    "            'fetal_development': ['development', 'growth', 'fetal', 'foetal', 'baby', 'fetus'],\n",
    "            'maternal_changes': ['mother', 'maternal', 'body', 'changes', 'symptoms'],\n",
    "            'nutrition': ['diet', 'food', 'nutrition', 'eat', 'meal', 'vitamin'],\n",
    "            'warning_signs': ['danger', 'warning', 'risk', 'emergency', 'complication'],\n",
    "            'normal_variations': ['normal', 'common', 'usual', 'typical', 'variant', 'variation']\n",
    "        }\n",
    "        \n",
    "    def _extract_pregnancy_stage(self, text: str) -> Dict[str, Any]:\n",
    "        \"\"\"Extract pregnancy stage information from text.\"\"\"\n",
    "        stages = {\n",
    "            'weeks': [],\n",
    "            'months': [],\n",
    "            'trimesters': []\n",
    "        }\n",
    "        \n",
    "        # Extract weeks\n",
    "        for match in self.stage_patterns['weeks'].finditer(text.lower()):\n",
    "            week_range = match.group(1)\n",
    "            if '-' in week_range:\n",
    "                start, end = map(int, week_range.split('-'))\n",
    "                stages['weeks'].extend(list(range(start, end + 1)))\n",
    "            else:\n",
    "                try:\n",
    "                    stages['weeks'].append(int(week_range))\n",
    "                except ValueError:\n",
    "                    pass\n",
    "        \n",
    "        # Extract months\n",
    "        for match in self.stage_patterns['months'].finditer(text.lower()):\n",
    "            month_range = match.group(1)\n",
    "            if '-' in month_range:\n",
    "                start, end = map(int, month_range.split('-'))\n",
    "                stages['months'].extend(list(range(start, end + 1)))\n",
    "            else:\n",
    "                try:\n",
    "                    stages['months'].append(int(month_range))\n",
    "                except ValueError:\n",
    "                    pass\n",
    "        \n",
    "        # Extract trimesters\n",
    "        for match in self.stage_patterns['trimesters'].finditer(text.lower()):\n",
    "            trimester = match.group(1).lower()\n",
    "            if trimester not in stages['trimesters']:\n",
    "                stages['trimesters'].append(trimester)\n",
    "        \n",
    "        return stages\n",
    "    \n",
    "    def _identify_topics(self, text: str) -> List[str]:\n",
    "        \"\"\"Identify maternal health topics in the text.\"\"\"\n",
    "        text_lower = text.lower()\n",
    "        identified_topics = []\n",
    "        \n",
    "        for topic, keywords in self.topic_keywords.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                identified_topics.append(topic)\n",
    "        \n",
    "        return identified_topics\n",
    "    \n",
    "    def process_text(self, text: str, source_name: str = \"\") -> List[Document]:\n",
    "        \"\"\"Enhanced processing for maternal health documents.\"\"\"\n",
    "        # Process using the parent method first\n",
    "        # docs = super().process_text(text, source_name)\n",
    "        \n",
    "        # # Enhance with maternal health specific metadata\n",
    "        # for doc in docs:\n",
    "        #     # Extract pregnancy stage information\n",
    "        #     stages = self._extract_pregnancy_stage(doc.page_content)\n",
    "        #     doc.metadata['pregnancy_stages'] = stages\n",
    "            \n",
    "        #     # Identify relevant topics\n",
    "        #     topics = self._identify_topics(doc.page_content)\n",
    "        #     doc.metadata['maternal_topics'] = topics\n",
    "            \n",
    "        #     # Flag content with medical advice or warnings\n",
    "        #     if any(warning_term in doc.page_content.lower() for warning_term in \n",
    "        #            ['warning', 'caution', 'danger', 'emergency', 'seek', 'consult']):\n",
    "        #         doc.metadata['contains_warnings'] = True\n",
    "            \n",
    "        #     # Flag normal variations content\n",
    "        #     if any(normal_term in doc.page_content.lower() for normal_term in \n",
    "        #            ['normal', 'common', 'typically', 'usually', 'generally']):\n",
    "        #         doc.metadata['discusses_normal_variations'] = True\n",
    "        doc_metadata = self._extract_document_metadata(text)\n",
    "        \n",
    "        # Add source information to metadata\n",
    "        if source_name:\n",
    "            doc_metadata[\"source\"] = source_name\n",
    "        \n",
    "        # Convert headers to markdown format for the splitter\n",
    "        # md_text = self.header_splitter._add_md_header(text)\n",
    "        \n",
    "        # Split on headers\n",
    "        # docs = self.header_splitter.split_text(md_text)\n",
    "        docs = self.semantic_chunker.create_semantic_chunks(text, doc_metadata)\n",
    "        \n",
    "        # Extract evidence levels and recommendation metadata\n",
    "        docs = self.evidence_extractor.transform_documents(docs)\n",
    "        \n",
    "        # Extract tables\n",
    "        docs = self.table_extractor.transform_documents(docs)\n",
    "        \n",
    "        \n",
    "        return docs\n",
    "        \n",
    "    def create_specialized_chunks(self, docs: List[Document]) -> List[Document]:\n",
    "        \"\"\"Create specialized maternal health chunks for improved retrieval.\"\"\"\n",
    "        specialized_chunks = []\n",
    "        \n",
    "        # Group documents by pregnancy stage\n",
    "        stage_groups = {}\n",
    "        \n",
    "        for doc in docs:\n",
    "            # Process week-specific chunks\n",
    "            for week in doc.metadata.get('pregnancy_stages', {}).get('weeks', []):\n",
    "                key = f\"week_{week}\"\n",
    "                if key not in stage_groups:\n",
    "                    stage_groups[key] = []\n",
    "                stage_groups[key].append(doc)\n",
    "            \n",
    "            # Process month-specific chunks\n",
    "            for month in doc.metadata.get('pregnancy_stages', {}).get('months', []):\n",
    "                key = f\"month_{month}\"\n",
    "                if key not in stage_groups:\n",
    "                    stage_groups[key] = []\n",
    "                stage_groups[key].append(doc)\n",
    "            \n",
    "            # Process trimester-specific chunks\n",
    "            for trimester in doc.metadata.get('pregnancy_stages', {}).get('trimesters', []):\n",
    "                key = f\"trimester_{trimester}\"\n",
    "                if key not in stage_groups:\n",
    "                    stage_groups[key] = []\n",
    "                stage_groups[key].append(doc)\n",
    "        \n",
    "        # Create specialized chunks for each stage group\n",
    "        for stage_key, stage_docs in stage_groups.items():\n",
    "            # Group by topics within stage\n",
    "            topic_contents = {}\n",
    "            \n",
    "            for doc in stage_docs:\n",
    "                for topic in doc.metadata.get('maternal_topics', []):\n",
    "                    if topic not in topic_contents:\n",
    "                        topic_contents[topic] = []\n",
    "                    topic_contents[topic].append(doc.page_content)\n",
    "            \n",
    "            # Create specialized chunks for each topic in this stage\n",
    "            for topic, contents in topic_contents.items():\n",
    "                if len(contents) >= 2:  # Only create specialized chunks if we have multiple sources\n",
    "                    specialized_chunk = Document(\n",
    "                        page_content=\"\\n\\n\".join(contents[:3]),  # Limit to avoid too-large chunks\n",
    "                        metadata={\n",
    "                            'chunk_type': 'specialized',\n",
    "                            'stage_key': stage_key,\n",
    "                            'topic': topic,\n",
    "                            'source_count': len(contents),\n",
    "                            'is_synthesized': True\n",
    "                        }\n",
    "                    )\n",
    "                    specialized_chunks.append(specialized_chunk)\n",
    "        \n",
    "        return specialized_chunks\n",
    "    \n",
    "    def create_vector_store(self, documents: List[Document], collection_name: Optional[str] = None):\n",
    "        \"\"\"Create enhanced vector store with specialized chunks.\"\"\"\n",
    "        # Create specialized chunks\n",
    "        specialized_chunks = self.create_specialized_chunks(documents)\n",
    "        \n",
    "        # Add specialized chunks to the document set\n",
    "        all_docs = documents + specialized_chunks\n",
    "        \n",
    "        # Create the vector store with all documents\n",
    "        return super().create_vector_store(all_docs, collection_name)\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "processor = MaternalHealthDocumentProcessor(\n",
    "        chunk_size=1000,\n",
    "        chunk_overlap=200\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting en-core-web-md==3.8.0\n",
      "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_md-3.8.0/en_core_web_md-3.8.0-py3-none-any.whl (33.5 MB)\n",
      "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m33.5/33.5 MB\u001b[0m \u001b[31m85.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n",
      "\u001b[?25hInstalling collected packages: en-core-web-md\n",
      "Successfully installed en-core-web-md-3.8.0\n",
      "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
      "You can now load the package via spacy.load('en_core_web_md')\n"
     ]
    }
   ],
   "source": [
    "!python3 -m spacy download en_core_web_md"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "documents = processor.load_documents(\"/home/vidhij2/nivi/test_docs\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='i\\nScreening for Syphilis  \\nDuring Pregnancy\\nTechnical &  \\nOperational Guidelines\\nMaternal Health Division \\nMinistry of Health & Family Welfare \\nGovernment of India \\nDecember 2014'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='SCREENING FOR\\nDURING PREGNANCY\\n\\nDesigned and printed with support from UNFPA\\nDesigned by: Rouge Communications, New Delhi\\nE-mail: rougecommunications@gmail.com\\n\\nMaternal Health Division \\nMinistry of Health & Family Welfare \\nGovernment of India \\nDecember 2014\\nSCREENING FOR\\nDURING PREGNANCY\\n\\n\\n\\nAs part of national and international commitments, India is steadfast in its \\nresolve to reduce the Maternal Mortality Ratio (MMR) by 75 percent of its 1990 \\nlevels i.e. about 560 deaths per 100,000 live births to 140 deaths per 100,000 \\nlive births by the year 2015.\\nGoing by the past trends in reduction of MMR, \\nIndia seems to be on the right track, and we hope to reach the MDG-5 target \\nfor our country by the end of next year.\\nHowever, we need to capitalize on the ground gained and consolidate what we \\nhave achieved.\\nPost 2015, the world will focus on achieving the Sustainable \\nDevelopment Goals (SDGs).'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='International discussions on SDGs clearly bring \\nout that not only do we need to continue working on reducing MMR to much \\nlower levels; we also need to focus on maternal morbidities that have an \\nadverse effect on not just the health of the mother but also on the foetus.\\nInfectious diseases such as Syphilis have the potential of being transmitted \\nfrom mother to child and also increase the risk of perinatal and neonatal \\nmortality.\\nCongenital Syphilis can be eliminated by the sincere implementation \\nof these guidelines.\\nThese guidelines are being brought out at a very opportune moment, addressing \\na need that is being felt not just at the national but at the global level.\\nI am \\nconfident that these guidelines will become an integral part of the antenatal \\ncare package and that states will take up the implementation of this initiative \\nwith full vigour and commitment.\\nLov Verma\\nHkkjr ljdkj \\nLokLF; ,oa ifjokj'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 2, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['hypertension'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='dY;k.k foHkkx \\nLokLF; ,oa ifjokj dY;k.k ea=ky;\\nyo oekZ \\nlfPko\\nGovernment of India \\nDepartment of Health & Family Welfare \\nMinistry of Health & Family Welfare \\nLov Verma \\nSecretary\\nPreface\\n\\nIndia is witnessing significant changes in the health sector.\\nImprovements \\nin the health systems with respect to infrastructure, personnel, and financial \\nallocations are already showing impact in terms of reductions in maternal and \\nchild mortality rates.\\nThe proportion of maternal deaths attributable to direct \\nobstetric causes is declining, because interventions to tackle causes such as \\nhaemorrhage, pregnancy induced hypertension etc. are being implemented.\\nAs we move forward toward achieving our national and international \\ncommitments, it becomes imperative to address the challenges of shifting \\nburden of disease, where now we see a greater proportion of maternal deaths \\nattributable to indirect causes such as infections.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 3, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes', 'warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Whilst we need to continue \\nour efforts for tackling obstetric complications, we also need to initiate work on \\nmanaging indirect causes that put a substantial proportion of our mothers and \\nchildren at risk.\\nSyphilis is one such infection for which mother to child transmission is one of \\nthe known routes for spread of the disease.\\nEarly and timely identification of \\npregnant women who have this infection, through use of simple diagnostic tests \\nis important to initiate the needed management in positive cases.\\nThis will not \\nonly prevent congenital transmission of the infection, but will also improve the \\nhealth of the mother.\\nI would like to congratulate the Maternal Health Division in framing these \\nguidelines with the help of NACO, institutional experts and development \\npartners.\\nThese guidelines are the first step towards managing this infection which cause \\nsignificant maternal and neonatal mortality and morbidity.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 4, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='I am hopeful that all \\nhealth personnel will take cognizance of these new guidelines and incorporate \\nscreening for this infection as an integral component of the antenatal care \\npackage.\\nC.K. Mishra\\nHkkjr ljdkj \\nLokLF; ,oa ifjokj\\ndY;k.k ea=ky; \\nfuekZ.k Hkou] ubZ fnYyh & 110011\\nGovernment of India \\nMinistry of Health & Family Welfare \\nNirman Bhavan, New Delhi - 110011\\nC.K Mishra, IAS\\nAdditional Secretary & \\nMission Director, NHM'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23061066, 23063809', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': ['weight']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Telefax : 23061066, 23063809 \\nE-mail : asmd-mohfw@nic.in\\nForeword\\n\\nPersons affected with sexually transmitted infection like syphilis form a \\nsubstantive proportion of our population, including pregnant women.\\nThese \\ninfections can easily be transmitted from mother to child.\\nTheir occurrence \\nduring pregnancy poses a risk to the health of not just the mother, but also that \\nof the newborn child.\\nPregnancies in many of the infected mothers end in spontaneous abortion, \\nlow birth weight babies or babies with severe infection.\\nUnlike many neonatal \\ninfections, congenital syphilis is preventable.\\nThe WHO has set a goal of \\neliminating congenital syphilis and urges countries to undertake appropriate \\npublic health measures such as antenatal screening and treatment of infected \\npregnant women to prevent this transmission.\\nDiagnostic tests for syphilis screening are relatively simple and cost effective.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23061066, 23063809', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Starting with point-of-care testing kits, these guidelines present detailed \\nalgorithms on the steps to be taken for confirmation and management of these \\ninfections once the pregnant woman is found to be positive on the basis of the \\nscreening tests.\\nIt is hoped that universal application of these simple screening \\ntests will go a long way in reducing the burden of syphilis and soon eliminate it.\\nThe guidelines have been prepared by Maternal Health Division with the active \\nsupport of NACO, institutional experts and development partners.\\nThese \\nguidelines aim to facilitate the State and District Programme OWfficers for \\neffective implementation.\\nDr. Rakesh Kumar\\nHkkjr ljdkj \\nLokLF; ,oa ifjokj\\ndY;k.k ea=ky; \\nfuekZ.k Hkou] ubZ fnYyh & 110011\\nGovernment of India \\nMinistry of Health & Family Welfare \\nNirman Bhavan, New Delhi - 110011\\nDr. RAKESH KUMAR, I.A.S'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Joint Secretary  \\nTelefax : 23061723 \\nE-mail : rk1992uk@gmail.com \\nE-mail : rkumar92@hotmail.com\\nForeword\\n\\nIn 2005, Ministry of Health and Family Welfare, Government of India, released \\nthe Guidelines for Skilled Attendance at Birth by ANMs and LHVs.\\nThis marked \\na paradigm shift in programming for improving maternal health as not only did \\nwe move away from the previous strategy of training traditional birth attendants, \\nbut, more importantly, ANMs and staff nurses were given the legal rights to \\nperform certain life saving interventions and administer life saving drugs in \\nclearly defined conditions and obstetric complications, which would otherwise \\nhave had an adverse impact on the mother’s health, including causing death in \\nextreme circumstances.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='These landmark changes, coupled with skill building \\nof human resource on the same and improved infrastructure, has resulted in \\nincreasing numbers of safe deliveries at public health facilities and reductions \\nin maternal mortality due to common obstetric complications.\\nEven though that work is far from over, and we need to continue to maintain \\nfocus on the direct obstetric causes of maternal mortality, data is beginning \\nto show an increasing proportions of non-obstetric causes and pre-existing \\nconditions as causes of maternal deaths.\\nsyphilis is one such infection which \\nhas an adverse impact on the health of the mother and the foetus.\\nsyphilis \\ninfection in the mother carries the risk of congenital transmission which can \\naffect the health of the newborn, in the immediate and long-term.\\nHkkjr ljdkj \\nLokLF; ,oa ifjokj'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 2, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='dY;k.k ea=ky; \\nfuekZ.k Hkou] ubZ fnYyh & 110011\\nGovernment of India \\nMinistry of Health & Family Welfare \\nNirman Bhavan, New Delhi - 110011\\nDr. H. BHUSHAN\\nDeputy Commissioner (MH)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 0, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content=\"Telefax : 23062930 \\nE-mail : drhbhushan@gmail.com\\nProgramme Officer's Message\\n\\nI would like to express that these guidelines would not have been possible \\nwithout the constant encouragement from Mr. C.K Mishra, AS & MD &  \\nMs Anuradha Gupta, Ex AS & MD.\\nDr. Rakesh Kumar, Joint Secretary \\n(RMNCH+A) headed the expert group meeting and gave valuable inputs in \\nframing this guideline.\\nI would like to acknowledge the contribution of all members of the Expert \\nGroup in developing the content of these technical and operational guidelines.\\nI would also like to acknowledge my colleagues in MH Division especially  \\nDr. Dinesh Baswal, DC (MH) and development partners for their valuable \\nefforts and inputs in developing this document.\\nI am extremely hopeful, that these guidelines, along with the others, will usher \\nin a new era of maternal health care in the country, where in every pregnancy \\nthe mother and child is protected not just from potential mortality, but also from \\ndebilitating illnesses.\"),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 1, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Dr Himanshu Bhushan\\n\\nx\\nScreening for Syphilis\\nDuring Pregnancy\\nList of Contributors\\n1 Shri C. K. Mishra AS & MD (NHM), MoHFW\\n2 Dr. Rakesh Kumar JS (RMNCH+A), MoHFW\\n3 Dr. Himanshu Bhushan DC (I/c MH), MoHFW\\n4 Dr. Dinesh Baswal    DC (MH), MoHFW\\n5 Dr. Manisha Malhotra DC (MH), MoHFW\\n6 Dr. Pratima Mittal Prof. & Head, Dept of Obstetrics & \\nGynaecology, VMMC & Safdarjung Hospital, \\nNew Delhi\\n7 Dr. M.K. Mittal Sr. Specialist / Consultant Radiologist, \\nSafdarjung Hospital, New Delhi\\n8 Dr. Bhartendu Kumar Assoc.\\nProf. of Surgery, SKMCH, Muzaffarpur\\n9 Dr. Ratna Kumar Chennai, Ex HoD, Institute of Obstetrics & \\nGynaecology, Chennai, Tamil Nadu\\n10 Dr. K. Kolanda Swamy Director Public Health, Govt. of TN, Chennai\\n11 Dr. Ragini Mehrotra HOD, Obstetrics & Gyneacology, AIIMS \\nBhopal\\n12 Dr. Sudhir Gupta Prof & Head, Dept of Gastroenterology, GMC \\n& Super-speciality Hospital,\\nNagpur\\n13 Dr. Somesh Gupta Assoc. Prof., Department of Dermatology & \\nVenereology, AIIMS, New Delhi\\n14 Dr. Suneeta Mittal Sr.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 2, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Consutant - Obstetrics & gynaecology, \\nFortis Hospital, Gurgaon\\n15 Dr. Archana Mishra DD (MH), GoMP\\n16 Dr. Aman Kumar Singh Technical Expert STI, NACO\\n17 Dr. Suchitra Pandit President, FOGSI\\n18 Dr. Achala Batra Dept. of Obstetrics & Gynaecology, Safdarjung \\nHospital, New Delhi\\n19 Dr. P.R. Deo UNFPA State Program Coordinator, Bhopal, \\nMadhya Pradesh\\n\\nxi\\nScreening for Syphilis\\nDuring Pregnancy\\n20 Dr. Anchita Patil National Programme Officer, UNFPA,  \\nNew Delhi\\n21 Dr. Pushkar Kumar Lead Consultant, MH, MoHFW\\n22 Dr. Rajeev Agarwal Senior Mgt.\\nConsultant, MH, MoHFW\\n23 Dr. Ravinder Kaur\\nSenior Consultant, MH, MoHFW\\n24 Dr. Gulfam Ahmed Hashmi Regional Coordinator, NRU, MoHFW\\n25 Dr. Ashish Chakraborty Regional Coordinator, NRU, MoHFW\\n26\\nMr. Prasanth K. S.     Senior Consultant, PHA Division, NHSRC\\n27\\nDr. Neelima Singh Faculty, Indian Institute of Health and Family \\nWelfare, Hyderabad\\n28 Dr. Nomita Chandiok ICMR\\n29'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 3, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Dr. Raja Mahendra Radiologist, Daga Hospital, Nagpur\\n30 Dr. Charu Lata Mahorkar Obstetrician & Gynaecologist, Nagpur\\n31 Dr. Arunabh Ray BTAST, Patna\\n32 Mr Shridhar Pandit Programme Officer, NRHM, Govt. of \\nMaharashtra\\n33 Dr Gorakh Gopalkrishna \\nMandrupkar\\nJoint Secretary, FOGSI\\n34\\nSharmila G. Neogi Maternal Health Specialist, USAID India \\n35 Dr. M. Naina Rani National Consultant PPTCT\\nWHO\\n36 Dr. Tarun Singh Sodha Consultant, MH, MoHFW\\n37 Dr. Sudhir Maknikar National RMNCH+A Expert, JSI\\nMGIMS Team\\n38'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 4, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Dr. B.S. Garg Secretary, KHS, MGIMS, Sevagram\\n39 Dr. Poonam Varma Shiv \\nKumar \\nProf. and Head, Dept. of Obstetrics & \\nGynaecology, MGIMS, Sevagram\\n40 Dr. Manjiri Ramteke Podder Assistant Prof., Dept of Obstetrics & \\nGynaecology, MGIMS, Sevagram\\n\\nxii\\nScreening for Syphilis  \\nDuring Pregnancy\\nList of Acronyms \\nANC Antenatal Care\\nART Antiretroviral Therapy\\nASHA Accredited Social Health Activist \\nCBO Community-based Organization\\nCMIS Computerized Management Information System\\nCS Congenital Syphilis\\nDSRC'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 5, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes', 'warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Designated STI/RTI Clinics\\nePTCT Elimination of Parent-to-Child Transmission \\nECS Elimination of Congenital Syphilis\\nEIA Enzyme Immunoassay\\nELISA Enzyme-linked Immunosorbent Assay\\nFSW Female Sex Worker\\nFTA-ABS Fluorescent Treponemal Antibody Absorption Test\\nHIV Human Immunodeficiency Virus\\nHMIS Health Management Information System\\nHRG High Risk Groups (for HIV)\\nHSS HIV Sentinel Surveillance\\nICS/ICT Immuno Chromatographic Strip (test)\\nICTC Integrated Counselling and Testing Centres\\nIEC Information Education and Communication\\nIg Immunoglobulin\\nF-ICTC Facility Integrated Counselling and Testing Centres\\nINGO International Non-governmental Organization\\nJSSK Janani Shishu Suraksha Karyakram\\n\\nxiii\\nScreening for Syphilis  \\nDuring Pregnancy\\nRMNCH+A Reproductive, Maternal, New Born, Child Health and  \\nAdolescent Health\\nMCTS Mother and Child Tracking System\\nMDGs Millennium Development Goals\\nMSM Men who have Sex with Men\\nMSW Male Sex Worker\\nMTCT Mother-to-Child Transmission \\nNGO Non-governmental Organization\\nNACO National AIDS Control Organisation\\nNACP National AIDS Control Programme\\nNHM National Health Mission\\nPCR Polymerase Chain Reaction\\nPPTCT Prevention of Parent-to-Child Transmission \\nRPR Test Rapid Plasma Reagin (Test)\\nRTI Reproductive Tract Infection\\nSEAR South-East Asia Region\\nSEARO South East Asia Regional Office (WHO)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 6, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='SRH Sexual and Reproductive Health\\nSTI Sexually Transmitted Infection\\nTPHA Treponema Pallidum Haemagglutination Assay\\nTP IgM Treponema Pallidum IgM Enzyme-linked Immunosorbent Assay\\nTPPA Treponema Pallidum Particle Agglutination Assay\\nVDRL Venereal Disease Research Laboratory (Test)\\nWHO World Health Organization\\n\\n\\n\\nIntroduction\\n1\\nCHAPTER\\n2\\nCHAPTER\\n3\\nCHAPTER\\n4\\nCHAPTER\\nTechnical Guidelines on Testing & \\nManagement of Syphilis\\nProtocol for Investigation & Management \\nof Syphilis\\nOperational Plan for Investigation and \\nManagement of Syphilis\\n02\\n05\\n08\\n17\\n29\\n37References\\nAnnexures\\nAnnexure – 1: Anaphylaxis Management \\nAnnexure – 2: Technical Specifications of Rapid Plasma  \\n Reagin (RPR) Test Kits for Syphilis Testing \\nAnnexure – 3: Technical Specifications of Treponemal-'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 7, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='specific Rapid (point-of-care) Diagnostic \\n Test for Syphilis \\nAnnexure – 4: Referral Slip \\nAnnexure – 5: Migration Form for Pregnant Women  \\n with Syphilis \\nAnnexure – 6: Monthly Syphilis Reporting Format for \\n State & District Programme Managers \\nAnnexure – 7: Monthly Syphilis Reporting Format for \\n Health Facility\\n\\n2\\nScreening for Syphilis  \\nDuring Pregnancy\\nIntroduction\\nSyphilis is a sexually transmitted infection caused by  \\nthe spirochaete bacterium Treponema Pallidum, \\nsubspecies Pallidum.\\nThe primary route of transmission \\nis through sexual contact; it may also be transmitted from \\nmother to foetus during pregnancy or at birth resulting in \\ncongenital syphilis.\\nThe signs and symptoms of syphilis vary depending on \\nwhich of the four stages it presents (primary, secondary, \\nlatent and tertiary).'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 8, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='The primary stage classically presents \\nwith a single chancre (a firm, painless, non-itchy skin \\nulceration); secondary syphilis with a diffuse rash which \\nfrequently involves the palms of the hands and soles of the \\nfeet; latent syphilis with little to no symptoms and tertiary \\nsyphilis with gummas, neurological or cardiac symptoms.\\n1.1  Disease Burden\\nData on the incidence and prevalence of STI in the South-\\nEast Asia Region (SEAR) are limited.\\nWHO estimates \\napproximately 600,000 pregnant women are infected with \\nsyphilis and 230,000 associated adverse outcomes occur \\nevery year in the SEAR.\\n1\\nCHAPTER\\n\\n3\\nScreening for Syphilis  \\nDuring Pregnancy\\nSyphilis in pregnancy is an under-recognized problem that carries a \\nsignificant public health and economic burden.\\nIt is estimated that there are \\n12 million people infected worldwide, with more than 90% of these cases \\nbeing from the developing countries.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 9, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Each year nearly 1.5 million pregnant \\nwomen around the world are infected with active syphilis.\\nDue to widespread \\navailability of Penicillin in the 1940s there was dramatic decrease in the rates \\nof infection, which have again increased since the turn of the millennium \\nin many countries, often in combination with HIV infection.\\nThis has been \\nattributed partly to unsafe sexual practices and decreasing use of condoms.\\nIn the 2010–11 round of HIV sentinel surveillance, the average serological \\nprevalence of syphilis (qualitative test result) among ANC attendees of 696 \\nselected ANC sites was 0.38%.\\nArunachal Pradesh (2.86%) has shown the \\nhighest prevalence of syphilis followed by West Bengal (1.91%), Rajasthan \\n(1.17%), Punjab (0.95%), Meghalaya (0.90%), Madhya Pradesh (0.66%), \\nAndaman Nicobar Island, Uttar Pradesh and Tripura (0.63%) and  \\nOdisha (0.62%).'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 10, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': ['weight']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1.2  Impact on the Millennium Development Goals \\n(MDGs) \\nWith 2015 approaching, international and national focus is on achieving the \\nMillennium Development Goals (MDGs).\\nScreening for and management of \\nsyphilis during pregnancy is the next step forward by the Government of India \\n(GoI) in achieving MDGs 4, 5, 6.\\nScreening and \\nmanagement of \\nsyphilis will result in \\nreduced incidence \\nof low birth weight \\n(LBW), perinatal \\ndeaths and congenital \\nsyphilis\\nReduction in the \\nincidence of stillbirth \\nand spontaneous \\nabortions will result in \\nimproved pregnancy \\noutcomes and \\nreduced maternal \\nmorbidity.\\nReduction in co-\\nmorbidities like HIV \\nwill occur due to \\nimproved behaviours \\nfollowing counselling\\n\\n4\\nScreening for Syphilis  \\nDuring Pregnancy\\n1.3  Consequences of Syphilis\\nThe global estimate of adverse outcomes of syphilis in pregnancy in 2008 \\nwas about 520,000.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 11, 'total_chunks_in_section': 19, 'chunk_type': 'recommendation', 'topics': ['fetal_development', 'maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Of this large number, early foetal deaths/stillbirths are \\n215,000; neonatal deaths 90,000; pre-term/LBW 65,000 and congenital \\ndiseases 150,000.\\nAn estimated 96% of maternal syphilis infection and 98% \\nof adverse outcomes occurred in low and middle-income countries.\\nFrom \\n2008 to 2012, maternal syphilis infections and adverse pregnancy outcomes \\ndeclined by 33%; however the pace of decline needs to be accelerated.\\n1.4  Need for National Guidelines\\nAs syphilis is known to cause adverse outcomes in pregnant women and \\nnewborns, these guidelines offer clear technical recommendations and \\noperational framework for screening pregnant women and managing them \\nwhen detected positive.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 12, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5\\nScreening for Syphilis  \\nDuring Pregnancy\\nTechnical Guidelines on \\nTesting and Management of \\nSyphilis During Pregnancy\\n2.1  Goal \\nTo reduce maternal and newborn morbidity and mortality \\nand move towards detection and treatment of maternal \\nsyphilis and elimination of congenital syphilis.\\n2.2  Objectives\\n Ʋ To ensure early screening of all pregnant women for \\nsyphilis, preferably in the first trimester;\\n Ʋ To detect and manage syphilis infection in pregnant \\nwomen and their partners;\\n Ʋ To ensure institutional delivery at (FRUs/higher level \\ninstitutions) of all syphilis-positive pregnant women; \\n Ʋ To prevent the transmission of syphilis from mother  \\nto child.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 13, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2\\nCHAPTER\\n\\n6\\nScreening for Syphilis  \\nDuring Pregnancy\\n2.3   Target Population\\n Ʋ All pregnant women and their newborns\\n Ʋ Partners of syphilis-positive pregnant women\\n2.4  Prerequisites for Testing and Management  \\nof Syphilis\\n Ʋ Availability of Point-of-Care (POC) testing at Sub-centres (SC) and \\noutreach sessions such as Village Health and Nutrition Days (VHNDs) \\n Ʋ Availability of POC test at any other facility where rapid plasma reagin \\n(RPR) testing is not available, including at centres where deliveries are \\nconducted\\n Ʋ Availability of RPR testing facility at all the health facilities above sub-\\ncentre\\n Ʋ All commodities and human resource for management of syphilis, \\nrelevant to the level of facility\\n » Availability of drugs, injectables and consumables required for the \\nmanagement of maternal and congenital syphilis\\n »'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 14, 'total_chunks_in_section': 19, 'chunk_type': 'recommendation', 'topics': ['warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='An emergency kit containing essential drugs, injections and supplies \\nfor managing anaphylactic shock\\n » Trained human resource to provide the management to pregnant \\nwomen after they test positive for syphilis\\n » Appropriate referral linkages to First Referral Units (FRU)/ Emergency \\nObstetric Care (EmOC) centers for conducting the delivery of syphilis-\\npositive pregnant women\\n » Availability of Ob-Gyn and pediatrician is mandatory at such FRUs\\n2.5  Selection of Facilities\\n Ʋ States are free to choose the number of districts where the programme \\nwill be implemented\\n Ʋ Once a district is chosen, implementation of the programme should \\nbe universal in all health care institutions in that district, right from the \\nmedical college to the sub-centre\\n Ʋ All health care facilities in the selected district should have all the relevant \\nprerequisites in place\\n Ʋ'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 15, 'total_chunks_in_section': 19, 'chunk_type': 'recommendation', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='The service providers and programme officer must be well oriented and \\ntrained regarding the programme\\n\\n7\\nScreening for Syphilis  \\nDuring Pregnancy\\n2.6  Steps for Implementation\\n Ʋ A Government order/policy decision on implementation of the programme \\nshould be issued by the State\\n Ʋ Testing and treatment for syphilis to be declared as an integral part of the \\nessential ANC package\\n Ʋ Orientation and training of all programme officers and service providers \\ninvolved in the programme\\n Ʋ Availability of test kits, consumables, drugs and other logistics, as \\nrelevant at health care facilities in the district identified for rolling out the \\nprogramme\\n Ʋ Adequate information education and communication (IEC) /interpersonal'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 16, 'total_chunks_in_section': 19, 'chunk_type': 'recommendation', 'topics': ['medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='communication (IPC) for generating awareness\\n Ʋ Availability of different formats, records, registers and other requisite \\nMonitoring and Evaluation (M&E) tools for documentation, data collection, \\ncollation and for review and evaluation of the programme\\n Ʋ Provision of adequate budget and timely release to the implementing \\ninstitutions\\n\\n8\\nScreening for Syphilis\\nDuring Pregnancy\\nProtocol for Investigation and \\nManagement of Syphilis\\n Ʋ All pregnant women should be tested for syphilis in \\nthe first ANC visit itself, which should be as early as \\npossible, by a POC test at the sub-centre level or at \\nany other facility where the woman visits for ANC, \\nwhere laboratory facilities for RPR are not available, \\nirrespective of her previous syphilitic status.\\nƲ Those women who go for ANC check-up at health care \\nfacilities where testing for RPR is available should be \\ntested by RPR method (qualitative and quantitative).'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 17, 'total_chunks_in_section': 19, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ Ideally, all women who test positive for syphilis \\nthrough POC should undergo testing by RPR also \\nfor confirmation of diagnosis and assessment of the \\nantibody titres.\\nThe latter is important not just for \\nensuring appropriate treatment for the woman but also \\nfor deciding on the line of treatment for the newborn.\\nƲ Those found positive either by POC or RPR should \\nbe treated for maternal syphilis as per the defined \\ntreatment protocol explained in this guideline.\\nƲ Women who are at high risk for syphilis (see box on \\nthe adjacent page), those who live in areas of high \\nprevalence of syphilis, those who have had adverse \\noutcomes of pregnancy previously or those who were \\nuntested earlier, should be screened again in the third \\ntrimester or at the time of delivery.\\nƲ Testing of spouse/partner of syphilis-positive women \\nshould be mandatory followed by treatment as per \\nprotocol for those found positive.\\n3\\nCHAPTER\\n\\n9\\nScreening for Syphilis'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telefax : 23062930', 'chunk_index': 18, 'total_chunks_in_section': 19, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='During Pregnancy\\nPregnant women considered to be at high risk for acquiring \\nSTIs, including Syphilis: \\n ◘ Women with current or past history of STI\\n ◘ Women with more than one sexual partner\\n ◘ Sex workers \\n ◘ Injecting drug users'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ensure readiness of emergency tray for management of \\nanaphylactic reactions:\\n ◘\\nThe tray should be kept in the day-care room.\\n◘\\nEvery morning the tray should be checked for replenishment of used \\ndrugs and for expiry dates of drugs on the tray.\\n◘ List of drugs and consumables that should always be available on the \\ntray:\\nInj Adrenaline, Inj Chlorpheniramine Maleate, Inj Dexamethasone, \\nInj Hydrocortisone succinate, Inj Deriphylline, Inj Furosemide, \\nInj Dopamine, Inj Sodium bicarbonate, Oxygen, Ringer Lactate, \\ndisposable needles, gloves, cotton swabs.\\n3.1  Treatment Regimen for Syphilis-positive Pregnant \\n       Women and their Partners\\n3.1.1  Treatment of maternal syphilis\\nAlthough severe allergy to penicillin is rare, the provider should rule \\nout history of allergy before administering penicillin.\\nThe emergency \\ndrugs for managing anaphylaxis should be kept ready prior to \\nadministering penicillin (see Anaphylaxis Management at Annexure 1).\\ni.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [3], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='In the early stage (primary and secondary syphilis of <2 years’ \\nduration; RPR titre< 1:8 approximately), a single intramuscular \\ninjection of 2.4 million IU benzathine benzyl penicillin is sufficient.\\nii.\\nIn the late stage (tertiary > 2 years or unknown duration, RPR \\ntitre>1:8 approximately), a total of three intramuscular injections of \\n2.4 million IU benzathine benzyl penicillin once a week for 3 weeks \\nneed to be given.\\nƲ For all syphilis-positive women detected during ANC by either POC or \\nRPR, their newborns should be tested by RPR.\\nƲ All newborns showing four-fold rise in titre compared to that of mother’s \\ntitre need to be hospitalized to initiate penicillin treatment for 10 days.\\n10'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Screening for Syphilis  \\nDuring Pregnancy\\nImportant facts about penicillin use:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Facts about benzathine penicillin injection:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['nutrition', 'warning_signs', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Facts about benzathine penicillin injection:\\n ◘ Benzathine penicillin injection is the only effective treatment for \\npreventing congenital syphilis, perinatal deaths, stillbirths and preterm \\ndeliveries in pregnant women with syphilis.\\n ◘ A study undertaken by Tais F Galvio, Lori M. Newman et al. (Feb \\n2013 Journal PLOS ONE) states that no case of serious adverse \\nreactions to benzathine penicillin injection was reported in pregnant \\nwomen and the incidence was very low in the general population.\\n ◘ Incidence of adverse reactions in pregnant women treated with \\nbenzathine penicillin injection for preventing congenital syphilis in \\nstudies conducted between 1954 and 2012 have shown only one \\ncase of skin rash.\\n ◘ Benefits of benzathine penicillin injection outweigh the risks of \\nadverse reactions.\\nTherefore, fears regarding use of benzathine penicillin injection among \\ndoctors should be dispelled.\\nAlternative Regimen for Penicillin-allergic Pregnant women'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Key points:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Key points: \\n ý\\nFor the treatment of syphilis during pregnancy, NO PROVEN \\nALTERNATIVES TO PENICILLIN exist.\\ný All infants of pregnant women treated with a non-penicillin regimen should \\nbe treated at birth as if mother was not sufficiently treated.\\ný\\nAlternative to penicillin should be considered ONLY for those syphilis-\\npositive pregnant women who have a history of severe penicillin allergy \\n(e.g. anaphylaxis).\\ný Erythromycin estolate is contraindicated because of drug-related \\nhepatotoxicity.\\nOnly erythromycin base or erythromycin ethyl succinate \\nshould be used.\\nThe partner or spouse should be treated with the same regimen.\\nRegimen 1                       \\n ◘ Early-stage syphilis: \\nErythromycin, 500 mg orally, \\n4 times daily for 15 days \\n ◘ Late-stage syphilis: \\nErythromycin, 500 mg orally, \\n4 times daily for 30 days\\nRegimen 2\\nPrimary syphilis (syphilitic \\nchancre): Azithromycin, 2 g \\norally as a single dose\\nOR\\n\\n11\\nScreening for Syphilis'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Key points:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [24, 6], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='During Pregnancy\\n3.1.2  Follow-up\\nFollow-up should be done during postnatal care (PNC) visits and in addition,  \\nat 6 months and 24 months after the treatment is administered.\\nFlowchart 1'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Syphilis screening of pregnant women using POC test and treatment of \\nmaternal syphilis at health care settings without laboratory support\\nCriteria for repeat test:     \\n ◘ Pregnant women considered to be at high risk for acquiring STI (those with current or past history of \\nSTI, women with more than one sexual partner, sex workers and injecting drug users);\\n ◘ Pregnant women with history of repeated abortions, stillbirths, past history of delivery of premature \\nbabies, preterm babies and neonatal deaths;\\n ◘ Women living in areas of high prevalence of syphilis;\\n ◘ Testing at the time of delivery will also be required to detect re-infection, particularly in those syphilis- \\npositive women whose partners were not treated;'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'First visit: ANC', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition', 'warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='First visit: ANC \\nregistration - by ANM at \\nSC, VHND etc.\\nScreen pregnant woman for \\nSyphlis using Point-of-Care \\n(POC) test\\nPregnant woman \\nfound syphilis reactive\\nPregnant woman found \\nsyphilis non-reactive\\nRetest high risk \\npregnant women* in \\nthird trimester or soon \\nafter delivery\\nPregnant woman \\nfound syphilis reactive\\nRefer to nearest \\nPHC/CHC/DH\\nRepeat RPR titre after delivery and \\nassess infant for appropriate treatment'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '1. Immediately treat pregnant woman', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Immediately treat pregnant woman'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '2. Conduct a qualitative and', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Conduct a qualitative and   \\n quantitative RPR/VDRL test.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '3. Test and treat the spouse / partner', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Test and treat the spouse / partner\\n\\n12\\nScreening for Syphilis  \\nDuring Pregnancy\\nFlowchart 2'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Algorithm for syphilis screening of pregnant women and treatment of \\nmaternal syphilis at health care settings with laboratory support\\nCriteria for repeat test:     \\n ◘ Pregnant women considered to be at high risk for acquiring STI (those with current or past \\nhistory of STI, women with more than one sexual partner, sex workers and injecting drug \\nusers) \\n ◘ Pregnant women with history of repeated abortions, stillbirths, past history of delivery of \\npremature babies, preterm babies and neonatal deaths\\n ◘ Women living in areas of high prevalence of syphilis\\n ◘ Testing at the time of delivery will also be required to detect re-infection, particularly in those \\nsyphilis-positive women whose partners were not treated.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'First visit: ANC registration', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition', 'warning_signs', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='First visit: ANC registration \\nat PHC or higher facility\\nScreen pregnant woman for \\nsyphilis using RPR/VDRL test \\n(qualitative & quantitative)\\nPregnant woman \\nfound syphilis reactive\\nPregnant woman found \\nsyphilis non-reactive\\nRetest high-risk* pregnant \\nwoman in third trimester \\nor soon after delivery\\nPregnant woman \\nfound syphilis reactive \\nin late third trimesterRepeat RPR/VDRL titre after \\ndelivery and assess infant \\nfor appropriate treatment'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '1. Immediately treat', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Immediately treat  \\npregnant woman'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '2. Conduct a quantitative and', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Conduct a quantitative and \\nqualitative RPR/VDRL test.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '3. Test and treat the spouse / partner', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Test and treat the spouse / partner\\n\\n13\\nScreening for Syphilis  \\nDuring Pregnancy\\nFlowchart 3\\nAlgorithm for syphilis screening of pregnant women coming directly in \\nlabour and treatment of maternal syphilis\\nPregnant woman \\ncoming directly in labour\\nScreen pregnant woman for \\nsyphlis using POC test\\nPregnant woman \\nfound syphilis reactive\\nPregnant woman found \\nsyphilis non-reactive\\nConduct a qualitative and \\nquantitative RPR/VDRL after delivery \\nfor both the mother and the newborn \\nfor comparing the antibody titre \\nlevels of the mother and the neonate'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '1. Immediately treat the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Immediately treat the  \\npregnant woman'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '2. Test and treat the spouse/partner', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Test and treat the spouse/partner\\n\\n14\\nScreening for Syphilis  \\nDuring Pregnancy\\n3.2 Neonatal Syphilis\\n3.2.1  Case Definitions \\nSuspected case of congenital syphilis\\nA stillborn or live-born baby of syphilis-reactive mother who has been \\ninadequately treated\\nConfirmed case of congenital syphilis\\nA live born child with serum quantitative RPR titre that is four-fold \\nhigher than the mother’s titre\\nOR\\nA child within first 2 years of life with clinical evidence of syphilis and \\nreactive syphilis serology irrespective of mother’s serology\\n3.2.2  Signs and Symptoms of Congenital Syphilis\\nCongenital syphilis may be asymptomatic, especially in the first few \\nweeks of life, in about 50% of cases.\\nUsually symptoms appear in the \\nfirst few months, but the clinical manifestations may be delayed until \\nthe second year of life.\\nThe most frequent clinical signs of congenital syphilis at birth are \\nhepatosplenomegaly (33% –100%), bone changes seen on x-ray \\nFig.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '2. Test and treat the spouse/partner', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['nutrition', 'normal_variations', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': ['weight']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1: Radiograph showing \\nlower end of humerus (with \\nperiostitis) and proximal \\nends of radius and ulna (with \\nmetaphysitis)\\n(75%–100%) (Fig.1), blistering \\nskin rash especially on palms \\nand soles (40%) (Fig.2), fever \\n(16%), low birth weight (10%–\\n40%), bleeding (10%), swelling \\nof the joints, abnormal facies, \\nsnuffles, oedema, abdominal \\ndistension, pallor, respiratory \\ndistress and pseudo-paralysis.\\nAn older child may have \\nstigmata (e.g. interstitial \\nkeratitis, nerve deafness, \\nanterior bowing of shins, frontal \\nbossing, mulberry molars, \\nHutchinson teeth, saddle nose, \\nrhagades, or Clutton joints).\\n15\\nScreening for Syphilis  \\nDuring Pregnancy\\nFig.\\n2: Blistering skin rash in neonates\\n3.3.3  Management of Congenital Syphilis \\nRegimen 1 (Prophylactic Treatment)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All asymptomatic babies who meet ALL the following criteria:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'delivery'], 'pregnancy_stages': {'weeks': [4], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='All asymptomatic babies who meet ALL the following criteria:\\n ◘ Have no serological evidence of syphilis and \\n ◘ Are born to mothers who were adequately treated for maternal \\nsyphilis with penicillin during the current pregnancy and\\n ◘ The mother has received the treatment at least 4 weeks prior  \\nto delivery'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Should be treated with a single dose of prophylactic penicillin:', 'chunk_index': 0, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [4], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Should be treated with a single dose of prophylactic penicillin: \\nBenzathine penicillin G 50,000 units/kg given as a single intramuscular \\ninjection.\\nRegimen 2 (Curative Treatment)\\nThis should be given to\\n ý All symptomatic babies (newborns and older)\\n ý\\nAll asymptomatic babies- \\nAsymptomatic newborns\\n ◘ Born to mothers who were treated with penicillin less than 4 \\nweeks before delivery\\n ◘\\nBorn to mothers who were treated with non-penicillin regimens \\n(erythromycin or azithromycin) during pregnancy \\n ◘ Born to mothers whose treatment status is unknown or \\nundocumented\\n\\n16\\nScreening for Syphilis\\nDuring Pregnancy\\nAsymptomatic infant/child\\n ◘\\nWhose RPR/VDRL titre is four-fold higher than that of the \\nmother at or after delivery \\n ◘\\nBorn to mothers with clinical evidence of syphilis\\n ◘ With a reactive syphilis IgM antibody test\\n ◘\\nBorn to mothers who did not complete the recommended \\ncourse of penicillin during pregnancy \\n ◘'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Should be treated with a single dose of prophylactic penicillin:', 'chunk_index': 1, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': ['weight']}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Born to mothers whose RPR/VDRL titres had not  \\ndropped four-fold\\nIntravenous (IV) treatment regimen \\nAqueous crystalline penicillin\\nG 100,000–150,000 million units/kg/day \\nintravenously.\\nIt could be given as 50,000 units/kg/dose IV every 12 hours \\nduring the first 7 days, and thereafter every 8 hours for 3 days to complete a \\ntotal of 10 days of treatment.\\nOR\\nIntramuscular (IM) treatment regimen \\n Ʋ Procaine penicillin 50,000 units/kg body weight intramuscularly as a \\nsingle daily dose for 10 days; \\n Ʋ Alternatively, benzathine penicillin G 50,000 units/kg IM in a single dose \\nHospitalization of the infant should be considered in order to ensure the full \\ncourse of treatment.\\nIf more than one day of treatment is missed, the \\nentire course of treatment should be restarted.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Should be treated with a single dose of prophylactic penicillin:', 'chunk_index': 2, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [24, 6], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='3.3.4  Follow-up\\nFollow-up should be done during PNC visits as well as at 6 months \\nand 24 months after the treatment is received.\\n\\n17\\nScreening for Syphilis  \\nDuring Pregnancy\\nOperational Plan for \\nInvestigation and \\nManagement of Syphilis\\n Ʋ\\nThe programme manager for the state should collect \\nthe data for the estimated number of pregnancies from \\neach of the districts and direct the district programme \\nmanager to ensure that all pregnant women attending \\nANC clinics at government health care facilities receive \\nscreening for syphilis, preferably as part of the first \\nANC visit itself.\\nƲ In the district, about 60% to 70% of the total estimated \\npregnancies will avail ANC screening from government \\nhealth care facilities (Sub-centre, PHC, CHC, Sub-\\ndivisional Hospital, District Hospital, Medical College, \\netc.).\\nƲ The programme manager at the district will estimate \\nthe caseloads per health care facility based on HMIS \\ndata.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Should be treated with a single dose of prophylactic penicillin:', 'chunk_index': 3, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ The programme manager will ensure that kits and \\nconsumables for syphilis screening are available based \\non the type of health care facility.\\nƲ Pregnant women will be screened as mentioned in the \\nalgorithm charts.\\n4\\nCHAPTER\\n\\n18\\nScreening for Syphilis\\nDuring Pregnancy\\n4.1  Awareness Generation at the Community Level\\nAll health care workers and professionals should generate awareness in the \\ncommunity about the importance of screening for syphilis in the antenatal \\nperiod by using various IEC methods and strategies including IPC.\\n4.2  Human Resources Involved\\nSpecialists, medical officers, laboratory technicians and other health care \\nworkers across different levels of health care facilities; no additional human \\nresources need to be recruited to implementing these guidelines.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Should be treated with a single dose of prophylactic penicillin:', 'chunk_index': 4, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='4.3  Role and Responsibilities – Defined by Levels of \\nHealth Care Facilities\\n4.3.1  Village:\\n Ʋ Generate awareness among pregnant women regarding the \\nimportance of routine ANC highlighting the importance of screening \\nfor syphilis during early pregnancy.\\nƲ Mobilize pregnant women to attend VHND/sub-centre as per the \\nANC registrations list for getting routine ANC and investigations.\\nƲ If the pregnant woman is syphilis-positive, ASHA should ensure \\nher treatment, testing and treatment of spouse/partner, delivery \\nin an FRU or higher facility through birth planning and prompt \\ninvestigation and treatment of the newborn.\\nƲ Enlist family support as it is required for testing and for ensuring \\ntreatment if the woman is found to be syphilis-positive.\\n4.3.2  Level I: Sub-centre/VHND\\n Ʋ Conduct ANC and testing for syphilis by POC test along with other \\nmandatory tests during ANC.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Should be treated with a single dose of prophylactic penicillin:', 'chunk_index': 5, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ If the pregnant woman is reactive to the POC test, she should be \\nreferred to PHC/CHC/Sub-divisional Hospital/District Hospital for \\ntreatment and RPR.\\nƲ Her spouse/partner should be encouraged to get tested and seek \\ntreatment if found positive.\\nƲ The ANM will record the test results in the MCP card and RCH \\nregister.\\nƲ All positive cases should be followed up for treatment.\\nƲ The test kit should be kept in the refrigerator to maintain the \\ntemperature at 2°C to 8°C.\\n19\\nScreening for Syphilis  \\nDuring Pregnancy\\n Ʋ If a refrigerator is not available at the sub-centre, then the kits \\nshould be kept at the PHC to maintain cold chain, and be brought \\nto the VHND or outreach sessions while ensuring that cold chain is \\nmaintained.\\n4.3.3  Level II: PHC/Corresponding urban centre'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All the jobs assigned above plus the following:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='All the jobs assigned above plus the following:\\n Ʋ RPR test has to be performed by the laboratory technician. In the \\nabsence of a laboratory technician, a staff nurse will do the POC \\ntest and refer syphilis-positive pregnant woman to the Medical \\nOfficer or to a higher centre for treatment and RPR test. \\n Ʋ The MO will provide treatment by using the standard treatment \\nprotocol for syphilis.\\n Ʋ The MO will also monitor the treatment/investigation required for \\nsyphilis-positive cases and refer to an FRU/higher level centre for \\nfurther medical management, if required and conduction of delivery \\nby the specialist. \\n4.3.4  Level III\\nA) DH and All CEmOC Centres'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All jobs as defined under Level II plus the following:', 'chunk_index': 0, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [3], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='All jobs as defined under Level II plus the following:\\n Ʋ Ob-Gyn to conduct the delivery of syphilis-positive pregnant \\nwomen\\n Ʋ Paediatricians to provide care to the newborn of a syphilis-\\npositive mother \\nB) Medical College and Other Super-speciality Centres\\nComprehensive management of all cases needing treatment of syphilis \\nincluding all referral cases\\n4.4  Roles and Responsibilities Defined by Cadre of \\nHealth Worker\\n4.4.1  District RCH Officer/State RCH Officer\\n Ʋ Plan the roll-out of syphilis testing among pregnant women\\n Ʋ Ensure that all facilities have adequate supply of test kits, \\nconsumables and drugs for at least 3 months\\n Ʋ Calculate the health facility-wise case load for sending the supplies \\nin advance as per consumption pattern\\n\\n20\\nScreening for Syphilis\\nDuring Pregnancy\\n Ʋ Coordinate with CMHO/Civil surgeon, State RCH Officer, DPMU \\nand DAPCU to strengthen service delivery in the field\\n Ʋ Monitor the programme to ensure:\\n »'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All jobs as defined under Level II plus the following:', 'chunk_index': 1, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='The storage of all supplies is in accordance with the \\nmanufacturer’s instructions\\n »\\nThe required drugs are part of the Essential Drugs List (EML)\\n »\\nTraining of all the health staff\\n » All the reporting units provide report on screening and treatment \\nof pregnant women for syphilis in HMIS\\n4.4.2  ANM/Staff Nurse\\n Ʋ Increase awareness among pregnant women regarding syphilis \\nscreening\\n Ʋ Register all pregnant women for ANC and screen for syphilis using \\nthe POC test during first ANC visit\\n Ʋ Maintain the ANC register, including record of syphilis test results.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All jobs as defined under Level II plus the following:', 'chunk_index': 2, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Ʋ Refer syphilis-positive pregnant women to higher health care \\nfacility for confirmation and treatment\\n Ʋ Follow-up syphilis-positive women and their newborns for \\ntreatment\\n Ʋ Assist/prepare HMIS and other relevant reports \\n4.4.3  Laboratory Technician\\n Ʋ Conduct syphilis testing test for all pregnant women visiting the \\nPHC and higher centres for ANC\\n Ʋ Maintain the laboratory register\\n Ʋ Store test kits as per guidelines\\n Ʋ Refer syphilis-positive pregnant women for treatment \\n Ʋ\\nKeep records\\n Ʋ Testing blood of newborns\\n4.4.4  Medical Officer\\n Ʋ Provide treatment to all the syphilis-positive women, \\n Ʋ Test and treat their spouse/partner \\n Ʋ Refer the syphilis-positive pregnant women to an FRU for \\ndelivery,and further testing\\n\\n21\\nScreening for Syphilis  \\nDuring Pregnancy'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All jobs as defined under Level II plus the following:', 'chunk_index': 3, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Ʋ Conduct follow-up test after treatment as per guidelines\\n Ʋ Follow-up of patient management \\n Ʋ Manage the cases of anaphylaxis if any occur\\n Ʋ Check for correctness of reporting \\n4.4.5  In-charge of DSRC (Designated STI/RTI Clinic)\\nDSRCs are mainly located at district hospitals\\n Ʋ Maintain the inventory and stock registers of drugs and test kits\\n Ʋ Build capacity of all new STI counsellors\\n Ʋ Sensitize the PHC- MOs and ANMs/ASHAs on updates of  \\nthe programme\\n Ʋ Provide mentoring and supportive supervisory visits to \\nhealth facilities\\n Ʋ At the STI clinic counselling of pregnant women and laboratory \\nreferral for testing\\n Ʋ Counselling all ANC attendees and partners coming to the ANC \\nclinic and referring to the laboratory for screening/confirmation  \\nof syphilis\\n4.4.6  Paediatrician/Gynaecologist\\n Ʋ Provide delivery services to all pregnant women who test positive \\nfor syphilis\\n Ʋ Help in assessing the antibody titres in the newborn’s blood by \\ndrawing blood from the neonate’s cubital vein and sending it to the \\nlaboratory technician for testing by RPR\\n Ʋ Provide treatment for the newborn and infant of a syphilis-positive \\nmother\\n Ʋ Provide comprehensive care to a syphilis-positive mother and  \\nher newborn\\n\\n22\\nScreening for Syphilis'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All jobs as defined under Level II plus the following:', 'chunk_index': 4, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'medical_tests', 'delivery', 'postpartum'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='During Pregnancy\\n4.5 Capacity Building of Human Resource\\n4.5.1 Training Needs for Different Cadres\\nCadre of  \\nHealth Care \\nFunctionary Type of Training Content of Training\\nASHA General \\norientation about \\nthe programme\\nOrientation on \\n ▪ Syphilis disease burden, consequences \\nfor pregnant women and neonates\\n ▪ IEC material on awareness \\nANM/LHV/SN Knowledge and \\nskills about POC \\nscreening test for \\nsyphilis\\nThe training for ASHAs, plus\\n ▪ POC testing technique\\n ▪ Interpreting POC test results\\n ▪ Referral required when the test is positive\\n ▪ Technique of testing \\nsensitivity of penicillin\\n ▪ Maintenance of records and \\ndifferent reporting formats\\nLaboratory \\ntechnician\\nKnowledge and \\nskills about RPR \\nand POC test for \\nsyphilis\\nThe training for ANMs plus\\n ▪ POC testing techniques\\n ▪ RPR testing techniques – \\nqualitative and quantitative\\n ▪ Interpreting POC and RPR test results\\n ▪ Referral required when the test is positive\\nMedical Officer Medical \\nmanagement of a \\nsyphilis-positive \\npregnant woman\\n ▪ Interpretation of RPR test results\\n ▪ Technique of administration of penicillin \\ninjection through the proper site and route\\n ▪ Medical management of \\nsyphilis, including alternative \\n(to penicillin) therapies\\n ▪ Referral to FRU for delivery and \\nmanagement of newborn\\nSpecialists \\n(Ob-Gyn, \\nPaediatrician)\\nSpecial obstetric \\ncare of syphilis-\\npositive pregnant \\nwomen\\nThe training for medical officers, plus\\n ▪ Special obstetric care: ante-partum, \\nintra-partum and postpartum\\n ▪ Comprehensive medical management \\nof syphilis-positive pregnant women\\n ▪ Technique of drawing venous blood \\nfrom newborn from the cubital vein \\nfor RPR test (by paediatrician only)\\n ▪ Management of the neonate of \\na syphilis-positive mother\\n\\n23\\nScreening for Syphilis  \\nDuring Pregnancy\\n4.5.2  Structure of Training for Syphilis Programme\\n Ʋ A one-day training will be organized for syphilis programme in \\nevery district\\n Ʋ All participants (programme managers and medical officers [MOs] \\nin-charge of STI Clinics/DSRCs/District AIDS Prevention & Control \\nUnits/Integrated Counselling and Testing centres/HFWTC/DTC \\nfaculty, Principals, ANMTC/LHVTC; School/s of Nursing; DNOs/\\nHEOs/ASHA Mentors/ANMs/ SNs/ LHVs/LTs/MOs/Specialists \\n(Obstetricians; Paediatricians, Dermatologists) will attend\\n Ʋ ASHAs will have a separate batch and 1-day training programme \\ncan be incorporated either into their existing module or a separate \\norientation programme at block level can be organized\\n4.5.3  Batch Size\\n Ʋ All health care facilities in a district will be mapped\\n Ʋ Health personnel of all health care service delivery points need to \\nbe oriented/ trained on a rotational basis\\n Ʋ One batch can have 40 to 60 trainees from all cadres \\n(heterogeneous group)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'All jobs as defined under Level II plus the following:', 'chunk_index': 5, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['medical_tests', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening', 'delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Ʋ One batch of trainees will comprise\\n  Programme managers: 3–5\\n  ANM/SN/LHV: 20–25\\n  LT: 5–10\\n  MO/ Ob-Gyn/Paediatrician and dermatologist/ pathologist or \\nmicrobiologist: 10–15\\n Ʋ Once the health personnel of the designated delivery points in \\nthe district have been trained on a priority basis, other health \\npersonnel involved in ANC care can be oriented\\n Ʋ District Training In-charge will prepare a training plan and  \\ncalendar accordingly\\n\\n24\\nScreening for Syphilis  \\nDuring Pregnancy\\n4.5.4  Training Sites'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Prerequisites:', 'chunk_index': 0, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Prerequisites:\\n Ʋ Seminar/Conference room with capacity of 50–60 participants\\n Ʋ Audio-visual and other training aids\\n Ʋ At least two in-house Ob-Gyn and one paediatrician\\n Ʋ Availability of in-house counsellor, pathologist/ microbiologist, \\ncommunity medicine faculty is desirable\\n Ʋ Any medical college/district hospital having the above \\nprerequisites can be chosen as a training site/venue\\n4.5.5  Trainers\\n Ʋ MO, Ob-Gyn, paediatrician and dermatologist/pathologist or \\nmicrobiologist/specialist in Community Medicine to be included as \\ntrainers as per their availability and area of expertise\\n Ʋ One-day training of trainers should be organized for 20–25 trainers \\nat medical college level\\n4.5.6  Training Material\\n Ʋ GoI guidelines on syphilis\\n Ʋ Any other teaching or training material synchronized with GoI \\nguidelines\\n Ʋ Job aids/Posters/Handouts/Flipcharts\\n Ʋ Presentations\\n Ʋ POC testing strips/cards\\n4.6  Monitoring and Evaluation Framework'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Prerequisites:', 'chunk_index': 1, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='This initiative envisages a focused and robust monitoring and evaluation \\nsystem with specific indicators mentioned below to monitor progress of the \\ninitiative across states so as to take appropriate programmatic responses.\\nNACO and the Maternal Health Division of MoHFW will monitor indicators \\nidentified as critical for monitoring at national level.\\nStates and districts will be \\nresponsible for monitoring of these indicators and for ensuring quality of data \\ncollection from the facilities.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Prerequisites:', 'chunk_index': 2, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='25\\nScreening for Syphilis  \\nDuring Pregnancy\\n4.6.1  Key performance indicators for Syphilis Screening (KPI)\\n Ʋ Number of pregnant women tested for syphilis out of total ANCs \\nregistered\\n Ʋ Total number of syphilis-positive pregnant women detected out of \\nthose tested \\n Ʋ Total number of pregnant women adequately treated (i.e. received \\none dose of benzathine penicillin injection) for syphilis\\n Ʋ Total number of confirmed cases of congenital syphilis \\n Ʋ Total number of babies born to syphilis-positive mothers who \\nreceived treatment \\n4.7  Budget\\n Ʋ Infrastructure: No additional infrastructure required\\n Ʋ Human resource: No separate human resource required\\n Ʋ Equipment/Instruments: No additional equipment or infrastructure \\nrequired\\n Ʋ Testing kits, consumables and drugs required for this programme need to \\nbe budgeted for\\nWhile estimating the budget required for rolling out this initiative, the following \\nneed to be considered\\n4.7.1  Estimated Case Loads\\n Ʋ All pregnant women availing ANC at public health care facilities will \\nbe screened for syphilis by strip/card test, or by RPR depending \\non where they access ANC services\\n Ʋ The pregnant women who test positive for syphilis by the POC \\ntest will need to be tested by RPR also (both qualitative and \\nquantitative)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Prerequisites:', 'chunk_index': 3, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ The pregnant women who test positive for syphilis by POC test will \\nneed benzathine penicillin injection treatment\\n Ʋ All spouses / partners of syphilis-positive women should ideally be \\ntested for syphilis too, and if found positive, then they too will need \\nto be treated\\n\\n26\\nScreening for Syphilis\\nDuring Pregnancy\\n Ʋ Newborns with congenital syphilis or where mothers were \\ninadequately treated will need to be treated with benzathine penicillin\\nEstimating these proportions from existing data or from reported data \\nfollowing initial roll-out will assist in budgeting for this initiative.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Prerequisites:', 'chunk_index': 4, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4.7.2  Records/Registers and Formats\\nThe following records and registers need to be printed and made \\navailable to the relevant service provider(s)\\n Ʋ Monthly syphilis reporting formats for state and district programme \\nmanagers (Annexure 6)\\n Ʋ Monthly syphilis reporting formats for health care facility (Annexure 7)\\n Ʋ Referral slip (Annexure 4)\\n Ʋ Migration form for Pregnant Women with syphilis (Annexure 5)\\n4.7.3  Drugs Consumables and Other Logistics\\n Ʋ Estimate the requirement of test kits, drugs, consumables like \\nlancets, gloves, swabs, etc.\\nand ensure supplies of the same\\n4.7.4  Training\\n Ʋ One-day training will be organized for syphilis programme at the  \\nstate level\\nƲ One-day training will be organized for syphilis programme in every \\ndistrict.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Prerequisites:', 'chunk_index': 5, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='ProgrammeManagers/ANMs/SNs/LHVs/LTs/MOs/OB-GYN/\\nPaediatricians/Pathologists/Microbiologists will attend\\n\\n27\\nScreening for Syphilis  \\nDuring Pregnancy\\nSr. \\nNo. Head\\nUnit Cost\\n(Rs.)\\nNumber of \\nParticipants Days\\nTotal\\n(Rs.)\\n1 TA for participants (to and fro) – \\nto be given as per actuals 3,000 50 1,50,000\\n2 DA to trainees 700 50 1 35,000\\n3 Lunch and tea 200 50 1 10,000\\n4 Per diem/Honorarium for \\ntrainers** 1,000 2 1 2,000\\n5 Logistic expenses such as for \\nstudy material, course material, \\nphotocopying, job aids, flip \\ncharts, LCD etc.\\n(Rate x days of training x \\nnumber of participants)\\n200 50 1 10,000\\nSub-total 2,07,000\\nIncidental overheads  \\n(10% of sub-total)\\n20,000\\nTotal for one batch of 50 \\ncandidates for 1-day training\\n2,27,000\\nSr. \\nNo. Head\\nUnit Cost\\n(Rs.)\\nNumber of \\nParticipants Days\\nTotal\\n(Rs.)\\nTA as per state norms\\n1 DA to District-level Programme \\nOfficers 700 10 1 7,000\\n2 DA to Staff Nurses/ANM/LHV  400 25 1 20,000\\n3 DA to Medical Officers/Ob-Gyn 700 15 1 10,500'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '4. Lunch and tea  200 50 1 10,000', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Lunch and tea  200 50 1 10,000\\n5 Honorarium to State-level Faculty** 1,000 2 1 2,000\\n6 Logistic expenses such as for \\nstudy material, course material, \\nphotocopying, job aids, flip charts, \\naudio-visuals etc.  \\n(Rate x number of participants)\\n200 50 -  10,000\\nSub-total 49,500\\nIncidental overheads  \\n(10% of sub-total) 5,000\\nTotal for batch of 50 54,500\\n1-day Training at State Level for Syphilis - Batch of 50\\n1-day Training of District-level Officers for Syphilis - Batch of 50'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Note:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Note: \\n** TA to be given as per state norms'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='The state needs to adjust the training norms as per the training load of the district and state\\nBudget: Training for Syphilis\\n\\n28'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Screening for Syphilis  \\nDuring Pregnancy\\nNote:\\n ◘\\nEvery district programme officer needs to undertake advance planning and budget estimates for \\nuniversal screening of syphilis in the district.\\n◘\\nThe state programme officer needs to reflect the budgetary requirement in the state/ NHM \\nProgramme Implementation Plan (PIP).\\n◘ State/district accounts manager needs to ensure timely submission of utilisation certificates and \\nstatements of expenditure.\\n◘ Necessary equipment/supplies either cash or in kind need to be made available in advance to \\nall the health care facilities in the district.\\n◘ Similarly, training institutes also need to be provided with the training budget as per the \\nestimates in advance.\\n◘\\nAny procurement that needs to be done should be through competitive and transparent bidding \\nprocess.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 8, 'chunk_type': 'general_text', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': ['blood pressure']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='29\\nScreening for Syphilis  \\nDuring Pregnancy\\nAnnexures\\nAnnexure – 1\\nAnaphylaxis Management\\nBefore administrating penicillin drugs or injections, ask the patient about \\nprevious allergies to penicillin.\\nSigns of possible Anaphylaxis\\n Ʋ Shock\\n Ʋ Difficulty in breathing\\n Ʋ Itchy rash or hives (urticarial)\\nManagement of Anaphylaxis\\n Ʋ Call for help\\n Ʋ Check\\n » Airway\\n » Breathing: Give mouth-to-mouth respiration, if necessary\\n » Circulation: Perform cardiopulmonary resuscitation, if necessary\\n Ʋ If Anaphylaxis, give Adrenaline intramuscularly (IM)\\n »\\nDosage: Adult 0.5 mL (if elderly, 0.3 mL), repeat every 5–10 minutes \\nuntil adequate response\\n » Check blood pressure and pulse every 5–10 minutes\\n Ʋ Give Hydrocortisone.\\nDosage:\\nAdult 250 mg IM\\n Ʋ Give Chlorpheniramine.\\nDosage: 10–20 mg or Diphenhydramine  \\n50–100 mg IM\\n Ʋ Transfer patient to hospital\\n »\\nRepeat Adrenaline injection if necessary.\\nTake extra doses with you\\n » Record all details of treatment.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 2, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Give a copy to the hospital as well as to \\nthe patient\\n » Stay with the patient until another doctor takes over care in person\\n\\n30\\nScreening for Syphilis\\nDuring Pregnancy\\nAnnexure – 2\\nTechnical Specifications of Rapid Plasma Reagin (RPR) Test Kits \\nfor Syphilis Testing\\n Ʋ The indigenous RPR kits should have been manufactured under \\nmanufacturing licence issued by the State Licensing Authority under \\nthe Drugs and Cosmetics Act.\\nThe imported kits should have been \\nimported under import licence issued by the DCG (I) under the Drugs \\nand Cosmetics Act.\\nƲ The assay should allow for qualitative and semi-quantitative \\ndetermination of reagin antibodies in serum or plasma for serological \\ndiagnosis of syphilis based on flocculation principle using non-\\ntreponemal antigens.\\nƲ The assay should be suitable to perform with either serum or plasma.\\nƲ The assay should have sensitivity of 80% or more in primary syphilis and \\na specificity of 90% or more.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 3, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [12], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ The assay should be calibrated to WHO reference serum and the same \\nshould be supported by statements in kit inserts and certificate from \\nmanufacturer.\\nƲ The test should be able to yield results within 20 minutes.\\nƲ The pack size of RPR test kit should be less than or equal to 50 tests \\nper kit.\\nƲ The assay components should include positive and negative serum \\ncontrols sufficient for conducting 20% of the tests (10% negative and \\n10% positive controls).\\nƲ The kit should have all essential accessories required for the test such \\nas cards, dropper, accelerator, etc., in adequate quantities for the \\nnumber of tests to be performed.\\nƲ The kit should have 5/6th of the shelf life or 12 months before expiry \\n(whichever is more) at the time of receipt by the consignee.\\nƲ The kit should have a storage temperature of 2°C to 8°C and supplier/\\nlocal agent should have the facility to store kits at 2°C to 8°C.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 4, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ Cumulative Time Temperature Indicator should be part of the kit and the \\nindicator technology used should be prequalified by WHO.\\nƲ Literature detailing the components, methodologies, validity criteria, \\nperformance characteristics, storage conditions, manufacturing and \\nexpiry dates should be provided with each kit.\\n31\\nScreening for Syphilis  \\nDuring Pregnancy\\nAnnexure – 3\\nTechnical Specifications of Treponemal-specific Rapid (Point-of-\\nCare) Diagnostic Test for Syphilis\\n Ʋ The assay should have solid phase coated with synthetic or recombinant \\ntype of Treponema Pallidum antigens.\\nƲ The assay may be based on any of the rapid test principles: \\n(Immunoconcentration/Dot blot immunoassay (vertical flow), dip stick and \\ncomb assay.\\nƲ The assay should quantitatively detect total anti-treponemal antibody (IgG \\nand IgM) in whole blood, serum or plasma for serological diagnosis of \\nsyphilis in all stages of infection.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 5, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [12], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ The assay should have an in-built positive and negative control for testing \\nthe validity of the test kits.\\nƲ The assay should have reactive and non-reactive controls with each kit in \\nadequate volume (minimum 10% of pack size).\\nƲ The kit should have 5/6th of the shelf life or 12 months before expiry \\n(whichever is more) at the time of receipt by the consignee.\\nƲ Adequate literature detailing the principle, components, methodologies, \\nvalidity criteria, bio-safety, performance characteristics, storage \\nconditions, limitation of assay, manufacture and expiry dates and \\nmethods of disposal should be provided with each kit.\\nƲ The imported rapid kit should have approval of the statutory authority in \\nits country of origin.\\nThe imported kits should have been registered and \\nlicensed in India by the Central Drugs Standard Control Organization \\n(CDSCO).\\nƲ'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 6, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='In case of indigenous manufacturers they should have a valid licence \\nissued by the competent authority defined under Drugs and Cosmetics \\nAct, 1940, after appropriate evaluation by the centres approved by the \\nCDSCO.\\nƲ The assay should have sensitivity of 90% or more and specificity of 95% \\nor more and the same should be supported by statements in kit insert and \\ncertificate from National Institute of Biological Sciences.\\nƲ The assay should be calibrated to WHO reference serum and the same \\nshould be supported by statements in kit insert and certificate from the \\nmanufacturer.\\n32\\nScreening for Syphilis  \\nDuring Pregnancy\\n Ʋ\\nThe manufacturer should ensure the following:\\n » The test should be packed such that there is a provision to conduct \\nsingle test at a time.\\n» The pack size of test kits should be in 50 (for peripheral health levels) \\nand 100 tests per kit (for secondary and tertiary health care level) but \\nnot more than 100 tests per kit.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 7, 'total_chunks_in_section': 8, 'chunk_type': 'recommendation', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Ʋ The manufacturer/authorized agent should ensure maintenance of cold \\nchain during storage and transport of kits at 2°C to 8°C.\\nƲ Total procedure time should not be more than 30 minutes.\\n33\\nScreening for Syphilis  \\nDuring Pregnancy\\nAnnexure – 4'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Referral Slip\\nName of referring facility: _________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Address: __________________________________Telephone:___________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Address: __________________________________Telephone:___________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name of the patient: _____________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of the patient: _____________________________________________\\nFather’s/Husband’s name: ___________________________________\\nContact no.:_________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Address: ____________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Address: ____________________________ \\nReferred on ____/____/____ (dd/mm/yy_________ (time) to_________\\n_______________________________(name of the facility) for management.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Provisional diagnosis: __________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Provisional diagnosis: __________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Summary of management:_______________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Summary of management:_______________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Blood group: ________________ Hb:_____', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Blood group: ________________ Hb:_____'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Status of Syphilis: ______________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Status of Syphilis: ______________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Other investigations: __________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Other investigations: __________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Procedures and critical interventions carried out\\nTreatment given: __________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Dose of penicillin: ___________ Duration:_______________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Dose of penicillin: ___________ Duration:_______________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Condition at time of referral: _________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Condition at time of referral: _________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Consciousness: Temp: ________ Pulse:_________ BP:____________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': ['bp']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Consciousness: Temp: ________ Pulse:_________ BP:____________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Reason for referral:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Reason for referral:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Mode of transport for referral: Govt./PPP/Vehicle arranged by patient', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Mode of transport for referral: Govt./PPP/Vehicle arranged by patient'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Telephonic information on referral provided to the institution referred to: No/', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Telephonic information on referral provided to the institution referred to: No/'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name of the person spoken to: _________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of the person spoken to: _________________________________\\nSignature of referring physician/health functionary:\\nName/Designation/Stamp:\\n\\n34\\nScreening for Syphilis  \\nDuring Pregnancy\\nAnnexure – 5'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Migration Form for Pregnant Women with Syphilis\\nName:________________________________________________________\\nHusband’s/Father’s name:________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Present address: _______________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Present address: _______________________________________________\\n_____________________________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name of Health Facility attended:__________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of Health Facility attended:__________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Migration address:______________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Migration address:______________________________________________ \\n_____________________________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Address of health facility to be attended:_____________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Address of health facility to be attended:_____________________________ \\n_____________________________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Diagnosis of Syphilis:______________________Date:______________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Diagnosis of Syphilis:______________________Date:______________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Period of gestation: ________weeks___________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Period of gestation: ________weeks___________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Treatment given:_______________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Treatment given:_______________________________________________ \\n____________________________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Information about migration given to:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Information about migration given to:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name:_______________________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name:_______________________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Designation:__________________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Designation:__________________________________________________\\nMobile no./Telephone no:________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Place of work:_________________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [6], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place of work:_________________________________________________\\nSignature of Doctor\\n\\n35\\nScreening for Syphilis  \\nDuring Pregnancy\\nAnnexure – 6\\nMonthly Syphilis Reporting Format for State & District \\nProgramme Managers for month of ...........……………year………...'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name of State:____________________Name of District:________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of State:____________________Name of District:________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Estimated number of pregnant women:______________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Estimated number of pregnant women:______________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Estimated number of deliveries:____________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Estimated number of deliveries:____________________________________\\n Ʋ Total number of ANC conducted (including all 4 ANC visits) in reporting \\nmonth:_______________\\n Ʋ Number of syphilis-positive pregnant women diagnosed out of total \\nnumber of ANC conducted in the reporting month:________________\\n Ʋ Total number of pregnant women who received adequate treatment \\n(i.e. received one dose of benzathine penicillin injection) for syphilis \\nout of total number of syphilis-positive women diagnosed in reporting \\nmonth:_______________\\n Ʋ Number of confirmed cases of congenital syphilis out of total number \\nof syphilis-positive pregnant women who delivered in the reporting \\nmonth:_______________\\n Ʋ Number of babies who received treatment who are born to syphilis-\\npositive mothers out of total number of syphilis-positive pregnant women \\ndiagnosed in reporting month:_________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Note:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [7], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Note: \\n ◘ Districts will report to their states.\\n ◘ Information will be compiled at state level to forward to GOI.\\n\\n36\\nScreening for Syphilis  \\nDuring Pregnancy\\nAnnexure – 7\\nMonthly Syphilis Reporting Format for Health Facility for  \\nMonth of …………………, Year………………'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name of State:___________________Name of District:_________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of State:___________________Name of District:_________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Name of Health Facility:__________________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of Health Facility:__________________________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Estimated number of pregnant women:______________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Estimated number of pregnant women:______________________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Estimated number of deliveries:____________________________________', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Estimated number of deliveries:____________________________________\\n Ʋ Total number of ANC conducted (including all 4 ANC visits) in reporting \\nmonth:________________\\n Ʋ Number of syphilis-positive pregnant women diagnosed out of total \\nnumber of ANC conducted in the reporting month:__________________\\n Ʋ Total number of pregnant women received adequate treatment (i.e. \\nreceived one dose of benzathine penicillin injection) for syphilis out \\nof total number of syphilis-positive women diagnosed in reporting \\nmonth:_________________\\n Ʋ Number of confirmed cases of congenital syphilis out of total number \\nof syphilis-positive pregnant women who delivered at the facility in the \\nreporting month:__________________\\n Ʋ Number of babies who received treatment who are born to syphilis-\\npositive mothers out of total number of syphilis-positive pregnant women \\nwho delivered in reporting month:____________________'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Note:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Note: \\n ◘ Health facility will report to District.\\n◘ Information will be compiled at district level for forwarding to state.\\n37\\nScreening for Syphilis  \\nDuring Pregnancy\\nReferences\\n Ʋ World Health Organization.\\nThe Global Elimination of Congenital Syphilis: \\nRationale and Strategy for Action.\\nGeneva, World Health Organization, \\n2007\\n Ʋ Investment Case for Eliminating Mother to Child Transmission of Syphilis:\\nPromoting Better Maternal and Child Health and Stronger Health Systems, \\nWHO Publications, 2012\\n Ʋ Eliminating Congenital Syphilis in South East Asia Region - A Feasible \\nStrategic Initiative 2011–2015; WHO Publication, 2012\\n Ʋ HIV Sentinel Surveillance Data for 2010–11, NACO\\n Ʋ Report on Global Sexually Transmitted Infection Surveillance,\\nWHO \\nPublications, 2013\\n Ʋ Singh AE, Romanowski B. Syphilis: Review with Emphasis on Clinical, \\nEpidemiologic and Some Biologic Features.\\nClinical Microbiological \\nReview, 1999, 12:187–209\\n Ʋ Brion LP et al.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Note:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Long Bone Radiographic Abnormalities as a Sign of Active \\nCongenital Syphilis in Asymptomatic Newborns.\\nPaediatrics, 1991.\\nƲ Davanzo R et al.\\nNeonatal and Post-neonatal Onset of Early Congenital'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Syphilis: A Report from Mozambique. Annals of Tropical Paediatrics, 1992,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Syphilis: A Report from Mozambique. Annals of Tropical Paediatrics, 1992, \\n12:445–450.\\n Ʋ Centre for Disease Control (CDC), STD Surveillance Case Definitions, STD \\nSurveillance, 2010\\n Ʋ Centre for Disease Control, MMWR, 2010, weekly/Vol.59/No.14,  \\nApril 16, 2010.\\n Ʋ National STI Guidelines.\\n Ʋ Tais F. Galvao1, Marcus T. et al. Safety of Benzathine Penicillin for'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Preventing Congenital Syphilis: A Systematic Review. PLOS ONE,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Preventing Congenital Syphilis: A Systematic Review. PLOS ONE, \\nFebruary 2013, Vol.8/No.2.\\n Ʋ Central Drugs Standard Control organization, DGHS, MoHFW, Govt. of \\nIndia. http://www.cdsco.nic.in/writereaddata/National%20List%20of%20\\nEssential%20Medicine-%20final%20copy.pdf (accessed on June 20, 2014)\\n Ʋ Operational Guidelines for ePTCT of Syphilis. NACO, 2014.\\n Ʋ Guidelines for Community Process, National Rural Health Mission, June \\n2013\\n Ʋ World Health Organization. Model List of Essential Medicines 17th \\nedition. Geneva. WHO 2011; Available from http://www.who.int/medicines/\\npublications/essentialmedicines/en/index.html \\n Ʋ World Health Organization. Methods for Surveillance and Monitoring of \\nCongenital Syphilis Elimination within Existing Systems. 2011.\\n\\nNotes\\n\\n\\n\\n\\n\\n\\n\\n42\\nScreening for Syphilis  \\nDuring Pregnancy\\nMaternal Health Division\\nMinistry of Health & Family Welfare\\nGovernment of India\\nNirman Bhawan, New Delhi-110011'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Syphilis_Doc_Low-res_5th_Jan.pdf', 'section_title': 'Website: www.mohfw.gov.in & www.nhm.gov.in', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Website: www.mohfw.gov.in & www.nhm.gov.in'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='i\\nTraining Manual\\nFor MMA in Early Gestation\\nTRAINING MANUAL \\nFor Medical Methods of Abortion (MMA) \\nin Early Gestation\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\nTRAINING MANUAL \\nFor Medical Methods of Abortion (MMA) \\nin Early Gestation\\nJULY 2022\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\ni\\nHealthy Village, Healthy Nation \\n \\n \\n \\nDR. SUMITA GHOSH'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [9], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Additional Commissioner \\nTelefax : 011-23063178 \\nE-mail : sumita.ghosh@nic.in \\n \\n \\n \\n \\n \\n \\nPreface \\nGOVERNMENT OF INDIA \\nMINISTRY OF HEALTH & FAMILY WELFARE \\nNIRMAN BHAVAN, MAULANA AZAD ROAD \\nNEW DELHI - 110011 \\n \\n \\n \\n \\n29’h July, 2022 \\n \\n \\nThe Medical Termination of Pregnancy Act, 1971 has recently been amended and the \\nMedical Termination of Pregnancy (Amendment ) Act, 2021 and the Medical \\nTermination of Pregnancy (Amendment) Rules, 2021 as prescribed under the Act have \\ncome into force.\\nThese amendments intend to increase the ambit and access of women \\nseeking legal abortion services for different reasons or indications.\\nThis will necessitate a \\nlarge pool of legal service providers and an increased number of facilities especially for \\nproviding safe and quality abortion services through Medical Methods in early gestation \\nage upto 9 weeks using globally proven technology.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='For capacity building of medical officer in Medical Methods of Abortion (MMA) in \\nperipheral facilities, this training manual has been developed in consultation with the \\nexpert group with representatives from the State Governments, Comprehensive \\nAbortion Care Training centres, and Professional/Non -profit organizations.\\nThe manual \\nwill be useful to the facilitators/trainers as well as the trainees who undergo this \\ntraining.\\nIt covers all aspects of Medical Methods of Abortion  including details about \\nits legal aspect, documentation of services, proper protocol of usage of drugs, \\ncounseling, complication management and post abortion contraception following MMA.\\nAlong with this, a guidance note has been prepared regarding requirement of the \\ntraining centres who will be implementing this training.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 2, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': ['fetal_development'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='States and UTs need to ensure availability of trained Registered Medical Practitioners at \\nCHCs and PHCs along with availability of drugs, so that women needing abortion care are \\nserved at the peripheral facilities with safety, quality, respect and dignity.\\nI am thankful to Dr P. Ashok Babu, Joint Secretary (RCH), MoHFW, for his guidance and \\nkeen engagement in taking forward the operationalization  of MMA trainings.\\nI am also \\nthankful to all the experts contributing towards the development of this manual \\nespecially lpas Development Foundation for taking a leading role in compilation.\\nI look forward to effective implementation  of amendments and initiation of Medical \\nMethods of Abortion training and thereby significantly address the issue of unsafe \\nabortions in the country.\\n(Dr. Sumita Ghosh)\\nTalking about AIDS is taking care of each other\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\niii\\nList of Expert Group Members\\nS.\\nNo.\\nName Designation'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Dr. P . Ashok Babu  Joint Secretary (RCH) Ministry of Health & Family Welfare,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Dr. P . Ashok Babu  Joint Secretary (RCH) Ministry of Health & Family Welfare, \\nGovernment of India.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Dr. Sumita Ghosh Additional Commissioner Incharge (CH, RBSK, AH, CAC & AD),', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Dr. Sumita Ghosh Additional Commissioner Incharge (CH, RBSK, AH, CAC & AD),\\nMinistry of Health & Family Welfare, Government of India.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Dr. Alok Banerjee Technical Advisor, Parivar Seva Sanstha, New Delhi.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Dr. Alok Banerjee Technical Advisor, Parivar Seva Sanstha, New Delhi.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Dr. Aparna Sharma Additional Professor, Department of Obstetrics & Gynaecology,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Dr. Aparna Sharma Additional Professor, Department of Obstetrics & Gynaecology, \\nAll India Institute of Medical Sciences, New Delhi.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Dr. Basab Mukherjee Vice President FOGSI & Consultant Gynaecologist, Woodlands', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Dr. Basab Mukherjee Vice President FOGSI & Consultant Gynaecologist, Woodlands \\nMultispecialty Hospital, Kolkata, West Bengal.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Dr. Indra Bhati', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='6. Dr. Indra Bhati\\nSenior Professor & Ex-Head, Department of Obstetrics & \\nGynaecology, Dr. S N Medical College & Hospital, Jodhpur, \\nRajasthan.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '7. Dr. Jyotsna Suri Professor & Unit Head, Department of Obstetrics & Gynaecology,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='7. Dr. Jyotsna Suri Professor & Unit Head, Department of Obstetrics & Gynaecology, \\nVMMC & Safdarjung Hospital, New Delhi.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '8. Dr. Ojaswini Patel', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='8. Dr. Ojaswini Patel\\nAssociate Professor, Department of Obstetrics & Gynaecology, \\nVSS Institute of Medical Sciences & Research, Burla, Sambalpur, \\nOdisha.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '9. Dr. Pratima Mittal Consultant & Ex-Professor, Department of Obstetrics &', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='9. Dr. Pratima Mittal Consultant & Ex-Professor, Department of Obstetrics & \\nGynaecology, VMMC and Safdarjung Hospital, New Delhi.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '10. Dr. Pushpa', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='10. Dr. Pushpa \\nChaudhary\\nTeam Lead, RMNCAH, World Health Organization.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '11. Dr. Pushpa Nagar', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='11. Dr. Pushpa Nagar\\nSenior Professor & Unit Head, Department of Obstetrics and \\nGynaecology, SMS Medical College & Zanana Hospital, Jaipur, \\nRajasthan.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '12. Dr. Rathnamala M.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='12. Dr. Rathnamala M.  \\nDesai\\nPresident FPA India.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '13. Dr. Sangeeta Batra Chief Technical Officer - Health Systems, Ipas Development', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['fetal_development'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='13. Dr. Sangeeta Batra Chief Technical Officer - Health Systems, Ipas Development \\nFoundation, New Delhi.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '14. Dr. Saswati Das Sexual & Reproductive Health and Rights Specialist,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='14. Dr. Saswati Das Sexual & Reproductive Health and Rights Specialist, \\nUnited Nations Population Fund, New Delhi.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '15. Dr. Savitha C.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='15. Dr. Savitha C.\\nProfessor & Head, Department of Obstetrics & Gynaecology, \\nBangalore Medical College & Vani Vilas Hospital, Bangalore, \\nKarnataka.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '16. Dr. Vanita Suri', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='16. Dr. Vanita Suri\\nProfessor and Head, Department of Obstetrics and Gynaecology, \\nPost Graduate Institute of Medical Education & Research, \\nChandigarh.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &', 'chunk_index': 0, 'total_chunks_in_section': 4, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': ['blood pressure', 'bp']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='17.\\nMs.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health & \\nFamily Welfare, Government of India.\\n\\nviii\\nTraining Manual\\n\\nTraining Manual\\nFor MMA in Early Gestation\\nv\\nList of Acronyms\\nBP    Blood Pressure\\nCAC    Comprehensive Abortion Care\\nCOC    Combined Oral Contraceptive \\nDLC   District Level Committee\\ngm    gram \\nHb    Haemoglobin\\nMP\\nA                 Medroxy Progesterone Acetate\\nIUCD    Intrauterine Contraceptive Device\\nIV    Intravenous\\nLMP   Last Menstrual Period\\nMBBS   Bachelor of Medicine and Bachelor of Surgery\\nmcg   microgram\\nmg    milligram\\nMMA   Medical Methods of Abortion\\nMTP    Medical Termination of Pregnancy\\nNHM    National Health Mission\\nP/S    Per Speculum\\nP/V    Per Vaginum\\nPOC    Products of Conception\\nRh     Rhesus (Blood group)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &', 'chunk_index': 1, 'total_chunks_in_section': 4, 'chunk_type': 'warning', 'topics': ['warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='RMP    Registered Medical Practitioner\\nSRS     Sample Registration Survey\\nUSG    Ultra Sonography\\nVA    Vacuum Aspiration\\nWHO    World Health Organization\\n\\nTraining Manual\\nFor MMA in Early Gestation\\nx\\n\\nTraining Manual\\nFor MMA in Early Gestation\\nvii\\nContents \\nPreface\\nList of Expert Group Members \\nList of Acronyms\\nIntroduction to Medical Methods of Abortion\\nMMA Training Pre-test Questionnaire\\nChapter 1: Medical Methods of Abortion - An Overview\\n1.1: Advantages and Limitations of MMA\\nChapter 2: Law (MTP Act) and MMA \\n2.1: Eligibility of the Provider\\n2.2: Eligibility of the Place \\n2.3: Consent for MMA Procedure \\n2.4: Documentation/Reporting of MMA Procedure\\nChapter 3: Indications/Contraindications for MMA\\n3.1: Indications for MMA \\n3.2: Contraindications for MMA \\n3.3: Special Precautions for MMA\\n3.4: Eligibility Checklist for MMA\\nChapter 4: About MMA Drugs \\n4.1: Drugs Used for MMA \\nChapter 5: MMA Protocol and Process \\n5.1: Drug Protocol\\n5.2: Process of MMA\\n5.3: Post MMA Contraception \\ni\\niii\\nv\\n1\\n2\\n5\\n5\\n6\\n6\\n6\\n7\\n7\\n13\\n13\\n13\\n14\\n14\\n15\\n15\\n18\\n18\\n18\\n26\\n\\nTraining Manual\\nFor MMA in Early Gestation\\nviii\\nChapter 6: Side Effects and Complications with MMA and their Management \\n6.1: Side Effects with MMA\\n6.2: Safety and Effectiveness\\n6.3: Complications and their Management \\n6.4:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &', 'chunk_index': 2, 'total_chunks_in_section': 4, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'nutrition', 'warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='Warning Symptoms and Signs\\nChapter 7: Comparison: V A and MMA Procedure \\nChapter 8: Schedule for MMA Trainings\\nReferences\\nAnnexures\\nAnnexure 1: Medical Methods of Abortion Counselling Skill Checklist\\nAnnexure 2: Essential Equipment, Instruments, Drugs, and  \\nConsumables  Required for MMA\\nAnnexure 3: MMA Card\\nMMA  Training Post–test Questionnaire \\n28\\n28\\n29\\n29\\n32\\n33\\n34\\n35\\n36\\n36\\n38\\n39\\n40\\n\\n1\\nTraining Manual\\nFor MMA in Early Gestation\\nIntroduction to \\nMedical Methods of Abortion\\nUnsafe abortions make a significant contribution to maternal morbidity and mortality.\\nAs per SRS 2001 - 03, abortion-related deaths account for nearly 8% of all maternal \\ndeaths in India.\\nNumerous barriers limit access to safe abortion services including \\nshortage and uneven distribution of trained providers; lack of infrastructure at the \\nfacilities; and lack of information about legality and availability of services among \\nwomen and the community.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &', 'chunk_index': 3, 'total_chunks_in_section': 4, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Medical Methods of Abortion (MMA) is one of the safe technologies for abortion \\ncare which offers an opportunity to increase accessibility and availability to abortion \\ncare services in early pregnancy.\\nIt can be offered at all levels of health care, including \\nprimary levels.\\nIt can also be provided on an outpatient basis.\\nMMA is a non-invasive technology and simplifies the requirements of place and \\nequipment as required for Vacuum Aspiration procedures.\\nThis manual explains use of MMA in early pregnancy up to nine weeks, as approved \\nunder the Medical Termination of Pregnancy (Amendment) Rules, 2021.\\nTraining Manual\\nFor MMA in Early Gestation\\n2\\nMedical Methods of Abortion Training\\nPre-test Questionnaire'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name:  ......................................................................................................................................................................', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name:  ......................................................................................................................................................................'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name of training centre: ........................................................................................................................................', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of training centre: ........................................................................................................................................'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\\nPlease put a tick under `True’ or `False’ for the following statements:\\nS.No. Statement    True False'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. MMA is a safe and effective method to terminate early', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. MMA is a safe and effective method to terminate early \\npregnancy upto 63 days.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. MMA may adversely affect the woman’s future fertility.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. MMA may adversely affect the woman’s future fertility.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. A physical examination of the woman is not required to provide', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. A physical examination of the woman is not required to provide \\nMMA services.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. A written consent of the woman seeking medical methods of', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. A written consent of the woman seeking medical methods of \\nabortion is mandatory on the prescribed format.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. A minimum of four visits are recommended to complete the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='5. A minimum of four visits are recommended to complete the \\nstandard MMA drug protocol.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Only a Registered Medical Practitioner, as under the MTP Act', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='6. Only a Registered Medical Practitioner, as under the MTP Act \\ncan prescribe MMA drugs.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '7. Fertility can return within 10 days of an abortion.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='7. Fertility can return within 10 days of an abortion.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '8. Most of the contraceptive methods can be started during the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='8. Most of the contraceptive methods can be started during the \\nprocess of MMA after confirming their eligibility.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '9. MMA drugs can cause congenital anomalies if pregnancy', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='9. MMA drugs can cause congenital anomalies if pregnancy \\ncontinues after their intake.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '10. A woman should be within accessible limits of a health facility', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='10. A woman should be within accessible limits of a health facility \\nduring the MMA process.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Please encircle the correct answer in the following questions:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Please encircle the correct answer in the following questions:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '11. Which of the following is recommended for pain management during MMA?', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='11. Which of the following is recommended for pain management during MMA?\\na. Tablet Paracetamol\\nb. Tablet Ibuprofen \\nc. Injection Diazepam\\nd. Paracervical block'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '12. Which of the following is the LEAST effective route for Misoprostol administration during the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='12. Which of the following is the LEAST effective route for Misoprostol administration during the \\nMMA process?\\na. Sublingual\\nb. Vaginal\\nc. Oral\\nd. Buccal\\n\\n3\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\\na. Combined Oral Contraceptive pills\\nb. Centchroman \\nc. IUCD\\nd. Injectables'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '14. Way to manage an incomplete abortion during the process of MMA is:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='14. Way to manage an incomplete abortion during the process of MMA is:\\na. Vacuum Aspiration\\nb. Repeat dose of Misoprostol\\nc. Either of the above two depending on the severity of bleeding'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='15.\\nIf pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\\na. Y es, additional dose can be tried\\nb.\\nNo, woman should be referred to higher centre for pregnancy termination with Vacuum \\nAspiration\\nc. Pregnancy should be continued\\n\\n\\n\\n5\\nTraining Manual\\nFor MMA in Early Gestation\\n1 Medical Methods of Abortion – An Overview\\nMMA is a non-surgical, non-invasive method for termination of pregnancy by using a combination of \\ndrugs.\\nIt provides women with another option for termination of pregnancy besides surgical methods \\nand should be offered in addition to other available safe abortion methods, whenever possible.\\n1.1:\\nAdvantages and Limitations of MMA\\nShare with the participants the advantages and limitations of Medical Methods of Abortion.\\nMMA is one of the safe technologies available for pregnancy termination.\\nIt is a non-surgical method \\nfor early abortions and has both advantages as well as limitations over other methods of pregnancy \\ntermination.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Advantages of MMA'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Abortion can be offered at an early stage of pregnancy upto 9 weeks of gestation, as approved under', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [9], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Abortion can be offered at an early stage of pregnancy upto 9 weeks of gestation, as approved under \\nMTP (Amendment) Rules, 2021.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Potentially more private, being similar to a natural miscarriage.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Potentially more private, being similar to a natural miscarriage.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Non-surgical method of abortion, and hence non-invasive.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Non-surgical method of abortion, and hence non-invasive.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. No anaesthesia required.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. No anaesthesia required.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Limited infrastructure needed, can be offered in settings where vacuum aspiration may not be', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Limited infrastructure needed, can be offered in settings where vacuum aspiration may not be \\npossible.\\nLimitations of MMA'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Multiple mandatory clinic/facility visits required during the MMA process.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Multiple mandatory clinic/facility visits required during the MMA process.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Bleeding may occur for 8-13 days.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Bleeding may occur for 8-13 days.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. There may be side effects of the MMA drugs like nausea, vomiting, chills, and dizziness.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. There may be side effects of the MMA drugs like nausea, vomiting, chills, and dizziness.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Once MMA drugs are taken, pregnancy should be terminated in case of continuation of that', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['fetal_development', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='4.\\nOnce MMA drugs are taken, pregnancy should be terminated in case of continuation of that \\npregnancy, since there exists a risk of foetal malformation.\\nTraining Manual\\nFor MMA in Early Gestation\\n6\\n2 Law (MTP Act) and MMA\\n2.1: Eligibility of the Provider\\nIn case of termination of pregnancy using Mifepristone and Misoprostol, only \\na Registered Medical Practitioner, as defined by the Medical Termination of \\nPregnancy (MTP) Act, can prescribe the drugs.\\n‘Registered Medical Practitioner (RMP)’ means a medical practitioner who possesses any recognized \\nmedical qualification (MBBS) as defined in the Indian Medical Council Act, 1956 (102 of 1956); \\nwhose name has been entered in a State Medical Register; and who has such experience or training in \\nGynaecology and Obstetrics as may be prescribed by Rules under this Act.\\nThe MTP (Amendment) Rules, 2021 require that an RMP should have one or more of the following \\nexperience or training in Gynaecology and Obstetrics to be able to provide MMA:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Independently performed ten cases of MMA under the supervision of an RMP in a hospital \\nestablished or maintained, or a training institute approved for this purpose, by the Government.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. At least three months experience at any hospital in the practice of Obstetrics and Gynaecology.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. At least three months experience at any hospital in the practice of Obstetrics and Gynaecology.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Post–graduate degree or diploma in Obstetrics and Gynaecology.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Post–graduate degree or diploma in Obstetrics and Gynaecology.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Completed six months as House Surgeon in Obstetrics and Gynaecology.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Completed six months as House Surgeon in Obstetrics and Gynaecology.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Assisted an RMP in 25 cases of medical termination of pregnancy of which at least five have been', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Assisted an RMP in 25 cases of medical termination of pregnancy of which at least five have been \\nperformed independently in a hospital established or maintained by the Government or a training \\ninstitute approved for this purpose by the Government.\\n2.2: Eligibility of the Place\\nShare with the participants the places from where MMA can be provided, as under the MTP Act.\\nIn accordance with the MTP Act, termination of pregnancy with'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'MMA shall be done at the following places:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='MMA shall be done at the following places:\\na. A hospital established or maintained by the Government, or\\nb.\\nA place for the time being approved for the purpose of this Act by the Government or a District \\nLevel Committee (DLC) constituted by the Government, with the Chief Medical Officer or District \\nHealth Officer as the Chairperson of the said Committee, or\\nc.\\nIn case of termination of early pregnancy up to nine weeks using Mifepristone and Misoprostol, an \\nRMP as under the MTP Act, can prescribe the drugs at his/her clinic provided he/she has access to \\na place approved for terminating pregnancy under the MTP Act.\\nThe clinic should display a certificate to this effect from the owner of the approved place.\\n7\\nTraining Manual\\nFor MMA in Early Gestation\\n2.3: Consent for MMA Procedure\\nAny woman 18 years and above can give her own consent for the MMA procedure.\\nFor minors and mentally ill women, consent of the guardian should be taken.\\nGuardian means a person having the care of them.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'MMA shall be done at the following places:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2.4: Documentation/Reporting of MMA Procedure\\nShare with the participants the documentation formats to be completed for MMA procedure, \\nas under the MTP Act.\\nSince MMA comes under the purview of the MTP Act, the documentation is similar to that required \\nfor vacuum aspiration procedure.\\nIt is mandatory to fill and record information for abortion cases \\nperformed by MMA in the following forms:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Form C – Consent Form – this form is completed before initiating the abortion procedure. This is', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Form C – Consent Form – this form is completed before initiating the abortion procedure. This is \\nsigned by the woman herself or guardian (in case of minor or mentally ill woman).'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Form I – RMP Opinion Form – this form is used for providing opinion by the RMP for providing', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Form I – RMP Opinion Form – this form is used for providing opinion by the RMP for providing \\ninduced abortion services.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Form II – Monthly Reporting Form – this form is completed by the hospital incharge/owner to', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Form II – Monthly Reporting Form – this form is completed by the hospital incharge/owner to \\nreport the total monthly cases to the district authorities.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Form III – Admission Register– this register is used for recording all the induced abortion cases,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Form III – Admission Register– this register is used for recording all the induced abortion cases, \\ndone by surgical as well as medical methods.\\nForm C \\n(See rule 9) \\n \\nI………………………………………………………daughter/wife of…………………………………………………………………………………….. \\naged about………………………….years of …………………………………………………………………………………………………..............  \\n(here state the permanent address) at present residing at……………………………………………….…………………………….. \\ndo hereby give my consent to the termination of my pregnancy at  ………………………………………………………………..  \\n.……………………………………………………………………………………(state the name of place where the pregnancy is to be \\nterminated)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:                                 Signature', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Date:                                 Signature \\n \\n \\n(To be filled in by guardian where the woman is a mentally ill person or minor) \\nI……………………………………………………………son/ daughter/ wife of ……………………………………………………………………… \\naged about………………………………..….years of………………………………………………………………........................................  \\n                                                                                                                     (permanent address) \\n \\nat present residing at …………………………………..............................................………………………………………………. do \\n hereby give my consent to the termination of the pregnancy of my ward ……………………………………………………… \\n……………………………………………………………… who is a minor/ mentally ill person at .……………………………………………  \\n…………………………………………………………………………………………………………………(place of termination of pregnancy)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:                               Signature', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Date:                               Signature\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n8\\nConsent Form (Form C)\\nForm C \\n(See rule 9) \\n \\nI………………………………………………………daughter/wife of…………………………………………………………………………………….. \\naged about………………………….years of …………………………………………………………………………………………………..............  \\n(here state the permanent address) at present residing at……………………………………………….…………………………….. \\ndo hereby give my consent to the termination of my pregnancy at  ………………………………………………………………..  \\n.……………………………………………………………………………………(state the name of place where the pregnancy is to be \\nterminated)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:                                 Signature', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Date:                                 Signature \\n \\n \\n(To be filled in by guardian where the woman is a mentally ill person or minor) \\nI……………………………………………………………son/ daughter/ wife of ……………………………………………………………………… \\naged about………………………………..….years of………………………………………………………………........................................  \\n                                                                                                                     (permanent address) \\n \\nat present residing at …………………………………..............................................………………………………………………. do \\n hereby give my consent to the termination of the pregnancy of my ward ……………………………………………………… \\n……………………………………………………………… who is a minor/ mentally ill person at .……………………………………………  \\n…………………………………………………………………………………………………………………(place of termination of pregnancy)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:                               Signature', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Date:                               Signature\\n\\n9\\nTraining Manual\\nFor MMA in Early Gestation\\nRMP Opinion Form (Form I)\\nFORM I  \\nRMP Opinion Form \\n(For gestation age upto twenty weeks)\\n[See Regulation 3] \\nI _\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_ \\n(Name and qualifications of the Registered Medical Practitioner in block letters)\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n(Full address of the Registered Medical Practitioner) \\n \\nhereby certify that I am of opinion, formed in good faith, that it is necessary to terminate the \\npregnancy of _\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n(Full name of pregnant woman in block letters) \\nresident of__\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n(Full address of pregnant woman in block letters) \\nfor the reasons given below*.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:                               Signature', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='I hereby give intimation that I terminated the pregnancy of the woman referred to above who  bears \\nthe Serial No.\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_ in the Admission Register of the hospital/approved place.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Date: \\nSignature of the Registered Medical Practitioner \\n  \\n*of the reasons specified items (a) to (e) write the one which is appropriate: \\na. in order to save the life of the pregnant women, \\nb. in order to prevent grave injury to the physical and mental health of the pregnant woman, \\nc. in view of the substantial risk that if the child was born it would suffer from such physical \\nor mental abnormalities as to be seriously handicapped, \\nd. as the pregnancy is alleged by pregnant woman to have been caused by rape,  \\ne. as the pregnancy has occurred as a result of failure of any contraceptive device or methods \\nused by a woman or her partner for the purpose of limiting the number of children  or \\npreventing pregnancy.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Note: Account may be taken of the pregnant woman’s actual or reasonably foreseeable environment', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': ['iron'], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Note: Account may be taken of the pregnant woman’s actual or reasonably foreseeable environment \\nin determining whether the continuance of her pregnancy would involve a grave injury to her physical \\nor mental health.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Date:                                                                                                                   Signature of the Registered Medical Practitioner', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [10], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Date:                                                                                                                   Signature of the Registered Medical Practitioner\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n10\\nMonthly Reporting Form (Form II)\\nFORM II \\n[ Refer Regulation 4(5) ] \\nMonth & Year: ………….…………..….'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Name of the State:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Name of the State:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Name of Hospital/approved place:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Name of Hospital/approved place:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Duration of pregnancy: (Give total number only under each sub-head)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [24, 9, 12, 20], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Duration of pregnancy: (Give total number only under each sub-head) \\n(a) Upto 9 weeks (Medical Methods of Abortion Only):  \\n(b) Upto 12 weeks (Surgical Methods of Abortion Only):  \\n(c) Between 12-20 weeks:  \\n(d) Between 20 -24 weeks: \\n(e) Beyond 24 weeks:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Religion of woman: (Give total number under each sub-head)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Religion of woman: (Give total number under each sub-head) \\n(a) Hindu:  \\n(b) Muslim:  \\n(c) Christian:  \\n(d) Others:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Termination with acceptance of contraception: (Give total number under each sub-head)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Termination with acceptance of contraception: (Give total number under each sub-head) \\n(a) Sterilization:  \\n(b) IUCD:  \\n(c) OCP/Injectable Contraceptive:  \\n(d) Others:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Reasons for termination: (Give total number under each sub-head)', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'warning', 'topics': ['warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [24, 20], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='6.\\nReasons for termination: (Give total number under each sub-head) \\nA. Up to 20 weeks of gestation \\n(a) Danger to the life of the pregnant woman:  \\n(b) Grave injury to the physical and mental health of the pregnant woman:  \\n(c) Pregnancy caused by rape:  \\n(d) Substantial risk that if the child was born, it would suffer from such physical or mental \\nabnormalities as to be seriously handicapped: \\n(e) Failure of any contraceptive device or method:  \\n \\nB. Between 20-24 weeks of gestation \\n(a) Survivors of Sexual Assault/Rape/Incest: \\n(b) Minors: \\n(c) Change of marital status during the ongoing pregnancy (widowhood and divorce):  \\n(d) Women with physical disabilities\\n[major disability as per criteria laid down under the Rights of \\nPersons with Disabilities Act, 2016 (49 of 2016)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Reasons for termination: (Give total number under each sub-head)', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [24], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content=']: \\n(e) Mentally ill women including mental retardation: \\n(f) The foetal malformation that has substantial risk of being incompatible with life or if the child  is \\nborn it may suffer from such physical or mental abnormalities to be seriously handicapped: \\n(g) Women with pregnancy in humanitarian settings or disasters or emergency situations as declared \\nby Government: \\n \\nC.\\nBeyond 24 weeks of gestation \\n(a) The foetal malformation that has substantial risk of being incompatible with life or if the child is \\nborn it may suffer from such physical or mental abnormalities to be seriously handicapped: \\n \\n \\n \\n \\nSignature of the Officer In-charge with Date\\n\\n11\\nTraining Manual\\nFor MMA in Early Gestation\\nAdmission Register (Form III)\\nFORM III \\n[ Refer Regulation 5 ] \\nAdmission Register \\n(To be destroyed on the expiry of five years from the date of the last entry in the Register)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name of Facility: ____________________________________________________      Month ____________________ Year __________', 'chunk_index': 0, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [24], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of Facility:\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\nMonth _\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\nYear\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\n_\\nS. \\nNo.\\nDate of \\nAdmission \\nName of \\nthe Patient \\nWife / \\nDaughter \\nof \\nAge Religion Address Duration of \\nPregnancy \\nReasons on \\nwhich \\nPregnancy \\nis \\nterminated \\nDate of \\ntermination \\nof \\nPregnancy \\nDate of \\ndischarge \\nof patient \\nResult & \\nRemarks \\nName of \\nRegistered \\nMedical \\nPractitioner(s) \\nby whom the \\nopinion is \\nformed \\n(For pregnancy \\nbeyond 24 weeks \\nmention the \\nnames of \\nMedical Board \\nmembers) \\nName of \\nRegistered \\nMedical \\nPractitioner(s) \\nby whom \\nPregnancy is \\nterminated \\nMethod \\nof MTP \\n \\n(MVA/ \\nEVA/ \\nMMA/ \\nD&C/ \\nOthers)\\nPost Abortion \\nContraception \\n \\n(Tubal Ligation \\n(TL)/IUCD/ \\nOCP/ \\nInjectables/ \\nOthers/ \\nNone) \\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16\\n\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name of Facility: ____________________________________________________      Month ____________________ Year __________', 'chunk_index': 1, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t It can be performed only by eligible RMPs as under the MTP (Amendment) Rules, 2021. \\n•\\t It can be performed for gestation age up to nine weeks, at approved sites as well as outdoor clinic of \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name of Facility: ____________________________________________________      Month ____________________ Year __________', 'chunk_index': 2, 'total_chunks_in_section': 3, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='12\\nFollowing are the key conditions/requirements for MTP using medical methods, as under the MTP Act:\\n•\\t It can be performed only by eligible RMPs as under the MTP (Amendment) Rules, 2021.\\n•\\t Documentation formats (Form C, I, II, III) are mandatory to be completed for MMA.\\nConfidentiality of the woman is to be fully ensured and her particulars should not be shared with anyone \\nexcept the person authorised by the law.\\n13\\nTraining Manual\\nFor MMA in Early Gestation\\n3.1: Indications for MMA\\nOption for MMA should be given to all women coming to a health facility seeking termination of \\npregnancy up to nine weeks of gestation (63 days from the first day of the last menstrual period in \\nwomen with regular cycles of approximately 28 days).\\n3.2: Contraindications for MMA'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Medical methods of abortion is contraindicated in women with:', 'chunk_index': 0, 'total_chunks_in_section': 5, 'chunk_type': 'recommendation', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['anaemia', 'hypertension'], 'medications': [], 'procedures': [], 'measurements': ['bp']}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Medical methods of abortion is contraindicated in women with:\\n•\\t Confirmed or suspected ectopic pregnancy 1 or undiagnosed adnexal mass, as Mifepristone or \\nMisoprostol cannot treat ectopic pregnancy\\n•\\t Anaemia (haemoglobin <8gm %)\\n•\\t Uncontrolled hypertension with BP >160/100mm Hg\\n•\\t Chronic adrenal failure\\n•\\t Severe renal, liver, or respiratory diseases\\n•\\t Uncontrolled seizure disorder\\n•\\t Inherited porphyria\\n•\\t Glaucoma\\n•\\t Allergy or intolerance to Mifepristone/Misoprostol or other prostaglandins\\nWomen with co-morbidities should be referred to higher centres.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Medical methods of abortion is contraindicated in women with:', 'chunk_index': 1, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Lower abdominal pain, usually one-sided, that may be sudden and intense, persistent, or cramping\\n•\\t Irregular vaginal bleeding or spotting\\n•\\t Fainting or dizziness that persists for more than a few seconds, possibly indicative of internal bleeding. Internal bleeding is not \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Medical methods of abortion is contraindicated in women with:', 'chunk_index': 2, 'total_chunks_in_section': 5, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Current long-term use of systemic corticosteroids (including those with severe uncontrolled asthma).\\n•\\t Coagulopathy or on anticoagulant therapy.\\n•\\t Pre-existing heart disease or cardiovascular risk factors. \\n•\\t Pregnancy with in-situ intrauterine contraceptive device (IUCD): IUCD must be removed before \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Medical methods of abortion is contraindicated in women with:', 'chunk_index': 3, 'total_chunks_in_section': 5, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='3 Indications/Contraindications for MMA\\nShare with the participants the indications, contraindications, and situations for \\nspecial precautions for prescribing MMA.\\n 1Signs/symptoms during ectopic pregnancy could include:\\n•\\t Lower abdominal pain, usually one-sided, that may be sudden and intense, persistent, or cramping\\n•\\t Irregular vaginal bleeding or spotting\\n•\\t Fainting or dizziness that persists for more than a few seconds, possibly indicative of internal bleeding.\\nEctopic pregnancy can be diagnosed with a careful history, examination, and USG\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n14\\n3.3: Special Precautions for MMA\\nBesides absolute contraindications, MMA drugs are to be used with caution in the following situations, \\nas given below:\\n•\\t Current long-term use of systemic corticosteroids (including those with severe uncontrolled asthma).'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Medical methods of abortion is contraindicated in women with:', 'chunk_index': 4, 'total_chunks_in_section': 5, 'chunk_type': 'warning', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['caesarean'], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': True}, page_content='•\\t Pregnancy with fibroid: Women with symptomatic large fibroids encroaching on endometrial cavity \\ncan have heavy bleeding and fibroids may interfere with the uterine contractility.\\n•\\t Pregnancy with uterine scar: Caution should be exercised when MMA is offered to women with a \\nprevious history of caesarean section, hysterotomy or myomectomy.\\n•\\t Bronchial asthma: Misoprostol is a weak bronchodilator and therefore, could be used in women \\nwith bronchial asthma.\\nHowever, prostaglandins other than Misoprostol should not be used.\\n•\\t Use of anti-tubercular drugs: These may decrease the efficacy of MMA drugs.\\n3.4: Eligibility Checklist for MMA\\nGiven below is a quick checklist to assess the eligibility of the woman for MMA.\\nOnly if all the answers \\nfrom 1 to 8 are “NO” , proceed with the procedure:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [9], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['hypertension'], 'medications': [], 'procedures': [], 'measurements': ['bp']}, 'contains_warning': False, 'contains_recommendation': True}, page_content='\\n\\n15\\nTraining Manual\\nFor MMA in Early Gestation\\n4 About MMA Drugs\\nShare with the participants the mechanism of action of the drugs used for MMA.\\n4.1: Drugs Used for MMA\\nRecommended drugs for MMA are Mifepristone and Misoprostol.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [9], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['hypertension'], 'medications': [], 'procedures': [], 'measurements': ['bp']}, 'contains_warning': False, 'contains_recommendation': True, 'parent_section_path': []}, page_content='Table 1: Eligibility Checklist\\nEligibility Checklist Ye s No\\n1 Gestation period or uterine size more than 9 weeks\\n2 Suspected or diagnosed ectopic pregnancy or undiagnosed adnexal \\nmass\\n3 History of bleeding disorders or inherited porphyrias\\n4 History of uncontrolled seizure disorder/respiratory/hepatic/renal \\ndisease\\n5 History of allergic reaction to Mifepristone/Misoprostol \\n6 History of uncontrolled hypertension with BP >160/100mm Hg\\n7 History of chronic adrenal failure or glaucoma\\n8 Woman looks anaemic/pale'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='5Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n3.1: Indications for MMA\\nOption\\tfor\\tMMA\\tshould\\tbe\\tgiven\\tto\\tall\\twomen\\tcoming\\tto\\ta\\thealth\\tfacility\\tseeking\\ttermination\\tof\\t\\npregnancy\\tup\\tto\\t7\\tweeks\\tof\\tgestation\\t(49\\tdays\\tfrom\\tthe\\tfirst\\tday\\tof\\tthe\\tlast\\tmenstrual\\tperiod\\tin\\t\\nwomen\\twith\\tregular\\tcycles\\tof\\tapproximately\\t28\\tdays)1'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 1: MMA Drugs (Mifepristone and Misoprostol)\\n3.2: Contraindications for MMA'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Women being prescribed MMA should be screened for the following common contraindications:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['normal_variations', 'delivery'], 'pregnancy_stages': {'weeks': [9], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['anaemia', 'hypertension'], 'medications': [], 'procedures': ['delivery'], 'measurements': ['bp']}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Women being prescribed MMA should be screened for the following common contraindications:\\n•\\t Anaemia\\t(haemoglobin\\t<8\\tgm\\t%)\\n•\\t Confirmed\\tor\\tsuspected\\tectopic\\tpregnancy/undiagnosed\\tadnexal\\tmass\\n•\\t Uncontrolled\\thypertension\\tor\\tBP\\t>\\t160/100\\tmm\\tHg\\n3\\nSection\\nIndications/Contraindications \\nfor MMA\\n1\\tIn\\tDecember\\t2008,\\tCombipack\\twith\\tMifepristone+\\tMisoprostol\\t(1\\ttablet\\tof\\tMifepristone\\t200mg\\tand\\t4\\ttablets\\tof\\tMisoprostol\\t200mcg\\t\\neach)\\twas\\tapproved\\tby\\tthe\\tCentral\\tDrugs\\tStandard\\tControl\\tOrganization,\\tDirectorate\\tGeneral\\tof\\tHealth\\tServices,\\tIndia,\\tfor\\tthe\\t\\ntermination\\tof\\tintra-uterine\\tpregnancy\\tfor\\tup\\tto\\t63\\tdays/9\\tweeks\\tgestation.\\nCAC\\tTraining\\t&\\tService\\tDelivery\\tGuidelines,\\t2010\\tby\\tMoHFW,\\tGoI\\trecommends\\tits\\tuse\\tup\\tto\\t49\\tdays\\tin\\tpublic\\tsector\\tsites,\\tin\\tline\\t\\nwith\\tthe\\tMTP\\tRules\\t2003.\\nA\\tproposed\\tamendment\\tto\\tthe\\tMTP\\tAct,\\t1971,\\tto\\tincrease\\tthe\\tgestation\\tlimit\\tfor\\tMMA\\tto\\t9\\tweeks\\tin\\tpublic\\tsector\\tsites\\tis\\tunder\\tprocess.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Women being prescribed MMA should be screened for the following common contraindications:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Till\\tthe\\tproposal\\tis\\tapproved,\\tMMA\\tin\\tpublic\\thealth\\tfacility\\twould\\tbe\\tallowed\\tonly\\tup\\tto\\t7\\tweeks.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 1: MMA Combipack (Mifepristone and Misoprostol)\\nMMA drugs are Schedule H drugs and are to be sold by retail on the prescription of a Registered \\nMedical Practitioner only.\\nMifepristone is an antiprogestin, which blocks the progesterone receptors in the endometrium, causing \\nthe necrosis of uterine lining and detachment of implanted embryo.\\nIt causes cervical softening, increases \\nsensitivity of the cervix and uterus to the action of prostaglandins and may initiate uterine contractions \\ntoo.\\nA small percentage of women (3%) may expel products of conception (POC) with Mifepristone \\nalone.\\nMisoprostol is a synthetic prostaglandin E1 analogue.\\nIt binds to the myometrial cells and leads to \\ncervical softening and dilatation and uterine contractions.\\nThis leads to the expulsion of POC from the \\nuterus.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Misoprostol has an advantage over other prostaglandins as it is well absorbed from different routes \\nof administration, is economical, stable at room temperature, and does not cause bronchoconstriction in \\ncomparison to PGF2alpha derivatives.\\nIt was earlier used for prevention and treatment of gastric ulcer.\\nTraining Manual\\nFor MMA in Early Gestation\\n16'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Different Routes of Misoprostol Administration:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Different Routes of Misoprostol Administration:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Sublingual (below the tongue)', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='1. Sublingual (below the tongue)\\n7Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n4.1: Drugs Used in MMA\\nRecommended\\tdrugs\\tfor\\tMMA\\tare\\tMifepristone\\tand\\tMisoprostol.\\nMMA drugs are Schedule H drugs and are to be sold by retail on the prescription of a \\nRegistered Medical Practitioner only.\\nMifepristone is\\tan\\tantiprogestin,\\twhich\\tblocks\\tthe\\tprogesterone\\treceptors\\tin\\tthe\\tendometrium,\\t\\ncausing\\tthe\\tnecrosis\\tof\\tuterine\\tlining\\tand\\tdetachment\\tof\\timplanted\\tembryo.\\nIt\\tcauses\\tcervical\\t\\nsoftening\\tand\\tan\\tincreased\\tproduction\\tof\\tprostaglandins,\\tcausing\\tuterine\\tcontractions.\\nA\\tsmall\\t\\npercentage\\tof\\twomen\\t(3%)\\tmay\\texpel\\tproducts\\tof\\tconception\\t(POC)\\twith\\tMifepristone\\talone.\\nMisoprostol is\\ta\\tsynthetic\\tprostaglandin\\tE1\\tanalogue.\\nIt\\tbinds\\tto\\tthe\\tmyometrial\\tcells,\\tcausing\\t\\nstrong\\tuterine\\tcontractions,\\tcervical\\tsoftening\\tand\\tdilatation.\\nThis\\tleads\\tto\\tthe\\texpulsion\\tof\\tPOC\\t\\nfrom\\tthe\\tuterus.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Sublingual (below the tongue)', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Misoprostol\\thas\\tan\\tadvantage\\tover\\tother\\tprostaglandins\\tas\\tit\\tis\\twell\\tabsorbed\\tfrom\\t\\ndifferent\\troutes\\tof\\tadministration,\\tis\\teconomical,\\tand\\tstable\\tat\\troom\\ttemperatures\\tin\\tcomparison\\t\\nto\\tPGF2alpha\\tderivatives.\\nIt\\twas\\tearlier\\tused\\tfor\\tprevention\\tand\\ttreatment\\tof\\tgastric\\tulcer.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Action of Misoprostol through different routes of administration:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Action of Misoprostol through different routes of administration:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Sublingual: Rapid\\tonset\\tof\\taction\\t(like\\toral\\troute)\\tand\\tlonger\\tduration\\tof\\taction\\t(like\\tvaginal\\troute);', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Sublingual: Rapid\\tonset\\tof\\taction\\t(like\\toral\\troute)\\tand\\tlonger\\tduration\\tof\\taction\\t(like\\tvaginal\\troute);'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 2: Sublingual administration of Misoprostol \\n4\\nSection\\nMMA Drugs'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 2: Sublingual administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Buccal (in the cheeks)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Buccal (in the cheeks)\\n8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels\\t\\nachieved\\tare\\tlower.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 3: Buccal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal\\t\\nadministration\\tmay\\tnot\\tcompletely\\tdissolve.\\tAs\\tthe\\tcore\\tof\\tthe\\ttablet\\tis\\tnon-medicated,\\tthis\\tdoes\\t\\nnot\\taffect\\tits\\tefficacy.\\tMoistening\\tthe\\ttablet\\tbefore\\tvaginal\\tadministration\\tdoes\\tnot\\timprove\\tefficacy\\t\\n(ACOG,\\t2009)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 4: Vaginal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 5: Oral administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 3: Buccal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Vaginal', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Vaginal \\n8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels\\t\\nachieved\\tare\\tlower.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 3: Buccal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal\\t\\nadministration\\tmay\\tnot\\tcompletely\\tdissolve.\\tAs\\tthe\\tcore\\tof\\tthe\\ttablet\\tis\\tnon-medicated,\\tthis\\tdoes\\t\\nnot\\taffect\\tits\\tefficacy.\\tMoistening\\tthe\\ttablet\\tbefore\\tvaginal\\tadministration\\tdoes\\tnot\\timprove\\tefficacy\\t\\n(ACOG,\\t2009)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 4: Vaginal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 5: Oral administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 4: Vaginal administration of Misoprostol\\n\\n17\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Oral', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Oral\\n8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels\\t\\nachieved\\tare\\tlower.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 3: Buccal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal\\t\\nadministration\\tmay\\tnot\\tcompletely\\tdissolve.\\tAs\\tthe\\tcore\\tof\\tthe\\ttablet\\tis\\tnon-medicated,\\tthis\\tdoes\\t\\nnot\\taffect\\tits\\tefficacy.\\tMoistening\\tthe\\ttablet\\tbefore\\tvaginal\\tadministration\\tdoes\\tnot\\timprove\\tefficacy\\t\\n(ACOG,\\t2009)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 4: Vaginal administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 5: Oral administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 5: Oral administration of Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Below is the graph with pharmacokinetics of Misoprostol by different routes:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Below is the graph with pharmacokinetics of Misoprostol by different routes:\\n9Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 6: Graph comparing pharmacokinetics of Misoprostol administered by different routes'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True, 'parent_section_path': []}, page_content='Table 1: Effectiveness of Misoprostol administered by different routes\\nRoute of \\nAdministration\\nOnset of \\nAction\\nDuration of Action Preferred/Recommended Route'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Sublingual Fastest Highest\\tplasma\\tlevels\\t\\nand\\tprolonged\\taction\\nMost\\trecommended\\nBuccal Quick Prolonged\\taction Recommended\\nVaginal Quick Prolonged\\taction Recommended \\nOral Quick Least\\tduration Least\\trecommended\\tbut\\tstill\\tcan\\tbe\\tgiven\\nThe table below indicates the effectiveness of Misoprostol when administered by different routes:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 2: Effectiveness of Misoprostol administered by different routes2'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 6: Graph comparing pharmacokinetics of Misoprostol administered by different routes\\nRoute of Administration Peak Levels Attained Bioavailability\\nSublingual Rapidly (30 minutes) Long duration (6 hours)\\nVaginal3 Gradually (70-80 minutes) Longest duration (>6 hours)\\nBuccal Gradually (70-80 minutes) Moderate duration (3 hours)\\nOral (only if gestation age is upto 7 \\nweeks)\\nRapidly (30 minutes) Short duration (2 hours)\\n 2Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167\\n 3Moistening the tablet before vaginal administration does not improve efficacy (ACOG, 2009)\\n- Plasma Misoprostol concentration (pg/ml)\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n18\\n5 MMA Protocol and Process\\nThe steps of the MMA procedure are divided based on the day of visit. Typically, it requires three \\nvisits (Day 1, 3 and 15). 2 nd visit on Day 3 is optional when the woman takes Misoprostol at home, in \\nconsultation with the provider.\\n5.1: Drug Protocol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 3: MMA Drug Protocol\\nShare with the participants the drug protocol to be used for MMA and the whole process of \\nabortion when performed by MMA.\\nVisit Day Drugs used\\nFirst 1 One  •\\t 200 mg Mifepristone oral;\\n•\\t Anti D 50 mcg, if Rh negative.\\nSecond 3 Three                     •\\t 800 mcg Misoprostol (four tablets of 200 mcg) sublingual/ \\nbuccal/vaginal/oral only if < 7 weeks;\\n•\\t Analgesic (Ibuprofen);\\n•\\t Antiemetic;\\n•\\t Offer contraception.\\nThird 15 Fifteen                       •\\t Confirm and ensure completion of abortion;\\n•\\t Offer contraception, if not already done so.\\n5.2: Process of MMA\\nA. First Visit/Day 1/Day of Mifepristone Administration\\nFirst visit starts with assessing the suitability of the woman to undergo medical methods of abortion.\\nSuitability is judged by taking a detailed history, conducting a clinical examination, necessary \\ninvestigations and excluding the contraindications.\\nFirst visit sometimes may not be the day of Mifepristone administration.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='It is the day of Mifepristone administration which is taken as Day 1.\\nIt is important to ensure that \\nwomen are already well evaluated and counselled, including contraceptive counselling, on Day 1 before \\nadministering Mifepristone.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Detailed History', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1.\\nDetailed History\\na. Demographic profile: age, religion, address etc.\\nb.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Detailed History', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['nutrition', 'warning_signs', 'normal_variations', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['hypertension'], 'medications': [], 'procedures': ['caesarean'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Menstrual history: length and duration of cycle, flow (excess or normal), and LMP\\n\\n19\\nTraining Manual\\nFor MMA in Early Gestation\\nc. Obstetric history: parity, live births, abortion (induced and spontaneous and if any complications), \\nprevious caesarean section (if any), last childbirth/abortion, and presently lactating or not\\nd. History of pre-existing medical/surgical conditions:\\n•\\t Hypertension\\n•\\t Heart disease\\n•\\t Diabetes mellitus\\n•\\t Epilepsy\\n•\\t Asthma (not a contraindication with PGE1)\\n•\\t Renal disease\\n•\\t Drug allergies including to Mifepristone / Misoprostol\\n•\\t Bleeding disorders\\n•\\t Current medication\\n•\\t Previous uterine/tubal/abdominal surgery/ectopic pregnancy\\n•\\t Treatment for infertility/Tuberculosis/pelvic inflammatory disease\\ne. History of any interference/drugs taken in this pregnancy to attempt termination/bleeding per \\nvaginum\\nf. Contraceptive history: type and duration of contraceptive used\\ng. Status of tetanus immunization: last dose received\\nh. Psychosocial assessment: to assess family support\\ni. History of sexual assault and domestic violence\\nEligibility of the woman may be assessed using the `Eligibility Checklist’ given in the Chapter 3: \\nIndications/Contraindications for MMA, section 3.4.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Counselling: General and Method-specific Counselling', 'chunk_index': 0, 'total_chunks_in_section': 4, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Ask about her existing knowledge and beliefs about abortion options.\\n•\\t Tell her about all the methods available for abortion and how each method differs from the other.\\n•\\t Discuss her contraceptive needs and counsel her accordingly for contraception after abortion. \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Counselling: General and Method-specific Counselling', 'chunk_index': 1, 'total_chunks_in_section': 4, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='2. Counselling: General and Method-specific Counselling\\nShare with the participants the general and MMA specific counselling points to be \\nconveyed to the woman while counselling for MMA procedure.\\nGeneral Counselling\\nWhile counselling the woman, attention must be paid to the following points:\\nThe counsellor needs to understand with empathy and sensitivity, why abortion is being sought.\\nInform her about return of fertility within 10 days of an abortion process/procedure.\\n•\\t Discuss infection prevention aspects like local hygiene, handwashing, and use of clean sanitary \\nnapkins, etc.\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n20\\nMethod-specific Counselling\\nIf the woman chooses MMA, she should be provided the following information:\\na.\\nIt is a non-invasive and non-surgical method.\\nb.\\nHowever, failure of the method or excessive bleeding (soaking two or more thick pads per hour for \\ntwo consecutive hours) may necessitate further management at a higher centre for vacuum aspiration.\\nc.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Counselling: General and Method-specific Counselling', 'chunk_index': 2, 'total_chunks_in_section': 4, 'chunk_type': 'recommendation', 'topics': ['maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='The process is similar to a natural miscarriage.\\nd.\\nShe needs to make a minimum of three visits to the facility (Day 1, 3, and 15).\\nHome administration \\nof Misoprostol is allowed on provider’s discretion.\\nIn such cases, the number of facility visits will \\nreduce to two (Day 1, and 15).\\ne.\\nShe must follow a definite drug protocol.\\nf.\\nShe has option of different routes of Misoprostol administration and would be helped to choose one.\\ng.\\nShe should stay within the accessible limits of the appropriate health care facility.\\nh.\\nThere could be teratogenic (harmful) effect on the foetus if the method fails and pregnancy continues.\\ni.\\nA small percentage of women (3%) may expel products with Mifepristone alone, but total drug \\nschedule with Misoprostol must be completed.\\nj.\\nDuring the abortion process, it is ideal to avoid intercourse to prevent infection, or hence use barrier \\nmethods.\\nk.\\nExplain the symptoms that would be experienced by her.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Counselling: General and Method-specific Counselling', 'chunk_index': 3, 'total_chunks_in_section': 4, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='12 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 3, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Figure 7: Counselling on MMA procedure\\nMethod-specific Counselling\\nIf\\tthe\\twoman\\tchooses\\tMMA,\\tshe\\tshould\\tbe\\tprovided\\tthe\\tfollowing\\tinformation:\\na)\\nIt\\tis\\ta\\tnon-invasive\\tand\\tnon-surgical\\tmethod\\nb)\\t The\\tprocess\\tis\\tsimilar\\tto\\ta\\tnatural\\tmiscarriage\\nc)\\nShe\\tneeds\\tto\\tmake\\ta\\tminimum\\tof\\tthree\\tvisits\\tto\\tthe\\tfacility\\t(day\\t1,\\t3,\\t&\\t15).\\nHome\\tadministration\\t\\nof\\tMisoprostol\\tis\\tallowed\\ton\\tprovider’s\\tdiscretion.\\nIn\\tsuch\\tcases,\\tthe\\tnumber\\tof\\tfacility\\tvisits\\t\\nwill\\treduce\\tto\\ttwo.\\nd)\\t She\\thas\\tto\\tfollow\\ta\\tdefinite\\tdrug\\tprotocol\\ne)\\t Counselling\\tabout\\tdifferent\\troutes\\tof\\tadministration\\nf)\\nShe\\thas\\tto\\tbe\\tready\\tfor\\tVA\\tprocedure\\tin\\tcase\\tof\\tfailure\\tof\\tthe\\tmethod\\tor\\texcessive\\tbleeding\\t\\n(soaking\\ttwo\\tor\\tmore\\tthick\\tpads\\tper\\thour\\tfor\\ttwo\\tconsecutive\\thours)\\t\\ng)\\t She\\thas\\tto\\tstay\\twithin\\tthe\\taccessible\\tlimits\\tof\\tthe\\tappropriate\\thealth\\tcare\\tfacility.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 3, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'normal_variations', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='She\\tshould\\t\\nnot\\tbe\\tleft\\tunattended\\tat\\thome\\t\\nh)\\t \\tExplain\\tthe\\tsymptoms\\tthat\\twould\\tbe\\texperienced\\tby\\ther,\\tfor\\texample:\\t\\n•\\t Bleeding\\tper\\tvaginum\\tis\\tan\\tessential\\tpart\\tof\\tthe\\tMMA\\tprocess\\tsince\\tit\\tis\\tsimilar\\tto\\t\\nmiscarriage.\\nBleeding\\tis\\tusually\\theavier\\tthan\\twhat\\tis\\texperienced\\tduring\\ta\\tmenstrual\\t\\nperiod.\\nBleeding\\toften\\tlasts\\tfor\\t8\\tto\\t13\\tdays.\\nSoaking\\tof\\ttwo\\tthick\\tpads\\twithin\\tone\\tto\\ttwo\\t\\nhours\\tafter\\ttaking\\tMisoprostol,\\tbut\\tdecreasing\\tover\\ttime\\tis\\tconsidered\\tnormal.\\n•\\t Abdominal\\tpain\\tis\\texperienced\\tas\\ta\\tpart\\tof\\tthe\\tMMA\\tprocess.\\nRefrain\\tfrom\\tdescribing\\t\\ncramping\\t pain\\t as\\t similar\\t to\\t labour\\t pains.\\nInstead,\\t it\\t can\\t be\\t compared\\t with\\t severe\\t\\nmenstrual\\tcramps.\\nSometimes\\tthe\\tpain\\tbegins\\tfollowing\\tingestion\\tof\\ttablet\\tMifepristone,\\t\\nbut\\tmost\\toften\\tit\\tstarts\\tone\\tto\\tthree\\thours\\tafter\\tMisoprostol\\tadministration\\tand\\tis\\theaviest\\t\\nduring\\tthe\\tactual\\tabortion\\tprocess,\\toften\\tlasting\\tup\\tto\\tfour\\thours.\\nIf\\tthe\\tpain\\tis\\tpersistent,\\t\\nthe\\tpossibility\\tof\\tectopic\\tpregnancy\\tshould\\talways\\tbe\\truled\\tout.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 2, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Nausea,\\tvomiting,\\tdiarrhoea,\\tetc.\\tare\\tnormal\\tside\\teffects\\tof\\tdrugs.\\ni)\\t There\\tcould\\tbe\\tteratogenic\\t(harmful)\\teffect\\ton\\tthe\\tfetus,\\tif\\tpregnancy\\tcontinues\\nj)\\t A\\tsmall\\tpercentage\\tof\\twomen\\t(3%)\\tmay\\texpel\\tproducts\\twith\\tMifepristone\\talone,\\tbut\\ttotal\\t\\ndrug\\tschedule\\twith\\tMisoprostol\\tmust\\tbe\\tcompleted\\nk)\\nDuring\\tthe\\tabortion\\tprocess,\\tit\\tis\\tideal\\tto\\tavoid\\tintercourse\\tto\\tprevent\\tinfection,\\tor\\tuse\\tbarrier\\t\\nmethods'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 7: Counselling on MMA procedure'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Share with the participants the expected symptoms during the process of MMA.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Expected Symptoms during MMA \\n    \\n•\\tBleeding per vaginum  is an essential part of the MMA process since it is similar to miscarriage.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['normal_variations', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Bleeding is usually heavier than what is experienced during a menstrual period. Bleeding often \\nlasts for 8 to 13 days. Soaking of two thick pads within one to two hours after taking Misoprostol, \\nis considered normal, but this should decrease over time. If it happens beyond 4 – 6 hours of taking \\nMisoprostol, the provider/facility should be contacted.\\n•\\t Abdominal pain is experienced as a part of the MMA process. Refrain from describing cramping \\npain like labour pains. Instead, it can be compared with severe menstrual cramps. Sometimes the \\npain begins following ingestion of tablet Mifepristone, but most often it starts after Misoprostol\\n\\n21'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Training Manual\\nFor MMA in Early Gestation\\nadministration and is heaviest during the actual abortion process, often lasting up to four hours. \\nIf the pain is persistent even after taking an analgesic, the possibility of ectopic pregnancy should \\nalways be ruled out.\\n•\\t Nausea, vomiting, and diarrhoea, etc. are normal side effects of drugs.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='For covering all the important points during the counselling of the woman before MMA, `Counselling \\nSkills Checklist’ may be referred to, which is given as`Annexure – 1.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Clinical Assessment and Eligibility Screening', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['screening'], 'measurements': ['blood pressure']}, 'contains_warning': False, 'contains_recommendation': True}, page_content='3. Clinical Assessment and Eligibility Screening\\nClinical assessment includes General Physical, Systemic, Abdominal and Pelvic Examination:\\na. Check for pallor: if pallor exists, heavy bleeding during the procedure may worsen the condition and \\nincrease the risk of shock and ill health.\\nb. Check Blood pressure; cardiovascular; and respiratory system for any pre-existing disease.\\nc. Look for any mass, rigidity, tenderness in abdominal examination.\\nd. Carry out Pelvic examination (P/S and P/V).\\n13Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nl)\\t Women\\twith\\tno\\tsupport\\tat\\thome:\\tarrangements\\tshould\\tbe\\tmade\\tfor\\ttransportation\\tto\\tthe\\t\\nhospital,\\tin\\tcase\\tof\\temergency\\tor\\tshould\\tbe\\tadmitted\\tfor\\tthe\\tMMA\\tprocedure'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. General Physical, Systemic, Abdominal and Pelvic Examination', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. General Physical, Systemic, Abdominal and Pelvic Examination\\na)\\t Check\\tfor\\tpallor:\\tif\\tpallor\\texists,\\theavy\\tbleeding\\tduring\\tthe\\tprocedure\\tmay\\tworsen\\tthe\\t\\ncondition\\tand\\tincrease\\tthe\\trisk\\tof\\tshock\\tand\\till\\thealth\\t\\nb)\\t Blood\\tpressure;\\tcardiovascular;\\tand\\trespiratory\\tsystem\\tfor\\tany\\tpre-existing\\tdisease\\nc)\\t Look\\tfor\\tany\\tmass,\\trigidity,\\ttenderness\\tin\\tabdominal\\texamination\\nd)\\t Carry\\tout\\tPelvic\\texamination\\t(P/S\\tand\\tP/V)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 8: Performing bimanual examination\\n•\\t P/S\\texamination:\\tlook\\tfor\\tinfection,\\tcervical\\terosion,\\tpolyp\\n•\\t P/V\\texamination:\\tcheck\\tthe\\tsize,\\tshape,\\tregularity\\tand\\tconsistency\\tof\\tuterus\\tto\\tconfirm\\t\\nthe\\tperiod\\tof\\tgestation\\tand\\tadenexal\\tmass\\t\\n•\\t Rule\\tout\\tectopic\\tpregnancy2,\\tin\\tcase\\tof\\tadenexal\\tmass/fullness\\tor\\ttenderness\\tin\\tadenexa\\t\\nor\\tcervical\\ttenderness\\n2\\tEctopic\\tpregnancies\\tcan\\tbe\\tdiagnosed\\twith\\ta\\tcareful\\thistory,\\texamination\\tand\\tUSG.\\nSince\\tit\\tis\\tan\\tobstetric\\tUSG,\\tit\\tmust\\tbe\\tdone\\tin\\t\\naccordance\\twith\\tPCPNDT\\tAct.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Symptoms during ectopic pregnancy might include:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\tAmenorrhea\\n•\\tNausea,\\tvomiting\\n•\\tLower\\tabdominal\\tpain,\\tusually\\tone\\t-\\tsided,\\tthat\\tmay\\tbe\\tsudden\\tand\\tintense,\\tpersistent,\\tor\\tcramping\\t\\n•\\tIrregular\\tvaginal\\tbleeding\\tor\\tspotting\\t\\n•\\tFainting\\tor\\tdizziness\\tthat\\tpersists\\tfor\\tmore\\tthan\\ta\\tfew\\tseconds\\tis\\tpossibly\\tindicative\\tof\\tinternal\\tbleeding.\\tInternal\\tbleeding\\tis\\tnot\\t\\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Symptoms during ectopic pregnancy might include:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Symptoms during ectopic pregnancy might include:\\n•\\tAmenorrhea\\n•\\tNausea,\\tvomiting\\n•\\tLower\\tabdominal\\tpain,\\tusually\\tone\\t-\\tsided,\\tthat\\tmay\\tbe\\tsudden\\tand\\tintense,\\tpersistent,\\tor\\tcramping\\t\\n•\\tIrregular\\tvaginal\\tbleeding\\tor\\tspotting\\t\\n•\\tFainting\\tor\\tdizziness\\tthat\\tpersists\\tfor\\tmore\\tthan\\ta\\tfew\\tseconds\\tis\\tpossibly\\tindicative\\tof\\tinternal\\tbleeding.\\nUterine evacuation methods whether vacuum aspiration or medical methods using Mifepristone and \\nMisoprostol, cannot terminate an ectopic pregnancy and hence should not be attempted in case of suspicion.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t P/S examination: look for infection, discharge (type), cervical erosion, polyp\\n•\\t P/V examination: check the size, direction, shape and regularity, and consistency of uterus to \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 8: Performing bimanual examination\\n•\\t P/S examination:\\nUterine size estimation through bimanual examination is the most critical skill required for MMA.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Investigations (Recommended)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='4. Investigations (Recommended)\\ni. Haemoglobin\\nii. Routine urine examination\\niii. Blood Group: ABO Rh especially in primigravida\\niv. Pregnancy test\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n22'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Investigations as per the need:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Women are unsure of LMP or have conceived during lactational amenorrhea.\\n•\\t Women with discrepancy between history and clinical findings.\\n•\\t Women with suspicion of ectopic pregnancy.\\n•\\t Provider is uncertain after bimanual examination, or inability to measure uterine size due to obesity, \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Investigations as per the need:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Investigations as per the need:\\nUltrasonography (USG): USG may be done at sites where these facilities are available.\\nHowever, it is not \\nmandatory for all women undergoing pregnancy termination with medical methods.\\nUSG needs to be \\nperformed when:\\n•\\t Women are unsure of LMP or have conceived during lactational amenorrhea.\\n•\\t Provider is uncertain about the completion of the process during the follow-up visit.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Contraceptive Options', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='5. Contraceptive Options\\nWoman’s acceptance for contraceptive method should not be a pre-condition for providing abortion \\nservices. However, all post abortion contraceptive options should be discussed with her, and she should \\nbe helped to choose the appropriate contraception for herself, based on her eligibility.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Informed Consent', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='6. Informed Consent\\nGet the consent of the woman/guardian in Form C. Also fill in the RMP Opinion Form (Form I), before \\nprescribing MMA drugs.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '7. Tablet Mifepristone (200mg) is administered orally', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='7. Tablet Mifepristone (200mg) is administered orally\\nAnti-D (50 mcg) given to Rh negative woman.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '8. Iron and Folic Acid Tablets', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': ['iron', 'folic acid'], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='8. Iron and Folic Acid Tablets\\n90 tablets (to be taken for next three months) should be given to all women undergoing MMA procedure.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '9. Sanitary Napkins', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='9. Sanitary Napkins\\nUse of sanitary napkins is recommended for prevention of infection.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '10. Antibiotics', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='10. Antibiotics\\nRoutine use of prophylactic antibiotics is not indicated.\\nAntibiotics should be given to women with suspected/evident reproductive tract infections. \\nRecommended antibiotics are Doxycycline 100 mg, twice a day for five days for non-lactating women, \\nand Azithromycin 500 mg, once a day for three days for lactating women.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '11. Give contact address and phone number of the service provider/facility where woman can go in', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='11. Give contact address and phone number of the service provider/facility where woman can go in \\ncase of an emergency.\\n\\n23\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '12. Complete the MMA card', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='12. Complete the MMA card\\nExplain the MMA card (Annexure - 3) to the woman and instruct her to note \\ndown her symptoms on it.\\nAt the sole discretion of the service provider, a woman can be given Misoprostol to be taken at home. \\nIn such cases, a thorough counselling on what is expected after taking Misoprostol, should be done. She \\nshould be called back on 15th day for follow up.\\nThe table below summarizes the tasks for Day 1 of the MMA protocol:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 4: Tasks for Day 1/Day of Mifepristone administration\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:\\nProvider’s Task Instructions to the Woman\\nDetailed history, rule out contraindications and \\nnote special precautions\\nTake tablet Mifepristone 200 mg orally\\nGeneral and MMA specific counselling What to expect after taking tablet Mifepristone\\nGeneral physical and pelvic examination\\nEstimation of gestation age by bimanual \\nexamination is the most important skill required \\nfor MMA\\nShe may have pain/bleeding in the next 2 days \\nTake analgesic, if required\\nFill in Form I, Form C\\nRecord investigations\\nReturn for Misoprostol on Day 3 (unless decided \\nby provider to give her for home administration)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': ['iron', 'folic acid'], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Discuss contraceptive options Avoid intercourse or use barrier methods\\nComplete MMA card with complete contact \\ninformation for emergency\\nKeep filling the symptoms on MMA card\\nMedication to be given:\\nMifepristone,\\nAnalgesic (Ibuprofen),\\nIron & Folic Acid (90 tablets),\\nSanitary napkins\\nReport to the provider/facility if there is:\\nExcessive bleeding\\nSevere pain abdomen\\nComplete the records in Form III (Admission \\nRegister)\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n24\\nB.  Second Visit/Day 3/Day of Misoprostol Administration'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Note any history of bleeding/pain or any other side effects after tablet Mifepristone: Some', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Note any history of bleeding/pain or any other side effects after tablet Mifepristone: Some \\nwomen will start bleeding after the administration of tablet Mifepristone.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Administer Misoprostol: Ask the woman to empty her bladder. Give/insert four tablets of 200', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Administer Misoprostol: Ask the woman to empty her bladder. Give/insert four tablets of 200 \\nmcg Misoprostol (total 800 mcg) by sublingual/buccal/vaginal route. Oral route may be used if \\npregnancy < 7 weeks.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Ask her to lie in bed for half an hour after vaginal insertion.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='3. Ask her to lie in bed for half an hour after vaginal insertion.\\nIf she vomits tablet Misoprostol within half an hour of its intake, the same dosage (800 mcg \\nMisoprostol) should be repeated, after giving an anti-emetic.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Observe the woman for four hours after Misoprostol administration in the clinic/hospital and', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': ['blood pressure']}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Observe the woman for four hours after Misoprostol administration in the clinic/hospital and \\nmonitor:\\ni. Pulse and blood pressure\\nii. Time of start of bleeding and expulsion of products (if it occurs)\\niii. Side effects of the drugs (e.g. chills)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Medication for pain relief: Usually the pain starts after taking Misoprostol, so analgesic can be taken', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='5. Medication for pain relief: Usually the pain starts after taking Misoprostol, so analgesic can be taken \\nwell in time before pain becomes intolerable. Tablet Ibuprofen 400 mg is recommended. Paracetamol \\nis not recommended for pain relief during the process of MMA. If pain does not subside on taking \\ndrugs, the possibility of ectopic pregnancy should be ruled out. Receiving complete information \\nduring counselling and reassurance during the process helps the woman to tolerate pain better.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Perform pelvic examination before the woman leaves the clinic/facility and if cervical os is open', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='6. Perform pelvic examination before the woman leaves the clinic/facility and if cervical os is open \\nand products are partially expelled, remove them digitally. She should be observed for another few \\nhours or till the expulsion of the POC is complete.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '7. In case the woman does not abort at the health centre or takes Misoprostol at home, inform her', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='7.\\nIn case the woman does not abort at the health centre or takes Misoprostol at home, inform her \\nabout: \\n•\\t Reporting back to the centre/service provider in case of excessive bleeding/acute  \\nabdominal pain\\n•\\t Warning signs and symptoms \\n•\\t Using clean sanitary napkins\\n•\\t Avoiding tampons and douche\\n•\\t Reporting back if there is no bleeding even 24 hours after taking Misoprostol'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '8. Side effects of the drugs such as nausea, vomiting, diarrhoea (usually mild), headache, fever, and', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='8. Side effects of the drugs such as nausea, vomiting, diarrhoea (usually mild), headache, fever, and \\ndizziness'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '9. Return for follow-up on the Day 15', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='9. Return for follow-up on the Day 15'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '10. Keep filling the MMA card', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='10.\\nKeep filling the MMA card\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:\\n\\n25\\nTraining Manual\\nFor MMA in Early Gestation\\nChart 1: Plan of action if there is no bleeding even 24 hours after administration of Misoprostol\\nContinuation of Pregnancy Non-viable Foetus/Missed \\nAbortion\\nRefer to Higher \\nCentre for Vacuum \\nAspiration\\nAdditional Dose of \\nMisoprostol\\n•\\t Detailed History,\\n•\\t Clinical Examination,\\n•\\t Ultrasonography\\nThe table below summarizes the tasks for Day 3 of the MMA protocol:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 5: Tasks for Day 3/Day of Misoprostol administration\\nProvider’s Task Instructions to the Woman\\nNote history of bleeding/pain in abdomen/other \\nside effects of tablet Mifepristone\\nLie in bed for 30 minutes if Misoprostol is \\ninserted vaginally\\nGive four tablets of Misoprostol (total 800 mcg) \\nsublingual/vaginal/buccal\\nPossible side effects – nausea, vomiting, \\ndiarrhoea, headache, chills, and dizziness\\nObserve for 4 – 6 hours in the facility Avoid intercourse till bleeding stops\\nPrescribe tablet Ibuprofen for pain relief Use clean sanitary napkins. Avoid tampons and \\ndouche'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Bimanual examination just before discharge from \\nthe facility\\nAvoid going out of station till the third visit\\nAntiemetics or antidiarrhoeal may be prescribed Report back if:\\nNo bleeding for even 24 hours after Misoprostol\\nExcessive bleeding – soaking 2 or more thick \\npads for 2 hours continuously\\nFever >24 hours after Misoprostol\\nExplain what to expect after Misoprostol \\nadministration\\nReturn for follow up on Day 15 or earlier, if \\nrequired\\nOCP/Injectables/Centchroman can be started if \\nchosen\\nKeep filling the MMA card\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n26\\nC.  Third Visit/Day 15/Follow-up Visit'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1.  Note relevant history/check MMA card', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1.  Note relevant history/check MMA card'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Carry out pelvic examination to ensure completion of abortion process/continuation of pregnancy', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Carry out pelvic examination to ensure completion of abortion process/continuation of pregnancy'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Reiterate contraceptive counselling and services', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Reiterate contraceptive counselling and services'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Advise USG if:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4.\\nAdvise USG if:\\n•\\t complete expulsion of POC not confirmed\\n•\\t continuation of pregnancy suspected\\n•\\t bleeding continues'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Ask the woman to report back if there are no periods within six weeks', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Ask the woman to report back if there are no periods within six weeks\\nThe table below summarizes the tasks for Day 15 of the MMA protocol:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 6: Tasks for Day 15/Follow up visit\\nProvider’s Task Instructions to the Woman\\nNote history of bleeding/pain in abdomen/ \\nexpulsion of POC\\nContraceptive advice as per the method chosen\\nPelvic examination to confirm completion of the \\nprocess. USG, if indicated\\nReport back if no periods within six weeks of \\ncompletion of abortion process\\nIUCD, if chosen by the woman and all \\ncontraindications are ruled out\\nReiterate contraceptive counselling  \\nand services\\n5.3: Post MMA Contraception'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Centchroman can be started on Day 3 of the MMA protocol.\\n•\\t IUCD can be inserted after confirming complete abortion and ruling out contraindications, on Day \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Condoms can be used even on Day 1 of MMA administration.\\n•\\t Tubal ligation can be done after the next menstrual cycle. However, if desirous of concurrent tubal \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 2, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 9: Contraceptive Methods\\n\\n27\\nTraining Manual\\nFor MMA in Early Gestation\\n•\\t Oral hormonal contraceptive methods, whether combined (estrogen and progestogen) or progestin-\\nonly, can be started on the day of the Misoprostol administration (Day 3) or Day 15 of the MMA \\nprotocol.\\n•\\t Injectable hormonal method (Injection-MPA/Antara Programme) can be started on Day 3 of the \\nMMA protocol.\\n•\\t Vasectomy, if chosen, can be done independent of the MMA procedure.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n28\\n6\\nSide Effects and Complications\\nwith MMA and their Management\\n6.1: Side Effects with MMA'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 7: Table below summarizes the day of initiation of contraceptive methods during the process of MMA\\nDay of MMA \\nProcess Day 1 Day 3 Day 15 After Next \\nMenstrual Cycle\\nContraceptive \\nMethods that \\nmaybe Initiated\\n•\\t Condoms •\\t COCs\\n•\\t Injectables\\n•\\t Centchroman\\n•\\t Condoms\\n•\\t IUCD\\n•\\t COCs\\n•\\t Condoms\\n•\\t Tubal ligation\\n•\\t IUCD\\n•\\t COCs\\n•\\t Injectables\\n•\\t Centchroman\\n•\\t Condoms'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Share with the participants the side effects and potential complications during the \\nprocess of MMA and their management.\\n19Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n6.1: Side Effects'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 10: Side effects with MMA drugs – headache, vomiting'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Common side effects experienced with MMA are:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'nutrition', 'normal_variations', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': True}, page_content='Common side effects experienced with MMA are:\\na)\\t Gastrointestinal\\tside\\teffects\\t\\nb)\\t Fever,\\twarmth\\tand\\tchills\\nc)\\t Headache\\tand\\tdizziness\\t\\n• Gastrointestinal Side Effects: Diarrhoea,\\t nausea\\tand\\tvomiting\\tare\\tcommonly\\treported\\tby\\t\\nwomen\\tfollowing\\tthe\\tuse\\tof\\tMisoprostol.\\nThese\\tside\\teffects\\tare\\tmild\\tand\\tself-limiting\\tand\\t\\npass\\toff\\twithout\\tany\\ttreatment.\\nAntiemetic\\tand\\tanti-diarrhoeal\\tmedicines\\tmay\\tbe\\tprescribed\\t\\nwhen\\tneeded.\\nORS\\tcan\\tbe\\tgiven\\tif\\tvomiting\\tor\\tdiarrhoea\\tis\\tsevere.\\nTab.\\tLoperamide\\tmay\\tbe\\t\\nprescribed\\tfor\\tdiarrhoea.\\n(but\\twith\\tcaution)\\t\\n• Fever, Warmth and Chills: Fever,\\t feeling\\tof\\twarmth\\tand\\tchills\\tare\\tshort-lived\\tand\\tself-\\nlimiting\\tside\\teffects.\\nTreatment\\tis\\tgenerally\\tnot\\trequired\\tbut\\tthe\\twoman\\tshould\\tknow\\tthat\\t\\nshe\\tmay\\texperience\\tthese\\tsymptoms.\\nPost-abortion\\tinfection\\tis\\trare\\tafter\\tMMA.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Common side effects experienced with MMA are:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['nutrition', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Persistent\\t\\nfever\\t\\t(>\\t38°C\\tfor\\ttwo\\treadings\\tfour\\thour\\tapart)\\tmay\\tindicate\\tinfection\\tand\\tmust\\tbe\\tevaluated\\t\\nand\\ttreated\\taccordingly.\\n6\\nSection\\nSide Effects and Complications \\nwith MMA and their Management'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['vomiting'], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 10: Side effects with MMA drugs – headache, vomiting'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Common side effects experienced with MMA are:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition', 'normal_variations', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['nausea', 'vomiting'], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Common side effects experienced with MMA are:\\na. Gastrointestinal side effects\\nb. Fever, warmth, and chills\\nc. Headache and dizziness\\n•\\t Gastrointestinal Side Effects: Diarrhoea, nausea and vomiting are commonly reported by women \\nfollowing the use of Misoprostol.\\nThese side effects are mild and self-limiting and pass off without \\nany treatment.\\nAntiemetic and anti-diarrhoeal medicines may be prescribed when needed.\\nORS can \\nbe given if vomiting or diarrhoea is severe.\\n•\\t Fever, Warmth, and Chills: Fever, feeling of warmth, and chills are short-lived and self-limiting side \\neffects.\\nTreatment is generally not required but the woman should know that she may experience \\nthese symptoms.\\nPersistent fever (> 38° C for two readings four hours apart) may indicate infection \\nand must be evaluated and treated accordingly, though post-abortion infection is rare during MMA.\\n•\\t Headache and Dizziness: Some women during the process of MMA report \\nheadache and dizziness.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Common side effects experienced with MMA are:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'warning', 'topics': ['nutrition', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='Headache is treated with non-narcotic analgesics \\nand mild dizziness of short duration is managed by hydration.\\nAdvise the \\nwoman to take plenty of fluids, rest and exercise caution while changing \\nposition.\\n29\\nTraining Manual\\nFor MMA in Early Gestation\\n6.2: Safety and Effectiveness \\nBefore proceeding with the complications associated with MMA, share with the participants \\nthe safety and effectiveness of MMA drugs.\\nSafety\\nMifepristone and Misoprostol are safe drugs for terminating pregnancy if the woman does not have any \\ncontraindications for their use.\\nEffectiveness\\nA combination of Mifepristone and Misoprostol has an effectiveness of 95 – 99% for termination of early \\npregnancy up to nine weeks.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Failed Abortion:  Women with continued signs of pregnancy or clinical signs of failed abortion should', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Failed Abortion:  Women with continued signs of pregnancy or clinical signs of failed abortion should \\nbe referred to higher centre as expeditiously as possible for further management.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Referral to higher centre for further appropriate management is needed in cases of:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Referral to higher centre for further appropriate management is needed in cases of:\\n•\\tContinuation of pregnancy after administration of MMA drugs\\n•\\t Excessive bleeding anytime during the MMA process\\n•\\t If abortion process is incomplete at the time of follow up visit \\n6.3: Complications and their Management'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Potential complications associated with MMA are:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Potential complications associated with MMA are:\\nA. Excessive vaginal bleeding\\nB. Incomplete abortion\\nC. Continuation of pregnancy\\nD. Infection\\nA. Excessive Vaginal Bleeding\\nSoaking two or more thick pads per hour for two consecutive hours need close \\nmonitoring of the woman.\\nIn this condition, she should report to the facility. \\nConduct examination, including bimanual examination, to rule out incomplete abortion and assess for \\nhypovolemia. Following should be done in such cases:\\n•\\t Fluid replacement: IV infusion with Ringers Lactate solution 30 drops per minute should be started \\nand simultaneous preparation for referral to the higher centre.\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n30\\nB. Incomplete Abortion\\nGenerally, these women present with excessive/continued bleeding.\\nRapid initial assessment of the woman’s vital parameters, haemodynamic stability \\nshould be done and proceeded accordingly:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. If her condition is unstable, resuscitate and stabilize her. Stabilization should be followed by', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='1. If her condition is unstable, resuscitate and stabilize her. Stabilization should be followed by \\nexamination and further management accordingly, including referral to the higher centre.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. If her condition is stable, proceed with the examination:', 'chunk_index': 0, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': ['maternal_changes', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='2.\\nIf her condition is stable, proceed with the examination:\\na.\\nIf POC is felt at the os, manage with digital evacuation.\\nFurther treatment will be based on the \\nseverity of bleeding and status of her general condition.\\ni.\\nShe may be offered an additional dose of Misoprostol (dosage given below) provided \\nbleeding is not heavy:\\n Misoprostol 600 mcg oral or 400 mcg sublingual can be repeated in such cases of \\nincomplete abortion.\\nii.\\nIf bleeding continues even after an additional dose of Misoprostol, she should be referred to \\nhigher centre for further management.\\niii.\\nIf bleeding is controlled and general condition improves, she may be treated conservatively \\nat the same facility and discharged when appropriate.\\nb.\\nIf no products are felt at the os, decide the line of management based on the clinical symptoms, \\npelvic examination, and USG findings:\\ni.\\nIf the gestation sac is visible but is non-viable, then an additional dose of Misoprostol \\n(dosage given above) may be offered to the woman.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. If her condition is stable, proceed with the examination:', 'chunk_index': 1, 'total_chunks_in_section': 6, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Wait for the products of conception \\nto be expelled with time.\\nThe woman should be counselled to return to the clinic after one \\nweek to ensure that the abortion is complete.\\nIf bleeding continues even after an additional dose of Misoprostol, she should be referred to \\nhigher centre for further management.\\nii.\\nIf no gestation sac is visible on USG but bleeding continues due to decidual bits in the \\nuterine cavity, manage conservatively, without any medication or intervention as these are \\nexpelled spontaneously in most cases.\\nAn additional visit after seven days will have to be \\nplanned to ensure completion of the process.\\nIf bleeding is profuse at any time during this process, she should be referred to higher centre \\nfor further management.\\niii.\\nIf USG shows viable gestation sac, refer the woman to higher centre for vacuum aspiration.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. If her condition is stable, proceed with the examination:', 'chunk_index': 2, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['nutrition', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='31\\nTraining Manual\\nFor MMA in Early Gestation\\nChart 2: Flow chart for Treatment of Incomplete Abortion\\nC.  Continuation of Pregnancy\\nIf the pregnancy continues despite taking drugs for MMA, it indicates that the drugs were ineffective.\\nIn \\nsuch cases, refer the woman to higher centre for pregnancy termination by Vacuum Aspiration in view \\nof the teratogenic effect of the drugs4. \\n4 Data on continuing pregnancy after Mifepristone exposure without Misoprostol are limited.\\nThe association between Misoprostol \\nand congenital anomalies is better established.\\nThe most typical malformations associated with Misoprostol use are Möbius \\nsyndrome, a rare disorder of cranial nerve palsies associated with limb anomalies and craniofacial defects, and terminal transverse \\nlimb defects.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. If her condition is stable, proceed with the examination:', 'chunk_index': 3, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Check vital signs \\n•\\t Ensure patent airway\\n•\\t Oxygen 0-5 lit/min, through \\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. If her condition is stable, proceed with the examination:', 'chunk_index': 4, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='•\\t Oxytocin\\n•\\t Antibiotics\\n'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. If her condition is stable, proceed with the examination:', 'chunk_index': 5, 'total_chunks_in_section': 6, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Although not clearly established, the proposed mechanism is vascular disruption due to uterine contractions leading \\nto disordered fetal development\\nRefer to \\nhigher centre\\nResuscitative Measures\\n•\\t Check vital signs \\n•\\t Ensure patent airway'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Unstable Condition\\nRefer to higher centre\\nStable Condition: Proceed with \\nexamination'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'POC at the os No POC at the os :', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='POC at the os No POC at the os : \\nPelvic examination, USG\\nNon-viable\\npregnancy\\nViable pregnancyDigital \\nevacuation; \\nAdditional \\nMisoprostol \\ndose;\\nDischarge/\\nrefer,\\nBased on her \\ncondition\\nAdditional dose \\nof Misoprostol; \\nFU after 7 days\\nTreat \\nconservatively; \\nFU after 7 days'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Presenting Symptoms:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': True}, page_content='Presenting Symptoms: \\n•\\t Continued bleeding \\n•\\t Excessive bleeding\\n•\\t With/without pain abdomen\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n32\\nD.  Infection\\nInfection of uterus is uncommon if all precautions are followed.\\nIf the woman has symptoms such as \\nfever, chills, foul-smelling discharge, or bleeding and pain in lower abdomen, uterine infection may be \\nsuspected.\\nStart broad spectrum antibiotics as soon as possible and refer her to the higher centre for \\nfurther management, if required.\\nThe recommended antibiotics are Doxycycline 100 mg, twice a day \\nfor five days for non-lactating women, and Azithromycin 500 mg, once a day for three days for lactating \\nwomen.\\n6.4: Warning Symptoms and Signs'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': True}, page_content='The warning symptoms and signs during the MMA process, for which she should immediately contact \\nthe service provider or facility should be explained to the woman.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Signs and symptoms are as below:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Signs and symptoms are as below:\\n•\\tExcessive bleeding, soaking two thick pads in an hour for two consecutive hours\\n•\\t Persistent severe pain abdomen, not relieved by analgesics\\n•\\t Fever\\n•\\t Foul smelling discharge\\n•\\t Fainting attacks\\n•\\t No/minimal bleeding even 24 hours after the administration of Misoprostol\\n•\\t No periods after six weeks of the completion of MMA process\\n\\n33\\nTraining Manual\\nFor MMA in Early Gestation\\n7 Comparison: V A and MMA Procedure\\nShare with the participants the comparative features of the medical and surgical methods of abortion.\\nThough, both vacuum aspiration as well as medical methods are safe technologies, both have their \\ndistinct features.\\nKey features are enumerated below:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'table', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [9, 12], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False, 'parent_section_path': []}, page_content='Table 8: Comparison of VA and MMA   \\nFeature Vacuum Aspiration Medical Methods\\nTechnique used Uterine contents evacuated \\nthrough a cannula attached to \\nelectric/manual vacuum source\\nExpulsion of uterine contents \\nwith drugs – Mifepristone and \\nMisoprostol\\nGestation limit for the \\ntechnology\\nCan be used upto 12 weeks Can be used upto 9 weeks\\nEffectiveness More than 98% 95-99%\\nTime taken for the procedure \\ncompletion\\n5-15 minutes May take 8 – 13 days\\nPOC check Possible and helpful in ensuring \\ncompletion\\nMay not be possible since \\npassed at home\\nMandatory number of visits for \\nthe procedure\\nOne Three (two visits in case \\nof home administration of \\nMisoprostol on provider’s \\ndiscretion)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Post procedure pain Moderate but remains for a \\nshort time\\nIntense for few hours during the \\nactual expulsion of the POCs\\nRisk of cervical and uterine \\ninjury\\nExists, not very common Does not exist\\nRisk of foetal malformation if \\nthe pregnancy continues\\nNo Ye s\\nProcedure done by RMP , as under the MTP Act RMP , as under the MTP Act'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Acceptability to woman Done as a day care procedure\\nAwake during the procedure\\nNon-invasive process;\\nMore private;\\nClose to natural miscarriage;\\nNo hospitalization\\n5Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n3.1: Indications for MMA\\nOption\\tfor\\tMMA\\tshould\\tbe\\tgiven\\tto\\tall\\twomen\\tcoming\\tto\\ta\\thealth\\tfacility\\tseeking\\ttermination\\tof\\t\\npregnancy\\tup\\tto\\t7\\tweeks\\tof\\tgestation\\t(49\\tdays\\tfrom\\tthe\\tfirst\\tday\\tof\\tthe\\tlast\\tmenstrual\\tperiod\\tin\\t\\nwomen\\twith\\tregular\\tcycles\\tof\\tapproximately\\t28\\tdays)1'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Figure 1: MMA Drugs (Mifepristone and Misoprostol)\\n3.2: Contraindications for MMA'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Women being prescribed MMA should be screened for the following common contraindications:', 'chunk_index': 0, 'total_chunks_in_section': 3, 'chunk_type': 'recommendation', 'topics': ['normal_variations', 'delivery'], 'pregnancy_stages': {'weeks': [9], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': ['anaemia', 'hypertension'], 'medications': [], 'procedures': ['delivery'], 'measurements': ['bp']}, 'contains_warning': False, 'contains_recommendation': True}, page_content='Women being prescribed MMA should be screened for the following common contraindications:\\n•\\t Anaemia\\t(haemoglobin\\t<8\\tgm\\t%)\\n•\\t Confirmed\\tor\\tsuspected\\tectopic\\tpregnancy/undiagnosed\\tadnexal\\tmass\\n•\\t Uncontrolled\\thypertension\\tor\\tBP\\t>\\t160/100\\tmm\\tHg\\n3\\nSection\\nIndications/Contraindications \\nfor MMA\\n1\\tIn\\tDecember\\t2008,\\tCombipack\\twith\\tMifepristone+\\tMisoprostol\\t(1\\ttablet\\tof\\tMifepristone\\t200mg\\tand\\t4\\ttablets\\tof\\tMisoprostol\\t200mcg\\t\\neach)\\twas\\tapproved\\tby\\tthe\\tCentral\\tDrugs\\tStandard\\tControl\\tOrganization,\\tDirectorate\\tGeneral\\tof\\tHealth\\tServices,\\tIndia,\\tfor\\tthe\\t\\ntermination\\tof\\tintra-uterine\\tpregnancy\\tfor\\tup\\tto\\t63\\tdays/9\\tweeks\\tgestation.\\nCAC\\tTraining\\t&\\tService\\tDelivery\\tGuidelines,\\t2010\\tby\\tMoHFW,\\tGoI\\trecommends\\tits\\tuse\\tup\\tto\\t49\\tdays\\tin\\tpublic\\tsector\\tsites,\\tin\\tline\\t\\nwith\\tthe\\tMTP\\tRules\\t2003.\\nA\\tproposed\\tamendment\\tto\\tthe\\tMTP\\tAct,\\t1971,\\tto\\tincrease\\tthe\\tgestation\\tlimit\\tfor\\tMMA\\tto\\t9\\tweeks\\tin\\tpublic\\tsector\\tsites\\tis\\tunder\\tprocess.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Women being prescribed MMA should be screened for the following common contraindications:', 'chunk_index': 1, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [9, 7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Till\\tthe\\tproposal\\tis\\tapproved,\\tMMA\\tin\\tpublic\\thealth\\tfacility\\twould\\tbe\\tallowed\\tonly\\tup\\tto\\t7\\tweeks.\\nTraining Manual\\nFor MMA in Early Gestation\\n34\\n8 Schedule for MMA Trainings\\nThis training is provided to the MBBS doctors to make them eligible to provide abortion services upto 9 \\nweeks gestation period by MMA only.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Women being prescribed MMA should be screened for the following common contraindications:', 'chunk_index': 2, 'total_chunks_in_section': 3, 'chunk_type': 'general_text', 'topics': ['warning_signs', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test', 'screening'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Agenda for MMA Trainings\\nTime Session\\n9.30 am - 10.00 am Registration & Pre-test\\n10.00 am - 10.30 am Introduction \\nGoal & Objectives \\n10.30 am - 11.30 am Overview of Medical Methods of Abortion\\n11.30 am - 12.30 pm Clinical Assessment and Eligibility Screening for MMA\\n12.30 pm - 1.30 pm Lunch\\n1.30 pm - 3.00 pm Counselling Skills for MMA & Practice\\n3.00 pm - 3.15 pm Tea\\n3.15 pm - 4.30 pm MTP Act & Rules related to MMA\\nDocumentation Formats\\n4.30 pm Evaluation and Planning for next day\\nTime Session\\n9.00 am - 12.00 pm Hands on Practice on Live Cases: \\nEligibility Screening; Counselling; Documentation\\n12.00 pm - 12.15 pm Tea\\n12.15 pm - 1.00 pm Dealing with Expected Side-effects of MMA Drugs\\n1.00 pm - 2.00 pm Lunch\\n2.00 pm - 3.00 pm Potential Complications with MMA and their Management\\n3.00 pm - 3.15 pm Tea\\n3.15 pm - 4.00 pm Operationalization of MMA Services at Facilities\\nTime Session\\n9.00 am - 12.00 pm Hands on Practice on Live Cases: \\nEligibility Screening; Counselling; Documentation\\n12.00 pm - 12.15 pm Tea\\n12.15 pm - 1.30 pm Post-abortion Contraception with MMA\\n1.30 pm - 2.30 pm Lunch\\n2.30 pm - 3.00 pm Post - test\\nTraining Evaluation\\n3.00 pm - 4.00 pm Next Steps & Valedictory \\nDay 1:\\nDay 2:\\nDay 3:\\n\\n35\\nTraining Manual\\nFor MMA in Early Gestation\\nReferences'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. MTP (Amendment) Act, 2021; MTP (Amendment) Rules, 2021', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. MTP (Amendment) Act, 2021; MTP (Amendment) Rules, 2021'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Comprehensive Abortion Care Training and Service Delivery Guidelines, MoHFW , Government', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['delivery'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['delivery'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Comprehensive Abortion Care Training and Service Delivery Guidelines, MoHFW , Government \\nof India. 2018'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Medical Management of Abortion. Geneva: World Health Organization. 2018', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Medical Management of Abortion. Geneva: World Health Organization. 2018'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. Post Abortion Family Planning Technical Update. Family Planning Division, MoHFW ,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. Post Abortion Family Planning Technical Update. Family Planning Division, MoHFW , \\nGovernment of India. 2016'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Clinical Practice Handbook for Safe Abortions. Geneva: World Health Orgnization. 2014', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Clinical Practice Handbook for Safe Abortions. Geneva: World Health Orgnization. 2014'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. ACOG: Medication Abortion upto 70 days of Gestation. 2014', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='6. ACOG: Medication Abortion upto 70 days of Gestation. 2014'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '7. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='7. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health \\nOrgnization. 2012'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '8. Shagufta Praveen et al: Comparison of sublingual, vaginal, and oral Misoprostol in cervical', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='8. Shagufta Praveen et al: Comparison of sublingual, vaginal, and oral Misoprostol in cervical \\nripening for first trimester abortion. Indian J Pharmacol. 2011 Apr; 43(2): 172–175'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '9. Guidelines for Early Medical Abortion in India using Mifepristone and Misoprostol. MoHFW ,', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='9. Guidelines for Early Medical Abortion in India using Mifepristone and Misoprostol. MoHFW , \\nWHO CCR in Human Reproduction, AIIMS Delhi. 2007'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '10. Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='10. Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n36\\nAnnexure – 1 Medical Methods of Abortion: Counselling  \\nSkills Checklist\\nDay 1: Skills required during first visit to clinic/facility\\n(Mifepristone administration)\\nYe s No\\nGreets the woman in a friendly, respectful manner; ensures privacy'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Confirms with her that she wants to terminate her pregnancy\\nExplains what to expect during the visit\\nAsks if she came with someone and if she would like that person to join her in \\nthe counselling\\nAsks about her general health, reproductive and medical history\\nExplains various abortion methods available, including their characteristics, \\neffectiveness and the visits required\\nExplores her views on abortion options and which abortion method is the best \\nfor her\\nIf the woman chooses medical methods of abortion provides more information \\non the method in simple terms\\nConfirms that she is eligible for medical methods of abortion (pregnancy upto \\nnine weeks)\\nClarifies the woman’s feelings on the possibility of having the abortion at home \\nand asks what support she has at home'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Ensures that she understands:', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'warning', 'topics': ['maternal_changes', 'warning_signs', 'normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='Ensures that she understands:\\n•\\t Common side effects and symptoms during the process\\n•\\t Importance of attending required clinic visits\\n•\\t Warning signs indicating the need to return to the clinic\\nExplains how Mifepristone and Misoprostol will be administered and what to \\nexpect after taking them\\nExplains that if the medical method of abortion fails, vacuum aspiration will be \\nnecessary to terminate the pregnancy at the higher centre\\nDiscusses various contraceptive methods and helps her to choose one\\nAsks the woman whether she has additional questions\\nObtains written'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Ensures that she understands:', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='informed consent\\nProvides Mifepristone 1 tablet 200 mg orally\\nExplains how to take pain management medication (analgesics)\\nExplains how to record the side effects experienced, if any, on the MMA card\\nExplains what to do in case of problems/emergency\\nGives the woman the address and telephone number of the clinic where she \\nmay go in case of an emergency\\nAsks her to return to the clinic for the second dose after two days\\n\\n37\\nTraining Manual\\nFor MMA in Early Gestation\\nDay 3:\\nSkills required during second visit to clinic/facility\\n(Misoprostol administration)\\nYe s No\\nGreets the woman in a friendly, respectful manner; ensures privacy\\nEnquires about her experience after taking Mifepristone (bleeding, passage of \\nPOC, discomfort, side effects)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 2, 'chunk_type': 'warning', 'topics': ['warning_signs'], 'pregnancy_stages': {'weeks': [7], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': True, 'contains_recommendation': False}, page_content='Checks the MMA card\\nExplains what to expect during this visit\\nAdministers Misoprostol in clinic (per protocol) four tablets:\\nsublingual/buccal/vaginal.\\nOral route may be used if pregnancy < 7 weeks\\nAsks the woman to rest in the clinic for four hours\\nObserves the woman in the clinic for bleeding, cramping, expulsion of POC\\nIf the woman leaves the clinic before she aborts, give her instructions and sup-\\nplies (pain medication, written instructions) for process at home\\nExplains how to record her experience of any side effect on the MMA card and \\nreminds her of the address and contact number of the clinic to visit in case of \\nan emergency\\nRecords the date of Misoprostol administration and counsels the woman to \\ncome for a follow-up visit on Day 15\\nReviews after-care instructions and provides information on warning signs \\nwhich indicate the need to return to the clinic or seek medical assistance\\nAsks the woman if she has any additional questions and clarifies them\\nDay 15:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 1, 'total_chunks_in_section': 2, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Skills required during third visit to clinic/facility (follow up)Ye s No\\nGreets the woman in a friendly, respectful manner; ensures privacy\\nEnquires about her experience of the abortion process, expulsion of POC and if \\nshe feels that the abortion is complete'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['maternal_changes'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Asks whether she is still having symptoms of pregnancy\\nExplains what to expect during this follow-up visit'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Assesses the completeness of the abortion by:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition', 'medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['ultrasound'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Assesses the completeness of the abortion by:\\n•\\t Taking a history of the abortion process (amount and duration of bleeding, \\nside effects, cramping, any POC expelled)\\n•\\t Conducting a physical examination (pelvic examination to assess the size \\nand consistency of the uterus and opening of the cervical os)\\n•\\t Advising/performing an ultrasound for the presence of gestation sac, if it is \\nstill unclear whether the abortion is complete\\nIf the abortion is not complete, discusses treatment options:\\nexpectant management, additional Misoprostol administration or referral to \\nhigher centre'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'If the pregnancy is continuing:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='If the pregnancy is continuing:\\n•\\t Discusses need for vacuum aspiration to terminate it at the higher centre'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'If the abortion is complete:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition', 'warning_signs'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='If the abortion is complete:\\n•\\tProvides information about return to fertility\\n•\\t Explains risks of repeated induced abortions\\n•\\t Counsels regarding contraceptive methods if not already chosen by her\\nAsks the woman if she has any additional questions and clarifies them\\nTells her that she can come back to the clinic/facility whenever she has any \\nproblem\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n38\\nAnnexure – 2 Essential Equipment, Instruments, Drugs and \\nConsumables Required for MMA\\nS. \\nNo.\\nItem PHC/non FRU \\nCHC FRU/SDH DH/MCH Remarks\\n(5, 10, 20 cases)'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. Equipment', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. Equipment\\n1.1 Examination table 1 1 2\\n1.2 Screen for privacy 1 1 2\\n1.3 Footstep 1 1 2'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. Instruments', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. Instruments\\n2.1 Cusco’s speculum \\n(large, medium)4 6 10'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. Drugs', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. Drugs\\n3.1 Tab Mifepristone 10 20 30\\n3.2 Tab Misoprostol 44 90 140\\n3.3 Tab Ibuprofen 30 60 120\\n3.4 Tab Doxycycline 20 40 80\\n3.5 Cap Azithromycin 12 24 48\\n3.6 Inj Oxytocin 10 20 30'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. I/V Fluids', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['normal_variations'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. I/V Fluids\\n4.1 Ringer Lactate 4 8 12\\n4.2 Normal Saline 2 4 6'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. Consumables', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='5. Consumables\\n5.1 Examination gloves 25 50 100\\n5.2 Utility gloves 1 1 2\\n5.3 Gauze (packets) 2 3 4\\n5.4 I/V set 2 3 4\\n5.5 I/V cannula 2 3 4\\n5.6 2 ml and 5 ml syringes 10 20 40\\n5.7 Povidone Iodine \\nSolution 2 3 4'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Sterilization', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['medical_tests'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': ['test'], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='6. Sterilization \\nequipment\\n6.1 Autoclave 1 1 1\\n6.2 Boiler 1 1 1\\n\\n39\\nTraining Manual\\nFor MMA in Early Gestation\\nAnnexure – 3 MMA Card\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n40\\nMedical Methods of Abortion Training\\nPost-test Questionnaire'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name:  ......................................................................................................................................................................', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name:  ......................................................................................................................................................................'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Name of training centre: ........................................................................................................................................', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Name of training centre: ........................................................................................................................................'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\\nPlease put a tick under `True’ or `False’ for the following statements:\\nS.No. Statement    True False'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '1. MMA is a safe and effective method to terminate early', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='1. MMA is a safe and effective method to terminate early \\npregnancy upto 63 days.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '2. MMA may adversely affect the woman’s future fertility.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='2. MMA may adversely affect the woman’s future fertility.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '3. A physical examination of the woman is not required to provide', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='3. A physical examination of the woman is not required to provide \\nMMA services.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '4. A written consent of the woman seeking medical methods of', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='4. A written consent of the woman seeking medical methods of \\nabortion is mandatory on the prescribed format.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '5. A minimum of four visits are recommended to complete the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='5. A minimum of four visits are recommended to complete the \\nstandard MMA drug protocol.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '6. Only a Registered Medical Practitioner, as under the MTP Act', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='6. Only a Registered Medical Practitioner, as under the MTP Act \\ncan prescribe MMA drugs.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '7. Fertility can return within 10 days of an abortion.', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='7. Fertility can return within 10 days of an abortion.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '8. Most of the contraceptive methods can be started during the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='8. Most of the contraceptive methods can be started during the \\nprocess of MMA after confirming their eligibility.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '9. MMA drugs can cause congenital anomalies if pregnancy', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='9. MMA drugs can cause congenital anomalies if pregnancy \\ncontinues after their intake.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '10. A woman should be within accessible limits of a health facility', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='10. A woman should be within accessible limits of a health facility \\nduring the MMA process.'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': 'Please encircle the correct answer in the following questions:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='Please encircle the correct answer in the following questions:'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '11. Which of the following is recommended for pain management during MMA?', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='11. Which of the following is recommended for pain management during MMA?\\na. Tablet Paracetamol\\nb. Tablet Ibuprofen \\nc. Injection Diazepam\\nd. Paracervical block'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '12. Which of the following is the LEAST effective route for Misoprostol administration during the', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='12. Which of the following is the LEAST effective route for Misoprostol administration during the \\nMMA process?\\na. Sublingual\\nb. Vaginal\\nc. Oral\\nd. Buccal\\n\\n41\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': [], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\\na. Combined Oral Contraceptive pills\\nb. Centchroman \\nc. IUCD\\nd. Injectables'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '14. Way to manage an incomplete abortion during the process of MMA is:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'general_text', 'topics': ['nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': False}, page_content='14. Way to manage an incomplete abortion during the process of MMA is:\\na. Vacuum Aspiration\\nb. Repeat dose of Misoprostol\\nc. Either of the above two depending on the severity of bleeding'),\n",
       " Document(metadata={'title': '', 'document_type': '', 'source': 'Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf', 'section_title': '15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:', 'chunk_index': 0, 'total_chunks_in_section': 1, 'chunk_type': 'recommendation', 'topics': ['fetal_development', 'nutrition'], 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'medical_entities': {'conditions': [], 'medications': [], 'procedures': [], 'measurements': []}, 'contains_warning': False, 'contains_recommendation': True}, page_content='15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\\na. Y es, additional dose can be tried\\nb. No, woman should be referred to higher centre for pregnancy termination with Vacuum \\nAspiration\\nc. Pregnancy should be continued\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n42\\nNotes\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\n44\\nThe Ministry of Health and Family Welfare acknowledges the support of Ipas Development \\nFoundation in circulation of the manual on Medical Methods of Abortion as part of its ongoing \\nefforts to improve the quality of comprehensive abortion care services for women in India.')]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "for doc in documents:\n",
    "    if doc.metadata['source']==\"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\":\n",
    "        print(doc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "================================================================================\n",
      "HIERARCHICAL CHUNKING OUTPUT\n",
      "================================================================================\n",
      "\n",
      "CHUNK 1:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "i\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Technical &  \n",
      "Operational Guidelines\n",
      "Maternal Health Division \n",
      "Ministry of Health & Family Welfare \n",
      "Government of India \n",
      "December 2014\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 2:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "SCREENING FOR\n",
      "DURING PREGNANCY\n",
      "\n",
      "Designed and printed with support from UNFPA\n",
      "Designed by: Rouge Communications, New Delhi\n",
      "E-mail: rougecommunications@gmail.com\n",
      "\n",
      "Maternal Health Division \n",
      "Ministry of Health & Family Welfare \n",
      "Government of India \n",
      "December 2014\n",
      "SCREENING FOR\n",
      "DURING PREGNANCY\n",
      "\n",
      "\n",
      "\n",
      "As part of national and international commitments, India is steadfast in its \n",
      "resolve to reduce the Maternal Mortality Ratio (MMR) by 75 percent of its 1990 \n",
      "levels i.e. about 560 deaths per 100,000 live births to 140 deaths per 100,000 \n",
      "live births by the year 2015.\n",
      "Going by the past trends in reduction of MMR, \n",
      "India seems to be on the right track, and we hope to reach the MDG-5 target \n",
      "for our country by the end of next year.\n",
      "However, we need to capitalize on the ground gained and consolidate what we \n",
      "have achieved.\n",
      "Post 2015, the world will focus on achieving the Sustainable \n",
      "Development Goals (SDGs).\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 3:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "International discussions on SDGs clearly bring \n",
      "out that not only do we need to continue working on reducing MMR to much \n",
      "lower levels; we also need to focus on maternal morbidities that have an \n",
      "adverse effect on not just the health of the mother but also on the foetus.\n",
      "Infectious diseases such as Syphilis have the potential of being transmitted \n",
      "from mother to child and also increase the risk of perinatal and neonatal \n",
      "mortality.\n",
      "Congenital Syphilis can be eliminated by the sincere implementation \n",
      "of these guidelines.\n",
      "These guidelines are being brought out at a very opportune moment, addressing \n",
      "a need that is being felt not just at the national but at the global level.\n",
      "I am \n",
      "confident that these guidelines will become an integral part of the antenatal \n",
      "care package and that states will take up the implementation of this initiative \n",
      "with full vigour and commitment.\n",
      "Lov Verma\n",
      "Hkkjr ljdkj \n",
      "LokLF; ,oa ifjokj\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 4:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "dY;k.k foHkkx \n",
      "LokLF; ,oa ifjokj dY;k.k ea=ky;\n",
      "yo oekZ \n",
      "lfPko\n",
      "Government of India \n",
      "Department of Health & Family Welfare \n",
      "Ministry of Health & Family Welfare \n",
      "Lov Verma \n",
      "Secretary\n",
      "Preface\n",
      "\n",
      "India is witnessing significant changes in the health sector.\n",
      "Improvements \n",
      "in the health systems with respect to infrastructure, personnel, and financial \n",
      "allocations are already showing impact in terms of reductions in maternal and \n",
      "child mortality rates.\n",
      "The proportion of maternal deaths attributable to direct \n",
      "obstetric causes is declining, because interventions to tackle causes such as \n",
      "haemorrhage, pregnancy induced hypertension etc. are being implemented.\n",
      "As we move forward toward achieving our national and international \n",
      "commitments, it becomes imperative to address the challenges of shifting \n",
      "burden of disease, where now we see a greater proportion of maternal deaths \n",
      "attributable to indirect causes such as infections.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 5:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Whilst we need to continue \n",
      "our efforts for tackling obstetric complications, we also need to initiate work on \n",
      "managing indirect causes that put a substantial proportion of our mothers and \n",
      "children at risk.\n",
      "Syphilis is one such infection for which mother to child transmission is one of \n",
      "the known routes for spread of the disease.\n",
      "Early and timely identification of \n",
      "pregnant women who have this infection, through use of simple diagnostic tests \n",
      "is important to initiate the needed management in positive cases.\n",
      "This will not \n",
      "only prevent congenital transmission of the infection, but will also improve the \n",
      "health of the mother.\n",
      "I would like to congratulate the Maternal Health Division in framing these \n",
      "guidelines with the help of NACO, institutional experts and development \n",
      "partners.\n",
      "These guidelines are the first step towards managing this infection which cause \n",
      "significant maternal and neonatal mortality and morbidity.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 6:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "I am hopeful that all \n",
      "health personnel will take cognizance of these new guidelines and incorporate \n",
      "screening for this infection as an integral component of the antenatal care \n",
      "package.\n",
      "C.K. Mishra\n",
      "Hkkjr ljdkj \n",
      "LokLF; ,oa ifjokj\n",
      "dY;k.k ea=ky; \n",
      "fuekZ.k Hkou] ubZ fnYyh & 110011\n",
      "Government of India \n",
      "Ministry of Health & Family Welfare \n",
      "Nirman Bhavan, New Delhi - 110011\n",
      "C.K Mishra, IAS\n",
      "Additional Secretary & \n",
      "Mission Director, NHM\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 7:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23061066, 23063809\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"weight\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Telefax : 23061066, 23063809 \n",
      "E-mail : asmd-mohfw@nic.in\n",
      "Foreword\n",
      "\n",
      "Persons affected with sexually transmitted infection like syphilis form a \n",
      "substantive proportion of our population, including pregnant women.\n",
      "These \n",
      "infections can easily be transmitted from mother to child.\n",
      "Their occurrence \n",
      "during pregnancy poses a risk to the health of not just the mother, but also that \n",
      "of the newborn child.\n",
      "Pregnancies in many of the infected mothers end in spontaneous abortion, \n",
      "low birth weight babies or babies with severe infection.\n",
      "Unlike many neonatal \n",
      "infections, congenital syphilis is preventable.\n",
      "The WHO has set a goal of \n",
      "eliminating congenital syphilis and urges countries to undertake appropriate \n",
      "public health measures such as antenatal screening and treatment of infected \n",
      "pregnant women to prevent this transmission.\n",
      "Diagnostic tests for syphilis screening are relatively simple and cost effective.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 8:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23061066, 23063809\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Starting with point-of-care testing kits, these guidelines present detailed \n",
      "algorithms on the steps to be taken for confirmation and management of these \n",
      "infections once the pregnant woman is found to be positive on the basis of the \n",
      "screening tests.\n",
      "It is hoped that universal application of these simple screening \n",
      "tests will go a long way in reducing the burden of syphilis and soon eliminate it.\n",
      "The guidelines have been prepared by Maternal Health Division with the active \n",
      "support of NACO, institutional experts and development partners.\n",
      "These \n",
      "guidelines aim to facilitate the State and District Programme OWfficers for \n",
      "effective implementation.\n",
      "Dr. Rakesh Kumar\n",
      "Hkkjr ljdkj \n",
      "LokLF; ,oa ifjokj\n",
      "dY;k.k ea=ky; \n",
      "fuekZ.k Hkou] ubZ fnYyh & 110011\n",
      "Government of India \n",
      "Ministry of Health & Family Welfare \n",
      "Nirman Bhavan, New Delhi - 110011\n",
      "Dr. RAKESH KUMAR, I.A.S\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 9:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Joint Secretary  \n",
      "Telefax : 23061723 \n",
      "E-mail : rk1992uk@gmail.com \n",
      "E-mail : rkumar92@hotmail.com\n",
      "Foreword\n",
      "\n",
      "In 2005, Ministry of Health and Family Welfare, Government of India, released \n",
      "the Guidelines for Skilled Attendance at Birth by ANMs and LHVs.\n",
      "This marked \n",
      "a paradigm shift in programming for improving maternal health as not only did \n",
      "we move away from the previous strategy of training traditional birth attendants, \n",
      "but, more importantly, ANMs and staff nurses were given the legal rights to \n",
      "perform certain life saving interventions and administer life saving drugs in \n",
      "clearly defined conditions and obstetric complications, which would otherwise \n",
      "have had an adverse impact on the mother’s health, including causing death in \n",
      "extreme circumstances.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 10:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "These landmark changes, coupled with skill building \n",
      "of human resource on the same and improved infrastructure, has resulted in \n",
      "increasing numbers of safe deliveries at public health facilities and reductions \n",
      "in maternal mortality due to common obstetric complications.\n",
      "Even though that work is far from over, and we need to continue to maintain \n",
      "focus on the direct obstetric causes of maternal mortality, data is beginning \n",
      "to show an increasing proportions of non-obstetric causes and pre-existing \n",
      "conditions as causes of maternal deaths.\n",
      "syphilis is one such infection which \n",
      "has an adverse impact on the health of the mother and the foetus.\n",
      "syphilis \n",
      "infection in the mother carries the risk of congenital transmission which can \n",
      "affect the health of the newborn, in the immediate and long-term.\n",
      "Hkkjr ljdkj \n",
      "LokLF; ,oa ifjokj\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 11:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "dY;k.k ea=ky; \n",
      "fuekZ.k Hkou] ubZ fnYyh & 110011\n",
      "Government of India \n",
      "Ministry of Health & Family Welfare \n",
      "Nirman Bhavan, New Delhi - 110011\n",
      "Dr. H. BHUSHAN\n",
      "Deputy Commissioner (MH)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 12:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Telefax : 23062930 \n",
      "E-mail : drhbhushan@gmail.com\n",
      "Programme Officer's Message\n",
      "\n",
      "I would like to express that these guidelines would not have been possible \n",
      "without the constant encouragement from Mr. C.K Mishra, AS & MD &  \n",
      "Ms Anuradha Gupta, Ex AS & MD.\n",
      "Dr. Rakesh Kumar, Joint Secretary \n",
      "(RMNCH+A) headed the expert group meeting and gave valuable inputs in \n",
      "framing this guideline.\n",
      "I would like to acknowledge the contribution of all members of the Expert \n",
      "Group in developing the content of these technical and operational guidelines.\n",
      "I would also like to acknowledge my colleagues in MH Division especially  \n",
      "Dr. Dinesh Baswal, DC (MH) and development partners for their valuable \n",
      "efforts and inputs in developing this document.\n",
      "I am extremely hopeful, that these guidelines, along with the others, will usher \n",
      "in a new era of maternal health care in the country, where in every pregnancy \n",
      "the mother and child is protected not just from potential mortality, but also from \n",
      "debilitating illnesses.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 13:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Dr Himanshu Bhushan\n",
      "\n",
      "x\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      "List of Contributors\n",
      "1 Shri C. K. Mishra AS & MD (NHM), MoHFW\n",
      "2 Dr. Rakesh Kumar JS (RMNCH+A), MoHFW\n",
      "3 Dr. Himanshu Bhushan DC (I/c MH), MoHFW\n",
      "4 Dr. Dinesh Baswal    DC (MH), MoHFW\n",
      "5 Dr. Manisha Malhotra DC (MH), MoHFW\n",
      "6 Dr. Pratima Mittal Prof. & Head, Dept of Obstetrics & \n",
      "Gynaecology, VMMC & Safdarjung Hospital, \n",
      "New Delhi\n",
      "7 Dr. M.K. Mittal Sr. Specialist / Consultant Radiologist, \n",
      "Safdarjung Hospital, New Delhi\n",
      "8 Dr. Bhartendu Kumar Assoc.\n",
      "Prof. of Surgery, SKMCH, Muzaffarpur\n",
      "9 Dr. Ratna Kumar Chennai, Ex HoD, Institute of Obstetrics & \n",
      "Gynaecology, Chennai, Tamil Nadu\n",
      "10 Dr. K. Kolanda Swamy Director Public Health, Govt. of TN, Chennai\n",
      "11 Dr. Ragini Mehrotra HOD, Obstetrics & Gyneacology, AIIMS \n",
      "Bhopal\n",
      "12 Dr. Sudhir Gupta Prof & Head, Dept of Gastroenterology, GMC \n",
      "& Super-speciality Hospital,\n",
      "Nagpur\n",
      "13 Dr. Somesh Gupta Assoc. Prof., Department of Dermatology & \n",
      "Venereology, AIIMS, New Delhi\n",
      "14 Dr. Suneeta Mittal Sr.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 14:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Consutant - Obstetrics & gynaecology, \n",
      "Fortis Hospital, Gurgaon\n",
      "15 Dr. Archana Mishra DD (MH), GoMP\n",
      "16 Dr. Aman Kumar Singh Technical Expert STI, NACO\n",
      "17 Dr. Suchitra Pandit President, FOGSI\n",
      "18 Dr. Achala Batra Dept. of Obstetrics & Gynaecology, Safdarjung \n",
      "Hospital, New Delhi\n",
      "19 Dr. P.R. Deo UNFPA State Program Coordinator, Bhopal, \n",
      "Madhya Pradesh\n",
      "\n",
      "xi\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      "20 Dr. Anchita Patil National Programme Officer, UNFPA,  \n",
      "New Delhi\n",
      "21 Dr. Pushkar Kumar Lead Consultant, MH, MoHFW\n",
      "22 Dr. Rajeev Agarwal Senior Mgt.\n",
      "Consultant, MH, MoHFW\n",
      "23 Dr. Ravinder Kaur\n",
      "Senior Consultant, MH, MoHFW\n",
      "24 Dr. Gulfam Ahmed Hashmi Regional Coordinator, NRU, MoHFW\n",
      "25 Dr. Ashish Chakraborty Regional Coordinator, NRU, MoHFW\n",
      "26\n",
      "Mr. Prasanth K. S.     Senior Consultant, PHA Division, NHSRC\n",
      "27\n",
      "Dr. Neelima Singh Faculty, Indian Institute of Health and Family \n",
      "Welfare, Hyderabad\n",
      "28 Dr. Nomita Chandiok ICMR\n",
      "29\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 15:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Dr. Raja Mahendra Radiologist, Daga Hospital, Nagpur\n",
      "30 Dr. Charu Lata Mahorkar Obstetrician & Gynaecologist, Nagpur\n",
      "31 Dr. Arunabh Ray BTAST, Patna\n",
      "32 Mr Shridhar Pandit Programme Officer, NRHM, Govt. of \n",
      "Maharashtra\n",
      "33 Dr Gorakh Gopalkrishna \n",
      "Mandrupkar\n",
      "Joint Secretary, FOGSI\n",
      "34\n",
      "Sharmila G. Neogi Maternal Health Specialist, USAID India \n",
      "35 Dr. M. Naina Rani National Consultant PPTCT\n",
      "WHO\n",
      "36 Dr. Tarun Singh Sodha Consultant, MH, MoHFW\n",
      "37 Dr. Sudhir Maknikar National RMNCH+A Expert, JSI\n",
      "MGIMS Team\n",
      "38\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 16:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Dr. B.S. Garg Secretary, KHS, MGIMS, Sevagram\n",
      "39 Dr. Poonam Varma Shiv \n",
      "Kumar \n",
      "Prof. and Head, Dept. of Obstetrics & \n",
      "Gynaecology, MGIMS, Sevagram\n",
      "40 Dr. Manjiri Ramteke Podder Assistant Prof., Dept of Obstetrics & \n",
      "Gynaecology, MGIMS, Sevagram\n",
      "\n",
      "xii\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "List of Acronyms \n",
      "ANC Antenatal Care\n",
      "ART Antiretroviral Therapy\n",
      "ASHA Accredited Social Health Activist \n",
      "CBO Community-based Organization\n",
      "CMIS Computerized Management Information System\n",
      "CS Congenital Syphilis\n",
      "DSRC\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 17:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 5,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Designated STI/RTI Clinics\n",
      "ePTCT Elimination of Parent-to-Child Transmission \n",
      "ECS Elimination of Congenital Syphilis\n",
      "EIA Enzyme Immunoassay\n",
      "ELISA Enzyme-linked Immunosorbent Assay\n",
      "FSW Female Sex Worker\n",
      "FTA-ABS Fluorescent Treponemal Antibody Absorption Test\n",
      "HIV Human Immunodeficiency Virus\n",
      "HMIS Health Management Information System\n",
      "HRG High Risk Groups (for HIV)\n",
      "HSS HIV Sentinel Surveillance\n",
      "ICS/ICT Immuno Chromatographic Strip (test)\n",
      "ICTC Integrated Counselling and Testing Centres\n",
      "IEC Information Education and Communication\n",
      "Ig Immunoglobulin\n",
      "F-ICTC Facility Integrated Counselling and Testing Centres\n",
      "INGO International Non-governmental Organization\n",
      "JSSK Janani Shishu Suraksha Karyakram\n",
      "\n",
      "xiii\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "RMNCH+A Reproductive, Maternal, New Born, Child Health and  \n",
      "Adolescent Health\n",
      "MCTS Mother and Child Tracking System\n",
      "MDGs Millennium Development Goals\n",
      "MSM Men who have Sex with Men\n",
      "MSW Male Sex Worker\n",
      "MTCT Mother-to-Child Transmission \n",
      "NGO Non-governmental Organization\n",
      "NACO National AIDS Control Organisation\n",
      "NACP National AIDS Control Programme\n",
      "NHM National Health Mission\n",
      "PCR Polymerase Chain Reaction\n",
      "PPTCT Prevention of Parent-to-Child Transmission \n",
      "RPR Test Rapid Plasma Reagin (Test)\n",
      "RTI Reproductive Tract Infection\n",
      "SEAR South-East Asia Region\n",
      "SEARO South East Asia Regional Office (WHO)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 18:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 6,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "SRH Sexual and Reproductive Health\n",
      "STI Sexually Transmitted Infection\n",
      "TPHA Treponema Pallidum Haemagglutination Assay\n",
      "TP IgM Treponema Pallidum IgM Enzyme-linked Immunosorbent Assay\n",
      "TPPA Treponema Pallidum Particle Agglutination Assay\n",
      "VDRL Venereal Disease Research Laboratory (Test)\n",
      "WHO World Health Organization\n",
      "\n",
      "\n",
      "\n",
      "Introduction\n",
      "1\n",
      "CHAPTER\n",
      "2\n",
      "CHAPTER\n",
      "3\n",
      "CHAPTER\n",
      "4\n",
      "CHAPTER\n",
      "Technical Guidelines on Testing & \n",
      "Management of Syphilis\n",
      "Protocol for Investigation & Management \n",
      "of Syphilis\n",
      "Operational Plan for Investigation and \n",
      "Management of Syphilis\n",
      "02\n",
      "05\n",
      "08\n",
      "17\n",
      "29\n",
      "37References\n",
      "Annexures\n",
      "Annexure – 1: Anaphylaxis Management \n",
      "Annexure – 2: Technical Specifications of Rapid Plasma  \n",
      " Reagin (RPR) Test Kits for Syphilis Testing \n",
      "Annexure – 3: Technical Specifications of Treponemal-\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 19:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 7,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "specific Rapid (point-of-care) Diagnostic \n",
      " Test for Syphilis \n",
      "Annexure – 4: Referral Slip \n",
      "Annexure – 5: Migration Form for Pregnant Women  \n",
      " with Syphilis \n",
      "Annexure – 6: Monthly Syphilis Reporting Format for \n",
      " State & District Programme Managers \n",
      "Annexure – 7: Monthly Syphilis Reporting Format for \n",
      " Health Facility\n",
      "\n",
      "2\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Introduction\n",
      "Syphilis is a sexually transmitted infection caused by  \n",
      "the spirochaete bacterium Treponema Pallidum, \n",
      "subspecies Pallidum.\n",
      "The primary route of transmission \n",
      "is through sexual contact; it may also be transmitted from \n",
      "mother to foetus during pregnancy or at birth resulting in \n",
      "congenital syphilis.\n",
      "The signs and symptoms of syphilis vary depending on \n",
      "which of the four stages it presents (primary, secondary, \n",
      "latent and tertiary).\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 20:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 8,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "The primary stage classically presents \n",
      "with a single chancre (a firm, painless, non-itchy skin \n",
      "ulceration); secondary syphilis with a diffuse rash which \n",
      "frequently involves the palms of the hands and soles of the \n",
      "feet; latent syphilis with little to no symptoms and tertiary \n",
      "syphilis with gummas, neurological or cardiac symptoms.\n",
      "1.1  Disease Burden\n",
      "Data on the incidence and prevalence of STI in the South-\n",
      "East Asia Region (SEAR) are limited.\n",
      "WHO estimates \n",
      "approximately 600,000 pregnant women are infected with \n",
      "syphilis and 230,000 associated adverse outcomes occur \n",
      "every year in the SEAR.\n",
      "1\n",
      "CHAPTER\n",
      "\n",
      "3\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Syphilis in pregnancy is an under-recognized problem that carries a \n",
      "significant public health and economic burden.\n",
      "It is estimated that there are \n",
      "12 million people infected worldwide, with more than 90% of these cases \n",
      "being from the developing countries.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 21:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 9,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Each year nearly 1.5 million pregnant \n",
      "women around the world are infected with active syphilis.\n",
      "Due to widespread \n",
      "availability of Penicillin in the 1940s there was dramatic decrease in the rates \n",
      "of infection, which have again increased since the turn of the millennium \n",
      "in many countries, often in combination with HIV infection.\n",
      "This has been \n",
      "attributed partly to unsafe sexual practices and decreasing use of condoms.\n",
      "In the 2010–11 round of HIV sentinel surveillance, the average serological \n",
      "prevalence of syphilis (qualitative test result) among ANC attendees of 696 \n",
      "selected ANC sites was 0.38%.\n",
      "Arunachal Pradesh (2.86%) has shown the \n",
      "highest prevalence of syphilis followed by West Bengal (1.91%), Rajasthan \n",
      "(1.17%), Punjab (0.95%), Meghalaya (0.90%), Madhya Pradesh (0.66%), \n",
      "Andaman Nicobar Island, Uttar Pradesh and Tripura (0.63%) and  \n",
      "Odisha (0.62%).\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 22:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 10,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"weight\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1.2  Impact on the Millennium Development Goals \n",
      "(MDGs) \n",
      "With 2015 approaching, international and national focus is on achieving the \n",
      "Millennium Development Goals (MDGs).\n",
      "Screening for and management of \n",
      "syphilis during pregnancy is the next step forward by the Government of India \n",
      "(GoI) in achieving MDGs 4, 5, 6.\n",
      "Screening and \n",
      "management of \n",
      "syphilis will result in \n",
      "reduced incidence \n",
      "of low birth weight \n",
      "(LBW), perinatal \n",
      "deaths and congenital \n",
      "syphilis\n",
      "Reduction in the \n",
      "incidence of stillbirth \n",
      "and spontaneous \n",
      "abortions will result in \n",
      "improved pregnancy \n",
      "outcomes and \n",
      "reduced maternal \n",
      "morbidity.\n",
      "Reduction in co-\n",
      "morbidities like HIV \n",
      "will occur due to \n",
      "improved behaviours \n",
      "following counselling\n",
      "\n",
      "4\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "1.3  Consequences of Syphilis\n",
      "The global estimate of adverse outcomes of syphilis in pregnancy in 2008 \n",
      "was about 520,000.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 23:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 11,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Of this large number, early foetal deaths/stillbirths are \n",
      "215,000; neonatal deaths 90,000; pre-term/LBW 65,000 and congenital \n",
      "diseases 150,000.\n",
      "An estimated 96% of maternal syphilis infection and 98% \n",
      "of adverse outcomes occurred in low and middle-income countries.\n",
      "From \n",
      "2008 to 2012, maternal syphilis infections and adverse pregnancy outcomes \n",
      "declined by 33%; however the pace of decline needs to be accelerated.\n",
      "1.4  Need for National Guidelines\n",
      "As syphilis is known to cause adverse outcomes in pregnant women and \n",
      "newborns, these guidelines offer clear technical recommendations and \n",
      "operational framework for screening pregnant women and managing them \n",
      "when detected positive.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 24:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 12,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": [\n",
      "      \"first\"\n",
      "    ]\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Technical Guidelines on \n",
      "Testing and Management of \n",
      "Syphilis During Pregnancy\n",
      "2.1  Goal \n",
      "To reduce maternal and newborn morbidity and mortality \n",
      "and move towards detection and treatment of maternal \n",
      "syphilis and elimination of congenital syphilis.\n",
      "2.2  Objectives\n",
      " Ʋ To ensure early screening of all pregnant women for \n",
      "syphilis, preferably in the first trimester;\n",
      " Ʋ To detect and manage syphilis infection in pregnant \n",
      "women and their partners;\n",
      " Ʋ To ensure institutional delivery at (FRUs/higher level \n",
      "institutions) of all syphilis-positive pregnant women; \n",
      " Ʋ To prevent the transmission of syphilis from mother  \n",
      "to child.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 25:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 13,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2\n",
      "CHAPTER\n",
      "\n",
      "6\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "2.3   Target Population\n",
      " Ʋ All pregnant women and their newborns\n",
      " Ʋ Partners of syphilis-positive pregnant women\n",
      "2.4  Prerequisites for Testing and Management  \n",
      "of Syphilis\n",
      " Ʋ Availability of Point-of-Care (POC) testing at Sub-centres (SC) and \n",
      "outreach sessions such as Village Health and Nutrition Days (VHNDs) \n",
      " Ʋ Availability of POC test at any other facility where rapid plasma reagin \n",
      "(RPR) testing is not available, including at centres where deliveries are \n",
      "conducted\n",
      " Ʋ Availability of RPR testing facility at all the health facilities above sub-\n",
      "centre\n",
      " Ʋ All commodities and human resource for management of syphilis, \n",
      "relevant to the level of facility\n",
      " » Availability of drugs, injectables and consumables required for the \n",
      "management of maternal and congenital syphilis\n",
      " »\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 26:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 14,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "An emergency kit containing essential drugs, injections and supplies \n",
      "for managing anaphylactic shock\n",
      " » Trained human resource to provide the management to pregnant \n",
      "women after they test positive for syphilis\n",
      " » Appropriate referral linkages to First Referral Units (FRU)/ Emergency \n",
      "Obstetric Care (EmOC) centers for conducting the delivery of syphilis-\n",
      "positive pregnant women\n",
      " » Availability of Ob-Gyn and pediatrician is mandatory at such FRUs\n",
      "2.5  Selection of Facilities\n",
      " Ʋ States are free to choose the number of districts where the programme \n",
      "will be implemented\n",
      " Ʋ Once a district is chosen, implementation of the programme should \n",
      "be universal in all health care institutions in that district, right from the \n",
      "medical college to the sub-centre\n",
      " Ʋ All health care facilities in the selected district should have all the relevant \n",
      "prerequisites in place\n",
      " Ʋ\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 27:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 15,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "The service providers and programme officer must be well oriented and \n",
      "trained regarding the programme\n",
      "\n",
      "7\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "2.6  Steps for Implementation\n",
      " Ʋ A Government order/policy decision on implementation of the programme \n",
      "should be issued by the State\n",
      " Ʋ Testing and treatment for syphilis to be declared as an integral part of the \n",
      "essential ANC package\n",
      " Ʋ Orientation and training of all programme officers and service providers \n",
      "involved in the programme\n",
      " Ʋ Availability of test kits, consumables, drugs and other logistics, as \n",
      "relevant at health care facilities in the district identified for rolling out the \n",
      "programme\n",
      " Ʋ Adequate information education and communication (IEC) /interpersonal\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 28:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 16,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "communication (IPC) for generating awareness\n",
      " Ʋ Availability of different formats, records, registers and other requisite \n",
      "Monitoring and Evaluation (M&E) tools for documentation, data collection, \n",
      "collation and for review and evaluation of the programme\n",
      " Ʋ Provision of adequate budget and timely release to the implementing \n",
      "institutions\n",
      "\n",
      "8\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      "Protocol for Investigation and \n",
      "Management of Syphilis\n",
      " Ʋ All pregnant women should be tested for syphilis in \n",
      "the first ANC visit itself, which should be as early as \n",
      "possible, by a POC test at the sub-centre level or at \n",
      "any other facility where the woman visits for ANC, \n",
      "where laboratory facilities for RPR are not available, \n",
      "irrespective of her previous syphilitic status.\n",
      "Ʋ Those women who go for ANC check-up at health care \n",
      "facilities where testing for RPR is available should be \n",
      "tested by RPR method (qualitative and quantitative).\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 29:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 17,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": [\n",
      "      \"third\"\n",
      "    ]\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ Ideally, all women who test positive for syphilis \n",
      "through POC should undergo testing by RPR also \n",
      "for confirmation of diagnosis and assessment of the \n",
      "antibody titres.\n",
      "The latter is important not just for \n",
      "ensuring appropriate treatment for the woman but also \n",
      "for deciding on the line of treatment for the newborn.\n",
      "Ʋ Those found positive either by POC or RPR should \n",
      "be treated for maternal syphilis as per the defined \n",
      "treatment protocol explained in this guideline.\n",
      "Ʋ Women who are at high risk for syphilis (see box on \n",
      "the adjacent page), those who live in areas of high \n",
      "prevalence of syphilis, those who have had adverse \n",
      "outcomes of pregnancy previously or those who were \n",
      "untested earlier, should be screened again in the third \n",
      "trimester or at the time of delivery.\n",
      "Ʋ Testing of spouse/partner of syphilis-positive women \n",
      "should be mandatory followed by treatment as per \n",
      "protocol for those found positive.\n",
      "3\n",
      "CHAPTER\n",
      "\n",
      "9\n",
      "Screening for Syphilis\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 30:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telefax : 23062930\",\n",
      "  \"chunk_index\": 18,\n",
      "  \"total_chunks_in_section\": 19,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "During Pregnancy\n",
      "Pregnant women considered to be at high risk for acquiring \n",
      "STIs, including Syphilis: \n",
      " ◘ Women with current or past history of STI\n",
      " ◘ Women with more than one sexual partner\n",
      " ◘ Sex workers \n",
      " ◘ Injecting drug users\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 31:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ensure readiness of emergency tray for management of \n",
      "anaphylactic reactions:\n",
      " ◘\n",
      "The tray should be kept in the day-care room.\n",
      "◘\n",
      "Every morning the tray should be checked for replenishment of used \n",
      "drugs and for expiry dates of drugs on the tray.\n",
      "◘ List of drugs and consumables that should always be available on the \n",
      "tray:\n",
      "Inj Adrenaline, Inj Chlorpheniramine Maleate, Inj Dexamethasone, \n",
      "Inj Hydrocortisone succinate, Inj Deriphylline, Inj Furosemide, \n",
      "Inj Dopamine, Inj Sodium bicarbonate, Oxygen, Ringer Lactate, \n",
      "disposable needles, gloves, cotton swabs.\n",
      "3.1  Treatment Regimen for Syphilis-positive Pregnant \n",
      "       Women and their Partners\n",
      "3.1.1  Treatment of maternal syphilis\n",
      "Although severe allergy to penicillin is rare, the provider should rule \n",
      "out history of allergy before administering penicillin.\n",
      "The emergency \n",
      "drugs for managing anaphylaxis should be kept ready prior to \n",
      "administering penicillin (see Anaphylaxis Management at Annexure 1).\n",
      "i.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 32:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      3\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "In the early stage (primary and secondary syphilis of <2 years’ \n",
      "duration; RPR titre< 1:8 approximately), a single intramuscular \n",
      "injection of 2.4 million IU benzathine benzyl penicillin is sufficient.\n",
      "ii.\n",
      "In the late stage (tertiary > 2 years or unknown duration, RPR \n",
      "titre>1:8 approximately), a total of three intramuscular injections of \n",
      "2.4 million IU benzathine benzyl penicillin once a week for 3 weeks \n",
      "need to be given.\n",
      "Ʋ For all syphilis-positive women detected during ANC by either POC or \n",
      "RPR, their newborns should be tested by RPR.\n",
      "Ʋ All newborns showing four-fold rise in titre compared to that of mother’s \n",
      "titre need to be hospitalized to initiate penicillin treatment for 10 days.\n",
      "10\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 33:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Important facts about penicillin use:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 34:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Facts about benzathine penicillin injection:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Facts about benzathine penicillin injection:\n",
      " ◘ Benzathine penicillin injection is the only effective treatment for \n",
      "preventing congenital syphilis, perinatal deaths, stillbirths and preterm \n",
      "deliveries in pregnant women with syphilis.\n",
      " ◘ A study undertaken by Tais F Galvio, Lori M. Newman et al. (Feb \n",
      "2013 Journal PLOS ONE) states that no case of serious adverse \n",
      "reactions to benzathine penicillin injection was reported in pregnant \n",
      "women and the incidence was very low in the general population.\n",
      " ◘ Incidence of adverse reactions in pregnant women treated with \n",
      "benzathine penicillin injection for preventing congenital syphilis in \n",
      "studies conducted between 1954 and 2012 have shown only one \n",
      "case of skin rash.\n",
      " ◘ Benefits of benzathine penicillin injection outweigh the risks of \n",
      "adverse reactions.\n",
      "Therefore, fears regarding use of benzathine penicillin injection among \n",
      "doctors should be dispelled.\n",
      "Alternative Regimen for Penicillin-allergic Pregnant women\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 35:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Key points:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Key points: \n",
      " ý\n",
      "For the treatment of syphilis during pregnancy, NO PROVEN \n",
      "ALTERNATIVES TO PENICILLIN exist.\n",
      "ý All infants of pregnant women treated with a non-penicillin regimen should \n",
      "be treated at birth as if mother was not sufficiently treated.\n",
      "ý\n",
      "Alternative to penicillin should be considered ONLY for those syphilis-\n",
      "positive pregnant women who have a history of severe penicillin allergy \n",
      "(e.g. anaphylaxis).\n",
      "ý Erythromycin estolate is contraindicated because of drug-related \n",
      "hepatotoxicity.\n",
      "Only erythromycin base or erythromycin ethyl succinate \n",
      "should be used.\n",
      "The partner or spouse should be treated with the same regimen.\n",
      "Regimen 1                       \n",
      " ◘ Early-stage syphilis: \n",
      "Erythromycin, 500 mg orally, \n",
      "4 times daily for 15 days \n",
      " ◘ Late-stage syphilis: \n",
      "Erythromycin, 500 mg orally, \n",
      "4 times daily for 30 days\n",
      "Regimen 2\n",
      "Primary syphilis (syphilitic \n",
      "chancre): Azithromycin, 2 g \n",
      "orally as a single dose\n",
      "OR\n",
      "\n",
      "11\n",
      "Screening for Syphilis\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 36:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Key points:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      24,\n",
      "      6\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "During Pregnancy\n",
      "3.1.2  Follow-up\n",
      "Follow-up should be done during postnatal care (PNC) visits and in addition,  \n",
      "at 6 months and 24 months after the treatment is administered.\n",
      "Flowchart 1\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 37:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Syphilis screening of pregnant women using POC test and treatment of \n",
      "maternal syphilis at health care settings without laboratory support\n",
      "Criteria for repeat test:     \n",
      " ◘ Pregnant women considered to be at high risk for acquiring STI (those with current or past history of \n",
      "STI, women with more than one sexual partner, sex workers and injecting drug users);\n",
      " ◘ Pregnant women with history of repeated abortions, stillbirths, past history of delivery of premature \n",
      "babies, preterm babies and neonatal deaths;\n",
      " ◘ Women living in areas of high prevalence of syphilis;\n",
      " ◘ Testing at the time of delivery will also be required to detect re-infection, particularly in those syphilis- \n",
      "positive women whose partners were not treated;\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 38:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"First visit: ANC\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": [\n",
      "      \"third\"\n",
      "    ]\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "First visit: ANC \n",
      "registration - by ANM at \n",
      "SC, VHND etc.\n",
      "Screen pregnant woman for \n",
      "Syphlis using Point-of-Care \n",
      "(POC) test\n",
      "Pregnant woman \n",
      "found syphilis reactive\n",
      "Pregnant woman found \n",
      "syphilis non-reactive\n",
      "Retest high risk \n",
      "pregnant women* in \n",
      "third trimester or soon \n",
      "after delivery\n",
      "Pregnant woman \n",
      "found syphilis reactive\n",
      "Refer to nearest \n",
      "PHC/CHC/DH\n",
      "Repeat RPR titre after delivery and \n",
      "assess infant for appropriate treatment\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 39:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"1. Immediately treat pregnant woman\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Immediately treat pregnant woman\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 40:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"2. Conduct a qualitative and\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Conduct a qualitative and   \n",
      " quantitative RPR/VDRL test.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 41:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"3. Test and treat the spouse / partner\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Test and treat the spouse / partner\n",
      "\n",
      "12\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Flowchart 2\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 42:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Algorithm for syphilis screening of pregnant women and treatment of \n",
      "maternal syphilis at health care settings with laboratory support\n",
      "Criteria for repeat test:     \n",
      " ◘ Pregnant women considered to be at high risk for acquiring STI (those with current or past \n",
      "history of STI, women with more than one sexual partner, sex workers and injecting drug \n",
      "users) \n",
      " ◘ Pregnant women with history of repeated abortions, stillbirths, past history of delivery of \n",
      "premature babies, preterm babies and neonatal deaths\n",
      " ◘ Women living in areas of high prevalence of syphilis\n",
      " ◘ Testing at the time of delivery will also be required to detect re-infection, particularly in those \n",
      "syphilis-positive women whose partners were not treated.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 43:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"First visit: ANC registration\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": [\n",
      "      \"third\"\n",
      "    ]\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "First visit: ANC registration \n",
      "at PHC or higher facility\n",
      "Screen pregnant woman for \n",
      "syphilis using RPR/VDRL test \n",
      "(qualitative & quantitative)\n",
      "Pregnant woman \n",
      "found syphilis reactive\n",
      "Pregnant woman found \n",
      "syphilis non-reactive\n",
      "Retest high-risk* pregnant \n",
      "woman in third trimester \n",
      "or soon after delivery\n",
      "Pregnant woman \n",
      "found syphilis reactive \n",
      "in late third trimesterRepeat RPR/VDRL titre after \n",
      "delivery and assess infant \n",
      "for appropriate treatment\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 44:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"1. Immediately treat\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Immediately treat  \n",
      "pregnant woman\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 45:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"2. Conduct a quantitative and\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Conduct a quantitative and \n",
      "qualitative RPR/VDRL test.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 46:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"3. Test and treat the spouse / partner\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Test and treat the spouse / partner\n",
      "\n",
      "13\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Flowchart 3\n",
      "Algorithm for syphilis screening of pregnant women coming directly in \n",
      "labour and treatment of maternal syphilis\n",
      "Pregnant woman \n",
      "coming directly in labour\n",
      "Screen pregnant woman for \n",
      "syphlis using POC test\n",
      "Pregnant woman \n",
      "found syphilis reactive\n",
      "Pregnant woman found \n",
      "syphilis non-reactive\n",
      "Conduct a qualitative and \n",
      "quantitative RPR/VDRL after delivery \n",
      "for both the mother and the newborn \n",
      "for comparing the antibody titre \n",
      "levels of the mother and the neonate\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 47:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"1. Immediately treat the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Immediately treat the  \n",
      "pregnant woman\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 48:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"2. Test and treat the spouse/partner\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"normal_variations\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Test and treat the spouse/partner\n",
      "\n",
      "14\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "3.2 Neonatal Syphilis\n",
      "3.2.1  Case Definitions \n",
      "Suspected case of congenital syphilis\n",
      "A stillborn or live-born baby of syphilis-reactive mother who has been \n",
      "inadequately treated\n",
      "Confirmed case of congenital syphilis\n",
      "A live born child with serum quantitative RPR titre that is four-fold \n",
      "higher than the mother’s titre\n",
      "OR\n",
      "A child within first 2 years of life with clinical evidence of syphilis and \n",
      "reactive syphilis serology irrespective of mother’s serology\n",
      "3.2.2  Signs and Symptoms of Congenital Syphilis\n",
      "Congenital syphilis may be asymptomatic, especially in the first few \n",
      "weeks of life, in about 50% of cases.\n",
      "Usually symptoms appear in the \n",
      "first few months, but the clinical manifestations may be delayed until \n",
      "the second year of life.\n",
      "The most frequent clinical signs of congenital syphilis at birth are \n",
      "hepatosplenomegaly (33% –100%), bone changes seen on x-ray \n",
      "Fig.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 49:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"2. Test and treat the spouse/partner\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"normal_variations\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"weight\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1: Radiograph showing \n",
      "lower end of humerus (with \n",
      "periostitis) and proximal \n",
      "ends of radius and ulna (with \n",
      "metaphysitis)\n",
      "(75%–100%) (Fig.1), blistering \n",
      "skin rash especially on palms \n",
      "and soles (40%) (Fig.2), fever \n",
      "(16%), low birth weight (10%–\n",
      "40%), bleeding (10%), swelling \n",
      "of the joints, abnormal facies, \n",
      "snuffles, oedema, abdominal \n",
      "distension, pallor, respiratory \n",
      "distress and pseudo-paralysis.\n",
      "An older child may have \n",
      "stigmata (e.g. interstitial \n",
      "keratitis, nerve deafness, \n",
      "anterior bowing of shins, frontal \n",
      "bossing, mulberry molars, \n",
      "Hutchinson teeth, saddle nose, \n",
      "rhagades, or Clutton joints).\n",
      "15\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Fig.\n",
      "2: Blistering skin rash in neonates\n",
      "3.3.3  Management of Congenital Syphilis \n",
      "Regimen 1 (Prophylactic Treatment)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 50:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All asymptomatic babies who meet ALL the following criteria:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      4\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "All asymptomatic babies who meet ALL the following criteria:\n",
      " ◘ Have no serological evidence of syphilis and \n",
      " ◘ Are born to mothers who were adequately treated for maternal \n",
      "syphilis with penicillin during the current pregnancy and\n",
      " ◘ The mother has received the treatment at least 4 weeks prior  \n",
      "to delivery\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 51:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Should be treated with a single dose of prophylactic penicillin:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      4\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Should be treated with a single dose of prophylactic penicillin: \n",
      "Benzathine penicillin G 50,000 units/kg given as a single intramuscular \n",
      "injection.\n",
      "Regimen 2 (Curative Treatment)\n",
      "This should be given to\n",
      " ý All symptomatic babies (newborns and older)\n",
      " ý\n",
      "All asymptomatic babies- \n",
      "Asymptomatic newborns\n",
      " ◘ Born to mothers who were treated with penicillin less than 4 \n",
      "weeks before delivery\n",
      " ◘\n",
      "Born to mothers who were treated with non-penicillin regimens \n",
      "(erythromycin or azithromycin) during pregnancy \n",
      " ◘ Born to mothers whose treatment status is unknown or \n",
      "undocumented\n",
      "\n",
      "16\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      "Asymptomatic infant/child\n",
      " ◘\n",
      "Whose RPR/VDRL titre is four-fold higher than that of the \n",
      "mother at or after delivery \n",
      " ◘\n",
      "Born to mothers with clinical evidence of syphilis\n",
      " ◘ With a reactive syphilis IgM antibody test\n",
      " ◘\n",
      "Born to mothers who did not complete the recommended \n",
      "course of penicillin during pregnancy \n",
      " ◘\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 52:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Should be treated with a single dose of prophylactic penicillin:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"weight\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Born to mothers whose RPR/VDRL titres had not  \n",
      "dropped four-fold\n",
      "Intravenous (IV) treatment regimen \n",
      "Aqueous crystalline penicillin\n",
      "G 100,000–150,000 million units/kg/day \n",
      "intravenously.\n",
      "It could be given as 50,000 units/kg/dose IV every 12 hours \n",
      "during the first 7 days, and thereafter every 8 hours for 3 days to complete a \n",
      "total of 10 days of treatment.\n",
      "OR\n",
      "Intramuscular (IM) treatment regimen \n",
      " Ʋ Procaine penicillin 50,000 units/kg body weight intramuscularly as a \n",
      "single daily dose for 10 days; \n",
      " Ʋ Alternatively, benzathine penicillin G 50,000 units/kg IM in a single dose \n",
      "Hospitalization of the infant should be considered in order to ensure the full \n",
      "course of treatment.\n",
      "If more than one day of treatment is missed, the \n",
      "entire course of treatment should be restarted.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 53:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Should be treated with a single dose of prophylactic penicillin:\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      24,\n",
      "      6\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "3.3.4  Follow-up\n",
      "Follow-up should be done during PNC visits as well as at 6 months \n",
      "and 24 months after the treatment is received.\n",
      "\n",
      "17\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Operational Plan for \n",
      "Investigation and \n",
      "Management of Syphilis\n",
      " Ʋ\n",
      "The programme manager for the state should collect \n",
      "the data for the estimated number of pregnancies from \n",
      "each of the districts and direct the district programme \n",
      "manager to ensure that all pregnant women attending \n",
      "ANC clinics at government health care facilities receive \n",
      "screening for syphilis, preferably as part of the first \n",
      "ANC visit itself.\n",
      "Ʋ In the district, about 60% to 70% of the total estimated \n",
      "pregnancies will avail ANC screening from government \n",
      "health care facilities (Sub-centre, PHC, CHC, Sub-\n",
      "divisional Hospital, District Hospital, Medical College, \n",
      "etc.).\n",
      "Ʋ The programme manager at the district will estimate \n",
      "the caseloads per health care facility based on HMIS \n",
      "data.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 54:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Should be treated with a single dose of prophylactic penicillin:\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ The programme manager will ensure that kits and \n",
      "consumables for syphilis screening are available based \n",
      "on the type of health care facility.\n",
      "Ʋ Pregnant women will be screened as mentioned in the \n",
      "algorithm charts.\n",
      "4\n",
      "CHAPTER\n",
      "\n",
      "18\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      "4.1  Awareness Generation at the Community Level\n",
      "All health care workers and professionals should generate awareness in the \n",
      "community about the importance of screening for syphilis in the antenatal \n",
      "period by using various IEC methods and strategies including IPC.\n",
      "4.2  Human Resources Involved\n",
      "Specialists, medical officers, laboratory technicians and other health care \n",
      "workers across different levels of health care facilities; no additional human \n",
      "resources need to be recruited to implementing these guidelines.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 55:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Should be treated with a single dose of prophylactic penicillin:\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "4.3  Role and Responsibilities – Defined by Levels of \n",
      "Health Care Facilities\n",
      "4.3.1  Village:\n",
      " Ʋ Generate awareness among pregnant women regarding the \n",
      "importance of routine ANC highlighting the importance of screening \n",
      "for syphilis during early pregnancy.\n",
      "Ʋ Mobilize pregnant women to attend VHND/sub-centre as per the \n",
      "ANC registrations list for getting routine ANC and investigations.\n",
      "Ʋ If the pregnant woman is syphilis-positive, ASHA should ensure \n",
      "her treatment, testing and treatment of spouse/partner, delivery \n",
      "in an FRU or higher facility through birth planning and prompt \n",
      "investigation and treatment of the newborn.\n",
      "Ʋ Enlist family support as it is required for testing and for ensuring \n",
      "treatment if the woman is found to be syphilis-positive.\n",
      "4.3.2  Level I: Sub-centre/VHND\n",
      " Ʋ Conduct ANC and testing for syphilis by POC test along with other \n",
      "mandatory tests during ANC.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 56:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Should be treated with a single dose of prophylactic penicillin:\",\n",
      "  \"chunk_index\": 5,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ If the pregnant woman is reactive to the POC test, she should be \n",
      "referred to PHC/CHC/Sub-divisional Hospital/District Hospital for \n",
      "treatment and RPR.\n",
      "Ʋ Her spouse/partner should be encouraged to get tested and seek \n",
      "treatment if found positive.\n",
      "Ʋ The ANM will record the test results in the MCP card and RCH \n",
      "register.\n",
      "Ʋ All positive cases should be followed up for treatment.\n",
      "Ʋ The test kit should be kept in the refrigerator to maintain the \n",
      "temperature at 2°C to 8°C.\n",
      "19\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      " Ʋ If a refrigerator is not available at the sub-centre, then the kits \n",
      "should be kept at the PHC to maintain cold chain, and be brought \n",
      "to the VHND or outreach sessions while ensuring that cold chain is \n",
      "maintained.\n",
      "4.3.3  Level II: PHC/Corresponding urban centre\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 57:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All the jobs assigned above plus the following:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "All the jobs assigned above plus the following:\n",
      " Ʋ RPR test has to be performed by the laboratory technician. In the \n",
      "absence of a laboratory technician, a staff nurse will do the POC \n",
      "test and refer syphilis-positive pregnant woman to the Medical \n",
      "Officer or to a higher centre for treatment and RPR test. \n",
      " Ʋ The MO will provide treatment by using the standard treatment \n",
      "protocol for syphilis.\n",
      " Ʋ The MO will also monitor the treatment/investigation required for \n",
      "syphilis-positive cases and refer to an FRU/higher level centre for \n",
      "further medical management, if required and conduction of delivery \n",
      "by the specialist. \n",
      "4.3.4  Level III\n",
      "A) DH and All CEmOC Centres\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 58:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All jobs as defined under Level II plus the following:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      3\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "All jobs as defined under Level II plus the following:\n",
      " Ʋ Ob-Gyn to conduct the delivery of syphilis-positive pregnant \n",
      "women\n",
      " Ʋ Paediatricians to provide care to the newborn of a syphilis-\n",
      "positive mother \n",
      "B) Medical College and Other Super-speciality Centres\n",
      "Comprehensive management of all cases needing treatment of syphilis \n",
      "including all referral cases\n",
      "4.4  Roles and Responsibilities Defined by Cadre of \n",
      "Health Worker\n",
      "4.4.1  District RCH Officer/State RCH Officer\n",
      " Ʋ Plan the roll-out of syphilis testing among pregnant women\n",
      " Ʋ Ensure that all facilities have adequate supply of test kits, \n",
      "consumables and drugs for at least 3 months\n",
      " Ʋ Calculate the health facility-wise case load for sending the supplies \n",
      "in advance as per consumption pattern\n",
      "\n",
      "20\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      " Ʋ Coordinate with CMHO/Civil surgeon, State RCH Officer, DPMU \n",
      "and DAPCU to strengthen service delivery in the field\n",
      " Ʋ Monitor the programme to ensure:\n",
      " »\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 59:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All jobs as defined under Level II plus the following:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "The storage of all supplies is in accordance with the \n",
      "manufacturer’s instructions\n",
      " »\n",
      "The required drugs are part of the Essential Drugs List (EML)\n",
      " »\n",
      "Training of all the health staff\n",
      " » All the reporting units provide report on screening and treatment \n",
      "of pregnant women for syphilis in HMIS\n",
      "4.4.2  ANM/Staff Nurse\n",
      " Ʋ Increase awareness among pregnant women regarding syphilis \n",
      "screening\n",
      " Ʋ Register all pregnant women for ANC and screen for syphilis using \n",
      "the POC test during first ANC visit\n",
      " Ʋ Maintain the ANC register, including record of syphilis test results.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 60:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All jobs as defined under Level II plus the following:\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ Refer syphilis-positive pregnant women to higher health care \n",
      "facility for confirmation and treatment\n",
      " Ʋ Follow-up syphilis-positive women and their newborns for \n",
      "treatment\n",
      " Ʋ Assist/prepare HMIS and other relevant reports \n",
      "4.4.3  Laboratory Technician\n",
      " Ʋ Conduct syphilis testing test for all pregnant women visiting the \n",
      "PHC and higher centres for ANC\n",
      " Ʋ Maintain the laboratory register\n",
      " Ʋ Store test kits as per guidelines\n",
      " Ʋ Refer syphilis-positive pregnant women for treatment \n",
      " Ʋ\n",
      "Keep records\n",
      " Ʋ Testing blood of newborns\n",
      "4.4.4  Medical Officer\n",
      " Ʋ Provide treatment to all the syphilis-positive women, \n",
      " Ʋ Test and treat their spouse/partner \n",
      " Ʋ Refer the syphilis-positive pregnant women to an FRU for \n",
      "delivery,and further testing\n",
      "\n",
      "21\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 61:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All jobs as defined under Level II plus the following:\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ Conduct follow-up test after treatment as per guidelines\n",
      " Ʋ Follow-up of patient management \n",
      " Ʋ Manage the cases of anaphylaxis if any occur\n",
      " Ʋ Check for correctness of reporting \n",
      "4.4.5  In-charge of DSRC (Designated STI/RTI Clinic)\n",
      "DSRCs are mainly located at district hospitals\n",
      " Ʋ Maintain the inventory and stock registers of drugs and test kits\n",
      " Ʋ Build capacity of all new STI counsellors\n",
      " Ʋ Sensitize the PHC- MOs and ANMs/ASHAs on updates of  \n",
      "the programme\n",
      " Ʋ Provide mentoring and supportive supervisory visits to \n",
      "health facilities\n",
      " Ʋ At the STI clinic counselling of pregnant women and laboratory \n",
      "referral for testing\n",
      " Ʋ Counselling all ANC attendees and partners coming to the ANC \n",
      "clinic and referring to the laboratory for screening/confirmation  \n",
      "of syphilis\n",
      "4.4.6  Paediatrician/Gynaecologist\n",
      " Ʋ Provide delivery services to all pregnant women who test positive \n",
      "for syphilis\n",
      " Ʋ Help in assessing the antibody titres in the newborn’s blood by \n",
      "drawing blood from the neonate’s cubital vein and sending it to the \n",
      "laboratory technician for testing by RPR\n",
      " Ʋ Provide treatment for the newborn and infant of a syphilis-positive \n",
      "mother\n",
      " Ʋ Provide comprehensive care to a syphilis-positive mother and  \n",
      "her newborn\n",
      "\n",
      "22\n",
      "Screening for Syphilis\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 62:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All jobs as defined under Level II plus the following:\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\",\n",
      "    \"delivery\",\n",
      "    \"postpartum\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "During Pregnancy\n",
      "4.5 Capacity Building of Human Resource\n",
      "4.5.1 Training Needs for Different Cadres\n",
      "Cadre of  \n",
      "Health Care \n",
      "Functionary Type of Training Content of Training\n",
      "ASHA General \n",
      "orientation about \n",
      "the programme\n",
      "Orientation on \n",
      " ▪ Syphilis disease burden, consequences \n",
      "for pregnant women and neonates\n",
      " ▪ IEC material on awareness \n",
      "ANM/LHV/SN Knowledge and \n",
      "skills about POC \n",
      "screening test for \n",
      "syphilis\n",
      "The training for ASHAs, plus\n",
      " ▪ POC testing technique\n",
      " ▪ Interpreting POC test results\n",
      " ▪ Referral required when the test is positive\n",
      " ▪ Technique of testing \n",
      "sensitivity of penicillin\n",
      " ▪ Maintenance of records and \n",
      "different reporting formats\n",
      "Laboratory \n",
      "technician\n",
      "Knowledge and \n",
      "skills about RPR \n",
      "and POC test for \n",
      "syphilis\n",
      "The training for ANMs plus\n",
      " ▪ POC testing techniques\n",
      " ▪ RPR testing techniques – \n",
      "qualitative and quantitative\n",
      " ▪ Interpreting POC and RPR test results\n",
      " ▪ Referral required when the test is positive\n",
      "Medical Officer Medical \n",
      "management of a \n",
      "syphilis-positive \n",
      "pregnant woman\n",
      " ▪ Interpretation of RPR test results\n",
      " ▪ Technique of administration of penicillin \n",
      "injection through the proper site and route\n",
      " ▪ Medical management of \n",
      "syphilis, including alternative \n",
      "(to penicillin) therapies\n",
      " ▪ Referral to FRU for delivery and \n",
      "management of newborn\n",
      "Specialists \n",
      "(Ob-Gyn, \n",
      "Paediatrician)\n",
      "Special obstetric \n",
      "care of syphilis-\n",
      "positive pregnant \n",
      "women\n",
      "The training for medical officers, plus\n",
      " ▪ Special obstetric care: ante-partum, \n",
      "intra-partum and postpartum\n",
      " ▪ Comprehensive medical management \n",
      "of syphilis-positive pregnant women\n",
      " ▪ Technique of drawing venous blood \n",
      "from newborn from the cubital vein \n",
      "for RPR test (by paediatrician only)\n",
      " ▪ Management of the neonate of \n",
      "a syphilis-positive mother\n",
      "\n",
      "23\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "4.5.2  Structure of Training for Syphilis Programme\n",
      " Ʋ A one-day training will be organized for syphilis programme in \n",
      "every district\n",
      " Ʋ All participants (programme managers and medical officers [MOs] \n",
      "in-charge of STI Clinics/DSRCs/District AIDS Prevention & Control \n",
      "Units/Integrated Counselling and Testing centres/HFWTC/DTC \n",
      "faculty, Principals, ANMTC/LHVTC; School/s of Nursing; DNOs/\n",
      "HEOs/ASHA Mentors/ANMs/ SNs/ LHVs/LTs/MOs/Specialists \n",
      "(Obstetricians; Paediatricians, Dermatologists) will attend\n",
      " Ʋ ASHAs will have a separate batch and 1-day training programme \n",
      "can be incorporated either into their existing module or a separate \n",
      "orientation programme at block level can be organized\n",
      "4.5.3  Batch Size\n",
      " Ʋ All health care facilities in a district will be mapped\n",
      " Ʋ Health personnel of all health care service delivery points need to \n",
      "be oriented/ trained on a rotational basis\n",
      " Ʋ One batch can have 40 to 60 trainees from all cadres \n",
      "(heterogeneous group)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 63:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"All jobs as defined under Level II plus the following:\",\n",
      "  \"chunk_index\": 5,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\",\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ One batch of trainees will comprise\n",
      "  Programme managers: 3–5\n",
      "  ANM/SN/LHV: 20–25\n",
      "  LT: 5–10\n",
      "  MO/ Ob-Gyn/Paediatrician and dermatologist/ pathologist or \n",
      "microbiologist: 10–15\n",
      " Ʋ Once the health personnel of the designated delivery points in \n",
      "the district have been trained on a priority basis, other health \n",
      "personnel involved in ANC care can be oriented\n",
      " Ʋ District Training In-charge will prepare a training plan and  \n",
      "calendar accordingly\n",
      "\n",
      "24\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "4.5.4  Training Sites\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 64:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Prerequisites:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Prerequisites:\n",
      " Ʋ Seminar/Conference room with capacity of 50–60 participants\n",
      " Ʋ Audio-visual and other training aids\n",
      " Ʋ At least two in-house Ob-Gyn and one paediatrician\n",
      " Ʋ Availability of in-house counsellor, pathologist/ microbiologist, \n",
      "community medicine faculty is desirable\n",
      " Ʋ Any medical college/district hospital having the above \n",
      "prerequisites can be chosen as a training site/venue\n",
      "4.5.5  Trainers\n",
      " Ʋ MO, Ob-Gyn, paediatrician and dermatologist/pathologist or \n",
      "microbiologist/specialist in Community Medicine to be included as \n",
      "trainers as per their availability and area of expertise\n",
      " Ʋ One-day training of trainers should be organized for 20–25 trainers \n",
      "at medical college level\n",
      "4.5.6  Training Material\n",
      " Ʋ GoI guidelines on syphilis\n",
      " Ʋ Any other teaching or training material synchronized with GoI \n",
      "guidelines\n",
      " Ʋ Job aids/Posters/Handouts/Flipcharts\n",
      " Ʋ Presentations\n",
      " Ʋ POC testing strips/cards\n",
      "4.6  Monitoring and Evaluation Framework\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 65:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Prerequisites:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "This initiative envisages a focused and robust monitoring and evaluation \n",
      "system with specific indicators mentioned below to monitor progress of the \n",
      "initiative across states so as to take appropriate programmatic responses.\n",
      "NACO and the Maternal Health Division of MoHFW will monitor indicators \n",
      "identified as critical for monitoring at national level.\n",
      "States and districts will be \n",
      "responsible for monitoring of these indicators and for ensuring quality of data \n",
      "collection from the facilities.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 66:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Prerequisites:\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "25\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "4.6.1  Key performance indicators for Syphilis Screening (KPI)\n",
      " Ʋ Number of pregnant women tested for syphilis out of total ANCs \n",
      "registered\n",
      " Ʋ Total number of syphilis-positive pregnant women detected out of \n",
      "those tested \n",
      " Ʋ Total number of pregnant women adequately treated (i.e. received \n",
      "one dose of benzathine penicillin injection) for syphilis\n",
      " Ʋ Total number of confirmed cases of congenital syphilis \n",
      " Ʋ Total number of babies born to syphilis-positive mothers who \n",
      "received treatment \n",
      "4.7  Budget\n",
      " Ʋ Infrastructure: No additional infrastructure required\n",
      " Ʋ Human resource: No separate human resource required\n",
      " Ʋ Equipment/Instruments: No additional equipment or infrastructure \n",
      "required\n",
      " Ʋ Testing kits, consumables and drugs required for this programme need to \n",
      "be budgeted for\n",
      "While estimating the budget required for rolling out this initiative, the following \n",
      "need to be considered\n",
      "4.7.1  Estimated Case Loads\n",
      " Ʋ All pregnant women availing ANC at public health care facilities will \n",
      "be screened for syphilis by strip/card test, or by RPR depending \n",
      "on where they access ANC services\n",
      " Ʋ The pregnant women who test positive for syphilis by the POC \n",
      "test will need to be tested by RPR also (both qualitative and \n",
      "quantitative)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 67:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Prerequisites:\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ The pregnant women who test positive for syphilis by POC test will \n",
      "need benzathine penicillin injection treatment\n",
      " Ʋ All spouses / partners of syphilis-positive women should ideally be \n",
      "tested for syphilis too, and if found positive, then they too will need \n",
      "to be treated\n",
      "\n",
      "26\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      " Ʋ Newborns with congenital syphilis or where mothers were \n",
      "inadequately treated will need to be treated with benzathine penicillin\n",
      "Estimating these proportions from existing data or from reported data \n",
      "following initial roll-out will assist in budgeting for this initiative.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 68:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Prerequisites:\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4.7.2  Records/Registers and Formats\n",
      "The following records and registers need to be printed and made \n",
      "available to the relevant service provider(s)\n",
      " Ʋ Monthly syphilis reporting formats for state and district programme \n",
      "managers (Annexure 6)\n",
      " Ʋ Monthly syphilis reporting formats for health care facility (Annexure 7)\n",
      " Ʋ Referral slip (Annexure 4)\n",
      " Ʋ Migration form for Pregnant Women with syphilis (Annexure 5)\n",
      "4.7.3  Drugs Consumables and Other Logistics\n",
      " Ʋ Estimate the requirement of test kits, drugs, consumables like \n",
      "lancets, gloves, swabs, etc.\n",
      "and ensure supplies of the same\n",
      "4.7.4  Training\n",
      " Ʋ One-day training will be organized for syphilis programme at the  \n",
      "state level\n",
      "Ʋ One-day training will be organized for syphilis programme in every \n",
      "district.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 69:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Prerequisites:\",\n",
      "  \"chunk_index\": 5,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "ProgrammeManagers/ANMs/SNs/LHVs/LTs/MOs/OB-GYN/\n",
      "Paediatricians/Pathologists/Microbiologists will attend\n",
      "\n",
      "27\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Sr. \n",
      "No. Head\n",
      "Unit Cost\n",
      "(Rs.)\n",
      "Number of \n",
      "Participants Days\n",
      "Total\n",
      "(Rs.)\n",
      "1 TA for participants (to and fro) – \n",
      "to be given as per actuals 3,000 50 1,50,000\n",
      "2 DA to trainees 700 50 1 35,000\n",
      "3 Lunch and tea 200 50 1 10,000\n",
      "4 Per diem/Honorarium for \n",
      "trainers** 1,000 2 1 2,000\n",
      "5 Logistic expenses such as for \n",
      "study material, course material, \n",
      "photocopying, job aids, flip \n",
      "charts, LCD etc.\n",
      "(Rate x days of training x \n",
      "number of participants)\n",
      "200 50 1 10,000\n",
      "Sub-total 2,07,000\n",
      "Incidental overheads  \n",
      "(10% of sub-total)\n",
      "20,000\n",
      "Total for one batch of 50 \n",
      "candidates for 1-day training\n",
      "2,27,000\n",
      "Sr. \n",
      "No. Head\n",
      "Unit Cost\n",
      "(Rs.)\n",
      "Number of \n",
      "Participants Days\n",
      "Total\n",
      "(Rs.)\n",
      "TA as per state norms\n",
      "1 DA to District-level Programme \n",
      "Officers 700 10 1 7,000\n",
      "2 DA to Staff Nurses/ANM/LHV  400 25 1 20,000\n",
      "3 DA to Medical Officers/Ob-Gyn 700 15 1 10,500\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 70:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"4. Lunch and tea  200 50 1 10,000\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Lunch and tea  200 50 1 10,000\n",
      "5 Honorarium to State-level Faculty** 1,000 2 1 2,000\n",
      "6 Logistic expenses such as for \n",
      "study material, course material, \n",
      "photocopying, job aids, flip charts, \n",
      "audio-visuals etc.  \n",
      "(Rate x number of participants)\n",
      "200 50 -  10,000\n",
      "Sub-total 49,500\n",
      "Incidental overheads  \n",
      "(10% of sub-total) 5,000\n",
      "Total for batch of 50 54,500\n",
      "1-day Training at State Level for Syphilis - Batch of 50\n",
      "1-day Training of District-level Officers for Syphilis - Batch of 50\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 71:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Note:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Note: \n",
      "** TA to be given as per state norms\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 72:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "The state needs to adjust the training norms as per the training load of the district and state\n",
      "Budget: Training for Syphilis\n",
      "\n",
      "28\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 73:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Note:\n",
      " ◘\n",
      "Every district programme officer needs to undertake advance planning and budget estimates for \n",
      "universal screening of syphilis in the district.\n",
      "◘\n",
      "The state programme officer needs to reflect the budgetary requirement in the state/ NHM \n",
      "Programme Implementation Plan (PIP).\n",
      "◘ State/district accounts manager needs to ensure timely submission of utilisation certificates and \n",
      "statements of expenditure.\n",
      "◘ Necessary equipment/supplies either cash or in kind need to be made available in advance to \n",
      "all the health care facilities in the district.\n",
      "◘ Similarly, training institutes also need to be provided with the training budget as per the \n",
      "estimates in advance.\n",
      "◘\n",
      "Any procurement that needs to be done should be through competitive and transparent bidding \n",
      "process.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 74:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"blood pressure\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "29\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Annexures\n",
      "Annexure – 1\n",
      "Anaphylaxis Management\n",
      "Before administrating penicillin drugs or injections, ask the patient about \n",
      "previous allergies to penicillin.\n",
      "Signs of possible Anaphylaxis\n",
      " Ʋ Shock\n",
      " Ʋ Difficulty in breathing\n",
      " Ʋ Itchy rash or hives (urticarial)\n",
      "Management of Anaphylaxis\n",
      " Ʋ Call for help\n",
      " Ʋ Check\n",
      " » Airway\n",
      " » Breathing: Give mouth-to-mouth respiration, if necessary\n",
      " » Circulation: Perform cardiopulmonary resuscitation, if necessary\n",
      " Ʋ If Anaphylaxis, give Adrenaline intramuscularly (IM)\n",
      " »\n",
      "Dosage: Adult 0.5 mL (if elderly, 0.3 mL), repeat every 5–10 minutes \n",
      "until adequate response\n",
      " » Check blood pressure and pulse every 5–10 minutes\n",
      " Ʋ Give Hydrocortisone.\n",
      "Dosage:\n",
      "Adult 250 mg IM\n",
      " Ʋ Give Chlorpheniramine.\n",
      "Dosage: 10–20 mg or Diphenhydramine  \n",
      "50–100 mg IM\n",
      " Ʋ Transfer patient to hospital\n",
      " »\n",
      "Repeat Adrenaline injection if necessary.\n",
      "Take extra doses with you\n",
      " » Record all details of treatment.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 75:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Give a copy to the hospital as well as to \n",
      "the patient\n",
      " » Stay with the patient until another doctor takes over care in person\n",
      "\n",
      "30\n",
      "Screening for Syphilis\n",
      "During Pregnancy\n",
      "Annexure – 2\n",
      "Technical Specifications of Rapid Plasma Reagin (RPR) Test Kits \n",
      "for Syphilis Testing\n",
      " Ʋ The indigenous RPR kits should have been manufactured under \n",
      "manufacturing licence issued by the State Licensing Authority under \n",
      "the Drugs and Cosmetics Act.\n",
      "The imported kits should have been \n",
      "imported under import licence issued by the DCG (I) under the Drugs \n",
      "and Cosmetics Act.\n",
      "Ʋ The assay should allow for qualitative and semi-quantitative \n",
      "determination of reagin antibodies in serum or plasma for serological \n",
      "diagnosis of syphilis based on flocculation principle using non-\n",
      "treponemal antigens.\n",
      "Ʋ The assay should be suitable to perform with either serum or plasma.\n",
      "Ʋ The assay should have sensitivity of 80% or more in primary syphilis and \n",
      "a specificity of 90% or more.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 76:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      12\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ The assay should be calibrated to WHO reference serum and the same \n",
      "should be supported by statements in kit inserts and certificate from \n",
      "manufacturer.\n",
      "Ʋ The test should be able to yield results within 20 minutes.\n",
      "Ʋ The pack size of RPR test kit should be less than or equal to 50 tests \n",
      "per kit.\n",
      "Ʋ The assay components should include positive and negative serum \n",
      "controls sufficient for conducting 20% of the tests (10% negative and \n",
      "10% positive controls).\n",
      "Ʋ The kit should have all essential accessories required for the test such \n",
      "as cards, dropper, accelerator, etc., in adequate quantities for the \n",
      "number of tests to be performed.\n",
      "Ʋ The kit should have 5/6th of the shelf life or 12 months before expiry \n",
      "(whichever is more) at the time of receipt by the consignee.\n",
      "Ʋ The kit should have a storage temperature of 2°C to 8°C and supplier/\n",
      "local agent should have the facility to store kits at 2°C to 8°C.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 77:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ Cumulative Time Temperature Indicator should be part of the kit and the \n",
      "indicator technology used should be prequalified by WHO.\n",
      "Ʋ Literature detailing the components, methodologies, validity criteria, \n",
      "performance characteristics, storage conditions, manufacturing and \n",
      "expiry dates should be provided with each kit.\n",
      "31\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Annexure – 3\n",
      "Technical Specifications of Treponemal-specific Rapid (Point-of-\n",
      "Care) Diagnostic Test for Syphilis\n",
      " Ʋ The assay should have solid phase coated with synthetic or recombinant \n",
      "type of Treponema Pallidum antigens.\n",
      "Ʋ The assay may be based on any of the rapid test principles: \n",
      "(Immunoconcentration/Dot blot immunoassay (vertical flow), dip stick and \n",
      "comb assay.\n",
      "Ʋ The assay should quantitatively detect total anti-treponemal antibody (IgG \n",
      "and IgM) in whole blood, serum or plasma for serological diagnosis of \n",
      "syphilis in all stages of infection.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 78:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 5,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      12\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ The assay should have an in-built positive and negative control for testing \n",
      "the validity of the test kits.\n",
      "Ʋ The assay should have reactive and non-reactive controls with each kit in \n",
      "adequate volume (minimum 10% of pack size).\n",
      "Ʋ The kit should have 5/6th of the shelf life or 12 months before expiry \n",
      "(whichever is more) at the time of receipt by the consignee.\n",
      "Ʋ Adequate literature detailing the principle, components, methodologies, \n",
      "validity criteria, bio-safety, performance characteristics, storage \n",
      "conditions, limitation of assay, manufacture and expiry dates and \n",
      "methods of disposal should be provided with each kit.\n",
      "Ʋ The imported rapid kit should have approval of the statutory authority in \n",
      "its country of origin.\n",
      "The imported kits should have been registered and \n",
      "licensed in India by the Central Drugs Standard Control Organization \n",
      "(CDSCO).\n",
      "Ʋ\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 79:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 6,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "In case of indigenous manufacturers they should have a valid licence \n",
      "issued by the competent authority defined under Drugs and Cosmetics \n",
      "Act, 1940, after appropriate evaluation by the centres approved by the \n",
      "CDSCO.\n",
      "Ʋ The assay should have sensitivity of 90% or more and specificity of 95% \n",
      "or more and the same should be supported by statements in kit insert and \n",
      "certificate from National Institute of Biological Sciences.\n",
      "Ʋ The assay should be calibrated to WHO reference serum and the same \n",
      "should be supported by statements in kit insert and certificate from the \n",
      "manufacturer.\n",
      "32\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      " Ʋ\n",
      "The manufacturer should ensure the following:\n",
      " » The test should be packed such that there is a provision to conduct \n",
      "single test at a time.\n",
      "» The pack size of test kits should be in 50 (for peripheral health levels) \n",
      "and 100 tests per kit (for secondary and tertiary health care level) but \n",
      "not more than 100 tests per kit.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 80:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 7,\n",
      "  \"total_chunks_in_section\": 8,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Ʋ The manufacturer/authorized agent should ensure maintenance of cold \n",
      "chain during storage and transport of kits at 2°C to 8°C.\n",
      "Ʋ Total procedure time should not be more than 30 minutes.\n",
      "33\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Annexure – 4\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 81:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Referral Slip\n",
      "Name of referring facility: _________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 82:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Address: __________________________________Telephone:___________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Address: __________________________________Telephone:___________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 83:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name of the patient: _____________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of the patient: _____________________________________________\n",
      "Father’s/Husband’s name: ___________________________________\n",
      "Contact no.:_________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 84:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Address: ____________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Address: ____________________________ \n",
      "Referred on ____/____/____ (dd/mm/yy_________ (time) to_________\n",
      "_______________________________(name of the facility) for management.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 85:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Provisional diagnosis: __________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Provisional diagnosis: __________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 86:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Summary of management:_______________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Summary of management:_______________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 87:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Blood group: ________________ Hb:_____\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Blood group: ________________ Hb:_____\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 88:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Status of Syphilis: ______________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Status of Syphilis: ______________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 89:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Other investigations: __________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Other investigations: __________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 90:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Procedures and critical interventions carried out\n",
      "Treatment given: __________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 91:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Dose of penicillin: ___________ Duration:_______________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Dose of penicillin: ___________ Duration:_______________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 92:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Condition at time of referral: _________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Condition at time of referral: _________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 93:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Consciousness: Temp: ________ Pulse:_________ BP:____________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Consciousness: Temp: ________ Pulse:_________ BP:____________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 94:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Reason for referral:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Reason for referral:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 95:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Mode of transport for referral: Govt./PPP/Vehicle arranged by patient\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Mode of transport for referral: Govt./PPP/Vehicle arranged by patient\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 96:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Telephonic information on referral provided to the institution referred to: No/\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Telephonic information on referral provided to the institution referred to: No/\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 97:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name of the person spoken to: _________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of the person spoken to: _________________________________\n",
      "Signature of referring physician/health functionary:\n",
      "Name/Designation/Stamp:\n",
      "\n",
      "34\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Annexure – 5\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 98:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Migration Form for Pregnant Women with Syphilis\n",
      "Name:________________________________________________________\n",
      "Husband’s/Father’s name:________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 99:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Present address: _______________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Present address: _______________________________________________\n",
      "_____________________________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 100:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name of Health Facility attended:__________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of Health Facility attended:__________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 101:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Migration address:______________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Migration address:______________________________________________ \n",
      "_____________________________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 102:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Address of health facility to be attended:_____________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Address of health facility to be attended:_____________________________ \n",
      "_____________________________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 103:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Diagnosis of Syphilis:______________________Date:______________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Diagnosis of Syphilis:______________________Date:______________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 104:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Period of gestation: ________weeks___________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Period of gestation: ________weeks___________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 105:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Treatment given:_______________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Treatment given:_______________________________________________ \n",
      "____________________________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 106:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Information about migration given to:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Information about migration given to:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 107:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name:_______________________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name:_______________________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 108:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Designation:__________________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Designation:__________________________________________________\n",
      "Mobile no./Telephone no:________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 109:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Place of work:_________________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      6\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place of work:_________________________________________________\n",
      "Signature of Doctor\n",
      "\n",
      "35\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Annexure – 6\n",
      "Monthly Syphilis Reporting Format for State & District \n",
      "Programme Managers for month of ...........……………year………...\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 110:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name of State:____________________Name of District:________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of State:____________________Name of District:________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 111:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Estimated number of pregnant women:______________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Estimated number of pregnant women:______________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 112:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Estimated number of deliveries:____________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Estimated number of deliveries:____________________________________\n",
      " Ʋ Total number of ANC conducted (including all 4 ANC visits) in reporting \n",
      "month:_______________\n",
      " Ʋ Number of syphilis-positive pregnant women diagnosed out of total \n",
      "number of ANC conducted in the reporting month:________________\n",
      " Ʋ Total number of pregnant women who received adequate treatment \n",
      "(i.e. received one dose of benzathine penicillin injection) for syphilis \n",
      "out of total number of syphilis-positive women diagnosed in reporting \n",
      "month:_______________\n",
      " Ʋ Number of confirmed cases of congenital syphilis out of total number \n",
      "of syphilis-positive pregnant women who delivered in the reporting \n",
      "month:_______________\n",
      " Ʋ Number of babies who received treatment who are born to syphilis-\n",
      "positive mothers out of total number of syphilis-positive pregnant women \n",
      "diagnosed in reporting month:_________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 113:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Note:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      7\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Note: \n",
      " ◘ Districts will report to their states.\n",
      " ◘ Information will be compiled at state level to forward to GOI.\n",
      "\n",
      "36\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Annexure – 7\n",
      "Monthly Syphilis Reporting Format for Health Facility for  \n",
      "Month of …………………, Year………………\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 114:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name of State:___________________Name of District:_________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of State:___________________Name of District:_________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 115:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Name of Health Facility:__________________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of Health Facility:__________________________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 116:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Estimated number of pregnant women:______________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Estimated number of pregnant women:______________________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 117:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Estimated number of deliveries:____________________________________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Estimated number of deliveries:____________________________________\n",
      " Ʋ Total number of ANC conducted (including all 4 ANC visits) in reporting \n",
      "month:________________\n",
      " Ʋ Number of syphilis-positive pregnant women diagnosed out of total \n",
      "number of ANC conducted in the reporting month:__________________\n",
      " Ʋ Total number of pregnant women received adequate treatment (i.e. \n",
      "received one dose of benzathine penicillin injection) for syphilis out \n",
      "of total number of syphilis-positive women diagnosed in reporting \n",
      "month:_________________\n",
      " Ʋ Number of confirmed cases of congenital syphilis out of total number \n",
      "of syphilis-positive pregnant women who delivered at the facility in the \n",
      "reporting month:__________________\n",
      " Ʋ Number of babies who received treatment who are born to syphilis-\n",
      "positive mothers out of total number of syphilis-positive pregnant women \n",
      "who delivered in reporting month:____________________\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 118:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Note:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Note: \n",
      " ◘ Health facility will report to District.\n",
      "◘ Information will be compiled at district level for forwarding to state.\n",
      "37\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "References\n",
      " Ʋ World Health Organization.\n",
      "The Global Elimination of Congenital Syphilis: \n",
      "Rationale and Strategy for Action.\n",
      "Geneva, World Health Organization, \n",
      "2007\n",
      " Ʋ Investment Case for Eliminating Mother to Child Transmission of Syphilis:\n",
      "Promoting Better Maternal and Child Health and Stronger Health Systems, \n",
      "WHO Publications, 2012\n",
      " Ʋ Eliminating Congenital Syphilis in South East Asia Region - A Feasible \n",
      "Strategic Initiative 2011–2015; WHO Publication, 2012\n",
      " Ʋ HIV Sentinel Surveillance Data for 2010–11, NACO\n",
      " Ʋ Report on Global Sexually Transmitted Infection Surveillance,\n",
      "WHO \n",
      "Publications, 2013\n",
      " Ʋ Singh AE, Romanowski B. Syphilis: Review with Emphasis on Clinical, \n",
      "Epidemiologic and Some Biologic Features.\n",
      "Clinical Microbiological \n",
      "Review, 1999, 12:187–209\n",
      " Ʋ Brion LP et al.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 119:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Note:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Long Bone Radiographic Abnormalities as a Sign of Active \n",
      "Congenital Syphilis in Asymptomatic Newborns.\n",
      "Paediatrics, 1991.\n",
      "Ʋ Davanzo R et al.\n",
      "Neonatal and Post-neonatal Onset of Early Congenital\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 120:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Syphilis: A Report from Mozambique. Annals of Tropical Paediatrics, 1992,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Syphilis: A Report from Mozambique. Annals of Tropical Paediatrics, 1992, \n",
      "12:445–450.\n",
      " Ʋ Centre for Disease Control (CDC), STD Surveillance Case Definitions, STD \n",
      "Surveillance, 2010\n",
      " Ʋ Centre for Disease Control, MMWR, 2010, weekly/Vol.59/No.14,  \n",
      "April 16, 2010.\n",
      " Ʋ National STI Guidelines.\n",
      " Ʋ Tais F. Galvao1, Marcus T. et al. Safety of Benzathine Penicillin for\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 121:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Preventing Congenital Syphilis: A Systematic Review. PLOS ONE,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Preventing Congenital Syphilis: A Systematic Review. PLOS ONE, \n",
      "February 2013, Vol.8/No.2.\n",
      " Ʋ Central Drugs Standard Control organization, DGHS, MoHFW, Govt. of \n",
      "India. http://www.cdsco.nic.in/writereaddata/National%20List%20of%20\n",
      "Essential%20Medicine-%20final%20copy.pdf (accessed on June 20, 2014)\n",
      " Ʋ Operational Guidelines for ePTCT of Syphilis. NACO, 2014.\n",
      " Ʋ Guidelines for Community Process, National Rural Health Mission, June \n",
      "2013\n",
      " Ʋ World Health Organization. Model List of Essential Medicines 17th \n",
      "edition. Geneva. WHO 2011; Available from http://www.who.int/medicines/\n",
      "publications/essentialmedicines/en/index.html \n",
      " Ʋ World Health Organization. Methods for Surveillance and Monitoring of \n",
      "Congenital Syphilis Elimination within Existing Systems. 2011.\n",
      "\n",
      "Notes\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "42\n",
      "Screening for Syphilis  \n",
      "During Pregnancy\n",
      "Maternal Health Division\n",
      "Ministry of Health & Family Welfare\n",
      "Government of India\n",
      "Nirman Bhawan, New Delhi-110011\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 122:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Syphilis_Doc_Low-res_5th_Jan.pdf\",\n",
      "  \"section_title\": \"Website: www.mohfw.gov.in & www.nhm.gov.in\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Website: www.mohfw.gov.in & www.nhm.gov.in\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 123:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "i\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "TRAINING MANUAL \n",
      "For Medical Methods of Abortion (MMA) \n",
      "in Early Gestation\n",
      "\n",
      "\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "TRAINING MANUAL \n",
      "For Medical Methods of Abortion (MMA) \n",
      "in Early Gestation\n",
      "JULY 2022\n",
      "\n",
      "\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "i\n",
      "Healthy Village, Healthy Nation \n",
      " \n",
      " \n",
      " \n",
      "DR. SUMITA GHOSH\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 124:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Additional Commissioner \n",
      "Telefax : 011-23063178 \n",
      "E-mail : sumita.ghosh@nic.in \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "Preface \n",
      "GOVERNMENT OF INDIA \n",
      "MINISTRY OF HEALTH & FAMILY WELFARE \n",
      "NIRMAN BHAVAN, MAULANA AZAD ROAD \n",
      "NEW DELHI - 110011 \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "29’h July, 2022 \n",
      " \n",
      " \n",
      "The Medical Termination of Pregnancy Act, 1971 has recently been amended and the \n",
      "Medical Termination of Pregnancy (Amendment ) Act, 2021 and the Medical \n",
      "Termination of Pregnancy (Amendment) Rules, 2021 as prescribed under the Act have \n",
      "come into force.\n",
      "These amendments intend to increase the ambit and access of women \n",
      "seeking legal abortion services for different reasons or indications.\n",
      "This will necessitate a \n",
      "large pool of legal service providers and an increased number of facilities especially for \n",
      "providing safe and quality abortion services through Medical Methods in early gestation \n",
      "age upto 9 weeks using globally proven technology.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 125:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "For capacity building of medical officer in Medical Methods of Abortion (MMA) in \n",
      "peripheral facilities, this training manual has been developed in consultation with the \n",
      "expert group with representatives from the State Governments, Comprehensive \n",
      "Abortion Care Training centres, and Professional/Non -profit organizations.\n",
      "The manual \n",
      "will be useful to the facilitators/trainers as well as the trainees who undergo this \n",
      "training.\n",
      "It covers all aspects of Medical Methods of Abortion  including details about \n",
      "its legal aspect, documentation of services, proper protocol of usage of drugs, \n",
      "counseling, complication management and post abortion contraception following MMA.\n",
      "Along with this, a guidance note has been prepared regarding requirement of the \n",
      "training centres who will be implementing this training.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 126:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "States and UTs need to ensure availability of trained Registered Medical Practitioners at \n",
      "CHCs and PHCs along with availability of drugs, so that women needing abortion care are \n",
      "served at the peripheral facilities with safety, quality, respect and dignity.\n",
      "I am thankful to Dr P. Ashok Babu, Joint Secretary (RCH), MoHFW, for his guidance and \n",
      "keen engagement in taking forward the operationalization  of MMA trainings.\n",
      "I am also \n",
      "thankful to all the experts contributing towards the development of this manual \n",
      "especially lpas Development Foundation for taking a leading role in compilation.\n",
      "I look forward to effective implementation  of amendments and initiation of Medical \n",
      "Methods of Abortion training and thereby significantly address the issue of unsafe \n",
      "abortions in the country.\n",
      "(Dr. Sumita Ghosh)\n",
      "Talking about AIDS is taking care of each other\n",
      "\n",
      "\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "iii\n",
      "List of Expert Group Members\n",
      "S.\n",
      "No.\n",
      "Name Designation\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 127:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Dr. P . Ashok Babu  Joint Secretary (RCH) Ministry of Health & Family Welfare,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Dr. P . Ashok Babu  Joint Secretary (RCH) Ministry of Health & Family Welfare, \n",
      "Government of India.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 128:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Dr. Sumita Ghosh Additional Commissioner Incharge (CH, RBSK, AH, CAC & AD),\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Dr. Sumita Ghosh Additional Commissioner Incharge (CH, RBSK, AH, CAC & AD),\n",
      "Ministry of Health & Family Welfare, Government of India.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 129:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Dr. Alok Banerjee Technical Advisor, Parivar Seva Sanstha, New Delhi.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Dr. Alok Banerjee Technical Advisor, Parivar Seva Sanstha, New Delhi.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 130:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Dr. Aparna Sharma Additional Professor, Department of Obstetrics & Gynaecology,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Dr. Aparna Sharma Additional Professor, Department of Obstetrics & Gynaecology, \n",
      "All India Institute of Medical Sciences, New Delhi.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 131:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Dr. Basab Mukherjee Vice President FOGSI & Consultant Gynaecologist, Woodlands\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Dr. Basab Mukherjee Vice President FOGSI & Consultant Gynaecologist, Woodlands \n",
      "Multispecialty Hospital, Kolkata, West Bengal.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 132:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Dr. Indra Bhati\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6. Dr. Indra Bhati\n",
      "Senior Professor & Ex-Head, Department of Obstetrics & \n",
      "Gynaecology, Dr. S N Medical College & Hospital, Jodhpur, \n",
      "Rajasthan.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 133:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"7. Dr. Jyotsna Suri Professor & Unit Head, Department of Obstetrics & Gynaecology,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "7. Dr. Jyotsna Suri Professor & Unit Head, Department of Obstetrics & Gynaecology, \n",
      "VMMC & Safdarjung Hospital, New Delhi.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 134:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"8. Dr. Ojaswini Patel\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "8. Dr. Ojaswini Patel\n",
      "Associate Professor, Department of Obstetrics & Gynaecology, \n",
      "VSS Institute of Medical Sciences & Research, Burla, Sambalpur, \n",
      "Odisha.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 135:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"9. Dr. Pratima Mittal Consultant & Ex-Professor, Department of Obstetrics &\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "9. Dr. Pratima Mittal Consultant & Ex-Professor, Department of Obstetrics & \n",
      "Gynaecology, VMMC and Safdarjung Hospital, New Delhi.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 136:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"10. Dr. Pushpa\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "10. Dr. Pushpa \n",
      "Chaudhary\n",
      "Team Lead, RMNCAH, World Health Organization.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 137:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"11. Dr. Pushpa Nagar\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "11. Dr. Pushpa Nagar\n",
      "Senior Professor & Unit Head, Department of Obstetrics and \n",
      "Gynaecology, SMS Medical College & Zanana Hospital, Jaipur, \n",
      "Rajasthan.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 138:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"12. Dr. Rathnamala M.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "12. Dr. Rathnamala M.  \n",
      "Desai\n",
      "President FPA India.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 139:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"13. Dr. Sangeeta Batra Chief Technical Officer - Health Systems, Ipas Development\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "13. Dr. Sangeeta Batra Chief Technical Officer - Health Systems, Ipas Development \n",
      "Foundation, New Delhi.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 140:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"14. Dr. Saswati Das Sexual & Reproductive Health and Rights Specialist,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "14. Dr. Saswati Das Sexual & Reproductive Health and Rights Specialist, \n",
      "United Nations Population Fund, New Delhi.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 141:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"15. Dr. Savitha C.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "15. Dr. Savitha C.\n",
      "Professor & Head, Department of Obstetrics & Gynaecology, \n",
      "Bangalore Medical College & Vani Vilas Hospital, Bangalore, \n",
      "Karnataka.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 142:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"16. Dr. Vanita Suri\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "16. Dr. Vanita Suri\n",
      "Professor and Head, Department of Obstetrics and Gynaecology, \n",
      "Post Graduate Institute of Medical Education & Research, \n",
      "Chandigarh.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 143:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"blood pressure\",\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "17.\n",
      "Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health & \n",
      "Family Welfare, Government of India.\n",
      "\n",
      "viii\n",
      "Training Manual\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "v\n",
      "List of Acronyms\n",
      "BP    Blood Pressure\n",
      "CAC    Comprehensive Abortion Care\n",
      "COC    Combined Oral Contraceptive \n",
      "DLC   District Level Committee\n",
      "gm    gram \n",
      "Hb    Haemoglobin\n",
      "MP\n",
      "A                 Medroxy Progesterone Acetate\n",
      "IUCD    Intrauterine Contraceptive Device\n",
      "IV    Intravenous\n",
      "LMP   Last Menstrual Period\n",
      "MBBS   Bachelor of Medicine and Bachelor of Surgery\n",
      "mcg   microgram\n",
      "mg    milligram\n",
      "MMA   Medical Methods of Abortion\n",
      "MTP    Medical Termination of Pregnancy\n",
      "NHM    National Health Mission\n",
      "P/S    Per Speculum\n",
      "P/V    Per Vaginum\n",
      "POC    Products of Conception\n",
      "Rh     Rhesus (Blood group)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 144:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "RMP    Registered Medical Practitioner\n",
      "SRS     Sample Registration Survey\n",
      "USG    Ultra Sonography\n",
      "VA    Vacuum Aspiration\n",
      "WHO    World Health Organization\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "x\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "vii\n",
      "Contents \n",
      "Preface\n",
      "List of Expert Group Members \n",
      "List of Acronyms\n",
      "Introduction to Medical Methods of Abortion\n",
      "MMA Training Pre-test Questionnaire\n",
      "Chapter 1: Medical Methods of Abortion - An Overview\n",
      "1.1: Advantages and Limitations of MMA\n",
      "Chapter 2: Law (MTP Act) and MMA \n",
      "2.1: Eligibility of the Provider\n",
      "2.2: Eligibility of the Place \n",
      "2.3: Consent for MMA Procedure \n",
      "2.4: Documentation/Reporting of MMA Procedure\n",
      "Chapter 3: Indications/Contraindications for MMA\n",
      "3.1: Indications for MMA \n",
      "3.2: Contraindications for MMA \n",
      "3.3: Special Precautions for MMA\n",
      "3.4: Eligibility Checklist for MMA\n",
      "Chapter 4: About MMA Drugs \n",
      "4.1: Drugs Used for MMA \n",
      "Chapter 5: MMA Protocol and Process \n",
      "5.1: Drug Protocol\n",
      "5.2: Process of MMA\n",
      "5.3: Post MMA Contraception \n",
      "i\n",
      "iii\n",
      "v\n",
      "1\n",
      "2\n",
      "5\n",
      "5\n",
      "6\n",
      "6\n",
      "6\n",
      "7\n",
      "7\n",
      "13\n",
      "13\n",
      "13\n",
      "14\n",
      "14\n",
      "15\n",
      "15\n",
      "18\n",
      "18\n",
      "18\n",
      "26\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "viii\n",
      "Chapter 6: Side Effects and Complications with MMA and their Management \n",
      "6.1: Side Effects with MMA\n",
      "6.2: Safety and Effectiveness\n",
      "6.3: Complications and their Management \n",
      "6.4:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 145:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Warning Symptoms and Signs\n",
      "Chapter 7: Comparison: V A and MMA Procedure \n",
      "Chapter 8: Schedule for MMA Trainings\n",
      "References\n",
      "Annexures\n",
      "Annexure 1: Medical Methods of Abortion Counselling Skill Checklist\n",
      "Annexure 2: Essential Equipment, Instruments, Drugs, and  \n",
      "Consumables  Required for MMA\n",
      "Annexure 3: MMA Card\n",
      "MMA  Training Post–test Questionnaire \n",
      "28\n",
      "28\n",
      "29\n",
      "29\n",
      "32\n",
      "33\n",
      "34\n",
      "35\n",
      "36\n",
      "36\n",
      "38\n",
      "39\n",
      "40\n",
      "\n",
      "1\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "Introduction to \n",
      "Medical Methods of Abortion\n",
      "Unsafe abortions make a significant contribution to maternal morbidity and mortality.\n",
      "As per SRS 2001 - 03, abortion-related deaths account for nearly 8% of all maternal \n",
      "deaths in India.\n",
      "Numerous barriers limit access to safe abortion services including \n",
      "shortage and uneven distribution of trained providers; lack of infrastructure at the \n",
      "facilities; and lack of information about legality and availability of services among \n",
      "women and the community.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 146:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Medical Methods of Abortion (MMA) is one of the safe technologies for abortion \n",
      "care which offers an opportunity to increase accessibility and availability to abortion \n",
      "care services in early pregnancy.\n",
      "It can be offered at all levels of health care, including \n",
      "primary levels.\n",
      "It can also be provided on an outpatient basis.\n",
      "MMA is a non-invasive technology and simplifies the requirements of place and \n",
      "equipment as required for Vacuum Aspiration procedures.\n",
      "This manual explains use of MMA in early pregnancy up to nine weeks, as approved \n",
      "under the Medical Termination of Pregnancy (Amendment) Rules, 2021.\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "2\n",
      "Medical Methods of Abortion Training\n",
      "Pre-test Questionnaire\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 147:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name:  ......................................................................................................................................................................\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name:  ......................................................................................................................................................................\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 148:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name of training centre: ........................................................................................................................................\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of training centre: ........................................................................................................................................\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 149:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\n",
      "Please put a tick under `True’ or `False’ for the following statements:\n",
      "S.No. Statement    True False\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 150:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. MMA is a safe and effective method to terminate early\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. MMA is a safe and effective method to terminate early \n",
      "pregnancy upto 63 days.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 151:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. MMA may adversely affect the woman\\u2019s future fertility.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. MMA may adversely affect the woman’s future fertility.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 152:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. A physical examination of the woman is not required to provide\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. A physical examination of the woman is not required to provide \n",
      "MMA services.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 153:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. A written consent of the woman seeking medical methods of\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. A written consent of the woman seeking medical methods of \n",
      "abortion is mandatory on the prescribed format.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 154:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. A minimum of four visits are recommended to complete the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "5. A minimum of four visits are recommended to complete the \n",
      "standard MMA drug protocol.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 155:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Only a Registered Medical Practitioner, as under the MTP Act\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6. Only a Registered Medical Practitioner, as under the MTP Act \n",
      "can prescribe MMA drugs.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 156:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"7. Fertility can return within 10 days of an abortion.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "7. Fertility can return within 10 days of an abortion.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 157:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"8. Most of the contraceptive methods can be started during the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "8. Most of the contraceptive methods can be started during the \n",
      "process of MMA after confirming their eligibility.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 158:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"9. MMA drugs can cause congenital anomalies if pregnancy\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "9. MMA drugs can cause congenital anomalies if pregnancy \n",
      "continues after their intake.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 159:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"10. A woman should be within accessible limits of a health facility\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "10. A woman should be within accessible limits of a health facility \n",
      "during the MMA process.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 160:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Please encircle the correct answer in the following questions:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Please encircle the correct answer in the following questions:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 161:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"11. Which of the following is recommended for pain management during MMA?\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "11. Which of the following is recommended for pain management during MMA?\n",
      "a. Tablet Paracetamol\n",
      "b. Tablet Ibuprofen \n",
      "c. Injection Diazepam\n",
      "d. Paracervical block\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 162:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"12. Which of the following is the LEAST effective route for Misoprostol administration during the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "12. Which of the following is the LEAST effective route for Misoprostol administration during the \n",
      "MMA process?\n",
      "a. Sublingual\n",
      "b. Vaginal\n",
      "c. Oral\n",
      "d. Buccal\n",
      "\n",
      "3\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 163:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\n",
      "a. Combined Oral Contraceptive pills\n",
      "b. Centchroman \n",
      "c. IUCD\n",
      "d. Injectables\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 164:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"14. Way to manage an incomplete abortion during the process of MMA is:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "14. Way to manage an incomplete abortion during the process of MMA is:\n",
      "a. Vacuum Aspiration\n",
      "b. Repeat dose of Misoprostol\n",
      "c. Either of the above two depending on the severity of bleeding\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 165:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "15.\n",
      "If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\n",
      "a. Y es, additional dose can be tried\n",
      "b.\n",
      "No, woman should be referred to higher centre for pregnancy termination with Vacuum \n",
      "Aspiration\n",
      "c. Pregnancy should be continued\n",
      "\n",
      "\n",
      "\n",
      "5\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "1 Medical Methods of Abortion – An Overview\n",
      "MMA is a non-surgical, non-invasive method for termination of pregnancy by using a combination of \n",
      "drugs.\n",
      "It provides women with another option for termination of pregnancy besides surgical methods \n",
      "and should be offered in addition to other available safe abortion methods, whenever possible.\n",
      "1.1:\n",
      "Advantages and Limitations of MMA\n",
      "Share with the participants the advantages and limitations of Medical Methods of Abortion.\n",
      "MMA is one of the safe technologies available for pregnancy termination.\n",
      "It is a non-surgical method \n",
      "for early abortions and has both advantages as well as limitations over other methods of pregnancy \n",
      "termination.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 166:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Advantages of MMA\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 167:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Abortion can be offered at an early stage of pregnancy upto 9 weeks of gestation, as approved under\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Abortion can be offered at an early stage of pregnancy upto 9 weeks of gestation, as approved under \n",
      "MTP (Amendment) Rules, 2021.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 168:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Potentially more private, being similar to a natural miscarriage.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Potentially more private, being similar to a natural miscarriage.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 169:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Non-surgical method of abortion, and hence non-invasive.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Non-surgical method of abortion, and hence non-invasive.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 170:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. No anaesthesia required.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. No anaesthesia required.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 171:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Limited infrastructure needed, can be offered in settings where vacuum aspiration may not be\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Limited infrastructure needed, can be offered in settings where vacuum aspiration may not be \n",
      "possible.\n",
      "Limitations of MMA\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 172:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Multiple mandatory clinic/facility visits required during the MMA process.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Multiple mandatory clinic/facility visits required during the MMA process.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 173:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Bleeding may occur for 8-13 days.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Bleeding may occur for 8-13 days.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 174:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. There may be side effects of the MMA drugs like nausea, vomiting, chills, and dizziness.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. There may be side effects of the MMA drugs like nausea, vomiting, chills, and dizziness.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 175:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Once MMA drugs are taken, pregnancy should be terminated in case of continuation of that\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "4.\n",
      "Once MMA drugs are taken, pregnancy should be terminated in case of continuation of that \n",
      "pregnancy, since there exists a risk of foetal malformation.\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "6\n",
      "2 Law (MTP Act) and MMA\n",
      "2.1: Eligibility of the Provider\n",
      "In case of termination of pregnancy using Mifepristone and Misoprostol, only \n",
      "a Registered Medical Practitioner, as defined by the Medical Termination of \n",
      "Pregnancy (MTP) Act, can prescribe the drugs.\n",
      "‘Registered Medical Practitioner (RMP)’ means a medical practitioner who possesses any recognized \n",
      "medical qualification (MBBS) as defined in the Indian Medical Council Act, 1956 (102 of 1956); \n",
      "whose name has been entered in a State Medical Register; and who has such experience or training in \n",
      "Gynaecology and Obstetrics as may be prescribed by Rules under this Act.\n",
      "The MTP (Amendment) Rules, 2021 require that an RMP should have one or more of the following \n",
      "experience or training in Gynaecology and Obstetrics to be able to provide MMA:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 176:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Independently performed ten cases of MMA under the supervision of an RMP in a hospital\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Independently performed ten cases of MMA under the supervision of an RMP in a hospital \n",
      "established or maintained, or a training institute approved for this purpose, by the Government.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 177:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. At least three months experience at any hospital in the practice of Obstetrics and Gynaecology.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. At least three months experience at any hospital in the practice of Obstetrics and Gynaecology.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 178:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Post\\u2013graduate degree or diploma in Obstetrics and Gynaecology.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Post–graduate degree or diploma in Obstetrics and Gynaecology.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 179:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Completed six months as House Surgeon in Obstetrics and Gynaecology.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Completed six months as House Surgeon in Obstetrics and Gynaecology.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 180:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Assisted an RMP in 25 cases of medical termination of pregnancy of which at least five have been\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Assisted an RMP in 25 cases of medical termination of pregnancy of which at least five have been \n",
      "performed independently in a hospital established or maintained by the Government or a training \n",
      "institute approved for this purpose by the Government.\n",
      "2.2: Eligibility of the Place\n",
      "Share with the participants the places from where MMA can be provided, as under the MTP Act.\n",
      "In accordance with the MTP Act, termination of pregnancy with\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 181:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"MMA shall be done at the following places:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "MMA shall be done at the following places:\n",
      "a. A hospital established or maintained by the Government, or\n",
      "b.\n",
      "A place for the time being approved for the purpose of this Act by the Government or a District \n",
      "Level Committee (DLC) constituted by the Government, with the Chief Medical Officer or District \n",
      "Health Officer as the Chairperson of the said Committee, or\n",
      "c.\n",
      "In case of termination of early pregnancy up to nine weeks using Mifepristone and Misoprostol, an \n",
      "RMP as under the MTP Act, can prescribe the drugs at his/her clinic provided he/she has access to \n",
      "a place approved for terminating pregnancy under the MTP Act.\n",
      "The clinic should display a certificate to this effect from the owner of the approved place.\n",
      "7\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "2.3: Consent for MMA Procedure\n",
      "Any woman 18 years and above can give her own consent for the MMA procedure.\n",
      "For minors and mentally ill women, consent of the guardian should be taken.\n",
      "Guardian means a person having the care of them.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 182:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"MMA shall be done at the following places:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2.4: Documentation/Reporting of MMA Procedure\n",
      "Share with the participants the documentation formats to be completed for MMA procedure, \n",
      "as under the MTP Act.\n",
      "Since MMA comes under the purview of the MTP Act, the documentation is similar to that required \n",
      "for vacuum aspiration procedure.\n",
      "It is mandatory to fill and record information for abortion cases \n",
      "performed by MMA in the following forms:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 183:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Form C \\u2013 Consent Form \\u2013 this form is completed before initiating the abortion procedure. This is\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Form C – Consent Form – this form is completed before initiating the abortion procedure. This is \n",
      "signed by the woman herself or guardian (in case of minor or mentally ill woman).\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 184:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Form I \\u2013 RMP Opinion Form \\u2013 this form is used for providing opinion by the RMP for providing\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Form I – RMP Opinion Form – this form is used for providing opinion by the RMP for providing \n",
      "induced abortion services.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 185:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Form II \\u2013 Monthly Reporting Form \\u2013 this form is completed by the hospital incharge/owner to\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Form II – Monthly Reporting Form – this form is completed by the hospital incharge/owner to \n",
      "report the total monthly cases to the district authorities.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 186:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Form III \\u2013 Admission Register\\u2013 this register is used for recording all the induced abortion cases,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Form III – Admission Register– this register is used for recording all the induced abortion cases, \n",
      "done by surgical as well as medical methods.\n",
      "Form C \n",
      "(See rule 9) \n",
      " \n",
      "I………………………………………………………daughter/wife of…………………………………………………………………………………….. \n",
      "aged about………………………….years of …………………………………………………………………………………………………..............  \n",
      "(here state the permanent address) at present residing at……………………………………………….…………………………….. \n",
      "do hereby give my consent to the termination of my pregnancy at  ………………………………………………………………..  \n",
      ".……………………………………………………………………………………(state the name of place where the pregnancy is to be \n",
      "terminated)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 187:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 188:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:                                 Signature\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Date:                                 Signature \n",
      " \n",
      " \n",
      "(To be filled in by guardian where the woman is a mentally ill person or minor) \n",
      "I……………………………………………………………son/ daughter/ wife of ……………………………………………………………………… \n",
      "aged about………………………………..….years of………………………………………………………………........................................  \n",
      "                                                                                                                     (permanent address) \n",
      " \n",
      "at present residing at …………………………………..............................................………………………………………………. do \n",
      " hereby give my consent to the termination of the pregnancy of my ward ……………………………………………………… \n",
      "……………………………………………………………… who is a minor/ mentally ill person at .……………………………………………  \n",
      "…………………………………………………………………………………………………………………(place of termination of pregnancy)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 189:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 190:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:                               Signature\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Date:                               Signature\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "8\n",
      "Consent Form (Form C)\n",
      "Form C \n",
      "(See rule 9) \n",
      " \n",
      "I………………………………………………………daughter/wife of…………………………………………………………………………………….. \n",
      "aged about………………………….years of …………………………………………………………………………………………………..............  \n",
      "(here state the permanent address) at present residing at……………………………………………….…………………………….. \n",
      "do hereby give my consent to the termination of my pregnancy at  ………………………………………………………………..  \n",
      ".……………………………………………………………………………………(state the name of place where the pregnancy is to be \n",
      "terminated)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 191:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 192:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:                                 Signature\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Date:                                 Signature \n",
      " \n",
      " \n",
      "(To be filled in by guardian where the woman is a mentally ill person or minor) \n",
      "I……………………………………………………………son/ daughter/ wife of ……………………………………………………………………… \n",
      "aged about………………………………..….years of………………………………………………………………........................................  \n",
      "                                                                                                                     (permanent address) \n",
      " \n",
      "at present residing at …………………………………..............................................………………………………………………. do \n",
      " hereby give my consent to the termination of the pregnancy of my ward ……………………………………………………… \n",
      "……………………………………………………………… who is a minor/ mentally ill person at .……………………………………………  \n",
      "…………………………………………………………………………………………………………………(place of termination of pregnancy)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 193:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 194:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:                               Signature\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Date:                               Signature\n",
      "\n",
      "9\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "RMP Opinion Form (Form I)\n",
      "FORM I  \n",
      "RMP Opinion Form \n",
      "(For gestation age upto twenty weeks)\n",
      "[See Regulation 3] \n",
      "I _\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_ \n",
      "(Name and qualifications of the Registered Medical Practitioner in block letters)\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "(Full address of the Registered Medical Practitioner) \n",
      " \n",
      "hereby certify that I am of opinion, formed in good faith, that it is necessary to terminate the \n",
      "pregnancy of _\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "(Full name of pregnant woman in block letters) \n",
      "resident of__\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "(Full address of pregnant woman in block letters) \n",
      "for the reasons given below*.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 195:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:                               Signature\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "I hereby give intimation that I terminated the pregnancy of the woman referred to above who  bears \n",
      "the Serial No.\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_ in the Admission Register of the hospital/approved place.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 196:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 197:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Date: \n",
      "Signature of the Registered Medical Practitioner \n",
      "  \n",
      "*of the reasons specified items (a) to (e) write the one which is appropriate: \n",
      "a. in order to save the life of the pregnant women, \n",
      "b. in order to prevent grave injury to the physical and mental health of the pregnant woman, \n",
      "c. in view of the substantial risk that if the child was born it would suffer from such physical \n",
      "or mental abnormalities as to be seriously handicapped, \n",
      "d. as the pregnancy is alleged by pregnant woman to have been caused by rape,  \n",
      "e. as the pregnancy has occurred as a result of failure of any contraceptive device or methods \n",
      "used by a woman or her partner for the purpose of limiting the number of children  or \n",
      "preventing pregnancy.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 198:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Note: Account may be taken of the pregnant woman\\u2019s actual or reasonably foreseeable environment\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [\n",
      "      \"iron\"\n",
      "    ],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Note: Account may be taken of the pregnant woman’s actual or reasonably foreseeable environment \n",
      "in determining whether the continuance of her pregnancy would involve a grave injury to her physical \n",
      "or mental health.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 199:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 200:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Date:                                                                                                                   Signature of the Registered Medical Practitioner\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [\n",
      "      10\n",
      "    ],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Date:                                                                                                                   Signature of the Registered Medical Practitioner\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "10\n",
      "Monthly Reporting Form (Form II)\n",
      "FORM II \n",
      "[ Refer Regulation 4(5) ] \n",
      "Month & Year: ………….…………..….\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 201:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Name of the State:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Name of the State:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 202:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Name of Hospital/approved place:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Name of Hospital/approved place:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 203:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Duration of pregnancy: (Give total number only under each sub-head)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      24,\n",
      "      9,\n",
      "      12,\n",
      "      20\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Duration of pregnancy: (Give total number only under each sub-head) \n",
      "(a) Upto 9 weeks (Medical Methods of Abortion Only):  \n",
      "(b) Upto 12 weeks (Surgical Methods of Abortion Only):  \n",
      "(c) Between 12-20 weeks:  \n",
      "(d) Between 20 -24 weeks: \n",
      "(e) Beyond 24 weeks:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 204:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Religion of woman: (Give total number under each sub-head)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Religion of woman: (Give total number under each sub-head) \n",
      "(a) Hindu:  \n",
      "(b) Muslim:  \n",
      "(c) Christian:  \n",
      "(d) Others:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 205:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Termination with acceptance of contraception: (Give total number under each sub-head)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Termination with acceptance of contraception: (Give total number under each sub-head) \n",
      "(a) Sterilization:  \n",
      "(b) IUCD:  \n",
      "(c) OCP/Injectable Contraceptive:  \n",
      "(d) Others:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 206:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Reasons for termination: (Give total number under each sub-head)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      24,\n",
      "      20\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6.\n",
      "Reasons for termination: (Give total number under each sub-head) \n",
      "A. Up to 20 weeks of gestation \n",
      "(a) Danger to the life of the pregnant woman:  \n",
      "(b) Grave injury to the physical and mental health of the pregnant woman:  \n",
      "(c) Pregnancy caused by rape:  \n",
      "(d) Substantial risk that if the child was born, it would suffer from such physical or mental \n",
      "abnormalities as to be seriously handicapped: \n",
      "(e) Failure of any contraceptive device or method:  \n",
      " \n",
      "B. Between 20-24 weeks of gestation \n",
      "(a) Survivors of Sexual Assault/Rape/Incest: \n",
      "(b) Minors: \n",
      "(c) Change of marital status during the ongoing pregnancy (widowhood and divorce):  \n",
      "(d) Women with physical disabilities\n",
      "[major disability as per criteria laid down under the Rights of \n",
      "Persons with Disabilities Act, 2016 (49 of 2016)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 207:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Reasons for termination: (Give total number under each sub-head)\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      24\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "]: \n",
      "(e) Mentally ill women including mental retardation: \n",
      "(f) The foetal malformation that has substantial risk of being incompatible with life or if the child  is \n",
      "born it may suffer from such physical or mental abnormalities to be seriously handicapped: \n",
      "(g) Women with pregnancy in humanitarian settings or disasters or emergency situations as declared \n",
      "by Government: \n",
      " \n",
      "C.\n",
      "Beyond 24 weeks of gestation \n",
      "(a) The foetal malformation that has substantial risk of being incompatible with life or if the child is \n",
      "born it may suffer from such physical or mental abnormalities to be seriously handicapped: \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "Signature of the Officer In-charge with Date\n",
      "\n",
      "11\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "Admission Register (Form III)\n",
      "FORM III \n",
      "[ Refer Regulation 5 ] \n",
      "Admission Register \n",
      "(To be destroyed on the expiry of five years from the date of the last entry in the Register)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 208:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name of Facility: ____________________________________________________      Month ____________________ Year __________\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      24\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of Facility:\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "Month _\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "Year\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "_\n",
      "S. \n",
      "No.\n",
      "Date of \n",
      "Admission \n",
      "Name of \n",
      "the Patient \n",
      "Wife / \n",
      "Daughter \n",
      "of \n",
      "Age Religion Address Duration of \n",
      "Pregnancy \n",
      "Reasons on \n",
      "which \n",
      "Pregnancy \n",
      "is \n",
      "terminated \n",
      "Date of \n",
      "termination \n",
      "of \n",
      "Pregnancy \n",
      "Date of \n",
      "discharge \n",
      "of patient \n",
      "Result & \n",
      "Remarks \n",
      "Name of \n",
      "Registered \n",
      "Medical \n",
      "Practitioner(s) \n",
      "by whom the \n",
      "opinion is \n",
      "formed \n",
      "(For pregnancy \n",
      "beyond 24 weeks \n",
      "mention the \n",
      "names of \n",
      "Medical Board \n",
      "members) \n",
      "Name of \n",
      "Registered \n",
      "Medical \n",
      "Practitioner(s) \n",
      "by whom \n",
      "Pregnancy is \n",
      "terminated \n",
      "Method \n",
      "of MTP \n",
      " \n",
      "(MVA/ \n",
      "EVA/ \n",
      "MMA/ \n",
      "D&C/ \n",
      "Others)\n",
      "Post Abortion \n",
      "Contraception \n",
      " \n",
      "(Tubal Ligation \n",
      "(TL)/IUCD/ \n",
      "OCP/ \n",
      "Injectables/ \n",
      "Others/ \n",
      "None) \n",
      "1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 209:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name of Facility: ____________________________________________________      Month ____________________ Year __________\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t It can be performed only by eligible RMPs as under the MTP (Amendment) Rules, 2021. \n",
      "•\t It can be performed for gestation age up to nine weeks, at approved sites as well as outdoor clinic of \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 210:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name of Facility: ____________________________________________________      Month ____________________ Year __________\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "12\n",
      "Following are the key conditions/requirements for MTP using medical methods, as under the MTP Act:\n",
      "•\t It can be performed only by eligible RMPs as under the MTP (Amendment) Rules, 2021.\n",
      "•\t Documentation formats (Form C, I, II, III) are mandatory to be completed for MMA.\n",
      "Confidentiality of the woman is to be fully ensured and her particulars should not be shared with anyone \n",
      "except the person authorised by the law.\n",
      "13\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "3.1: Indications for MMA\n",
      "Option for MMA should be given to all women coming to a health facility seeking termination of \n",
      "pregnancy up to nine weeks of gestation (63 days from the first day of the last menstrual period in \n",
      "women with regular cycles of approximately 28 days).\n",
      "3.2: Contraindications for MMA\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 211:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Medical methods of abortion is contraindicated in women with:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"anaemia\",\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Medical methods of abortion is contraindicated in women with:\n",
      "•\t Confirmed or suspected ectopic pregnancy 1 or undiagnosed adnexal mass, as Mifepristone or \n",
      "Misoprostol cannot treat ectopic pregnancy\n",
      "•\t Anaemia (haemoglobin <8gm %)\n",
      "•\t Uncontrolled hypertension with BP >160/100mm Hg\n",
      "•\t Chronic adrenal failure\n",
      "•\t Severe renal, liver, or respiratory diseases\n",
      "•\t Uncontrolled seizure disorder\n",
      "•\t Inherited porphyria\n",
      "•\t Glaucoma\n",
      "•\t Allergy or intolerance to Mifepristone/Misoprostol or other prostaglandins\n",
      "Women with co-morbidities should be referred to higher centres.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 212:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Medical methods of abortion is contraindicated in women with:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Lower abdominal pain, usually one-sided, that may be sudden and intense, persistent, or cramping\n",
      "•\t Irregular vaginal bleeding or spotting\n",
      "•\t Fainting or dizziness that persists for more than a few seconds, possibly indicative of internal bleeding. Internal bleeding is not \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 213:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Medical methods of abortion is contraindicated in women with:\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Current long-term use of systemic corticosteroids (including those with severe uncontrolled asthma).\n",
      "•\t Coagulopathy or on anticoagulant therapy.\n",
      "•\t Pre-existing heart disease or cardiovascular risk factors. \n",
      "•\t Pregnancy with in-situ intrauterine contraceptive device (IUCD): IUCD must be removed before \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 214:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Medical methods of abortion is contraindicated in women with:\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3 Indications/Contraindications for MMA\n",
      "Share with the participants the indications, contraindications, and situations for \n",
      "special precautions for prescribing MMA.\n",
      " 1Signs/symptoms during ectopic pregnancy could include:\n",
      "•\t Lower abdominal pain, usually one-sided, that may be sudden and intense, persistent, or cramping\n",
      "•\t Irregular vaginal bleeding or spotting\n",
      "•\t Fainting or dizziness that persists for more than a few seconds, possibly indicative of internal bleeding.\n",
      "Ectopic pregnancy can be diagnosed with a careful history, examination, and USG\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "14\n",
      "3.3: Special Precautions for MMA\n",
      "Besides absolute contraindications, MMA drugs are to be used with caution in the following situations, \n",
      "as given below:\n",
      "•\t Current long-term use of systemic corticosteroids (including those with severe uncontrolled asthma).\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 215:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Medical methods of abortion is contraindicated in women with:\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 5,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"caesarean\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Pregnancy with fibroid: Women with symptomatic large fibroids encroaching on endometrial cavity \n",
      "can have heavy bleeding and fibroids may interfere with the uterine contractility.\n",
      "•\t Pregnancy with uterine scar: Caution should be exercised when MMA is offered to women with a \n",
      "previous history of caesarean section, hysterotomy or myomectomy.\n",
      "•\t Bronchial asthma: Misoprostol is a weak bronchodilator and therefore, could be used in women \n",
      "with bronchial asthma.\n",
      "However, prostaglandins other than Misoprostol should not be used.\n",
      "•\t Use of anti-tubercular drugs: These may decrease the efficacy of MMA drugs.\n",
      "3.4: Eligibility Checklist for MMA\n",
      "Given below is a quick checklist to assess the eligibility of the woman for MMA.\n",
      "Only if all the answers \n",
      "from 1 to 8 are “NO” , proceed with the procedure:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 216:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "\n",
      "\n",
      "15\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "4 About MMA Drugs\n",
      "Share with the participants the mechanism of action of the drugs used for MMA.\n",
      "4.1: Drugs Used for MMA\n",
      "Recommended drugs for MMA are Mifepristone and Misoprostol.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 217:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 1: Eligibility Checklist\n",
      "Eligibility Checklist Ye s No\n",
      "1 Gestation period or uterine size more than 9 weeks\n",
      "2 Suspected or diagnosed ectopic pregnancy or undiagnosed adnexal \n",
      "mass\n",
      "3 History of bleeding disorders or inherited porphyrias\n",
      "4 History of uncontrolled seizure disorder/respiratory/hepatic/renal \n",
      "disease\n",
      "5 History of allergic reaction to Mifepristone/Misoprostol \n",
      "6 History of uncontrolled hypertension with BP >160/100mm Hg\n",
      "7 History of chronic adrenal failure or glaucoma\n",
      "8 Woman looks anaemic/pale\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 218:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "5Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "3.1: Indications for MMA\n",
      "Option\tfor\tMMA\tshould\tbe\tgiven\tto\tall\twomen\tcoming\tto\ta\thealth\tfacility\tseeking\ttermination\tof\t\n",
      "pregnancy\tup\tto\t7\tweeks\tof\tgestation\t(49\tdays\tfrom\tthe\tfirst\tday\tof\tthe\tlast\tmenstrual\tperiod\tin\t\n",
      "women\twith\tregular\tcycles\tof\tapproximately\t28\tdays)1\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 219:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 1: MMA Drugs (Mifepristone and Misoprostol)\n",
      "3.2: Contraindications for MMA\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 220:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Women being prescribed MMA should be screened for the following common contraindications:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"anaemia\",\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Women being prescribed MMA should be screened for the following common contraindications:\n",
      "•\t Anaemia\t(haemoglobin\t<8\tgm\t%)\n",
      "•\t Confirmed\tor\tsuspected\tectopic\tpregnancy/undiagnosed\tadnexal\tmass\n",
      "•\t Uncontrolled\thypertension\tor\tBP\t>\t160/100\tmm\tHg\n",
      "3\n",
      "Section\n",
      "Indications/Contraindications \n",
      "for MMA\n",
      "1\tIn\tDecember\t2008,\tCombipack\twith\tMifepristone+\tMisoprostol\t(1\ttablet\tof\tMifepristone\t200mg\tand\t4\ttablets\tof\tMisoprostol\t200mcg\t\n",
      "each)\twas\tapproved\tby\tthe\tCentral\tDrugs\tStandard\tControl\tOrganization,\tDirectorate\tGeneral\tof\tHealth\tServices,\tIndia,\tfor\tthe\t\n",
      "termination\tof\tintra-uterine\tpregnancy\tfor\tup\tto\t63\tdays/9\tweeks\tgestation.\n",
      "CAC\tTraining\t&\tService\tDelivery\tGuidelines,\t2010\tby\tMoHFW,\tGoI\trecommends\tits\tuse\tup\tto\t49\tdays\tin\tpublic\tsector\tsites,\tin\tline\t\n",
      "with\tthe\tMTP\tRules\t2003.\n",
      "A\tproposed\tamendment\tto\tthe\tMTP\tAct,\t1971,\tto\tincrease\tthe\tgestation\tlimit\tfor\tMMA\tto\t9\tweeks\tin\tpublic\tsector\tsites\tis\tunder\tprocess.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 221:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Women being prescribed MMA should be screened for the following common contraindications:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Till\tthe\tproposal\tis\tapproved,\tMMA\tin\tpublic\thealth\tfacility\twould\tbe\tallowed\tonly\tup\tto\t7\tweeks.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 222:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 1: MMA Combipack (Mifepristone and Misoprostol)\n",
      "MMA drugs are Schedule H drugs and are to be sold by retail on the prescription of a Registered \n",
      "Medical Practitioner only.\n",
      "Mifepristone is an antiprogestin, which blocks the progesterone receptors in the endometrium, causing \n",
      "the necrosis of uterine lining and detachment of implanted embryo.\n",
      "It causes cervical softening, increases \n",
      "sensitivity of the cervix and uterus to the action of prostaglandins and may initiate uterine contractions \n",
      "too.\n",
      "A small percentage of women (3%) may expel products of conception (POC) with Mifepristone \n",
      "alone.\n",
      "Misoprostol is a synthetic prostaglandin E1 analogue.\n",
      "It binds to the myometrial cells and leads to \n",
      "cervical softening and dilatation and uterine contractions.\n",
      "This leads to the expulsion of POC from the \n",
      "uterus.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 223:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Misoprostol has an advantage over other prostaglandins as it is well absorbed from different routes \n",
      "of administration, is economical, stable at room temperature, and does not cause bronchoconstriction in \n",
      "comparison to PGF2alpha derivatives.\n",
      "It was earlier used for prevention and treatment of gastric ulcer.\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "16\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 224:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Different Routes of Misoprostol Administration:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Different Routes of Misoprostol Administration:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 225:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Sublingual (below the tongue)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "1. Sublingual (below the tongue)\n",
      "7Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "4.1: Drugs Used in MMA\n",
      "Recommended\tdrugs\tfor\tMMA\tare\tMifepristone\tand\tMisoprostol.\n",
      "MMA drugs are Schedule H drugs and are to be sold by retail on the prescription of a \n",
      "Registered Medical Practitioner only.\n",
      "Mifepristone is\tan\tantiprogestin,\twhich\tblocks\tthe\tprogesterone\treceptors\tin\tthe\tendometrium,\t\n",
      "causing\tthe\tnecrosis\tof\tuterine\tlining\tand\tdetachment\tof\timplanted\tembryo.\n",
      "It\tcauses\tcervical\t\n",
      "softening\tand\tan\tincreased\tproduction\tof\tprostaglandins,\tcausing\tuterine\tcontractions.\n",
      "A\tsmall\t\n",
      "percentage\tof\twomen\t(3%)\tmay\texpel\tproducts\tof\tconception\t(POC)\twith\tMifepristone\talone.\n",
      "Misoprostol is\ta\tsynthetic\tprostaglandin\tE1\tanalogue.\n",
      "It\tbinds\tto\tthe\tmyometrial\tcells,\tcausing\t\n",
      "strong\tuterine\tcontractions,\tcervical\tsoftening\tand\tdilatation.\n",
      "This\tleads\tto\tthe\texpulsion\tof\tPOC\t\n",
      "from\tthe\tuterus.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 226:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Sublingual (below the tongue)\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Misoprostol\thas\tan\tadvantage\tover\tother\tprostaglandins\tas\tit\tis\twell\tabsorbed\tfrom\t\n",
      "different\troutes\tof\tadministration,\tis\teconomical,\tand\tstable\tat\troom\ttemperatures\tin\tcomparison\t\n",
      "to\tPGF2alpha\tderivatives.\n",
      "It\twas\tearlier\tused\tfor\tprevention\tand\ttreatment\tof\tgastric\tulcer.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 227:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Action of Misoprostol through different routes of administration:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Action of Misoprostol through different routes of administration:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 228:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Sublingual: Rapid\\tonset\\tof\\taction\\t(like\\toral\\troute)\\tand\\tlonger\\tduration\\tof\\taction\\t(like\\tvaginal\\troute);\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Sublingual: Rapid\tonset\tof\taction\t(like\toral\troute)\tand\tlonger\tduration\tof\taction\t(like\tvaginal\troute);\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 229:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 2: Sublingual administration of Misoprostol \n",
      "4\n",
      "Section\n",
      "MMA Drugs\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 230:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 2: Sublingual administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 231:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Buccal (in the cheeks)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Buccal (in the cheeks)\n",
      "8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 232:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Buccal: Onset\tand\tduration\tof\taction\tis\tquite\tsimilar\tto\tthe\tvaginal\troute\talthough\tthe\tserum\tlevels\t\n",
      "achieved\tare\tlower.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 233:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 3: Buccal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 234:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Vaginal: Gradual\tonset\tbut\tlonger\tduration\tand\tsustained\taction.\tMisoprostol\ttablets\ton\tvaginal\t\n",
      "administration\tmay\tnot\tcompletely\tdissolve.\tAs\tthe\tcore\tof\tthe\ttablet\tis\tnon-medicated,\tthis\tdoes\t\n",
      "not\taffect\tits\tefficacy.\tMoistening\tthe\ttablet\tbefore\tvaginal\tadministration\tdoes\tnot\timprove\tefficacy\t\n",
      "(ACOG,\t2009)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 235:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 4: Vaginal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 236:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Oral: Rapid\tonset\tbut\tshort\ttotal\tduration\tof\taction\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 237:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 5: Oral administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 238:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 3: Buccal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 239:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Vaginal\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Vaginal \n",
      "8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 240:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Buccal: Onset\tand\tduration\tof\taction\tis\tquite\tsimilar\tto\tthe\tvaginal\troute\talthough\tthe\tserum\tlevels\t\n",
      "achieved\tare\tlower.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 241:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 3: Buccal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 242:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Vaginal: Gradual\tonset\tbut\tlonger\tduration\tand\tsustained\taction.\tMisoprostol\ttablets\ton\tvaginal\t\n",
      "administration\tmay\tnot\tcompletely\tdissolve.\tAs\tthe\tcore\tof\tthe\ttablet\tis\tnon-medicated,\tthis\tdoes\t\n",
      "not\taffect\tits\tefficacy.\tMoistening\tthe\ttablet\tbefore\tvaginal\tadministration\tdoes\tnot\timprove\tefficacy\t\n",
      "(ACOG,\t2009)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 243:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 4: Vaginal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 244:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Oral: Rapid\tonset\tbut\tshort\ttotal\tduration\tof\taction\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 245:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 5: Oral administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 246:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 4: Vaginal administration of Misoprostol\n",
      "\n",
      "17\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 247:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Oral\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Oral\n",
      "8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 248:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Buccal: Onset\\tand\\tduration\\tof\\taction\\tis\\tquite\\tsimilar\\tto\\tthe\\tvaginal\\troute\\talthough\\tthe\\tserum\\tlevels\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Buccal: Onset\tand\tduration\tof\taction\tis\tquite\tsimilar\tto\tthe\tvaginal\troute\talthough\tthe\tserum\tlevels\t\n",
      "achieved\tare\tlower.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 249:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 3: Buccal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 250:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Vaginal: Gradual\\tonset\\tbut\\tlonger\\tduration\\tand\\tsustained\\taction.\\tMisoprostol\\ttablets\\ton\\tvaginal\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Vaginal: Gradual\tonset\tbut\tlonger\tduration\tand\tsustained\taction.\tMisoprostol\ttablets\ton\tvaginal\t\n",
      "administration\tmay\tnot\tcompletely\tdissolve.\tAs\tthe\tcore\tof\tthe\ttablet\tis\tnon-medicated,\tthis\tdoes\t\n",
      "not\taffect\tits\tefficacy.\tMoistening\tthe\ttablet\tbefore\tvaginal\tadministration\tdoes\tnot\timprove\tefficacy\t\n",
      "(ACOG,\t2009)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 251:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 4: Vaginal administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 252:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Oral: Rapid\\tonset\\tbut\\tshort\\ttotal\\tduration\\tof\\taction\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Oral: Rapid\tonset\tbut\tshort\ttotal\tduration\tof\taction\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 253:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 5: Oral administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 254:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 5: Oral administration of Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 255:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Below is the graph with pharmacokinetics of Misoprostol by different routes:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Below is the graph with pharmacokinetics of Misoprostol by different routes:\n",
      "9Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 256:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 6: Graph comparing pharmacokinetics of Misoprostol administered by different routes\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 257:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 1: Effectiveness of Misoprostol administered by different routes\n",
      "Route of \n",
      "Administration\n",
      "Onset of \n",
      "Action\n",
      "Duration of Action Preferred/Recommended Route\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 258:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Sublingual Fastest Highest\tplasma\tlevels\t\n",
      "and\tprolonged\taction\n",
      "Most\trecommended\n",
      "Buccal Quick Prolonged\taction Recommended\n",
      "Vaginal Quick Prolonged\taction Recommended \n",
      "Oral Quick Least\tduration Least\trecommended\tbut\tstill\tcan\tbe\tgiven\n",
      "The table below indicates the effectiveness of Misoprostol when administered by different routes:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 259:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 2: Effectiveness of Misoprostol administered by different routes2\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 260:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 6: Graph comparing pharmacokinetics of Misoprostol administered by different routes\n",
      "Route of Administration Peak Levels Attained Bioavailability\n",
      "Sublingual Rapidly (30 minutes) Long duration (6 hours)\n",
      "Vaginal3 Gradually (70-80 minutes) Longest duration (>6 hours)\n",
      "Buccal Gradually (70-80 minutes) Moderate duration (3 hours)\n",
      "Oral (only if gestation age is upto 7 \n",
      "weeks)\n",
      "Rapidly (30 minutes) Short duration (2 hours)\n",
      " 2Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167\n",
      " 3Moistening the tablet before vaginal administration does not improve efficacy (ACOG, 2009)\n",
      "- Plasma Misoprostol concentration (pg/ml)\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "18\n",
      "5 MMA Protocol and Process\n",
      "The steps of the MMA procedure are divided based on the day of visit. Typically, it requires three \n",
      "visits (Day 1, 3 and 15). 2 nd visit on Day 3 is optional when the woman takes Misoprostol at home, in \n",
      "consultation with the provider.\n",
      "5.1: Drug Protocol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 261:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 3: MMA Drug Protocol\n",
      "Share with the participants the drug protocol to be used for MMA and the whole process of \n",
      "abortion when performed by MMA.\n",
      "Visit Day Drugs used\n",
      "First 1 One  •\t 200 mg Mifepristone oral;\n",
      "•\t Anti D 50 mcg, if Rh negative.\n",
      "Second 3 Three                     •\t 800 mcg Misoprostol (four tablets of 200 mcg) sublingual/ \n",
      "buccal/vaginal/oral only if < 7 weeks;\n",
      "•\t Analgesic (Ibuprofen);\n",
      "•\t Antiemetic;\n",
      "•\t Offer contraception.\n",
      "Third 15 Fifteen                       •\t Confirm and ensure completion of abortion;\n",
      "•\t Offer contraception, if not already done so.\n",
      "5.2: Process of MMA\n",
      "A. First Visit/Day 1/Day of Mifepristone Administration\n",
      "First visit starts with assessing the suitability of the woman to undergo medical methods of abortion.\n",
      "Suitability is judged by taking a detailed history, conducting a clinical examination, necessary \n",
      "investigations and excluding the contraindications.\n",
      "First visit sometimes may not be the day of Mifepristone administration.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 262:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "It is the day of Mifepristone administration which is taken as Day 1.\n",
      "It is important to ensure that \n",
      "women are already well evaluated and counselled, including contraceptive counselling, on Day 1 before \n",
      "administering Mifepristone.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 263:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Detailed History\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1.\n",
      "Detailed History\n",
      "a. Demographic profile: age, religion, address etc.\n",
      "b.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 264:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Detailed History\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"caesarean\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Menstrual history: length and duration of cycle, flow (excess or normal), and LMP\n",
      "\n",
      "19\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "c. Obstetric history: parity, live births, abortion (induced and spontaneous and if any complications), \n",
      "previous caesarean section (if any), last childbirth/abortion, and presently lactating or not\n",
      "d. History of pre-existing medical/surgical conditions:\n",
      "•\t Hypertension\n",
      "•\t Heart disease\n",
      "•\t Diabetes mellitus\n",
      "•\t Epilepsy\n",
      "•\t Asthma (not a contraindication with PGE1)\n",
      "•\t Renal disease\n",
      "•\t Drug allergies including to Mifepristone / Misoprostol\n",
      "•\t Bleeding disorders\n",
      "•\t Current medication\n",
      "•\t Previous uterine/tubal/abdominal surgery/ectopic pregnancy\n",
      "•\t Treatment for infertility/Tuberculosis/pelvic inflammatory disease\n",
      "e. History of any interference/drugs taken in this pregnancy to attempt termination/bleeding per \n",
      "vaginum\n",
      "f. Contraceptive history: type and duration of contraceptive used\n",
      "g. Status of tetanus immunization: last dose received\n",
      "h. Psychosocial assessment: to assess family support\n",
      "i. History of sexual assault and domestic violence\n",
      "Eligibility of the woman may be assessed using the `Eligibility Checklist’ given in the Chapter 3: \n",
      "Indications/Contraindications for MMA, section 3.4.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 265:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Counselling: General and Method-specific Counselling\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Ask about her existing knowledge and beliefs about abortion options.\n",
      "•\t Tell her about all the methods available for abortion and how each method differs from the other.\n",
      "•\t Discuss her contraceptive needs and counsel her accordingly for contraception after abortion. \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 266:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Counselling: General and Method-specific Counselling\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "2. Counselling: General and Method-specific Counselling\n",
      "Share with the participants the general and MMA specific counselling points to be \n",
      "conveyed to the woman while counselling for MMA procedure.\n",
      "General Counselling\n",
      "While counselling the woman, attention must be paid to the following points:\n",
      "The counsellor needs to understand with empathy and sensitivity, why abortion is being sought.\n",
      "Inform her about return of fertility within 10 days of an abortion process/procedure.\n",
      "•\t Discuss infection prevention aspects like local hygiene, handwashing, and use of clean sanitary \n",
      "napkins, etc.\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "20\n",
      "Method-specific Counselling\n",
      "If the woman chooses MMA, she should be provided the following information:\n",
      "a.\n",
      "It is a non-invasive and non-surgical method.\n",
      "b.\n",
      "However, failure of the method or excessive bleeding (soaking two or more thick pads per hour for \n",
      "two consecutive hours) may necessitate further management at a higher centre for vacuum aspiration.\n",
      "c.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 267:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Counselling: General and Method-specific Counselling\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "The process is similar to a natural miscarriage.\n",
      "d.\n",
      "She needs to make a minimum of three visits to the facility (Day 1, 3, and 15).\n",
      "Home administration \n",
      "of Misoprostol is allowed on provider’s discretion.\n",
      "In such cases, the number of facility visits will \n",
      "reduce to two (Day 1, and 15).\n",
      "e.\n",
      "She must follow a definite drug protocol.\n",
      "f.\n",
      "She has option of different routes of Misoprostol administration and would be helped to choose one.\n",
      "g.\n",
      "She should stay within the accessible limits of the appropriate health care facility.\n",
      "h.\n",
      "There could be teratogenic (harmful) effect on the foetus if the method fails and pregnancy continues.\n",
      "i.\n",
      "A small percentage of women (3%) may expel products with Mifepristone alone, but total drug \n",
      "schedule with Misoprostol must be completed.\n",
      "j.\n",
      "During the abortion process, it is ideal to avoid intercourse to prevent infection, or hence use barrier \n",
      "methods.\n",
      "k.\n",
      "Explain the symptoms that would be experienced by her.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 268:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Counselling: General and Method-specific Counselling\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 4,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "12 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 269:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 7: Counselling on MMA procedure\n",
      "Method-specific Counselling\n",
      "If\tthe\twoman\tchooses\tMMA,\tshe\tshould\tbe\tprovided\tthe\tfollowing\tinformation:\n",
      "a)\n",
      "It\tis\ta\tnon-invasive\tand\tnon-surgical\tmethod\n",
      "b)\t The\tprocess\tis\tsimilar\tto\ta\tnatural\tmiscarriage\n",
      "c)\n",
      "She\tneeds\tto\tmake\ta\tminimum\tof\tthree\tvisits\tto\tthe\tfacility\t(day\t1,\t3,\t&\t15).\n",
      "Home\tadministration\t\n",
      "of\tMisoprostol\tis\tallowed\ton\tprovider’s\tdiscretion.\n",
      "In\tsuch\tcases,\tthe\tnumber\tof\tfacility\tvisits\t\n",
      "will\treduce\tto\ttwo.\n",
      "d)\t She\thas\tto\tfollow\ta\tdefinite\tdrug\tprotocol\n",
      "e)\t Counselling\tabout\tdifferent\troutes\tof\tadministration\n",
      "f)\n",
      "She\thas\tto\tbe\tready\tfor\tVA\tprocedure\tin\tcase\tof\tfailure\tof\tthe\tmethod\tor\texcessive\tbleeding\t\n",
      "(soaking\ttwo\tor\tmore\tthick\tpads\tper\thour\tfor\ttwo\tconsecutive\thours)\t\n",
      "g)\t She\thas\tto\tstay\twithin\tthe\taccessible\tlimits\tof\tthe\tappropriate\thealth\tcare\tfacility.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 270:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"normal_variations\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "She\tshould\t\n",
      "not\tbe\tleft\tunattended\tat\thome\t\n",
      "h)\t \tExplain\tthe\tsymptoms\tthat\twould\tbe\texperienced\tby\ther,\tfor\texample:\t\n",
      "•\t Bleeding\tper\tvaginum\tis\tan\tessential\tpart\tof\tthe\tMMA\tprocess\tsince\tit\tis\tsimilar\tto\t\n",
      "miscarriage.\n",
      "Bleeding\tis\tusually\theavier\tthan\twhat\tis\texperienced\tduring\ta\tmenstrual\t\n",
      "period.\n",
      "Bleeding\toften\tlasts\tfor\t8\tto\t13\tdays.\n",
      "Soaking\tof\ttwo\tthick\tpads\twithin\tone\tto\ttwo\t\n",
      "hours\tafter\ttaking\tMisoprostol,\tbut\tdecreasing\tover\ttime\tis\tconsidered\tnormal.\n",
      "•\t Abdominal\tpain\tis\texperienced\tas\ta\tpart\tof\tthe\tMMA\tprocess.\n",
      "Refrain\tfrom\tdescribing\t\n",
      "cramping\t pain\t as\t similar\t to\t labour\t pains.\n",
      "Instead,\t it\t can\t be\t compared\t with\t severe\t\n",
      "menstrual\tcramps.\n",
      "Sometimes\tthe\tpain\tbegins\tfollowing\tingestion\tof\ttablet\tMifepristone,\t\n",
      "but\tmost\toften\tit\tstarts\tone\tto\tthree\thours\tafter\tMisoprostol\tadministration\tand\tis\theaviest\t\n",
      "during\tthe\tactual\tabortion\tprocess,\toften\tlasting\tup\tto\tfour\thours.\n",
      "If\tthe\tpain\tis\tpersistent,\t\n",
      "the\tpossibility\tof\tectopic\tpregnancy\tshould\talways\tbe\truled\tout.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 271:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Nausea,\tvomiting,\tdiarrhoea,\tetc.\tare\tnormal\tside\teffects\tof\tdrugs.\n",
      "i)\t There\tcould\tbe\tteratogenic\t(harmful)\teffect\ton\tthe\tfetus,\tif\tpregnancy\tcontinues\n",
      "j)\t A\tsmall\tpercentage\tof\twomen\t(3%)\tmay\texpel\tproducts\twith\tMifepristone\talone,\tbut\ttotal\t\n",
      "drug\tschedule\twith\tMisoprostol\tmust\tbe\tcompleted\n",
      "k)\n",
      "During\tthe\tabortion\tprocess,\tit\tis\tideal\tto\tavoid\tintercourse\tto\tprevent\tinfection,\tor\tuse\tbarrier\t\n",
      "methods\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 272:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 7: Counselling on MMA procedure\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 273:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Share with the participants the expected symptoms during the process of MMA.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 274:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Expected Symptoms during MMA \n",
      "    \n",
      "•\tBleeding per vaginum  is an essential part of the MMA process since it is similar to miscarriage.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 275:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Bleeding is usually heavier than what is experienced during a menstrual period. Bleeding often \n",
      "lasts for 8 to 13 days. Soaking of two thick pads within one to two hours after taking Misoprostol, \n",
      "is considered normal, but this should decrease over time. If it happens beyond 4 – 6 hours of taking \n",
      "Misoprostol, the provider/facility should be contacted.\n",
      "•\t Abdominal pain is experienced as a part of the MMA process. Refrain from describing cramping \n",
      "pain like labour pains. Instead, it can be compared with severe menstrual cramps. Sometimes the \n",
      "pain begins following ingestion of tablet Mifepristone, but most often it starts after Misoprostol\n",
      "\n",
      "21\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 276:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "administration and is heaviest during the actual abortion process, often lasting up to four hours. \n",
      "If the pain is persistent even after taking an analgesic, the possibility of ectopic pregnancy should \n",
      "always be ruled out.\n",
      "•\t Nausea, vomiting, and diarrhoea, etc. are normal side effects of drugs.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 277:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "For covering all the important points during the counselling of the woman before MMA, `Counselling \n",
      "Skills Checklist’ may be referred to, which is given as`Annexure – 1.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 278:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Clinical Assessment and Eligibility Screening\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"blood pressure\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "3. Clinical Assessment and Eligibility Screening\n",
      "Clinical assessment includes General Physical, Systemic, Abdominal and Pelvic Examination:\n",
      "a. Check for pallor: if pallor exists, heavy bleeding during the procedure may worsen the condition and \n",
      "increase the risk of shock and ill health.\n",
      "b. Check Blood pressure; cardiovascular; and respiratory system for any pre-existing disease.\n",
      "c. Look for any mass, rigidity, tenderness in abdominal examination.\n",
      "d. Carry out Pelvic examination (P/S and P/V).\n",
      "13Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "l)\t Women\twith\tno\tsupport\tat\thome:\tarrangements\tshould\tbe\tmade\tfor\ttransportation\tto\tthe\t\n",
      "hospital,\tin\tcase\tof\temergency\tor\tshould\tbe\tadmitted\tfor\tthe\tMMA\tprocedure\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 279:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. General Physical, Systemic, Abdominal and Pelvic Examination\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. General Physical, Systemic, Abdominal and Pelvic Examination\n",
      "a)\t Check\tfor\tpallor:\tif\tpallor\texists,\theavy\tbleeding\tduring\tthe\tprocedure\tmay\tworsen\tthe\t\n",
      "condition\tand\tincrease\tthe\trisk\tof\tshock\tand\till\thealth\t\n",
      "b)\t Blood\tpressure;\tcardiovascular;\tand\trespiratory\tsystem\tfor\tany\tpre-existing\tdisease\n",
      "c)\t Look\tfor\tany\tmass,\trigidity,\ttenderness\tin\tabdominal\texamination\n",
      "d)\t Carry\tout\tPelvic\texamination\t(P/S\tand\tP/V)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 280:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 8: Performing bimanual examination\n",
      "•\t P/S\texamination:\tlook\tfor\tinfection,\tcervical\terosion,\tpolyp\n",
      "•\t P/V\texamination:\tcheck\tthe\tsize,\tshape,\tregularity\tand\tconsistency\tof\tuterus\tto\tconfirm\t\n",
      "the\tperiod\tof\tgestation\tand\tadenexal\tmass\t\n",
      "•\t Rule\tout\tectopic\tpregnancy2,\tin\tcase\tof\tadenexal\tmass/fullness\tor\ttenderness\tin\tadenexa\t\n",
      "or\tcervical\ttenderness\n",
      "2\tEctopic\tpregnancies\tcan\tbe\tdiagnosed\twith\ta\tcareful\thistory,\texamination\tand\tUSG.\n",
      "Since\tit\tis\tan\tobstetric\tUSG,\tit\tmust\tbe\tdone\tin\t\n",
      "accordance\twith\tPCPNDT\tAct.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 281:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Symptoms during ectopic pregnancy might include:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\tAmenorrhea\n",
      "•\tNausea,\tvomiting\n",
      "•\tLower\tabdominal\tpain,\tusually\tone\t-\tsided,\tthat\tmay\tbe\tsudden\tand\tintense,\tpersistent,\tor\tcramping\t\n",
      "•\tIrregular\tvaginal\tbleeding\tor\tspotting\t\n",
      "•\tFainting\tor\tdizziness\tthat\tpersists\tfor\tmore\tthan\ta\tfew\tseconds\tis\tpossibly\tindicative\tof\tinternal\tbleeding.\tInternal\tbleeding\tis\tnot\t\n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 282:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Symptoms during ectopic pregnancy might include:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Symptoms during ectopic pregnancy might include:\n",
      "•\tAmenorrhea\n",
      "•\tNausea,\tvomiting\n",
      "•\tLower\tabdominal\tpain,\tusually\tone\t-\tsided,\tthat\tmay\tbe\tsudden\tand\tintense,\tpersistent,\tor\tcramping\t\n",
      "•\tIrregular\tvaginal\tbleeding\tor\tspotting\t\n",
      "•\tFainting\tor\tdizziness\tthat\tpersists\tfor\tmore\tthan\ta\tfew\tseconds\tis\tpossibly\tindicative\tof\tinternal\tbleeding.\n",
      "Uterine evacuation methods whether vacuum aspiration or medical methods using Mifepristone and \n",
      "Misoprostol, cannot terminate an ectopic pregnancy and hence should not be attempted in case of suspicion.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 283:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t P/S examination: look for infection, discharge (type), cervical erosion, polyp\n",
      "•\t P/V examination: check the size, direction, shape and regularity, and consistency of uterus to \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 284:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 8: Performing bimanual examination\n",
      "•\t P/S examination:\n",
      "Uterine size estimation through bimanual examination is the most critical skill required for MMA.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 285:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Investigations (Recommended)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "4. Investigations (Recommended)\n",
      "i. Haemoglobin\n",
      "ii. Routine urine examination\n",
      "iii. Blood Group: ABO Rh especially in primigravida\n",
      "iv. Pregnancy test\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "22\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 286:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Investigations as per the need:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Women are unsure of LMP or have conceived during lactational amenorrhea.\n",
      "•\t Women with discrepancy between history and clinical findings.\n",
      "•\t Women with suspicion of ectopic pregnancy.\n",
      "•\t Provider is uncertain after bimanual examination, or inability to measure uterine size due to obesity, \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 287:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Investigations as per the need:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Investigations as per the need:\n",
      "Ultrasonography (USG): USG may be done at sites where these facilities are available.\n",
      "However, it is not \n",
      "mandatory for all women undergoing pregnancy termination with medical methods.\n",
      "USG needs to be \n",
      "performed when:\n",
      "•\t Women are unsure of LMP or have conceived during lactational amenorrhea.\n",
      "•\t Provider is uncertain about the completion of the process during the follow-up visit.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 288:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Contraceptive Options\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "5. Contraceptive Options\n",
      "Woman’s acceptance for contraceptive method should not be a pre-condition for providing abortion \n",
      "services. However, all post abortion contraceptive options should be discussed with her, and she should \n",
      "be helped to choose the appropriate contraception for herself, based on her eligibility.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 289:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Informed Consent\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6. Informed Consent\n",
      "Get the consent of the woman/guardian in Form C. Also fill in the RMP Opinion Form (Form I), before \n",
      "prescribing MMA drugs.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 290:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"7. Tablet Mifepristone (200mg) is administered orally\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "7. Tablet Mifepristone (200mg) is administered orally\n",
      "Anti-D (50 mcg) given to Rh negative woman.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 291:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"8. Iron and Folic Acid Tablets\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [\n",
      "      \"iron\",\n",
      "      \"folic acid\"\n",
      "    ],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "8. Iron and Folic Acid Tablets\n",
      "90 tablets (to be taken for next three months) should be given to all women undergoing MMA procedure.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 292:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"9. Sanitary Napkins\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "9. Sanitary Napkins\n",
      "Use of sanitary napkins is recommended for prevention of infection.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 293:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"10. Antibiotics\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "10. Antibiotics\n",
      "Routine use of prophylactic antibiotics is not indicated.\n",
      "Antibiotics should be given to women with suspected/evident reproductive tract infections. \n",
      "Recommended antibiotics are Doxycycline 100 mg, twice a day for five days for non-lactating women, \n",
      "and Azithromycin 500 mg, once a day for three days for lactating women.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 294:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"11. Give contact address and phone number of the service provider/facility where woman can go in\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "11. Give contact address and phone number of the service provider/facility where woman can go in \n",
      "case of an emergency.\n",
      "\n",
      "23\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 295:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"12. Complete the MMA card\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "12. Complete the MMA card\n",
      "Explain the MMA card (Annexure - 3) to the woman and instruct her to note \n",
      "down her symptoms on it.\n",
      "At the sole discretion of the service provider, a woman can be given Misoprostol to be taken at home. \n",
      "In such cases, a thorough counselling on what is expected after taking Misoprostol, should be done. She \n",
      "should be called back on 15th day for follow up.\n",
      "The table below summarizes the tasks for Day 1 of the MMA protocol:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 296:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 4: Tasks for Day 1/Day of Mifepristone administration\n",
      ":\n",
      "V-2\n",
      "Rp-2 / Aug 08, 2016\n",
      "thick\n",
      ":\n",
      "Provider’s Task Instructions to the Woman\n",
      "Detailed history, rule out contraindications and \n",
      "note special precautions\n",
      "Take tablet Mifepristone 200 mg orally\n",
      "General and MMA specific counselling What to expect after taking tablet Mifepristone\n",
      "General physical and pelvic examination\n",
      "Estimation of gestation age by bimanual \n",
      "examination is the most important skill required \n",
      "for MMA\n",
      "She may have pain/bleeding in the next 2 days \n",
      "Take analgesic, if required\n",
      "Fill in Form I, Form C\n",
      "Record investigations\n",
      "Return for Misoprostol on Day 3 (unless decided \n",
      "by provider to give her for home administration)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 297:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [\n",
      "      \"iron\",\n",
      "      \"folic acid\"\n",
      "    ],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Discuss contraceptive options Avoid intercourse or use barrier methods\n",
      "Complete MMA card with complete contact \n",
      "information for emergency\n",
      "Keep filling the symptoms on MMA card\n",
      "Medication to be given:\n",
      "Mifepristone,\n",
      "Analgesic (Ibuprofen),\n",
      "Iron & Folic Acid (90 tablets),\n",
      "Sanitary napkins\n",
      "Report to the provider/facility if there is:\n",
      "Excessive bleeding\n",
      "Severe pain abdomen\n",
      "Complete the records in Form III (Admission \n",
      "Register)\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "24\n",
      "B.  Second Visit/Day 3/Day of Misoprostol Administration\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 298:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Note any history of bleeding/pain or any other side effects after tablet Mifepristone: Some\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Note any history of bleeding/pain or any other side effects after tablet Mifepristone: Some \n",
      "women will start bleeding after the administration of tablet Mifepristone.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 299:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Administer Misoprostol: Ask the woman to empty her bladder. Give/insert four tablets of 200\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Administer Misoprostol: Ask the woman to empty her bladder. Give/insert four tablets of 200 \n",
      "mcg Misoprostol (total 800 mcg) by sublingual/buccal/vaginal route. Oral route may be used if \n",
      "pregnancy < 7 weeks.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 300:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Ask her to lie in bed for half an hour after vaginal insertion.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "3. Ask her to lie in bed for half an hour after vaginal insertion.\n",
      "If she vomits tablet Misoprostol within half an hour of its intake, the same dosage (800 mcg \n",
      "Misoprostol) should be repeated, after giving an anti-emetic.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 301:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Observe the woman for four hours after Misoprostol administration in the clinic/hospital and\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": [\n",
      "      \"blood pressure\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Observe the woman for four hours after Misoprostol administration in the clinic/hospital and \n",
      "monitor:\n",
      "i. Pulse and blood pressure\n",
      "ii. Time of start of bleeding and expulsion of products (if it occurs)\n",
      "iii. Side effects of the drugs (e.g. chills)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 302:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Medication for pain relief: Usually the pain starts after taking Misoprostol, so analgesic can be taken\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "5. Medication for pain relief: Usually the pain starts after taking Misoprostol, so analgesic can be taken \n",
      "well in time before pain becomes intolerable. Tablet Ibuprofen 400 mg is recommended. Paracetamol \n",
      "is not recommended for pain relief during the process of MMA. If pain does not subside on taking \n",
      "drugs, the possibility of ectopic pregnancy should be ruled out. Receiving complete information \n",
      "during counselling and reassurance during the process helps the woman to tolerate pain better.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 303:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Perform pelvic examination before the woman leaves the clinic/facility and if cervical os is open\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "6. Perform pelvic examination before the woman leaves the clinic/facility and if cervical os is open \n",
      "and products are partially expelled, remove them digitally. She should be observed for another few \n",
      "hours or till the expulsion of the POC is complete.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 304:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"7. In case the woman does not abort at the health centre or takes Misoprostol at home, inform her\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "7.\n",
      "In case the woman does not abort at the health centre or takes Misoprostol at home, inform her \n",
      "about: \n",
      "•\t Reporting back to the centre/service provider in case of excessive bleeding/acute  \n",
      "abdominal pain\n",
      "•\t Warning signs and symptoms \n",
      "•\t Using clean sanitary napkins\n",
      "•\t Avoiding tampons and douche\n",
      "•\t Reporting back if there is no bleeding even 24 hours after taking Misoprostol\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 305:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"8. Side effects of the drugs such as nausea, vomiting, diarrhoea (usually mild), headache, fever, and\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "8. Side effects of the drugs such as nausea, vomiting, diarrhoea (usually mild), headache, fever, and \n",
      "dizziness\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 306:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"9. Return for follow-up on the Day 15\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "9. Return for follow-up on the Day 15\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 307:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"10. Keep filling the MMA card\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "10.\n",
      "Keep filling the MMA card\n",
      ":\n",
      "V-2\n",
      "Rp-2 / Aug 08, 2016\n",
      "thick\n",
      ":\n",
      "\n",
      "25\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "Chart 1: Plan of action if there is no bleeding even 24 hours after administration of Misoprostol\n",
      "Continuation of Pregnancy Non-viable Foetus/Missed \n",
      "Abortion\n",
      "Refer to Higher \n",
      "Centre for Vacuum \n",
      "Aspiration\n",
      "Additional Dose of \n",
      "Misoprostol\n",
      "•\t Detailed History,\n",
      "•\t Clinical Examination,\n",
      "•\t Ultrasonography\n",
      "The table below summarizes the tasks for Day 3 of the MMA protocol:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 308:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 5: Tasks for Day 3/Day of Misoprostol administration\n",
      "Provider’s Task Instructions to the Woman\n",
      "Note history of bleeding/pain in abdomen/other \n",
      "side effects of tablet Mifepristone\n",
      "Lie in bed for 30 minutes if Misoprostol is \n",
      "inserted vaginally\n",
      "Give four tablets of Misoprostol (total 800 mcg) \n",
      "sublingual/vaginal/buccal\n",
      "Possible side effects – nausea, vomiting, \n",
      "diarrhoea, headache, chills, and dizziness\n",
      "Observe for 4 – 6 hours in the facility Avoid intercourse till bleeding stops\n",
      "Prescribe tablet Ibuprofen for pain relief Use clean sanitary napkins. Avoid tampons and \n",
      "douche\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 309:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Bimanual examination just before discharge from \n",
      "the facility\n",
      "Avoid going out of station till the third visit\n",
      "Antiemetics or antidiarrhoeal may be prescribed Report back if:\n",
      "No bleeding for even 24 hours after Misoprostol\n",
      "Excessive bleeding – soaking 2 or more thick \n",
      "pads for 2 hours continuously\n",
      "Fever >24 hours after Misoprostol\n",
      "Explain what to expect after Misoprostol \n",
      "administration\n",
      "Return for follow up on Day 15 or earlier, if \n",
      "required\n",
      "OCP/Injectables/Centchroman can be started if \n",
      "chosen\n",
      "Keep filling the MMA card\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "26\n",
      "C.  Third Visit/Day 15/Follow-up Visit\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 310:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1.  Note relevant history/check MMA card\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1.  Note relevant history/check MMA card\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 311:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Carry out pelvic examination to ensure completion of abortion process/continuation of pregnancy\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Carry out pelvic examination to ensure completion of abortion process/continuation of pregnancy\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 312:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Reiterate contraceptive counselling and services\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Reiterate contraceptive counselling and services\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 313:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Advise USG if:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4.\n",
      "Advise USG if:\n",
      "•\t complete expulsion of POC not confirmed\n",
      "•\t continuation of pregnancy suspected\n",
      "•\t bleeding continues\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 314:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Ask the woman to report back if there are no periods within six weeks\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Ask the woman to report back if there are no periods within six weeks\n",
      "The table below summarizes the tasks for Day 15 of the MMA protocol:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 315:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 6: Tasks for Day 15/Follow up visit\n",
      "Provider’s Task Instructions to the Woman\n",
      "Note history of bleeding/pain in abdomen/ \n",
      "expulsion of POC\n",
      "Contraceptive advice as per the method chosen\n",
      "Pelvic examination to confirm completion of the \n",
      "process. USG, if indicated\n",
      "Report back if no periods within six weeks of \n",
      "completion of abortion process\n",
      "IUCD, if chosen by the woman and all \n",
      "contraindications are ruled out\n",
      "Reiterate contraceptive counselling  \n",
      "and services\n",
      "5.3: Post MMA Contraception\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 316:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Centchroman can be started on Day 3 of the MMA protocol.\n",
      "•\t IUCD can be inserted after confirming complete abortion and ruling out contraindications, on Day \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 317:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Condoms can be used even on Day 1 of MMA administration.\n",
      "•\t Tubal ligation can be done after the next menstrual cycle. However, if desirous of concurrent tubal \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 318:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 9: Contraceptive Methods\n",
      "\n",
      "27\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "•\t Oral hormonal contraceptive methods, whether combined (estrogen and progestogen) or progestin-\n",
      "only, can be started on the day of the Misoprostol administration (Day 3) or Day 15 of the MMA \n",
      "protocol.\n",
      "•\t Injectable hormonal method (Injection-MPA/Antara Programme) can be started on Day 3 of the \n",
      "MMA protocol.\n",
      "•\t Vasectomy, if chosen, can be done independent of the MMA procedure.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 319:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "28\n",
      "6\n",
      "Side Effects and Complications\n",
      "with MMA and their Management\n",
      "6.1: Side Effects with MMA\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 320:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 7: Table below summarizes the day of initiation of contraceptive methods during the process of MMA\n",
      "Day of MMA \n",
      "Process Day 1 Day 3 Day 15 After Next \n",
      "Menstrual Cycle\n",
      "Contraceptive \n",
      "Methods that \n",
      "maybe Initiated\n",
      "•\t Condoms •\t COCs\n",
      "•\t Injectables\n",
      "•\t Centchroman\n",
      "•\t Condoms\n",
      "•\t IUCD\n",
      "•\t COCs\n",
      "•\t Condoms\n",
      "•\t Tubal ligation\n",
      "•\t IUCD\n",
      "•\t COCs\n",
      "•\t Injectables\n",
      "•\t Centchroman\n",
      "•\t Condoms\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 321:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Share with the participants the side effects and potential complications during the \n",
      "process of MMA and their management.\n",
      "19Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "6.1: Side Effects\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 322:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 10: Side effects with MMA drugs – headache, vomiting\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 323:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Common side effects experienced with MMA are:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"normal_variations\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Common side effects experienced with MMA are:\n",
      "a)\t Gastrointestinal\tside\teffects\t\n",
      "b)\t Fever,\twarmth\tand\tchills\n",
      "c)\t Headache\tand\tdizziness\t\n",
      "• Gastrointestinal Side Effects: Diarrhoea,\t nausea\tand\tvomiting\tare\tcommonly\treported\tby\t\n",
      "women\tfollowing\tthe\tuse\tof\tMisoprostol.\n",
      "These\tside\teffects\tare\tmild\tand\tself-limiting\tand\t\n",
      "pass\toff\twithout\tany\ttreatment.\n",
      "Antiemetic\tand\tanti-diarrhoeal\tmedicines\tmay\tbe\tprescribed\t\n",
      "when\tneeded.\n",
      "ORS\tcan\tbe\tgiven\tif\tvomiting\tor\tdiarrhoea\tis\tsevere.\n",
      "Tab.\tLoperamide\tmay\tbe\t\n",
      "prescribed\tfor\tdiarrhoea.\n",
      "(but\twith\tcaution)\t\n",
      "• Fever, Warmth and Chills: Fever,\t feeling\tof\twarmth\tand\tchills\tare\tshort-lived\tand\tself-\n",
      "limiting\tside\teffects.\n",
      "Treatment\tis\tgenerally\tnot\trequired\tbut\tthe\twoman\tshould\tknow\tthat\t\n",
      "she\tmay\texperience\tthese\tsymptoms.\n",
      "Post-abortion\tinfection\tis\trare\tafter\tMMA.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 324:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Common side effects experienced with MMA are:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Persistent\t\n",
      "fever\t\t(>\t38°C\tfor\ttwo\treadings\tfour\thour\tapart)\tmay\tindicate\tinfection\tand\tmust\tbe\tevaluated\t\n",
      "and\ttreated\taccordingly.\n",
      "6\n",
      "Section\n",
      "Side Effects and Complications \n",
      "with MMA and their Management\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 325:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 10: Side effects with MMA drugs – headache, vomiting\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 326:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Common side effects experienced with MMA are:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\",\n",
      "    \"normal_variations\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"nausea\",\n",
      "      \"vomiting\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Common side effects experienced with MMA are:\n",
      "a. Gastrointestinal side effects\n",
      "b. Fever, warmth, and chills\n",
      "c. Headache and dizziness\n",
      "•\t Gastrointestinal Side Effects: Diarrhoea, nausea and vomiting are commonly reported by women \n",
      "following the use of Misoprostol.\n",
      "These side effects are mild and self-limiting and pass off without \n",
      "any treatment.\n",
      "Antiemetic and anti-diarrhoeal medicines may be prescribed when needed.\n",
      "ORS can \n",
      "be given if vomiting or diarrhoea is severe.\n",
      "•\t Fever, Warmth, and Chills: Fever, feeling of warmth, and chills are short-lived and self-limiting side \n",
      "effects.\n",
      "Treatment is generally not required but the woman should know that she may experience \n",
      "these symptoms.\n",
      "Persistent fever (> 38° C for two readings four hours apart) may indicate infection \n",
      "and must be evaluated and treated accordingly, though post-abortion infection is rare during MMA.\n",
      "•\t Headache and Dizziness: Some women during the process of MMA report \n",
      "headache and dizziness.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 327:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Common side effects experienced with MMA are:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Headache is treated with non-narcotic analgesics \n",
      "and mild dizziness of short duration is managed by hydration.\n",
      "Advise the \n",
      "woman to take plenty of fluids, rest and exercise caution while changing \n",
      "position.\n",
      "29\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "6.2: Safety and Effectiveness \n",
      "Before proceeding with the complications associated with MMA, share with the participants \n",
      "the safety and effectiveness of MMA drugs.\n",
      "Safety\n",
      "Mifepristone and Misoprostol are safe drugs for terminating pregnancy if the woman does not have any \n",
      "contraindications for their use.\n",
      "Effectiveness\n",
      "A combination of Mifepristone and Misoprostol has an effectiveness of 95 – 99% for termination of early \n",
      "pregnancy up to nine weeks.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 328:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Failed Abortion:  Women with continued signs of pregnancy or clinical signs of failed abortion should\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Failed Abortion:  Women with continued signs of pregnancy or clinical signs of failed abortion should \n",
      "be referred to higher centre as expeditiously as possible for further management.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 329:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Referral to higher centre for further appropriate management is needed in cases of:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Referral to higher centre for further appropriate management is needed in cases of:\n",
      "•\tContinuation of pregnancy after administration of MMA drugs\n",
      "•\t Excessive bleeding anytime during the MMA process\n",
      "•\t If abortion process is incomplete at the time of follow up visit \n",
      "6.3: Complications and their Management\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 330:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Potential complications associated with MMA are:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Potential complications associated with MMA are:\n",
      "A. Excessive vaginal bleeding\n",
      "B. Incomplete abortion\n",
      "C. Continuation of pregnancy\n",
      "D. Infection\n",
      "A. Excessive Vaginal Bleeding\n",
      "Soaking two or more thick pads per hour for two consecutive hours need close \n",
      "monitoring of the woman.\n",
      "In this condition, she should report to the facility. \n",
      "Conduct examination, including bimanual examination, to rule out incomplete abortion and assess for \n",
      "hypovolemia. Following should be done in such cases:\n",
      "•\t Fluid replacement: IV infusion with Ringers Lactate solution 30 drops per minute should be started \n",
      "and simultaneous preparation for referral to the higher centre.\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "30\n",
      "B. Incomplete Abortion\n",
      "Generally, these women present with excessive/continued bleeding.\n",
      "Rapid initial assessment of the woman’s vital parameters, haemodynamic stability \n",
      "should be done and proceeded accordingly:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 331:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. If her condition is unstable, resuscitate and stabilize her. Stabilization should be followed by\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "1. If her condition is unstable, resuscitate and stabilize her. Stabilization should be followed by \n",
      "examination and further management accordingly, including referral to the higher centre.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 332:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. If her condition is stable, proceed with the examination:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "2.\n",
      "If her condition is stable, proceed with the examination:\n",
      "a.\n",
      "If POC is felt at the os, manage with digital evacuation.\n",
      "Further treatment will be based on the \n",
      "severity of bleeding and status of her general condition.\n",
      "i.\n",
      "She may be offered an additional dose of Misoprostol (dosage given below) provided \n",
      "bleeding is not heavy:\n",
      " Misoprostol 600 mcg oral or 400 mcg sublingual can be repeated in such cases of \n",
      "incomplete abortion.\n",
      "ii.\n",
      "If bleeding continues even after an additional dose of Misoprostol, she should be referred to \n",
      "higher centre for further management.\n",
      "iii.\n",
      "If bleeding is controlled and general condition improves, she may be treated conservatively \n",
      "at the same facility and discharged when appropriate.\n",
      "b.\n",
      "If no products are felt at the os, decide the line of management based on the clinical symptoms, \n",
      "pelvic examination, and USG findings:\n",
      "i.\n",
      "If the gestation sac is visible but is non-viable, then an additional dose of Misoprostol \n",
      "(dosage given above) may be offered to the woman.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 333:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. If her condition is stable, proceed with the examination:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Wait for the products of conception \n",
      "to be expelled with time.\n",
      "The woman should be counselled to return to the clinic after one \n",
      "week to ensure that the abortion is complete.\n",
      "If bleeding continues even after an additional dose of Misoprostol, she should be referred to \n",
      "higher centre for further management.\n",
      "ii.\n",
      "If no gestation sac is visible on USG but bleeding continues due to decidual bits in the \n",
      "uterine cavity, manage conservatively, without any medication or intervention as these are \n",
      "expelled spontaneously in most cases.\n",
      "An additional visit after seven days will have to be \n",
      "planned to ensure completion of the process.\n",
      "If bleeding is profuse at any time during this process, she should be referred to higher centre \n",
      "for further management.\n",
      "iii.\n",
      "If USG shows viable gestation sac, refer the woman to higher centre for vacuum aspiration.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 334:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. If her condition is stable, proceed with the examination:\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "31\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "Chart 2: Flow chart for Treatment of Incomplete Abortion\n",
      "C.  Continuation of Pregnancy\n",
      "If the pregnancy continues despite taking drugs for MMA, it indicates that the drugs were ineffective.\n",
      "In \n",
      "such cases, refer the woman to higher centre for pregnancy termination by Vacuum Aspiration in view \n",
      "of the teratogenic effect of the drugs4. \n",
      "4 Data on continuing pregnancy after Mifepristone exposure without Misoprostol are limited.\n",
      "The association between Misoprostol \n",
      "and congenital anomalies is better established.\n",
      "The most typical malformations associated with Misoprostol use are Möbius \n",
      "syndrome, a rare disorder of cranial nerve palsies associated with limb anomalies and craniofacial defects, and terminal transverse \n",
      "limb defects.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 335:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. If her condition is stable, proceed with the examination:\",\n",
      "  \"chunk_index\": 3,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Check vital signs \n",
      "•\t Ensure patent airway\n",
      "•\t Oxygen 0-5 lit/min, through \n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 336:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. If her condition is stable, proceed with the examination:\",\n",
      "  \"chunk_index\": 4,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "•\t Oxytocin\n",
      "•\t Antibiotics\n",
      "\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 337:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. If her condition is stable, proceed with the examination:\",\n",
      "  \"chunk_index\": 5,\n",
      "  \"total_chunks_in_section\": 6,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Although not clearly established, the proposed mechanism is vascular disruption due to uterine contractions leading \n",
      "to disordered fetal development\n",
      "Refer to \n",
      "higher centre\n",
      "Resuscitative Measures\n",
      "•\t Check vital signs \n",
      "•\t Ensure patent airway\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 338:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Unstable Condition\n",
      "Refer to higher centre\n",
      "Stable Condition: Proceed with \n",
      "examination\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 339:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"POC at the os No POC at the os :\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "POC at the os No POC at the os : \n",
      "Pelvic examination, USG\n",
      "Non-viable\n",
      "pregnancy\n",
      "Viable pregnancyDigital \n",
      "evacuation; \n",
      "Additional \n",
      "Misoprostol \n",
      "dose;\n",
      "Discharge/\n",
      "refer,\n",
      "Based on her \n",
      "condition\n",
      "Additional dose \n",
      "of Misoprostol; \n",
      "FU after 7 days\n",
      "Treat \n",
      "conservatively; \n",
      "FU after 7 days\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 340:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Presenting Symptoms:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Presenting Symptoms: \n",
      "•\t Continued bleeding \n",
      "•\t Excessive bleeding\n",
      "•\t With/without pain abdomen\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "32\n",
      "D.  Infection\n",
      "Infection of uterus is uncommon if all precautions are followed.\n",
      "If the woman has symptoms such as \n",
      "fever, chills, foul-smelling discharge, or bleeding and pain in lower abdomen, uterine infection may be \n",
      "suspected.\n",
      "Start broad spectrum antibiotics as soon as possible and refer her to the higher centre for \n",
      "further management, if required.\n",
      "The recommended antibiotics are Doxycycline 100 mg, twice a day \n",
      "for five days for non-lactating women, and Azithromycin 500 mg, once a day for three days for lactating \n",
      "women.\n",
      "6.4: Warning Symptoms and Signs\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 341:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "The warning symptoms and signs during the MMA process, for which she should immediately contact \n",
      "the service provider or facility should be explained to the woman.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 342:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Signs and symptoms are as below:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Signs and symptoms are as below:\n",
      "•\tExcessive bleeding, soaking two thick pads in an hour for two consecutive hours\n",
      "•\t Persistent severe pain abdomen, not relieved by analgesics\n",
      "•\t Fever\n",
      "•\t Foul smelling discharge\n",
      "•\t Fainting attacks\n",
      "•\t No/minimal bleeding even 24 hours after the administration of Misoprostol\n",
      "•\t No periods after six weeks of the completion of MMA process\n",
      "\n",
      "33\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "7 Comparison: V A and MMA Procedure\n",
      "Share with the participants the comparative features of the medical and surgical methods of abortion.\n",
      "Though, both vacuum aspiration as well as medical methods are safe technologies, both have their \n",
      "distinct features.\n",
      "Key features are enumerated below:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 343:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"table\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9,\n",
      "      12\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false,\n",
      "  \"parent_section_path\": []\n",
      "}\n",
      "----------------------------------------\n",
      "Table 8: Comparison of VA and MMA   \n",
      "Feature Vacuum Aspiration Medical Methods\n",
      "Technique used Uterine contents evacuated \n",
      "through a cannula attached to \n",
      "electric/manual vacuum source\n",
      "Expulsion of uterine contents \n",
      "with drugs – Mifepristone and \n",
      "Misoprostol\n",
      "Gestation limit for the \n",
      "technology\n",
      "Can be used upto 12 weeks Can be used upto 9 weeks\n",
      "Effectiveness More than 98% 95-99%\n",
      "Time taken for the procedure \n",
      "completion\n",
      "5-15 minutes May take 8 – 13 days\n",
      "POC check Possible and helpful in ensuring \n",
      "completion\n",
      "May not be possible since \n",
      "passed at home\n",
      "Mandatory number of visits for \n",
      "the procedure\n",
      "One Three (two visits in case \n",
      "of home administration of \n",
      "Misoprostol on provider’s \n",
      "discretion)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 344:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Post procedure pain Moderate but remains for a \n",
      "short time\n",
      "Intense for few hours during the \n",
      "actual expulsion of the POCs\n",
      "Risk of cervical and uterine \n",
      "injury\n",
      "Exists, not very common Does not exist\n",
      "Risk of foetal malformation if \n",
      "the pregnancy continues\n",
      "No Ye s\n",
      "Procedure done by RMP , as under the MTP Act RMP , as under the MTP Act\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 345:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Acceptability to woman Done as a day care procedure\n",
      "Awake during the procedure\n",
      "Non-invasive process;\n",
      "More private;\n",
      "Close to natural miscarriage;\n",
      "No hospitalization\n",
      "5Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\n",
      "3.1: Indications for MMA\n",
      "Option\tfor\tMMA\tshould\tbe\tgiven\tto\tall\twomen\tcoming\tto\ta\thealth\tfacility\tseeking\ttermination\tof\t\n",
      "pregnancy\tup\tto\t7\tweeks\tof\tgestation\t(49\tdays\tfrom\tthe\tfirst\tday\tof\tthe\tlast\tmenstrual\tperiod\tin\t\n",
      "women\twith\tregular\tcycles\tof\tapproximately\t28\tdays)1\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 346:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Figure 1: MMA Drugs (Mifepristone and Misoprostol)\n",
      "3.2: Contraindications for MMA\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 347:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Women being prescribed MMA should be screened for the following common contraindications:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\",\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [\n",
      "      \"anaemia\",\n",
      "      \"hypertension\"\n",
      "    ],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": [\n",
      "      \"bp\"\n",
      "    ]\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "Women being prescribed MMA should be screened for the following common contraindications:\n",
      "•\t Anaemia\t(haemoglobin\t<8\tgm\t%)\n",
      "•\t Confirmed\tor\tsuspected\tectopic\tpregnancy/undiagnosed\tadnexal\tmass\n",
      "•\t Uncontrolled\thypertension\tor\tBP\t>\t160/100\tmm\tHg\n",
      "3\n",
      "Section\n",
      "Indications/Contraindications \n",
      "for MMA\n",
      "1\tIn\tDecember\t2008,\tCombipack\twith\tMifepristone+\tMisoprostol\t(1\ttablet\tof\tMifepristone\t200mg\tand\t4\ttablets\tof\tMisoprostol\t200mcg\t\n",
      "each)\twas\tapproved\tby\tthe\tCentral\tDrugs\tStandard\tControl\tOrganization,\tDirectorate\tGeneral\tof\tHealth\tServices,\tIndia,\tfor\tthe\t\n",
      "termination\tof\tintra-uterine\tpregnancy\tfor\tup\tto\t63\tdays/9\tweeks\tgestation.\n",
      "CAC\tTraining\t&\tService\tDelivery\tGuidelines,\t2010\tby\tMoHFW,\tGoI\trecommends\tits\tuse\tup\tto\t49\tdays\tin\tpublic\tsector\tsites,\tin\tline\t\n",
      "with\tthe\tMTP\tRules\t2003.\n",
      "A\tproposed\tamendment\tto\tthe\tMTP\tAct,\t1971,\tto\tincrease\tthe\tgestation\tlimit\tfor\tMMA\tto\t9\tweeks\tin\tpublic\tsector\tsites\tis\tunder\tprocess.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 348:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Women being prescribed MMA should be screened for the following common contraindications:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      9,\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Till\tthe\tproposal\tis\tapproved,\tMMA\tin\tpublic\thealth\tfacility\twould\tbe\tallowed\tonly\tup\tto\t7\tweeks.\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "34\n",
      "8 Schedule for MMA Trainings\n",
      "This training is provided to the MBBS doctors to make them eligible to provide abortion services upto 9 \n",
      "weeks gestation period by MMA only.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 349:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Women being prescribed MMA should be screened for the following common contraindications:\",\n",
      "  \"chunk_index\": 2,\n",
      "  \"total_chunks_in_section\": 3,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\",\n",
      "      \"screening\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Agenda for MMA Trainings\n",
      "Time Session\n",
      "9.30 am - 10.00 am Registration & Pre-test\n",
      "10.00 am - 10.30 am Introduction \n",
      "Goal & Objectives \n",
      "10.30 am - 11.30 am Overview of Medical Methods of Abortion\n",
      "11.30 am - 12.30 pm Clinical Assessment and Eligibility Screening for MMA\n",
      "12.30 pm - 1.30 pm Lunch\n",
      "1.30 pm - 3.00 pm Counselling Skills for MMA & Practice\n",
      "3.00 pm - 3.15 pm Tea\n",
      "3.15 pm - 4.30 pm MTP Act & Rules related to MMA\n",
      "Documentation Formats\n",
      "4.30 pm Evaluation and Planning for next day\n",
      "Time Session\n",
      "9.00 am - 12.00 pm Hands on Practice on Live Cases: \n",
      "Eligibility Screening; Counselling; Documentation\n",
      "12.00 pm - 12.15 pm Tea\n",
      "12.15 pm - 1.00 pm Dealing with Expected Side-effects of MMA Drugs\n",
      "1.00 pm - 2.00 pm Lunch\n",
      "2.00 pm - 3.00 pm Potential Complications with MMA and their Management\n",
      "3.00 pm - 3.15 pm Tea\n",
      "3.15 pm - 4.00 pm Operationalization of MMA Services at Facilities\n",
      "Time Session\n",
      "9.00 am - 12.00 pm Hands on Practice on Live Cases: \n",
      "Eligibility Screening; Counselling; Documentation\n",
      "12.00 pm - 12.15 pm Tea\n",
      "12.15 pm - 1.30 pm Post-abortion Contraception with MMA\n",
      "1.30 pm - 2.30 pm Lunch\n",
      "2.30 pm - 3.00 pm Post - test\n",
      "Training Evaluation\n",
      "3.00 pm - 4.00 pm Next Steps & Valedictory \n",
      "Day 1:\n",
      "Day 2:\n",
      "Day 3:\n",
      "\n",
      "35\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "References\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 350:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. MTP (Amendment) Act, 2021; MTP (Amendment) Rules, 2021\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. MTP (Amendment) Act, 2021; MTP (Amendment) Rules, 2021\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 351:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Comprehensive Abortion Care Training and Service Delivery Guidelines, MoHFW , Government\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"delivery\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"delivery\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Comprehensive Abortion Care Training and Service Delivery Guidelines, MoHFW , Government \n",
      "of India. 2018\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 352:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Medical Management of Abortion. Geneva: World Health Organization. 2018\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Medical Management of Abortion. Geneva: World Health Organization. 2018\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 353:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. Post Abortion Family Planning Technical Update. Family Planning Division, MoHFW ,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. Post Abortion Family Planning Technical Update. Family Planning Division, MoHFW , \n",
      "Government of India. 2016\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 354:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Clinical Practice Handbook for Safe Abortions. Geneva: World Health Orgnization. 2014\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Clinical Practice Handbook for Safe Abortions. Geneva: World Health Orgnization. 2014\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 355:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. ACOG: Medication Abortion upto 70 days of Gestation. 2014\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6. ACOG: Medication Abortion upto 70 days of Gestation. 2014\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 356:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"7. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "7. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health \n",
      "Orgnization. 2012\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 357:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"8. Shagufta Praveen et al: Comparison of sublingual, vaginal, and oral Misoprostol in cervical\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": [\n",
      "      \"first\"\n",
      "    ]\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "8. Shagufta Praveen et al: Comparison of sublingual, vaginal, and oral Misoprostol in cervical \n",
      "ripening for first trimester abortion. Indian J Pharmacol. 2011 Apr; 43(2): 172–175\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 358:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"9. Guidelines for Early Medical Abortion in India using Mifepristone and Misoprostol. MoHFW ,\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "9. Guidelines for Early Medical Abortion in India using Mifepristone and Misoprostol. MoHFW , \n",
      "WHO CCR in Human Reproduction, AIIMS Delhi. 2007\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 359:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"10. Tang et al, Int J Gynecol Obste (2007), 99 S160 \\u2013 S167\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "10. Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "36\n",
      "Annexure – 1 Medical Methods of Abortion: Counselling  \n",
      "Skills Checklist\n",
      "Day 1: Skills required during first visit to clinic/facility\n",
      "(Mifepristone administration)\n",
      "Ye s No\n",
      "Greets the woman in a friendly, respectful manner; ensures privacy\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 360:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Confirms with her that she wants to terminate her pregnancy\n",
      "Explains what to expect during the visit\n",
      "Asks if she came with someone and if she would like that person to join her in \n",
      "the counselling\n",
      "Asks about her general health, reproductive and medical history\n",
      "Explains various abortion methods available, including their characteristics, \n",
      "effectiveness and the visits required\n",
      "Explores her views on abortion options and which abortion method is the best \n",
      "for her\n",
      "If the woman chooses medical methods of abortion provides more information \n",
      "on the method in simple terms\n",
      "Confirms that she is eligible for medical methods of abortion (pregnancy upto \n",
      "nine weeks)\n",
      "Clarifies the woman’s feelings on the possibility of having the abortion at home \n",
      "and asks what support she has at home\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 361:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Ensures that she understands:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\",\n",
      "    \"warning_signs\",\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Ensures that she understands:\n",
      "•\t Common side effects and symptoms during the process\n",
      "•\t Importance of attending required clinic visits\n",
      "•\t Warning signs indicating the need to return to the clinic\n",
      "Explains how Mifepristone and Misoprostol will be administered and what to \n",
      "expect after taking them\n",
      "Explains that if the medical method of abortion fails, vacuum aspiration will be \n",
      "necessary to terminate the pregnancy at the higher centre\n",
      "Discusses various contraceptive methods and helps her to choose one\n",
      "Asks the woman whether she has additional questions\n",
      "Obtains written\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 362:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Ensures that she understands:\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "informed consent\n",
      "Provides Mifepristone 1 tablet 200 mg orally\n",
      "Explains how to take pain management medication (analgesics)\n",
      "Explains how to record the side effects experienced, if any, on the MMA card\n",
      "Explains what to do in case of problems/emergency\n",
      "Gives the woman the address and telephone number of the clinic where she \n",
      "may go in case of an emergency\n",
      "Asks her to return to the clinic for the second dose after two days\n",
      "\n",
      "37\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "Day 3:\n",
      "Skills required during second visit to clinic/facility\n",
      "(Misoprostol administration)\n",
      "Ye s No\n",
      "Greets the woman in a friendly, respectful manner; ensures privacy\n",
      "Enquires about her experience after taking Mifepristone (bleeding, passage of \n",
      "POC, discomfort, side effects)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 363:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"warning\",\n",
      "  \"topics\": [\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [\n",
      "      7\n",
      "    ],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": true,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Checks the MMA card\n",
      "Explains what to expect during this visit\n",
      "Administers Misoprostol in clinic (per protocol) four tablets:\n",
      "sublingual/buccal/vaginal.\n",
      "Oral route may be used if pregnancy < 7 weeks\n",
      "Asks the woman to rest in the clinic for four hours\n",
      "Observes the woman in the clinic for bleeding, cramping, expulsion of POC\n",
      "If the woman leaves the clinic before she aborts, give her instructions and sup-\n",
      "plies (pain medication, written instructions) for process at home\n",
      "Explains how to record her experience of any side effect on the MMA card and \n",
      "reminds her of the address and contact number of the clinic to visit in case of \n",
      "an emergency\n",
      "Records the date of Misoprostol administration and counsels the woman to \n",
      "come for a follow-up visit on Day 15\n",
      "Reviews after-care instructions and provides information on warning signs \n",
      "which indicate the need to return to the clinic or seek medical assistance\n",
      "Asks the woman if she has any additional questions and clarifies them\n",
      "Day 15:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 364:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 1,\n",
      "  \"total_chunks_in_section\": 2,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Skills required during third visit to clinic/facility (follow up)Ye s No\n",
      "Greets the woman in a friendly, respectful manner; ensures privacy\n",
      "Enquires about her experience of the abortion process, expulsion of POC and if \n",
      "she feels that the abortion is complete\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 365:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"maternal_changes\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Asks whether she is still having symptoms of pregnancy\n",
      "Explains what to expect during this follow-up visit\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 366:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Assesses the completeness of the abortion by:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"ultrasound\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Assesses the completeness of the abortion by:\n",
      "•\t Taking a history of the abortion process (amount and duration of bleeding, \n",
      "side effects, cramping, any POC expelled)\n",
      "•\t Conducting a physical examination (pelvic examination to assess the size \n",
      "and consistency of the uterus and opening of the cervical os)\n",
      "•\t Advising/performing an ultrasound for the presence of gestation sac, if it is \n",
      "still unclear whether the abortion is complete\n",
      "If the abortion is not complete, discusses treatment options:\n",
      "expectant management, additional Misoprostol administration or referral to \n",
      "higher centre\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 367:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"If the pregnancy is continuing:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "If the pregnancy is continuing:\n",
      "•\t Discusses need for vacuum aspiration to terminate it at the higher centre\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 368:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"If the abortion is complete:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\",\n",
      "    \"warning_signs\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "If the abortion is complete:\n",
      "•\tProvides information about return to fertility\n",
      "•\t Explains risks of repeated induced abortions\n",
      "•\t Counsels regarding contraceptive methods if not already chosen by her\n",
      "Asks the woman if she has any additional questions and clarifies them\n",
      "Tells her that she can come back to the clinic/facility whenever she has any \n",
      "problem\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "38\n",
      "Annexure – 2 Essential Equipment, Instruments, Drugs and \n",
      "Consumables Required for MMA\n",
      "S. \n",
      "No.\n",
      "Item PHC/non FRU \n",
      "CHC FRU/SDH DH/MCH Remarks\n",
      "(5, 10, 20 cases)\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 369:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. Equipment\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. Equipment\n",
      "1.1 Examination table 1 1 2\n",
      "1.2 Screen for privacy 1 1 2\n",
      "1.3 Footstep 1 1 2\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 370:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. Instruments\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. Instruments\n",
      "2.1 Cusco’s speculum \n",
      "(large, medium)4 6 10\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 371:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. Drugs\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. Drugs\n",
      "3.1 Tab Mifepristone 10 20 30\n",
      "3.2 Tab Misoprostol 44 90 140\n",
      "3.3 Tab Ibuprofen 30 60 120\n",
      "3.4 Tab Doxycycline 20 40 80\n",
      "3.5 Cap Azithromycin 12 24 48\n",
      "3.6 Inj Oxytocin 10 20 30\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 372:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. I/V Fluids\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"normal_variations\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. I/V Fluids\n",
      "4.1 Ringer Lactate 4 8 12\n",
      "4.2 Normal Saline 2 4 6\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 373:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. Consumables\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "5. Consumables\n",
      "5.1 Examination gloves 25 50 100\n",
      "5.2 Utility gloves 1 1 2\n",
      "5.3 Gauze (packets) 2 3 4\n",
      "5.4 I/V set 2 3 4\n",
      "5.5 I/V cannula 2 3 4\n",
      "5.6 2 ml and 5 ml syringes 10 20 40\n",
      "5.7 Povidone Iodine \n",
      "Solution 2 3 4\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 374:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Sterilization\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"medical_tests\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [\n",
      "      \"test\"\n",
      "    ],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6. Sterilization \n",
      "equipment\n",
      "6.1 Autoclave 1 1 1\n",
      "6.2 Boiler 1 1 1\n",
      "\n",
      "39\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "Annexure – 3 MMA Card\n",
      ":\n",
      "V-2\n",
      "Rp-2 / Aug 08, 2016\n",
      "thick\n",
      ":\n",
      ":\n",
      "V-2\n",
      "Rp-2 / Aug 08, 2016\n",
      "thick\n",
      ":\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "40\n",
      "Medical Methods of Abortion Training\n",
      "Post-test Questionnaire\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 375:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name:  ......................................................................................................................................................................\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name:  ......................................................................................................................................................................\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 376:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Name of training centre: ........................................................................................................................................\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Name of training centre: ........................................................................................................................................\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 377:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Dates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\n",
      "Please put a tick under `True’ or `False’ for the following statements:\n",
      "S.No. Statement    True False\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 378:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"1. MMA is a safe and effective method to terminate early\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "1. MMA is a safe and effective method to terminate early \n",
      "pregnancy upto 63 days.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 379:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"2. MMA may adversely affect the woman\\u2019s future fertility.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "2. MMA may adversely affect the woman’s future fertility.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 380:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"3. A physical examination of the woman is not required to provide\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "3. A physical examination of the woman is not required to provide \n",
      "MMA services.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 381:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"4. A written consent of the woman seeking medical methods of\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "4. A written consent of the woman seeking medical methods of \n",
      "abortion is mandatory on the prescribed format.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 382:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"5. A minimum of four visits are recommended to complete the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "5. A minimum of four visits are recommended to complete the \n",
      "standard MMA drug protocol.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 383:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"6. Only a Registered Medical Practitioner, as under the MTP Act\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "6. Only a Registered Medical Practitioner, as under the MTP Act \n",
      "can prescribe MMA drugs.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 384:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"7. Fertility can return within 10 days of an abortion.\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "7. Fertility can return within 10 days of an abortion.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 385:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"8. Most of the contraceptive methods can be started during the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "8. Most of the contraceptive methods can be started during the \n",
      "process of MMA after confirming their eligibility.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 386:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"9. MMA drugs can cause congenital anomalies if pregnancy\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "9. MMA drugs can cause congenital anomalies if pregnancy \n",
      "continues after their intake.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 387:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"10. A woman should be within accessible limits of a health facility\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "10. A woman should be within accessible limits of a health facility \n",
      "during the MMA process.\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 388:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"Please encircle the correct answer in the following questions:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "Please encircle the correct answer in the following questions:\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 389:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"11. Which of the following is recommended for pain management during MMA?\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "11. Which of the following is recommended for pain management during MMA?\n",
      "a. Tablet Paracetamol\n",
      "b. Tablet Ibuprofen \n",
      "c. Injection Diazepam\n",
      "d. Paracervical block\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 390:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"12. Which of the following is the LEAST effective route for Misoprostol administration during the\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "12. Which of the following is the LEAST effective route for Misoprostol administration during the \n",
      "MMA process?\n",
      "a. Sublingual\n",
      "b. Vaginal\n",
      "c. Oral\n",
      "d. Buccal\n",
      "\n",
      "41\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 391:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\n",
      "a. Combined Oral Contraceptive pills\n",
      "b. Centchroman \n",
      "c. IUCD\n",
      "d. Injectables\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 392:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"14. Way to manage an incomplete abortion during the process of MMA is:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"general_text\",\n",
      "  \"topics\": [\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": false\n",
      "}\n",
      "----------------------------------------\n",
      "14. Way to manage an incomplete abortion during the process of MMA is:\n",
      "a. Vacuum Aspiration\n",
      "b. Repeat dose of Misoprostol\n",
      "c. Either of the above two depending on the severity of bleeding\n",
      "----------------------------------------\n",
      "\n",
      "CHUNK 393:\n",
      "Metadata: {\n",
      "  \"title\": \"\",\n",
      "  \"document_type\": \"\",\n",
      "  \"source\": \"Training_Manual_for_Medical_Methods_of_Abortion_(MMA)_in_Early_Gestation.pdf\",\n",
      "  \"section_title\": \"15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\",\n",
      "  \"chunk_index\": 0,\n",
      "  \"total_chunks_in_section\": 1,\n",
      "  \"chunk_type\": \"recommendation\",\n",
      "  \"topics\": [\n",
      "    \"fetal_development\",\n",
      "    \"nutrition\"\n",
      "  ],\n",
      "  \"pregnancy_stages\": {\n",
      "    \"weeks\": [],\n",
      "    \"months\": [],\n",
      "    \"trimesters\": []\n",
      "  },\n",
      "  \"medical_entities\": {\n",
      "    \"conditions\": [],\n",
      "    \"medications\": [],\n",
      "    \"procedures\": [],\n",
      "    \"measurements\": []\n",
      "  },\n",
      "  \"contains_warning\": false,\n",
      "  \"contains_recommendation\": true\n",
      "}\n",
      "----------------------------------------\n",
      "15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\n",
      "a. Y es, additional dose can be tried\n",
      "b. No, woman should be referred to higher centre for pregnancy termination with Vacuum \n",
      "Aspiration\n",
      "c. Pregnancy should be continued\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "42\n",
      "Notes\n",
      "\n",
      "\n",
      "\n",
      "Training Manual\n",
      "For MMA in Early Gestation\n",
      "44\n",
      "The Ministry of Health and Family Welfare acknowledges the support of Ipas Development \n",
      "Foundation in circulation of the manual on Medical Methods of Abortion as part of its ongoing \n",
      "efforts to improve the quality of comprehensive abortion care services for women in India.\n",
      "----------------------------------------\n"
     ]
    }
   ],
   "source": [
    "h_chunks = [{\"content\": doc.page_content, \"metadata\": doc.metadata} for doc in documents]\n",
    "    \n",
    "    # Visualize results\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "print(\"HIERARCHICAL CHUNKING OUTPUT\")\n",
    "print(\"=\"*80)\n",
    "for i, chunk in enumerate(h_chunks):\n",
    "    print(f\"\\nCHUNK {i+1}:\")\n",
    "    print(f\"Metadata: {json.dumps(chunk['metadata'], indent=2)}\")\n",
    "    print(\"-\"*40)\n",
    "    print(chunk[\"content\"])\n",
    "    print(\"-\"*40)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='i\\nTraining Manual\\nFor MMA in Early Gestation\\nTRAINING MANUAL\\nFor Medical Methods of Abortion (MMA)\\nin Early Gestation  \\nTraining Manual\\nFor MMA in Early Gestation\\nTRAINING MANUAL\\nFor Medical Methods of Abortion (MMA)\\nin Early Gestation\\nJULY 2022  \\nTraining Manual\\nFor MMA in Early Gestation\\ni\\nHealthy Village, Healthy Nation  \\nDR. SUMITA GHOSH\\nAdditional Commissioner\\nTelefax : 011-23063178\\nE-mail : sumita.ghosh@nic.in  \\nPreface\\nGOVERNMENT OF INDIA\\nMINISTRY OF HEALTH & FAMILY WELFARE\\nNIRMAN BHAVAN, MAULANA AZAD ROAD\\nNEW DELHI - 110011  \\n29’h July, 2022  \\nThe Medical Termination of Pregnancy Act, 1971 has recently been amended and the\\nMedical Termination of Pregnancy (Amendment ) Act, 2021 and the Medical\\nTermination of Pregnancy (Amendment) Rules, 2021 as prescribed under the Act have\\ncome into force. These amendments intend to increase the ambit and access of women\\nseeking legal abortion services for different reasons or indications. This will necessitate a'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='come into force. These amendments intend to increase the ambit and access of women\\nseeking legal abortion services for different reasons or indications. This will necessitate a\\nlarge pool of legal service providers and an increased number of facilities especially for\\nproviding safe and quality abortion services through Medical Methods in early gestation\\nage upto 9 weeks using globally proven technology.\\nFor capacity building of medical officer in Medical Methods of Abortion (MMA) in\\nperipheral facilities, this training manual has been developed in consultation with the\\nexpert group with representatives from the State Governments, Comprehensive\\nAbortion Care Training centres, and Professional/Non -profit organizations. The manual\\nwill be useful to the facilitators/trainers as well as the trainees who undergo this\\ntraining. It covers all aspects of Medical Methods of Abortion  including details about\\nits legal aspect, documentation of services, proper protocol of usage of drugs,'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='training. It covers all aspects of Medical Methods of Abortion  including details about\\nits legal aspect, documentation of services, proper protocol of usage of drugs,\\ncounseling, complication management and post abortion contraception following MMA.\\nAlong with this, a guidance note has been prepared regarding requirement of the\\ntraining centres who will be implementing this training.\\nStates and UTs need to ensure availability of trained Registered Medical Practitioners at\\nCHCs and PHCs along with availability of drugs, so that women needing abortion care are\\nserved at the peripheral facilities with safety, quality, respect and dignity.\\nI am thankful to Dr P. Ashok Babu, Joint Secretary (RCH), MoHFW, for his guidance and\\nkeen engagement in taking forward the operationalization  of MMA trainings. I am also\\nthankful to all the experts contributing towards the development of this manual\\nespecially lpas Development Foundation for taking a leading role in compilation.'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='thankful to all the experts contributing towards the development of this manual\\nespecially lpas Development Foundation for taking a leading role in compilation.\\nI look forward to effective implementation  of amendments and initiation of Medical\\nMethods of Abortion training and thereby significantly address the issue of unsafe\\nabortions in the country.  \\n(Dr. Sumita Ghosh)  \\nTalking about AIDS is taking care of each other  \\nTraining Manual\\nFor MMA in Early Gestation\\niii\\nList of Expert Group Members\\nS. No. Name Designation\\n1. Dr. P . Ashok Babu  Joint Secretary (RCH) Ministry of Health & Family Welfare,\\nGovernment of India.\\n2. Dr. Sumita Ghosh Additional Commissioner Incharge (CH, RBSK, AH, CAC & AD),\\nMinistry of Health & Family Welfare, Government of India.\\n3. Dr. Alok Banerjee Technical Advisor, Parivar Seva Sanstha, New Delhi.\\n4. Dr. Aparna Sharma Additional Professor, Department of Obstetrics & Gynaecology,\\nAll India Institute of Medical Sciences, New Delhi.'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='4. Dr. Aparna Sharma Additional Professor, Department of Obstetrics & Gynaecology,\\nAll India Institute of Medical Sciences, New Delhi.\\n5. Dr. Basab Mukherjee Vice President FOGSI & Consultant Gynaecologist, Woodlands\\nMultispecialty Hospital, Kolkata, West Bengal.\\n6. Dr. Indra Bhati\\nSenior Professor & Ex-Head, Department of Obstetrics &\\nGynaecology, Dr. S N Medical College & Hospital, Jodhpur,\\nRajasthan.\\n7. Dr. Jyotsna Suri Professor & Unit Head, Department of Obstetrics & Gynaecology,\\nVMMC & Safdarjung Hospital, New Delhi.\\n8. Dr. Ojaswini Patel\\nAssociate Professor, Department of Obstetrics & Gynaecology,\\nVSS Institute of Medical Sciences & Research, Burla, Sambalpur,\\nOdisha.\\n9. Dr. Pratima Mittal Consultant & Ex-Professor, Department of Obstetrics &\\nGynaecology, VMMC and Safdarjung Hospital, New Delhi.\\n10. Dr. Pushpa\\nChaudhary\\nTeam Lead, RMNCAH, World Health Organization.\\n11. Dr. Pushpa Nagar\\nSenior Professor & Unit Head, Department of Obstetrics and'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development'], 'contains_warnings': True}, page_content='10. Dr. Pushpa\\nChaudhary\\nTeam Lead, RMNCAH, World Health Organization.\\n11. Dr. Pushpa Nagar\\nSenior Professor & Unit Head, Department of Obstetrics and\\nGynaecology, SMS Medical College & Zanana Hospital, Jaipur,\\nRajasthan.\\n12. Dr. Rathnamala M.\\nDesai\\nPresident FPA India.\\n13. Dr. Sangeeta Batra Chief Technical Officer - Health Systems, Ipas Development\\nFoundation, New Delhi.\\n14. Dr. Saswati Das Sexual & Reproductive Health and Rights Specialist,\\nUnited Nations Population Fund, New Delhi.\\n15. Dr. Savitha C.\\nProfessor & Head, Department of Obstetrics & Gynaecology,\\nBangalore Medical College & Vani Vilas Hospital, Bangalore,\\nKarnataka.\\n16. Dr. Vanita Suri\\nProfessor and Head, Department of Obstetrics and Gynaecology,\\nPost Graduate Institute of Medical Education & Research,\\nChandigarh.\\n17. Ms.  Nidhi Verma Consultant, Comprehensive Abortion Care, Ministry of Health &\\nFamily Welfare, Government of India.  \\nviii\\nTraining Manual  \\nTraining Manual\\nFor MMA in Early Gestation\\nv\\nList of Acronyms'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Family Welfare, Government of India.  \\nviii\\nTraining Manual  \\nTraining Manual\\nFor MMA in Early Gestation\\nv\\nList of Acronyms\\nBP    Blood Pressure\\nCAC    Comprehensive Abortion Care\\nCOC    Combined Oral Contraceptive\\nDLC   District Level Committee\\ngm    gram\\nHb    Haemoglobin\\nMP A                 Medroxy Progesterone Acetate\\nIUCD    Intrauterine Contraceptive Device\\nIV    Intravenous\\nLMP   Last Menstrual Period\\nMBBS   Bachelor of Medicine and Bachelor of Surgery\\nmcg   microgram\\nmg    milligram\\nMMA   Medical Methods of Abortion\\nMTP    Medical Termination of Pregnancy\\nNHM    National Health Mission\\nP/S    Per Speculum\\nP/V    Per Vaginum\\nPOC    Products of Conception\\nRh     Rhesus (Blood group)\\nRMP    Registered Medical Practitioner\\nSRS     Sample Registration Survey\\nUSG    Ultra Sonography\\nVA    Vacuum Aspiration\\nWHO    World Health Organization  \\nTraining Manual\\nFor MMA in Early Gestation\\nx  \\nTraining Manual\\nFor MMA in Early Gestation\\nvii\\nContents\\nPreface\\nList of Expert Group Members'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='VA    Vacuum Aspiration\\nWHO    World Health Organization  \\nTraining Manual\\nFor MMA in Early Gestation\\nx  \\nTraining Manual\\nFor MMA in Early Gestation\\nvii\\nContents\\nPreface\\nList of Expert Group Members\\nList of Acronyms\\nIntroduction to Medical Methods of Abortion\\nMMA Training Pre-test Questionnaire'),\n",
       " Document(metadata={'chapter': '1 Medical Methods of Abortion - An Overview', 'section_path': ['1 Medical Methods of Abortion - An Overview'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='1.1: Advantages and Limitations of MMA'),\n",
       " Document(metadata={'chapter': '2 Law (MTP Act) and MMA', 'section_path': ['2 Law (MTP Act) and MMA'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='2.1: Eligibility of the Provider\\n2.2: Eligibility of the Place\\n2.3: Consent for MMA Procedure\\n2.4: Documentation/Reporting of MMA Procedure'),\n",
       " Document(metadata={'chapter': '3 Indications/Contraindications for MMA', 'section_path': ['3 Indications/Contraindications for MMA'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='3.1: Indications for MMA\\n3.2: Contraindications for MMA\\n3.3: Special Precautions for MMA\\n3.4: Eligibility Checklist for MMA'),\n",
       " Document(metadata={'chapter': '4 About MMA Drugs', 'section_path': ['4 About MMA Drugs'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='4.1: Drugs Used for MMA'),\n",
       " Document(metadata={'chapter': '5 MMA Protocol and Process', 'section_path': ['5 MMA Protocol and Process'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='5.1: Drug Protocol\\n5.2: Process of MMA\\n5.3: Post MMA Contraception\\ni\\niii\\nv\\n1\\n2\\n5\\n5\\n6\\n6\\n6\\n7\\n7\\n13\\n13\\n13\\n14\\n14\\n15\\n15\\n18\\n18\\n18\\n26  \\nTraining Manual\\nFor MMA in Early Gestation\\nviii'),\n",
       " Document(metadata={'chapter': '6 Side Effects and Complications with MMA and their Management', 'section_path': ['6 Side Effects and Complications with MMA and their Management'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='6.1: Side Effects with MMA\\n6.2: Safety and Effectiveness\\n6.3: Complications and their Management\\n6.4: Warning Symptoms and Signs'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section_path': ['8 Schedule for MMA Trainings'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='References\\nAnnexures\\nAnnexure 1: Medical Methods of Abortion Counselling Skill Checklist\\nAnnexure 2: Essential Equipment, Instruments, Drugs, and\\nConsumables  Required for MMA\\nAnnexure 3: MMA Card\\nMMA  Training Post–test Questionnaire\\n28\\n28\\n29\\n29\\n32\\n33\\n34\\n35\\n36\\n36\\n38\\n39\\n40  \\n1\\nTraining Manual\\nFor MMA in Early Gestation\\nIntroduction to\\nMedical Methods of Abortion\\nUnsafe abortions make a significant contribution to maternal morbidity and mortality.\\nAs per SRS 2001 - 03, abortion-related deaths account for nearly 8% of all maternal\\ndeaths in India. Numerous barriers limit access to safe abortion services including\\nshortage and uneven distribution of trained providers; lack of infrastructure at the\\nfacilities; and lack of information about legality and availability of services among\\nwomen and the community.\\nMedical Methods of Abortion (MMA) is one of the safe technologies for abortion\\ncare which offers an opportunity to increase accessibility and availability to abortion'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section_path': ['8 Schedule for MMA Trainings'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='women and the community.\\nMedical Methods of Abortion (MMA) is one of the safe technologies for abortion\\ncare which offers an opportunity to increase accessibility and availability to abortion\\ncare services in early pregnancy. It can be offered at all levels of health care, including\\nprimary levels. It can also be provided on an outpatient basis.\\nMMA is a non-invasive technology and simplifies the requirements of place and\\nequipment as required for Vacuum Aspiration procedures.\\nThis manual explains use of MMA in early pregnancy up to nine weeks, as approved\\nunder the Medical Termination of Pregnancy (Amendment) Rules, 2021.  \\nTraining Manual\\nFor MMA in Early Gestation\\n2\\nMedical Methods of Abortion Training\\nPre-test Questionnaire\\nName:  ......................................................................................................................................................................'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section_path': ['8 Schedule for MMA Trainings'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Pre-test Questionnaire\\nName:  ......................................................................................................................................................................\\nName of training centre: ........................................................................................................................................\\nDates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\\nPlease put a tick under `True’ or `False’ for the following statements:\\nS.No. Statement    True False'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'MMA is a safe and effective method to terminate early', 'section_path': ['8 Schedule for MMA Trainings', 'MMA is a safe and effective method to terminate early'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='pregnancy upto 63 days.\\n2. MMA may adversely affect the woman’s future fertility.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A physical examination of the woman is not required to provide', 'section_path': ['8 Schedule for MMA Trainings', 'A physical examination of the woman is not required to provide'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='MMA services.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A written consent of the woman seeking medical methods of', 'section_path': ['8 Schedule for MMA Trainings', 'A written consent of the woman seeking medical methods of'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='abortion is mandatory on the prescribed format.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A minimum of four visits are recommended to complete the', 'section_path': ['8 Schedule for MMA Trainings', 'A minimum of four visits are recommended to complete the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='standard MMA drug protocol.\\n6. Only a Registered Medical Practitioner, as under the MTP Act\\ncan prescribe MMA drugs.\\n7. Fertility can return within 10 days of an abortion.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Most of the contraceptive methods can be started during the', 'section_path': ['8 Schedule for MMA Trainings', 'Most of the contraceptive methods can be started during the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='process of MMA after confirming their eligibility.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'MMA drugs can cause congenital anomalies if pregnancy', 'section_path': ['8 Schedule for MMA Trainings', 'MMA drugs can cause congenital anomalies if pregnancy'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='continues after their intake.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A woman should be within accessible limits of a health facility', 'section_path': ['8 Schedule for MMA Trainings', 'A woman should be within accessible limits of a health facility'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='during the MMA process.\\nPlease encircle the correct answer in the following questions:\\n11. Which of the following is recommended for pain management during MMA?\\na. Tablet Paracetamol\\nb. Tablet Ibuprofen\\nc. Injection Diazepam\\nd. Paracervical block'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Which of the following is the LEAST effective route for Misoprostol administration during the', 'section_path': ['8 Schedule for MMA Trainings', 'Which of the following is the LEAST effective route for Misoprostol administration during the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='MMA process?\\na. Sublingual\\nb. Vaginal\\nc. Oral\\nd. Buccal  \\n3\\nTraining Manual\\nFor MMA in Early Gestation\\n13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\\na. Combined Oral Contraceptive pills\\nb. Centchroman\\nc. IUCD\\nd. Injectables'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Way to manage an incomplete abortion during the process of MMA is:', 'section_path': ['8 Schedule for MMA Trainings', 'Way to manage an incomplete abortion during the process of MMA is:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='a. Vacuum Aspiration\\nb. Repeat dose of Misoprostol\\nc. Either of the above two depending on the severity of bleeding\\n15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\\na. Y es, additional dose can be tried\\nb. No, woman should be referred to higher centre for pregnancy termination with Vacuum\\nAspiration\\nc. Pregnancy should be continued  \\n5\\nTraining Manual\\nFor MMA in Early Gestation\\n1 Medical Methods of Abortion – An Overview\\nMMA is a non-surgical, non-invasive method for termination of pregnancy by using a combination of\\ndrugs. It provides women with another option for termination of pregnancy besides surgical methods\\nand should be offered in addition to other available safe abortion methods, whenever possible.\\n1.1: Advantages and Limitations of MMA\\nShare with the participants the advantages and limitations of Medical Methods of Abortion.\\nMMA is one of the safe technologies available for pregnancy termination. It is a non-surgical method'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Way to manage an incomplete abortion during the process of MMA is:', 'section_path': ['8 Schedule for MMA Trainings', 'Way to manage an incomplete abortion during the process of MMA is:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Share with the participants the advantages and limitations of Medical Methods of Abortion.\\nMMA is one of the safe technologies available for pregnancy termination. It is a non-surgical method\\nfor early abortions and has both advantages as well as limitations over other methods of pregnancy\\ntermination.\\nAdvantages of MMA\\n1. Abortion can be offered at an early stage of pregnancy upto 9 weeks of gestation, as approved under\\nMTP (Amendment) Rules, 2021.\\n2. Potentially more private, being similar to a natural miscarriage.\\n3. Non-surgical method of abortion, and hence non-invasive.\\n4. No anaesthesia required.\\n5. Limited infrastructure needed, can be offered in settings where vacuum aspiration may not be\\npossible.\\nLimitations of MMA\\n1. Multiple mandatory clinic/facility visits required during the MMA process.\\n2. Bleeding may occur for 8-13 days.\\n3. There may be side effects of the MMA drugs like nausea, vomiting, chills, and dizziness.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Way to manage an incomplete abortion during the process of MMA is:', 'section_path': ['8 Schedule for MMA Trainings', 'Way to manage an incomplete abortion during the process of MMA is:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='2. Bleeding may occur for 8-13 days.\\n3. There may be side effects of the MMA drugs like nausea, vomiting, chills, and dizziness.\\n4. Once MMA drugs are taken, pregnancy should be terminated in case of continuation of that\\npregnancy, since there exists a risk of foetal malformation.  \\nTraining Manual\\nFor MMA in Early Gestation\\n6\\n2 Law (MTP Act) and MMA\\n2.1: Eligibility of the Provider\\nIn case of termination of pregnancy using Mifepristone and Misoprostol, only\\na Registered Medical Practitioner, as defined by the Medical Termination of\\nPregnancy (MTP) Act, can prescribe the drugs.\\n‘Registered Medical Practitioner (RMP)’ means a medical practitioner who possesses any recognized\\nmedical qualification (MBBS) as defined in the Indian Medical Council Act, 1956 (102 of 1956);\\nwhose name has been entered in a State Medical Register; and who has such experience or training in\\nGynaecology and Obstetrics as may be prescribed by Rules under this Act.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Way to manage an incomplete abortion during the process of MMA is:', 'section_path': ['8 Schedule for MMA Trainings', 'Way to manage an incomplete abortion during the process of MMA is:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='whose name has been entered in a State Medical Register; and who has such experience or training in\\nGynaecology and Obstetrics as may be prescribed by Rules under this Act.\\nThe MTP (Amendment) Rules, 2021 require that an RMP should have one or more of the following\\nexperience or training in Gynaecology and Obstetrics to be able to provide MMA:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='established or maintained, or a training institute approved for this purpose, by the Government.\\n2. At least three months experience at any hospital in the practice of Obstetrics and Gynaecology.\\n3. Post–graduate degree or diploma in Obstetrics and Gynaecology.\\n4. Completed six months as House Surgeon in Obstetrics and Gynaecology.\\n5. Assisted an RMP in 25 cases of medical termination of pregnancy of which at least five have been\\nperformed independently in a hospital established or maintained by the Government or a training\\ninstitute approved for this purpose by the Government.\\n2.2: Eligibility of the Place\\nShare with the participants the places from where MMA can be provided, as under the MTP Act.\\nIn accordance with the MTP Act, termination of pregnancy with\\nMMA shall be done at the following places:\\na. A hospital established or maintained by the Government, or\\nb. A place for the time being approved for the purpose of this Act by the Government or a District'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='a. A hospital established or maintained by the Government, or\\nb. A place for the time being approved for the purpose of this Act by the Government or a District\\nLevel Committee (DLC) constituted by the Government, with the Chief Medical Officer or District\\nHealth Officer as the Chairperson of the said Committee, or\\nc. In case of termination of early pregnancy up to nine weeks using Mifepristone and Misoprostol, an\\nRMP as under the MTP Act, can prescribe the drugs at his/her clinic provided he/she has access to\\na place approved for terminating pregnancy under the MTP Act.\\nThe clinic should display a certificate to this effect from the owner of the approved place.  \\n7\\nTraining Manual\\nFor MMA in Early Gestation\\n2.3: Consent for MMA Procedure\\nAny woman 18 years and above can give her own consent for the MMA procedure.\\nFor minors and mentally ill women, consent of the guardian should be taken.\\nGuardian means a person having the care of them.\\n2.4: Documentation/Reporting of MMA Procedure'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='For minors and mentally ill women, consent of the guardian should be taken.\\nGuardian means a person having the care of them.\\n2.4: Documentation/Reporting of MMA Procedure\\nShare with the participants the documentation formats to be completed for MMA procedure,\\nas under the MTP Act.\\nSince MMA comes under the purview of the MTP Act, the documentation is similar to that required\\nfor vacuum aspiration procedure. It is mandatory to fill and record information for abortion cases\\nperformed by MMA in the following forms:\\n1. Form C – Consent Form – this form is completed before initiating the abortion procedure. This is\\nsigned by the woman herself or guardian (in case of minor or mentally ill woman).\\n2. Form I – RMP Opinion Form – this form is used for providing opinion by the RMP for providing\\ninduced abortion services.\\n3. Form II – Monthly Reporting Form – this form is completed by the hospital incharge/owner to\\nreport the total monthly cases to the district authorities.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='induced abortion services.\\n3. Form II – Monthly Reporting Form – this form is completed by the hospital incharge/owner to\\nreport the total monthly cases to the district authorities.\\n4. Form III – Admission Register– this register is used for recording all the induced abortion cases,\\ndone by surgical as well as medical methods.\\nForm C\\n(See rule 9)  \\nI………………………………………………………daughter/wife of……………………………………………………………………………………..\\naged about………………………….years of …………………………………………………………………………………………………..............\\n(here state the permanent address) at present residing at……………………………………………….……………………………..\\ndo hereby give my consent to the termination of my pregnancy at  ………………………………………………………………..\\n.……………………………………………………………………………………(state the name of place where the pregnancy is to be\\nterminated)  \\nPlace:\\nDate:                                 Signature  \\n(To be filled in by guardian where the woman is a mentally ill person or minor)'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='terminated)  \\nPlace:\\nDate:                                 Signature  \\n(To be filled in by guardian where the woman is a mentally ill person or minor)\\nI……………………………………………………………son/ daughter/ wife of ………………………………………………………………………\\naged about………………………………..….years of………………………………………………………………........................................\\n(permanent address)  \\nat present residing at …………………………………..............................................………………………………………………. do\\nhereby give my consent to the termination of the pregnancy of my ward ………………………………………………………\\n……………………………………………………………… who is a minor/ mentally ill person at .……………………………………………\\n…………………………………………………………………………………………………………………(place of termination of pregnancy)  \\nPlace:  \\nDate:                               Signature  \\nTraining Manual\\nFor MMA in Early Gestation\\n8\\nConsent Form (Form C)\\nForm C\\n(See rule 9)  \\nI………………………………………………………daughter/wife of……………………………………………………………………………………..'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Training Manual\\nFor MMA in Early Gestation\\n8\\nConsent Form (Form C)\\nForm C\\n(See rule 9)  \\nI………………………………………………………daughter/wife of……………………………………………………………………………………..\\naged about………………………….years of …………………………………………………………………………………………………..............\\n(here state the permanent address) at present residing at……………………………………………….……………………………..\\ndo hereby give my consent to the termination of my pregnancy at  ………………………………………………………………..\\n.……………………………………………………………………………………(state the name of place where the pregnancy is to be\\nterminated)  \\nPlace:\\nDate:                                 Signature  \\n(To be filled in by guardian where the woman is a mentally ill person or minor)\\nI……………………………………………………………son/ daughter/ wife of ………………………………………………………………………\\naged about………………………………..….years of………………………………………………………………........................................\\n(permanent address)  \\nat present residing at …………………………………..............................................………………………………………………. do'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='(permanent address)  \\nat present residing at …………………………………..............................................………………………………………………. do\\nhereby give my consent to the termination of the pregnancy of my ward ………………………………………………………\\n……………………………………………………………… who is a minor/ mentally ill person at .……………………………………………\\n…………………………………………………………………………………………………………………(place of termination of pregnancy)  \\nPlace:  \\nDate:                               Signature  \\n9\\nTraining Manual\\nFor MMA in Early Gestation\\nRMP Opinion Form (Form I)\\nFORM I\\nRMP Opinion Form\\n(For gestation age upto twenty weeks)\\n[See Regulation 3]\\nI _________________________________________________________________________________\\n(Name and qualifications of the Registered Medical Practitioner in block letters)\\n__________________________________________________________________________________\\n(Full address of the Registered Medical Practitioner)  \\nhereby certify that I am of opinion, formed in good faith, that it is necessary to terminate the'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='(Full address of the Registered Medical Practitioner)  \\nhereby certify that I am of opinion, formed in good faith, that it is necessary to terminate the\\npregnancy of _______________________________________________________________________\\n(Full name of pregnant woman in block letters)\\nresident of_________________________________________________________________________\\n(Full address of pregnant woman in block letters)\\nfor the reasons given below*.  \\nI hereby give intimation that I terminated the pregnancy of the woman referred to above who  bears\\nthe Serial No. ______________________ in the Admission Register of the hospital/approved place.  \\nPlace:\\nDate:\\nSignature of the Registered Medical Practitioner  \\n*of the reasons specified items (a) to (e) write the one which is appropriate:\\na. in order to save the life of the pregnant women,\\nb. in order to prevent grave injury to the physical and mental health of the pregnant woman,'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='a. in order to save the life of the pregnant women,\\nb. in order to prevent grave injury to the physical and mental health of the pregnant woman,\\nc. in view of the substantial risk that if the child was born it would suffer from such physical\\nor mental abnormalities as to be seriously handicapped,\\nd. as the pregnancy is alleged by pregnant woman to have been caused by rape,\\ne. as the pregnancy has occurred as a result of failure of any contraceptive device or methods\\nused by a woman or her partner for the purpose of limiting the number of children  or\\npreventing pregnancy.\\nNote: Account may be taken of the pregnant woman’s actual or reasonably foreseeable environment\\nin determining whether the continuance of her pregnancy would involve a grave injury to her physical\\nor mental health.  \\nPlace:\\nDate:                                                                                                                   Signature of the Registered Medical Practitioner  \\nTraining Manual'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital', 'section_path': ['8 Schedule for MMA Trainings', 'Independently performed ten cases of MMA under the supervision of an RMP in a hospital'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Place:\\nDate:                                                                                                                   Signature of the Registered Medical Practitioner  \\nTraining Manual\\nFor MMA in Early Gestation\\n10\\nMonthly Reporting Form (Form II)\\nFORM II\\n[ Refer Regulation 4(5) ]\\nMonth & Year: ………….…………..….'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='2. Name of Hospital/approved place:\\n3. Duration of pregnancy: (Give total number only under each sub-head)\\n(a) Upto 9 weeks (Medical Methods of Abortion Only):\\n(b) Upto 12 weeks (Surgical Methods of Abortion Only):\\n(c) Between 12-20 weeks:\\n(d) Between 20 -24 weeks:\\n(e) Beyond 24 weeks:  \\n4. Religion of woman: (Give total number under each sub-head)\\n(a) Hindu:\\n(b) Muslim:\\n(c) Christian:\\n(d) Others:  \\n5. Termination with acceptance of contraception: (Give total number under each sub-head)\\n(a) Sterilization:\\n(b) IUCD:\\n(c) OCP/Injectable Contraceptive:\\n(d) Others:  \\n6. Reasons for termination: (Give total number under each sub-head)\\nA. Up to 20 weeks of gestation\\n(a) Danger to the life of the pregnant woman:\\n(b) Grave injury to the physical and mental health of the pregnant woman:\\n(c) Pregnancy caused by rape:\\n(d) Substantial risk that if the child was born, it would suffer from such physical or mental\\nabnormalities as to be seriously handicapped:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='(c) Pregnancy caused by rape:\\n(d) Substantial risk that if the child was born, it would suffer from such physical or mental\\nabnormalities as to be seriously handicapped:\\n(e) Failure of any contraceptive device or method:  \\nB. Between 20-24 weeks of gestation\\n(a) Survivors of Sexual Assault/Rape/Incest:\\n(b) Minors:\\n(c) Change of marital status during the ongoing pregnancy (widowhood and divorce):\\n(d) Women with physical disabilities [major disability as per criteria laid down under the Rights of\\nPersons with Disabilities Act, 2016 (49 of 2016)]:\\n(e) Mentally ill women including mental retardation:\\n(f) The foetal malformation that has substantial risk of being incompatible with life or if the child  is\\nborn it may suffer from such physical or mental abnormalities to be seriously handicapped:\\n(g) Women with pregnancy in humanitarian settings or disasters or emergency situations as declared\\nby Government:  \\nC. Beyond 24 weeks of gestation'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='(g) Women with pregnancy in humanitarian settings or disasters or emergency situations as declared\\nby Government:  \\nC. Beyond 24 weeks of gestation\\n(a) The foetal malformation that has substantial risk of being incompatible with life or if the child is\\nborn it may suffer from such physical or mental abnormalities to be seriously handicapped:  \\nSignature of the Officer In-charge with Date  \\n11\\nTraining Manual\\nFor MMA in Early Gestation\\nAdmission Register (Form III)\\nFORM III\\n[ Refer Regulation 5 ]\\nAdmission Register\\n(To be destroyed on the expiry of five years from the date of the last entry in the Register)  \\nName of Facility: ____________________________________________________      Month ____________________ Year __________  \\nS.\\nNo.\\nDate of\\nAdmission\\nName of\\nthe Patient\\nWife /\\nDaughter\\nof\\nAge Religion Address Duration of\\nPregnancy\\nReasons on\\nwhich\\nPregnancy\\nis\\nterminated\\nDate of\\ntermination\\nof\\nPregnancy\\nDate of\\ndischarge\\nof patient\\nResult &\\nRemarks\\nName of\\nRegistered\\nMedical'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='of\\nAge Religion Address Duration of\\nPregnancy\\nReasons on\\nwhich\\nPregnancy\\nis\\nterminated\\nDate of\\ntermination\\nof\\nPregnancy\\nDate of\\ndischarge\\nof patient\\nResult &\\nRemarks\\nName of\\nRegistered\\nMedical\\nPractitioner(s)\\nby whom the\\nopinion is\\nformed\\n(For pregnancy\\nbeyond 24 weeks\\nmention the\\nnames of\\nMedical Board\\nmembers)\\nName of\\nRegistered\\nMedical\\nPractitioner(s)\\nby whom\\nPregnancy is\\nterminated\\nMethod\\nof MTP  \\n(MVA/\\nEVA/\\nMMA/\\nD&C/\\nOthers)\\nPost Abortion\\nContraception  \\n(Tubal Ligation\\n(TL)/IUCD/\\nOCP/\\nInjectables/\\nOthers/\\nNone)\\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  \\nTraining Manual\\nFor MMA in Early Gestation\\n12\\nFollowing are the key conditions/requirements for MTP using medical methods, as under the MTP Act:\\n• It can be performed only by eligible RMPs as under the MTP (Amendment) Rules, 2021.\\n• It can be performed for gestation age up to nine weeks, at approved sites as well as outdoor clinic of'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='• It can be performed only by eligible RMPs as under the MTP (Amendment) Rules, 2021.\\n• It can be performed for gestation age up to nine weeks, at approved sites as well as outdoor clinic of\\nan RMP with referral linkages, provided a certificate of access to an approved site is displayed at the\\nclinic.\\n• Documentation formats (Form C, I, II, III) are mandatory to be completed for MMA.\\nConfidentiality of the woman is to be fully ensured and her particulars should not be shared with anyone\\nexcept the person authorised by the law.  \\n13\\nTraining Manual\\nFor MMA in Early Gestation\\n3.1: Indications for MMA\\nOption for MMA should be given to all women coming to a health facility seeking termination of\\npregnancy up to nine weeks of gestation (63 days from the first day of the last menstrual period in\\nwomen with regular cycles of approximately 28 days).\\n3.2: Contraindications for MMA\\nMedical methods of abortion is contraindicated in women with:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='women with regular cycles of approximately 28 days).\\n3.2: Contraindications for MMA\\nMedical methods of abortion is contraindicated in women with:\\n• Confirmed or suspected ectopic pregnancy 1 or undiagnosed adnexal mass, as Mifepristone or\\nMisoprostol cannot treat ectopic pregnancy\\n• Anaemia (haemoglobin <8gm %)\\n• Uncontrolled hypertension with BP >160/100mm Hg\\n• Chronic adrenal failure\\n• Severe renal, liver, or respiratory diseases\\n• Uncontrolled seizure disorder\\n• Inherited porphyria\\n• Glaucoma\\n• Allergy or intolerance to Mifepristone/Misoprostol or other prostaglandins\\nWomen with co-morbidities should be referred to higher centres.\\n3 Indications/Contraindications for MMA\\nShare with the participants the indications, contraindications, and situations for\\nspecial precautions for prescribing MMA.\\n1Signs/symptoms during ectopic pregnancy could include:\\n• Lower abdominal pain, usually one-sided, that may be sudden and intense, persistent, or cramping'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='special precautions for prescribing MMA.\\n1Signs/symptoms during ectopic pregnancy could include:\\n• Lower abdominal pain, usually one-sided, that may be sudden and intense, persistent, or cramping\\n• Irregular vaginal bleeding or spotting\\n• Fainting or dizziness that persists for more than a few seconds, possibly indicative of internal bleeding. Internal bleeding is not\\nnecessarily accompanied by vaginal bleeding\\n• Uterine size that is smaller than expected\\n• Palpable adnexal mass\\n• Tender cervical movements\\n• No POC after a vacuum aspiration procedure\\nWhen ectopic pregnancy is suspected, transfer the woman as soon as possible to a facility that can confirm diagnosis and begin\\ntreatment. Ectopic pregnancy can be diagnosed with a careful history, examination, and USG  \\nTraining Manual\\nFor MMA in Early Gestation\\n14\\n3.3: Special Precautions for MMA\\nBesides absolute contraindications, MMA drugs are to be used with caution in the following situations,\\nas given below:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='Training Manual\\nFor MMA in Early Gestation\\n14\\n3.3: Special Precautions for MMA\\nBesides absolute contraindications, MMA drugs are to be used with caution in the following situations,\\nas given below:\\n• Current long-term use of systemic corticosteroids (including those with severe uncontrolled asthma).\\n• Coagulopathy or on anticoagulant therapy.\\n• Pre-existing heart disease or cardiovascular risk factors.\\n• Pregnancy with in-situ intrauterine contraceptive device (IUCD): IUCD must be removed before\\ngiving drugs for abortion.\\n• Pregnancy with fibroid: Women with symptomatic large fibroids encroaching on endometrial cavity\\ncan have heavy bleeding and fibroids may interfere with the uterine contractility.\\n• Pregnancy with uterine scar: Caution should be exercised when MMA is offered to women with a\\nprevious history of caesarean section, hysterotomy or myomectomy.\\n• Bronchial asthma: Misoprostol is a weak bronchodilator and therefore, could be used in women'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='previous history of caesarean section, hysterotomy or myomectomy.\\n• Bronchial asthma: Misoprostol is a weak bronchodilator and therefore, could be used in women\\nwith bronchial asthma. However, prostaglandins other than Misoprostol should not be used.\\n• Use of anti-tubercular drugs: These may decrease the efficacy of MMA drugs.\\n3.4: Eligibility Checklist for MMA\\nGiven below is a quick checklist to assess the eligibility of the woman for MMA. Only if all the answers\\nfrom 1 to 8 are “NO” , proceed with the procedure:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Name of the State:', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['8 Schedule for MMA Trainings', 'Name of the State:'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [2], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 1: Eligibility Checklist\\nEligibility Checklist Ye s No\\n1 Gestation period or uterine size more than 9 weeks\\n2 Suspected or diagnosed ectopic pregnancy or undiagnosed adnexal\\nmass\\n3 History of bleeding disorders or inherited porphyrias\\n4 History of uncontrolled seizure disorder/respiratory/hepatic/renal\\ndisease\\n5 History of allergic reaction to Mifepristone/Misoprostol\\n6 History of uncontrolled hypertension with BP >160/100mm Hg\\n7 History of chronic adrenal failure or glaucoma\\n8 Woman looks anaemic/pale  \\n15\\nTraining Manual\\nFor MMA in Early Gestation\\n4 About MMA Drugs\\nShare with the participants the mechanism of action of the drugs used for MMA.\\n4.1: Drugs Used for MMA\\nRecommended drugs for MMA are Mifepristone and Misoprostol.\\n5Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n3.1: Indications for MMA\\nOptionforMMAshouldbegiventoallwomencomingtoahealthfacilityseekingterminationof\\npregnancyupto7weeksofgestation(49daysfromthefirstdayofthelastmenstrualperiodin\\nwomenwithregularcyclesofapproximately28days)1\\nFigure 1: MMA Drugs (Mifepristone and Misoprostol)\\n3.2: Contraindications for MMA\\nWomen being prescribed MMA should be screened for the following common contraindications:\\n• Anaemia(haemoglobin<8gm%)\\n• Confirmedorsuspectedectopicpregnancy/undiagnosedadnexalmass\\n• UncontrolledhypertensionorBP>160/100mmHg\\n3\\nSection\\nIndications/Contraindications\\nfor MMA\\n1InDecember2008,CombipackwithMifepristone+Misoprostol(1tabletofMifepristone200mgand4tabletsofMisoprostol200mcg\\neach)wasapprovedbytheCentralDrugsStandardControlOrganization,DirectorateGeneralofHealthServices,India,forthe\\nterminationofintra-uterinepregnancyforupto63days/9weeksgestation.\\nCACTraining&ServiceDeliveryGuidelines,2010byMoHFW,GoIrecommendsitsuseupto49daysinpublicsectorsites,inline\\nwiththeMTPRules2003.\\nAproposedamendmenttotheMTPAct,1971,toincreasethegestationlimitforMMAto9weeksinpublicsectorsitesisunderprocess.\\nTilltheproposalisapproved,MMAinpublichealthfacilitywouldbeallowedonlyupto7weeks.\\nFigure 1: MMA Combipack (Mifepristone and Misoprostol)\\nMMA drugs are Schedule H drugs and are to be sold by retail on the prescription of a Registered\\nMedical Practitioner only.\\nMifepristone is an antiprogestin, which blocks the progesterone receptors in the endometrium, causing\\nthe necrosis of uterine lining and detachment of implanted embryo. It causes cervical softening, increases\\nsensitivity of the cervix and uterus to the action of prostaglandins and may initiate uterine contractions\\ntoo. A small percentage of women (3%) may expel products of conception (POC) with Mifepristone\\nalone.\\nMisoprostol is a synthetic prostaglandin E1 analogue. It binds to the myometrial cells and leads to\\ncervical softening and dilatation and uterine contractions. This leads to the expulsion of POC from the\\nuterus. Misoprostol has an advantage over other prostaglandins as it is well absorbed from different routes\\nof administration, is economical, stable at room temperature, and does not cause bronchoconstriction in\\ncomparison to PGF2alpha derivatives.\\nIt was earlier used for prevention and treatment of gastric ulcer.  \\nTraining Manual\\nFor MMA in Early Gestation\\n16\\nDifferent Routes of Misoprostol Administration:\\n1. Sublingual (below the tongue)\\n7Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n4.1: Drugs Used in MMA\\nRecommendeddrugsforMMAareMifepristoneandMisoprostol.\\nMMA drugs are Schedule H drugs and are to be sold by retail on the prescription of a\\nRegistered Medical Practitioner only.\\nMifepristone isanantiprogestin,whichblockstheprogesteronereceptorsintheendometrium,\\ncausingthenecrosisofuterinelininganddetachmentofimplantedembryo.Itcausescervical\\nsofteningandanincreasedproductionofprostaglandins,causinguterinecontractions.Asmall\\npercentageofwomen(3%)mayexpelproductsofconception(POC)withMifepristonealone.\\nMisoprostol isasyntheticprostaglandinE1analogue.Itbindstothemyometrialcells,causing\\nstronguterinecontractions,cervicalsofteninganddilatation.ThisleadstotheexpulsionofPOC\\nfromtheuterus.Misoprostolhasanadvantageoverotherprostaglandinsasitiswellabsorbedfrom\\ndifferentroutesofadministration,iseconomical,andstableatroomtemperaturesincomparison\\ntoPGF2alphaderivatives.\\nItwasearlierusedforpreventionandtreatmentofgastriculcer.\\nAction of Misoprostol through different routes of administration:\\nSublingual: Rapidonsetofaction(likeoralroute)andlongerdurationofaction(likevaginalroute);\\nFigure 2: Sublingual administration of Misoprostol\\n4\\nSection\\nMMA Drugs\\nFigure 2: Sublingual administration of Misoprostol\\n2. Buccal (in the cheeks)\\n8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nBuccal: Onsetanddurationofactionisquitesimilartothevaginalroutealthoughtheserumlevels\\nachievedarelower.\\nFigure 3: Buccal administration of Misoprostol\\nVaginal: Gradualonsetbutlongerdurationandsustainedaction.Misoprostoltabletsonvaginal\\nadministrationmaynotcompletelydissolve.Asthecoreofthetabletisnon-medicated,thisdoes\\nnotaffectitsefficacy.Moisteningthetabletbeforevaginaladministrationdoesnotimproveefficacy\\n(ACOG,2009)\\nFigure 4: Vaginal administration of Misoprostol\\nOral: Rapidonsetbutshorttotaldurationofaction\\nFigure 5: Oral administration of Misoprostol\\nFigure 3: Buccal administration of Misoprostol'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Vaginal', 'section_path': ['8 Schedule for MMA Trainings', 'Vaginal'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nBuccal: Onsetanddurationofactionisquitesimilartothevaginalroutealthoughtheserumlevels\\nachievedarelower.\\nFigure 3: Buccal administration of Misoprostol\\nVaginal: Gradualonsetbutlongerdurationandsustainedaction.Misoprostoltabletsonvaginal\\nadministrationmaynotcompletelydissolve.Asthecoreofthetabletisnon-medicated,thisdoes\\nnotaffectitsefficacy.Moisteningthetabletbeforevaginaladministrationdoesnotimproveefficacy\\n(ACOG,2009)\\nFigure 4: Vaginal administration of Misoprostol\\nOral: Rapidonsetbutshorttotaldurationofaction\\nFigure 5: Oral administration of Misoprostol\\nFigure 4: Vaginal administration of Misoprostol  \\n17\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Oral', 'section_path': ['8 Schedule for MMA Trainings', 'Oral'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='8 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nBuccal: Onsetanddurationofactionisquitesimilartothevaginalroutealthoughtheserumlevels\\nachievedarelower.\\nFigure 3: Buccal administration of Misoprostol\\nVaginal: Gradualonsetbutlongerdurationandsustainedaction.Misoprostoltabletsonvaginal\\nadministrationmaynotcompletelydissolve.Asthecoreofthetabletisnon-medicated,thisdoes\\nnotaffectitsefficacy.Moisteningthetabletbeforevaginaladministrationdoesnotimproveefficacy\\n(ACOG,2009)\\nFigure 4: Vaginal administration of Misoprostol\\nOral: Rapidonsetbutshorttotaldurationofaction\\nFigure 5: Oral administration of Misoprostol\\nFigure 5: Oral administration of Misoprostol\\nBelow is the graph with pharmacokinetics of Misoprostol by different routes:\\n9Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nFigure 6: Graph comparing pharmacokinetics of Misoprostol administered by different routes\\n'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Oral', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['8 Schedule for MMA Trainings', 'Oral'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 1: Effectiveness of Misoprostol administered by different routes\\nRoute of\\nAdministration\\nOnset of\\nAction\\nDuration of Action Preferred/Recommended Route\\nSublingual Fastest Highestplasmalevels\\nandprolongedaction\\nMostrecommended\\nBuccal Quick Prolongedaction Recommended\\nVaginal Quick Prolongedaction Recommended\\nOral Quick Leastduration Leastrecommendedbutstillcanbegiven\\nThe table below indicates the effectiveness of Misoprostol when administered by different routes:\\nTable 2: Effectiveness of Misoprostol administered by different routes2\\nFigure 6: Graph comparing pharmacokinetics of Misoprostol administered by different routes\\nRoute of Administration Peak Levels Attained Bioavailability\\nSublingual Rapidly (30 minutes) Long duration (6 hours)\\nVaginal3 Gradually (70-80 minutes) Longest duration (>6 hours)\\nBuccal Gradually (70-80 minutes) Moderate duration (3 hours)\\nOral (only if gestation age is upto 7\\nweeks)\\nRapidly (30 minutes) Short duration (2 hours)\\n2Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167\\n3Moistening the tablet before vaginal administration does not improve efficacy (ACOG, 2009)\\n- Plasma Misoprostol concentration (pg/ml)  \\nTraining Manual\\nFor MMA in Early Gestation\\n18\\n5 MMA Protocol and Process\\nThe steps of the MMA procedure are divided based on the day of visit. Typically, it requires three\\nvisits (Day 1, 3 and 15). 2 nd visit on Day 3 is optional when the woman takes Misoprostol at home, in\\nconsultation with the provider.\\n5.1: Drug Protocol\\nTable 3: MMA Drug Protocol\\nShare with the participants the drug protocol to be used for MMA and the whole process of\\nabortion when performed by MMA.\\nVisit Day Drugs used\\nFirst 1 One  • 200 mg Mifepristone oral;\\n• Anti D 50 mcg, if Rh negative.\\nSecond 3 Three                     • 800 mcg Misoprostol (four tablets of 200 mcg) sublingual/\\nbuccal/vaginal/oral only if < 7 weeks;\\n• Analgesic (Ibuprofen);\\n• Antiemetic;\\n• Offer contraception.\\nThird 15 Fifteen                       • Confirm and ensure completion of abortion;\\n• Offer contraception, if not already done so.\\n5.2: Process of MMA\\nA. First Visit/Day 1/Day of Mifepristone Administration\\nFirst visit starts with assessing the suitability of the woman to undergo medical methods of abortion.\\nSuitability is judged by taking a detailed history, conducting a clinical examination, necessary\\ninvestigations and excluding the contraindications.\\nFirst visit sometimes may not be the day of Mifepristone administration.\\nIt is the day of Mifepristone administration which is taken as Day 1. It is important to ensure that\\nwomen are already well evaluated and counselled, including contraceptive counselling, on Day 1 before\\nadministering Mifepristone.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Detailed History', 'section_path': ['8 Schedule for MMA Trainings', 'Detailed History'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='a. Demographic profile: age, religion, address etc.\\nb. Menstrual history: length and duration of cycle, flow (excess or normal), and LMP  \\n19\\nTraining Manual\\nFor MMA in Early Gestation\\nc. Obstetric history: parity, live births, abortion (induced and spontaneous and if any complications),\\nprevious caesarean section (if any), last childbirth/abortion, and presently lactating or not\\nd. History of pre-existing medical/surgical conditions:\\n• Hypertension\\n• Heart disease\\n• Diabetes mellitus\\n• Epilepsy\\n• Asthma (not a contraindication with PGE1)\\n• Renal disease\\n• Drug allergies including to Mifepristone / Misoprostol\\n• Bleeding disorders\\n• Current medication\\n• Previous uterine/tubal/abdominal surgery/ectopic pregnancy\\n• Treatment for infertility/Tuberculosis/pelvic inflammatory disease\\ne. History of any interference/drugs taken in this pregnancy to attempt termination/bleeding per\\nvaginum\\nf. Contraceptive history: type and duration of contraceptive used'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Detailed History', 'section_path': ['8 Schedule for MMA Trainings', 'Detailed History'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='e. History of any interference/drugs taken in this pregnancy to attempt termination/bleeding per\\nvaginum\\nf. Contraceptive history: type and duration of contraceptive used\\ng. Status of tetanus immunization: last dose received\\nh. Psychosocial assessment: to assess family support\\ni. History of sexual assault and domestic violence\\nEligibility of the woman may be assessed using the `Eligibility Checklist’ given in the Chapter 3:\\nIndications/Contraindications for MMA, section 3.4.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Share with the participants the general and MMA specific counselling points to be\\nconveyed to the woman while counselling for MMA procedure.\\nGeneral Counselling\\nWhile counselling the woman, attention must be paid to the following points:\\nThe counsellor needs to understand with empathy and sensitivity, why abortion is being sought.\\n• Ask about her existing knowledge and beliefs about abortion options.\\n• Tell her about all the methods available for abortion and how each method differs from the other.\\n• Discuss her contraceptive needs and counsel her accordingly for contraception after abortion.\\nInform her about return of fertility within 10 days of an abortion process/procedure.\\n• Discuss infection prevention aspects like local hygiene, handwashing, and use of clean sanitary\\nnapkins, etc.  \\nTraining Manual\\nFor MMA in Early Gestation\\n20\\nMethod-specific Counselling\\nIf the woman chooses MMA, she should be provided the following information:\\na. It is a non-invasive and non-surgical method.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Training Manual\\nFor MMA in Early Gestation\\n20\\nMethod-specific Counselling\\nIf the woman chooses MMA, she should be provided the following information:\\na. It is a non-invasive and non-surgical method.\\nb. However, failure of the method or excessive bleeding (soaking two or more thick pads per hour for\\ntwo consecutive hours) may necessitate further management at a higher centre for vacuum aspiration.\\nc. The process is similar to a natural miscarriage.\\nd. She needs to make a minimum of three visits to the facility (Day 1, 3, and 15). Home administration\\nof Misoprostol is allowed on provider’s discretion. In such cases, the number of facility visits will\\nreduce to two (Day 1, and 15).\\ne. She must follow a definite drug protocol.\\nf. She has option of different routes of Misoprostol administration and would be helped to choose one.\\ng. She should stay within the accessible limits of the appropriate health care facility.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='f. She has option of different routes of Misoprostol administration and would be helped to choose one.\\ng. She should stay within the accessible limits of the appropriate health care facility.\\nh. There could be teratogenic (harmful) effect on the foetus if the method fails and pregnancy continues.\\ni. A small percentage of women (3%) may expel products with Mifepristone alone, but total drug\\nschedule with Misoprostol must be completed.\\nj. During the abortion process, it is ideal to avoid intercourse to prevent infection, or hence use barrier\\nmethods.\\nk. Explain the symptoms that would be experienced by her.\\n12 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nFigure 7: Counselling on MMA procedure\\nMethod-specific Counselling\\nIfthewomanchoosesMMA,sheshouldbeprovidedthefollowinginformation:\\na) Itisanon-invasiveandnon-surgicalmethod\\nb) Theprocessissimilartoanaturalmiscarriage'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Method-specific Counselling\\nIfthewomanchoosesMMA,sheshouldbeprovidedthefollowinginformation:\\na) Itisanon-invasiveandnon-surgicalmethod\\nb) Theprocessissimilartoanaturalmiscarriage\\nc) Sheneedstomakeaminimumofthreevisitstothefacility(day1,3,&15).Homeadministration\\nofMisoprostolisallowedonprovider’sdiscretion.Insuchcases,thenumberoffacilityvisits\\nwillreducetotwo.\\nd) Shehastofollowadefinitedrugprotocol\\ne) Counsellingaboutdifferentroutesofadministration\\nf) ShehastobereadyforVAprocedureincaseoffailureofthemethodorexcessivebleeding\\n(soakingtwoormorethickpadsperhourfortwoconsecutivehours)\\ng) Shehastostaywithintheaccessiblelimitsoftheappropriatehealthcarefacility.Sheshould\\nnotbeleftunattendedathome\\nh) Explainthesymptomsthatwouldbeexperiencedbyher,forexample:\\n• BleedingpervaginumisanessentialpartoftheMMAprocesssinceitissimilarto\\nmiscarriage.Bleedingisusuallyheavierthanwhatisexperiencedduringamenstrual\\nperiod.Bleedingoftenlastsfor8to13days.Soakingoftwothickpadswithinonetotwo'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='miscarriage.Bleedingisusuallyheavierthanwhatisexperiencedduringamenstrual\\nperiod.Bleedingoftenlastsfor8to13days.Soakingoftwothickpadswithinonetotwo\\nhoursaftertakingMisoprostol,butdecreasingovertimeisconsiderednormal.\\n• AbdominalpainisexperiencedasapartoftheMMAprocess.Refrainfromdescribing\\ncramping pain as similar to labour pains. Instead, it can be compared with severe\\nmenstrualcramps.SometimesthepainbeginsfollowingingestionoftabletMifepristone,\\nbutmostoftenitstartsonetothreehoursafterMisoprostoladministrationandisheaviest\\nduringtheactualabortionprocess,oftenlastinguptofourhours.Ifthepainispersistent,\\nthepossibilityofectopicpregnancyshouldalwaysberuledout.\\n• Nausea,vomiting,diarrhoea,etc.arenormalsideeffectsofdrugs.\\ni) Therecouldbeteratogenic(harmful)effectonthefetus,ifpregnancycontinues\\nj) Asmallpercentageofwomen(3%)mayexpelproductswithMifepristonealone,buttotal\\ndrugschedulewithMisoprostolmustbecompleted'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='i) Therecouldbeteratogenic(harmful)effectonthefetus,ifpregnancycontinues\\nj) Asmallpercentageofwomen(3%)mayexpelproductswithMifepristonealone,buttotal\\ndrugschedulewithMisoprostolmustbecompleted\\nk) Duringtheabortionprocess,itisidealtoavoidintercoursetopreventinfection,orusebarrier\\nmethods\\nFigure 7: Counselling on MMA procedure\\nShare with the participants the expected symptoms during the process of MMA.\\nExpected Symptoms during MMA  \\n•Bleeding per vaginum  is an essential part of the MMA process since it is similar to miscarriage.\\nBleeding is usually heavier than what is experienced during a menstrual period. Bleeding often\\nlasts for 8 to 13 days. Soaking of two thick pads within one to two hours after taking Misoprostol,\\nis considered normal, but this should decrease over time. If it happens beyond 4 – 6 hours of taking\\nMisoprostol, the provider/facility should be contacted.\\n• Abdominal pain is experienced as a part of the MMA process. Refrain from describing cramping'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Counselling: General and Method-specific Counselling', 'section_path': ['8 Schedule for MMA Trainings', 'Counselling: General and Method-specific Counselling'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='Misoprostol, the provider/facility should be contacted.\\n• Abdominal pain is experienced as a part of the MMA process. Refrain from describing cramping\\npain like labour pains. Instead, it can be compared with severe menstrual cramps. Sometimes the\\npain begins following ingestion of tablet Mifepristone, but most often it starts after Misoprostol  \\n21\\nTraining Manual\\nFor MMA in Early Gestation\\nadministration and is heaviest during the actual abortion process, often lasting up to four hours.\\nIf the pain is persistent even after taking an analgesic, the possibility of ectopic pregnancy should\\nalways be ruled out.\\n• Nausea, vomiting, and diarrhoea, etc. are normal side effects of drugs.\\nFor covering all the important points during the counselling of the woman before MMA, `Counselling\\nSkills Checklist’ may be referred to, which is given as`Annexure – 1.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Clinical Assessment and Eligibility Screening', 'section_path': ['8 Schedule for MMA Trainings', 'Clinical Assessment and Eligibility Screening'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='Clinical assessment includes General Physical, Systemic, Abdominal and Pelvic Examination:\\na. Check for pallor: if pallor exists, heavy bleeding during the procedure may worsen the condition and\\nincrease the risk of shock and ill health.\\nb. Check Blood pressure; cardiovascular; and respiratory system for any pre-existing disease.\\nc. Look for any mass, rigidity, tenderness in abdominal examination.\\nd. Carry out Pelvic examination (P/S and P/V).\\n13Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\nl) Womenwithnosupportathome:arrangementsshouldbemadefortransportationtothe\\nhospital,incaseofemergencyorshouldbeadmittedfortheMMAprocedure\\n3. General Physical, Systemic, Abdominal and Pelvic Examination\\na) Checkforpallor:ifpallorexists,heavybleedingduringtheproceduremayworsenthe\\nconditionandincreasetheriskofshockandillhealth\\nb) Bloodpressure;cardiovascular;andrespiratorysystemforanypre-existingdisease'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Clinical Assessment and Eligibility Screening', 'section_path': ['8 Schedule for MMA Trainings', 'Clinical Assessment and Eligibility Screening'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='conditionandincreasetheriskofshockandillhealth\\nb) Bloodpressure;cardiovascular;andrespiratorysystemforanypre-existingdisease\\nc) Lookforanymass,rigidity,tendernessinabdominalexamination\\nd) CarryoutPelvicexamination(P/SandP/V)\\nFigure 8: Performing bimanual examination\\n• P/Sexamination:lookforinfection,cervicalerosion,polyp\\n• P/Vexamination:checkthesize,shape,regularityandconsistencyofuterustoconfirm\\ntheperiodofgestationandadenexalmass\\n• Ruleoutectopicpregnancy2,incaseofadenexalmass/fullnessortendernessinadenexa\\norcervicaltenderness\\n2Ectopicpregnanciescanbediagnosedwithacarefulhistory,examinationandUSG.SinceitisanobstetricUSG,itmustbedonein\\naccordancewithPCPNDTAct.\\nSymptoms during ectopic pregnancy might include:\\n•Amenorrhea\\n•Nausea,vomiting\\n•Lowerabdominalpain,usuallyone-sided,thatmaybesuddenandintense,persistent,orcramping\\n•Irregularvaginalbleedingorspotting\\n•Faintingordizzinessthatpersistsformorethanafewsecondsispossiblyindicativeofinternalbleeding.Internalbleedingisnot'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Clinical Assessment and Eligibility Screening', 'section_path': ['8 Schedule for MMA Trainings', 'Clinical Assessment and Eligibility Screening'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='•Irregularvaginalbleedingorspotting\\n•Faintingordizzinessthatpersistsformorethanafewsecondsispossiblyindicativeofinternalbleeding.Internalbleedingisnot\\nnecessarilyaccompaniedbyvaginalbleeding  \\nSigns\\n•Uterinesizethatissmallerthanexpected\\n•Palpableadenexalmass\\n•Tendercervicalmovements\\nInadditiontotheabovesymptomsandsigns,ruleoutectopicpregnancywhileperformingvacuumaspirationifnoPOCevacuated\\naftertheprocedure\\nWhenectopicpregnancyissuspected,referthewomanassoonaspossibletoahigherfacilityforconfirmationofdiagnosisand\\ninitiatingtreatment.Uterine evacuation methods whether vacuum aspiration or medical methods using Mifepristone and\\nMisoprostol, cannot terminate an ectopic pregnancy and hence should not be attempted in case of suspicion.\\nFigure 8: Performing bimanual examination\\n• P/S examination: look for infection, discharge (type), cervical erosion, polyp\\n• P/V examination: check the size, direction, shape and regularity, and consistency of uterus to'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Clinical Assessment and Eligibility Screening', 'section_path': ['8 Schedule for MMA Trainings', 'Clinical Assessment and Eligibility Screening'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='• P/S examination: look for infection, discharge (type), cervical erosion, polyp\\n• P/V examination: check the size, direction, shape and regularity, and consistency of uterus to\\nconfirm the period of gestation and rule out adnexal mass\\n• Rule out ectopic pregnancy, in case of adnexal mass/fullness or tenderness in adnexa or cervix\\nUterine size estimation through bimanual examination is the most critical skill required for MMA.\\n4. Investigations (Recommended)\\ni. Haemoglobin\\nii. Routine urine examination\\niii. Blood Group: ABO Rh especially in primigravida\\niv. Pregnancy test  \\nTraining Manual\\nFor MMA in Early Gestation\\n22\\nInvestigations as per the need:\\nUltrasonography (USG): USG may be done at sites where these facilities are available. However, it is not\\nmandatory for all women undergoing pregnancy termination with medical methods. USG needs to be\\nperformed when:\\n• Women are unsure of LMP or have conceived during lactational amenorrhea.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Clinical Assessment and Eligibility Screening', 'section_path': ['8 Schedule for MMA Trainings', 'Clinical Assessment and Eligibility Screening'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='mandatory for all women undergoing pregnancy termination with medical methods. USG needs to be\\nperformed when:\\n• Women are unsure of LMP or have conceived during lactational amenorrhea.\\n• Women with discrepancy between history and clinical findings.\\n• Women with suspicion of ectopic pregnancy.\\n• Provider is uncertain after bimanual examination, or inability to measure uterine size due to obesity,\\nand/or pelvic discomfort.\\n• Provider is uncertain about the completion of the process during the follow-up visit.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Contraceptive Options', 'section_path': ['8 Schedule for MMA Trainings', 'Contraceptive Options'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Woman’s acceptance for contraceptive method should not be a pre-condition for providing abortion\\nservices. However, all post abortion contraceptive options should be discussed with her, and she should\\nbe helped to choose the appropriate contraception for herself, based on her eligibility.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Informed Consent', 'section_path': ['8 Schedule for MMA Trainings', 'Informed Consent'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Get the consent of the woman/guardian in Form C. Also fill in the RMP Opinion Form (Form I), before\\nprescribing MMA drugs.\\n7. Tablet Mifepristone (200mg) is administered orally\\nAnti-D (50 mcg) given to Rh negative woman.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Iron and Folic Acid Tablets', 'section_path': ['8 Schedule for MMA Trainings', 'Iron and Folic Acid Tablets'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='90 tablets (to be taken for next three months) should be given to all women undergoing MMA procedure.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Sanitary Napkins', 'section_path': ['8 Schedule for MMA Trainings', 'Sanitary Napkins'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Use of sanitary napkins is recommended for prevention of infection.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Antibiotics', 'section_path': ['8 Schedule for MMA Trainings', 'Antibiotics'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='Routine use of prophylactic antibiotics is not indicated.\\nAntibiotics should be given to women with suspected/evident reproductive tract infections.\\nRecommended antibiotics are Doxycycline 100 mg, twice a day for five days for non-lactating women,\\nand Azithromycin 500 mg, once a day for three days for lactating women.\\n11. Give contact address and phone number of the service provider/facility where woman can go in\\ncase of an emergency.  \\n23\\nTraining Manual\\nFor MMA in Early Gestation'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Complete the MMA card', 'section_path': ['8 Schedule for MMA Trainings', 'Complete the MMA card'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Explain the MMA card (Annexure - 3) to the woman and instruct her to note\\ndown her symptoms on it.\\nAt the sole discretion of the service provider, a woman can be given Misoprostol to be taken at home.\\nIn such cases, a thorough counselling on what is expected after taking Misoprostol, should be done. She\\nshould be called back on 15th day for follow up.\\nThe table below summarizes the tasks for Day 1 of the MMA protocol:\\n'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Complete the MMA card', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['8 Schedule for MMA Trainings', 'Complete the MMA card'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 4: Tasks for Day 1/Day of Mifepristone administration\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:\\nProvider’s Task Instructions to the Woman\\nDetailed history, rule out contraindications and\\nnote special precautions\\nTake tablet Mifepristone 200 mg orally\\nGeneral and MMA specific counselling What to expect after taking tablet Mifepristone\\nGeneral physical and pelvic examination\\nEstimation of gestation age by bimanual\\nexamination is the most important skill required\\nfor MMA\\nShe may have pain/bleeding in the next 2 days\\nTake analgesic, if required\\nFill in Form I, Form C\\nRecord investigations\\nReturn for Misoprostol on Day 3 (unless decided\\nby provider to give her for home administration)\\nDiscuss contraceptive options Avoid intercourse or use barrier methods\\nComplete MMA card with complete contact\\ninformation for emergency\\nKeep filling the symptoms on MMA card\\nMedication to be given:\\nMifepristone,\\nAnalgesic (Ibuprofen),\\nIron & Folic Acid (90 tablets),\\nSanitary napkins\\nReport to the provider/facility if there is:\\nExcessive bleeding\\nSevere pain abdomen\\nComplete the records in Form III (Admission\\nRegister)  \\nTraining Manual\\nFor MMA in Early Gestation\\n24\\nB.  Second Visit/Day 3/Day of Misoprostol Administration\\n1. Note any history of bleeding/pain or any other side effects after tablet Mifepristone: Some\\nwomen will start bleeding after the administration of tablet Mifepristone.\\n2. Administer Misoprostol: Ask the woman to empty her bladder. Give/insert four tablets of 200\\nmcg Misoprostol (total 800 mcg) by sublingual/buccal/vaginal route. Oral route may be used if\\npregnancy < 7 weeks.\\n3. Ask her to lie in bed for half an hour after vaginal insertion.\\nIf she vomits tablet Misoprostol within half an hour of its intake, the same dosage (800 mcg\\nMisoprostol) should be repeated, after giving an anti-emetic.\\n4. Observe the woman for four hours after Misoprostol administration in the clinic/hospital and\\nmonitor:\\ni. Pulse and blood pressure\\nii. Time of start of bleeding and expulsion of products (if it occurs)\\niii. Side effects of the drugs (e.g. chills)\\n5. Medication for pain relief: Usually the pain starts after taking Misoprostol, so analgesic can be taken\\nwell in time before pain becomes intolerable. Tablet Ibuprofen 400 mg is recommended. Paracetamol\\nis not recommended for pain relief during the process of MMA. If pain does not subside on taking\\ndrugs, the possibility of ectopic pregnancy should be ruled out. Receiving complete information\\nduring counselling and reassurance during the process helps the woman to tolerate pain better.\\n6. Perform pelvic examination before the woman leaves the clinic/facility and if cervical os is open\\nand products are partially expelled, remove them digitally. She should be observed for another few\\nhours or till the expulsion of the POC is complete.\\n7. In case the woman does not abort at the health centre or takes Misoprostol at home, inform her\\nabout:\\n• Reporting back to the centre/service provider in case of excessive bleeding/acute\\nabdominal pain\\n• Warning signs and symptoms\\n• Using clean sanitary napkins\\n• Avoiding tampons and douche\\n• Reporting back if there is no bleeding even 24 hours after taking Misoprostol\\n8. Side effects of the drugs such as nausea, vomiting, diarrhoea (usually mild), headache, fever, and\\ndizziness\\n9. Return for follow-up on the Day 15'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Keep filling the MMA card', 'section_path': ['8 Schedule for MMA Trainings', 'Keep filling the MMA card'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content=':\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:  \\n25\\nTraining Manual\\nFor MMA in Early Gestation\\nChart 1: Plan of action if there is no bleeding even 24 hours after administration of Misoprostol\\nContinuation of Pregnancy Non-viable Foetus/Missed\\nAbortion\\nRefer to Higher\\nCentre for Vacuum\\nAspiration\\nAdditional Dose of\\nMisoprostol\\n• Detailed History,\\n• Clinical Examination,\\n• Ultrasonography\\nThe table below summarizes the tasks for Day 3 of the MMA protocol:\\n'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Keep filling the MMA card', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['8 Schedule for MMA Trainings', 'Keep filling the MMA card'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Table 5: Tasks for Day 3/Day of Misoprostol administration\\nProvider’s Task Instructions to the Woman\\nNote history of bleeding/pain in abdomen/other\\nside effects of tablet Mifepristone\\nLie in bed for 30 minutes if Misoprostol is\\ninserted vaginally\\nGive four tablets of Misoprostol (total 800 mcg)\\nsublingual/vaginal/buccal\\nPossible side effects – nausea, vomiting,\\ndiarrhoea, headache, chills, and dizziness\\nObserve for 4 – 6 hours in the facility Avoid intercourse till bleeding stops\\nPrescribe tablet Ibuprofen for pain relief Use clean sanitary napkins. Avoid tampons and\\ndouche\\nBimanual examination just before discharge from\\nthe facility\\nAvoid going out of station till the third visit\\nAntiemetics or antidiarrhoeal may be prescribed Report back if:\\nNo bleeding for even 24 hours after Misoprostol\\nExcessive bleeding – soaking 2 or more thick\\npads for 2 hours continuously\\nFever >24 hours after Misoprostol\\nExplain what to expect after Misoprostol\\nadministration\\nReturn for follow up on Day 15 or earlier, if\\nrequired\\nOCP/Injectables/Centchroman can be started if\\nchosen\\nKeep filling the MMA card  \\nTraining Manual\\nFor MMA in Early Gestation\\n26\\nC.  Third Visit/Day 15/Follow-up Visit\\n1.  Note relevant history/check MMA card\\n2. Carry out pelvic examination to ensure completion of abortion process/continuation of pregnancy'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Advise USG if:', 'section_path': ['8 Schedule for MMA Trainings', 'Advise USG if:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='• complete expulsion of POC not confirmed\\n• continuation of pregnancy suspected\\n• bleeding continues'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 6: Tasks for Day 15/Follow up visit\\nProvider’s Task Instructions to the Woman\\nNote history of bleeding/pain in abdomen/\\nexpulsion of POC\\nContraceptive advice as per the method chosen\\nPelvic examination to confirm completion of the\\nprocess. USG, if indicated\\nReport back if no periods within six weeks of\\ncompletion of abortion process\\nIUCD, if chosen by the woman and all\\ncontraindications are ruled out\\nReiterate contraceptive counselling\\nand services\\n5.3: Post MMA Contraception\\nFigure 9: Contraceptive Methods  \\n27\\nTraining Manual\\nFor MMA in Early Gestation\\n• Oral hormonal contraceptive methods, whether combined (estrogen and progestogen) or progestin-\\nonly, can be started on the day of the Misoprostol administration (Day 3) or Day 15 of the MMA\\nprotocol.\\n• Injectable hormonal method (Injection-MPA/Antara Programme) can be started on Day 3 of the\\nMMA protocol.\\n• Centchroman can be started on Day 3 of the MMA protocol.\\n• IUCD can be inserted after confirming complete abortion and ruling out contraindications, on Day\\n15 of MMA protocol.\\n• Condoms can be used even on Day 1 of MMA administration.\\n• Tubal ligation can be done after the next menstrual cycle. However, if desirous of concurrent tubal\\nligation, woman maybe referred to the higher centre for vacuum aspiration with concurrent tubal\\nligation.\\n• Vasectomy, if chosen, can be done independent of the MMA procedure.\\nTable 7: Table below summarizes the day of initiation of contraceptive methods during the process of MMA\\nDay of MMA\\nProcess Day 1 Day 3 Day 15 After Next\\nMenstrual Cycle\\nContraceptive\\nMethods that\\nmaybe Initiated\\n• Condoms • COCs\\n• Injectables\\n• Centchroman\\n• Condoms\\n• IUCD\\n• COCs\\n• Condoms\\n• Tubal ligation\\n• IUCD\\n• COCs\\n• Injectables\\n• Centchroman\\n• Condoms  \\nTraining Manual\\nFor MMA in Early Gestation\\n28\\n6\\nSide Effects and Complications\\nwith MMA and their Management\\n6.1: Side Effects with MMA\\nShare with the participants the side effects and potential complications during the\\nprocess of MMA and their management.\\n19Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n6.1: Side Effects\\nFigure 10: Side effects with MMA drugs – headache, vomiting\\nCommon side effects experienced with MMA are:\\na) Gastrointestinalsideeffects\\nb) Fever,warmthandchills\\nc) Headacheanddizziness\\n• Gastrointestinal Side Effects: Diarrhoea, nauseaandvomitingarecommonlyreportedby\\nwomenfollowingtheuseofMisoprostol.Thesesideeffectsaremildandself-limitingand\\npassoffwithoutanytreatment.Antiemeticandanti-diarrhoealmedicinesmaybeprescribed\\nwhenneeded.ORScanbegivenifvomitingordiarrhoeaissevere.Tab.Loperamidemaybe\\nprescribedfordiarrhoea.(butwithcaution)\\n• Fever, Warmth and Chills: Fever, feelingofwarmthandchillsareshort-livedandself-\\nlimitingsideeffects.Treatmentisgenerallynotrequiredbutthewomanshouldknowthat\\nshemayexperiencethesesymptoms.Post-abortioninfectionisrareafterMMA.Persistent\\nfever(>38°Cfortworeadingsfourhourapart)mayindicateinfectionandmustbeevaluated\\nandtreatedaccordingly.\\n6\\nSection\\nSide Effects and Complications\\nwith MMA and their Management\\nFigure 10: Side effects with MMA drugs – headache, vomiting\\nCommon side effects experienced with MMA are:\\na. Gastrointestinal side effects\\nb. Fever, warmth, and chills\\nc. Headache and dizziness\\n• Gastrointestinal Side Effects: Diarrhoea, nausea and vomiting are commonly reported by women\\nfollowing the use of Misoprostol. These side effects are mild and self-limiting and pass off without\\nany treatment. Antiemetic and anti-diarrhoeal medicines may be prescribed when needed. ORS can\\nbe given if vomiting or diarrhoea is severe.\\n• Fever, Warmth, and Chills: Fever, feeling of warmth, and chills are short-lived and self-limiting side\\neffects. Treatment is generally not required but the woman should know that she may experience\\nthese symptoms. Persistent fever (> 38° C for two readings four hours apart) may indicate infection\\nand must be evaluated and treated accordingly, though post-abortion infection is rare during MMA.\\n• Headache and Dizziness: Some women during the process of MMA report\\nheadache and dizziness. Headache is treated with non-narcotic analgesics\\nand mild dizziness of short duration is managed by hydration. Advise the\\nwoman to take plenty of fluids, rest and exercise caution while changing\\nposition.  \\n29\\nTraining Manual\\nFor MMA in Early Gestation\\n6.2: Safety and Effectiveness\\nBefore proceeding with the complications associated with MMA, share with the participants\\nthe safety and effectiveness of MMA drugs.\\nSafety\\nMifepristone and Misoprostol are safe drugs for terminating pregnancy if the woman does not have any\\ncontraindications for their use.\\nEffectiveness\\nA combination of Mifepristone and Misoprostol has an effectiveness of 95 – 99% for termination of early\\npregnancy up to nine weeks.\\nFailed Abortion:  Women with continued signs of pregnancy or clinical signs of failed abortion should\\nbe referred to higher centre as expeditiously as possible for further management.\\nReferral to higher centre for further appropriate management is needed in cases of:\\n•Continuation of pregnancy after administration of MMA drugs\\n• Excessive bleeding anytime during the MMA process\\n• If abortion process is incomplete at the time of follow up visit\\n6.3: Complications and their Management\\nPotential complications associated with MMA are:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Excessive Vaginal Bleeding', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Excessive Vaginal Bleeding'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Soaking two or more thick pads per hour for two consecutive hours need close\\nmonitoring of the woman.\\nIn this condition, she should report to the facility.\\nConduct examination, including bimanual examination, to rule out incomplete abortion and assess for\\nhypovolemia. Following should be done in such cases:\\n• Fluid replacement: IV infusion with Ringers Lactate solution 30 drops per minute should be started\\nand simultaneous preparation for referral to the higher centre.  \\nTraining Manual\\nFor MMA in Early Gestation\\n30'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Incomplete Abortion', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Incomplete Abortion'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition'], 'discusses_normal_variations': True}, page_content='Generally, these women present with excessive/continued bleeding.\\nRapid initial assessment of the woman’s vital parameters, haemodynamic stability\\nshould be done and proceeded accordingly:\\n1. If her condition is unstable, resuscitate and stabilize her. Stabilization should be followed by\\nexamination and further management accordingly, including referral to the higher centre.\\n2. If her condition is stable, proceed with the examination:\\na. If POC is felt at the os, manage with digital evacuation. Further treatment will be based on the\\nseverity of bleeding and status of her general condition.\\ni. She may be offered an additional dose of Misoprostol (dosage given below) provided\\nbleeding is not heavy:\\nMisoprostol 600 mcg oral or 400 mcg sublingual can be repeated in such cases of\\nincomplete abortion.\\nii. If bleeding continues even after an additional dose of Misoprostol, she should be referred to\\nhigher centre for further management.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Incomplete Abortion', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Incomplete Abortion'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='incomplete abortion.\\nii. If bleeding continues even after an additional dose of Misoprostol, she should be referred to\\nhigher centre for further management.\\niii. If bleeding is controlled and general condition improves, she may be treated conservatively\\nat the same facility and discharged when appropriate.\\nb. If no products are felt at the os, decide the line of management based on the clinical symptoms,\\npelvic examination, and USG findings:\\ni. If the gestation sac is visible but is non-viable, then an additional dose of Misoprostol\\n(dosage given above) may be offered to the woman. Wait for the products of conception\\nto be expelled with time. The woman should be counselled to return to the clinic after one\\nweek to ensure that the abortion is complete.\\nIf bleeding continues even after an additional dose of Misoprostol, she should be referred to\\nhigher centre for further management.\\nii. If no gestation sac is visible on USG but bleeding continues due to decidual bits in the'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Incomplete Abortion', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Incomplete Abortion'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='higher centre for further management.\\nii. If no gestation sac is visible on USG but bleeding continues due to decidual bits in the\\nuterine cavity, manage conservatively, without any medication or intervention as these are\\nexpelled spontaneously in most cases. An additional visit after seven days will have to be\\nplanned to ensure completion of the process.\\nIf bleeding is profuse at any time during this process, she should be referred to higher centre\\nfor further management.\\niii. If USG shows viable gestation sac, refer the woman to higher centre for vacuum aspiration.  \\n31\\nTraining Manual\\nFor MMA in Early Gestation\\nChart 2: Flow chart for Treatment of Incomplete Abortion'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Continuation of Pregnancy', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Continuation of Pregnancy'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations']}, page_content='If the pregnancy continues despite taking drugs for MMA, it indicates that the drugs were ineffective. In\\nsuch cases, refer the woman to higher centre for pregnancy termination by Vacuum Aspiration in view\\nof the teratogenic effect of the drugs4.\\n4 Data on continuing pregnancy after Mifepristone exposure without Misoprostol are limited. The association between Misoprostol\\nand congenital anomalies is better established. The most typical malformations associated with Misoprostol use are Möbius\\nsyndrome, a rare disorder of cranial nerve palsies associated with limb anomalies and craniofacial defects, and terminal transverse\\nlimb defects. Although not clearly established, the proposed mechanism is vascular disruption due to uterine contractions leading\\nto disordered fetal development\\nRefer to\\nhigher centre\\nResuscitative Measures\\n• Check vital signs\\n• Ensure patent airway\\n• Oxygen 0-5 lit/min, through\\nmask/nasal cathetar\\n• I/V fluids, NS/RL with 18G\\ncannula\\n• Oxytocin\\n• Antibiotics'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Continuation of Pregnancy', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Continuation of Pregnancy'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='higher centre\\nResuscitative Measures\\n• Check vital signs\\n• Ensure patent airway\\n• Oxygen 0-5 lit/min, through\\nmask/nasal cathetar\\n• I/V fluids, NS/RL with 18G\\ncannula\\n• Oxytocin\\n• Antibiotics\\nNo sac, only\\ndecidual bits\\nUnstable Condition\\nRefer to higher centre\\nStable Condition: Proceed with\\nexamination\\nPOC at the os No POC at the os :\\nPelvic examination, USG\\nNon-viable\\npregnancy\\nViable pregnancyDigital\\nevacuation;\\nAdditional\\nMisoprostol\\ndose;\\nDischarge/\\nrefer,\\nBased on her\\ncondition\\nAdditional dose\\nof Misoprostol;\\nFU after 7 days\\nTreat\\nconservatively;\\nFU after 7 days\\nPresenting Symptoms:\\n• Continued bleeding\\n• Excessive bleeding\\n• With/without pain abdomen  \\nTraining Manual\\nFor MMA in Early Gestation\\n32'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Infection', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Infection'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Infection of uterus is uncommon if all precautions are followed. If the woman has symptoms such as\\nfever, chills, foul-smelling discharge, or bleeding and pain in lower abdomen, uterine infection may be\\nsuspected. Start broad spectrum antibiotics as soon as possible and refer her to the higher centre for\\nfurther management, if required. The recommended antibiotics are Doxycycline 100 mg, twice a day\\nfor five days for non-lactating women, and Azithromycin 500 mg, once a day for three days for lactating\\nwomen.\\n6.4: Warning Symptoms and Signs\\nThe warning symptoms and signs during the MMA process, for which she should immediately contact\\nthe service provider or facility should be explained to the woman.\\nSigns and symptoms are as below:\\n•Excessive bleeding, soaking two thick pads in an hour for two consecutive hours\\n• Persistent severe pain abdomen, not relieved by analgesics\\n• Fever\\n• Foul smelling discharge\\n• Fainting attacks'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Infection', 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Infection'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='•Excessive bleeding, soaking two thick pads in an hour for two consecutive hours\\n• Persistent severe pain abdomen, not relieved by analgesics\\n• Fever\\n• Foul smelling discharge\\n• Fainting attacks\\n• No/minimal bleeding even 24 hours after the administration of Misoprostol\\n• No periods after six weeks of the completion of MMA process  \\n33\\nTraining Manual\\nFor MMA in Early Gestation\\n7 Comparison: V A and MMA Procedure\\nShare with the participants the comparative features of the medical and surgical methods of abortion.\\nThough, both vacuum aspiration as well as medical methods are safe technologies, both have their\\ndistinct features. Key features are enumerated below:'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Ask the woman to report back if there are no periods within six weeks', 'subsection': 'Infection', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['8 Schedule for MMA Trainings', 'Ask the woman to report back if there are no periods within six weeks', 'Infection'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 8: Comparison of VA and MMA\\nFeature Vacuum Aspiration Medical Methods\\nTechnique used Uterine contents evacuated\\nthrough a cannula attached to\\nelectric/manual vacuum source\\nExpulsion of uterine contents\\nwith drugs – Mifepristone and\\nMisoprostol\\nGestation limit for the\\ntechnology\\nCan be used upto 12 weeks Can be used upto 9 weeks\\nEffectiveness More than 98% 95-99%\\nTime taken for the procedure\\ncompletion\\n5-15 minutes May take 8 – 13 days\\nPOC check Possible and helpful in ensuring\\ncompletion\\nMay not be possible since\\npassed at home\\nMandatory number of visits for\\nthe procedure\\nOne Three (two visits in case\\nof home administration of\\nMisoprostol on provider’s\\ndiscretion)\\nPost procedure pain Moderate but remains for a\\nshort time\\nIntense for few hours during the\\nactual expulsion of the POCs\\nRisk of cervical and uterine\\ninjury\\nExists, not very common Does not exist\\nRisk of foetal malformation if\\nthe pregnancy continues\\nNo Ye s\\nProcedure done by RMP , as under the MTP Act RMP , as under the MTP Act\\nAcceptability to woman Done as a day care procedure\\nAwake during the procedure\\nNon-invasive process;\\nMore private;\\nClose to natural miscarriage;\\nNo hospitalization\\n5Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion\\n3.1: Indications for MMA\\nOptionforMMAshouldbegiventoallwomencomingtoahealthfacilityseekingterminationof\\npregnancyupto7weeksofgestation(49daysfromthefirstdayofthelastmenstrualperiodin\\nwomenwithregularcyclesofapproximately28days)1\\nFigure 1: MMA Drugs (Mifepristone and Misoprostol)\\n3.2: Contraindications for MMA\\nWomen being prescribed MMA should be screened for the following common contraindications:\\n• Anaemia(haemoglobin<8gm%)\\n• Confirmedorsuspectedectopicpregnancy/undiagnosedadnexalmass\\n• UncontrolledhypertensionorBP>160/100mmHg\\n3\\nSection\\nIndications/Contraindications\\nfor MMA\\n1InDecember2008,CombipackwithMifepristone+Misoprostol(1tabletofMifepristone200mgand4tabletsofMisoprostol200mcg\\neach)wasapprovedbytheCentralDrugsStandardControlOrganization,DirectorateGeneralofHealthServices,India,forthe\\nterminationofintra-uterinepregnancyforupto63days/9weeksgestation.\\nCACTraining&ServiceDeliveryGuidelines,2010byMoHFW,GoIrecommendsitsuseupto49daysinpublicsectorsites,inline\\nwiththeMTPRules2003.\\nAproposedamendmenttotheMTPAct,1971,toincreasethegestationlimitforMMAto9weeksinpublicsectorsitesisunderprocess.\\nTilltheproposalisapproved,MMAinpublichealthfacilitywouldbeallowedonlyupto7weeks.  \\nTraining Manual\\nFor MMA in Early Gestation\\n34\\n8 Schedule for MMA Trainings\\nThis training is provided to the MBBS doctors to make them eligible to provide abortion services upto 9\\nweeks gestation period by MMA only.\\nAgenda for MMA Trainings\\nTime Session\\n9.30 am - 10.00 am Registration & Pre-test\\n10.00 am - 10.30 am Introduction\\nGoal & Objectives\\n10.30 am - 11.30 am Overview of Medical Methods of Abortion\\n11.30 am - 12.30 pm Clinical Assessment and Eligibility Screening for MMA\\n12.30 pm - 1.30 pm Lunch\\n1.30 pm - 3.00 pm Counselling Skills for MMA & Practice\\n3.00 pm - 3.15 pm Tea\\n3.15 pm - 4.30 pm MTP Act & Rules related to MMA\\nDocumentation Formats\\n4.30 pm Evaluation and Planning for next day\\nTime Session\\n9.00 am - 12.00 pm Hands on Practice on Live Cases:\\nEligibility Screening; Counselling; Documentation\\n12.00 pm - 12.15 pm Tea\\n12.15 pm - 1.00 pm Dealing with Expected Side-effects of MMA Drugs\\n1.00 pm - 2.00 pm Lunch\\n2.00 pm - 3.00 pm Potential Complications with MMA and their Management\\n3.00 pm - 3.15 pm Tea\\n3.15 pm - 4.00 pm Operationalization of MMA Services at Facilities\\nTime Session\\n9.00 am - 12.00 pm Hands on Practice on Live Cases:\\nEligibility Screening; Counselling; Documentation\\n12.00 pm - 12.15 pm Tea\\n12.15 pm - 1.30 pm Post-abortion Contraception with MMA\\n1.30 pm - 2.30 pm Lunch\\n2.30 pm - 3.00 pm Post - test\\nTraining Evaluation\\n3.00 pm - 4.00 pm Next Steps & Valedictory\\nDay 1:\\nDay 2:\\nDay 3:  \\n35\\nTraining Manual\\nFor MMA in Early Gestation\\nReferences\\n1. MTP (Amendment) Act, 2021; MTP (Amendment) Rules, 2021\\n2. Comprehensive Abortion Care Training and Service Delivery Guidelines, MoHFW , Government\\nof India. 2018\\n3. Medical Management of Abortion. Geneva: World Health Organization. 2018\\n4. Post Abortion Family Planning Technical Update. Family Planning Division, MoHFW ,\\nGovernment of India. 2016\\n5. Clinical Practice Handbook for Safe Abortions. Geneva: World Health Orgnization. 2014\\n6. ACOG: Medication Abortion upto 70 days of Gestation. 2014\\n7. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health\\nOrgnization. 2012\\n8. Shagufta Praveen et al: Comparison of sublingual, vaginal, and oral Misoprostol in cervical\\nripening for first trimester abortion. Indian J Pharmacol. 2011 Apr; 43(2): 172–175\\n9. Guidelines for Early Medical Abortion in India using Mifepristone and Misoprostol. MoHFW ,\\nWHO CCR in Human Reproduction, AIIMS Delhi. 2007\\n10. Tang et al, Int J Gynecol Obste (2007), 99 S160 – S167  \\nTraining Manual\\nFor MMA in Early Gestation\\n36\\nAnnexure – 1 Medical Methods of Abortion: Counselling\\nSkills Checklist\\nDay 1: Skills required during first visit to clinic/facility\\n(Mifepristone administration)\\nYe s No\\nGreets the woman in a friendly, respectful manner; ensures privacy\\nConfirms with her that she wants to terminate her pregnancy\\nExplains what to expect during the visit\\nAsks if she came with someone and if she would like that person to join her in\\nthe counselling\\nAsks about her general health, reproductive and medical history\\nExplains various abortion methods available, including their characteristics,\\neffectiveness and the visits required\\nExplores her views on abortion options and which abortion method is the best\\nfor her\\nIf the woman chooses medical methods of abortion provides more information\\non the method in simple terms\\nConfirms that she is eligible for medical methods of abortion (pregnancy upto\\nnine weeks)\\nClarifies the woman’s feelings on the possibility of having the abortion at home\\nand asks what support she has at home\\nEnsures that she understands:\\n• Common side effects and symptoms during the process\\n• Importance of attending required clinic visits\\n• Warning signs indicating the need to return to the clinic\\nExplains how Mifepristone and Misoprostol will be administered and what to\\nexpect after taking them\\nExplains that if the medical method of abortion fails, vacuum aspiration will be\\nnecessary to terminate the pregnancy at the higher centre\\nDiscusses various contraceptive methods and helps her to choose one\\nAsks the woman whether she has additional questions\\nObtains written informed consent\\nProvides Mifepristone 1 tablet 200 mg orally\\nExplains how to take pain management medication (analgesics)\\nExplains how to record the side effects experienced, if any, on the MMA card\\nExplains what to do in case of problems/emergency\\nGives the woman the address and telephone number of the clinic where she\\nmay go in case of an emergency\\nAsks her to return to the clinic for the second dose after two days  \\n37\\nTraining Manual\\nFor MMA in Early Gestation\\nDay 3: Skills required during second visit to clinic/facility\\n(Misoprostol administration)\\nYe s No\\nGreets the woman in a friendly, respectful manner; ensures privacy\\nEnquires about her experience after taking Mifepristone (bleeding, passage of\\nPOC, discomfort, side effects)\\nChecks the MMA card\\nExplains what to expect during this visit\\nAdministers Misoprostol in clinic (per protocol) four tablets:\\nsublingual/buccal/vaginal. Oral route may be used if pregnancy < 7 weeks\\nAsks the woman to rest in the clinic for four hours\\nObserves the woman in the clinic for bleeding, cramping, expulsion of POC\\nIf the woman leaves the clinic before she aborts, give her instructions and sup-\\nplies (pain medication, written instructions) for process at home\\nExplains how to record her experience of any side effect on the MMA card and\\nreminds her of the address and contact number of the clinic to visit in case of\\nan emergency\\nRecords the date of Misoprostol administration and counsels the woman to\\ncome for a follow-up visit on Day 15\\nReviews after-care instructions and provides information on warning signs\\nwhich indicate the need to return to the clinic or seek medical assistance\\nAsks the woman if she has any additional questions and clarifies them\\nDay 15: Skills required during third visit to clinic/facility (follow up)Ye s No\\nGreets the woman in a friendly, respectful manner; ensures privacy\\nEnquires about her experience of the abortion process, expulsion of POC and if\\nshe feels that the abortion is complete\\nAsks whether she is still having symptoms of pregnancy\\nExplains what to expect during this follow-up visit\\nAssesses the completeness of the abortion by:\\n• Taking a history of the abortion process (amount and duration of bleeding,\\nside effects, cramping, any POC expelled)\\n• Conducting a physical examination (pelvic examination to assess the size\\nand consistency of the uterus and opening of the cervical os)\\n• Advising/performing an ultrasound for the presence of gestation sac, if it is\\nstill unclear whether the abortion is complete\\nIf the abortion is not complete, discusses treatment options:\\nexpectant management, additional Misoprostol administration or referral to\\nhigher centre\\nIf the pregnancy is continuing:\\n• Discusses need for vacuum aspiration to terminate it at the higher centre\\nIf the abortion is complete:\\n•Provides information about return to fertility\\n• Explains risks of repeated induced abortions\\n• Counsels regarding contraceptive methods if not already chosen by her\\nAsks the woman if she has any additional questions and clarifies them\\nTells her that she can come back to the clinic/facility whenever she has any\\nproblem  \\nTraining Manual\\nFor MMA in Early Gestation\\n38\\nAnnexure – 2 Essential Equipment, Instruments, Drugs and\\nConsumables Required for MMA\\nS.\\nNo. Item PHC/non FRU\\nCHC FRU/SDH DH/MCH Remarks\\n(5, 10, 20 cases)'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Equipment', 'section_path': ['8 Schedule for MMA Trainings', 'Equipment'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='1.1 Examination table 1 1 2\\n1.2 Screen for privacy 1 1 2\\n1.3 Footstep 1 1 2'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Instruments', 'section_path': ['8 Schedule for MMA Trainings', 'Instruments'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='2.1 Cusco’s speculum\\n(large, medium)4 6 10'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Drugs', 'section_path': ['8 Schedule for MMA Trainings', 'Drugs'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='3.1 Tab Mifepristone 10 20 30\\n3.2 Tab Misoprostol 44 90 140\\n3.3 Tab Ibuprofen 30 60 120\\n3.4 Tab Doxycycline 20 40 80\\n3.5 Cap Azithromycin 12 24 48\\n3.6 Inj Oxytocin 10 20 30\\n4. I/V Fluids\\n4.1 Ringer Lactate 4 8 12\\n4.2 Normal Saline 2 4 6'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Consumables', 'section_path': ['8 Schedule for MMA Trainings', 'Consumables'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='5.1 Examination gloves 25 50 100\\n5.2 Utility gloves 1 1 2\\n5.3 Gauze (packets) 2 3 4\\n5.4 I/V set 2 3 4\\n5.5 I/V cannula 2 3 4\\n5.6 2 ml and 5 ml syringes 10 20 40'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Povidone Iodine', 'section_path': ['8 Schedule for MMA Trainings', 'Povidone Iodine'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Solution 2 3 4'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Sterilization', 'section_path': ['8 Schedule for MMA Trainings', 'Sterilization'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='equipment\\n6.1 Autoclave 1 1 1\\n6.2 Boiler 1 1 1  \\n39\\nTraining Manual\\nFor MMA in Early Gestation\\nAnnexure – 3 MMA Card\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:\\n:\\nV-2\\nRp-2 / Aug 08, 2016\\nthick\\n:  \\nTraining Manual\\nFor MMA in Early Gestation\\n40\\nMedical Methods of Abortion Training\\nPost-test Questionnaire\\nName:  ......................................................................................................................................................................\\nName of training centre: ........................................................................................................................................\\nDates of training: from ................................................(dd/mm/yy) to .........................................(dd/mm/yy)\\nPlease put a tick under `True’ or `False’ for the following statements:\\nS.No. Statement    True False'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'MMA is a safe and effective method to terminate early', 'section_path': ['8 Schedule for MMA Trainings', 'MMA is a safe and effective method to terminate early'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='pregnancy upto 63 days.\\n2. MMA may adversely affect the woman’s future fertility.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A physical examination of the woman is not required to provide', 'section_path': ['8 Schedule for MMA Trainings', 'A physical examination of the woman is not required to provide'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='MMA services.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A written consent of the woman seeking medical methods of', 'section_path': ['8 Schedule for MMA Trainings', 'A written consent of the woman seeking medical methods of'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='abortion is mandatory on the prescribed format.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A minimum of four visits are recommended to complete the', 'section_path': ['8 Schedule for MMA Trainings', 'A minimum of four visits are recommended to complete the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='standard MMA drug protocol.\\n6. Only a Registered Medical Practitioner, as under the MTP Act\\ncan prescribe MMA drugs.\\n7. Fertility can return within 10 days of an abortion.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Most of the contraceptive methods can be started during the', 'section_path': ['8 Schedule for MMA Trainings', 'Most of the contraceptive methods can be started during the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='process of MMA after confirming their eligibility.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'MMA drugs can cause congenital anomalies if pregnancy', 'section_path': ['8 Schedule for MMA Trainings', 'MMA drugs can cause congenital anomalies if pregnancy'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='continues after their intake.'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'A woman should be within accessible limits of a health facility', 'section_path': ['8 Schedule for MMA Trainings', 'A woman should be within accessible limits of a health facility'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='during the MMA process.\\nPlease encircle the correct answer in the following questions:\\n11. Which of the following is recommended for pain management during MMA?\\na. Tablet Paracetamol\\nb. Tablet Ibuprofen\\nc. Injection Diazepam\\nd. Paracervical block'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Which of the following is the LEAST effective route for Misoprostol administration during the', 'section_path': ['8 Schedule for MMA Trainings', 'Which of the following is the LEAST effective route for Misoprostol administration during the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='MMA process?\\na. Sublingual\\nb. Vaginal\\nc. Oral\\nd. Buccal  \\n41\\nTraining Manual\\nFor MMA in Early Gestation\\n13. Which contraceptive methods CANNOT be started on the day of taking Misoprostol?\\na. Combined Oral Contraceptive pills\\nb. Centchroman\\nc. IUCD\\nd. Injectables'),\n",
       " Document(metadata={'chapter': '8 Schedule for MMA Trainings', 'section': 'Way to manage an incomplete abortion during the process of MMA is:', 'section_path': ['8 Schedule for MMA Trainings', 'Way to manage an incomplete abortion during the process of MMA is:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='a. Vacuum Aspiration\\nb. Repeat dose of Misoprostol\\nc. Either of the above two depending on the severity of bleeding\\n15. If pregnancy continues after MMA, it should be terminated by a repeat dose of MMA drugs:\\na. Y es, additional dose can be tried\\nb. No, woman should be referred to higher centre for pregnancy termination with Vacuum\\nAspiration\\nc. Pregnancy should be continued  \\nTraining Manual\\nFor MMA in Early Gestation\\n42\\nNotes  \\nTraining Manual\\nFor MMA in Early Gestation\\n44\\nThe Ministry of Health and Family Welfare acknowledges the support of Ipas Development\\nFoundation in circulation of the manual on Medical Methods of Abortion as part of its ongoing\\nefforts to improve the quality of comprehensive abortion care services for women in India.'),\n",
       " Document(metadata={'section_path': [], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='1\\nTraining Manual on Care During Pregnancy and Child Birth\\nfor Community Health Officer\\nat Ayushman Bharat - Health and Wellness Centres\\n2021  \\n2  \\n3\\nTable of Contents Page No.'),\n",
       " Document(metadata={'chapter': '6 Recording Reporing for Reviewing ANC services 55', 'section_path': ['6 Recording Reporing for Reviewing ANC services 55'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Annexure 1: Service Delivery frame work 57\\nAnnexure 2: Blood Pressure Measurement 58\\nAnnexure 3: Height and Weight Measurement 59\\nAnnexure 4: Pelvic Examination 60\\nAnnexure 5: Haemoglobin Test 62\\nAnnexure 6: Urine Sugar and Albumin Test 63\\nAnnexure 7: Blood Sugar Testing by Glucometer 64\\nAnnexure 8: Medical Nutrition Therapy 66\\nAnnexure 9: Malaria Rapid Diagnostic Test 68\\nAnnexure 10: Rapid Diagnostic Test for Syphilis  70\\nAnnexure 11: Rapid Diagnostic Test for Hepatitis B 71\\nAnnexure 12: Rapid Diagnostic Test For HIV/AIDS 72\\nAnnexure 13: Monthly Format for Sub Center and Equivalent Institutions 73\\nAnnexure 14: Monthly Format for PHC and Equivalent Institutions 74  \\n4\\nLIST OF ABBREVIATIONS\\nANM Auxillary Nurse Midwife\\nANC Antenatal Care\\nBCC Behavioural Change Communication\\nCHC Community Health Centre\\nCHO Community Health Officer\\nCMO Chief Medical Officer\\nCAC Comprehensive Abortion Care\\nDH District Hospital\\nEMTCT Elimination of mother to child transmission\\nFRU First referral unit'),\n",
       " Document(metadata={'chapter': '6 Recording Reporing for Reviewing ANC services 55', 'section_path': ['6 Recording Reporing for Reviewing ANC services 55'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='CHO Community Health Officer\\nCMO Chief Medical Officer\\nCAC Comprehensive Abortion Care\\nDH District Hospital\\nEMTCT Elimination of mother to child transmission\\nFRU First referral unit\\nGDM Gestational Diabetes mellitus\\nHIV Human Immuno Virus\\nHDU High Dependency Unit\\nHMIS Health Management Information System\\nICU Intensive care unit\\nICDS Integrated Child Development Services\\nIEC Information Education Communication\\nJSY Janani Suraksha yojana\\nJSSK Janani Shishu Suraksha Karyakram\\nMTP Medical Termination of Pregnancy\\nMDSR Maternal Death Surveillance Response\\nMCH Maternal and Child Health\\nMC Medical College\\nNHP National Health Policy\\nNHM National Health Mission\\nSHC-HWC Sub-Health Centre-Health and Wellness Centre\\nSRS Sample Registration System\\nSDH Sub districtHospital\\nSBA Skill Birth Attendant\\nVHND Village Health Nutrition Day\\nVHSND Village Health Sanitation and Nutrition Day  \\n5\\nIndia has made substantial progress in reducing maternal mortality through evidence-based interventions, financial'),\n",
       " Document(metadata={'chapter': '6 Recording Reporing for Reviewing ANC services 55', 'section_path': ['6 Recording Reporing for Reviewing ANC services 55'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='VHSND Village Health Sanitation and Nutrition Day  \\n5\\nIndia has made substantial progress in reducing maternal mortality through evidence-based interventions, financial\\nresources, infrastructure and human resource strengthening, health promotion strategies, since the launch of\\nNational Health Mission.\\nTo have a better understanding of the progress made in reducing the maternal mortality the progress made so\\nfar is given below:\\nProgress & Target\\nMaternal Health\\nIndicator\\nSRS 2011-13 Current status\\n(SRS 2016-18)\\nNHP Goal\\n(2020)\\nSDG Goal\\n2030\\nMaternal Mortality Ratio 167 113 100 <70\\nIndia’s maternal mortality ratio reduced 54 points from 167 deaths per 100,000 live births (SRS’ 2011-2013) to\\n113 deaths (SRS’ 2016-18). The SDG goal is to have the global MMR at <70 per 100000 live births while the\\nNHP target is to reduce the Maternal Mortality Ratio to 100 by the year 2020.\\nAs per SRS 2016-2018, 5 states have achieved the SDG target while 11 states have already achieved the NHP'),\n",
       " Document(metadata={'chapter': '6 Recording Reporing for Reviewing ANC services 55', 'section_path': ['6 Recording Reporing for Reviewing ANC services 55'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='NHP target is to reduce the Maternal Mortality Ratio to 100 by the year 2020.\\nAs per SRS 2016-2018, 5 states have achieved the SDG target while 11 states have already achieved the NHP\\n2017 targets. The names of these states are given in the table below.\\nStates achieved SDG (70/lakh live\\nbirths)\\nKerala (43), Maharashtra(46) and\\nTamil Nadu(60), Telangana (63),\\nAndhra Pradesh(65)\\nSRS (2016-2018)\\nStates achieved NHP 2017\\nGoals (100/lakh live births)\\nKerala (43), Maharashtra (46),\\nTamil Nadu (60), Telangana (63),\\nAndhra Pradesh (65), Jharkhand\\n(71), Gujarat (75), Haryana (91),\\nKarnataka (92), West Bengal (98),\\nUttarakhand (99)\\nSRS (2016-2018)  \\nAge wise distribution of Maternal Death'),\n",
       " Document(metadata={'chapter': '1 Status of Maternal Health in India', 'section_path': ['1 Status of Maternal Health in India'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='and Service Delivery Framework  \\n6\\nAge wise distribution of the maternal deaths show that 65% of maternal deaths are happening in the age group\\nof 20 to 29 (SRS 2016-2018). The major reasons for maternal deaths are high blood pressure, post-partum\\nhaemorrhage, obstructed labour and abortion.\\nIndia experienced an estimated 30,000 maternal deaths in the year 2018 (HMIS division), this is a decrease of\\n2,400 yearly maternal deaths from 2017.This decrease has happened largely due to improved implementation of\\nkey government interventions under National Health Mission which are shown in the picture below.  \\nThis module will support the Community Health Officer in refreshing their knowledge regarding antenatal and\\npostnatal care of pregnant women.\\nIn order to achieve further decline in maternal mortality as envisaged in the NHM 2017, it is important to ensure\\nthat every pregnant woman delivering in health facilities is entitled to respectful maternity care during pregnancy'),\n",
       " Document(metadata={'chapter': '1 Status of Maternal Health in India', 'section_path': ['1 Status of Maternal Health in India'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='that every pregnant woman delivering in health facilities is entitled to respectful maternity care during pregnancy\\nand labour. The various components that define ‘Respectful Maternity Care’ are as follows:  \\n7\\nAs a CHO, you should inform the MPWs and ASHAs about the importance of respectful maternity care and to\\ncreate awareness among the community about entitlements of pregnant women and mothers of infants. The\\nservice guarantee at the public health facilities are as follows:  \\n8  \\n9\\nFRAMEWORK FOR MATERNAL HEALTH SERVICES\\nThe Community Health Officer as envisaged in AYUSHMAN BHARAT is the nodal person for the Health and\\nWellness Centre and they will be working as ambassadors of Ayushman Bharat. The essential outputs for the\\nCommunity Health officer for the maternal health programme will be as under'),\n",
       " Document(metadata={'chapter': '1 Status of Maternal Health in India', 'section': 'SERVICE PROVISION', 'section_path': ['1 Status of Maternal Health in India', 'SERVICE PROVISION'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Community health officer is a trained health worker and is designated to be the in-charge of the health\\nand wellness centre. Thus, service provision becomes one of the key areas of activity. The service\\nprovision has been divided in field level service provision and community level service provision.\\n1.1  Field level/Community level service provision\\nField level (village level) service provision forms one of the core components of the work to be done\\nby Community Health Officer. This activity will ensure that quality care is brought nearest to the\\ncommunity. The following activities need to be conducted by CHO in field:\\n1.1.1 Village Health, Sanitation and Nutrition Days (VHSND):\\n1.1.1.1 VHSND plan is made so as to cover all pockets under the geographical area in the jurisdiction of health\\nand wellness centre including hilly, tribal, underserved, hard-to-reach areas.\\n1.1.1.2 Be the lead service provider in VHSND of hard-to-reach and underserved areas or areas with poor'),\n",
       " Document(metadata={'chapter': '1 Status of Maternal Health in India', 'section': 'SERVICE PROVISION', 'section_path': ['1 Status of Maternal Health in India', 'SERVICE PROVISION'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='and wellness centre including hilly, tribal, underserved, hard-to-reach areas.\\n1.1.1.2 Be the lead service provider in VHSND of hard-to-reach and underserved areas or areas with poor\\nANC registration and high home deliveries.\\n1.1.1.3 Services provided in VHSND\\nServices Actions\\nAntenatal care • All pregnant women are to be registered\\n• Registered pregnant women to be given ANC\\n• Dropout pregnant women eligible for ANC are to be tracked and given services\\nImmunization • All eligible children are to be given vaccines as per immunization schedule\\n• All dropout children who do not receive vaccines as per the scheduled doses are\\nto be vaccinated\\n• Vitamin A solution is to be administered to under-five children\\nNutrition • All under-six children are to be weighed every month and their height to be\\nrecorded every quarter, and data to be entered in CAS application and plotted\\non MCP card simultaneously by AWW\\n• Underweight and wasted children are to be identified and managed appropriately.'),\n",
       " Document(metadata={'chapter': '1 Status of Maternal Health in India', 'section': 'SERVICE PROVISION', 'section_path': ['1 Status of Maternal Health in India', 'SERVICE PROVISION'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='recorded every quarter, and data to be entered in CAS application and plotted\\non MCP card simultaneously by AWW\\n• Underweight and wasted children are to be identified and managed appropriately.\\nIdentified SAM children with medical complications to be referred to the NRC or\\nhealth facility with paediatric care facilities. All under-six children to be provided\\nsupplementary nutrition\\nFamily Planning • All eligible couples are to be given condoms, Combined Oral Contraceptives\\n(COCs), Centchroman (Chhaya), Emergency Contraceptives Pills (ECP) as per\\ntheir choice and referrals made for other contraceptive services\\nHBV, Syphillis and HIV • Screening and referral, ensuring confidentiality (HIV)'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section_path': ['2 Maternal Health Service Provision'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='10\\n1.1.1.4 In these field level VHSNDs the CHO should in coordination with ANM and ASHA, undertake all the\\nimportant tasks to be done as per VHSND guidelines, like, ensuring 100 percent attendance of all ANC\\nwomen enrolled in that VHSND, ANC check-up including blood pressure, sugar, haemoglobin etc.,\\nidentification of high-risk pregnancy, immunization of ANC, IFA distribution, calcium distribution etc.\\n1.1.1.5 CHO should ensure that all the pregnant women are registered in first trimester of pregnancy and all\\npregnant women should have 4 ANC check-ups done.\\n1.1.1.6 Counselling to the pregnant women regarding iron and folic acid tablets, calcium tablets, diet etc.\\n1.1.1.7 Counsel about comprehensive abortion services.\\n1.1.1.8 Investigation for Malaria, dengue, HbsAg should be provided.\\n1.1.2 Universal Screening for GDM, HIV and Syphilis\\n1.1.2.1 CHO should ensure that all the pregnant women should mandatorily have tested for GDM, HIV and\\nSyphilis in VHSND clinic.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section_path': ['2 Maternal Health Service Provision'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='1.1.2 Universal Screening for GDM, HIV and Syphilis\\n1.1.2.1 CHO should ensure that all the pregnant women should mandatorily have tested for GDM, HIV and\\nSyphilis in VHSND clinic.\\n1.1.3 Janani Suraksha Yojana (JSY):\\n1.1.3.1 CHO should ensure that all the ANC mothers have got their bank account opened so that the direct\\nbenefit transfer of incentives can happen.\\n1.1.4 Janani Shishu Suraksha Karyakram (JSSK)\\n1.1.4.1 CHO should ensure that all the ANC mothers are made aware of all the entitlements under the JSSK\\nprogram like: Free referral and transport to the hospital and drop back, free drugs and diagnostics, Free\\ndiet. This will ensure that out of pocket expenditure does not happen.\\n1.1.5 Home delivery:\\n1.1.5.1 CHO should ensure that a proper birth plan is made, and the pregnant woman is counselled to have\\nan institutional delivery.\\n1.1.5.2 The CHO should be ensuring that in case the pregnant women undergoes home delivery, then the\\nhome delivery is conducted by them.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section_path': ['2 Maternal Health Service Provision'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='an institutional delivery.\\n1.1.5.2 The CHO should be ensuring that in case the pregnant women undergoes home delivery, then the\\nhome delivery is conducted by them.\\n1.1.6 Home Visits to Mother in PNC period:\\n1.1.6.1 CHO should visit all the PNC women’s home within 48 hours of birth, and on 3rd, 7th, 14th, 28th\\nand 42nd day of pregnancy.\\n1.1.6.2 In this visit, the CHO should do a thorough examination of the PNC women as per guidelines and do\\nproper reporting in the formats.\\n1.1.7 Maternal Death Review:\\n1.1.7.1 Actively take part in identifying and reporting all the female deaths in the reproductive age groups and\\nreporting them.\\n1.1.7.2 Help the team in community based maternal death review.  \\n11'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'Facility Level service provision', 'section_path': ['2 Maternal Health Service Provision', 'Facility Level service provision'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='1.2.1 Routine OPD: CHO should ensure that all the OPD services are happening daily and pregnant\\nwomen are examined daily.\\n1.2.2 VHSND: CHO should conduct VHSND in the SHC-HWC and provide all the range of services as\\nmentioned in field level VHSND above.\\n1.2.3 Labour Room and Delivery:\\ni. In place where the HWC is a delivery point the CHO (Nurse) will do the normal delivery of the pregnant\\nwoman only after getting SBA training.\\nii. All the identified high-risk pregnant women should be referred to higher centre.\\niii. CHO will ensure that the labour room is equipped as per the maternal health guidelines and all the\\nlogistics and drugs as needed in the labour room should be present.\\niv. Partograph should be plotted and active management of third stage of labour should be done for all\\ndelivery cases.\\nv. All the complications of delivery cases like PPH, Eclampsia etc. to be stabilised and then referred to\\nappropriate higher centres where the care for that health condition is available.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'Facility Level service provision', 'section_path': ['2 Maternal Health Service Provision', 'Facility Level service provision'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='v. All the complications of delivery cases like PPH, Eclampsia etc. to be stabilised and then referred to\\nappropriate higher centres where the care for that health condition is available.\\nvi. Undertake breast crawl and initiate breastfeeding. Every newborn, when placed on mother’s abdomen,\\nsoon after birth, has the ability to find its mother’s breast on its own and to decide when to breastfeed.\\nThis is called ‘Breast Crawl’, which is helpful to baby as early initiation of breastfeeding is successfully\\nestablished for nutrition, and to the mother as it helps in uterine contraction for faster expulsion of\\nplacenta, reduce maternal blood loss and prevents anemia. CHO should support the mother to provide\\nconfidence and direction to baby.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'SUPERVISORY', 'section_path': ['2 Maternal Health Service Provision', 'SUPERVISORY'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='2.1.1 The CHO will supervise all the work done by her team of ANM and ASHA with regard to maternal\\nhealth programme.\\n2.1.1.1 Supervisor of ANM:\\na. Early diagnosis of pregnancy using Nischay Kits.\\nb. Register all the pregnant women in the first trimester of pregnancy.\\nc. Ensuring four antenatal care checks in VHSND.\\nd. Provide Folic acid and Iron, folic acid tablet to and calcium tablets to all normal and anemic (mild and\\nmoderate) pregnant women as per their blood haemoglobin level.\\ne. Provide TT/TD immunization to all pregnant women.\\nf. Test all pregnant women for urine albumin and sugar, haemoglobin, syphilis, HIV and blood grouping.\\ng. Counselling regarding care during pregnancy including information about nutritional requirements  \\n12\\nh. Identifying high risk pregnancies and appropriate referral.\\ni. Supporting birth planning.\\nj. Maintaining the RCH register and do entry for ANMOL Portal.\\nk. Ensuring bank account for all pregnant women for JSY and other DBT transfer.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'SUPERVISORY', 'section_path': ['2 Maternal Health Service Provision', 'SUPERVISORY'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': []}, page_content='i. Supporting birth planning.\\nj. Maintaining the RCH register and do entry for ANMOL Portal.\\nk. Ensuring bank account for all pregnant women for JSY and other DBT transfer.\\nl. Making PNC home visit on 0, 3, 7, 14, 21, 28 days.\\nm. Support and hand hold ANM in her supervision of ASHA.\\nn. Help and support ANM in doing the birth planning of the pregnant women.\\n2.1.1.2 Supervisor and Mentor of ASHA:\\na. CHO may and should act as a resource person for training of ASHA.\\nb. Guide the ASHA in beneficiary mobilisation for VHSND.\\nc. Motivate and guide ASHA for taking the pregnant women for check-up in PMSMA clinic and to\\ndelivery points during labour.\\nd. Motivate and guide ASHA for ensuring adherence to IFA and Calcium supplementation during\\npregnancy.\\n3. REFERRAL & LINKAGES\\n3.1 Up referral with PHC, CHC, DH/MC\\n3.1.1 Pradhan Mantri Surakshit Matritwa Ashwasan(PMSMA)\\n3.1.1.1 CHO should ensure that all pregnant women in second and third trimester should compulsorily attend'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'SUPERVISORY', 'section_path': ['2 Maternal Health Service Provision', 'SUPERVISORY'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='3.1 Up referral with PHC, CHC, DH/MC\\n3.1.1 Pradhan Mantri Surakshit Matritwa Ashwasan(PMSMA)\\n3.1.1.1 CHO should ensure that all pregnant women in second and third trimester should compulsorily attend\\nat least one PMSMA clinic.\\n3.1.2 High Risk ANC and Complications of Delivery:\\n3.1.2.1 CHO should map the higher facilities (PHC, CHC, SDH,DH) with respect to the type of emergency\\nmaternal health service provided by them and establish linkages with them so that assured up referral\\ncan be done.\\n3.1.2.2  Example: A case of postpartum haemorrhage, eclampsia, retained placenta and sepsis should be\\nreferred directly to a centre with blood transfusion facility and posting of a gynaecologist/EmOC trained\\nmedical officer.\\n3.1.2.3  Example: Pregnant women with high blood pressure or GDM, or Syphilis can be referred to a PHC or\\na CHC with MBBS Medical Officer or for PMSMA.\\n3.1.2.4 All the high-risk pregnant women should be referred to higher facility with a properly filled referral slip,'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'SUPERVISORY', 'section_path': ['2 Maternal Health Service Provision', 'SUPERVISORY'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='a CHC with MBBS Medical Officer or for PMSMA.\\n3.1.2.4 All the high-risk pregnant women should be referred to higher facility with a properly filled referral slip,\\nwhich will help in identifying the complication for which the pregnant women has been referred for, the\\ntreatment given so far and help needed.\\n3.1.2.5 CHO should telephonically contact the higher centre and inform them about the referral made.  \\n13\\n3.1.3 Comprehensive Abortion Care\\n3.1.3.1 CHO should identify women who need the services for medical or surgical termination of pregnancy\\nand refer them to appropriate higher centre.\\n3.2 Back referral from PHC, CHC, DH/MC.\\n3.2.1 CHO should ensure that all the pregnant women who were referred to a higher centre should be back\\nreferred to the CHO and the CHO should ensure treatment compliance and follow up on the advice\\ngiven by higher centre.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'Down Referral to ASHA', 'section_path': ['2 Maternal Health Service Provision', 'Down Referral to ASHA'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='3.3.1 CHO should guide the ASHA regarding the follow-up and ensuring treatment compliance to the\\npregnant women.'),\n",
       " Document(metadata={'chapter': '2 Maternal Health Service Provision', 'section': 'Linkages with Line departments', 'section_path': ['2 Maternal Health Service Provision', 'Linkages with Line departments'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='3.4.1 Linkages with ICDS for organising VHSND and maternal nutrition.\\n3.4.2 Linkages with ICTC for referral and testing and treatment of HIV suspected cases.\\n3.4.3 Linkages with RNTCP for referral and testing and treatment of pregnant women with TB  \\n14'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Quality antenatal care is the cornerstone to improve maternal health and a crucial challenge. Good quality\\nand full completion of ANC check-ups are critical for reducing the persisting burden of maternal and newborn\\nmortality. In this chapter you will learn about the importance of early detection of pregnancy, antenatal care and\\nits essential components including:\\n∙ Calculation of expected pregnancies\\n∙ Schedule of antenatal assessment\\n∙ History taking for pregnant mothers\\n∙ Physical Examination, General Examination and Abdominal Examination\\n∙ ANC related Investigations– Urine test for pregnancy, Haemoglobin Test, Urine test for proteins and sugar,Oral\\nGlucose Tolerance Test (OGTT),RDT for Malaria, HIV, Dengue, HBsAg, and RDT for Syphilis etc.\\n∙ Counselling\\na. Calculation of Expected Pregnancies\\nTo ensure complete registration, it is essential that you know the estimated number of pregnancies to be registered'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ Counselling\\na. Calculation of Expected Pregnancies\\nTo ensure complete registration, it is essential that you know the estimated number of pregnancies to be registered\\nannually in your area. In case the number of pregnancies registered is less than that of the estimated pregnancies,\\nyou need to track down the pregnancies you have missed with the help of ASHAs and ANMs\\nYou have learnt in Induction Module, the calculation of expected pregnancies at your Sub Centre Health and\\nWellness Centres of 5000 population.Suppose the birth rate of the district is 20 per 1000 population, then,\\n100 children will be born for a population of 5000; then 110 women will become pregnant in the population,\\nconsidering 10 % wastage; in any month, you should have about at least 52-53 pregnancies registered with you.\\nSome women may be receiving ANC from the private sector. Ensure that their names with the names of the\\nfacilities where they are registered are mentioned in your RCH register/ANMOL.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='Some women may be receiving ANC from the private sector. Ensure that their names with the names of the\\nfacilities where they are registered are mentioned in your RCH register/ANMOL.\\nb. Early detection of pregnancy\\nEarly diagnosis of pregnancy is necessary to ensure adequate care to pregnant mother, foetal growth and\\ndevelopment and safe delivery. It should be undertaken as early as possible after the first missed period. ASHAs\\nhave a list of eligible couples for their population and undertake household visits to facilitate early identification of\\npregnancy using Nishchay kits.\\nUndertaking Pregnancy Detection Test:\\nProcedure\\n∙ Remove the pregnancy test Cassette from the\\npregnancy kit. Keep this card on a flat surface.\\n∙ Use the dropper to take morning sample of urine. Put\\n2-3 drops in the well-marked ‘S’.\\n∙ Wait for 5 minutes.  \\n15\\nResult:\\n∙ If one red band appears in the result window ‘R’, the pregnancy test is negative.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='2-3 drops in the well-marked ‘S’.\\n∙ Wait for 5 minutes.  \\n15\\nResult:\\n∙ If one red band appears in the result window ‘R’, the pregnancy test is negative.\\n∙ If two parallel red bands appear, the pregnancy test is positive.\\nc. Determining LMP and EDD:\\n∙ As a first step you would take the menstrual history to calculate\\nthe EDD and prepare a birth plan.\\n∙ Recall that the LMP refers to the FIRST day of the woman’s last\\nmenstrual period.\\n∙ Make sure that the woman is not referring to the date of the first\\nmissed period, i.e., the date when menstruation was expected to\\noccur the following month and failed to occur.\\n∙ If the woman is unable to remember the exact date, encourage\\nher to remember some major event,festival, or occurrence which\\nshe might link with her LMP.\\n∙ If the exact date of the LMP is not known and it is late in the pregnancy, ask for the date when the foetal\\nmovements were first felt. This is known as ‘quickening’ and is felt at around 20 weeks of gestation. This'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='movements were first felt. This is known as ‘quickening’ and is felt at around 20 weeks of gestation. This\\ninformation would give a rough idea about the period of gestation, which needs to be correlated with the\\nfundal height to estimate the gestational age.\\n∙ Calculate the EDD using the formula in box. It is based on the assumption that the menstrual cycle of the\\nwoman was regular before conception and that it was a 28–30 days’ cycle.\\nEDD = Date of LMP + 9 months + 7 days\\nd. Schedule of Antenatal visits and Timing of Registration:\\n∙ The first visit or registration of a pregnant woman for ANC should take place as soon as the pregnancy is\\nsuspected, and you would need to ensure that ASHAs and MPWs are able to register all pregnant women\\nfrom the HWC service area.\\n∙ Including the registration, four antenatal check-ups should be ensured for every pregnant woman as per the\\nschedule below:\\nNo. of Visit Timings of Visit\\n1st Visit Within 12 weeks, preferably as soon as pregnancy is suspected'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [3, 4], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='schedule below:\\nNo. of Visit Timings of Visit\\n1st Visit Within 12 weeks, preferably as soon as pregnancy is suspected\\n2nd Visit Between 14-26 weeks\\n3rd Visit Between 28-36 weeks\\n4th Visit Between 36 weeks and term\\nPMSMA check-up In 2nd or 3rd trimester\\nAs a CHO, under PMSMA you will need to:\\n∙ Follow up with ASHAs to ensure that at least one ANC is conducted by the Medical Officer of the PHC.\\n∙ Inform and refer the mother to avail ANC check-ups as part of the Pradhan Mantri Surakshit Matritva\\nAbhiyan. This programme aims to provide assured, comprehensive, and quality antenatal care, free of cost,\\nuniversally to all pregnant women on the 9th of every month at designated government health facilities.  \\n16\\n∙ Inform the pregnant mothers and caregivers that under PMSMA programme, free antenatal check-up services\\nat designated PHCs/CHC/DH would be provided by specialists such as Obs-Gynaec/Radiologists/physicians'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='at designated PHCs/CHC/DH would be provided by specialists such as Obs-Gynaec/Radiologists/physicians\\nwith support from private sector doctors to supplement the efforts of the government hospital.\\n∙ Ensure that the ASHA maintains the line list of beneficiaries.\\n∙ Create awareness on the importance of regular health check-ups during ANC period including PMSMA and\\nalso after delivery i.e., during postnatal care period.\\n∙ Support ASHA and ANM in identifying missed-out cases that is those pregnant women who have not\\nregistered and have not received any antenatal care services.\\n∙ Support ASHA and ANM in identifying left out pregnant women,i.e., those pregnant women who after\\nregistering or receiving first ANC check-up have not received three more ANC check-ups.\\n∙ Ensure mobilisation of beneficiaries to avail services during PMSMA.\\n∙ Ensure that those high-risk pregnant women who have been referred to higher level centre during the previous'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Importance of Antenatal Care', 'section_path': ['3 Care during Pregnancy', 'Importance of Antenatal Care'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='∙ Ensure mobilisation of beneficiaries to avail services during PMSMA.\\n∙ Ensure that those high-risk pregnant women who have been referred to higher level centre during the previous\\nPMSMA, visit the higher centre for management and treatment of the complications.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Antenatal Assessment and its Components', 'section_path': ['3 Care during Pregnancy', 'Antenatal Assessment and its Components'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['nutrition']}, page_content='Essential Components of Antenatal Care\\n∙ Early registration (Refer Section 2.4)\\n∙ History taking\\n∙ Physical examination (Weight, BP, pallor, respiratory rate, edema)\\n∙ Abdominal palpation\\n∙ Vaginal examination\\n∙ Laboratory investigations – Hb, Urine for sugar and proteins, Rapid testing for Syphilis screening, tieup with\\nnearest ICTC/PPTCT Centre for: Rapid testing kits for HIV screening and Referral and management of +ve\\ncases, OGTT testing for Gestational Diabetes, Ultrasound etc.\\n∙ Optional Investigations – Hepatitis B and Australia Antigen testing and Thyroid Stimulating Hormone\\n∙ Tetanus Toxoid Vaccination or Tetanus and Adult Diphtheria (td) Vaccine\\n∙ IFA and Calcium Supplementation\\n∙ Calcium Supplementation – Two tablets of Calcium after first trimester for next six months\\n∙ Deworming\\n∙ Malaria Prophylaxis and Treatment\\n∙ Nutritional Counselling\\n∙ Micro birth planning\\na. History Taking\\nThe history taking is important because it will help to:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Antenatal Assessment and its Components', 'section_path': ['3 Care during Pregnancy', 'Antenatal Assessment and its Components'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='∙ Deworming\\n∙ Malaria Prophylaxis and Treatment\\n∙ Nutritional Counselling\\n∙ Micro birth planning\\na. History Taking\\nThe history taking is important because it will help to:\\n∙ Identify whether there were complications during previous pregnancy that may have a bearing on the present\\none.  \\n17\\n∙ Identify any current medical/surgical or obstetric condition(s) that may complicate the present pregnancy.\\nWhile taking the history, it is important to ensure privacy and make the woman feel calm and relaxed. As the\\npregnant woman will be under your care for nine months it is important that you establish a rapport with her and\\nmake her feel comfortable. Remember to record all findings in the MCP card and highlight abnormal findings. In\\ncase the pregnant woman has not met the MPWs and ASHAs of her area, you will need to introduce her to your\\nteam members and inform that these members of your team will also contact her at home or during VHSND'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Antenatal Assessment and its Components', 'section_path': ['3 Care during Pregnancy', 'Antenatal Assessment and its Components'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='team members and inform that these members of your team will also contact her at home or during VHSND\\nsessions to undertake – time-to-time ANC assessment, provide information and counselling and other necessary\\nservices such asTT immunization etc.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Start with collecting the following history:', 'section_path': ['3 Care during Pregnancy', 'Start with collecting the following history:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='- Age of woman\\n- Order of pregnancy\\n- Birth interval'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Normal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased\\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExamine symptoms of complications – Fever, persistent vomiting with dehydration, palpitations,\\ntiredness, breathlessness at rest/on mild exertion, generalised swelling of body/facial puffiness, severe\\nheadache and/or blurring of vision, passing smaller amount of urine or burning micturition, leaking or bleeding\\nper vagina, abnormal vaginal discharge/itching, high blood pressure detected in ANC, leaking for more than\\n12 hours without labour pain and decreased or absent foetal movements and presence of goitre.\\n3. Take Obstetric History– It is essential to ask the woman about her previous pregnancies or obstetric\\nhistory to determine if there were any complications in previous pregnancies. Some complications may recur\\nduring the present pregnancy. Obtain the following information while taking the obstetric history:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='during the present pregnancy. Obtain the following information while taking the obstetric history:\\n∙ Ask about the number of previous pregnancies. Confirm whether they were all live births, and if there was\\nany still birth, abortion or any child who died.\\n∙ Ascertain the date and outcome of each event, along with the birth weight, if known. It is especially\\nimportant to know about the last pregnancy.\\n∙ Obtain information about any obstetric complications and events in the previous pregnancies. The\\ncomplications and events to be inquired about are as follows:Recurrent early abortion, post-abortion\\ncomplications, hypertension, pre-eclampsia or eclampsia, Ante-Partum Hemorrhage (APH), breech or\\ntransverse presentation, obstructed labour, including dystocia, perineal injuries/tears, Excessive bleeding\\nafter delivery and puerperal sepsis.\\n∙ Ascertain whether the woman has had any obstetrical operations (caesarean sections/instrumental'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='after delivery and puerperal sepsis.\\n∙ Ascertain whether the woman has had any obstetrical operations (caesarean sections/instrumental\\ndelivery/vaginal or breech delivery/manual removal of the placenta).\\n∙ Ask for a history of blood transfusions.\\n4. Ask for any Current/Past Systemic Illnesses– Find out whether the woman has or is suffering from\\nany of the following:High blood pressure (hypertension), diabetes, breathlessness on exertion, palpitations\\n(heart disease), chronic cough, blood in the sputum, prolonged fever (tuberculosis), renal disease, thyroid\\ndysfunction (Hypothyroidism and Hyperthyroidism) or any previous thyroid surgery, convulsions (epilepsy),  \\n18\\nattacks of breathlessness or asthma, jaundice, malaria and any other illnesses, e.g., Reproductive Tract\\nInfection (RTI), Sexually Transmitted Infection(STI) and HIV/AIDS.\\n5. Family history of systemic illness – Ask the woman whether there is a family history of hypertension'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Infection (RTI), Sexually Transmitted Infection(STI) and HIV/AIDS.\\n5. Family history of systemic illness – Ask the woman whether there is a family history of hypertension\\nthyroid dysfunction, diabetes or tuberculosis,asthma,thalassemia or whether anybody in the family has received\\nrepeated blood transfusions.If present, such a history predisposes the woman to developing these problems\\nduring pregnancy (e.g., hypertensive disorders of pregnancy and gestational diabetes).\\nYou must also ask if anybody in the family has had twins and/or given birth to an infant with congenital\\nmalformation, as the presence of such a history in the family increases the chances of the woman giving birth\\nto a child with the same condition.\\n6. History of Drug Intake or Allergies – It is important to find out if the woman is allergic to any drug, or\\nif she is taking any drug that might be harmful to the foetus.\\n7. History of Intake of Harmful Substances – Ask the woman if she chews or smokes tobacco and/takes'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='if she is taking any drug that might be harmful to the foetus.\\n7. History of Intake of Harmful Substances – Ask the woman if she chews or smokes tobacco and/takes\\nalcohol. The woman should be advised to stop consuming alcohol and using tobacco during pregnancy or\\neven after the delivery because it may cause other problems/complications, such as addiction and/or cancer.\\nFurther, passive smoking can harm the foetus.\\nIndications for Referral based on history of pregnant woman\\nRefer pregnant women to the 24-hour PHC for ANC and delivery:\\na. If you identify any symptoms of complications\\nb. If you identify the following from previous obstetric history:\\n∙ Stillbirth or neonatal loss\\n∙ Three or more spontaneous consecutive abortions\\n∙ Obstructed labour\\n∙ Premature births, twins, or multiple pregnancies\\n∙ Weight of the previous baby <2500 g or >4500 g\\n∙ Admission for hypertension or pre-eclampsia/eclampsia in the previous pregnancy\\n∙ Surgery on the reproductive tract\\n∙ Congenital anomaly'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='∙ Weight of the previous baby <2500 g or >4500 g\\n∙ Admission for hypertension or pre-eclampsia/eclampsia in the previous pregnancy\\n∙ Surgery on the reproductive tract\\n∙ Congenital anomaly\\n∙ Treatment for infertility\\n∙ Spinal deformities, such as scoliosis/kyphosis/polio\\n∙ Rh negative in the previous pregnancy\\nc. If you identify any past systemic illness\\nd. If there is history of thalassemia  \\n19\\nc. Physical Examination\\nThis activity needs to be conducted during all the visits. The initial\\nreadings may be taken as a baseline with which the later readings are\\nto be compared.\\nGeneral examination involves following steps:\\nLook for Pallor:\\nPresence of pallor indicates anemia. Examine the woman’s conjunctiva,\\nnails, tongue, oral mucosa and palms. Increase in pallor is linked with\\nworsening anemia and should be verified with haemoglobin estimation\\nand other investigations to identify the needs for referral to the PHC-\\nMedical Officer in case anemia worsens.\\nLook for Jaundice:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='worsening anemia and should be verified with haemoglobin estimation\\nand other investigations to identify the needs for referral to the PHC-\\nMedical Officer in case anemia worsens.\\nLook for Jaundice:\\n1. Jaundice is a yellowish staining of the skin and sclera (the whites of the eyes), caused by high levels of the\\nchemical bilirubin in the blood. Jaundice is not a disease, but a sign that can occur in many different diseases.\\n2. Look for yellowish discoloration of the skin and sclera. The colour of the skin and sclera vary depending on\\nthe level of bilirubin. When the bilirubin level is mildly elevated, they are yellowish. When the bilirubin level\\nis high, they tend to be brown.\\nMeasure and record Pulse:\\nThe normal pulse rate is 60–90 beats per minute. If the pulse rate is persistently high or low, with or\\nwithout other symptoms, the woman requires medical attention at the PHC/FRU.\\nMeasure and record Respiratory rate:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='without other symptoms, the woman requires medical attention at the PHC/FRU.\\nMeasure and record Respiratory rate:\\nNormal respiratory rate is 18-20 breaths per minute. If the RR is above 30 breaths per minute and pallor\\nis present, it indicates severe anemia, heart disease or other associated medical problems.\\nShe must be immediately referred to the PHC-Medical Officer for further investigation and\\nmanagement of any illness that may be present.\\nLook for Oedema:\\n∙ Oedema (swelling), which appears in the evening and\\ndisappears in the morning after a full night’s sleep, could\\nbe a normal manifestation of pregnancy.\\n∙ Any oedema of the face, hands, abdominal wall, and\\nvulva is abnormal. Oedema can be suspected if a woman\\ncomplains of abnormal tightening of any rings on her\\nfingers.\\n∙ If there is oedema in association with high blood pressure,\\nheart disease, anaemia or proteinuria, the woman should\\nbe referred to FRU.\\n∙ Non-pitting oedema indicates hypothyroidism or filariasis'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ If there is oedema in association with high blood pressure,\\nheart disease, anaemia or proteinuria, the woman should\\nbe referred to FRU.\\n∙ Non-pitting oedema indicates hypothyroidism or filariasis\\nand requires immediate referral to FRU for investigations.  \\n20\\nMeasure and record Blood Pressure:\\n∙ Measure the woman’s blood pressure at every visit (Annexure\\n2). This is important to rule out hypertensive disorders of\\npregnancy.\\n∙ Hypertension is diagnosed when two consecutive readings\\ntaken four hours or more apart show the systolic blood pressure\\nto be 140 mmHg or more and/or the diastolic blood pressure\\nto be 90 mmHg or more.\\n∙ High blood pressure during pregnancy may signify Pregnancy-\\nInduced Hypertension (PIH) and/or chronic hypertension.\\n∙ If the woman has high blood pressure, check her urine for the\\npresence of albumin. The presence of albumin (+2) together\\nwith high blood pressure is sufficient to categorise her as having\\npre-eclampsia.  Refer her to the PHC-MO immediately.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='presence of albumin. The presence of albumin (+2) together\\nwith high blood pressure is sufficient to categorise her as having\\npre-eclampsia.  Refer her to the PHC-MO immediately.\\n∙ If the diastolic blood pressure of the woman is above 110 mmHg, it is a danger sign that points towards\\nimminent eclampsia. The urine albumin should be estimated at the earliest. If it is strongly positive, the woman\\nshould be referred to the FRU IMMEDIATELY.\\n∙ If the woman has high blood pressure but no urine albumin, she should be referred to the PHC Medical Officer.\\n∙ A woman with PIH, pre-eclampsia or imminent eclampsia requires hospitalisation and supervised treatment\\nat a 24-hour PHC/FRU.\\n∙ CHO/ANM/ASHA must keep in touch with the woman or her family and undertake appropriate follow up\\nof these cases.\\nMeasure and record weight:\\n∙ A pregnant woman’s weight should be taken at each visit. The\\nweight taken during the first visit/registration should be treated\\nas the baseline weight.(Annexure 2)'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['fetal_development', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Measure and record weight:\\n∙ A pregnant woman’s weight should be taken at each visit. The\\nweight taken during the first visit/registration should be treated\\nas the baseline weight.(Annexure 2)\\n∙ Normally, a woman should gain 9-11 kg during her pregnancy.\\nIdeally after the first trimester, a pregnant woman gains around\\n2 kg every month.\\n∙ An inadequate dietary intake can be suspected if the woman\\ngains less than 2 kg per month. She needs to be put on food\\nsupplementation and counselled for adequate dietary intake.\\nLowweight gain usually leads to Intrauterine Growth Retardation\\n(IUGR) and results in the birth of a baby with a low birth weight.\\n∙ Excessive weight gain (more than 3 kg in a month) should raise\\nsuspicion of preeclampsia, twins (multiple pregnancy) or diabetes. Take the woman’s blood pressure and test\\nher urine for proteinuria or sugar. If her blood pressure is high, i.e., more than 140/90 mmHg, and her urine\\nhas proteins or sugar, refer her to the PHC-Medical Officer.  \\n21'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 11, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='her urine for proteinuria or sugar. If her blood pressure is high, i.e., more than 140/90 mmHg, and her urine\\nhas proteins or sugar, refer her to the PHC-Medical Officer.  \\n21\\nNutritional Assessment:\\nPregnant women should be routinely monitored during their ANC visits at facility and community level. After the\\nregistration process, a three-point algorithm should be followed by front line health workers to screen and manage\\npregnant women:\\n∙ Assess (Screen) - Take history, measure all vitals, look for all clinical signs, lab investigations.\\n∙ Classify- The pregnant women will be classified as per table 2 below:\\nCategories  Not at Nutritional\\nRisk\\nAt-Nutritional Risk At Severe Nutritional\\nRisk and Medical Risk\\nAge ≥20 years and 18-<20 years or <18 years or\\nHeight ≥150 cm  and 145-149.9 cm or <145 cm [or\\nBody Mass Index (if\\npregnancy <20 weeks)\\nBMI 18.5-22.9 Kg/m2 or Thinness: BMI 16-\\n18.49 Kg/m2 or\\nSevere thinness: BMI\\n<16 Kg/m2 or\\nOverweight: 23-24.99\\nKg/m2] or\\nObese: 25 Kg/m2 or'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 12, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='Body Mass Index (if\\npregnancy <20 weeks)\\nBMI 18.5-22.9 Kg/m2 or Thinness: BMI 16-\\n18.49 Kg/m2 or\\nSevere thinness: BMI\\n<16 Kg/m2 or\\nOverweight: 23-24.99\\nKg/m2] or\\nObese: 25 Kg/m2 or\\nGestational weight\\ngain\\n2 kg/month, second\\ntrimester onwards\\n<1kg/month [8,9] and\\n>3 kg/month second\\ntrimester onwards or\\nHaemoglobin level ≥11g/dl  7-10.9 g/dl  <7 g/dl or\\nAny medical risk/\\nclinical signs\\nNo sign of night\\nblindness/visible Goitre/\\nskeletal fluorosis and No\\nmedical risk\\nSigns of night blindness/\\npallor: eyes/tongue/\\nnails/palm/visible Goitre/\\nskeletal fluorosis\\nSymptoms suggesting\\nmedical illnesses\\n∙ Supplement/Counsel/Refer- Depending on the classification, supplementation, counselling and/or\\nreferral should be done. Management of pregnant women can be done through interventions given in section\\n2.4.\\n∙ Prophylaxis during Pregnancy\\nPreventive Measures\\nIntervention Composition Dose Regime Timing & Duration Condition\\nTablet Folic Acid 500 microgram One tablet once\\na day'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 13, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third', 'second']}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='2.4.\\n∙ Prophylaxis during Pregnancy\\nPreventive Measures\\nIntervention Composition Dose Regime Timing & Duration Condition\\nTablet Folic Acid 500 microgram One tablet once\\na day\\n1st trimester (once pregnancy\\nconfirmed)\\nNeural tube\\ndefects in foetus\\nTablet Iron Folic\\nAcid (IFA)\\n60 mg Iron and\\n0.5 mg Folic\\nAcid\\nOne tablet once\\na day\\nIn second and third trimester of\\npregnancy for 6 months (180 tablets)\\nand continued for 6 months after\\ndelivery (180 tablets) taken after\\nmeals preferably after dinner\\nAnemia\\nInjection\\nTetanus Toxoid\\n(TT)\\n0.5 ml Tetanus\\nToxoid\\n2 injections\\none month\\napart OR One\\nBooster (I/M in\\nupper arm)\\n1st dose at ANC registration, followed\\nby 2nd dose after one month. Give\\nonly Booster if immunised with 2\\ninjections in previous pregnancy\\nwithin last 3 years\\nMaternal and\\nNeonatal\\nTetanus  \\n22\\nTablet Calcium 500 mg\\ncalcium and\\n250 IU Vitamin\\nD3\\nOne tablet twice\\na day (total 1\\ngm calcium\\ndaily)\\nFrom second trimester (14 weeks)\\nonwards throughout pregnancy for 6'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 14, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Neonatal\\nTetanus  \\n22\\nTablet Calcium 500 mg\\ncalcium and\\n250 IU Vitamin\\nD3\\nOne tablet twice\\na day (total 1\\ngm calcium\\ndaily)\\nFrom second trimester (14 weeks)\\nonwards throughout pregnancy for 6\\nmonths (360 tablets) and continued\\nfor 6 months after delivery (360\\ntablets) taken in between meals Iron\\nfolic acid tablet and calcium tablets\\nshould not be taken together at the\\nsame time. There should be a gap\\nof at least 2 hours between IFA and\\ncalcium for better absorption of\\nboth. Calcium should not be taken\\nimmediately after a meal.\\nPregnancy\\nInduced\\nHypertension\\nand Preterm\\nBirths\\nTablet\\nAlbendazole\\n(Deworming)\\n400 mg One tablet once\\nonly (under\\nobservation)\\nAfter 1st trimester (after 12 weeks) Worm\\ninfestation,\\nanemia,\\nmalnutrition\\nInsecticide\\nTreated Bed-\\nNets (ITN)\\nAt 1st ANC visit Malaria\\nLook for Symptoms of thyroid dysfunction or the presence of goitre:\\nUncontrolled hypothyroidism during pregnancy can lead to preeclampsia, anaemia, miscarriage, low birth weight'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 15, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='Look for Symptoms of thyroid dysfunction or the presence of goitre:\\nUncontrolled hypothyroidism during pregnancy can lead to preeclampsia, anaemia, miscarriage, low birth weight\\nbaby, stillbirth, and rarely congestive heart failure.\\n∙ Look for the symptoms of hypothyroidism: Feeling tired, unable to stand cold temperatures, hoarse voice,\\nswelling of the face, weight gain, constipation, skin and hair changes, including dry skin and loss of eyebrows,\\ncarpal tunnel syndrome (hand tingling or pain), slow heart rate, muscle cramps and irregular menstrual\\nperiods.\\n∙ Routine screening for hypothyroidism during pregnancy is not recommended. A pregnant woman with\\nsymptoms of hypothyroidism, a history of hypothyroidism, or with other endocrine system conditions or\\nhigh-risk pregnant woman should be screened for hypothyroidism.\\n∙ ASHA/ANM will identify pregnant women at risk for hypothyroidism and refer to SHC-HWC and counsel'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 16, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='high-risk pregnant woman should be screened for hypothyroidism.\\n∙ ASHA/ANM will identify pregnant women at risk for hypothyroidism and refer to SHC-HWC and counsel\\nthem for timely testing and follow up. You should make sure that periodic visits are made as per schedule by\\nPW diagnosed with hypothyroidism and that there are no dropouts.\\n∙ You should inform PHC-MO, in case a pregnant woman who has been diagnosed with hypothyroidism is\\nmoving out of the area, a detailed report should be given to her regarding the management plan so that she\\nis able to follow up and continue her treatment wherever she goes.\\nBreast examination:\\n∙ Observe the size and shape of the nipples for the presence of inverted or flat nipples. Try and pull out the\\nnipples to see if they can be pulled out easily. If the nipples are inverted, the woman must be advised to pull\\non them and roll them between the thumb and index finger.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 17, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='nipples to see if they can be pulled out easily. If the nipples are inverted, the woman must be advised to pull\\non them and roll them between the thumb and index finger.\\n∙ A 10cc or 20cc disposable plastic syringe can also be used for correcting inverted nipples. Cut the barrel of\\nthe syringe from the end where the needle is attached. Take out the plunger and put it in from the opposite  \\n23\\nend, which is the cut end of the syringe. Push the piston forward fully, and gently place the open end of\\nthe barrel in such a way that it encircles the nipple and areola. Pull back the plunger, thus creating negative\\npressure. The nipple will be sucked into the barrel and pulled out in the process.\\n∙ Look for crusting and soreness of the nipples. If these are present, the woman must be advised on breast\\nhygiene and the use of emollients such as milk cream.\\nThe breasts must be palpated for any lumps or tenderness. If there are lumps or tenderness,\\nrefer the woman to the MO.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Ask for Symptoms:', 'section_path': ['3 Care during Pregnancy', 'Ask for Symptoms:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 18, 'total_chunks': 19, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='hygiene and the use of emollients such as milk cream.\\nThe breasts must be palpated for any lumps or tenderness. If there are lumps or tenderness,\\nrefer the woman to the MO.\\nFigure 1: Correcting an inverted nipple using a syringe\\nc. Abdominal Examination\\nAbdominal examination helps you to monitor the progress of pregnancy andfoetal growth, check for foetal lie and\\npresentationand auscultate foetal heart sounds.\\nPreparation for abdominal examination- Ensure privacy, examination room should be well lit and airy,woman\\nis asked to empty her bladder,explain the women about the procedure/process,to make her comfortable keep\\ntalking to her,she lies supine with legs partially flexed,stand on her right side and palpate the uterus with warm\\nhands.\\nSteps for abdominal examination:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Measuring Fundal height:', 'section_path': ['3 Care during Pregnancy', 'Measuring Fundal height:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='This indicates the progress of pregnancy and foetal growth. The uterus becomes an abdominal organ after 12\\nweeks of gestation. The gestational age (in weeks) corresponds to the fundal height (in cm) after 24 weeks of\\ngestation. The normal fundal height is different at different weeks of pregnancy. Follow the following steps for\\nmeasuring fundal height\\n∙ Divide the abdomen into parts by imaginary lines to estimate the gestational age through the fundal height.\\n∙ The most important line is the one passing through the umbilicus.\\n∙ Divide the lower abdomen (below the umbilicus) into three parts, with two equidistant lines between the\\nsymphysis pubis and the umbilicus.\\n∙ Similarly, divide the upper abdomen into three parts, again with two imaginary equidistant lines, between the\\numbilicus and the xiphisternum.  \\n24\\n∙ Keep the ulnar border of curved left hand on woman’s abdomen parallel to symphysis pubis. Start from'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Measuring Fundal height:', 'section_path': ['3 Care during Pregnancy', 'Measuring Fundal height:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='umbilicus and the xiphisternum.  \\n24\\n∙ Keep the ulnar border of curved left hand on woman’s abdomen parallel to symphysis pubis. Start from\\nxiphisternum and gradually proceed towards symphysis pubis lifting the hand between each step till a bulge/\\nresistance of uterine fundus is felt. Mark the level of fundus.\\n∙ Remember that while measuring the fundal height, the woman’s legs should be kept straight and not flexed.\\nSee where the fundus of the uterus is and judge according to the indicators given below in figure 2:\\nFigure 2: Measurement of Fundal Height\\nIf there is any disparity between the fundal height and the\\ngestational age as calculated from the LMP or if there is a\\ndifference of 3 cm or more or if there is no growth compared to\\nthe previous check-up, then it should be considered significant.\\nSuch cases require further investigation and should be referred\\nto the MO.\\nIf the height of the uterus is more or less than that indicated'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Measuring Fundal height:', 'section_path': ['3 Care during Pregnancy', 'Measuring Fundal height:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='Such cases require further investigation and should be referred\\nto the MO.\\nIf the height of the uterus is more or less than that indicated\\nby the period of amenorrhea, the possible reasons could be as\\nfollows, given in table below:\\nFigure 3: Assessment of Fundal Height\\nHeight of the uterus more than that\\nindicated by the period of amenorrhea:\\nHeight of the uterus less than that indicated by\\nthe period of amenorrhea:\\n∙ Wrong date of LMP\\n∙ Full bladder\\n∙ Multiple pregnancy/large baby\\n∙ Polyhydramnios\\n∙ Hydrocephalus\\n∙ Hydatidiform mole\\n∙ Wrong date of LMP\\n∙ IUGR\\n∙ Missed abortion\\n∙ Intrauterine Death (IUD)\\n∙ Transverse lie\\n12th week Just palpable above the symphysis pubis\\n16th week  At lower one- third of the distance between the\\nsymphysis pubis and umbilicus\\n20th week  At two-thirds of the distance between the\\nsymphysis pubis and umbilicus\\n24th week  At the level of the umbilicus\\n28th week  At lower one- third of the distance between the\\numbilicus and xiphisternum'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Measuring Fundal height:', 'section_path': ['3 Care during Pregnancy', 'Measuring Fundal height:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [25], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='symphysis pubis and umbilicus\\n24th week  At the level of the umbilicus\\n28th week  At lower one- third of the distance between the\\numbilicus and xiphisternum\\n32nd week  At two-thirds of the distance between the\\numbilicus and xiphisternum\\n36th week  At the level of the xiphisternum\\n40th week  Sinks back to the level of the 32nd week. but the\\nflanks are full, unlike that in the 32nd week  \\n25'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal lie and Presentation:', 'section_path': ['3 Care during Pregnancy', 'Foetal lie and Presentation:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Determining the foetal lie and presentation is relevant only in late pregnancy (32 weeks onwards). Before that, it\\nis important to only palpate the foetal parts while conducting an abdominal examination.\\nThe normal lie at term in the majority of pregnancies is longitudinal, with a cephalic presentation.\\nAny other lie is abnormal, and the woman must be referred to an FRU for the delivery.\\nPalpation to determine foetal lie and presentation\\n∙ The pelvic grips (four in number) are performed to determine the lie and the presenting part of the foetus. The\\ngrips are Fundal grip, Lateral grip, Superficial pelvic grip and Deep pelvic grip (shown in figure 4).\\n∙ Palpate for the foetal lie and assess whether it is longitudinal, transverse or oblique. Remember that even if a\\nmalpresentation is diagnosed before 36 weeks, no active management or intervention is recommended at that\\npoint of time. Advise the woman to go in for an institutional delivery.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal lie and Presentation:', 'section_path': ['3 Care during Pregnancy', 'Foetal lie and Presentation:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='malpresentation is diagnosed before 36 weeks, no active management or intervention is recommended at that\\npoint of time. Advise the woman to go in for an institutional delivery.\\n∙ All health workers should be able to recognise a transverse lie. Missing it can be disastrous because there is no\\nmechanism by which a woman with a transverse lie can deliver normally, i.e., vaginally. The woman needs\\nan elective caesarean section, i.e., she must not go into labour. She should, therefore, be referred to an FRU\\nwhere emergency obstetric services and facilities for a caesarean section are available.\\nFundal Palpation/Fundal Grip: Helps to\\ndetermine lie and presentation of foetus\\nLateral Palpation/Lateral Grip: Helps to locate\\nfoetal back\\nFirst Pelvic Grip/Superficial Pelvic Grip:\\nHelps to determine whether head or breech is\\npresenting at pelvic brim\\nSecond Pelvic Grip/Deep Pelvic Grip: Helps\\nto know the degree of flexion of head'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal lie and Presentation:', 'section_path': ['3 Care during Pregnancy', 'Foetal lie and Presentation:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='First Pelvic Grip/Superficial Pelvic Grip:\\nHelps to determine whether head or breech is\\npresenting at pelvic brim\\nSecond Pelvic Grip/Deep Pelvic Grip: Helps\\nto know the degree of flexion of head\\nFigure 4: Four grips to determine the foetal lie and presentation  \\n26'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='∙ Foetal movement are reliable sign of foetal well-being\\n∙ These are felt around 18-22 weeks of pregnancy (felt earlier in multigravida than primigravida)\\n∙ Normally 10-12 foetal movements should be felt by the pregnant woman in a day\\n∙ Decreased foetal movements may be an indication of foetal distress\\n∙ Pattern of foetal movement may change prior to labour due to reduced space. But foetal activity should\\ncontinue throughout pregnancy and labour\\n4. Foetal Heart Sound (FHS) and Rate (FHR)\\n∙ FHS is heard per abdomen by stethoscope/fetoscope\\nafter 24 weeks of pregnancy\\n∙ Normal FHR is 120-160 beats per min\\n∙ FHR < 120 beats per min or > 160 beats per\\nminindicates foetal distress and calls for referral\\n∙ Best heard on the side of the back of the foetus\\n∙ In vertex presentation FHS is best heard midway\\nbetween the line joining the umbilicus and the anterior\\nsuperior iliac spine on the side of the back\\n∙ In breech presentation FHS is heard above the umbilicus'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='between the line joining the umbilicus and the anterior\\nsuperior iliac spine on the side of the back\\n∙ In breech presentation FHS is heard above the umbilicus\\n∙ Count the FHS for one full minute (FHR)\\nFigure 11: Location of FHS using foetoscope\\nFigure 10: Auscultation of FHS\\n(Note: ROA right occipitoanterior\\nLOA left occipitoanterior)  \\n27\\nKey points to remember\\n∙ An abdominal examination and auscultation of FHS must be recorded during each visit to monitor\\nprogress of pregnancy, foetal viability and growth\\n∙ Maintain privacy and obtain verbal consent before examination\\n∙ The bladder should be emptied before examination\\n∙ During palpation, ensure that the woman partially flexes her legs and knees\\n∙ foetal lie and presentation may be ascertained in palpation during the 3rd trimester\\n∙ Correlate the fundal height in weeks with LMP and also correlate with fundal –symphysis pubic\\nheight in cm\\nd. Vaginal Examination'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='∙ Correlate the fundal height in weeks with LMP and also correlate with fundal –symphysis pubic\\nheight in cm\\nd. Vaginal Examination\\nVaginal examination is a tool to assess the cervix’s favourability for induction or to confirm the progress of labour\\nby assessing the cervical dilatation. Detailed step wise procedure is enclosed in annexure 3.\\nVaginal examination should not be carried out if there is any history of vaginal bleeding, previous history of\\nmiscarriage, and early rupture of membrane.Prior to the procedure, an abdominal assessment and auscultation\\nof the foetal heart should be undertaken.\\nIndications for referral based on Physical Examination of Pregnant Woman\\nRefer the pregnant woman to 24-hour PHC/FRU for further examination in following cases:\\na. If you identify any symptoms of complications\\nb. If you identify the following from physical examination\\n∙ Severe anemia (Hb less than 7gm/dl or paleness inside eyelids and fingernails)'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='a. If you identify any symptoms of complications\\nb. If you identify the following from physical examination\\n∙ Severe anemia (Hb less than 7gm/dl or paleness inside eyelids and fingernails)\\n∙ Jaundice (yellowish discoloration of skin and conjunctiva or high bilirubin level)\\n∙ Pulse rate >90 beats/min or <60 beats/min\\n∙ Respiratory rate > 30 breaths/min along with anemia\\n∙ Oedema of face, hands, abdominal walland vulva or tightening of finger rings\\n∙ Oedema with high blood pressure, heart disease or proteinuria\\n∙ Non pitting oedema with hypothyroidism or filariasis\\n∙ Pregnancy induced hypertension (BP more than 140/90 mm Hg)\\n∙ Pre-eclampsia (High BP along with albuminuria)\\n∙ Imminent eclampsia (Diastolic pressure above 110 mm Hg with albuminuria)\\n∙ Excessive weight gain (more than 3kg/month) along with pre-eclampsia or diabetes\\n∙ Foetal growth retardation\\n∙ Multi-foetal pregnancy\\n∙ Lump or tenderness in breast\\n∙ Uterus height more than 3cm different from gestational age'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='∙ Foetal growth retardation\\n∙ Multi-foetal pregnancy\\n∙ Lump or tenderness in breast\\n∙ Uterus height more than 3cm different from gestational age\\n∙ No foetal movement/heart sound\\n∙ Foetal distress\\n∙ Breech presentation and foetal lie other than longitudinal  \\n28\\ne. Laboratory Investigations\\nLab investigations that will need to be undertaken at the level of HWC-SHCs for ANC assessment are as follows:\\na. Pregnancy Detection Test (refer section 2.1)\\nb. Haemoglobin Test (See Annexure 5)\\nc. Complete Urine Analysis – urine test for albumin and sugar (see Annexure 6)\\nd. Blood sugar testing\\ne. Testing for Malaria if the woman complains of fever with chills (See Annexure 9)\\nf. HIV (Antibodies to HIV 1 and 2)\\ng. RDT for HBsAg\\nh. RDT for Syphilis\\nBlood sugar Examination for Gestational Diabetes Mellitus:\\nTesting for GDM is recommended twice during\\nANC by ANM/CHO by using plasma calibrated\\nglucometer. The first testing should be done\\nduring first antenatal contact as early as possible'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Testing for GDM is recommended twice during\\nANC by ANM/CHO by using plasma calibrated\\nglucometer. The first testing should be done\\nduring first antenatal contact as early as possible\\nin pregnancy. The second testing should be done\\nduring 24-28 weeks of pregnancy if the first test\\nis negative. There should be at least 4 weeks gap\\nbetween the two tests. The test is to be conducted\\nfor every pregnant woman even if she comes\\nlate in pregnancy for ANC at the time of first\\ncontact. If she presents herself beyond 28 weeks\\nof pregnancy, only one test is to be done at the first point of contact. If the test is positive at any point, refer to\\nPHC-MO. Detailed steps of performing blood sugar examination are enclosed in Annexure 7.\\nManagement of GDM at HWC-SHC – All PW who test positive for GDM for the first time should be started\\non Medical Nutrition Therapy (MNT) for 2 weeks.Management through MNT described in Annexure 8.\\nRapid Diagnostic Test for Syphilis:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='on Medical Nutrition Therapy (MNT) for 2 weeks.Management through MNT described in Annexure 8.\\nRapid Diagnostic Test for Syphilis:\\n∙ Availability of Point-of-Care (POC) testing at Sub-centres and outreach sessions such as Village Health\\nSanitation and Nutrition Days (VHSNDs) for all pregnant women and newborns to prevent maternal syphilis\\nand congenital syphilis in newborns.\\n∙ All pregnant women should be tested for syphilis in the first ANC visit itself, which should be as early as\\npossible. The steps of syphilis examination described in Annexure 10.\\n∙ For all syphilis-positive women detected during ANC by either POC or RPR, their newborns should be tested\\nby RPR at PHC/CHC.\\n∙ Women who are at high risk for syphilis, those who live in areas of high prevalence of syphilis, or those who\\nwere untested earlier, should be screened again in the third trimester or at the time of delivery'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='were untested earlier, should be screened again in the third trimester or at the time of delivery\\n∙ The CHO/ANM will record the test results in the MCP card and RCH register. All positive cases should be\\nfollowed up for treatment.\\nUrine Test for the presence of sugar To diagnose women with gestational diabetes\\nGestational diabetes (GDM) is a\\ncondition of high blood glucose levels\\namong women during pregnancy. It usually\\ndisappears after the birth of the baby.\\nRisk factors\\n• Obesity - with a BMI of 30 or over\\n• Family history of Type 2 diabetes\\n• If the mother had previously delivered\\nlarger babies (4 kilograms or more)\\n• If the woman has high blood pressure\\nComplications of Gestational\\nDiabetes\\n• An extra large baby, which can cause a difficult delivery, possible nerve damage, and even stillbirth.\\n• Later development of type 2 diabetes in the mother and the baby.\\nHigh blood\\nglucose level\\nin mother\\nBrings extra\\nglucose to\\nbaby\\nCause baby to put\\non extra weight  \\n29'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='• Later development of type 2 diabetes in the mother and the baby.\\nHigh blood\\nglucose level\\nin mother\\nBrings extra\\nglucose to\\nbaby\\nCause baby to put\\non extra weight  \\n29\\nRapid Diagnostic Test for HBsAg: Rapid diagnostic test for hepatitis is a visual, rapid, sensitive and\\naccurate one step immunoassay for the qualitative detection of Hepatitis B Surface Antigen (HBsAg) in human\\nserum or plasma. Detail steps are enclosed in Annexure 11.\\nRapid Diagnostic Test for HIV/AIDS: The test is a screening test for anti-HIV-1 & anti-HIV-2. Detail steps\\nare enclosed in Annexure 12.\\nYou will need to refer the pregnant woman to PHC for the following tests that need to be conducted during the\\npregnancy: Blood group and Rh type, Total Leucocyte Count, Differential Leucocyte Count, Platelet Count,\\nBleeding and Clotting Test, Serum Bilirubin, Thyroid test, VDRL/RPR (Rapid Plasma Reaginand Ultrasound).'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='Bleeding and Clotting Test, Serum Bilirubin, Thyroid test, VDRL/RPR (Rapid Plasma Reaginand Ultrasound).\\nAlong with examination and investigations, you may also notice some common problems during the pregnancy\\nand take appropriate actions as per table 3 given below:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Foetal Movements:', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['3 Care during Pregnancy', 'Foetal Movements:'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 3: Common Problems of Pregnancy and action to be taken at SHC-HWC by CHOs:\\nSymptoms Signs/\\ninvestigations\\nMost\\nprobable\\ndiagnosis\\nAction(s) to be taken\\nHeart Burn and Nausea Reflux\\noesophagitis\\n∙ Advise the woman to avoid spicy and\\noily foods.\\n∙ Ask her to take cold milk during\\nattacks.\\n∙ If severe, antacids may be prescribed.\\nVomiting during the first\\ntrimester\\nMay be\\nphysiological\\n(morning\\nsickness)\\n∙ Advise the woman to eat small\\nfrequent meals; avoid greasy food; eat\\nlots of green vegetables; and drink\\nplenty of fluids.\\n∙ If vomiting is excessive in the morning,\\nask her to eat dry foods, such as roti/\\nparatha, biscuits, or toast, after waking\\nup in the morning.\\nExcessive vomiting, especially\\nafter the first trimester\\nThe woman may\\nbe dehydrated—\\ndry tongue, loss\\nof skin turgor,\\ndecreased urine\\noutput in severe\\ncases.\\nHyper- emesis\\ngravidarum\\n∙ Start IV and refer to 24 hour PHC/\\nFRU\\nPalpitations, easy fatiguability,\\nbreathlessness at rest\\nConjunctival\\nand/or pallor of\\nthe palm present\\nHb <7g/dl\\nSevere\\nanaemia\\n∙ Refer her to the MO at FRU for further\\nmanagement.\\n∙ Advise her to have a hospital delivery.  \\n30\\nPuffiness of the face,\\ngeneralised body oedema\\nCheck protein in\\nurine. Check BP.\\nIf BP >140/90\\nmmHg on 2\\nreadings and\\nproteinuria\\nabsent\\nHypertensive\\ndisorder of\\npregnancy\\n∙ Advise her to reduce workload and to\\nrest.\\n∙ Advise on danger signs.\\n∙ Re-assess at the next antenatal visit or\\nin one week if more than eight months\\npregnant.\\n∙ If hypertension persists after one\\nweek or at next visit, refer to hospital\\nor MO.\\nIf diastolic BP is\\n≥90 mmHg on\\ntwo readings and\\n2+ proteinuria\\nPre-eclampsia  ∙ Refer to hospital.\\n∙ Revise birth plan.\\nPuffiness of the face,\\ngeneralised body oedema\\nSevere headache\\nBlurred vision\\nEpigastric pain\\nReduced urine output\\nIf diastolic BP is\\n≥110 mmHg and\\n3+ proteinuria\\nSevere Pre-\\neclampsia\\n∙ Give Injection Magsulf, 5 g (10 ml),\\ndeep IM, in each buttock.\\n∙ Refer urgently to PHC/FRU.\\nIncreased frequency of\\nurination up to 10-12 weeks of\\npregnancy\\nMay be\\nphysiological\\ndue to pressure\\nof the gravid\\nuterus on the\\nurinary bladder\\n∙ Reassure her that it will be relieved on\\nits own.\\nIncreased frequency of\\nurination after 12 weeks,\\nor persistent symptoms, or\\nburning on urination\\nTenderness\\nmay be present\\nat the sides of\\nthe abdomen\\nand back. Body\\ntemperature may\\nbe raised.\\nUTI  ∙ Refer the woman to the MO at the\\nPHC.  \\n31\\nConstipation Physiological  ∙ Advise the woman to take more fluids,\\nleafy vegetables and a fibre rich diet.\\n∙ If not relieved, give her Isabgol (2\\ntablespoons to be taken at bedtime,\\nwith water or milk).\\n∙ Do NOT prescribe strong laxatives as\\nthey may start uterine contractions\\nPain in abdomen Fainting\\nRetropubic/\\nsuprapubic pain\\n∙ Ectopic\\npregnancy\\n∙ UTI\\n∙ Refer the woman to the MO at the\\nFRU.\\nBleeding P/V, before 20 weeks\\nof gestation.\\n∙ Check the\\npulse and BP\\nto assess for\\nshock.\\n∙ Ask for\\nhistory of\\nviolence\\n∙ Threatened\\nabortion/\\nsponta-\\nneous\\nabortion/\\nhydatidi-\\nform mole/\\nectopic\\npregnancy\\n∙ Spon-\\ntaneous\\nabortion\\ndue to\\nviolence\\n∙ If the woman is bleeding and the\\nretained products of conception can\\nbe seen coming out from the vagina,\\nremove them with your finger.\\n∙ Start IV fluids.\\n∙ Refer her to the MO of a 24-hour\\nPHC/FRU.\\n∙ Put her in touch with local support\\ngroups.\\n∙ Do NOT carry out a vaginal\\nexamination under any circumstances.\\nBleeding P/V, after 20 weeks\\nof gestation\\nCheck the pulse\\nand BP to assess\\nfor shock.\\nAntepartum\\nhaemorrhage\\nFever\\nBody\\ntemperature is\\nraised Peripheral\\nsmear for\\nmalarial parasite\\n+ve\\nSite of\\ninfection\\nsomewhere,\\nincluding\\npossible sepsis\\nMalaria\\n∙ Refer her to the MO at 24-hour PHC/\\nFRU.\\n∙ If malaria is diagnosed, refer her to\\nthe PHC for management of malaria\\naccording to the NVBDCP guidelines\\nDecreased or absent foetal\\nmovements\\nFHS heard and is\\nwithin the normal\\nrange of 120-\\n160/ minute.\\nBaby is Normal.  ∙ Re-assure the woman.\\n∙ Repeat FHS after 15 minutes.\\n∙ If the FHS is still out of the normal\\nrange, refer her to the MO at 24-hour\\nPHC/FRU\\nFHS heard, but\\nthe rate is 160/\\nminute\\nFoetal distress  ∙ Inform the woman and her family that\\nthe baby might not be well.\\n∙ Refer her to the MO at 24-hour PHC/\\nFRU.FHS not heard Intrauterine\\nfoetal death  \\n32\\nAbnormal vaginal discharge,\\nwith or without abdominal\\npain\\nVaginal discharge\\nwith or without\\nodour\\nRTI/STI Refer the woman to the MO. Advise her\\non vaginal hygiene, i.e., cleaning the\\nexternal genitalia with soap and water.\\nLeaking of watery fluids P/V. Wet pads/cloths Premature\\nRupture of\\nMembrane\\n(PROM)\\n∙ Refer the woman to the MO at FRU\\n∙ Eyes roll\\n∙ Face and limbs twitch\\n∙ Body gets stiff and shakes\\n∙ Fists clinched\\nConvulsions/\\nFits\\n∙ Refer the woman to the MO at FRU\\n∙ Skin rashes with Itching\\n∙ Presence of pus-filled boils\\nScabies and\\nBoils\\n∙ For boils, advice the woman to apply\\nhot fermentations to the area thrice\\ndaily.\\n∙ If no improvement after two days,\\nrefer to PHC\\n∙ For scabies, refer to PHC'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Interventions', 'section_path': ['3 Care during Pregnancy', 'Interventions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='a. Tetanus Toxoid Vaccination or Tetanus and adult Diphtheria Vaccination\\nTetanus Toxoid (TT) vaccine has been replaced with Tetanus and adult\\ndiphtheria (Td) vaccine. The use of Td rather TT is recommended during\\npregnancy to protect against maternal and neonatal tetanus and diphtheria\\nduring prenatal care.\\nAvailable TT will be used first before starting use of Td. The\\nroute, site, dose of td injection is same as TT.\\n∙ A pregnant woman must get td/TT (0.5ml, deep intramuscular in upper arm) during the first antenatal visit.\\n∙ The 2nd injection should preferably be given at least at one month after first dose.\\n∙ If woman receives first dose after 38 weeks of pregnancy, then the second dose may be given in the postnatal\\nperiod, after a gap of 4 weeks.\\n∙ If mother received two td/TT doses in last pregnancy and mother gets again pregnant within 3 years than\\nonly one dose of td/TT is given called as Booster dose.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Interventions', 'section_path': ['3 Care during Pregnancy', 'Interventions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='period, after a gap of 4 weeks.\\n∙ If mother received two td/TT doses in last pregnancy and mother gets again pregnant within 3 years than\\nonly one dose of td/TT is given called as Booster dose.\\n∙ Inform her that there may be a slight swelling, pain, or redness at the site of the injection for a day or two.  \\n33\\nb. Prevention and Management of Anemia (Nutritional and Non-nutritional)\\nAnemia is a condition in which the number of red blood cells,\\n(RBCs) and consequently their oxygen-carrying capacity, is\\ninsufficient to meet the body’s physiological needs. Anemia is a\\nsignificant public health challenge in India. It results from one or\\nmore of the following:\\n∙ Defective red cell production\\n∙ Increased red cell destruction or blood loss\\nAnemia during pregnancy is associated with premature birth,\\nintra and post-partum haemorrhage, low birth weight, stillbirths\\nand maternal deaths.\\nIn 2018, the MoHFW launched the Anemia Mukt Bharat (AMB) strategy to reduce the anemia prevalence in six'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Interventions', 'section_path': ['3 Care during Pregnancy', 'Interventions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='intra and post-partum haemorrhage, low birth weight, stillbirths\\nand maternal deaths.\\nIn 2018, the MoHFW launched the Anemia Mukt Bharat (AMB) strategy to reduce the anemia prevalence in six\\ntarget age groups, namely children 6-59 months, children 5-9 years, adolescents 10-19 years, pregnant women,\\nlactating women and women of reproductive age (15-49 years). The strategy adopts a multi-pronged 6x6x6\\napproach to address both nutritional and non-nutritional anaemia through continuum of care.\\nTypes of anaemia:\\n1. Nutritional Anemia: It is caused due to deficiency of micro-nutrient such as minerals (iron, zinc, copper,\\nselenium etc.) and vitamins (Folic acid, Vit. B12, Vit. B6)\\n2. Non-nutritional Anemia: Due to haemoglobinopathies (thalassemia and sickle cell anemia), Soil\\nTransmitted helminths inflammation, fluorosis and malaria and chronic diseases such as tuberculosis etc.\\nMost common prevalent nutritional deficiency in India is iron deficiency anemia (50%)'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Interventions', 'section_path': ['3 Care during Pregnancy', 'Interventions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Transmitted helminths inflammation, fluorosis and malaria and chronic diseases such as tuberculosis etc.\\nMost common prevalent nutritional deficiency in India is iron deficiency anemia (50%)\\nGrading of anaemia as per WHO is as mentioned in Table below:\\nPopulation Anemia\\nMild Moderate Severe\\nPregnant women 10.0-10.9gm/dl 7-9.9 gm/dl <7gm/dl\\nNutritional anemia:\\nThe cause, signs and symptoms of nutritional anemia is as under:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Interventions', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['3 Care during Pregnancy', 'Interventions'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Table 9: Causes, signs and symptoms of Nutritional Anemia\\nCauses of nutritional anaemia:Signs and symptoms of anaemia:\\n∙ Inadequate intake of the dietary\\niron\\n∙ Improper absorption of iron\\n∙ Loss of iron from the body\\n∙ Worm infestations\\n∙ Tiredness and weakness\\n∙ Breathlessness\\n∙ Pale face, nails, tongue and conjunctiva of eyes\\n∙ Lack of concentration\\n∙ Reduces capacity to work thus decreased productivity\\n∙ Limits learning ability\\n∙ Causes loss of appetite\\n∙ Affects the growth and development\\n∙ Increases vulnerability to infections due to decrease in immunity  \\n34\\nNon-nutritional anemia:\\nNon-nutritional anemia can be due to chronic blood loss in conditions such as heavy menstruation and/or\\nhaemorrhoids. Non-nutritional anemia can also be due to haemoglobinopathies such as sickle cell disease and\\nthalassemia. In areas endemic for malaria, fluorosis and haemoglobinopathies, non-nutritional anemia is a\\ncommon finding.\\nIn the endemic areas, special focus should be given to integrate screening and treatment of anemia, along with\\nscreening and treatment of malaria, haemoglobinopathies and fluorosis respectively.\\nPrevention & Control of anaemia: Intake of adequate and balanced nutrition will cover all the required nutrients\\nto prevent nutritional anaemia.\\nSources of dietary iron: Iron from food comes in two forms: heme and non-heme. Heme is found only in animal\\nflesh like meat, eggs and fish etc. Non-heme iron is found in plant foods like whole grains, nuts, seeds, legumes,\\nand leafy greens. Non-heme iron is also found in animal flesh (as animals consume plant foods with non-heme\\niron) and fortified foods.  \\nHeme and non-heme sources of dietary iron\\nOther than dietary supplements, management of nutritional (Iron deficiency) anemia through iron folic acid\\nsupplementation should be done as per the flow chart given below:\\nFor mild anemia:\\nIf Haemoglobin is 10–10.9 gm/dl (mild anemia)\\nFirst level of treatment\\n(at all levels of care)\\n∙ Two tablets of Iron and Folic Acid tablet (60 mg elemental Iron and\\n500 mcg Folic Acid) daily, orally given by the health provider during\\nthe ANC contact\\nFollow-up  ∙ Every 2 months for compliance of treatment by health provider at\\nregular ANC clinics/PMSMA/VHSND platform/home visits.\\n∙ The contact is to be utilised by the health provider to also conduct\\nhaemoglobin estimation of the anemic cases using digital invasive\\nhemoglobinometer.\\n∙ If haemoglobin levels have come up to normal level (Hb>10.9 gm/dl),\\ndiscontinue the treatment and switch to prophylactic IFA dose.  \\n35\\nIf no improvement after first level of\\ntreatment\\n∙ If no improvement in haemoglobin (<1 g/dl increase) after two months\\nof treatment, refer to First Referral Unit (FRU)/District Hospital (DH)\\nfor further investigation (Complete Blood Count/Hemogram) and\\ncase-specific management.\\nIf Haemoglobin is 7-9.9 gm/dl (moderate anemia)\\nFirst level of treatment\\n(at all levels of care)\\n∙ Two tablets of Iron and Folic Acid tablet (60 mg elemental Iron and\\n500 mcg Folic Acid) daily, orally given by the health provider during\\nthe ANC contact\\nFollow up  ∙ Every month for compliance of treatment by health provider at regular\\nANC clinics/PMSMA/VHSND platform.\\n∙ The contact is to be utilised by the health provider to also conduct\\nhaemoglobin estimation of the anemic cases using digital invasive\\nhemoglobinometer every month.\\n∙ If haemoglobin levels have come up to normal level (Hb>10.9 gm/\\ndl), discontinue the treatment and continue with the prophylactic IFA\\ndose.\\nIf no improvement after first level of\\ntreatment\\n∙ If no improvement in haemoglobin (<1 g/dl increase) after two months\\nof treatment, refer to First Referral Unit (FRU)/District Hospital (DH)\\nby health provider.\\n∙ The case to be referred to FRU/DH for further investigations (Complete\\nBlood Count/ Hemogram) to ascertain the cause of anemia. If anemia\\nis due to iron deficiency and poor compliance with oral iron therapy\\nand period of pregnancy is more than 34 weeks, it can be treated with\\neither Iron-Sorbitol-Citric acid given IM or IV iron. Women with Hb<\\n8 g/dl and period of gestation 36 weeks or beyond may require blood\\ntransfusion.\\nIf Haemoglobin is 5.0–6.9 gm/dl (severe anemia)\\nFirst level of treatment  ∙ Management of severe anemia in pregnant women will be done by the\\nmedical officer at PHC/CHC/FRU/DH\\n∙ For severely anemic pregnant women with haemoglobin less than\\n5 g/dl, immediate hospitalisation irrespective of period of gestation\\nwhere round-the-clock specialist care is available. She will require\\nhospitalisation for care till Hb crosses 8 g/dl or till delivery.  \\n36\\nIn case of moderate and severe anemia:\\nAnaemia Hb < 9.9 gm/dl\\nModerate anaemia (Hb 7-9.9 gm/dl) Severe anaemia (Hb < 7 gm/dl)\\nGestational\\nage <  32 weeks\\nGestational age\\nbetween\\n32 to 34 weeks\\nGestational\\nage ≥ 34 weeks\\nHb 5.0-6.9\\ngm/dl\\nHb <  5.0\\nmg/dl\\nGestational\\nage �  34\\nweeks: Refer\\nurgently to\\nFRU/DH for\\nfurther\\ninvestigation\\n(Complete\\nblood count/\\nHemogram)\\nfor cause of\\nanemia, in\\ncase of ID,\\ntreatment will\\nbe done using\\nIV Iron\\nSucrose\\nImmediate\\nhospitalisation\\nirrespective of\\ngestation for\\ninvestigation\\nand blood\\ntransfusion\\nGestational week >  34 weeks:\\nImmediate hospitalisation\\nirrespective of gestation for\\nblood transfusion\\nTwo tablets of Iron and\\nFolic Acid tablet (60 mg\\nelemental Iron and 500\\nmcg Folic Acid daily\\nRefer to FRU/DH for\\nfurther investigations\\n(complete blood\\ncount/hemogram) and\\ncase management, if\\nfound to be ID\\nFollow up after\\n30 days for\\ncompliance and\\nHb testing\\nIn case of non-\\ncompliance or\\nloss to follow\\nup\\nParental\\ntreatment with\\nIVIS\\nImprovement in\\nHb ≥ 1 gm/dl\\nNo improvement\\nin Hb level\\nContinue IFA\\ntablets and\\ncheck Hb level\\nat the end of\\nnd\\n2  month\\nRefer to FRU/DH\\nfor further\\ninvestigations\\n(complete blood\\ncount/hemogram)\\nand case\\nmanagement\\nIf Hb level >  11\\ngm/dl continue\\nwith\\nprophylactic IFA\\ntablets  \\n37\\nc. Calcium Supplementation and Nutritional Intervention\\n∙ The calcium supplementation in pregnancy reduces incidence of pre-eclampsia and other hypertensive\\ndisorders in pregnancy. It is therefore important to take one tablet daily twice a day containing 500 mg of\\nelemental calcium and 250 IU vitamin D3 started from 14 weeks of pregnancy upto six months post-partum.\\n∙ One calcium tablet should be taken with the morning/afternoon meal and the second tablet with the evening/\\nnight meal. It is not advisable to take both calcium tablets together with iron because calcium interferes with\\niron absorption. Calcium tablets should not be taken empty stomach since it causes gastritis.\\n∙ Nutritional Intervention – Encourage the mother to include milk and milk rich foods in diet, fox tail millet\\n(ragi), til, etc.\\nd. Deworming\\n∙ Hook worm infestation also leads to iron deficiency anemia in pregnant women. It is therefore important\\nto take a single dose of 400 mg of Albendazole at second trimester of pregnancy. It would be provided at\\nVHSND by ANM and at HWC-SHC by CHO.\\ne. Malaria Prophylaxis and Treatment\\n∙ No prophylaxis is recommended, but insecticide-treated bed nets or Long-Lasting Insecticidal Nets (LLIN)\\nshould be given on a priority basis to pregnant women in malaria-endemic areas. These women should be\\ncounselled on how to use the LLINs.\\n∙ In high malaria-endemic areas, pregnant women should be routinely tested for malaria at the first antenatal\\nvisit. Screen the woman for malaria every month by conducting the rapid diagnostic test even if she does not\\nmanifest any symptoms of malaria.\\n∙ If a pregnant woman shows symptoms of malaria at any time, she should be tested. If the result is positive,\\nrefer her to the PHC-HWC for treatment.\\nRoles and Responsibilities of CHO in Care during Pregnancy:'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Clinical Functions', 'section_path': ['3 Care during Pregnancy', 'Clinical Functions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='∙ Facilitate, undertake, and monitor early registration (first trimester) of pregnancy within 12 weeks.\\n∙ Ensure minimal 4 ANC assessment for all pregnant mothers and identify high-risk pregnancies or those with\\ncomplications. These could be done by MPWs as outreach sessions or by you at HWCs. However, you should\\nundertake the ANC assessment of all pregnant women in your service area especially in the last trimester of\\npregnancy.\\n∙ Actively facilitate referral for high-risk cases and followup all these cases same as per the management plan\\nsuggested by PHC MO.\\n∙ Undertake and ensure necessary counselling of all pregnant women on importance of ANC, institutional\\ndelivery, signs of labour, recognising danger signs during pregnancy, prevention of anemia, consumption of\\nIFA/calcium, nutritional counselling etc.\\n∙ Ensure completion of all necessary lab investigations to be undertaken during pregnancy.\\n∙ Facilitate and monitor for enrolment in AWC for supplementary nutrition.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Clinical Functions', 'section_path': ['3 Care during Pregnancy', 'Clinical Functions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='∙ Ensure completion of all necessary lab investigations to be undertaken during pregnancy.\\n∙ Facilitate and monitor for enrolment in AWC for supplementary nutrition.\\n∙ If a pregnant woman comes to SHC-HWC directly your role will be:  \\n38\\n¾ Register the pregnant woman in RCH register\\n¾ Provide all essential components of Full ANC at SHC-HWC:\\n- At least 180 IFA tablets\\n- Two doses of TT/Td injection\\n- History taking & physical examination\\n- Abdominal Examination\\n- Nutrition and Family planning Counselling\\n- Lab investigations\\n∙ Help the women to plan and prepare for birth (Birth preparedness/micro birth plan).\\n∙ Identify and track the high-risk pregnant women and counsel them to go for regular anti natal check-ups at\\nPHC by medical officer.\\n∙ Follow up of HRP to ensure institutional delivery.\\n∙ Mapping of all referral sites for institutional delivery and management of complications.\\n∙ Educate the PW/family members about signs of labour and danger signs of obstetric complications, where'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Clinical Functions', 'section_path': ['3 Care during Pregnancy', 'Clinical Functions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs'], 'contains_warnings': True}, page_content='∙ Mapping of all referral sites for institutional delivery and management of complications.\\n∙ Educate the PW/family members about signs of labour and danger signs of obstetric complications, where\\nto go if an emergency arises, and how to arrange for transportation, money, and blood donors in case of an\\nemergency and entitlements under government schemes such as JSY, JSSK, PMSMA, SUMAN and PMVVY\\netc.\\n∙ Counselling on essential newborn care practices (breast feeding, keeping baby worm, neonatal sepsis)and\\nclarify the myths/misconceptions about newborn care\\n∙ If pregnant woman is HIV positive, tie up with nearest Integrated Counselling and Testing Centre (ICTC) for\\nprevention of parent to child transmission'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Public Health Functions', 'section_path': ['3 Care during Pregnancy', 'Public Health Functions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='∙ Ensure that ANM/ASHA maintain the line list of HRP women, and they must be individually tracked for\\ngetting their routine medicines, periodic consultation, and timely referrals.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Managerial Functions', 'section_path': ['3 Care during Pregnancy', 'Managerial Functions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='∙ Ensure that ASHAs and MPWs are able to identify all pregnant women within the HWC service area especially\\nthose from remote villages, marginalised and vulnerable sections of the community.\\n∙ Support ASHAs/MPWs in completing micro-birth planning for all pregnant mothers.\\n∙ Inform regarding entitlements for pregnant mothers such as JSY,JSSK, PMSMA, SUMAN, PMMVY and\\nfacilitate registration of all eligible pregnant mothers to avail the maternity benefits provided by the government.\\n∙ Ensure that ASHA provide follow-up visits after delivery to mother and child as per HBNC/HBYC.\\n∙ Provide at least 10% joint visits to high-risk cases with your team and 2 VHSND visits per month to support\\nyour team and provide genuine feedback after the visits and resolve any issues if they are facing at field level.\\n∙ Ensure that quality services are provided at VHSND by using VHSND supervision checklist such as services\\nprovided, availability of necessary equipment and drugs.'),\n",
       " Document(metadata={'chapter': '3 Care during Pregnancy', 'section': 'Managerial Functions', 'section_path': ['3 Care during Pregnancy', 'Managerial Functions'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='∙ Ensure that quality services are provided at VHSND by using VHSND supervision checklist such as services\\nprovided, availability of necessary equipment and drugs.\\n∙ Ensure that all commodities required for outreach services are available with ASHAs and ANMs such as family  \\n39\\nplanning commodities, ASHA drug kit, misoprostol, MCP cards and IEC material.\\n∙ Ensure that all records of RCH register/ANMOL, VHSND, MCP card, maternal death and household visits\\nare maintained by ANM/ASHA\\n∙ Plan refresher trainings of primary care team with PHC-MO in RMNCAH+N, communicable and NCDs.\\n∙ Ensure that all drugs, diagnostics, equipment and consumables are available at HWC-SHC as per guidelines.\\n∙ Update records of PW in sub-centre reporting format, RCH register, HMIS (if desktop is available) and ensure\\nrecording of complete information in MCP cards.\\n∙ Ensure the completeness of data and send timely to the PHC/Block level so that DEO enter data in RCH\\nportal timely.  \\n40'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section_path': ['4 Counselling during Pregnancy'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='As a CHO, one of your key roles will be to ensure that all pregnant women receive the necessary counselling\\neither by you at HWC-SHC or through your team members during VHSND, outreach ANC sessions.\\nAll pregnant mothers need to be counselled for the following:'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Birth preparedness for safe institutional delivery and Schemes and Entitlement for pregnant mothers offered', 'section_path': ['4 Counselling during Pregnancy', 'Birth preparedness for safe institutional delivery and Schemes and Entitlement for pregnant mothers offered'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='by the government\\n2. Early identification of complications – recognising danger signs during pregnancy, labour and after delivery/\\nabortion'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True}, page_content='a. Planning and Preparing for Birth (Birth Preparedness)\\nWhat is Birth Preparedness?\\nThis is a method of planning in advance by the pregnant mother and her family for a safe and comfortable\\ndelivery and for care after delivery. ASHAs help every family make this plan in consultation with the ANM. You\\nwould need to ensure that this micro birth planning is completed for every pregnant woman either at HWC-SHC\\nor at the community level by ASHAs/MPWs.\\nMicro-birth planning has the following components:\\n∙ Registration of pregnant woman and filling up of the Maternal and Child Protection\\n∙ Card and JSY card/below poverty line (BPL) certificates/necessary proof or certificates for the purpose of\\nkeeping a record.\\n∙ Informing the woman about the dates of antenatal visits, schedule for TT injections and the EDD.\\n∙ Identifying the place of delivery and the person who would conduct the delivery.\\n∙ Identifying a referral facility and the mode of referral.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True}, page_content='∙ Identifying the place of delivery and the person who would conduct the delivery.\\n∙ Identifying a referral facility and the mode of referral.\\n∙ Taking the necessary steps to arrange for transport for the beneficiary.\\n∙ Making sure that funds are available to the ANM/ASHA.\\nWhen should a birth preparedness plan be ready?\\nIt should be ready as early as possible after confirming the pregnancy, and in consultation with the family (husband,\\nmother-in-law, or other decision makers). You should review the plan in the third trimester (after seventh month)\\nwith the family, ASHA and the ANM. At this time, the choice of institution and the transport should be finalised.\\nDetails of the activities to be carried out while planning and preparing for birth are:\\n∙ Informing and completing registration of pregnancy: During the woman’s first antenatal visit, MPW\\nwill fill up the MCP card and the RCH register. She will inform her of the dates of her subsequent antenatal'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='will fill up the MCP card and the RCH register. She will inform her of the dates of her subsequent antenatal\\nvisits and emphasize the importance of making all these visits in time.  \\n41\\n∙ Identifying the appropriate health facility for the delivery: All pregnant women must be encouraged\\nto opt for an institutional delivery. Explain to the woman why delivery at a health facility is recommended and\\nemphasize the following:\\n- Complications can develop at any time during pregnancy, during delivery or in the postnatal period.\\n- These complications are not always predictable. If they are not handled by professionals at the health\\nfacility, they can cost the mother and/or the baby their life.\\n- Since a health facility has staff, equipment, supplies and drugs, it can provide the best care. It also has a\\nreferral system should the need for referral arise.\\n∙ If there are no complications and mother and her family are reluctant or unable to go to the 24x7 PHC or if'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='referral system should the need for referral arise.\\n∙ If there are no complications and mother and her family are reluctant or unable to go to the 24x7 PHC or if\\nit is too far away and if your HWC-SHC is a delivery point and facilities of labour room and prompt referral\\nare available you can tell the mother to avail delivery care in your HWC.\\n∙ If there are no complications or not a high-risk case for developing complications and the\\nmother and family insist on delivering at home, despite counselling: You could work with the\\nPHC-MO to enable a delivery SBA trained ANM. This should be agreed to only if you are sure that the family\\ncan organise transport and funds at very short notice and you and delivery conducted by SBA trained ANM\\nare able to arrive within 30 minutes of the onset of labour at the home/Sub-Centre and should be able to stay\\nthrough the process of labour and for a few hours afterwards. A team of two or three women with experience\\nin attending labour would be helpful.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='through the process of labour and for a few hours afterwards. A team of two or three women with experience\\nin attending labour would be helpful.\\n∙ Recognising the signs of labour: Advice the woman to go to the health facility or inform the ASHA to\\ncontact you and ANM if the woman has any one of the following signs, which indicate the start of labour:\\n- A bloody, sticky discharge from the vagina (‘show’)\\n- Painful uterine contractions increasing in duration, frequency and intensity with the passage of time.\\n∙ Arrangement for referral transport: Delay in reaching a health care facility is one of the major ‘delays’\\nresponsible for maternal mortality. It is, therefore, necessary to ensure the following:\\n- If the woman has decided to deliver at a health facility, provide her the contact details of 108 and other\\ngovernment referral transport available to ensure that a vehicle is available to transport her to the health\\nfacility whenever required.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='government referral transport available to ensure that a vehicle is available to transport her to the health\\nfacility whenever required.\\n- The contact number of the ambulance or vehicle provided by the state, private or any other provider,\\nshould be available with You/ANM/ASHA, and should be communicated to the pregnant woman and her\\nfamily members.\\n- If a vehicle is not available in the village, help of the panchayat, village health committee, Mahila Mandals,\\nyouth groups or any other such groups can be taken to decide on how to obtain a vehicle in case of an\\nemergency.\\n∙ Finances: The woman and her family should be assisted in calculating an estimate of expenses of the\\ndelivery and related aspects (such as transport). They should also be advised to keep an emergency fund or\\nhave a source for emergency funding in case of complications. Keep in mind the various schemes that are'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Post-natal Family Planning', 'section_path': ['4 Counselling during Pregnancy', 'Post-natal Family Planning'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='have a source for emergency funding in case of complications. Keep in mind the various schemes that are\\navailable for assisting women with transportation facilities or providing funds for maternal health (such as the\\nJSY, JSSK) and whatever other schemes may have been launched in your state. Help the woman and her\\nfamily access these schemes and collect the allocated funds to pay for the delivery.Also, keep yourself up to  \\n42\\ndate on any new schemes that may be launched by the GoI and the state government from time to time.\\nb. Complication Readiness—Recognising Danger Signs During Pregnancy, Labour and after\\nDelivery/Abortion - You must ensure screening of all high-risk pregnant women and facilitate their\\ninstitutional deliveries at appropriate health facility with prior information to the newborn care unit.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Vaginal Bleeding', 'section_path': ['4 Counselling during Pregnancy', 'Vaginal Bleeding'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='∙ Early pregnancy-before 20 weeks of pregnancy\\n∙ Late pregnancy-after 20 weeks of pregnancy or Ante-Partum Haemorrhage (APH)\\nVaginal bleeding in early pregnancy:\\nThe probable causes could be a threatened or spontaneous abortion, an\\nectopic pregnancy or a hydatidiform mole.\\na. Incomplete spontaneous abortion\\nThe following are the signs of incomplete spontaneous abortion:\\n∙ There is heavy bleeding and lower abdominal pain.\\n∙ There is a history of expulsion of the Products of Conception (POC).\\n∙ Abdominal examination shows the presence of uterine tenderness, and\\nthe fundal height is less than the period of gestation.\\nManagement:\\n∙ If retained POC are seen in the vagina, remove them gently with a finger. The procedure must be carried out\\nunder aseptic conditions.\\n∙ If the bleeding does not stop and/or the woman is in shock, establish an intravenous line immediately and\\ngive intravenous fluids rapidly.\\n∙ Send the woman to the MO with a referral slip.\\nb. Complete abortion'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Vaginal Bleeding', 'section_path': ['4 Counselling during Pregnancy', 'Vaginal Bleeding'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='give intravenous fluids rapidly.\\n∙ Send the woman to the MO with a referral slip.\\nb. Complete abortion\\nThe following are the signs of complete abortion:\\n∙ There is light bleeding or there has been heavy bleeding which has now stopped.\\n∙ There is lower abdominal pain.\\n∙ There is a history of expulsion of POC.\\n∙ Abdominal examination shows a uterus that is softer than normal, and the fundal height is less than the\\nperiod of gestation.\\nManagement:\\n∙ Observe the woman for 4-6 hours. Advise her to take rest.\\n∙ If the bleeding decreases or stops, explain the facts to her, reassure her and advise her to go home after you\\nhave checked her vital signs.\\n∙ Advise her to return to you or the MO if the bleeding recurs.  \\n43\\nc. Threatened abortion\\nThe following are the signs of threatened abortion:\\n∙ There is light bleeding.\\n∙ The woman complains of lower abdominal pain.\\n∙ There is no history of expulsion of POC.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Vaginal Bleeding', 'section_path': ['4 Counselling during Pregnancy', 'Vaginal Bleeding'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='43\\nc. Threatened abortion\\nThe following are the signs of threatened abortion:\\n∙ There is light bleeding.\\n∙ The woman complains of lower abdominal pain.\\n∙ There is no history of expulsion of POC.\\n∙ Abdominal examination shows the uterus to be softer than normal, and the fundal height corresponds to the\\nperiod of gestation.\\n∙ On P/V examination, the cervical os is found to be closed.\\nManagement:\\n∙ If the bleeding decreases or stops, explain the facts to the woman, reassure her and advise her to go home\\nafter you have checked her vital signs.\\n∙ Advise her to avoid strenuous exercise/work and to avoid sexual intercourse.\\n∙ Advise her to take bed rest.\\n∙ Send her to the MO with a referral slip for further advice.\\nVaginal bleeding in late pregnancy (APH):\\nThe most serious causes are placenta praevia (placenta lying at or near the cervix), abruptio placentae (detachment\\nof the placenta before the birth of the foetus) or a ruptured uterus. Any bleeding (light or heavy) at this'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Vaginal Bleeding', 'section_path': ['4 Counselling during Pregnancy', 'Vaginal Bleeding'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='of the placenta before the birth of the foetus) or a ruptured uterus. Any bleeding (light or heavy) at this\\ntime of pregnancy is dangerous.\\nRemember:\\nP/V should not be performed in women who have bleeding during pregnancy beyond 20 weeks.\\nManagement:\\nA woman with placenta praevia, abruptio placentae or ruptured uterus should not be managed at the SHC-HWC\\nbecause there are no facilities for blood transfusion or surgical intervention, if required. Refer such a woman\\nimmediately to an FRU equipped with facilities for surgical obstetrics, blood transfusion and anaesthesia after\\nestablishing an intravenous line.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ PIH includes:\\n¾ Hypertension—systolic blood pressure of 140 mmHg or more and/or diastolic blood pressure of 90\\nmmHg or more, on two consecutive readings taken four hours or more a part.\\n¾ Pre-eclampsia—hypertension with proteinuria\\n¾ Eclampsia—hypertension with proteinuria and convulsions\\n∙ Measure the woman’s blood pressure during every antenatal and postnatal visit. If it is high (more than\\n140/90 mmHg), check it again after four hours. If the situation is urgent, the blood pressure should be\\nmeasured after one hour.\\n∙ If the woman has hypertension, check her urine for the presence of proteins. The combination of a raised\\nblood pressure and proteinuria is sufficient to categorise the woman as having pre-eclampsia.  \\n44\\n∙ Refer the woman to the 24x7 PHC/FRU so that she can receive anti-hypertensive medication. She should be\\nmanaged at home as per the advice of the MO.\\n∙ Keep in touch with the woman or her family and undertake appropriate follow-up of these cases.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='managed at home as per the advice of the MO.\\n∙ Keep in touch with the woman or her family and undertake appropriate follow-up of these cases.\\n3. Convulsions—Eclampsia\\n∙ Eclampsia is characterised by:\\n¾ Convulsions\\n¾ High blood pressure (a systolic blood pressure of 140 mmHg or more and/or a diastolic blood pressure\\nof 90 mmHg or more)\\n¾ Proteinuria +2 or more.\\n∙ If the woman has convulsions, offer supportive care. The initial management of convulsions includes the\\nfollowing:\\n¾ Ensure that the airway is clear and she is breathing well.\\n¾ If the woman is unconscious, position her on her left lateral side to reduce the risk of aspiration (vomitus\\nand blood).\\n¾ Clean the mouth and nostrils by applying gentle suction and remove the secretions.\\n¾ Remove any visible obstruction or foreign body from her mouth.\\n¾ Keep a padded mouth gag between the upper and lower jaw to prevent tongue bite (do not attempt this\\nduring a convulsion).\\n¾ Keep her in the left lateral position.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='¾ Keep a padded mouth gag between the upper and lower jaw to prevent tongue bite (do not attempt this\\nduring a convulsion).\\n¾ Keep her in the left lateral position.\\n¾ Refer and accompany the woman to the FRU, if possible. Manage any convulsions that may occur on the\\nway.\\nc. Health and Nutritional Counselling\\nCounselling messages for pregnant women:\\n∙ At least 4 ANC check-ups along with one additional check up on 9th of every\\nmonth under the PMSMA during entire pregnancy should be attended.\\n∙ Benefits of ANC registration including timely identification and treatment of\\npregnancy related problems, information on safe institutional delivery, nutrition\\nand lifestyle, provision of IFA, calcium and deworming tablets, tetanus diphtheria\\nvaccination, government entitlements should be explained.\\n∙ To achieve optimal weight gain (10-12kg) during pregnancy, at least one food\\nitem from all five food groups (cereals, pulses (sprouts), soy products, animal'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='∙ To achieve optimal weight gain (10-12kg) during pregnancy, at least one food\\nitem from all five food groups (cereals, pulses (sprouts), soy products, animal\\nIf SHC-HWC is a delivery point: Administer the first dose of Magnesium Sulphate injection as per standard\\nprotocol. Immediately arrange to refer the woman to an FRU and ensure that she reaches the FRU as\\nearly as possible, preferably within two hours of receiving the first dose of Magnesium Sulphate injection.\\nIf delivery is imminent, you may not have the time to transport the woman to an FRU. In this case, deliver\\nthe baby after giving the first dose of Magnesium Sulphate injection. After the delivery, you must refer her,\\ntogether with the baby, to the FRU for further management.  \\n45\\nproducts such as milk and milk products/ egg/chicken, fish/meat, fruits and vegetables) should be consumed\\neveryday.\\n∙ At least 3 main meals and 2 nutritious snacks should be consumed, second trimester onwards.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='everyday.\\n∙ At least 3 main meals and 2 nutritious snacks should be consumed, second trimester onwards.\\n∙ Supplementary nutrition provided by the Anganwadi centre should be consumed regularly along with daily\\ndiet.\\n∙ During pregnancy consumption of iron-folic acid (red coloured) tablet prevents anemia. Consumption of\\nvitamin C rich foods like lemon, guava, orange and amla facilitates absorption of iron. The pregnant women\\nshould be informed about the importance of dietary diversity and encouraged to consume locally available\\nnutritious food.\\n∙ Consumption of calcium (white coloured) tablets prevents pre-eclampsia/eclampsia (high blood pressure,\\nconvulsions).\\n∙ Vitamin A is helpful in improving the eyesight, increasing immunity of body. Foods rich in vitamin A such\\nas green leafy vegetables, yellow and orange coloured fruits, milk and milk products, tomato, egg, liver etc.\\nshould be consumed.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs']}, page_content='as green leafy vegetables, yellow and orange coloured fruits, milk and milk products, tomato, egg, liver etc.\\nshould be consumed.\\n∙ Consumption of double fortified salt is beneficial for the cognitive development of the baby. In case of using\\niodized salts, it should be used along with fortified rice, wheat flour, oil and milk preparations.\\n∙ Personal hygiene should be maintained to prevent infections. Maintaining oral health, washing hands, safe\\ndrinking water, use of clean fuel for cooking should be emphasized upon.\\n∙ Importance of family support during pregnancy should be emphasized.\\n∙ Adequate rest for 2 hours in the day and 8 hours of sleep at night daily and heavy objects should not be lifted.\\n∙ At least thirty minutes of brisk walking/ light exercise should be done.\\n∙ Consumption of alcohol, beedi, cigarette, gutkha, tobacco should be avoided as it can have deleterious effect\\non the foetus.'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ Consumption of alcohol, beedi, cigarette, gutkha, tobacco should be avoided as it can have deleterious effect\\non the foetus.\\n∙ Early (within 1 hour of birth) and exclusive breastfeeding (till 6 months) should be promoted.\\n∙ Information on government schemes like JSSK, ICDS, NRLM/SRLM, PDS and JSY, PMMVY should be\\ngiven.\\n∙ At least 3 years gap should be maintained between 2 pregnancies using family planning methods that are\\navailable free of cost at any public health facility.  \\n46'),\n",
       " Document(metadata={'chapter': '4 Counselling during Pregnancy', 'section': 'Pregnancy Induced Hypertension', 'chunk_type': 'table', 'parent_section_path': [], 'section_path': ['4 Counselling during Pregnancy', 'Pregnancy Induced Hypertension'], 'document_title': '', 'document_type': '', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='Table 4: Counselling messages for high risk pregnant women\\nAnemia  ∙ Intake of iron rich food like green leafy vegetables (Chaulai and drumstick leaves etc.),\\nwhole grains, meat, fish, jaggery, nuts etc.\\n∙ Tannins in tea and caffeine in coffee and calcium supplements should be avoided with\\nor immediately before or after meals as they reduce iron absorption.\\n∙ Adding vitamin C rich foods (such as amla, lemon, tomato, guava etc) to regular diet can\\nimprove the absorption of iron\\n∙ Though the tablets should be taken preferably early in the morning on an empty stomach,\\nshe may take the tablets with meals or at night. This will help avoid nausea.\\n∙ She should not worry about black stools. This is normal while taking IFA tablets.\\n∙ If she has constipation, ask her to drink more water. These side-effects are not serious.\\n∙ She should avoid taking the tablets with tea, coffee or milk as they reduce the absorption\\nof iron.\\n∙ Vit. C increases iron absorption. The IFA tablet can preferably be taken with Vit. C rich\\nsource such as Lemon water, amla etc.\\n∙ Tablets containing calcium should not be taken at the same time as IFA tablets, as the\\nabsorption of iron is reduced in the presence of calcium. There should be a minimum of\\ntwo-hour gap in consumption of IFA and calcium tablet.\\n∙ Although IFA tablets may make a woman feel less tired than before, advise her not to\\nstop the tablets despite feeling better.\\n∙ She should return to you if she has problems in taking IFA tablets. In areas\\nendemic for haemoglobinopathies, sensitisation of the population on screening for\\nhaemoglobinopathies through CBC and monitor treatment compliance to be ensured\\nby ANM.\\n∙ Refer the identified cases of haemoglobinopathies to higher centres for further\\nconfirmation and treatment. In areas endemic for malaria, with the help of ASHA and\\nANM, ensure every household in the village is provided with LLIN.\\n∙ Oversee the availability of IFA, supply chain, adverse events reporting for the catchment\\narea and sharing about the gaps found, if any, with MO of concerned PHC.\\n∙ Regular physical activity is required for maintaining good metabolism so that the food\\ningested is properly assimilated and utilised to have a healthy body and healthy baby.\\nRegular physical activity is also important for reducing stress. Other activities like yoga\\nsessions etc also aid in maintaining hormonal balance, improving flexibility of body and\\nreducing mental stress.\\nYoga Sessions: Invite the pregnant women to yoga sessions at HWC-SHC  \\n47\\nHypertension  ∙ At least 4 servings of calcium-rich foods like dairy products (milk, paneer, curd), soya\\nmilk, whole pulses, whole cereals, green leafy vegetables and ragi/nuts\\n∙ Potassium-rich foods like ragi, wheat, Bengal gram, cowpea, moong, peas, red gram,\\ncolocassia, coriander seeds, fenugreek seeds, musambi, apricots, banana, cherries, etc.\\n∙ Small and frequent meals should be taken\\n∙ Avoid fasting or missing any meal\\n∙ Plenty of water (2-3 litre/day) should be taken to keep the bowels regular\\n∙ Intake of processed foods, rich in fat, salt and sugar should be restricted\\n∙ Keep salt intake to less than 6 grams/day (approximately 1tsp full/day)\\n∙ Regular physical activity should be done (e.g., yoga, walking, etc.) for 30 minutes\\nGestational\\nDiabetes\\nMellitis\\n∙ Refined carbohydrate foods like sweets, fruit juices, table sugar, starchy vegetables, etc.\\nshould be avoided\\n∙ Carbohydrate foods should be spread through the day over 3 small meals and 2-3 snacks\\neach day to maintain blood glucose levels\\n∙ Fried foods should be avoided. Instead serve steamed, boiled or sautéed food\\n∙ Whole fruits should be preferred over juices\\n∙ Prefer fish or chicken over red or organ meat\\n∙ Fibre should be increased in the diet by including salad, beans, non- starchy vegetables,\\nwhole fruit, whole grain cereals, whole pulses, flax seeds and oat bran as they help\\ncontrol blood sugar levels\\n∙ Drink water, buttermilk, soups, and other unsweetened healthy beverages instead of\\nsoda or fruit juices\\n∙ Intake of processed foods, rich in fat, salt and sugar should be restricted specially pickles,\\nchutneys, murabbas\\n∙ Regular physical activity must be encouraged (e.g., yoga, walking, etc.) like 30 minutes\\nof walk, two times a day.\\nDo’s and Don’ts of Nutrition in Pregnancy\\nDo’s Don’ts\\nFrequent meals of nutritious food- around 1/4th times\\nextra than the normal diet\\nAvoid bulky food\\nTake biscuits, rusks or other carbohydrate rich foods early\\nin the morning to avoid morning sickness.\\nAvoid stale, spicy and fatty foods\\nMake your diet rich in whole grains, fruits, vegetables,\\nand lean protein\\nAvoid taking medication without consultation\\nInclude fibre rich food in diet Avoid fast food and caffeinated drinks\\nTake in plenty of water, rest for atleast 2 hours during the\\nday in addition to 8-hour rest at night\\nAvoid alcohol intake  \\n48\\nUse iodised salt for cooking or double fortified salt for\\ncooking and consumption of fortified products (rice/\\nwheat flour/oils/milk)\\nDon’t do strenuous work\\nConsume folic acid, IFA, Calcium and Albendazole tablet\\nas advised by the health worker\\nd. Counsel regarding Breastfeeding\\nImportance of Breastfeeding for Newborn and Mother\\nBenefits of early initiation of breastfeeding to newborn\\n∙ Early initiation of breastfeeding is extremely important for establishing successful lactation as babies are\\nnormally very alert and responsive within one hour after delivery. They are ready to suckle and attach to the\\nbreast easily.\\n∙ Early initiation also provides the benefits of colostrum to the baby. Colostrum is the first yellow and thicker\\nbreastmilk secreted in small amounts in the first 3-4 days and it contains high concentration of protective\\nimmunoglobulins and cells. It acts as the first natural immunization for newborn. The numerous benefits of\\ncolostrum and early initiation of breastfeeding are as under:\\n» Provides all the necessary nutrients in right amount for the baby’s growth\\n» Protects the baby against diarrhoea, respiratory problems and other infections\\n» It is richer in Vitamin A and K than normal breastmilk\\n» It helps to prevent jaundice in the newborn\\n» It helps to clean baby’s intestine\\n» Breastfeeding enhances the emotional bond between child and the mother and provides warmth, love and\\naffection\\nBenefits of Breastfeeding to Mothers\\n∙ It reduces risk of PPH (excessive post-delivery bleeding) and thus prevents anemia.\\n∙ Breastfeeding has protective effect against breast and ovarian cancers.\\n∙ Obesity is less common among breastfeeding mothers; breastfeeding helps the mother regain her normal\\nfigure.\\n∙ Breastfeeding satisfies the mother emotionally.\\n∙ Exclusive breastfeeding has a contraceptive effect for first few months.\\nKey messages on breastfeeding to mothers:\\n∙ Advocacy on breastfeeding and providing information on correct breastfeeding practices: Mothers and\\ncaregivers are to be counselled on breastfeeding as the gold standard feeding option for babies.\\n∙ During third trimester, breast examination needs to be done mandatorily. Examination of the breasts to be\\nconducted for diagnosis and management of difficult breast conditions – flat nipples, inverted nipples, sore\\nnipples, cracked nipples, engorgement of breast, mastitis, etc., for appropriate and timely management of\\nany problems.\\n∙ Counselling on importance of colostrum feeding and role of early initiation of breastfeeding in establishing\\nexclusive breastfeeding initiation of early skin-to-skin contact with the newborn. It provides warmth, helps in\\nbonding of mother and child, and also stimulates breas t milk production  \\n49\\n∙ Practices of giving pre-lacteal feeds must be discouraged due to its harmful effects on both mother and\\nnewborn. (Anything given to the baby to drink before starting breastfeeding is called prelacteal feeding. This\\ncan be sugar water, honey, glucose, water, gur, janam-ghutti, saunf-water or ajwain water etc.)\\n∙ Prelacteal feeds may lead to infection, interfere with the success of breastfeeding and the baby will not get the\\nadvantages of colostrum feeding.\\n∙ Mother should be advised to seek support if mother faces any problem in breastfeeding from health workers\\n– ASHA/ANM/CHO/MO. (You may refer to the module on newborn, infant and child health services for\\ndetails of breastfeeding and management of breast-feeding problems.)\\n∙ Specific counselling and management if mother is HIV positive. Provide information on where to seek further\\nadvice and support for breastfeeding.\\n∙ Counselling on infant feeding for working mothers, mother with condition of not enough milk, mothers on\\nmedication or with specific illnesses must be ensured.\\n∙ Counselling on importance of exclusive breastfeeding for six months for health and development of newborn\\nand infants.\\ne. Sex during Pregnancy\\n∙ It is safe to have sex throughout pregnancy, as long as the pregnancy is uncomplicated.\\n∙ Some women experience a decreased desire for sex during pregnancy. The husband should be informed that\\nthis is normal and the woman’s consent should be sought before engaging in sex.\\n∙ Some couples find engaging in sex uncomfortable during pregnancy. The husband must see to the comfort of\\nthe woman while engaging in sexual activities.\\n∙ Advice couples to have safe sex and use condoms especially if the woman has discharge or itching in the\\nvaginal area or the husband has urethral discharge or experiences burning while urinating.\\n∙ The couple should be advised to abstain from having sex during the first six weeks postpartum or longer if the\\nperineal wounds have not healed by then.\\nf. Domestic Violence\\n∙ The husband and immediate family members of the pregnant woman should be briefed about the serious\\nconsequences that violence could have on the pregnancy, on the woman’s health and on the physical and\\nmental health of the child to be born. The woman herself should be counselled in private and enabled to\\naccess support systems from within or outside the family, during and after the pregnancy. Health workers\\nshould be alert to signs of continuing violence even in the post-partum period\\ng. Family Planning\\n∙ Pregnancy is the best period for family planning counselling as it gives the couple time to think about and\\nchoose the method they would want to use after the birth of their baby. Ask about the couple’s plans for having\\nmore children. If they desire more children, then advise them that a gap of 3-4 years between pregnancies is\\nhealthy for the mother and the child.\\n∙ The couple should be given advice on the range of contraceptive methods available to them. You, ASHA and\\nMPW can explain about the suitable contraceptive methods during pregnancy based on the details provided\\nin family planning module.  \\n50'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section_path': ['5 Postnatal Care for Mothers'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='The first 42 days after birth is the postnatal period and is crucial for the mother and the newborn. First 48 hours,\\nfollowed by the first one week are the most crucial period asmost of the fatal and near-fatal maternal and neonatal\\ncomplications occur during this period. Evidence has shown that more than 60% of maternal deaths take place\\nduring the post-partum period.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Number and timing of post-partum visits:', 'section_path': ['5 Postnatal Care for Mothers', 'Number and timing of post-partum visits:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Every pregnant woman and her newborn should be examined either by you or your MPWs as per the following\\nschedule. In case woman is unable to come to HWC, MPW should visit the mother for completing these\\nexaminations.\\nVisits After home delivery After delivery at PHC/FRU\\nDelivery at HWC-SC (Woman discharged after 48 hours)\\nFirst visit 1st day (within 24 hours) NA*\\nSecond visit 3rd day after delivery 3rd day after delivery\\nThird visit 7th day after delivery 7th day after delivery\\nFourth visit 6 weeks after delivery 6 weeks after delivery\\n*In case the mother and the newborn return home before 24 hours, then PNC visit should be planned on 1st day\\nfor institutional delivery.\\nAs a CHO,you can either undertake postnatal examination yourself or for some reason if the mother could not\\nvisit HWCs you make sure that MPWs visit mother’s household, complete these visits, and update information\\nin MCP Card and RCH register.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'First visit for mother', 'subsection': 'History-taking', 'section_path': ['5 Postnatal Care for Mothers', 'First visit for mother', 'History-taking'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='This is especially important if you were not present for the delivery. Review the events at labour and birth to\\nidentify any risk factor or events during the birth that may be important in the management of the mother and\\nthe baby. Ask the following:\\n1. Where did the delivery take place?\\n2. Who conducted the delivery?'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='a. Complication during delivery?\\nb. Bleeding(confirm number of pads should be less than 5/day)?\\nc. Convulsions or loss of consciousness?\\nd. Pain in thighs and abdomen?\\ne. Dribbling or retention of urine?\\nf. Any breast tenderness?\\n4. Has the mother started breastfeeding the baby?\\n5. Has she started her regular diet?\\n6. Are there any other complaints?  \\n51'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Examination', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Examination'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='∙ Check the woman’s pulse, blood pressure, temperature, and respiratory rate.\\n∙ Check for the presence of pallor.\\n∙ Conduct an abdominal examination. Normally, the uterus will be well contracted, i.e., hard and round. If it is\\nsoft and uterine tenderness is present, then refer the woman to the FRU.\\n∙ Examine the vulva and perineum for the presence of any tear, swelling or discharge of pus. If any of these is\\npresent, refer the woman to the FRU.\\n∙ Examine the pad for bleeding to assess if the bleeding is heavy and see if the lochia is healthy and does not\\nsmell foul (for puerperal sepsis). If these signs are present, refer the woman to the FRU.\\n∙ Examine the breasts for any lumps or tenderness, check the condition of the nipples and observe breastfeeding.\\nIf the woman has any complaints regarding the condition of her breasts, refer her to the MOs at PHC/FRU.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='Give the woman and her family the following advice:\\nPost-partum care and hygiene\\n∙ She should have someone near her for the first 24 hours to take care of her and the baby.\\n∙ She should wash the perineum daily and after passing stools.\\n∙ The sanitary pads must be changed every 4-6 hours or more frequently if there is heavy lochia. This is\\nessential to ensure that the woman does not contract any infection.\\n∙ Cloth pads should be washed with soap and water and dried in the sun. It is, however, preferable to use\\nsanitary pads, which can be thrown away.\\n∙ Bathe daily.\\n∙ Wash her hands before and after handling the baby, especially after cleaning and before feeding the baby.\\n∙ Take enough rest and sleep.\\n∙ Rooming in of the mother with the baby is advisable. Advise the mother on how to look after her newborn,\\ne.g., how to bathe the newborn, maintain warmth and exclusive breastfeeding.\\nNutrition'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='∙ Rooming in of the mother with the baby is advisable. Advise the mother on how to look after her newborn,\\ne.g., how to bathe the newborn, maintain warmth and exclusive breastfeeding.\\nNutrition\\nShe should increase her intake of food and fluids. Advise her to refrain from observing taboos that exist in the\\ncommunity against nutritionally healthy foods (e.g., the taboo against eating solid food for six days).Talk to the\\nwoman’s family members, such as her husband and mother-in-law, to encourage them to ensure that she eats\\nenough and avoids heavy physical work. Advice on regular intake of IFA and Calcium tablets.\\nContraception\\n∙ Advise the couple regarding the return of fertility. Advise the couple on birth spacing or limiting the size of\\nthe family.\\n∙ Advice the couple to abstain from sexual intercourse for about 6 weeks post-partum, or till the perineal\\nwounds heal.  \\n52\\nBreastfeeding\\nBenefits of exclusive breastfeeding and continued breastfeeding to newborn, infants and children'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='wounds heal.  \\n52\\nBreastfeeding\\nBenefits of exclusive breastfeeding and continued breastfeeding to newborn, infants and children\\n∙ It provides complete nutritional staple to the infant up to the age of six months, up to half of nutritional\\nrequirements between 6-12 months and up to one-third, between 12 and 24 months.\\n∙ Breastmilk contains adequate calories and provides the right kind of proteins, fats, lactose, vitamins, iron and\\nother minerals, enzymes, and water in the amounts necessary for the baby.\\n∙ Breastmilk contains enough water which is sufficient for very dry and hot climates.\\n∙ Breastmilk has many anti-infective properties and protects the child against several infections including\\ndiarrhoea and pneumonia. Moreover, it is easily digested and is free from contaminants and incurs no additional\\ncost to families.\\n∙ Breastfeeding helps in environment protection as it is natural and no industrial processing is involved.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='cost to families.\\n∙ Breastfeeding helps in environment protection as it is natural and no industrial processing is involved.\\n∙ Breastfed babies are less prone to have diabetes, heart disease, eczema, asthma and other allergic disorders\\nand adult onset NCDs.\\n∙ Benefits on raising I.Q. – adds up to 3 IQ points across all income levels which improves academic performance,\\nlong term earnings and productivity.\\nKey points to remember regarding breastfeeding during PNC\\n∙ Counselling on exclusive breastfeeding for six months. Baby should be fed on demand and ‘cues’, such as\\nsuckling movements and suckling sounds should be identified before the baby cries.\\n∙ Let the newborn suckle from only one breast at each feed and continue at that breast until she/he finished by\\nhim/herself, so that she/he gets adequate amount of fat-rich hindmilk. Feed from the other breast during the\\nnext feed.\\n∙ Every mother, especially for the first time should receive breastfeeding support from the Doctors/CHO/'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='next feed.\\n∙ Every mother, especially for the first time should receive breastfeeding support from the Doctors/CHO/\\nNursing staff or community health worker (in case of home delivery) with regards to correct positioning,\\nattachment, latching and management/treatment in case of common breastfeeding/lactation problems such\\nas breast engorgement, cracked nipple, fissures and delay in ‘coming in’ of milk.\\n∙ In case of operative birth, the mother should be motivated and supported to initiate breastfeeding within first\\nhour of birth.\\n∙ If breastfeeding is still not initiated, ask the reason for not initiating the breastfeeding and then assist her in\\nbreastfeeding the baby immediately.\\n∙ Baby should not be given water or any liquid other than breastmilk unless medically indicated. Emphasise that\\nbreast milk is enough in quantity to satisfy the baby’s hunger and that the baby does not even require water\\nwhile being breastfed.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='breast milk is enough in quantity to satisfy the baby’s hunger and that the baby does not even require water\\nwhile being breastfed.\\n∙ Examine for breast conditions such as cracked nipple, inverted nipple etc. and management if required.\\nBreastfeeding positions and problems are explained in detail in Newborn and Infant Module.\\n∙ Observe breastfeeding and check if there is proper attachment and effective suckling. The mothers and\\ncaregivers should be informed that breastfeeding is the gold standard feeding option for babies.\\n∙ Breastfeed frequently, i.e., at least 6-8 times during the day and 2-3 times during the night.  \\n53\\n∙ Counselling on infant feeding for working mothers, mother with condition of not enough milk, mothers on\\nmedication or with specific illnesses must be ensured for appropriate management and referral, if required.\\n∙ Counselling on infant feeding options in context of HIV (for mother identified as HIV positive) during antenatal\\nperiod and after birth.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Is there a history of', 'subsection': 'Counselling during first visit', 'section_path': ['5 Postnatal Care for Mothers', 'Is there a history of', 'Counselling during first visit'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='∙ Counselling on infant feeding options in context of HIV (for mother identified as HIV positive) during antenatal\\nperiod and after birth.\\n∙ Ensuring IEC/BCC material on early initiation of breastfeeding and exclusive breastfeeding is available in local\\nlanguage.\\nRegistration of birth\\nExplain the importance of getting the birth of the baby registered with the local panchayat. This is a legal\\ndocument. The child will require the birth certificate for many purposes in the future, e.g., school admission.'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Second and third visits for mother', 'subsection': 'History-taking', 'section_path': ['5 Postnatal Care for Mothers', 'Second and third visits for mother', 'History-taking'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='A similar history needs to be taken as during the first visit. Apart from the questions asked during the first visit,\\nalso ask the mother the following:\\n∙ Is there continued bleeding P/V? This, i.e., post-partum bleeding occurring 24 hours or more after delivery,\\nis known as ‘delayed’ PPH. Refer to the PHC/CHC/DH.\\n∙ Is there foul-smelling vaginal discharge? This could be indicative of puerperal sepsis.\\n∙ Has there been any fever?\\n∙ Is there a history of swelling (engorgement) and/or tenderness of the breast/issues in breast feeding?\\n∙ Is there any pain or problem while passing urine (dribbling or leaking)? Is there fatigue and is she ‘not feeling well’?\\n∙ Does she feel unhappy or cry easily? This indicates post-partum depression, and usually occurs 4-7 days after\\ndelivery. Assure her that everything will be fine and refer her to the MO only if the problem persists.\\n∙ Are there any other complaints?'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Second and third visits for mother', 'subsection': 'Examination', 'section_path': ['5 Postnatal Care for Mothers', 'Second and third visits for mother', 'Examination'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='∙ This is similar to the examination conducted during the first visit. During second and third PNC visit for\\nwomen who have undergone c-section, an examination of post-caesarean section surgical site for any signs of\\nsurgical site infection like fever, purulent (pus) discharge in, or coming from the wound (including evidence of\\nan abscess) or any reopening of the surgical wound or painful, spreading erythema surrounding the surgical\\nsite should be noted and managed/referred accordingly.\\nC. Management/counselling\\nDiet and rest\\n∙ Inform the mother that during lactation, she needs to eat more than her normal pre-pregnancy diet. This is\\nbecause she needs to regain her strength during the period of exclusive breastfeeding and also for her baby to\\nderive its full nutritional requirements from breast milk.\\n∙ She should be advised to take foods rich in calories, proteins, iron, vitamins and other micro-nutrients (milk'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Second and third visits for mother', 'subsection': 'Examination', 'section_path': ['5 Postnatal Care for Mothers', 'Second and third visits for mother', 'Examination'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='derive its full nutritional requirements from breast milk.\\n∙ She should be advised to take foods rich in calories, proteins, iron, vitamins and other micro-nutrients (milk\\nand milk products, such as curd and cottage cheese; green leafy vegetables and other seasonal vegetables;\\npulses; eggs; meat, including fish and poultry; groundnuts; ragi; jaggery; fruits, such as mango, guava, orange,\\nsweet lime and watermelon).  \\n54\\n∙ She should be counselled to consume one IFA and one calcium tablet each daily for at least 6 months after\\ndelivery.\\n∙ The taboos on food imposed by the family and community are usually stronger and greater in number in the\\npost-partum period and during lactation than during pregnancy.\\n∙ These should be enquired into, and the mother should be advised against following them if they are harmful\\nto her and/or her baby.\\n∙ The mother needs sufficient rest during the post-partum period; to be able to regain her strength. Advise her'),\n",
       " Document(metadata={'chapter': '5 Postnatal Care for Mothers', 'section': 'Second and third visits for mother', 'subsection': 'Examination', 'section_path': ['5 Postnatal Care for Mothers', 'Second and third visits for mother', 'Examination'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='to her and/or her baby.\\n∙ The mother needs sufficient rest during the post-partum period; to be able to regain her strength. Advise her\\nto refrain from doing any heavy work during the post-partum period, and to focus solely on looking after\\nherself and her baby. Her family members should also be advised to ensure this.\\nContraception\\n∙ Inform the mother that whenever her periods begin again and/or she stops exclusive breastfeeding, she can\\nconceive even after a single act of unprotected sex.\\n∙ Check if the couple is using any contraceptive method and inform the couple about the various choices of\\ncontraceptive methods available and help them choose the method most suitable to them.  \\n55'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section_path': ['6 Recording and Reporting for'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Reviewing ANC Services\\nCommunity Health Officer worker has the role of a supervisor and manager apart from their clinical responsibilities.\\nIt is critical for them to understand the records and reports being maintained at various levels/areas of services by\\nthe services provides. They must know how to review these documents for their complete and correct information.\\nThis review will also help the CHO to know the status of ANC services at his facility, outreach sessions and help\\nin taking necessary action based on the gaps/challenges identified as per his/her observations.\\nAfter the review, the Community Health officer must acknowledge and compliment the service providers doing\\nquality work and reporting and encouraging others to fill the records as and when they are meant to be filled. Few\\nof the important documents a medical officer should review during his supportive supervision visits and monthly\\nreview meetings are as follows:'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section_path': ['6 Recording and Reporting for'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='of the important documents a medical officer should review during his supportive supervision visits and monthly\\nreview meetings are as follows:\\nRecords and reports When to fill/submit By whom Review and action by\\nMCP card For each pregnant woman\\nat each visit\\nANM MO\\nRCH register For each pregnant woman\\nat each visit\\nANM MO/MOIC\\nForm 6 At every month end ANM MO/MOIC\\nForm 7a, 7 At every month end SN/LHV MOIC\\nForm 8a, 8 At every month end SN/LHV/HM MOIC'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Mother and Child Protection Card', 'section_path': ['6 Recording and Reporting for', 'Mother and Child Protection Card'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Mother and Child Protection (MCP) card is meant for the record of each pregnant woman’s antenatal care record.\\nThis card has to be filled for each pregnant woman by the service provider giving antenatal care. The woman\\nmust be encouraged to bring this card to the facility or outreach (VHSND) session whenever she comes for her\\nANC check-up'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'RCH Register', 'section_path': ['6 Recording and Reporting for', 'RCH Register'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='This register has columns to document the details of the antenatal care of each woman seen on a particular ANC\\nday/session. The details of the woman must be entered immediately as she is examined and her antenatal care\\ninterventions are completed for that visit before she leaves the facility. This will help the provider to fill all the\\nrelevant columns for ANC for the woman on the day of the visit and while she is there. Filling this register at the\\nend of the ANC day/session must be avoided as that may lead to missing out on the important information of the\\npregnant woman. Also, there will be chance of wrong entries. This missed/wrong information will cause filling of\\nincorrect details in the monthly reporting format at the end of the month. The MO must ensure that the providers\\nare filling the RCH register completely and correctly for each pregnant woman by telling them its importance.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Form 6, 7a, 7 and 8 should be used during monthly review meetings.\\nWhile conducting review meeting with the ANMs and ASHAs of his/her catchment area, community health\\nofficer should use the form 6 (annexure 13 form 6) which is filled and submitted at the end of each month by\\nthe ANM. The performance of ANM as well as any gaps in logistics/supplies can be assessed through this format.  \\n56\\nTo understand the performance of his/her catchment area, medical officer should regularly review the form 7\\n(annexure 14 form 7) for PHC and form 8 for CHC/SD/DH.\\n6.4 Providing Feedback During Review Meetings/Supportive Supervision Visit\\nProviding feedback to the staff of the facility and the field area is one of the major tasks as a supervisor and mentor\\nto ensure quality service delivery. The quality of the feedback helps the staff to either work with high motivation\\nand trust in his/her support to them or get demotivated and feel insulted. This communication depends heavily on'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='and trust in his/her support to them or get demotivated and feel insulted. This communication depends heavily on\\ngood interpersonal communication. CHO must view himself or herself as a team leader responsible for improving\\nthe knowledge and skills of his/her staff by supporting them by identifying gaps and guiding to improve them\\nthan to just find fault in their work. The medical officer must keep the following points in mind while providing\\nconstructive and supportive feedback to the staff.\\nKey points for providing effective feedback\\n• It should be provided in a non-threatening and supportive manner.\\n• Tone of voice should be authoratative but mild and firm and not harsh.\\n• Should make the service provider feel comfortable while receiving feedback.\\n• It should be timely, specific and clear.\\n• For constructive and supportive feedback, provide positive points first and then the gaps which need\\nimprovement and how to improve.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='• It should be timely, specific and clear.\\n• For constructive and supportive feedback, provide positive points first and then the gaps which need\\nimprovement and how to improve.\\n• It should be helpful to the service provider in identfying gaps and their solutions or how to do the task\\ndifferently and in a better way.\\n• Never point out any mistakes of the service providers in front of the clients.\\n• Try to understand the challenges faced by the service providers working in their area and address them in\\nthe best possible way.\\n• Can be given individually and in a group setting also.\\n• Always recognise and praise the work of the service providers done well to keep them motivated and happy.  \\n57\\nAnnexure 1 :  Service delivery framework\\nRole of ASHA Role of MPW Role of CHO\\nMaternal\\nHealth\\nServices\\n∙ Preparation of eligible\\ncouples list in the village\\n∙ Identification of pregnant\\nmother and to facilitate their\\nregistration\\n∙ Ensuring ANC check-ups by\\nhome-to-home visits\\n∙ Support MPWs in'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='∙ Preparation of eligible\\ncouples list in the village\\n∙ Identification of pregnant\\nmother and to facilitate their\\nregistration\\n∙ Ensuring ANC check-ups by\\nhome-to-home visits\\n∙ Support MPWs in\\norganisation of VHSND\\n∙ Mobilisation of pregnant\\nwoman for accessing ANC\\nservices at VHSND or\\nPMSMA site\\n∙ Counsel women on birth\\npreparedness, importance of\\nsafe delivery, breastfeeding\\nand complementary feeding,\\nimmunization, contraception\\nand prevention of common\\ninfections. Supporting health\\nservice delivery through\\nhome visits, first-aid, and\\nimmunization sessions\\n∙ Create awareness and\\nprovide information to the\\ncommunity on determinants\\nof health such as nutrition,\\nbasic sanitation and hygienic\\npractices, healthy living and\\nworking conditions\\n∙ Ensure notification of\\nmaternal death\\n∙ Ensure early identification of\\npregnancies and registration\\npreferably within first\\ntrimester\\n∙ Ensure at least 4 ANC check-\\nups along with essential\\ndiagnostics and medications\\n∙ Counselling of pregnant'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='pregnancies and registration\\npreferably within first\\ntrimester\\n∙ Ensure at least 4 ANC check-\\nups along with essential\\ndiagnostics and medications\\n∙ Counselling of pregnant\\nwomen on micro-\\nbirth planning, birth\\npreparedness, danger signs\\nof pregnancies and nutrition\\n∙ Identification of high-risk\\npregnancies and prompt\\nreferral\\n∙ Conduct institutional\\ndelivery and referral for\\ncomplicated cases\\n∙ Provide post-partum care\\nduring VHSND and through\\nhome visits\\n∙ Mentoring of ASHAs and\\nAWW on maternal health\\nservices\\n∙ Facilitate and support\\nbeneficiary in incentivisation\\n(JSY, PMMYJ)\\n∙ Ensure notification &\\nfacilitate verbal autopsy in\\nMDSR\\n∙ Ensure regular updation in\\nRCH portal\\n∙ Provide facility-based\\nantenatal, intranatal\\nand postnatal services\\n∙ Ensure basic\\nmanagement, referral\\nand follow-up of HRPs\\nthrough MPW/ASHA\\n∙ Support MPW in\\nensuring 100%\\nregistration of\\npregnancies within\\ncatchment area in first\\ntrimester\\n∙ Support MPW in\\nensuring 100%\\ncomplete ANC for all\\npregnant women in'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes']}, page_content='through MPW/ASHA\\n∙ Support MPW in\\nensuring 100%\\nregistration of\\npregnancies within\\ncatchment area in first\\ntrimester\\n∙ Support MPW in\\nensuring 100%\\ncomplete ANC for all\\npregnant women in\\ncatchment area\\n∙ Mentor ASHAs, AWW\\nand MPWs for providing\\nmaternal health services\\n∙ Supportive supervision\\nvisits to the VHSNDs/\\nvillages in the catchment\\narea to ensure optimum\\ncoverage of maternal\\nhealth services\\n∙ Ensure availability of\\ndrugs, diagnostics,\\nconsumables and\\nequipment essential\\nfor providing maternal\\nhealth services at HWC.\\n∙ Ensure monthly\\nreview based on HMIS\\nindicators  \\n58\\nAnnexure 2 :  Blood Pressure Measurement\\nSteps\\n1. Select the type of blood pressure instrument.\\n2. Check that the bulb is properly attached to the tubing and there are no cracks or leakage.\\n3. Ask the person to sit on a chair or lie down on her left side or slightly tilt to the left on a flat surface.\\n4. Place the apparatus on a horizontal surface at the level of the person’s heart.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Monthly Reporting Formats', 'section_path': ['6 Recording and Reporting for', 'Monthly Reporting Formats'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='3. Ask the person to sit on a chair or lie down on her left side or slightly tilt to the left on a flat surface.\\n4. Place the apparatus on a horizontal surface at the level of the person’s heart.\\n5. Note any zero error, and replace with a functional sphygmomanometer.\\n6. Tie the cuff 3 cm above the elbow, placing both the tubes in front.\\n7. Raise the pressure of the cuff to 30 mmHg above the level at which pulse is no longer felt.\\n8. Release pressure slowly and listen with stethoscope keeping it on brachial artery at the elbow.\\n9. Note the reading where the sound is heard (systolic pressure).\\n10. Follow the sound and note reading where the sound disappears (diastolic).\\n11. Deflate and remove the cuff; close the mercury column knob.\\n12. Record the reading on the MCP card.\\n13. In the case of an electronic sphygmomanometer, tie the cuff in the same way and keep the arms stable.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='screen.  \\n59\\nAnnexure 3 :  Weight and Height Recording\\nSteps:  Weight Recording\\n1. Keep the weighing scale on a hard, flat surface and check for zero error before taking the weight.\\n2. Ask the woman to stand straight on the weighing scale, looking ahead and holding her head upright.\\n3. Read the scale from the top.\\n4. Record the weight to the nearest 100 g.\\n5. Record the findings on the MCP card.\\nSteps:  Height Recording\\n1. Keep the stadiometer (height measuring scale) on the floor against wall.  Identify how much is each\\ndivision.\\n2. Ask the woman to stand straight on the stadiometer, looking ahead and holding the head upright.\\n3. Tell the woman to place the legs together, bringing the ankles and knees together.\\n4. Read the scale.\\n5. Record the height to the nearest 0.1 cm/mm (depending upon the stadiometer used).\\n6. Explain results to the patient and record on MCP card.\\n7. What is the importance of checking height during ANC visit.  \\n60\\nAnnexure 4 :  Pelvic/Vaginal Examination\\nSteps'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='6. Explain results to the patient and record on MCP card.\\n7. What is the importance of checking height during ANC visit.  \\n60\\nAnnexure 4 :  Pelvic/Vaginal Examination\\nSteps\\n1 Keep the following equipment ready:\\n∙ Sterile/surgical gloves\\n∙ Apron\\n∙ Boiled and cooled/sterile swabs in Dettol\\n∙ 0.5% chlorine solution for decontamination\\n2 Ask women to pass urine and lie down with her knees flexed and legs apart.\\n3 Cover her to maintain privacy and then uncover the genital areas.\\n4 Wash your hands with soap and water and wear sterile gloves.\\n5 Check the vulva for the presence of:\\n∙ Mucus discharge\\n∙ Excessive watery discharge\\n∙ Foul smelling discharge\\n6 Clean the vulva from above downwards with one gloved hand (not the examining hand) by using\\nswab.\\nExamining the vagina –Examining the cervix and deciding the stage of labour\\n1 Use the thumb and forefinger of the left hand to part the labia majora, so that the vaginal opening is'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='swab.\\nExamining the vagina –Examining the cervix and deciding the stage of labour\\n1 Use the thumb and forefinger of the left hand to part the labia majora, so that the vaginal opening is\\nclearly visible. Gently insert the index and middle finger of examining hand into vagina.\\n2 Keep other hand on the women’s lower abdomen just above the pubic symphysis. When examining\\nfinger reach the end of vagina, turn your fingers upwards so that they come in contact with cervix.\\n3 Feel the cervix. It should be soft and elastic, and closely applied to the presenting part.\\n4 Measure the dilatation of cervical os by inserting your middle and index finger into the open cervix\\nand gently opening the fingers to reach the cervical rim (distance in cm between the outer aspects of\\nboth examining finger).\\n∙ 0 cm indicates a close external cervical os\\n∙ 10 cm indicates full dilatation\\n5 Deciding stages of labour:'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='both examining finger).\\n∙ 0 cm indicates a close external cervical os\\n∙ 10 cm indicates full dilatation\\n5 Deciding stages of labour:\\n∙ If the cervix is dilated 1-3 cm, and the contractions are weak and less than 2 in 10 minutes, this\\nis the first stage of labour; but the woman is not in active labour yet.\\n∙ If the cervix is dilated >3 cm, but not fully, the woman is still in the first stage of labour. However,\\nshe is now in active labour.\\n∙ Full cervical dilatation (10 cm; the cervix is no longer felt on vaginal examination), a bulging thin\\nperineum, a gaping vagina and anus, and the head visible through the introitus, even in between\\ncontractions indicate the second stage of labour, and that delivery is imminent. (see annexure –\\ndescribe vaginal examination procedure in detail)  \\n61\\n6 Feel the application of the cervix to the presenting part:\\n∙ If the cervix is well applied to the presenting part, it is favourable sign.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='describe vaginal examination procedure in detail)  \\n61\\n6 Feel the application of the cervix to the presenting part:\\n∙ If the cervix is well applied to the presenting part, it is favourable sign.\\n∙ If the cervix is not well applied to the presenting part, you have to be alert.\\n7 Feel the membranes:\\n∙ Intact membranes can be felt as bulging balloon during a contraction through the dilating os.\\n∙ Feel the umbilical cord, if it is felt, it is a case of cord presentation and requires urgent referral to\\nFRU.\\n∙ If the membrane has ruptured, check whether the amniotic fluid is clear or meconium stained.\\n8 Assessing the pelvis:\\n∙ Try to reach the sacral promontory if the head is not engaged. If the sacral promontory is felt, the\\npelvis is contracted. Refer the women to FRU for specialist care.\\n∙ If the sacral promontory is not felt, trace downward and feel for sacral hollow. A well curved\\nsacrum is favourable.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='pelvis is contracted. Refer the women to FRU for specialist care.\\n∙ If the sacral promontory is not felt, trace downward and feel for sacral hollow. A well curved\\nsacrum is favourable.\\n∙ Spread your two fingers to feel the ischial spines. If both ischial spines can be felt at same time,\\nthe pelvic cavity is contracted. Refer to FRU for further care.\\n9 Gently remove your fingers from the vagina and immerse your gloved hand in 0.55 of chlorine\\nsolution and dispose in leak proof container/plastic bag.  \\n62\\nAnnexure 5 :  Haemoglobin estimation\\nSteps\\n1. Keep all the necessary items ready:  Digital hemoglobinometer with batteries or charger, micro\\ncuvettes or strips, lancets, alcohol swab/sprit cotton, sterile gloves, tissue paper, biohazard container\\nto dispose the used lancets, micro cuvettes/strips.\\n2. Turn “ON” the hemoglobinometer:\\nIn cuvette based hemoglobinometer\\nAfter the monitor shows three dashes, pull the cuvette holder in its loading position. Fill the'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='2. Turn “ON” the hemoglobinometer:\\nIn cuvette based hemoglobinometer\\nAfter the monitor shows three dashes, pull the cuvette holder in its loading position. Fill the\\nmicrocuvette in one continuous process. The correct amount of blood (10 μl) is drawn into the\\nmicrocuvette. The microcuvette should be completely filled. Wipe away any excess blood on the\\noutside of the microcuvette tip. Check for air bubbles in the filled microcuvette. If present, use a\\nnew microcuvette. Place the filled microcuvette in the cuvette holder (within 40 seconds after filling\\nthe cuvette). Push the cuvette holder to its measuring position. Read and record the result. Remove\\nand discard the microcuvette in the appropriate bio-hazard container. Push the cuvette holder back\\ninto the instrument.\\nIf strip based hemoglobinometer is used, the system will undergo an auto-check and auto\\ncalibration after which the battery level, date, time and strip’s batch code are displayed within 2'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='If strip based hemoglobinometer is used, the system will undergo an auto-check and auto\\ncalibration after which the battery level, date, time and strip’s batch code are displayed within 2\\nseconds. Enter the code mentioned on the strip bottle. The meter would flash ‘strip’ symbol on the\\ndisplay.\\nInsert a fresh test strip into the meter with the arrows on the strip facing up andpointing towards\\nthe display. Ensure the correct positioning of the strip with the guiding V notch.\\nThe meter would flash ‘drop’ symbol on the display. Allow the second drop of the blood to fall\\ntocompletely cover the white coloured test area. Read and record the result. Remove the used\\nteststrip from the meter and dispose in appropriate biohazard container.\\n3. Wash hands and wear loose gloves.\\n4. Choose the third (middle) or fourth (ring) finger of the non-dominant hand of the beneficiary for the\\nfinger prick. Avoid the thumb and little finger. Avoid fingers with thick calluses. Avoid fingers with'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the', 'section_path': ['6 Recording and Reporting for', 'Press the ON button and both systolic and diastolic pressure will be displayed automatically on the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='finger prick. Avoid the thumb and little finger. Avoid fingers with thick calluses. Avoid fingers with\\ntight rings as they may constrict blood flow.\\n5. Ask the subject to rub their hands to promote blood flow.\\n6. Wipe the fingertip with the alcohol pad and let it air dry completely.\\nDo not blow on the finger to dry the alcohol. Do not wipe off the alcohol. Do not perform\\nthe finger prick until alcohol has completely evaporated.\\n7. Hold the finger firmly just below the centre of the fingertip.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Press and trigger the lancet flat and firmly against the finger at the puncture sites away from the', 'section_path': ['6 Recording and Reporting for', 'Press and trigger the lancet flat and firmly against the finger at the puncture sites away from the'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='midline.\\n9. Discard lancet in biohazard container.\\n10. Release pressure and allow a full drop of blood to collect on finger.\\n11. Once a drop of blood has collected on the finger, use the cotton or tissue to wipe away the first drop\\nof blood.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Use the second or third drop of blood for estimation of haemoglobin', 'section_path': ['6 Recording and Reporting for', 'Use the second or third drop of blood for estimation of haemoglobin'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='63\\nAnnexure 6 :  Urine testing for Sugar and Albumin\\nSteps\\n1. Keep all the necessary items ready: urine specimen collection bottles/containers and dipsticks.\\n2. Check the expiry date on the kit and carefully read the instructions before use.\\n3. Remove one strip from the bottle and screw the cap tightly.\\n4. Completely immerse the reagent area of the strip in the urine and remove it immediately.\\n5. Remove the strip of the urine and tap at the edge of container to remove excess urine.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'For glucose: compare the blue reagent area against the colour chart area on the bottle and re-', 'section_path': ['6 Recording and Reporting for', 'For glucose: compare the blue reagent area against the colour chart area on the bottle and re-'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='cord the finding (time as per manufacturer’s instruction).'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'For urine albumin: compare the yellow reagent area against the colour chart area on the bottle', 'section_path': ['6 Recording and Reporting for', 'For urine albumin: compare the yellow reagent area against the colour chart area on the bottle'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='and record the finding (time as per manufacturer’s instruction).\\n8. Dispose of strip and urine as per GoI protocol.  \\n64\\nAnnexure 7 :  Blood Sugar Testing by Glucometer\\nSteps\\n1 Preparatory Steps of performing blood sugar examination:\\n∙ Single step testing using 75 g oral glucose and measuring plasma glucose 2 hour after inges-\\ntion.\\n∙ 75g glucose is to be given orally after dissolving in approximately 300ml water whether the PW\\ncomes in fasting or non-fasting state, irrespective of the last meal. The intake of the solution\\nhas to be completed within 5 minutes.\\n∙ A plasma standardised glucometer should be used to evaluate blood glucose 2 hours after the\\noral glucose load.\\n∙ If vomiting occurs within 30 min of oral glucose intake, the test has to be repeated the next\\nday, if vomiting occurs after 30 minutes, the test continues.\\n∙ The threshold plasma glucose level of ≥140 mg/dL (more than or equal to 140) is taken as cut\\noff for diagnosis of GDM.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Preparing Lancing Device for Blood sample:', 'section_path': ['6 Recording and Reporting for', 'Preparing Lancing Device for Blood sample:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ Wash your hands and the sample site with soap and warm water. Rinse and dry thoroughly.\\n∙ Unscrew and remove the adjustable tip.\\n∙ Insert a new disposable lancet firmly into the carrier.\\n∙ Twist off and set aside the protective cover of the disposable lancet and replace the adjustable\\ntip.\\n∙ Choose a depth of penetration by rotating the top portion of the adjustable tip until the setting\\nnumber matches the arrow.\\n∙ To cock the lancing device, hold the tip in one hand. Pull the sliding barrel on with the other\\nhand. The lancing device is cocked when you feel a click.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Using lancing device at fingertip sampling site', 'section_path': ['6 Recording and Reporting for', 'Using lancing device at fingertip sampling site'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='∙ Place the cocked lancing device against the pad of the finger. The best puncture sites are on\\nthe middle or ring fingers. Choose a different site each time you test. Repeated puncturing at\\nthe same sample site may cause pain or skin calluses.\\n∙ Press the release button. Remove the device from the finger. Wait a few seconds.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Testing your blood glucose level', 'section_path': ['6 Recording and Reporting for', 'Testing your blood glucose level'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ Insert a test strip with contact bars facing up into the test strip port. Push the strip gently until\\nthe meter beeps. Then the symbol will appear on the screen. Use your lancing device to get\\nblood sample.\\n∙ A minimum volume of 0.5 microlitre is needed to fill the confirmation window. After the\\nsymbol appears on the screen, apply the blood sample to the narrow end of the test strip until\\nthe meter beeps.  \\n65'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Normal reference values', 'section_path': ['6 Recording and Reporting for', 'Normal reference values'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='RBS:70-110 mg/dl\\nFBS: 70- 99mg/dl\\nPPBS:<140mg/dl'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='∙ The test result will appear after the meter counts down from 5 to 1. The result will be au-\\ntomatically stored in the meter’s memory. If the test strip is removed after the test result is\\ndisplayed, the meter will automatically switch off after 3 seconds. Discard used test strips safely\\nin biohazard containers.\\n∙ The meter memory can store up to ten (10) results at one time. The results will be saved in\\nthe order it was measured, and you can view stored results by pushing the button. When the\\nbutton is pushed, number ‘1’ will appear on the screen for one second, and then the result will\\nbe shown.\\n∙ This is the most recent test result that is saved in the memory. To go on to the second recent\\nresult, press the button again. Now number ‘2’ will appear for one second and the next result\\nwill be displayed. By repeating this process, you can go through to result number 10 which is\\nthe oldest data saved in the memory.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='will be displayed. By repeating this process, you can go through to result number 10 which is\\nthe oldest data saved in the memory.\\n∙ To exit from the memory mode, press and hold down the button for about two (2) seconds.\\nThe meter will turn off.  \\n66\\nAnnexure 8 :  Medical Nutrition Therapy\\nThe meal plan composition:\\n∙ The recommended composition of the GDM mother diet is~50%-60% calories from carbohydrate, 10-\\n20% from protein, and 25-30% from fat.\\n∙ The distribution of calories, particularly carbohydrates, makes a difference in the postprandial blood\\nsugars. The total intake of carbohydrates should be controlled and monitored and carbohydrate foods with\\na lower glycaemic index should be emphasised.\\nImportant tips for planning meals for GDM mother\\n∙ A mother should follow discipline regarding meal timings. Eating heavy at one meal or skipping any meal\\nor fasting for long hours should be avoided. She should include all food groups in her daily diet, i.e., cereal,'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='or fasting for long hours should be avoided. She should include all food groups in her daily diet, i.e., cereal,\\npulses, milk and milk products, fruits, vegetable, and fats. For non-vegetarian mothers, eggs, low-fat meat\\nlike well-cooked fish or chicken can be included. Meal plan should be divided into 3 major meals (breakfast,\\nlunch and dinner) and 2-3 mid-day snacks.\\nBreakfast\\n∙ A pregnant woman should start her day with a healthy breakfast. She should never skip her breakfast.\\nBreakfast should consist of 1-2 carbohydrate servings (like chapati/dalia/sandwich/poha/idli etc.) as\\nmentioned in exchange list along with one serving from protein rich foods (like milk/curd/paneer/egg\\netc.).\\nLunch/dinner\\n∙ In lunch and dinner, the thali/plate can be divided in two halves.\\n∙ Fill the first half with vegetables like bottle gourd, ridge gourd, lettuce, broccoli, spinach, carrots, green\\nbeans, tomatoes, celery, cabbage, mushrooms etc., as vegetable provide fibre which helps in controlling'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='beans, tomatoes, celery, cabbage, mushrooms etc., as vegetable provide fibre which helps in controlling\\npost prandial glucose level.\\n∙ The remaining half should be divided into two equal ¼th parts.\\n∙ The ¼ portion of the plate can be filled with protein rich food like dal, soy nuggets, tofu, eggs, paneer,\\nchicken, fish etc.\\n∙ The remaining ¼ can be filled with chapati, brown rice, bread, cereals etc.\\n∙ Mother should have at least 1 serving of low fat, sugar-free yoghurt, curd or milk.\\n∙ It is also important for a mother to have at least 1 serving of fruits like guava, apple, berries or any citrus\\nfruits.\\n∙ Carbohydrate serving in lunch and dinner should be between 2 to 3. Taking heavy meals should be\\navoided.\\n∙ Skipping lunch and dinner and taking meal at irregular time should be avoided.\\nMid-day snack\\n∙ Along with major meals a pregnant woman should consume at least 2-3 healthy mid-day snacks.\\n∙ One to two carbohydrate serving can be taken in mid-day snack.  \\n67'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Mid-day snack\\n∙ Along with major meals a pregnant woman should consume at least 2-3 healthy mid-day snacks.\\n∙ One to two carbohydrate serving can be taken in mid-day snack.  \\n67\\n∙ A mother should maintain 2-3 hours gap with major meal when taking mid-day snack.\\n∙ Eating fried foods or junk foods or food with high amount of free sugars should be avoided.\\n∙ Some options for snack could be murmura chat, sprouts, vegetable dalia, vegetable poha, idli, vegetable\\nuttapam, besanchilla with low amount of oil etc.\\nGeneral tips\\n∙ Fried foods should be avoided;the mother should rather steam, boil or sauté food in a non-stick pan.\\n∙ Whole fruits should be preferred over juices.\\n∙ Prefer fish or chicken over red or organ meat.\\n∙ Fibre should be increased in the diet by including salad, beans, non-starchy vegetables, whole fruit, whole\\ngrain cereals, whole pulses.\\n∙ A mother should drink water, buttermilk, soups, soy milk and other unsweetened healthy beverages\\ninstead of soda or fruit juice.  \\n68'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='grain cereals, whole pulses.\\n∙ A mother should drink water, buttermilk, soups, soy milk and other unsweetened healthy beverages\\ninstead of soda or fruit juice.  \\n68\\nAnnexure 9 :  Rapid Diagnostic Test (RDT) for\\nMalaria\\nSteps to prepare the thick and thin smear\\n1. Select the ring finger of the left hand.\\n2. Clean with antiseptic or sterile wipes.\\n3. Dispose of the cotton swab as per GoI protocol.\\n4. Allow the finger to airdry.\\n5. Puncture at sides of the flesh pad of the finger avoiding the centre and the tip of the finger.\\n6. Allow the blood to come up automatically.\\n7. Don’t squeeze the finger.\\n8. Hold the slide by the edges.\\n9. Touch the drop of blood with a clean slide.\\n10. Collect 3 drops to prepare a thick smear and 1 drop for a thin smear. Place the thin and thick\\nsmear at either end of the slide.\\n11. To prepare a thin smear, touch a single drop of blood with the edge of the slide.\\n12. Keep the slide in front of the second drop and allow the blood to spread.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Viewing test results in meter memory', 'section_path': ['6 Recording and Reporting for', 'Viewing test results in meter memory'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='smear at either end of the slide.\\n11. To prepare a thin smear, touch a single drop of blood with the edge of the slide.\\n12. Keep the slide in front of the second drop and allow the blood to spread.\\n13. Hold it at an angle of 45 degrees and spread with a rapid but not brisk movement.\\n14. Write the slide number on the same side as the thin smear.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Spread the drop of blood with the corner of the slide to make a circle or a square of approximately', 'section_path': ['6 Recording and Reporting for', 'Spread the drop of blood with the corner of the slide to make a circle or a square of approximately'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='1 cm in diameter.\\n16. Wrap and send the slide to the laboratory for staining and to be examined under the microscope.\\nSteps for malaria testing using the rapid diagnostic test kit (RDT)\\n1. Store the kits at the recommended temperature.\\n2. Check that the RDT kit is not damaged.\\n3. Check the expiry date on the kit.\\n4. Remove the RDT packaging and take the dropper from the foil pouch and place it on a flat, dry\\nsurface.\\n5. Label the RDT with the patient’s ID and the date the test was performed.\\n6. Allow the reagents to reach room temperature if kept in cold chain.\\n7. Select the finger for puncture, clean with spirit swab and allow to air-dry.\\n8. Puncture the finger with a sterile lancet.\\n9. Slowly add 1 drop of blood to the sample well and add 2 drops of the assay diluents.\\n10. As the test begins to work, a purple colour will be seen moving across the result window in the\\ncentre of the test device.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Spread the drop of blood with the corner of the slide to make a circle or a square of approximately', 'section_path': ['6 Recording and Reporting for', 'Spread the drop of blood with the corner of the slide to make a circle or a square of approximately'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='10. As the test begins to work, a purple colour will be seen moving across the result window in the\\ncentre of the test device.\\n11. Interpret test* result at 5-20 mins (do not interpret after 20 mins) as per the manufacturer’s\\ninstructions.  \\n69\\n*Interpretation of the result for monovalent RDT kit:\\nNegative\\nresult\\nIf only one line (band) appears, the test has worked and the patient is negative for malaria.\\nPositive\\nresult\\nIf 2 lines (bands) appear within15-20 mins, the person is suffering from P. falciparum\\nmalaria.\\nInvalid\\nresult\\nIf no line appears within 15-20 mins, discard and repeat the test.\\n*Interpretation of the result for bivalent RDT kit:\\nNegative\\nresult\\nIf only 1 line (band) appears at C (control),the test has worked and the patient is negative for malaria\\nPositive\\nresult\\nIf 2 lines (bands) appear within 15-20 mins at C (control) and T1, the person is suffering from\\nP. falciparum malaria.\\nPositive\\nresult'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Spread the drop of blood with the corner of the slide to make a circle or a square of approximately', 'section_path': ['6 Recording and Reporting for', 'Spread the drop of blood with the corner of the slide to make a circle or a square of approximately'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Positive\\nresult\\nIf 2 lines (bands) appear within 15-20 mins at C (control) and T1, the person is suffering from\\nP. falciparum malaria.\\nPositive\\nresult\\nIf 2 lines (bands) appear within 15-20 mins at C (control) andT2, the person is suffering from\\nP. vivax malaria.\\nPositive\\nresult\\nIf 3 lines (bands) appear within 15-20 mins at C (control), T1 and T2, the person is suffering\\nfrom both P. falciparum and P. vivax malaria.\\nInvalid\\ntest\\nIf no line appears within 15-20 mins, discard and repeat the test.  \\n70\\nAnnexure 10 : Rapid Diagnostic Test for Syphilis\\nSteps'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'STORAGE: The test syphilis test kit should be kept in the refrigerator to maintain the temperature', 'section_path': ['6 Recording and Reporting for', 'STORAGE: The test syphilis test kit should be kept in the refrigerator to maintain the temperature'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='at 2°C to 8°C. If a refrigerator is not available at the sub-centre, then the kits should be kept at the\\nPHC to maintain cold chain and be brought to the VHSND or outreach sessions while ensuring that\\ncold chain is maintained.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'PROCEDRE:', 'section_path': ['6 Recording and Reporting for', 'PROCEDRE:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ Remove test device from foil pouch.\\n∙ Add 20 uL whole blood to the sample well and 3-4 drops of assay diluent.\\n∙ Interpret test results within 10 minutes.\\n∙ Negative result: presence of only one purple colour band visible within the result window.\\n∙ Positive result: Presence of both ‘T’ and ‘C’ bands visible within the result window.\\n∙ Invalid result: No purple band visible within the result window.\\nNegative\\nPositive\\nSample Test Control\\nWeak Positive\\nInvalid  \\n71\\nAnnexure 11 : Rapid Diagnostic Test for Hepatitis B\\nSteps\\n1. SAMPLE/SPECIMEN COLLECTION & STORAGE\\n∙ Test should be performed on human serum or plasma only immediately after collection.\\n∙ If not tested immediately, specimen should be refrigerated at 2-8°C up to 3 days following collec-\\ntion.\\n∙ If testing within 3 days is not possible, specimen should be stored frozen at 20°C.\\n∙ Haemolysed specimen or specimen with microbial contamination should be discarded and fresh\\naliquot should be collected.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'PROCEDRE:', 'section_path': ['6 Recording and Reporting for', 'PROCEDRE:'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='∙ Haemolysed specimen or specimen with microbial contamination should be discarded and fresh\\naliquot should be collected.\\n2. TEST PROCEDURE: Procedure should be followed as per kit manual. Briefly, the procedure is as\\nfollows:\\n∙ Bring the required number of test foil pouches and specimen to room temperature prior to test-\\ning.\\n∙ Take out device from the foil pouch.\\n∙ Label the test card with patient’s name or identification number.\\n∙ Add 2 drops (70 μl) of human serum/plasma specimen into the sample well using the dropper\\nprovided (use separate dropper/microtip for each specimen).\\n∙ Allow reaction to occur during the next 20 minutes.\\n∙ Read results at 20 minutes.\\n∙ Discard the test kit immediately after reading result at 20 minutes, considering it to be potentially\\ninfectious.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'INTERPRETATION OF RESULT', 'section_path': ['6 Recording and Reporting for', 'INTERPRETATION OF RESULT'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='REACTIVE: Appearance of pink coloured line, one each in test region “T” and control region “C”\\nindicates that the sample is REACTIVE for HBsAg.\\nNON-REACTIVE: Appearance of one distinct pink line in the control region “C” only, indicates\\nthat the sample is “NON-REACTIVE” for HBsAg.\\nINVALID: When neither control line nor the test line appears on the membrane, the test should be\\ntreated as invalid which maybe because of following reasons:\\na. Improper storage at temperature other than the recommended temperature.\\nb. Wrong procedure.\\nc. Long atmospheric exposure of the test device after opening the pouch.\\nThe test should be repeated using a new test card and test sample.  \\n72\\nAnnexure 12 : Rapid Diagnostic Test for HIV/AIDS\\nSteps\\n1 Materials and reagents: HIV TRI-DOT test device, buffer solution, Protein- A conjugate. Negative\\ncontrol, positive control, sample dropper\\n2 Storage: Store the entire kit at 2-8°C in the coolest and driest area available. Do not use the kit beyond'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'INTERPRETATION OF RESULT', 'section_path': ['6 Recording and Reporting for', 'INTERPRETATION OF RESULT'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='control, positive control, sample dropper\\n2 Storage: Store the entire kit at 2-8°C in the coolest and driest area available. Do not use the kit beyond\\nthe expiry date. Do not freeze the kit components.\\n3 Specimen/ sample collection\\n∙ Collect blood in a clean dry sterile vial and allow to clot\\n∙ It is recommended that fresh sample should be used if possible.\\n∙ If serum is not to be assayed immediately, it should be stored at 2-8°C or frozen at minus 20°C (-20°C).\\n∙ Haemolysed specimen or specimen with microbial contamination should be discarded and fresh aliquot\\nshould be collected.\\n4 Procedure: Procedure should be followed as per kit manual. Briefly, the procedure is as follows:\\n∙ Add 3 drops of Buffer Solution to the centre of the device\\n∙ Hold the dropper vertically and add 1 drop of patient’s sample 50μl (serum or plasma) using the sample\\ndropper provided (use a separate sample dropper for each specimen to be tested).\\n∙ Add 5 drops of Buffer Solution.'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'INTERPRETATION OF RESULT', 'section_path': ['6 Recording and Reporting for', 'INTERPRETATION OF RESULT'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='dropper provided (use a separate sample dropper for each specimen to be tested).\\n∙ Add 5 drops of Buffer Solution.\\n∙ Add 2 drops of Protein-A Conjugate directly from the conjugate vial.\\n∙ Add 5 drops of Buffer Solution and read results.\\n∙ Read results immediately and discard the device considering it to be potentially infectious.\\n5 Interpretation of results:\\nNON-REACTIVE: If only one Dot (only the Control Dot) appears, the specimen is non-reactive for\\nantibodies either to HIV-1 or HIV-2. Interpret sample as non-reactive.\\nREACTIVE:\\n∙ If two Dots, one for the control and the other\\nfor HIV-1appear, the specimen is reactive for\\nantibodies to HIV-1.\\n∙ If two Dots, one for the control and the other\\nfor HIV-2appear, the specimen is reactive for\\nantibodies to HIV-2.\\n∙ If all the three Dots, one each for control, HIV-1\\n& HIV-2 appear, the specimen is reactive for\\nantibodies to HIV-1 & HIV-2.\\nINVALID TEST: If no Dot appears after the test is complete, either with clear background or with'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'INTERPRETATION OF RESULT', 'section_path': ['6 Recording and Reporting for', 'INTERPRETATION OF RESULT'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='& HIV-2 appear, the specimen is reactive for\\nantibodies to HIV-1 & HIV-2.\\nINVALID TEST: If no Dot appears after the test is complete, either with clear background or with\\ncomplete pinkish/purple background as, the test indicates ERROR. This may indicate a procedural error or\\ndeterioration of specimen/reagents or particulate matter in the specimen. The specimen should be tested\\non a new device.\\nTest : Negative Test : Positive\\nINV ALID INV ALID\\nTest : Positive  \\n73\\nAnnexure 13 : Monthly Format for Sub Centre and\\nEquivalent Institutions\\nMinistry of Health & Family Welfare\\n(Monitoring & Evaluation Division)\\nMonthly Format for Sub Center and Equivalent Institutions  \\nState: Due for Submission on 5th of following Month\\nDistrict: Month\\nBlock: Ye a r\\nCity/ Town/\\nVillage\\nFacility name\\nFacility type Public                                  Private\\nLocation Rural                                     Urban\\nNumbers reported during the month\\nPart A REPRODUCTIVE AND CHILD HEALTH'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'INTERPRETATION OF RESULT', 'section_path': ['6 Recording and Reporting for', 'INTERPRETATION OF RESULT'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Facility type Public                                  Private\\nLocation Rural                                     Urban\\nNumbers reported during the month\\nPart A REPRODUCTIVE AND CHILD HEALTH\\nM1 Ante Natal Care (ANC) Services'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='1.1.1 Out of the total ANC registered, number registered within 1st trimester (within 12 weeks)\\n1.2 Tetanus Toxoid (TT) Immunisation to Pregnant Women (PW)\\n1.2.1 Number of PW given TT1\\n1.2.2 Number of PW given TT2\\n1.2.3 Number of PW given TT Booster\\n1.2.4 Number of PW given 180 Iron Folic Acid (IFA) tablets\\n1.2.5 Number of PW given 360 Calcium tablets\\n1.2.6 Number of PW given one Albendazole tablet during the 2nd trimester\\n1.2.7 Number of PW received 4 or more ANC check ups\\n1.2.8 Number of PW given ANC Corticosteroids in Pre Term Labour\\n1.3 Pregnant women (PW) with Hypertension (BP>140/90)\\n1.3.1 New cases of PW with hypertension detected\\n1.3.1.a Out of the new cases of PW with hypertension detected, cases managed at institution\\n1.4 Pregnant women (PW) with Anaemia\\n1.4.1 Number of PW tested for Haemoglobin (Hb )\\n1.4.2 Number of PW having Hb level<11 (tested cases)\\n1.4.3 Number of PW having Hb level<7 (tested cases)\\nM2 Deliveries'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Deliveries conducted at Home', 'section_path': ['6 Recording and Reporting for', 'Deliveries conducted at Home'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='2.1.1 Number of Home Deliveries attended by\\n2.1.1.a Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM)\\n2.1.1.b Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.)\\n2.1.2 Number of PW given Tablet Misoprostol during home delivery\\n2.1.3 Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery\\n2.1.4 Number of Institutional Deliveries conducted\\n2.1.4.a Out of total institutional deliveries number of women discharged within 48 hours of delivery\\n2.1.4.b Number of newborns received 6 HBNC visits after Institutional Delivery\\nM3 Pregnancy outcome & details of new-born\\n3.1 Pregnancy Outcome (in number)\\n3.1.1 Live Birth\\n3.1.1.a Live Birth - Male\\n3.1.1.b Live Birth - Female\\n3.1.2 Number of Pre term newborns ( < 37 weeks of pregnancy)\\n3.1.3 Still Birth\\n3.2 Abortion (spontaneous+\\nMonthly - Subcenterl of 5  \\n74\\nAnnexure 14 : Monthly Format for PHC and\\nEquivalent Institutions'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Deliveries conducted at Home', 'section_path': ['6 Recording and Reporting for', 'Deliveries conducted at Home'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='3.1.3 Still Birth\\n3.2 Abortion (spontaneous+\\nMonthly - Subcenterl of 5  \\n74\\nAnnexure 14 : Monthly Format for PHC and\\nEquivalent Institutions\\nMinistry of Health & Family Welfare\\n(Monitoring & Evaluation Division)\\nMonthly Format for PHC & Equivalent Institutions  \\nState: Due for Submission on 5th of following Month\\nDistrict: Month\\nBlock: Ye a r\\nCity/ Town/\\nFacility\\nname\\nFacility type Public                                  Private\\nLocation Rural                                     Urban\\nNumbers reported during the month\\nPart A REPRODUCTIVE AND CHILD HEALTH\\nM1 Ante Natal Care (ANC) Services'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='1.1.1 Out of the total ANC registered, number registered within 1st trimester (within 12 weeks)\\n1.2 Tetanus Toxoid (TT) Immunisation to Pregnant Women (PW)\\n1.2.1 Number of PW given TT1\\n1.2.2 Number of PW given TT2\\n1.2.3 Number of PW given TT Booster\\n1.2.4 Number of PW given 180 Iron Folic Acid (IFA) tablets\\n1.2.5 Number of PW given 360 Calcium tablets\\n1.2.6 Number of PW given one Albendazole tablet during the 2nd trimester\\n1.2.7 Number of PW received 4 or more ANC check ups\\n1.2.8 Number of PW given ANC Corticosteroids in Pre Term Labour\\n1.3 Pregnant women (PW) with Hypertension (BP>140/90)\\n1.3.1 New cases of PW with hypertension detected\\n1.3.1.a Out of the new cases of PW with hypertension detected, cases managed at institution\\n1.4 Pregnant women (PW) with Anaemia\\n1.4.1 Number of PW tested for Haemoglobin (Hb )\\n1.4.2 Number of PW having Hb level<11 (tested cases)\\n1.4.3 Number of PW having Hb level<7 (tested cases)\\n1.4.4 Number of PW having severe anaemia (Hb<7) treated'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='1.4.2 Number of PW having Hb level<11 (tested cases)\\n1.4.3 Number of PW having Hb level<7 (tested cases)\\n1.4.4 Number of PW having severe anaemia (Hb<7) treated\\n1.5 Pregnant women (PW) with Gestational Diabetes Mellitus (GDM)\\n1.5.1 Number of PW tested for Blood Sugar\\n1.5.2 Number of PW tested positive for GDM\\n1.5.3 Number of PW given insulin out of total tested positive for GDM\\n1.6 Pregnant Women (PW) with Syphilis\\n1.6.1 Point of Care (POC) tests conducted for Syphilis\\n1.6.1.a Number of PW tested using POC test for Syphilis\\n1.6.1.b Number of PW tested positive using POC test for Syphilis\\n1.6.2 Veneral Disease Research Laboratory (VDRL) / Rapid Plasma Reason (RPR) tests conducted\\n1.6.2.a Out of the PW tested positive using POC test, numbers tested using RPR\\n1.6.2.b Number of PW tested using RPR as 1’ test\\n1.6.2.c Number of PW tested positive using RPR as 1’ test\\n1.6.2.d Out of the above (1.6.2 c) Number of PW treated for Syphilis using at least one Injection Benzathine'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='1.6.2.c Number of PW tested positive using RPR as 1’ test\\n1.6.2.d Out of the above (1.6.2 c) Number of PW treated for Syphilis using at least one Injection Benzathine\\nPenicillin (2.4 million.\\n1.6.3 Number of infant born to seropositive mother who received treatment\\nMonthly- PHC 1 of 6  \\n75\\nReferences\\n1. Guidelines for Antenatal Care and Skilled Attendance at Birth by ANM’s/LHV’s/SN’s. Maternal Health\\nDivision. Ministry of Health and Family Welfare. Government of India. April 2010.\\n2. Guidelines for Pregnancy Care and Management of Common Obstetric Complications by Medical Officers.\\nMaternal Health Division. Ministry of Health and Family Welfare. Government of India. April 2005\\n3. Daksh Skills Lab (RMNCH + A) Training Manual for trainers\\n4. Daksh Skills Lab (RMNCH + A) Training Manual for participants\\n5. Dakshta 3 days training\\n6. Dakshta 5 days TOT\\n7. Anemia Mukt Bharat Operational guidelines for program managers 2018  \\n76\\nList of Contributors'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition'], 'contains_warnings': True}, page_content='5. Dakshta 3 days training\\n6. Dakshta 5 days TOT\\n7. Anemia Mukt Bharat Operational guidelines for program managers 2018  \\n76\\nList of Contributors\\nMinistry of Health and Family Welfare (MoHFW)\\nDr. Manohar Agnani Addl. Secretary\\nMs. Preeti Pant Joint Secretary\\nDr. Patibandla Ashok Babu Joint Secretary\\nDr. S.K Sikdar Advisor (FP & MH)\\nDr. Sumita Ghosh Addl. Commissioner & Incharge (CH, AH, RBSK, CAC, ADs)\\nDr. Teja Ram Addl. Commissioner & Incharge (MH & FP)\\nDr. Sila Deb Addl. Commissioner & Incharge (CH Nutrition)\\nDr. Neeta Singh Sr. Consultant - Child Health Nutrition\\nDr. Vishal Kumar Sr. Consultant - Child Health Nutrition\\nDr. Nisha Singh Sr. Consultant - Child Health Nutrition\\nMs. Amita Chauhan Sr. Consultant, NHM\\nMs. Nidhi Verma Consultant, Comprehensive Abortion Care Program\\nDevelopment Partners\\nDr. Renu Srivastava Strategy Director, Newborn Child Health, UPTSU, IHAT\\nDr. Deepti Agarwal National Professional officer, WHO'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development'], 'contains_warnings': True}, page_content='Development Partners\\nDr. Renu Srivastava Strategy Director, Newborn Child Health, UPTSU, IHAT\\nDr. Deepti Agarwal National Professional officer, WHO\\nDr. Pragati Singh National Program Officer, SRHR, WHO Country of India\\nDr. Nidhi Bhatt National Consultant-FP , WHO Country of India\\nMs. Shikha Bansal National Consultant-AH, WHO Country of India\\nDr. Prairna Koul National Consultant-AH, UNICEF India\\nDr. Rakshita Khanijou Consultant, WHO Country of India\\nJhpiego team\\nNational Health Systems Resource Centre (NHSRC)\\nMaj Gen (Prof) Atul Kotwal Executive Director\\nDr. M A Balasubramanya Advisor, Community Processes and Comprehensive Primary Health Care\\nDr. Neha Dumka Lead Consultant, Knowledge Management Division\\nDr. Suman Senior Consultant, Community Processes and Comprehensive Primary\\nHealth Care\\nDr. Shalini Singh Former Senior Consultant, Community Processes and Comprehensive\\nPrimary Health Care\\nDr. Rupsa Banerjee Former Senior Consultant, Community Processes and Comprehensive'),\n",
       " Document(metadata={'chapter': '6 Recording and Reporting for', 'section': 'Total number of pregnant women registered for ANC', 'section_path': ['6 Recording and Reporting for', 'Total number of pregnant women registered for ANC'], 'document_title': '', 'document_type': '', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='Health Care\\nDr. Shalini Singh Former Senior Consultant, Community Processes and Comprehensive\\nPrimary Health Care\\nDr. Rupsa Banerjee Former Senior Consultant, Community Processes and Comprehensive\\nPrimary Health Care\\nMs. Ima Chopra Consultant, Community Processes and Comprehensive Primary Health Care\\nMs. Haifa Thaha Consultant, Community Processes and Comprehensive Primary Health Care\\nMs. Sandhani Gogoi Consultant, Community Processes and Comprehensive Primary Health\\nCare, Regional Resource Centre for NorthEastern States (branch of NHSRC)\\nDr. Vijaya Shekhar Salkar Junior Consultant, Community Processes and Comprehensive Primary\\nHealth Care'),\n",
       " Document(metadata={'section_path': [], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='WHO recommendations on antenatal care\\nfor a positive pregnancy experience  \\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience.\\nI.World Health Organization.\\nISBN 978 92 4 154991 2\\nSubject headings are available from WHO institutional repository\\n© World Health Organization 2016\\nAll rights reserved. Publications of the World Health Organization are available on the WHO website\\n(http:/ /www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia,\\n1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int).\\nRequests for permission to reproduce or translate WHO publications – whether for sale or for\\nnon-commercial distribution – should be addressed to WHO Press through the WHO website\\n(http:/ /www.who.int/ about/licensing/ copyright_form).\\nThe designations employed and the presentation of the material in this publication do not imply the expression of'),\n",
       " Document(metadata={'section_path': [], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='(http:/ /www.who.int/ about/licensing/ copyright_form).\\nThe designations employed and the presentation of the material in this publication do not imply the expression of\\nany opinion whatsoever on the part of the World Health Organization concerning the legal status of any country,\\nterritory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and\\ndashed lines on maps represent approximate border lines for which there may not yet be full agreement.\\nThe mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed\\nor recommended by the World Health Organization in preference to others of a similar nature that are not\\nmentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital\\nletters.\\nAll reasonable precautions have been taken by the World Health Organization to verify the information contained'),\n",
       " Document(metadata={'section_path': [], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='letters.\\nAll reasonable precautions have been taken by the World Health Organization to verify the information contained\\nin this publication. However, the published material is being distributed without warranty of any kind, either\\nexpressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no\\nevent shall the World Health Organization be liable for damages arising from its use.\\nDesign and layout by Green Ink (www.greenink.co.uk)\\nPrinted in Luxembourg  \\nContents\\nAcknowledgements v\\nAcronyms and abbreviations vii\\nExecutive summary ix\\n1. Introduction 1\\n2. Methods 4\\n3. Evidence and recommendations 13\\nA. Nutritional interventions 14\\nB. Maternal and fetal assessment 40\\nC. Preventive measures 63\\nD. Interventions for common physiological symptoms 74\\nE. Health systems interventions to improve the utilization and quality of ANC 85'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='2016 WHO ANC model 105\\n5. Research implications 118\\n6. Dissemination, applicability and updating of the guideline and recommendations 120\\nReferences  123\\nAnnex 1:  External e xperts and WHO staff involved in the preparation of this guideline 137\\nAnnex 2: Other WHO guidelines with rec ommendations relevant to routine ANC 141\\nAnnex 3:  Summary of declarations of int erest from the Guideline Development Group\\n(GDG) member s and how they were managed 143\\nAnnex 4:  Implementation consider ations for ANC guideline recommendations 145\\nWeb annexes:WHO recommendations on antenatal care for a positive pregnancy experience*\\nWeb annex 1:  Priorit y questions and outcomes for the antenatal care (ANC) interventions\\nidentified for this guideline\\nWeb annex 2:  Chang es from the approved scope of this guideline\\nWeb annex 3:  Guideline Dev elopment Group (GDG) judgements related to the recommendations\\nWeb supplement: WHO recommendations on antenatal care for a positive pregnancy experience:'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Web annex 3:  Guideline Dev elopment Group (GDG) judgements related to the recommendations\\nWeb supplement: WHO recommendations on antenatal care for a positive pregnancy experience:\\nevidenc e base*\\nThe standardized criteria used in grading the evidence and the GRADE tables have been published in this\\nseparate Web supplement. These evidence tables are referred to within this document by number, prefixed with\\n\"EB\" (for evidence base), for ease of reference.\\n*available at: www.who.int/ reproductivehealth/ publications/ maternal_perinatal_health/ anc-positive-pregnancy-experience/ en/  \\n« T o achieve the Every Woman Every Child\\nvision and the Global Strategy for Women\\'s,\\nChildren\\'s and Adolescents\\' Health, we need\\ninnovative, evidence-based approaches to\\nantenatal care. I welcome these guidelines,\\nwhich aim to put women at the centre of care,\\nenhancing their experience of pregnancy and\\nensuring that babies have the best possible\\nstart in life. »'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='antenatal care. I welcome these guidelines,\\nwhich aim to put women at the centre of care,\\nenhancing their experience of pregnancy and\\nensuring that babies have the best possible\\nstart in life. »\\nBan Ki-moon, United Nations Secretary-General  \\nvAcknowledgements\\nAcknowledgements\\nThe Departments of Reproductive Health and Research (RHR), Nutrition for Health and Development (NHD),\\nand Maternal, Newborn, Child and Adolescent Health (MCA) of the World Health Organization (WHO)\\ngratefully acknowledge the contributions that many individuals and organizations have made to the development\\nof this guideline.\\nA.Metin Gülmezoglu, Matthews Mathai, Olufemi Oladapo, Juan Pablo Peña-Rosas and Özge T unçalp were the\\nmembers of the WHO Steering Group that managed the guideline development process. The members of the\\nGuideline Development Group (GDG) included Mohammed Ariful Aram, Françoise Cluzeau, Luz Maria De-Regil,'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='Guideline Development Group (GDG) included Mohammed Ariful Aram, Françoise Cluzeau, Luz Maria De-Regil,\\nAft Ghérissi, Gill Gyte, Rintaro Mori, James Neilson, Lynnette Neufeld, Lisa Noguchi, Nafissa Osman, Erika Ota,\\nT omas Pantoja, Bob Pattinson, Kathleen Rasmussen, Niveen Abu Rmeileh, Harshpal Singh Sachdev, Rusidah\\nSelamat, Charlotte Warren and Charles Wisonge. James Neilson served as chair of the GDG.\\nWe would also like to thank the following WHO regional advisors for their contributions: Karima Gholbzouri,\\nGunta Lazdane, Bremen de Mucio, Mari Nagai, Leopold Ouedraogo, Neena Raina and Susan Serruya. We\\nwould also like to thank the following individuals for their contributions to the guideline process, including the\\nscoping: Manzi Anatole, Rifat Atun, Himanshu Bhushan, Jacquelyn Caglia, Chompilas Chongsomchai, Morseda\\nChowdhury, Mengistu Hailemariam, Stephen Hodgins, Annie Kearns, Ana Langer, Pisake Lumbiganon, T aiwo'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Chowdhury, Mengistu Hailemariam, Stephen Hodgins, Annie Kearns, Ana Langer, Pisake Lumbiganon, T aiwo\\nOyelade, Jeffrey Smith, Petra ten Hoope-Bender, James Tielsch and Rownak Khan.\\nSpecial thanks to the authors of the Cochrane systematic reviews used in this guideline for their assistance and\\ncollaboration in preparing or updating them. Sonja Henderson, Frances Kellie and Nancy Medley coordinated\\nthe updating of the relevant Cochrane systematic reviews. Soo Downe and Kenny Finlayson performed the\\nscoping and qualitative reviews on the views of women and providers with regard to antenatal care (ANC). For\\nthe evidence on interventions, Edguardo Abalos, Monica Chamillard and Virginia Dias reviewed and graded the\\nscientific evidence. For the evidence on test accuracy, Khalid Khan and Ewelina Rogozinska reviewed and graded\\nthe scientific evidence. Theresa Lawrie reviewed the evidence grading, and drafted the evidence summaries.'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='the scientific evidence. Theresa Lawrie reviewed the evidence grading, and drafted the evidence summaries.\\nSimon Lewin and Claire Glenton contributed to the preparation of the evidence summaries on ANC delivery\\noptions and provided technical support on the DECIDE framework (Developing & Evaluating Communication\\nstrategies to support Informed Decisions & Practice based on Evidence). Emma Allanson coordinated the\\npopulation of the DECIDE frameworks. Jenny Moberg reviewed and summarized the indirect evidence on ANC\\ndelivery. Ipek Gurol-Urganci, Charles O’Donovan and Inger Scheel reviewed data on the implementation of\\nfocused ANC (FANC) from country case studies to support the guideline recommendations. The members of the\\nWHO Steering Group and Theresa Lawrie drafted the final guideline document.\\nWe thank the observers who represented various organizations during the guideline development process,'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='WHO Steering Group and Theresa Lawrie drafted the final guideline document.\\nWe thank the observers who represented various organizations during the guideline development process,\\nincluding: France Donnay of the Bill & Melinda Gates Foundation; Rita Borg-Xuereb of the International\\nConfederation of Midwives (ICM); Diogo Ayres-de-Campos and CN Purandare of the International Federation of\\nGynecology and Obstetrics (FIGO); Luc de Bernis of the United Nations Population Fund (UNFPA); and Roland\\nKupka of the United Nations Children’s Fund (UNICEF); and Deborah Armbruster and Karen Fogg of the United\\nStates Agency for International Development (USAID).\\nWe appreciate the feedback provided by a large number of international stakeholders during the scoping\\nexercise that took place as part of the guideline development process. We also would like to thank the following\\nindividuals who contributed to this process and reviewed the guideline document: Andrea Bosman, Maurice'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='individuals who contributed to this process and reviewed the guideline document: Andrea Bosman, Maurice\\nBucagu,Jahnavi Daru, Claudia Garcia-Moreno,Haileyesus Getahun, Rodolfo Gomez,T racey Goodman, T amar\\nKabakian,Avinash Kanchar, Philipp Lambach,Sarah de Masi, Frances McConville,Antonio Montresor, Justin\\nOrtiz,Anayda Portela, Jeremy Pratt, LisaRogers, Nathalie Roos, Silvia Schwarte,Maria Pura Solon, João Paulo\\nSouza,Petr Velebil,T eodora Wi, Ahmadu Yakubu, Yacouba Yaro and Gerardo Zamora.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\nvi\\nFunding was provided for this guideline by USAID and the Bill & Melinda Gates Foundation, supplemented by the\\nUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research T raining\\nin Human Reproduction (HRP) core budget. The views of the funding bodies have not influenced the content of\\nthis guideline.  \\nviiAcronyms and abbreviations\\nAcronyms and abbreviations\\nANC  antenatal care'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='this guideline.  \\nviiAcronyms and abbreviations\\nAcronyms and abbreviations\\nANC  antenatal care\\nASB  as ymptomatic bacteriuria\\nBMI  body mass inde x\\nCERQual Confidenc e in the Evidence from Reviews of Qualitative Research\\nCI  c onfidence interval\\nCTG  car diotocography\\nDECIDE  Dev eloping and Evaluating Communication strategies to support Informed Decisions\\nand Practice based on Evidence\\nDOI  declaration of int erest\\nEB  e vidence base\\nEGWG  ex cessive gestational weight gain\\nERG  External R eview Group\\nFANC  focused ant enatal care\\nFIGO  International F ederation of Gynecology and Obstetrics\\nGBS  group B str eptococcus\\nGDG  Guideline Dev elopment Group\\nGRADE  Grading of R ecommendations Assessment, Development and Evaluation\\nGRC  Guidelines Re view Committee\\nGREAT  Guideline-driven, R esearch priorities, Evidence synthesis, Application of evidence,\\nand T ransfer of knowledge\\nHb  haemoglobin\\nHIC  high-inc ome country\\nHIV  human immunodeficiency virus'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='GREAT  Guideline-driven, R esearch priorities, Evidence synthesis, Application of evidence,\\nand T ransfer of knowledge\\nHb  haemoglobin\\nHIC  high-inc ome country\\nHIV  human immunodeficiency virus\\nHRP  UNDP/UNFP A/UNICEF/WHO/World Bank Special Programme of Research, Development\\nand Research T raining in Human Reproduction\\nICM  International C onfederation of Midwives\\nIPT p  intermitt ent preventive treatment in pregnancy\\nIPT p-SP  intermitt ent preventive treatment in pregnancy with sulfadoxine-pyrimethamine\\nIQR  int erquartile range\\nIUGR  intraut erine growth restriction\\nIVR  Initiative f or Vaccine Research\\nLMIC  low - and middle-income country\\nMCA  Department of Mat ernal, Newborn, Child and Adolescent Health (at WHO)\\nMD  mean difference\\nMLCC  midwife-led c ontinuity of care\\nMMN  multiple micronutrient\\nMUAC  mid-upper arm circumf erence\\nNHD  Department of Nutrition f or Health and Development (at WHO)\\nNRS  non-r andomized study'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='MLCC  midwife-led c ontinuity of care\\nMMN  multiple micronutrient\\nMUAC  mid-upper arm circumf erence\\nNHD  Department of Nutrition f or Health and Development (at WHO)\\nNRS  non-r andomized study  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\nviii\\nOR  odds ratio\\nPAHO  Pan American Health Or ganization (WHO Regional Office for the Americas)\\nPCG  Pr egnancy and Childbirth Group (Cochrane Collaboration)\\nPICO  population (P), int ervention (I), comparator (C), outcome (O)\\nPLA  participat ory learning and action\\nPMNCH  The P artnership for Maternal, Newborn & Child Health\\nPMR  perinatal mortalit y rate\\nPrEP  pr e-exposure prophylaxis\\nPROM  prelabour ruptur e of membranes\\nPWG  participat ory women’s group\\nRCT  randomiz ed controlled trial\\nRh  rhesus\\nRHR  Department of R eproductive Health and Research (at WHO)\\nRR  r elative risk\\nRUTI  recurr ent urinary tract infections\\nSFH  s ymphysis-fundal height\\nSGA  small for g estational age\\nSP   sulfado xine-pyrimethamine'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 11, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='RR  r elative risk\\nRUTI  recurr ent urinary tract infections\\nSFH  s ymphysis-fundal height\\nSGA  small for g estational age\\nSP   sulfado xine-pyrimethamine\\nTB  tuber culosis\\nTBA  traditional bir th attendant\\nT dap tetanus/ diphtheria/ acellular pertussis\\nTDF  tenof ovir disoproxil fumarate\\nTT  t etanus toxoid\\nTT-CV  tetanus t oxoid-containing vaccine\\nTWG  T echnical W orking Group\\nUN  Unit ed Nations\\nUNDP  United Nations De velopment Programme\\nUNFPA  United Nations P opulation Fund\\nUNICEF  United Nations C hildren’s Fund\\nUNIMMAP United Nations int ernational multiple micronutrient preparation\\nUS$  United Stat es (US) dollar\\nUSAID  United Stat es Agency for International Development\\nUTI  urinary tract inf ection\\nWHO  World Health Or ganization  \\nixExecutive summary\\nExecutive summary\\nIntroduction\\nIn 2016, at the start of the Sustainable Development Goals (SDGs) era, pregnancy-related preventable morbidity'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 12, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='WHO  World Health Or ganization  \\nixExecutive summary\\nExecutive summary\\nIntroduction\\nIn 2016, at the start of the Sustainable Development Goals (SDGs) era, pregnancy-related preventable morbidity\\nand mortality remains unacceptably high. While substantial progress has been made, countries need to\\nconsolidate and increase these advances, and to expand their agendas to go beyond survival, with a view to\\nmaximizing the health and potential of their populations.\\nThe World Health Organization (WHO) envisions a world where every pregnant woman and newborn receives\\nquality care throughout the pregnancy, childbirth and the postnatal period. Within the continuum of reproductive\\nhealth care, antenatal care (ANC) provides a platform for important health-care functions, including health\\npromotion, screening and diagnosis, and disease prevention. It has been established that by implementing timely'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 13, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='promotion, screening and diagnosis, and disease prevention. It has been established that by implementing timely\\nand appropriate evidence-based practices, ANC can save lives. Crucially, ANC also provides the opportunity to\\ncommunicate with and support women, families and communities at a critical time in the course of a woman’s\\nlife. The process of developing these recommendations on ANC has highlighted the importance of providing\\neffective communication about physiological, biomedical, behavioural and sociocultural issues, and effective\\nsupport, including social, cultural, emotional and psychological support, to pregnant women in a respectful way.\\nThese communication and support functions of ANC are key, not only to saving lives, but to improving lives,\\nhealth-care utilization and quality of care. Women’s positive experiences during ANC and childbirth can create\\nthe foundations for healthy motherhood.'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 14, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='health-care utilization and quality of care. Women’s positive experiences during ANC and childbirth can create\\nthe foundations for healthy motherhood.\\nThis is a comprehensive WHO guideline on routine ANC for pregnant women and adolescent girls. The aim is\\nfor these recommendations to complement existing WHO guidelines on the management of specific pregnancy-\\nrelated complications. The guidance is intended to reflect and respond to the complex nature of the issues\\nsurrounding the practice and delivery of ANC, and to prioritize person-centred health and well-being – not only\\nthe prevention of death and morbidity – in accordance with a human rights-based approach.\\nThe scope of this guideline was informed by a systematic review of women’s views, which shows that women\\nwant a positive pregnancy experience from ANC. A positive pregnancy experience is defined as maintaining\\nphysical and sociocultural normality, maintaining a healthy pregnancy for mother and baby (including preventing'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 15, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='physical and sociocultural normality, maintaining a healthy pregnancy for mother and baby (including preventing\\nor treating risks, illness and death), having an effective transition to positive labour and birth, and achieving\\npositive motherhood (including maternal self-esteem, competence and autonomy).\\nRecognizing that a woman’s experience of care is key to transforming ANC and creating thriving families and\\ncommunities, this guideline addresses the following questions:\\nnn What are the evidence-based practices during ANC that improve outcomes and lead to a positive pregnancy\\nexperience?\\nnn How should these practices be delivered?\\nGuideline development methods\\nThese ANC recommendations are intended to inform the development of relevant health-care policies and\\nclinical protocols. The guideline was developed using standard operating procedures in accordance with the\\nprocess described in the WHO handbook for guideline development. Briefly, these procedures include:'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 16, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='process described in the WHO handbook for guideline development. Briefly, these procedures include:\\n(i) identification of priority questions and outcomes; (ii) evidence retrieval and synthesis; (iii) assessment of\\nthe evidence; (iv) formulation of the recommendations; and (v) planning for implementation, dissemination,\\nimpact evaluation and updating of the guideline. The quality of the scientific evidence underpinning the\\nrecommendations was graded using the Grading of Recommendations Assessment, Development and  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\nx\\nEvaluation (GRADE) and Confidence in the Evidence from Reviews of Qualitative research (GRADE-CERQual)\\napproaches, for quantitative and qualitative evidence, respectively. Up-to-date systematic reviews were used\\nto prepare evidence profiles for priority questions. The DECIDE (Developing and Evaluating Communication'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 17, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='to prepare evidence profiles for priority questions. The DECIDE (Developing and Evaluating Communication\\nStrategies to support Informed Decisions and Practice based on Evidence) framework, an evidence-to-decision\\ntool that includes intervention effects, values, resources, equity, acceptability and feasibility criteria, was used\\nto guide the formulation and approval of recommendations by the Guideline Development Group (GDG) – an\\ninternational group of experts assembled for the purpose of developing this guideline – at three T echnical\\nConsultations between October 2015 and March 2016.\\nRecommendations\\nThe WHO T echnical Consultations led to the development of 39 recommendations related to five types\\nof interventions: A. Nutritional interventions, B. Maternal and fetal assessment, C. Preventive measures,\\nD.Interventions for common physiological symptoms, and E. Health system interventions to improve utilization'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 18, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='D.Interventions for common physiological symptoms, and E. Health system interventions to improve utilization\\nand quality of ANC. Interventions were either recommended, not recommended, or recommended under certain\\nconditions based on the GDG’s judgements according to the DECIDE criteria, which informed both the direction\\nand context, if any, of the recommendation. T o ensure that each recommendation is correctly understood\\nand applied in practice, the context of all context-specific recommendations is clearly stated within each\\nrecommendation, and the contributing experts provided additional remarks where needed. Users of the guideline\\nshould refer to these remarks, which are presented along with the evidence summaries within the guideline. In\\naddition, ANC-relevant recommendations from current guidance produced by other WHO departments were\\nsystematically identified and 10 such recommendations were consolidated into this guideline for the purpose of'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 19, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition'], 'contains_warnings': True}, page_content='systematically identified and 10 such recommendations were consolidated into this guideline for the purpose of\\nproviding a comprehensive document for end-users. All 49 recommendations on ANC for a positive pregnancy\\nexperience are summarized in T able 1.\\nIn accordance with WHO guideline development standards, these recommendations will be reviewed and\\nupdated following the identification of new evidence, with major reviews and updates at least every five years.\\nWHO welcomes suggestions regarding additional questions for inclusion in future updates of the guideline.\\nAt the T echnical Consultations, the implementation considerations of individual recommendations and of the\\nguideline as a whole were discussed. The GDG, emphasizing the evidence indicating increased fetal deaths and\\nlesser satisfaction of women with the four-visit model (also known as focused or basic ANC), decided to increase'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 20, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='lesser satisfaction of women with the four-visit model (also known as focused or basic ANC), decided to increase\\nthe recommended number of contacts between the mother and the health-care providers at time points that may\\nfacilitate assessment of well-being and provision of interventions to improve outcomes if problems are identified\\n(see Recommendation E.7 in T able 1). The recommendations in this guideline should be implemented alongside\\nother quality-improvement activities. Derivative products of this guideline will include a practical implementation\\nmanual for health-care practitioners, which will incorporate ANC recommendations and established good\\nclinical practices. T able 1 summarizes the list of all interventions evaluated by the GDG and therefore includes\\ninterventions that are recommended, only recommended under certain conditions (including research), and\\ninterventions that are not recommended.  \\nxiExecutive summary'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 21, 'total_chunks': 22, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='interventions that are recommended, only recommended under certain conditions (including research), and\\ninterventions that are not recommended.  \\nxiExecutive summary\\nT able 1: Summary list of WHO recommendations on antenatal care (ANC) for a positive pregnancy\\nexperience\\nThese recommendations apply to pregnant women and adolescent girls within the context of routine ANC'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Nutritional interventions', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='Recommendation Type of\\nrecommendation\\nDietary\\ninterventions\\nA.1.1: Counselling about healthy eating and keeping physically active\\nduring pregnancy is recommended for pregnant women to stay healthy\\nand to prevent excessive weight gain during pregnancy.\\na\\nRecommended\\nA.1.2: In undernourished populations, nutrition education on increasing\\ndaily energy and protein intake is recommended for pregnant women to\\nreduce the risk of low-birth-weight neonates.\\nContext-specific\\nrecommendation\\nA.1.3: In undernourished populations, balanced energy and protein\\ndietary supplementation is recommended for pregnant women to reduce\\nthe risk of stillbirths and small-for-gestational-age neonates.\\nContext-specific\\nrecommendation\\nA.1.4: In undernourished populations, high-protein supplementation\\nis not recommended for pregnant women to improve maternal and\\nperinatal outcomes.\\nNot recommended\\nIron and folic acid\\nsupplements\\nA.2.1: Daily oral iron and folic acid supplementation with 30mg to 60mg'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Nutritional interventions', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='perinatal outcomes.\\nNot recommended\\nIron and folic acid\\nsupplements\\nA.2.1: Daily oral iron and folic acid supplementation with 30mg to 60mg\\nof elemental iron\\nb and 400 g (0.4mg) of folic acidc is recommended\\nfor pregnant women to prevent maternal anaemia, puerperal sepsis, low\\nbirth weight, and preterm birth.\\nd\\nRecommended\\nA.2.2: Intermittent oral iron and folic acid supplementation with 120\\nmg of elemental iron\\ne and 2800 g (2.8mg) of folic acid once weekly is\\nrecommended for pregnant women to improve maternal and neonatal\\noutcomes if daily iron is not acceptable due to side-effects, and in\\npopulations with an anaemia prevalence among pregnant women of less\\nthan 20%.\\nf\\nContext-specific\\nrecommendation\\nCalcium\\nsupplements\\nA.3: In populations with low dietary calcium intake, daily calcium\\nsupplementation (1.5–2.0g oral elemental calcium) is recommended for\\npregnant women to reduce the risk of pre-eclampsia.\\ng\\nContext-specific\\nrecommendation\\nVitamin A\\nsupplements'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Nutritional interventions', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='supplementation (1.5–2.0g oral elemental calcium) is recommended for\\npregnant women to reduce the risk of pre-eclampsia.\\ng\\nContext-specific\\nrecommendation\\nVitamin A\\nsupplements\\nA.4: Vitamin A supplementation is only recommended for pregnant\\nwomen in areas where vitamin A deficiency is a severe public health\\nproblem,\\nh to prevent night blindness.i\\nContext-specific\\nrecommendation\\na. A healthy diet contains adequate energy, protein, vitamins and minerals, obtained through the consumption of a variety of foods,\\nincluding green and orange vegetables, meat, fish, beans, nuts, whole grains and fruit.b. The equivalent of 60 mg of elemental iron is 300 mg of ferrous sulfate hepahydrate, 180 mg of ferrous fumarate or 500 mg of ferrous\\ngluconate.c. Folic acid should be commenced as early as possible (ideally before conception) to prevent neural tube defects.\\nd. This recommendation supersedes the previous recommendation found in the WHO publication Guideline: daily iron and folic acid'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Nutritional interventions', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='d. This recommendation supersedes the previous recommendation found in the WHO publication Guideline: daily iron and folic acid\\nsupplementation in pregnant women (2012).e. The equivalent of 120mg of elemental iron equals 600 mg of ferrous sulfate heptahydrate, 360 mg of ferrous fumarate or 1000 mg of\\nferrous gluconate.f. This recommendation supersedes the previous recommendation in the WHO publication Guideline: intermittent iron and folic acid\\nsupplementation in non-anaemic pregnant women (2012).g. This recommendation is consistent with the WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia (2011) and\\nsupersedes the previous recommendation found in the WHO publication Guideline: calcium supplementation in pregnant women (2013).h. Vitamin A deficiency is a severe public health problem if >5% of women in a population have a history of night blindness in their most'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Nutritional interventions', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='recent pregnancy in the previous 3–5 years that ended in a live birth, or if > 20% of pregnant women have a serum retinol level\\n<0.70\\nmol/L. Determination of vitamin A deficiency as a public health problem involves estimating the prevalence of deficiency in a\\npopulation by using specific biochemical and clinical indicators of vitamin A status.\\ni. This recommendation supersedes the previous recommendation found in the WHO publication Guideline: vitamin A supplementation in\\npregnant women (2011).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\nxii\\nZinc supplements A.5: Zinc supplementation for pregnant women is only recommended in\\nthe context of rigorous research.\\nContext-specific\\nrecommendation\\n(research)\\nMultiple\\nmicronutrient\\nsupplements\\nA.6: Multiple micronutrient supplementation is not recommended for\\npregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nVitamin B6\\n(pyridoxine)\\nsupplements'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Nutritional interventions', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='supplements\\nA.6: Multiple micronutrient supplementation is not recommended for\\npregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nVitamin B6\\n(pyridoxine)\\nsupplements\\nA.7: Vitamin B6 (pyridoxine) supplementation is not recommended for\\npregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nVitamin E and C\\nsupplements\\nA.8: Vitamin E and C supplementation is not recommended for pregnant\\nwomen to improve maternal and perinatal outcomes.\\nNot recommended\\nVitamin D\\nsupplements\\nA.9: Vitamin D supplementation is not recommended for pregnant\\nwomen to improve maternal and perinatal outcomes.j\\nNot recommended\\nRestricting caffeine\\nintake\\nA.10: For pregnant women with high daily caffeine intake (more than\\n300mg per day),k lowering daily caffeine intake during pregnancy is\\nrecommended to reduce the risk of pregnancy loss and low-birth-weight\\nneonates.\\nContext-specific\\nrecommendation'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Recommendation Type of\\nrecommendation\\nB.1: Maternal assessment\\nAnaemia B.1.1: Full blood count testing is the recommended method for diagnosing\\nanaemia in pregnancy. In settings where full blood count testing is not\\navailable, on-site haemoglobin testing with a haemoglobinometer is\\nrecommended over the use of the haemoglobin colour scale as the\\nmethod for diagnosing anaemia in pregnancy.\\nContext-specific\\nrecommendation\\nAsymptomatic\\nbacteriuria (ASB)\\nB.1.2: Midstream urine culture is the recommended method for\\ndiagnosing asymptomatic bacteriuria (ASB) in pregnancy. In settings\\nwhere urine culture is not available, on-site midstream urine Gram-\\nstaining is recommended over the use of dipstick tests as the method for\\ndiagnosing ASB in pregnancy.\\nContext-specific\\nrecommendation\\nIntimate partner\\nviolence (IPV)\\nB.1.3: Clinical enquiry about the possibility of intimate partner violence\\n(IPV) should be strongly considered at antenatal care visits when'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='recommendation\\nIntimate partner\\nviolence (IPV)\\nB.1.3: Clinical enquiry about the possibility of intimate partner violence\\n(IPV) should be strongly considered at antenatal care visits when\\nassessing conditions that may be caused or complicated by IPV in order\\nto improve clinical diagnosis and subsequent care, where there is the\\ncapacity to provide a supportive response (including referral where\\nappropriate) and where the WHO minimum requirements are met.m n\\nContext-specific\\nrecommendation\\nj. This recommendation supersedes the previous recommendation found in the WHO publication Guideline: vitamin D supplementation in\\npregnant women (2012).\\nk. This includes any product, beverage or food containing caffeine (i.e. brewed coffee, tea, cola-type soft drinks, caffeinated energy drinks,\\nchocolate, caffeine tablets).\\nl. Evidence on essential ANC activities, such as measuring maternal blood pressure, proteinuria and weight, and checking for fetal heart'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='chocolate, caffeine tablets).\\nl. Evidence on essential ANC activities, such as measuring maternal blood pressure, proteinuria and weight, and checking for fetal heart\\nsounds, was not assessed by the GDG as these activities are considered to be part of good clinical practice.\\nm. Minimum requirements are: a protocol/ standard operating procedure; training on how to ask about IPV, and on how to provide the\\nminimum response or beyond; private setting; confidentiality ensured; system for referral in place; and time to allow for appropriate\\ndisclosure.\\nn. This recommendation is consistent with Responding to intimate partner violence and sexual violence against women: WHO clinical and policy\\nguidelines (2013).  \\nxiiiExecutive summary\\nRecommendations integrated from other WHO guidelines that are relevant to ANC maternal assessment\\nGestational\\ndiabetes mellitus\\n(GDM)\\nB.1.4: Hyperglycaemia first detected at any time during pregnancy'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Recommendations integrated from other WHO guidelines that are relevant to ANC maternal assessment\\nGestational\\ndiabetes mellitus\\n(GDM)\\nB.1.4: Hyperglycaemia first detected at any time during pregnancy\\nshould be classified as either gestational diabetes mellitus (GDM) or\\ndiabetes mellitus in pregnancy, according to WHO criteria.o\\nRecommended\\nT obacco use B.1.5: Health-care providers should ask all pregnant women about their\\ntobacco use (past and present) and exposure to second-hand smoke as\\nearly as possible in the pregnancy and at every antenatal care visit.p\\nRecommended\\nSubstance use B.1.6: Health-care providers should ask all pregnant women about their\\nuse of alcohol and other substances (past and present) as early as\\npossible in the pregnancy and at every antenatal care visit.q\\nRecommended\\nHuman immuno-\\ndeficiency virus\\n(HIV) and syphilis\\nB.1.7: In high-prevalence settings,r provider-initiated testing and\\ncounselling (PITC) for HIV should be considered a routine component'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='Recommended\\nHuman immuno-\\ndeficiency virus\\n(HIV) and syphilis\\nB.1.7: In high-prevalence settings,r provider-initiated testing and\\ncounselling (PITC) for HIV should be considered a routine component\\nof the package of care for pregnant women in all antenatal care settings.\\nIn low-prevalence settings, PITC can be considered for pregnant women\\nin antenatal care settings as a key component of the effort to eliminate\\nmother-to-child transmission of HIV, and to integrate HIV testing\\nwith syphilis, viral or other key tests, as relevant to the setting, and to\\nstrengthen the underlying maternal and child health systems.s\\nRecommended\\nT uberculosis (TB) B.1.8: In settings where the tuberculosis (TB) prevalence in the general\\npopulation is 100/100000 population or higher, systematic screening\\nfor active TB should be considered for pregnant women as part of\\nantenatal care.t\\nContext-specific\\nrecommendation\\nB.2: Fetal assessment\\nDaily fetal\\nmovement\\ncounting'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='for active TB should be considered for pregnant women as part of\\nantenatal care.t\\nContext-specific\\nrecommendation\\nB.2: Fetal assessment\\nDaily fetal\\nmovement\\ncounting\\nB.2.1: Daily fetal movement counting, such as with “count-to-ten” kick\\ncharts, is only recommended in the context of rigorous research.\\nContext-specific\\nrecommendation\\n(research)\\nSymphysis-fundal\\nheight (SFH)\\nmeasurement\\nB.2.2: Replacing abdominal palpation with symphysis-fundal height\\n(SFH) measurement for the assessment of fetal growth is not\\nrecommended to improve perinatal outcomes. A change from what\\nis usually practiced (abdominal palpation or SFH measurement) in a\\nparticular setting is not recommended.\\nContext-specific\\nrecommendation\\nAntenatal cardio-\\ntocography\\nB.2.3: Routine antenatal cardiotocographyu is not recommended for\\npregnant women to improve maternal and perinatal outcomes.\\nNot recommended'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='recommendation\\nAntenatal cardio-\\ntocography\\nB.2.3: Routine antenatal cardiotocographyu is not recommended for\\npregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\no. This is not a recommendation on routine screening for hyperglycaemia in pregnancy. It has been adapted and integrated from the WHO\\npublication Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy (2013), which states that GDM should be\\ndiagnosed at any time in pregnancy if one or more of the following criteria are met:\\n•fasting plasma glucose 5.1–6.9 mmol/L (92–125 mg/ dL)\\n•1-hour plasma glucose >10.0mmol/L (180mg/ dL) following a 75g oral glucose load\\n•2-hour plasma glucose 8.5–11.0 mmol/L (153–199 mg/ dL) following a 75g oral glucose load.\\nDiabetes mellitus in pregnancy should be diagnosed if one or more of the following criteria are met:\\n•fasting plasma glucose >7.0mmol/L (126mg/ dL)\\n•2-hour plasma glucose >11.1mmol/L (200mg/ dL) following a 75g oral glucose load'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='•fasting plasma glucose >7.0mmol/L (126mg/ dL)\\n•2-hour plasma glucose >11.1mmol/L (200mg/ dL) following a 75g oral glucose load\\n•random plasma glucose >11.1mmol/L (200mg/ dL) in the presence of diabetes symptoms.p. Integrated from WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy\\n(2013).\\nq. Integrated from the WHO publication Guidelines for the identification and management of substance use and substance use disorders in\\npregnancy (2014).\\nr. High-prevalence settings are defined in the 2015 WHO publication Consolidated guidelines on HIV testing services as settings with greater\\nthan 5% HIV prevalence in the population being tested. Low-prevalence settings are those with less than 5% HIV prevalence in the\\npopulation being tested. In settings with a generalized or concentrated HIV epidemic, retesting of HIV-negative women should be'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='population being tested. In settings with a generalized or concentrated HIV epidemic, retesting of HIV-negative women should be\\nperformed in the third trimester because of the high risk of acquiring HIV infection during pregnancy; please refer to Recommendation\\nB.1.7 for details.s. Adapted and integrated from the WHO publication Consolidated guidelines on HIV testing services (2015).\\nt. Adapted and integrated from the WHO publication Systematic screening for active tuberculosis: principles and recommendations (2013).\\nu. Cardiotocography is a continuous recording of the fetal heart rate and uterine contractions obtained via an ultrasound transducer placed\\non the mother’s abdomen.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\nxiv\\nUltrasound scan B.2.4: One ultrasound scan before 24 weeks of gestation (early\\nultrasound) is recommended for pregnant women to estimate\\ngestational age, improve detection of fetal anomalies and multiple'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='ultrasound) is recommended for pregnant women to estimate\\ngestational age, improve detection of fetal anomalies and multiple\\npregnancies, reduce induction of labour for post-term pregnancy, and\\nimprove a woman’s pregnancy experience.\\nRecommended\\nDoppler ultrasound\\nof fetal blood\\nvessels\\nB.2.5: Routine Doppler ultrasound examination is not recommended for\\npregnant women to improve maternal and perinatal outcomes.v\\nNot recommended'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Preventive measures', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Recommendation Type of\\nrecommendation\\nAntibiotics for\\nasymptomatic\\nbacteriuria (ASB)\\nC.1: A seven-day antibiotic regimen is recommended for all pregnant\\nwomen with asymptomatic bacteriuria (ASB) to prevent persistent\\nbacteriuria, preterm birth and low birth weight.\\nRecommended\\nAntibiotic\\nprophylaxis to\\nprevent recurrent\\nurinary tract\\ninfections\\nC.2: Antibiotic prophylaxis is only recommended to prevent recurrent\\nurinary tract infections in pregnant women in the context of rigorous\\nresearch.\\nContext-specific\\nrecommendation\\n(research)\\nAntenatal anti-D\\nimmunoglobulin\\nadministration\\nC.3: Antenatal prophylaxis with anti-D immunoglobulin in non-sensitized\\nRh-negative pregnant women at 28 and 34 weeks of gestation to prevent\\nRhD alloimmunization is only recommended in the context of rigorous\\nresearch.\\nContext-specific\\nrecommendation\\n(research)\\nPreventive\\nanthelminthic\\ntreatment\\nC.4: In endemic areas, w preventive anthelminthic treatment is'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Preventive measures', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first', 'second']}, 'maternal_topics': ['nutrition']}, page_content='research.\\nContext-specific\\nrecommendation\\n(research)\\nPreventive\\nanthelminthic\\ntreatment\\nC.4: In endemic areas, w preventive anthelminthic treatment is\\nrecommended for pregnant women after the first trimester as part of\\nworm infection reduction programmes.x\\nContext-specific\\nrecommendation\\nT etanus toxoid\\nvaccination\\nC.5: T etanus toxoid vaccination is recommended for all pregnant women,\\ndepending on previous tetanus vaccination exposure, to prevent neonatal\\nmortality from tetanus.y\\nRecommended\\nRecommendations integrated from other WHO guidelines that are relevant to ANC\\nMalaria prevention:\\nintermittent\\npreventive\\ntreatment in\\npregnancy (IPT p)\\nC.6: In malaria-endemic areas in Africa, intermittent preventive\\ntreatment with sulfadoxine-pyrimethamine (IPT p-SP) is recommended\\nfor all pregnant women. Dosing should start in the second trimester, and\\ndoses should be given at least one month apart, with the objective of\\nensuring that at least three doses are received.z\\nContext-specific'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Preventive measures', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='doses should be given at least one month apart, with the objective of\\nensuring that at least three doses are received.z\\nContext-specific\\nrecommendation\\nPre-exposure\\nprophylaxis (PrEP)\\nfor HIV prevention\\nC.7: Oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil\\nfumarate (TDF) should be offered as an additional prevention choice\\nfor pregnant women at substantial risk of HIV infection as part of\\ncombination prevention approaches.aa\\nContext-specific\\nrecommendation\\nv. Doppler ultrasound technology evaluates umbilical artery (and other fetal arteries) waveforms to assess fetal well-being in the third\\ntrimester of pregnancy.\\nw. Areas with greater than 20% prevalence of infection with any soil-transmitted helminths.\\nx. Consistent with the WHO publication Guideline: preventive chemotherapy to control soil-transmitted helminth infections in high-risk groups\\n(2016, in press).'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Preventive measures', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='x. Consistent with the WHO publication Guideline: preventive chemotherapy to control soil-transmitted helminth infections in high-risk groups\\n(2016, in press).\\ny. This recommendation is consistent with the WHO guideline on Maternal immunization against tetanus (2006). The dosing schedule\\ndepends on the previous tetanus vaccination exposure.\\nz. Integrated from the WHO publication Guidelines for the treatment of malaria (2015), which also states: “WHO recommends that, in areas\\nof moderate-to-high malaria transmission of Africa, IPT p-SP be given to all pregnant women at each scheduled ANC visit, starting as\\nearly as possible in the second trimester, provided that the doses of SP are given at least 1 month apart. WHO recommends a package of\\ninterventions for preventing malaria during pregnancy, which includes promotion and use of insecticide-treated nets, as well as IPT p-SP”.'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Preventive measures', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='interventions for preventing malaria during pregnancy, which includes promotion and use of insecticide-treated nets, as well as IPT p-SP”.\\nT o ensure that pregnant women in endemic areas start IPT p-SP as early as possible in the second trimester, policy-makers should ensure\\nhealth system contact with women at 13 weeks of gestation.aa. Integrated from the WHO publication Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (2015).\\nSubstantial risk of HIV infection is defined by an incidence of HIV infection in the absence of PrEP that is sufficiently high (>3%\\nincidence) to make offering PrEP potentially cost-saving (or cost-effective). Offering PrEP to people at substantial risk of HIV infection\\nmaximizes the benefits relative to the risks and costs.  \\nxvExecutive summary'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Recommendation Type of\\nrecommendation\\nNausea and\\nvomiting\\nD.1: Ginger, chamomile, vitamin B6 and/ or acupuncture are\\nrecommended for the relief of nausea in early pregnancy, based on a\\nwoman’s preferences and available options.\\nRecommended\\nHeartburn D.2: Advice on diet and lifestyle is recommended to prevent and\\nrelieve heartburn in pregnancy. Antacid preparations can be offered to\\nwomen with troublesome symptoms that are not relieved by lifestyle\\nmodification.\\nRecommended\\nLeg cramps D.3: Magnesium, calcium or non-pharmacological treatment options can\\nbe used for the relief of leg cramps in pregnancy, based on a woman’s\\npreferences and available options.\\nRecommended\\nLow back and\\npelvic pain\\nD.4: Regular exercise throughout pregnancy is recommended to prevent\\nlow back and pelvic pain. There are a number of different treatment\\noptions that can be used, such as physiotherapy, support belts and\\nacupuncture, based on a woman’s preferences and available options.\\nRecommended'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='options that can be used, such as physiotherapy, support belts and\\nacupuncture, based on a woman’s preferences and available options.\\nRecommended\\nConstipation D.5: Wheat bran or other fibre supplements can be used to relieve\\nconstipation in pregnancy if the condition fails to respond to dietary\\nmodification, based on a woman’s preferences and available options.\\nRecommended\\nVaricose veins and\\noedema\\nD.6: Non-pharmacological options, such as compression stockings,\\nleg elevation and water immersion, can be used for the management\\nof varicose veins and oedema in pregnancy, based on a woman’s\\npreferences and available options.\\nRecommended'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Health systems interventions to improve the utilization and quality of antenatal care', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Health systems interventions to improve the utilization and quality of antenatal care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Recommendation Type of\\nrecommendation\\nWoman-held case\\nnotes\\nE.1: It is recommended that each pregnant woman carries her own case\\nnotes during pregnancy to improve continuity, quality of care and her\\npregnancy experience.\\nRecommended\\nMidwife-led\\ncontinuity of care\\nE.2: Midwife-led continuity-of-care models, in which a known midwife\\nor small group of known midwives supports a woman throughout the\\nantenatal, intrapartum and postnatal continuum, are recommended\\nfor pregnant women in settings with well functioning midwifery\\nprogrammes.\\nContext-specific\\nrecommendation\\nGroup antenatal\\ncare\\nE.3: Group antenatal care provided by qualified health-care professionals\\nmay be offered as an alternative to individual antenatal care for pregnant\\nwomen in the context of rigorous research, depending on a woman’s\\npreferences and provided that the infrastructure and resources for\\ndelivery of group antenatal care are available.\\nContext-specific\\nrecommendation\\n(research)\\nCommunity-based\\ninterventions'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Health systems interventions to improve the utilization and quality of antenatal care', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Health systems interventions to improve the utilization and quality of antenatal care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='preferences and provided that the infrastructure and resources for\\ndelivery of group antenatal care are available.\\nContext-specific\\nrecommendation\\n(research)\\nCommunity-based\\ninterventions\\nto improve\\ncommunication\\nand support\\nE.4.1: The implementation of community mobilization through facilitated\\nparticipatory learning and action (PLA) cycles with women’s groups is\\nrecommended to improve maternal and newborn health, particularly in\\nrural settings with low access to health services.\\nab Participatory women’s\\ngroups represent an opportunity for women to discuss their needs during\\npregnancy, including barriers to reaching care, and to increase support to\\npregnant women.\\nContext-specific\\nrecommendation\\nE.4.2: Packages of interventions that include household and community\\nmobilization and antenatal home visits are recommended to improve\\nantenatal care utilization and perinatal health outcomes, particularly in\\nrural settings with low access to health services.\\nContext-specific\\nrecommendation'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Health systems interventions to improve the utilization and quality of antenatal care', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Health systems interventions to improve the utilization and quality of antenatal care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='antenatal care utilization and perinatal health outcomes, particularly in\\nrural settings with low access to health services.\\nContext-specific\\nrecommendation\\nab. Integrated from WHO recommendations on community mobilization through facilitated participatory learning and action cycles with women’s\\ngroups for maternal and newborn health (2014).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\nxvi\\nT ask shifting\\ncomponents of\\nantenatal care\\ndeliveryac\\nE.5.1: T ask shifting the promotion of health-related behaviours for\\nmaternal and newborn healthad to a broad range of cadres, including\\nlay health workers, auxiliary nurses, nurses, midwives and doctors is\\nrecommended.\\nRecommended\\nE.5.2: T ask shifting the distribution of recommended nutritional\\nsupplements and intermittent preventive treatment in pregnancy (IPT p)\\nfor malaria prevention to a broad range of cadres, including auxiliary\\nnurses, nurses, midwives and doctors is recommended.\\nRecommended\\nRecruitment and'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Health systems interventions to improve the utilization and quality of antenatal care', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Health systems interventions to improve the utilization and quality of antenatal care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='for malaria prevention to a broad range of cadres, including auxiliary\\nnurses, nurses, midwives and doctors is recommended.\\nRecommended\\nRecruitment and\\nretention of staff\\nin rural and remote\\nareasae\\nE.6: Policy-makers should consider educational, regulatory, financial,\\nand personal and professional support interventions to recruit and retain\\nqualified health workers in rural and remote areas.\\nContext-specific\\nrecommendation\\nAntenatal care\\ncontact schedules\\nE.7: Antenatal care models with a minimum of eight contacts are\\nrecommended to reduce perinatal mortality and improve women’s\\nexperience of care.\\nRecommended\\nac. Recommendations adapted and integrated from the WHO guideline on Optimizing health worker roles to improve access to key maternal and\\nnewborn health interventions through task shifting (OptimizeMNH) (2012).\\nad. Including promotion of the following: care-seeking behaviour and ANC utilization; birth preparedness and complication readiness;'),\n",
       " Document(metadata={'section': 'Implementation of the ANC guideline and rec ommendations: introducing the', 'subsection': 'Health systems interventions to improve the utilization and quality of antenatal care', 'section_path': ['Implementation of the ANC guideline and rec ommendations: introducing the', 'Health systems interventions to improve the utilization and quality of antenatal care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='ad. Including promotion of the following: care-seeking behaviour and ANC utilization; birth preparedness and complication readiness;\\nsleeping under insecticide-treated bednets; skilled care for childbirth; companionship in labour and childbirth; nutritional advice;\\nnutritional supplements; other context-specific supplements and interventions; HIV testing during pregnancy; exclusive breastfeeding;\\npostnatal care and family planning; immunization according to national guidelines.ae. Recommendation adapted and integrated from the WHO publication Increasing access to health workers in remote and rural areas through\\nimproved retention: global policy recommendations (2010).  \\n1Chapter 1. Introduction'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='International human rights law includes fundamental\\ncommitments of states to enable women and\\nadolescent girls to survive pregnancy and childbirth\\nas part of their enjoyment of sexual and reproductive\\nhealth and rights and living a life of dignity (1). The\\nWorld Health Organization (WHO) envisions a world\\nwhere “every pregnant woman and newborn receives\\nquality care throughout the pregnancy, childbirth and\\nthe postnatal period” (2). However, approximately\\n303000 women and adolescent girls died as a result\\nof pregnancy and childbirth-related complications in\\n2015 (3). Around 99% of maternal deaths occur in\\nlow-resource settings and most can be prevented(4).\\nSimilarly, approximately 2.6 million babies were\\nstillborn in 2015, also mainly in low-resource\\nsettings(5). Nevertheless, there is evidence that\\neffective interventions exist at reasonable cost for the\\nprevention or treatment of virtually all life-threatening\\nmaternal complications (6), and almost two thirds'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='effective interventions exist at reasonable cost for the\\nprevention or treatment of virtually all life-threatening\\nmaternal complications (6), and almost two thirds\\nof the global maternal and neonatal disease burden\\ncould be alleviated through optimal adaptation and\\nuptake of existing research findings (7). But a human\\nrights-based approach is not just about avoiding\\ndeath and morbidity – it is about enabling health and\\nwell-being while respecting dignity and rights.\\nAntenatal care (ANC) can be defined as the care\\nprovided by skilled health-care professionals to\\npregnant women and adolescent girls in order to\\nensure the best health conditions for both mother\\nand baby during pregnancy. The components of\\nANC include: risk identification; prevention and\\nmanagement of pregnancy-related or concurrent\\ndiseases; and health education and health promotion.\\nANC reduces maternal and perinatal morbidity\\nand mortality both directly, through detection and'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='management of pregnancy-related or concurrent\\ndiseases; and health education and health promotion.\\nANC reduces maternal and perinatal morbidity\\nand mortality both directly, through detection and\\ntreatment of pregnancy-related complications, and\\nindirectly, through the identification of women and\\ngirls at increased risk of developing complications\\nduring labour and delivery, thus ensuring referral\\nto an appropriate level of care (8). In addition, as\\nindirect causes of maternal morbidity and mortality,\\nsuch as HIV and malaria infections, contribute\\nto approximately 25% of maternal deaths and\\nnear-misses (9), ANC also provides an important\\nopportunity to prevent and manage concurrent\\ndiseases through integrated service delivery (10).\\nIn low- and middle-income countries (LMICs), ANC\\nutilization has increased since the introduction in\\n2002 of the WHO ANC model, known as focused\\nANC (FANC) or basic ANC, which is a goal-\\norientated approach to delivering evidence-based'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='utilization has increased since the introduction in\\n2002 of the WHO ANC model, known as focused\\nANC (FANC) or basic ANC, which is a goal-\\norientated approach to delivering evidence-based\\ninterventions carried out at four critical times during\\npregnancy (11, 12). However, globally, during the\\nperiod 2007–2014, only 64% of pregnant women\\nattended the WHO-recommended minimum four\\ncontacts for ANC, suggesting that much more work\\nneeds to be done to address ANC utilization and\\nquality.\\nCurrently, WHO guidance on routine ANC is\\nfragmented, with related recommendations published\\nacross several different WHO guidelines and\\npractical manuals. The 2002 FANC implementation\\nmanual, for example (12), does not contain relevant\\ncontext-specific guidance, which needs to be sought\\nelsewhere. In addition, evidence on the possible harm\\nof the FANC model has recently become available,\\nnecessitating a review.\\nThis up-to-date, consolidated guideline for routine\\nANC has been produced by the WHO Department'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='of the FANC model has recently become available,\\nnecessitating a review.\\nThis up-to-date, consolidated guideline for routine\\nANC has been produced by the WHO Department\\nof Reproductive Health and Research (RHR), in\\ncollaboration with the Department of Nutrition for\\nHealth and Development (NHD) and the Department\\nof Maternal, Newborn, Child and Adolescent Health\\n(MCA), as part of WHO’s normative work on\\nsupporting evidence-informed policies and practices.\\nBy reviewing, updating and bringing together ANC-\\nrelated WHO recommendations regarding “what”\\nshould be offered and “how” it should be delivered\\nin the form of this guideline, it is hoped that policy-\\nmakers will more easily be able to adapt, adopt\\nand implement these new ANC recommendations,\\npresented in Chapter 3, which have also been\\nconfigured to form the 2016 WHO ANC model,\\npresented in Chapter 4.\\nA scoping review was conducted to inform this\\nguideline, and it revealed that what women want and'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='configured to form the 2016 WHO ANC model,\\npresented in Chapter 4.\\nA scoping review was conducted to inform this\\nguideline, and it revealed that what women want and  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n2\\nexpect from ANC is to have a “positive pregnancy\\nexperience”.\\nA positive pregnancy experience is defined as:\\nnn maintaining physical and sociocultural\\nnormality\\nnn maintaining a healthy pregnancy for mother\\nand baby (including preventing and treating\\nrisks, illness and death)\\nnn having an effective transition to positive labour\\nand birth, and\\nnn achieving positive motherhood (including\\nmaternal self-esteem, competence and\\nautonomy) (13).\\nThe emotional, psychological and social needs of\\nadolescent girls and vulnerable groups (including\\nwomen with disabilities, women with mental health\\nconcerns, women living with HIV, sex workers,\\ndisplaced and war-affected women, ethnic and racial\\nminorities, among others) can be greater than for'),\n",
       " Document(metadata={'section': 'Background', 'section_path': ['Background'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='women with disabilities, women with mental health\\nconcerns, women living with HIV, sex workers,\\ndisplaced and war-affected women, ethnic and racial\\nminorities, among others) can be greater than for\\nother women. Therefore, the aim of this guideline is to\\nprovide a clear, evidence-based framework for ANC\\npractices that empowers all pregnant women and\\nadolescent girls to access the type of person-centred\\ncare that they want and need, in accordance with a\\nhuman rights-based approach. This ANC guideline\\nis part of the ongoing work of WHO in developing\\nevidence-based guidelines to improve quality of\\ncare for mothers and their babies throughout the\\nantenatal, intrapartum and postnatal continuum.'),\n",
       " Document(metadata={'section': 'T arget audience', 'section_path': ['T arget audience'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='The recommendations in this guideline are intended\\nto inform the development of relevant national- and\\nlocal-level health policies and clinical protocols.\\nTherefore, the target audience of this guideline\\nincludes national and local public health policy-\\nmakers, implementers and managers of national\\nand local maternal and child health programmes,\\nconcerned nongovernmental and other organizations,\\nprofessional societies involved in the planning and\\nmanagement of maternal and child health services,\\nhealth professionals (including obstetricians,\\nmidwives, nurses and general medical practitioners)\\nand academic staff involved in training health\\nprofessionals.'),\n",
       " Document(metadata={'section': 'Scope of the guideline', 'section_path': ['Scope of the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs']}, page_content='Population of interest\\nThis guideline is relevant to all pregnant women and\\nadolescent girls receiving ANC in any health-care\\nfacility or community-based setting, and to their\\nunborn fetuses and newborns. While the guideline\\naddresses the detection of pregnancy-related\\ncomplications and the prevention of concurrent\\ndiseases at routine ANC visits, it does not address\\nthe subsequent treatment of such complications\\nor diseases, where the consequence of detection is\\nreferral for additional management or specialist care\\nfrom a different provider. Thus, the management\\nof women and adolescent girls with high-risk\\npregnancies is beyond the scope of this ANC\\nguideline, which is aimed at providing guidance\\non routine ANC. It is therefore complementary to\\nexisting WHO guidance on specific pregnancy-\\nrelated complications.\\nPriority questions\\nThe priority questions and outcomes guiding\\nthe evidence review and synthesis for the\\nrecommendations in this ANC guideline are listed'),\n",
       " Document(metadata={'section': 'Scope of the guideline', 'section_path': ['Scope of the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='related complications.\\nPriority questions\\nThe priority questions and outcomes guiding\\nthe evidence review and synthesis for the\\nrecommendations in this ANC guideline are listed\\nin Web annex1 according to the following five\\nheadings, which reflect the five types of interventions\\naddressed by the recommendations, as presented in'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'subsection': 'Interventions for common physiological', 'section_path': ['3 of this document:', 'Interventions for common physiological'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='symptoms'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'subsection': 'Health systems interventions to improve the', 'section_path': ['3 of this document:', 'Health systems interventions to improve the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='utilization and quality of ANC.\\nFor further information, see section 2.6: Identifying\\npriority questions and outcomes. Changes made\\nto the approved scope of priority questions for the\\nguideline are described in Web annex2.  \\n3Chapter 1. Introduction\\nOutcomes of interest\\nThe outcomes of interests included maternal and\\nfetal/ neonatal outcomes, as well as test accuracy and\\nhealth system outcomes (Box1).\\nBox 1: Guideline outcomes of interest\\nMaternal outcomes Fetal/neonatal outcomes\\nInfections Neonatal infections\\nAnaemia Small for gestational age\\nPre-eclampsia/ eclampsia Low birth weight\\nGestational diabetes mellitus Preterm birth\\nMode of delivery Congenital anomalies\\nExcessive weight gain Macrosomia/large for gestational age\\nIntimate partner violence Fetal/ neonatal mortality\\nSide-effects\\nSymptomatic relief\\nMaternal mortality\\nMaternal satisfaction and/ or women’s rating of\\nusefulness of treatment\\nT est accuracy outcomes Health system outcomes\\nSensitivity and specificity ANC coverage'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'subsection': 'Health systems interventions to improve the', 'section_path': ['3 of this document:', 'Health systems interventions to improve the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Symptomatic relief\\nMaternal mortality\\nMaternal satisfaction and/ or women’s rating of\\nusefulness of treatment\\nT est accuracy outcomes Health system outcomes\\nSensitivity and specificity ANC coverage\\nFacility-based delivery  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n4'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Methods', 'section_path': ['3 of this document:', 'Methods'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='The guideline was developed in accordance with\\nthe methods described in the WHO handbook for\\nguideline development (14). In summary, the process\\nincluded: identification of priority questions and\\noutcomes, retrieval of evidence, assessment\\nand synthesis of the evidence, formulation\\nof recommendations, and planning for the\\nimplementation, dissemination, impact evaluation\\nand updating of the guideline.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'contains_warnings': True}, page_content='The WHO Steering Group that guided the entire\\nguideline development process comprised WHO\\nstaff members from the Department of Reproductive\\nHealth and Research (RHR), the Department of\\nMaternal, Newborn, Child and Adolescent Health\\n(MCA), and the Department of Nutrition for Health\\nand Development (NHD) (see Annex1 for the list\\nof members). Regional advisors from WHO regions\\nalso participated in the guideline development\\nprocess. The Steering Group drafted the initial scope\\nof the guideline and drafted the key recommendation\\nquestions in PICO format (population, intervention,\\ncomparator, outcome), identified individuals to be\\ninvited to participate as guideline methodologists\\nand as members of the systematic review teams,\\nthe Guideline Development Group (GDG) and\\nthe External Review Group (ERG), supervised the\\nevidence retrieval and synthesis, organized the\\nT echnical Consultations (or GDG meetings), drafted\\nrecommendations, and finalized and published the'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development'], 'contains_warnings': True}, page_content='the External Review Group (ERG), supervised the\\nevidence retrieval and synthesis, organized the\\nT echnical Consultations (or GDG meetings), drafted\\nrecommendations, and finalized and published the\\nguideline document. Additionally, the Steering Group\\nwill oversee dissemination of the guideline.\\n2.2 Guideline Development Group (GDG)\\nThe Steering Group identified and invited 20 external\\nexperts and stakeholders from the six WHO regions\\nto form the GDG, ensuring geographic representation,\\ngender balance, and no important conflicts of\\ninterest. The GDG was a diverse group of individuals\\nwith expertise in research, guideline development\\nmethods, and clinical policy and programmes relating\\nto interventions for ANC and service delivery, also\\nincluding a patient/ consumer representative. The\\ncurriculum vitae of the members were published\\non the RHR departmental website prior to the GDG\\nmeetings (which occurred between October 2015\\nand March 2016). Subgroups were invited to each of'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='curriculum vitae of the members were published\\non the RHR departmental website prior to the GDG\\nmeetings (which occurred between October 2015\\nand March 2016). Subgroups were invited to each of\\nthe meetings based on their expertise.\\nSelected members of the GDG provided input into\\nthe drafting of the scope of the guideline, the PICO\\nquestions and the prioritization of outcomes, which\\nguided the evidence reviews. The GDG as a whole\\nappraised the evidence used to inform the guideline,\\nadvised on the interpretation of this evidence,\\nformulated the final recommendations at face-\\nto-face meetings, and reviewed and approved the\\nfinal guideline document before its submission to\\nthe WHO Guidelines Review Committee (GRC) for\\napproval. A list of the members of the GDG can be\\nfound in Annex1.\\n2.3 External Review Group (ERG)\\nThe membership of the ERG was geographically\\nand gender-balanced, and there were no important\\nconflicts of interest that prohibited any member'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='found in Annex1.\\n2.3 External Review Group (ERG)\\nThe membership of the ERG was geographically\\nand gender-balanced, and there were no important\\nconflicts of interest that prohibited any member\\nfrom serving (see Annex1 for the list of members).\\nThere were six members of the ERG, including\\ntechnical experts and other stakeholders with\\nsufficient interests in the provision of evidence-\\nbased ANC. This group peer reviewed the final\\nguideline document to identify any factual errors and\\ncomment on the clarity of the language, contextual\\nissues, and implications for implementation. The\\ngroup ensured that the guideline decision-making\\nprocesses had considered and incorporated the\\ncontextual values and preferences of persons\\naffected by the recommendations, including\\npregnant women, health-care professionals and\\npolicy-makers. It was not within the ERG’s remit to\\nchange recommendations previously formulated by\\nthe GDG.\\n2.4 T echnical Working Group (TWG)\\nThe TWG comprised systematic review teams'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='policy-makers. It was not within the ERG’s remit to\\nchange recommendations previously formulated by\\nthe GDG.\\n2.4 T echnical Working Group (TWG)\\nThe TWG comprised systematic review teams\\nand guideline methodologists. In relation to\\nquantitative evidence on the effectiveness of different\\ninterventions, the Cochrane Pregnancy and Childbirth\\nGroup (PCG) provided input on the scoping of the\\nguideline and supervised the updating of all relevant\\nsystematic reviews following the standard processes  \\n5Chapter 2. Methods\\nof the Cochrane Collaboration. The WHO Steering\\nGroup worked closely with methodologists from the\\nCentro Rosarino de Estudios Perinatales (CREP), in\\nArgentina, to appraise the evidence from systematic\\nreviews using GRADE (Grading of Recommendations\\nAssessment, Development and Evaluation)\\nmethodology (15).\\nFor qualitative data related to women’s and health-\\ncare professionals’ views on ANC, two qualitative\\nmeta-synthesis experts from the University of'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='methodology (15).\\nFor qualitative data related to women’s and health-\\ncare professionals’ views on ANC, two qualitative\\nmeta-synthesis experts from the University of\\nCentral Lancashire, in the United Kingdom of Great\\nBritain and Northern Ireland (United Kingdom),\\nsystematically reviewed qualitative studies and\\nsynthesized the evidence to inform the GDG’s\\ndecision-making, in collaboration with the Steering\\nGroup and methodologists from the Norwegian Public\\nHealth Institute.\\nIn addition, methodologists from Queen Mary\\nUniversity of London, in the United Kingdom,\\nconducted test accuracy reviews of diagnostic tests\\nrelevant to the provision of ANC to support this\\nguideline. The Steering Group also worked closely\\nwith experts from the Norwegian Public Health\\nInstitute, who assisted with methodological issues\\nrelating to the GRADE, GRADE-CERQual (Confidence\\nin the Evidence from Reviews of Qualitative Research)\\n(16), and DECIDE (Developing and Evaluating'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'WHO Steering Group', 'section_path': ['3 of this document:', 'WHO Steering Group'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='Institute, who assisted with methodological issues\\nrelating to the GRADE, GRADE-CERQual (Confidence\\nin the Evidence from Reviews of Qualitative Research)\\n(16), and DECIDE (Developing and Evaluating\\nCommunication Strategies to Support Informed\\nDecisions and Practice Based on Evidence) (17) tools\\n(see sections2.8, 2.10 and 2.11). In addition, the\\nSteering Group consulted two researchers from the\\nLondon School of Hygiene and T ropical Medicine and\\nthe Norwegian Public Health Institute, who reviewed\\ncountry case studies to investigate implementation\\nissues relating to the WHO focused ANC (FANC)\\nmodel. Members of the TWG are listed in Annex1.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'External partners and observers', 'section_path': ['3 of this document:', 'External partners and observers'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='Representatives of the International Federation of\\nGynecology and Obstetrics (FIGO), the International\\nConfederation of Midwives (ICM), the United\\nNations Population Fund (UNFPA), the United States\\nAgency for International Development (USAID)\\nand the United Nations Children’s Fund (UNICEF)\\nwere invited to the final GDG meeting to serve as\\nobservers. All these organizations are potential\\nimplementers of the proposed guideline with a\\nhistory of collaboration with the WHO Departments\\nof RHR and MCA in guideline dissemination and\\nimplementation.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Identifying priority questions and', 'section_path': ['3 of this document:', 'Identifying priority questions and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='outcomes\\nThe WHO Department of RHR, in collaboration with\\nmethodologists from CREP, conducted a scoping\\nexercise in 2014 to identify and map clinical practice\\nguidelines related to ANC. Eighty-five documents\\nwith ANC recommendations were identified\\n– 15 related to routine ANC and 70 to specific\\nsituations relevant to ANC (18). Of the 15 related to\\nroutine ANC, three were issued by WHO (19–21),\\nwhile the rest were issued by governmental and\\nnongovernmental organizations (NGOs) in Australia,\\nCanada, Hong Kong, India, Japan, Poland, the United\\nKingdom and the United States of America (USA).\\nSimilarly, of the 70 guidelines related to specific\\nsituations relevant to ANC, 91% were from Canada,\\nthe United Kingdom and the USA, i.e.high-income\\ncountries (HICs), while low- and middle-income\\ncountries (LMICs) were poorly represented. An\\nexisting, recent, up-to-date guideline relevant to\\nroutine ANC that was adaptable to different resource\\nsettings was not identified. This scoping exercise'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Identifying priority questions and', 'section_path': ['3 of this document:', 'Identifying priority questions and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='existing, recent, up-to-date guideline relevant to\\nroutine ANC that was adaptable to different resource\\nsettings was not identified. This scoping exercise\\nalso informed the choice of outcomes for the ANC\\nguideline, which was supplemented by outcomes\\nidentified by a preliminary search of the Cochrane\\nDatabase of Systematic Reviews for existing key\\nsystematic reviews relevant to the antenatal period.\\nBased on these initial steps, the WHO Steering Group\\ndeveloped a framework for discussion at a scoping\\nmeeting, held in Geneva in April 2014, to identify\\npriority questions about the provision of ANC as\\nwell as to inform the scoping for the guideline in\\nterms of approach, focus, questions and outcomes.\\nAt this meeting, it was decided that the scope of\\nthis guideline should prioritize the applicability of\\ninterventions in LMIC settings. Specific genetic tests\\nfor detection of inherited conditions were considered\\nbeyond the scope of this guideline. In addition, the'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Identifying priority questions and', 'section_path': ['3 of this document:', 'Identifying priority questions and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='interventions in LMIC settings. Specific genetic tests\\nfor detection of inherited conditions were considered\\nbeyond the scope of this guideline. In addition, the\\nscoping process highlighted the need to identify\\nwomen-centred interventions and outcomes for\\nANC. T o this end, a qualitative systematic review was\\nconducted to understand what women want, need\\nand value in pregnancy and ANC (22). The findings\\nof this systematic review suggested that the primary\\noutcome for pregnant women is a “positive pregnancy\\nexperience” (as defined in section 1.1), which\\nrequires the provision of effective clinical practices\\n(interventions and tests), relevant and timely\\ninformation, and psychosocial and emotional support\\nby practitioners with good clinical and interpersonal\\nskills, within a well functioning health system. Initially  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n6\\na list of ANC outcomes was prioritized for the whole'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Identifying priority questions and', 'section_path': ['3 of this document:', 'Identifying priority questions and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True}, page_content='skills, within a well functioning health system. Initially  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n6\\na list of ANC outcomes was prioritized for the whole\\nANC period. However, due to important differences\\nbetween the types of interventions and the range of\\npotential outcomes, these outcomes were further\\nprioritized separately for individual questions.\\nInformed by the qualitative review of women’s views,\\nincluding values and preferences related to ANC, we\\nincluded assessment of maternal satisfaction with\\na particular intervention, and maternal rating of the\\nusefulness of a particular intervention.\\nThroughout the scoping process, the Steering Group\\nconsulted and engaged with other WHO departments\\nthat have issued guidelines with implications for the\\nantenatal period, incorporating their feedback and\\ntechnical expertise into the scoping. The process\\nand approach were also presented at a number of\\nmeetings and international conferences between'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Identifying priority questions and', 'section_path': ['3 of this document:', 'Identifying priority questions and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes'], 'contains_warnings': True}, page_content='antenatal period, incorporating their feedback and\\ntechnical expertise into the scoping. The process\\nand approach were also presented at a number of\\nmeetings and international conferences between\\nApril 2014 and March 2015 to elicit further feedback\\nfrom stakeholders.\\nThis scoping and consultation process led to the\\nidentification of priority questions and outcomes\\nrelated to the effectiveness of clinical, test accuracy,\\nand health systems interventions aimed at achieving\\na positive pregnancy experience that includes a\\nhealthy mother and a healthy baby. These questions\\nand outcomes are listed in Web annex 1.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'ANC-related recommendations in other', 'section_path': ['3 of this document:', 'ANC-related recommendations in other'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='WHO guidelines\\nT o avoid duplication and ensure harmonization of\\nrecommendations across WHO departments and\\npublications, we searched all relevant WHO GRC-\\napproved guidelines and identified 21 guidelines\\ncontaining recommendations relevant to ANC (see\\nAnnex 2). These recommendations were mapped\\nto the priority questions for this new guideline\\nand the Steering Group reached out to the WHO\\ndepartments and technical units that had issued the\\nrelevant guidance to engage and collaborate with\\nthem throughout the process of developing this new\\nANC guideline. Recommendations found in other\\nWHO guidelines that related to health promotion\\nand the identification of risk factors (e.g. smoking,\\nHIV) during ANC were considered to be within the\\nscope of the guideline, whereas recommendations\\non management and treatment of risk factors,\\ncomplications and concurrent diseases were deemed\\nto be beyond the scope of the guideline; for these,\\nthe guideline user is referred to the relevant separate'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'ANC-related recommendations in other', 'section_path': ['3 of this document:', 'ANC-related recommendations in other'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='complications and concurrent diseases were deemed\\nto be beyond the scope of the guideline; for these,\\nthe guideline user is referred to the relevant separate\\nWHO guidance via a weblink provided along with the\\n“remarks” following each recommendation.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Focus and approach', 'section_path': ['3 of this document:', 'Focus and approach'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='T o capture and examine the complex nature of the\\nissues that are important during the ANC period,\\nwithin the context of health systems and the\\ncontinuum of care, the focus of this guideline is the\\nessential core package of ANC that all pregnant\\nwomen and adolescent girls should receive, with the\\nflexibility to employ a variety of options based on\\nthe context of different countries (i.e. in terms of the\\ncontent of the model, who provides the care, where\\nthe care is provided, and how the care is provided to\\nmeet women’s needs). Therefore, the overarching\\nquestions addressed by this guideline focused on the\\nfollowing:\\nnn What are the evidence-based practices during the\\nANC period for improving outcomes related to the\\nfollowing?\\nn– nutritional interventions (see section 3.A)\\nn– maternal and fetal assessment (see section 3.B)\\nn– preventive measures (see section 3.C)\\nn– interventions for common physiological\\nsymptoms (see section 3.D)\\nnn How  should these evidence-based practices be'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Focus and approach', 'section_path': ['3 of this document:', 'Focus and approach'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='n– preventive measures (see section 3.C)\\nn– interventions for common physiological\\nsymptoms (see section 3.D)\\nnn How  should these evidence-based practices be\\ndelivered to improve outcomes?\\nn– health systems interventions to improve the\\nutilization and quality of ANC (see section 3.E).\\nThe guideline focuses on the core ANC clinical\\npackage that all women should receive at routine\\nANC visits. The management of identified\\ncomplications or concurrent diseases or risk factors\\nthat require additional treatment or specialist care\\nand follow-up is beyond the scope of this guideline.\\nThe DECIDE framework is a tool that has been\\ndeveloped to help decision-makers consider a range\\nof relevant criteria, including benefits, harms, values,\\nresources, equity, acceptability and feasibility (17). T o\\nsynthesize and examine evidence across the domains\\nof DECIDE (see section2.11), the preparatory work for\\nthe ANC guideline was organized according to five'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Focus and approach', 'section_path': ['3 of this document:', 'Focus and approach'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='synthesize and examine evidence across the domains\\nof DECIDE (see section2.11), the preparatory work for\\nthe ANC guideline was organized according to five\\nwork streams, using both quantitative and qualitative\\ndata sources, as summarized in Box 2.  \\n7Chapter 2. Methods'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='Evidence to support this guideline was derived from\\na number of sources by the T echnical Working Group\\n(TWG) of methodologists and systematic review\\nteams that worked closely with the Steering Group.\\nEvidence on effectiveness was mostly derived from\\nCochrane reviews of randomized controlled trials\\n(RCT s). The Steering Group, in collaboration with\\nthe Cochrane PCG and methodologists from CREP,\\ninitially identified all Cochrane systematic reviews\\nand protocols relevant to ANC. The Cochrane\\nPCG T rials Register1 was searched for new trials\\nand the relevant systematic reviews were updated\\naccordingly. The updating or completion of Cochrane\\nreviews was a collaborative process between authors\\nof the individual reviews, staff of the PCG, and\\nmethodologists from CREP.\\nAssessment of the quality of individual studies\\nincluded in Cochrane reviews of intervention\\nstudies follows specific and explicit methods for\\nassessing the risk of bias using six standard criteria'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='Assessment of the quality of individual studies\\nincluded in Cochrane reviews of intervention\\nstudies follows specific and explicit methods for\\nassessing the risk of bias using six standard criteria\\noutlined in the Cochrane handbook for systematic\\nreviews of interventions (23). Each included study is\\n1 The Cochrane PCG T rials Register is maintained by the\\nPCG’s T rial Search Coordinator and contains trials identified\\nfrom: monthly searches of the Cochrane Central Register of\\nControlled T rials (CENTRAL); weekly searches of MEDLINE;\\nweekly searches of Embase; hand-searches of 30 journals\\nand the proceedings of major conferences; weekly “current\\nawareness” alerts for a further 44 journals; and monthly\\nBioMed Central email alerts (24). For further information, see:\\nhttp:/ / pregnancy.cochrane.org/ pregnancy-and-childbirth-\\ngroups-trials-register\\nassessed and rated by reviewers to be at low, high\\nor unclear risk of bias for sequence generation,'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='http:/ / pregnancy.cochrane.org/ pregnancy-and-childbirth-\\ngroups-trials-register\\nassessed and rated by reviewers to be at low, high\\nor unclear risk of bias for sequence generation,\\nallocation concealment, blinding of study personnel\\nand participants, attrition, selective reporting and\\nother sources of bias, such as publication bias. The\\nassessment of these six criteria provides an overall\\nrisk of bias that indicates the likely magnitude and\\ndirection of the bias and how it is likely to impact the\\nreview findings.\\nThe WHO Steering Group and the methodologists in\\nthe TWG determined the suitability of each Cochrane\\nsystematic review to provide the evidence base for\\nthe key PICO questions. For suitable reviews, CREP\\nmethodologists retrieved the evidence relevant to\\nANC guideline outcomes, which was evaluated\\naccording to standard operating procedures approved\\nby the Steering Group.\\nIf a low-quality review or no systematic review was\\nidentified on a priority question, a new systematic'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='according to standard operating procedures approved\\nby the Steering Group.\\nIf a low-quality review or no systematic review was\\nidentified on a priority question, a new systematic\\nreview was commissioned from external experts. This\\nwas the case with all DTA reviews, the qualitative\\nreviews on women’s and health-care providers’\\nviews on ANC, and the review on “factors affecting\\nANC intervention implementation at country\\nlevel”. In these instances, the external researchers\\nwere asked to prepare standard protocols before\\nembarking on the systematic reviews, including clear\\nPICO questions, criteria for identification of studies\\n(including search strategies for different bibliographic\\ndatabases), methods for assessing risk of bias and the\\nplan for data analysis. The protocols were reviewed\\nand endorsed by the Steering Group and selected\\nBox 2: Five work streams for preparation of the ANC guideline\\nANC guideline work streams Methodology Assessment of evidence'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='and endorsed by the Steering Group and selected\\nBox 2: Five work streams for preparation of the ANC guideline\\nANC guideline work streams Methodology Assessment of evidence\\nIndividual interventions for clinical\\npractices and delivery of ANC\\nEffectiveness reviews, systematic\\nreviews\\nGRADE\\nAntenatal testing T est accuracy reviews GRADE\\nBarriers and facilitators to access to\\nand provision of ANC\\nQualitative evidence synthesis GRADE-CERQual\\nLarge-scale programme review/\\ncountry case studies of ANC\\nMixed-methods review, focusing\\non contextual and health system\\nfactors affecting implementation\\nNot applicable\\nHealth-system level interventions to\\nimprove access to and provision of\\nANC services\\nEffectiveness reviews GRADE  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n8\\ncontent experts among the GDG members. WHO\\ninformation retrieval specialists reviewed the search\\nstrategies.\\nIn addition to the Cochrane review evidence, for'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='8\\ncontent experts among the GDG members. WHO\\ninformation retrieval specialists reviewed the search\\nstrategies.\\nIn addition to the Cochrane review evidence, for\\nthree questions related to health systems (i.e.\\nthose on women-held case notes, group ANC, and\\ninterventions to communicate with and support\\npregnant women), indirect evidence was sought,\\ndue to a paucity of direct evidence. This work was\\ncommissioned from experts at the Norwegian Public\\nHealth Institute who conducted a systematic search\\nfor indirect evidence on effects of these interventions\\ncovering the preceding five years (i.e. from January\\n2011 to January 2016), but found no additional\\nevidence.\\nThe DTA reviews on haemoglobin and urine tests\\nwere commissioned from methodologists from\\nQueen Mary University of London, in the United\\nKingdom. For these reviews, Embase, LILACS,\\nMEDLINE (OVID), SCOPUS and Web of Science were\\nsearched from inception to January 2015, and grey\\nliterature was sought by searching GreyOpen.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Kingdom. For these reviews, Embase, LILACS,\\nMEDLINE (OVID), SCOPUS and Web of Science were\\nsearched from inception to January 2015, and grey\\nliterature was sought by searching GreyOpen.\\nT wo qualitative reviews were commissioned from\\nexperts from the University of Central Lancashire,\\nUnited Kingdom:\\n1. T o explore the views, attitudes and experiences of\\npregnant and postnatal women in high-, medium-\\nand low-income countries in relation to factors\\nthat might form barriers to, or facilitators of, their\\nuse of routine ANC services.\\n2. T o explore the views, attitudes and experiences of\\nhealth-care providers in high-, medium- and low-\\nincome countries in relation to factors that might\\nform barriers to, or facilitators of, their provision of\\ngood quality routine ANC services.\\nStudies published before 2000 were excluded, to\\nensure that the data reflected the current generation\\nof women who may encounter ANC, and the current\\ngeneration of ANC providers. This date range was'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Studies published before 2000 were excluded, to\\nensure that the data reflected the current generation\\nof women who may encounter ANC, and the current\\ngeneration of ANC providers. This date range was\\nalso intended to capture the time period since the\\n2002 introduction of the WHO FANC or “basic”\\nANC model, which includes four goal-orientated\\nANC visits (12).\\nFinally, two researchers from the London School of\\nHygiene and T ropical Medicine and the Norwegian\\nPublic Health Institute undertook a review of case\\nstudies reporting the experiences of countries.\\nThe review focused on methods of uptake and\\nimplementation of the WHO FANC model, problems\\nexperienced by service users and other stakeholders,\\nand the broader context. Data were collected\\nfrom published studies, reports and other policy\\ndocuments (see the Web supplement2 for the search\\nstrategy), and semi-structured interviews with key\\nstakeholders for each country case study, which\\nincluded Argentina, Kenya, Thailand and the United'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Evidence identification and retrieval', 'section_path': ['3 of this document:', 'Evidence identification and retrieval'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='documents (see the Web supplement2 for the search\\nstrategy), and semi-structured interviews with key\\nstakeholders for each country case study, which\\nincluded Argentina, Kenya, Thailand and the United\\nRepublic of T anzania.\\nThe entire systematic review development process\\nwas iterative, with the methodologists in constant\\ncommunication with the Steering Group to discuss\\nchallenges and agree on solutions. The search\\nstrategies for evidence identification and retrieval can\\nbe found in Web supplement.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Quality assessment and grading of the', 'section_path': ['3 of this document:', 'Quality assessment and grading of the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='evidence\\nThe GRADE approach (15) to appraising the quality\\nof quantitative evidence was used for all the critical\\noutcomes identified in the PICOs, and a GRADE\\nprofile was prepared for each quantitative outcome\\nwithin each PICO. Accordingly, the quality of evidence\\nfor each outcome was rated as “high”, “moderate”,\\n“low”, or “very low” based on a set of criteria. As\\na baseline, RCT s provided “high-quality” evidence,\\nwhile non-randomized trials and observational\\nstudies provided “low-quality” evidence. This\\nbaseline quality rating was then downgraded based\\non consideration of risk of bias, inconsistency,\\nimprecision, indirectness and publication bias. For\\nobservational studies, other considerations, such as\\nmagnitude of effect, could lead to upgrading of the\\nrating if there were no limitations that indicated a\\nneed for downgrading. Grading of Cochrane review\\nevidence and DTA evidence was performed by CREP\\nand the methodologists from Queen Mary University'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Quality assessment and grading of the', 'section_path': ['3 of this document:', 'Quality assessment and grading of the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='rating if there were no limitations that indicated a\\nneed for downgrading. Grading of Cochrane review\\nevidence and DTA evidence was performed by CREP\\nand the methodologists from Queen Mary University\\nof London, respectively, in accordance with standard\\noperating procedures approved by the Steering Group.\\nStudies identified for the qualitative reviews were\\nsubjected to a simple quality appraisal system using\\na validated instrument that rated studies against 11\\ncriteria, and then allocated a score from A to D, with\\nD indicating the presence of significant flaws that\\nare very likely to affect the credibility, transferability,\\ndependability and/ or confirmability of the study (25).\\n2 Available at: www.who.int/ reproductivehealth/ publications/\\nmaternal_perinatal_health/ anc-positive-pregnancy-experience/\\nen/  \\n9Chapter 2. Methods\\nStudies scoring D were excluded on grounds of poor\\nquality.\\nThe findings of the qualitative reviews were appraised'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Quality assessment and grading of the', 'section_path': ['3 of this document:', 'Quality assessment and grading of the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='en/  \\n9Chapter 2. Methods\\nStudies scoring D were excluded on grounds of poor\\nquality.\\nThe findings of the qualitative reviews were appraised\\nfor quality using the GRADE-CERQual tool (16, 26).\\nThe GRADE-CERQual tool, which uses a similar\\napproach conceptually to other GRADE tools,\\nprovides a transparent method for assessing and\\nassigning the level of confidence that can be placed\\nin evidence from reviews of qualitative research. The\\nqualitative review team used the GRADE-CERQual\\ntool to assess the confidence in qualitative review\\nfindings, which were assigned to evidence domains\\non values, acceptability and feasibility according to\\nfour components: methodological limitations of the\\nindividual studies, adequacy of data, coherence and\\nrelevance to the review question of the individual\\nstudies contributing to a review finding.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='The Steering Group supervised and finalized the\\npreparation of evidence summaries and evidence\\nprofiles in collaboration with the guideline\\nmethodologists, using the DECIDE framework (17).\\nDECIDE is an evidence-to-decision (EtD) tool that\\nincludes explicit and systematic consideration of\\nevidence on interventions in terms of six domains:\\neffects, values, resources, equity, acceptability and\\nfeasibility. For each priority question, judgements\\nare made on the impact of the intervention on each\\nof these domains, in order to inform and guide\\nthe decision-making process. Using the DECIDE\\nframework, the Steering Group created summary\\ndocuments for each priority question covering\\nevidence on each of the six domains.\\nnn Effects: The evidence on maternal and perinatal\\noutcomes was described. Where benefits clearly\\noutweighed harms, or vice versa, there was a\\ngreater likelihood of a clear judgement in favour\\nof or against the option, respectively. Uncertainty'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition'], 'discusses_normal_variations': True}, page_content='outcomes was described. Where benefits clearly\\noutweighed harms, or vice versa, there was a\\ngreater likelihood of a clear judgement in favour\\nof or against the option, respectively. Uncertainty\\nabout the net benefits or harms and small net\\nbenefits often led to a judgement that neither\\nfavoured the intervention nor the comparator. The\\nhigher the certainty of evidence on benefits across\\noutcomes, the higher the likelihood of a judgement\\nin favour of the intervention.\\nnn Values: This relates to the relative importance\\nassigned to the outcomes of the intervention by\\nthose affected by them, how such importance\\nvaries within and across settings, and whether this\\nimportance is surrounded by any uncertainty. A\\nscoping review of what women want from ANC\\ninformed the ANC guideline (13). Evidence showed\\nthat women from high-, middle- and low-resource\\nsettings generally valued having a “positive\\npregnancy experience” achieved through three\\nequally important ANC components – effective'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'discusses_normal_variations': True}, page_content='that women from high-, middle- and low-resource\\nsettings generally valued having a “positive\\npregnancy experience” achieved through three\\nequally important ANC components – effective\\nclinical practices (interventions and tests), relevant\\nand timely information, and psychosocial and\\nemotional support – each provided by practitioners\\nwith good clinical and interpersonal skills within\\na well functioning health system. Reviewers\\nhad high confidence in the evidence. Therefore,\\ninterventions that facilitated this composite\\noutcome were more likely to lead to a judgement in\\nfavour of the intervention.\\nnn Resources: The most relevant resources in\\nthe context of the implementation of the ANC\\ninterventions in this guideline mainly included\\ncosts for providing medicines, supplies, equipment\\nand skilled human resources. A judgement in\\nfavour or against the intervention was likely\\nwhere the resource implications were clearly\\nadvantageous or disadvantageous. Cost evaluation'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='and skilled human resources. A judgement in\\nfavour or against the intervention was likely\\nwhere the resource implications were clearly\\nadvantageous or disadvantageous. Cost evaluation\\nrelied on reported estimates obtained during\\nthe evidence retrieval process, a 2013 treatment\\nassumption report (27), the WHO compendium\\nof innovative health technologies for low-resource\\nsettings (28), as well as experiences and opinions\\nof the GDG members. It was recognized that\\nactual costing of interventions is context-specific\\nand not feasible for a global guideline.\\nnn Equity: This section was informed by the 2015\\nWHO report on inequalities in reproductive,\\nmaternal, newborn and child health, which\\nshowed that women in LMICs who are poor, least\\neducated, and residing in rural areas have lower\\nANC coverage and worse pregnancy outcomes\\nthan the more advantaged women in LMICs (29).\\nTheir neonates also have worse health outcomes.\\nTherefore, judgements were more likely to favour'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content=\"ANC coverage and worse pregnancy outcomes\\nthan the more advantaged women in LMICs (29).\\nTheir neonates also have worse health outcomes.\\nTherefore, judgements were more likely to favour\\nthe interventions if they could reduce health\\ndifferences among different groups of women and\\ntheir families.\\nnn Acceptability: Qualitative evidence from the\\nsystematic reviews on women's and providers’\\nviews informed judgements for this domain. The\\nlower the acceptability, the lower the likelihood of\\na judgement in favour of the intervention.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n10\\nnn Feasibility: Feasibility is influenced by factors\\nsuch as the resources available, infrastructure and\\ntraining. Qualitative evidence from the systematic\\nreviews and country case studies informed\\njudgements for this domain. Where barriers\\nexisted, it was less likely that a judgement would\\nbe made in favour of the intervention.\\nAdditional evidence of potential harms or unintended\"),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='judgements for this domain. Where barriers\\nexisted, it was less likely that a judgement would\\nbe made in favour of the intervention.\\nAdditional evidence of potential harms or unintended\\nconsequences was described in the “additional\\nconsiderations” sub-section of each evidence\\nsummary (see text for each recommendation\\npresented in Chapter 3).\\nThree types of draft recommendation were made,\\nnamely:\\nnn Recommended\\nnn Context-specific recommendation:\\nn– only in the context of rigorous research\\nn– only with targeted monitoring and evaluation\\nn– only in other specific contexts\\nnn Not recommended.\\nIn the absence of evidence of benefits, evidence of\\npotential harm led to a recommendation against\\nthe option. Where evidence of potential harm was\\nfound for interventions that were also found to\\nhave evidence of important benefits, depending on\\nthe level of certainty and likely impact of the harm,\\nsuch evidence of potential harm was more likely to\\nlead to a context-specific recommendation for the'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='the level of certainty and likely impact of the harm,\\nsuch evidence of potential harm was more likely to\\nlead to a context-specific recommendation for the\\nintervention (where the context is explicitly stated\\nwithin the recommendation).\\nThese evidence summaries and draft\\nrecommendations, including GRADE tables and other\\nrelated documents, were provided to members of the\\nGDG for comments in advance of the series of three\\nT echnical Consultations on the ANC guideline. The\\ncertainty of the graded evidence on effectiveness\\nwas systematically interpreted in the text according\\nto guidance on reporting review evidence from the\\nCochrane Effective Practice and Organization of Care\\n(EPOC) Group (30).\\nThe GDG members and other participants were\\nsubsequently invited to attend three T echnical\\nConsultations (also called GDG meetings) organized\\nat the WHO headquarters in Geneva, Switzerland,\\nthe first two in October 2015 and the third in March\\n2016 (see Annex1 for a full list of participants) to'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Formulation of the recommendations', 'section_path': ['3 of this document:', 'Formulation of the recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='at the WHO headquarters in Geneva, Switzerland,\\nthe first two in October 2015 and the third in March\\n2016 (see Annex1 for a full list of participants) to\\nreview the evidence and formulate recommendations\\nfor the ANC guideline. At these meetings, under the\\nleadership of the GDG chair, GDG members reviewed\\nthe evidence summaries, the draft recommendations\\nand any comments received through preliminary\\nfeedback. The purpose of the meetings was to\\nreach consensus on each judgement and each\\nrecommendation, including its direction and context\\n(if any), and to discuss implementation, monitoring\\nand evaluation, and research priorities related to the\\nrecommendations.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Decision-making during the GDG', 'section_path': ['3 of this document:', 'Decision-making during the GDG'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='meetings\\nThe GDG meetings were guided by a clear protocol.\\nEach of the three meetings was designed to allow\\nparticipants to discuss each of the recommendations\\ndrafted by the Steering Group. Where necessary,\\neach of these recommendations was revised\\nthrough a process of group discussion. The final\\nadoption of each recommendation was confirmed\\nby consensus (i.e. full agreement among all\\nGDG members). The GDG also determined the\\ncontext of recommendations at the meetings\\nby the same process of consensus, based on\\ndiscussions around the balance of evidence on\\nbenefits and disadvantages of the interventions\\nacross the domains evaluated. If GDG members\\nhad been unable to reach a consensus, the disputed\\nrecommendation, or any other decision, would have\\nbeen put to a vote, by a show of hands.\\n2.13 Declaration of interests (DOI) by\\nexternal contributors\\nIn accordance with the WHO handbook for guideline\\ndevelopment (14), all GDG members, ERG members'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Decision-making during the GDG', 'section_path': ['3 of this document:', 'Decision-making during the GDG'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='been put to a vote, by a show of hands.\\n2.13 Declaration of interests (DOI) by\\nexternal contributors\\nIn accordance with the WHO handbook for guideline\\ndevelopment (14), all GDG members, ERG members\\nand other external collaborators were asked to\\ndeclare in writing any competing interests (whether\\nacademic, financial or other) at the time of the\\ninvitation to participate in the ANC guideline\\ndevelopment process. The standard WHO form\\nfor DOI was completed and signed by each expert\\nand sent electronically to the responsible technical\\nofficer. The WHO Steering Group reviewed all the\\nDOI forms before finalizing experts’ invitations to\\nparticipate. All experts were instructed to notify the\\nresponsible technical officer of any change in relevant\\ninterests during the course of the process, in order to\\nupdate and review conflicts of interest accordingly.\\nIn addition, experts were requested to submit an\\nelectronic copy of their curriculum vitae along with  \\n11Chapter 2. Methods'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Decision-making during the GDG', 'section_path': ['3 of this document:', 'Decision-making during the GDG'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='update and review conflicts of interest accordingly.\\nIn addition, experts were requested to submit an\\nelectronic copy of their curriculum vitae along with  \\n11Chapter 2. Methods\\nthe completed DOI form. The responsible technical\\nofficer collated and reviewed signed DOI forms and\\ncurriculum vitae, in conjunction with the director of\\nthe WHO Department of RHR and, with input from\\nthe Steering Group, determined whether a conflict of\\ninterest existed. Where any conflict of interest was\\ndeclared, the Steering Group determined whether it\\nwas serious enough to affect the individual’s ability\\nto make objective judgements about the evidence\\nor recommendations. T o ensure consistency, the\\nSteering Group applied the criteria for assessing the\\nseverity of a conflict of interest in the WHO handbook\\nfor guideline development (14).\\nAll findings from the received DOI statements\\nwere managed in accordance with the WHO DOI\\nguidelines on a case-by-case basis. Where a conflict'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Decision-making during the GDG', 'section_path': ['3 of this document:', 'Decision-making during the GDG'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='for guideline development (14).\\nAll findings from the received DOI statements\\nwere managed in accordance with the WHO DOI\\nguidelines on a case-by-case basis. Where a conflict\\nof interest was not considered significant enough to\\npose any risk to the guideline development process\\nor reduce its credibility, the expert was only required\\nto declare such conflict at the GDG meeting and no\\nfurther action was taken. Conflicts of interest that\\nwarranted action by WHO staff arose where experts\\nhad performed primary research or a systematic\\nreview related to any guideline recommendations;\\nin such cases, the experts were restricted from\\nparticipating in discussions and/ or formulating any\\nrecommendation related to the area of their conflict\\nof interest. At the final GDG meeting, members\\nwere required again to state any conflicts of interest\\nopenly to the entire group, and were required to\\nsubmit a signed and updated version of their earlier\\nDOI statements. A summary of the DOI statements'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Decision-making during the GDG', 'section_path': ['3 of this document:', 'Decision-making during the GDG'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='openly to the entire group, and were required to\\nsubmit a signed and updated version of their earlier\\nDOI statements. A summary of the DOI statements\\nand information on how conflicts of interest were\\nmanaged are included in Annex 3.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Document preparation and peer', 'section_path': ['3 of this document:', 'Document preparation and peer'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='review\\nFollowing these three GDG meetings, members of the\\nSteering Group prepared a draft of the full guideline\\ndocument with revisions to accurately reflect the\\ndeliberations and decisions of the GDG participants.\\nThis draft guideline was then sent electronically to\\nthe GDG participants for further comments before\\nit was sent to the ERG. The Steering Group carefully\\nevaluated the input of the peer reviewers for inclusion\\nin the guideline document and made revisions to the\\nguideline draft as needed. After the GDG meetings\\nand peer review process, further modifications to\\nthe guideline by the Steering Group were limited to\\ncorrections of factual errors and improvements in\\nlanguage to address any lack of clarity. The revised\\nfinal version was returned electronically to the GDG\\nfor final approval.'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Presentation of guideline content', 'section_path': ['3 of this document:', 'Presentation of guideline content'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='A summary of the recommendations is presented in\\nT able1 within the executive summary at the beginning\\nof this guideline. As evidence was evaluated for\\nseveral outcomes and six domains (effects, values,\\nresources, equity, acceptability, feasibility) for\\neach recommendation, we have not presented the\\ndecisions on quality of evidence in this summary\\ntable. Summary tables of the main considerations\\n(including certainty of the evidence on effects) for\\neach recommendation are presented in Web annex3.\\nThe “Evidence and recommendations” section of\\nthe guideline (Chapter 3) summarizes the evidence\\nand other considerations reviewed by the GDG at\\nthe T echnical Consultations. T o improve readability,\\nthe “values” domain has been described (and\\nhighlighted in a box entitled “Women’s values”) at\\nthe beginning of each section for the five types of\\ninterventions, instead of for each recommendation,\\nto avoid repetition. The language used to interpret'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Presentation of guideline content', 'section_path': ['3 of this document:', 'Presentation of guideline content'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='the beginning of each section for the five types of\\ninterventions, instead of for each recommendation,\\nto avoid repetition. The language used to interpret\\nthe Cochrane review evidence on effects is consistent\\nwith the EPOC approach (30). Evidence assessed as\\nbeing of very low certainty is not presented in the\\ntext, but can be found in the Web supplement.\\nThe Steering Group consolidated recommendations\\ninto this guideline from other recent, GRC-approved\\nWHO guidelines relevant to the provision of\\ncomprehensive, integrated routine ANC to women\\nin certain contexts or for certain conditions. In most\\ninstances, these recommendations are identical\\nto those found in the specific separate guideline.\\nWhere we have integrated recommendations,\\nthe strength of the recommendation and quality\\nof the evidence as determined by the respective\\nGDGs for those guidelines has been recorded in\\nthe remarks section of the recommendation. Such\\nrecommendations are indicated by a footnote'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Presentation of guideline content', 'section_path': ['3 of this document:', 'Presentation of guideline content'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='of the evidence as determined by the respective\\nGDGs for those guidelines has been recorded in\\nthe remarks section of the recommendation. Such\\nrecommendations are indicated by a footnote\\nin the ANC guideline text specifying that the\\nrecommendation has been “integrated from” the\\nspecific guideline. A few recommendations required\\nadaptation for the purposes of the ANC guideline,\\nand the Steering Group consulted the relevant WHO\\ndepartments that produced the specific guidance\\nto confirm that adaptations were consistent with\\noriginal recommendations. Such recommendations  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n12\\nare indicated by a footnote in the ANC guideline\\ntext specifying that the recommendation has\\nbeen “adapted and integrated from” the specific\\nguideline. An example of where this was done is\\nfor the recommendation on task shifting, where the\\nrecommendations on multiple interventions were\\nadapted to apply to the task shifting of routine ANC'),\n",
       " Document(metadata={'chapter': '3 of this document:', 'section': 'Presentation of guideline content', 'section_path': ['3 of this document:', 'Presentation of guideline content'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='guideline. An example of where this was done is\\nfor the recommendation on task shifting, where the\\nrecommendations on multiple interventions were\\nadapted to apply to the task shifting of routine ANC\\ninterventions only. In all instances, guideline users\\nare referred to the specific WHO guidance for more\\ndetails, including implementation considerations,\\nfor these recommendations. Implementation of the\\nANC guideline and recommendations is discussed\\nin Chapter 4, and implementation considerations\\nrelated to each GDG recommendation can be found\\nin Annex 4.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='13'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='This ANC guideline includes 39 recommendations\\nadopted by the Guideline Development Group\\n(GDG), and 10 recommendations relevant to ANC\\nthat have been consolidated into this guideline\\nfrom other existing WHO guidelines that have\\nbeen recently approved by the Guidelines Review\\nCommittee (GRC). Evidence on the effectiveness of\\ninterventions was derived from 47 systematic reviews\\n(41 Cochrane systematic reviews, 2 test accuracy\\nreviews and 4 non-Cochrane reviews of non-\\nrandomized studies) and was summarized in GRADE\\ntables. A scoping review of what women want from\\nANC and what outcomes matter to women informed\\nthe values domain. T wo qualitative systematic\\nreviews on women’s and providers’ views and a\\nreview of country case studies contributed evidence\\non the acceptability and feasibility of interventions.\\nEvidence and considerations on equity and resources\\nalso informed the GDG recommendations.\\nThis chapter provides the recommendations with\\nthe corresponding narrative summaries, grouped'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Evidence and considerations on equity and resources\\nalso informed the GDG recommendations.\\nThis chapter provides the recommendations with\\nthe corresponding narrative summaries, grouped\\naccording to the type of intervention, namely:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Interventions for common physiological', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Interventions for common physiological'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='symptoms'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Health systems interventions to improve the', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Health systems interventions to improve the'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True}, page_content='utilization and quality of ANC.\\nThe corresponding GRADE tables for\\nrecommendations are referred to in this chapter as\\n“evidence base” (EB) tables, numbered according\\nto the specific recommendations they refer to.\\nThese tables are presented separately in the\\nWeb supplement to this document.3 Evidence-to-\\ndecision tables with GDG judgements related to\\nthe evidence and considerations for all domains\\nare presented in Web annex 3 of this guideline.\\nIn addition, implementation considerations and\\nresearch priorities related to these recommendations,\\nbased on the GDG discussions during the T echnical\\nConsultations, can be found in the next chapters of\\nthe guideline (Chapter 4: Implementation of the ANC\\nguideline and recommendations; Chapter 5: Research\\nimplications).\\n3 Available at: www.who.int/ reproductivehealth/ publications/\\nmaternal_perinatal_health/ anc-positive-pregnancy-experience/\\nen/  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n14'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='Background\\nPregnancy requires a healthy diet that includes\\nan adequate intake of energy, protein, vitamins\\nand minerals to meet maternal and fetal needs.\\nHowever, for many pregnant women, dietary intake\\nof vegetables, meat, dairy products and fruit is often\\ninsufficient to meet these needs, particularly in low-\\nand middle-income countries (LMICs) where multiple\\nnutritional deficiencies often co-exist. In resource-\\npoor countries in sub-Saharan Africa, south-central\\nand south-east Asia, maternal undernutrition is highly\\nprevalent and is recognized as a key determinant of\\npoor perinatal outcomes (31). However, obesity and\\noverweight is also associated with poor pregnancy\\noutcomes and many women in a variety of settings\\ngain excessive weight during pregnancy. While\\nobesity has historically been a condition associated\\nwith affluence, there is some evidence to suggest a\\nshift in the burden of overweight and obesity from\\nadvantaged to disadvantaged populations (32).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='with affluence, there is some evidence to suggest a\\nshift in the burden of overweight and obesity from\\nadvantaged to disadvantaged populations (32).\\nAnaemia is associated with iron, folate and vitamin\\nA deficiencies. It is estimated to affect 38.2% of\\npregnant women globally, with the highest prevalence\\nin the WHO regions of South-East Asia (48.7%) and\\nAfrica (46.3%), medium prevalence in the Eastern\\nMediterranean Region (38.9%) and the lowest\\nprevalence in the WHO regions of the Western\\nPacific (24.3%), the Americas (24.9%) and Europe\\n(25.8%) (33).\\nMajor contributory factors to anaemia include\\nparasitic infections such as malaria, hookworm and\\nschistosomiasis, in areas where these infections\\nare endemic. In addition, chronic infections such as\\ntuberculosis (TB) and HIV, and haemoglobinopathies\\nsuch as sickle-cell disease, contribute to the\\nprevalence of anaemia. It is estimated that 0.8million\\npregnant women globally have severe anaemia\\n(defined as a blood haemoglobin concentration'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='such as sickle-cell disease, contribute to the\\nprevalence of anaemia. It is estimated that 0.8million\\npregnant women globally have severe anaemia\\n(defined as a blood haemoglobin concentration\\n<70g/L) (33). In pregnancy, severe anaemia is\\nassociated with an increased risk of maternal and\\ninfant mortality (34). It is estimated that about half of\\nthe anaemia found in pregnant women is amenable\\nto iron supplementation (33); however, this may\\nbe quite variable and is likely to be much lower in\\nmalaria-endemic areas.\\nIn addition to causing anaemia, iron deficiency\\nadversely affects the use of energy sources by\\nmuscles and, thus, physical capacity and work\\nperformance, and also adversely affects immune\\nstatus and morbidity from infections (35). Folate\\n(vitaminB9) deficiency, in addition to anaemia it is\\nalso linked to fetal neural tube defects (36). VitaminA\\ndeficiency affects about 19million pregnant women,\\nmostly in Africa and South-East Asia, causing night\\nblindness (37).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='also linked to fetal neural tube defects (36). VitaminA\\ndeficiency affects about 19million pregnant women,\\nmostly in Africa and South-East Asia, causing night\\nblindness (37).\\nCalcium deficiency is associated with an increased\\nrisk of pre-eclampsia (38), and deficiencies of other\\nvitamins and minerals, such as vitamin E, C, B6 and\\nzinc, have also been postulated to play a role in\\npre-eclampsia. Zinc deficiency is associated with\\nimpaired immunity (39). Vitamin C intake enhances\\niron absorption from the gut; however, zinc, iron\\nand other mineral supplements may compete\\nfor absorption, and it is unclear whether such\\ninteractions have health consequences (39).\\nFor the ANC guideline, the GDG evaluated the\\nevidence on various vitamin and mineral supplements\\nthat might theoretically lead to improved maternal\\nand perinatal outcomes. In addition, as both\\nundernourishment and overnourishment may have\\nnegative consequences for pregnant women and\\ntheir babies, the GDG also evaluated evidence on'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Evidence and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['3 Evidence and recommendations', 'Evidence and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='and perinatal outcomes. In addition, as both\\nundernourishment and overnourishment may have\\nnegative consequences for pregnant women and\\ntheir babies, the GDG also evaluated evidence on\\nthe effects of various dietary interventions to reduce\\nthe impact of these conditions. Caffeine is possibly\\nthe most widely used psychoactive substance in the\\nworld (40), and the GDG also evaluated evidence\\non the impact, if any, of caffeine restriction during\\npregnancy.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='15\\nA.1: Dietary interventions\\nA1.1: Counselling on healthy eating and physical activity'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='during pregnancy is recommended for pregnant women to stay healthy and to prevent excessive\\nweight gain during pregnancy. (Recommended)\\nRemarks\\n• A healthy diet contains adequate energy, protein, vitamins and minerals, obtained through the\\nconsumption of a variety of foods, including green and orange vegetables, meat, fish, beans, nuts, whole\\ngrains and fruit (41).\\n• Stakeholders may wish to consider culturally appropriate healthy eating and exercise interventions\\nto prevent excessive weight gain in pregnancy, particularly for populations with a high prevalence of\\noverweight and obesity, depending on resources and women’s preferences. Interventions should be\\nwoman-centred and delivered in a non-judgemental manner, and developed to ensure appropriate weight\\ngain (see further information in points below).\\n• A healthy lifestyle includes aerobic physical activity and strength-conditioning exercise aimed at'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='gain (see further information in points below).\\n• A healthy lifestyle includes aerobic physical activity and strength-conditioning exercise aimed at\\nmaintaining a good level of fitness throughout pregnancy, without trying to reach peak fitness level or\\ntrain for athletic competition. Women should choose activities with minimal risk of loss of balance and\\nfetal trauma (42).\\n• Most normal gestational weight gain occurs after 20 weeks of gestation and the definition of “normal” is\\nsubject to regional variations, but should take into consideration pre-pregnant body mass index (BMI).\\nAccording to the Institute of Medicine classification (43), women who are underweight at the start of\\npregnancy (i.e. BMI <18.5kg/ m2) should aim to gain 12.5–18kg, women who are normal weight at the\\nstart of pregnancy (i.e. BMI 18.5–24.9kg/ m2) should aim to gain 11.5–16kg, overweight women (i.e. BMI\\n25–29.9k g /m2) should aim to gain 7–11.5kg, and obese women(i.e. BMI >30kg/ m2) should aim to gain\\n5–9kg.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='25–29.9k g /m2) should aim to gain 7–11.5kg, and obese women(i.e. BMI >30kg/ m2) should aim to gain\\n5–9kg.\\n• Most evidence on healthy eating and exercise interventions comes from high-income countries (HICs),\\nand the GDG noted that that there are at least 40 ongoing trials in HICs in this field. The GDG noted that\\nresearch is needed on the effects, feasibility and acceptability of healthy eating and exercise interventions\\nin LMICs.\\n• Pregnancy may be an optimal time for behaviour change interventions among populations with a high\\nprevalence of overweight and obesity, and the longer-term impact of these interventions on women,\\nchildren and partners needs investigation.\\n• The GDG noted that a strong training package is needed for practitioners, including standardized\\nguidance on nutrition. This guidance should be evidence-based, sustainable, reproducible, accessible and\\nadaptable to different cultural settings.\\nWomen’s values'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='guidance on nutrition. This guidance should be evidence-based, sustainable, reproducible, accessible and\\nadaptable to different cultural settings.\\nWomen’s values\\nA scoping review of what women want from ANC and what outcomes they value informed the ANC guideline (13).\\nEvidence showed that women from high-, medium- and low-resource settings valued having a positive pregnancy\\nexperience, the components of which included the provision of effective clinical practices (interventions and tests,\\nincluding nutritional supplements), relevant and timely information (including dietary and nutritional advice) and\\npsychosocial and emotional support, by knowledgeable, supportive and respectful health-care practitioners, to\\noptimize maternal and newborn health (high confidence in the evidence).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n16\\nSummary of evidence and considerations\\nEffects of diet and exercise interventions\\ncompared with no diet and exercise'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='WHO recommendations on antenatal care for a positive pregnancy experience\\n16\\nSummary of evidence and considerations\\nEffects of diet and exercise interventions\\ncompared with no diet and exercise\\ninterventions (EB T ableA.1.1)\\nThe evidence on the effects of healthy eating and\\nexercise interventions was derived from a Cochrane\\nreview that included 65 randomized controlled trials\\n(RCT s), mostly conducted in HICs (44). Thirty-four\\ntrials recruited women from the general population\\n(i.e. women of a wide range of BMIs at baseline),\\n24 trials recruited overweight and/ or obese women\\nand seven recruited women defined as being at\\nhigh risk of gestational diabetes. In total, 49 RCT s\\ninvolving 11444 women contributed data to the\\nreview’s meta-analyses. Diet interventions were\\ndefined as a special selection of food or energy\\nintake to which a participant was restricted, which\\nwere most commonly “healthy eating” types of diets.\\nExercise interventions were defined by reviewers as'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='intake to which a participant was restricted, which\\nwere most commonly “healthy eating” types of diets.\\nExercise interventions were defined by reviewers as\\nany activity requiring physical effort, carried out to\\nsustain or improve health or fitness, and these were\\neither prescribed/unsupervised (e.g. 30 minutes of\\ndaily walking), supervised (e.g. a weekly supervised\\ngroup exercise class) or both. These interventions\\nwere usually compared with “standard ANC” and\\naimed to prevent excessive gestational weight gain\\n(EGWG).\\nMost trials recruited women between 10 and 20\\nweeks of gestation. There was substantial variation\\nin the number of contacts (i.e. counselling/ exercise\\nsessions), type of intervention and method of\\ndelivery. Data were grouped according to the type\\nof intervention (i.e. diet only, exercise only, diet and\\nexercise counselling, diet and supervised exercise)\\nand the average effects across trials were estimated\\nusing the random effects model. Separate analyses'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='exercise counselling, diet and supervised exercise)\\nand the average effects across trials were estimated\\nusing the random effects model. Separate analyses\\nwere performed according to type of intervention and\\nthe risk of weight-related complications. Most data\\nin the overall analyses were derived from trials of\\ncombined diet and exercise interventions.\\nMaternal outcomes\\nHigh-certainty evidence shows that women receiving\\ndiet and/ or exercise interventions as part of ANC to\\nprevent EGWG are less likely to experience EGWG\\n(24 trials, 7096 women; relative risk [RR]: 0.80,\\n95% confidence interval [CI]: 0.73–0.87; absolute\\neffect of 91 fewer women with EGWG per 1000 on\\naverage). Subgroup analyses were consistent with\\nthese findings.\\nHigh-certainty evidence shows that diet and/ or\\nexercise interventions have little or no effect on pre-\\neclampsia risk (15 trials, 5330 women; RR: 0.95, 95%\\nCI: 0.77–1.16). However, moderate-certainty evidence\\nindicates that diet and/ or exercise interventions'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='eclampsia risk (15 trials, 5330 women; RR: 0.95, 95%\\nCI: 0.77–1.16). However, moderate-certainty evidence\\nindicates that diet and/ or exercise interventions\\nprobably prevent hypertension in pregnancy (11 trials,\\n5162 women; RR: 0.70, 95% CI: 0.51–0.96).\\nLow-certainty evidence suggests that diet and/ or\\nexercise interventions may have little or no effect on\\ncaesarean section (28 trials, 7534 women; RR: 0.95,\\n95% CI: 0.88–1.03); however, low-certainty evidence\\nfrom the diet and exercise counselling subgroup\\nof trials suggests that reductions in caesarean\\nsection rates may be possible with this intervention\\n(9trials, 3406 women; RR: 0.87, 95% CI: 0.75–1.01).\\nModerate-certainty evidence indicates that diet\\nand/ or exercise interventions probably make little or\\nno difference to induction of labour (8 trials, 3832\\nwomen; RR: 1.06, 95% CI: 0.94–1.19).\\nLow-certainty evidence suggests that diet and/\\nor exercise interventions may reduce the risk of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs']}, page_content='no difference to induction of labour (8 trials, 3832\\nwomen; RR: 1.06, 95% CI: 0.94–1.19).\\nLow-certainty evidence suggests that diet and/\\nor exercise interventions may reduce the risk of\\ngestational diabetes mellitus (GDM) (19 trials, 7279\\nwomen; RR: 0.82, 95% CI: 0.67–1.01).\\nFetal and neonatal outcomes\\nModerate-certainty evidence suggests that diet\\nand/ or exercise interventions probably prevent\\nneonatal macrosomia (27 trials, 8598 women; RR:\\n0.93, 95% CI: 0.86–1.02), particularly in overweight\\nand obese women receiving diet and exercise\\ncounselling interventions (9 trials, 3252 neonates;\\nRR: 0.85, 95% CI: 0.73–1.00). However, moderate-\\ncertainty evidence indicates that diet and exercise\\ninterventions probably have little or no effect on\\nneonatal hypoglycaemia (4 trials, 2601 neonates;\\nRR: 0.95, 95% CI: 0.76–1.18) or shoulder dystocia\\n(4trials, 3253 neonates; RR: 1.02, 95% CI: 0.57–1.83).\\nLow-certainty evidence suggests that neonatal'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.1: Counselling about healthy eating and keeping physically active', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='neonatal hypoglycaemia (4 trials, 2601 neonates;\\nRR: 0.95, 95% CI: 0.76–1.18) or shoulder dystocia\\n(4trials, 3253 neonates; RR: 1.02, 95% CI: 0.57–1.83).\\nLow-certainty evidence suggests that neonatal\\nrespiratory morbidity may occur less frequently with\\ndiet and exercise counselling interventions than\\ncontrols, particularly among overweight and obese\\nwomen (2studies, 2256 women; RR: 0.47, 95% CI:\\n0.26–0.85).\\nLow-certainty evidence suggests that diet and/ or\\nexercise interventions may have little or no effect on\\npreterm birth (16 trials, 5923 women; RR: 0.91, 95%\\nCI: 0.68–1.22), and the evidence on low-birth-weight\\nneonates is very uncertain. Perinatal mortality was\\nnot reported in the review.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='17\\nAdditional considerations\\nnn High-certainty evidence from the review also\\nshows that low gestational weight gain is more\\nlikely to occur with these interventions (11 trials,\\n4422 women; RR: 1.14, CI: 1.02–1.27); the clinical\\nrelevance of this finding is not known.\\nnn The effects, acceptability and feasibility of diet\\nand exercise interventions in LMICs has not been\\nestablished.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nCost implications of diet and exercise interventions\\nfor health services are highly variable. For example,\\nsupervised diet and exercise interventions can\\nhave high associated costs, mainly due to staff\\ncosts for time spent supervising, while counselling\\ninterventions might have relatively low costs. For\\npregnant women, the interventions might also have\\nresource implications in terms of transport costs,\\ntime off work and child-minding costs, particularly if\\nthe intervention requires additional antenatal visits.\\nEquity'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs'], 'discusses_normal_variations': True}, page_content='resource implications in terms of transport costs,\\ntime off work and child-minding costs, particularly if\\nthe intervention requires additional antenatal visits.\\nEquity\\nMost of the evidence came from trials conducted\\nin HICs. Recent studies have reported a shift\\nin the burden of overweight and obesity from\\nadvantaged to disadvantaged populations (32). Such\\na trend increases the risk of associated pregnancy\\ncomplications, as well as cardiometabolic problems,\\namong pregnant women from disadvantaged\\npopulations. These risks might be further exacerbated\\namong women in low-resource community settings,\\nas these settings may not be equipped to deal with\\ncomplications.\\nAcceptability\\nQualitative evidence indicates that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence in'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition'], 'discusses_normal_variations': True}, page_content='of knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence in\\nthe evidence) (22). It also suggests that women may\\nbe less likely to engage with health services if advice\\nis delivered in a hurried or didactic manner (high\\nconfidence in the evidence) (22). Therefore, these\\ntypes of interventions are more likely to be acceptable\\nif the interventions are delivered in an unhurried\\nand supportive way, which may also facilitate better\\nengagement with ANC services. Qualitative evidence\\non health-care providers’ views of ANC suggests\\nthat they may be keen to offer general health-care\\nadvice and specific pregnancy-related information\\n(low confidence in the evidence) but they sometimes\\nfeel they do not have the appropriate training and\\nlack the resources and time to deliver the service in\\nthe informative, supportive and caring manner that'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='feel they do not have the appropriate training and\\nlack the resources and time to deliver the service in\\nthe informative, supportive and caring manner that\\nwomen want (high confidence in the evidence) (45).\\nFeasibility\\nIn a number of LMIC settings, providers feel that\\na lack of resources may limit implementation of\\nrecommended interventions (high confidence in the\\nevidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n18\\nA.1.2: Nutrition education on energy and protein intake'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.2: In undernourished populations, nutrition education on increasing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='daily energy and protein intake is recommended for pregnant women to reduce the risk of low-\\nbirth-weight neonates. (Context-specific recommendation)\\nRemarks\\n• Undernourishment is usually defined by a low BMI (i.e. being underweight). For adults, a 20–39%\\nprevalence of underweight women is considered a high prevalence of underweight and 40% or higher\\nis considered a very high prevalence (46). Mid-upper arm circumference (MUAC) may also be useful to\\nidentify protein–energy malnutrition in individual pregnant women and to determine its prevalence in this\\npopulation (31). However, the optimal cut-off points may need to be determined for individual countries\\nbased on context-specific cost–benefit analyses (31).\\n• Anthropometric characteristics of the general population are changing, and this needs to be taken into\\naccount by regularly reassessing the prevalence of undernutrition to ensure that the intervention remains\\nrelevant.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.2: In undernourished populations, nutrition education on increasing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='account by regularly reassessing the prevalence of undernutrition to ensure that the intervention remains\\nrelevant.\\n• The GDG noted that a strong training package is needed for practitioners, including standardized\\nguidance on nutrition. This guidance should be evidence-based, sustainable, reproducible, accessible and\\nadaptable to different cultural settings.\\n• Stakeholders might wish to consider alternative delivery platforms (e.g. peer counsellors, media\\nreminders) and task shifting for delivery of this intervention.\\n• Areas that are highly food insecure or those with little access to a variety of foods may wish to consider\\nadditional complementary interventions, such as distribution of balanced protein and energy supplements\\n(see Recommendation A.1.3).\\nSummary of evidence and considerations\\nEffects of nutritional education to increase\\nenergy and protein intake versus no nutritional\\neducation intervention (EB T able A.1.2)\\nEvidence on the effects of nutritional education was'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.2: In undernourished populations, nutrition education on increasing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='Effects of nutritional education to increase\\nenergy and protein intake versus no nutritional\\neducation intervention (EB T able A.1.2)\\nEvidence on the effects of nutritional education was\\nderived from a Cochrane review (47). Five trials\\nconducted between 1975 and 2013 in Bangladesh,\\nGreece and the USA, involving 1090 pregnant\\nwomen, contributed data to this comparison.\\nNutritional education interventions were delivered\\none-to-one or in group classes and included\\neducation to improve the “quality” of diet, increase\\nenergy and protein intake, or improve knowledge\\nof the nutritional value of different foods, including\\nenergy, protein, vitamins and iron. The Bangladesh\\nstudy also involved cookery demonstrations.\\nMaternal outcomes\\nEvidence on gestational weight gain was of very low\\ncertainty. There was no other evidence available on\\nmaternal outcomes in the review for this comparison.\\nFetal and neonatal outcomes\\nLow-certainty evidence shows that antenatal dietary'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.2: In undernourished populations, nutrition education on increasing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='certainty. There was no other evidence available on\\nmaternal outcomes in the review for this comparison.\\nFetal and neonatal outcomes\\nLow-certainty evidence shows that antenatal dietary\\neducation may reduce low-birth-weight neonates\\n(300 women; RR: 0.04, 95% CI: 0.01–0.14), but may\\nhave little or no effect on small-for-gestational-age\\n(SGA) neonates (2 trials, 449 women; RR: 0.46,\\n95% CI: 0.21–0.98), stillbirths (1 trial, 431 women;\\nRR: 0.37, 95% CI: 0.07–1.90) or neonatal deaths\\n(1 trial, 448 women; RR: 1.28, 95% CI: 0.35–4.72).\\nEvidence on preterm birth was judged to be of very\\nlow certainty.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nResource costs are variable and mainly related to\\nstaffing and counselling time.\\nEquity\\nIn many LMICs, pregnancy outcomes and ANC\\ncoverage are worse among women who are poor,\\nleast educated and residing in rural areas (29).\\nMany low-income countries still struggle with'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.2: In undernourished populations, nutrition education on increasing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Equity\\nIn many LMICs, pregnancy outcomes and ANC\\ncoverage are worse among women who are poor,\\nleast educated and residing in rural areas (29).\\nMany low-income countries still struggle with\\nwidespread poverty and hunger, particularly among\\nrural populations (48). Findings from a study of\\nantenatal food supplementation and micronutrient\\nsupplements in rural Bangladesh suggest that food\\nsupplementation interventions might be associated\\nwith better ANC adherence among women with'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='19\\nless education but not among those with more\\neducation (49). Therefore, providing antenatal food\\nsupplements could help to address inequalities by\\nimproving maternal nutritional status and increasing\\nANC coverage among disadvantaged women.\\nAcceptability\\nQualitative evidence indicates that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence in\\nthe evidence) (22). It also suggests that women may\\nbe less likely to engage with health services if advice\\nis delivered in a hurried or didactic manner (high\\nconfidence in the evidence) (22). Therefore, these\\ntypes of interventions are more likely to be acceptable\\nif the interventions are delivered in an unhurried\\nand supportive way, which may also facilitate better\\nengagement with ANC services. Qualitative evidence'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='if the interventions are delivered in an unhurried\\nand supportive way, which may also facilitate better\\nengagement with ANC services. Qualitative evidence\\non health-care providers’ views of ANC suggests\\nthat they may be keen to offer general health-care\\nadvice and specific pregnancy-related information\\n(low confidence in the evidence) but they sometimes\\nfeel they do not have the appropriate training and\\nlack the resources and time to deliver the service in\\nthe informative, supportive and caring manner that\\nwomen want (high confidence in the evidence) (45).\\nFeasibility\\nIn a number of LMIC settings, providers feel that\\na lack of resources may limit implementation of\\nrecommended interventions (high confidence in the\\nevidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n20\\nA.1.3: Energy and protein dietary supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.3: In undernourished populations, balanced energy and protein dietary', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='supplementation is recommended for pregnant women to reduce the risk of stillbirths and small-\\nfor-gestational-age neonates. (Context-specific recommendation)\\nRemarks\\n• The GDG stressed that this recommendation is for populations or settings with a high prevalence\\nof undernourished pregnant women, and not for individual pregnant women identified as being\\nundernourished.\\n• Undernourishment is usually defined by a low BMI (i.e. being underweight). For adults, a 20–39%\\nprevalence of underweight women is considered a high prevalence of underweight and 40% or higher is\\nconsidered a very high prevalence (46). MUAC may also be useful to identify protein–energy malnutrition\\nin individual pregnant women and to determine its prevalence in this population (31). However, the\\noptimal cut-off points may need to be determined for individual countries based on context-specific cost–\\nbenefit analyses (31).\\n• Establishment of a quality assurance process is important to guarantee that balanced energy and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.3: In undernourished populations, balanced energy and protein dietary', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='benefit analyses (31).\\n• Establishment of a quality assurance process is important to guarantee that balanced energy and\\nprotein food supplements are manufactured, packaged and stored in a controlled and uncontaminated\\nenvironment. The cost and logistical implications associated with balanced energy and protein\\nsupplements might be mitigated by local production of supplements, provided that a quality assurance\\nprocess is established.\\n• A continual, adequate supply of supplements is required for programme success. This requires a clear\\nunderstanding and investment in procurement and supply chain management.\\n• Programmes should be designed and continually improved based on locally generated data and\\nexperiences. Examples relevant to this guideline include:\\n– Improving delivery, acceptability and utilization of this intervention by pregnant women (i.e.\\novercoming supply and utilization barriers).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.3: In undernourished populations, balanced energy and protein dietary', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='experiences. Examples relevant to this guideline include:\\n– Improving delivery, acceptability and utilization of this intervention by pregnant women (i.e.\\novercoming supply and utilization barriers).\\n– Distribution of balanced energy and protein supplements may not be feasible only through the\\nlocal schedule of ANC visits; additional visits may need to be scheduled. The costs related to these\\nadditional visits should be considered. In the absence of antenatal visits, too few visits, or when the\\nfirst visit comes too late, consideration should be given to alternative platforms for delivery (e.g.\\ncommunity health workers, task shifting in specific settings).\\n– Values and preferences related to the types and amounts of balanced energy and protein supplements\\nmay vary.\\n• Monitoring and evaluation should include evaluation of household-level storage facilities, spoilage,\\nwastage, retailing, sharing and other issues related to food distribution.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.3: In undernourished populations, balanced energy and protein dietary', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='may vary.\\n• Monitoring and evaluation should include evaluation of household-level storage facilities, spoilage,\\nwastage, retailing, sharing and other issues related to food distribution.\\n• Each country will need to understand the context-specific etiology of undernutrition at the national and\\nsub-national levels. For instance, where seasonality is a predictor of food availability, the programme\\nshould consider this and adapt to the conditions as needed (e.g. provision of more or less food of\\ndifferent types in different seasons). In addition, a better understanding is needed of whether alternatives\\nto energy and protein supplements – such as cash or vouchers, or improved local and national food\\nproduction and distribution – can lead to better or equivalent results.\\n• Anthropometric characteristics of the general population are changing, and this needs to be taken into\\naccount to ensure that only those women who are likely to benefit (i.e. only undernourished women) are\\nincluded.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.3: In undernourished populations, balanced energy and protein dietary', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='account to ensure that only those women who are likely to benefit (i.e. only undernourished women) are\\nincluded.\\n• The GDG noted that it is not known whether there are risks associated with providing this intervention to\\nwomen with a high BMI.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='21\\nSummary of evidence and considerations\\nEffects of balanced energy and protein\\nsupplements compared with no supplements or\\nplacebo (EB T able A.1.3)\\nEvidence on the effects of balanced energy and protein\\nsupplements compared with no supplementation or\\nplacebo was derived from a Cochrane review (47).\\nT welve trials, involving 6705 women, were included\\nin this comparison. Most data were derived from\\ntrials conducted in LMICs, including Burkina Faso,\\nColombia, Gambia, Ghana, India, Indonesia, South\\nAfrica and T aiwan, China. The balanced energy and\\nprotein supplements used were in various forms,\\nincluding fortified beverages, biscuits and powders.\\nMaternal outcomes\\nThe only maternal outcome reported for this\\ncomparison in the review, of those outcomes\\nprioritized for this guideline, was pre-eclampsia.\\nHowever, the evidence on this outcome, based on two\\nsmall trials, was assessed as very uncertain.\\nFetal and neonatal outcomes\\nModerate-certainty evidence shows that balanced'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='However, the evidence on this outcome, based on two\\nsmall trials, was assessed as very uncertain.\\nFetal and neonatal outcomes\\nModerate-certainty evidence shows that balanced\\nenergy and protein supplementation probably\\nreduces SGA neonates (7 trials, 4408 women; RR:\\n0.79, 95% CI: 0.69–0.90) and stillbirths (5 trials,\\n3408 women; RR: 0.60, 95% CI: 0.39–0.94), but\\nprobably has no effect on preterm birth (5 trials,\\n3384 women; RR: 0.96, 95% CI: 0.80–1.16). Low-\\ncertainty evidence suggests that it may have little or\\nno effect on neonatal deaths (5 trials, 3381 women;\\nRR: 0.68, 95% CI: 0.43–1.07). Low birth weight was\\nnot reported for this comparison in the review.\\nAdditional considerations\\nnn In the review, mean birth weight (in grams) was\\nreported and the findings favoured the balanced\\nenergy and protein supplementation group\\n(11trials, 5385 neonates; mean difference [MD]:\\n40.96, 95% CI: 4.66–77.26). This evidence was\\ngraded as moderate-quality evidence in the review\\n(47).\\nValues'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='energy and protein supplementation group\\n(11trials, 5385 neonates; mean difference [MD]:\\n40.96, 95% CI: 4.66–77.26). This evidence was\\ngraded as moderate-quality evidence in the review\\n(47).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nThe cost of balanced energy and protein supplements\\nis relatively high. There may also be cost implications\\nwith respect to transport, storage and training.\\nEquity\\nIn many LMICs, pregnancy outcomes and ANC\\ncoverage are worse among women who are poor,\\nleast educated and residing in rural areas (29).\\nMany low-income countries still struggle with\\nwidespread poverty and hunger, particularly among\\nrural populations (48). Findings from a study of\\nantenatal food supplementation and micronutrient\\nsupplements in rural Bangladesh suggest that food\\nsupplementation interventions might be associated\\nwith better ANC adherence among women with\\nless education but not among those with more'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='supplements in rural Bangladesh suggest that food\\nsupplementation interventions might be associated\\nwith better ANC adherence among women with\\nless education but not among those with more\\neducation (49). Therefore, providing antenatal food\\nsupplements could help to address inequalities by\\nimproving maternal nutritional status and increasing\\nANC coverage among disadvantaged women.\\nAcceptability\\nQualitative evidence indicates that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence in\\nthe evidence) (22). It also suggests that women may\\nbe less likely to engage with health services if advice\\nis delivered in a hurried or didactic manner (high\\nconfidence in the evidence) (22). Therefore, these\\ntypes of interventions are more likely to be acceptable'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='is delivered in a hurried or didactic manner (high\\nconfidence in the evidence) (22). Therefore, these\\ntypes of interventions are more likely to be acceptable\\nif the interventions are delivered in an unhurried\\nand supportive way, which may also facilitate better\\nengagement with ANC services. Qualitative evidence\\non health-care providers’ views of ANC suggests\\nthat they may be keen to offer general health-care\\nadvice and specific pregnancy-related information\\n(low confidence in the evidence) but they sometimes\\nfeel they do not have the appropriate training and\\nlack the resources and time to deliver the service in\\nthe informative, supportive and caring manner that\\nwomen want (high confidence in the evidence) (45).\\nFeasibility\\nProviding balanced protein and energy supplements\\nmay be associated with logistical issues, as\\nsupplements are bulky and will require adequate\\ntransport and storage facilities to ensure continual\\nsupplies. Qualitative evidence from LMIC settings'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='may be associated with logistical issues, as\\nsupplements are bulky and will require adequate\\ntransport and storage facilities to ensure continual\\nsupplies. Qualitative evidence from LMIC settings\\nindicates that providers feel that a lack of resources\\nmay limit implementation of recommended\\ninterventions (high confidence in the evidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n22\\nA.1.4: High-protein supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.4: In undernourished populations, high-protein supplementation', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='is not recommended for pregnant women to improve maternal and perinatal outcomes. (Not\\nrecommended)\\nRemarks\\n• The GDG noted that there is insufficient evidence on the benefits, if any, of high-protein supplementation.\\n• Further research on the effects of high-protein supplements in undernourished populations is not\\nconsidered a research priority.\\nSummary of evidence and considerations\\nEffects of high-protein supplementation\\ncompared with controls (EB T able A.1.4)\\nEvidence on the effects of high-protein\\nsupplementation was derived from the same\\nCochrane review as for Recommendations A.1.2\\nand A.1.3 (47). The review included one trial of\\nhigh-protein supplementation compared with a\\nmicronutrient supplement conducted in the 1970s,\\ninvolving 1051 low-income, black women in the USA.\\nMaternal outcomes\\nNone of the outcomes prioritized for this guideline\\nwere reported for this comparison in the review.\\nFetal and neonatal outcomes\\nHigh-certainty evidence shows that high-protein'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.4: In undernourished populations, high-protein supplementation', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='Maternal outcomes\\nNone of the outcomes prioritized for this guideline\\nwere reported for this comparison in the review.\\nFetal and neonatal outcomes\\nHigh-certainty evidence shows that high-protein\\nsupplementation increases SGA neonates (1trial,\\n505neonates; RR: 1.58, 95% CI: 1.03–2.41).\\nModerate-certainty evidence indicates that high-\\nprotein supplementation probably has little or no\\neffect on preterm birth (1 study, 505 women; RR: 1.14,\\n95% CI: 0.83–1.56). Low-certainty evidence suggests\\nthat high-protein supplementation may have little or\\nno effect on stillbirths (1 trial, 529 babies; RR: 0.81,\\n95% CI: 0.31–2.15; certainty of evidence downgraded\\ndue to imprecision) and neonatal deaths (1 trial,\\n529neonates; RR: 2.78, 95% CI: 0.75–10.36).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nThe cost of high-protein supplements is relatively\\nhigh. There may also be cost implications with\\nrespect to transport, storage and training.\\nEquity'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.4: In undernourished populations, high-protein supplementation', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='Background (p.15).\\nResources\\nThe cost of high-protein supplements is relatively\\nhigh. There may also be cost implications with\\nrespect to transport, storage and training.\\nEquity\\nIn many LMICs, pregnancy outcomes and ANC\\ncoverage are worse among women who are poor,\\nleast educated and residing in rural areas (29). Many\\nlow-income countries still struggle with widespread\\npoverty and hunger, particularly among rural\\npopulations (48). Therefore, providing antenatal food\\nsupplements could help to address inequalities by\\nimproving maternal nutritional status and increasing\\nANC coverage among disadvantaged women.\\nAcceptability\\nQualitative evidence indicates that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence\\nin the evidence) (22). It also suggests that women'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.4: In undernourished populations, high-protein supplementation', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='or nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence\\nin the evidence) (22). It also suggests that women\\nmay be less likely to engage with health services if\\nadvice is delivered in a hurried or didactic manner\\n(high confidence in the evidence) (22). Qualitative\\nevidence on health-care providers’ views of ANC\\nsuggests that they may be keen to offer general\\nhealth-care advice and specific pregnancy-related\\ninformation (low confidence in the evidence) but\\nthey sometimes feel they do not have the appropriate\\ntraining and lack the resources and time to deliver\\nthe service in the informative, supportive and caring\\nmanner that women want (high confidence in the\\nevidence) (45).\\nFeasibility\\nProviding high-protein supplements may be\\nassociated with logistical issues, as supplements are\\nbulky and will require adequate transport and storage\\nfacilities to ensure continual supplies. Qualitative\\nevidence from LMIC settings indicates that providers'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.1.4: In undernourished populations, high-protein supplementation', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='bulky and will require adequate transport and storage\\nfacilities to ensure continual supplies. Qualitative\\nevidence from LMIC settings indicates that providers\\nfeel that a lack of resources may limit implementation\\nof recommended interventions (high confidence in\\nthe evidence) (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='23\\nA.2: Iron and folic acid supplements\\nA.2.1: Daily iron and folic acid supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third', 'second']}, 'maternal_topics': ['maternal_changes']}, page_content='60 mg of elemental iron a and 400 µg (0.4mg) folic acid b  is recommended for pregnant\\nwomen to prevent maternal anaemia, puerperal sepsis, low birth weight, and preterm birth. c\\n(Recommended)\\nRemarks\\n• This recommendation supersedes the 2012 WHO Guideline: daily iron and folic acid supplementation in\\npregnant women (36) and should be considered alongside Recommendation A.2.2 on intermittent iron.\\n• In settings where anaemia in pregnant women is a severe public health problem (i.e. where at least 40%\\nof pregnant women have a blood haemoglobin [Hb] concentration < 110 g/L), a daily dose of 60 mg of\\nelemental iron is preferred over a lower dose.\\n• In the first and third trimesters, the Hb threshold for diagnosing anaemia is 110 g/L; in the second\\ntrimester, the threshold is 105 g/L (50).\\n• If a woman is diagnosed with anaemia during pregnancy, her daily elemental iron should be increased'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='trimester, the threshold is 105 g/L (50).\\n• If a woman is diagnosed with anaemia during pregnancy, her daily elemental iron should be increased\\nto 120 mg until her Hb concentration rises to normal (Hb 110 g/L or higher) (34, 51). Thereafter, she can\\nresume the standard daily antenatal iron dose to prevent recurrence of anaemia.\\n• Effective communication with pregnant women about diet and healthy eating – including providing\\ninformation about food sources of vitamins and minerals, and dietary diversity – is an integral part of\\npreventing anaemia and providing quality ANC.\\n• Effective communication strategies are vital for improving the acceptability of, and adherence to,\\nsupplementation schemes.\\n• Stakeholders may need to consider ways of reminding pregnant women to take their supplements and of\\nassisting them to manage associated side-effects.\\n• In areas with endemic infections that may cause anaemia through blood loss, increased red cell'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='assisting them to manage associated side-effects.\\n• In areas with endemic infections that may cause anaemia through blood loss, increased red cell\\ndestruction or decreased red cell production, such as malaria and hookworm, measures to prevent,\\ndiagnose and treat these infections should be implemented.\\n• Oral supplements are available as capsules or tablets (including soluble tablets, and dissolvable and\\nmodified-release tablets) (52). Establishment of a quality assurance process is important to guarantee\\nthat supplements are manufactured, packaged and stored in a controlled and uncontaminated\\nenvironment (53).\\n• A better understanding of the etiology of anaemia (e.g. malaria endemnicity, haemoglobinopathies) and\\nthe prevalence of risk factors is needed at the country level, to inform context-specific adaptations of this\\nrecommendation.\\n• Standardized definitions of side-effects are needed to facilitate monitoring and evaluation.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='recommendation.\\n• Standardized definitions of side-effects are needed to facilitate monitoring and evaluation.\\n• Development and improvement of integrated surveillance systems are needed to link the assessment of\\nanaemia and iron status at the country level to national and global surveillance systems.\\n• T o reach the most vulnerable populations and ensure a timely and continuous supply of supplements,\\nstakeholders may wish to consider task shifting the provision of iron supplementation in community\\nsettings with poor access to health-care professionals (see Recommendation E.6.1, in section E: Health\\nsystems interventions to improve the utilization and quality of ANC).\\na The equivalent of 60 mg of elemental iron is 300 mg of ferrous sulfate hepahydrate, 180 mg of ferrous fumarate or 500 mg of ferrous gluconate.\\nb Folic acid should be commenced as early as possible (ideally before conception) to prevent neural tube defects.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='b Folic acid should be commenced as early as possible (ideally before conception) to prevent neural tube defects.\\nc This recommendation supersedes the previous WHO recommendation found in the 2012 Guideline: daily iron and folic acid supplementation in pregnant women\\n(36).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n24\\nSummary of evidence and considerations\\nEffects of any daily iron and folic acid\\nsupplements compared with no daily iron and\\nfolic acid supplements (EB T able A.2.1)\\nThe evidence on the effects of daily iron and/ or\\nfolic acid was derived from a Cochrane review of\\n61trials conducted in low-, middle- and high-income\\ncountries (54). T wenty-three trials were conducted\\nin countries with some malaria risk, of which two\\nreported malaria outcomes. Overall, 44trials\\ninvolving 43274 women contributed data to the\\nreview’s meta-analyses. The trials compared daily\\noral iron supplementation, with or without folic acid'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='reported malaria outcomes. Overall, 44trials\\ninvolving 43274 women contributed data to the\\nreview’s meta-analyses. The trials compared daily\\noral iron supplementation, with or without folic acid\\nor other vitamin and mineral supplements, with\\nvarious control groups (folic acid only, placebo, no\\nintervention, other vitamin and mineral supplements\\nwithout iron or folic acid). Most of the evidence was\\nderived from studies comparing iron supplementation\\nwith no iron supplementation. In most trials, women\\nbegan taking supplements before 20weeks of\\ngestation and continued taking supplements until\\ndelivery. The most commonly used dose of elemental\\niron was 60mg daily (range: 30–240mg) and that of\\nfolic acid was 400µg daily.\\nMaternal outcomes\\nAnaemia was reported in many different ways and\\nat different time points during pregnancy and the\\npuerperium. Low-certainty evidence shows that\\ndaily iron supplementation may reduce the risk of\\nanaemia at term (defined as blood Hb concentration'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='at different time points during pregnancy and the\\npuerperium. Low-certainty evidence shows that\\ndaily iron supplementation may reduce the risk of\\nanaemia at term (defined as blood Hb concentration\\n<110g/L at 37 weeks of gestation or later) (14 trials,\\n2199 women; RR: 0.30, 95% CI: 0.19–0.46) and\\nsevere postpartum anaemia (defined as Hb <80g/L)\\n(8trials, 1339 women; RR: 0.04, 95% CI: 0.01–0.28).\\nLow-certainty evidence also shows that daily\\niron supplementation may increase maternal Hb\\nconcentrations at or near term (34 weeks of gestation\\nor more) (19 trials, 3704 women; MD: 8.88g/L\\nhigher, 95% CI: 6.96–10.8g/L) and may increase the\\nproportion of women with a high maternal Hb at or\\nnear term (Hb >130g/L at 34 weeks of gestation\\nor later) (8 trials, 2156 women; RR: 3.07, 95% CI:\\n1.18–8.02).\\nRegarding maternal morbidity, moderate-certainty\\nevidence shows that daily iron supplementation\\nprobably reduces the risk of maternal puerperal\\ninfections (4 trials, 4374 women; RR: 0.68, 95% CI:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='Regarding maternal morbidity, moderate-certainty\\nevidence shows that daily iron supplementation\\nprobably reduces the risk of maternal puerperal\\ninfections (4 trials, 4374 women; RR: 0.68, 95% CI:\\n0.5–0.92). Low-certainty evidence shows that daily\\niron supplementation may have little or no effect on\\npre-eclampsia (4 trials, 1704 women; RR: 1.63, 95%\\nCI: 0.87–3.07) and antepartum haemorrhage (2trials,\\n1157 women; RR: 1.48, 95% CI: 0.51–4.31), and\\nmoderate-certainty evidence shows that it probably\\nhas little or no effect on postpartum haemorrhage\\n(4 trials, 1488 women; RR: 0.93, 95% CI: 0.59–1.49).\\nEvidence on other morbidity outcomes, including\\nplacental abruption and blood transfusions, is of very\\nlow certainty.\\nLow-certainty evidence shows that daily iron\\nsupplementation may have little or no effect on\\nmaternal mortality (2 trials, 12560 women; RR:\\n0.33, 95% CI: 0.01–8.19). Women’s satisfaction was\\nevaluated in one small trial (49 women), which found'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='supplementation may have little or no effect on\\nmaternal mortality (2 trials, 12560 women; RR:\\n0.33, 95% CI: 0.01–8.19). Women’s satisfaction was\\nevaluated in one small trial (49 women), which found\\nlittle difference between daily iron and control groups.\\nSide-effects: Moderate-certainty evidence indicates\\nthat daily iron supplementation probably has little or\\nno effect on the risk of experiencing any side-effect\\n(11 trials, 2425 women; RR: 1.29, 95% CI: 0.83–2.02),\\nand that it may have little or no effect on constipation\\n(4 trials, 1495 women; RR: 0.95, 95% CI: 0.62–1.43),\\nheartburn (3 trials, 1323 women; RR: 1.19, 95% CI:\\n0.86–1.66) and vomiting (4 trials, 1392 women; RR:\\n0.88, 95% CI: 0.59–1.30). Evidence that daily iron\\nhas little or no effect on nausea is of low certainty\\n(4 trials, 1377 women; RR: 1.21, 95% CI: 0.72–2.03).\\nHigh-certainty evidence shows that diarrhoea is\\nless common with daily iron supplements (3 trials,\\n1088women; RR: 0.55, 95% CI: 0.32–0.93).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='(4 trials, 1377 women; RR: 1.21, 95% CI: 0.72–2.03).\\nHigh-certainty evidence shows that diarrhoea is\\nless common with daily iron supplements (3 trials,\\n1088women; RR: 0.55, 95% CI: 0.32–0.93).\\nFetal and neonatal outcomes\\nLow-certainty evidence shows that daily iron\\nmay reduce the risk of low-birth-weight neonates\\n(<2500g) (11 trials, 17613 neonates; RR: 0.84, 95%\\nCI: 0.69–1.03). High-certainty evidence shows that\\nit does not reduce the risk of preterm birth before 37\\nweeks of gestation (13 trials, 19286 women; RR: 0.93,\\n95% CI: 0.84–1.03), but it does reduce the risk of very\\npreterm birth (i.e. less than 34 weeks of gestation)\\n(5trials, 3749 women; RR: 0.51, 95% CI: 0.29–0.91).\\nLow-certainty evidence suggests that daily iron may\\nhave little or no effect on congenital anomalies (4\\ntrials, 14636 neonates; RR: 0.88, 95% CI: 0.58–1.33).\\nModerate-certainty evidence indicates that daily iron\\nprobably has little or no effect on neonatal deaths (4'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.1: Daily oral iron and folic acid supplementation with 30 mg to', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='trials, 14636 neonates; RR: 0.88, 95% CI: 0.58–1.33).\\nModerate-certainty evidence indicates that daily iron\\nprobably has little or no effect on neonatal deaths (4\\ntrials, 16603 neonates; RR: 0.91, 95% CI: 0.71–1.18).\\nNeonatal infections and SGA were not reviewed as\\noutcomes.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='25\\nAdditional considerations\\nnn Evidence from subgroups tended to be consistent\\nwith the overall findings for the main outcomes.\\nMore details can be found in the Web supplement\\n(EB T able A.2.1).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nDaily iron and folic acid supplements are relatively\\nlow cost, at less than 1 United States dollar (US$1)\\nper pregnant woman (27).\\nEquity\\nIron deficiency and parasitic infections are more\\ncommon in LMICs and disadvantaged populations.\\nPoor, rural and least-educated populations also\\nexperience the highest maternal, infant and child\\nmortality (29). Increasing coverage of effective\\nnutritional interventions to prevent anaemia,\\nparticularly among disadvantaged populations,\\nmight help to address maternal and newborn health\\ninequalities.\\nAcceptability\\nQualitative evidence suggests that the availability of\\niron supplements may actively encourage women to\\nengage with ANC providers (low confidence in the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='inequalities.\\nAcceptability\\nQualitative evidence suggests that the availability of\\niron supplements may actively encourage women to\\nengage with ANC providers (low confidence in the\\nevidence) (22). However, where there are additional\\ncosts associated with supplementation or where\\nthe supplements may be unavailable (because of\\nresource constraints) women are less likely to engage\\nwith ANC services (high confidence in the evidence).\\nLower doses of iron may be associated with fewer\\nside-effects and therefore may be more acceptable to\\nwomen than higher doses.\\nFeasibility\\nQualitative evidence about the views of health-care\\nproviders suggests that resource constraints, both in\\nterms of the availability of the supplements and the\\nlack of suitably trained staff to deliver them, may limit\\nimplementation (high confidence in the evidence)\\n(45).\\na The equivalent of 120 mg of elemental iron is 600 mg of ferrous sulfate hepahydrate, 360 mg of ferrous fumarate or 1000 mg of ferrous gluconate.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='(45).\\na The equivalent of 120 mg of elemental iron is 600 mg of ferrous sulfate hepahydrate, 360 mg of ferrous fumarate or 1000 mg of ferrous gluconate.\\nA.2.2: Intermittent iron and folic acid supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='of elemental iron a and 2800 µg (2.8mg) of folic acid once weekly is recommended for pregnant\\nwomen to improve maternal and neonatal outcomes if daily iron is not acceptable due to side-\\neffects, and in populations with an anaemia prevalence among pregnant women of less than\\n20%. (Context-specific recommendation)\\nRemarks\\n• This recommendation supersedes the previous WHO recommendation in the 2012 Guideline: intermittent\\niron and folic acid supplementation in non-anaemic pregnant women (55) and should be considered\\nalongside Recommendation A.1.1.\\n• In general, anaemia prevalence of less than 20% is classified as a mild public health problem (33).\\n• Before commencing intermittent iron supplementation, accurate measurement of maternal blood Hb\\nconcentrations is needed to confirm the absence of anaemia. Therefore, this recommendation may require\\na strong health system to facilitate accurate Hb measurement and to monitor anaemia status throughout\\npregnancy.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='a strong health system to facilitate accurate Hb measurement and to monitor anaemia status throughout\\npregnancy.\\n• If a woman is diagnosed with anaemia (Hb < 110 g/L) during ANC, she should be given 120 mg of\\nelemental iron and 400 µg (0.4 mg) of folic acid daily until her Hb concentration rises to normal (Hb 110\\ng/L or higher) (34, 51). Thereafter, she can continue with the standard daily antenatal iron and folic acid\\ndose (or the intermittent regimen if daily iron is not acceptable due to side-effects) to prevent recurrence\\nof anaemia.\\n• Stakeholders may need to consider ways of reminding pregnant women to take their supplements on an\\nintermittent basis and of assisting them to manage associated side-effects.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n26\\nSummary of evidence and considerations\\nEffects of intermittent iron and folic acid\\nsupplements compared with daily iron and folic\\nacid supplements (EBT ableA.2.2)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='26\\nSummary of evidence and considerations\\nEffects of intermittent iron and folic acid\\nsupplements compared with daily iron and folic\\nacid supplements (EBT ableA.2.2)\\nThe evidence on the effects of intermittent iron and\\nfolic acid was derived from a Cochrane review that\\nincluded 27 trials from 15 countries; however, only\\n21 trials (involving 5490 women) contributed data\\nto the review’s meta-analyses (56). All trials were\\nconducted in LMICs with some degree of malaria\\nrisk (Argentina, Bangladesh, China, Guatemala,\\nIndia, Indonesia, the Islamic Republic of Iran, Malawi,\\nMalaysia, Mexico, Pakistan, Republic of Korea, Sri\\nLanka, Thailand and VietNam); however, only one\\ntrial specifically reported that it was conducted in a\\nmalaria-endemic area.\\nMost of the intermittent iron regimens involved\\nwomen taking weekly supplements, most commonly\\n120mg elemental iron per week (range: 80–200mg\\nweekly), which was compared with daily regimens,\\nmost commonly 60mg elemental iron daily (range:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='women taking weekly supplements, most commonly\\n120mg elemental iron per week (range: 80–200mg\\nweekly), which was compared with daily regimens,\\nmost commonly 60mg elemental iron daily (range:\\n40–120mg daily). Where folic acid was also\\nprovided in the trials, it was administered weekly in\\nthe intermittent supplement groups (range: 400–\\n3500µg weekly) compared with the usual standard\\ndaily dose for control groups.\\nMaternal outcomes\\nAnaemia was reported in different ways across\\ntrials. Low-certainty evidence suggests there may\\nbe little or no difference between intermittent\\nand daily iron supplementation in the effect on\\nanaemia at term (4 trials, 676 women; RR: 1.22,\\n95% CI: 0.84–1.80). Moderate-certainty evidence\\nshows that anaemia at or near term (defined as a\\nHb of <110 g/L at 34 weeks of gestation or later)\\nprobably occurs more frequently with intermittent\\nthan daily iron supplementation (8 trials, 1385\\nwomen; RR: 1.66, 95% CI: 1.09–2.53), and that'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Hb of <110 g/L at 34 weeks of gestation or later)\\nprobably occurs more frequently with intermittent\\nthan daily iron supplementation (8 trials, 1385\\nwomen; RR: 1.66, 95% CI: 1.09–2.53), and that\\nintermittent iron supplementation is probably less\\nlikely to be associated with a Hb concentration of\\nmore than 130g/L than daily iron (15 trials, 2616\\nwomen; RR: 0.53, 95% CI: 0.38–0.74). No events of\\nsevere anaemia occurred in either group in six trials\\nreporting this outcome (1240 women). The evidence\\non mean Hb concentrations at or near term and\\nsevere postpartum anaemia is of very low certainty.\\nLimited evidence on maternal morbidity from\\none small trial (110 women) was assessed as\\nvery uncertain. Maternal infections and maternal\\nsatisfaction were not evaluated in the review.\\nSide-effects: Moderate-certainty evidence shows\\nthat intermittent iron supplementation is probably\\nless commonly associated with nausea than daily iron\\nsupplementation (7 trials, 1034 women; RR:0.60,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Side-effects: Moderate-certainty evidence shows\\nthat intermittent iron supplementation is probably\\nless commonly associated with nausea than daily iron\\nsupplementation (7 trials, 1034 women; RR:0.60,\\n95% CI: 0.37–0.97). However, the evidence on\\nother specific side-effects (constipation, diarrhoea,\\nheartburn or vomiting) or any side-effect is of very\\nlow certainty.\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that intermittent\\niron supplementation may have a similar effect\\nto daily iron supplementation on low birth weight\\n(<2500g) (8 trials, 1898 neonates; RR: 0.82, 95%\\nCI: 0.50–1.22). However, the evidence on preterm\\nbirth and very preterm birth was assessed as\\nvery uncertain. Evidence on the relative effects of\\nintermittent versus daily iron supplementation on\\nneonatal mortality is also very uncertain. Neonatal\\ninfections and SGA outcomes were not included in\\nthe review.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='neonatal mortality is also very uncertain. Neonatal\\ninfections and SGA outcomes were not included in\\nthe review.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nIntermittent iron and folic acid supplementation\\nmight cost a little less than daily iron and folic acid\\nsupplementation due to the lower total weekly dose\\nof iron.\\nEquity\\nIntermittent iron and folic acid supplementation may\\nhave less impact on health inequalities than daily iron\\nand folic acid supplementation, as anaemia is more\\ncommon in disadvantaged populations.\\nAcceptability\\nQualitative evidence suggests that the availability of\\niron supplements may actively encourage women to\\nengage with ANC providers (low confidence in the\\nevidence) (22). However, where there are additional\\ncosts associated with supplementation or where\\nthe supplements may be unavailable (because of\\nresource constraints) women are less likely to engage\\nwith ANC services (high confidence in the evidence).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.2.2: Intermittent oral iron and folic acid supplementation with 120mg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='the supplements may be unavailable (because of\\nresource constraints) women are less likely to engage\\nwith ANC services (high confidence in the evidence).\\nWomen may find intermittent iron supplementation\\nmore acceptable than daily iron supplementation,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='27\\nparticularly if they experience side-effects with daily\\niron supplements.\\nFeasibility\\nIntermittent iron may be more feasible in some low-\\nresource settings if it costs less than daily iron.\\nA.3: Calcium supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='supplementation (1.5–2.0g oral elemental calcium) is recommended for pregnant women to\\nreduce the risk of pre-eclampsia. (Context-specific recommendation)\\nRemarks\\n• This recommendation is consistent with the 2011 WHO recommendations for prevention and treatment of\\npre-eclampsia and eclampsia (57) (strong recommendation, moderate-quality evidence) and supersedes\\nthe WHO recommendation found in the 2013 Guideline: calcium supplementation in pregnant women (38).\\n• Dietary counselling of pregnant women should promote adequate calcium intake through locally\\navailable, calcium-rich foods.\\n• Dividing the dose of calcium may improve acceptability. The suggested scheme for calcium\\nsupplementation is 1.5–2g daily, with the total dose divided into three doses, preferably taken at\\nmealtimes.\\n• Negative interactions between iron and calcium supplements may occur. Therefore, the two nutrients\\nshould preferably be administered several hours apart rather than concomitantly (38).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='mealtimes.\\n• Negative interactions between iron and calcium supplements may occur. Therefore, the two nutrients\\nshould preferably be administered several hours apart rather than concomitantly (38).\\n• As there is no clear evidence on the timing of initiation of calcium supplementation, stakeholders may\\nwish to commence supplementation at the first ANC visit, given the possibility of compliance issues.\\n• T o reach the most vulnerable populations and ensure a timely and continuous supply of supplements,\\nstakeholders may wish to consider task shifting the provision of calcium supplementation in community\\nsettings with poor access to health-care professionals (see Recommendation E.6.1, in section E: Health\\nsystems interventions to improve the utilization and quality of ANC).\\n• The implementation and impact of this recommendation should be monitored at the health service,\\nregional and country levels, based on clearly defined criteria and indicators associated with locally agreed'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='regional and country levels, based on clearly defined criteria and indicators associated with locally agreed\\ntargets. Successes and failures should be evaluated to inform integration of this recommendation into the\\nANC package.\\n• Further WHO guidance on prevention and treatment of pre-eclampsia and eclampsia is\\navailable in the 2011 WHO recommendations (57), available at: http:/ / apps.who.int/iris/\\nbitstream/10665/ 44703/1/9789241548335_eng.pdf\\nSummary of evidence and considerations\\nEffects of calcium supplements compared\\nwith no calcium supplements (for outcomes\\nother than hypertension/ pre-eclampsia)\\n(EBT ableA.3)\\nEvidence on the effects of calcium supplements on\\noutcomes other than hypertension/ pre-eclampsia\\nwas derived from a Cochrane systematic review (58).\\nThe review included data from 23 trials involving\\n18587 pregnant women. The aim of the review was\\nto determine the effect of calcium on maternal and\\nperinatal outcomes other than hypertension. There'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='The review included data from 23 trials involving\\n18587 pregnant women. The aim of the review was\\nto determine the effect of calcium on maternal and\\nperinatal outcomes other than hypertension. There\\nis a separate Cochrane review on the latter (59),\\nwhich has been referenced to support existing WHO\\nrecommendations on calcium supplementation to\\nprevent pre-eclampsia in populations with low dietary\\ncalcium intake (38, 57).\\nIn 14 trials, daily calcium doses ranged from\\n1000mg to 2000mg, and in the remainder it was\\nless than 1000mg. Eleven trials started calcium\\nsupplementation at or after 20 weeks of gestation,\\nfive trials started before 20 weeks, and the rest did\\nnot specify when supplementation was initiated. The\\nprimary outcome of 16 of the trials was pregnancy-\\ninduced hypertension. For outcomes other than\\nhypertension, few trials contributed to each outcome;\\nthis is the evidence presented in this section.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n28'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='hypertension, few trials contributed to each outcome;\\nthis is the evidence presented in this section.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n28\\nMaternal outcomes\\nHigh-certainty evidence shows that calcium\\nsupplementation does not have important effects\\non maternal anaemia (1 trial, 1098 women; RR:\\n1.04, 95% CI: 0.90–1.22) or caesarean section rates\\n(9trials, 7440 women; RR: 0.99, 95% CI: 0.89–1.10).\\nModerate-certainty evidence indicates that calcium\\nsupplementation probably has little or no effect on\\nmaternal mortality (2 trials, 8974 women; RR: 0.29,\\n95% CI: 0.06–1.38) and probably makes little or\\nno difference to the risk of urinary tract infections\\n(3trials, 1743 women; RR: 0.95, 95% CI: 0.69–1.30).\\nLow-certainty evidence suggests that calcium\\nsupplementation may make little or no difference\\nto maternal weight gain (3 trials; MD: –29.46g per\\nweek, 95% CI: –119.80 to 60.89g per week). Maternal\\nsatisfaction was not reported in any of the trials'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='to maternal weight gain (3 trials; MD: –29.46g per\\nweek, 95% CI: –119.80 to 60.89g per week). Maternal\\nsatisfaction was not reported in any of the trials\\nincluded in the Cochrane review.\\nSide-effects: Calcium supplementation makes little\\nor no difference to the risk of “any side-effect”, a\\ncomposite outcome including headache, vomiting,\\nbackache, swelling, vaginal and urinary complaints,\\ndyspepsia and abdominal pain (1 trial, 8312 women;\\nRR: 1.02, 95% CI: 0.93–1.12), and probably makes little\\nor no difference to the risk of urinary stones (3trials,\\n13419 women; RR: 1.11, 95% CI: 0.48–2.54), renal colic\\n(1 trial, 8312 women; RR: 1.67, 95% CI: 0.40–6.99) and\\nimpaired renal function (1 trial, 4589 women; RR: 0.91,\\n95% CI: 0.51–1.64), all assessed as moderate-certainty\\nevidence. Low-certainty evidence suggests that it may\\nhave little or no effect on the risk of gallstones (1 trial,\\n518 women; RR: 1.35, 95% CI: 0.48–3.85).\\nFetal and neonatal outcomes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='evidence. Low-certainty evidence suggests that it may\\nhave little or no effect on the risk of gallstones (1 trial,\\n518 women; RR: 1.35, 95% CI: 0.48–3.85).\\nFetal and neonatal outcomes\\nCalcium supplementation probably has little or no ef-\\nfect on low-birth-weight babies (<2500g), as indicat-\\ned by evidence that was of moderate certainty due to\\ninconsistency (6 trials, 14162 women; RR: 0.93, 95%\\nCI: 0.81–1.07). Low-certainty evidence suggests that it\\nmay have little or no effect on preterm birth before 37\\nweeks of gestation (13 trials, 16139 women; RR: 0.86,\\n95% CI: 0.70–1.05). However, when trials are stratified\\nby dose (<1000mg vs ≥1000mg), moderate-certain-\\nty evidence shows that high-dose calcium supplemen-\\ntation probably reduces preterm birth (12trials, 15479\\nwomen; RR: 0.81, 95% CI: 0.66–0.99).\\nLow-certainty evidence suggests that calcium\\nsupplementation may make little or no difference\\nto perinatal mortality (8 trials, 15785 women; RR:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs']}, page_content='women; RR: 0.81, 95% CI: 0.66–0.99).\\nLow-certainty evidence suggests that calcium\\nsupplementation may make little or no difference\\nto perinatal mortality (8 trials, 15785 women; RR:\\n0.87, 95% CI: 0.72–1.06), and moderate-certainty\\nevidence shows that it probably has little or no effect\\non stillbirths or fetal deaths (6 trials, 15269 women;\\nRR:0.91, 95% CI: 0.72–1.14).\\nAdditional considerations\\nnn In the WHO recommendations for prevention and\\ntreatment of pre-eclampsia and eclampsia (2011), the\\nrecommendation on calcium states: “In areas where\\ndietary calcium intake is low, calcium supplementa-\\ntion during pregnancy (at doses of 1.5–2.0g elemen-\\ntal calcium/ day) is recommended for the prevention\\nof pre-eclampsia in all women, but especially in\\nthose at high risk of developing pre-eclampsia\\n(strong recommendation)” (57). This recommenda-\\ntion is based on moderate-quality evidence showing\\na 64% risk reduction (CI: 35–80%) in pre-eclamp-\\nsia among women or populations with low baseline'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='(strong recommendation)” (57). This recommenda-\\ntion is based on moderate-quality evidence showing\\na 64% risk reduction (CI: 35–80%) in pre-eclamp-\\nsia among women or populations with low baseline\\ndietary calcium intake (57).\\nnn In considering the evidence from the review of\\n“non-hypertensive” effects, the GDG agreed\\nthat the effect of calcium on preterm birth is\\nprobably not distinct from the effect on preventing\\npre-eclampsia, as preterm birth is frequently a\\nconsequence of pre-eclampsia.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p. 15).\\nResources\\nThe GDG noted that the cost of calcium (3×1 tablet\\n600mg per day for 6 months = US$11.50) (27) is\\nrelatively high compared with supplements such as\\niron and folic acid. The weight of the supplement may\\nalso have cost and logistical implications with respect\\nto storage and transport.\\nEquity\\nIn many LMICs, women who are poor, least educated\\nand residing in rural areas have worse pregnancy'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.3: In populations with low dietary calcium intake, daily calcium', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='also have cost and logistical implications with respect\\nto storage and transport.\\nEquity\\nIn many LMICs, women who are poor, least educated\\nand residing in rural areas have worse pregnancy\\noutcomes than do more advantaged women (29).\\nPreterm birth is the most common cause of neonatal\\nmortality, with the majority of deaths occurring in\\nLMICs. Therefore, effective nutritional interventions in\\ndisadvantaged populations aimed at reducing preterm\\nbirth could help to address health inequalities.\\nAcceptability\\nQualitative evidence indicates that women in a variety\\nof settings tend to view ANC as a source of knowledge\\nand information and that they generally appreciate any\\nadvice (including dietary or nutritional) that may lead\\nto a healthy baby and a positive pregnancy experience\\n(high confidence in the evidence) (22). However,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='29\\ncalcium carbonate tablets might be unpalatable\\nto many women, as they can be large and have a\\npowdery texture (59). In addition, this intervention\\nusually involves taking three tablets a day, which\\nsignificantly increasing the number of tablets a woman\\nis required to take on a daily basis (i.e. in addition to\\niron and folic acid). This could have implications for\\nboth acceptability and compliance, which needs to be\\nassessed in a programmatic context.\\nFeasibility\\nIn addition to the cost, providing calcium\\nsupplements may be associated with logistical issues\\n(e.g.supplements are bulky and require adequate\\ntransport and storage to maintain stock in facilities)\\nand other challenges (e.g. forecasting). Qualitative\\nevidence on health-care providers’ views suggests that\\nresource constraints may limit implementation (high\\nconfidence in the evidence) (45).\\nA.4: Vitamin A supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='women in areas where vitamin A deficiency is a severe public health problem, to prevent night\\nblindness. (Context-specific recommendation)\\nRemarks\\n• This recommendation supersedes the previous WHO recommendation found in the 2011 Guideline:\\nvitamin A supplementation in pregnant women (60).\\n• Vitamin A is not recommended to improve maternal and perinatal outcomes.\\n• Vitamin A deficiency is a severe public health problem if 5% or more of women in a population have\\na history of night blindness in their most recent pregnancy in the previous 3–5 years that ended in a\\nlive birth, or if 20% or more of pregnant women have a serum retinol level below 0.70 µmol/L (61).\\nDetermination of vitamin A deficiency as a public health problem involves estimating the prevalence of\\ndeficiency in a population by using specific biochemical and clinical indicators of vitamin A status.\\n• Pregnant women should be encouraged to receive adequate nutrition, which is best achieved through'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='• Pregnant women should be encouraged to receive adequate nutrition, which is best achieved through\\nconsumption of a healthy, balanced diet, and to refer to WHO guidance on healthy eating (41).\\n• In areas where supplementation is indicated for vitamin A deficiency, it can be given daily or weekly.\\nExisting WHO guidance suggests a dose of up to 10 000 IU vitamin A per day, or a weekly dose of up to\\n25 000 IU (60).\\n• A single dose of a vitamin A supplement greater than 25 000 IU is not recommended as its safety\\nis uncertain. Furthermore, a single dose of a vitamin A supplement greater than 25 000 IU might be\\nteratogenic if consumed between day 15 and day 60 from conception (60).\\n• There is no demonstrated benefit from taking vitamin A supplements in populations where habitual daily\\nvitamin A intakes exceed 8000 IU or 2400 µg, and the potential risk of adverse events increases with\\nhigher intakes (above 10000 IU) if supplements are routinely taken by people in these populations (62).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='higher intakes (above 10000 IU) if supplements are routinely taken by people in these populations (62).\\nSummary of evidence and considerations\\nEffects of vitamin A supplements compared with\\nno vitamin A supplements (EB T able A.4)\\nThe evidence was derived from a Cochrane\\nsystematic review of 19 trials of vitamin A (with\\nor without other supplements) compared with\\nno vitamin A (or placebo, or other supplements)\\ninvolving over 310000 women (63). All but one trial\\n(conducted in the United Kingdom) were conducted\\nin LMICs, including Bangladesh, China, Ghana,\\nIndia, Indonesia, Malawi, Nepal, South Africa and\\nthe United Republic of T anzania. Most trials were\\nconducted in vitamin A deficient populations, with\\none study including only women living with HIV. T rials\\nvaried considerably in design, including in the dose\\nand timing of the intervention. T en trials contributed\\ndata to the comparison of vitamin A alone versus\\nplacebo or no treatment.\\nMaternal outcomes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='and timing of the intervention. T en trials contributed\\ndata to the comparison of vitamin A alone versus\\nplacebo or no treatment.\\nMaternal outcomes\\nModerate-certainty evidence shows that vitamin A\\nsupplementation in vitamin A deficient populations\\nduring pregnancy probably reduces maternal anaemia\\n(3 trials, 15649 women; RR: 0.64, 95% CI: 0.43–\\n0.94), but that it probably has little or no effect on  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n30\\nmaternal mortality (4 trials, 101574 women; RR: 0.88,\\n95% CI: 0.65–1.20). Low-certainty evidence on a\\ncomposite outcome for maternal infection (including\\nfever for more than one week at one week postnatally,\\npuerperal fever greater than 38°C, subclinical mastitis\\nand/ or bacterial vaginosis) suggests that vitaminA\\nsupplementation may reduce maternal infection\\n(5trials, 17313 women; average RR: 0.45, 95% CI:\\n0.2–0.99). Side-effects and other maternal ANC\\nguideline outcomes were not reported in the trials.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='supplementation may reduce maternal infection\\n(5trials, 17313 women; average RR: 0.45, 95% CI:\\n0.2–0.99). Side-effects and other maternal ANC\\nguideline outcomes were not reported in the trials.\\nFetal and neonatal outcomes\\nHigh-certainly evidence shows that vitamin A\\nsupplementation makes little or no difference to\\nperinatal mortality (76176 women; RR: 1.01, 95%\\nCI: 0.95–1.07), neonatal mortality (3 trials, 89556\\nneonates; RR: 0.97, 95% CI: 0.90–1.05) or stillbirths\\n(2 trials, 122850 neonates; RR: 1.04, 95% CI:\\n0.98–1.10). Moderate-certainty evidence indicates\\nthat vitamin A supplementation probably has little\\nor no effect on low birth weight (<2500g) (4 trials,\\n14599 neonates; RR: 0. 1.02, 95% CI: 0.89–1.16), and\\nlow-certainty evidence suggests that it may have little\\nor no effect on preterm birth (5 trials, 40137 women;\\nRR: 0.98, 95% CI: 0.94–1.01). Neonatal infections and\\ncongenital anomalies were not reported in the trials.\\nAdditional considerations'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='or no effect on preterm birth (5 trials, 40137 women;\\nRR: 0.98, 95% CI: 0.94–1.01). Neonatal infections and\\ncongenital anomalies were not reported in the trials.\\nAdditional considerations\\nnn Moderate-certainty evidence shows that\\nvitamin A supplementation reduces night\\nblindness in pregnant women living in areas\\nwith a high prevalence of this condition (2 trials,\\napproximately 100000 women; RR: 0.79, 95% CI:\\n0.64–0.98).\\nnn Miscarriage and teratogenicity have been\\nassociated with high vitamin A intake within 60\\ndays of conception; however, a WHO expert group\\nconsultation in 1998 concluded that daily doses of\\nup to 3000µg per day after day 60 are probably\\nsafe, especially in areas where vitamin A deficiency\\nis common (62).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nVitamin A supplements are relatively inexpensive\\nat approximately US$0.30 per woman per month\\n(10000IU per day or 25000IU per week) (27).\\nVitamin A can be given as a daily or weekly'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='Resources\\nVitamin A supplements are relatively inexpensive\\nat approximately US$0.30 per woman per month\\n(10000IU per day or 25000IU per week) (27).\\nVitamin A can be given as a daily or weekly\\nsupplement.\\nEquity\\nEffective nutritional interventions in disadvantaged\\npopulations could help to address health inequalities\\nby improving nutritional status and promoting good\\nmaternal health.\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and a\\npositive pregnancy experience (high confidence in the\\nevidence) (22).\\nFeasibility\\nQualitative evidence shows that where there are\\nadditional costs associated with supplements\\n(high confidence in the evidence) or where the\\nrecommended intervention is unavailable because\\nof resource constraints (low confidence in the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.4: Vitamin A supplementation is only recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='additional costs associated with supplements\\n(high confidence in the evidence) or where the\\nrecommended intervention is unavailable because\\nof resource constraints (low confidence in the\\nevidence), women may be less likely to engage with\\nANC (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='31\\nA.5: Zinc supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.5: Zinc supplementation for pregnant women is only recommended in', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='the context of rigorous research. (Context-specific recommendation – research)\\nRemarks\\n• Many of the included studies were at risk of bias, which influenced the certainty of the review evidence on\\nthe effects of zinc supplementation.\\n• The low-certainty evidence that zinc supplementation may reduce preterm birth warrants further\\ninvestigation, as do the other outcomes for which the evidence is very uncertain (e.g. perinatal mortality,\\nneonatal sepsis), particularly in zinc-deficient populations with no food fortification strategy in place.\\nFurther research should aim to clarify to what extent zinc supplementation competes with iron and/ or\\ncalcium antenatal supplements for absorption. The GDG considered that food fortification may be a more\\ncost–effective strategy and that more evidence is needed on the cost–effectiveness of food fortification\\nstrategies.\\nSummary of evidence and considerations\\nEffects of zinc supplements compared with no\\nzinc supplements (EB T able A.5)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.5: Zinc supplementation for pregnant women is only recommended in', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations']}, page_content='strategies.\\nSummary of evidence and considerations\\nEffects of zinc supplements compared with no\\nzinc supplements (EB T able A.5)\\nThe evidence was derived from a Cochrane review\\nthat included 21 trials involving more than 17000\\nwomen (64). Most studies were conducted in\\nLMICs, including Bangladesh, Chile, China, Egypt,\\nGhana, Indonesia, the Islamic Republic of Iran, Nepal,\\nPakistan, Peru and South Africa. Six trials were\\nconducted in Denmark, the United Kingdom and\\nthe USA. Daily zinc supplementation was compared\\nwith no intervention or placebo. There was a wide\\nvariation among trials in terms of trial size (range:\\n56–4926 women), zinc dosage (range: 5–90 mg per\\nday), nutritional and zinc status at trial entry, initiation\\nand duration of supplementation (starting before\\nconception in one trial, first or second trimester in the\\nmajority, or after 26 weeks of gestation in two trials,\\nuntil delivery), and compliance with treatment.\\nMaternal outcomes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.5: Zinc supplementation for pregnant women is only recommended in', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='conception in one trial, first or second trimester in the\\nmajority, or after 26 weeks of gestation in two trials,\\nuntil delivery), and compliance with treatment.\\nMaternal outcomes\\nModerate-certainty evidence indicates that zinc\\nsupplementation probably makes little or no\\ndifference to the risk of any maternal infections\\n(3trials, 1185 women; RR: 1.06; 95% CI: 0.74–1.53).\\nThe evidence on caesarean section, pre-eclampsia\\nand side-effects (maternal taste and smell\\ndysfunction) is of very low certainty, and the review\\ndid not include anaemia, maternal mortality or\\nmaternal satisfaction as review outcomes.\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that zinc\\nsupplementation probably makes little or no\\ndifference to the risk of having SGA (8 trials, 4252\\nnewborns; RR: 1.02; 95% CI: 0.94–1.11) or low-birth-\\nweight neonates (14 trials, 5643 neonates; RR: 0.93,\\n95% CI: 0.78–1.12). However, low-certainty evidence\\nsuggests that zinc supplementation may reduce'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.5: Zinc supplementation for pregnant women is only recommended in', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='weight neonates (14 trials, 5643 neonates; RR: 0.93,\\n95% CI: 0.78–1.12). However, low-certainty evidence\\nsuggests that zinc supplementation may reduce\\npreterm birth (16 trials, 7637 women; RR: 0.86, 95%\\nCI: 0.76–0.97), particularly in women with presumed\\nlow zinc intake or poor nutrition (14 trials, 7099\\nwomen; RR: 0.87, 95% CI: 0.77–0.98).\\nLow-certainty evidence suggests that zinc sup ple-\\nment  ation may ha ve little or no effect on congenital\\nanomalies (6 trials, 1240 newborns; RR: 0.67, 95% CI:\\n0.33–1.34) and macrosomia (defined in the review as\\n“high birth weight”; 5 trials, 2837 neonates; RR: 1.00,\\n95% CI: 0.84–1.18). Evidence on perinatal mortality\\nand neonatal sepsis is of very low certainty.\\nAdditional considerations\\nnn The trials were clinically heterogeneous, therefore\\nit is unclear what dose and timing of zinc\\nsupplementation, if any, might lead to a possible\\nreduction in preterm birth.\\nnn There is little or no evidence on side-effects of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.5: Zinc supplementation for pregnant women is only recommended in', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='it is unclear what dose and timing of zinc\\nsupplementation, if any, might lead to a possible\\nreduction in preterm birth.\\nnn There is little or no evidence on side-effects of\\nzinc supplementation. In addition, it is unclear to\\nwhat extent zinc might compete with iron and/ or\\ncalcium for absorption. Maternal anaemia was not\\nevaluated in the review.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nZinc costs approximately US$1.30 for 100 tablets of\\n20mg (i.e. less than US$3.00 for a 6-month supply\\nbased on a daily dose of 20mg) (27).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n32\\nA.6: Multiple micronutrient (MMN) supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.6: Multiple micronutrient supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='pregnant women to improve maternal and perinatal outcomes. (Not recommended)\\nRemarks\\n• There is some evidence of additional benefit of MMN supplements containing 13–15 different\\nmicronutrients (including iron and folic acid) over iron and folic acid supplements alone, but there is\\nalso some evidence of risk, and some important gaps in the evidence. Although the GDG agreed that\\noverall there was insufficient evidence to warrant a recommendation, the group agreed that policy-\\nmakers in populations with a high prevalence of nutritional deficiencies might consider the benefits of\\nMMN supplements on maternal health to outweigh the disadvantages, and may choose to give MMN\\nsupplements that include iron and folic acid.\\n• More research is needed to determine which micronutrients improve maternal and perinatal outcomes,\\nand how these can be optimally combined into a single supplement.\\nEquity\\nEffective interventions to improve maternal nutrition\\nin disadvantaged populations could help to address'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.6: Multiple micronutrient supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='and how these can be optimally combined into a single supplement.\\nEquity\\nEffective interventions to improve maternal nutrition\\nin disadvantaged populations could help to address\\nhealth inequalities. A WHO report shows that\\ninequalities in neonatal, infant and child mortality,\\nas well as stunting prevalence, can be demonstrated\\naccording to economic status, education and place of\\nresidence in LMICs. The prevalence of stunting may\\nbe a good indicator of zinc deficiency in LMICs (39).\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and they generally\\nappreciate any professional advice (including dietary\\nor nutritional) that may lead to a healthy baby and a\\npositive pregnancy experience (high confidence in the\\nevidence) (22).\\nFeasibility\\nIt may be more feasible to fortify food with zinc\\nrather than to provide zinc as a single supplement,\\nparticularly in settings with a high prevalence of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.6: Multiple micronutrient supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='evidence) (22).\\nFeasibility\\nIt may be more feasible to fortify food with zinc\\nrather than to provide zinc as a single supplement,\\nparticularly in settings with a high prevalence of\\nstunting in children.\\nSummary of evidence and considerations\\nEffects of MMN supplements (with 13–15\\ndifferent MMNs) compared with iron and folic\\nacid supplements (EB T able A.6)\\nThe evidence was derived from a Cochrane review\\nthat included 17 trials involving 137791 women\\n(65); however, only 14 trials contributed data to\\nthis comparison. These 14 trials were all conducted\\nin LMICs: Bangladesh (2), Burkina Faso (1), China\\n(2), Guinea-Bissau (1), Indonesia (2), Mexico (1),\\nNepal (2), Niger (1), Pakistan (1) and Zimbabwe\\n(1). The trials compared supplements containing\\n13–15 micronutrients (including iron and folic acid)\\nwith iron and folic acid supplements only, except\\nfor one trial in which the control arm comprised\\niron only. Nine trials evaluated supplements with'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.6: Multiple micronutrient supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='with iron and folic acid supplements only, except\\nfor one trial in which the control arm comprised\\niron only. Nine trials evaluated supplements with\\n15micronutrients, including vitamin A, B1, B2, B6,\\nB12, C, D and E, copper, folic acid, iodine, iron, niacin,\\nselenium and zinc, with exactly the same dosages as\\nthe UN international MMN preparation (UNIMMAP)\\n(66). Evidence from these UNIMMAP trials was\\nsynthesized together with trials of 13 and 14 MMN\\nsupplements, and in separate subgroup analyses\\nusing the random effects method. Subgroup analyses\\nwere performed according to the dose of iron (60 mg\\nor 30 mg) used in the control arm. Analyses can be\\nfound in the Web supplement (EB T able A.6).\\nMaternal outcomes\\nHigh-certainty evidence shows that MMN\\nsupplementation has a similar effect to iron and folic\\nacid supplements only (standard care) on maternal\\nanaemia (5 trials; RR: 0.98, 95% CI: 0.85–1.13).\\nCompared to iron and folic acid only, moderate-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.6: Multiple micronutrient supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='acid supplements only (standard care) on maternal\\nanaemia (5 trials; RR: 0.98, 95% CI: 0.85–1.13).\\nCompared to iron and folic acid only, moderate-\\ncertainty evidence indicates that MMN supplements\\nprobably make little or no difference to caesarean\\nsection rates (4 trials; RR: 1.03, 95% CI: 0.75–1.43)\\nand low-certainty evidence suggests that they may\\nhave little or no effect on maternal mortality (3 trials;\\nRR: 0.97, 95% CI: 0.63–1.48). There was no evidence\\nrelating to maternal satisfaction or side-effects.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='33\\nFetal and neonatal outcomes\\nHigh-certainty evidence shows that MMN\\nsupplementation reduces the risk of having a low-\\nbirth-weight neonate compared with iron and folic\\nacid supplements only (14 trials; RR: 0.88, 95%\\nCI: 0.85–0.91), but moderate-certainty evidence\\nindicates that it probably makes little or no difference\\nto the risk of having an SGA neonate (13 trials; RR:\\n0.98, 95% CI: 0.96–1.00). High-certainty evidence\\nshows that MMN supplements make little or no\\ndifference to preterm birth rates (14 trials; RR: 0.95,\\n95% CI: 0.88–1.03). Moderate-certainty evidence\\nshows that MMN supplements probably make little\\nor no difference to perinatal mortality (11 trials; RR:\\n1.00, 95% CI: 0.85–1.19), neonatal mortality (11\\ntrials; RR: 0.99, 95% CI: 0.90–1.08) or stillbirths (14\\ntrials; RR: 0.97, 95% CI: 0.86–1.09). The evidence\\non congenital anomalies is of low certainty and\\ninconclusive (1 trial, 1200 women; RR: 0.99, 95% CI:\\n0.14–7.00).\\nHigh-certainty evidence from analyses restricted'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'discusses_normal_variations': True}, page_content='on congenital anomalies is of low certainty and\\ninconclusive (1 trial, 1200 women; RR: 0.99, 95% CI:\\n0.14–7.00).\\nHigh-certainty evidence from analyses restricted\\nto trials of UNIMMAP only are consistent with the\\noverall findings, with the exception that it shows that\\nUNIMMAP reduces the risk of having an SGA neonate\\ncompared with iron and folic acid supplements only\\n(8trials; RR: 0.85, 95% CI: 0.77–0.94).\\nSubgroup analyses according to the iron dose in\\nthe control group are generally consistent with the\\noverall findings. However, for the subgroup of studies\\nthat compared MMN supplements to 60mg iron\\nand 400µg folic acid, a harmful effect of MMNs on\\nneonatal mortality cannot be excluded (6trials; RR:\\n1.22, 95% CI: 0.95–1.57).\\nAdditional considerations\\nnn A separate review of the effects of MMN\\nsupplementation during pregnancy on child\\nhealth benefits pooled data from nine of the trials\\nincluded in the Cochrane review and found no\\nevidence of beneficial effects on child mortality,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='supplementation during pregnancy on child\\nhealth benefits pooled data from nine of the trials\\nincluded in the Cochrane review and found no\\nevidence of beneficial effects on child mortality,\\ngrowth or cognitive function (67).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p. 15).\\nResources\\nUNIMMAP supplements cost about US$3 per\\nwoman per pregnancy, whereas iron and folic acid\\nsupplementation costs less than US$1 (27).\\nEquity\\nEffective interventions to improve maternal nutrition\\nin disadvantaged populations could help to address\\nmaternal and neonatal health inequalities by\\nimproving maternal health and preventing illness\\nrelated to nutritional deficiencies. However, the cost\\ndifference between MMNs and iron and folic acid\\nsupplementation may have an impact on affordability\\nfor disadvantaged populations, especially those\\nin remote and rural areas, because they are often\\nexpected to pay for visits and supplements in addition'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition'], 'discusses_normal_variations': True}, page_content='for disadvantaged populations, especially those\\nin remote and rural areas, because they are often\\nexpected to pay for visits and supplements in addition\\nto bearing greater transport costs due to the greater\\ndistance to travel to ANC services (68).\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings tend to view ANC as a source\\nof knowledge and information and that they\\ngenerally appreciate any advice (including dietary\\nor nutritional) that may lead to a healthy baby and\\na positive pregnancy experience (high confidence\\nin the evidence) (22). However, it has been noted\\nthat the lack of appropriate training on MMN\\nsupplementation has been reported by health-care\\nproviders as a major gap (68).\\nFeasibility\\nFrom the demand side, MMN supplementation\\nshould be as feasible as iron and folic acid\\nsupplementation if supplements are free and\\navailable, and it will face the same challenges in terms\\nof compliance. However, on the supply side, there'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='should be as feasible as iron and folic acid\\nsupplementation if supplements are free and\\navailable, and it will face the same challenges in terms\\nof compliance. However, on the supply side, there\\nmay be several barriers to overcome, such as changes\\nin regulatory norms and policies (e.g. tariffs, labelling,\\nimports, government oversight, etc.), ensuring\\nsustainable MMN production (local or imported),\\nproduct availability and quality. Great variability in\\nfeasibility across countries and within them would be\\nexpected (68).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n34\\nA.7: Vitamin B6 (pyridoxine) supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.7: Vitamin B6 (pyridoxine) supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='pregnant women to improve maternal and perinatal outcomes. (Not recommended)\\nRemarks\\n• Pregnant women should be encouraged to receive adequate nutrition, which is best achieved through\\nconsumption of a healthy, balanced diet, and to refer to guidelines on healthy eating (41).\\n• The GDG agreed that there is insufficient evidence on the benefits and harms, if any, of routine vitamin B6\\nsupplementation in pregnancy. However, research on the effects of routine vitamin B6 supplementation\\nfor pregnant women on maternal and perinatal outcomes is not considered a research priority.\\nSummary of evidence and considerations\\nEffects of vitamin B6 supplements compared\\nwith no vitamin B6 supplements (EB T able A.7)\\nThe evidence was derived from a Cochrane review\\nthat included four trials involving approximately\\n1646 pregnant women (69). Studies were conducted\\nin HICs between 1960 and 1984. Vitamin B6\\n(pyridoxine) given intramuscularly as a single dose\\n(100mg) or orally as capsules or lozenges (2.6mg'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.7: Vitamin B6 (pyridoxine) supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='1646 pregnant women (69). Studies were conducted\\nin HICs between 1960 and 1984. Vitamin B6\\n(pyridoxine) given intramuscularly as a single dose\\n(100mg) or orally as capsules or lozenges (2.6mg\\nto 20mg per day) was compared with placebo or no\\ntreatment. Only two out of four studies contributed\\ndata to this comparison.\\nMaternal outcomes\\nLow-certainty evidence suggests that oral pyridoxine\\nsupplements may have little or no effect on pre-\\neclampsia (2 trials, 1197 women; RR: 1.71, 95% CI:\\n0.85–3.45). No other maternal outcomes relevant to\\nthe ANC guideline were reported in the review.\\nFetal and neonatal outcomes\\nT rials contributed no data on low birth weight,\\npreterm birth or other ANC guideline outcomes.\\nMean birth weight was evaluated in one small trial\\nbut the evidence is very uncertain. There was no\\nevidence on congenital anomalies.\\nAdditional considerations\\nnn Moderate-certainty evidence shows that vitamin\\nB6 probably provides some relief for nausea'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.7: Vitamin B6 (pyridoxine) supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='evidence on congenital anomalies.\\nAdditional considerations\\nnn Moderate-certainty evidence shows that vitamin\\nB6 probably provides some relief for nausea\\nduring pregnancy (see evidence summary for\\nRecommendation D.1, in section D: Interventions\\nfor common physiological symptoms).\\nnn Vitamin B6 deficiency alone is uncommon; it\\nmostly occurs in combination with deficiencies of\\nother B vitamins (70).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nAs a single supplement, vitamin B6 (pyridoxine\\nhydrochloride tablets) can cost about US$2.50 for\\n90×10 mg tablets (71).\\nEquity\\nEffective interventions to improve maternal nutrition\\nin disadvantaged populations could help to address\\nhealth inequalities.\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings tend to view ANC as a source of\\nknowledge and information and that they generally\\nappreciate any professional advice (including dietary'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.7: Vitamin B6 (pyridoxine) supplementation is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition'], 'discusses_normal_variations': True}, page_content='variety of settings tend to view ANC as a source of\\nknowledge and information and that they generally\\nappreciate any professional advice (including dietary\\nor nutritional) that may lead to a healthy baby and a\\npositive pregnancy experience (high confidence in the\\nevidence) (22).\\nFeasibility\\nQualitative evidence shows that where there are\\nadditional costs associated with supplements\\n(high confidence in the evidence) or where the\\nrecommended intervention is unavailable because\\nof resource constraints (low confidence in the\\nevidence), women may be less likely to engage with\\nANC services (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='35\\nA.8: Vitamin E and C supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='women to improve maternal and perinatal outcomes. (Not recommended)\\nRemarks\\n• The GDG noted that vitamin E and C combined supplements were evaluated mainly in the context of\\npreventing pre-eclampsia. Vitamin C is important for improving the bioavailability of oral iron, but this\\nwas not considered within the context of the Cochrane reviews. In addition, low-certainty evidence on\\nvitamin C alone suggests that it may prevent prelabour rupture of membranes (PROM). Therefore, the\\nGDG agreed that future research should consider vitamin C supplements separately from vitamin E and C\\nsupplements.\\n• Pregnant women should be encouraged to receive adequate nutrition, which is best achieved through\\nconsumption of a healthy, balanced diet, and to refer to guidelines on healthy eating (41). It is relatively\\neasy to consume sufficient quantities of vitamin C from food sources.\\nSummary of evidence and considerations\\nEffects of vitamin E and C supplements\\ncompared with no vitamin E and C supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='easy to consume sufficient quantities of vitamin C from food sources.\\nSummary of evidence and considerations\\nEffects of vitamin E and C supplements\\ncompared with no vitamin E and C supplements\\n(EB T ableA.8)\\nThe evidence was derived from two Cochrane\\nsystematic reviews that included 17 trials conducted in\\nlow-, middle- and high-income countries contributed\\ndata (72, 73). The trials assessed vitamin E plus\\nvitamin C combined supplements compared with\\nplacebo or no vitamin E and C supplements. The most\\ncommonly used dose of vitaminE was 400IU daily\\n(15 trials) and vitamin C was 1000mg daily (13trials).\\nThe primary outcome of 14 trials was pre-eclampsia\\nand nine of the trials recruited women at “high” or\\n“increased” risk of pre-eclampsia. Most of the trials\\ncommenced supplementation in the second trimester.\\nMaternal outcomes\\nModerate-certainty evidence shows that vitamin E\\nand C combined supplements probably have little or\\nno effect on the risk of developing pre-eclampsia (14'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='Maternal outcomes\\nModerate-certainty evidence shows that vitamin E\\nand C combined supplements probably have little or\\nno effect on the risk of developing pre-eclampsia (14\\nstudies, 20878 women; RR: 0.91 95% CI: 0.79–1.06)\\nand eclampsia (8 trials, 19471 women; RR: 1.67, 95%\\nCI: 0.82–3.41). Moderate-certainty evidence also\\nshows that vitamin E and C supplements probably\\nhave little or no effect on maternal mortality (7 trials,\\n17120 women; RR: 0.60, 95% CI: 0.14–2.51) and\\ncaesarean section (6 trials, 15297 women; RR: 1.02,\\n95% CI: 0.97–1.07).\\nSide-effects: High-certainty evidence shows that\\nvitamin E and C supplementation is associated with\\nan increased risk of abdominal pain during pregnancy\\n(1 trial, 1877 women; RR: 1.66, 95% CI: 1.16–2.37;\\nabsolute effect of 32 more per 1000 women).\\nFetal and neonatal outcomes\\nHigh-certainty evidence indicates that vitamin E and\\nC supplementation does not have an important effect\\non SGA (11 trials, 20202 women; RR: 0.98, 95% CI:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='Fetal and neonatal outcomes\\nHigh-certainty evidence indicates that vitamin E and\\nC supplementation does not have an important effect\\non SGA (11 trials, 20202 women; RR: 0.98, 95% CI:\\n0.91–1.06). Moderate-certainty evidence shows that\\nvitamin E and C supplements probably have little or\\nno effect on preterm birth (11 trials, 20565 neonates;\\nRR: 0.98, 95% CI: 0.88–1.09), neonatal infections\\n(5trials, 13324 neonates; RR: 1.10, 95% CI: 0.73–1.67)\\nand congenital anomalies (4 trials, 5511 neonates;\\nRR: 1.16, 95% CI: 0.83–1.63).\\nAdditional considerations\\nnn The high-certainty evidence on abdominal pain is\\nderived from a large, well designed trial in which\\nabdominal pain occurred in 7.9% of women in the\\nvitamin E and C supplement group and 4.8% of\\nwomen in the placebo group.\\nnn Despite the certainty of these effects of vitamin E\\nand C supplementation, the biological explanations\\nfor these adverse effects are not established.\\nnn Moderate-certainty evidence indicates that'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='nn Despite the certainty of these effects of vitamin E\\nand C supplementation, the biological explanations\\nfor these adverse effects are not established.\\nnn Moderate-certainty evidence indicates that\\nvitamin E and C supplements probably reduce the\\nrisk of placental abruption (7 trials, 14922 women;\\nRR: 0.64, 95% CI: 0.44–0.93; absolute effect of 3\\nfewer abruptions per 1000) but make little or no\\ndifference to the risk of antepartum haemorrhage\\nfrom any cause (2 trials, 12256 women; RR: 1.25,\\n95% CI: 0.85–1.82).\\nnn High-certainty evidence shows vitamin E and\\nC supplementation increases PROM at term\\n(37 weeks of gestation or more) (2 trials, 2504\\nwomen; RR: 1.77, 95% CI: 1.37–2.28; absolute effect\\nof 52 more cases of PROM per 1000).\\nnn The trial contributing the most data on PROM was\\nstopped early, based on their PROM data, when  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n36\\nonly a quarter of the planned sample (10000\\nwomen) had been accrued.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='stopped early, based on their PROM data, when  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n36\\nonly a quarter of the planned sample (10000\\nwomen) had been accrued.\\nnn Low- to moderate-certainty evidence on vitamin\\nC only suggests that vitamin C alone (in doses\\nranging from 100mg to 1000 mg) may reduce\\npreterm PROM (5 studies, 1282 women; RR: 0.66,\\n95% CI: 0.48–0.91) and term PROM (1 study, 170\\nwomen; RR: 0.55, 95% CI: 0.32–0.94).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nVitamin E (tocopherol) 400 IU daily can cost about\\nUS$8 for a month’s supply. Costs of vitaminC vary\\nwidely; chewable vitamin C tablets (1000 mg) can\\ncost about US$3 for a month’s supply (74).\\nEquity\\nEffective interventions to reduce pre-eclampsia\\ncould help to address health inequalities because\\nmortality from pre-eclampsia mainly occurs among\\ndisadvantaged populations.\\nAcceptability\\nQualitative evidence suggests that women in a'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.8: Vitamin E and C supplementation is not recommended for pregnant', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition'], 'discusses_normal_variations': True}, page_content='could help to address health inequalities because\\nmortality from pre-eclampsia mainly occurs among\\ndisadvantaged populations.\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings tend to view ANC as a source of\\nknowledge and information and that they generally\\nappreciate any professional advice (including dietary\\nor nutritional) that may lead to a healthy baby and a\\npositive pregnancy experience (high confidence in the\\nevidence) (22).\\nFeasibility\\nQualitative evidence shows that where there are\\nadditional costs associated with supplements\\n(high confidence in the evidence) or where the\\nrecommended intervention is unavailable because\\nof resource constraints (low confidence in the\\nevidence), women may be less likely to engage with\\nANC services (45).\\nA.9: Vitamin D supplements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.9: Vitamin D supplementation is not recommended for pregnant women', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='to improve maternal and perinatal outcomes. (Not recommended)\\nRemarks\\n• This recommendation supersedes the previous WHO recommendation found in the 2012 Guideline:\\nvitamin D supplementation in pregnant women (75).\\n• Pregnant women should be advised that sunlight is the most important source of vitamin D. The amount\\nof time needed in the sun is not known and depends on many variables, such as the amount of skin\\nexposed, the time of day, latitude and season, skin pigmentation (darker skin pigments synthesize less\\nvitamin D than lighter pigments) and sunscreen use (75).\\n• Pregnant women should be encouraged to receive adequate nutrition, which is best achieved through\\nconsumption of a healthy, balanced diet, and to refer to guidelines on healthy eating (41).\\n• For pregnant women with documented vitamin D deficiency, vitamin D supplements may be given at the\\ncurrent recommended nutrient intake (RNI) of 200 IU (5 µg) per day.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.9: Vitamin D supplementation is not recommended for pregnant women', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='• For pregnant women with documented vitamin D deficiency, vitamin D supplements may be given at the\\ncurrent recommended nutrient intake (RNI) of 200 IU (5 µg) per day.\\n• According to the Cochrane review, there are 23 ongoing or unpublished studies on vitamin D\\nsupplementation in pregnancy (76). Evidence from these trials should help to clarify the current\\nuncertainties regarding vitamin D effects, particularly the effect on preterm birth, and any other\\nassociated benefits or harms of vitamin D when combined with other vitamins and minerals, particularly\\ncalcium.\\nSummary of evidence and considerations\\nThe evidence was derived from a Cochrane\\nsystematic review that included 15 trials assessing\\n2833 women (76). Nine trials were conducted in\\nLMICs (Bangladesh, Brazil, China, India and the\\nIslamic Republic of Iran) and six were conducted in\\nHICs (France, New Zealand, Russia and the United\\nKingdom). Sample sizes ranged from 40 to 400\\nwomen. Nine trials compared the effects of vitamin D'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.9: Vitamin D supplementation is not recommended for pregnant women', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Islamic Republic of Iran) and six were conducted in\\nHICs (France, New Zealand, Russia and the United\\nKingdom). Sample sizes ranged from 40 to 400\\nwomen. Nine trials compared the effects of vitamin D\\nalone versus placebo or no supplementation, and six\\ntrials compared the effects of vitamin D plus calcium'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='37\\nversus placebo or no supplementation. The dose and\\nregimen of vitamin D varied widely among the trials.\\na) Effects of vitamin D supplements alone versus\\nplacebo or no supplement (EB T able A.9)\\nNine trials contributed data to this comparison. Six\\ntrials evaluated daily vitamin D with daily doses\\nranging from 400IU to 2000IU. T wo trials evaluated\\na single dose of 200000 IU given at about 28\\nweeks of gestation, one trial evaluated a weekly\\ndose of 35000IU during the third trimester, and one\\ntrial administered 1–4 vitamin D doses (60000–\\n480000IU in total) depending on the participants’\\nbaseline serum 25-hydroxy-vitamin D levels.\\nMaternal outcomes\\nThe evidence on pre-eclampsia, GDM, maternal\\nmortality, caesarean section and side-effects is very\\nuncertain (i.e. all findings were assessed as very low-\\ncertainty evidence).\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that vitaminD\\nsupplementation may reduce low-birth-weight\\nneonates (3 trials, 493 women; RR: 0.40, 95%'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='certainty evidence).\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that vitaminD\\nsupplementation may reduce low-birth-weight\\nneonates (3 trials, 493 women; RR: 0.40, 95%\\nCI: 0.24–0.67) and preterm birth (<37 weeks of\\ngestation) (3 trials, 477 women; RR: 0.36, 95%\\nCI: 0.14–0.93), but may have little or no effect on\\nneonatal deaths (2 trials, 282 women, RR: 0.27; 95%\\nCI: 0.04–1.67) and stillbirths (3 trials, 540 women;\\nRR: 0.35, 95% CI: 0.06–1.99).\\nb) Effects of vitamin D plus calcium supplements\\nversus placebo or no supplement (EB T able A.9)\\nSix trials contributed data to this comparison. Vitamin\\nD doses ranged from 200IU to 1250IU daily and\\ncalcium doses ranged from 375mg to 1250mg daily.\\nMaternal outcomes\\nModerate-certainty evidence shows that vitamin\\nD plus calcium probably reduces pre-eclampsia\\n(3trials, 798 women; RR: 0.51; 95% CI: 0.32–0.80),\\nbut low-certainty evidence suggest that it may have\\nlittle or no effect on GDM (1 trial, 54 women, 1 event;'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='(3trials, 798 women; RR: 0.51; 95% CI: 0.32–0.80),\\nbut low-certainty evidence suggest that it may have\\nlittle or no effect on GDM (1 trial, 54 women, 1 event;\\nRR: 0.43, 95% CI: 0.05–3.45).\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that vitamin\\nD plus calcium probably increases preterm birth\\n(<37weeks of gestation) (3 trials, 798 women;\\nRR:1.57, 95% CI: 1.02–2.43). Low-certainty evidence\\nsuggests that vitamin D plus calcium has little or no\\neffect on neonatal mortality (1 trial, 660 women; RR:\\n0.20, 95% CI: 0.01–4.14).\\nAdditional considerations\\nnn Due to the limited evidence currently available to\\ndirectly assess the benefits and harms of the use of\\nvitaminD supplementation alone in pregnancy for\\nimproving maternal and infant health outcomes,\\nthe use of this intervention during pregnancy as\\npart of routine ANC is not recommended (75).\\nnn The moderate-certainty evidence showing that\\nadding vitaminD to calcium supplementation'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='the use of this intervention during pregnancy as\\npart of routine ANC is not recommended (75).\\nnn The moderate-certainty evidence showing that\\nadding vitaminD to calcium supplementation\\nprobably increases preterm birth is of concern and\\nthis potential harm needs further investigation.\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nVitamin D supplements can cost from US$2 per\\nmonth, depending on the dose prescribed (74).\\nEquity\\nEffective interventions to improve maternal nutrition\\nin disadvantaged populations could help to address\\nhealth inequalities.\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings tend to view ANC as a source of\\nknowledge and information and that they generally\\nappreciate any professional advice (including dietary\\nor nutritional) that may lead to a healthy baby and a\\npositive pregnancy experience (high confidence in the\\nevidence) (22).\\nFeasibility\\nQualitative evidence shows that where there are'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='or nutritional) that may lead to a healthy baby and a\\npositive pregnancy experience (high confidence in the\\nevidence) (22).\\nFeasibility\\nQualitative evidence shows that where there are\\nadditional costs associated with supplements\\n(high confidence in the evidence) or where the\\nrecommended intervention is unavailable because\\nof resource constraints (low confidence in the\\nevidence), women may be less likely to engage with\\nANC services (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n38\\nA.10: Restricting caffeine intake'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.10: For pregnant women with high daily caffeine intake (more than', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='300mg per day), a lowering daily caffeine intake during pregnancy is recommended to reduce the\\nrisk of pregnancy loss and low-birth-weight neonates. (Context-specific recommendation)\\nRemarks\\n• Pregnant women should be informed that a high daily caffeine intake (> 300 mg per day) is probably\\nassociated with a higher risk of pregnancy loss and low birth weight.\\n• Caffeine is a stimulant found in tea, coffee, soft-drinks, chocolate, kola nuts and some over-the-counter\\nmedicines. Coffee is probably the most common source of high caffeine intake. A cup of instant coffee\\ncan contain about 60 mg of caffeine; however, some commercially brewed coffee brands contain more\\nthan 150 mg of caffeine per serving.\\n• Caffeine-containing teas (black tea and green tea) and soft drinks (colas and iced tea) usually contain\\nless than 50mg per 250 mL serving.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.10: For pregnant women with high daily caffeine intake (more than', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='than 150 mg of caffeine per serving.\\n• Caffeine-containing teas (black tea and green tea) and soft drinks (colas and iced tea) usually contain\\nless than 50mg per 250 mL serving.\\na This includes any product, beverage or food containing caffeine (i.e. brewed coffee, tea, cola-type soft drinks, caffeinated energy drinks, chocolate, caffeine\\ntablets).\\nSummary of evidence and considerations\\na) Effects of decaffeinated coffee versus\\ncaffeinated coffee (RCT evidence) (EB\\nT ableA.10a)\\nSome evidence on the effects of caffeine intake\\nwas derived from a Cochrane review that included\\ntwo RCT s (40). Only one of the trials, conducted in\\nDenmark, contributed evidence. In this trial, 1207\\npregnant women drinking more than three cups of\\ncoffee a day were randomized to receive instant\\ndecaffeinated coffee (intervention group) versus\\ninstant caffeinated coffee (control group) in order\\nto assess the effect of caffeine reduction during\\npregnancy. In this trial, a cup of caffeinated coffee'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.10: For pregnant women with high daily caffeine intake (more than', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='instant caffeinated coffee (control group) in order\\nto assess the effect of caffeine reduction during\\npregnancy. In this trial, a cup of caffeinated coffee\\nwas estimated to contain 65 mg caffeine. Other\\nsources of caffeine, such as cola, tea and chocolate\\nwere not restricted. Mean daily caffeine intake in\\nthe decaffeinated coffee group was 117 mg per day\\n(interquartile range [IQR]: 56–228 mg) compared\\nwith 317 mg per day (IQR: 229–461 mg) in the\\ncaffeinated coffee group.\\nMaternal outcomes\\nNone of the maternal outcomes addressed in the\\nANC guideline were reported in the review.\\nFetal and neonatal outcomes\\nLow-certainty evidence from one trial shows that\\nrestricting caffeine intake (replacing caffeinated\\ncoffee with decaffeinated coffee) may have little or\\nno effect on SGA (1150 neonates; RR: 0.97, 95% CI:\\n0.57–1.64), mean birth weight (1197 neonates; MD:\\n20.00, 95% CI: –48.68 to 88.68) and preterm birth\\n(1153 neonates; RR: 0.81, 95% CI: 0.48–1.37).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.10: For pregnant women with high daily caffeine intake (more than', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='no effect on SGA (1150 neonates; RR: 0.97, 95% CI:\\n0.57–1.64), mean birth weight (1197 neonates; MD:\\n20.00, 95% CI: –48.68 to 88.68) and preterm birth\\n(1153 neonates; RR: 0.81, 95% CI: 0.48–1.37).\\nNo data were available on congenital anomalies or\\nperinatal mortality.\\nb) Effects of high caffeine intake versus\\nmoderate, low or no caffeine intake (non-\\nrandomized study evidence) (EB T able A.10b)\\nThe GDG considered the evidence from RCT s to be\\ninsufficient to make a recommendation on caffeine\\nrestriction and additional evidence from reviews of\\nnon-randomized studies (NRSs) was thus evaluated.\\nT wo NRS reviews asked the question, “Is there an\\nassociation between maternal caffeine intake and the\\nrisk of low birth weight?” (77, 78), and two reviews\\nasked the question “Is there an association between\\nmaternal caffeine intake and the risk of pregnancy\\nloss?” (79, 80). In these reviews, low caffeine intake\\nwas defined as less than 150mg caffeine per day,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.10: For pregnant women with high daily caffeine intake (more than', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='maternal caffeine intake and the risk of pregnancy\\nloss?” (79, 80). In these reviews, low caffeine intake\\nwas defined as less than 150mg caffeine per day,\\nand high caffeine intake was defined as more than\\n300mg or more than 350mg per day. All four reviews\\nadjusted data for smoking and other variables, and\\nperformed dose–response meta-analyses.\\nFetal and neonatal outcomes: low birth weight\\nModerate-certainty evidence from one review shows\\nthat high caffeine intake (more than 300mg) is\\nprobably associated with a greater risk of low birth\\nweight than low or no caffeine intake (12 studies;\\nodds ratio [OR]: 1.38, 95% CI: 1.10–1.73) (78). Very\\nlow- to moderate-certainty evidence from the other\\nreview was stratified according to dose and shows\\nthat very low caffeine intake may be associated with\\nfewer low-birth-weight neonates than low (5 studies;\\nRR: 1.13, 95% CI: 1.06–1.21), moderate (7 studies; RR:\\n1.38, 95% CI: 1.18–1.62) or high caffeine intake (8'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION A.10: For pregnant women with high daily caffeine intake (more than', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='fewer low-birth-weight neonates than low (5 studies;\\nRR: 1.13, 95% CI: 1.06–1.21), moderate (7 studies; RR:\\n1.38, 95% CI: 1.18–1.62) or high caffeine intake (8\\nstudies; RR: 1.60, 95% CI: 1.24–2.08) (77).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='39\\nFetal and neonatal outcomes: stillbirths\\nThe reviews reported “pregnancy loss”, a composite\\noutcome comprising stillbirths and miscarriages.\\nModerate-certainty evidence from one review (80)\\nshows that any caffeine intake probably increases\\npregnancy loss compared with controls (no\\nexposure) (18 studies; OR: 1.32, 95% CI: 1.24–1.40).\\nHowever, pregnancy loss is probably more common\\namong pregnant women with moderate caffeine\\nintake (18 studies; OR: 1.28, 95% CI: 1.16–1.42) and\\nhigh caffeine intake (17 studies, OR: 1.60, 1.46–1.76),\\nbut not more common with low caffeine intake\\n(13studies; OR: 1.04, 95% CI: 0.94–1.15) compared\\nwith controls. This NRS evidence was upgraded to\\n“moderate-certainty” due to the presence of a dose–\\nresponse relationship. A dose–response relationship\\nwas also observed in the other review but the\\nevidence was less certain (79).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nCommunicating with pregnant women about'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs'], 'discusses_normal_variations': True}, page_content='was also observed in the other review but the\\nevidence was less certain (79).\\nValues\\nPlease see “Women’s values” in section 3.A:\\nBackground (p.15).\\nResources\\nCommunicating with pregnant women about\\nthe probable risks of high caffeine intake during\\npregnancy is a relatively low-cost intervention.\\nEquity\\nInterventions to restrict coffee intake during\\npregnancy are unlikely to impact health inequalities\\nas coffee consumption tends to be associated\\nwith affluence. However, it is unclear whether the\\nconsumption of caffeine through other sources might\\nbe a problem for pregnant women in disadvantaged\\npopulations.\\nAcceptability\\nQualitative evidence indicates that women in a\\nvariety of settings generally appreciate any advice\\n(including dietary or nutritional) that may lead to a\\nhealthy baby and a positive pregnancy experience\\n(high confidence in the evidence) (22). Evidence\\non health-care providers’ views on ANC suggests\\nthat they may be keen to offer general health-care'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='healthy baby and a positive pregnancy experience\\n(high confidence in the evidence) (22). Evidence\\non health-care providers’ views on ANC suggests\\nthat they may be keen to offer general health-care\\nadvice and specific pregnancy-related information\\n(low confidence in the evidence) but they sometimes\\nfeel they do not have the appropriate training and\\nlack the resources and time to deliver the service in\\nthe informative, supportive and caring manner that\\nwomen want (high confidence in the evidence) (45).\\nFeasibility\\nA lack of suitably trained staff to deliver health\\npromotion interventions may limit implementation\\n(high confidence in the evidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n40'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['3 Evidence and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='B.1: Maternal assessment\\nBackground\\nHypertensive disorders of pregnancy are important\\ncauses of maternal and perinatal morbidity and\\nmortality, with approximately a quarter of maternal\\ndeaths and near misses estimated to be due to pre-\\neclampsia and eclampsia (9). Antenatal screening\\nfor pre-eclampsia is an essential part of good ANC.\\nIt is routinely performed by measuring maternal\\nblood pressure and checking for proteinuria at each\\nANC contact and, upon detection of pre-eclampsia,\\nspecific management is required to prevent eclampsia\\nand other poor maternal and perinatal outcomes\\n(57). The GDG did not evaluate evidence or make a\\nrecommendation on this procedure, therefore, which\\nit considers to be an essential component of Good\\nClinical Practice in ANC.\\nAs part of the ANC guideline development,\\nspecifically in relation to maternal assessment,\\nthe GDG considered evidence and other relevant\\ninformation on interventions to detect the following\\nconditions in pregnancy:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['3 Evidence and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='specifically in relation to maternal assessment,\\nthe GDG considered evidence and other relevant\\ninformation on interventions to detect the following\\nconditions in pregnancy:\\nnn Anaemia: Defined as a blood haemoglobin (Hb)\\nconcentration below 110g/L, anaemia is the\\nworld’s second leading cause of disability, and one\\nof the most serious global public health problems,\\nwith the global prevalence of anaemia among\\npregnant women at about 38% (33). Clinical\\nassessment (inspection of the conjunctiva for\\npallor) is a common method of detecting anaemia\\nbut has been shown to be quite inaccurate.\\nIn HICs, performing a full blood count, which\\nquantifies the blood Hb level, is part of routine\\nANC (81). However, this and other available\\ntests may be expensive, complex or impractical\\nfor use in rural or LMIC settings. A low-cost and\\nreliable method of detecting anaemia is therefore\\nneeded for places with no or limited access\\nto laboratory facilities. WHO developed the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['3 Evidence and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='for use in rural or LMIC settings. A low-cost and\\nreliable method of detecting anaemia is therefore\\nneeded for places with no or limited access\\nto laboratory facilities. WHO developed the\\nhaemoglobin colour scale, a low-cost method that\\nis performed by placing a drop of undiluted blood\\non specially made chromatography paper and\\nmatching it against a range of colours representing\\ndifferent Hb values in 20g/L increments (82).\\nWith haemoglobinometer tests, undiluted blood\\nis placed directly into a microcuvette, which\\nis inserted into the haemoglobinometer (or\\nphotometer) to produce a reading (82).\\nnn Asymptomatic bacteriuria (ASB): ASB is a\\ncommon urinary tract condition that is associated\\nwith an increased risk of urinary tract infections\\n(cystitis and pyelonephritis) in pregnant women.\\nEscherichia coli is associated with up to 80%\\nof isolates; other pathogens include Klebsiella\\nspecies, Proteus mirabilis and group B streptococcus\\n(GBS) (83). Methods for diagnosing ASB include'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['3 Evidence and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Escherichia coli is associated with up to 80%\\nof isolates; other pathogens include Klebsiella\\nspecies, Proteus mirabilis and group B streptococcus\\n(GBS) (83). Methods for diagnosing ASB include\\nmidstream urine culture (the gold standard), Gram\\nstain and urine dipstick tests. A urine culture can\\ntake up to seven days to get a result, with the\\nthreshold for diagnosis usually defined as the\\npresence of 105 colony-forming units (cfu)/ mL of\\na single organism (84). The Gram stain test uses\\ncolour stains (crystal violet and safrininO) to\\nexaggerate and distinguish between Gram-positive\\n(purple) and Gram-negative (red) organisms on a\\nprepared glass slide. Urine dipsticks test for nitrites,\\nwhich are not found in normal urine, and leucocytes,\\nwhich are identified by a reaction with leucocyte\\nesterase, to identify the presence of bacteria and\\npus in the urine, respectively. ASB is associated\\nwith an increased risk of preterm birth; once\\ndetected it is, therefore, usually actively managed'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['3 Evidence and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='esterase, to identify the presence of bacteria and\\npus in the urine, respectively. ASB is associated\\nwith an increased risk of preterm birth; once\\ndetected it is, therefore, usually actively managed\\nwith antibiotics (see also Recommendation C.1, in\\nsectionC: Preventive measures).\\nnn Intimate partner violence (IPV): IPV, defined as\\nany behaviour within an intimate relationship that\\ncauses physical, psychological or sexual harm to\\nthose in the relationship, is now recognized as a\\nglobal public health issue. Worldwide, almost one\\nthird of all women who have been in a relationship\\nhave experienced physical and/ or sexual violence\\nby their intimate partner (85). Emotional abuse\\n(being humiliated, insulted, intimidated and\\nsubjected to controlling behaviours such as not\\nbeing permitted to see friends or family) also\\nadversely impacts the health of individuals (85).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='41\\nIPV is associated with chronic problems in women,\\nincluding poor reproductive health (e.g. a history of\\nSTIs including HIV, unintended pregnancy, abortion\\nand/ or miscarriage), depression, substance use\\nand other mental health problems (85). During\\npregnancy, IPV is a potentially preventable risk\\nfactor for various adverse outcomes, including\\nmaternal and fetal death. Clinical enquiry about IPV\\naims to identify women who have experienced or\\nare experiencing IPV, in order to offer interventions\\nleading to improved outcomes. Some governments\\nand professional organizations recommend\\nscreening all women for IPV rather than asking only\\nwomen with symptoms (86).\\nIn addition to GDG recommendations on the\\nabove, recommendations on diagnosing gestational\\ndiabetes mellitus (GDM) and screening for tobacco\\nsmoking, alcohol and substance abuse, TB and HIV\\ninfection have been integrated into this chapter from\\nthe respective existing WHO guidance on these\\nconditions.\\nWomen’s values'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='smoking, alcohol and substance abuse, TB and HIV\\ninfection have been integrated into this chapter from\\nthe respective existing WHO guidance on these\\nconditions.\\nWomen’s values\\nA scoping review of what women want from ANC\\nand what outcomes they value informed the ANC\\nguideline (13). Evidence showed that women from\\nhigh-, medium- and low-resource settings valued\\nhaving a positive pregnancy experience. Within the\\ncontext of maternal and fetal assessment, women\\nvalued the opportunity to receive screening and\\ntests to optimize their health and that of their baby\\nas long as individual procedures were explained to\\nthem clearly and administered by knowledgeable,\\nsupportive and respectful health-care practitioners\\n(high confidence in the evidence).\\nB.1.1: Anaemia'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='anaemia during pregnancy. In settings where full blood count testing is not available, on-\\nsite haemoglobin testing with a haemoglobinometer is recommended over the use of the\\nhaemoglobin colour scale as the method for diagnosing anaemia in pregnancy.\\n(Context-specific recommendation)\\nRemarks\\n• The GDG agreed that the high recurrent costs of Hb testing with haemoglobinometers might reduce the\\nfeasibility of this method in some low-resource settings, in which case the WHO haemoglobin colour\\nscale method may be used.\\n• Other low-technology on-site methods for detecting anaemia need development and/ or investigation.\\nSummary of evidence and considerations\\nT est accuracy of on-site Hb testing with\\nhaemoglobinometer and haemoglobin colour\\nscale (HCS) methods to detect anaemia (EB\\nT able B.1.1)\\nThe evidence was derived from a test accuracy\\nreview conducted to support the ANC guideline\\n(81). Only one study (671 women) contributed data\\n(87). The study, conducted in Malawi, assessed'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='The evidence was derived from a test accuracy\\nreview conducted to support the ANC guideline\\n(81). Only one study (671 women) contributed data\\n(87). The study, conducted in Malawi, assessed\\nthe test accuracy of on-site Hb testing with a\\nhaemoglobinometer (HemoCue®) and the HCS\\nmethod in comparison to a full blood count test\\nperformed by an electronic counter (Coulter counter),\\nthe reference standard.\\nModerate-certainty evidence shows that the\\nsensitivity and specificity of the haemoglobinometer\\ntest in detecting anaemia (Hb<110 g/L) are\\napproximately 0.85 (95% CI: 0.79–0.90) and\\n0.80 (95% CI: 0.76–0.83), respectively, while the\\nsensitivity and specificity of the HCS method are\\nlower at approximately 0.75 (95% CI: 0.71–0.80) and\\n0.47 (95% CI: 0.41–0.53), respectively.\\nFor severe anaemia (defined in the study as\\nHb<60g/L), moderate-certainty evidence\\nshows that the sensitivity and specificity of the\\nhaemoglobinometer test are approximately 0.83'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='For severe anaemia (defined in the study as\\nHb<60g/L), moderate-certainty evidence\\nshows that the sensitivity and specificity of the\\nhaemoglobinometer test are approximately 0.83\\n(95% CI: 0.44–0.97) and 0.99 (95% CI: 0.98–1.00),\\nrespectively, while for the HCS method they are\\napproximately 0.50 (95% CI: 0.15–0.85) and 0.98\\n(95% CI: 0.97–0.99), respectively.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n42\\nAdditional considerations\\nnn In absolute numbers, the data mean that in\\nsettings with an anaemia prevalence of 38%, the\\nhaemoglobinometer test will probably miss about\\n57 anaemic women (95% CI: 38–80) out of every\\n1000 women tested, whereas the HCS method\\nwill probably miss about 95 anaemic women (95%\\nCI: 76–110) out of every 1000 women tested. For\\npopulations with a severe anaemia prevalence of\\n5%, the haemoglobinometer test will probably\\nmiss about nine women with severe anaemia\\n(95% CI: 2–27) out of every 1000 women tested,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='populations with a severe anaemia prevalence of\\n5%, the haemoglobinometer test will probably\\nmiss about nine women with severe anaemia\\n(95% CI: 2–27) out of every 1000 women tested,\\nwhereas the HCS method will probably miss about\\n25 women with severe anaemia (95% CI: 3–43)\\nout of every 1000 women tested.\\nnn The main limitation of the evidence is the\\nlow number of women identified with severe\\nanaemia, which affects the precision of the\\nestimates. However, the evidence suggests that\\nthe haemoglobinometer test is probably more\\naccurate than the HCS method. As there are no\\ndirect comparisons in test accuracy studies and, as\\nconfidence intervals for sensitivity and specificity of\\nthe two methods overlap, there is some uncertainty\\nabout the relative accuracy of these tests.\\nnn The review also evaluated the test accuracy of\\nclinical assessment (4 studies, 1853 women),\\ngiving a sensitivity for clinical assessment of 0.64\\n(95% CI: 22–94) and a specificity of 0.63 (95% CI:'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='nn The review also evaluated the test accuracy of\\nclinical assessment (4 studies, 1853 women),\\ngiving a sensitivity for clinical assessment of 0.64\\n(95% CI: 22–94) and a specificity of 0.63 (95% CI:\\n23–91) for detecting anaemia (Hb <110g/L). Thus,\\nthe HCS method might be more sensitive but less\\nspecific than clinical assessment.\\nnn In settings where iron supplementation is routinely\\nused by pregnant women, the consequence of\\nmissing women with severe anaemia is more\\nserious than that of missing women with mild or\\nmoderate anaemia, as women with severe anaemia\\nusually require additional treatment. Therefore,\\nthe accuracy of on-site Hb tests to detect severe\\nanaemia in pregnancy is probably more important\\nthan the ability to detect Hb below 110g/L.\\nnn A study of various Hb testing methods in Malawi\\nfound the haemoglobinometer method to be the\\nmost user-friendly method (82).\\nValues\\nPlease see “Women’s values” in section 3.B.1:\\nMaternal assessment: Background (p.41).\\nResources'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='found the haemoglobinometer method to be the\\nmost user-friendly method (82).\\nValues\\nPlease see “Women’s values” in section 3.B.1:\\nMaternal assessment: Background (p.41).\\nResources\\nAny health-care provider can perform both the\\nhaemoglobinometer and HCS methods after\\nminimal training. The haemoglobinometer and HCS\\nmethods have been estimated to cost approximately\\nUS$0.75 and US$0.12 per test, respectively (82).\\nBoth methods require needles for finger pricks,\\ncotton balls, gloves and Sterets® skin cleansing\\nswabs; however, the higher costs associated with\\nhaemoglobinometer tests are mainly due to supplies\\n(cuvettes and controls), equipment costs and\\nmaintenance.\\nEquity\\nThe highest prevalence of maternal anaemia occurs\\nin Africa and South-East Asia, where parasitic\\ninfections are major contributory factors (33).\\nAnaemia increases perinatal risks for mothers and\\nnewborns and contributes to preventable mortality.\\nAccurate, low-cost, simple-to-use tests to detect'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'discusses_normal_variations': True}, page_content='infections are major contributory factors (33).\\nAnaemia increases perinatal risks for mothers and\\nnewborns and contributes to preventable mortality.\\nAccurate, low-cost, simple-to-use tests to detect\\nanaemia might help to address health inequalities\\nby improving the detection and subsequent\\nmanagement of women with anaemia, particularly\\nsevere anaemia, in low-resource settings.\\nAcceptability\\nQualitative evidence from a variety of settings\\nindicates that women generally appreciate clinical\\ntests that support their well-being during pregnancy\\n(moderate confidence in the evidence) (22).\\nHowever, evidence from LMICs indicates that where\\nthere are likely to be additional costs associated with\\ntests, or where the recommended interventions are\\nunavailable because of resource constraints, women\\nmay be less likely to engage with ANC services (high\\nconfidence in the evidence).\\nFeasibility\\nQualitative evidence from providers in various LMICs'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.1: Full blood count testing is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='unavailable because of resource constraints, women\\nmay be less likely to engage with ANC services (high\\nconfidence in the evidence).\\nFeasibility\\nQualitative evidence from providers in various LMICs\\nindicates that a lack of resources, both in terms of the\\navailability of the diagnostic equipment and potential\\ntreatments, as well as the lack of suitably trained staff\\nto deliver the service, may limit implementation of\\nrecommended interventions (high confidence in the\\nevidence) (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='43\\nB.1.2: Asymptomatic bacteriuria (ASB)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='asymptomatic bacteriuria (ASB) in pregnancy. In settings where urine culture is not available,\\non-site midstream urine Gram-staining is recommended over the use of dipstick tests as the\\nmethod for diagnosing ASB in pregnancy. (Context-specific recommendation)\\nRemarks\\n• This recommendation should be considered alongside Recommendation C.1 on ASB treatment (see\\nsection C: Preventive measures).\\n• The GDG agreed that the higher resource costs associated with Gram stain testing might reduce the\\nfeasibility of this method in low-resource settings, in which case, dipstick tests may be used.\\n• The GDG agreed that ASB is a priority research topic, given its association with preterm birth and the\\nuncertainty around urine testing and treatment in settings with different levels of ASB prevalence.\\nSpecifically, studies are needed that compare on-site testing and treatment versus testing plus\\nconfirmation of test with treatment on confirmatory culture, to explore health and other relevant'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Specifically, studies are needed that compare on-site testing and treatment versus testing plus\\nconfirmation of test with treatment on confirmatory culture, to explore health and other relevant\\noutcomes, including acceptability, feasibility and antimicrobial resistance. In addition, better on-site tests\\nneed to be developed to improve accuracy and feasibility of testing and to reduce overtreatment of ASB.\\nResearch is also needed to determine the prevalence of ASB at which targeted testing and treatment\\nrather than universal testing and treatment might be effective.\\nSummary of evidence and considerations\\nT est accuracy of on-site urine Gram staining and\\ndipsticks to detect ASB (EB T ableB.1.2)\\nThe evidence was derived from a test accuracy\\nreview of on-site urine tests conducted to support\\nthe ANC guideline (88). Four studies (1904 pregnant\\nwomen) contributed data on urine Gram staining and\\neight studies (5690 pregnant women) contributed\\ndata on urine dipsticks. Most of the studies were'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='women) contributed data on urine Gram staining and\\neight studies (5690 pregnant women) contributed\\ndata on urine dipsticks. Most of the studies were\\nconducted in LMICs. The average prevalence of ASB\\nin the studies was 8%. A Gram stain was positive\\nif one or more bacteria were detected per oil-\\nimmersed field, and a dipstick test was positive if it\\ndetected either nitrites or leucocytes. The reference\\nstandard used was urine culture with a threshold of\\n105 cfu/ mL.\\nHowever, the certainty of the evidence on the\\naccuracy of both Gram stain tests and dipstick tests\\nis very low, with pooled sensitivity and specificity of\\nthe Gram stain test estimated at 0.86 (95% CI: 0.80–\\n0.91) and 0.97 (95% CI: 0.93–0.99), respectively, and\\npooled sensitivity and specificity for urine dipsticks\\nestimated at 0.73 (95% CI: 0.59–0.83) and 0.89\\n(95% CI: 0.79–0.94), respectively. A positive nitrite\\ntest alone on dipsticks was found to be less sensitive\\nbut more specific than when urine leucocytes were'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='(95% CI: 0.79–0.94), respectively. A positive nitrite\\ntest alone on dipsticks was found to be less sensitive\\nbut more specific than when urine leucocytes were\\nalso considered.\\nAdditional considerations\\nnn A high level of accuracy in detecting ASB is\\nimportant to avoid treating women unnecessarily,\\nparticularly in view of increasing antimicrobial\\nresistance. Based on the uncertain evidence above,\\nand assuming a prevalence of ASB of 9%, there\\nwould be 18 and 118 false-positive tests per 1000\\nwomen tested with Gram stain and dipstick tests,\\nrespectively. This suggests that, in settings where\\npregnant women are treated for ASB, dipstick\\ndiagnosis of ASB might lead to many women\\nreceiving unnecessary treatment.\\nnn Dipstick tests are multi-test strips that, in addition\\nto testing for nitrites and leucocytes, may also\\ninclude detection of urine protein and glucose.\\nHowever, the accuracy of dipsticks to detect\\nconditions associated with proteinuria (pre-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='to testing for nitrites and leucocytes, may also\\ninclude detection of urine protein and glucose.\\nHowever, the accuracy of dipsticks to detect\\nconditions associated with proteinuria (pre-\\neclampsia) and glycosuria (diabetes mellitus) is\\nconsidered to be low.\\nValues\\nPlease see “Women’s values” in section 3.B.1:\\nMaternal assessment: Background (p.41).\\nResources\\nDipsticks are relatively low cost compared with the\\nGram stain test, as the latter requires trained staff\\nand laboratory equipment and supplies (microscope,\\nglass slides, reagents, Bunsen burner or slide\\nwarmer). Gram stain tests take longer to perform and  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n44\\nto produce results than urine dipstick tests (10–30\\nminutes vs 60 seconds).\\nEquity\\nPreterm birth is the leading cause of neonatal death\\nworldwide, with most deaths occurring in LMICs.\\nTimely diagnosis and treatment of risk factors\\nassociated with preterm birth might therefore help to'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'discusses_normal_variations': True}, page_content='worldwide, with most deaths occurring in LMICs.\\nTimely diagnosis and treatment of risk factors\\nassociated with preterm birth might therefore help to\\naddress health inequalities.\\nAcceptability\\nQualitative evidence from a range of settings\\nsuggests that women view ANC as a source of\\nknowledge, information and clinical expertise and\\nthat they generally appreciate the tests and advice\\nthey are offered (high confidence in the evidence)\\n(22). However, engagement with ANC services may\\nbe limited if tests and procedures are not explained\\nproperly or when women feel their beliefs and\\ntraditions are being overlooked or ignored by health-\\ncare professionals. In addition, if the Gram stain\\ntest is associated with long waiting times at ANC\\nor having to return for test results, this may be less\\nacceptable to women, as it might have additional\\ncost and convenience implications for them (high\\nconfidence in the evidence). Health professionals are'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.2: Midstream urine culture is the recommended method for diagnosing', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='acceptable to women, as it might have additional\\ncost and convenience implications for them (high\\nconfidence in the evidence). Health professionals are\\nlikely to prefer the dipstick test as it is associated with\\nless effort (no need to label samples for laboratory\\nassessment, perform tests or schedule follow-up\\nvisits to provide the results) and might provide\\nadditional information pertaining to other conditions\\n(pre-eclampsia and diabetes mellitus) (high\\nconfidence in the evidence).\\nFeasibility\\nQualitative evidence indicates that, in some LMIC\\nsettings, the lack of diagnostic equipment at ANC\\nfacilities discourages women from attending, and\\nthat providers often do not have the diagnostic\\nequipment, supplies or skills to perform tests (high\\nconfidence in the evidence) (45). Therefore, urine\\ndipstick tests, which are cheaper and easy to perform,\\nmight be more feasible in low-resource settings.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='45\\na Minimum requir ements are: a protocol/ standard operating procedure; training on how to ask about IPV, and on how to provide the minimum response or\\nbeyond; private setting; confidentiality ensured; system for referral in place; and time to allow for appropriate disclosure.\\nB.1.3: Intimate partner violence (IPV)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='(IPV) should be strongly considered at antenatal care visits when assessing conditions that\\nmay be caused or complicated by IPV in order to improve clinical diagnosis and subsequent\\ncare, where there is the capacity to provide a supportive response (including referral\\nwhere appropriate) and where the WHO minimum requirements are met.a (Context-specific\\nrecommendation)\\nRemarks\\n• This recommendation is consistent with the 2013 publication Responding to intimate partner violence and\\nsexual violence against women: WHO clinical and policy guidelines (86). The evidence on clinical enquiry was\\nindirect (strong recommendation) and the evidence on universal screening was judged as being of low to\\nmoderate quality (conditional recommendation).\\n• “Universal screening” or “routine enquiry” (i.e. asking all women at all health-care encounters) about\\nIPV is not recommended. However, the WHO guidelines identify ANC as a setting where routine enquiry'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'contains_warnings': True}, page_content='IPV is not recommended. However, the WHO guidelines identify ANC as a setting where routine enquiry\\ncould be implemented if providers are well trained on a first-line response and minimum requirements are\\nmet (86).\\n• Examples of conditions during pregnancy that may be caused or complicated by IPV include (86):\\n– traumatic injury, particularly if repeated and with vague or implausible explanations;\\n– intrusive partner or husband present at consultations;\\n– adverse reproductive outcomes, including multiple unintended pregnancies and/ or terminations, delay\\nin seeking ANC, adverse birth outcomes, repeated STIs;\\n– unexplained or repeated genitourinary symptoms;\\n– symptoms of depression and anxiety;\\n– alcohol and other substance use;\\n– self-harm, suicidality, symptoms of depression and anxiety.\\n• The GDG agreed that, despite a paucity of evidence, it was important to make a recommendation due to'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='– alcohol and other substance use;\\n– self-harm, suicidality, symptoms of depression and anxiety.\\n• The GDG agreed that, despite a paucity of evidence, it was important to make a recommendation due to\\nthe high prevalence and importance of IPV. ANC provides an opportunity to enquire about IPV among\\nwomen for whom barriers to accessing health care may exist, and also allows for the possibility for\\nfollow-up during ANC with appropriate supportive interventions, such as counselling and empowerment\\ninterventions. However, the evidence on benefits and potential harms of clinical enquiry and subsequent\\ninterventions is lacking or uncertain.\\n• A minimum condition for health-care providers to ask women about violence is that it must be safe to do\\nso (i.e. the partner is not present) and that identification of IPV is followed by an appropriate response.\\nIn addition, providers must be trained to ask questions in the correct way and to respond appropriately to\\nwomen who disclose violence (86).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations']}, page_content='In addition, providers must be trained to ask questions in the correct way and to respond appropriately to\\nwomen who disclose violence (86).\\n• Research on IPV is needed to answer the following questions:\\n– Which are the most effective strategies for identifying, preventing and managing IPV in pregnancy?\\n– Does asking routinely about violence impact on ANC attendance?\\n– Can interventions targeted at partners of pregnant women prevent IPV?\\n• Detailed guidance on responding to IPV and sexual violence against women can be found in the\\n2013 WHO clinical and policy guidelines (86), available at: http:/ /www.who.int/ reproductivehealth/\\npublications/violence/9789241548595/ en/  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n46\\nSummary of evidence and considerations\\nEffects of universal screening to detect IPV\\ncompared with no screening (usual care) (EB\\nT ableB.1.3)\\nThe evidence on screening for IPV was derived from'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs', 'normal_variations'], 'contains_warnings': True}, page_content='46\\nSummary of evidence and considerations\\nEffects of universal screening to detect IPV\\ncompared with no screening (usual care) (EB\\nT ableB.1.3)\\nThe evidence on screening for IPV was derived from\\na Cochrane review that included two trials conducted\\nin urban ANC settings in HICs (Canada and the\\nUSA), involving 663 pregnant women (89). In one\\ntrial, 410 women were randomized before 26 weeks\\nof gestation to a computer-based abuse assessment\\nscreening tool, with and without a provider cue\\nsheet (giving the results of the assessment to the\\nprovider), prior to ANC consultation with a health-\\ncare provider. In the other trial (a cluster-RCT),\\nproviders administered a face-to-face screening\\ntool that screened for 15 risk factors, including IPV,\\nto women between 12 and 30 weeks of gestation in\\nthe intervention clusters, while women in the control\\nclusters received usual ANC.\\nLow-certainty evidence from the review suggests\\nthat abuse assessment screening may identify more'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations']}, page_content='the intervention clusters, while women in the control\\nclusters received usual ANC.\\nLow-certainty evidence from the review suggests\\nthat abuse assessment screening may identify more\\npregnant women with IPV than those identified\\nthrough usual ANC (2 trials, 663 women; OR: 4.28,\\n95% CI: 1.77–10.36).\\nAdditional considerations\\nnn The review also pooled data on IPV screening\\nversus no IPV screening from other health-care\\nsettings (involving pregnant and non-pregnant\\nwomen), and the pooled effect estimate favoured\\nscreening to detect IPV (7 trials, 4393 women; OR:\\n2.35, 95% CI: 1.53–3.59).\\nnn Another Cochrane review evaluated interventions\\nto prevent or reduce IPV (90). Uncertain evidence\\nfrom one study suggests that pregnant women\\nwho receive IPV interventions (e.g. multiple\\ncounselling sessions) to prevent or reduce IPV\\nmay report fewer episodes of partner violence\\nduring pregnancy and the postpartum period\\n(306 women; RR: 0.62, 95% CI: 0.43–0.88), but'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='counselling sessions) to prevent or reduce IPV\\nmay report fewer episodes of partner violence\\nduring pregnancy and the postpartum period\\n(306 women; RR: 0.62, 95% CI: 0.43–0.88), but\\nevidence on this and other outcomes is largely\\ninconclusive.\\nnn Most of the review evidence comes from HICs\\nwhere the prevalence of women experiencing\\nIPV in the previous 12 months ranged from 3%\\nto 6%. However, in many settings, particularly\\nthose where economic and sociocultural factors\\nfoster a culture more permissive of violence\\nagainst women, the lifetime prevalence is higher\\nthan 30%. Notably, the prevalence among young\\nwomen (under 20 years old) approaches 30%,\\nsuggesting that violence commonly starts early in\\nwomen’s relationships (85).\\nnn Severe IPV in pregnancy (such as being beaten up,\\nchoked or burnt on purpose, being threatened with\\nor having a weapon used against her, and sexual\\nviolence) (85) is more common among women\\nwho are in relationships that have also been'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='choked or burnt on purpose, being threatened with\\nor having a weapon used against her, and sexual\\nviolence) (85) is more common among women\\nwho are in relationships that have also been\\nseverely abusive outside of pregnancy.\\nnn WHO’s clinical handbook on Health care for women\\nsubjected to intimate partner violence or sexual\\nviolence (2014) provides practical guidance on how\\nto respond (91).\\nValues\\nPlease see “Women’s values” in section 3.B.1:\\nMaternal assessment: Background (p.41).\\nResources\\nClinical enquiry about IPV can be conducted face-\\nto-face or by providing women with a written or\\ncomputer-based questionnaire. Although the costs\\nof implementing these methods can vary, they might\\nbe relatively low. Subsequent management and IPV\\nsupport linked to the screening intervention, however,\\nrequires sophisticated training and can therefore have\\nsignificant cost implications. The GDG considered\\nthat training and resources in low-resource settings'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='requires sophisticated training and can therefore have\\nsignificant cost implications. The GDG considered\\nthat training and resources in low-resource settings\\nmight be best targeted towards first response to IPV\\nrather than IPV screening.\\nEquity\\nIPV is highly prevalent in many LMICs and among\\ndisadvantaged populations (92, 93). Effective\\ninterventions to enquire about IPV in disadvantaged\\npopulations might help to identify those at risk of IPV-\\nrelated adverse outcomes, and facilitate the provision\\nof appropriate supportive interventions leading to\\nimproved equity. However, more evidence is needed.\\nAcceptability\\nQualitative evidence from a range of settings on\\nwomen’s views of ANC suggests that pregnant\\nwomen would like to be seen by a kind and\\nsupportive health-care provider who has the time\\nto discuss issues of this nature in a private setting\\n(high confidence in the evidence) (22). However,\\nevidence from LMICs suggests that women may be'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.3: Clinical enquiry about the possibility of intimate partner violence', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='supportive health-care provider who has the time\\nto discuss issues of this nature in a private setting\\n(high confidence in the evidence) (22). However,\\nevidence from LMICs suggests that women may be\\nunlikely to respond favourably to cursory exchanges\\nof information with providers who they sometimes\\nperceive to be hurried, uncaring and occasionally\\nabusive (high confidence in the evidence). In addition,\\nsome women may not appreciate enquiries of this\\nnature, particularly those living in male-dominated,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='47\\npatriarchal societies, where women’s financial\\ndependence on their husbands may influence their\\nwillingness to discuss IPV, especially if the health\\nprofessional is male (22).\\nFrom the providers’ perspective, qualitative evidence\\nmainly from HICs suggests that providers often\\nfind it difficult to enquire about for IPV for the\\nfollowing reasons: they do not feel they have enough\\nknowledge, training or time to discuss IPV in a\\nsensitive manner; the presence of the partner acts as\\na barrier; they may have experienced IPV themselves;\\nand they lack knowledge and guidance about the\\navailability of additional support services (counselling,\\nsocial work, etc.) (high confidence in the evidence).\\nProviders highlight the midwife-led continuity of\\ncare (MLCC) model as a way of achieving a positive,\\ntrusting and empathetic relationship with pregnant\\nwomen (moderate confidence in the evidence) (see\\nRecommendationE.2, in section E: Health systems'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='care (MLCC) model as a way of achieving a positive,\\ntrusting and empathetic relationship with pregnant\\nwomen (moderate confidence in the evidence) (see\\nRecommendationE.2, in section E: Health systems\\ninterventions to improve the utilization and quality of\\nANC).\\nFeasibility\\nFollowing IPV clinical enquiry, complex, multifaceted,\\nculturally specific interventions are required to\\nmanage IPV, which could be challenging in many low-\\nresource settings. However, emerging evidence from\\nHICs shows that medium-duration empowerment\\ncounselling and advocacy/ support, including a safety\\ncomponent, offered by trained health-care providers\\ncould be beneficial, and the feasibility of such\\ninterventions in LMIC settings needs investigation\\n(86).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n48\\nB.1.4: Gestational diabetes mellitus (GDM)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B1.4: Hyperglycaemia first detected at any time during pregnancy should', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='be classified as either gestational diabetes mellitus (GDM) or diabetes mellitus in pregnancy,\\naccording to WHO criteria.a (Recommended)\\nRemarks\\n• This recommendation has been integrated from the 2013 WHO publication Diagnostic criteria and\\nclassification of hyperglycaemia first detected in pregnancy (the strength of the recommendation and the\\nquality of the evidence were not stated) (94).\\n• WHO currently does not have a recommendation on whether or how to screen for GDM, and screening\\nstrategies for GDM are considered a priority area for research, particularly in LMICs.\\n• Diabetes mellitus in pregnancy differs from GDM in that the hyperglycaemia is more severe and does not\\nresolve after pregnancy as it does with GDM.\\n• A systematic review of cohort studies shows that women with hyperglycaemia (diabetes mellitus\\nand GDM) detected during pregnancy are at greater risk of adverse pregnancy outcomes, including'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B1.4: Hyperglycaemia first detected at any time during pregnancy should', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='• A systematic review of cohort studies shows that women with hyperglycaemia (diabetes mellitus\\nand GDM) detected during pregnancy are at greater risk of adverse pregnancy outcomes, including\\nmacrosomia, pre-eclampsia/hypertensive disorders in pregnancy, and shoulder dystocia. T reatment\\nof GDM, which usually involves a stepped approach of lifestyle changes (nutritional counselling and\\nexercise) followed by oral blood-glucose-lowering agents or insulin if necessary, is effective in reducing\\nthese poor outcomes (94).\\n• There are many uncertainties about the cost–effectiveness of different screening strategies, the\\nprevalence of GDM and diabetes mellitus according to the 2013 criteria in diverse populations, and the\\nimpact of earlier diagnosis on pregnancy outcomes (see Chapter 5: Research implications) (94).\\n• The usual window for diagnosing GDM is between 24 and 28 weeks of gestation. Risk factor screening'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B1.4: Hyperglycaemia first detected at any time during pregnancy should', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='impact of earlier diagnosis on pregnancy outcomes (see Chapter 5: Research implications) (94).\\n• The usual window for diagnosing GDM is between 24 and 28 weeks of gestation. Risk factor screening\\nis used in some settings as a strategy to determine the need for a 2-hour 75 g oral glucose tolerance test\\n(OGTT). These include a BMI of greater than 30 kg/ m2, previous GDM, previous macrosomia, family\\nhistory of diabetes mellitus, and ethnicity with a high prevalence of diabetes mellitus (95). In addition,\\nglycosuria on dipstick testing (2+ or above on one occasion, or 1+ on two or more occasions) may indicate\\nundiagnosed GDM and, if this is observed, performing an OGTT could be considered (95).\\n• The management approach for women classified with diabetes mellitus in pregnancy (i.e. severe\\nhyperglycaemia first detected in pregnancy) usually differs from the approach for women with GDM,\\nparticularly when diagnosed early in pregnancy; however, the principles of management are similar and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B1.4: Hyperglycaemia first detected at any time during pregnancy should', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='hyperglycaemia first detected in pregnancy) usually differs from the approach for women with GDM,\\nparticularly when diagnosed early in pregnancy; however, the principles of management are similar and\\nboth require referral and increased monitoring.\\n• Further information and considerations related to this recommendation can be found in the 2013 WHO\\nguideline (94), available at: http:/ /www.who.int/ diabetes/ publications/Hyperglycaemia_In_Pregnancy/\\nen/\\na This is not a recommendation on routine screening for hyperglycaemia in pregnancy. It has been adapted and integrated from the 2013 WHO publication (94),\\nwhich states that GDM should be diagnosed at any time in pregnancy if one or more of the following criteria are met:\\n• fasting plasma glucose 5.1–6.9 mmol/L (92–125 mg/ dL)\\n• 1-hour plasma glucose  10.0 mmol/L (180 mg/ dL) following a 75 g oral glucose load\\n• 2-hour plasma glucose 8.5–11.0 mmol/L (153–199 mg/ dL) following a 75 g oral glucose load'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B1.4: Hyperglycaemia first detected at any time during pregnancy should', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='• 1-hour plasma glucose  10.0 mmol/L (180 mg/ dL) following a 75 g oral glucose load\\n• 2-hour plasma glucose 8.5–11.0 mmol/L (153–199 mg/ dL) following a 75 g oral glucose load\\nDiabetes mellitus in pregnancy should be diagnosed if one or more of the following criteria are met:\\n• fasting plasma glucose  7.0 mmol/L (126 mg/ dL)\\n• 2-hour plasma glucose  11.1 mmol/L (200 mg/ dL) following a 75 g oral glucose load\\n• random plasma glucose  11.1 mmol/L (200 mg/ dL) in the presence of diabetes symptoms..'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='49\\nB.1.5: T obacco use'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.5: Health-care providers should ask all pregnant women about their', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='tobacco use (past and present) and exposure to second-hand smoke as early as possible in\\npregnancy and at every antenatal care visit. (Recommended)\\nRemarks\\n• This strong recommendation based on low-quality evidence has been integrated from the 2013 WHO\\nrecommendations for the prevention and management of tobacco use and second-hand smoke exposure in\\npregnancy (96). Related recommendations from this guideline include the following:\\n– Health-care providers should routinely offer advice and psychosocial interventions for tobacco\\ncessation to all pregnant women who are either current tobacco users or recent tobacco quitters (strong\\nrecommendation based on moderate quality evidence).\\n– All health-care facilities should be smoke-free to protect the health of all staff, patients and visitors,\\nincluding pregnant women (strong recommendation based on low-quality evidence).\\n– Health-care providers should provide pregnant women, their partners and other household members'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.5: Health-care providers should ask all pregnant women about their', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='including pregnant women (strong recommendation based on low-quality evidence).\\n– Health-care providers should provide pregnant women, their partners and other household members\\nwith advice and information about the risks of second-hand smoke (SHS) exposure from all forms of\\nsmoked tobacco, as well as strategies to reduce SHS in the home (strong recommendation based on low-\\nquality evidence).\\n– Health-care providers should, wherever possible, engage directly with partners and other household\\nmembers to inform them of all the risks of SHS exposure to pregnant women from all forms of tobacco,\\nand to promote reduction of exposure and offer smoking cessation support (strong recommendation\\nbased on low-quality evidence).\\n• Further guidance on strategies to prevent and manage tobacco use and SHS exposure can be found in the\\n2013 WHO recommendations (96), available at: http:/ /www.who.int/tobacco/ publications/ pregnancy/\\nguidelinestobaccosmokeexposure/ en/'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.5: Health-care providers should ask all pregnant women about their', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='2013 WHO recommendations (96), available at: http:/ /www.who.int/tobacco/ publications/ pregnancy/\\nguidelinestobaccosmokeexposure/ en/  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n50\\nB.1.6: Substance use'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.6: Health-care providers should ask all pregnant women about their', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='use of alcohol and other substances (past and present) as early as possible in the pregnancy and\\nat every antenatal care visit. (Recommended)\\nRemarks\\n• This strong recommendation based on low-quality evidence has been integrated from the 2014 WHO\\nGuidelines for the identification and management of substance use and substance use disorders in pregnancy (97).\\nThe overarching principles of this guideline aimed to prioritize prevention, ensure access to prevention\\nand treatment services, respect women’s autonomy, provide comprehensive care, and safeguard against\\ndiscrimination and stigmatization.\\n• The GDG responsible for the recommendation noted that asking women at every ANC visit is important\\nas some women are more likely to report sensitive information only after a trusting relationship has been\\nestablished.\\n• Pregnant women should be advised of the potential health risks to themselves and to their babies posed by\\nalcohol and drug use.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.6: Health-care providers should ask all pregnant women about their', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='established.\\n• Pregnant women should be advised of the potential health risks to themselves and to their babies posed by\\nalcohol and drug use.\\n• Validated screening instruments for alcohol and other substance use and substance use disorders are\\navailable (refer to Annex 3 of the 2014 guidelines [97]).\\n• Health-care providers should be prepared to intervene or refer all pregnant women who are identified as\\nusing alcohol and/ or drugs (past and present).\\n• For women identified as being dependent on alcohol or drugs, further recommendations from the guideline\\ninclude the following:\\n– Health-care providers should at the earliest opportunity advise pregnant women dependent on alcohol\\nor drugs to cease their alcohol or drug use and offer, or refer them to, detoxification services under\\nmedical supervision, where necessary and applicable (strong recommendation based on very low-quality\\nevidence).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.6: Health-care providers should ask all pregnant women about their', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='medical supervision, where necessary and applicable (strong recommendation based on very low-quality\\nevidence).\\n– Health-care providers should offer a brief intervention to all pregnant women using alcohol or drugs\\n(strong recommendation based on low-quality evidence).\\n• It was decided that despite the low-quality evidence on effects of brief psychosocial interventions, the\\nbenefit (potential reduction of alcohol and substance use) outweighed any potential harms, which were\\nconsidered to be minimal.\\n• A brief intervention is a structured therapy of short duration (typically 5–30 minutes) offered with the aim\\nof assisting an individual to cease or reduce use of a psychoactive substance.\\n• Further guidance on interventions and strategies to identify and manage substance use and substance use\\ndisorders in pregnancy can be found in the 2014 WHO guidelines (97), available at: http:/ /www.who.int/\\nsubstance_abuse/ publications/ pregnancy_guidelines/ en/'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='51\\nB.1.7: Human immunodeficiency virus (HIV) and syphilis'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='counselling (PITC) for HIV should be considered a routine component of the package of care\\nfor pregnancy women in all antenatal care settings. In low-prevalence settings, PITC can be\\nconsidered for pregnant women in antenatal care settings as a key component of the effort to\\neliminate mother-to-child transmission of HIV, and to integrate HIV testing with syphilis, viral or\\nother key tests, as relevant to the setting, and to strengthen the underlying maternal and child\\nhealth systems. (Recommended)\\nRemarks\\n• This recommendation has been integrated from the 2015 WHO Consolidated guidelines on HIV testing\\nservices (98) (the strength of the recommendation and the quality of the evidence were not stated).\\n• PITC denotes an HIV testing service that is routinely offered in a health-care facility and includes\\nproviding pre-test information and obtaining consent, with the option for individuals to decline testing.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='providing pre-test information and obtaining consent, with the option for individuals to decline testing.\\nPITC has proved highly acceptable and has increased the uptake of HIV testing in LMICs (98).\\n• The availability of HIV testing at ANC services is responsible for the high level of knowledge of HIV status\\namong women in many countries, which has allowed women and infants to benefit from ART.\\n• WHO recommends that ART should be initiated in all pregnant women diagnosed with HIV at any CD4\\ncount and continued lifelong (99). This recommendation is based on evidence that shows that providing\\nART to all pregnant and breastfeeding women living with HIV improves individual health outcomes,\\nprevents mother-to-child transmission of HIV, and prevents horizontal transmission of HIV from the\\nmother to an uninfected sexual partner.\\n• Other recommendations relevant to ANC services from the Consolidated guidelines on HIV testing services\\ninclude the following (98):'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='mother to an uninfected sexual partner.\\n• Other recommendations relevant to ANC services from the Consolidated guidelines on HIV testing services\\ninclude the following (98):\\n– On disclosure: Initiatives should be put in place to enforce privacy protection and institute policy,\\nlaws and norms that prevent discrimination and promote tolerance and acceptance of people\\nliving with HIV. This can help create environments where disclosure of HIV status is easier (strong\\nrecommendation, low-quality evidence).\\n– On retesting: In settings with a generalized HIV epidemic:b Retest all HIV-negative pregnant women\\nin the third trimester, during labour or postpartum because of the high risk of acquiring HIV infection\\nduring pregnancy (strength of recommendation and quality of evidence not stated).\\n– On retesting: In settings with a concentrated HIV epidemic:c Retest HIV-negative pregnant women\\nwho are in a serodiscordant couple or from a key population groupd (strength of recommendation and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='– On retesting: In settings with a concentrated HIV epidemic:c Retest HIV-negative pregnant women\\nwho are in a serodiscordant couple or from a key population groupd (strength of recommendation and\\nquality of evidence not stated).\\n– On retesting before ART initiation: National programmes should retest all people newly and previously\\ndiagnosed with HIV before they enrol in care and initiate ART (strength of recommendation and quality\\nof evidence not stated).\\n– On testing strategies: In settings with greater than 5% HIV prevalence in the population being tested,\\na diagnosis of HIV-positive should be issued to people with two sequential reactive tests. In settings\\nwith less than 5% HIV prevalence in the population being tested, a diagnosis of HIV-positive should\\nbe issued to people with three sequential reactive tests (strength of recommendation and quality of\\nevidence not stated).\\n– On task shifting: Lay providers who are trained and supervised can independently conduct safe'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first', 'third']}, 'maternal_topics': ['maternal_changes']}, page_content='evidence not stated).\\n– On task shifting: Lay providers who are trained and supervised can independently conduct safe\\nand effective HIV testing using rapid diagnostic tests (strong recommendation, moderate-quality\\nevidence).\\n• Further guidance on HIV testing can be found in the 2015 WHO guidelines (98), available at:\\nhttp:/ /www.who.int/hiv/ pub/ guidelines/hiv-testing-services/ en/\\n• In addition, the 2015 Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV\\n(99) is available at: http:/ /www.who.int/hiv/ pub/ guidelines/ earlyrelease-arv/ en/\\n• T o prevent mother-to-child transmission of syphilis, all pregnant women should be screened for syphilis at\\nthe first ANC visit in the first trimester and again in the third trimester of pregnancy. For further guidance  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n52\\non screening, please refer to the 2006 WHO publication Prevention of mother-to-child transmission of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='WHO recommendations on antenatal care for a positive pregnancy experience\\n52\\non screening, please refer to the 2006 WHO publication Prevention of mother-to-child transmission of\\nsyphilis (100), available at: http:/ /www.who.int/ reproductivehealth/ publications/ maternal_perinatal_\\nhealth/ prevention_mtct_syphilis.pdf\\n• The latest (2016) WHO guidelines on the treatment of chlamydia, gonorrhoea and syphilis, and on\\nthe prevention of sexual transmission of Zika virus (101–104), are available at: http:/ /www.who.int/\\nreproductivehealth/ publications/ rtis/ clinical/ en/\\na High-prevalence settings are defined in the 2015 WHO publication Consolidated guidelines on HIV testing services as settings with greater than 5% HIV\\nprevalence in the population being tested. Low-prevalence settings are settings with less than 5% HIV prevalence in the population being tested (98).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.7: In high-prevalence settings, a provider-initiated testing and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='prevalence in the population being tested. Low-prevalence settings are settings with less than 5% HIV prevalence in the population being tested (98).\\nb A generalized HIV epidemic is when HIV is firmly established in the general population. Numerical proxy: HIV prevalence is consistently over 1% in pregnant\\nwomen attending antenatal clinics (98).\\nc A concentrated HIV epidemic is when HIV has spread rapidly in a defined subpopulation (or key population, see next footnote) but is not well established in\\nthe general population (98).\\nd Key populations are defined in the 2015 WHO guidelines as the following groups: men who have sex with men, people in prison or other closed settings,\\npeople who inject drugs, sex workers and transgender people (98).\\nB.1.8: Tuberculosis (TB)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.8: In settings where the tuberculosis (TB) prevalence in the general', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='population is 100/100000 population or higher, systematic screening for active TB should be\\nconsidered for pregnant women as part of antenatal care. (Context-specific recommendation)\\nRemarks\\n• This recommendation has been adapted and integrated from the 2013 WHO publication Systematic\\nscreening for active tuberculosis: principles and recommendations, where it was considered a conditional\\nrecommendation based on very low-quality evidence (105).\\n• Systematic screening is defined as the systematic identification of people with suspected active TB in a\\npredetermined target group, using tests, examinations or other procedures that can be applied rapidly.\\nOptions for initial screening include screening for symptoms (either for cough lasting longer than two\\nweeks, or any symptoms compatible with TB, including a cough of any duration, haemoptysis, weight loss,\\nfever or night sweats) or screening with chest radiography. The use of chest radiography in pregnant women'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.8: In settings where the tuberculosis (TB) prevalence in the general', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='fever or night sweats) or screening with chest radiography. The use of chest radiography in pregnant women\\nposes no significant risk but the national guidelines for the use of radiography during pregnancy should be\\nfollowed (105).\\n• Before screening is initiated, high-quality TB diagnosis, treatment, care, management and support should\\nbe in place, and there should be the capacity to scale these up further to match the anticipated rise in case\\ndetection that may occur as a result of screening.\\n• The panel responsible for making this recommendation noted that it may not be possible to implement it in\\nresource-constrained settings.\\n• Other recommendations relevant to ANC services from the same publication include the following (105):\\n– Household contacts and other close contacts should be systematically screened for TB (strong\\nrecommendation, very low-quality evidence).\\n– People living with HIV should be systematically screened for active TB at each visit to a health-care'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.8: In settings where the tuberculosis (TB) prevalence in the general', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='recommendation, very low-quality evidence).\\n– People living with HIV should be systematically screened for active TB at each visit to a health-care\\nfacility (strong recommendation, very low-quality evidence).\\n– Systematic screening for active TB may be considered also for other subpopulations that have very\\npoor access to health care, such as people living in urban slums, homeless people, people living in\\nremote areas with poor access to health care, and other vulnerable or marginalized groups including\\nsome indigenous populations, migrants and refugees (conditional recommendation, very low-quality\\nevidence).\\n• TB increases the risk of preterm birth, perinatal death and other pregnancy complications. Initiating TB\\ntreatment early is associated with better maternal and infant outcomes than late initiation (105).\\n• T o better understand the local burden of TB in pregnancy, health systems may benefit from capturing\\npregnancy status in registers that track TB screening and treatment.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.1.8: In settings where the tuberculosis (TB) prevalence in the general', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='• T o better understand the local burden of TB in pregnancy, health systems may benefit from capturing\\npregnancy status in registers that track TB screening and treatment.\\n• Further information and considerations related to this recommendation can be found in the 2013 WHO\\nrecommendations (105), available at: http:/ /www.who.int/tb/tbscreening/ en/'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='53\\nB.2: Fetal assessment\\nBackground\\nAssessment of fetal growth and well-being is\\nan important part of ANC. The GDG considered\\nevidence and other relevant information on the\\nfollowing interventions to assess fetal growth and\\nwell-being in healthy pregnant women not at risk of\\nadverse perinatal outcomes:\\nnn Daily fetal movement counting: Maternal\\nperception of reduced fetal movements is\\nassociated with poor perinatal outcomes,\\nincluding fetal death (106). Daily fetal movement\\ncounting, such as the Cardiff “count-to-ten”\\nmethod using kick charts, is a way of screening\\nfor fetal well-being, by which a woman counts\\ndaily fetal movements to assess the condition\\nof her baby. The aim of this is to try to reduce\\nperinatal mortality by alerting health workers\\nwhen the baby might be compromised (107).\\nDaily fetal movement counting may be used\\nroutinely in all pregnant women or only in women\\nwho are considered to be at increased risk of\\nadverse perinatal outcomes. Early detection of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Daily fetal movement counting may be used\\nroutinely in all pregnant women or only in women\\nwho are considered to be at increased risk of\\nadverse perinatal outcomes. Early detection of\\nfetal compromise could lead to timely clinical\\ninterventions to reduce poor perinatal outcomes\\nbut might lead to maternal anxiety or unnecessary\\nclinical interventions. It is also possible that the\\nperiod between decreased fetal movements and\\nfetal death might be too short to allow effective\\naction to be taken (108).\\nnn Symphysis-fundal height (SFH) measurement:\\nSFH measurement is a commonly-practiced\\nmethod of fetal growth assessment that uses a\\ntape measure to measure the SFH, in order to\\ndetect intrauterine growth restriction (IUGR).\\nIt also has the potential to detect multiple\\npregnancy, macrosomia, polyhydramnios and\\noligohydramnios. For fetuses growing normally,\\nfrom 24 weeks of gestation, the SFH measurement\\nin centimetres should correspond to the number'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='pregnancy, macrosomia, polyhydramnios and\\noligohydramnios. For fetuses growing normally,\\nfrom 24 weeks of gestation, the SFH measurement\\nin centimetres should correspond to the number\\nof weeks of gestation, with an allowance of a 2-cm\\ndifference either way (109). Other methods of fetal\\ngrowth assessment include abdominal palpation of\\nfundal height in relation to anatomical landmarks\\nsuch as the umbilicus and xiphisternum, abdominal\\ngirth measurement, and serial ultrasound\\nmeasurement of the fetal parameters (109).\\nAccurate low-cost methods for detecting abnormal\\ngrowth are desirable because ultrasound, the most\\naccurate screening tool, is resource-intensive and\\nnot widely available in LMICs.\\nnn Routine antenatal cardiotocography (CTG):\\nCTG is a continuous recording of the fetal heart\\nrate and uterine contractions obtained via an\\nultrasound transducer placed on the mother’s\\nabdomen. CTG is widely used in pregnancy\\nas a method of assessing fetal well-being,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='rate and uterine contractions obtained via an\\nultrasound transducer placed on the mother’s\\nabdomen. CTG is widely used in pregnancy\\nas a method of assessing fetal well-being,\\npredominantly in pregnancies with increased risk\\nof complications and during labour.\\nnn Fetal ultrasound examination: Diagnostic\\nultrasound examination is employed in a variety\\nof specific circumstances during pregnancy, such\\nas where there are concerns about fetal growth\\nand after clinical complications. However, because\\nadverse outcomes may also occur in pregnancies\\nwithout clear risk factors, assumptions have been\\nmade that antenatal ultrasound examination in\\nall pregnancies will prove beneficial by enabling\\nearlier detection of problems that may not be\\napparent (110) – such as multiple pregnancies,\\nIUGR, congenital anomalies, malpresentation\\nand placenta praevia – and by allowing accurate\\ngestational age estimation, leading to timely\\nand appropriate management of pregnancy\\ncomplications.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='IUGR, congenital anomalies, malpresentation\\nand placenta praevia – and by allowing accurate\\ngestational age estimation, leading to timely\\nand appropriate management of pregnancy\\ncomplications.\\nnn Fetal Doppler ultrasound examination: Doppler\\nultrasound technology evaluates umbilical artery\\n(and other fetal arteries) waveforms to assess\\nfetal well-being in the third trimester of pregnancy.\\nIt is widely used in high-risk pregnancies to\\nidentify fetal compromise and thus reduce\\nperinatal mortality (111, 112). Therefore, it might\\nalso be useful when performed as an antenatal\\nintervention to detect fetal compromise and\\npredict complications, particularly IUGR and\\npre-eclampsia, in apparently healthy pregnancies.\\nDoppler ultrasound is useful for distinguishing\\nbetween fetuses that are growth-restricted\\n(IUGR) and those that are constitutionally small\\n(SGA) (113). It can be performed as part of a\\nfetal ultrasound examination or separately. The\\nexamination quantifies blood flow through the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='(IUGR) and those that are constitutionally small\\n(SGA) (113). It can be performed as part of a\\nfetal ultrasound examination or separately. The\\nexamination quantifies blood flow through the\\numbilical artery as either a pulsatility index or a\\nresistive index (114). A high resistance to blood\\nflow often indicates an increased risk of IUGR and\\npre-eclampsia and indicates the need for further\\ninvestigation.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n54\\nB.2.1: Daily fetal movement counting'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.1: Daily fetal movement counting, such as with “count-to-ten”', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='kick charts, is only recommended in the context of rigorous research. (Context-specific\\nrecommendation – research)\\nRemarks\\n• Fetal movement counting is when a pregnant woman counts and records her baby’s movements in order\\nto monitor the baby’s health. Various methods have been described, with further monitoring variously\\nindicated depending on the method used, for example, if fewer than six distinct movements are felt within\\n2 hours (115) or fewer than 10distinct movements are felt within 12 hours (the Cardiff “count to ten”\\nmethod) (106).\\n• While daily fetal movement counting is not recommended, healthy pregnant women should be made\\naware of the importance of fetal movements in the third trimester and of reporting reduced fetal\\nmovements.\\n• Clinical enquiry by ANC providers at each ANC visit about maternal perception of fetal movements is\\nrecommended as part of good clinical practice. Women who perceive poor or reduced fetal movements'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.1: Daily fetal movement counting, such as with “count-to-ten”', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='• Clinical enquiry by ANC providers at each ANC visit about maternal perception of fetal movements is\\nrecommended as part of good clinical practice. Women who perceive poor or reduced fetal movements\\nrequire further monitoring (e.g. with daily fetal movement counting) and investigation, if indicated.\\n• The GDG agreed that more research is needed on the effects of daily fetal movement counting in the third\\ntrimester of pregnancy, particularly in LMIC settings with a high prevalence of unexplained stillbirths.\\nWomen’s values\\nA scoping review of what women want from ANC and what outcomes they value informed the ANC guideline (13).\\nEvidence showed that women from high-, medium- and low-resource settings valued having a positive pregnancy\\nexperience. Within the context of maternal and fetal assessment, women valued the opportunity to receive screening\\nand tests to optimize their health and that of their baby as long as individual procedures were explained to them'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.1: Daily fetal movement counting, such as with “count-to-ten”', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='and tests to optimize their health and that of their baby as long as individual procedures were explained to them\\nclearly and administered by knowledgeable, supportive and respectful health-care practitioners (high confidence in\\nthe evidence).\\nSummary of evidence and considerations\\nEffects of daily maternal fetal movement\\ncounting compared with standard ANC (EB\\nT able B.2.1)\\nThe evidence on the effects of daily fetal movement\\ncounting was derived from a Cochrane review\\n(107). T wo RCT s from HICs contributed data for this\\ncomparison. One was a large, multicentre, cluster\\nRCT (68654 women) conducted in Belgium, Ireland,\\nSweden, the United Kingdom and the USA, which\\ncompared a “count-to-ten” fetal movement counting\\nkick chart with standard ANC in women with\\nuncomplicated pregnancies recruited between 28\\nand 32 weeks of gestation. Women in the standard\\nANC group were asked about fetal movements at\\neach ANC visit. The other trial was a multicentre'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.1: Daily fetal movement counting, such as with “count-to-ten”', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='uncomplicated pregnancies recruited between 28\\nand 32 weeks of gestation. Women in the standard\\nANC group were asked about fetal movements at\\neach ANC visit. The other trial was a multicentre\\nRCT conducted in Norway involving 1123 women that\\ncompared a modified “count-to-ten” fetal movement\\ncounting protocol with standard care.\\nMaternal outcomes\\nLow-certainty evidence suggests that daily fetal\\nmovement counting may make little or no difference\\nto caesarean section (1 trial, 1076 women; RR: 0.93,\\n95% CI: 0.60–1.44) or assisted vaginal delivery rates\\n(1 trial, 1076 women; RR: 1.04, 95% CI: 0.65–1.66).\\nWith regard to maternal satisfaction, low-certainty\\nevidence suggests that daily fetal movement counting\\nmay reduce mean anxiety scores (1 trial, 1013 women;\\nstandardized MD: –0.22, 95% CI: –0.35 to –0.10).\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that there may be\\nlittle or no difference to preterm birth (1 trial, 1076'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='55\\nneonates; RR: 0.81, 95% CI: 0.46–1.46) and low birth\\nweight (1 trial, 1076 neonates; RR: 0.98, 95% CI:\\n0.66–1.44) with daily fetal movement counting.\\nThere were no perinatal deaths in the Norwegian\\ntrial (1076 women). Low-certainty evidence from the\\nlarge cluster RCT, which reported the weighted mean\\ndifference in stillbirth rates between intervention\\nand control clusters, suggests that fetal movement\\ncounting may make little or no difference to stillbirth\\nrates (weighted MD: 0.23, 95% CI: –0.61 to 1.07).\\nAdditional considerations\\nnn These trials were conducted in HICs with low\\nstillbirth rates, therefore the findings on effects\\nmay not apply equally to settings with high\\nstillbirth rates.\\nnn In the cluster RCT, despite fetal movement\\ncounting, most fetuses detected as being\\ncompromised by reduced fetal movements had\\ndied by the time the mothers received medical\\nattention.\\nnn There was a trend towards increased CTG and\\nantenatal hospital admissions in the intervention'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='compromised by reduced fetal movements had\\ndied by the time the mothers received medical\\nattention.\\nnn There was a trend towards increased CTG and\\nantenatal hospital admissions in the intervention\\nclusters of the cluster RCT. Antenatal hospital\\nadmissions were also more frequent in the\\nintervention arm of the Norwegian RCT (107).\\nnn Findings from an additional RCT that was\\nunpublished at the time of the Cochrane review\\nsupport the Cochrane evidence that daily fetal\\nmovement counting may reduce maternal anxiety\\n(115).\\nValues\\nPlease see “Women’s values” in section 3.B.2: Fetal\\nassessment: Background (p.54).\\nResources\\nFetal movement counting is a low-cost intervention\\non its own, but it could be resource-intensive if it\\nleads to unnecessary additional interventions or\\nhospital admissions.\\nEquity\\nLMICs bear the global burden of perinatal morbidity\\nand mortality, and women who are poor, least\\neducated and residing in rural areas of LMICs have\\nlower ANC coverage and worse pregnancy outcomes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs'], 'discusses_normal_variations': True}, page_content='LMICs bear the global burden of perinatal morbidity\\nand mortality, and women who are poor, least\\neducated and residing in rural areas of LMICs have\\nlower ANC coverage and worse pregnancy outcomes\\nthan more advantaged women (29). Therefore,\\nsimple, effective, low-cost antenatal interventions to\\nassess fetal well-being could help to address health\\ninequalities by improving detection of complications\\nin low-resource settings.\\nAcceptability\\nQualitative evidence shows that women generally\\nappreciate the knowledge and information they can\\nacquire from health-care providers during ANC visits,\\nprovided this is explained properly and delivered in\\na consistent, caring and culturally sensitive manner\\n(high confidence in the evidence) (22). It also shows\\nthat health professionals want to give appropriate\\ninformation and advice to women but sometimes\\nthey don’t feel suitably trained to do so (high\\nconfidence in the evidence) (45).\\nFeasibility\\nFrom the perspective of women who live far from'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='information and advice to women but sometimes\\nthey don’t feel suitably trained to do so (high\\nconfidence in the evidence) (45).\\nFeasibility\\nFrom the perspective of women who live far from\\nANC clinics and who may not have the resources or\\ntime to attend ANC regularly, and the perspective\\nof ANC providers with limited resources, this\\nintervention may offer a practical and cost–effective\\napproach to monitoring fetal well-being if it’s shown\\nto be effective (high confidence in the evidence)\\n(22, 45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n56\\nB.2.2: Symphysis-fundal height (SFH) measurement'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.2: Replacing abdominal palpation with symphysis-fundal height (SFH)', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='measurement for the assessment of fetal growth is not recommended to improve perinatal\\noutcomes. A change from what is usually practiced (abdominal palpation or SFH measurement)\\nin a particular setting is not recommended. (Context-specific recommendation)\\nRemarks\\n• SFH measurement is routinely practiced in many ANC settings. Due to a lack of clear evidence of\\naccuracy or superiority of either SFH measurement or clinical palpation to assess fetal growth, the GDG\\ndoes not recommend a change of practice.\\n• The GDG agreed that there is a lack of evidence on SFH, rather than a lack of effectiveness, particularly in\\nLMIC settings.\\n• Apart from false reassurance, which might occur with both SFH measurement and clinical palpation,\\nthere is no evidence of harm with SFH measurement.\\n• Research is needed to determine the role of SFH measurement in detecting abnormal fetal growth and\\nother risk factors for perinatal morbidity (e.g. multiple pregnancy, polyhydramnios) in settings where'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.2: Replacing abdominal palpation with symphysis-fundal height (SFH)', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='other risk factors for perinatal morbidity (e.g. multiple pregnancy, polyhydramnios) in settings where\\nantenatal ultrasound is not available.\\nSummary of evidence and considerations\\nEffects of SFH measurement versus abdominal\\npalpation (EB T ableB.2.2)\\nThe evidence on the effects of SFH measurement\\nwas derived from a Cochrane review that included\\nonly one trial conducted in Denmark involving\\n1639 pregnant women enrolled at about 14\\nweeks of gestation (109). SFH measurement or\\nabdominal palpation were performed from 28\\nweeks of gestation. Most women had at least three\\nassessments, with measurements plotted on a chart.\\nMaternal outcomes\\nLow-certainty evidence suggests that there may be\\nlittle or no difference in the effect of SFH measurement\\nversus clinical palpation on caesarean section (1639\\nwomen; RR: 0.72, 95% CI: 0.31–1.67) and induction of\\nlabour (1639 women; RR: 0.84, 95% CI: 0.45–1.58).\\nFetal and neonatal outcomes\\nModerate-certainty evidence shows that SFH'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.2: Replacing abdominal palpation with symphysis-fundal height (SFH)', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='women; RR: 0.72, 95% CI: 0.31–1.67) and induction of\\nlabour (1639 women; RR: 0.84, 95% CI: 0.45–1.58).\\nFetal and neonatal outcomes\\nModerate-certainty evidence shows that SFH\\nmeasurement versus clinical palpation probably makes\\nlittle or no difference to the antenatal detection of SGA\\nneonates (1639 women; RR: 1.32, 95%CI: 0.92–1.90)\\nand low-certainty evidence suggests that it may make\\nlittle or no difference to perinatal mortality (1639\\nwomen; RR: 1.25, 95%CI: 0.38–4.07). No other ANC\\nguideline outcomes were reported in the review.\\nAdditional considerations\\nnn The GDG also considered evidence from a test\\naccuracy review regarding the accuracy of SFH\\nin predicting SGA at birth (birthweight <10th\\ncentile), where SGA was a proxy outcome for\\nIUGR (116). The DTA review included seven\\nstudies conducted in HICs, which used different\\nmeasurement thresholds to detect SGA. SFH\\nmeasurement had a sensitivity ranging from 0.27\\nto 0.76, suggesting that it fails to identify up to'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.2: Replacing abdominal palpation with symphysis-fundal height (SFH)', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='studies conducted in HICs, which used different\\nmeasurement thresholds to detect SGA. SFH\\nmeasurement had a sensitivity ranging from 0.27\\nto 0.76, suggesting that it fails to identify up to\\n73% of pregnancies affected by SGA at birth.\\nHowever, there was generally a high degree of\\nspecificity (0.79–0.92), suggesting that a normal\\nSFH measurement may be a reasonable indicator\\nof a healthy baby. In practice, this could mean that\\nfew healthy pregnancies are referred for ultrasound\\nexamination; however, most true SGA cases may\\nbe missed. Comparable test accuracy evidence on\\nabdominal palpation is not available.\\nValues\\nPlease see “Women’s values” in section 3.B.2: Fetal\\nassessment: Background (p.54).\\nResources\\nBoth abdominal palpation and SFH measurement are\\nlow-cost interventions with the main cost being staff\\ntraining. SFH requires tape measures to be available.\\nEquity\\nLMICs bear the global burden of perinatal morbidity\\nand mortality, and women who are poor, least'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.2: Replacing abdominal palpation with symphysis-fundal height (SFH)', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='training. SFH requires tape measures to be available.\\nEquity\\nLMICs bear the global burden of perinatal morbidity\\nand mortality, and women who are poor, least\\neducated and residing in rural areas of LMICs have\\nlower ANC coverage and worse pregnancy outcomes\\nthan more advantaged women (29). Therefore,\\nsimple, effective, low-cost, routine antenatal'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='57\\ninterventions to assess fetal well-being could help to\\naddress health inequalities by improving detection of\\ncomplications in low-resource settings.\\nAcceptability\\nSFH and clinical palpation are non-invasive approaches\\nfor fetal assessment, which are widely used and not\\nknown to be associated with acceptability issues.\\nHowever, in some settings women experience a sense\\nof shame during physical examinations, and this\\nneeds to be addressed with sensitivity by health-care\\nproviders (low confidence in the evidence) (22).\\nFeasibility\\nBoth methods are considered equally feasible,\\nprovided tape measures are available.\\nB.2.3: Antenatal cardiotocography (CTG)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.3: Routine antenatal cardiotocography is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='pregnant women to improve maternal and perinatal outcomes. (Not recommended)\\nRemarks\\n• CTG is the continuous recording of the fetal heart rate and uterine contractions obtained via an\\nultrasound transducer placed on the mother’s abdomen.\\n• There is currently no evidence on effects or other considerations that supports the use of antenatal\\n(prelabour) CTG as part of routine ANC.\\n• A lack of evidence of benefits associated with CTG in high-risk pregnancies suggests that the evaluation\\nof antenatal CTG in healthy pregnant women is not a research priority.\\nSummary of evidence and considerations\\nEffects of routine antenatal CTG versus no\\nroutine antenatal CTG (EB T able B.2.3)\\nA Cochrane review of routine antenatal CTG for fetal\\nassessment identified no eligible studies of routine\\nCTG and all six included studies involved women with\\nhigh-risk pregnancies (117).\\nAdditional considerations\\nnn Low-certainty evidence on antenatal CTG in high-\\nrisk pregnancies suggests that this intervention'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.3: Routine antenatal cardiotocography is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs'], 'discusses_normal_variations': True}, page_content='high-risk pregnancies (117).\\nAdditional considerations\\nnn Low-certainty evidence on antenatal CTG in high-\\nrisk pregnancies suggests that this intervention\\nmay have little or no effect on perinatal mortality\\nand caesarean section (117).\\nValues\\nPlease see “Women’s values” in section 3.B.2: Fetal\\nassessment: Background (p.54).\\nResources\\nCTG machines are costly (starting from about\\nUS$450)4, require maintenance and supplies of\\nultrasound gel, and require staff training in their use\\nand interpretation.  \\n4 Crude estimate based on Int ernet search.\\nEquity\\nSimple, effective, low-cost, antenatal interventions to\\nassess fetal well-being could help to address health\\ninequalities by improving detection of complications\\nin low-resource settings, which bear the burden of\\nperinatal mortality.\\nAcceptability\\nQualitative evidence from a variety of settings\\nindicates that women generally appreciate the use of\\ntechnology to monitor pregnancy (high confidence'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.3: Routine antenatal cardiotocography is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'discusses_normal_variations': True}, page_content='perinatal mortality.\\nAcceptability\\nQualitative evidence from a variety of settings\\nindicates that women generally appreciate the use of\\ntechnology to monitor pregnancy (high confidence\\nin the evidence), and a lack of modern equipment at\\nANC facilities in LMICs may discourage women from\\nattending (moderate confidence in the evidence)\\n(22). However, in some LMICs, women hold the belief\\nthat pregnancy is a healthy condition and may be\\nresistant to CTG use unless they have experienced a\\nprevious pregnancy complication (high confidence\\nin the evidence). Acceptability may be further\\ncompromised if the reasons for using CTG are not\\nproperly explained (high confidence in the evidence).\\nFeasibility\\nHealth-care providers in LMIC settings feel that a\\nlack of modern equipment and training limits the\\nimplementation of this type of intervention (high\\nconfidence in the evidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n58'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.3: Routine antenatal cardiotocography is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='implementation of this type of intervention (high\\nconfidence in the evidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n58\\na T wo members of the GDG (Lisa Noguchi and Charlotte Warren) indicated that they would prefer to recommend this intervention in specific contexts with\\ncapacity to conduct close monitoring and evaluation to ensure a basic standard of implementation (including adequate capacity to diagnose and manage\\ncomplications) and monitor for potential adverse effects on delivery of other critical maternal and newborn health interventions.\\nB.2.4: Ultrasound scan'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.4: One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies, reduce induction of labour for post-term pregnancy, and improve a woman’s pregnancy experience.', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='Remarks\\n• The benefits of an early ultrasound scan are not improved upon and cannot be replicated with a late\\nultrasound scan where there has not been an early ultrasound scan. Therefore, an ultrasound scan after\\n24 weeks of gestation (late ultrasound) is not recommended for pregnant women who have had an early\\nultrasound scan. However, stakeholders should consider offering a late ultrasound scan to pregnant\\nwomen who have not had an early ultrasound scan, for the purposes of identifying the number of fetuses,\\npresentation and placental location.\\n• The GDG noted that the effects of introducing antenatal ultrasound on population health outcomes and\\nhealth systems in rural, low-resource settings are unproven. However, the introduction of ultrasound to\\ndetect pregnancy complications and confirm fetal viability to the woman and her family in these settings\\ncould plausibly increase ANC service utilization and reduce morbidity and mortality, when accompanied'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.4: One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies, reduce induction of labour for post-term pregnancy, and improve a woman’s pregnancy experience.', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='could plausibly increase ANC service utilization and reduce morbidity and mortality, when accompanied\\nby appropriate gestational age estimation, diagnosis, referral and management.\\n• The ongoing multicountry trial that is under way should contribute further evidence on health effects,\\nhealth care utilization and implementation-related information on ultrasound in rural, low-resource\\nsettings (118).\\n• The GDG acknowledged that the use of early pregnancy ultrasound has not been shown to reduce\\nperinatal mortality. The GDG put emphasis on other benefits of ultrasound (mentioned in points above)\\nand the increased accuracy of gestational age assessment, which would assist management in case of\\nsuspected preterm birth and reduce labour induction for post-term pregnancies.\\n• The GDG acknowledges that implementing and scaling up this recommendation in low-resource settings\\nwill be associated with a variety of challenges that may include political (budgeting for fees and tariffs),'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.4: One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies, reduce induction of labour for post-term pregnancy, and improve a woman’s pregnancy experience.', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='will be associated with a variety of challenges that may include political (budgeting for fees and tariffs),\\nlogistical (equipment maintenance, supplies, technical support), infrastructural (ensuring a reliable power\\nsupply and secure storage) and resources.\\n• The GDG noted that antenatal ultrasound is an intervention that can potentially be task shifted from\\ntrained sonographers and doctors to trained nurses, midwives and clinical officers, provided that ongoing\\ntraining, staff retention, quality improvement activities and supervision are ensured.\\n• Stakeholders might be able to offset/ reduce the cost of antenatal ultrasound if the ultrasound equipment\\nis also used for other indications (e.g. obstetric emergencies) or by other medical departments.\\n• The implementation and impact of this recommendation on health outcomes, facility utilization and\\nequity should be monitored at the health service, regional and country levels, based on clearly defined'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.4: One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies, reduce induction of labour for post-term pregnancy, and improve a woman’s pregnancy experience.', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='equity should be monitored at the health service, regional and country levels, based on clearly defined\\ncriteria and indicators associated with locally agreed targets.a\\n• For further guidance, please refer to the WHO Manual of diagnostic ultrasound (119), available at:\\nhttp:/ /www.who.int/ medical_devices/ publications/ manual_ultrasound_pack1-2/ en/\\nSummary of evidence and considerations\\na) Effects of an ultrasound scan before 24 weeks\\nof gestation (early ultrasound scan) versus\\nselective ultrasound scan (EB T able B.2.4a)\\nThe evidence on early ultrasound was derived from\\na Cochrane review that included 11 RCT s conducted\\nin Australia, Norway, South Africa, Sweden, the\\nUnited Kingdom and the USA, involving 37505\\nwomen (120). The intervention in all trials involved\\nan ultrasound scan before 24 weeks of gestation,\\nwith women in the control arm undergoing selective\\nscans if indicated (or, in one study, concealed\\nscans, the results of which were not shared with'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.4: One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies, reduce induction of labour for post-term pregnancy, and improve a woman’s pregnancy experience.', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='an ultrasound scan before 24 weeks of gestation,\\nwith women in the control arm undergoing selective\\nscans if indicated (or, in one study, concealed\\nscans, the results of which were not shared with\\nclinicians unless requested). The scans usually\\nincluded assessment of gestational age (biparietal\\ndiameter with or without head circumference and\\nfemur length), fetal anatomy, number of fetuses and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='59\\nlocation of the placenta. Scans were performed in\\nmost trials between 10 and 20 weeks of gestation,\\nwith three trials evaluating scans before 14 weeks,\\nand three trials evaluating an intervention comprising\\nboth early (at 18–20 weeks) and late scans (at 31–33\\nweeks).\\nMaternal outcomes\\nModerate-certainty evidence suggests that an early\\nultrasound scan probably has little or no effect on\\ncaesarean section rates (5 trials, 22193 women; RR:\\n1.05; 95% CI: 0.98–1.12). However, low-certainty\\nevidence suggests that early ultrasound may lead\\nto a reduction in induction of labour for post-term\\npregnancy (8 trials, 25516 women; RR: 0.59, 95% CI:\\n0.42–0.83).\\nRegarding maternal satisfaction, low-certainty\\nevidence suggests that fewer women may report\\nfeeling worried about their pregnancy after an early\\nultrasound scan (1 trial, 635 women; RR: 0.80, 95%\\nCI: 0.65–0.99).\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that early\\nultrasound scans may increase the detection of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='ultrasound scan (1 trial, 635 women; RR: 0.80, 95%\\nCI: 0.65–0.99).\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that early\\nultrasound scans may increase the detection of\\ncongenital anomalies (2 trials, 17158 women; RR:\\n3.46, 95% CI: 1.67–7.14). However, detection rates\\nwere low for both groups (16% vs 4%, respectively)\\nwith 346/387 neonates with abnormalities (89%)\\nbeing undetected by 24 weeks of gestation.\\nLow-certainty evidence suggests that early\\nultrasound may make little or no difference to\\nperinatal mortality (10 trials, 35737 births; RR: 0.89,\\n95% CI: 0.70–1.12) and low birth weight (4 trials,\\n15868 neonates; RR: 1.04, 95% CI: 0.82–1.33).\\nModerate-certainty evidence also shows that it\\nprobably has little or no effect on SGA (3 trials, 17105\\nneonates; RR: 1.05, 95% CI: 0.81–1.35).\\nb) Effects of an ultrasound scan after 24 weeks\\nof gestation (late ultrasound scan) versus no late\\nultrasound scan (EB T able B.2.4b)\\nThis evidence on late ultrasound was derived from'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='b) Effects of an ultrasound scan after 24 weeks\\nof gestation (late ultrasound scan) versus no late\\nultrasound scan (EB T able B.2.4b)\\nThis evidence on late ultrasound was derived from\\na Cochrane review that included 13 RCT s conducted\\nin HICs (121). Most women in these trials underwent\\nearly ultrasound scan and were randomized to receive\\nan additional third trimester scan or to selective or\\nconcealed ultrasound scan. The purpose of the late\\nscan in these trials, which was usually performed\\nbetween 30 and 36 weeks of gestation, variably\\nincluded assessment of fetal anatomy, estimated\\nweight, amniotic fluid volume and/ or placental\\nmaturity.\\nMaternal outcomes\\nModerate-certainty evidence suggests that a late\\nultrasound scan probably has little or no effect on\\ncaesarean section (6 trials, 22663 women; RR: 1.03,\\n95% CI: 0.92–1.15), instrumental delivery (5 trials,\\n12310 women; RR: 1.05, 95% CI: 0.95–1.16) and\\ninduction of labour (6 trials, 22663 women; RR: 0.93,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='95% CI: 0.92–1.15), instrumental delivery (5 trials,\\n12310 women; RR: 1.05, 95% CI: 0.95–1.16) and\\ninduction of labour (6 trials, 22663 women; RR: 0.93,\\n95% CI: 0.81–1.07). Maternal satisfaction was not\\nassessed in this review.\\nFetal and neonatal outcomes\\nModerate-certainty evidence suggests that a late\\nultrasound scan probably has little or no effect\\non perinatal mortality (8 trials, 30675 births; RR:\\n1.01, 95% CI: 0.67–1.54) and preterm birth (2 trials,\\n17151 neonates; RR: 0.96, 95% CI: 0.85–1.08). Low-\\ncertainty evidence suggests that it may have little or\\nno effect on SGA (4 trials, 20293 neonates; RR: 0.98,\\n95% CI: 0.74–1.28) and low birth weight (3 trials,\\n4510 neonates; RR: 0.92, 95% CI: 0.71–1.18).\\nAdditional considerations\\nnn The evidence on ultrasound is derived mainly\\nfrom HICs, where early ultrasound is a standard\\ncomponent of ANC to establish an accurate\\ngestational age and identify pregnancy\\ncomplications. The impact of ultrasound screening'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='from HICs, where early ultrasound is a standard\\ncomponent of ANC to establish an accurate\\ngestational age and identify pregnancy\\ncomplications. The impact of ultrasound screening\\nin low-resource settings is currently unknown but\\nthe low rates of maternal and perinatal mortality\\nexperienced in HICs indirectly suggests that\\nultrasound is an important component of quality\\nANC services.\\nnn Evidence from the Cochrane review on early\\nultrasound suggests that multiple pregnancies may\\nbe less likely to be missed/undetected by 24–26\\nweeks of gestation with early ultrasound (120).\\nOf 295 multiple pregnancies occurring in seven\\ntrials (approximately 24000 trial participants),\\n1% (2/153) were undetected by 24–26 weeks\\nof gestation with early ultrasound screening\\ncompared with 39% (56/142) in the control group\\n(RR: 0.07, 95% CI: 0.03–0.17; graded by review\\nauthors as low-quality evidence).\\nnn The Cochrane review also evaluated several safety\\noutcomes in offspring and found no evidence of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='(RR: 0.07, 95% CI: 0.03–0.17; graded by review\\nauthors as low-quality evidence).\\nnn The Cochrane review also evaluated several safety\\noutcomes in offspring and found no evidence of\\ndifferences in school performance, vision and\\nhearing, disabilities or dyslexia.\\nnn An ongoing multicountry cluster RCT of antenatal\\nultrasound in the Democratic Republic of the\\nCongo, Guatemala, Kenya, Pakistan and Zambia  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n60\\nshould contribute data on health outcomes and\\nhealth care utilization, as well as implementation-\\nrelated information on ultrasound in rural, low-\\nresource settings (118). The trial intervention\\ninvolves a two-week obstetric ultrasound training\\ncourse for health workers (e.g. midwives, nurses,\\nclinical officers) to perform ultrasound scans at\\n18–22 weeks and 32–36 weeks of gestation in each\\nparticipant enrolled.\\nnn Accurate gestational age dating is critical for the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='clinical officers) to perform ultrasound scans at\\n18–22 weeks and 32–36 weeks of gestation in each\\nparticipant enrolled.\\nnn Accurate gestational age dating is critical for the\\nappropriate delivery of time-sensitive interventions\\nin pregnancy, as well as management of pregnancy\\ncomplications, particularly pre-eclampsia and\\npreterm birth, which are major causes of maternal\\nand perinatal morbidity and mortality in LMICs,\\nand early ultrasound is useful for this purpose.\\nValues\\nPlease see “Women’s values” in section 3.B.2: Fetal\\nassessment: Background (p.54).\\nResources\\nThe cost of ultrasound equipment, especially portable\\ncompact units, has decreased (122), and they are\\ncurrently available at less than US$10000 (28).\\nThus, given the cost of equipment, maintenance,\\nsupplies (ultrasound gel), replacement batteries,\\ninitial and ongoing staff training and supervision, and\\nstaffing costs (allowing 15–45 minutes per scan),\\nroutine ultrasound scans may have considerable'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes'], 'discusses_normal_variations': True}, page_content='initial and ongoing staff training and supervision, and\\nstaffing costs (allowing 15–45 minutes per scan),\\nroutine ultrasound scans may have considerable\\nresource implications for LMIC settings.\\nEquity\\nEffective interventions to increase uptake and quality\\nof ANC services, and improve the experience of\\ncare, are needed in LMICs to prevent maternal and\\nperinatal mortality and improve equity. However, if\\nwomen are expected to pay for ultrasound scans,\\nor if scans are not available to women living in rural\\nareas due to feasibility issues, this intervention could\\nperpetuate inequalities. In addition, ultrasound sexing\\nof the fetus in some low-income countries has a\\nnegative impact on gender equity and needs to be\\nmonitored.\\nAcceptability\\nQualitative evidence shows that women generally\\nappreciate the knowledge and information they can\\nacquire from health-care providers and that they\\nare willing to be screened and tested for a variety of\\nconditions, provided the information and procedures'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='acquire from health-care providers and that they\\nare willing to be screened and tested for a variety of\\nconditions, provided the information and procedures\\nare explained properly and delivered in a caring\\nand culturally sensitive manner (high confidence\\nin the evidence) (22). Evidence also shows that, in\\nsome LMICs, the lack of modern technology (like\\nultrasound equipment) at ANC facilities discourages\\nsome women from attending (high confidence in\\nthe evidence) (22). This suggests that the offer of\\nultrasound might attract women to use ANC facilities,\\nwhich may also lead to earlier ANC attendance.\\nSpecific studies not included in the main qualitative\\nreview indicate that women value the opportunity\\nto see their baby via ultrasound and find the test\\nreassuring (123). However, there is some evidence\\nthat women do not understand that ultrasound is\\na diagnostic tool, and that adverse findings during\\nscans might increase anxiety and distress (124).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'discusses_normal_variations': True}, page_content='reassuring (123). However, there is some evidence\\nthat women do not understand that ultrasound is\\na diagnostic tool, and that adverse findings during\\nscans might increase anxiety and distress (124).\\nQualitative evidence from health-care providers\\nshows that they generally want to provide screening\\nand testing procedures, but sometimes don’t feel\\nsuitably trained to do so (high confidence in the\\nevidence) (45). This suggests that they might\\nwelcome ultrasound scans to assist with accurate\\ngestational age estimation and to identify potential\\nrisk factors, such as multiple pregnancies, if\\nappropriately trained and supported.\\nFeasibility\\nFeasibility challenges of antenatal ultrasound scans\\nin LMICs includes equipment procurement and staff\\ntraining, ensuring a power supply (via a power point\\nor rechargeable batteries) and secure storage, regular\\nequipment maintenance, maintaining adequate and\\ncontinual supplies of ultrasound gel, and ongoing\\ntechnical support and supervision.  \\n61'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='or rechargeable batteries) and secure storage, regular\\nequipment maintenance, maintaining adequate and\\ncontinual supplies of ultrasound gel, and ongoing\\ntechnical support and supervision.  \\n61\\nB.2.5: Doppler ultrasound of fetal blood vessels'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.5: Routine Doppler ultrasound examination is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='pregnant women to improve maternal and perinatal outcomes. (Not recommended)\\nRemarks\\n• The GDG noted that the evidence base for the use of Doppler ultrasound of fetal blood vessels in high-\\nrisk pregnancy is already established.\\n• The GDG agreed that the value of a single Doppler ultrasound examination of fetal blood vessels for all\\npregnant women in the third trimester needs rigorous evaluation, particularly in LMIC settings. Future\\ntrials should be designed to evaluate the effect of a single Doppler ultrasound on preventable perinatal\\ndeaths.\\nSummary of evidence and considerations\\nEffects of Doppler ultrasound examination of\\nfetal blood vessels compared with no Doppler\\nultrasound examination (EB T able B.2.5)\\nThe evidence on Doppler ultrasound examination\\nwas derived from a Cochrane review that included\\nfive trials involving 14624 women in HICs (Australia,\\nFrance and the United Kingdom) (114). One study\\nevaluated a single Doppler examination at 28–34'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.5: Routine Doppler ultrasound examination is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='was derived from a Cochrane review that included\\nfive trials involving 14624 women in HICs (Australia,\\nFrance and the United Kingdom) (114). One study\\nevaluated a single Doppler examination at 28–34\\nweeks of gestation, three studies evaluated multiple\\nDoppler examinations from as early as 18 weeks,\\nand one study evaluated women undergoing single\\nor multiple examinations from 26 to 36 weeks\\nof gestation. Data were evaluated together and\\nseparately for single and multiple examinations.\\nWomen in the control arms received standard ANC\\nwith no (or concealed) Doppler examination.\\nMaternal outcomes\\nThe available moderate-certainty evidence suggests\\nthat antenatal Doppler ultrasound probably makes\\nlittle or no difference to caesarean section rates\\n(2trials, 6373 women; RR: 0.98, 95% CI: 0.85–1.13)\\nand assisted vaginal birth (2 trials, 6884 women;\\nRR: 1.04, 95% CI: 0.96–1.12). No other maternal\\noutcomes that were prioritized for the ANC guideline\\nwere reported in the trials.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.5: Routine Doppler ultrasound examination is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='and assisted vaginal birth (2 trials, 6884 women;\\nRR: 1.04, 95% CI: 0.96–1.12). No other maternal\\noutcomes that were prioritized for the ANC guideline\\nwere reported in the trials.\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that Doppler\\nultrasound may have little or no effect on perinatal\\nmortality (4 trials, 11183 women; RR: 0.80, 95% CI:\\n0.35–1.83). Moderate-certainty evidence indicates\\nthat the intervention probably has little or no effect\\non preterm birth (4 trials, 12162 women; RR: 1.02,\\n95% CI: 0.87–1.18).\\nAdditional considerations\\nnn Subgroup analyses according to the number\\nof Doppler ultrasound examinations (single or\\nmultiple) are largely consistent with the overall\\nfindings. However, low-certainty evidence from the\\nsingle examination subgroup suggests that a single\\nDoppler ultrasound examination might reduce\\nperinatal mortality (1 trial, 3890 women; RR: 0.36,\\n95% CI: 0.13–0.99).\\nValues\\nPlease see “Women’s values” in section 3.B.2: Fetal'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.5: Routine Doppler ultrasound examination is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='Doppler ultrasound examination might reduce\\nperinatal mortality (1 trial, 3890 women; RR: 0.36,\\n95% CI: 0.13–0.99).\\nValues\\nPlease see “Women’s values” in section 3.B.2: Fetal\\nassessment: Background (p.54).\\nResources\\nThe cost of ultrasound equipment, especially portable\\ncompact units, has decreased (122), and they are\\ncurrently available at less than US$10000 (28).\\nThus, given the cost of equipment, maintenance,\\nsupplies (ultrasound gel), replacement batteries,\\ninitial and ongoing staff training and supervision, and\\nstaffing costs, routine Doppler ultrasound scans may\\nhave considerable resource implications for LMIC\\nsettings.\\nEquity\\nRCT evidence on maternal and perinatal effects of\\nDoppler ultrasound examination is currently derived\\nfrom HICs and high-quality research is needed on\\nthis intervention in LMICs to determine whether, by\\nimproving detection of pregnancy complications, it\\ncan reduce perinatal mortality and improve health\\nequity.\\nAcceptability'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.5: Routine Doppler ultrasound examination is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'discusses_normal_variations': True}, page_content='this intervention in LMICs to determine whether, by\\nimproving detection of pregnancy complications, it\\ncan reduce perinatal mortality and improve health\\nequity.\\nAcceptability\\nQualitative evidence shows that women generally\\nappreciate the knowledge and information they can\\nacquire from health-care providers and that they  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n62\\nare willing to be screened and tested for a variety of\\nconditions, provided the information and procedures\\nare explained properly and delivered in a caring\\nand culturally sensitive manner (high confidence\\nin the evidence) (22). Evidence also shows that, in\\nsome LMICs, the lack of modern technology (like\\nultrasound equipment) at ANC facilities discourages\\nsome women from attending (high confidence in the\\nevidence) (22).\\nQualitative evidence from health-care providers\\nshows that they generally want to provide screening\\nand testing procedures, but sometimes don’t feel'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION B.2.5: Routine Doppler ultrasound examination is not recommended for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'discusses_normal_variations': True}, page_content='evidence) (22).\\nQualitative evidence from health-care providers\\nshows that they generally want to provide screening\\nand testing procedures, but sometimes don’t feel\\nsuitably trained to do so (high confidence in the\\nevidence) (45). This suggests that they might\\nwelcome Doppler ultrasound scans to identify\\npotential risk factors, if appropriately trained and\\nsupported.\\nFeasibility\\nFeasibility challenges of Doppler ultrasound scans\\nin LMICs include equipment procurement and staff\\ntraining, ensuring a power supply (via a power point\\nor rechargeable batteries) and secure storage, regular\\nequipment maintenance, maintaining adequate and\\ncontinual supplies of ultrasound gel, and ongoing\\ntechnical support and supervision.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='63'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='Background\\nThe GDG considered the evidence and other relevant\\ninformation to inform recommendations on antenatal\\ninterventions to prevent the following conditions.\\nnn Asymptomatic bacteriuria (ASB): Defined as true\\nbacteriuria in the absence of specific symptoms\\nof acute urinary tract infection, ASB is common\\nin pregnancy, with rates as high as 74% reported\\nin some LMICs (125). Escherichia coli is associated\\nwith up to 80% of isolates (83). Other pathogens\\ninclude Klebsiella species, Proteus mirabilis and\\ngroup B streptococcus (GBS). While ASB in non-\\npregnant women is generally benign, in pregnant\\nwomen obstruction to the flow of urine by the\\ngrowing fetus and womb leads to stasis in the\\nurinary tract and increases the likelihood of acute\\npyelonephritis. If untreated, up to 45% of pregnant\\nwomen with ASB may develop this complication\\n(126), which is associated with an increased risk of\\npreterm birth.\\nnn Recurrent urinary tract infections: A recurrent'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='women with ASB may develop this complication\\n(126), which is associated with an increased risk of\\npreterm birth.\\nnn Recurrent urinary tract infections: A recurrent\\nurinary tract infection (RUTI) is a symptomatic\\ninfection of the urinary tract (bladder and kidneys)\\nthat follows the resolution of a previous urinary\\ntract infection (UTI), generally after treatment.\\nDefinitions of RUTI vary and include two UTIs\\nwithin the previous six months, or a history of one\\nor more UTIs before or during pregnancy (127).\\nRUTIs are common in women who are pregnant\\nand have been associated with adverse pregnancy\\noutcomes including preterm birth and small-for-\\ngestational-age newborns (127). Pyelonephritis\\n(infection of the kidneys) is estimated to occur in\\n2% of pregnancies, with a recurrence rate of up to\\n23% within the same pregnancy or soon after the\\nbirth (128). Little is known about the best way to\\nprevent RUTI in pregnancy.\\nnn Rhesus D alloimmunization: Rhesus (Rh) negative'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='23% within the same pregnancy or soon after the\\nbirth (128). Little is known about the best way to\\nprevent RUTI in pregnancy.\\nnn Rhesus D alloimmunization: Rhesus (Rh) negative\\nmothers can develop Rh antibodies if they have an\\nRh-positive newborn, causing haemolytic disease\\nof the newborn (HDN) in subsequent pregnancies.\\nAdministering anti-D immunoglobulin to Rh-\\nnegative women within 72hours of giving birth\\nto an Rh-positive baby is an effective way of\\npreventing RhD alloimmunization and HDN (129).\\nHowever, Rhesus alloimmunization occurring in\\nthe third trimester due to occult transplacental\\nhaemorrhages will not be prevented by postpartum\\nanti-D.\\nnn Soil-transmitted helminthiasis: Over 50% of\\npregnant women in LMICs suffer from anaemia,\\nand helminthiasis is a major contributory cause\\nin endemic areas (33). Soil-transmitted helminths\\nare parasitic infections caused mainly by\\nroundworms (Ascaris lumbricoides), hookworms\\n(Necator americanus and Ancylostoma duodenale),'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='in endemic areas (33). Soil-transmitted helminths\\nare parasitic infections caused mainly by\\nroundworms (Ascaris lumbricoides), hookworms\\n(Necator americanus and Ancylostoma duodenale),\\nand whipworms (Trichuris trichiura). These worms\\n(particularly hookworms) feed on blood and\\ncause further bleeding by releasing anticoagulant\\ncompounds, thereby causing iron-deficiency\\nanaemia (130). They may also reduce the\\nabsorption of iron and other nutrients by causing\\nanorexia, vomiting and diarrhoea (131).\\nnn Neonatal tetanus: T etanus is an acute disease\\ncaused by an exotoxin produced by Clostridium\\ntetani. Neonatal infection usually occurs through\\nthe exposure of the unhealed umbilical cord stump\\nto tetanus spores, which are universally present in\\nsoil, and newborns need to have received maternal\\nantibodies via the placenta to be protected at birth.\\nNeonatal disease usually presents within the first\\ntwo weeks of life and involves generalized rigidity'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='antibodies via the placenta to be protected at birth.\\nNeonatal disease usually presents within the first\\ntwo weeks of life and involves generalized rigidity\\nand painful muscle spasms, which in the absence\\nof medical treatment leads to death in most\\ncases (132). Global vaccination programmes have\\nreduced the global burden of neonatal tetanus\\ndeaths and continue to do so; estimates show a\\nreduction from an estimated 146000 in 2000\\nto 58000 (CI: 20000–276000) in 2010 (133).\\nHowever, because tetanus spores are ubiquitous\\nin the environment, eradication is not biologically\\nfeasible and high immunization coverage remains\\nessential (134).\\nIn addition to GDG recommendations on the\\nabove, this section of the guideline includes\\ntwo recommendations on disease prevention in\\npregnancy that have been integrated from WHO\\nguidelines on malaria and HIV prevention that are\\nrelevant to routine ANC.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n64'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='pregnancy that have been integrated from WHO\\nguidelines on malaria and HIV prevention that are\\nrelevant to routine ANC.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n64\\nC.1: Antibiotics for asymptomatic bacteriuria (ASB)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'recommendation': 'RECOMMENDATION C.1: A seven-day antibiotic regimen is recommended for all pregnant', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='women with asymptomatic bacteriuria (ASB) to prevent persistent bacteriuria, preterm birth\\nand low birth weight. (Recommended)\\nRemarks\\n• This recommendation should be considered alongside the recommendation on ASB diagnosis\\n(Recommendation B.1.2).\\n• Stakeholders may wish to consider context-specific ASB screening and treatment based on ASB and\\npreterm birth prevalence, as it may not be appropriate in settings with low prevalence.\\n• Evidence on preterm birth is of low certainty and large multicentre trials are needed to confirm whether\\nscreening and antibiotic treatment reduces preterm birth and perinatal mortality in LMICs. Such trials\\nshould also aim to evaluate the effects of group B streptococcus (GBS) screening and treatment.\\n• Studies have shown that GBS bacteriuria is a sign of heavy GBS colonization, which may not be\\neradicated by antibiotic treatment. GBS bacteriuria is a risk factor for having an infant with early onset'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'recommendation': 'RECOMMENDATION C.1: A seven-day antibiotic regimen is recommended for all pregnant', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='eradicated by antibiotic treatment. GBS bacteriuria is a risk factor for having an infant with early onset\\nGBS disease. WHO recommends that pregnant women with GBS colonization receive intrapartum\\nantibiotic administration to prevent early neonatal GBS infection (see WHO recommendations for\\nprevention and treatment of maternal peripartum infections [135]).\\n• Preterm birth indicators should be monitored with this intervention, as should changes in antimicrobial\\nresistance.\\nWomen’s values\\nA scoping review of what women want from ANC and what outcomes they value informed the ANC guideline (13).\\nEvidence showed that women from high-, medium- and low-resource settings valued having a positive pregnancy\\nexperience. This included the tailored (rather than routine) use of biomedical tests and effective preventive\\ninterventions to optimize pregnancy and newborn health, and the ability of health-care practitioners to explain and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'recommendation': 'RECOMMENDATION C.1: A seven-day antibiotic regimen is recommended for all pregnant', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='interventions to optimize pregnancy and newborn health, and the ability of health-care practitioners to explain and\\ndeliver these procedures in a knowledgeable, supportive and respectful manner (high confidence in the evidence).\\nSummary of evidence and considerations\\nEffects of antibiotics for ASB versus no\\nantibiotics or placebo (EB T able C.1)\\nThe evidence on the effects of antibiotics for ASB\\nwas derived from a Cochrane review that included\\n14 trials involving approximately 2000 women (83).\\nMost trials were conducted in HICs between 1960\\nand 1987. T ypes of antibiotics included sulfonamides,\\nampicillin, nitrofurantoin and some antibiotics that\\nare no longer recommended for use in pregnancy,\\nsuch as tetracycline. T reatment duration between\\ntrials varied widely from a single dose, to continuous\\ntreatment throughout pregnancy. Bacteriuria\\nwas usually defined as at least one clean-catch,\\nmidstream or catheterized urine specimen with more\\nthan 100000 bacteria/ mL on culture, but other'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Preventive measures', 'recommendation': 'RECOMMENDATION C.1: A seven-day antibiotic regimen is recommended for all pregnant', 'section_path': ['3 Evidence and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='treatment throughout pregnancy. Bacteriuria\\nwas usually defined as at least one clean-catch,\\nmidstream or catheterized urine specimen with more\\nthan 100000 bacteria/ mL on culture, but other\\ndefinitions were also used.\\nMaternal outcomes\\nThe only maternal ANC guideline outcomes reported\\nwere infection outcomes. Low-certainty evidence\\nsuggests that antibiotics may reduce persistent\\nbacteriuria (4 trials, 596 women; RR: 0.30, 95% CI:\\n0.18–0.53); however, the evidence on the effect on\\npyelonephritis is very uncertain.\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that antibiotics for\\nASB may reduce low-birth-weight neonates (8 trials,\\n1437 neonates; RR: 0.64, 95% CI: 0.45–0.93) and\\npreterm birth (2 trials, 142 women; RR: 0.27, 95% CI:\\n0.11–0.62). No other ANC guideline outcomes were\\nreported.\\nAdditional considerations\\nnn The GDG also evaluated evidence on treatment\\nduration (single dose versus short-course'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='65\\n[4–7days]) from a related Cochrane review that\\nincluded 13 trials involving 1622 women (136). T en\\ntrials compared different durations of treatment\\nwith the same antibiotic, and the remaining three\\ncompared different durations of treatment with\\ndifferent drugs. A wide variety of antibiotics was\\nused. The resulting pooled evidence on bacterial\\npersistence (7 trials), recurrent ASB (8 trials)\\nand pyelonephritis (2 trials) was judged as\\nvery uncertain. However, on sensitivity analysis\\nincluding high-quality trials of amoxicillin and\\nnitrofurantoin only, the high-certainty evidence\\nindicates that bacterial persistence is reduced\\nwith a short course rather than a single dose (2\\ntrials, 803 women; RR: 1.72, 95% CI: 1.27–2.33).\\nHigh-certainty evidence from one large trial shows\\nthat a seven-day course of nitrofurantoin is more\\neffective than a one-day treatment to reduce low\\nbirth weight (714 neonates; RR: 1.65, 95% CI:\\n1.06–2.57). Low-certainty evidence suggests that'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='that a seven-day course of nitrofurantoin is more\\neffective than a one-day treatment to reduce low\\nbirth weight (714 neonates; RR: 1.65, 95% CI:\\n1.06–2.57). Low-certainty evidence suggests that\\nsingle-dose treatments may be associated with\\nfewer side-effects (7 trials, 1460 women; RR: 0.70,\\n95% CI: 0.56–0.88). See Web supplement (EB\\nT ableC.1).\\nnn The GDG also evaluated evidence on the test\\naccuracy of urine Gram staining and dipstick\\ntesting (see Recommendation B.1.2 in section 3.B).\\nValues\\nSee “Women’s values” at the beginning of section 3.C:\\nBackground (p.64).\\nResources\\nAntibiotic costs vary. Amoxicillin and trimethoprim\\nare much cheaper (potentially around US$1–2 for a\\nweek’s supply) than nitrofurantoin, which can cost\\nabout US$7–10 for a week’s supply of tablets (137).\\nRepeated urine testing to check for clearance of\\nASB has cost implications for laboratory and human\\nresources, as well as for the affected women. The\\nemergence of antimicrobial resistance is of concern'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs'], 'discusses_normal_variations': True}, page_content='ASB has cost implications for laboratory and human\\nresources, as well as for the affected women. The\\nemergence of antimicrobial resistance is of concern\\nand may limit the choice of antimicrobials (125).\\nEquity\\nPreterm birth is the leading cause of neonatal\\ndeath worldwide, with most deaths occurring in\\nLMICs; therefore, preventing preterm birth among\\ndisadvantaged populations might help to address\\ninequalities.\\nAcceptability\\nIn LMICs, some women hold the belief that\\npregnancy is a healthy condition and may not accept\\nthe use of antibiotics in this context (particularly\\nif they have no symptoms) unless they have\\nexperienced a previous pregnancy complication (high\\nconfidence in the evidence) (22). Others view ANC\\nas a source of knowledge, information and medical\\nsafety, and generally appreciate the interventions\\nand advice they are offered (high confidence in the\\nevidence). However, engagement may be limited if\\nthis type of intervention is not explained properly. In'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='and advice they are offered (high confidence in the\\nevidence). However, engagement may be limited if\\nthis type of intervention is not explained properly. In\\naddition, where there are likely to be additional costs\\nassociated with treatment, women are less likely to\\nengage (high confidence in the evidence).\\nFeasibility\\nA lack of resources in LMICs, both in terms of\\nthe availability of the medicines and testing,\\nand the lack of suitably trained staff to provide\\nrelevant information and perform tests, may limit\\nimplementation (high confidence in the evidence)\\n(45).\\nC.2: Antibiotic prophylaxis to prevent recurrent urinary tract infections\\n(RUTI)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.2: Antibiotic prophylaxis is only recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='recurrent urinary tract infections in pregnant women in the context of rigorous research.\\n(Context-specific recommendation – research)\\nRemarks\\n• Further research is needed to determine the best strategies for preventing RUTI in pregnancy, including\\nthe effects of antibiotic prophylaxis on pregnancy-related outcomes and changes in antimicrobial\\nresistance.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n66\\nSummary of evidence and considerations\\nEffects of prophylactic antibiotics to\\nprevent RUTI compared with no antibiotics\\n(EBT ableC.2)\\nThe evidence on the effects of prophylactic antibiotics\\nto prevent RUTI was derived from a Cochrane review\\nin which only one trial in the USA involving 200\\npregnant women contributed data (127). Women\\nadmitted to hospital with pyelonephritis were\\nrandomized, after the acute phase, to prophylactic\\nantibiotics (nitrofurantoin 50mg three times daily)\\nfor the remainder of the pregnancy plus close'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.2: Antibiotic prophylaxis is only recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='admitted to hospital with pyelonephritis were\\nrandomized, after the acute phase, to prophylactic\\nantibiotics (nitrofurantoin 50mg three times daily)\\nfor the remainder of the pregnancy plus close\\nsurveillance (regular clinic visits and urine culture,\\nwith antibiotics on positive culture), or to close\\nsurveillance only.\\nMaternal outcomes\\nEvidence from this single study on the risk of\\nrecurrent pyelonephritis and RUTI with prophylactic\\nantibiotics is very uncertain. No other maternal ANC\\nguideline outcomes were reported in the study.\\nFetal and neonatal outcomes\\nEvidence on the risk of low birth weight and preterm\\nbirth with prophylactic antibiotics is very uncertain.\\nNo other fetal and neonatal ANC guideline outcomes\\nwere reported in the study.\\nAdditional considerations\\nnn Antibiotic prophylaxis to prevent RUTI may lead to\\nincreased antimicrobial resistance and there is a\\nlack of evidence on this potential consequence.\\nValues\\nSee “Women’s values” at the beginning of section'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.2: Antibiotic prophylaxis is only recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'discusses_normal_variations': True}, page_content='increased antimicrobial resistance and there is a\\nlack of evidence on this potential consequence.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.C: Background (p.64).\\nResources\\nAntibiotic costs vary. T rimethoprim is cheaper\\nthan nitrofurantoin, which can cost about US$5 for\\n28×100mg tablets (137).\\nEquity\\nImpact not known.\\nAcceptability\\nIn LMICs, some women hold the belief that\\npregnancy is a healthy condition and may not accept\\nthe use of antibiotics in this context (particularly\\nif they have no symptoms) unless they have\\nexperienced a previous pregnancy complication (high\\nconfidence in the evidence) (22). Others view ANC\\nas a source of knowledge, information and medical\\nsafety and generally appreciate the interventions\\nand advice they are offered (high confidence in the\\nevidence). However, engagement may be limited if\\nthis type of intervention is not explained properly. In\\naddition, where there are likely to be additional costs'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.2: Antibiotic prophylaxis is only recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='evidence). However, engagement may be limited if\\nthis type of intervention is not explained properly. In\\naddition, where there are likely to be additional costs\\nassociated with treatment, women are less likely to\\nengage (high confidence in the evidence).\\nFeasibility\\nA lack of resources in LMICs, both in terms of the\\navailability of the medicines and testing, and the lack\\nof suitably trained staff to provide relevant information\\nand perform tests, may limit implementation (high\\nconfidence in the evidence) (45).\\nC.3: Antenatal anti-D immunoglobulin prophylaxis'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.3: Antenatal prophylaxis with anti-D immunoglobulin in non-sensitized', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Rh-negative pregnant women at 28 and 34weeks of gestation to prevent RhD alloimmunization\\nis recommended only in the context of rigorous research. (Context-specific recommendation –\\nresearch)\\nRemarks\\n• This context-specific recommendation relates to anti-D prophylaxis during pregnancy and not the\\npractice of giving anti-D after childbirth, for which there is high-certainty evidence of its effect of reducing\\nRhD alloimmunization in subsequent pregnancies (129). Anti-D should still be given postnatally when\\nindicated.\\n• Determining the prevalence of RhD alloimmunization and associated poor outcomes among women in\\nLMIC settings, as well as developing strategies to manage this condition, is considered a research priority'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'normal_variations']}, page_content='67\\nSummary of evidence and considerations\\nEffects of antenatal anti-D immunoglobulin\\nprophylaxis in non-sensitized Rh-negative\\npregnant  women compared with no intervention\\n(EB T able C.3)\\nThe evidence on the effects of antenatal anti-D\\nprophylaxis was derived from a Cochrane review that\\nincluded two RCT s involving over 4500 Rh-negative\\npregnant women (138). Most participants were\\nprimigravidas. Both trials compared antenatal anti-D\\nprophylaxis with no antenatal anti-D prophylaxis. One\\ntrial used a dose of 500IU, the other used 250IU,\\ngiven at 28 and 34weeks of gestation. Data were\\navailable for 3902 pregnancies, and more than half\\nthe participants gave birth to Rh-positive newborns\\n(2297). All women with Rh-positive newborns\\nreceived postpartum anti-D immunoglobulin as per\\nusual management. The primary outcome was the\\npresence of Rh-antibodies in maternal blood (a proxy\\nfor neonatal morbidity). No maternal ANC guideline\\noutcomes (including maternal satisfaction and side-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='presence of Rh-antibodies in maternal blood (a proxy\\nfor neonatal morbidity). No maternal ANC guideline\\noutcomes (including maternal satisfaction and side-\\neffects) and few perinatal guideline outcomes were\\nreported in these trials.\\nFetal and neonatal outcomes\\nEvidence on the effect of antenatal anti-D on RhD\\nalloimmunization during pregnancy, suggesting\\nlittle or no difference in effect, is very uncertain. In\\naddition, the evidence on the effect on postpartum\\nRhD alloimmunization and alloimmunization up\\nto 12months postpartum among women giving\\nbirth to Rh-positive newborns (n=2297 and 2048,\\nrespectively) is very uncertain, partly because events\\nwere rare. Evidence on the effect of antenatal anti-D\\non neonatal morbidity (jaundice) from one trial (1882\\nneonates) is also very uncertain, partly because\\nevents were rare. No other ANC guideline outcomes\\nwere reported in the review.\\nAdditional considerations\\nnn Low-certainty evidence from the Cochrane review'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='events were rare. No other ANC guideline outcomes\\nwere reported in the review.\\nAdditional considerations\\nnn Low-certainty evidence from the Cochrane review\\nsuggests that Rh-negative women who receive\\nantenatal anti-D are less likely to register a\\npositive Kleihauer test (which detects fetal cells\\nin maternal blood) during pregnancy (1 trial, 1884\\nwomen; RR: 0.60, 95% CI: 0.41–0.88) and at the\\nbirth of a Rh-positive neonate (1 trial, 1189 women;\\nRR: 0.60, 95% CI: 0.46–0.79).\\nnn In the Cochrane review, the rate of RhD alloimmuni-\\nzation during pregnancy, the postpartum period and\\nup to 12months later among women in the control\\ngroup was 0.6%, 1.1% and 1.5%, respectively.\\nnn Rates of RhD alloimmunization in subsequent\\npregnancies were not reported in the trials.\\nnn There is no evidence on optimal dose of antenatal\\nanti-D prophylaxis and various regimens are\\nused. There are two ongoing studies listed in the\\nCochrane review, which may help to clarify issues'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='nn There is no evidence on optimal dose of antenatal\\nanti-D prophylaxis and various regimens are\\nused. There are two ongoing studies listed in the\\nCochrane review, which may help to clarify issues\\naround effects and dosage once completed.\\nnn Only 60% of Rh-negative primigravidas will have\\nan Rh-positive newborn, therefore 40% of Rh-\\nnegative women will receive anti-D unnecessarily\\nwith antenatal anti-D prophylaxis (138).\\nValues\\nSee “Women’s values” at the beginning of section\\n3.C: Background (p.64).\\nResources\\nA single dose of anti-D can cost around US$50\\n(500IU) to US$87 (1500IU) (139), depending on the\\nbrand and local taxes; therefore, the cost of antenatal\\nprophylaxis for two 500IU doses could be as much\\nas US$100 per woman. Additional costs will include\\nscreening for blood typing in settings where Rh blood\\ntests are not currently performed.\\nEquity\\nThe contribution of RhD alloimmunization to\\nperinatal morbidity and mortality in various LMIC'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='screening for blood typing in settings where Rh blood\\ntests are not currently performed.\\nEquity\\nThe contribution of RhD alloimmunization to\\nperinatal morbidity and mortality in various LMIC\\nsettings is uncertain and it is not known whether\\nantenatal anti-D for non-sensitized Rh-negative\\nwomen will impact on equity.\\nAcceptability\\nAnti-D immunoglobulin is derived from human\\nplasma and is administered by injection, which may\\nnot be acceptable to all women. Qualitative evidence\\nindicates that engagement may be limited if tests and\\nprocedures are not explained properly to women, or\\nwhen women feel their beliefs, traditions and social\\nsupport mechanisms are overlooked or ignored by\\nhealth-care professionals (high confidence in the\\nevidence) (22).\\nFeasibility\\nIn a number of LMIC settings providers feel that a\\nlack of resources, both in terms of the availability\\nof the medicines and the lack of suitably trained\\nstaff to provide relevant information, may limit'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='lack of resources, both in terms of the availability\\nof the medicines and the lack of suitably trained\\nstaff to provide relevant information, may limit\\nimplementation of recommended interventions\\n(high confidence in the evidence) (45). Anti-D needs\\nrefrigeration at 2–8°C, which may not be feasible in\\nsome LMIC settings.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n68\\nC.4: Preventive anthelminthic treatment'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.4: In endemic areas, a preventive anthelminthic treatment is', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='recommended for pregnant women after the first trimester as part of worm infection reduction\\nprogrammes. (Context-specific recommendation)\\nRemarks\\n• This recommendation is consistent with the WHO Guideline: preventive chemotherapy to control soil-\\ntransmitted helminth infections in high-risk groups (140), which states that:\\n“Preventive chemotherapy (deworming), using single-dose albendazole (400 mg) or\\nmebendazole (500 mg) is recommended as a public health intervention for pregnant women,\\nafter the first trimester, living in areas where both: (1) the baseline prevalence of hookworm\\nand/ or T. trichiura infection is 20% or more and (2) where anaemia is a severe public health\\nproblem, with prevalence of 40% or higher among pregnant women, in order to reduce the\\nburden of hookworm and T. trichiura infection (conditional recommendation, moderate quality of\\nevidence).”\\n• Endemic areas are areas where the prevalence of hookworm and/ or whipworm infection is 20% or more.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.4: In endemic areas, a preventive anthelminthic treatment is', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='evidence).”\\n• Endemic areas are areas where the prevalence of hookworm and/ or whipworm infection is 20% or more.\\nAnaemia is considered a severe public health problem when the prevalence among pregnant women is\\n40% or higher.\\n• Infected pregnant women in non-endemic areas should receive anthelminthic treatment in the second\\nor third trimester on a case-by-case basis (140). A single dose of albendazole (400 mg) or mebendazole\\n(500 mg) should be used (140, 141).\\n• The safety of these drugs in pregnancy has not been unequivocally established; however, the benefits are\\nconsidered to outweigh the disadvantages (141, 142).\\n• WHO recommends a treatment strategy comprising two treatments per year in high-risk settings with\\na prevalence of  50% for soil-transmitted helminthiasis, and once per year in areas with a 20–50%\\nprevalence (140).\\n• For further guidance on soil-transmitted helminth infections, refer to the WHO Guideline: preventive'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.4: In endemic areas, a preventive anthelminthic treatment is', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='prevalence (140).\\n• For further guidance on soil-transmitted helminth infections, refer to the WHO Guideline: preventive\\nchemotherapy to control soil-transmitted helminth infections in high-risk groups (currently in press) (140).\\na Greater than 20% prevalence of infection with any soil-transmitted helminths.\\nSummary of evidence and considerations\\nEffects of prophylactic anthelminthic treatment\\nagainst soil-transmitted helminths administered\\nin the second trimester of pregnancy compared\\nwith no intervention or placebo (EB T able C.4)\\nThe following evidence on the effects of prophylactic\\nanthelminthic treatment was derived from a\\nCochrane review that included four trials conducted\\nin Peru, Sierra Leone and Uganda, involving 4265\\npregnant women (142). In two trials (Peru and Sierra\\nLeone), the anthelminthic medication (albendazole\\nor mebendazole) was administered as a single dose\\nin the second trimester, with or without daily iron and\\nfolic acid supplements, irrespective of the presence'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.4: In endemic areas, a preventive anthelminthic treatment is', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes']}, page_content='or mebendazole) was administered as a single dose\\nin the second trimester, with or without daily iron and\\nfolic acid supplements, irrespective of the presence\\nof proven helminthiasis. The frequency of anaemia\\n(Hb <110g/L) in these two trials was 56% and 47%,\\nrespectively, and the frequency of intestinal worms\\nranged from 20% to 64.2% for roundworm, 46.4%\\nto 65.6% for hookworm, and 74.4% to 82% for\\nwhipworm. One small Ugandan trial administered a\\nsingle dose of albendazole (400mg) or placebo to\\nwomen in the second trimester, irrespective of the\\nproven presence of helminthiasis; baseline prevalence\\nwas 15%, 38% and 6% for ascariasis, hookworm and\\ntrichuriasis, respectively. The other Ugandan RCT\\ncontributed data on albendazole plus ivermectin\\nversus ivermectin only, administered as single doses\\nto pregnant women in the second trimester; all\\nwomen were infected with an intestinal helminth at\\ntrial entry.\\nMaternal outcomes\\nLow-certainty evidence suggests that a single dose of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.4: In endemic areas, a preventive anthelminthic treatment is', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='to pregnant women in the second trimester; all\\nwomen were infected with an intestinal helminth at\\ntrial entry.\\nMaternal outcomes\\nLow-certainty evidence suggests that a single dose of\\nalbendazole or mebendazole in the second trimester\\nof pregnancy may have little or no effect on maternal\\nanaemia (defined as Hb <11g/ dL) (4 trials, 3266\\nwomen; RR: 0.94; 95% CI: 0.81–1.10).\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that a single\\ndose of albendazole or mebendazole in the second'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='69\\ntrimester of pregnancy probably has little or no effect\\non preterm birth (2 trials, 1318 women; RR: 0.88, 95%\\nCI: 0.43–1.78) or perinatal mortality (2 trials, 3385\\nwomen; RR: 1.09, 95% CI: 0.71–1.67). No other ANC\\nguideline outcomes were reported in the review.\\nAdditional considerations\\nnn None of the trials in the Cochrane review evaluated\\neffects of more than one dose of anthelminthics.\\nFindings from large non-randomized studies\\n(NRSs) suggest that prophylactic anthelminthic\\ntreatment may have beneficial effects for mothers\\nand newborns living in endemic areas (143–145):\\nn– One NRS, including approximately 5000\\npregnant women in Nepal with a 74%\\nprevalence of hookworm infection, reported\\na 41% reduction in six-month infant mortality\\namong women receiving two doses of\\nalbendazole (one each in the second and third\\ntrimesters) compared with no treatment (95%\\nCI: 18–57%) (143). This study also showed\\nreductions in severe maternal anaemia with\\nalbendazole.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third', 'first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='albendazole (one each in the second and third\\ntrimesters) compared with no treatment (95%\\nCI: 18–57%) (143). This study also showed\\nreductions in severe maternal anaemia with\\nalbendazole.\\nn– A study from Sri Lanka involving approximately\\n7000 women compared mebendazole with\\nno treatment and found fewer stillbirths and\\nperinatal deaths among women receiving\\nmebendazole (1.9% vs 3.3%; OR: 0.55, 95%\\nCI: 0.40–0.77), and little difference in the\\noccurrence of congenital anomalies (1.8% vs\\n1.5%, for intervention and controls, respectively;\\nOR: 1.24, 95% CI: 0.80–1.91), even among the\\n407 women who had taken mebendazole in the\\nfirst trimester against medical advice (145).\\nnn The WHO manual on Preventive chemotherapy in\\nhuman helminthiasis stresses that every opportunity\\nshould be taken to reach at-risk populations\\nthrough existing channels (141).\\nnn Cross-referencing other WHO guidelines, the\\nupcoming 2016 WHO Guideline: preventive\\nchemotherapy to control soil-transmitted helminth'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='through existing channels (141).\\nnn Cross-referencing other WHO guidelines, the\\nupcoming 2016 WHO Guideline: preventive\\nchemotherapy to control soil-transmitted helminth\\ninfections in high-risk groups recommends that a\\nsingle dose of albendazole or mebendazole should\\nbe offered to pregnant women in the second and\\nthird trimesters of pregnancy where the prevalence\\nof any soil-transmitted helminth infection\\n(roundworm, hookworm and whipworm) exceeds\\n20% (140).\\nnn Preventive helminthic treatment helps to lessen\\nthe burden of other infections, e.g. HIV, malaria\\nand TB, and contributes to a sustained reduction of\\ntransmission (142).\\nValues\\nSee “Women’s values” at the beginning of section\\n3.C: Background (p.64).\\nResources\\nPreventive chemotherapy against helminthic\\ninfections is a cost–effective intervention. The\\nmarket price of a single tablet of generic albendazole\\n(400mg) or mebendazole (500mg) is about\\nUS$0.02–0.03 (141).\\nEquity\\nHelminthic infections are widely prevalent in poverty-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='market price of a single tablet of generic albendazole\\n(400mg) or mebendazole (500mg) is about\\nUS$0.02–0.03 (141).\\nEquity\\nHelminthic infections are widely prevalent in poverty-\\nstricken regions and control of this disease aims to\\nalleviate suffering, reduce poverty and support equity\\n(141).\\nAcceptability\\nAffected women are often asymptomatic and may\\nnot perceive the need for treatment. Therefore, the\\nprevalence of soil-based helminthiasis in a particular\\nsetting is likely to influence women’s and providers’\\npreferences. Studies of anthelminthic programmes\\namong non-pregnant cohorts, e.g. schoolchildren, in\\nendemic areas have shown high levels of acceptability\\n(146). For women receiving preventive treatment in\\nendemic areas, worms are often visible in the stools\\nthe day after treatment, and this may reinforce the\\nvalue of the intervention. However, where there\\nare likely to be additional costs associated with\\ntreatment (high confidence in the evidence) or where'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='value of the intervention. However, where there\\nare likely to be additional costs associated with\\ntreatment (high confidence in the evidence) or where\\nthe intervention is unavailable because of resource\\nconstraints (low confidence in the evidence) women\\nmay be less likely to engage with services (45).\\nFeasibility\\nIn a number of LMIC settings providers feel that a\\nlack of resources, both in terms of the availability\\nof the medicines and the lack of suitably trained\\nstaff to provide relevant information, may limit\\nimplementation of recommended interventions (high\\nconfidence in the evidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n70\\nC.5: T etanus toxoid vaccination'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.5: T etanus toxoid vaccination is recommended for all pregnant women,', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='depending on previous tetanus vaccination exposure, to prevent neonatal mortality from\\ntetanus. (Recommended)\\nRemarks\\n• This recommendation is consistent with recommendations from the 2006 WHO guideline on Maternal\\nimmunization against tetanus (134). The GDG endorses the 2006 guideline approach, which recommends\\nthe following.\\n– If a pregnant woman has not previously been vaccinated, or if her immunization status is unknown,\\nshe should receive two doses of a tetanus toxoid-containing vaccine (TT-CV) one month apart with\\nthe second dose given at least two weeks before delivery. T wo doses protect against tetanus infection\\nfor 1–3 years in most people. A third dose is recommended six months after the second dose, which\\nshould extend protection to at least five years.\\n– T wo further doses for women who are first vaccinated against tetanus during pregnancy should be\\ngiven after the third dose, in the two subsequent years or during two subsequent pregnancies.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.5: T etanus toxoid vaccination is recommended for all pregnant women,', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='– T wo further doses for women who are first vaccinated against tetanus during pregnancy should be\\ngiven after the third dose, in the two subsequent years or during two subsequent pregnancies.\\n– If a woman has had 1–4 doses of a TT-CV in the past, she should receive one dose of a TT-CV during\\neach subsequent pregnancy to a total of five doses (five doses protects throughout the childbearing\\nyears).\\n• T etanus vaccination and clean delivery practices are major components of the strategy to eradicate\\nmaternal and neonatal tetanus globally (147).\\n• Effective surveillance is critical for identifying areas or populations at high risk of neonatal tetanus and for\\nmonitoring the impact of interventions.\\n• A monitoring system should include an immunization register, personal vaccination cards and maternal\\nhealth records, which should be held by the woman.\\n• For effective implementation, ANC health-care providers need to be trained in tetanus vaccination and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.5: T etanus toxoid vaccination is recommended for all pregnant women,', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='health records, which should be held by the woman.\\n• For effective implementation, ANC health-care providers need to be trained in tetanus vaccination and\\nthe vaccine, equipment and supplies (refrigerator, needles and syringes) need to be readily available at\\nANC services.\\n• Policy-makers in low prevalence/high-income settings may choose not to include tetanus vaccination\\namong ANC interventions if effective tetanus immunization programmes and good post-exposure\\nprophylaxis exist outside of pregnancy.\\n• ANC contacts should be used to verify the vaccination status of pregnant women, and administer\\nany vaccines that are recommended in the national immunization schedule. ANC contacts are also\\nopportunities to explain the importance of infant vaccination and communicate the infant/ child\\nvaccination schedule to pregnant women.\\n• Further information can be found in the WHO guidance (134), available at: http:/ /www.who.int/'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.5: T etanus toxoid vaccination is recommended for all pregnant women,', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='vaccination schedule to pregnant women.\\n• Further information can be found in the WHO guidance (134), available at: http:/ /www.who.int/\\nreproductivehealth/ publications/ maternal_perinatal_health/immunization_tetanus.pdf; and in WHO’s\\nvaccine position papers, available at: http:/ /www.who.int/immunization/ documents/ positionpapers/ en\\nSummary of evidence and considerations\\nEffects of antenatal tetanus toxoid (TT)\\nvaccination compared with no, other or placebo\\nvaccination (EB T able C.5)\\nThe evidence on the effects of TT vaccination was\\nderived from a Cochrane review that assessed\\nthe effect of tetanus vaccination in women of\\nreproductive age or pregnant women to prevent\\nneonatal tetanus (148). T wo RCT s contributed data:\\none was conducted in Colombia between 1961 and\\n1965 and compared a tetanus vaccine (aluminium\\nphosphate adsorbed tetanus toxoid [10LF]; 3doses)\\nwith an influenza vaccine (1618 women, 1182\\nneonates); the other was conducted in the USA and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.5: T etanus toxoid vaccination is recommended for all pregnant women,', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='1965 and compared a tetanus vaccine (aluminium\\nphosphate adsorbed tetanus toxoid [10LF]; 3doses)\\nwith an influenza vaccine (1618 women, 1182\\nneonates); the other was conducted in the USA and\\ncompared a combined vaccine (tetanus/ diphtheria/\\nacellular pertussis [T dap]; 1 dose) with saline placebo\\nin 48 pregnant women between 30 and 32weeks of\\ngestation. Due to the relative paucity of RCT data,\\nadditional evidence on effects is also considered in\\nthe “Additional considerations” section.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='71\\nMaternal outcomes\\nLow-certainty evidence suggests that local side-\\neffects, such as pain, were more common with the\\nT dap vaccination than placebo (48 women; RR: 3.94,\\n95% CI: 1.41–11.01). There is no evidence on other\\nmaternal outcomes.\\nFetal and neonatal outcomes\\nLow-certainty evidence from the Colombian trial\\nsuggests that there may be fewer neonatal tetanus\\ncases among neonates whose mothers receive\\nTTvaccination than among those who do not (1182\\nneonates; RR: 0.20, 95% CI: 0.10–0.40). Moderate-\\ncertainty evidence suggests that two or more doses\\nof TT probably reduce neonatal mortality from\\nany cause (1 trial, 688 neonates; RR: 0.31, 95% CI:\\n0.17–0.55). Further low-certainty evidence suggests\\nthat neonatal mortality from tetanus may be reduced\\namong neonates whose mothers receive at least two\\nTT doses (1 trial, 688 neonates; RR: 0.02, 95% CI:\\n0.00–0.30), but not among neonates whose mothers\\nreceive only one dose (1 trial, 494 neonates; RR: 0.57,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='TT doses (1 trial, 688 neonates; RR: 0.02, 95% CI:\\n0.00–0.30), but not among neonates whose mothers\\nreceive only one dose (1 trial, 494 neonates; RR: 0.57,\\n95% CI: 0.26–1.24). Congenital anomalies and other\\nANC guideline outcomes were not reported in the\\ntrials.\\nAdditional considerations\\nnn A systematic review that pooled data from the\\nColombian trial with that of a large cohort study\\nof antenatal TT vaccination from India found\\nmoderate-certainty evidence to support a large\\neffect (94% reduction) on neonatal tetanus deaths\\nin favour of TT vaccination with at least two doses\\nin pregnant women and women of childbearing\\nage (2 trials, 2146 neonates; RR: 0.06, 95% CI:\\n0.02–0.20) (149).\\nnn TT vaccination has been widely used over\\n40 years, leading to a substantial decrease in\\nneonatal tetanus and an increase in neonatal\\nsurvival, with no sign of possible harm to pregnant\\nwomen or their fetuses (150). The WHO strategy\\nfor eliminating maternal and neonatal tetanus'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='neonatal tetanus and an increase in neonatal\\nsurvival, with no sign of possible harm to pregnant\\nwomen or their fetuses (150). The WHO strategy\\nfor eliminating maternal and neonatal tetanus\\nincludes immunization of pregnant women,\\nsupplementary immunization activities in selected\\nhigh-risk areas, promotion of clean deliveries and\\nclean cord practices, and reliable neonatal tetanus\\nsurveillance (134).\\nValues\\nSee “Women’s values” at the beginning of section\\n3.C: Background (p.64).\\nResources\\nThe cost of three doses of TT vaccine has been\\nestimated at around US$3 per woman (151), although\\nlower costs in vaccination programmes have been\\nreported (152). The need for cold-chain equipment\\nand staff training may add to costs.\\nEquity\\nMost deaths from neonatal tetanus occur in countries\\nwith low coverage of facility-based births, ANC and\\ntetanus vaccination (149). In addition, in LMICs,\\nANC coverage and infant mortality is often unequal\\nbetween the most- and least-educated, urban and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'discusses_normal_variations': True}, page_content='tetanus vaccination (149). In addition, in LMICs,\\nANC coverage and infant mortality is often unequal\\nbetween the most- and least-educated, urban and\\nrural, and richest and poorest populations (29).\\nTherefore, increasing tetanus immunity in LMICs\\nand among disadvantaged populations could help to\\naddress inequalities.\\nAcceptability\\nQualitative evidence indicates that most women\\nview ANC as a source of knowledge, information\\nand medical safety, and generally appreciate the\\ninterventions and advice they are offered. However,\\nengagement may be limited if vaccinations are\\nnot explained properly or when women feel their\\nbeliefs, traditions and social support mechanisms are\\noverlooked or ignored by health-care professionals\\n(high confidence in the evidence) (22). Lack of\\nengagement may be compounded if services are\\ndelivered in a hurried, inflexible, didactic manner\\n(high confidence in the evidence).\\nFeasibility\\nAntenatal services provide a convenient opportunity'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='engagement may be compounded if services are\\ndelivered in a hurried, inflexible, didactic manner\\n(high confidence in the evidence).\\nFeasibility\\nAntenatal services provide a convenient opportunity\\nfor vaccinating pregnant women, particularly in\\nsettings without effective childhood immunization\\nprogrammes. Qualitative evidence indicates that if\\nthere are additional costs associated with vaccination\\n(including transport costs and loss of earnings),\\nuptake may be limited (high confidence in the\\nevidence) (22). In addition, ANC providers in many\\nLMIC settings feel that a lack of resources, both in\\nterms of the availability of vaccines and the lack of\\nsuitably trained staff, may limit implementation (high\\nconfidence in the evidence) (45).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n72\\nC.6: Intermittent preventive treatment of malaria in pregnancy (IPTp)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.6: In malaria-endemic areas in Africa, intermittent preventive treatment', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='with sulfadoxine-pyrimethamine (IPTp-SP) is recommended for all pregnant women. Dosing\\nshould start in the second trimester, and doses should be given at least one month apart, with\\nthe objective of ensuring that at least three doses are received. (Context-specific recommendation)\\nRemarks\\n• This recommendation has been integrated from the WHO Guidelines for the treatment of malaria (2015),\\nwhere it is considered to be a strong recommendation based on high-quality evidence (153).\\n• Malaria infection during pregnancy is a major public health problem, with substantial risks for the mother,\\nher fetus and the newborn. WHO recommends a package of interventions for preventing and controlling\\nmalaria during pregnancy, which includes promotion and use of insecticide-treated nets, appropriate\\ncase management with prompt, effective treatment, and, in areas with moderate to high transmission of\\nPlasmodium falciparum, administration of IPT p-SP (153).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.6: In malaria-endemic areas in Africa, intermittent preventive treatment', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='case management with prompt, effective treatment, and, in areas with moderate to high transmission of\\nPlasmodium falciparum, administration of IPT p-SP (153).\\n• The high-quality evidence supporting this recommendation was derived from a systematic review\\nof seven RCT s conducted in malaria-endemic countries, which shows that three or more doses of\\nsulfadoxine-pyrimethamine (SP) is associated with reduced maternal parasitaemia, fewer low-birth-\\nweight infants and increased mean birth weight compared with two doses only (154).\\n• The malaria GDG noted that most evidence was derived from women in their first and second pregnancies;\\nhowever, the limited evidence on IPT p-SP from women in their third and subsequent pregnancies was\\nconsistent with benefit (153).\\n• T o ensure that pregnant women in endemic areas start IPT p-SP as early as possible in the second\\ntrimester, policy-makers should ensure health system contact with women at 13weeks of gestation.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.6: In malaria-endemic areas in Africa, intermittent preventive treatment', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': []}, page_content='• T o ensure that pregnant women in endemic areas start IPT p-SP as early as possible in the second\\ntrimester, policy-makers should ensure health system contact with women at 13weeks of gestation.\\nPolicy-makers could also consider supplying women with their first SP dose at the first ANC visit with\\ninstructions about the date (corresponding to 13weeks of gestation) on which the medicine should be\\ntaken.\\n• SP acts by interfering with folic acid synthesis in the malaria parasite, thereby inhibiting its life-cycle.\\nThere is some evidence that high doses of supplemented folic acid (i.e. 5mg daily or more) may interfere\\nwith the efficacy of SP in pregnancy (155). Countries should ensure that they procure and distribute folic\\nacid supplements for antenatal use at the recommended antenatal dosage (i.e. 0.4mg daily).\\n• The malaria GDG noted that there is insufficient evidence on the safety, efficacy and pharmacokinetics of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.6: In malaria-endemic areas in Africa, intermittent preventive treatment', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': []}, page_content='acid supplements for antenatal use at the recommended antenatal dosage (i.e. 0.4mg daily).\\n• The malaria GDG noted that there is insufficient evidence on the safety, efficacy and pharmacokinetics of\\nmost antimalarial agents in pregnancy, particularly during the first trimester (153).\\n• Detailed evidence and guidance related to the recommendation can be found in the 2015 guidelines (153),\\navailable at: http:/ /www.who.int/ malaria/ publications/ atoz/9789241549127 / en/'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='73\\nC.7: Pre-exposure prophylaxis for HIV prevention'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.7: Oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='fumarate (TDF) should be offered as an additional prevention choice for pregnant women at\\nsubstantial risk of HIV infection as part of combination prevention approaches.\\n(Context-specific recommendation)\\nRemarks\\n• This recommendation has been integrated from the WHO guideline on when to start antiretroviral therapy\\nand on pre-exposure prophylaxis for HIV (2015), where it is considered to be a strong recommendation\\nbased on high-quality evidence (99). The evidence and further guidance related to the recommendation\\ncan be found in this guideline.\\n• “Substantial risk” is provisionally defined as HIV incidence greater than 3 per 100 person-years in the\\nabsence of PrEP, but individual risk varies within this group depending on individual behaviour and\\nthe characteristics of sexual partners. Local epidemiological evidence concerning risk factors and HIV\\nincidence should be used to inform implementation.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION C.7: Oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='the characteristics of sexual partners. Local epidemiological evidence concerning risk factors and HIV\\nincidence should be used to inform implementation.\\n• Thresholds for offering PrEP may vary depending on a variety of considerations, including resources,\\nfeasibility and demand.\\n• The level of protection is strongly correlated with adherence.\\n• Detailed evidence and guidance related to this recommendation can be found in the 2015 guideline (99),\\navailable at: http:/ /www.who.int/hiv/ pub/ guidelines/ earlyrelease-arv/ en/  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n74'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Interventions for common', 'section_path': ['3 Evidence and recommendations', 'Interventions for common'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'normal_variations'], 'discusses_normal_variations': True}, page_content='physiological symptoms\\nBackground\\nWomen’s bodies undergo substantial changes\\nduring pregnancy, which are brought about by both\\nhormonal and mechanical effects. These changes lead\\nto a variety of common symptoms – including nausea\\nand vomiting, low back and pelvic pain, heartburn,\\nvaricose veins, constipation and leg cramps – that in\\nsome women cause severe discomfort and negatively\\naffects their pregnancy experience. In general,\\nsymptoms associated with mechanical effects, e.g.\\npelvic pain, heartburn and varicose veins, often\\nworsen as pregnancy progresses.\\nSymptoms of nausea and vomiting are experienced\\nby approximately 70% of pregnant women and\\nusually occur in the first trimester of pregnancy\\n(156); however, approximately 20% of women may\\nexperience nausea and vomiting beyond 20weeks of\\ngestation (157). Low back and pelvic pain is estimated\\nto occur in half of pregnant women, 8% of whom\\nexperience severe disability (158). Symptoms of\\nheartburn occur in two thirds of pregnant women,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Interventions for common', 'section_path': ['3 Evidence and recommendations', 'Interventions for common'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='gestation (157). Low back and pelvic pain is estimated\\nto occur in half of pregnant women, 8% of whom\\nexperience severe disability (158). Symptoms of\\nheartburn occur in two thirds of pregnant women,\\nand may be worse after eating and lying down (159).\\nVaricose veins usually occur in the legs, but can also\\noccur in the vulva and rectum, and may be associated\\nwith pain, night cramps, aching and heaviness,\\nand worsen with long periods of standing (160).\\nConstipation can be very troublesome and may be\\ncomplicated by haemorrhoids (161). Leg cramps often\\noccur at night and can be very painful, affecting sleep\\nand daily activities (162). Suggested approaches to\\nmanage common physiological symptoms include a\\nvariety of non-pharmacological and pharmacological\\noptions and the GDG considered the evidence and\\nother relevant information on these approaches.\\nWomen’s values:\\nA scoping review of what women want from ANC\\nand what outcomes they value informed the ANC'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Interventions for common', 'section_path': ['3 Evidence and recommendations', 'Interventions for common'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='other relevant information on these approaches.\\nWomen’s values:\\nA scoping review of what women want from ANC\\nand what outcomes they value informed the ANC\\nguideline (13). Evidence showed that women from\\nhigh-, medium- and low-resource settings valued\\nhaving a positive pregnancy experience. This\\nincluded woman-centred advice and treatment for\\ncommon physiological symptoms (high confidence\\nin the evidence). In many LMICs, this also included\\nsupport and respect for women’s use of alternative\\nor traditional approaches to the diagnosis and\\ntreatment of common pregnancy-related symptoms\\n(moderate confidence in the evidence).\\nD.1: Interventions for nausea and vomiting'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Interventions for common', 'recommendation': 'RECOMMENDATION D.1: Ginger, chamomile, vitamin B6 and/ or acupuncture are recommended', 'section_path': ['3 Evidence and recommendations', 'Interventions for common'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='for the relief of nausea in early pregnancy, based on a woman’s preferences and available\\noptions. (Recommended)\\nRemarks\\n• In the absence of stronger evidence, the GDG agreed that these non-pharmacological options are unlikely\\nto have harmful effects on mother and baby.\\n• Women should be informed that symptoms of nausea and vomiting usually resolve in the second half of\\npregnancy.\\n• Pharmacological treatments for nausea and vomiting, such as doxylamine and metoclopramide, should\\nbe reserved for those pregnant women experiencing distressing symptoms that are not relieved by non-\\npharmacological options, under the supervision of a medical doctor.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='75\\nSummary of evidence and considerations\\nEffects of interventions for nausea and\\nvomiting compared with other, no or placebo\\ninterventions (EB T able D.1)\\nThe evidence on the effects of various interventions\\nfor nausea and vomiting in pregnancy was derived\\nfrom a Cochrane systematic review (157). The\\nreview included 41 trials involving 5449 women in\\nwhom a wide variety of pharmacological and non-\\npharmacological interventions were evaluated.\\nT rials were conducted in a variety of HICs and\\nLMICs, and most included pregnant women at less\\nthan 16 weeks of gestation with mild to moderate\\nnausea and vomiting. Alternative therapies and\\nnon-pharmacological agents evaluated included\\nacupuncture, acupressure, vitamin B6, ginger,\\nchamomile, mint oil and lemon oil. Pharmacological\\nagents included antihistamines, phenothiazines,\\ndopamine-receptor antagonists and serotonin 5-HT3\\nreceptor antagonists. Due to heterogeneity among\\nthe types of interventions and reporting of outcomes,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='dopamine-receptor antagonists and serotonin 5-HT3\\nreceptor antagonists. Due to heterogeneity among\\nthe types of interventions and reporting of outcomes,\\nreviewers were seldom able to pool data. The primary\\noutcome of all interventions was maternal relief\\nfrom symptoms (usually measured using the Rhodes\\nIndex), and perinatal outcomes relevant to this\\nguideline were rarely reported.\\nNon-pharmacological agents versus placebo or no\\ntreatment\\nT en trials evaluated non-pharmacological\\ninterventions including ginger (prepared as syrup,\\ncapsules or powder within biscuits) (7 trials from\\nthe Islamic Republic of Iran, Pakistan, Thailand\\nand the USA involving 578 participants), lemon oil\\n(one Iranian study, 100 participants), mint oil (one\\nIranian study, 60 participants), chamomile (one\\nIranian study, 105 participants), and vitamin B6\\ninterventions (two studies in Thailand and the USA;\\n416 participants) compared with no treatment or\\nplacebo.\\nGinger: Low-certainty evidence from several small'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='interventions (two studies in Thailand and the USA;\\n416 participants) compared with no treatment or\\nplacebo.\\nGinger: Low-certainty evidence from several small\\nindividual studies suggests that ginger may relieve\\nsymptoms of nausea and vomiting. A study from\\nPakistan found that ginger reduced nausea symptom\\nscores (68 women; MD: 1.38 lower on day 3, 95%\\nCI: 0.03–2.73 lower), and vomiting symptom scores\\n(64 women; MD: 1.14 lower, 95% CI: 0.37–1.91 lower),\\nand an Iranian study showed improvements in nausea\\nand vomiting symptom scores on day 7 in women\\ntaking ginger supplements compared with placebo\\n(95 women; MD: 4.19 lower, 95% CI: 1.73–6.65\\nlower). Data from the studies in Thailand and the\\nUSA showed a similar direction of effect on nausea\\nsymptoms in favour of ginger.\\nLemon oil: Low-certainty evidence from one small\\nIranian study suggests that lemon oil may make little\\nor no difference to nausea and vomiting symptom\\nscores (100 women; MD: 0.46 lower on day 3,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Lemon oil: Low-certainty evidence from one small\\nIranian study suggests that lemon oil may make little\\nor no difference to nausea and vomiting symptom\\nscores (100 women; MD: 0.46 lower on day 3,\\n95% CI: 1.27 lower to 0.35 higher), or to maternal\\nsatisfaction (the number of women satisfied with\\ntreatment) (1 trial, 100 women; RR: 1.47, 95% CI:\\n0.91–2.37).\\nMint oil: The evidence on mint oil’s ability to relieve\\nsymptoms of nausea and vomiting is of very low\\ncertainty.\\nChamomile: Low-certainty evidence from one small\\nstudy suggests that chamomile may reduce nausea\\nand vomiting symptoms scores (70 women; MD: 5.74\\nlower, 95% CI: 3.17–8.31 lower).\\nVitamin B6 (pyridoxine): Moderate-certainty\\nevidence from two trials (one used 25 mg oral vitamin\\nB6 8-hourly for 3 days, the other used 10 mg oral\\nvitamin B6 8-hourly for 5 days) shows that vitamin\\nB6 probably reduces nausea symptoms scores\\n(388 women, trials measured the change in nausea\\nscores from baseline to day 3; MD: 0.92 higher score'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='vitamin B6 8-hourly for 5 days) shows that vitamin\\nB6 probably reduces nausea symptoms scores\\n(388 women, trials measured the change in nausea\\nscores from baseline to day 3; MD: 0.92 higher score\\nchange, 95% 0.4–1.44 higher), but low-certainty\\nevidence suggests that it may have little or no effect\\non vomiting (2 trials, 392 women; RR: 0.76, 95% CI:\\n0.35–1.66).\\nAcupuncture and acupressure versus placebo or no\\ntreatment\\nFive studies (601 participants) evaluated P6 (inner\\nforearm) acupressure versus placebo, one Thai study\\n(91 participants) evaluated auricular acupressure\\n(round magnetic balls used as ear pellets) versus no\\ntreatment, one study in the USA (230 participants)\\nevaluated P6 acustimulation therapy (nerve\\nstimulation at the P6 acupuncture point) versus\\nplacebo, and a four-arm Australian study (593\\nwomen) evaluated traditional Chinese acupuncture or\\nP6 acupuncture versus P6 placebo acupuncture or no\\nintervention.\\nLow-certainty evidence suggests that P6 acupressure'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='women) evaluated traditional Chinese acupuncture or\\nP6 acupuncture versus P6 placebo acupuncture or no\\nintervention.\\nLow-certainty evidence suggests that P6 acupressure\\nmay reduce nausea symptom scores (100 women;\\nMD: 1.7 lower, 95% CI: 0.99–2.41 lower) and reduce\\nthe number of vomiting episodes (MD: 0.9 lower,\\n95% CI: 0.74–1.06 lower). Low-certainty evidence  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n76\\nsuggests that auricular acupressure may also reduce\\nnausea symptom scores (91 women; MD: 3.6 lower,\\n95% CI: 0.58–6.62 lower), as may traditional Chinese\\nacupuncture (296 women; MD: 0.7 lower, 95% CI:\\n0.04–1.36 lower). Low-certainty evidence suggests\\nthat P6 acupuncture may make little or no difference\\nto mean nausea scores compared with P6 placebo\\nacupuncture (296 women; MD: 0.3 lower, 95% CI:\\n1.0 lower to 0.4 higher).\\nPharmacological agents versus placebo\\nOne study evaluated an antihistamine (doxylamine)\\nand another evaluated a dopamine-receptor'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='1.0 lower to 0.4 higher).\\nPharmacological agents versus placebo\\nOne study evaluated an antihistamine (doxylamine)\\nand another evaluated a dopamine-receptor\\nantagonist (metoclopramide). Certain other drugs\\nevaluated in the review (hydroxyzine, thiethylperazine\\nand fluphenazine) are from old studies and these\\ndrugs are no longer used in pregnant women due to\\nsafety concerns.\\nModerate-certainty evidence suggests that\\ndoxylamine plus vitamin B6 probably reduces nausea\\nand vomiting symptom scores compared with\\nplacebo (1 study, 256 women; MD: 0.9 lower on day\\n15, 95% CI: 0.25–1.55 lower). Low-certainty evidence\\nfrom this study suggests that there may be little or no\\ndifference in headache (256 women; RR: 0.81, 95%\\nCI: 0.45–1.48) or drowsiness (256 women; RR: 1.21,\\n95% CI: 0.64–2.27) between doxylamine plus vitamin\\nB6 and placebo.\\nLow-certainty evidence on metoclopramide (10mg)\\nsuggests that this agent may reduce nausea symptom\\nscores (1 trial, 68 women; MD: 2.94 lower on day 3,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='B6 and placebo.\\nLow-certainty evidence on metoclopramide (10mg)\\nsuggests that this agent may reduce nausea symptom\\nscores (1 trial, 68 women; MD: 2.94 lower on day 3,\\n95% CI: 1.33–4.55 lower). There was no side-effect\\ndata on metoclopramide in the review.\\nNo studies compared ondansetron (a 5HT3 receptor\\nantagonist) with placebo. T wo small studies\\ncompared ondansetron with metoclopramide and\\ndoxylamine, respectively, but evidence on relative\\neffects was uncertain.\\nAdditional considerations\\nnn Low-certainty evidence from single studies\\ncomparing different non-pharmacological\\ninterventions with each other – namely\\nacupuncture plus vitamin B6 versus P6\\nacupuncture plus placebo (66 participants),\\ntraditional acupuncture and P6 acupuncture\\n(296 participants), ginger versus chamomile\\n(70participants), P6 acupuncture versus ginger\\n(98 participants), and ginger versus vitamin B6\\n(123 participants) – suggests there may be little\\nor no difference in effects on relief of nausea\\nsymptoms.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='(98 participants), and ginger versus vitamin B6\\n(123 participants) – suggests there may be little\\nor no difference in effects on relief of nausea\\nsymptoms.\\nnn Low-certainty evidence suggests that there may\\nbe little or no difference between ginger and\\nmetoclopramide on nausea symptom scores\\n(1trial, 68 women; MD: 1.56 higher, 95% 0.22\\nlower to 3.34 higher) or vomiting symptom scores\\n(68 women; MD: 0.33 higher, 95% CI: 0.69 lower\\nto 1.35 higher) on day 3 after the intervention.\\nnn Side-effects and safety of pharmacological agents\\nwere poorly reported in the included studies.\\nHowever, drowsiness is a common side-effect of\\nvarious antihistamines used to treat nausea and\\nvomiting.\\nnn Metoclopramide is generally not recommended\\nin the first trimester of pregnancy, but is widely\\nused (163). A study of over 81700 singleton\\nbirths in Israel reported that they found no\\nstatistically significant differences in the risk of\\nmajor congenital malformations, low birth weight,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='used (163). A study of over 81700 singleton\\nbirths in Israel reported that they found no\\nstatistically significant differences in the risk of\\nmajor congenital malformations, low birth weight,\\npreterm birth or perinatal death between neonates\\nexposed (3458 neonates) and not exposed to\\nmetoclopramide in the first trimester of gestation.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nCosts associated with non-pharmacological remedies\\nvary. Acupuncture requires professional training and\\nskills and is probably associated with higher costs.\\nVitamin B6 (pyridoxine hydrochloride tablets) could\\ncost about US$2.50 for 90 × 10 mg tablets (74).\\nEquity\\nThe impact on equity is not known.\\nAcceptability\\nQualitative evidence from a range of LMICs\\nsuggests that women may be more likely to turn to\\ntraditional healers, herbal remedies or traditional\\nbirth attendants (TBAs) to treat these symptoms\\n(moderate confidence in the evidence) (22). In'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='suggests that women may be more likely to turn to\\ntraditional healers, herbal remedies or traditional\\nbirth attendants (TBAs) to treat these symptoms\\n(moderate confidence in the evidence) (22). In\\naddition, evidence from a diverse range of settings\\nindicates that while women generally appreciate\\nthe interventions and information provided during\\nantenatal visits, they are less likely to engage with\\nservices if their beliefs, traditions and socioeconomic\\ncircumstances are ignored or overlooked by health-\\ncare providers and/ or policy-makers (high confidence  \\n77\\nin the evidence). This may be particularly pertinent\\nfor acupuncture or acupressure, which may be\\nculturally alien and/ or poorly understood in certain\\ncontexts.\\nFeasibility\\nA lack of suitably trained staff may limit feasibility\\nof certain interventions (high confidence in the\\nevidence) (45).\\nD.2: Interventions for heartburn'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='heartburn in pregnancy. Antacid preparations can be offered to women with troublesome\\nsymptoms that are not relieved by lifestyle modification. (Recommended)\\nRemarks\\n• Lifestyle advice to prevent and relieve symptoms of heartburn includes avoidance of large, fatty meals and\\nalcohol, cessation of smoking, and raising the head of the bed to sleep.\\n• The GDG agreed that antacids, such as magnesium carbonate and aluminium hydroxide preparations, are\\nprobably unlikely to cause harm in recommended dosages.\\n• There is no evidence that preparations containing more than one antacid are better than simpler\\npreparations.\\n• Antacids may impair absorption of other drugs (164), and therefore should not be taken within two hours\\nof iron and folic acid supplements.\\nSummary of evidence and considerations\\nEffects of interventions for heartburn compared\\nwith other, no or placebo interventions (EB\\nT ableD.2)\\nThe evidence on the effects of various interventions for'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='Summary of evidence and considerations\\nEffects of interventions for heartburn compared\\nwith other, no or placebo interventions (EB\\nT ableD.2)\\nThe evidence on the effects of various interventions for\\nheartburn in pregnancy comes from a Cochrane review\\nthat included nine trials involving 725 pregnant women\\nwith heartburn; however, only four trials (358 women)\\ncontributed data (159). One of these, from the 1960s,\\nevaluated intramuscular prostigmine, which is no\\nlonger used, therefore these data were not considered\\nfor the guideline. The three remaining studies\\nconducted in Brazil, Italy and the USA evaluated\\na magnesium hydroxide–aluminium hydroxide–\\nsimeticone complex versus placebo (156 women),\\nsucrulfate (aluminium hydroxide and sulfated sucrose)\\nversus advice on diet and lifestyle changes (66\\nwomen), and acupuncture versus no treatment (36\\nwomen). Evidence on symptom relief was generally\\nassessed to be of low to very low certainty and no'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='versus advice on diet and lifestyle changes (66\\nwomen), and acupuncture versus no treatment (36\\nwomen). Evidence on symptom relief was generally\\nassessed to be of low to very low certainty and no\\nperinatal outcomes relevant to this guideline were\\nreported. Evidence on side-effects for all comparisons\\nwas assessed as being of very low certainty.\\nPharmacological interventions versus placebo\\nLow-certainty evidence suggests that complete\\nrelief from heartburn may occur more frequently\\nwith magnesium hydroxide–aluminium hydroxide–\\nsimethicone liquid and tablets than placebo (156\\nwomen; RR: 2.04, 95% CI: 1.44–2.89).\\nPharmacological interventions versus advice on diet\\nand lifestyle changes\\nLow-certainty evidence suggests that complete\\nrelief from heartburn may occur more frequently\\nwith sucralfate than with advice on diet and lifestyle\\nchanges (65 women; RR: 2.41, 95% CI: 1.42–4.07).\\nAcupuncture versus no treatment\\nData on relief of heartburn was not available in the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='with sucralfate than with advice on diet and lifestyle\\nchanges (65 women; RR: 2.41, 95% CI: 1.42–4.07).\\nAcupuncture versus no treatment\\nData on relief of heartburn was not available in the\\nreview for this comparison. Low-certainty evidence\\nsuggests that weekly acupuncture in pregnant\\nwomen with heartburn may improve the ability to\\nsleep (36 women; RR: 2.80, 95% CI: 1.14–6.86) and\\neat (36 women; RR: 2.40, 95% CI: 1.11–5.18), a proxy\\noutcome for maternal satisfaction.\\nAdditional considerations\\nnn Heartburn during pregnancy is a common problem\\nthat can be self-treated with over-the-counter\\nproducts containing antacids such as magnesium\\ncarbonate, aluminium hydroxide or calcium\\ncarbonate.\\nnn The Cochrane review found no evidence on\\nprescription drugs for heartburn, such as\\nomeprazole and ranitidine, which are not known to\\nbe harmful in pregnancy (159).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n78\\nValues\\nSee “Women’s values” at the beginning of section'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='be harmful in pregnancy (159).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n78\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nCosts of antacids vary widely, but generic products\\ncan be relatively low cost. Acupuncture requires\\nprofessional training and skills and is likely to be\\nassociated with higher costs.\\nEquity\\nThe prevalence of health-seeking behaviour and\\ntreatment for heartburn in pregnancy may be unequal\\namong advantaged and disadvantaged women.\\nHowever, it is not known whether interventions to\\nrelieve heartburn might impact inequalities.\\nAcceptability\\nQualitative evidence from a range of LMICs suggests\\nthat women may be more likely to turn to traditional\\nhealers, herbal remedies or TBAs to treat these\\nsymptoms (moderate confidence in the evidence)\\n(22). In addition, evidence from a diverse range\\nof settings indicates that while women generally\\nappreciate the interventions and information'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='symptoms (moderate confidence in the evidence)\\n(22). In addition, evidence from a diverse range\\nof settings indicates that while women generally\\nappreciate the interventions and information\\nprovided during antenatal visits, they are less likely\\nto engage with services if their beliefs, traditions\\nand socioeconomic circumstances are ignored or\\noverlooked by health-care providers and/ or policy-\\nmakers (high confidence in the evidence). This may\\nbe particularly pertinent for an intervention like\\nacupuncture, which may be culturally alien and/\\nor poorly understood in certain contexts. Indirect\\nevidence also indicates that women welcome the\\npregnancy-related advice and guidance given by\\nhealth-care professionals during antenatal visits,\\nso may respond to lifestyle suggestions favourably\\n(moderate confidence in the evidence).\\nFeasibility\\nQualitative evidence suggests that a lack of resources\\nmay limit the offer of treatment for this condition\\n(high confidence in the evidence) (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.2: Advice on diet and lifestyle is recommended to prevent and relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='(moderate confidence in the evidence).\\nFeasibility\\nQualitative evidence suggests that a lack of resources\\nmay limit the offer of treatment for this condition\\n(high confidence in the evidence) (45).\\nD.3: Interventions for leg cramps'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.3: Magnesium, calcium or non-pharmacological treatment options can', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition'], 'discusses_normal_variations': True}, page_content='be used for the relief of leg cramps in pregnancy, based on a woman’s preferences and available\\noptions. (Recommended)\\nRemarks\\n• The review found no evidence on the effect of non-pharmacological therapies, such as muscle stretching,\\nrelaxation, heat therapy, dorsiflexion of the foot and massage.\\n• The evidence on magnesium and calcium is generally of low certainty. However, the GDG agreed that\\nthey are unlikely to be harmful in the dose schedules evaluated in included studies.\\n• Further research into the etiology and prevalence of leg cramps in pregnancy, and the role (if any) of\\nmagnesium and calcium in symptom relief, is needed.\\nSummary of evidence and considerations\\nEffects of interventions for leg cramps compared\\nwith other, no or placebo interventions (EB\\nT ableD.3)\\nThe evidence on the effects of various interventions\\nfor leg cramps in pregnancy is derived from a\\nCochrane review that included six small trials\\ninvolving 390 pregnant women with leg cramps (162).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.3: Magnesium, calcium or non-pharmacological treatment options can', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='The evidence on the effects of various interventions\\nfor leg cramps in pregnancy is derived from a\\nCochrane review that included six small trials\\ninvolving 390 pregnant women with leg cramps (162).\\nThree studies from Norway (42 women), Sweden\\n(69 women) and Thailand (86 women) contributed\\ndata on oral magnesium compared with placebo.\\nOne study from Sweden (43 women) compared oral\\ncalcium with no treatment; a study conducted in the\\nIslamic Republic of Iran (42 women) compared oral\\nvitamins B6 and B1 with no treatment; and another\\nconducted in Sweden compared oral calcium with\\nvitamin C (30 women). Symptom relief, measured\\nin different ways, was the primary outcome in these\\nstudies, and other maternal and perinatal outcomes\\nrelevant to this guideline were not reported.\\nOral magnesium versus placebo\\nIn three small studies, women in the intervention\\ngroup were given 300–360mg magnesium per day\\nin two or three divided doses. Studies measured'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.3: Magnesium, calcium or non-pharmacological treatment options can', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Oral magnesium versus placebo\\nIn three small studies, women in the intervention\\ngroup were given 300–360mg magnesium per day\\nin two or three divided doses. Studies measured\\npersistence or occurrence of leg cramps in different\\nways, so results could not be pooled. Moderate-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='79\\ncertainty evidence from the Thai study suggests\\nthat women receiving magnesium are more likely\\nto experience a 50% reduction in the number of\\nleg cramps (1 trial, 86 women; RR: 1.42, 95% CI:\\n1.09–1.86). The same direction of effect was found in\\nthe Swedish study, which reported the outcome “no\\nleg cramps” after treatment, but the evidence was\\nof low certainty (1 trial, 69 women; RR: 5.66, 95%\\nCI: 1.35–23.68). Low-certainty evidence suggests\\nthat oral magnesium has little or no effect on the\\noccurrence of potential side-effects, including nausea,\\ndiarrhoea, flatulence and bloating. Evidence from the\\nthird study was judged to be very uncertain.\\nOral calcium versus no treatment\\nCalcium, 1g twice daily for two weeks, was compared\\nwith no treatment in one small study. Low-certainty\\nevidence suggests that women receiving calcium\\ntreatment are more likely to experience no leg cramps\\nafter treatment (43 women; RR: 8.59, 95% CI:\\n1.19–62.07).\\nOral calcium versus vitamin C'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='evidence suggests that women receiving calcium\\ntreatment are more likely to experience no leg cramps\\nafter treatment (43 women; RR: 8.59, 95% CI:\\n1.19–62.07).\\nOral calcium versus vitamin C\\nLow-certainty evidence suggests that there may be\\nlittle or no difference between calcium and vitamin C\\nin the effect (if any) on complete symptom relief from\\nleg cramps (RR: 1.33, 95% CI: 0.53–3.38).\\nOral vitamin B1 and B6 versus no treatment\\nOne study evaluated this comparison, with 21 women\\nreceiving vitamin B1 (100mg) plus B6 (40mg) once\\ndaily for two weeks and 21 women receiving no\\ntreatment; however, the low-certainty findings are\\ncontradictory and difficult to interpret.\\nAdditional considerations\\nnn The review found no evidence on non-\\npharmacological therapies, such as muscle\\nstretching, massage, relaxation, heat therapy and\\ndorsiflexion of the foot.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nMagnesium and calcium supplements are'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition'], 'discusses_normal_variations': True}, page_content='dorsiflexion of the foot.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nMagnesium and calcium supplements are\\nrelatively low-cost interventions, particularly when\\nadministered for limited periods of two to four weeks.\\nEquity\\nThe potential etiology of leg cramps being related\\nto a nutritional deficiency (magnesium) suggests\\nthat the prevalence of leg cramps might be\\nhigher in disadvantaged populations. In theory,\\ntherefore, nutritional interventions may have equity\\nimplications, but evidence is needed.\\nAcceptability\\nQualitative evidence from a diverse range of\\nsettings suggests that women generally appreciate\\nthe pregnancy-related advice given by health-\\ncare professionals during ANC, so may respond\\nto supplement suggestions favourably (moderate\\nconfidence in the evidence) (22). Evidence from\\nsome LMICs suggests that women hold the belief\\nthat pregnancy is a healthy condition and may turn'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='to supplement suggestions favourably (moderate\\nconfidence in the evidence) (22). Evidence from\\nsome LMICs suggests that women hold the belief\\nthat pregnancy is a healthy condition and may turn\\nto traditional healers and/ or herbal remedies to treat\\nthese kinds of associated symptoms (high confidence\\nin the evidence).\\nFeasibility\\nQualitative evidence suggests that a lack of resources\\nmay limit the offer of treatment for this condition\\n(high confidence in the evidence) (45). In addition,\\nwhere there are additional costs for pregnant women\\nassociated with treatment, women are less likely to\\nuse it.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n80\\nD.4: Interventions for low back and pelvic pain'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.4: Regular exercise throughout pregnancy is recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='low back and pelvic pain. There are a number of different treatment options that can be used,\\nsuch as physiotherapy, support belts and acupuncture, based on a woman’s preferences and\\navailable options. (Recommended)\\nRemarks\\n• Exercise to prevent low back and pelvic pain in pregnancy can take place on land or in water. While\\nexercise may also be helpful to relieve low back pain, it could exacerbate pelvic pain associated with\\nsymphysis pubis dysfunction and is not recommended for this condition.\\n• Regular exercise is a key component of lifestyle interventions, which are recommended for pregnant\\nwomen as part of ANC to prevent excessive weight gain in pregnancy (see Recommendation A.9).\\n• Pregnant women with low back and/ or pelvic pain should be informed that symptoms usually improve in\\nthe months after birth.\\n• Women should be informed that it is unclear whether there are side-effects to alternative treatment\\noptions due to a paucity of data.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.4: Regular exercise throughout pregnancy is recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='the months after birth.\\n• Women should be informed that it is unclear whether there are side-effects to alternative treatment\\noptions due to a paucity of data.\\n• Standardized reporting of outcomes is needed for future research on treatment for low back and/ or pelvic\\npain in pregnancy.\\nSummary of evidence and considerations\\nEffects of interventions for low back and pelvic\\npain compared with other, no or placebo\\ninterventions (EB T ableD.4)\\nThe evidence on the effects of various interventions\\nfor low back and pelvic pain in pregnancy was derived\\nfrom a Cochrane review that included 34trials\\ninvolving 5121 women (165). The definitions and\\nterminology of low back and pelvic pain varied such\\nthat in 15 trials the interventions were aimed at\\nreducing low back pain, in six trials interventions were\\nfor pelvic pain, and in 13 trials the interventions were\\nfor low back and pelvic pain. Most trials evaluated\\ntreatment; however, six trials evaluated prevention.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.4: Regular exercise throughout pregnancy is recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='for pelvic pain, and in 13 trials the interventions were\\nfor low back and pelvic pain. Most trials evaluated\\ntreatment; however, six trials evaluated prevention.\\nFew trials contributed data to analyses and several\\nindividual study findings were described only in\\nnarrative. Main outcomes were relief of symptoms\\nand functional disability, and perinatal outcomes\\nrelevant to this guideline were not reported.\\nComparisons included:\\n1. any exercise (plus standard care) versus\\nstandard care\\n2. acupuncture (plus standard care) versus sham\\nacupuncture (plus standard care)\\n3. acupuncture (plus standard care) versus\\nindividualized physiotherapy (plus standard care)\\n4. osteopathic manipulation (plus standard care)\\nversus standard care\\n5. one type of support belt versus another typee\\n6. multimodal interventions versus standard care.\\nAny exercise (plus standard care) versus standard\\ncare\\nSeven trials (645 women) contributed data to this\\ncomparison for low back pain. T rials were conducted'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.4: Regular exercise throughout pregnancy is recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Any exercise (plus standard care) versus standard\\ncare\\nSeven trials (645 women) contributed data to this\\ncomparison for low back pain. T rials were conducted\\nin Brazil, the Islamic Republic of Iran, Norway, South\\nAfrica and Thailand. Exercise interventions varied\\nfrom individually supervised exercise to group\\nexercise, including yoga and aqua-aerobics, and\\nsome included education via CDs and booklets.\\nInterventions ran for 8–12 weeks and the presence\\nor intensity of pain was assessed in most trials using\\nvisual analogue scales. However, the evidence on\\nsymptom relief from a meta-analysis of these seven\\nstudies is very uncertain. Low-certainty evidence\\nsuggests that functional disability scores are better\\nwith exercise interventions for low back pain (2trials,\\n146 women; standardized MD: 0.56 lower, 95%\\nCI: 0.23–0.89 lower). Evidence on pain intensity\\n(symptom scores) for low back pain was assessed\\nas very uncertain.\\nLow-certainty evidence suggests that an 8- to'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.4: Regular exercise throughout pregnancy is recommended to prevent', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='CI: 0.23–0.89 lower). Evidence on pain intensity\\n(symptom scores) for low back pain was assessed\\nas very uncertain.\\nLow-certainty evidence suggests that an 8- to\\n12-week exercise programme may reduce low\\nback and pelvic pain compared with standard care\\n(4trials, 1176 women; RR: 0.66, 95% CI: 0.45–0.97)\\nand moderate-certainty evidence shows that\\nhealthy pregnant women taking part in an exercise\\nprogramme are probably less likely to take sick leave\\nrelated to low back and pelvic pain (2 trials, 1062\\nwomen; RR: 0.76; 95% CI: 0.62–0.94).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='81\\nAcupuncture (plus standard care) versus sham\\nacupuncture (plus standard care)\\nFour small studies conducted in Sweden and the USA\\nevaluated the effects of acupuncture plus standard\\ncare versus sham acupuncture plus standard care.\\nHowever, little data were extracted from these studies\\nand data could not be pooled. Low-certainty evidence\\nfrom one study suggests that acupuncture may\\nrelieve low back and pelvic pain (72 women; RR:4.16,\\n95% CI: 1.77–9.78). Evidence from other studies was\\nvariously reported and very uncertain.\\nAcupuncture (plus standard care) versus\\nindividualized physiotherapy (plus standard care)\\nOne small study conducted in Sweden involving 46\\nwomen with low back and pelvic pain evaluated this\\ncomparison. Women’s satisfaction with treatment\\nwas the main outcome, but the evidence was\\nassessed as very uncertain.\\nOsteopathic manipulation therapy (OMT) (plus\\nstandard care) versus no osteopathic manipulation\\n(standard care)\\nThree studies evaluated OMT; however, data could'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='assessed as very uncertain.\\nOsteopathic manipulation therapy (OMT) (plus\\nstandard care) versus no osteopathic manipulation\\n(standard care)\\nThree studies evaluated OMT; however, data could\\nnot be pooled and the evidence from individual\\nstudies is inconsistent. The largest study involving\\n400 women compared OMT plus standard care with\\nplacebo ultrasound plus standard care, or standard\\ncare only. Limited data from this study suggests that\\nOMT may relieve low back pain symptoms more\\nthan standard care, and may lead to lower functional\\ndisability scores, but may not be better than placebo\\nultrasound for these outcomes.\\nOne type of support belt versus another type\\nOne small study conducted in Australia compared\\ntwo types of support belts in womewith low back\\npain, the BellyBra® and T ubigrip® (N=94) and the\\nevidence from this study was assessed as very low-\\ncertainty evidence.\\nMultimodal interventions versus standard care\\nOne study in the USA reported the effect of a'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='evidence from this study was assessed as very low-\\ncertainty evidence.\\nMultimodal interventions versus standard care\\nOne study in the USA reported the effect of a\\nmultimodal intervention that included weekly manual\\ntherapy by a chiropractic specialist, combined with daily\\nexercise at home, and education versus standard care\\n(rest, exercise, heat pads and analgesics) on low back\\nand pelvic pain. Moderate-certainty evidence suggests\\nthat the multimodal intervention is probably associated\\nwith better pain scores (1 study, 169 women; MD: 2.70\\nlower, 95% CI: 1.86–3.54 lower) and better functional\\ndisability scores (MD: 1.40 lower; 95% CI: 0.71–2.09\\nlower) compared with standard care.\\nAdditional considerations\\nnn It is not clear whether the evidence on exercise\\ninterventions applies equally to low back pain and\\npelvic pain, or equally to prevention and treatment,\\nas data from studies of prevention and treatment\\nwere pooled. Evidence from two studies on the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='interventions applies equally to low back pain and\\npelvic pain, or equally to prevention and treatment,\\nas data from studies of prevention and treatment\\nwere pooled. Evidence from two studies on the\\neffect of exercise plus education suggests that\\nsuch interventions may have little or no effect on\\npreventing pelvic pain (RR: 0.97; 95% CI: 0.77–\\n1.23).\\nnn Very low-certainty evidence on a number of other\\ninterventions, such as transcutaneous electrical\\nnerve stimulation (TENS), progressive muscle\\nrelaxation with music, craniosacral therapy, and\\nacetaminophen (paracetamol) – which were\\nevaluated in single small trials with apparent relief\\nof symptoms relative to standard care – was also\\npresented in the review.\\nnn Standard care of low back and pelvic pain\\nsymptoms usually comprises rest, hot or cold\\ncompresses, and paracetamol analgesia.\\nnn There is a paucity of evidence on potential side-\\neffects of alternative therapies, e.g. chiropractic\\nand osteopathic manipulation, and further high-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='compresses, and paracetamol analgesia.\\nnn There is a paucity of evidence on potential side-\\neffects of alternative therapies, e.g. chiropractic\\nand osteopathic manipulation, and further high-\\nquality research is needed to establish whether\\nthese therapies are beneficial for low back and/ or\\npelvic pain and safe during pregnancy.\\nnn Exercise in pregnancy has been shown to have\\nother benefits for pregnant women, including\\nreducing excessive gestational weight gain (see\\nRecommendation A.9).\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nExercise can be administered in a group setting\\nand individually at home; therefore, the cost of\\nexercise interventions varies. Support belts are\\navailable commercially from under US$ 10 per item.5\\nPhysiotherapy and acupuncture require specialist\\ntraining and are therefore likely to be more resource\\nintensive.\\nEquity\\nImproving access to low back and pelvic pain\\ninterventions may reduce inequalities by reducing'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'discusses_normal_variations': True}, page_content='training and are therefore likely to be more resource\\nintensive.\\nEquity\\nImproving access to low back and pelvic pain\\ninterventions may reduce inequalities by reducing\\nfunctional disability and sick leave related to low back\\nand pelvic pain among disadvantaged women.\\n5 Based on Internet sear ch.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n82\\nAcceptability\\nQualitative evidence from a diverse range of settings,\\nindicates that while women generally appreciate\\nthe interventions and information provided during\\nantenatal visits, they are less likely to engage with\\nservices if their beliefs, traditions and socioeconomic\\ncircumstances are ignored or overlooked by health-\\ncare providers and/ or policy-makers (high confidence\\nin the evidence) (22). This may be particularly\\npertinent for an intervention like acupuncture, which\\nmay be culturally alien and/ or poorly understood in\\ncertain contexts. In addition, where there are likely to'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='pertinent for an intervention like acupuncture, which\\nmay be culturally alien and/ or poorly understood in\\ncertain contexts. In addition, where there are likely to\\nbe additional costs associated with treatment or where\\nthe treatment may be unavailable (because of resource\\nconstraints), women are less likely to engage with\\nhealth services (high confidence in the evidence).\\nFeasibility\\nA lack of resources may limit the offer of treatment for\\nthis condition (high confidence in the evidence) (45).\\nD.5: Interventions for constipation'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.5: Wheat bran or other fibre supplements can be used to relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='constipation in pregnancy if the condition fails to respond to dietary modification, based\\non a woman’s preferences and available options. (Recommended)\\nRemarks\\n• Dietary advice to reduce constipation during pregnancy should include promoting adequate intake of\\nwater and dietary fibre (found in vegetables, nuts, fruit and whole grains).\\n• For women with troublesome constipation that is not relieved by dietary modification or fibre\\nsupplementation, stakeholders may wish to consider intermittent use of poorly absorbed laxatives.\\nSummary of evidence and considerations\\nEffects of interventions for constipation\\ncompared with other, no or placebo\\ninterventions (EB T ableD.5)\\nThe evidence on the effects of various interventions\\nfor constipation in pregnancy was derived from\\na Cochrane review to which only two small RCT s\\ninvolving 180 women contributed data (161). Both\\nstudies were conducted in the United Kingdom\\namong pregnant women with constipation. One'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.5: Wheat bran or other fibre supplements can be used to relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='a Cochrane review to which only two small RCT s\\ninvolving 180 women contributed data (161). Both\\nstudies were conducted in the United Kingdom\\namong pregnant women with constipation. One\\ncompared fibre supplementation with no intervention\\n(40women), the other compared stimulant laxatives\\nwith bulk-forming laxatives (140 women). No\\nperinatal outcomes relevant to this guideline were\\nreported.\\nFibre supplementation versus no intervention\\nEvidence from the small study evaluating fibre\\nsupplementation versus no intervention on\\nconstipation relief (reported as mean frequency of\\nstools) was assessed as being very uncertain.\\nStimulant laxatives versus bulk-forming laxatives\\nT wo stimulant laxatives were used in this 1970s study,\\nsenna and Normax®. The latter (containing dantron)\\nis potentially carcinogenic and now only used in\\nterminally ill people; however, data on stimulant\\nlaxatives were not available separately for senna.\\nEvidence on relative symptom relief, side-effects'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.5: Wheat bran or other fibre supplements can be used to relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='is potentially carcinogenic and now only used in\\nterminally ill people; however, data on stimulant\\nlaxatives were not available separately for senna.\\nEvidence on relative symptom relief, side-effects\\n(abdominal discomfort, diarrhoea), and maternal\\nsatisfaction for stimulant laxatives versus bulk-\\nforming laxatives (sterculia with or without frangula)\\nwas assessed as being very uncertain.\\nAdditional considerations\\nnn Various bulk-forming (wheat bran or oat bran\\nfibre supplements, sterculia, methylcellulose,\\nispaghula husk), osmotic (lactulose) and stimulant\\nlaxatives (senna) are available as over-the-counter\\nmedications for constipation and are not known to\\nbe harmful in pregnancy (166).\\nnn The absorption of vitamins and mineral\\nsupplements could potentially be compromised by\\nlaxatives.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nCosts will vary according to the intervention and\\nregion. Cereal fibre supplements can be relatively low-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.5: Wheat bran or other fibre supplements can be used to relieve', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Values\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nCosts will vary according to the intervention and\\nregion. Cereal fibre supplements can be relatively low-\\ncost at around US$1.5 per 375g bag of wheat bran.6\\n6 Based on Internet sear ch.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='83\\nEquity\\nIt is not known whether interventions to relieve\\nconstipation might impact inequalities.\\nAcceptability\\nQualitative evidence from a range of LMICs suggests\\nthat women may be more likely to turn to traditional\\nhealers, herbal remedies or TBAs to treat these\\nsymptoms (moderate confidence in the evidence)\\n(22). Evidence from a diverse range of settings\\nindicates that while women generally appreciate\\nthe interventions and information provided during\\nantenatal visits, they are less likely to engage with\\nservices if their beliefs, traditions and socioeconomic\\ncircumstances are ignored or overlooked by health-\\ncare providers and/ or policy-makers (high confidence\\nin the evidence).\\nFeasibility\\nOther qualitative evidence suggests that a lack\\nof resources may limit the offer of treatment for\\nconstipation (high confidence in the evidence) (45).\\nD.6: Interventions for varicose veins and oedema'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.6: Non-pharmacological options, such as compression stockings, leg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='elevation and water immersion, can be used for the management of varicose veins and oedema\\nin pregnancy based on a woman’s preferences and available options. (Recommended)\\nRemarks\\n• Women should be informed that symptoms associated with varicose veins may worsen as pregnancy\\nprogresses but that most women will experience some improvement within a few months of giving birth.\\n• Rest, leg elevation and water immersion are low-cost interventions that are unlikely to be harmful.\\nSummary of evidence and considerations\\nEffects of interventions for varicose veins and\\noedema compared with other, no or placebo\\ninterventions (EB T able D.6)\\nThe evidence on the effects of various interventions\\nfor varicose veins in pregnancy was derived from\\na Cochrane review that included seven small trials\\ninvolving 326 women with varicose veins and/ or\\noedema, and various types of interventions, including\\nrutoside (a phlebotonic drug) versus placebo (two\\ntrials), foot massage by a professional masseur for'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.6: Non-pharmacological options, such as compression stockings, leg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='oedema, and various types of interventions, including\\nrutoside (a phlebotonic drug) versus placebo (two\\ntrials), foot massage by a professional masseur for\\nfive days versus no intervention (1 trial, 80 women),\\nintermittent external pneumatic compression with\\na pump versus rest (1 trial, 35 women), standing in\\nwater at a temperature between 29°C and 33°C for\\n20 minutes (water immersion) versus leg elevation\\n(1 trial, 32 women) and reflexology versus rest\\n(1trial, 55 women) (160). Another trial comparing\\ncompression stockings with rest in the left lateral\\nposition did not contribute any data. Fetal and\\nneonatal outcomes relevant to the ANC guideline\\nwere not reported in these studies.\\nPharmacological interventions versus placebo or no\\nintervention\\nOnly one small trial conducted in 1975 (69 women)\\ncontributed data. Low-certainty evidence from this\\ntrial suggests that rutoside may reduce symptoms\\n(nocturnal cramps, paraesthesia, tiredness)\\nassociated with varicose veins compared with'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.6: Non-pharmacological options, such as compression stockings, leg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='contributed data. Low-certainty evidence from this\\ntrial suggests that rutoside may reduce symptoms\\n(nocturnal cramps, paraesthesia, tiredness)\\nassociated with varicose veins compared with\\nplacebo (69 women; RR: 1.89, 95% CI: 1.11–3.22).\\nHowever, no side-effect data were reported.\\nNon-pharmacological interventions versus placebo\\nor no intervention\\nLow-certainty evidence suggests that reflexology\\nmay reduce oedema symptoms compared with rest\\nonly (55 women; RR: 9.09, 95% CI: 1.41–58.54)\\nand that water immersion may reduce oedema\\nsymptoms (leg volume) compared with leg elevation\\n(32 women; RR: 0.43, 95% CI: 0.22–0.83). Low-\\ncertainty evidence suggests that there may be little\\nor no difference in oedema symptoms (measured\\nas lower leg circumference in centimetres) between\\nfoot massage and no intervention (80 women; MD\\nin cm: 0.11 less, 95% CI: 1.02 less to 0.80 more)\\nand between intermittent pneumatic compression\\nand rest (measured as mean leg volume, unit of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.6: Non-pharmacological options, such as compression stockings, leg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='foot massage and no intervention (80 women; MD\\nin cm: 0.11 less, 95% CI: 1.02 less to 0.80 more)\\nand between intermittent pneumatic compression\\nand rest (measured as mean leg volume, unit of\\nanalysis unclear) (35 women; MD: 258.8 lower,\\n95% CI: 566.91 lower to 49.31 higher). Only one\\nstudy (reflexology versus rest) evaluated women’s\\nsatisfaction, but the evidence is of very low\\ncertainty.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n84\\nAdditional considerations\\nnn Compression stockings combined with leg\\nelevation is the most common non-surgical\\nmanagement for varicose veins and oedema;\\nhowever, the Cochrane review found no evidence\\non this practice in pregnancy (160). Compression\\nstockings are also widely used to prevent\\nmorbidity in non-pregnant people with varicose\\nveins and the evidence for this practice in a related\\nCochrane review of compression stockings was\\ngenerally very uncertain (167).\\nValues\\nSee “Women’s values” at the beginning of section'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.6: Non-pharmacological options, such as compression stockings, leg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition'], 'discusses_normal_variations': True}, page_content='veins and the evidence for this practice in a related\\nCochrane review of compression stockings was\\ngenerally very uncertain (167).\\nValues\\nSee “Women’s values” at the beginning of section\\n3.D: Background (p.74).\\nResources\\nPostural interventions are low-cost interventions.\\nThe cost of compression stockings varies but they\\ncan cost more than US$15 per pair. Reflexology and\\nprofessional massage require specialist training, and\\nare, therefore, likely to be more costly.\\nEquity\\nIt is not known whether interventions to relieve\\nvaricose veins and oedema might impact inequalities.\\nAcceptability\\nQualitative evidence from a range of LMICs suggests\\nthat women may be more likely to turn to traditional\\nhealers, herbal remedies or TBAs to treat these\\nsymptoms (moderate confidence in the evidence)\\n(22). In addition, evidence from a diverse range\\nof settings indicates that while women generally\\nappreciate the interventions and information\\nprovided during antenatal visits, they are less likely'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION D.6: Non-pharmacological options, such as compression stockings, leg', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition'], 'discusses_normal_variations': True}, page_content='(22). In addition, evidence from a diverse range\\nof settings indicates that while women generally\\nappreciate the interventions and information\\nprovided during antenatal visits, they are less likely\\nto engage with services if their beliefs, traditions\\nand socioeconomic circumstances are ignored or\\noverlooked by health-care providers and/ or policy-\\nmakers (high confidence in the evidence). This may\\nbe particularly pertinent for an intervention like\\nreflexology, which may be culturally alien and/ or\\npoorly understood in certain contexts. Qualitative\\nevidence shows that, where there are likely to be\\nadditional costs associated with treatment or where\\nthe treatment may be unavailable (because of resource\\nconstraints), women are less likely to engage with\\nhealth services (high confidence in the evidence).\\nFeasibility\\nThe evidence also suggests that a lack of resources\\nmay limit the offer of treatment for varicose veins and\\noedema (high confidence in the evidence) (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='85'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'subsection': 'Health systems interventions to', 'section_path': ['3 Evidence and recommendations', 'Health systems interventions to'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='improve the utilization and quality\\nof ANC\\nBackground\\nThere is a multitude of interventions that can be\\nemployed to improve the utilization and quality of\\nANC depending on the context and setting. For the\\npurposes of this guideline, the GDG considered the\\nfollowing interventions:\\n1. Women-held case notes (home-based records)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Community-based interventions to improve', 'section_path': ['3 Evidence and recommendations', 'Community-based interventions to improve'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='communication and support'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='7. ANC contact schedules.\\nHow to deliver the type and quality of ANC that\\nwomen want is a vast and complex field of research.\\nInterventions designed to increase staff competency,\\nto improve staff well-being, and other interventions\\n(e.g. financial incentives) to increase access and use\\nof ANC are broad topics that were considered beyond\\nthe scope of this guideline.\\nnn Women-held case notes: In many countries,\\nwomen are given their own case notes (or home-\\nbased records) to carry during pregnancy. Case\\nnotes may be held in paper (e.g. card, journal,\\nhandbook) or electronic formats (e.g. memory\\nstick), and women are expected to take them\\nalong to all health visits. If women then move, or\\nare referred from one facility to another, and in the\\ncase of complications where immediate access\\nto medical records is not always possible, the\\npractice of women-held case notes may improve\\nthe availability of women’s medical records\\n(168). Women-held case notes might also be an'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='to medical records is not always possible, the\\npractice of women-held case notes may improve\\nthe availability of women’s medical records\\n(168). Women-held case notes might also be an\\neffective tool to improve health awareness and\\nclient–provider communication (169). Inadequate\\ninfrastructure and resources often hamper efficient\\nrecord-keeping, therefore, case notes may be\\nless likely to get lost when held personally. In\\naddition, the practice may facilitate more accurate\\nestimation of gestational age, which is integral to\\nevidence-based decision-making, due to improved\\ncontinuity of fetal growth records (170).\\nnn Midwife-led continuity of care (MLCC) models:\\nMidwives are the primary providers of care in\\nmany ANC settings (171). In MLCC models, a\\nknown and trusted midwife (caseload midwifery),\\nor small group of known midwives (team\\nmidwifery), supports a woman throughout the\\nantenatal, intrapartum and postnatal period, to\\nfacilitate a healthy pregnancy and childbirth, and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='or small group of known midwives (team\\nmidwifery), supports a woman throughout the\\nantenatal, intrapartum and postnatal period, to\\nfacilitate a healthy pregnancy and childbirth, and\\nhealthy parenting practices (172). The MLCC\\nmodel includes: continuity of care; monitoring\\nthe physical, psychological, spiritual and social\\nwell-being of the woman and family throughout\\nthe childbearing cycle; providing the woman with\\nindividualized education, counselling and ANC;\\nattendance during labour, birth and the immediate\\npostpartum period by a known midwife; ongoing\\nsupport during the postnatal period; minimizing\\nunnecessary technological interventions; and\\nidentifying, referring and coordinating care for\\nwomen who require obstetric or other specialist\\nattention (173). Thus, the MLCC model exists\\nwithin a multidisciplinary network in which\\nconsultation and referral to other care providers\\noccurs when necessary. The MLCC model is\\nusually aimed at providing care to healthy women'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='within a multidisciplinary network in which\\nconsultation and referral to other care providers\\noccurs when necessary. The MLCC model is\\nusually aimed at providing care to healthy women\\nwith uncomplicated pregnancies.\\nnn Group ANC: ANC conventionally takes the form\\nof a one-on-one consultation between a pregnant\\nwoman and her health-care provider. However,\\ngroup ANC integrates the usual individual\\npregnancy health assessment with tailored group\\neducational activities and peer support, with\\nthe aim of motivating behaviour change among\\npregnant women, improving pregnancy outcomes,\\nand increasing women’s satisfaction (174). The\\nintervention typically involves self-assessment\\nactivities (e.g. blood pressure measurement),\\ngroup education with facilitated discussion, and  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n86\\ntime to socialize. Group ANC needs to be delivered\\nin a space large enough to accommodate a group\\nof women, with a private area for examinations.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='86\\ntime to socialize. Group ANC needs to be delivered\\nin a space large enough to accommodate a group\\nof women, with a private area for examinations.\\nnn Community-based interventions to improve\\ncommunication and support: The scoping review\\nconducted for the ANC guideline identified\\ncommunication and support for women as\\nintegral components of positive pregnancy\\nexperiences. The term “communicate” refers to\\nthe act of sharing information, education and\\ncommunication with women about timely and\\nrelevant physiological, biomedical, behavioural\\nand sociocultural issues; “support” refers to social,\\ncultural, emotional and psychological support (13).\\nHaving access to appropriate communication and\\nsupport is a key element of a quality ANC service.\\nA human-rights-based approach recognizes that\\nwomen are entitled to participate in decisions that\\naffect their sexual and reproductive health (1). In\\naddition, pregnant women have a right to access\\nquality health-care services and, particularly in'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='affect their sexual and reproductive health (1). In\\naddition, pregnant women have a right to access\\nquality health-care services and, particularly in\\nlow-resource settings, may need to be empowered\\nto do so. Interventions that increase the dialogue\\naround awareness of a women’s rights, barriers\\nand facilitators to utilizing ANC rvices and keeping\\nhealthy during pregnancy and beyond (including\\ndialogue around newborn care and postnatal\\nfamily planning), and providing women and their\\npartners with support in addressing challenges\\nthey may face, may lead to improved ANC uptake\\nand quality of care.\\nnn ANC contact schedules: In 2002, the WHO\\nrecommended a focused or goal-orientated\\napproach to ANC to improve quality of care and\\nincrease ANC coverage, particularly in LMICs (12).\\nThe focused ANC (FANC) model, also known as\\nthe basic ANC model, includes four ANC visits\\noccurring between 8 and 12weeks of gestation,\\nbetween 24 and 26weeks, at 32weeks, and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='The focused ANC (FANC) model, also known as\\nthe basic ANC model, includes four ANC visits\\noccurring between 8 and 12weeks of gestation,\\nbetween 24 and 26weeks, at 32weeks, and\\nbetween 36 and 38weeks. Guidance on each visit\\nincludes specific evidence-based interventions for\\nhealthy pregnant women (called “goal-oriented”),\\nwith appropriate referral of high-risk women and\\nthose who develop pregnancy complications. The\\nnumber of visits in this model is considerably fewer\\nthan in ANC models used in HICs.\\nThe GDG considered the available evidence and\\nother relevant information on these interventions to\\ndetermine whether they should be recommended for\\nANC (Recommendations E1 to E5). The GDG also\\nconsidered existing recommendations from other\\nWHO guidelines on task shifting and recruitment and\\nretention of staff in rural areas (Recommendations E5\\nand E6).\\nWomen’s values\\nA scoping review of what women want from ANC\\nand what outcomes they value informed the ANC'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Recruitment and retention of staff', 'section_path': ['3 Evidence and recommendations', 'Recruitment and retention of staff'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='retention of staff in rural areas (Recommendations E5\\nand E6).\\nWomen’s values\\nA scoping review of what women want from ANC\\nand what outcomes they value informed the ANC\\nguideline (13). Evidence showed that women from\\nhigh-, medium- and low-resource settings valued\\nhaving a positive pregnancy experience. Within a\\nhealth systems context, this included the adoption\\nof flexible appointment systems and continuity of\\nprovider care where women were given privacy and\\ntime to build authentic and supportive relationships\\nwith maternity-care providers (high confidence in\\nthe evidence).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='87\\nE.1: Women-held case notes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='notes during pregnancy to improve continuity, quality of care and her pregnancy experience.\\n(Recommended)\\nRemarks\\n• The GDG noted that women-held case notes are widely used and are often the only medical records\\navailable in various LMIC settings.\\n• The GDG agreed that the benefits of women-held case notes outweigh the disadvantages. However,\\ncareful consideration should be given as to what personal information it is necessary to include in the\\ncase notes, to avoid stigma and discrimination in certain settings. In addition, health-system planners\\nshould ensure that admission to hospitals or other health-care facilities do not depend on women\\npresenting their case notes.\\n• Health-system planners should consider which form the women-held case notes should take (electronic\\nor paper-based), whether whole sets of case notes will be held by women or only specific parts of them,\\nand how copies will be kept by health-care facilities.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='or paper-based), whether whole sets of case notes will be held by women or only specific parts of them,\\nand how copies will be kept by health-care facilities.\\n• For paper-based systems, health-system planners also need to ensure that case notes are durable and\\ntransportable. Health systems that give women access to their case notes through electronic systems\\nneed to ensure that all pregnant women have access to the appropriate technology and that attention is\\npaid to data security.\\n• Health-system planners should ensure that the contents of the case notes are accessible to all pregnant\\nwomen through the use of appropriate, local languages and appropriate reading levels.\\nSummary of evidence and considerations\\nEffects of women-held case notes compared\\nwith other practices (EB T able E.1)\\nThe evidence on the effects of women-held case\\nnotes was mostly derived from a Cochrane review that\\nincluded four small trials involving 1176 women (168).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='with other practices (EB T able E.1)\\nThe evidence on the effects of women-held case\\nnotes was mostly derived from a Cochrane review that\\nincluded four small trials involving 1176 women (168).\\nT rials were conducted in Australia, Mongolia and the\\nUnited Kingdom (2 trials). In three trials, women in\\nthe intervention groups were given their complete\\nantenatal records (paper) to carry during pregnancy.\\nIn the remaining trial, a cluster randomized controlled\\ntrial (RCT) involving 501 women in Mongolia, women\\nin the intervention group carried a maternal and child\\nhealth handbook that included antenatal, postnatal and\\nchild health records. Antenatal records were facility-\\nheld in the control groups. Data on ANC coverage\\nfor the Mongolian trial were derived separately from\\nanother Cochrane review (175).\\nMaternal outcomes\\nWith regard to maternal satisfaction, moderate-\\ncertainty evidence indicates that women who carry\\ntheir own case notes are probably more likely to feel'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='Maternal outcomes\\nWith regard to maternal satisfaction, moderate-\\ncertainty evidence indicates that women who carry\\ntheir own case notes are probably more likely to feel\\nin control of their pregnancy experience than women\\nwhose records are facility-held (2 trials, 450 women;\\nRR: 1.56, 95% CI: 1.18–2.06). Low-certainty evidence\\nsuggests that women-held case notes may have\\nlittle or no effect on women’s satisfaction with ANC\\n(2 trials, 698 women; RR: 1.09, 95% CI: 0.92–1.29).\\nEvidence on caesarean section was very uncertain\\nand other guideline outcomes were not reported in\\nthe review.\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that women-held\\ncase notes may have little or no effect on perinatal\\nmortality (2 trials, 713 women; RR: 0.77, 95% CI:\\n0.17–3.48). No other fetal and neonatal outcomes\\nwere reported in the review.\\nCoverage outcomes\\nLow-certainty evidence suggests that women-held\\ncase notes may have little or no effect on ANC'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='0.17–3.48). No other fetal and neonatal outcomes\\nwere reported in the review.\\nCoverage outcomes\\nLow-certainty evidence suggests that women-held\\ncase notes may have little or no effect on ANC\\ncoverage of four or more visits (1 trial, 501 women;\\nRR: 1.25, 95% CI: 0.31–5.00).\\nAdditional considerations\\nnn Other evidence from the review suggests that\\nthere may be little or no difference in the risk of\\ncase notes being lost or left at home for a visit\\n(2trials, 347 women; RR: 0.38, 95% CI: 0.04–\\n3.84).\\nnn A WHO multicentre cohort study of home-based\\nmaternal records (HBMR), involving 590862\\nwomen in Egypt, India, Pakistan, Philippines,  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n88\\nSenegal, Sri Lanka, Y emen and Zambia, was\\nconducted between 1984 and 1988 (176). The\\nstudy reported that “The introduction of the HBMR\\nincreased the diagnosis and referral of at-risk\\npregnant women and newborn infants, improved\\nfamily planning and health education, increased'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='study reported that “The introduction of the HBMR\\nincreased the diagnosis and referral of at-risk\\npregnant women and newborn infants, improved\\nfamily planning and health education, increased\\ntetanus toxoid immunization, and provided a\\nmeans of collecting health information in the\\ncommunity. The HBMR was liked by mothers,\\ncommunity health workers and other health-\\ncare personnel because, by using it, the mothers\\nbecame more involved in looking after their own\\nhealth and that of their babies.”\\nValues\\nSee “Women’s values” at the beginning of section 3.E:\\nBackground (p.86).\\nResources\\nResource implications differ depending on whether\\nelectronic or paper-based systems are used.\\nElectronic systems require more resources. Paper-\\nbased systems require the production of durable,\\ntransportable journals, as well as systems for keeping\\ncopies. The need to adapt and/ or translate journals\\nmay add to costs.\\nEquity\\nThe GDG considered that women-held case notes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='transportable journals, as well as systems for keeping\\ncopies. The need to adapt and/ or translate journals\\nmay add to costs.\\nEquity\\nThe GDG considered that women-held case notes\\ncould be subject to abuse and used to discriminate\\nagainst women who do not have them, or if the\\ninformation contained in the notes is associated with\\nstigma (e.g. HIV-positive status). Less-educated\\nwomen with lower health literacy may be less able\\nto read and understand their own case notes, which\\nmight perpetuate inequalities.\\nAcceptability\\nQualitative evidence suggests that women from a\\nvariety of settings are likely to favour carrying their\\ncase notes because of the increased opportunity to\\nacquire pregnancy and health-related information\\nand the associated sense of empowerment this brings\\n(high confidence in the evidence) (22). There may\\nbe potential for abuse of the system in some LMIC\\nsettings, for example, by limiting access to hospitals\\nfor women who do not have case notes, particularly'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'discusses_normal_variations': True}, page_content='be potential for abuse of the system in some LMIC\\nsettings, for example, by limiting access to hospitals\\nfor women who do not have case notes, particularly\\nwhere maternity services are under-resourced\\n(moderate confidence in the evidence). Further\\nevidence from a mixed-methods review supports\\nRCT evidence that women feel more satisfied when\\nthey carry, or have access to, their own case notes\\n(177). These review findings were not subject to\\nGRADE-CERQual assessments of confidence, and\\nwere derived primarily from high-income settings\\n(36 out of 37 studies). Findings also suggest that\\nproviders are generally happy for women to carry\\ntheir own case notes, but feel the implementation of\\nthe approach may generate additional administrative\\nresponsibilities. Providers also raised concerns about\\ndata security, sensitivity of the shared information,\\nand the potential for data to be lost because of\\nfragmented systems.\\nFeasibility\\nThere may be prohibitive additional costs associated'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.1: It is recommended that each pregnant woman carries her own case', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='data security, sensitivity of the shared information,\\nand the potential for data to be lost because of\\nfragmented systems.\\nFeasibility\\nThere may be prohibitive additional costs associated\\nwith using an electronic system (USB memory sticks,\\nsoftware packages, etc.) in some LMIC settings (high\\nconfidence in the evidence), although paper-based\\nrecords may require little in the way of extra cost or\\nresources (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='89\\nE.2: Midwife-led continuity of care (MLCC)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='small group of known midwives supports a woman throughout the antenatal, intrapartum and\\npostnatal continuum, are recommended for pregnant women in settings with well functioning\\nmidwifery programmes. (Context-specific recommendation)\\nRemarks\\n• MLCC models are models of care in which a known and trusted midwife (caseload midwifery), or small\\ngroup of known midwives (team midwifery), supports a woman throughout the antenatal, intrapartum\\nand postnatal period, to facilitate a healthy pregnancy and childbirth, and healthy parenting practices.\\n• MLCC models are complex interventions and it is unclear whether the pathway of influence producing\\nthese positive effects is the continuity of care, the midwifery philosophy of care or both. The midwifery\\nphilosophy inherent in MLCC models may or may not be enacted in standard midwife practice in other\\nmodels of care.\\n• Policy-makers in settings without well functioning midwife programmes should consider implementing'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='models of care.\\n• Policy-makers in settings without well functioning midwife programmes should consider implementing\\nthis model only after successfully scaling up of the number and quality of practising midwives. In addition,\\nstakeholders may wish to consider ways of providing continuous care through other care providers, because\\nwomen value continuity of care.\\n• The panel noted that with this model of care it is important to monitor resource use, and provider burnout\\nand workload, to determine whether caseload or team care models are more sustainable in individual\\nsettings.\\n• MLCC requires that well trained midwives are available in sufficient numbers for each woman to see one\\nor only a small group of midwives throughout pregnancy and during childbirth. This model may therefore\\nrequire a shift in resources to ensure that the health system has access to a sufficient number of midwives\\nwith reasonable caseloads.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='require a shift in resources to ensure that the health system has access to a sufficient number of midwives\\nwith reasonable caseloads.\\n• The introduction of MLCC may lead to a shift in the roles and responsibilities of midwives as well as other\\nhealth-care professionals who have previously been responsible for antenatal and postnatal care. Where\\nthis is the case, implementation is likely to be more effective if all relevant stakeholders are consulted\\nand human resources departments are involved. In some settings, government-level consultation with\\nprofessional organizations could also aid implementation processes.\\n• The need for additional one-off or continuing training and education should be assessed, and should be\\nprovided where necessary.\\nSummary of evidence and considerations\\nEffects of MLCC models compared with other\\nmodels of care (EB T able E.2)\\nThe evidence on the effects of MLCC models of care\\nwas derived from a Cochrane review that included'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='Effects of MLCC models compared with other\\nmodels of care (EB T able E.2)\\nThe evidence on the effects of MLCC models of care\\nwas derived from a Cochrane review that included\\n15 trials involving 17674 women, in which pregnant\\nwomen were randomized to receive ANC either by\\nMLCC models or by other models of care (172). All\\nthe studies included were conducted in public health\\nsystems in HICs (Australia, Canada, Ireland and\\nthe United Kingdom) and 14 out of 15 contributed\\ndata. Eight trials compared an MLCC model with\\na shared care model, three trials compared MLCC\\nwith medical-led care, and three compared MLCC\\nwith “standard care” (mixed-care options, including\\nmidwife-led non-continuous care, medical-led, and\\nshared care). Some MLCC models included routine\\nvisits to an obstetrician and/ or family doctor. Eight\\ntrials included women with “low-risk” pregnancies\\nonly; six also included women with “high-risk”\\npregnancies. Four trials evaluated one-to-one'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='visits to an obstetrician and/ or family doctor. Eight\\ntrials included women with “low-risk” pregnancies\\nonly; six also included women with “high-risk”\\npregnancies. Four trials evaluated one-to-one\\n(caseload) MLCC and 10 trials evaluated team MLCC.\\nCaseload sizes for one-to-one models ranged from 32\\nto 45 pregnant women per midwife per year. Levels of\\ncontinuity of care were measured (as the proportion\\nof births attended to by a known carer), and were\\nin the ranges of 63–98% for MLCC and 0–21% for\\nother models. A random effects model was used in all\\nmeta-analyses.\\nMaternal outcomes\\nModerate-certainty evidence shows that MLCC\\ncompared with other models of care probably slightly\\nincreases the chance of a vaginal birth (12 trials,\\n16687 participants; RR: 1.05, 95% CI: 1.03–1.07).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n90\\nMLCC may reduce caesarean sections (14 trials,\\n17674 participants; RR: 0.92, 95% CI: 0.84–1.00),'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='WHO recommendations on antenatal care for a positive pregnancy experience\\n90\\nMLCC may reduce caesarean sections (14 trials,\\n17674 participants; RR: 0.92, 95% CI: 0.84–1.00),\\nhowever, this evidence is of low certainty and includes\\nthe possibility of no effect. Low-certainty evidence\\nsuggests that MLCC models may be associated with\\nlower rates of instrumental vaginal delivery than\\nother models (13 trials, 17501 participants; RR: 0.90,\\n95% CI: 0.83–0.97).\\nMaternal satisfaction: The Cochrane review tabulated\\ndata on women’s satisfaction pertaining to various\\naspects of antenatal, intrapartum and postnatal care.\\nA meta-analysis on satisfaction with ANC only was\\nperformed for the purposes of this guideline (see EB\\nT ableE.2), the findings of which suggest that MLCC\\nmodels may increase the proportion of women\\nreporting high levels of satisfaction with the ANC\\ncompared with other models (4 trials, 5419 women;\\nRR: 1.31, 95% CI: 1.11–1.54; low-certainty evidence).\\nFetal and neonatal outcomes'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition', 'warning_signs']}, page_content='reporting high levels of satisfaction with the ANC\\ncompared with other models (4 trials, 5419 women;\\nRR: 1.31, 95% CI: 1.11–1.54; low-certainty evidence).\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that MLCC\\nprobably reduces the risk of preterm birth (8 trials,\\n13338 participants; RR: 0.76, 95% CI: 0.64–0.91)\\nand probably reduces perinatal mortality (defined in\\nthe review as fetal loss after 24 weeks of gestation\\nand neonatal death) (13 trials, 17561 women; RR:\\n0.84, 95% CI: 0.71–0.99). However, low-certainty\\nevidence suggests that it may have little or no effect\\non low birth weight (7 trials, 11458 women; RR: 0.96,\\n95% CI: 0.82–1.13). Evidence on other ANC guideline\\noutcomes was not available in the review.\\nAdditional considerations\\nnn Although the mechanism for the probable\\nreduction in preterm birth and perinatal death\\nis unclear, the GDG considered the consistency\\nof the results and the absence of harm to be\\nimportant.\\nValues'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='nn Although the mechanism for the probable\\nreduction in preterm birth and perinatal death\\nis unclear, the GDG considered the consistency\\nof the results and the absence of harm to be\\nimportant.\\nValues\\nSee “Women’s values” at the beginning of section 3.E:\\nBackground (p.86).\\nResources\\nIn settings with well functioning midwife programmes,\\na shift in resources may be necessary to ensure\\nthat the health system has sufficient midwives with\\nreasonable caseloads. There may also be training costs\\nassociated with changing to an MLCC model. However,\\none study in the Cochrane review found that ANC\\nprovider costs were 20–25% lower with the MLCC\\nmodel than other midwife-led care due to differences\\nin staff costs (178).\\nEquity\\nEquitable coverage and improvements in the quality\\nof midwifery practice are major challenges in many\\nLMICs (171). MLCC models in any setting have the\\npotential to help to address health inequalities, for\\nexample, by providing a more supportive setting for'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='LMICs (171). MLCC models in any setting have the\\npotential to help to address health inequalities, for\\nexample, by providing a more supportive setting for\\ndisadvantaged women to disclose information that\\nmay facilitate the identification of risk factors for poor\\noutcomes, such as intimate partner violence.\\nAcceptability\\nQualitative evidence synthesized from a wide variety\\nof settings and contexts indicates that women\\nwelcome the opportunity to build supportive,\\ncaring relationships with a midwife or a small\\nnumber of midwives during the maternity phase\\n(high confidence in the evidence) and appreciate\\na consistent, unhurried, woman-centred approach\\nduring ANC visits (high confidence in the evidence)\\n(22). Evidence from providers, mainly in HICs,\\nindicates that they view MLCC as a way of achieving\\nthe authentic, supportive relationships that women\\ndesire (moderate confidence in the evidence). There\\nis very little evidence on MLCC models from LMICs.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.2: Midwife-led continuity-of-care models, in which a known midwife or', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='the authentic, supportive relationships that women\\ndesire (moderate confidence in the evidence). There\\nis very little evidence on MLCC models from LMICs.\\nHowever, indirect evidence from providers in these\\nlocations suggests that they would welcome the\\nopportunity to use an MLCC model but feel they do\\nnot have the resources to do so (low confidence in\\nthe evidence).\\nFeasibility\\nQualitative evidence from high-, medium- and\\nlow-resource settings highlights concerns among\\nproviders about potential staffing issues, e.g. for the\\ndelivery of caseload or one-to-one approaches (high\\nconfidence in the evidence) (45).'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='91\\nE.3: Group antenatal care'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'normal_variations']}, page_content='may be offered as an alternative to individual antenatal care for pregnant women in the context\\nof rigorous research, depending on a woman’s preferences and provided that the infrastructure\\nand resources for delivery of group antenatal care are available. (Context-specific recommendation\\n– research)\\nRemarks\\n• With the group ANC model, the first visit for all pregnant women is an individual visit. Then at subsequent\\nvisits, the usual individual pregnancy health assessment, held in a private examination area, is integrated\\ninto a group ANC session, with facilitated educational activities and peer support.\\n• Health-care facilities need to be seeing sufficient numbers of pregnant women, as allocation to groups is\\nideally performed according to gestational age.\\n• Health-care providers need to have appropriate facilities to deal with group sessions, including access\\nto large, well ventilated rooms or sheltered spaces with adequate seating. A private space should be'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='to large, well ventilated rooms or sheltered spaces with adequate seating. A private space should be\\navailable for examinations, and opportunities should be given for private conversations.\\n• Group ANC may take longer than individual ANC, and this may pose practical problems for some women\\nin terms of work and childcare. Health-care providers should be able to offer a variety of time slots for\\ngroup sessions (morning, afternoon, evening) and should consider making individual care available as\\nwell.\\n• The GDG noted that group ANC may have acceptability and feasibility issues in settings where perceived\\ndifferences keep people apart, e.g. women from different castes in India may not wish to be in a group\\ntogether.\\n• Group ANC studies are under way in Nepal, Uganda and five other low-income countries, and the GDG\\nwas informed by a GDG member that some of these studies are due to report soon. Core outcomes of'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content=\"• Group ANC studies are under way in Nepal, Uganda and five other low-income countries, and the GDG\\nwas informed by a GDG member that some of these studies are due to report soon. Core outcomes of\\nstudies of group ANC should include maternal and perinatal health outcomes, coverage, and women's\\nand providers' experiences.\\nSummary of evidence and considerations\\nEffects of group ANC compared with individual\\nANC (EB T able E.3)\\nThe evidence on the effects of group ANC was\\nderived from a Cochrane review that included\\nfour trials involving 2350 women (174). T wo trials\\nfrom the USA used a group ANC model known as\\nCenteringPregnancy®, in which group ANC was\\nconducted in circles of 8–12 women of similar\\ngestational age, meeting for 8–10 sessions during\\npregnancy, with each session lasting 90–120 minutes.\\nssions included self-assessment activities (blood\\npressure measurement), facilitated educational\\ndiscussions and time to socialize, with individual\"),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='ssions included self-assessment activities (blood\\npressure measurement), facilitated educational\\ndiscussions and time to socialize, with individual\\nexaminations performed in a private/ screened-\\noff area. One trial conducted in Sweden used a\\ngroup model similar to the USA model but mainly\\nassessed provider outcomes and contributed little\\ndata to the review. The fourth trial, conducted in the\\nIslamic Republic of Iran, was a cluster-RCT in which\\ngroup ANC was described as being similar to the\\nCenteringPregnancy® approach.\\nMaternal outcomes\\nModerate-certainty evidence indicates that group\\nANC probably does not have an important effect on\\nvaginal birth rates compared with individual ANC\\n(1 trial, 322 women; RR: 0.96, 95% CI: 0.80–1.15).\\nBut low-certainty evidence suggests that it may lead\\nto higher women’s satisfaction scores (1 trial, 993\\nwomen; MD: 4.9, 95% CI: 3.10–6.70).\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that group'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='to higher women’s satisfaction scores (1 trial, 993\\nwomen; MD: 4.9, 95% CI: 3.10–6.70).\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that group\\nANC probably has little or no effect on low birth\\nweight (3 trials, 1935 neonates; RR: 0.92, 95% CI:\\n0.68–1.23) and low-certainty evidence suggests that\\nit may have little or no effect on perinatal mortality\\n(3trials, 1943 neonates; RR: 0.63, 95% CI: 0.32–1.25).\\nHowever, low-certainty evidence also suggests that\\ngroup ANC may reduce preterm birth (3 trials, 1888\\nwomen; RR: 0.75, 95% CI: 0.57–1.00); this evidence\\nincludes the possibility of no effect. Evidence on\\nthe risk of having an SGA neonate is of a very low\\ncertainty.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n92\\nAdditional considerations\\nnn There is little evidence on the effects of group\\nANC from LMICs. However, a feasibility study\\nconducted in Ghana suggests that group ANC\\nmight improve women’s pregnancy experiences,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='nn There is little evidence on the effects of group\\nANC from LMICs. However, a feasibility study\\nconducted in Ghana suggests that group ANC\\nmight improve women’s pregnancy experiences,\\nand providers’ experiences, and potentially\\nimprove health outcomes in low-income settings,\\ndue to improved health literacy and better\\nengagement of pregnant women with ANC (179).\\nnn It is plausible that group ANC may have an impact\\non other outcomes outside the scope of the\\nANC guideline, such as breastfeeding initiation\\nand postnatal contraception, by improving\\ncommunication and social support related to these\\nhealthy behaviours; but the evidence on these\\npotential effects is limited (180).\\nValues\\nSee “Women’s values” at the beginning of section 3.E:\\nBackground (p.86).\\nResources\\nIt has been suggested that group ANC may be\\nassociated with lower health-care provider costs due\\nto increased staff productivity and efficiency; e.g.\\nhealth-care providers do not need to repeat advice'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='associated with lower health-care provider costs due\\nto increased staff productivity and efficiency; e.g.\\nhealth-care providers do not need to repeat advice\\nto each woman individually, and they may be less\\nlikely to feel overwhelmed by long queues of women\\nwaiting to be seen (181, 182). However, training and\\nsupervising health-care providers to conduct group-\\nbased counselling and participatory discussions is\\nalso associated with cost. Group ANC visits take\\nlonger than individual visits, therefore, from a user\\nperspective, there may be additional costs associated\\nwith the time each pregnant woman needs to take\\noff work. However, in many settings, long waiting\\ntimes are the norm, so group ANC with a scheduled\\nappointment could represent a reduced visit time.\\nEquity\\nLess-educated women are more likely to have poor\\nmaternal health literacy than more-educated women\\n(179). Therefore, interventions such as group ANC that\\naim to improve women’s ability to access, understand'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='maternal health literacy than more-educated women\\n(179). Therefore, interventions such as group ANC that\\naim to improve women’s ability to access, understand\\nand use educational materials could have a positive\\nimpact on reducing health inequalities by improving\\nmaternal health literacy among disadvantaged\\nwomen. In addition, social support is often lacking for\\ndisadvantaged women and group ANC may help to\\nreduce inequalities by facilitating the development of\\npeer support networks. However, in certain settings,\\nwhere group ANC sessions take longer than standard\\nANC visits, there may be greater cost implications\\nfor disadvantaged women. In addition, in settings\\nwith poor transport systems or variable weather, the\\nappointment system with group ANC may not be\\nsuitable and may have a negative impact on equity\\nfor women living in remote areas. Furthermore, some\\ndisadvantaged women might find it harder to disclose\\npersonal information in a group setting and might'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='for women living in remote areas. Furthermore, some\\ndisadvantaged women might find it harder to disclose\\npersonal information in a group setting and might\\nprefer a more private approach to ANC.\\nAcceptability\\nQualitative evidence from several HICs suggests\\nthat women enjoy the group format and use the\\nopportunity to build socially supportive relationships\\nwith other pregnant women and health-care\\nprofessionals (high confidence in the evidence)\\n(22). The flexibility of the format allows women to\\nexchange valuable information with each other and\\ndiscuss pregnancy-related concerns in a relaxed\\nand informal manner (high confidence in the\\nevidence). Most women appreciate the additional\\ntime inherent in the group approach (high confidence\\nin the evidence), although some women do not\\nattend group sessions because of the additional\\ntime commitments (moderate confidence in the\\nevidence). Some women have reservations about the\\nlack of privacy during the group sessions, particularly'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='attend group sessions because of the additional\\ntime commitments (moderate confidence in the\\nevidence). Some women have reservations about the\\nlack of privacy during the group sessions, particularly\\nduring physical examinations (low confidence in\\nthe evidence) and the desire to have partners/\\nhusbands included varies (moderate confidence\\nin the evidence). Evidence from providers in HICs\\nsuggests they find group sessions to be enjoyable\\nand satisfying and a more efficient use of their\\ntime (moderate confidence in the evidence) (45).\\nProviders also identified the group approach as a way\\nof providing continuity of care (moderate confidence\\nin the evidence).\\nFeasibility\\nQualitative evidence from high-resource settings\\nsuggests that health-care professionals view the\\nfacilitative components of group ANC as a skill\\nrequiring additional investment in terms of training\\nand provider commitment (moderate confidence\\nin the evidence) (45). Some providers also feel that'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.3: Group antenatal care provided by qualified health-care professionals', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='facilitative components of group ANC as a skill\\nrequiring additional investment in terms of training\\nand provider commitment (moderate confidence\\nin the evidence) (45). Some providers also feel that\\nclinics need to be better equipped to deliver group\\nsessions, i.e. clinics need to have large enough rooms\\nwith adequate seating (moderate confidence in the\\nevidence). The feasibility of group ANC in low-\\nresource settings needs further research; however,\\npilot studies in Ghana, Malawi and the United\\nRepublic of T anzania suggest that group ANC is\\nfeasible in these settings (181). It has been suggested\\nthat group ANC may be a feasible way of improving'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='93\\nANC quality in settings where relatively few providers\\nattend to relatively large numbers of women in a\\nlimited time and, as such, effective communication\\ncan be challenging (182). Others have suggested\\nthat the group approach may be a sustainable way of\\nproviding continuity of care (181).\\nE.4: Community-based interventions to improve communication and support\\nE.4.1: Facilitated participatory learning and action (PLA) cycles with women’s groups'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True}, page_content='participatory learning and action (PLA) cycles with women’s groups is recommended to improve\\nmaternal and newborn health, particularly in rural settings with low access to health services.\\nParticipatory women’s groups represent an opportunity for women to discuss their needs during\\npregnancy, including barriers to reaching care, and to increase support to pregnant women.\\n(Context-specific recommendation)\\nRemarks\\n• Part of this recommendation was integrated from WHO recommendations on community mobilization\\nthrough facilitated participatory learning and action cycles with women’s groups for maternal and newborn\\nhealth (2014) (183).\\n• The pathways of influence of this multifaceted, context-specific intervention on maternal and newborn\\noutcomes are difficult to assess. Women meeting to identify their needs and seek solutions plays an\\nimportant role; mechanisms related to additional activities that are organized based on the solutions\\nidentified at the meetings may also play a role.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='important role; mechanisms related to additional activities that are organized based on the solutions\\nidentified at the meetings may also play a role.\\n• Detailed information and guidance related to the recommendation, including important implementation\\nconsiderations, can be found in the 2014 WHO recommendations on PLA cycles (183), available at:\\nhttp:/ /www.who.int/ maternal_child_adolescent/ documents/ community-mobilization-maternal-\\nnewborn/ en/\\nSummary of evidence and considerations\\nEffects of community mobilization through\\nfacilitated PLA cycles and women’s groups\\nversus standard care (EB T able E.4.1)\\nThe evidence on the effects of community\\nmobilization interventions was synthesized for this\\nguideline from data derived from a Cochrane review\\nof health system and community-level interventions\\nfor improving ANC coverage and health outcomes\\n(175). Seven cluster-RCT s conducted between 1999\\nand 2011, involving approximately 116805 women,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='of health system and community-level interventions\\nfor improving ANC coverage and health outcomes\\n(175). Seven cluster-RCT s conducted between 1999\\nand 2011, involving approximately 116805 women,\\ncontributed data to this comparison. T rials were\\nconducted in Bangladesh (2), India (2), Malawi (2)\\nand Nepal (1), and six out of seven were conducted\\nin low-resource, rural settings (184–190). The\\nintervention consisted of involving women (pregnant\\nand non-pregnant) in PLA cycles facilitated by\\ntrained facilitators, with the aim of identifying,\\nprioritizing and addressing problems women face\\naround pregnancy, childbirth and after birth, and\\nempowering women to seek care and choose healthy\\npregnancy and newborn care behaviours (191).\\nMeetings were usually held on a monthly basis and\\nspecific activities were prioritized according to the\\nlocal context and conditions. Coverage of women’s\\ngroup meetings ranged from one group per 309 to\\none group per 1414 people in the population among'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='local context and conditions. Coverage of women’s\\ngroup meetings ranged from one group per 309 to\\none group per 1414 people in the population among\\nincluded trials, with the proportion of pregnant\\nwomen attending groups ranging from 2% to 51%.\\nFive out of seven trials were conducted against\\na backdrop of context-specific health system\\nstrengthening in both intervention and control\\narms; these included training of TBAs and provision\\nof basic equipment to TBAs and/ or primary care\\nfacilities in four trials. Random effects models were\\nused and sensitivity analyses were performed by\\nincluding only those trials in which pregnant women\\ncomprised more than 30% of the women’s groups.\\nMaternal outcomes\\nLow-certainty evidence suggests that participatory\\nwomen’s groups (PWGs) may reduce maternal\\nmortality (7 trials; RR: 0.78, 95% CI: 0.60–1.03). This\\ninterpretation is confirmed by the sensitivity analysis\\nthat included only those trials in which the women’s'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='mortality (7 trials; RR: 0.78, 95% CI: 0.60–1.03). This\\ninterpretation is confirmed by the sensitivity analysis\\nthat included only those trials in which the women’s  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n94\\ngroups included more than 30% pregnant women\\n(4trials; RR: 0.67, 95% CI: 0.47–0.95).\\nFetal and neonatal outcomes\\nLow-certainty evidence suggests that PWGs may\\nreduce perinatal mortality (6 trials; RR: 0.91, 95% CI:\\n0.82–1.01). This interpretation is confirmed by the\\nsensitivity analysis that included only those trials in\\nwhich pregnant women comprised more than 30%\\nof the women’s groups (4 trials; RR: 0.85, 95% CI:\\n0.77–0.94).\\nCoverage outcomes\\nLow-certainty evidence suggests that PWGs may\\nhave little or no effect on ANC coverage of at least\\nfour visits (3 trials; RR: 1.05, 95% CI: 0.78–1.41),\\nfacility-based delivery (5 trials; RR: 1.04, 95% CI:\\n0.89–1.22) and ANC coverage of at least one visit\\n(6trials; RR: 1.43, 95% CI: 0.81–2.51). However,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='facility-based delivery (5 trials; RR: 1.04, 95% CI:\\n0.89–1.22) and ANC coverage of at least one visit\\n(6trials; RR: 1.43, 95% CI: 0.81–2.51). However,\\nevidence from the sensitivity analysis, which included\\nonly those trials in which pregnant women comprised\\nmore than 30% of the women’s groups, suggests that\\nPWGs may increase ANC coverage of at least one\\nvisit (3 trials; RR: 1.77, 95% CI: 1.21–2.58).\\nAdditional considerations\\nFindings are consistent with a 2013 review of PWGs\\n(191), which provided low-quality evidence that\\nwomen’s groups reduced maternal mortality (OR:\\n0.63, 95% CI: 0.32–0.94) and moderate-quality\\nevidence that women’s groups reduced neonatal\\nmortality (OR: 0.77, 95% CI: 0.65–0.90). The latter\\nreview formed the evidence base for the 2014 WHO\\nrecommendation on PWGs (183).\\nnn The existing WHO recommendation on PWGs is\\nas follows:\\n“The implementation of community\\nmobilization through facilitated participatory\\nlearning and action cycles with women’s groups'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True}, page_content='nn The existing WHO recommendation on PWGs is\\nas follows:\\n“The implementation of community\\nmobilization through facilitated participatory\\nlearning and action cycles with women’s groups\\nis recommended to improve maternal and\\nnewborn health, particularly in rural settings\\nwith low access to health services (strong\\nrecommendation; moderate-quality evidence\\non neonatal mortality, low-quality evidence\\nfor maternal mortality and care-seeking\\noutcomes)” (183).\\nThe GDG that developed this recommendation\\nadvised that any intervention designed to\\nincrease access to health services should be\\nimplemented in tandem with strategies to\\nimprove the quality of the health services. It\\nalso highlighted the need for more research\\nto understand the effects of community\\nmobilization on care-seeking outcomes in\\ndifferent contexts, and recommended the need\\nfor close monitoring and evaluation to ensure\\nhigh quality implementation adapted to the\\nlocal context.\\nValues'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.1: The implementation of community mobilization through facilitated', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 8, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='mobilization on care-seeking outcomes in\\ndifferent contexts, and recommended the need\\nfor close monitoring and evaluation to ensure\\nhigh quality implementation adapted to the\\nlocal context.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.E:Background (p.86).\\nResources, Equity, Acceptability and Feasibility\\nSee the “Summary of evidence and considerations”\\nfor Recommendation E.4.2.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='95\\nE.4.2: Community mobilization and antenatal home visits'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='mobilization and antenatal home visits are recommended to improve antenatal care utilization\\nand perinatal health outcomes, particularly in rural settings with low access to health services.\\n(Context-specific recommendation)\\nRemarks\\n• The GDG agreed that the extent to which these packages improve communication and support for\\npregnant women is not clear.\\n• As a stand-alone intervention, the evidence does not support the use of antenatal home visits by lay\\nhealth workers during pregnancy to improve ANC utilization health outcomes. While the quality and\\neffectiveness of communication during home visits, and the extent to which they increase support\\nfor women, is not clear, antenatal home visits may be helpful in ensuring continuity of care across the\\nantenatal, intrapartum and postnatal periods and in promoting other healthy behaviour.\\n• Stakeholders need to be clear that antenatal home visits by lay health workers do not replace ANC visits.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='antenatal, intrapartum and postnatal periods and in promoting other healthy behaviour.\\n• Stakeholders need to be clear that antenatal home visits by lay health workers do not replace ANC visits.\\n• Stakeholders should implement health system strengthening interventions alongside these community-\\nbased interventions.\\n• Health-care providers need initial and ongoing training in communication with women and their partners.\\nFor women’s groups and community mobilization, providers also need training on group facilitation, in the\\nconvening of public meetings and in other methods of communication.\\n• Information for women and community members should be provided in languages and formats accessible\\nto them and programme planners need to ensure that health-care providers/facilitators have reliable\\nsupplies of appropriate information materials.\\n• Programme planners should be aware of the potential for additional costs associated with home visits and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='supplies of appropriate information materials.\\n• Programme planners should be aware of the potential for additional costs associated with home visits and\\ncommunity mobilization initiatives, including the potential need for extra staff and travel expenses.\\n• When considering the use of antenatal home visits, women’s groups, partner involvement or community\\nmobilization, programme planners need to ensure that these can be implemented in a way that respects\\nand facilitates women’s needs for privacy as well as their choices and their autonomy in decision-making.\\nBy offering pregnant women a range of opportunities for contact, communication and support, their\\nindividual preferences and circumstances should also be addressed.\\n• Further research is needed on the acceptability and feasibility of mixed-gender communication, the\\noptimal methods for community mobilization, the best model for integration with health systems,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='• Further research is needed on the acceptability and feasibility of mixed-gender communication, the\\noptimal methods for community mobilization, the best model for integration with health systems,\\ncontinuity elements of home visits, and the mechanisms of effect of these interventions.\\nSummary of evidence and considerations\\nEffects of communication and support provided\\nto women through community mobilization and\\nhome visits during pregnancy versus standard\\ncare (EB T able E.4.2)\\nThe evidence on the effects of community\\nmobilization and antenatal home visits was\\nsynthesized from data derived from a Cochrane\\nreview of health system and community-level\\ninterventions for improving ANC coverage and health\\noutcomes (175). Four large cluster-RCT s conducted\\nin rural Bangladesh, India and Pakistan contributed\\ndata on packages of interventions involving\\ncommunity mobilization and antenatal home visits\\nversus no intervention (192–195). Health system'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['maternal_changes'], 'contains_warnings': True, 'discusses_normal_variations': True}, page_content='in rural Bangladesh, India and Pakistan contributed\\ndata on packages of interventions involving\\ncommunity mobilization and antenatal home visits\\nversus no intervention (192–195). Health system\\nstrengthening occurred in both the intervention\\nand control groups in two of the trials. The focus of\\nthese packages was generally to promote maternal\\nhealth education, ANC attendance and other care-\\nseeking behaviour, tetanus toxoid vaccinations\\nand iron and folic acid supplements, and birth and\\nnewborn-care preparedness. Household visits\\nwere performed by trained lay health workers and\\nconsisted of at least two visits during pregnancy.\\nIn two trials, these visits were targeted to occur at\\n12–16weeks of gestation and 32–34weeks; in one\\ntrial, these visits both occurred in the third trimester;\\nand in the fourth trial the timing of the visits was\\nnot specified. Multilevel community mobilization\\nstrategies included advocacy work with community\\nstakeholders (community leaders, teachers, and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['normal_variations'], 'discusses_normal_variations': True}, page_content='and in the fourth trial the timing of the visits was\\nnot specified. Multilevel community mobilization\\nstrategies included advocacy work with community\\nstakeholders (community leaders, teachers, and  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n96\\nother respected members), TBAs, husbands or\\npartners, and households (husbands or partners,\\nwomen, and other family members). T wo intervention\\npackages included group education sessions for\\nwomen focusing on key knowledge and behaviour\\naround pregnancy and early neonatal care, including\\npromotion of ANC and other health education. One\\nintervention package included husband education\\nvia booklets and audio cassettes. T raining of TBAs\\nto recognize common obstetric and newborn\\nemergencies was a component of three intervention\\npackages. In one trial, telecommunication systems\\nwith transport linkages were also set up as part of\\nthe intervention package. In another trial, community'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='packages. In one trial, telecommunication systems\\nwith transport linkages were also set up as part of\\nthe intervention package. In another trial, community\\nhealth committees were encouraged to establish an\\nemergency transport fund and use local vehicles,\\nin addition to advocacy work, household visits and\\nwomen’s meetings.\\nMaternal outcomes\\nModerate-certainty evidence indicates that\\nintervention packages with community mobilization\\nand antenatal home visits probably have little or no\\neffect on maternal mortality (2 trials; RR: 0.76, 95%\\nCI: 0.44–1.31).\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that\\nintervention packages with community mobilization\\nand antenatal home visits probably reduce perinatal\\nmortality (3 trials; RR: 0.65, 95% CI: 0.48–0.88).\\nCoverage outcomes\\nHigh-certainty evidence shows that intervention\\npackages with community mobilization and antenatal\\nhome visits improve ANC coverage of at least one'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Coverage outcomes\\nHigh-certainty evidence shows that intervention\\npackages with community mobilization and antenatal\\nhome visits improve ANC coverage of at least one\\nvisit (4 trials; RR: 1.76, 95% CI: 1.43–2.16). However,\\nmoderate-certainty evidence indicates that they\\nprobably have little or no effect on ANC coverage\\nof at least four visits (1trial; RR: 1.51, 95% CI: 0.50–\\n4.59) or facility-based birth (3 trials; RR: 1.46, 95%\\nCI: 0.87–2.46).\\nAdditional considerations\\nnn The GDG also considered evidence on antenatal\\nhome visits as a stand-alone intervention, but\\ndid not make a separate recommendation on\\nthis intervention due to the lack of evidence of\\nbenefits related to the ANC guideline outcomes.\\nIn brief, evidence of moderate- to high-certainty\\nsuggests that stand-alone antenatal home visits\\nhave little or no effect on ANC visit coverage\\nof at least four visits (4 trials; RR: 1.09, 95% CI:\\n0.99–1.22), facility-based birth (4 trials; RR: 1.08,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='have little or no effect on ANC visit coverage\\nof at least four visits (4 trials; RR: 1.09, 95% CI:\\n0.99–1.22), facility-based birth (4 trials; RR: 1.08,\\n95% CI: 0.87–1.35), perinatal mortality (4 trials;\\nRR: 0.91, 95% CI: 0.79–1.05) and preterm birth\\n(1 trial; RR: 0.88, 95% CI: 0.54–1.44) (see Web\\nsupplement).\\nnn The 2013 WHO recommendations on postnatal care\\nof the mother and newborn include the following\\nrecommendation:\\n“Home visits in the first week after birth are\\nrecommended for care of the mother and\\nnewborn (strong recommendation based\\non high-quality evidence for newborns and\\nlow-quality evidence for mothers).” This\\nrecommendation is accompanied by the\\nremark “Depending on the existing health\\nsystem in different settings, these home\\nvisits can be made by midwives, other skilled\\nproviders or well trained and supervised\\nCHWs [community health workers]” (196).\\nnn The 2011 WHO guidelines on Preventing early\\npregnancy and poor reproductive outcomes among'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='providers or well trained and supervised\\nCHWs [community health workers]” (196).\\nnn The 2011 WHO guidelines on Preventing early\\npregnancy and poor reproductive outcomes among\\nadolescents in developing countries strongly\\nrecommend the following in relation to the\\noutcome “Increase use of skilled antenatal,\\nchildbirth and postnatal care among adolescents”:\\nn– “Provide information to all pregnant adolescents\\nand other stakeholders about the importance of\\nutilizing skilled antenatal care.”\\nn– “Provide information to all pregnant adolescents\\nand other stakeholders about the importance of\\nutilizing skilled childbirth care.”\\nn– “Promote birth and emergency preparedness\\nin antenatal care strategies for pregnant\\nadolescents (in household, community and\\nhealth facility settings)” (197).\\nnn Several WHO recommendations included in the\\n2015 WHO recommendations on health promotion\\ninterventions for maternal and newborn health\\nare relevant to community-based interventions to'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.4.2: Packages of interventions that include household and community', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='nn Several WHO recommendations included in the\\n2015 WHO recommendations on health promotion\\ninterventions for maternal and newborn health\\nare relevant to community-based interventions to\\nimprove communication and support for women\\nduring pregnancy (198) – these are presented in\\nBox 3.\\nValues\\nSee “Women’s values” at the beginning of section 3.E:\\nBackground (p.86).\\nResources\\nA systematic review of the cost–effectiveness of\\nstrategies to improve the utilization and provision\\nof maternal and newborn health care in low- and\\nlower-middle-income countries reported that\\nthere was reasonably strong evidence for the'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='97\\nBox 3: Relevant recommendations from the 2015 WHO recommendations on health promotion\\ninterventions for maternal and newborn health\\nRecommendation 1: Birth preparedness and complication readiness interventions are recommended to\\nincrease the use of skilled care at birth and to increase the timely use of facility care for obstetric and newborn\\ncomplications. (Strong recommendation, very low-quality evidence.)\\nRecommendation 2: Interventions to promote the involvement of men during pregnancy, childbirth and after\\nbirth are recommended to facilitate and support improved self-care of women, improved home care practices\\nfor women and newborns, and improved use of skilled care during pregnancy, childbirth and the postnatal\\nperiod for women and newborns. (Strong recommendation, very low-quality evidence.) These interventions are\\nrecommended provided that they are implemented in a way that respects, promotes and facilitates women’s'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='recommended provided that they are implemented in a way that respects, promotes and facilitates women’s\\nchoices and their autonomy in decision-making, and supports women in taking care of themselves and their\\nnewborns. In order to ensure this, rigorous monitoring and evaluation of implementation is recommended.\\nRecommendation 3 on interventions to promote awareness of human, sexual and reproductive rights and the right\\nto access quality skilled care: Because of the paucity of evidence available, additional research is recommended.\\nThe GDG supports, as a matter of principle, the importance for MNH programmes to inform women about their\\nright to health and to access quality skilled care, and to continue to empower them to access such care.\\nRecommendation 6 on partnership with traditional birth attendants (TBAs): Where TBAs remain the\\nmain providers of care at birth, dialogue with TBAs, women, families, communities and service providers is'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='main providers of care at birth, dialogue with TBAs, women, families, communities and service providers is\\nrecommended in order to define and agree on alternative roles for TBAs, recognizing the important role they can\\nplay in supporting the health of women and newborns. (Strong recommendation, very low-quality evidence.)\\nRecommendation 7 : Ongoing dialogue with communities is recommended as an essential component in defining\\nthe characteristics of culturally appropriate, quality maternity care services that address the needs of women and\\nnewborns and incorporate their cultural preferences. Mechanisms that ensure women’s voices are meaningfully\\nincluded in these dialogues are also recommended. (Strong recommendation, very low-quality evidence.)\\nRecommendation 11: Community participation in quality-improvement processes for maternity care services is\\nrecommended to improve quality of care from the perspectives of women, communities and health-care providers.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='recommended to improve quality of care from the perspectives of women, communities and health-care providers.\\nCommunities should be involved in jointly defining and assessing quality. Mechanisms that ensure women’s voices\\nare meaningfully included are also recommended. (Strong recommendation, very low-quality evidence.)\\nRecommendation 12: Community participation in programme planning, implementation and monitoring is\\nrecommended to improve use of skilled care during pregnancy, childbirth and the postnatal period for women and\\nnewborns, increase the timely use of facility care for obstetric and newborn complications and improve maternal\\nand newborn health. Mechanisms that ensure women’s voices are meaningfully included are also recommended.\\n(Strong recommendation, very low-quality evidence.)\\nSource: WHO, 2015 (198).\\ncost–effectiveness of the use of PLA cycles (199).\\nEstimated costs per life saved for PLA cycle\\ninterventions alone was US$268 and for community'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Source: WHO, 2015 (198).\\ncost–effectiveness of the use of PLA cycles (199).\\nEstimated costs per life saved for PLA cycle\\ninterventions alone was US$268 and for community\\nmobilization combined with home visits during\\npregnancy and/ or health system strengthening,\\ncosts ranged from US$707 to US$1489 per death\\naverted. However, costs of these interventions\\nare difficult to estimate and depend on context.\\nCosting must also take into account the facilitators’\\ntime, training and supervision; these elements are\\nconsidered key to the quality of implementation and\\nthe success of the intervention.\\nEquity\\nInterventions such as PLA cycles, community\\nmobilization and home visits during pregnancy are\\na way of facilitating dialogue and action with, and\\nempowering, disadvantaged populations to engage in\\nefforts to improve health and to strengthen broader\\ncommunity support. The women’s groups PLA cycles,\\nin particular, were conducted in marginalized areas'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='efforts to improve health and to strengthen broader\\ncommunity support. The women’s groups PLA cycles,\\nin particular, were conducted in marginalized areas\\nwhere other support mechanisms often do not exist.\\nInterventions to engage male partners/husbands and\\nothers in the community to support women to make\\nhealthy choices for themselves and their children  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n98\\nmay help to address inequalities. However, when\\nengaging men, it is important to consider women’s\\npreferences, as including male partners could also\\nhave a negative effect for women who would prefer to\\ndiscuss pregnancy-related and other matters without\\ntheir partner’s involvement.\\nAcceptability\\nQualitative evidence suggests that women in a\\nvariety of settings and contexts readily engage with\\ninterventions designed to increase communication and\\nsupport, provided they are delivered in a caring and\\nrespectful manner (high confidence in the evidence)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='interventions designed to increase communication and\\nsupport, provided they are delivered in a caring and\\nrespectful manner (high confidence in the evidence)\\n(22). The use of women’s groups is likely to fulfil two\\nkey requirements of ANC from a woman’s perspective\\n– the opportunity to receive and share relevant\\ninformation and the opportunity to develop supportive\\nrelationships with other women and health-care\\nproviders (high confidence in the evidence). Evidence\\nfrom women and providers in LMICs also highlighted\\nthe importance of active community engagement\\nin the design and delivery of informational-based\\nservices, especially in communities where traditional\\nbeliefs may differ from conventional understandings\\n(moderate confidence in the evidence). Qualitative\\nevidence from providers suggests that there is a\\nwillingness to supply pregnancy-related information\\nand offer psychological/ emotional support to women\\nprovided that resources are available (high confidence'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='willingness to supply pregnancy-related information\\nand offer psychological/ emotional support to women\\nprovided that resources are available (high confidence\\nin the evidence) and the services are delivered in\\na coordinated, organized manner with appropriate\\nmanagerial support (moderate confidence in the\\nevidence) (45).\\nFeasibility\\nQualitative evidence suggests that, where health-care\\nproviders are involved in facilitating women’s groups,\\nthey may need additional training to help with the\\nfacilitative components and this may be a barrier\\nin some resource-poor settings (high confidence in\\nthe evidence). Similarly, the extra costs associated\\nwith home visits in terms of additional staff and\\nextra resources may limit implementation in some\\nLMICs (high confidence in the evidence) (45). It has\\nbeen suggested that community-based interventions\\nintroduced through existing public sector health\\nworkers and local health systems may be more\\nfeasible and more likely to succeed than project-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 9, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='been suggested that community-based interventions\\nintroduced through existing public sector health\\nworkers and local health systems may be more\\nfeasible and more likely to succeed than project-\\nbased interventions (200).  \\n99\\nE.5: T ask shifting components of antenatal care delivery'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.5.1: T ask shifting the promotion of health-related behaviours for', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='maternal and newborn health a to a broad range of cadres, including lay health workers, auxiliary\\nnurses, nurses, midwives and doctors is recommended. (Recommended)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.5.2: T ask shifting the distribution of recommended nutritional', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='supplements and intermittent preventive treatment in pregnancy (IPTp) for malaria prevention\\nto a broad range of cadres, including auxiliary nurses, nurses, midwives and doctors is\\nrecommended. (Recommended)\\nRemarks\\n• Recommendations E.5.1 and E.5.2 have been adapted and integrated from Optimizing health worker roles to\\nimprove access to key maternal and newborn health interventions through task shifting (OptimizeMNH) (2012)\\n(201).\\n• The GDG noted that, while task shifting has an important role to play in allowing flexibility in health-care\\ndelivery in low-resource settings, policy-makers need to work towards midwife-led care for all women.\\n• Lay health workers need to be recognized and integrated into the system, and not be working alone, i.e.\\ntask shifting needs to occur within a team approach.\\n• The mandate of all health workers involved in task shifting programmes needs to be clear.\\n• In a separate guideline on HIV testing services (98), WHO recommends that lay providers who are'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.5.2: T ask shifting the distribution of recommended nutritional', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs'], 'contains_warnings': True}, page_content='• The mandate of all health workers involved in task shifting programmes needs to be clear.\\n• In a separate guideline on HIV testing services (98), WHO recommends that lay providers who are\\ntrained and supervised can independently conduct safe and effective HIV testing using rapid tests (see\\nRecommendation B.1.8).\\n• The GDG noted that it may be feasible to task shift antenatal ultrasound to midwives with the appropriate\\ntraining, staffing, mentoring and referral systems in place.\\n• Further research is needed on the mechanism of effect of MLCC and whether continuity of care can be\\ntask shifted.\\n• Further information on this recommendation can be found in the OptimizeMNH guideline (201), available\\nat: http:/ /www.who.int/ reproductivehealth/ publications/ maternal_perinatal_health/978924504843/ en/\\na Including promotion of the f ollowing: care-seeking behaviour and ANC utilization; birth preparedness and complication readiness; sleeping under insecticide-'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.5.2: T ask shifting the distribution of recommended nutritional', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='a Including promotion of the f ollowing: care-seeking behaviour and ANC utilization; birth preparedness and complication readiness; sleeping under insecticide-\\ntreated bednets; skilled care for childbirth; companionship in labour and childbirth; nutritional advice; nutritional supplements; HIV testing during pregnancy;\\nexclusive breastfeeding; postnatal care and family planning; immunization according to national guidelines.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n100\\nE.6: Recruitment and retention of staff in rural and remote areas'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.6: Policy-makers should consider educational, regulatory, financial, and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='personal and professional support interventions to recruit and retain qualified health workers in\\nrural and remote areas. (Context-specific recommendation)\\nRemarks\\n• Recommendation E.6 has been adapted and integrated for the ANC guideline from the 2010 WHO\\npublication Increasing access to health workers in remote and rural areas through improved retention: global\\npolicy recommendations (202).\\n• Strong recommendations (abridged) on recruitment and staff retention from the above guideline include\\nthe following.\\n– Use targeted admission policies to enrol students with a rural background in education programmes\\nfor various health disciplines and/ or establish a health-care professional school outside of major cities.\\n– Revise undergraduate and postgraduate curricula to include rural health topics and clinical rotations in\\nrural areas so as to enhance the competencies of health-care professionals working in rural areas.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.6: Policy-makers should consider educational, regulatory, financial, and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='rural areas so as to enhance the competencies of health-care professionals working in rural areas.\\n– Improve living conditions for health workers and their families and invest in infrastructure and services\\n(sanitation, electricity, telecommunications, schools, etc.).\\n– Provide a good and safe working environment, including appropriate equipment and supplies,\\nsupportive supervision and mentoring.\\n– Identify and implement appropriate outreach activities to facilitate cooperation between health\\nworkers from better-served areas and those in underserved areas, and, where feasible, use tele-health\\nto provide additional support.\\n– Develop and support career development programmes and provide senior posts in rural areas so that\\nhealth workers can move up the career path as a result of experience, education and training, without\\nnecessarily leaving rural areas.\\n– Support the development of professional networks, rural health-care professional associations,'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.6: Policy-makers should consider educational, regulatory, financial, and', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='necessarily leaving rural areas.\\n– Support the development of professional networks, rural health-care professional associations,\\nrural health journals, etc., to improve the morale and status of rural providers and reduce feelings of\\nprofessional isolation.\\n– Adopt public recognition measures such as rural health days, awards and titles at local, national and\\ninternational levels to lift the profile of working in rural areas.\\n• Conditional educational, regulatory and financial recommendations from this guideline can be found\\nin the WHO global policy recommendations document (202), available at: http:/ /www.who.int/hrh/\\nretention/ guidelines/ en/'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='101\\nE.7: Antenatal care contact schedules'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='recommended to reduce perinatal mortality and improve women’s experience of care.\\n(Recommended)\\nRemarks\\n• The GDG stresses that the four-visit focused ANC (FANC) model does not offer women adequate\\ncontact with health-care practitioners and is no longer recommended. With the FANC model, the first\\nANC visit occurs before 12weeks of pregnancy, the second around 26weeks, the third around 32weeks,\\nand the fourth between 36 and 38weeks of gestation. Thereafter, women are advised to return to ANC\\nat 41weeks of gestation or sooner if they experience danger signs. Each ANC visit involves specific goals\\naimed at improving triage and timely referral of high-risk women and includes educational components\\n(12). However, up-to-date evidence shows that the FANC model, which was developed in the 1990s, is\\nprobably associated with more perinatal deaths than models that comprise at least eight ANC visits.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='(12). However, up-to-date evidence shows that the FANC model, which was developed in the 1990s, is\\nprobably associated with more perinatal deaths than models that comprise at least eight ANC visits.\\nFurthermore, evidence suggests that more ANC visits, irrespective of the resource setting, is probably\\nassociated with greater maternal satisfaction than less ANC visits.\\n• The GDG prefers the word “contact” to “visit”, as it implies an active connection between a\\npregnant woman and a health-care provider that is not implicit with the word “visit”. In terms of\\nthe operationalization of this recommendation, “contact” can be adapted to local contexts through\\ncommunity outreach programmes and lay health worker involvement.\\n• The decision regarding the number of contacts with a health system was also influenced by the following:\\n– evidence supporting improving safety during pregnancy through increased frequency of maternal and\\nfetal assessment to detect problems;'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='– evidence supporting improving safety during pregnancy through increased frequency of maternal and\\nfetal assessment to detect problems;\\n– evidence supporting improving health system communication and support around pregnancy for\\nwomen and families;\\n– evidence from HIC studies indicating no important differences in maternal and perinatal health\\noutcomes between ANC models that included at least eight contacts and ANC models that included\\nmore (11–15) contacts (203);\\n– evidence indicating that more contact between pregnant women and knowledgeable, supportive and\\nrespectful health-care practitioners is more likely to lead to a positive pregnancy experience.\\n• Implementation considerations related to this recommendation and the mapping of guideline\\nrecommendations to ANC contacts are presented in Chapter 4: Implementation of the ANC guideline and\\nrecommendations.\\nSummary of evidence and considerations\\nEffects of the FANC model (with four visits)'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='recommendations.\\nSummary of evidence and considerations\\nEffects of the FANC model (with four visits)\\ncompared with “standard” ANC (with at least\\neight ANC visits planned) (EB T able E.7)\\nThe evidence on the effects of FANC (the four-visit\\nANC model) was derived from a Cochrane review\\non “reduced-visit” ANC models versus “standard”\\ncare models (with at least eight ANC visits planned)\\nthat included seven RCT s (203). Four individual RCT s\\nwere conducted in HICs (the United Kingdom and the\\nUSA) and three large cluster-RCT s were conducted in\\nLMICs, including one conducted in Argentina, Cuba,\\nSaudi Arabia and Thailand (204), and two conducted\\nin Zimbabwe. The LMIC trials evaluated the FANC\\nmodel compared with “standard” ANC models that\\nplanned for at least eight visits (12). Three cluster-\\nRCT s involving more than 50000 women contributed\\ndata. The median number of visits achieved in the\\nFANC arms of these trials ranged from four to five'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='RCT s involving more than 50000 women contributed\\ndata. The median number of visits achieved in the\\nFANC arms of these trials ranged from four to five\\nvisits and the median number of visits achieved in the\\nstandard ANC arms ranged from four to eight visits.\\nMaternal outcomes\\nHigh-certainty evidence shows that FANC had little\\nor no effect on caesarean section rates (1 trial, 24526\\nwomen; RR: 1.00, 95% CI: 0.89–1.11), and low-\\ncertainty evidence suggests that it may make little or\\nno difference to maternal mortality (3 trials, 51504\\nwomen; RR: 1.13, 95% CI: 0.5–2.57).\\nWith regard to maternal satisfaction, outcomes\\nwere reported narratively in the review, as data were\\nsparse. In a survey conducted among a subset of  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n102\\nwomen participating in the WHO trial, fewer women\\nwere satisfied with the frequency of visits in the\\nFANC model than in the standard model (77.4%\\nversus 87.2%) and women in the FANC model were'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='102\\nwomen participating in the WHO trial, fewer women\\nwere satisfied with the frequency of visits in the\\nFANC model than in the standard model (77.4%\\nversus 87.2%) and women in the FANC model were\\nless likely to be satisfied with the spacing between\\nvisits compared with the standard model (72.7%\\nversus 81%). This evidence was not formally graded\\ndue to insufficient data.\\nFetal and neonatal outcomes\\nModerate-certainty evidence indicates that FANC\\nprobably increases perinatal mortality compared\\nwith “standard” ANC with more visits (3 trials, 51323\\nwomen; RR: 1.15, 95% CI: 1.01–1.32). Based on this RR,\\nthe illustrative impact on perinatal mortality rates are\\nshown in Box4.\\nModerate-certainty evidence indicates that FANC\\nprobably has little or no effect on preterm birth\\n(3trials, 47 094 women; RR: 0.99, 95%CI:0.91–1.08)\\nand low birth weight (3trials, 46 220 women;\\nRR:1.04, 95% CI: 0.97–1.12) compared with\\n“standard” ANC. In addition, low-certainty evidence'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='(3trials, 47 094 women; RR: 0.99, 95%CI:0.91–1.08)\\nand low birth weight (3trials, 46 220 women;\\nRR:1.04, 95% CI: 0.97–1.12) compared with\\n“standard” ANC. In addition, low-certainty evidence\\nsuggests that FANC probably makes little or no\\ndifference to SGA (3 trials, 43 094 women; RR: 1.01,\\n95% CI: 0.88–1.17).\\nAdditional considerations\\nnn The GDG noted that the review authors explored\\nreasons for the effect on perinatal mortality and\\nthe effect persisted in various exploratory analyses.\\nnn In 2012, the WHO undertook a secondary analysis\\nof perinatal mortality data from the WHO FANC\\ntrial (205). This secondary analysis, which included\\n18365 low-risk and 6160 high-risk women, found\\nan increase in the overall risk of perinatal mortality\\nbetween 32 and 36weeks of gestation with FANC\\ncompared with “standard” ANC in both low- and\\nhigh-risk populations.\\nnn It is not clear whether the philosophy of the FANC\\napproach, with regard to improving quality of care'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='compared with “standard” ANC in both low- and\\nhigh-risk populations.\\nnn It is not clear whether the philosophy of the FANC\\napproach, with regard to improving quality of care\\nat each ANC visit, was implemented effectively\\nin the trials. However, if this element is neglected,\\na poorly executed FANC model may then simply\\nrepresent reduced health provider contact, and\\na reduced opportunity to detect risk factors and\\ncomplications, and to address women’s concerns.\\nnn The GDG panel considered unpublished findings\\nof a two-year audit of perinatal mortality from\\nthe Mpumalanga region of South Africa that has\\nimplemented the FANC model (206). The audit\\nfrom September 2013 to August 2015 comprised\\ndata of 149308 births of neonates weighing\\nmore than 1000g, among which there were 3893\\nperinatal deaths (giving a PMR of 24.8 per 1000\\nbirths). Stillbirth risk was plotted according to\\ngestational age and three peaks in the occurrence\\nof stillbirths were noted, one at around 31weeks'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='perinatal deaths (giving a PMR of 24.8 per 1000\\nbirths). Stillbirth risk was plotted according to\\ngestational age and three peaks in the occurrence\\nof stillbirths were noted, one at around 31weeks\\nof gestation, another at around 37weeks, and the\\nthird occurring at 40weeks or more. When these\\ndata were compared with stillbirth data from\\nanother South Africa province, which uses a model\\nof ANC that includes fortnightly ANC visits from\\n28weeks of gestation, the latter showed a gradual\\nrise in the overall stillbirth risk from 28weeks, with\\na single (and lower) peak at 40weeks or more,\\ni.e. no additional peaks at 30 and 37weeks. These\\ndata are consistent with those from the secondary\\nanalysis of the WHO trial and suggest that\\nadditional visits in the third trimester may prevent\\nstillbirths.\\nnn The GDG also considered the evidence from the\\nCochrane review on reduced visit ANC models\\nof at least eight visits versus “standard” ANC\\nmodels with 11–15 visits from four RCT s in HICs'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'recommendation': 'RECOMMENDATION E.7: Antenatal care models with a minimum of eight contacts are', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 10, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='nn The GDG also considered the evidence from the\\nCochrane review on reduced visit ANC models\\nof at least eight visits versus “standard” ANC\\nmodels with 11–15 visits from four RCT s in HICs\\n(203). Low-certainty evidence suggested that the\\nreduced-visit model (with at least eight visits)\\nmay be associated with increased preterm birth\\nBox 4: Illustration of the impact of focused ANC (FANC) on perinatal mortality rates (PMR)\\nAssumed PMR\\n(“Standard” ANC)\\nIllustrative PMR a\\n(FANC model)\\nAbsolute increase in\\nperinatal deaths\\n10 deaths per 1000 births 12 deaths per 1000 births\\n(10–13 deaths)\\n2 deaths per 1000 births\\n(0–3 deaths)\\n25 deaths per 1000 births 29 deaths per 1000 births\\n(25–33 deaths)\\n4 deaths per 1000 births\\n(0–8 deaths)\\n50 deaths per 1000 births 58 deaths per 1000 births\\n(50–66 deaths)\\n8 deaths per 1000 births\\n(0–16 deaths)aBased on RR: 1.15, 95% CI: 1.01–1.32.'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='103\\n(3trials; RR: 1.24, 1.01–1.52), but no other important\\neffects on health outcomes were noted. In general,\\nhowever, evidence from these individual studies\\nalso suggests that the reduced-visit models may be\\nassociated with lower women’s satisfaction.\\nnn The GDG considered unpublished evidence from\\nfour country case studies (Argentina, Kenya,\\nThailand and the United Republic of T anzania)\\nwhere the FANC model has been implemented\\n(207). Provider compliance was noted to be\\nproblematic in some settings, as were shortages\\nof equipment, supplies and staff. Integration of\\nservices was found to be particularly challenging,\\nespecially in settings with a high prevalence of\\nendemic infections (e.g. malaria, TB, sexually\\ntransmitted infections, helminthiasis). Guidance\\non implementation of the FANC model in such\\nsettings was found to be inadequate, as was the\\namount of time allowed within the four-visit model\\nto provide integrated care.\\nnn Findings on provider compliance from these case'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs'], 'contains_warnings': True}, page_content='settings was found to be inadequate, as was the\\namount of time allowed within the four-visit model\\nto provide integrated care.\\nnn Findings on provider compliance from these case\\nstudies are consistent with published findings from\\nrural Burkina Faso, Uganda and the United Republic\\nof T anzania (208). Health-care providers in this\\nstudy were found to variably omit certain practices\\nfrom the FANC model, including blood pressure\\nmeasurement and provision of information on\\ndanger signs, and to spend less than 15minutes\\nper ANC visit. Such reports suggest that fitting all\\nthe components of the FANC model into four visits\\nis difficult to achieve in some low-resource settings\\nwhere services are already overstretched. In\\naddition, in low-resource settings, when the target\\nis set at four ANC visits, due to the various barriers\\nto ANC use, far fewer than four visits may actually\\nbe achieved.\\nnn Programmatic evidence from Ghana and Kenya\\nindicates similar levels of satisfaction between'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='to ANC use, far fewer than four visits may actually\\nbe achieved.\\nnn Programmatic evidence from Ghana and Kenya\\nindicates similar levels of satisfaction between\\nFANC and standard ANC, with sources of\\ndissatisfaction with both models being long\\nwaiting times and costs associated with care (209,\\n210).\\nnn Emotional and psychosocial needs are variable\\nand the needs of vulnerable groups (including\\nadolescent girls, displaced and war-affected\\nwomen, women with disabilities, women with\\nmental health concerns, women living with HIV,\\nsex workers, ethnic and racial minorities, among\\nothers) can be greater than for other women.\\nTherefore, the number and content of visits should\\nbe adaptable to local context and to the individual\\nwoman.\\nValues\\nSee “Women’s values” at the beginning of section\\n3.E:Background (p.86).\\nResources\\nT wo trials evaluated cost implications of two\\nmodels of ANC with reduced visits, one in the\\nUnited Kingdom and one in two LMICs (Cuba and'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='3.E:Background (p.86).\\nResources\\nT wo trials evaluated cost implications of two\\nmodels of ANC with reduced visits, one in the\\nUnited Kingdom and one in two LMICs (Cuba and\\nThailand). Costs per pregnancy to both women and\\nproviders were lower with the reduced visits models\\nin both settings. Time spent accessing care was also\\nsignificantly shorter with reduced visits models. In the\\nUnited Kingdom trial, there was an increase in costs\\nrelated to neonatal intensive care unit stays in the\\nreduced visit model.\\nEquity\\nPreventable maternal and perinatal mortality is\\nhighest among disadvantaged populations, which\\nare at greater risk of various health problems, such\\nas nutritional deficiencies and infections, that\\npredispose women to poor pregnancy outcomes.\\nThis suggests that, in LMICs, more and better quality\\ncontact between pregnant women with health-care\\nproviders would help to address health inequalities.\\nAcceptability\\nEvidence from high-, medium- and low-resource'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='contact between pregnant women with health-care\\nproviders would help to address health inequalities.\\nAcceptability\\nEvidence from high-, medium- and low-resource\\nsettings suggests that women do not like reduced\\nvisit schedules and would prefer more contact with\\nantenatal services (moderate confidence in the\\nevidence) (22). Women value the opportunity to build\\nsupportive relationships during their pregnancy (high\\nconfidence in the evidence) and for some women,\\nespecially in LMIC settings, the reduced visit schedule\\nmay limit their ability to develop these relationships,\\nboth with health-care professionals and with other\\npregnant women (low confidence in the evidence).\\nIn some low-income settings where women rely on\\nhusbands or partners to financially support their\\nantenatal visits, the reduced visit schedule limits\\ntheir ability to procure additional finance (low\\nconfidence in the evidence). However, the reduced\\nvisit schedule may be appreciated by some women'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='antenatal visits, the reduced visit schedule limits\\ntheir ability to procure additional finance (low\\nconfidence in the evidence). However, the reduced\\nvisit schedule may be appreciated by some women\\nin a range of LMIC settings because of the potential\\nfor cost savings, e.g. loss of domestic income from\\nextra clinic attendance and/ or associated travel costs\\n(low confidence in the evidence). Indirect evidence\\nalso suggests that women are much more likely to\\nengage with antenatal services if care is provided\\nby knowledgeable, kind health-care professionals\\nwho have the time and resources to deliver genuine\\nwoman-centred care, regardless of the number of  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n104\\nvisits (high confidence in the evidence). Specific\\nevidence from providers relating to reduced visit\\nschedules or the adoption of FANC is sparse and,\\nin some LMICs, highlights concerns around the\\navailability of equipment and resources, staff'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section_path': ['3 Evidence and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='evidence from providers relating to reduced visit\\nschedules or the adoption of FANC is sparse and,\\nin some LMICs, highlights concerns around the\\navailability of equipment and resources, staff\\nshortages and inadequate training – issues that\\nare pertinent to all models of ANC delivery in low-\\nresource settings.\\nFeasibility\\nQualitative evidence suggests that some providers\\nin LMICs feel that the reduced visit schedule is a\\nmore efficient use of staff time and is less likely to\\ndeplete limited supplies of equipment and medicine\\n(moderate confidence in the evidence) (45).\\nProgramme reports from Ghana and Kenya stress\\nthat inadequate equipment, supplies, infrastructure\\nand training may hamper implementation (209,\\n210). Providers have also raised concerns about\\nthe difficulty of incorporating all of the FANC\\ncomponents into relatively short appointments,\\nespecially in LMICs (Burkina Faso, Uganda and the\\nUnited Republic of T anzania) where services are\\nalready stretched (208, 211).  \\n105'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Implementation of the ANC', 'section_path': ['3 Evidence and recommendations', 'Implementation of the ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='guideline and recommendations:\\nintroducing the 2016 WHO ANC model\\nThe ultimate goal of this guideline and its\\nrecommendations is to improve the quality\\nof ANC and to improve maternal, fetal and\\nnewborn outcomes related to ANC. These ANC\\nrecommendations need to be deliverable within an\\nappropriate model of care that can be adapted to\\ndifferent countries, local contexts and the individual\\nwoman. With the contributions of the members of\\nthe Guideline Development Group (GDG), WHO\\nreviewed existing models of delivering ANC with\\nfull consideration of the range of interventions\\nrecommended within this guideline (Chapter 3).\\nRecommendationE.7 states that “Antenatal care\\nmodels with a minimum of eight contacts are\\nrecommended to reduce perinatal mortality and\\nimprove women’s experience of care”; taking this as\\na foundation, the GDG reviewed how ANC should\\nbe delivered in terms of both the timing and content\\nof each of the ANC contacts, and arrived at a new'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Implementation of the ANC', 'section_path': ['3 Evidence and recommendations', 'Implementation of the ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first', 'second', 'third']}, 'maternal_topics': []}, page_content='a foundation, the GDG reviewed how ANC should\\nbe delivered in terms of both the timing and content\\nof each of the ANC contacts, and arrived at a new\\nmodel – the 2016 WHO ANC model – which replaces\\nthe previous four-visit focused ANC (FANC) model.\\nFor the purpose of developing this new ANC model,\\nthe ANC guideline recommendations were mapped to\\nthe eight contacts based on the evidence supporting\\neach recommendation and the optimal timing of\\ndelivery of the recommended interventions to achieve\\nmaximal impact.\\nThe 2016 WHO ANC model recommends a minimum\\nof eight ANC contacts, with the first contact\\nscheduled to take place in the first trimester (up to\\n12 weeks of gestation), two contacts scheduled in the\\nsecond trimester (at 20 and 26 weeks of gestation)\\nand five contacts scheduled in the third trimester (at\\n30, 34, 36, 38 and 40 weeks). Within this model, the\\nword “contact” has been used instead of “visit”, as\\nit implies an active connection between a pregnant'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Implementation of the ANC', 'section_path': ['3 Evidence and recommendations', 'Implementation of the ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='30, 34, 36, 38 and 40 weeks). Within this model, the\\nword “contact” has been used instead of “visit”, as\\nit implies an active connection between a pregnant\\nwoman and a health-care provider that is not implicit\\nwith the word “visit”. It should be noted that the list\\nof interventions to be delivered at each contact and\\ndetails about where they are delivered and by whom\\n(see T able 2) are not meant to be prescriptive but,\\nrather, adaptable to the individual woman and the\\nlocal context, to allow flexibility in the delivery of the\\nrecommended interventions. Different to the FANC\\nmodel, an additional contact is now recommended\\nat 20 weeks of gestation, and an additional three\\ncontacts are recommended in the third trimester\\n(defined as the period from 28 weeks of gestation\\nup to delivery), since this represents the period of\\ngreatest antenatal risk for mother and baby (see\\nBox5). At these third-trimester contacts, ANC\\nproviders should aim to reduce preventable morbidity'),\n",
       " Document(metadata={'chapter': '3 Evidence and recommendations', 'section': 'Implementation of the ANC', 'section_path': ['3 Evidence and recommendations', 'Implementation of the ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='greatest antenatal risk for mother and baby (see\\nBox5). At these third-trimester contacts, ANC\\nproviders should aim to reduce preventable morbidity\\nand mortality through systematic monitoring of\\nmaternal and fetal well-being, particularly in relation\\nto hypertensive disorders and other complications\\nthat may be asymptomatic but detectable during this\\ncritical period.\\nIf the quality of ANC is poor and women’s experience\\nof it is negative, the evidence shows that women\\nwill not attend ANC, irrespective of the number of\\nrecommended contacts in the ANC model. Thus,\\nthe overarching aim of the 2016 WHO ANC model\\nis to provide pregnant women with respectful,'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first', 'second', 'third']}, 'maternal_topics': []}, page_content='Box 5: Comparing ANC schedules\\nWHO FANC\\nmodel\\n2016 WHO ANC\\nmodel\\nFirst trimester\\nVisit 1: 8–12 weeks Contact 1: up to 12 weeks\\nSecond trimester\\nVisit 2: 24–26 weeks\\nContact 2: 20 weeks\\nContact 3: 26 weeks\\nThird trimester\\nVisit 3: 32 weeks\\nVisit 4: 36–38 weeks\\nContact 4: 30 weeks\\nContact 5: 34 weeks\\nContact 6: 36 weeks\\nContact 7: 38 weeks\\nContact 8: 40 weeks\\nReturn for delivery at 41 weeks if not given birth.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n106\\nindividualized, person-centred care at every\\ncontact, with implementation of effective clinical\\npractices (interventions and tests), and provision of\\nrelevant and timely information, and psychosocial\\nand emotional support, by practitioners with\\ngood clinical and interpersonal skills within a well\\nfunctioning health system. Effective implementation\\nof ANC requires a health systems approach and\\nstrengthening focusing on continuity of care,\\nintegrated service delivery, availability of supplies and'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='of ANC requires a health systems approach and\\nstrengthening focusing on continuity of care,\\nintegrated service delivery, availability of supplies and\\ncommodities and empowered health-care providers.\\nThere are many different ways for health system\\nplanners to optimize ANC delivery by employing\\na range of strategies that can improve the\\nutilization and quality of ANC. The health system\\nrecommendations in this guideline have focused\\nmainly on those strategies that address continuity\\nof care, and improve communication with, and\\nsupport for, women (Recommendations E.1–E.4). The\\nrecommendations on task shifting and recruitment of\\nstaff (Recommendations E.5.1, E.5.2 and E.6) are also\\nimportant, as provider experience and attitudes have\\nan impact on the capacity of health systems to deliver\\nquality ANC; barriers to provider recruitment and job\\nsatisfaction will need to be addressed to successfully\\nimplement this guideline. Such barriers have been'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='quality ANC; barriers to provider recruitment and job\\nsatisfaction will need to be addressed to successfully\\nimplement this guideline. Such barriers have been\\nshown to be significant in LMICs, and can prevent the\\nprovision of quality midwifery care (212). In addition\\nto improving the quality of care, these health system\\nrecommendations are intended to encourage health\\nsystem planners to operationalize the recommended\\neight ANC contacts in ways that are feasible in the\\nlocal context.\\nT able 2 shows the WHO ANC guideline\\nrecommendations mapped to the eight\\nrecommended contacts, thus presenting a summary\\nframework for the 2016 WHO ANC model in\\nsupport of a positive pregnancy experience. This\\ntable does not include good clinical practices,\\nsuch as measuring blood pressure, proteinuria\\nand weight, checking for fetal heart sounds, which\\nwould be included as part of an implementation\\nmanual aimed at practitioners. Practices that are\\nnot recommended have been included in the table'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='and weight, checking for fetal heart sounds, which\\nwould be included as part of an implementation\\nmanual aimed at practitioners. Practices that are\\nnot recommended have been included in the table\\nfor informational purposes and highlighted in grey.\\nContext-specific recommendations for which rigorous\\nresearch is required before they can be considered\\nfor implementation have not been mapped to the\\nschedule of contacts.\\nAny intervention that is missed at an ANC contact,\\nfor any reason, should in principle be included at the\\nnext contact. Effective communication should be\\nfacilitated at all ANC contacts, to cover: presence of\\nany symptoms; promotion of healthy pregnancies and\\nnewborns through lifestyle choices; individualized\\nadvice and support; timely information on tests,\\nsupplements and treatments; birth-preparedness and\\ncomplication-readiness planning; postnatal family\\nplanning options; and the timing and purpose of ANC\\ncontacts. T opics for individualized advice and support'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='complication-readiness planning; postnatal family\\nplanning options; and the timing and purpose of ANC\\ncontacts. T opics for individualized advice and support\\ncan include healthy eating, physical activity, nutrition,\\ntobacco, substance use, caffeine intake, physiological\\nsymptoms, malaria and HIV prevention, and blood\\ntest results and retests. Communication should occur\\nin a respectful, individualized and person-centred\\nway. An effective referral system and emergency\\ntransport are also essential components of this ANC\\nmodel.\\nWithin the 2016 WHO ANC model, there are two\\nopportunities to arrange a single early ultrasound\\nscan (i.e. before 24 weeks of gestation): either at\\nthe first contact (up to 12 weeks of gestation) or at\\nthe second contact (20 weeks). The GDG suggests\\nthis pragmatic approach in order to increase the\\nproportion of pregnancies with accurate gestational\\nage assessments, especially in settings where\\nANC utilization is historically low; lack of accurate'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='proportion of pregnancies with accurate gestational\\nage assessments, especially in settings where\\nANC utilization is historically low; lack of accurate\\ngestational age assessment can compromise the\\ndiagnosis and/ or management of complications (such\\nas preterm birth and pre-eclampsia). It is important\\nto highlight that the frequency and exact timing of\\nsome of these ANC practices and interventions –\\nespecially related to malaria, tuberculosis and HIV\\n– may need to be adapted, based on the local context,\\npopulation and health system. Please refer to Box 6\\nat the end of this chapter for considerations related\\nto the adoption, scale-up and implementation of the\\n2016 WHO ANC model.\\nThe GDG agreed that implementation of the 2016\\nWHO ANC model should not wait for a large\\nmulticentre trial to be conducted to determine the\\noptimal number of contacts, or the impact of the\\nadditional recommended interventions, such as\\nultrasound, on pregnancy outcomes, resources,'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='multicentre trial to be conducted to determine the\\noptimal number of contacts, or the impact of the\\nadditional recommended interventions, such as\\nultrasound, on pregnancy outcomes, resources,\\nequity and the other domains; rather, following\\nimplementation of the model, it should be subject\\nto ongoing monitoring and evaluation. It should\\nbe remembered that the four-visit model has  \\n107Chapter 4. Implementation of the ANC guideline and recommendations\\nsignificantly increased stillbirth risk compared\\nto standard models with eight or more contacts.\\nUnderstandably, policy-makers and health-care\\nproviders might feel that an increase in the number of\\nANC contacts with an emphasis on quality of care will\\nincrease the burden on already overstretched health\\nsystems. However, the GDG agreed that there is likely\\nto be little impact on lives saved or improved without\\nsubstantial investment in improving the quality\\nof ANC services provided in LMICs. International'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='to be little impact on lives saved or improved without\\nsubstantial investment in improving the quality\\nof ANC services provided in LMICs. International\\nhuman rights law requires that States use “maximum\\navailable resources” to realize economic, social and\\ncultural rights, which includes women’s rights to\\nsexual and reproductive health (1). Ensuring that\\nwomen’s rights to sexual and reproductive health are\\nsupported requires meeting standards with regard\\nto the availability, accessibility, acceptability and\\nquality of health-care facilities, supplies and services\\n(1). Specifically, in addition to other health system\\nstrengthening initiatives, investment is urgently\\nneeded to address the shortage and training of\\nmidwives and other health-care providers able to\\noffer ANC. Such investment should be considered a\\ntop priority as quality health care around pregnancy\\nand childbirth has far-reaching benefits for\\nindividuals, families, communities and countries.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='offer ANC. Such investment should be considered a\\ntop priority as quality health care around pregnancy\\nand childbirth has far-reaching benefits for\\nindividuals, families, communities and countries.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n108\\na. A healthy diet contains adequate energy, protein, vitamins and minerals, obtained through the consumption of a variety of foods, including green and orange vegetables, meat, fish, beans, nuts, whole grains and fruit.\\nb. The equivalent of 60 mg of elemental iron is 300 mg of ferrous sulfate hepahydrate, 180 mg of ferrous fumarate or 500 mg of ferrous gluconate.\\nc. Folic acid should be commenced as early as possible (ideally before conception) to prevent neural tube defects.\\nd. This recommendation supersedes the previous recommendation found in the 2012 WHO publication Guideline: daily iron and folic acid supplementation in pregnant women (36).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='d. This recommendation supersedes the previous recommendation found in the 2012 WHO publication Guideline: daily iron and folic acid supplementation in pregnant women (36).\\nT able 2: The 2016 WHO ANC model for a positive pregnancy experience: recommendations mapped to eight scheduled ANC contacts\\nOverarching aim: T o provide pregnant women with respectful, individualized, person-centred care at every contact, with implementation of effective clinical practices (interventions and tests), and provision of relevant\\nand timely information, and psychosocial and emotional support, by practitioners with good clinical and interpersonal skills within a well functioning health system.Notes:\\n• These recommendations apply to pregnant women and adolescent girls within the context of routine ANC.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section_path': ['4 Implementation of the ANC guideline and recommendations'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='• These recommendations apply to pregnant women and adolescent girls within the context of routine ANC.\\n• This table does not include good clinical practices, such as measuring blood pressure, proteinuria and weight, and checking for fetal heart sounds, which would be included as part of an implementation manual aimed at practitioners.\\n• Remarks detailed in the shaded box with each recommendation should be taken into account when planning the implementation of these recommendations.\\nType of intervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='Dietary interventions\\nA.1.1: Counselling about healthy eating and keeping physically active during pregnancy is recommended for pregnant women to stay healthy and to prevent excessive weight gain during pregnancy.\\na\\nRecommended X X X X X X X X\\nA.1.2: In undernourished populations, nutrition education on increasing daily energy and protein intake is recommended for pregnant women to reduce the risk of low-birth-weight neonates.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nA.1.3: In undernourished populations, balanced energy and protein dietary supplementation is recommended for pregnant women to reduce the risk of stillbirths and small-for-gestational-age neonates.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nA.1.4: In undernourished populations, high-protein supplementation is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nIron and folic acid supplements'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='A.1.4: In undernourished populations, high-protein supplementation is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nIron and folic acid supplements\\nA.2.1: Daily oral iron and folic acid  supplementation with 30mg to 60mg of elemental iron\\nb and 400µg\\n(0.4 mg) of folic acidc is recommended for pregnant women to\\nprevent maternal anaemia, puerperal sepsis, low birth weight, and preterm birth.\\nd\\nRecommended X X X X X X X X  \\n109Chapter 4. Implementation of the ANC guideline and recommendations\\ne. The equivalent of 120 mg of elemental iron equals 600 mg of ferrous sulfate heptahydrate, 360 mg of ferrous fumarate or 1000 mg of ferrous gluconate.\\nf. This recommendation supersedes the previous recommendation in the 2012 WHO publication Guideline: intermittent iron and folic acid supplementation in non-anaemic pregnant women (55).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='f. This recommendation supersedes the previous recommendation in the 2012 WHO publication Guideline: intermittent iron and folic acid supplementation in non-anaemic pregnant women (55).\\ng. This recommendation is consistent with the 2011 WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia (57) and supersedes the previous recommendation found in the 2013 WHO\\npublication Guideline: calcium supplementation in pregnant women (38).\\nh. Vitamin A deficiency is a severe public health problem if  5% of women in a population have a history of night blindness in their most recent pregnancy in the previous 3–5 years that ended in a live birth, or if\\n20% of pregnant women have a serum retinol level < 0.70 µmol/L. Determination of vitamin A deficiency as a public health problem involves estimating the prevalence of deficiency in a population by using\\nspecific biochemical and clinical indicators of vitamin A status.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='specific biochemical and clinical indicators of vitamin A status.\\ni. This recommendation supersedes the previous recommendation found in the 2011 WHO publication Guideline: vitamin A supplementation in pregnant women (60).\\nType of intervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nIron and folic acid supplements\\nA.2.2: Intermittent oral iron and folic acid supplementation with 120 mg of elemental iron\\ne and 2800 µg (2.8 mg) of folic acid once weekly\\nis recommended for pregnant women to improve maternal and neonatal outcomes if daily iron is not acceptable due to side-effects, and in populations with an anaemia prevalence among pregnant women of less than 20%.\\nf\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nCalcium supplements'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='f\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nCalcium supplements\\nA.3: In populations with low dietary calcium intake, daily calcium supplementation (1.5–2.0g oral elemental calcium)  is recommended for pregnant women to reduce the risk of  pre-eclampsia.\\ng\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nVitamin A supplements\\nA.4: Vitamin A supplementation is only recommended for pregnant women in areas where vitamin A deficiency is a severe public health problem,\\nh to prevent night blindness.i\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nZinc supplements A.5: Zinc supplementation for pregnant women is only recommended in the context of rigorous research.\\nContext-specific\\nrecommendation\\n(research)\\nMultiple micronutrient supplements\\nA.6: Multiple micronutrient supplementation is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nVitamin B6 (pyridoxine) supplements'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='A.6: Multiple micronutrient supplementation is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nNot recommended\\nVitamin B6 (pyridoxine) supplements\\nA.7: Vitamin B6 (pyridoxine) supplementation is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nNot recommended  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n110\\nj. This recommendation supersedes the previous recommendation found in the 2012 WHO publication Guideline: vitamin D supplementation in pregnant women (75).\\nk. This includes any product, beverage or food containing caffeine (i.e. brewed coffee, tea, cola-type soft drinks, caffeinated energy drinks, chocolate, caffeine tablets).\\nl. Evidence on essential ANC activities, such as measuring maternal blood pressure, proteinuria and weight, and checking for fetal heart sounds, was not assessed by the GDG as these activities are considered to be\\npart of good clinical practice.\\nType of intervention'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 7, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='part of good clinical practice.\\nType of intervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nVitamin E and C supplements\\nA.8: Vitamin E and C supplementation is not recommended for\\npregnant women to improve  maternal and perinatal out comes.\\nNot recommended\\nVitamin D supplements\\nA.9: Vitamin D supplementation is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nj\\nNot recommended\\nRestricting caffeine intake\\nA.10.1: For pregnant women with high daily caffeine intake (more than 300 mg per day),\\nk lowering daily caffeine intake during pregnancy\\nis recommended to reduce the risk of pregnancy loss and low-birth-weight neonates.\\nContext-specific\\nrecommendation\\nX X X X X X X X'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Anaemia B.1.1: Full blood count testing is the recommended method for diagnosing anaemia in pregnancy. In settings where full blood count testing is not available, on-site haemoglobin testing with a haemoglobinometer is recommended over the use of the haemoglobin colour scale as the method for diagnosing anaemia in pregnancy.\\nContext-specific\\nrecommendation\\nX X X\\nAsymptomatic bacteriuria (ASB)\\nB.1.2: Midstream urine culture is the recommended method for diagnosing asymptomatic bacteriuria (ASB) in pregnancy. In settings where urine culture is not available, on-site midstream urine Gram-staining is recommended over the use of dipstick tests as the method for diagnosing ASB in pregnancy.\\nContext-specific\\nrecommendation\\nX X X  \\n111Chapter 4. Implementation of the ANC guideline and recommendations'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Context-specific\\nrecommendation\\nX X X  \\n111Chapter 4. Implementation of the ANC guideline and recommendations\\nm. Minimum requirements are: a protocol/ standard operating procedure; training on how to ask about IPV, and on how to provide the minimum response or beyond; private setting; confidentiality ensured; system for\\nreferral in place; and time to allow for appropriate disclosure.\\nn. This recommendation is consistent with the 2013 publication Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines (86).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='n. This recommendation is consistent with the 2013 publication Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines (86).\\no. This is not a recommendation on routine screening for hyperglycaemia in pregnancy. It has been adapted and integrated from the 2013 WHO publication Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy (94), which states that GDM should be diagnosed at any time in pregnancy if one or more of the following criteria are met: •fasting plasma glucose 5.1–6.9 mmol/L (92–125 mg/ dL)•1-hour plasma glucose\\n10.0 mmol/L (180 mg/ dL) following a 75 g oral glucose load\\n•2-hour plasma glucose 8.5–11.0 mmol/L (153–199 mg/ dL) following a 75 g oral glucose load.Diabetes mellitus in pregnancy should be diagnosed if one or more of the following criteria are met: •fasting plasma glucose\\n7.0 mmol/L (126 mg/ dL)\\n•2-hour plasma glucose  11.1 mmol/L (200 mg/ dL) following a 75 g oral glucose load'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='7.0 mmol/L (126 mg/ dL)\\n•2-hour plasma glucose  11.1 mmol/L (200 mg/ dL) following a 75 g oral glucose load\\n•random plasma glucose  11.1 mmol/L (200 mg/ dL) in the presence of diabetes symptoms.\\np. Integrated from the 2013 publication WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy (96).\\nq. Integrated from the 2014 WHO publication Guidelines for the identification and management of substance use and substance use disorders in pregnancy (97).\\nType of intervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nIntimate partner violence (IPV)'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Eight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nIntimate partner violence (IPV)\\nB.1.3: Clinical enquiry about the possibility of intimate partner violence (IPV) should be strongly considered at antenatal care visits when assessing conditions that may be caused or complicated by IPV in order to improve clinical diagnosis and subsequent care, where there is the capacity to provide a supportive response (including referral where appropriate) and where the WHO minimum requirements are met.\\nm n\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nGestational diabetes mellitus (GDM)\\nB.1.4: Hyperglycaemia first detected at any time during pregnancy should be classified as either, gestational diabetes mellitus (GDM) or diabetes mellitus in pregnancy, according to WHO 2013 criteria.\\no\\nRecommended X X X X X X X X'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='o\\nRecommended X X X X X X X X\\nT obacco use B.1.5: Health-care providers should ask all pregnant women about their tobacco use (past and present) and exposure to second-hand smoke as early as possible in the pregnancy and at every antenatal care visit.\\np\\nRecommended X X X X X X X X\\nSubstance use B.1.6: Health-care providers should ask all pregnant women about their use of alcohol and other substances (past and present) as early as possible in the pregnancy and at every antenatal care visit.\\nq\\nRecommended X X X X X X X X  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n112\\nr. High-prevalence settings are defined in the 2015 WHO publication Consolidated guidelines on HIV testing services as settings with greater than 5% HIV prevalence in the population being tested (98). Low-prevalence'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs']}, page_content='settings are those with less than 5% HIV prevalence in the population being tested. In settings with a generalized or concentrated HIV epidemic, retesting of HIV-negative women should be performed in the third trimester because of the high risk of acquiring HIV infection during pregnancy; please refer to Recommendation B.1.7 for details.\\ns. Adapted and integrated from the 2015 WHO publication Consolidated guidelines on HIV testing services (98).\\nt. Adapted and integrated from the 2013 WHO publication Systematic screening for active tuberculosis: principles and recommendations (105).\\nu. Cardiotocography (CTG) is a continuous recording of the fetal heart rate and uterine contractions obtained via an ultrasound transducer placed on the mother’s abdomen.\\nType of intervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Recommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nHuman  immunodeficiency virus (HIV) and syphilis\\nB.1.7: In high prevalence settings,\\nr provider-initiated testing and\\ncounselling (PITC) for HIV should be considered a routine component of the package of care for pregnant women in all antenatal care settings. In low-prevalence settings, PITC can be considered for pregnant women in antenatal care as a key component of the effort to eliminate mother-to-child transmission of HIV, and to integrate HIV testing with syphilis, viral or other key tests, as relevant to the setting, and to strengthen the underlying maternal and child health systems.\\ns\\nRecommended X'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='s\\nRecommended X\\nTuberculosis (TB) B.1.8: In settings where the tuberculosis (TB) prevalence in the general population is 100/100000 population or higher, systematic screening for active TB should be considered for pregnant women as part of antenatal care.\\nt\\nContext-specific\\nrecommendation\\nX\\nDaily fetal movement counting\\nB.2.1: Daily fetal movement counting, such as with “count-to-ten” kick charts, is only recommended in the context of rigorous research.\\nContext-specific\\nrecommendation\\n(research)\\nSymphysis-fundal height (SFH) measurement\\nB.2.2: Replacing abdominal palpation with symphysis-fundal height (SFH) measurement for the assessment of fetal growth is not recommended to improve perinatal outcomes. A change from what is usually practiced (abdominal palpation or SFH measurement) in a particular setting is not recommended.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nAntenatal cardio-tocography\\nB.2.3: Routine antenatal cardiotocography\\nu is not recommended for'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='Context-specific\\nrecommendation\\nX X X X X X X X\\nAntenatal cardio-tocography\\nB.2.3: Routine antenatal cardiotocography\\nu is not recommended for\\npregnant women to improve maternal and perinatal outcomes.\\nNot recommended  \\n113Chapter 4. Implementation of the ANC guideline and recommendations\\nType of\\nintervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nUltrasound scan B.2.4: One ultrasound scan before 24 weeks of gestation (early ultrasound) is recommended for pregnant women to estimate gestational age, improve detection of fetal anomalies and multiple pregnancies, reduce induction of labour for post-term pregnancy, and improve a woman’s pregnancy experience.\\nRecommended X X\\nDoppler ultrasound of fetal blood vessels'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment l', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment l'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 11, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='Recommended X X\\nDoppler ultrasound of fetal blood vessels\\nB.2.5: Routine Doppler ultrasound examination is not recommended for pregnant women to improve maternal and perinatal outcomes.\\nv\\nNot recommended'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Preventive measures', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Antibiotics for asymptomatic bacteriuria (ASB)\\nC.1: A seven-day antibiotic regimen is recommended for all pregnant women with asymptomatic bacteriuria (ASB) to prevent persistent bacteriuria, preterm birth and low birth weight.\\nRecommended X X X\\nAntibiotic prophylaxis to prevent recurrent urinary tract infections\\nC.2: Antibiotic prophylaxis is only recommended to prevent recurrent urinary tract infections in pregnant women in the context of rigorous research.\\nContext-specific\\nrecommendation\\n(research)\\nAntenatal anti-D immunoglobulin administration\\nC.3: Antenatal prophylaxis with anti-D immunoglobulin in non-sensitized Rh-negative pregnant women at 28 and 34weeks of gestation to prevent RhD alloimmunization is only recommended in the context of rigorous research.\\nContext-specific\\nrecommendation\\n(research)\\nPreventive anthelminthic treatment\\nC.4: In endemic areas\\nw, preventive anthelminthic treatment is'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Preventive measures', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first', 'third']}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='Context-specific\\nrecommendation\\n(research)\\nPreventive anthelminthic treatment\\nC.4: In endemic areas\\nw, preventive anthelminthic treatment is\\nrecommended for pregnant women after the first trimester as part of worm infection reduction programmes.\\nx\\nContext-specific\\nrecommendation\\nX\\nv. Doppler ultrasound technology evaluates umbilical artery (and other fetal arteries) waveforms to assess fetal well-being in the third trimester of pregnancy.\\nw. Areas with greater than 20% prevalence of infection with any soil-transmitted helminths.\\nx. Consistent with the 2016 WHO publication Guideline: preventive chemotherapy to control soil-transmitted helminth infections in high-risk groups (140).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n114\\nType of\\nintervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Preventive measures', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['nutrition']}, page_content='Recommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nT etanus toxoid vaccination\\nC.5: T etanus toxoid vaccination is recommended for all pregnant women, depending on previous tetanus vaccination exposure, to prevent neonatal mortality from tetanus.\\ny\\nRecommended X\\nMalaria prevention: Intermittent preventive treatment in pregnancy (IPTp)\\nC.6: In malaria-endemic areas in Africa, intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT p-SP) is recommended for all pregnant women. Dosing should start in the second trimester, and doses should be given at least one month apart, with the objective of ensuring that at least three doses are received.\\nz\\nContext-specific\\nrecommendation\\nX\\n(13\\nweeks)\\nX X X X X\\nPre-exposure prophylaxis for HIV prevention'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Preventive measures', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='z\\nContext-specific\\nrecommendation\\nX\\n(13\\nweeks)\\nX X X X X\\nPre-exposure prophylaxis for HIV prevention\\nC.7: Oral pre-exposure prophylaxis (PrEP) containing tenofovir  disoproxil fumarate (TDF) should be offered as an additional prevention choice for pregnant women at substantial risk of HIV infection as part of combination prevention approaches.\\naa\\nContext-specific\\nrecommendation\\nX'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Nausea and vomiting\\nD.1: Ginger, chamomile, vitamin B6 and/ or acupuncture are recommended for the relief of nausea in early pregnancy, based on a woman’s preferences and available options.\\nRecommended X X X\\nHeartburn D.2: Advice on diet and lifestyle is recommended to prevent and relieve heartburn in pregnancy. Antacid preparations can be used to women with troublesome symptoms that are not relieved by lifestyle modification.\\nRecommended X X X X X X X X\\ny. This recommendation is consistent with the 2006 WHO guideline on Maternal immunization against tetanus (134). The dosing schedule depends on the previous tetanus vaccination exposure; please refer to Recommendation C.5 for details.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['second']}, 'maternal_topics': ['nutrition']}, page_content='z. Integrated from the 2015 WHO publication Guidelines for the treatment of malaria, which also states: “WHO recommends that, in areas of moderate-to-high malaria transmission of Africa, IPT p-SP be given to all pregnant women at each scheduled antenatal care visit, starting as early as possible in the second trimester, provided that the doses of SP are given at least 1 month apart. WHO recommends a package of interventions for preventing malaria during pregnancy, which includes promotion and use of insecticide-treated nets, as well as IPT p-SP” (153). T o ensure that pregnant women in endemic areas start IPT p-SP as early as possible in the second trimester, policy-makers should ensure health system contact with women at 13 weeks of gestation.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='aa. Integrated from the 2015 WHO publication Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (99). Substantial risk of HIV infection is defined by an incidence of HIV infection in the absence of PrEP that is sufficiently high (> 3% incidence) to make offering PrEP potentially cost-saving (or cost–effective). Offering PrEP to people at substantial risk of HIV infection maximizes the benefits relative to the risks and costs.  \\n115Chapter 4. Implementation of the ANC guideline and recommendations\\nType of\\nintervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nLeg cramps D.3: Magnesium, calcium or non-pharmacological treatment options can be used for the relief of leg cramps in pregnancy, based on a woman’s preferences and available options.\\nRecommended X X X X X X X X\\nLow back and pelvic pain'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Recommended X X X X X X X X\\nLow back and pelvic pain\\nD.4: Regular exercise throughout pregnancy is recommended to prevent low back and pelvic pain. There are a number of different treatment options that can be used, such as physiotherapy, support belts and acupuncture, based on a woman’s preferences and available options.\\nRecommended X X X X X X X X\\nConstipation D.5: Wheat bran or other fibre supplements can be used to relieve constipation in pregnancy if the condition fails to respond to dietary modification, based on a woman’s preferences and available options.\\nRecommended X X X X X X X X\\nVaricose veins and oedema\\nD.6: Non-pharmacological options, such as compression stockings, leg elevation and water immersion, can be used for the management of varicose veins and oedema in pregnancy, based on a woman’s preferences and available options.\\nRecommended X X X X X X X X\\nE: Health systems interventions to improve utilization and quality of antenatal care\\nWoman-held case notes'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Recommended X X X X X X X X\\nE: Health systems interventions to improve utilization and quality of antenatal care\\nWoman-held case notes\\nE.1: It is recommended that each pregnant woman carries her own case notes during pregnancy to improve continuity, quality of care and her pregnancy experience.\\nRecommended X X X X X X X X\\nMidwife-led continuity of care\\nE.2: Midwife-led continuity of care models, in which a known midwife or small group of known midwives supports a woman throughout the antenatal, intrapartum and postnatal continuum, are recommended for pregnant women in settings with well functioning midwifery programmes.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nGroup antenatal care\\nE.3:\\nGroup antenatal care provided by qualified health-care'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Context-specific\\nrecommendation\\nX X X X X X X X\\nGroup antenatal care\\nE.3:\\nGroup antenatal care provided by qualified health-care\\nprofessionals may be offered as an alternative to individual antenatal care for pregnant women in the context of rigorous research, depending on a woman’s preferences and provided that the infrastructure and resources for delivery of group antenatal care are available.\\nContext-specific\\nrecommendation\\n(research)  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n116\\nType of\\nintervention\\nRecommendation Type of\\nrecommendation\\nEight scheduled ANC contacts\\n(weeks of gestation)\\n1 2 3 4 5 6 7 8\\n(12\\nweeks)\\n(20\\nweeks)\\n(26\\nweeks)\\n(30\\nweeks)\\n(34\\nweeks)\\n(36\\nweeks)\\n(38\\nweeks)\\n(40\\nweeks)\\nCommunity-based interventions to improve  communication and support\\nE.4.1: The implementation of community mobilization through\\nfacilitated participatory learning and action (PLA) cycles with women’s'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 6, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Community-based interventions to improve  communication and support\\nE.4.1: The implementation of community mobilization through\\nfacilitated participatory learning and action (PLA) cycles with women’s\\ngroups is recommended to improve maternal and newborn health, particularly in rural settings with low access to health services.\\nab\\nParticipatory women’s groups represent an opportunity for women to discuss their needs during pregnancy, including barriers to reaching care, and to increase support to pregnant women.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nE.4.2: Packages of interventions that include household and community mobilization and antenatal home visits are recommended to improve antenatal care utilization and perinatal health outcomes, particularly in rural settings with low access to health services.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nT ask shifting components of  antenatal care delivery\\nac'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 7, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='Context-specific\\nrecommendation\\nX X X X X X X X\\nT ask shifting components of  antenatal care delivery\\nac\\nE.5.1: T ask shifting the promotion of health-related behaviours for maternal and newborn health\\nad to a broad range of cadres, including\\nlay health workers, auxiliary nurses, nurses, midwives and doctors is recommended.\\nRecommended X X X X X X X X\\nE.5.2: T ask shifting the distribution of recommended nutritional supplements and intermittent preventive treatment in pregnancy (IPT p) for malaria prevention to a broad range of cadres, including auxiliary nurses, nurses, midwives and doctors is recommended.\\nRecommended X X X X X X X X\\nRecruitment and retention of staff in rural and remote areas\\nae\\nE.6: Policy-makers should consider educational, regulatory, financial, and personal and professional support interventions to recruit and retain qualified health workers in rural and remote areas.\\nContext-specific\\nrecommendation\\nX X X X X X X X\\nAntenatal care contact schedules'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 8, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs'], 'contains_warnings': True}, page_content='Context-specific\\nrecommendation\\nX X X X X X X X\\nAntenatal care contact schedules\\nE.7: Antenatal care models with a minimum of eight contacts are recommended to reduce perinatal mortality and improve women’s experience of care.\\nRecommended X X X X X X X X\\nab. Integrated from the 2014 publication WHO recommendations on community mobilization through facilitated participatory learning and action cycles with women’s groups for maternal and newborn health (183).\\nac. Including promotion of the following: care-seeking behaviour and ANC utilization; birth preparedness and complication readiness; sleeping under insecticide-treated bednets; skilled care for childbirth; companionship in labour and childbirth; nutritional advice; nutritional supplements; other context-specific supplements and interventions; HIV testing during pregnancy; exclusive breastfeeding; postnatal care and family planning; immunization according to national guidelines.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 9, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='ad. Recommendations adapted and integrated from the 2012 WHO guideline on Optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting (OptimizeMNH) (201).\\nae. Adapted and integrated from the 2010 WHO publication Increasing access to health workers in remote and rural areas through improved retention: global policy recommendations (202).  \\n117Chapter 4. Implementation of the ANC guideline and recommendations\\nBox 6: Considerations for the adoption, scale-up and implementation of the 2016 WHO ANC\\nmodel\\nHealth policy considerations for adoption and scale-up of the model\\nnn There needs to be a firm government commitment to scale up implementation of ANC services to\\nachieve national coverage at health-care facilitates; national support must be secured for the whole\\npackage rather than for specific components, to avoid fragmentation of services.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 10, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='achieve national coverage at health-care facilitates; national support must be secured for the whole\\npackage rather than for specific components, to avoid fragmentation of services.\\nnn In low-income countries, donors may play a significant role in scaling up the implementation of the\\nmodel. Sponsoring mechanisms that support domestically driven processes to scale up the whole model\\nare more likely to be helpful than mechanisms that support only a part of the package.\\nnn T o set the policy agenda, to secure broad anchoring and to ensure progress in policy formulation and\\ndecision-making, stakeholders should be targeted among both elected and bureaucratic officials. In\\naddition, representatives of training facilities and the relevant medical specialties should be included in\\nparticipatory processes at all stages, including prior to an actual policy decision, to secure broad support\\nfor scaling-up.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 11, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='participatory processes at all stages, including prior to an actual policy decision, to secure broad support\\nfor scaling-up.\\nnn T o facilitate negotiations and planning, information on the expected impact of the model on users,\\nproviders (e.g. workload, training requirements) and costs should be assessed and disseminated.\\nnn The model must be adapted to local contexts and service-delivery settings.\\nHealth system or organizational-level considerations for implementation of the model\\nnn Introduction of the model should involve pre-service training institutions and professional bodies, so that\\ntraining curricula for ANC can be updated as quickly and smoothly as possible.\\nnn Long-term planning is needed for resource generation and budget allocation to strengthen and sustain\\nhigh-quality ANC services.\\nnn In-service training and supervisory models will need to be developed according to health-care providers’'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 12, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='high-quality ANC services.\\nnn In-service training and supervisory models will need to be developed according to health-care providers’\\nprofessional requirements, considering the content, duration and procedures for the selection of\\nproviders for training. These models can also be explicitly designed to address staff turnover, particularly\\nin low-resource settings.\\nnn Standardized tools will need to be developed for supervision, ensuring that supervisors are able to\\nsupport and enable health-care providers to deliver integrated, comprehensive ANC services.\\nnn A strategy for task shifting may need to be developed to optimize the use of human resources.\\nnn T ools or “job aids” for ANC implementation (e.g. ANC cards) will need to be simplified and updated with\\nall key information in accordance with the model.\\nnn Strategies will need to be devised to improve supply chain management according to local requirements,'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 13, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='all key information in accordance with the model.\\nnn Strategies will need to be devised to improve supply chain management according to local requirements,\\nsuch as developing protocols for the procedures of obtaining and maintaining the stock of supplies,\\nencouraging providers to collect and monitor data on the stock levels and strengthening the provider-\\nlevel coordination and follow-up of medicines and health-care supplies required for implementation of\\nthe ANC model.\\nUser-level considerations for implementation of the model\\nnn Community-sensitizing activities should be undertaken to disseminate information about the importance\\nof each component of ANC, and pregnant women’s right to attend ANC for their health and the health\\nof their unborn baby. This information should provide details about the timing and content of the\\nrecommended ANC contacts, and about the expected user fees.\\nnn It may be possible to reduce waiting times by reorganizing ANC services and/ or client flow.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 14, 'total_chunks': 15, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='recommended ANC contacts, and about the expected user fees.\\nnn It may be possible to reduce waiting times by reorganizing ANC services and/ or client flow.\\nFor specific implementation considerations related to the individual recommendations, see Annex 4.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n118\\nBox 7: Priority research questions, by type of intervention'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='• What are the effects, feasibility, acceptability and equity implications of healthy eating and exercise interventions\\nin LMICs?\\n• Can an intervention package with standardized guidance on nutrition be developed that is evidence-based,\\nsustainable, reproducible, accessible and adaptable to different cultural settings?\\n• Research is needed at country level to better understand the context-specific etiology of under-nutrition. Do\\nalternatives to energy and protein supplements, such as cash or vouchers for pregnant women, or improved local\\nand national food production and distribution, lead to improved maternal and perinatal outcomes?\\n• What is the most effective, acceptable and feasible regimen of recommended supplements (iron, calcium and\\nfolic acid)? Could micronutrients be combined into a single, or slow-release, formulation? T o what extent do iron\\nand calcium (or zinc) supplements compete for absorption?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='folic acid)? Could micronutrients be combined into a single, or slow-release, formulation? T o what extent do iron\\nand calcium (or zinc) supplements compete for absorption?\\n• What is the most cost-effective iron compound and formulation (coated versus not) in terms of benefits and side-\\neffects?\\n• Can a rapid, portable, less invasive, and field-friendly test for iron deficiency anaemia be developed?\\n• Are there haemoconcentration risks associated with haemoglobin concentrations of more than 130g/L in\\npregnancy?\\n• What are the biological mechanisms underlying the relationships among calcium supplementation, pre-\\neclampsia, HELLP syndrome (haemolysis, elevated liver enzymes, low platelet count) and preterm birth?\\n• What is the minimal dose and optimal commencement schedule for calcium supplementation to achieve a\\npositive effect on pre-eclampsia and preterm birth?\\n• What is the effect of zinc supplementation on maternal outcomes (e.g. infections) and perinatal outcomes (e.g.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Nutritional interventions', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Nutritional interventions'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='positive effect on pre-eclampsia and preterm birth?\\n• What is the effect of zinc supplementation on maternal outcomes (e.g. infections) and perinatal outcomes (e.g.\\npreterm birth, SGA, neonatal infections, perinatal morbidity)? What is the optimal dose of zinc supplementation\\nin pregnancy, particularly in zinc-deficient populations with no food fortification strategy in place?\\n• Does vitamin C reduce PROM and improve maternal and perinatal outcomes?\\n• Does vitamin D increase the risk of preterm birth when it’s combined with calcium?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='• Can better and more cost–effective on-site tests to diagnose anaemia be developed?\\n• What are the effects of on-site urine testing (dipsticks or Gram stain) with antibiotic treatment for ASB versus\\nurine testing plus culture confirmation of urine test, followed by ASB treatment if indicated, on pregnancy and\\nother relevant outcomes, including equity, acceptability, feasibility and antimicrobial resistance?\\n• Can better on-site tests to diagnose ASB be developed to improve accuracy and feasibility of ASB testing and\\nreduce overtreatment of ASB? What is the threshold prevalence of ASB at which targeted testing and treatment\\nrather than universal testing and treatment might be a more effective strategy?\\n• Which strategies to enquire about and manage IPV are the most effective? Do interventions to enquire about IPV\\nhave an impact on ANC attendance? Can interventions focusing on partners prevent IPV? Does enquiry about'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'subsection': 'Maternal and fetal assessment', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Maternal and fetal assessment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='have an impact on ANC attendance? Can interventions focusing on partners prevent IPV? Does enquiry about\\nIPV (with appropriate referral) have an impact on maternal and perinatal outcomes?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='During the guideline development process, the\\nGuideline Development Group (GDG) identified\\nimportant knowledge gaps that need to be addressed\\nthrough primary research. The certainty of evidence\\nwas rated as “low” or “very low” for a number of\\ninterventions evaluated. According to GRADE\\nmethodology (15), this implies that further research\\non interventions with “low” or “very low” certainty\\nevidence for important outcomes is likely to have\\nan impact on future certainty and subsequent\\nrecommendations related to these interventions. The\\nGDG identified knowledge gaps based on this concept\\nand prioritized related research questions according to\\nwhether further research would be likely to promote\\nequity, be feasible to implement, and contribute to\\nimprovements in the pregnancy experience of women.\\nIn Box 7, priority research questions are grouped\\naccording to the grouping of the recommendations in\\nthis ANC guideline (i.e. types of interventions) and are'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='In Box 7, priority research questions are grouped\\naccording to the grouping of the recommendations in\\nthis ANC guideline (i.e. types of interventions) and are\\nlisted in a similar order to the recommendations.  \\n• What is the prevalence of GDM and diabetes mellitus in pregnancy, according to the new criteria, in various\\npopulations and ethnic groups? What are the best screening strategies for GDM and what are the prevalence\\nthresholds at which these are cost-effective?\\n• What is the effect of daily fetal movement counting, such as the use of “count-to-ten” kick charts, in the third\\ntrimester of pregnancy on perinatal outcomes in LMICs?\\n• What are the effects and accuracy of SFH measurement to detect abnormal fetal growth and other risk factors for\\nperinatal morbidity (e.g. multiple pregnancy, polyhydramnios) in settings without routine ultrasound?\\n• Can a single routine Doppler ultrasound examination of fetal blood vessels for all pregnant women in the third'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['third']}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='• Can a single routine Doppler ultrasound examination of fetal blood vessels for all pregnant women in the third\\ntrimester accurately detect or predict pregnancy complications, particularly IUGR and pre-eclampsia, and lead to\\nimproved pregnancy outcomes?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'subsection': 'Preventive measures', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications', 'Preventive measures'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='• What are the effects of prophylactic antibiotics to prevent RUTI in pregnancy, compared to monitoring with use of\\nantibiotics only when indicated, on maternal infections, perinatal morbidity and antimicrobial drug resistance?\\n• What is the prevalence of Rh alloimmunization and associated poor outcomes among pregnant women in LMIC\\nsettings? Can cost-effective strategies be developed to manage this condition in LMICS and improve equity?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'subsection': 'Interventions for common physiological symptoms', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications', 'Interventions for common physiological symptoms'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'normal_variations'], 'discusses_normal_variations': True}, page_content='• What is the prevalence of common physiological symptoms among pregnant women in low-resource settings,\\nand can the offer of treatment of these symptoms reduce health inequality, improve ANC coverage and improve\\nwomen’s pregnancy experiences?\\n• What is the etiology of leg cramps in pregnancy, and does treatment with magnesium and/ or calcium relieve\\nsymptoms?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'subsection': 'Health systems interventions to improve utilization and quality of ANC', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications', 'Health systems interventions to improve utilization and quality of ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='• What should be included in women-held case notes, and how can discrepancies across different records be\\nreduced to improve quality of care?\\n• What is the pathway of influence of midwife-led continuity of care (MLCC)? Is it specifically the continuity,\\nthe provider–client relationship or the midwifery philosophy that leads to better health outcomes and\\nmaternal satisfaction? Can this effect be replicated with other cadres of health-care providers, e.g. auxiliary\\nnurse midwives, nurses, family doctors, etc.? How can ANC in LMICs be structured to incorporate the active\\ningredients of MLCC, particularly in settings where the number of midwives is very limited?\\n• What are the effects, feasibility and resource implications of MLCC in LMICs? Which models are most feasible\\n(i.e.caseload or team models)? Can a continuity model for group ANC be developed for settings where other\\nMLCC models are not feasible?'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'subsection': 'Health systems interventions to improve utilization and quality of ANC', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications', 'Health systems interventions to improve utilization and quality of ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='(i.e.caseload or team models)? Can a continuity model for group ANC be developed for settings where other\\nMLCC models are not feasible?\\n• Can a group ANC model be developed for LMICs, to provide guidance on the optimal group size, frequency and\\ncontent of group ANC contacts?\\n• Is group ANC acceptable (data should include the views of women who decline to participate), feasible and\\ncost-effective in LMIC settings?\\n• Are mixed models (group and individual ANC) feasible and acceptable, and are there benefits to mixed models?\\n• What are the effects of group ANC on maternal and perinatal health outcomes, coverage outcomes (ANC\\ncontacts and facility-based births), and women’s and providers’ experiences?\\n• Should women with complicated pregnancies also be offered group ANC, for the communication and social\\nsupport aspects, in addition to receiving specialist care?\\n• How acceptable and feasible are mixed-gender community mobilization groups? What are the optimal methods'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'subsection': 'Health systems interventions to improve utilization and quality of ANC', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications', 'Health systems interventions to improve utilization and quality of ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='support aspects, in addition to receiving specialist care?\\n• How acceptable and feasible are mixed-gender community mobilization groups? What are the optimal methods\\nfor community-based interventions to improve communication and support for pregnant women and adolescent\\ngirls; to improve integration of community-based mobilization efforts with health systems; and to ensure\\ncontinuity of care with home visits? What are the mechanisms of effect of these interventions?\\n• Can the 2016 WHO ANC model with a minimum of eight contacts impact the quality of ANC in LMICs, and\\nwhat is the effect on health, values, acceptability, resources, feasibility and equity parameters?\\nANC: antenatal care; ASB: asymptomatic bacteriuria; GDM: gestational diabetes mellitus; IPV: intimate partner violence;\\nLMICs: low- and middle-income countries; MLCC: midwife-led continuity of care; PROM: prelabour rupture of membranes;'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Research implications', 'subsection': 'Health systems interventions to improve utilization and quality of ANC', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Research implications', 'Health systems interventions to improve utilization and quality of ANC'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='LMICs: low- and middle-income countries; MLCC: midwife-led continuity of care; PROM: prelabour rupture of membranes;\\nRUTI: recurrent urinary tract infections; SFH: symphysis-fundal height; SGA: small for gestational age  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n120\\n6. Dissemination, applicability\\nand updating of the guideline and\\nrecommendations'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Dissemination', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Dissemination'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='This guideline will be available online for download and\\nalso as a printed publication. Online versions will be\\navailable via the websites of the WHO Departments\\nof Reproductive Health and Research (RHR), Nutrition\\nfor Health and Development (NHD) and Maternal,\\nNewborn, Child and Adolescent Health (MCA),\\nand through the WHO Reproductive Health Library\\n(RHL).7 Print versions will be distributed to WHO\\nregional and country offices, ministries of health, WHO\\ncollaborating centres, NGO partners and professional\\nassociations, using the same distribution list that was\\ndeveloped for the implementation of focused ANC\\n(FANC). The guideline will be accompanied by an\\nindependent critical appraisal based on the AGREE\\ninstrument (Appraisal of Guidelines for Research &\\nEvaluation) (213). T echnical meetings will be held\\nwithin the WHO Departments of RHR, NHD and\\nMCA to share the recommendations and derivative\\nproducts, which will include a practical manual for'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Dissemination', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Dissemination'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='Evaluation) (213). T echnical meetings will be held\\nwithin the WHO Departments of RHR, NHD and\\nMCA to share the recommendations and derivative\\nproducts, which will include a practical manual for\\nimplementation of the new 2016 WHO ANC model,\\nwith the teams responsible for policy and programme\\nimplementation.\\nT wo sets of evidence briefs will be developed: one set\\nfor policy-makers and programme managers and the\\nother set for health-care professionals. These evidence\\nbriefs, which will highlight the recommendations\\nand implementation-related contextual issues, will\\nbe developed and disseminated in collaboration\\nUSAID, FIGO and ICM. The briefs will be organized in\\nalignment with the different sections of the guideline,\\nfor example focusing on nutrition, maternal and fetal\\nassessment or preventive measures to allow for\\nderivative products to be tailored and disseminated\\naccordingly to partners.\\nThe executive summary and recommendations\\nfrom this publication will be translated into the six'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Dissemination', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Dissemination'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='derivative products to be tailored and disseminated\\naccordingly to partners.\\nThe executive summary and recommendations\\nfrom this publication will be translated into the six\\nUN languages for dissemination through the WHO\\n7 RHL is available at: http:/ / apps.who.int/ rhl/ en/\\nregional offices and during meetings organized by, or\\nattended by, staff of the WHO Departments of RHR,\\nMCA and NHD.\\nIn addition to online and print versions of this\\nguideline, an interactive web-based version\\nis planned, which will be developed by a\\nprofessional infographics group. This will facilitate\\nthe dissemination and uptake of the guideline\\nrecommendations by making them available online\\nin a user-friendly format, and will allow a platform\\nfor cross-referenced recommendations to be\\nupdated on an ongoing basis to ensure that the\\nrecommendations are up to date. Furthermore, this\\nwould allow for products to be organized by different\\ntopics (e.g. nutrition) and allow for focused activities'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Dissemination', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Dissemination'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='recommendations are up to date. Furthermore, this\\nwould allow for products to be organized by different\\ntopics (e.g. nutrition) and allow for focused activities\\nand products to be developed. English, French,\\nPortuguese and Spanish (the latter in collaboration\\nwith the WHO Regional Office for the Americas/Pan\\nAmerican Health Organization [PAHO]) web-based\\nversions are planned and have been budgeted for.\\nThe guideline will also be launched on the WHO\\nDepartment of RHR official website as part of the\\nmonthly \"HRP News”. This site currently has over\\n3000 subscribers including clinicians, programme\\nmanagers, policy-makers and health service users\\nfrom all around the world. In addition, a number of\\narticles presenting the recommendations and key\\nimplementation considerations will be published, in\\ncompliance with WHO’s open access and copyright\\npolicies. Relevant WHO clusters, departments\\nand partnerships, such as HIV / AIDS, T uberculosis\\nand Malaria, the Initiative for Vaccine Research'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Dissemination', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Dissemination'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='compliance with WHO’s open access and copyright\\npolicies. Relevant WHO clusters, departments\\nand partnerships, such as HIV / AIDS, T uberculosis\\nand Malaria, the Initiative for Vaccine Research\\n(IVR) and the Partnership for Maternal, Newborn\\n& Child Health (PMNCH) will also be part of this\\ndissemination process.\\nIn an effort to increase dissemination of WHO\\nguidelines on sexual and reproductive health and\\nrights, a search function with the ability to search the\\ndatabase of WHO guidelines and recommendations\\nhas been created and recently launched by  \\n121Chapter 6. Dissemination, applicability and updating\\nthe Department of RHR.8 The ANC guideline\\nrecommendations will be made available via this new\\nsearch function.\\nThe Maternal and Perinatal Health and Preventing\\nUnsafe Abortion team of the WHO Department\\nof RHR, in collaboration with the Departments of\\nNHD and MCA and other partners, will support\\nnational and subnational working groups to adapt'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Dissemination', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Dissemination'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 5, 'total_chunks': 6, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='Unsafe Abortion team of the WHO Department\\nof RHR, in collaboration with the Departments of\\nNHD and MCA and other partners, will support\\nnational and subnational working groups to adapt\\nand implement the guideline. This process will\\ninclude the development or revision of existing\\nnational guidelines or protocols in line with the WHO\\nguideline. The GREAT Network (Guideline-driven,\\nResearch priorities, Evidence synthesis, Application\\nof evidence, and T ransfer of knowledge) will be used\\nto bring together relevant stakeholders to identify\\nand assess the priorities, barriers and facilitators to\\nguideline implementation, and to support the efforts\\nof stakeholders to develop adaptations and guideline\\nimplementation strategies tailored to the local\\ncontext (214). This includes technical support for\\nlocal guideline implementers in the development of\\ntraining manuals, flow charts and quality indicators,\\nas well as participation in stakeholder meetings.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Applicability issues', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Applicability issues'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Anticipated impact of the guideline on the\\norganization of ANC\\nEffective implementation of the recommendations\\nin this guideline will likely require reorganization of\\ncare and redistribution of health-care resources,\\nparticularly in low- and middle-income countries\\n(LMICs). The potential barriers to implementation\\ninclude the following:\\nnn lack of human resources with the necessary\\nexpertise and skills to implement, supervise and\\nsupport recommended practices, including client\\ncounselling;\\nnn lack of infrastructure to support interventions, e.g.\\nlack of power to support ultrasound equipment;\\nnn lack of physical space to conduct individual or\\ngroup-based counselling;\\nnn lack of community understanding of the new\\nmodel of care, particularly around the contact\\nschedule and potentially longer wait times;\\nnn lack of physical resources, e.g. equipment, test kits,\\nsupplies, medicines and nutritional supplements;\\n8 This can be accessed at: search.optimizemnh.org'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Applicability issues', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Applicability issues'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='nn lack of physical resources, e.g. equipment, test kits,\\nsupplies, medicines and nutritional supplements;\\n8 This can be accessed at: search.optimizemnh.org\\nnn lack of effective referral mechanisms and care\\npathways for women identified as needing\\nadditional care;\\nnn lack of understanding of the value of newly\\nrecommended interventions among health-care\\nproviders and system managers.\\nnn lack of health information management systems\\n(HMISs) designed to document and monitor\\nrecommended practices (e.g. client cards,\\nregisters, etc.).\\nGiven the potential barriers noted above, a\\nphased approach to adoption, adaptation and\\nimplementation of the guideline recommendations\\nmay be prudent. Various strategies for addressing\\nthese barriers and facilitating implementation have\\nbeen suggested in the list of considerations at the end\\nof Chapter 4.\\nMonitoring and evaluating the impact of\\nthe guideline\\nThe implementation and impact of these\\nrecommendations will be monitored at the health-'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Applicability issues', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Applicability issues'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='of Chapter 4.\\nMonitoring and evaluating the impact of\\nthe guideline\\nThe implementation and impact of these\\nrecommendations will be monitored at the health-\\nservice, regional and country levels, based on clearly\\ndefined criteria and indicators that are associated\\nwith locally agreed targets. In collaboration with\\nthe monitoring and evaluation teams of the\\nWHO Departments of RHR and MCA, data on\\ncountry- and regional-level implementation of the\\nrecommendations will be collected and evaluated in\\nthe short to medium term to evaluate their impact on\\nnational policies of individual WHO Member States.\\nInterrupted time series, clinical audits or criterion-\\nbased audits could be used to obtain the relevant\\ndata on the interventions contained in this guideline.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Updating the guideline', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Updating the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'nutrition']}, page_content='In accordance with the concept of WHO’s GREAT\\nNetwork, which employs a systematic and continuous\\nprocess of identifying and bridging evidence gaps\\nfollowing guideline implementation (214), the\\nproposed guideline will be updated five years\\nafter publication unless significant new evidence\\nemerges that necessitates earlier revision. The WHO\\nSteering Group will continue to follow the research\\ndevelopments in the area of ANC, particularly for\\nthose questions for which no evidence was found and\\nthose that are supported by low-quality evidence,\\nwhere new recommendations or a change in the\\npublished recommendation may be warranted,  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n122\\nrespectively. Any concern about the validity of any\\nrecommendation will be promptly communicated via\\nthe interactive website for the guideline,9 and plans\\nwill be made to update the recommendation, as\\nneeded.\\nT wo years after publication and dissemination of'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Updating the guideline', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Updating the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='the interactive website for the guideline,9 and plans\\nwill be made to update the recommendation, as\\nneeded.\\nT wo years after publication and dissemination of\\nthe guideline, an online survey will be conducted\\nthrough WHO regional and country offices and\\nthrough selected respondents of other user groups\\n(e.g. professional societies, NGOs) to gauge the\\nstatus and extent of in-country utilization and\\nadaptation, and whether any recommendations in the\\nguideline have been implemented or influenced policy\\ndecisions. This survey will also help in gathering\\nfeedback relevant to future modifications. Requests\\nfor additional guidance may also be received from\\nWHO Member States. Stakeholders can address\\nsuggestions for additional questions for inclusion\\nin the updated version of the guideline to the WHO\\nDepartment of RHR by email (reproductivehealth@\\nwho.int).\\nAs the guideline nears the end of the proposed\\nfive-year validity period, the responsible technical'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Updating the guideline', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Updating the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Department of RHR by email (reproductivehealth@\\nwho.int).\\nAs the guideline nears the end of the proposed\\nfive-year validity period, the responsible technical\\nofficer (or another designated WHO staff person),\\nin conjunction with the WHO Steering Group, will\\nassess the currency of the recommendations and\\nthe need for new guidance on the topic. This will be\\nachieved by performing a scoping exercise among\\ntechnical experts, health professionals, researchers\\nand service users to identify controversial or priority\\nareas where further evidence-based guidance may be\\nneeded.\\n9 Available at: www.who.int/ reproductivehealth/ publications/\\nmaternal_perinatal_health/ anc-positive-pregnancy-experience/\\nen/\\nAll technical products developed during the process\\nof developing this guideline – including full reports of\\nsystematic reviews, corresponding search strategies\\nand dates of searches, Cochrane Review Manager\\n(RevMan)10 files customized for priority outcomes,'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Updating the guideline', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Updating the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='systematic reviews, corresponding search strategies\\nand dates of searches, Cochrane Review Manager\\n(RevMan)10 files customized for priority outcomes,\\nand the basis for quality rating of outcomes within\\nthe GRADE process – will be archived in the\\ndepartmental shared folder for future reference and\\nuse. Where there are concerns about the validity of a\\nparticular recommendation based on new evidence,\\nthe systematic review addressing the primary\\nquestion will be updated. T o update the review, the\\nsearch strategy used for the initial review will be\\napplied, possibly by the same systematic review team\\nor another team if the initial review team is no longer\\navailable.\\nAny new questions identified following the scoping\\nexercise at the end of five years will undergo a similar\\nprocess of evidence retrieval, synthesis and grading\\nin accordance with the WHO standards for guideline\\ndevelopment.\\nThe guideline development process exposed several\\nknowledge gaps related to antenatal screening of'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Updating the guideline', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Updating the guideline'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='in accordance with the WHO standards for guideline\\ndevelopment.\\nThe guideline development process exposed several\\nknowledge gaps related to antenatal screening of\\nGDM, syphilis and haemoglobinopathies. WHO aims\\nto develop further guidance around these topics\\nso that the appropriate recommendations can be\\nincluded in updated ANC guidance. In addition, future\\nupdates will aim to include more recommendations\\non how to improve ANC utilization, quality and\\ndelivery, which will be informed by new WHO\\nguidance on improving the quality of care throughout\\nthe antenatal, intrapartum and postnatal continuum.\\n10 For further information, see: http:/ /www.cochrane.org/ revman  \\nReferences\\n123\\nReferences'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Office of the United Nations High Commissioner', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Office of the United Nations High Commissioner'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='for Human Rights (OHCHR). T echnical guidance\\non the application of a human rights-based\\napproach to the implementation of policies and\\nprogrammes to reduce preventable maternal\\nmorbidity and mortality. Human Rights\\nCouncil, twentieth session. New Y ork (NY):\\nUnited Nations General Assembly; 2012 (A/\\nHRC/21/22; http:/ /www2.ohchr.org/ english/\\nissues/women/ docs/ A.HRC.21.22_en.pdf,\\naccessed 28 September 2016).\\n2. T unçalp Ö, Were WM, MacLennan C, Oladapo\\nOT, Gülmezoglu AM, Bahl R et al. Quality of\\ncare for pregnant women and newborns-the\\nWHO vision. BJOG. 2015;122(8):1045–9.\\ndoi:10.1111/1471-0528.13451.\\n3. Alkema L, Chou D, Hogan D, Zhang S, Moller\\nA-B, Gemmill A et al.; United Nations Maternal\\nMortality Estimation Inter-Agency Group\\ncollaborators and technical advisory group.\\nGlobal, regional, and national levels and trends\\nin maternal mortality between 1990 and 2015,\\nwith scenario-based projections to 2030:\\na systematic analysis by the UN Maternal'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Office of the United Nations High Commissioner', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Office of the United Nations High Commissioner'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Global, regional, and national levels and trends\\nin maternal mortality between 1990 and 2015,\\nwith scenario-based projections to 2030:\\na systematic analysis by the UN Maternal\\nMortality Estimation Inter-Agency Group.\\nLancet. 2016;387(10017):462–74. doi:10.1016/\\nS0140-6736(15)00838-7.\\n4. Maternal mortality. Fact sheet No.348; Geneva:\\nWorld Health Organization; 2014 (http:/ /www.\\nwho.int/ mediacentre/factsheets/fs348/ en/\\nindex.html, accessed 22 June 2014).\\n5. Blencowe H, Cousens S, Bianchi Jassir F, Chou\\nD, Mathers C et al. National, regional, and\\nworldwide estimates of stillbirth rates in 2015,\\nwith trends from 2000: a systematic analysis.\\nLancet. 2016;4(2):e98–108. doi:10.1016/S2214-\\n109X(15)00275-2.\\n6. Campbell OMR, Graham WJ; The Lancet\\nMaternal Survival Series Steering Group.\\nStrategies for reducing maternal mortality:\\ngetting on with what works. Lancet.\\n2006;368:1284–99.\\n7. Fisk NM, McKee M, Atun, R. Relative and\\nabsolute addressability of global disease burden'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Office of the United Nations High Commissioner', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Office of the United Nations High Commissioner'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Strategies for reducing maternal mortality:\\ngetting on with what works. Lancet.\\n2006;368:1284–99.\\n7. Fisk NM, McKee M, Atun, R. Relative and\\nabsolute addressability of global disease burden\\nin maternal and perinatal health by investment in\\nR&D. T rop Med Int Health. 2011;16(6):662-8.\\n8. Carroli G, Rooney C, Villar J. How effective\\nis antenatal care in preventing maternal\\nmortality and serious morbidity? An overview\\nof the evidence. Paediatr Perinat Epidemiol.\\n2001;15(Suppl 1):1–42.\\n9. Souza JP, Gülmezoglu AM, Vogel J, Carroli G,\\nLumbiganon P, Qureshi Z et al. Moving beyond\\nessential interventions for reduction of maternal\\nmortality (the WHO Multi-country Survey\\non Maternal and Newborn Health): a cross-\\nsectional study. Lancet. 2013;381(9879):1747–\\n55. doi:10.1016/S0140-6736(13)60686-8.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Integrated Management of Pregnancy and', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Integrated Management of Pregnancy and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='Childbirth (IMPAC). In: Maternal, newborn,\\nchild and adolescent health [WHO web page].\\nGeneva: World Health Organization\\n(http:/ /www.who.int/ maternal_child_\\nadolescent/topics/ maternal/impac/ en/,\\naccessed 17October 2016).\\n11. Lincetto O, Mothebesoane-Anoh, Gomez P,\\nMunjanja S. Chapter 2: Antenatal care. In:\\nLawn J, Kerber K, editors. Opportunities for\\nAfrica’s Newborns: practical data, policy and\\nprogrammatic support for newborn care in\\nAfrica. Geneva: World Health Organization;\\n2006: 51–62 (http:/ /www.who.int/ pmnch/\\nmedia/ publications/ aonsectionIII_2.pdf,\\naccessed 6 October 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO antenatal care randomized trial: manual', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO antenatal care randomized trial: manual'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='for the implementation of the new model.\\nGeneva: World Health Organization; 2002\\n(http:/ /www.who.int/ reproductivehealth/\\npublications/ maternal_perinatal_health/\\nRHR_01_30/ en/, accessed 6 October 2016).\\n13. Downe S, Finlayson K, T unçalp Ö, Gülmezoglu\\nAM. What matters to women: a scoping\\nreview to identify the processes and\\noutcomes of antenatal care provision that  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n124\\nare important to healthy pregnant women.\\nBJOG. 2016;123(4):529–39. doi:10.1111/1471-\\n0528.13819.\\n14. WHO handbook for guideline development, 2nd\\nedition. Geneva: World Health Organization;\\n2014 (http:/ /www.who.int/kms/handbook_2nd_\\ned.pdf, accessed 6 October 2016).\\n15. GRADE [website]. The GRADE Working Group;\\n2016 (http:/ / gradeworkinggroup.org/, accessed\\n27 October 2016).\\n16. GRADE-CERQual [website]. The GRADE-\\nCERQual Project Group; 2016 (https:/ / cerqual.\\norg/, accessed 27 October 2016).\\n17. DECIDE [website]. The DECIDE Project; 2016'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO antenatal care randomized trial: manual', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO antenatal care randomized trial: manual'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='27 October 2016).\\n16. GRADE-CERQual [website]. The GRADE-\\nCERQual Project Group; 2016 (https:/ / cerqual.\\norg/, accessed 27 October 2016).\\n17. DECIDE [website]. The DECIDE Project; 2016\\n(http:/ /www.decide-collaboration.eu/, accessed\\n27 October 2016).\\n18. Abalos A, Chamillard M, Diaz V, T unçalp Ö,\\nGülmezoglu AM. Antenatal care for healthy\\npregnant women: a mapping of interventions\\nfrom existing guidelines to inform the\\ndevelopment of new WHO guidance on\\nantenatal care. BJOG. 2016;123(4):519–28.\\ndoi:10.1111/1471-0528.13820.\\n19. WHO, United Nations Population Fund,\\nUnited Nations Children’s Fund. Integrated\\nManagement of Pregnancy and Childbirth.\\nPregnancy, childbirth, postpartum and newborn\\ncare: a guide for essential practice, 3rd edition.\\nGeneva: World Health Organization (WHO);\\n2015 (http:/ /www.who.int/ maternal_child_\\nadolescent/ documents/imca-essential-practice-\\nguide/ en/, accessed 26 September 2016).\\n20. Di Mario S, Basevi V, Gori G, Spettoli D.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO antenatal care randomized trial: manual', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO antenatal care randomized trial: manual'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='2015 (http:/ /www.who.int/ maternal_child_\\nadolescent/ documents/imca-essential-practice-\\nguide/ en/, accessed 26 September 2016).\\n20. Di Mario S, Basevi V, Gori G, Spettoli D.\\nWhat is the effectiveness of antenatal care?\\n(supplement). Health Evidence Network report.\\nCopenhagen: WHO Regional Office for Europe;\\n2005 (http:/ /www.euro.who.int/ data/ assets/\\npdf_file/0005/74660/E87997.pdf, accessed\\n26September 2016).\\n21. Essential interventions, commodities and\\nguidelines for reproductive, maternal, newborn\\nand child health: a global review of the key\\ninterventions related to reproductive, maternal,\\nnewborn and child health (RMNCH). Geneva:\\nThe Partnership for Maternal, Newborn & Child\\nHealth (PMNCH); 2011 (http:/ /www.who.int/\\npmnch/topics/ part_publications/ essential_\\ninterventions_18_01_2012.pdf, accessed\\n29September 2016).\\n22. Downe S, Finlayson K, T unçalp Ö, Gülmezoglu\\nAM. Factors that influence the use of routine\\nantenatal services by pregnant women: a'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO antenatal care randomized trial: manual', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO antenatal care randomized trial: manual'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='interventions_18_01_2012.pdf, accessed\\n29September 2016).\\n22. Downe S, Finlayson K, T unçalp Ö, Gülmezoglu\\nAM. Factors that influence the use of routine\\nantenatal services by pregnant women: a\\nqualitative evidence synthesis. Cochrane\\nDatabase Syst Rev. 2016;(10):CD012392.\\n23. Higgins JPT, Green S, editors. Cochrane\\nhandbook for systematic reviews of\\ninterventions, version 5.1.0 (updated March\\n2011). The Cochrane Collaboration; 2011\\n(http:/ /handbook.cochrane.org/, accessed\\n29September 2016).\\n24. Cochrane Pregnancy and Childbirth Group.\\nPregnancy and Childbirth Group’s T rials Register\\n[website]. The Cochrane Collaboration; 2016\\n(http:/ / pregnancy.cochrane.org/ pregnancy-\\nand-childbirth-groups-trials-register, accessed\\n27October 2016).\\n25. Walsh D, Downe S. Appraising the quality of\\nqualitative research. Midwifery. 2006;22(2):108–\\n19. doi:10.1016/j.midw.2005.05.004.\\n26. Lewin S, Glenton C, Munthe-Kaas H, Carlsen\\nB, Colvin CJ, Gülmezoglu AM et al. Using'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO antenatal care randomized trial: manual', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO antenatal care randomized trial: manual'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='qualitative research. Midwifery. 2006;22(2):108–\\n19. doi:10.1016/j.midw.2005.05.004.\\n26. Lewin S, Glenton C, Munthe-Kaas H, Carlsen\\nB, Colvin CJ, Gülmezoglu AM et al. Using\\nqualitative evidence in decision making for\\nhealth and social interventions: an approach to\\nassess confidence in findings from qualitative\\nevidence syntheses (GRADE-CERQual). PLoS\\nMed. 2015;12(10):e1001895. doi:10.1371/journal.\\npmed.1001895.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'OneHealth Model: intervention treatment', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'OneHealth Model: intervention treatment'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='assumptions (draft 28 September). Geneva\\nand Glastonbury (CT): United Nations\\nInterAgency Working Group on Costing and\\nthe Futures Institute; 2013 (http:/ / avenirhealth.\\norg/Download/Spectrum/Manuals/\\nIntervention%20Assumptions%202013%20\\n9%2028.pdf, accessed 4 October 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO compendium of innovative health', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO compendium of innovative health'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='technologies for low-resource settings,\\n2011–2014: assistive devices, eHealth\\nsolutions, medical devices, other technologies,  \\nReferences\\n125\\ntechnologies for outbreaks. Geneva: World\\nHealth Organization; 2015 (http:/ /www.who.int/\\nmedical_devices/innovation/ compendium/ en/,\\naccessed 26 September 2016).\\n29. State of inequality: reproductive, maternal,\\nnewborn and child health. Geneva: World Health\\nOrganization; 2015 (http:/ /www.who.int/ gho/\\nhealth_equity/ report_2015/ en/, accessed\\n29September 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Effective Practice and Organisation of Care', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Effective Practice and Organisation of Care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='(EPOC). EPOC Resources for review authors.\\nOslo: Norwegian Knowledge Centre for the\\nHealth Services; 2015 (http:/ / epoc.cochrane.\\norg/ epoc-specific-resources-review-authors,\\naccessed 28 September 2016).\\n31. T ang AM, Chung M, Dong K, T errin N, Edmonds\\nA, Assefa N et al. Determining a global mid-\\nupper arm circumference cutoff to assess\\nmalnutrition in pregnant women. Washington\\n(DC): FHI 360/Food and Nutrition T echnical\\nAssistance III Project (FANTA); 2016 (http:/ /\\nwww.fantaproject.org/ sites/ default/files/\\nresources/FANTA-MUAC-cutoffs-pregnant-\\nwomen-June2016.pdf, accessed 26 September\\n2016).\\n32. Popkin S, Slining MM. New dynamics in\\nglobal obesity facing low- and middle-income\\ncountries. Obes Rev. 2013;14(2):11–20.\\ndoi:10.1111/ obr.12102.\\n33. The global prevalence of anaemia in 2011.\\nGeneva: World Health Organization; 2015\\n(http:/ / apps.who.int/iris/bitstream/\\n10665/177094/1/9789241564960_eng.pdf,\\naccessed 29 September 2016).\\n34. WHO; de Benoist B, McLean E, Egli I, Cogswell'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Effective Practice and Organisation of Care', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Effective Practice and Organisation of Care'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Geneva: World Health Organization; 2015\\n(http:/ / apps.who.int/iris/bitstream/\\n10665/177094/1/9789241564960_eng.pdf,\\naccessed 29 September 2016).\\n34. WHO; de Benoist B, McLean E, Egli I, Cogswell\\nM, editors. Worldwide prevalence of anaemia\\n1993–2005. WHO global database on\\nanaemia. Geneva: World Health Organization\\n(WHO); 2008 (http:/ / apps.who.int/iris/\\nbitstream/10665/ 43894/1/9789241596657_\\neng.pdf, accessed 26 September 2016).\\n35. United Nations Children’s Fund, United Nations\\nUniversity, WHO. Iron deficiency anaemia:\\nassessment, prevention, and control: a guide for\\nprogramme managers. Geneva: World Health\\nOrganization (WHO); 2001 (WHO/NHD/01.3;\\nhttp:/ /www.who.int/ nutrition/ publications/\\nen/ida_assessment_prevention_control.pdf,\\naccessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Guideline: daily iron and folic acid', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Guideline: daily iron and folic acid'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='supplementation in pregnant women. Geneva:\\nWorld Health Organization; 2012 (http:/ /www.\\nwho.int/ nutrition/ publications/ micronutrients/\\nguidelines/ daily_ifa_supp_pregnant_women/\\nen/, accessed 28 September 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Global prevalence of vitamin A deficiency in', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Global prevalence of vitamin A deficiency in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition', 'warning_signs']}, page_content='populations at risk 1995–2005. WHO Global\\nDatabase on vitamin A deficiency. Geneva:\\nWorld Health Organization; 2009 (http:/ /www.\\nwho.int/ nutrition/ publications/ micronutrients/\\nvitamin_a_deficiency/9789241598019/ en/,\\naccessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Guideline: calcium supplementation in', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Guideline: calcium supplementation in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='pregnant women. Geneva: World Health\\nOrganization; 2013 (http:/ / apps.who.int/iris/\\nbitstream/10665/85120/1/9789241505376_\\neng.pdf, accessed 28 September 2016).\\n39. Roohani N, Hurrell R, Kelishadi R, Schulin'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Guideline: calcium supplementation in', 'subsection': 'Zinc and its importance for human', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Guideline: calcium supplementation in', 'Zinc and its importance for human'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='health: an integrative review. J Res Med Sci.\\n2013;18(2):144–57.\\n40. Jahanfar S, Jaafar SH. Effects of restricted\\ncaffeine intake by mother on fetal, neonatal and\\npregnancy outcomes. Cochrane Database Syst\\nRev. 2015;(6):CD006965.\\n41. Healthy diet. Fact sheet No. 394. Geneva: World\\nHealth Organization; 2015 (http:/ /www.who.int/\\nmediacentre/factsheets/fs394/ en/, accessed\\n1November 2016).\\n42. Exercise in pregnancy. RCOG Statement\\nNo.4. Royal College of Obstetricians and\\nGynaecologists. 2006:1–7 (https:/ /www.\\nrcog.org.uk/ en/ guidelines-research-services/\\nguidelines/ exercise-in-pregnancy-statement-\\nno.4/, accessed 24 October 2016).\\n43. Rasmussen KM, Yaktine AL, editors;\\nInstitute of Medicine and National Research\\nCouncil. Weight gain during pregnancy:\\nre-examining the guidelines. Washington\\n(DC): The National Academies Press; 2009\\n(http:/ /www.nationalacademies.org/hmd/  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n126'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Guideline: calcium supplementation in', 'subsection': 'Zinc and its importance for human', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Guideline: calcium supplementation in', 'Zinc and its importance for human'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='(DC): The National Academies Press; 2009\\n(http:/ /www.nationalacademies.org/hmd/  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n126\\nReports/2009/Weight-Gain-During-Pregnancy-\\nReexaminingthe-Guidelines.aspx, accessed\\n29September 2016).\\n44. Muktabhant B, Lawrie TA, Lumbiganon P,\\nLaopaiboon M. Diet or exercise, or both, for\\npreventing excessive gestational weight gain\\nin pregnancy. Cochrane Database Syst Rev.\\n2015;(6):CD007145.\\n45. Downe S, Finlayson K, T unçalp Ö, Gülmezoglu\\nAM. Factors that influence the provision of good\\nquality routine antenatal care services by health\\nstaff: a qualitative evidence synthesis. Cochrane\\nDatabase Syst Rev. 2016 (in press).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Physical status: the use and interpretation', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Physical status: the use and interpretation'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='of anthropometry: report of a WHO Expert\\nCommittee. T echnical Report Series No. 854.\\nGeneva: World Health Organization; 1995\\n(http:/ /whqlibdoc.who.int/trs/WHO_TRS_854.\\npdf, accessed 28 September 2016).\\n47. Ota E, Hori H, Mori R, T obe-Gai R, Farrar'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Physical status: the use and interpretation', 'subsection': 'Antenatal dietary education and', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Physical status: the use and interpretation', 'Antenatal dietary education and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='supplementation to increase energy and\\nprotein intake. Cochrane Database Syst Rev.\\n2015;(6):CD000032.\\n48. Food Security Portal [website]. Washington\\n(DC): International Food Policy Research Institute\\n(IFPRI); 2012 (http:/ /www.foodsecurityportal.\\norg/, accessed 28 September 2016).\\n49. Shaheen R, Streatfield PK, Naved RT, Lindholm\\nL, Persson LÅ. Equity in adherence to and\\neffect of prenatal food and micronutrient\\nsupplementation on child mortality: results from\\nthe MINIMat randomized trial, Bangladesh. BMC\\nPublic Health. 2014;14:5. doi:10.1186/1471-2458-\\n14-5.\\n50. The clinical use of blood in general medicine,\\nobstetrics, paediatrics, surgery & anaesthesia,\\ntrauma & burns. Geneva: World Health\\nOrganization; 1998 (http:/ /www.who.int/\\nbloodsafety/ clinical_use/ en/Manual_EN.pdf,\\naccessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Iron and folate supplementation: integrated', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Iron and folate supplementation: integrated'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='management of pregnancy and childbirth\\n(IMPAC). Standards for maternal and neonatal\\ncare 1.8. Geneva: Department of Making\\nPregnancy Safer, World Health Organization;\\n2006 (http:/ /www.who.int/ reproductivehealth/\\npublications/ maternal_perinatal_health/\\niron_folate_supplementation.pdf, accessed\\n29September 2016).\\n52. The international pharmacopoeia, 5th edition,\\nvolumes 1 and 2. Geneva: World Health\\nOrganization; 2015 (http:/ / apps.who.int/ phint/\\nen/ p/ about, accessed 4 October 2016).'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'The WHO Expert Committee on Specifications', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'The WHO Expert Committee on Specifications'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='for Pharmaceutical Preparations. Quality\\nassurance of pharmaceuticals: meeting a major\\npublic health challenge. Geneva: World Health\\nOrganization; 2007 (WHO/PSM/QSM/2007.5;\\nhttp:/ /www.who.int/ medicines/ publications/\\nbrochure_pharma.pdf, accessed 4 October 2016).\\n54. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN,\\nDowswell T. Daily oral iron supplementation\\nduring pregnancy. Cochrane Database Syst Rev.\\n2015;(7):CD004736.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Guideline: intermittent iron and folic', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Guideline: intermittent iron and folic'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='acid supplementation in non-anaemic\\npregnant women. Geneva: World Health\\nOrganization; 2012 (http:/ / apps.who.int/iris/\\nbitstream/10665/75335/1/9789241502016_\\neng.pdf, accessed 28 September 2016).\\n56. Peña-Rosas JP, De-Regil LM, Gomez\\nMalave H, Flores-Urrutia MC, Dowswell T.\\nIntermittent oral iron supplementation during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(19):CD009997.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'WHO recommendations for prevention', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'WHO recommendations for prevention'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='and treatment of pre-eclampsia and\\neclampsia. Geneva: World Health\\nOrganization; 2011 (http:/ / apps.who.int/iris/\\nbitstream/10665/ 44703/1/9789241548335_\\neng.pdf, accessed 29 September 2016).\\n58. Buppasiri P, Lumbiganon P, Thinkhamrop J,\\nNgamjarus C, Laopaiboon M, Medley N. Calcium\\nsupplementation (other than for preventing\\nor treating hypertension) for improving\\npregnancy and infant outcomes. Cochrane\\nDatabase Syst Rev. 2015;(2):CD007079.\\ndoi:10.1002/14651858.CD007079.pub3.  \\nReferences\\n127\\n59. Hofmeyr GJ, Lawrie TA, Atallah ÁN, Duley L,\\nT orloni MR. Calcium supplementation during\\npregnancy for preventing hypertensive disorders\\nand related problems. Cochrane Database Syst\\nRev. 2014;(6):CD001059.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Guideline: vitamin A supplementation in', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Guideline: vitamin A supplementation in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='pregnant women. Geneva: World Health\\nOrganization; 2011 (http:/ / apps.who.int/iris/\\nbitstream/10665/ 44625/1/9789241501781_\\neng.pdf, accessed 29 September 2016).\\n61. Sommer A, Davidson FR. Assessment and\\ncontrol of vitamin A deficiency: the Annecy\\nAccords. J Nutr. 2002;132:2845S-50S.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Safe vitamin A dosage during pregnancy', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Safe vitamin A dosage during pregnancy'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': [], 'contains_warnings': True}, page_content='and lactation. Recommendations and report\\nof a consultation. Micronutrient series.\\nGeneva: World Health Organization; 1998\\n(WHO/NUT /98.4; http:/ / apps.who.int/iris/\\nbitstream/10665/63838/1/WHO_NUT_98.4_\\neng.pdf, accessed 29 September 2016).\\n63. McCauley ME, van den Broek N, Dou L, Othman'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Safe vitamin A dosage during pregnancy', 'subsection': 'Vitamin A supplementation during pregnancy', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Safe vitamin A dosage during pregnancy', 'Vitamin A supplementation during pregnancy'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='for maternal and newborn outcomes. Cochrane\\nDatabase Syst Rev. 2015;(10):CD008666.\\n64. Ota E, Mori R, Middleton P, T obe-Gai\\nR, Mahomed K, Miyazaki C et al. Zinc\\nsupplementation for improving pregnancy and\\ninfant outcome. Cochrane Database Syst Rev.\\n2015;(2):CD000230.\\n65. Haider BA, Bhutta ZA. Multiple-micronutrient\\nsupplementation for women during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(11):CD004905.\\n66. UNICEF, WHO, United Nations University.\\nComposition of a multi-micronutrient\\nsupplement to be used in pilot programmes\\namong pregnancy women in developing\\ncountries: report of a United Nations Children’s\\nFund (UNICEF), World Health Organization\\n(WHO) and United Nations University\\nworkshop. New Y ork (NY): UNICEF; 1999\\n(http:/ / apps.who.int/iris/handle/10665/75358,\\naccessed 18 December 2015).\\n67. Devakumar D, Fall CHD, Sachdev HS,\\nMargetts BM, Osmond C, Wells JCK et al.\\nMaternal antenatal multiple micronutrient\\nsupplementation for long-term health benefits in'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'Safe vitamin A dosage during pregnancy', 'subsection': 'Vitamin A supplementation during pregnancy', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'Safe vitamin A dosage during pregnancy', 'Vitamin A supplementation during pregnancy'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='accessed 18 December 2015).\\n67. Devakumar D, Fall CHD, Sachdev HS,\\nMargetts BM, Osmond C, Wells JCK et al.\\nMaternal antenatal multiple micronutrient\\nsupplementation for long-term health benefits in\\nchildren: a systematic review and meta-analysis.\\nBMC Med. 2016;14(1):90. doi:10.1186/ s12916-\\n016-0633-3.'),\n",
       " Document(metadata={'chapter': '4 Implementation of the ANC guideline and recommendations', 'section': 'T echnical consultation: multiple micronutrient', 'section_path': ['4 Implementation of the ANC guideline and recommendations', 'T echnical consultation: multiple micronutrient'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='supplements in pregnancy: implementation\\nconsiderations for successful integration\\ninto existing programmes. Meeting held in\\ncollaboration with United Nations Children’s\\nFund (UNICEF) and the Micronutrient Initiative\\n(MI). Geneva: World Health Organization;\\n18–20 August 2015 (http:/ /www.who.int/\\nnutrition/ events/2015_meeting_microsupp_\\npregnancy_18to20aug/ en/, accessed 27 October\\n2016).\\n69. Salam RA, Zuberi NF, Bhutta ZA. Pyridoxine\\n(vitamin B6) supplementation during\\npregnancy or labour for maternal and neonatal\\noutcomes. Cochrane Database Syst Rev.\\n2015;(6):CD000179.\\n70. Allen L, de Benoist B, Dary O, Hurrell R,\\neditors. Guidelines on food fortification\\nwith micronutrients. Geneva: World Health\\nOrganization and Food and Agriculture\\nOrganization of the United Nations; 2006\\n(http:/ /www.who.int/ nutrition/ publications/\\nguide_food_fortification_micronutrients.pdf,\\naccessed 29 September 2016).\\n71. Joint Formulary Committee. Vitamin deficiency.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section_path': ['9 Blood and Nutrition. In: British'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='National Formulary (BNF) 72. London: BMJ\\nPublishing Group Ltd and Royal Pharmaceutical\\nSociety; 2016.\\n72. Rumbold A, Ota E, Hori H, Miyazaki C,\\nCrowther CA. Vitamin E supplementation\\nin pregnancy. Cochrane Database Syst Rev.\\n2015;(9):CD004069.\\n73. Rumbold A, Ota E, Nagata C, Shahrook S,\\nCrowther CA. Vitamin C supplementation\\nin pregnancy. Cochrane Database Syst Rev.\\n2015;(9):CD004072.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n128\\n74. Joint Formulary Committee. Vitamin deficiency.  \\nNational Formulary (BNF) 72. London: BMJ\\nPublishing Group Ltd and Royal Pharmaceutical\\nSociety; 2016.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Guideline: Vitamin D supplementation in', 'section_path': ['9 Blood and Nutrition. In: British', 'Guideline: Vitamin D supplementation in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition', 'warning_signs']}, page_content='pregnant women. Geneva: World Health\\nOrganization; 2012 (http:/ / apps.who.int/iris/\\nbitstream/10665/85313/1/9789241504935_\\neng.pdf, accessed 4 October 2016).\\n76. De-Regil LM, Palacios C, Lombardo LK, Peña-\\nRosas JP. Vitamin D supplementation for women\\nduring pregnancy. Cochrane Database Syst Rev.\\n2016;(1):CD008873.\\n77. Chen LW, Wu Y , Neelakantan N, Chong MF,\\nPan A, van Dam RM. Maternal caffeine intake\\nduring pregnancy is associated with risk of low\\nbirth weight: a systematic review and dose-\\nresponse meta-analysis. BMC Med. 2014;12:174.\\ndoi:10.1186/ s12916-014-0174-6.\\n78. Rhee J, Kim R, Kim Y , T am M, Lai Y , Keum N,\\nOldenburg CE. Maternal caffeine consumption\\nduring pregnancy and risk of low birth weight: a\\ndose-response meta-analysis of observational\\nstudies. PLoS One. 2015;10(7):e0132334.\\ndoi:10.1371/journal.pone.0132334.\\n79. Chen LW, Wu Y , Neelakantan N, Chong MF,\\nPan A, van Dam RM. Maternal caffeine intake\\nduring pregnancy and risk of pregnancy'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Guideline: Vitamin D supplementation in', 'section_path': ['9 Blood and Nutrition. In: British', 'Guideline: Vitamin D supplementation in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='doi:10.1371/journal.pone.0132334.\\n79. Chen LW, Wu Y , Neelakantan N, Chong MF,\\nPan A, van Dam RM. Maternal caffeine intake\\nduring pregnancy and risk of pregnancy\\nloss: a categorical and dose-response meta-\\nanalysis of prospective studies. Public Health\\nNutr. 2016:19(7):1233–44. doi:10.1017 /\\nS1368980015002463.\\n80. Li J, Zhao H, Song JM, Zhang J, T ang YL, Xin\\nCM. A meta-analysis of risk of pregnancy\\nloss and caffeine and coffee consumption\\nduring pregnancy. Int J Gynaecol Obstet.\\n2015;130(2):116-22. doi:10.1016/j.\\nijgo.2015.03.033.\\n81. Sobhy S, Rogozinska E, Khan KS. Accuracy of on-\\nsite tests to detect anaemia in antenatal care: a\\nsystematic review. BJOG. 2016 (in press).\\n82. Medina Lara A, Mundy C, Kandulu J,\\nChisuwo L, Bates I. Evaluation and costs of\\ndifferent haemoglobin methods for use in\\ndistrict hospitals in Malawi. J Clin Pathol.\\n2005;58(1):56–60.\\n83. Smaill FM, Vazquez JC. Antibiotics\\nfor asymptomatic bacteriuria in\\npregnancy. Cochrane Database Syst Rev.\\n2015;(8):CD000490.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Guideline: Vitamin D supplementation in', 'section_path': ['9 Blood and Nutrition. In: British', 'Guideline: Vitamin D supplementation in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 3, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='district hospitals in Malawi. J Clin Pathol.\\n2005;58(1):56–60.\\n83. Smaill FM, Vazquez JC. Antibiotics\\nfor asymptomatic bacteriuria in\\npregnancy. Cochrane Database Syst Rev.\\n2015;(8):CD000490.\\n84. Schmiemann G, Kniehl E, Gebhardt K,\\nMatejczyk MM, Hummers-Pradier E.\\nThe diagnosis of urinary tract infection: a\\nsystematic review. Deutsches Ärzteblatt\\nInternational. 2010;107(21):361–7. doi:10.3238/\\narztebl.2010.0361.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Global and regional estimates of violence', 'section_path': ['9 Blood and Nutrition. In: British', 'Global and regional estimates of violence'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='against women: prevalence and health effects of\\nintimate partner violence and non-partner sexual\\nviolence. Geneva: World Health Organization;\\n2013 (http:/ /www.who.int/ reproductivehealth/\\npublications/violence/9789241564625/ en/,\\naccessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Responding to intimate partner violence and', 'section_path': ['9 Blood and Nutrition. In: British', 'Responding to intimate partner violence and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='sexual violence against women: WHO clinical\\nand policy guidelines. Geneva: World Health\\nOrganization; 2013 (http:/ / apps.who.int/ rhl/\\nguidelines/9789241548595/ en/, accessed\\n29September 2016).\\n87. van den Broek NR, Ntonya C, Mhango E,\\nWhite SA. Diagnosing anaemia in pregnancy\\nin rural clinics: assessing the potential of the\\nHaemoglobin Colour Scale. Bull World Health\\nOrgan. 1999;77(1):15–21.\\n88. Rogozinska E, Formina S, Zamora J, Mignini L,\\nKhan KS. Accuracy of on-site tests to detect\\nasymptomatic bacteriuria in pregnancy: a\\nsystematic review and meta-analysis. Obstet\\nGynecol. 2016;128(3):495–503. doi:10.1097 /\\nAOG.0000000000001597.\\n89. O’Doherty L, Hegarty K, Ramsay J, Davidson LL,\\nFeder G, T aft A. Screening women for intimate\\npartner violence in healthcare settings. Cochrane\\nDatabase Syst Rev. 2015;(7):CD007007.\\n90. Jahanfar S, Howard LM, Medley N. Interventions\\nfor preventing or reducing domestic violence\\nagainst pregnant women. Cochrane Database\\nSyst Rev. 2014;(11):CD009414.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Responding to intimate partner violence and', 'section_path': ['9 Blood and Nutrition. In: British', 'Responding to intimate partner violence and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='90. Jahanfar S, Howard LM, Medley N. Interventions\\nfor preventing or reducing domestic violence\\nagainst pregnant women. Cochrane Database\\nSyst Rev. 2014;(11):CD009414.  \\nReferences\\n129'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Health care for women subjected to intimate', 'section_path': ['9 Blood and Nutrition. In: British', 'Health care for women subjected to intimate'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='partner violence or sexual violence: a clinical\\nhandbook. Geneva: World Health Organization;\\n2014 (WHO/RHR/14.26; http:/ /www.who.int/\\nreproductivehealth/ publications/violence/vaw-\\nclinical-handbook/ en/, accessed 26October\\n2016).\\n92. Abramsky T, Devries K, Kiss L, Francisco\\nL, Nakuti J, Musuya T et al. A community\\nmobilization intervention to prevent violence\\nagainst women and reduce HIV / AIDS risk in\\nKampala, Uganda (the SASA! Study): study\\nprotocol for a cluster randomised controlled trial.\\nT rials. 2012;13:96. doi:10.1186/1745-6215-13-96.\\n93. Krishnan S, Subbiah K, Chandra P, Srinivasan'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Health care for women subjected to intimate', 'subsection': 'Minimizing risks and monitoring safety of an', 'section_path': ['9 Blood and Nutrition. In: British', 'Health care for women subjected to intimate', 'Minimizing risks and monitoring safety of an'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='antenatal care intervention to mitigate domestic\\nviolence among young Indian women: The\\nDil Mil trial. BMC Public Health. 2012;12:943.\\ndoi:10.1186/1471-2458-12-943.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Diagnostic criteria and classification of', 'section_path': ['9 Blood and Nutrition. In: British', 'Diagnostic criteria and classification of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='hyperglycaemia first detected in pregnancy.\\nGeneva: World Health Organization; 2013\\n(WHO/NMH/MND/13.2; http:/ /www.who.\\nint/ diabetes/ publications/Hyperglycaemia_In_\\nPregnancy/ en/, accessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Antenatal care for uncomplicated pregnancies:', 'section_path': ['9 Blood and Nutrition. In: British', 'Antenatal care for uncomplicated pregnancies:'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='clinical guideline [CG62]. United Kingdom:\\nNational Institute for Health and Clinical\\nExcellence; 2008 (updated 2016) (https:/ /\\nwww.nice.org.uk/ guidance/ cg62, accessed\\n30September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations for the prevention and', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations for the prevention and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='management of tobacco use and second-hand\\nsmoke exposure in pregnancy. Geneva:\\nWorld Health Organization; 2013 (http:/ /\\nwww.who.int/tobacco/ publications/ pregnancy/\\nguidelinestobaccosmokeexposure/ en/, accessed\\n29September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Guidelines for the identification and', 'section_path': ['9 Blood and Nutrition. In: British', 'Guidelines for the identification and'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='management of substance use and substance\\nuse disorders in pregnancy. Geneva: World\\nHealth Organization; 2014 (http:/ /www.who.\\nint/ substance_abuse/ publications/ pregnancy_\\nguidelines/ en/, accessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Consolidated guidelines on HIV testing', 'section_path': ['9 Blood and Nutrition. In: British', 'Consolidated guidelines on HIV testing'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='services 2015. Geneva: World Health\\nOrganization; 2015 (http:/ / apps.who.int/iris/\\nbitstream/10665/179870/1/9789241508926_\\neng.pdf, accessed 29 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Guideline on when to start antiretroviral', 'section_path': ['9 Blood and Nutrition. In: British', 'Guideline on when to start antiretroviral'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='therapy and on pre-exposure prophylaxis for\\nHIV. Geneva: World Health Organization;\\n2015 (http:/ / apps.who.int/iris/\\nbitstream/10665/186275/1/9789241509565_\\neng.pdf, accessed 4 October 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Prevention of mother-to-child transmission of', 'section_path': ['9 Blood and Nutrition. In: British', 'Prevention of mother-to-child transmission of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='syphilis: integrated management of pregnancy\\nand childbirth (IMPAC). Standards for maternal\\nand neonatal care 1.3. Geneva: Department\\nof Making Pregnancy Safer, World Health\\nOrganization; 2006 (http:/ /www.who.int/\\nreproductivehealth/ publications/ maternal_\\nperinatal_health/ prevention_mtct_syphilis.pdf,\\naccessed 14 September 2016)'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO guidelines for the treatment of Chlamydia', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO guidelines for the treatment of Chlamydia'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='trachomatis. Geneva: World Health Organization;\\n2016 (http:/ /www.who.int/ reproductivehealth/\\npublications/ rtis/ chlamydia-treatment-\\nguidelines/ en/, accessed 27 October 2016)'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO guidelines for the treatment of', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO guidelines for the treatment of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Neisseria gonorrhoeae. Geneva: World Health\\nOrganization; 2016 (http:/ /www.who.\\nint/ reproductivehealth/ publications/ rtis/\\ngonorrhoea-treatment-guidelines/ en/, accessed\\n27October 2016)'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO guidelines for the treatment of Treponema', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO guidelines for the treatment of Treponema'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='pallidum (syphilis). Geneva: World Health\\nOrganization; 2016 (http:/ /www.who.int/\\nreproductivehealth/ publications/ rtis/ syphilis-\\ntreatment-guidelines/ en/, accessed 27October\\n2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Prevention of sexual transmission of Zika', 'section_path': ['9 Blood and Nutrition. In: British', 'Prevention of sexual transmission of Zika'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='virus: interim guidance. Geneva: World\\nHealth Organization; 2016 (http:/ /www.\\nwho.int/ csr/ resources/ publications/zika/\\nsexual-transmission-prevention/ en/, accessed\\n27October 2016).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n130'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'normal_variations'], 'discusses_normal_variations': True}, page_content='principles and recommendations. Geneva: World\\nHealth Organization; 2013 (http:/ /www.who.int/\\ntb/ publications/Final_TB_Screening_guidelines.\\npdf, accessed 29 September 2016).\\n106. Pearson JF, Weaver JB. Fetal activity and\\nfetal wellbeing: an evaluation. Br Med J.\\n1976;1(6021):1305-7.\\n107. Mangesi L, Hofmeyr GJ, Smith V, Smyth RMD.\\nFetal movement counting for assessment of\\nfetal wellbeing. Cochrane Database Syst Rev.\\n2015;(10):CD004909.\\n108. Enkin M, Keirse MJNC, Neilson JP, Crowther\\nC, Duley L, Hodnett E et al. A guide to effective\\ncare in pregnancy and childbirth, third edition.\\nOxford: Oxford University Press; 2000.\\n109. Robert Peter J, Ho JJ, Valliapan J, Sivasangari S.\\nSymphysial fundal height (SFH) measurement\\nin pregnancy for detecting abnormal fetal\\ngrowth. Cochrane Database Syst Rev.\\n2015;(9):CD008136.\\n110. Whitworth M, Bricker L, Mullan C. Ultrasound for\\nfetal assessment in early pregnancy. Cochrane\\nDatabase Syst Rev. 2015;(7):CD007058.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='growth. Cochrane Database Syst Rev.\\n2015;(9):CD008136.\\n110. Whitworth M, Bricker L, Mullan C. Ultrasound for\\nfetal assessment in early pregnancy. Cochrane\\nDatabase Syst Rev. 2015;(7):CD007058.\\n111. Maulik D, Mundy D, Heitmann E, Maulik'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'subsection': 'Evidence-based approach to umbilical', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:', 'Evidence-based approach to umbilical'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'warning_signs', 'normal_variations'], 'discusses_normal_variations': True}, page_content='artery Doppler fetal surveillance in high-\\nrisk pregnancies: an update. Clin Obstet\\nGynecol. 2010;53(4):869–78. doi:10.1097 /\\nGRF.0b013e3181fbb5f5.\\n112. Alfirevic Z, Stampalija T, Gyte GML. Fetal\\nand umbilical Doppler ultrasound in high-risk\\npregnancies. Cochrane Database Syst Rev.\\n2013;(11):CD007529.\\n113. Soothill PW, Ajayi RA, Campbell S, Nicolaides\\nKH. Prediction of morbidity in small and\\nnormally grown fetuses by fetal heart rate\\nvariability, biophysical profile score and umbilical\\nartery Doppler studies. Brit J Obstet Gynaecol.\\n1993;100:742–5.\\n114. Alfirevic Z, Stampalija T, Medley N. Fetal\\nand umbilical Doppler ultrasound in normal\\npregnancy. Cochrane Database Syst Rev.\\n2015;(4):CD001450.\\n115. Delaram M, Shams S. The effect of foetal\\nmovement counting on maternal anxiety: a\\nrandomised, controlled trial. J Obstet Gynaecol.\\n2015:39–43. doi:10.3109/01443615.2015.10257\\n26.\\n116. Pay ASD, Wiik J, Backe B, Jacobsson B, Strandell\\nA, Klovning A. Symphysis-fundus height'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'subsection': 'Evidence-based approach to umbilical', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:', 'Evidence-based approach to umbilical'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='randomised, controlled trial. J Obstet Gynaecol.\\n2015:39–43. doi:10.3109/01443615.2015.10257\\n26.\\n116. Pay ASD, Wiik J, Backe B, Jacobsson B, Strandell\\nA, Klovning A. Symphysis-fundus height\\nmeasurement to predict small-for-gestational-\\nage status at birth: a systematic review. BMC\\nPregnancy Childbirth. 2015;15:22. doi:10.1186/\\ns12884-015-0461-z.\\n117. Grivell RM, Alfirevic Z, Gyte GML, Devane'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'subsection': 'Antenatal cardiotocography for fetal', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:', 'Antenatal cardiotocography for fetal'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='assessment. Cochrane Database Syst Rev.\\n2015;(9):CD007863.\\n118. McClure EM, Nathan RO, Saleem S, Esamai F,\\nGarces A, Chomba E et al. First look: a cluster-\\nrandomized trial of ultrasound to improve\\npregnancy outcomes in low income country\\nsettings. BMC Pregnancy Childbirth. 2014;14:73.\\ndoi:10.1186/1471-2393-14-73.\\n119. Manual of diagnostic ultrasound, second\\nedition. Geneva: World Health Organization;\\n2013 (http:/ /www.who.int/ medical_devices/\\npublications/ manual_ultrasound_pack1-2/ en/,\\naccessed 26 October 2016).\\n120. Whitworth M, Bricker L, Mullan C. Ultrasound for\\nfetal assessment in early pregnancy. Cochrane\\nDatabase Syst Rev. 2015;(7):CD007058.\\n121. Bricker L, Medley N, Pratt JJ. Routine\\nultrasound in late pregnancy (after 24 weeks’\\ngestation). Cochrane Database Syst Rev.\\n2015;(6):CD001451.\\n122. Harris RD, Marks WM. Compact ultrasound\\nfor improving maternal and perinatal care in\\nlow-resource settings. J Ultrasound Med. 2009.\\n28(8):1067–76.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'subsection': 'Antenatal cardiotocography for fetal', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:', 'Antenatal cardiotocography for fetal'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition', 'warning_signs']}, page_content='2015;(6):CD001451.\\n122. Harris RD, Marks WM. Compact ultrasound\\nfor improving maternal and perinatal care in\\nlow-resource settings. J Ultrasound Med. 2009.\\n28(8):1067–76.\\n123. Oluoch DA, Mwangome N, Kemp B, Seale AC,\\nKoech AC, Papagrotghiou AT et al. “Y ou cannot\\nknow if it’s a baby or not a baby”: uptake,\\nprovision and perceptions of antenatal care and\\nroutine ultrasound scanning in rural Kenya. BMC\\nPregnancy Childbirth. 2015;15:127. doi:10.1186/\\ns12884-015-0565-5.  \\nReferences\\n131\\n124. Heyman B, Hundt G, Sandall J, Spencer K,\\nWilliams C, Grellier R, Pitson L. On being at\\nhigher risk: a qualitative study of prenatal\\nscreening for chromosomal anomalies. Soc\\nSci Med. 2006(62);2360–72. doi:10.1016/j.\\nsocscimed.2005.10.018.\\n125. Rizvi M, Khan F, Shukla I, Malik A, Shaheen.\\nRising prevalence of antimicrobial resistance\\nin urinary tract infections during pregnancy:\\nnecessity for exploring newer treatment\\noptions. J Lab Physicians. 2011;3(2):98–103.\\ndoi:10.4103/0974-2727.86842.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'subsection': 'Antenatal cardiotocography for fetal', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:', 'Antenatal cardiotocography for fetal'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='in urinary tract infections during pregnancy:\\nnecessity for exploring newer treatment\\noptions. J Lab Physicians. 2011;3(2):98–103.\\ndoi:10.4103/0974-2727.86842.\\n126. Wang E, Smaill F. Infection in pregnancy. In:\\nChalmers I, Enkin MW, Keirse MJNC, editors.\\nEffective care in pregnancy and childbirth.\\nOxford: Oxford University Press; 1989:534–7.\\n127. Schneeberger C, Geerlings SE, Middleton P,\\nCrowther CA. Interventions for preventing\\nrecurrent urinary tract infection during\\npregnancy. Cochrane Database Syst Rev.\\n2012;(11):CD009279.\\n128. Gilstrap LC 3rd, Cunningham FG, Whalley\\nPJ. Acute pyelonephritis in pregnancy: an\\nanterospective study. Obstet Gynecol.\\n1981;57(4):409–13.\\n129. Crowther C, Middleton P. Anti-D adminstration\\nafter childbirth for preventing rhesus\\nalloimmunization. Cochrane Database Syst Rev.\\n1997;(2):CD000021.\\n130. Salam RA, Haider BA, Humayun Q, Bhutta\\nZA. Effect of administration of antihelminthics\\nfor soil-transmitted helminths during'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Systematic screening for active tuberculosis:', 'subsection': 'Antenatal cardiotocography for fetal', 'section_path': ['9 Blood and Nutrition. In: British', 'Systematic screening for active tuberculosis:', 'Antenatal cardiotocography for fetal'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='alloimmunization. Cochrane Database Syst Rev.\\n1997;(2):CD000021.\\n130. Salam RA, Haider BA, Humayun Q, Bhutta\\nZA. Effect of administration of antihelminthics\\nfor soil-transmitted helminths during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(6):CD005547.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Controlling disease due to helminth', 'section_path': ['9 Blood and Nutrition. In: British', 'Controlling disease due to helminth'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='infections. Geneva: World Health\\nOrganization; 2003 (http:/ / apps.who.int/iris/\\nbitstream/10665/ 42707 /1/9241562390.pdf,\\naccessed 29 September 2016).\\n132. Blencowe H, Lawn J, Vandelaer J, Roper M,\\nCousens S. T etanus toxoid immunization to\\nreduce mortality from neonatal tetanus. Int J\\nEpidemiol. 2010;39(Suppl 1):i102–i109.\\n133. Lui L, Johnson HL, Cousens S, Perin J, Scott S,\\nLawn JE et al. Global, regional, and national\\ncauses of child mortality: an updated systematic\\nanalysis for 2010 with time trends since 2000.\\nLancet. 2012;379:2151–61.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Maternal immunization against tetanus:', 'section_path': ['9 Blood and Nutrition. In: British', 'Maternal immunization against tetanus:'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='integrated management of pregnancy and\\nchildbirth (IMPAC). Standards for maternal and\\nneonatal care 1.1. Geneva: Department of Making\\nPregnancy Safer, World Health Organization;\\n2006 (http:/ /www.who.int/ reproductivehealth/\\npublications/ maternal_perinatal_health/\\nimmunization_tetanus.pdf, accessed 28\\nSeptember 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations for prevention', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations for prevention'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'nutrition']}, page_content='and treatment of maternal peripartum\\ninfections. Geneva: World Health\\nOrganization; 2015 (http:/ / apps.who.int/iris/\\nbitstream/10665/186171/1/9789241549363_\\neng.pdf, accessed 28 September 2016).\\n136. Widmer M, Lopez I, Gülmezoglu AM,\\nMignini L, Roganti A. Duration of treatment\\nfor asymptomatic bacteriuria during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(11):CD000491.\\n137. Joint Formulary Committee. Urinary tract\\ninfections. Chapter 5: Infection. In: British\\nNational Formulary (BNF) 72. London: BMJ\\nPublishing Group Ltd and Royal Pharmaceutical\\nSociety; 2016.\\n138. McBain RD, Crowther CA, Middleton P. Anti-D\\nadministration in pregnancy for preventing\\nRhesus alloimmunization. Cochrane Database\\nSyst Rev. 2015;(9):CD000020.\\n139. Joint Formulary Committee. Immunoglobulin\\ntherapy. Chapter 14: Vaccines. In: British\\nNational Formulary (BNF) 72. London: BMJ\\nPublishing Group Ltd and Royal Pharmaceutical\\nSociety; 2016.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Guideline: preventive chemotherapy to control', 'section_path': ['9 Blood and Nutrition. In: British', 'Guideline: preventive chemotherapy to control'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='soil-transmitted helminth infections in high-risk\\ngroups. Geneva: World Health Organization;\\n2016 (in press).  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n132'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Preventive chemotherapy in human', 'section_path': ['9 Blood and Nutrition. In: British', 'Preventive chemotherapy in human'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='helminthiasis: coordinated use of\\nantihelminthic drugs in control interventions:\\na manual for health professionals and\\nprogramme managers. Geneva: World Health\\nOrganization; 2006 (http:/ / apps.who.int/iris/\\nbitstream/10665/ 43545/1/9241547103_eng.\\npdf, accessed 26 September 2016).\\n142. Salam RA, Haider BA, Humayun Q, Bhutta\\nZA. Effect of administration of antihelminthics\\nfor soil-transmitted helminths during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(6):CD005547.\\n143. Christian P, Khatry SK, West KP, Jr. Antenatal\\nanthelmintic treatment, birth weight,\\nand infant survival in rural Nepal. Lancet.\\n2004;364(9438):981–3.\\n144. Passerini L, Casey GJ, Biggs BA, Cong DT, Phu LB,\\nPhuc TQ et al. Increased birth weight associated\\nwith regular pre-pregnancy deworming\\nand weekly iron-folic acid supplementation\\nfor Vietnamese women. PLoS Negl T rop\\nDis. 2012;6(4):e1608. doi:10.1371/journal.\\npntd.0001608.\\n145. de Silva N R, Sirisena JL, Gunasekera DP, Ismail'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Preventive chemotherapy in human', 'section_path': ['9 Blood and Nutrition. In: British', 'Preventive chemotherapy in human'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='and weekly iron-folic acid supplementation\\nfor Vietnamese women. PLoS Negl T rop\\nDis. 2012;6(4):e1608. doi:10.1371/journal.\\npntd.0001608.\\n145. de Silva N R, Sirisena JL, Gunasekera DP, Ismail\\nMM, de Silva HJ. Effect of mebendazole therapy\\nduring pregnancy on birth outcome. Lancet.\\n1999;353(9159):1145–9.\\n146. Mondadori E, Ehrhardt A, Le Anh T, T ran Cong\\nD, Sepe G, Van Huyen N et al. Appreciation of\\nschool deworming program by parents in Ha\\nGiang Province (Vietnam). Southeast Asian J\\nT rop Med Public Health. 2006;37:1095–8.\\n147. Thwaites CL, Loan HT. Eradication of tetanus. Br\\nMed Bull. 2015;116(1):69–77. doi:10.1093/bmb/\\nldv044.\\n148. Demicheli V, Barale A, Rivetti A. Vaccines\\nfor women for preventing neonatal\\ntetanus. Cochrane Database Syst Rev.\\n2015;(7):CD002959.\\n149. Blencowe H, Lawn J, Vandelaer J, Roper M,\\nCousens S. T etanus toxoid immunization to\\nreduce mortality from neonatal tetanus. Int J\\nEpidemiol. 2010;39(Suppl1):i102-i109.\\n150. Statement on tetanus toxoid vaccine. Geneva:'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Preventive chemotherapy in human', 'section_path': ['9 Blood and Nutrition. In: British', 'Preventive chemotherapy in human'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='Cousens S. T etanus toxoid immunization to\\nreduce mortality from neonatal tetanus. Int J\\nEpidemiol. 2010;39(Suppl1):i102-i109.\\n150. Statement on tetanus toxoid vaccine. Geneva:\\nWorld Health Organization; 2014 (http:/ /www.\\nwho.int/immunization/ statement_on_tetanus_\\ntoxoid_vaccine.pdf, accessed 25 June 2016).\\n151. Wolfson LJ, Gasse F, Lee-Martin S-P, Lydon\\nP, Magan A, Tibouti A et al. Estimating the\\ncosts of achieving the WHO–UNICEF Global\\nImmunization Vision and Strategy, 2006–2015.\\nBull World Health Organ. 2008;86(1):27–39.\\n152. Mvundura M, Kien VD, Nga NT, Robertson J,\\nCuong NV, T ung HT et al. How much does it cost\\nto get a dose of vaccine to the service delivery\\nlocation? Empirical evidence from Vietnam’s\\nExpanded Program on Immunization. Vaccine.\\n2014;32:834–8.\\n153. Guidelines for the treatment of malaria,\\nthird edition. Geneva: World Health\\nOrganization; 2015 (http:/ / apps.who.int/iris/\\nbitstream/10665/162441/1/9789241549127_\\neng.pdf, accessed 28 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Preventive chemotherapy in human', 'section_path': ['9 Blood and Nutrition. In: British', 'Preventive chemotherapy in human'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['warning_signs']}, page_content='third edition. Geneva: World Health\\nOrganization; 2015 (http:/ / apps.who.int/iris/\\nbitstream/10665/162441/1/9789241549127_\\neng.pdf, accessed 28 September 2016).\\n154. Kayentao K, Garner P, van Eijk AM, Naidoo\\nI, Roper C, Mulokozi A et al. Intermittent\\npreventive therapy for malaria during pregnancy\\nusing 2 vs 3 or more doses of sulfadoxine–\\npyrimethamine and risk of low birth weight in\\nAfrica: systematic review and meta-analysis.\\nJAMA. 2013;309:594–604.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='Pregnancy Working Group. Consensus\\nstatement on folic acid supplementation during\\npregnancy. Geneva; 2015 (https:/ /www.pmi.gov/\\ndocs/ default-source/ default-document-library/\\ntools-curricula/ consensus-statement-folic-\\nacid-supplementation-during-pregnancy.pdf,\\naccessed 26 September 2016).\\n156. Einarson TR, Piwko C, Koren G. Quantifying\\nthe global rates of nausea and vomiting of\\npregnancy: a meta analysis. J Popul Ther Clin\\nPharmacol. 2013;20(2):e171–83.\\n157. Matthews A, Haas DM, O’Mathúna DP,\\nDowswell T. Interventions for nausea and\\nvomiting in early pregnancy. Cochrane Database\\nSyst Rev. 2015;(9):CD007575.  \\nReferences\\n133\\n158. Albert H, Godskesen M, Westergaard J.\\nPrognosis in four syndromes of pregnancy-\\nrelated pelvic pain. Acta Obstet Gynecol Scand.\\n2001;80:505–10.\\n159. Phupong V, Hanprasertpong T. Interventions for\\nheartburn in pregnancy. Cochrane Database Syst\\nRev. 2015;(9):CD011379.\\n160. Smyth RMD, Aflaifel N, Bamigboye AA.\\nInterventions for varicose veins and leg oedema'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 2, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='heartburn in pregnancy. Cochrane Database Syst\\nRev. 2015;(9):CD011379.\\n160. Smyth RMD, Aflaifel N, Bamigboye AA.\\nInterventions for varicose veins and leg oedema\\nin pregnancy. Cochrane Database Syst Rev.\\n2015;(10):CD001066.\\n161. Rungsiprakarn P, Laopaiboon M,\\nSangkomkamhang US, Lumbiganon P, Pratt\\nJJ. Interventions for treating constipation\\nin pregnancy. Cochrane Database Syst Rev.\\n2015;(9):CD011448.\\n162. Zhou K, West HM, Zhang J, Xu L, Li'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'subsection': 'Interventions for leg cramps in', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in', 'Interventions for leg cramps in'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': ['first']}, 'maternal_topics': ['nutrition']}, page_content='pregnancy. Cochrane Database Syst Rev.\\n2015;(8):CD010655.\\n163. Matok I, Gorodischer R, Koren G, Sheiner\\nE, Wiznitzer A, Levy A. The safety of\\nmetoclopramide use in first trimester of\\npregnancy. N Engl J Med. 2009;360:2528–35.\\n164. Joint Formulary Committee. Disorders of gastric\\nacid and ulceration. Chapter 1: Gastro-intestinal\\nsystem. In: British National Formulary (BNF) 72.\\nLondon: BMJ Publishing Group Ltd and Royal\\nPharmaceutical Society; 2016.\\n165. Liddle SD, Pennick V. Interventions for preventing\\nand treating low-back and pelvic pain during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(9):CD001139.\\n166. Joint Formulary Committee. Constipation and\\nbowel cleansing. Chapter 1: Gastro-intestinal\\nsystem. In: British National Formulary (BNF) 72.\\nLondon: BMJ Publishing Group Ltd and Royal\\nPharmaceutical Society; 2016.\\n167. Shingler S, Robertson L, Boghossian S, Stewart'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'subsection': 'Compression stockings for the initial', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in', 'Compression stockings for the initial'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes', 'nutrition']}, page_content='treatment of varicose veins in patients without\\nvenous ulceration. Cochrane Database Syst Rev.\\n2013;(12):CD00881.\\n168. Brown HC, Smith HJ, Mori R, Noma H. Giving\\nwomen their own case notes to carry during\\npregnancy. Cochrane Database Syst Rev.\\n2015;(10):CD002856.\\n169. Mori R, Y onemoto N, Noma H, Ochirbat T,\\nBarber E, Soyolgerel G et al. The maternal and\\nchild health (MCH) handbook in Mongolia: a\\ncluster-randomized, controlled trial. PLoS One\\n2015;10(4):e0119772.\\n170. Hofmeyr GJ, Pattinson RC, Nikodem VC,\\nGülmezoglu AM. Charting fetal growth. J\\nComprehensive Health. 1994;5:62–7.\\n171. ten Hoope-Bender P, de Bernis L, Campbell\\nJ, Downe S, Fauveau V, Fogstad H et al.\\nImprovement of maternal and newborn health\\nthrough midwifery. Lancet Special Issue.\\n2014;384(9949):1226–35. doi:10.1016/S0140-\\n6736(14)60930-2.\\n172. Sandall J, Soltani H, Gates S, Shennan A,\\nDevane D. Midwife-led continuity models\\nversus other models of care for childbearing\\nwomen. Cochrane Database Syst Rev.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'subsection': 'Compression stockings for the initial', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in', 'Compression stockings for the initial'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['nutrition']}, page_content='6736(14)60930-2.\\n172. Sandall J, Soltani H, Gates S, Shennan A,\\nDevane D. Midwife-led continuity models\\nversus other models of care for childbearing\\nwomen. Cochrane Database Syst Rev.\\n2015;(9):CD004667.\\n173. Sandall J. The contribution of continuity of\\nmidwifery care to high quality maternity care.\\nLondon: The Royal College of Midwives; 2014\\n(https:/ /www.rcm.org.uk/ sites/ default/files/\\nContinuity%20of%20Care%20A5%20Web.pdf,\\naccessed 26 September 2016).\\n174. Catling CJ, Medley N, Foureur M, Ryan C, Leap N,\\nT eate A, Homer CSE. Group versus conventional\\nantenatal care for women. Cochrane Database\\nSyst Rev. 2015;(2):CD007622.\\n175. Mbuagbaw L, Medley N, Darzi AJ, Richardson\\nM, Habiba Garga K, Ongolo-Zogo P. Health\\nsystem and community level interventions\\nfor improving antenatal care coverage and\\nhealth outcomes. Cochrane Database Syst Rev.\\n2015;(12):CD010994.\\n176. Shah PM, Selwyn BJ, Shah K, Kumar V and\\ncollaborators. Evaluation of the home-based'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'subsection': 'Compression stockings for the initial', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in', 'Compression stockings for the initial'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes', 'warning_signs']}, page_content='for improving antenatal care coverage and\\nhealth outcomes. Cochrane Database Syst Rev.\\n2015;(12):CD010994.\\n176. Shah PM, Selwyn BJ, Shah K, Kumar V and\\ncollaborators. Evaluation of the home-based\\nmaternal record: a WHO collaborative study. Bull\\nWorld Health Organ. 1993;71(5):535–48.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n134\\n177. Hawley G, Janamian T, Jackson C, Wilkinson SA.\\nIn a maternity shared-care environment, what\\ndo we know about the paper hand-held and\\nelectronic health record: a systematic literature\\nreview. BMC Pregnancy Childbirth. 2014;14:52.\\ndoi:10.1186/1471-2393-14-52.\\n178. T racy SK, Hartz DL, T racy MB, Allen J, Forti A,\\nHall B et al. Caseload midwifery care versus\\nstandard maternity care for women of any risk:\\nM@NGO, a randomised controlled trial. Lancet.\\n2013;382(9906):1723–32. doi:10.1016/S0140-\\n6736(13)61406-3.\\n179. Lori JR, Munro ML, Chuey MR. Use of a\\nfacilitated discussion model for antenatal'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Roll Back Malaria Partnership Malaria in', 'subsection': 'Compression stockings for the initial', 'section_path': ['9 Blood and Nutrition. In: British', 'Roll Back Malaria Partnership Malaria in', 'Compression stockings for the initial'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 4, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'maternal_changes']}, page_content='M@NGO, a randomised controlled trial. Lancet.\\n2013;382(9906):1723–32. doi:10.1016/S0140-\\n6736(13)61406-3.\\n179. Lori JR, Munro ML, Chuey MR. Use of a\\nfacilitated discussion model for antenatal\\ncare to improve communication. Internat J\\nNurs Stud. 2016;54:84–94. doi:10.1016/j.\\nijnurstu.2015.03.018.\\n180. Ruiz-Merazo E, Lopez-Yarto M, McDonald SD.\\nGroup prenatal care versus individual prenatal\\ncare: a systematic review and meta-analysis. J\\nObstet Gynaecol Can. 2012;34(3):223–9.\\n181. Patil CL, Abrams ET, Klima C, Kaponda CP,\\nLeshabari SC, Vonderheid SC et al.\\nCenteringPregnancy-Africa: a pilot of group\\nantenatal care to address Millennium\\nDevelopment Goals. Midwifery. 2013;29(10):\\n1190–8. doi:10.1016/j.midw.2013.05.008.\\n182. Jafari F, Eftekhar H, Fotouhi A, Mohammad K,\\nHantoushzadeh S. Comparison of maternal and\\nneonatal outcomes of group versus individual\\nprenatal care: a new experience in Iran. Health\\nCare for Women Int. 2010;31(7):571–84.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on community', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on community'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='mobilization through facilitated participatory\\nlearning and action cycles with women’s groups\\nfor maternal and newborn health. Geneva: World\\nHealth Organization; 2014 (http:/ /www.who.\\nint/ maternal_child_adolescent/ documents/\\ncommunity-mobilization-maternal-newborn/\\nen/, accessed 29 September 2016).\\n184. Azad K, Barnett S, Banerjee B, Shaha S, Khan\\nK, Rego AR et al. Effect of scaling up women’s\\ngroups on birth outcomes in three rural districts\\nin Bangladesh: a cluster-randomised controlled\\ntrial. Lancet. 2010;375(9721):1193–202.\\ndoi:10.1016/S0140-6736(10)60142-0.\\n185. Colbourn T, Nambiar B, Bondo A, Makwenda\\nC, T setekani E, Makonda-Ridley A et al.\\nEffects of quality improvement in health\\nfacilities and community mobilization through\\nwomen’s groups on maternal, neonatal and\\nperinatal mortality in three districts of Malawi:\\nMaiKhanda, a cluster randomized controlled\\neffectiveness trial. Int Health. 2013;5(3):180–95.\\ndoi:10.1093/inthealth/iht011.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on community', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on community'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='perinatal mortality in three districts of Malawi:\\nMaiKhanda, a cluster randomized controlled\\neffectiveness trial. Int Health. 2013;5(3):180–95.\\ndoi:10.1093/inthealth/iht011.\\n186. Fottrell E, Azad K, Kuddus A, Y ounes L, Shaha S,\\nNahar T et al. The effect of increased coverage\\nof participatory women’s groups on neonatal\\nmortality in Bangladesh: a cluster randomized\\ntrial. JAMA Pediatr. 2013;167(9):816–25.\\ndoi:10.1001/jamapediatrics.2013.2534.\\n187. Lewycka S, Mwansambo C, Rosato M, Kazembe\\nP, Phiri T, Mganga A et al. Effect of women’s\\ngroups and volunteer peer counselling on rates\\nof mortality, morbidity, and health behaviours\\nin mothers and children in rural Malawi\\n(MaiMwana): a factorial, cluster-randomised\\ncontrolled trial. Lancet. 2013;381(9879):1721–35.\\ndoi:10.1016/S0140-6736(12)61959-X.\\n188. Manandhar DS, Osrin D, Shrestha BP, Mesko N,\\nMorrison J, T umbahangphe KM et al. Effect of a\\nparticipatory intervention with women’s groups\\non birth outcomes in Nepal: cluster-randomised'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on community', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on community'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='188. Manandhar DS, Osrin D, Shrestha BP, Mesko N,\\nMorrison J, T umbahangphe KM et al. Effect of a\\nparticipatory intervention with women’s groups\\non birth outcomes in Nepal: cluster-randomised\\ncontrolled trial. Lancet. 2004;364:970–9.\\n189. More NS, Bapat U, Das S, Alcock G, Patil S, Porel\\nM et al. Community mobilization in Mumbai\\nslums to improve perinatal care and outcomes:\\na cluster randomized controlled trial. PLoS\\nMed. 2012;9(7):e1001257. doi:10.1371/journal.\\npmed.1001257.\\n190. T ripathy P, Nair N, Barnett S, Mahapatra R,\\nBorghi J, Rath S et al. Effect of a participatory\\nintervention with women’s groups on birth\\noutcomes and maternal depression in Jharkhand\\nand Orissa, India: a cluster-randomised\\ncontrolled trial. Lancet. 2010;375(9721):1182–92.\\ndoi:10.1016/S0140-6736(09)62042-0.\\n191. Prost A, Colbourn T, Seward N, Azad K,\\nCoomarasamy A, Copas A et al. Women’s\\ngroups practising participatory learning and\\naction to improve maternal and newborn health'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on community', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on community'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 3, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='191. Prost A, Colbourn T, Seward N, Azad K,\\nCoomarasamy A, Copas A et al. Women’s\\ngroups practising participatory learning and\\naction to improve maternal and newborn health\\nin low-resource settings: a systematic review and\\nmeta-analysis. Lancet. 2013;381(9879):1736–46.  \\nReferences\\n135\\ndoi:10.1016/S0140-6736(13)60685-6. [Erratum\\nin: Lancet. 2014;383(9931):1806.]\\n192. Baqui AH, El-Arifeen S, Darmstadt GL, Ahmed\\nS, Williams EK, Seraji HR et al.; Projahnmo Study\\nGroup. Effect of community-based newborn-\\ncare intervention package implemented through\\ntwo service-delivery strategies in Sylhet district,\\nBangladesh: a cluster-randomised controlled\\ntrial. Lancet. 2008;371(9628):1936–44.\\ndoi:10.1016/S0140-6736(08)60835-1.\\n193. Bhutta ZA, Soofi S, Cousens S, Mohammad\\nS, Memon ZA, Ali I et al. Improvement of\\nperinatal and newborn care in rural Pakistan\\nthrough community-based strategies: a\\ncluster-randomised effectiveness trial. Lancet.\\n2011;377(9763):403–12. doi:10.1016/S0140-\\n6736(10)62274-X.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on community', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on community'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 4, 'total_chunks': 5, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='perinatal and newborn care in rural Pakistan\\nthrough community-based strategies: a\\ncluster-randomised effectiveness trial. Lancet.\\n2011;377(9763):403–12. doi:10.1016/S0140-\\n6736(10)62274-X.\\n194. Kumar V, Mohanty S, Kumar A, Misra RP,\\nSantosham M, Awasthi S et al.; Saksham\\nStudy Group. Effect of community-based\\nbehavior change management on neonatal\\nmortality in Shivgarh, Uttar Pradesh, India: a\\ncluster-randomised controlled trial. Lancet.\\n2008;372(9644):1151–62. doi:10.1016/S0140-\\n6736(08)61483-X.\\n195. Midhet F, Becker S. Impact of community-based\\nintervention on maternal and neonatal health\\nindicators: results from a community randomized\\ntrial in rural Balochistan, Pakistan. Reprod\\nHealth. 2010;7:30. doi:10.1186/1742-4755-7-30.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on postnatal care of', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on postnatal care of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='the mother and newborn. Geneva: World Health\\nOrganization; 2014 (http:/ / apps.who.int/iris/\\nbitstream/10665/97603/1/9789241506649_\\neng.pdf, accessed 28 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO guidelines on preventing early', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO guidelines on preventing early'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='pregnancy and poor reproductive outcomes\\namong adolescents in developing countries.\\nGeneva: World Health Organization;\\n2011 (http:/ / apps.who.int/iris/\\nbitstream/10665/ 44691/1/9789241502214_\\neng.pdf, accessed 28 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations on health', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations on health'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='promotion interventions for maternal and\\nnewborn health. Geneva: World Health\\nOrganization; 2015 (http:/ / apps.who.int/ /iris/\\nbitstream/10665/172427 /1/9789241508742_\\nreport_eng.pdf, accessed 28 September 2016).\\n199. Mangham-Jefferies L, Pitt C, Cousens S, Mills A,\\nSchellenberg J. Cost-effectiveness of strategies\\nto improve the utilization and provision of\\nmaternal and newborn health care in low-\\nincome and lower-middle-income countries: a\\nsystematic review. BMC Pregnancy Childbirth.\\n2014;14:243. doi:10.1186/1471-2393-14-243.\\n200. Memon ZA, Khan GN, Soofi SB, Baig IY , Bhutta\\nZA. Impact of a community-based perinatal and\\nnewborn preventive care package on perinatal\\nand neonatal mortality in a remote mountainous\\ndistrict in Northern Pakistan. BMC Pregnancy\\nChildbirth. 2015;15:106. doi:10.1186/ s12884-015-\\n0538-8.'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'WHO recommendations: optimizing health', 'section_path': ['9 Blood and Nutrition. In: British', 'WHO recommendations: optimizing health'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['maternal_changes']}, page_content='worker roles to improve access to key\\nmaternal and newborn health interventions\\nthrough task shifting. Geneva: World Health\\nOrganization; 2012 (http:/ / apps.who.int/iris/\\nbitstream/10665/77764/1/9789241504843_\\neng.pdf, accessed 28 September 2016).'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Increasing access to health workers in remote', 'section_path': ['9 Blood and Nutrition. In: British', 'Increasing access to health workers in remote'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='and rural areas through improved retention:\\nglobal policy recommendations. Geneva: World\\nHealth Organization; 2010 (http:/ /www.who.\\nint/hrh/ retention/ guidelines/ en/, accessed\\n28September 2016).\\n203. Dowswell T, Carroli G, Duley L, Gates S,\\nGülmezoglu AM, Khan-Neelofur D, Piaggio'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Increasing access to health workers in remote', 'subsection': 'Alternative versus standard packages of', 'section_path': ['9 Blood and Nutrition. In: British', 'Increasing access to health workers in remote', 'Alternative versus standard packages of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 0, 'total_chunks': 14, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development', 'warning_signs']}, page_content='antenatal care for low-risk pregnancy. Cochrane\\nDatabase Syst Rev. 2015;(7):CD000934.\\n204. Villar J, Ba’aqeel H, Piaggio G, Lumbiganon P,\\nMiguel Belizan J, Farnot U et al. WHO antenatal\\ncare randomised trial for the evaluation of a\\nnew model of routine antenatal care. Lancet.\\n2001;357(9268):1551–64.\\n205. Vogel JP, Habib NA, Souza JP, Gulmezoglu AM,\\nDowswell T, Carroli G et al. Antenatal care\\npackages with reduced visits and perinatal\\nmortality: a secondary analysis of the WHO\\nAntenatal Care T rial. Reprod Health. 2013;10:19.\\ndoi:10.1186/1742-4755-10-19.  \\nWHO recommendations on antenatal care for a positive pregnancy experience\\n136\\n206. Pattinson R. 2016. Audit of Mpumalanga\\nstillbirths. Presentation at ANC guideline\\ndevelopment group meeting (21–23 March).\\nGeneva: World Health Organization; 2016.\\n207. Gurol I, Scheel I. Adoption and implementation\\nof ANC guidelines at large scale. Presentation at\\nANC guideline development group meeting (21–'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Increasing access to health workers in remote', 'subsection': 'Alternative versus standard packages of', 'section_path': ['9 Blood and Nutrition. In: British', 'Increasing access to health workers in remote', 'Alternative versus standard packages of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 1, 'total_chunks': 14, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': ['fetal_development']}, page_content='Geneva: World Health Organization; 2016.\\n207. Gurol I, Scheel I. Adoption and implementation\\nof ANC guidelines at large scale. Presentation at\\nANC guideline development group meeting (21–\\n23 March). Geneva: World Health Organization;\\n2016.\\n208. Conrad P, Schmid G, Tientrebeogo J, Moses A,\\nKirenga S, Neuhann F et al. Compliance with\\nfocused antenatal care services: do health\\nworkers in rural Burkina Faso, Uganda and\\nT anzania perform all ANC procedures? T rop\\nMed Int Health. 2012;17:300–7. doi:10.1111/\\nj.1365-3156.2011.02923.x.\\n209. Nyarko P, Birungi H, Armar-Klamesu M,\\nArhinful D, Degarnus S, Odoi-Agyarko H,\\nBrew G. Acceptability and feasibility of\\nintroducing the WHO focused antenatal\\ncare package in Ghana. FRONTIERS final\\nreport. Washington (DC): Population Council;\\n2006 (http:/ / citeseerx.ist.psu.edu/viewdoc/\\ndownload?rep=rep1&type=pdf&doi=10.1.1.175.\\n8828, accessed 28 September 2016).\\n210. Birungi H, Onyango-Ouma W. Acceptability and\\nsustainability of the WHO focused antenatal'),\n",
       " Document(metadata={'chapter': '9 Blood and Nutrition. In: British', 'section': 'Increasing access to health workers in remote', 'subsection': 'Alternative versus standard packages of', 'section_path': ['9 Blood and Nutrition. In: British', 'Increasing access to health workers in remote', 'Alternative versus standard packages of'], 'document_title': 'antenatal care \\nfor a positive pregnancy experience\\n\\nWHO Library Cataloguing-in-Publication Data\\nWHO recommendations on antenatal care for a positive pregnancy experience', 'document_type': 'WHO Guidelines', 'chunk_type': 'text', 'chunk_index': 2, 'total_chunks': 14, 'pregnancy_stages': {'weeks': [], 'months': [], 'trimesters': []}, 'maternal_topics': []}, page_content='download?rep=rep1&type=pdf&doi=10.1.1.175.\\n8828, accessed 28 September 2016).\\n210. Birungi H, Onyango-Ouma W. Acceptability and\\nsustainability of the WHO focused antenatal\\ncare package in Kenya. Frontiers in Reproductive\\nHealth Program, Population Council; 2006\\n(http:/ / citeseerx.ist.psu.edu/viewdoc/\\ndownload?doi=10.1.1.175.8488&rep=rep1&type=\\npdf, accessed 28 September 2016).\\n211. Von Both C, Fleßa S, Makuwani A, Mpembeni R,\\nAlbrecht J. How much time do health services\\nspend on antenatal care? Implications for the\\nintroduction of the focused antenatal care\\nmodel in T anzania. BMC Pregnancy Childbirth.\\n2006;6:22.\\n212. Filby A, McConville F, Portela A. What prevents\\nquality midwifery care? A systematic mapping of\\nbarriers in low and middle income countries from\\nthe provider perspective. PLoS One. 2016;11(5):\\ne153391. doi:10.1371/journal.pone.0153391.\\n213. AGREE II-Global Rating Scale (GRS) Instrument.\\nAGREE Enterprise; 2016 (http:/ /www.agreetrust.'),\n",
       " ...]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processed 393 chunks\n"
     ]
    }
   ],
   "source": [
    "print(f\"Processed {len(documents)} chunks\")\n",
    "        \n",
    "        # Create vector store\n",
    "# vector_store = processor.create_vector_store(documents,collection_name=\"heirchical_chunking_rag\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import re\n",
    "import json\n",
    "import uuid\n",
    "from typing import List, Dict, Any, Optional, Tuple\n",
    "from dataclasses import dataclass\n",
    "from functools import lru_cache\n",
    "from tqdm import tqdm\n",
    "\n",
    "# LangChain imports\n",
    "from langchain.document_loaders import TextLoader, PyPDFLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain.docstore.document import Document\n",
    "from langchain.schema import BaseDocumentTransformer\n",
    "from langchain.vectorstores import FAISS\n",
    "from langchain.embeddings import OpenAIEmbeddings\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "from langchain.chains import RetrievalQA\n",
    "from langchain.prompts import PromptTemplate\n",
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "\n",
    "class SemanticMaternalHealthProcessor:\n",
    "    \"\"\"Specialized processor for maternal health documents.\"\"\"\n",
    "    \n",
    "    def __init__(\n",
    "        self,\n",
    "        chunk_size: int = 3000,  # Large chunks for better context\n",
    "        chunk_overlap: int = 400,  # Substantial overlap\n",
    "        embedding_model_name: str = \"sentence-transformers/paraphrase-multilingual-MiniLM-L12-v2\",\n",
    "        db_directory: str = \"maternal_health_db\"\n",
    "    ):\n",
    "        self.chunk_size = chunk_size\n",
    "        self.chunk_overlap = chunk_overlap\n",
    "        self.embedding_model_name = embedding_model_name\n",
    "        self.db_directory = db_directory\n",
    "        self.db = None\n",
    "        \n",
    "        # Create db directory if it doesn't exist\n",
    "        os.makedirs(db_directory, exist_ok=True)\n",
    "        \n",
    "        # Initialize embedding model\n",
    "        self.embeddings =  HuggingFaceEmbeddings(model_name=embedding_model_name)\n",
    "        \n",
    "        # Load SpaCy for text processing\n",
    "        try:\n",
    "            import spacy\n",
    "            try:\n",
    "                self.nlp = spacy.load(\"en_core_web_md\")\n",
    "            except OSError:\n",
    "                print(\"Downloading SpaCy model...\")\n",
    "                spacy.cli.download(\"en_core_web_md\")\n",
    "                self.nlp = spacy.load(\"en_core_web_md\")\n",
    "        except ImportError:\n",
    "            print(\"SpaCy not available. Some features will be limited.\")\n",
    "            self.nlp = None\n",
    "\n",
    "        index_path = os.path.join(db_directory, \"index.faiss\")\n",
    "        if os.path.exists(index_path):\n",
    "            self.db = FAISS.load_local(\n",
    "                folder_path=db_directory,\n",
    "                embeddings=self.embeddings,\n",
    "                allow_dangerous_deserialization=True\n",
    "            )\n",
    "        else:\n",
    "            self.db = None\n",
    "        \n",
    "        # Compile regex patterns for better performance\n",
    "        self._compile_regex_patterns()\n",
    "        \n",
    "        # Initialize topic and entity dictionaries\n",
    "        self._initialize_keywords()\n",
    "    \n",
    "    def _compile_regex_patterns(self):\n",
    "        \"\"\"Compile all regex patterns used in processing.\"\"\"\n",
    "        # Section boundary patterns\n",
    "        self.section_patterns = [\n",
    "            r'^(?:[0-9]+\\.){1,3}\\s+[A-Z]',           # Numbered sections (1.2.3 Title)\n",
    "            r'^[A-Z][A-Za-z\\s]+:',                    # Title with colon (Pregnancy Symptoms:)\n",
    "            r'^[A-Z][A-Za-z\\s]+ during [A-Za-z\\s]+',  # \"X during Y\" patterns\n",
    "            r'^(?:Table|Figure|Box)\\s+[0-9]+:',       # Tables and figures\n",
    "            r'^WARNING:',                              # Warning sections\n",
    "            r'^NOTE:',                                 # Note sections\n",
    "            r'^CHAPTER\\s+[0-9]+',                     # Chapter headers\n",
    "            r'^(?:SECTION|Section)\\s+[0-9]+:?'        # Section headers\n",
    "        ]\n",
    "        self.section_regex = re.compile('|'.join(f'({pattern})' for pattern in self.section_patterns), \n",
    "                                      re.MULTILINE)\n",
    "        \n",
    "        # Preservation block patterns\n",
    "        self.preservation_patterns = [\n",
    "            # Lists\n",
    "            r'(?:^[•\\-\\*]\\s+.+\\n){2,}',  \n",
    "            # Tables with multiple columns\n",
    "            r'(?:\\|.+\\|.+\\|.+\\n){2,}',\n",
    "            # Structured recommendations\n",
    "            r'Recommendation:[\\s\\S]+?(?:Evidence|Strength|Quality)',\n",
    "            # Numbered steps/procedures\n",
    "            r'(?:^[0-9]+\\.\\s+.+\\n){2,}',\n",
    "            # Warning blocks\n",
    "            r'(?:Warning|Caution|Alert|CAUTION|WARNING|ALERT):[\\s\\S]+?(?:\\n\\n|\\Z)'\n",
    "        ]\n",
    "        self.preservation_regex = re.compile('|'.join(f'({pattern})' for pattern in self.preservation_patterns), \n",
    "                                          re.MULTILINE)\n",
    "        \n",
    "        # Pregnancy stage patterns\n",
    "        self.week_pattern = re.compile(r'(?:week|weeks)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+week', re.IGNORECASE)\n",
    "        self.month_pattern = re.compile(r'(?:month|months)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+month', re.IGNORECASE)\n",
    "        self.trimester_pattern = re.compile(r'(first|second|third)\\s+trimester', re.IGNORECASE)\n",
    "        \n",
    "        # Document metadata patterns\n",
    "        self.title_pattern = re.compile(r'((?:Maternal|Pregnancy|Prenatal|Antenatal|Postnatal|Postpartum)[\\s\\w]+(?:Care|Health|Guide|Manual|Protocol))', re.IGNORECASE)\n",
    "    \n",
    "    def _initialize_keywords(self):\n",
    "        \"\"\"Initialize keyword dictionaries for maternal health topics and entities.\"\"\"\n",
    "        # Topic keywords\n",
    "        self.topic_keywords = {\n",
    "            'fetal_development': ['development', 'growth', 'fetal', 'foetal', 'baby', 'fetus', 'embryo'],\n",
    "            'maternal_changes': ['mother', 'maternal', 'body', 'changes', 'symptoms', 'physical'],\n",
    "            'nutrition': ['diet', 'food', 'nutrition', 'eat', 'meal', 'vitamin', 'nutrient', 'folate', 'iron'],\n",
    "            'warning_signs': ['danger', 'warning', 'risk', 'emergency', 'complication', 'problem'],\n",
    "            'normal_variations': ['normal', 'common', 'usual', 'typical', 'variant', 'variation', 'expected'],\n",
    "            'medical_tests': ['test', 'scan', 'ultrasound', 'screening', 'monitor', 'measurement'],\n",
    "            'delivery': ['birth', 'labor', 'labour', 'delivery', 'contractions', 'childbirth'],\n",
    "            'postpartum': ['after birth', 'post-delivery', 'postpartum', 'post-natal', 'breastfeeding'],\n",
    "            'mental_health': ['mental', 'depression', 'anxiety', 'mood', 'stress', 'emotional'],\n",
    "            'prenatal_care': ['prenatal', 'antenatal', 'checkup', 'visit', 'appointment', 'healthcare']\n",
    "        }\n",
    "        \n",
    "        # Medical entity dictionaries\n",
    "        self.condition_keywords = set([\n",
    "            \"preeclampsia\", \"eclampsia\", \"gestational diabetes\", \"anemia\", \"anaemia\", \n",
    "            \"hypertension\", \"nausea\", \"vomiting\", \"morning sickness\", \"hyperemesis\", \n",
    "            \"placenta previa\", \"preterm labor\", \"preterm birth\", \"ectopic pregnancy\",\n",
    "            \"miscarriage\", \"bleeding\", \"spotting\", \"edema\", \"swelling\", \"back pain\"\n",
    "        ])\n",
    "        \n",
    "        self.medication_keywords = set([\n",
    "            \"iron\", \"folate\", \"folic acid\", \"vitamin\", \"supplement\", \"prenatal vitamin\",\n",
    "            \"calcium\", \"magnesium\", \"zinc\", \"omega-3\", \"aspirin\", \"antacid\", \"insulin\"\n",
    "        ])\n",
    "        \n",
    "        self.procedure_keywords = set([\n",
    "            \"ultrasound\", \"scan\", \"test\", \"screening\", \"amniocentesis\", \"delivery\", \n",
    "            \"c-section\", \"cesarean\", \"caesarean\", \"induction\", \"epidural\", \"monitoring\",\n",
    "            \"glucose test\", \"blood test\", \"urine test\", \"group b strep\", \"genetic screening\"\n",
    "        ])\n",
    "        \n",
    "        self.measurement_keywords = set([\n",
    "            \"weight\", \"blood pressure\", \"fundal height\", \"bp\", \"heart rate\", \"fetal heart rate\",\n",
    "            \"bpm\", \"glucose\", \"temperature\", \"hcg\", \"hemoglobin\", \"haemoglobin\", \"blood sugar\"\n",
    "        ])\n",
    "    \n",
    "    @lru_cache(maxsize=32)\n",
    "    def _extract_document_metadata(self, text_sample: str) -> Dict[str, str]:\n",
    "        \"\"\"Extract document-level metadata from text sample.\"\"\"\n",
    "        # Try to identify the document title\n",
    "        title_match = self.title_pattern.search(text_sample)\n",
    "        title = title_match.group(1) if title_match else \"Maternal Health Document\"\n",
    "        \n",
    "        # Determine document type\n",
    "        doc_type = \"Maternal Health Guidelines\"\n",
    "        if \"protocol\" in text_sample.lower():\n",
    "            doc_type = \"Maternal Health Protocol\"\n",
    "        elif \"manual\" in text_sample.lower():\n",
    "            doc_type = \"Maternal Health Manual\"\n",
    "        elif \"guide\" in text_sample.lower():\n",
    "            doc_type = \"Maternal Health Guide\"\n",
    "        \n",
    "        return {\n",
    "            \"title\": title,\n",
    "            \"document_type\": doc_type\n",
    "        }\n",
    "    \n",
    "    def split_text_into_sections(self, text: str) -> List[str]:\n",
    "        \"\"\"Split text into semantically meaningful sections.\"\"\"\n",
    "        # If text is small enough, don't bother splitting\n",
    "        if len(text) < 5000:\n",
    "            return [text]\n",
    "        \n",
    "        # Find all semantic boundaries\n",
    "        section_boundaries = [match.start() for match in self.section_regex.finditer(text)]\n",
    "        \n",
    "        # Filter out boundaries that are too close together (< 1500 chars)\n",
    "        if section_boundaries:\n",
    "            filtered_boundaries = [section_boundaries[0]]\n",
    "            for i in range(1, len(section_boundaries)):\n",
    "                if section_boundaries[i] - filtered_boundaries[-1] >= 1500:\n",
    "                    filtered_boundaries.append(section_boundaries[i])\n",
    "            section_boundaries = filtered_boundaries\n",
    "        \n",
    "        if not section_boundaries:\n",
    "            # If no sections detected, return the whole text\n",
    "            return [text]\n",
    "        \n",
    "        # Add the start and end of text to boundaries\n",
    "        section_boundaries = [0] + section_boundaries + [len(text)]\n",
    "        \n",
    "        # Create sections based on boundaries\n",
    "        sections = []\n",
    "        for i in range(len(section_boundaries) - 1):\n",
    "            section_text = text[section_boundaries[i]:section_boundaries[i+1]].strip()\n",
    "            if section_text and len(section_text) > 500:  # Only include substantial sections\n",
    "                sections.append(section_text)\n",
    "        \n",
    "        return sections\n",
    "    \n",
    "    def find_preservation_blocks(self, text: str) -> List[Tuple[int, int, str]]:\n",
    "        \"\"\"Find blocks of text that should be preserved.\"\"\"\n",
    "        preserved_blocks = []\n",
    "        \n",
    "        for match in self.preservation_regex.finditer(text):\n",
    "            preserved_blocks.append((match.start(), match.end(), match.group(0)))\n",
    "        \n",
    "        return preserved_blocks\n",
    "    \n",
    "    def segment_by_semantic_boundaries(self, section: str) -> List[str]:\n",
    "        \"\"\"Split a section into semantic chunks respecting preserved blocks.\"\"\"\n",
    "        max_chunk_size = self.chunk_size\n",
    "        \n",
    "        # Find blocks that should be preserved\n",
    "        preserved_blocks = self.find_preservation_blocks(section)\n",
    "        \n",
    "        # If section is short enough, return it as-is\n",
    "        if len(section) <= max_chunk_size and not preserved_blocks:\n",
    "            return [section]\n",
    "        \n",
    "        # If we don't have SpaCy available, use a simple approach\n",
    "        if self.nlp is None:\n",
    "            # Split on double newlines\n",
    "            subsections = re.split(r'\\n\\n+', section)\n",
    "            \n",
    "            # Merge subsections to form chunks of appropriate size\n",
    "            chunks = []\n",
    "            current_chunk = []\n",
    "            current_length = 0\n",
    "            \n",
    "            for subsection in subsections:\n",
    "                if current_length + len(subsection) <= max_chunk_size or not current_chunk:\n",
    "                    current_chunk.append(subsection)\n",
    "                    current_length += len(subsection) + 2  # +2 for newlines\n",
    "                else:\n",
    "                    chunks.append(\"\\n\\n\".join(current_chunk))\n",
    "                    current_chunk = [subsection]\n",
    "                    current_length = len(subsection)\n",
    "            \n",
    "            if current_chunk:\n",
    "                chunks.append(\"\\n\\n\".join(current_chunk))\n",
    "            \n",
    "            return chunks\n",
    "        \n",
    "        # Process text with SpaCy for sentence boundaries\n",
    "        doc = self.nlp(section)\n",
    "        sentences = list(doc.sents)\n",
    "        \n",
    "        # Create chunks respecting sentence boundaries and preserved blocks\n",
    "        chunks = []\n",
    "        current_chunk = []\n",
    "        current_length = 0\n",
    "        \n",
    "        i = 0\n",
    "        while i < len(sentences):\n",
    "            sentence = sentences[i]\n",
    "            \n",
    "            # Check if this sentence is within a preserved block\n",
    "            in_preserved_block = False\n",
    "            for start, end, block_text in preserved_blocks:\n",
    "                if start <= sentence.start_char < end:\n",
    "                    # This sentence is part of a preserved block\n",
    "                    # If we have a current chunk, add it first\n",
    "                    if current_chunk:\n",
    "                        chunks.append('\\n'.join(current_chunk))\n",
    "                        current_chunk = []\n",
    "                        current_length = 0\n",
    "                    \n",
    "                    # Add the entire block as a chunk\n",
    "                    chunks.append(block_text)\n",
    "                    \n",
    "                    # Skip all sentences in this block\n",
    "                    while i < len(sentences) and sentences[i].start_char < end:\n",
    "                        i += 1\n",
    "                    \n",
    "                    in_preserved_block = True\n",
    "                    break\n",
    "            \n",
    "            if in_preserved_block:\n",
    "                # Continue to next sentence\n",
    "                continue\n",
    "            \n",
    "            # If not in a preserved block, process normally\n",
    "            sentence_text = sentence.text.strip()\n",
    "            \n",
    "            # If adding this sentence would exceed max size, create a new chunk\n",
    "            if current_length + len(sentence_text) > max_chunk_size and current_chunk:\n",
    "                chunks.append('\\n'.join(current_chunk))\n",
    "                current_chunk = []\n",
    "                current_length = 0\n",
    "            \n",
    "            # Add sentence to current chunk\n",
    "            current_chunk.append(sentence_text)\n",
    "            current_length += len(sentence_text)\n",
    "            i += 1\n",
    "        \n",
    "        # Add final chunk\n",
    "        if current_chunk:\n",
    "            chunks.append('\\n'.join(current_chunk))\n",
    "        \n",
    "        # If we ended up with very small chunks, try to merge them\n",
    "        if len(chunks) > 1:\n",
    "            merged_chunks = []\n",
    "            temp_chunk = \"\"\n",
    "            temp_length = 0\n",
    "            \n",
    "            for chunk in chunks:\n",
    "                # Allow 15% overflow for maternal health content - context is crucial\n",
    "                if temp_length + len(chunk) <= max_chunk_size * 1.15:\n",
    "                    temp_chunk = temp_chunk + \"\\n\\n\" + chunk if temp_chunk else chunk\n",
    "                    temp_length += len(chunk) + (2 if temp_chunk else 0)\n",
    "                else:\n",
    "                    if temp_chunk:\n",
    "                        merged_chunks.append(temp_chunk)\n",
    "                    temp_chunk = chunk\n",
    "                    temp_length = len(chunk)\n",
    "            \n",
    "            if temp_chunk:\n",
    "                merged_chunks.append(temp_chunk)\n",
    "            \n",
    "            # Only use merged chunks if we actually reduced the number\n",
    "            if len(merged_chunks) < len(chunks):\n",
    "                return merged_chunks\n",
    "        \n",
    "        return chunks\n",
    "    \n",
    "    def identify_topics(self, text: str) -> List[str]:\n",
    "        \"\"\"Identify maternal health topics in the text.\"\"\"\n",
    "        text_lower = text.lower()\n",
    "        identified_topics = []\n",
    "        \n",
    "        for topic, keywords in self.topic_keywords.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                identified_topics.append(topic)\n",
    "        \n",
    "        return identified_topics\n",
    "    \n",
    "    def extract_pregnancy_stage(self, text: str) -> Dict[str, List]:\n",
    "        \"\"\"Extract pregnancy stages mentioned in the text.\"\"\"\n",
    "        stages = {\n",
    "            \"weeks\": [],\n",
    "            \"months\": [],\n",
    "            \"trimesters\": []\n",
    "        }\n",
    "        \n",
    "        # Extract weeks\n",
    "        for match in self.week_pattern.finditer(text):\n",
    "            week_str = match.group(1) or match.group(2)\n",
    "            if week_str:\n",
    "                if '-' in week_str:\n",
    "                    try:\n",
    "                        start, end = map(int, week_str.split('-'))\n",
    "                        stages[\"weeks\"].extend(list(range(start, end + 1)))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "                else:\n",
    "                    try:\n",
    "                        stages[\"weeks\"].append(int(week_str))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "        \n",
    "        # Extract months\n",
    "        for match in self.month_pattern.finditer(text):\n",
    "            month_str = match.group(1) or match.group(2)\n",
    "            if month_str:\n",
    "                if '-' in month_str:\n",
    "                    try:\n",
    "                        start, end = map(int, month_str.split('-'))\n",
    "                        stages[\"months\"].extend(list(range(start, end + 1)))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "                else:\n",
    "                    try:\n",
    "                        stages[\"months\"].append(int(month_str))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "        \n",
    "        # Extract trimesters\n",
    "        for match in self.trimester_pattern.finditer(text):\n",
    "            trimester = match.group(1).lower()\n",
    "            stages[\"trimesters\"].append(trimester)\n",
    "        \n",
    "        # Remove duplicates\n",
    "        for key in stages:\n",
    "            stages[key] = list(set(stages[key]))\n",
    "        \n",
    "        return stages\n",
    "    \n",
    "    def extract_medical_entities(self, text: str) -> Dict[str, List[str]]:\n",
    "        \"\"\"Extract medical entities from text.\"\"\"\n",
    "        text_lower = text.lower()\n",
    "        \n",
    "        entities = {\n",
    "            \"conditions\": [],\n",
    "            \"medications\": [],\n",
    "            \"procedures\": [],\n",
    "            \"measurements\": []\n",
    "        }\n",
    "        \n",
    "        # Extract entities using keyword matching - optimized with sets\n",
    "        for condition in self.condition_keywords:\n",
    "            if condition in text_lower:\n",
    "                entities[\"conditions\"].append(condition)\n",
    "        \n",
    "        for medication in self.medication_keywords:\n",
    "            if medication in text_lower:\n",
    "                entities[\"medications\"].append(medication)\n",
    "        \n",
    "        for procedure in self.procedure_keywords:\n",
    "            if procedure in text_lower:\n",
    "                entities[\"procedures\"].append(procedure)\n",
    "        \n",
    "        for measurement in self.measurement_keywords:\n",
    "            if measurement in text_lower:\n",
    "                entities[\"measurements\"].append(measurement)\n",
    "        \n",
    "        # Process with SpaCy for more advanced entity extraction if available\n",
    "        if self.nlp is not None:\n",
    "            doc = self.nlp(text)\n",
    "            \n",
    "            # Extract named entities from SpaCy\n",
    "            for ent in doc.ents:\n",
    "                if ent.label_ == \"CONDITION\" and ent.text.lower() not in entities[\"conditions\"]:\n",
    "                    entities[\"conditions\"].append(ent.text.lower())\n",
    "                elif ent.label_ == \"MEDICATION\" and ent.text.lower() not in entities[\"medications\"]:\n",
    "                    entities[\"medications\"].append(ent.text.lower())\n",
    "                elif ent.label_ == \"PROCEDURE\" and ent.text.lower() not in entities[\"procedures\"]:\n",
    "                    entities[\"procedures\"].append(ent.text.lower())\n",
    "        \n",
    "        return entities\n",
    "    \n",
    "    def determine_chunk_type(self, text: str) -> str:\n",
    "        \"\"\"Determine the type of content in a chunk.\"\"\"\n",
    "        text_lower = text.lower()\n",
    "        \n",
    "        # Check for warning content\n",
    "        if any(warning in text_lower for warning in [\"warning\", \"caution\", \"danger\", \"alert\", \"emergency\"]):\n",
    "            return \"warning\"\n",
    "        \n",
    "        # Check for recommendation content\n",
    "        if any(rec in text_lower for rec in [\"recommend\", \"advised\", \"should\", \"must\", \"important\"]):\n",
    "            return \"recommendation\"\n",
    "        \n",
    "        # Check for table content\n",
    "        if re.search(r'(?:\\|.+\\|.+\\|.+\\n){2,}', text) or re.search(r'Table\\s+[0-9]+:', text):\n",
    "            return \"table\"\n",
    "        \n",
    "        # Check for list content\n",
    "        if re.search(r'(?:^[•\\-\\*]\\s+.+\\n){2,}', text):\n",
    "            return \"list\"\n",
    "        \n",
    "        # Default type\n",
    "        return \"general_text\"\n",
    "    \n",
    "    def create_semantic_chunks(self, text: str, source_name: str = \"\") -> List[Document]:\n",
    "        \"\"\"Create semantically meaningful chunks from text.\"\"\"\n",
    "        # Extract document metadata\n",
    "        doc_metadata = self._extract_document_metadata(text[:3000])\n",
    "        \n",
    "        # Add source information to metadata\n",
    "        if source_name:\n",
    "            doc_metadata[\"source\"] = source_name\n",
    "        \n",
    "        # Split text into sections\n",
    "        print(\"Splitting text into sections...\")\n",
    "        sections = self.split_text_into_sections(text)\n",
    "        print(f\"Created {len(sections)} sections\")\n",
    "        \n",
    "        # Process each section into chunks\n",
    "        documents = []\n",
    "        \n",
    "        # Use tqdm for progress tracking\n",
    "        for section_idx, section in enumerate(tqdm(sections, desc=\"Processing sections\")):\n",
    "            # Extract section title\n",
    "            section_title = \"\"\n",
    "            first_line = section.split('\\n')[0].strip()\n",
    "            if re.match(r'^[0-9\\.]+\\s+|^[A-Z][A-Za-z\\s]+:', first_line):\n",
    "                section_title = first_line\n",
    "            \n",
    "            # Create semantic chunks from section\n",
    "            chunks = self.segment_by_semantic_boundaries(section)\n",
    "            \n",
    "            for i, chunk in enumerate(chunks):\n",
    "                # Skip empty chunks\n",
    "                if not chunk.strip():\n",
    "                    continue\n",
    "                \n",
    "                # Extract semantic metadata\n",
    "                topics = self.identify_topics(chunk)\n",
    "                pregnancy_stages = self.extract_pregnancy_stage(chunk)\n",
    "                medical_entities = self.extract_medical_entities(chunk)\n",
    "                \n",
    "                # Determine chunk type\n",
    "                chunk_type = self.determine_chunk_type(chunk)\n",
    "                \n",
    "                # Create document with metadata\n",
    "                chunk_metadata = {\n",
    "                    **doc_metadata,\n",
    "                    \"section_title\": section_title,\n",
    "                    \"section_index\": section_idx,\n",
    "                    \"chunk_index\": i,\n",
    "                    \"total_chunks_in_section\": len(chunks),\n",
    "                    \"chunk_type\": chunk_type,\n",
    "                    \"topics\": topics,\n",
    "                    \"pregnancy_stages\": pregnancy_stages,\n",
    "                    \"medical_entities\": medical_entities,\n",
    "                    \"contains_warning\": chunk_type == \"warning\" or any(warning in chunk.lower() \n",
    "                                                                     for warning in [\"warning\", \"caution\", \"danger\"]),\n",
    "                    \"contains_recommendation\": chunk_type == \"recommendation\" or any(rec in chunk.lower() \n",
    "                                                                                   for rec in [\"recommend\", \"advised\", \"should\"])\n",
    "                }\n",
    "                \n",
    "                # Create document\n",
    "                doc = Document(\n",
    "                    page_content=chunk,\n",
    "                    metadata=chunk_metadata\n",
    "                )\n",
    "                \n",
    "                documents.append(doc)\n",
    "        \n",
    "        return documents\n",
    "    \n",
    "    def create_specialized_chunks(self, docs: List[Document]) -> List[Document]:\n",
    "        \"\"\"Create specialized maternal health chunks for improved retrieval.\"\"\"\n",
    "        specialized_chunks = []\n",
    "        \n",
    "        print(\"Creating specialized chunks...\")\n",
    "        # Group documents by pregnancy stage\n",
    "        stage_groups = {}\n",
    "        \n",
    "        for doc in docs:\n",
    "            # Process week-specific chunks\n",
    "            for week in doc.metadata.get('pregnancy_stages', {}).get('weeks', []):\n",
    "                key = f\"week_{week}\"\n",
    "                if key not in stage_groups:\n",
    "                    stage_groups[key] = []\n",
    "                stage_groups[key].append(doc)\n",
    "            \n",
    "            # Process month-specific chunks\n",
    "            for month in doc.metadata.get('pregnancy_stages', {}).get('months', []):\n",
    "                key = f\"month_{month}\"\n",
    "                if key not in stage_groups:\n",
    "                    stage_groups[key] = []\n",
    "                stage_groups[key].append(doc)\n",
    "            \n",
    "            # Process trimester-specific chunks\n",
    "            for trimester in doc.metadata.get('pregnancy_stages', {}).get('trimesters', []):\n",
    "                key = f\"trimester_{trimester}\"\n",
    "                if key not in stage_groups:\n",
    "                    stage_groups[key] = []\n",
    "                stage_groups[key].append(doc)\n",
    "        \n",
    "        # Create specialized chunks for each stage group\n",
    "        for stage_key, stage_docs in stage_groups.items():\n",
    "            # Skip if too few documents\n",
    "            if len(stage_docs) < 2:\n",
    "                continue\n",
    "                \n",
    "            # Group by topics within stage\n",
    "            topic_contents = {}\n",
    "            \n",
    "            for doc in stage_docs:\n",
    "                for topic in doc.metadata.get('topics', []):\n",
    "                    if topic not in topic_contents:\n",
    "                        topic_contents[topic] = []\n",
    "                    topic_contents[topic].append(doc.page_content)\n",
    "            \n",
    "            # Create specialized chunks for each topic in this stage\n",
    "            for topic, contents in topic_contents.items():\n",
    "                if len(contents) >= 2:  # Only create specialized chunks if we have multiple sources\n",
    "                    # Select the best content (first 3 chunks or up to 6000 chars)\n",
    "                    selected_contents = []\n",
    "                    total_length = 0\n",
    "                    \n",
    "                    for content in contents:\n",
    "                        if len(selected_contents) < 3 and total_length < 6000:\n",
    "                            selected_contents.append(content)\n",
    "                            total_length += len(content)\n",
    "                    \n",
    "                    # Create the specialized chunk\n",
    "                    specialized_content = \"\\n\\n\".join(selected_contents)\n",
    "                    specialized_chunk = Document(\n",
    "                        page_content=specialized_content,\n",
    "                        metadata={\n",
    "                            'chunk_type': 'specialized',\n",
    "                            'stage_key': stage_key,\n",
    "                            'topic': topic,\n",
    "                            'source_count': len(contents),\n",
    "                            'is_synthesized': True\n",
    "                        }\n",
    "                    )\n",
    "                    specialized_chunks.append(specialized_chunk)\n",
    "        \n",
    "        print(f\"Created {len(specialized_chunks)} specialized chunks\")\n",
    "        return specialized_chunks\n",
    "    \n",
    "    def load_documents(self, input_path: str) -> List[Document]:\n",
    "        \"\"\"Load documents from file or directory.\"\"\"\n",
    "        documents = []\n",
    "        \n",
    "        if os.path.isdir(input_path):\n",
    "            # Process all files in directory\n",
    "            print(f\"Loading files from directory: {input_path}\")\n",
    "            file_paths = []\n",
    "            for filename in os.listdir(input_path):\n",
    "                file_path = os.path.join(input_path, filename)\n",
    "                if os.path.isfile(file_path):\n",
    "                    file_paths.append(file_path)\n",
    "            \n",
    "            # Process files with progress tracking\n",
    "            for file_path in tqdm(file_paths, desc=\"Processing files\"):\n",
    "                documents.extend(self._load_single_document(file_path))\n",
    "        else:\n",
    "            # Process single file\n",
    "            print(f\"Loading file: {input_path}\")\n",
    "            documents = self._load_single_document(input_path)\n",
    "        \n",
    "        return documents\n",
    "    \n",
    "    def _load_single_document(self, file_path: str) -> List[Document]:\n",
    "        \"\"\"Load and process a single document.\"\"\"\n",
    "        # Load the document\n",
    "        if file_path.lower().endswith('.pdf'):\n",
    "            loader = PyPDFLoader(file_path)\n",
    "            pages = loader.load()\n",
    "            text = \"\\n\\n\".join([page.page_content for page in pages])\n",
    "        else:\n",
    "            with open(file_path, 'r', encoding='utf-8') as f:\n",
    "                text = f.read()\n",
    "        \n",
    "        # Process the text\n",
    "        source_name = os.path.basename(file_path)\n",
    "        return self.create_semantic_chunks(text, source_name)\n",
    "    \n",
    "    def create_vector_store(self, documents: List[Document], collection_name: Optional[str] = None):\n",
    "        \"\"\"Create a vector store from processed documents.\"\"\"\n",
    "        # Create a unique collection name if not provided\n",
    "        if collection_name is None:\n",
    "            collection_name = f\"maternal_health_{uuid.uuid4().hex[:8]}\"\n",
    "        \n",
    "        # Create specialized chunks to enhance retrieval\n",
    "        specialized_chunks = self.create_specialized_chunks(documents)\n",
    "        \n",
    "        # Combine regular and specialized chunks\n",
    "        all_docs = documents + specialized_chunks\n",
    "        \n",
    "        # Create database directory if it doesn't exist\n",
    "        index_path = os.path.join(self.db_directory, collection_name)\n",
    "        os.makedirs(index_path, exist_ok=True)\n",
    "        \n",
    "        # Initialize FAISS index from documents\n",
    "        print(f\"Creating vector store with {len(all_docs)} documents...\")\n",
    "        self.db = FAISS.from_documents(\n",
    "            documents=all_docs,\n",
    "            embedding=self.embeddings\n",
    "        )\n",
    "        \n",
    "        # Save to disk\n",
    "        self.db.save_local(index_path)\n",
    "        print(f\"Vector store saved to {index_path}\")\n",
    "        \n",
    "        return self.db\n",
    "    \n",
    "    def load_vector_store(self, collection_name: str):\n",
    "        \"\"\"Load an existing vector store.\"\"\"\n",
    "        index_path = os.path.join(self.db_directory, collection_name)\n",
    "        if not os.path.exists(index_path):\n",
    "            raise ValueError(f\"Vector store {collection_name} does not exist at {index_path}\")\n",
    "        \n",
    "        self.db = FAISS.load_local(\n",
    "            folder_path=index_path,\n",
    "            embeddings=self.embeddings,\n",
    "            allow_dangerous_deserialization=True\n",
    "        )\n",
    "        \n",
    "        return self.db\n",
    "    \n",
    "    def create_retrieval_chain(self, model_name: str = \"gpt-4\", temperature: float = 0.0) -> RetrievalQA:\n",
    "        \"\"\"Create a retrieval chain for question answering.\"\"\"\n",
    "        if self.db is None:\n",
    "            raise ValueError(\"No vector store available. Please create or load a vector store first.\")\n",
    "        \n",
    "        # Initialize model\n",
    "        llm = ChatOpenAI(\n",
    "            model=model_name,\n",
    "            temperature=temperature\n",
    "        )\n",
    "        \n",
    "        # Create maternal health specific prompt\n",
    "        qa_prompt = PromptTemplate(\n",
    "            template=\"\"\"You are a maternal health expert assistant. Use the following pieces of context to answer the question at the end.\n",
    "            Focus on providing accurate, clinically relevant information for pregnant women and healthcare providers.\n",
    "            If the information isn't in the context, just say \"I don't have enough information to answer that question\" - don't make up information.\n",
    "            \n",
    "            {context}\n",
    "            \n",
    "            Question: {question}\n",
    "            \n",
    "            Answer:\"\"\",\n",
    "            input_variables=[\"context\", \"question\"]\n",
    "        )\n",
    "        \n",
    "        # Create the chain\n",
    "        chain = RetrievalQA.from_chain_type(\n",
    "            llm=llm,\n",
    "            chain_type=\"stuff\",\n",
    "            retriever=self.db.as_retriever(search_kwargs={\"k\": 7}),  # Get more context for maternal health\n",
    "            chain_type_kwargs={\"prompt\": qa_prompt},\n",
    "            return_source_documents=True\n",
    "        )\n",
    "        \n",
    "        return chain\n",
    "\n",
    "\n",
    "# Main Application Functions\n",
    "\n",
    "# def setup_api_key():\n",
    "#     \"\"\"Set up OpenAI API key from environment or config file.\"\"\"\n",
    "#     api_key = os.environ.get(\"OPENAI_API_KEY\")\n",
    "#     if not api_key:\n",
    "#         # Check for config file\n",
    "#         config_path = os.path.join(os.path.expanduser(\"~\"), \".maternal_health_config\")\n",
    "#         if os.path.exists(config_path):\n",
    "#             with open(config_path, 'r') as f:\n",
    "#                 config = json.load(f)\n",
    "#                 api_key = config.get(\"openai_api_key\")\n",
    "    \n",
    "#     if api_key:\n",
    "#         os.environ[\"OPENAI_API_KEY\"] = api_key\n",
    "#         return True\n",
    "#     else:\n",
    "#         print(\"Warning: No OpenAI API key found. Please set OPENAI_API_KEY environment variable.\")\n",
    "#         return False\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "till now there have been 4 different rag/chunking ways - heirarchical ( but this actually included semantic as well)\n",
    "semantic in its name- 2\n",
    "hybrid"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading files from directory: /home/vidhij2/nivi/maternal-documents\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files:   0%|          | 0/23 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 39 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 39/39 [00:04<00:00,  8.68it/s]\n",
      "Processing files:   4%|▍         | 1/23 [00:09<03:29,  9.54s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 52 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 52/52 [00:07<00:00,  7.03it/s]\n",
      "Processing files:   9%|▊         | 2/23 [00:18<03:19,  9.49s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 100 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 100/100 [00:29<00:00,  3.35it/s]\n",
      "Processing files:  13%|█▎        | 3/23 [00:53<06:54, 20.72s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 11 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 11/11 [00:02<00:00,  4.57it/s]\n",
      "Processing files:  17%|█▋        | 4/23 [00:56<04:21, 13.76s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 25 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 25/25 [00:03<00:00,  7.96it/s]\n",
      "Processing files:  22%|██▏       | 5/23 [01:02<03:20, 11.13s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 18 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 18/18 [00:03<00:00,  5.73it/s]\n",
      "Processing files:  26%|██▌       | 6/23 [01:07<02:32,  8.97s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 97 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 97/97 [00:14<00:00,  6.69it/s]\n",
      "Processing files:  30%|███       | 7/23 [01:56<05:52, 22.01s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 17 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 17/17 [00:04<00:00,  4.13it/s]\n",
      "Processing files:  35%|███▍      | 8/23 [02:03<04:19, 17.28s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 3 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00, 10.64it/s]\n",
      "Processing files:  39%|███▉      | 9/23 [02:03<02:48, 12.00s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 19 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 19/19 [00:02<00:00,  6.78it/s]\n",
      "Processing files:  43%|████▎     | 10/23 [02:16<02:37, 12.14s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 1 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 27.25it/s]\n",
      "Processing files:  48%|████▊     | 11/23 [02:16<01:41,  8.46s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 20 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 20/20 [00:03<00:00,  6.09it/s]\n",
      "Processing files:  52%|█████▏    | 12/23 [02:20<01:17,  7.08s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 25 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 25/25 [00:03<00:00,  6.76it/s]\n",
      "Processing files:  57%|█████▋    | 13/23 [02:25<01:06,  6.62s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 5 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00,  6.29it/s]\n",
      "Processing files:  61%|██████    | 14/23 [02:29<00:50,  5.64s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 39 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 39/39 [00:06<00:00,  5.87it/s]\n",
      "Processing files:  65%|██████▌   | 15/23 [02:36<00:49,  6.13s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 4 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  4.92it/s]\n",
      "Processing files:  70%|██████▉   | 16/23 [02:37<00:32,  4.71s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 8 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 8/8 [00:01<00:00,  7.38it/s]\n",
      "Processing files:  74%|███████▍  | 17/23 [02:41<00:26,  4.41s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 57 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 57/57 [00:09<00:00,  5.91it/s]\n",
      "Processing files:  78%|███████▊  | 18/23 [02:54<00:35,  7.08s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 15 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 15/15 [00:01<00:00, 11.03it/s]\n",
      "Processing files:  83%|████████▎ | 19/23 [03:03<00:30,  7.59s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 59 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 59/59 [00:11<00:00,  4.95it/s]\n",
      "Processing files:  87%|████████▋ | 20/23 [03:18<00:28,  9.64s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 10 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 10/10 [00:01<00:00,  7.74it/s]\n",
      "Processing files:  91%|█████████▏| 21/23 [03:20<00:14,  7.32s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 22 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 22/22 [00:03<00:00,  6.10it/s]\n",
      "Processing files:  96%|█████████▌| 22/23 [03:36<00:09,  9.95s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Splitting text into sections...\n",
      "Created 16 sections\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing sections: 100%|██████████| 16/16 [00:01<00:00,  8.13it/s]\n",
      "Processing files: 100%|██████████| 23/23 [03:39<00:00,  9.52s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processed 1008 document chunks\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "\n",
    "    \n",
    "    # Determine output directory\n",
    "# if output_dir is None:\n",
    "#     output_dir = f\"maternal_health_db_{uuid.uuid4().hex[:6]}\"\n",
    "\n",
    "# Initialize processor\n",
    "processor = SemanticMaternalHealthProcessor(\n",
    "    chunk_size=3000,\n",
    "    chunk_overlap=200,\n",
    "    db_directory= \"/data/user_data/vidhij2/medical_db/heirchical_chunking_rag\"\n",
    ")\n",
    "\n",
    "# Load and process documents\n",
    "# print(f\"Loading documents from {input_path}...\")\n",
    "documents = processor.load_documents(\"/home/vidhij2/nivi/maternal-documents\")\n",
    "print(f\"Processed {len(documents)} document chunks\")\n",
    "\n",
    "# Create vector store\n",
    "# print(f\"Creating vector store in {output_dir}...\")\n",
    "# db = processor.create_vector_store(documents)\n",
    "\n",
    "# print(f\"Processing complete! Vector store created with {len(documents)} chunks.\")\n",
    "# return db"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Creating specialized chunks...\n",
      "Created 342 specialized chunks\n",
      "Creating vector store with 1350 documents...\n",
      "Vector store saved to /data/user_data/vidhij2/medical_db/heirchical_chunking_rag/maternal_health_bb066ff4\n"
     ]
    }
   ],
   "source": [
    "db = processor.create_vector_store(documents)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FAISS index loaded successfully with 3020 vvectors.\n"
     ]
    }
   ],
   "source": [
    "\n",
    "embeddings = OpenAIEmbeddings(model=\"text-embedding-ada-002\")\n",
    "faiss_index_path = \"/data/user_data/vidhij2/medical_db/heirchical_chunking_rag\"\n",
    "\n",
    "# Load FAISS vector store\n",
    "vector_store = FAISS.load_local(folder_path=faiss_index_path, embeddings=embeddings, allow_dangerous_deserialization=True)\n",
    "\n",
    "print(f\"FAISS index loaded successfully with {vector_store.index.ntotal} vvectors.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FAISS index loaded successfully with 1350 vvectors.\n"
     ]
    }
   ],
   "source": [
    "embeddings =  HuggingFaceEmbeddings(model_name=\"sentence-transformers/paraphrase-multilingual-MiniLM-L12-v2\")\n",
    "faiss_index_path = \"/data/user_data/vidhij2/medical_db/heirchical_chunking_rag/maternal_health_bb066ff4\"\n",
    "\n",
    "# Load FAISS vector store\n",
    "vector_store_2 = FAISS.load_local(folder_path=faiss_index_path, embeddings=embeddings, allow_dangerous_deserialization=True)\n",
    "\n",
    "print(f\"FAISS index loaded successfully with {vector_store_2.index.ntotal} vvectors.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_452228/3314463875.py:7: LangChainDeprecationWarning: The method `BaseRetriever.get_relevant_documents` was deprecated in langchain-core 0.1.46 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  retrieved_chunks = retriever.get_relevant_documents(query)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Retrieved Chunk 1: Pregnant now or within the last year?\n",
      "Get medical care right away if you experience any of the following symptoms:\n",
      "These could be signs of very serious complications. If you can’t reach a healthcare provider, go to the\n",
      "emergency room. Be sure to tell them you are pregnant or were pregnant within the...\n",
      "\n",
      "Retrieved Chunk 2: Normal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased\n",
      "frequency of urination. These symptoms may cause discomfort to the woman.\n",
      "Examine symptoms of complications – Fever, persistent vomiting with dehydration, palpitations,\n",
      "tiredness, breathlessness at rest/on...\n",
      "\n",
      "Retrieved Chunk 3: medical facility when\n",
      "labour starts or in case\n",
      "of a complication.\n",
      "• Adequate finance and\n",
      "transport should be\n",
      "arranged beforehand.\n",
      "• A blood donor should\n",
      "be identified for any\n",
      "unforeseen emergencies.\n",
      "Care and support by husband\n",
      "and mother-in-law gives\n",
      "emotional support and confidence\n",
      "in child bearing...\n",
      "\n",
      "Retrieved Chunk 4: 5.  Consult to a doctor as soon as you experience any of the nine danger signs – 1) Excessive swelling in the feet and puf ﬁ ness on face\n",
      "2) Difﬁ culty in breathing 3) Severe pain and burning sensation during urination 4) Repeated fever during pregnancy or within one month\n",
      "of delivery 5) Severe stom...\n",
      "\n",
      "Retrieved Chunk 5: by the government\n",
      "2. Early identification of complications – recognising danger signs during pregnancy, labour and after delivery/\n",
      "abortion...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "retriever = vector_store.as_retriever(search_type=\"similarity\", search_kwargs={\"k\": 5})\n",
    "\n",
    "# Example medical query\n",
    "query = \"What are the early signs of pregnancy complications?\"\n",
    "\n",
    "# Retrieve relevant document chunks\n",
    "retrieved_chunks = retriever.get_relevant_documents(query)\n",
    "\n",
    "# Print retrieved content\n",
    "for i, chunk in enumerate(retrieved_chunks):\n",
    "    print(f\"Retrieved Chunk {i+1}: {chunk.page_content[:300]}...\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### testing vector stores"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Retrieved Chunk 1: If the uterus remains soft  and fl abby, the woman may be suff ering from Atonic PPH.\n",
      "Manage as per the steps given for management of Atonic PPH in Module 2.\n",
      "(Practise Conducting AMTSL - Checklist No. 2.5 in SBA Handbook)\n",
      "Fourth stage of labour\n",
      "Th e fi rst two hours aft er the delivery of the placen...\n",
      "\n",
      "Retrieved Chunk 2: Th e pregnancy test should be off ered to any woman \n",
      "in the reproductive age group who comes to you with a history of amenorrhoea or symptoms \n",
      "of pregnancy.\n",
      "Th e GoI has made the ‘Nischay’ pregnancy test kit available across the country.\n",
      "Other test kits \n",
      "are also available in the market.\n",
      "Th ese kits...\n",
      "\n",
      "Retrieved Chunk 3: 143. Christian P, Khatry SK, West KP, Jr. Antenatal \n",
      "anthelmintic treatment, birth weight, \n",
      "and infant survival in rural Nepal. Lancet. \n",
      "2004;364(9438):981–3.\n",
      "144. Passerini L, Casey GJ, Biggs BA, Cong DT, Phu LB, \n",
      "Phuc TQ et al. Increased birth weight associated \n",
      "with regular pre-pregnancy dewormin...\n",
      "\n",
      "Retrieved Chunk 4: Name of Mother: Date (dd/mm/yy) & Time \n",
      "(\n",
      "__am/pm): \n",
      "LMP:                   EDD:    POG (wks): \n",
      "Name of Midwife doing assessment:\n",
      "Name of Resident/Obstetrician / Doctor doing assessment:\n",
      "Gravida / Parity: Blood Group (ABO Rh): \n",
      "If none of the following criteria is present, women can be admitted to M...\n",
      "\n",
      "Retrieved Chunk 5: IUGR : Intrauterine Growth Retardation\n",
      "JSY : Janani Suraksha Y ojana\n",
      "KMC : Kangaroo Mother Care\n",
      "LAM : Lactational Amenorrhea Method\n",
      "LHV : Lady Health Visitor\n",
      "LLIN : Long-Lasting Insecticidal Net\n",
      "LMP : Last Menstrual Period\n",
      "LPS : Low Performing States\n",
      "MMR : Maternal Mortality Ratio\n",
      "MO : Medical Offi ...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "etriever = vector_store_2.as_retriever(search_type=\"similarity\", search_kwargs={\"k\": 5})\n",
    "\n",
    "# Example medical query\n",
    "query = \"mein 2.5 mnths, pregnant hu, par merko ulti nhi ho rhi, kya yeh problem hai\"\n",
    "\n",
    "# Retrieve relevant document chunks\n",
    "retrieved_chunks = retriever.get_relevant_documents(query)\n",
    "\n",
    "# Print retrieved content\n",
    "for i, chunk in enumerate(retrieved_chunks):\n",
    "    print(f\"Retrieved Chunk {i+1}: {chunk.page_content[:300]}...\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Retrieved Chunk 1: These changes lead \n",
      "to a variety of common symptoms – including nausea \n",
      "and vomiting, low back and pelvic pain, heartburn, \n",
      "varicose veins, constipation and leg cramps – that in \n",
      "some women cause severe discomfort and negatively \n",
      "affects their pregnancy experience.\n",
      "In general, \n",
      "symptoms associated w...\n",
      "\n",
      "Retrieved Chunk 2: Pregnant now or within the last year?\n",
      "Get medical care right away if you experience any of the following symptoms:\n",
      "These could be signs of very serious complications. If you can’t reach a healthcare provider, go to the  \n",
      "emergency room. Be sure to tell them you are pregnant or were pregnant within t...\n",
      "\n",
      "Retrieved Chunk 3: 3.  It is normal to experience nausea and vomiting in early pregnancy; still you should try to eat at least 3 main meals and 1 nutritious snack as \n",
      "this will help you and your baby to meet nutrient requirements\n",
      "4.\n",
      "As your baby’s brain and spinal cord are developing, include foods rich in folate such...\n",
      "\n",
      "Retrieved Chunk 4: 3. Vaginal Bleeding\n",
      " ∙ Early pregnancy-before 20 weeks of pregnancy\n",
      " ∙ Late pregnancy-after 20 weeks of pregnancy or Ante-Partum Haemorrhage (APH)\n",
      "Vaginal bleeding in early pregnancy: \n",
      "The probable causes could be a threatened or spontaneous abortion, an \n",
      "ectopic pregnancy or a hydatidiform mole.\n",
      "a....\n",
      "\n",
      "Retrieved Chunk 5: Symptoms during pregnancy\n",
      "Y ou must ask the woman about the symptoms that might be causing her some discomfort. \n",
      "Symptoms can be normal for any pregnancy or it can indicate a complication which needs \n",
      "immediate attention. Ask her about the following symptoms: \n",
      "Box 3: Symptoms indicating discomfort\n",
      "/...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "retriever = vector_store_2.as_retriever(search_type=\"similarity\", search_kwargs={\"k\": 5})\n",
    "\n",
    "# Example medical query\n",
    "query = \"मैं 2.5 महीने की गर्भवती हूँ और उल्टी नहीं हो रही है, क्या यह सामान्य है?\"\n",
    "\n",
    "# Retrieve relevant document chunks\n",
    "retrieved_chunks = retriever.get_relevant_documents(query)\n",
    "\n",
    "# Print retrieved content\n",
    "for i, chunk in enumerate(retrieved_chunks):\n",
    "    print(f\"Retrieved Chunk {i+1}: {chunk.page_content[:300]}...\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### just a function calling semantic preproceesing and chunking and then testing "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def process_maternal_health_documents(\n",
    "    input_path: str,\n",
    "    output_dir: str = None,\n",
    "    chunk_size: int = 3000,\n",
    "    chunk_overlap: int = 400\n",
    ") -> FAISS:\n",
    "    \"\"\"Process maternal health documents and create a vector store.\"\"\"\n",
    "    # Set up API key\n",
    "    setup_api_key()\n",
    "    \n",
    "    # Determine output directory\n",
    "    if output_dir is None:\n",
    "        output_dir = f\"maternal_health_db_{uuid.uuid4().hex[:6]}\"\n",
    "    \n",
    "    # Initialize processor\n",
    "    processor = SemanticMaternalHealthProcessor(\n",
    "        chunk_size=chunk_size,\n",
    "        chunk_overlap=chunk_overlap,\n",
    "        db_directory=output_dir\n",
    "    )\n",
    "    \n",
    "    # Load and process documents\n",
    "    print(f\"Loading documents from {input_path}...\")\n",
    "    documents = processor.load_documents(input_path)\n",
    "    print(f\"Processed {len(documents)} document chunks\")\n",
    "    \n",
    "    # Create vector store\n",
    "    print(f\"Creating vector store in {output_dir}...\")\n",
    "    db = processor.create_vector_store(documents)\n",
    "    \n",
    "    print(f\"Processing complete! Vector store created with {len(documents)} chunks.\")\n",
    "    return db\n",
    "\n",
    "\n",
    "def answer_question(\n",
    "    chain: RetrievalQA,\n",
    "    question: str,\n",
    "    verbose: bool = False\n",
    ") -> Dict[str, Any]:\n",
    "    \"\"\"Ask a question and get an answer using the retrieval chain.\"\"\"\n",
    "    result = chain({\"query\": question})\n",
    "    \n",
    "    if verbose:\n",
    "        print(\"\\nSources:\")\n",
    "        for i, doc in enumerate(result.get(\"source_documents\", [])):\n",
    "            print(f\"\\nSource {i+1}:\")\n",
    "            print(f\"Content: {doc.page_content[:200]}...\")\n",
    "            print(f\"Metadata: {doc.metadata}\")\n",
    "    \n",
    "    return {\n",
    "        \"answer\": result[\"result\"],\n",
    "        \"sources\": result.get(\"source_documents\", [])\n",
    "    }\n",
    "\n",
    "\n",
    "def run_maternal_health_qa_system():\n",
    "    \"\"\"Run the complete maternal health QA system with command line interface.\"\"\"\n",
    "    import argparse\n",
    "    \n",
    "    parser = argparse.ArgumentParser(description=\"Maternal Health Document Processing and QA System\")\n",
    "    parser.add_argument(\"--input\", \"-i\", help=\"Path to input document or directory\", required=True)\n",
    "    parser.add_argument(\"--output-dir\", \"-o\", help=\"Directory to save vector store\", default=None)\n",
    "    parser.add_argument(\"--chunk-size\", \"-c\", type=int, default=3000, help=\"Chunk size for text splitting\")\n",
    "    parser.add_argument(\"--chunk-overlap\", \"-v\", type=int, default=400, help=\"Chunk overlap for text splitting\")\n",
    "    parser.add_argument(\"--load\", \"-l\", help=\"Load existing vector store\", default=None)\n",
    "    parser.add_argument(\"--model\", \"-m\", help=\"OpenAI model to use\", default=\"gpt-4\")\n",
    "    \n",
    "    args = parser.parse_args()\n",
    "    \n",
    "    # Setup API key\n",
    "    if not setup_api_key():\n",
    "        print(\"Error: OpenAI API key is required.\")\n",
    "        return\n",
    "    \n",
    "    # Initialize processor\n",
    "    processor = SemanticMaternalHealthProcessor(\n",
    "        chunk_size=args.chunk_size,\n",
    "        chunk_overlap=args.chunk_overlap,\n",
    "        db_directory=args.output_dir or \"maternal_health_db\"\n",
    "    )\n",
    "    \n",
    "    # Process or load documents\n",
    "    if args.load:\n",
    "        print(f\"Loading existing vector store from {args.load}...\")\n",
    "        db = processor.load_vector_store(args.load)\n",
    "    else:\n",
    "        print(f\"Processing documents from {args.input}...\")\n",
    "        documents = processor.load_documents(args.input)\n",
    "        print(f\"Creating vector store...\")\n",
    "        db = processor.create_vector_store(documents)\n",
    "    \n",
    "    # Create retrieval chain\n",
    "    print(f\"Creating QA chain with model {args.model}...\")\n",
    "    chain = processor.create_retrieval_chain(model_name=args.model)\n",
    "    \n",
    "    # Interactive question answering\n",
    "    print(\"\\nMaternal Health QA System Ready!\")\n",
    "    print(\"Type 'exit' or 'quit' to end the session.\")\n",
    "    \n",
    "    while True:\n",
    "        question = input(\"\\nEnter your question: \")\n",
    "        if question.lower() in (\"exit\", \"quit\"):\n",
    "            break\n",
    "        \n",
    "        print(\"\\nProcessing your question...\")\n",
    "        try:\n",
    "            result = answer_question(chain, question, verbose=True)\n",
    "            print(\"\\nAnswer:\", result[\"answer\"])\n",
    "        except Exception as e:\n",
    "            print(f\"Error processing question: {str(e)}\")\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    run_maternal_health_qa_system()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_431193/2268525692.py:165: LangChainDeprecationWarning: The class `OpenAIEmbeddings` was deprecated in LangChain 0.0.9 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-openai package and should be used instead. To use it run `pip install -U :class:`~langchain-openai` and import as `from :class:`~langchain_openai import OpenAIEmbeddings``.\n",
      "  self.embeddings = OpenAIEmbeddings(model=embedding_model_name)\n"
     ]
    }
   ],
   "source": [
    "processor = MaternalHealthDocumentProcessor(\n",
    "            chunk_size=3000,\n",
    "            chunk_overlap=200,\n",
    "        )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading files: 0it [00:00, ?it/s]\n"
     ]
    }
   ],
   "source": [
    "documents = processor.load_documents(\"/home/vidhij2/nivi/test_docs\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def process_documents(\n",
    "    input_path: str,\n",
    "    output_dir: str = None, \n",
    "    document_type: str = \"medical\",\n",
    "    chunk_size: int = 1000,\n",
    "    chunk_overlap: int = 200\n",
    ") -> FAISS:\n",
    "    \"\"\"Process medical or maternal health documents and create a vector store.\"\"\"\n",
    "    # Set up API key\n",
    "    setup_api_key()\n",
    "    \n",
    "    # Determine output directory\n",
    "    if output_dir is None:\n",
    "        output_dir = f\"{document_type}_db_{uuid.uuid4().hex[:6]}\"\n",
    "    \n",
    "    # Initialize appropriate processor\n",
    "    if document_type.lower() == \"maternal\":\n",
    "        processor = MaternalHealthDocumentProcessor(\n",
    "            chunk_size=chunk_size,\n",
    "            chunk_overlap=chunk_overlap,\n",
    "            db_directory=output_dir\n",
    "        )\n",
    "        print(\"Using Maternal Health Document Processor\")\n",
    "    else:\n",
    "        processor = MedicalDocumentProcessor(\n",
    "            chunk_size=chunk_size,\n",
    "            chunk_overlap=chunk_overlap,\n",
    "            db_directory=output_dir\n",
    "        )\n",
    "        print(\"Using Medical Document Processor\")\n",
    "    \n",
    "    # Load and process documents\n",
    "    print(f\"Loading documents from {input_path}...\")\n",
    "    documents = processor.load_documents(input_path)\n",
    "    print(f\"Processed {len(documents)} document chunks\")\n",
    "    \n",
    "    # Create vector store\n",
    "    print(f\"Creating vector store in {output_dir}...\")\n",
    "    db = processor.create_vector_store(documents)\n",
    "    \n",
    "    print(f\"Processing complete! Vector store created with {len(documents)} chunks.\")\n",
    "    return db\n",
    "\n",
    "\n",
    "def create_retrieval_chain(\n",
    "    vector_store,\n",
    "    model_name: str = \"gpt-4\",\n",
    "    temperature: float = 0.0\n",
    ") -> RetrievalQA:\n",
    "    \"\"\"Create a retrieval chain for question answering.\"\"\"\n",
    "    # Initialize model\n",
    "    llm = ChatOpenAI(\n",
    "        model=model_name,\n",
    "        temperature=temperature\n",
    "    )\n",
    "    \n",
    "    # Create retrieval QA chain\n",
    "    qa_prompt = PromptTemplate(\n",
    "        template=\"\"\"You are a medical expert assistant. Use the following pieces of context to answer the question at the end. \n",
    "        If you don't know the answer, just say that you don't know, don't try to make up an answer.\n",
    "        \n",
    "        {context}\n",
    "        \n",
    "        Question: {question}\n",
    "        \"\"\",\n",
    "        input_variables=[\"context\", \"question\"]\n",
    "    )\n",
    "    \n",
    "    chain = RetrievalQA.from_chain_type(\n",
    "        llm=llm,\n",
    "        chain_type=\"stuff\",\n",
    "        retriever=vector_store.as_retriever(search_kwargs={\"k\": 5}),\n",
    "        chain_type_kwargs={\"prompt\": qa_prompt},\n",
    "        return_source_documents=True\n",
    "    )\n",
    "    \n",
    "    return chain\n",
    "\n",
    "\n",
    "def answer_question(\n",
    "    chain: RetrievalQA,\n",
    "    question: str,\n",
    "    verbose: bool = False\n",
    ") -> str:\n",
    "    \"\"\"Ask a question and get an answer using the retrieval chain.\"\"\"\n",
    "    result = chain({\"query\": question})\n",
    "    \n",
    "    if verbose:\n",
    "        print(\"\\nSources:\")\n",
    "        for i, doc in enumerate(result.get(\"source_documents\", [])):\n",
    "            print(f\"\\nSource {i+1}:\")\n",
    "            print(f\"Content: {doc.page_content[:200]}...\")\n",
    "            print(f\"Metadata: {doc.metadata}\")\n",
    "    \n",
    "    return result[\"result\"]\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    import argparse\n",
    "    \n",
    "    parser = argparse.ArgumentParser(description=\"Process medical documents and create a vector store\")\n",
    "    parser.add_argument(\"input_path\", help=\"Path to input document or directory\")\n",
    "    parser.add_argument(\"--output-dir\", help=\"Directory to save vector store\", default=None)\n",
    "    parser.add_argument(\"--document-type\", choices=[\"medical\", \"maternal\"], default=\"medical\",\n",
    "                      help=\"Type of documents to process\")\n",
    "    parser.add_argument(\"--chunk-size\", type=int, default=1000, help=\"Chunk size for text splitting\")\n",
    "    parser.add_argument(\"--chunk-overlap\", type=int, default=200, help=\"Chunk overlap for text splitting\")\n",
    "    \n",
    "    args = parser.parse_args()\n",
    "    \n",
    "    # Process documents\n",
    "    db = process_documents(\n",
    "        input_path=args.input_path,\n",
    "        output_dir=args.output_dir,\n",
    "        document_type=args.document_type,\n",
    "        chunk_size=args.chunk_size,\n",
    "        chunk_overlap=args.chunk_overlap\n",
    "    )\n",
    "    \n",
    "    # Create retrieval chain\n",
    "    chain = create_retrieval_chain(db)\n",
    "    \n",
    "    # Interactive question answering\n",
    "    print(\"\\nDocument processing complete! You can now ask questions.\")\n",
    "    print(\"Type 'exit' to quit.\")\n",
    "    \n",
    "    while True:\n",
    "        question = input(\"\\nQuestion: \")\n",
    "        if question.lower() == \"exit\":\n",
    "            break\n",
    "        \n",
    "        answer = answer_question(chain, question, verbose=True)\n",
    "        print(f\"\\nAnswer: {answer}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "class MultiDocumentReasoner:\n",
    "    \"\"\"Performs multi-document reasoning for maternal health queries.\"\"\"\n",
    "    \n",
    "    def __init__(self, vector_db, model_name=\"gpt-4o\"):\n",
    "        self.vector_db = vector_db\n",
    "        self.llm = ChatOpenAI(model_name=model_name, temperature=0)\n",
    "    \n",
    "    def _retrieve_relevant_chunks(self, query: str, k: int = 10) -> List[Document]:\n",
    "        \"\"\"Retrieve relevant chunks with enhanced filtering.\"\"\"\n",
    "        # Extract pregnancy stage from query if present\n",
    "        stage_info = self._extract_stage_from_query(query)\n",
    "        \n",
    "        # Extract intent and topics from query\n",
    "        query_intent = self._analyze_query_intent(query)\n",
    "        \n",
    "        # Basic retrieval\n",
    "        retrieved_docs = self.vector_db.similarity_search(query, k=k*2)  # Get more than needed for filtering\n",
    "        \n",
    "        # Apply filters based on query\n",
    "        filtered_docs = self._filter_documents(retrieved_docs, stage_info, query_intent)\n",
    "        \n",
    "        # Rerank based on relevance score\n",
    "        ranked_docs = self._rerank_documents(filtered_docs, query)\n",
    "        \n",
    "        return ranked_docs[:k]\n",
    "    \n",
    "    def _extract_stage_from_query(self, query: str) -> Dict[str, Any]:\n",
    "        \"\"\"Extract pregnancy stage information from the query.\"\"\"\n",
    "        # You can reuse the stage extraction logic from the document processor\n",
    "        processor = MaternalHealthDocumentProcessor()\n",
    "        return processor._extract_pregnancy_stage(query)\n",
    "    \n",
    "    def _analyze_query_intent(self, query: str) -> Dict[str, Any]:\n",
    "        \"\"\"Analyze the intent and topics in the query.\"\"\"\n",
    "        query_lower = query.lower()\n",
    "        \n",
    "        # Detect if query is about normal variations\n",
    "        is_normal_query = any(term in query_lower for term in \n",
    "                             ['normal', 'common', 'usual', 'typically', 'expected'])\n",
    "        \n",
    "        # Detect if query is about safety concerns\n",
    "        is_safety_query = any(term in query_lower for term in \n",
    "                             ['safe', 'danger', 'risk', 'harmful', 'warning', 'symptom'])\n",
    "        \n",
    "        # Detect if query is about recommendations\n",
    "        is_recommendation_query = any(term in query_lower for term in \n",
    "                                    ['should', 'recommend', 'advised', 'best', 'better'])\n",
    "        \n",
    "        # Identify topics\n",
    "        processor = MaternalHealthDocumentProcessor()\n",
    "        topics = processor._identify_topics(query)\n",
    "        \n",
    "        return {\n",
    "            'is_normal_query': is_normal_query,\n",
    "            'is_safety_query': is_safety_query,\n",
    "            'is_recommendation_query': is_recommendation_query,\n",
    "            'topics': topics\n",
    "        }\n",
    "    \n",
    "    def _filter_documents(self, documents: List[Document], \n",
    "                         stage_info: Dict[str, Any], \n",
    "                         query_intent: Dict[str, Any]) -> List[Document]:\n",
    "        \"\"\"Filter documents based on query analysis.\"\"\"\n",
    "        filtered_docs = []\n",
    "        \n",
    "        for doc in documents:\n",
    "            relevance_score = 0\n",
    "            \n",
    "            # Stage relevance\n",
    "            doc_stages = doc.metadata.get('pregnancy_stages', {})\n",
    "            \n",
    "            # Check for stage match\n",
    "            stage_match = False\n",
    "            for week in stage_info.get('weeks', []):\n",
    "                if week in doc_stages.get('weeks', []):\n",
    "                    stage_match = True\n",
    "                    relevance_score += 3\n",
    "                    break\n",
    "                    \n",
    "            for month in stage_info.get('months', []):\n",
    "                if month in doc_stages.get('months', []):\n",
    "                    stage_match = True\n",
    "                    relevance_score += 3\n",
    "                    break\n",
    "                    \n",
    "            for trimester in stage_info.get('trimesters', []):\n",
    "                if trimester in doc_stages.get('trimesters', []):\n",
    "                    stage_match = True\n",
    "                    relevance_score += 3\n",
    "                    break\n",
    "            \n",
    "            # Topic relevance\n",
    "            for topic in query_intent.get('topics', []):\n",
    "                if topic in doc.metadata.get('maternal_topics', []):\n",
    "                    relevance_score += 2\n",
    "            \n",
    "            # Intent relevance\n",
    "            if query_intent.get('is_normal_query') and doc.metadata.get('discusses_normal_variations'):\n",
    "                relevance_score += 2\n",
    "                \n",
    "            if query_intent.get('is_safety_query') and doc.metadata.get('contains_warnings'):\n",
    "                relevance_score += 2\n",
    "                \n",
    "            if query_intent.get('is_recommendation_query') and doc.metadata.get('chunk_type') == 'recommendation':\n",
    "                relevance_score += 2\n",
    "            \n",
    "            # Specialized chunks get a boost\n",
    "            if doc.metadata.get('chunk_type') == 'specialized':\n",
    "                relevance_score += 1\n",
    "            \n",
    "            # Add relevance score to document metadata\n",
    "            doc.metadata['relevance_score'] = relevance_score\n",
    "            \n",
    "            # Add document to filtered list if it has any relevance\n",
    "            if relevance_score > 0 or not (stage_info.get('weeks') or stage_info.get('months') or stage_info.get('trimesters')):\n",
    "                filtered_docs.append(doc)\n",
    "        \n",
    "        return filtered_docs\n",
    "    \n",
    "    def _rerank_documents(self, documents: List[Document], query: str) -> List[Document]:\n",
    "        \"\"\"Rerank documents based on relevance score and content diversity.\"\"\"\n",
    "        # Sort by relevance score\n",
    "        ranked_docs = sorted(documents, key=lambda x: x.metadata.get('relevance_score', 0), reverse=True)\n",
    "        \n",
    "        # Ensure diversity of topics and chunk types\n",
    "        diverse_docs = []\n",
    "        seen_topics = set()\n",
    "        seen_chunk_types = set()\n",
    "        \n",
    "        # First, add specialized chunks if available\n",
    "        for doc in [d for d in ranked_docs if d.metadata.get('chunk_type') == 'specialized']:\n",
    "            topic = doc.metadata.get('topic')\n",
    "            if topic not in seen_topics:\n",
    "                diverse_docs.append(doc)\n",
    "                seen_topics.add(topic)\n",
    "        \n",
    "        # Then add other documents to ensure diversity\n",
    "        for doc in ranked_docs:\n",
    "            # Skip already added specialized chunks\n",
    "            if doc in diverse_docs:\n",
    "                continue\n",
    "                \n",
    "            topics = doc.metadata.get('maternal_topics', [])\n",
    "            chunk_type = doc.metadata.get('chunk_type')\n",
    "            \n",
    "            # Check if this document adds diversity\n",
    "            adds_diversity = False\n",
    "            \n",
    "            # If we haven't seen this chunk type yet\n",
    "            if chunk_type not in seen_chunk_types:\n",
    "                adds_diversity = True\n",
    "                seen_chunk_types.add(chunk_type)\n",
    "            \n",
    "            # If it covers topics we haven't seen yet\n",
    "            for topic in topics:\n",
    "                if topic not in seen_topics:\n",
    "                    adds_diversity = True\n",
    "                    seen_topics.add(topic)\n",
    "            \n",
    "            # Add document if it adds diversity or is highly relevant\n",
    "            if adds_diversity or doc.metadata.get('relevance_score', 0) >= 3:\n",
    "                diverse_docs.append(doc)\n",
    "                \n",
    "            # Stop once we have enough diverse documents\n",
    "            if len(diverse_docs) >= 10:\n",
    "                break\n",
    "        \n",
    "        # If we don't have enough diverse docs, add more from ranked docs\n",
    "        if len(diverse_docs) < 5 and len(ranked_docs) > len(diverse_docs):\n",
    "            remaining_docs = [doc for doc in ranked_docs if doc not in diverse_docs]\n",
    "            diverse_docs.extend(remaining_docs[:5-len(diverse_docs)])\n",
    "        \n",
    "        return diverse_docs\n",
    "    \n",
    "    def _analyze_document_relationships(self, documents: List[Document]) -> Dict[str, Any]:\n",
    "        \"\"\"Analyze relationships between retrieved documents.\"\"\"\n",
    "        # Identify contradictions\n",
    "        contradictions = []\n",
    "        supports = []\n",
    "        extensions = []\n",
    "        \n",
    "        # Compare each pair of documents\n",
    "        for i, doc1 in enumerate(documents):\n",
    "            for j, doc2 in enumerate(documents[i+1:], i+1):\n",
    "                # Skip if documents are from same section\n",
    "                if doc1.metadata.get('section_path') == doc2.metadata.get('section_path'):\n",
    "                    continue\n",
    "                \n",
    "                # Check for contradictions or support using semantic similarity\n",
    "                similarity = self._compute_semantic_similarity(doc1.page_content, doc2.page_content)\n",
    "                \n",
    "                # High similarity but different topics might indicate support\n",
    "                if similarity > 0.85 and set(doc1.metadata.get('maternal_topics', [])) != set(doc2.metadata.get('maternal_topics', [])):\n",
    "                    supports.append((i, j, similarity))\n",
    "                \n",
    "                # Medium similarity with same topic might indicate extension\n",
    "                elif 0.6 < similarity < 0.85 and set(doc1.metadata.get('maternal_topics', [])) & set(doc2.metadata.get('maternal_topics', [])):\n",
    "                    extensions.append((i, j, similarity))\n",
    "                \n",
    "                # Low similarity with same topic might indicate potential contradiction\n",
    "                elif similarity < 0.4 and set(doc1.metadata.get('maternal_topics', [])) & set(doc2.metadata.get('maternal_topics', [])):\n",
    "                    # This is just a heuristic - real contradiction detection would need more sophisticated analysis\n",
    "                    contradictions.append((i, j, similarity))\n",
    "        \n",
    "        return {\n",
    "            'contradictions': contradictions,\n",
    "            'supports': supports,\n",
    "            'extensions': extensions\n",
    "        }\n",
    "    \n",
    "    def _compute_semantic_similarity(self, text1: str, text2: str) -> float:\n",
    "        \"\"\"Compute semantic similarity between two text passages.\"\"\"\n",
    "        # This is a placeholder - you would use your embedding model here\n",
    "        # For simplicity, we'll return a random similarity score\n",
    "        import random\n",
    "        return random.uniform(0, 1)\n",
    "    \n",
    "    def answer_query(self, query: str) -> Dict[str, Any]:\n",
    "        \"\"\"Answer a maternal health query with multi-document reasoning.\"\"\"\n",
    "        # Retrieve relevant documents\n",
    "        documents = self._retrieve_relevant_chunks(query)\n",
    "        \n",
    "        # Analyze document relationships\n",
    "        relationships = self._analyze_document_relationships(documents)\n",
    "        \n",
    "        # Create a reasoning prompt\n",
    "        reasoning_prompt = self._create_reasoning_prompt(query, documents, relationships)\n",
    "        \n",
    "        # Generate the reasoning chain\n",
    "        reasoning_chain = self.llm.predict(reasoning_prompt)\n",
    "        \n",
    "        # Create a response synthesis prompt\n",
    "        synthesis_prompt = self._create_synthesis_prompt(query, documents, reasoning_chain)\n",
    "        \n",
    "        # Generate the final response\n",
    "        response = self.llm.predict(synthesis_prompt)\n",
    "        \n",
    "        return {\n",
    "            'query': query,\n",
    "            'documents': documents,\n",
    "            'reasoning_chain': reasoning_chain,\n",
    "            'response': response\n",
    "        }\n",
    "    \n",
    "    def _create_reasoning_prompt(self, query: str, documents: List[Document], relationships: Dict[str, Any]) -> str:\n",
    "        \"\"\"Create a prompt for the reasoning chain.\"\"\"\n",
    "        prompt = f\"\"\"You are a medical reasoning expert focusing on maternal health. \n",
    "        Analyze the following documents to answer this query: \"{query}\"\n",
    "        \n",
    "        RETRIEVED DOCUMENTS:\n",
    "        \"\"\"\n",
    "        \n",
    "        for i, doc in enumerate(documents):\n",
    "            prompt += f\"\\n--- Document {i+1} ---\\n\"\n",
    "            prompt += f\"Source: {doc.metadata.get('source', 'Unknown')}\\n\"\n",
    "            prompt += f\"Section: {' > '.join(doc.metadata.get('section_path', []))}\\n\"\n",
    "            prompt += f\"Type: {doc.metadata.get('chunk_type', 'text')}\\n\"\n",
    "            \n",
    "            if doc.metadata.get('pregnancy_stages'):\n",
    "                stages = doc.metadata.get('pregnancy_stages', {})\n",
    "                stage_info = []\n",
    "                if stages.get('weeks'):\n",
    "                    stage_info.append(f\"Weeks: {stages.get('weeks')}\")\n",
    "                if stages.get('months'):\n",
    "                    stage_info.append(f\"Months: {stages.get('months')}\")\n",
    "                if stages.get('trimesters'):\n",
    "                    stage_info.append(f\"Trimesters: {stages.get('trimesters')}\")\n",
    "                \n",
    "                if stage_info:\n",
    "                    prompt += f\"Stages: {', '.join(stage_info)}\\n\"\n",
    "            \n",
    "            prompt += f\"Content: {doc.page_content}\\n\"\n",
    "        \n",
    "        # Add information about document relationships\n",
    "        if relationships['contradictions']:\n",
    "            prompt += \"\\nPotential contradictions detected between these documents:\\n\"\n",
    "            for i, j, score in relationships['contradictions']:\n",
    "                prompt += f\"- Documents {i+1} and {j+1} (similarity: {score:.2f})\\n\"\n",
    "        \n",
    "        if relationships['supports']:\n",
    "            prompt += \"\\nThese documents appear to support each other:\\n\"\n",
    "            for i, j, score in relationships['supports']:\n",
    "                prompt += f\"- Documents {i+1} and {j+1} (similarity: {score:.2f})\\n\"\n",
    "        \n",
    "        if relationships['extensions']:\n",
    "            prompt += \"\\nThese documents appear to extend each other's information:\\n\"\n",
    "            for i, j, score in relationships['extensions']:\n",
    "                prompt += f\"- Documents {i+1} and {j+1} (similarity: {score:.2f})\\n\"\n",
    "        \n",
    "        prompt += \"\"\"\n",
    "        TASK:\n",
    "        1. Identify the key facts relevant to the query from each document\n",
    "        2. Resolve any contradictions or inconsistencies\n",
    "        3. Determine which facts are most relevant and medically accurate\n",
    "        4. Formulate a coherent understanding that synthesizes information across all documents\n",
    "        5. Note any important medical caveats or warnings that should be included\n",
    "        \n",
    "        Work through this step-by-step:\n",
    "        \"\"\"\n",
    "        \n",
    "        return prompt\n",
    "    \n",
    "    def _create_synthesis_prompt(self, query: str, documents: List[Document], reasoning: str) -> str:\n",
    "        \"\"\"Create a prompt for synthesizing the final response.\"\"\"\n",
    "        prompt = f\"\"\"You are a maternal health expert providing evidence-based information. \n",
    "        Based on the query and reasoning below, synthesize a comprehensive, accurate response.\n",
    "        \n",
    "        QUERY: {query}\n",
    "        \n",
    "        REASONING PROCESS:\n",
    "        {reasoning}\n",
    "        \n",
    "        Using the reasoning above, create a response that:\n",
    "        1. Directly addresses the user's query with medically accurate information\n",
    "        2. Clearly ties information to the appropriate pregnancy stage (if relevant)\n",
    "        3. Acknowledges any limitations in available information\n",
    "        4. Includes appropriate medical caveats or warnings\n",
    "        5. Maintains an authoritative but reassuring tone\n",
    "        6. Cites the source/origin of key information (e.g., \"according to medical guidelines...\")\n",
    "        \n",
    "        RESPONSE:\n",
    "        \"\"\"\n",
    "        \n",
    "        return prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re  # Add import for regex\n",
    "from langchain.chains import RetrievalQA\n",
    "from langchain.prompts import PromptTemplate\n",
    "from typing import List, Dict, Any, Optional, Tuple\n",
    "from langchain.vectorstores import FAISS\n",
    "from langchain.embeddings import HuggingFaceEmbeddings, OpenAIEmbeddings\n",
    "from langchain.schema import Document\n",
    "import os\n",
    "import time\n",
    "\n",
    "class EnhancedMedicalRAG:\n",
    "    \"\"\"\n",
    "    Combined medical RAG system with multi-document reasoning capabilities\n",
    "    for maternal health and medical documents.\n",
    "    \"\"\"\n",
    "\n",
    "    def __init__(\n",
    "        self,\n",
    "        vector_store: FAISS,\n",
    "        model_name: str = \"gpt-4o\",\n",
    "        temperature: float = 0.0,\n",
    "        embeddings = None\n",
    "    ):\n",
    "        self.vector_store = vector_store\n",
    "        self.llm = ChatOpenAI(model_name=model_name, temperature=temperature)\n",
    "        self.embeddings = embeddings or OpenAIEmbeddings()\n",
    "        \n",
    "        # Core prompt template for simple RAG responses\n",
    "        self.rag_prompt = PromptTemplate(\n",
    "            template=\"\"\"You are a medical assistant. Use ONLY the provided context to answer.\n",
    "\n",
    "Context:\n",
    "{context}\n",
    "\n",
    "Question: {question}\n",
    "\n",
    "Instructions:\n",
    "1. If context lacks information, respond: \"I don't have enough information...\"\n",
    "2. Cite recommendations, evidence levels, sources.\n",
    "3. Be concise, comprehensive.\n",
    "4. Present all perspectives if conflicting.\n",
    "5. Quote recommendations exactly.\n",
    "6. Answer in the language of the question.\n",
    "\n",
    "Answer:\"\"\",\n",
    "            input_variables=[\"context\", \"question\"]\n",
    "        )\n",
    "\n",
    "        # Simple retriever setup\n",
    "        self.retriever = vector_store.as_retriever(search_kwargs={\"k\": 10})\n",
    "\n",
    "        # Setup QA chain for simple retrieval mode\n",
    "        self.qa_chain = RetrievalQA.from_chain_type(\n",
    "            llm=self.llm,\n",
    "            retriever=self.retriever,\n",
    "            return_source_documents=True,\n",
    "            chain_type=\"stuff\",\n",
    "            chain_type_kwargs={\"prompt\": self.rag_prompt}\n",
    "        )\n",
    "\n",
    "    def translate_query(self, query: str) -> str:\n",
    "        \"\"\"Translate non-English queries to English while preserving medical meaning.\"\"\"\n",
    "        translation_prompt = PromptTemplate(\n",
    "            template=\"\"\"Translate the following user query to English, preserving its medical meaning:\n",
    "\n",
    "Query: {query}\n",
    "\n",
    "Translation:\"\"\",\n",
    "            input_variables=[\"query\"]\n",
    "        )\n",
    "        response = self.llm(translation_prompt.format_prompt(query=query).to_messages())\n",
    "        return response.content.strip()\n",
    "\n",
    "    def _extract_stage_from_query(self, query: str) -> Dict[str, Any]:\n",
    "        \"\"\"Extract pregnancy stage information from the query.\"\"\"\n",
    "        # Extract weeks (e.g., \"week 12\", \"12th week\", \"weeks 12-14\")\n",
    "        week_pattern = re.compile(r'(?:week|weeks)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+week', re.IGNORECASE)\n",
    "        \n",
    "        # Extract months (e.g., \"month 3\", \"3rd month\", \"months 4-6\")\n",
    "        month_pattern = re.compile(r'(?:month|months)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+month', re.IGNORECASE)\n",
    "        \n",
    "        # Extract trimesters (e.g., \"first trimester\", \"second trimester\")\n",
    "        trimester_pattern = re.compile(r'(first|second|third)\\s+trimester', re.IGNORECASE)\n",
    "        \n",
    "        stages = {\n",
    "            \"weeks\": [],\n",
    "            \"months\": [],\n",
    "            \"trimesters\": []\n",
    "        }\n",
    "        \n",
    "        # Extract weeks\n",
    "        for match in week_pattern.finditer(query):\n",
    "            week_str = match.group(1) or match.group(2)\n",
    "            if '-' in week_str:\n",
    "                start, end = map(int, week_str.split('-'))\n",
    "                stages[\"weeks\"].extend(list(range(start, end + 1)))\n",
    "            else:\n",
    "                stages[\"weeks\"].append(int(week_str))\n",
    "        \n",
    "        # Extract months\n",
    "        for match in month_pattern.finditer(query):\n",
    "            month_str = match.group(1) or match.group(2)\n",
    "            if '-' in month_str:\n",
    "                start, end = map(int, month_str.split('-'))\n",
    "                stages[\"months\"].extend(list(range(start, end + 1)))\n",
    "            else:\n",
    "                stages[\"months\"].append(int(month_str))\n",
    "        \n",
    "        # Extract trimesters\n",
    "        for match in trimester_pattern.finditer(query):\n",
    "            trimester = match.group(1).lower()\n",
    "            stages[\"trimesters\"].append(trimester)\n",
    "        \n",
    "        # Remove duplicates\n",
    "        for key in stages:\n",
    "            stages[key] = list(set(stages[key]))\n",
    "        \n",
    "        return stages\n",
    "\n",
    "    def _analyze_query_intent(self, query: str) -> Dict[str, Any]:\n",
    "        \"\"\"Analyze the intent and topics in the query.\"\"\"\n",
    "        query_lower = query.lower()\n",
    "        \n",
    "        # Detect if query is about normal variations\n",
    "        is_normal_query = any(term in query_lower for term in \n",
    "                             ['normal', 'common', 'usual', 'typically', 'expected'])\n",
    "        \n",
    "        # Detect if query is about safety concerns\n",
    "        is_safety_query = any(term in query_lower for term in \n",
    "                             ['safe', 'danger', 'risk', 'harmful', 'warning', 'symptom'])\n",
    "        \n",
    "        # Detect if query is about recommendations\n",
    "        is_recommendation_query = any(term in query_lower for term in \n",
    "                                    ['should', 'recommend', 'advised', 'best', 'better'])\n",
    "        \n",
    "        # Check if the query is about a medical topic\n",
    "        maternal_topics = []\n",
    "        topic_keywords = {\n",
    "            'fetal_development': ['development', 'growth', 'fetal', 'foetal', 'baby', 'fetus'],\n",
    "            'maternal_changes': ['mother', 'maternal', 'body', 'changes', 'symptoms'],\n",
    "            'nutrition': ['diet', 'food', 'nutrition', 'eat', 'meal', 'vitamin'],\n",
    "            'warning_signs': ['danger', 'warning', 'risk', 'emergency', 'complication'],\n",
    "            'normal_variations': ['normal', 'common', 'usual', 'typical', 'variant', 'variation'],\n",
    "            'medical_tests': ['test', 'scan', 'ultrasound', 'screening', 'monitor'],\n",
    "            'delivery': ['birth', 'labor', 'labour', 'delivery', 'contractions'],\n",
    "            'postpartum': ['after birth', 'post-delivery', 'postpartum', 'post-natal', 'breastfeeding']\n",
    "        }\n",
    "        \n",
    "        for topic, keywords in topic_keywords.items():\n",
    "            if any(keyword in query_lower for keyword in keywords):\n",
    "                maternal_topics.append(topic)\n",
    "        \n",
    "        return {\n",
    "            'is_normal_query': is_normal_query,\n",
    "            'is_safety_query': is_safety_query,\n",
    "            'is_recommendation_query': is_recommendation_query,\n",
    "            'topics': maternal_topics\n",
    "        }\n",
    "\n",
    "    def _enhanced_retrieval(self, query: str, k: int = 10) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Enhanced retrieval that considers query intent, pregnancy stage,\n",
    "        and performs filtering and diversity-aware reranking.\n",
    "        \"\"\"\n",
    "        # Extract stage and intent information\n",
    "        stage_info = self._extract_stage_from_query(query)\n",
    "        query_intent = self._analyze_query_intent(query)\n",
    "        \n",
    "        # Get more documents than needed for filtering\n",
    "        initial_docs = self.vector_store.similarity_search(query, k=k*2)\n",
    "        \n",
    "        # Filter and score documents based on relevance to query\n",
    "        scored_docs = []\n",
    "        for doc in initial_docs:\n",
    "            relevance_score = 0\n",
    "            \n",
    "            # Stage relevance\n",
    "            doc_stages = doc.metadata.get('pregnancy_stages', {})\n",
    "            \n",
    "            # Check for stage match\n",
    "            if stage_info.get('weeks') or stage_info.get('months') or stage_info.get('trimesters'):\n",
    "                stage_match = False\n",
    "                \n",
    "                for week in stage_info.get('weeks', []):\n",
    "                    if week in doc_stages.get('weeks', []):\n",
    "                        stage_match = True\n",
    "                        relevance_score += 3\n",
    "                        break\n",
    "                        \n",
    "                for month in stage_info.get('months', []):\n",
    "                    if month in doc_stages.get('months', []):\n",
    "                        stage_match = True\n",
    "                        relevance_score += 3\n",
    "                        break\n",
    "                        \n",
    "                for trimester in stage_info.get('trimesters', []):\n",
    "                    if trimester in doc_stages.get('trimesters', []):\n",
    "                        stage_match = True\n",
    "                        relevance_score += 3\n",
    "                        break\n",
    "            else:\n",
    "                # No specific stage in query, so no penalty\n",
    "                stage_match = True\n",
    "            \n",
    "            # Topic relevance\n",
    "            for topic in query_intent.get('topics', []):\n",
    "                if topic in doc.metadata.get('topics', []) or topic in doc.metadata.get('maternal_topics', []):\n",
    "                    relevance_score += 2\n",
    "            \n",
    "            # Intent relevance\n",
    "            if query_intent.get('is_normal_query') and doc.metadata.get('discusses_normal_variations', False):\n",
    "                relevance_score += 2\n",
    "                \n",
    "            if query_intent.get('is_safety_query') and doc.metadata.get('contains_warning', False):\n",
    "                relevance_score += 2\n",
    "                \n",
    "            if query_intent.get('is_recommendation_query') and doc.metadata.get('chunk_type') == 'recommendation':\n",
    "                relevance_score += 2\n",
    "            \n",
    "            # Specialized chunks get a boost\n",
    "            if doc.metadata.get('chunk_type') == 'specialized':\n",
    "                relevance_score += 1\n",
    "                \n",
    "            # Recommendation chunks get a boost for evidence-based medicine\n",
    "            if doc.metadata.get('chunk_type') == 'recommendation':\n",
    "                relevance_score += 1\n",
    "            \n",
    "            # Add relevance score to document metadata\n",
    "            doc.metadata['relevance_score'] = relevance_score\n",
    "            \n",
    "            # Add document to scored list if it has any relevance or if there was no stage in query\n",
    "            if relevance_score > 0 or not (stage_info.get('weeks') or stage_info.get('months') or stage_info.get('trimesters')):\n",
    "                scored_docs.append(doc)\n",
    "        \n",
    "        # Ensure diversity in the final set (topics, chunk types, etc.)\n",
    "        final_docs = self._ensure_diverse_docs(scored_docs, query_intent, k)\n",
    "        \n",
    "        return final_docs\n",
    "\n",
    "    def _ensure_diverse_docs(self, docs: List[Document], query_intent: Dict[str, Any], k: int) -> List[Document]:\n",
    "        \"\"\"Ensure diversity in the retrieved documents.\"\"\"\n",
    "        # Start with docs sorted by relevance score\n",
    "        sorted_docs = sorted(docs, key=lambda x: x.metadata.get('relevance_score', 0), reverse=True)\n",
    "        \n",
    "        # Ensure diversity of topics and chunk types\n",
    "        diverse_docs = []\n",
    "        seen_topics = set()\n",
    "        seen_chunk_types = set()\n",
    "        \n",
    "        # First add specialized chunks if available and relevant to query topics\n",
    "        for doc in [d for d in sorted_docs if d.metadata.get('chunk_type') == 'specialized']:\n",
    "            # Check if this specialized chunk is relevant to the query topics\n",
    "            doc_topic = doc.metadata.get('topic', '')\n",
    "            if doc_topic and doc_topic in query_intent.get('topics', []):\n",
    "                diverse_docs.append(doc)\n",
    "                seen_topics.add(doc_topic)\n",
    "        \n",
    "        # Then add recommendation chunks if query is seeking recommendations\n",
    "        if query_intent.get('is_recommendation_query'):\n",
    "            for doc in [d for d in sorted_docs if d.metadata.get('chunk_type') == 'recommendation']:\n",
    "                if len(diverse_docs) >= k:\n",
    "                    break\n",
    "                    \n",
    "                # Skip if already added\n",
    "                if doc in diverse_docs:\n",
    "                    continue\n",
    "                    \n",
    "                diverse_docs.append(doc)\n",
    "                seen_chunk_types.add('recommendation')\n",
    "        \n",
    "        # Then add warning chunks if query is about safety\n",
    "        if query_intent.get('is_safety_query'):\n",
    "            for doc in [d for d in sorted_docs if doc.metadata.get('contains_warning', False)]:\n",
    "                if len(diverse_docs) >= k:\n",
    "                    break\n",
    "                    \n",
    "                # Skip if already added\n",
    "                if doc in diverse_docs:\n",
    "                    continue\n",
    "                    \n",
    "                diverse_docs.append(doc)\n",
    "                seen_chunk_types.add('warning')\n",
    "        \n",
    "        # Finally add remaining docs, prioritizing diversity\n",
    "        for doc in sorted_docs:\n",
    "            # Skip if already added\n",
    "            if doc in diverse_docs:\n",
    "                continue\n",
    "                \n",
    "            # Stop if we have enough docs\n",
    "            if len(diverse_docs) >= k:\n",
    "                break\n",
    "                \n",
    "            topics = doc.metadata.get('topics', []) or doc.metadata.get('maternal_topics', [])\n",
    "            chunk_type = doc.metadata.get('chunk_type', 'text')\n",
    "            \n",
    "            # Check if this document adds diversity\n",
    "            adds_diversity = False\n",
    "            \n",
    "            # If we haven't seen this chunk type yet\n",
    "            if chunk_type not in seen_chunk_types:\n",
    "                adds_diversity = True\n",
    "                seen_chunk_types.add(chunk_type)\n",
    "            \n",
    "            # If it covers topics we haven't seen yet\n",
    "            for topic in topics:\n",
    "                if topic not in seen_topics:\n",
    "                    adds_diversity = True\n",
    "                    seen_topics.add(topic)\n",
    "            \n",
    "            # Add document if it adds diversity or is highly relevant\n",
    "            if adds_diversity or doc.metadata.get('relevance_score', 0) >= 3:\n",
    "                diverse_docs.append(doc)\n",
    "        \n",
    "        # If we still don't have enough, add the highest scoring remaining docs\n",
    "        if len(diverse_docs) < k:\n",
    "            remaining_docs = [doc for doc in sorted_docs if doc not in diverse_docs]\n",
    "            diverse_docs.extend(remaining_docs[:k-len(diverse_docs)])\n",
    "        \n",
    "        return diverse_docs[:k]\n",
    "\n",
    "    def _analyze_document_relationships(self, documents: List[Document]) -> Dict[str, Any]:\n",
    "        \"\"\"Analyze relationships between retrieved documents.\"\"\"\n",
    "        # Skip if too few documents\n",
    "        if len(documents) < 2:\n",
    "            return {\n",
    "                'contradictions': [],\n",
    "                'supports': [],\n",
    "                'extensions': []\n",
    "            }\n",
    "            \n",
    "        # Identify relationships\n",
    "        contradictions = []\n",
    "        supports = []\n",
    "        extensions = []\n",
    "        \n",
    "        # Compare each pair of documents\n",
    "        for i, doc1 in enumerate(documents):\n",
    "            for j, doc2 in enumerate(documents[i+1:], i+1):\n",
    "                # Skip if documents are from same section (if section path exists)\n",
    "                if (doc1.metadata.get('section_path') and doc2.metadata.get('section_path') and\n",
    "                    doc1.metadata.get('section_path') == doc2.metadata.get('section_path')):\n",
    "                    continue\n",
    "                \n",
    "                # Check for contradictions or support using semantic similarity\n",
    "                similarity = self._compute_semantic_similarity(doc1.page_content, doc2.page_content)\n",
    "                \n",
    "                # Get topics for both docs\n",
    "                topics1 = set(doc1.metadata.get('topics', []) or doc1.metadata.get('maternal_topics', []))\n",
    "                topics2 = set(doc2.metadata.get('topics', []) or doc2.metadata.get('maternal_topics', []))\n",
    "                common_topics = topics1 & topics2\n",
    "                \n",
    "                # High similarity but different topics might indicate support\n",
    "                if similarity > 0.85 and topics1 != topics2:\n",
    "                    supports.append((i, j, similarity))\n",
    "                \n",
    "                # Medium similarity with same topic might indicate extension\n",
    "                elif 0.6 < similarity < 0.85 and common_topics:\n",
    "                    extensions.append((i, j, similarity))\n",
    "                \n",
    "                # Low similarity with same topic might indicate potential contradiction\n",
    "                elif similarity < 0.4 and common_topics:\n",
    "                    # This is just a heuristic - real contradiction detection would need more analysis\n",
    "                    contradictions.append((i, j, similarity))\n",
    "        \n",
    "        return {\n",
    "            'contradictions': contradictions,\n",
    "            'supports': supports,\n",
    "            'extensions': extensions\n",
    "        }\n",
    "    \n",
    "    def _compute_semantic_similarity(self, text1: str, text2: str) -> float:\n",
    "        \"\"\"Compute semantic similarity between two text passages using embeddings.\"\"\"\n",
    "        try:\n",
    "            # Get embeddings for both texts\n",
    "            if hasattr(self.embeddings, 'embed_query'):\n",
    "                # OpenAI embeddings\n",
    "                embedding1 = self.embeddings.embed_query(text1)\n",
    "                embedding2 = self.embeddings.embed_query(text2)\n",
    "            else:\n",
    "                # Other embedding models\n",
    "                embedding1 = self.embeddings.embed_documents([text1])[0]\n",
    "                embedding2 = self.embeddings.embed_documents([text2])[0]\n",
    "            \n",
    "            # Compute cosine similarity\n",
    "            import numpy as np\n",
    "            similarity = np.dot(embedding1, embedding2) / (np.linalg.norm(embedding1) * np.linalg.norm(embedding2))\n",
    "            return float(similarity)\n",
    "        except Exception as e:\n",
    "            print(f\"Error computing similarity: {e}\")\n",
    "            # Return a moderate similarity as fallback\n",
    "            return 0.5\n",
    "\n",
    "    def simple_query(self, question: str, filters: Dict[str, Any] = None, translate: bool = True) -> Dict[str, Any]:\n",
    "        \"\"\"Simple query method that uses basic RAG without multi-document reasoning.\"\"\"\n",
    "        original_question = question\n",
    "        \n",
    "        # Translate if needed\n",
    "        if translate and not all(ord(c) < 128 for c in question):\n",
    "            question = self.translate_query(question)\n",
    "        \n",
    "        # Apply filters if provided\n",
    "        if filters:\n",
    "            self.retriever.search_kwargs[\"filter\"] = filters\n",
    "        \n",
    "        # Execute the query with simple RAG\n",
    "        result = self.qa_chain({\"query\": question})\n",
    "        \n",
    "        # Extract source information\n",
    "        sources = []\n",
    "        for doc in result.get(\"source_documents\", []):\n",
    "            source_info = {\n",
    "                \"content\": doc.page_content[:200] + \"...\" if len(doc.page_content) > 200 else doc.page_content,\n",
    "                \"metadata\": doc.metadata\n",
    "            }\n",
    "            sources.append(source_info)\n",
    "        \n",
    "        # Return the result\n",
    "        return {\n",
    "            \"question_original\": original_question,\n",
    "            \"question_translated\": question if translate and original_question != question else None,\n",
    "            \"answer\": result[\"result\"],\n",
    "            \"sources\": sources\n",
    "        }\n",
    "\n",
    "    def query_with_reasoning(self, question: str, translate: bool = True) -> Dict[str, Any]:\n",
    "        \"\"\"\n",
    "        Answer a query using multi-document reasoning for more complex questions.\n",
    "        This approach uses a two-step process that first reasons across documents\n",
    "        and then synthesizes a comprehensive answer.\n",
    "        \"\"\"\n",
    "        original_question = question\n",
    "        start_time = time.time()\n",
    "        \n",
    "        # Translate if needed\n",
    "        if translate and not all(ord(c) < 128 for c in question):\n",
    "            question = self.translate_query(question)\n",
    "        \n",
    "        # Retrieve documents with enhanced filtering and diversity\n",
    "        documents = self._enhanced_retrieval(question, k=8)\n",
    "        \n",
    "        # Skip reasoning for simple queries with few documents\n",
    "        if len(documents) <= 2:\n",
    "            simple_result = self.simple_query(question, translate=False)\n",
    "            simple_result[\"reasoning_method\"] = \"simple\"\n",
    "            simple_result[\"execution_time\"] = time.time() - start_time\n",
    "            return simple_result\n",
    "        \n",
    "        # Analyze document relationships\n",
    "        relationships = self._analyze_document_relationships(documents)\n",
    "        \n",
    "        # Skip to simple RAG if no interesting relationships found\n",
    "        if (not relationships['contradictions'] and not relationships['supports'] \n",
    "                and not relationships['extensions']):\n",
    "            simple_result = self.simple_query(question, translate=False)\n",
    "            simple_result[\"reasoning_method\"] = \"simple\"\n",
    "            simple_result[\"execution_time\"] = time.time() - start_time\n",
    "            return simple_result\n",
    "        \n",
    "        # Step 1: Create and execute the reasoning prompt\n",
    "        reasoning_prompt = self._create_reasoning_prompt(question, documents, relationships)\n",
    "        reasoning_chain = self.llm(reasoning_prompt.format_prompt().to_messages()).content\n",
    "        \n",
    "        # Step 2: Create and execute the synthesis prompt\n",
    "        synthesis_prompt = self._create_synthesis_prompt(question, reasoning_chain)\n",
    "        final_answer = self.llm(synthesis_prompt.format_prompt().to_messages()).content\n",
    "        \n",
    "        # Extract source information\n",
    "        sources = []\n",
    "        for doc in documents:\n",
    "            source_info = {\n",
    "                \"content\": doc.page_content[:200] + \"...\" if len(doc.page_content) > 200 else doc.page_content,\n",
    "                \"metadata\": doc.metadata\n",
    "            }\n",
    "            sources.append(source_info)\n",
    "        \n",
    "        # Return the result\n",
    "        return {\n",
    "            \"question_original\": original_question,\n",
    "            \"question_translated\": question if translate and original_question != question else None,\n",
    "            \"answer\": final_answer,\n",
    "            \"reasoning_chain\": reasoning_chain,\n",
    "            \"sources\": sources,\n",
    "            \"reasoning_method\": \"multi-document\",\n",
    "            \"execution_time\": time.time() - start_time\n",
    "        }\n",
    "\n",
    "    def _create_reasoning_prompt(self, query: str, documents: List[Document], relationships: Dict[str, Any]) -> PromptTemplate:\n",
    "        \"\"\"Create a prompt for the reasoning chain.\"\"\"\n",
    "        template = \"\"\"You are a medical reasoning expert focusing on maternal health. \n",
    "        Analyze the following documents to answer this query: \"{query}\"\n",
    "        \n",
    "        RETRIEVED DOCUMENTS:\n",
    "        {documents}\n",
    "        \n",
    "        {relationships}\n",
    "        \n",
    "        TASK:\n",
    "        1. Identify the key facts relevant to the query from each document\n",
    "        2. Resolve any contradictions or inconsistencies\n",
    "        3. Determine which facts are most relevant and medically accurate\n",
    "        4. Formulate a coherent understanding that synthesizes information across all documents\n",
    "        5. Note any important medical caveats or warnings that should be included\n",
    "        \n",
    "        Work through this step-by-step:\n",
    "        \"\"\"\n",
    "        \n",
    "        # Format documents text\n",
    "        docs_text = \"\"\n",
    "        for i, doc in enumerate(documents):\n",
    "            docs_text += f\"\\n--- Document {i+1} ---\\n\"\n",
    "            docs_text += f\"Source: {doc.metadata.get('source', 'Unknown')}\\n\"\n",
    "            \n",
    "            if doc.metadata.get('section_path'):\n",
    "                docs_text += f\"Section: {' > '.join(doc.metadata.get('section_path'))}\\n\"\n",
    "            elif doc.metadata.get('section_title'):\n",
    "                docs_text += f\"Section: {doc.metadata.get('section_title')}\\n\"\n",
    "                \n",
    "            docs_text += f\"Type: {doc.metadata.get('chunk_type', 'text')}\\n\"\n",
    "            \n",
    "            if doc.metadata.get('pregnancy_stages'):\n",
    "                stages = doc.metadata.get('pregnancy_stages', {})\n",
    "                stage_info = []\n",
    "                if stages.get('weeks'):\n",
    "                    stage_info.append(f\"Weeks: {stages.get('weeks')}\")\n",
    "                if stages.get('months'):\n",
    "                    stage_info.append(f\"Months: {stages.get('months')}\")\n",
    "                if stages.get('trimesters'):\n",
    "                    stage_info.append(f\"Trimesters: {stages.get('trimesters')}\")\n",
    "                \n",
    "                if stage_info:\n",
    "                    docs_text += f\"Stages: {', '.join(stage_info)}\\n\"\n",
    "            \n",
    "            docs_text += f\"Content: {doc.page_content}\\n\"\n",
    "        \n",
    "        # Format relationships text\n",
    "        relationships_text = \"\"\n",
    "        if relationships['contradictions']:\n",
    "            relationships_text += \"\\nPotential contradictions detected between these documents:\\n\"\n",
    "            for i, j, score in relationships['contradictions']:\n",
    "                relationships_text += f\"- Documents {i+1} and {j+1} (similarity: {score:.2f})\\n\"\n",
    "        \n",
    "        if relationships['supports']:\n",
    "            relationships_text += \"\\nThese documents appear to support each other:\\n\"\n",
    "            for i, j, score in relationships['supports']:\n",
    "                relationships_text += f\"- Documents {i+1} and {j+1} (similarity: {score:.2f})\\n\"\n",
    "        \n",
    "        if relationships['extensions']:\n",
    "            relationships_text += \"\\nThese documents appear to extend each other's information:\\n\"\n",
    "            for i, j, score in relationships['extensions']:\n",
    "                relationships_text += f\"- Documents {i+1} and {j+1} (similarity: {score:.2f})\\n\"\n",
    "        \n",
    "        return PromptTemplate(\n",
    "            template=template,\n",
    "            input_variables=[\"query\"],\n",
    "            partial_variables={\n",
    "                \"documents\": docs_text,\n",
    "                \"relationships\": relationships_text\n",
    "            }\n",
    "        )\n",
    "    \n",
    "    def _create_synthesis_prompt(self, query: str, reasoning: str) -> PromptTemplate:\n",
    "        \"\"\"Create a prompt for synthesizing the final response.\"\"\"\n",
    "        template = \"\"\"You are a maternal health expert providing evidence-based information. \n",
    "        Based on the query and reasoning below, synthesize a comprehensive, accurate response.\n",
    "        \n",
    "        QUERY: {query}\n",
    "        \n",
    "        REASONING PROCESS:\n",
    "        {reasoning}\n",
    "        \n",
    "        Using the reasoning above, create a response that:\n",
    "        1. Directly addresses the user's query with medically accurate information\n",
    "        2. Clearly ties information to the appropriate pregnancy stage (if relevant)\n",
    "        3. Acknowledges any limitations in available information\n",
    "        4. Includes appropriate medical caveats or warnings\n",
    "        5. Maintains an authoritative but reassuring tone\n",
    "        6. Cites the source/origin of key information (e.g., \"according to medical guidelines...\")\n",
    "        \n",
    "        RESPONSE:\n",
    "        \"\"\"\n",
    "        \n",
    "        return PromptTemplate(\n",
    "            template=template,\n",
    "            input_variables=[\"query\"],\n",
    "            partial_variables={\"reasoning\": reasoning}\n",
    "        )\n",
    "\n",
    "    def query(self, question: str, filters: Dict[str, Any] = None, use_reasoning: bool = True, translate: bool = True) -> Dict[str, Any]:\n",
    "        \"\"\"\n",
    "        Main query method that chooses between simple RAG and multi-document reasoning\n",
    "        based on the complexity of the question and user preference.\n",
    "        \"\"\"\n",
    "        if use_reasoning:\n",
    "            result = self.query_with_reasoning(question, translate=translate)\n",
    "            \n",
    "            # Apply filters if needed and re-run with simple RAG\n",
    "            if filters:\n",
    "                simple_result = self.simple_query(question, filters=filters, translate=False)\n",
    "                # If simple result is more specific due to filters, use it\n",
    "                if len(simple_result[\"sources\"]) < len(result[\"sources\"]):\n",
    "                    return simple_result\n",
    "        else:\n",
    "            result = self.simple_query(question, filters=filters, translate=translate)\n",
    "        \n",
    "        return result\n",
    "\n",
    "    def query_recommendations(self, question: str, evidence_level: str = None, use_reasoning: bool = True) -> Dict[str, Any]:\n",
    "        \"\"\"Query specifically for recommendations with optional evidence level filtering.\"\"\"\n",
    "        filters = {\"chunk_type\": \"recommendation\"}\n",
    "        if evidence_level:\n",
    "            filters[\"evidence_level\"] = {\"$regex\": f\"{evidence_level.lower()}.*evidence\"}\n",
    "        \n",
    "        return self.query(question, filters=filters, use_reasoning=use_reasoning)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'vector_store' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[4], line 2\u001b[0m\n\u001b[1;32m      1\u001b[0m rag \u001b[38;5;241m=\u001b[39m EnhancedMedicalRAG(\n\u001b[0;32m----> 2\u001b[0m     vector_store\u001b[38;5;241m=\u001b[39m\u001b[43mvector_store\u001b[49m,\n\u001b[1;32m      3\u001b[0m     model_name\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mgpt-4o\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;66;03m# Can also use gpt-3.5-turbo for faster/cheaper responses\u001b[39;00m\n\u001b[1;32m      4\u001b[0m \n\u001b[1;32m      5\u001b[0m )\n\u001b[1;32m      7\u001b[0m \u001b[38;5;66;03m# Example 1: Simple query\u001b[39;00m\n\u001b[1;32m      8\u001b[0m result \u001b[38;5;241m=\u001b[39m rag\u001b[38;5;241m.\u001b[39msimple_query(\n\u001b[1;32m      9\u001b[0m     question\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mWhat foods should I avoid during pregnancy?\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     10\u001b[0m )\n",
      "\u001b[0;31mNameError\u001b[0m: name 'vector_store' is not defined"
     ]
    }
   ],
   "source": [
    "rag = EnhancedMedicalRAG(\n",
    "    vector_store=vector_store,\n",
    "    model_name=\"gpt-4o\" # Can also use gpt-3.5-turbo for faster/cheaper responses\n",
    "\n",
    ")\n",
    "\n",
    "# Example 1: Simple query\n",
    "result = rag.simple_query(\n",
    "    question=\"What foods should I avoid during pregnancy?\"\n",
    ")\n",
    "print(f\"Simple Query Answer: {result['answer']}\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# maternal health pipeline ( used this for hybrid rag)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# ─── NEW: helper wrapper ────────────────────────────────────────────────────────\n",
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "\n",
    "class E5Embeddings(HuggingFaceEmbeddings):\n",
    "    \"\"\"\n",
    "    Adds the 'query: ' / 'passage: ' prefixes that E5‑instruct models expect.\n",
    "    Everything else (batch‑ing, normalisation, device etc.) is inherited.\n",
    "    \"\"\"\n",
    "    def __init__(self, device: str = \"cpu\",\n",
    "                 model_name: str = \"intfloat/multilingual-e5-large-instruct\",\n",
    "                 batch_size: int = 32):\n",
    "        super().__init__(\n",
    "            model_name=model_name,\n",
    "            model_kwargs={\"device\": device},\n",
    "            encode_kwargs={\n",
    "                \"normalize_embeddings\": True,\n",
    "                \"batch_size\": batch_size\n",
    "            },\n",
    "        )\n",
    "        self._query_prefix   = \"query: \"\n",
    "        self._passage_prefix = \"passage: \"\n",
    "\n",
    "    # LangChain will call these two methods internally  ↓\n",
    "    def embed_query(self, text: str):\n",
    "        return super().embed_query(self._query_prefix + text)\n",
    "\n",
    "    def embed_documents(self, texts):\n",
    "        texts = [self._passage_prefix + t for t in texts]\n",
    "        return super().embed_documents(texts)\n",
    "# ────────────────────────────────────────────────────────────────────────────────\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import re\n",
    "import json\n",
    "import uuid\n",
    "from typing import List, Dict, Any, Optional, Tuple, Set\n",
    "from dataclasses import dataclass\n",
    "from functools import lru_cache\n",
    "import logging\n",
    "from tqdm import tqdm\n",
    "\n",
    "# LangChain imports\n",
    "from langchain.document_loaders import TextLoader, PyPDFLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain.docstore.document import Document\n",
    "from langchain.schema import BaseDocumentTransformer\n",
    "from langchain.vectorstores import FAISS\n",
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "from langchain.llms import OpenAI\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "from langchain.chains import RetrievalQA\n",
    "from langchain.prompts import PromptTemplate\n",
    "\n",
    "# Configure logging\n",
    "logging.basicConfig(\n",
    "    level=logging.INFO,\n",
    "    format='%(asctime)s - %(levelname)s - %(message)s',\n",
    "    handlers=[\n",
    "        logging.FileHandler(\"maternal_health_pipeline.log\"),\n",
    "        logging.StreamHandler()\n",
    "    ]\n",
    ")\n",
    "logger = logging.getLogger(__name__)\n",
    "\n",
    "class MaternalHealthPipeline:\n",
    "    \"\"\"\n",
    "    Comprehensive pipeline for processing and retrieving maternal health documents.\n",
    "    This implements a hybrid semantic-hierarchical chunking approach optimized for\n",
    "    maternal health content and patient queries.\n",
    "    \"\"\"\n",
    "    \n",
    "    def __init__(\n",
    "        self,\n",
    "        chunk_size: int = 2500,\n",
    "        chunk_overlap: int = 400,\n",
    "        embedding_model_name: str = \"google/muril-base-cased\",  # MuRIL for multilingual support\n",
    "        db_directory: str = \"maternal_health_db\",\n",
    "        spacy_model: str = \"en_core_web_md\",\n",
    "        use_spacy: bool = True\n",
    "    ):\n",
    "        \"\"\"\n",
    "        Initialize the maternal health document pipeline.\n",
    "        \n",
    "        Args:\n",
    "            chunk_size: Target size for document chunks\n",
    "            chunk_overlap: Amount of overlap between chunks\n",
    "            embedding_model_name: HuggingFace model for embeddings\n",
    "            db_directory: Directory to store vector database\n",
    "            spacy_model: SpaCy model for NLP processing\n",
    "            use_spacy: Whether to use SpaCy for enhanced NLP\n",
    "        \"\"\"\n",
    "        self.chunk_size = chunk_size\n",
    "        self.chunk_overlap = chunk_overlap\n",
    "        self.embedding_model_name = embedding_model_name\n",
    "        self.db_directory = db_directory\n",
    "        self.db = None\n",
    "        \n",
    "        # Create db directory if it doesn't exist\n",
    "        os.makedirs(db_directory, exist_ok=True)\n",
    "        \n",
    "        # Initialize embedding model - use MuRIL for better multilingual support\n",
    "        logger.info(f\"Initializing embeddings model: {embedding_model_name}\")\n",
    "        self.embeddings = E5Embeddings(device=\"cuda\")\n",
    "        # Initialize SpaCy if requested\n",
    "        self.use_spacy = use_spacy\n",
    "        if use_spacy:\n",
    "            try:\n",
    "                import spacy\n",
    "                try:\n",
    "                    self.nlp = spacy.load(spacy_model)\n",
    "                    logger.info(f\"Loaded SpaCy model: {spacy_model}\")\n",
    "                except OSError:\n",
    "                    logger.info(f\"Downloading SpaCy model: {spacy_model}\")\n",
    "                    spacy.cli.download(spacy_model)\n",
    "                    self.nlp = spacy.load(spacy_model)\n",
    "            except ImportError:\n",
    "                logger.warning(\"SpaCy not available. Some features will be limited.\")\n",
    "                self.use_spacy = False\n",
    "                self.nlp = None\n",
    "        else:\n",
    "            self.nlp = None\n",
    "\n",
    "        # Check for existing vector store\n",
    "        index_path = os.path.join(db_directory, \"index.faiss\")\n",
    "        if os.path.exists(index_path):\n",
    "            logger.info(f\"Loading existing vector store from {index_path}\")\n",
    "            self.db = FAISS.load_local(\n",
    "                folder_path=db_directory,\n",
    "                embeddings=self.embeddings,\n",
    "                allow_dangerous_deserialization=True\n",
    "            )\n",
    "        else:\n",
    "            self.db = None\n",
    "        \n",
    "        # Compile regex patterns\n",
    "        self._compile_regex_patterns()\n",
    "        \n",
    "        # Initialize domain-specific knowledge\n",
    "        self._initialize_domain_knowledge()\n",
    "    \n",
    "    def _compile_regex_patterns(self):\n",
    "        \"\"\"Compile all regex patterns used across the pipeline for performance.\"\"\"\n",
    "        # Document structure patterns\n",
    "        self.structure_patterns = {\n",
    "            # Formal headers in guidelines\n",
    "            'formal_header': re.compile(r'^(?:[0-9]+\\.){1,3}\\s+[A-Z]|^(?:CHAPTER|Section|SECTION)\\s+[0-9IVX]+', re.MULTILINE),\n",
    "            \n",
    "            # Natural language headers\n",
    "            'nl_header': re.compile(r'^[A-Z][A-Za-z\\s]+:$|^[A-Z][A-Za-z\\s]+ during [A-Za-z\\s]+$', re.MULTILINE),\n",
    "            \n",
    "            # Special content markers\n",
    "            'special_marker': re.compile(r'^(?:NOTE|WARNING|CAUTION|RECOMMENDATION|EVIDENCE|BOX|Table|Figure):?', re.MULTILINE),\n",
    "            \n",
    "            # Document boundaries\n",
    "            'doc_boundary': re.compile(r'(?:\\n\\s*){3,}|\\f|(?:=+\\s*){3,}|(?:-+\\s*){3,}')\n",
    "        }\n",
    "        \n",
    "        # Content preservation patterns\n",
    "        self.preservation_patterns = {\n",
    "            # Lists\n",
    "            'list': re.compile(r'(?:^[•\\-\\*√]\\s+.+(?:\\n|$)){2,}', re.MULTILINE),\n",
    "            \n",
    "            # Tables (various formats)\n",
    "            'table': re.compile(r'(?:\\|.+\\|.+\\|.+\\n){2,}|(?:^[\\w\\s]+\\t+[\\w\\s]+\\t+[\\w\\s]+(?:\\n|$)){2,}', re.MULTILINE),\n",
    "            \n",
    "            # Warning blocks\n",
    "            'warning': re.compile(r'(?:Warning|Caution|Alert|WARNING|CAUTION|ALERT):[\\s\\S]+?(?:\\n\\n|\\Z)', re.MULTILINE),\n",
    "            \n",
    "            # Recommendation blocks\n",
    "            'recommendation': re.compile(r'(?:Recommendation|RECOMMENDATION):[\\s\\S]+?(?:\\n\\n|\\Z)', re.MULTILINE),\n",
    "            \n",
    "            # Numbered steps/procedures\n",
    "            'steps': re.compile(r'(?:^[0-9]+\\.\\s+.+(?:\\n|$)){2,}', re.MULTILINE)\n",
    "        }\n",
    "        \n",
    "        # Pregnancy stage patterns\n",
    "        self.stage_patterns = {\n",
    "            'week': re.compile(r'(?:week|weeks)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+week', re.IGNORECASE),\n",
    "            'month': re.compile(r'(?:month|months)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+month', re.IGNORECASE),\n",
    "            'trimester': re.compile(r'(first|second|third)\\s+trimester', re.IGNORECASE),\n",
    "            'stage': re.compile(r'(preconception|prenatal|antenatal|perinatal|intrapartum|postpartum|postnatal)', re.IGNORECASE)\n",
    "        }\n",
    "        \n",
    "        # Clinical patterns\n",
    "        self.clinical_patterns = {\n",
    "            'measurement': re.compile(r'(\\d+(?:\\.\\d+)?)\\s*(cm|mm|kg|g|lb|oz|bpm|mmHg|%|mg|mcg|IU)', re.IGNORECASE),\n",
    "            'dosage': re.compile(r'(\\d+(?:\\.\\d+)?)\\s*(mg|mcg|g|ml|IU|units)\\s+(\\d+(?:-\\d+)?)\\s*times?(\\/day|\\/week|daily|weekly)', re.IGNORECASE)\n",
    "        }\n",
    "    \n",
    "    def _initialize_domain_knowledge(self):\n",
    "        \"\"\"Initialize comprehensive domain knowledge for maternal health.\"\"\"\n",
    "        # Document categories\n",
    "        self.doc_categories = {\n",
    "            'clinical': ['guideline', 'protocol', 'recommendation', 'clinical', 'medical', 'treatment', 'diagnosis', 'procedure'],\n",
    "            'educational': ['education', 'information', 'guide', 'leaflet', 'brochure', 'advice'],\n",
    "            'nutritional': ['nutrition', 'diet', 'food', 'eating', 'meal', 'vitamin', 'supplement'],\n",
    "            'behavioral': ['behavior', 'behaviour', 'habit', 'lifestyle', 'exercise', 'activity', 'practice'],\n",
    "            'emotional': ['emotional', 'mental', 'psychological', 'feeling', 'support', 'stress', 'anxiety', 'depression']\n",
    "        }\n",
    "        \n",
    "        # Pregnancy stages (for improved stage detection)\n",
    "        self.pregnancy_stages = {\n",
    "            'preconception': ['planning', 'before pregnancy', 'preconception', 'pre-conception', 'fertility'],\n",
    "            'first_trimester': ['first trimester', 'early pregnancy', 'weeks 1-12', '1st trimester'],\n",
    "            'second_trimester': ['second trimester', 'mid pregnancy', 'weeks 13-26', '2nd trimester'],\n",
    "            'third_trimester': ['third trimester', 'late pregnancy', 'weeks 27-40', '3rd trimester'],\n",
    "            'labor_delivery': ['labor', 'labour', 'delivery', 'birth', 'childbirth', 'intrapartum'],\n",
    "            'postpartum': ['postpartum', 'postnatal', 'after birth', 'puerperium', 'fourth trimester', '4th trimester']\n",
    "        }\n",
    "        \n",
    "        # Common maternal health topics\n",
    "        self.maternal_topics = {\n",
    "            'fetal_development': ['development', 'growth', 'fetal', 'foetal', 'baby', 'fetus', 'embryo'],\n",
    "            'maternal_changes': ['mother', 'maternal', 'body', 'changes', 'symptoms', 'physical'],\n",
    "            'nutrition': ['diet', 'food', 'nutrition', 'eat', 'meal', 'vitamin', 'nutrient', 'folate', 'iron'],\n",
    "            'warning_signs': ['danger', 'warning', 'risk', 'emergency', 'complication', 'problem'],\n",
    "            'normal_variations': ['normal', 'common', 'usual', 'typical', 'variant', 'variation', 'expected'],\n",
    "            'medical_tests': ['test', 'scan', 'ultrasound', 'screening', 'monitor', 'measurement'],\n",
    "            'delivery': ['birth', 'labor', 'labour', 'delivery', 'contractions', 'childbirth'],\n",
    "            'postpartum': ['after birth', 'post-delivery', 'postpartum', 'post-natal', 'breastfeeding'],\n",
    "            'mental_health': ['mental', 'depression', 'anxiety', 'mood', 'stress', 'emotional'],\n",
    "            'prenatal_care': ['prenatal', 'antenatal', 'checkup', 'visit', 'appointment', 'healthcare']\n",
    "        }\n",
    "        \n",
    "        # Common patient concerns (for enhanced retrieval)\n",
    "        self.patient_concerns = {\n",
    "            'pain': ['pain', 'ache', 'discomfort', 'hurt', 'sore', 'cramp'],\n",
    "            'bleeding': ['bleed', 'blood', 'spotting', 'hemorrhage', 'discharge'],\n",
    "            'movement': ['movement', 'kick', 'active', 'moving', 'stirring', 'flutter'],\n",
    "            'nausea': ['nausea', 'vomit', 'sick', 'morning sickness', 'hyperemesis'],\n",
    "            'sleep': ['sleep', 'insomnia', 'tired', 'fatigue', 'exhausted', 'rest'],\n",
    "            'emotions': ['emotion', 'mood', 'cry', 'anxiety', 'worry', 'fear', 'depression'],\n",
    "            'nutrition': ['eat', 'food', 'diet', 'craving', 'appetite', 'weight', 'nutrition']\n",
    "        }\n",
    "        \n",
    "        # Medical entities\n",
    "        self.medical_entities = {\n",
    "            'conditions': [\n",
    "                'preeclampsia', 'eclampsia', 'gestational diabetes', 'anemia', 'anaemia',\n",
    "                'hypertension', 'nausea', 'vomiting', 'morning sickness', 'hyperemesis',\n",
    "                'placenta previa', 'preterm labor', 'preterm birth', 'ectopic pregnancy',\n",
    "                'miscarriage', 'bleeding', 'spotting', 'edema', 'swelling', 'back pain',\n",
    "                'postpartum depression', 'postpartum hemorrhage', 'mastitis', 'HELLP syndrome',\n",
    "                'gestational hypertension', 'cholestasis', 'UTI', 'yeast infection'\n",
    "            ],\n",
    "            'medications': [\n",
    "                'iron', 'folate', 'folic acid', 'vitamin', 'supplement', 'prenatal vitamin',\n",
    "                'calcium', 'magnesium', 'zinc', 'omega-3', 'aspirin', 'antacid', 'insulin',\n",
    "                'labetalol', 'methyldopa', 'nifedipine', 'paracetamol', 'acetaminophen',\n",
    "                'ibuprofen', 'metformin', 'heparin', 'progesterone', 'oxytocin', 'epidural'\n",
    "            ],\n",
    "            'procedures': [\n",
    "                'ultrasound', 'scan', 'test', 'screening', 'amniocentesis', 'delivery',\n",
    "                'c-section', 'cesarean', 'caesarean', 'induction', 'epidural', 'monitoring',\n",
    "                'glucose test', 'blood test', 'urine test', 'group b strep', 'genetic screening',\n",
    "                'CVS', 'chorionic villus sampling', 'NIPT', 'NST', 'non-stress test',\n",
    "                'biophysical profile', 'cervical check', 'membrane sweep'\n",
    "            ],\n",
    "            'measurements': [\n",
    "                'weight', 'blood pressure', 'fundal height', 'bp', 'heart rate', 'fetal heart rate',\n",
    "                'bpm', 'glucose', 'temperature', 'hcg', 'hemoglobin', 'haemoglobin', 'blood sugar',\n",
    "                'contractions', 'dilation', 'effacement', 'station', 'bilirubin', 'amniotic fluid index'\n",
    "            ]\n",
    "        }\n",
    "    \n",
    "    @lru_cache(maxsize=32)\n",
    "    def _extract_document_metadata(self, text_sample: str, filename: str = None) -> Dict[str, Any]:\n",
    "        \"\"\"\n",
    "        Extract document-level metadata from text sample.\n",
    "        \n",
    "        Args:\n",
    "            text_sample: Representative sample of document text\n",
    "            filename: Original document filename\n",
    "            \n",
    "        Returns:\n",
    "            Dict containing document metadata\n",
    "        \"\"\"\n",
    "        text_lower = text_sample.lower()\n",
    "        metadata = {\n",
    "            \"filename\": filename,\n",
    "            \"document_categories\": []\n",
    "        }\n",
    "        \n",
    "        # Extract document categories\n",
    "        for category, keywords in self.doc_categories.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                metadata[\"document_categories\"].append(category)\n",
    "        \n",
    "        # Determine document type by content and filename patterns\n",
    "        doc_type = \"Maternal Health Document\"  # Default\n",
    "        \n",
    "        if filename:\n",
    "            filename_lower = filename.lower()\n",
    "            if any(term in filename_lower for term in ['guideline', 'guide', 'protocol']):\n",
    "                if 'anc' in filename_lower or 'prenatal' in filename_lower or 'antenatal' in filename_lower:\n",
    "                    doc_type = \"Antenatal Care Guideline\"\n",
    "                elif 'pnc' in filename_lower or 'postnatal' in filename_lower or 'postpartum' in filename_lower:\n",
    "                    doc_type = \"Postnatal Care Guideline\"\n",
    "                elif 'nutr' in filename_lower or 'diet' in filename_lower or 'food' in filename_lower:\n",
    "                    doc_type = \"Maternal Nutrition Guide\"\n",
    "                elif 'ppd' in filename_lower or 'depress' in filename_lower or 'mental' in filename_lower:\n",
    "                    doc_type = \"Maternal Mental Health Guide\"\n",
    "                else:\n",
    "                    doc_type = \"Clinical Guideline\"\n",
    "        \n",
    "        # Look for title in content\n",
    "        title_pattern = re.compile(r'^[A-Z][\\w\\s:]+(?:Guidelines?|Protocol|Care|Health|Management)', re.MULTILINE)\n",
    "        title_match = title_pattern.search(text_sample[:2000])\n",
    "        if title_match:\n",
    "            metadata[\"title\"] = title_match.group(0).strip()\n",
    "        else:\n",
    "            # Try to construct title from filename if available\n",
    "            if filename:\n",
    "                base_name = os.path.splitext(os.path.basename(filename))[0]\n",
    "                # Convert snake_case or kebab-case to Title Case\n",
    "                base_name = re.sub(r'[_-]', ' ', base_name).title()\n",
    "                metadata[\"title\"] = base_name\n",
    "            else:\n",
    "                metadata[\"title\"] = doc_type\n",
    "        \n",
    "        metadata[\"document_type\"] = doc_type\n",
    "        \n",
    "        # Extract primary pregnancy stages\n",
    "        primary_stages = []\n",
    "        for stage, keywords in self.pregnancy_stages.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                primary_stages.append(stage)\n",
    "        \n",
    "        metadata[\"primary_stages\"] = primary_stages\n",
    "        \n",
    "        return metadata\n",
    "    \n",
    "    def extract_pregnancy_stages(self, text: str) -> Dict[str, List]:\n",
    "        \"\"\"\n",
    "        Extract all pregnancy stages mentioned in the text.\n",
    "        \n",
    "        Args:\n",
    "            text: Text to analyze\n",
    "            \n",
    "        Returns:\n",
    "            Dict with pregnancy stage information\n",
    "        \"\"\"\n",
    "        stages = {\n",
    "            \"weeks\": [],\n",
    "            \"months\": [],\n",
    "            \"trimesters\": [],\n",
    "            \"named_stages\": []\n",
    "        }\n",
    "        \n",
    "        # Extract weeks\n",
    "        for match in self.stage_patterns['week'].finditer(text):\n",
    "            week_str = match.group(1) or match.group(2)\n",
    "            if week_str:\n",
    "                if '-' in week_str:\n",
    "                    try:\n",
    "                        start, end = map(int, week_str.split('-'))\n",
    "                        stages[\"weeks\"].extend(list(range(start, end + 1)))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "                else:\n",
    "                    try:\n",
    "                        stages[\"weeks\"].append(int(week_str))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "        \n",
    "        # Extract months\n",
    "        for match in self.stage_patterns['month'].finditer(text):\n",
    "            month_str = match.group(1) or match.group(2)\n",
    "            if month_str:\n",
    "                if '-' in month_str:\n",
    "                    try:\n",
    "                        start, end = map(int, month_str.split('-'))\n",
    "                        stages[\"months\"].extend(list(range(start, end + 1)))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "                else:\n",
    "                    try:\n",
    "                        stages[\"months\"].append(int(month_str))\n",
    "                    except ValueError:\n",
    "                        pass\n",
    "        \n",
    "        # Extract trimesters\n",
    "        for match in self.stage_patterns['trimester'].finditer(text):\n",
    "            trimester = match.group(1).lower()\n",
    "            stages[\"trimesters\"].append(trimester)\n",
    "        \n",
    "        # Extract named stages\n",
    "        for match in self.stage_patterns['stage'].finditer(text):\n",
    "            named_stage = match.group(1).lower()\n",
    "            stages[\"named_stages\"].append(named_stage)\n",
    "        \n",
    "        # Remove duplicates\n",
    "        for key in stages:\n",
    "            stages[key] = list(set(stages[key]))\n",
    "            \n",
    "        # Map to standard stage categorization\n",
    "        standard_stages = set()\n",
    "        \n",
    "        # Map from weeks to standard stages\n",
    "        for week in stages[\"weeks\"]:\n",
    "            if 1 <= week <= 12:\n",
    "                standard_stages.add(\"first_trimester\")\n",
    "            elif 13 <= week <= 26:\n",
    "                standard_stages.add(\"second_trimester\")\n",
    "            elif 27 <= week <= 42:\n",
    "                standard_stages.add(\"third_trimester\")\n",
    "        \n",
    "        # Map from months to standard stages\n",
    "        for month in stages[\"months\"]:\n",
    "            if 1 <= month <= 3:\n",
    "                standard_stages.add(\"first_trimester\")\n",
    "            elif 4 <= month <= 6:\n",
    "                standard_stages.add(\"second_trimester\")\n",
    "            elif 7 <= month <= 10:\n",
    "                standard_stages.add(\"third_trimester\")\n",
    "        \n",
    "        # Map from named trimesters\n",
    "        for trimester in stages[\"trimesters\"]:\n",
    "            if trimester == \"first\":\n",
    "                standard_stages.add(\"first_trimester\")\n",
    "            elif trimester == \"second\":\n",
    "                standard_stages.add(\"second_trimester\")\n",
    "            elif trimester == \"third\":\n",
    "                standard_stages.add(\"third_trimester\")\n",
    "        \n",
    "        # Map from named stages\n",
    "        for stage in stages[\"named_stages\"]:\n",
    "            if stage in [\"preconception\", \"pre-conception\"]:\n",
    "                standard_stages.add(\"preconception\")\n",
    "            elif stage in [\"prenatal\", \"antenatal\"]:\n",
    "                # These are general terms - don't add a specific stage\n",
    "                pass\n",
    "            elif stage == \"perinatal\":\n",
    "                standard_stages.add(\"labor_delivery\")\n",
    "            elif stage == \"intrapartum\":\n",
    "                standard_stages.add(\"labor_delivery\")\n",
    "            elif stage in [\"postpartum\", \"postnatal\"]:\n",
    "                standard_stages.add(\"postpartum\")\n",
    "        \n",
    "        stages[\"standard_stages\"] = list(standard_stages)\n",
    "        \n",
    "        return stages\n",
    "    \n",
    "    def extract_medical_entities(self, text: str) -> Dict[str, List[str]]:\n",
    "        \"\"\"\n",
    "        Extract medical entities from text using pattern matching and NLP.\n",
    "        \n",
    "        Args:\n",
    "            text: Text to analyze\n",
    "            \n",
    "        Returns:\n",
    "            Dict with medical entities by category\n",
    "        \"\"\"\n",
    "        text_lower = text.lower()\n",
    "        \n",
    "        entities = {\n",
    "            \"conditions\": [],\n",
    "            \"medications\": [],\n",
    "            \"procedures\": [],\n",
    "            \"measurements\": []\n",
    "        }\n",
    "        \n",
    "        # Extract entities using pattern matching\n",
    "        for entity_type, entity_list in self.medical_entities.items():\n",
    "            for entity in entity_list:\n",
    "                if entity in text_lower:\n",
    "                    entities[entity_type].append(entity)\n",
    "        \n",
    "        # Extract measurements using regex\n",
    "        for match in self.clinical_patterns['measurement'].finditer(text):\n",
    "            measurement = match.group(0)\n",
    "            if measurement not in entities[\"measurements\"]:\n",
    "                entities[\"measurements\"].append(measurement)\n",
    "        \n",
    "        # Extract dosages using regex\n",
    "        for match in self.clinical_patterns['dosage'].finditer(text):\n",
    "            dosage = match.group(0)\n",
    "            if dosage not in entities[\"medications\"]:\n",
    "                entities[\"medications\"].append(dosage)\n",
    "        \n",
    "        # Use SpaCy for enhanced entity extraction if available\n",
    "        if self.use_spacy and self.nlp is not None:\n",
    "            try:\n",
    "                # Process with SpaCy - limit text length to avoid memory issues\n",
    "                # Truncate to ~10,000 chars for efficiency\n",
    "                truncated_text = text[:10000] if len(text) > 10000 else text\n",
    "                doc = self.nlp(truncated_text)\n",
    "                \n",
    "                # Extract medical entities from SpaCy\n",
    "                for ent in doc.ents:\n",
    "                    ent_text = ent.text.lower()\n",
    "                    \n",
    "                    # Map SpaCy entities to our categories\n",
    "                    if ent.label_ in [\"CONDITION\", \"DISEASE\", \"PROBLEM\"]:\n",
    "                        if ent_text not in entities[\"conditions\"]:\n",
    "                            entities[\"conditions\"].append(ent_text)\n",
    "                    elif ent.label_ in [\"TREATMENT\", \"PROCEDURE\"]:\n",
    "                        if ent_text not in entities[\"procedures\"]:\n",
    "                            entities[\"procedures\"].append(ent_text)\n",
    "                    elif ent.label_ in [\"MEDICATION\", \"DRUG\"]:\n",
    "                        if ent_text not in entities[\"medications\"]:\n",
    "                            entities[\"medications\"].append(ent_text)\n",
    "                    elif ent.label_ in [\"QUANTITY\"] and any(unit in ent_text for unit in [\"mg\", \"kg\", \"cm\", \"mmHg\", \"bpm\"]):\n",
    "                        if ent_text not in entities[\"measurements\"]:\n",
    "                            entities[\"measurements\"].append(ent_text)\n",
    "            except Exception as e:\n",
    "                logger.warning(f\"Error during SpaCy processing: {e}\")\n",
    "        \n",
    "        return entities\n",
    "    \n",
    "    def identify_topics_and_concerns(self, text: str) -> Dict[str, List[str]]:\n",
    "        \"\"\"\n",
    "        Identify maternal health topics and patient concerns in text.\n",
    "        \n",
    "        Args:\n",
    "            text: Text to analyze\n",
    "            \n",
    "        Returns:\n",
    "            Dict with identified topics and concerns\n",
    "        \"\"\"\n",
    "        text_lower = text.lower()\n",
    "        results = {\n",
    "            \"topics\": [],\n",
    "            \"concerns\": [],\n",
    "            \"content_types\": []\n",
    "        }\n",
    "        \n",
    "        # Identify topics\n",
    "        for topic, keywords in self.maternal_topics.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                results[\"topics\"].append(topic)\n",
    "        \n",
    "        # Identify patient concerns\n",
    "        for concern, keywords in self.patient_concerns.items():\n",
    "            if any(keyword in text_lower for keyword in keywords):\n",
    "                results[\"concerns\"].append(concern)\n",
    "        \n",
    "        # Identify content types\n",
    "        content_indicators = {\n",
    "            \"warning\": [\"warning\", \"caution\", \"danger\", \"alert\", \"emergency\", \"attention\"],\n",
    "            \"recommendation\": [\"recommend\", \"should\", \"advised\", \"advise\", \"important\", \"must\"],\n",
    "            \"information\": [\"information\", \"facts\", \"overview\", \"background\", \"introduction\"],\n",
    "            \"instruction\": [\"step\", \"steps\", \"procedure\", \"instructions\", \"follow\", \"method\"],\n",
    "            \"faq\": [\"question\", \"answer\", \"frequently\", \"asked\", \"faq\", \"q&a\", \"q:\", \"a:\"]\n",
    "        }\n",
    "        \n",
    "        for content_type, indicators in content_indicators.items():\n",
    "            if any(indicator in text_lower for indicator in indicators):\n",
    "                results[\"content_types\"].append(content_type)\n",
    "        \n",
    "        # Check for lists and tables using regex\n",
    "        if self.preservation_patterns['list'].search(text):\n",
    "            results[\"content_types\"].append(\"list\")\n",
    "        \n",
    "        if self.preservation_patterns['table'].search(text):\n",
    "            results[\"content_types\"].append(\"table\")\n",
    "        \n",
    "        return results\n",
    "    \n",
    "    def split_text_into_sections(self, text: str) -> List[Tuple[str, str]]:\n",
    "        \"\"\"\n",
    "        Split text into semantically meaningful sections with headers.\n",
    "        \n",
    "        Args:\n",
    "            text: Full document text\n",
    "            \n",
    "        Returns:\n",
    "            List of (header, section_text) tuples\n",
    "        \"\"\"\n",
    "        # If text is small enough, don't bother splitting\n",
    "        if len(text) < 5000:\n",
    "            return [(\"\", text)]\n",
    "        \n",
    "        # Find all semantic boundaries using header patterns\n",
    "        header_positions = []\n",
    "        \n",
    "        # Collect positions of all types of headers\n",
    "        for pattern_name, pattern in self.structure_patterns.items():\n",
    "            if pattern_name in ['formal_header', 'nl_header', 'special_marker']:\n",
    "                for match in pattern.finditer(text):\n",
    "                    header_positions.append((match.start(), match.group(0)))\n",
    "        \n",
    "        # Sort header positions by their occurrence in text\n",
    "        header_positions.sort(key=lambda x: x[0])\n",
    "        \n",
    "        # Filter out headers that are too close together (likely not real section headers)\n",
    "        if header_positions:\n",
    "            filtered_positions = [(0, \"\")]  # Start with the beginning of text\n",
    "            for pos, header in header_positions:\n",
    "                # Only keep headers that are at least 500 chars from the previous header\n",
    "                if pos - filtered_positions[-1][0] >= 500:\n",
    "                    filtered_positions.append((pos, header))\n",
    "            \n",
    "            # If we only have the start position, there are no useful headers\n",
    "            if len(filtered_positions) == 1:\n",
    "                return [(\"\", text)]\n",
    "            \n",
    "            # Create sections based on header positions\n",
    "            sections = []\n",
    "            for i in range(len(filtered_positions) - 1):\n",
    "                start_pos, header = filtered_positions[i]\n",
    "                end_pos = filtered_positions[i+1][0]\n",
    "                \n",
    "                # Skip the first \"header\" which is just the start position\n",
    "                if i == 0 and start_pos == 0 and header == \"\":\n",
    "                    continue\n",
    "                \n",
    "                section_text = text[start_pos:end_pos].strip()\n",
    "                if section_text:\n",
    "                    sections.append((header.strip(), section_text))\n",
    "            \n",
    "            # Don't forget the last section\n",
    "            last_pos, last_header = filtered_positions[-1]\n",
    "            last_section = text[last_pos:].strip()\n",
    "            if last_section:\n",
    "                sections.append((last_header.strip(), last_section))\n",
    "            \n",
    "            return sections if sections else [(\"\", text)]\n",
    "        else:\n",
    "            # If no headers detected, return the whole text\n",
    "            return [(\"\", text)]\n",
    "    \n",
    "    def find_preservation_blocks(self, text: str) -> List[Tuple[int, int, str, str]]:\n",
    "        \"\"\"\n",
    "        Find blocks of text that should be preserved during chunking.\n",
    "        \n",
    "        Args:\n",
    "            text: Text to analyze\n",
    "            \n",
    "        Returns:\n",
    "            List of (start_pos, end_pos, block_text, block_type) tuples\n",
    "        \"\"\"\n",
    "        preserved_blocks = []\n",
    "        \n",
    "        # Check each preservation pattern\n",
    "        for block_type, pattern in self.preservation_patterns.items():\n",
    "            for match in pattern.finditer(text):\n",
    "                preserved_blocks.append((match.start(), match.end(), match.group(0), block_type))\n",
    "        \n",
    "        # Sort by start position\n",
    "        preserved_blocks.sort(key=lambda x: x[0])\n",
    "        \n",
    "        return preserved_blocks\n",
    "    \n",
    "    def create_semantic_chunks(self, section_text: str, section_header: str, doc_metadata: Dict[str, Any]) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Create semantically meaningful chunks from a section of text.\n",
    "        \n",
    "        Args:\n",
    "            section_text: Text of the section to chunk\n",
    "            section_header: Header of the section\n",
    "            doc_metadata: Document-level metadata\n",
    "            \n",
    "        Returns:\n",
    "            List of Document objects with chunks and metadata\n",
    "        \"\"\"\n",
    "        # If section is small enough, keep it as one chunk\n",
    "        if len(section_text) <= self.chunk_size:\n",
    "            return [self._create_chunk_document(section_text, section_header, doc_metadata)]\n",
    "        \n",
    "        # Find blocks that should be preserved\n",
    "        preserved_blocks = self.find_preservation_blocks(section_text)\n",
    "        \n",
    "        chunks = []\n",
    "        \n",
    "        # If we have SpaCy available, use sentence boundaries for better chunking\n",
    "        if self.use_spacy and self.nlp is not None:\n",
    "            # Handle preserved blocks first\n",
    "            if preserved_blocks:\n",
    "                # Create a map of positions to skip (preserved blocks)\n",
    "                skip_ranges = [(start, end) for start, end, _, _ in preserved_blocks]\n",
    "                \n",
    "                # Process text outside preserved blocks with sentence boundaries\n",
    "                current_pos = 0\n",
    "                current_chunk = []\n",
    "                current_length = 0\n",
    "                \n",
    "                try:\n",
    "                    # Process text in chunks to avoid memory issues with very large texts\n",
    "                    segment_length = 50000  # Process 50k chars at a time\n",
    "                    for i in range(0, len(section_text), segment_length):\n",
    "                        segment = section_text[i:i+segment_length]\n",
    "                        \n",
    "                        # Adjust positions to account for the segment offset\n",
    "                        segment_offset = i\n",
    "                        \n",
    "                        # Process with SpaCy for sentence boundaries\n",
    "                        doc = self.nlp(segment)\n",
    "                        sentences = list(doc.sents)\n",
    "                        \n",
    "                        for sentence in sentences:\n",
    "                            # Adjust sentence positions to absolute document position\n",
    "                            abs_start = sentence.start_char + segment_offset\n",
    "                            abs_end = sentence.end_char + segment_offset\n",
    "                            \n",
    "                            # Check if this sentence overlaps with any preserved block\n",
    "                            in_preserved_block = False\n",
    "                            for start, end in skip_ranges:\n",
    "                                if (start <= abs_start < end) or (start < abs_end <= end) or (abs_start <= start and abs_end >= end):\n",
    "                                    in_preserved_block = True\n",
    "                                    break\n",
    "                            \n",
    "                            if in_preserved_block:\n",
    "                                continue\n",
    "                                \n",
    "                            sentence_text = sentence.text.strip()\n",
    "                            \n",
    "                            # If adding this sentence exceeds chunk size, create a new chunk\n",
    "                            if current_length + len(sentence_text) > self.chunk_size and current_chunk:\n",
    "                                chunk_text = ' '.join(current_chunk)\n",
    "                                chunks.append(self._create_chunk_document(chunk_text, section_header, doc_metadata))\n",
    "                                current_chunk = []\n",
    "                                current_length = 0\n",
    "                            \n",
    "                            # Add sentence to current chunk\n",
    "                            current_chunk.append(sentence_text)\n",
    "                            current_length += len(sentence_text) + 1  # +1 for space\n",
    "                        \n",
    "                except Exception as e:\n",
    "                    logger.warning(f\"Error during SpaCy processing: {e}\")\n",
    "                    # Fall back to simpler chunking method\n",
    "                    return self._simple_chunk_section(section_text, section_header, doc_metadata, preserved_blocks)\n",
    "                \n",
    "                # Add final chunk\n",
    "                if current_chunk:\n",
    "                    chunk_text = ' '.join(current_chunk)\n",
    "                    chunks.append(self._create_chunk_document(chunk_text, section_header, doc_metadata))\n",
    "                \n",
    "                # Now add preserved blocks as separate chunks\n",
    "                for start, end, block_text, block_type in preserved_blocks:\n",
    "                    block_metadata = doc_metadata.copy()\n",
    "                    block_metadata[\"content_type\"] = block_type\n",
    "                    chunks.append(self._create_chunk_document(block_text, section_header, block_metadata))\n",
    "            else:\n",
    "                # No preserved blocks, process entire text with sentence boundaries\n",
    "                try:\n",
    "                    # Process text in chunks to avoid memory issues\n",
    "                    current_chunk = []\n",
    "                    current_length = 0\n",
    "                    \n",
    "                    # Process text in segments\n",
    "                    segment_length = 50000  # Process 50k chars at a time\n",
    "                    for i in range(0, len(section_text), segment_length):\n",
    "                        segment = section_text[i:i+segment_length]\n",
    "                        \n",
    "                        # Process with SpaCy for sentence boundaries\n",
    "                        doc = self.nlp(segment)\n",
    "                        sentences = list(doc.sents)\n",
    "                        \n",
    "                        for sentence in sentences:\n",
    "                            sentence_text = sentence.text.strip()\n",
    "                            \n",
    "                            # If adding this sentence exceeds chunk size, create a new chunk\n",
    "                            if current_length + len(sentence_text) > self.chunk_size and current_chunk:\n",
    "                                chunk_text = ' '.join(current_chunk)\n",
    "                                chunks.append(self._create_chunk_document(chunk_text, section_header, doc_metadata))\n",
    "                                current_chunk = []\n",
    "                                current_length = 0\n",
    "                            \n",
    "                            # Add sentence to current chunk\n",
    "                            current_chunk.append(sentence_text)\n",
    "                            current_length += len(sentence_text) + 1  # +1 for space\n",
    "                    \n",
    "                    # Add final chunk\n",
    "                    if current_chunk:\n",
    "                        chunk_text = ' '.join(current_chunk)\n",
    "                        chunks.append(self._create_chunk_document(chunk_text, section_header, doc_metadata))\n",
    "                        \n",
    "                except Exception as e:\n",
    "                    logger.warning(f\"Error during SpaCy processing: {e}\")\n",
    "                    # Fall back to simpler chunking method\n",
    "                    return self._simple_chunk_section(section_text, section_header, doc_metadata, preserved_blocks)\n",
    "        else:\n",
    "            # SpaCy not available, use simpler chunking\n",
    "            chunks = self._simple_chunk_section(section_text, section_header, doc_metadata, preserved_blocks)\n",
    "        \n",
    "        return chunks\n",
    "    \n",
    "    def _simple_chunk_section(self, text: str, header: str, metadata: Dict[str, Any], \n",
    "                            preserved_blocks: List[Tuple[int, int, str, str]]) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Chunk text using paragraph boundaries when SpaCy is not available.\n",
    "        \n",
    "        Args:\n",
    "            text: Text to chunk\n",
    "            header: Section header\n",
    "            metadata: Document metadata\n",
    "            preserved_blocks: List of preserved blocks\n",
    "            \n",
    "        Returns:\n",
    "            List of Document objects\n",
    "        \"\"\"\n",
    "        chunks = []\n",
    "        \n",
    "        # Handle preserved blocks first\n",
    "        if preserved_blocks:\n",
    "            # Sort preserved blocks by position\n",
    "            preserved_blocks.sort(key=lambda x: x[0])\n",
    "            \n",
    "            # Keep track of the current position\n",
    "            current_pos = 0\n",
    "            \n",
    "            # Process text segments between preserved blocks\n",
    "            for start, end, block_text, block_type in preserved_blocks:\n",
    "                # Handle text before this preserved block\n",
    "                if start > current_pos:\n",
    "                    preceding_text = text[current_pos:start].strip()\n",
    "                    if preceding_text:\n",
    "                        # Chunk this text by paragraphs\n",
    "                        preceding_chunks = self._chunk_by_paragraphs(preceding_text, header, metadata)\n",
    "                        chunks.extend(preceding_chunks)\n",
    "                \n",
    "                # Add the preserved block as its own chunk\n",
    "                block_metadata = metadata.copy()\n",
    "                block_metadata[\"content_type\"] = block_type\n",
    "                chunks.append(self._create_chunk_document(block_text, header, block_metadata))\n",
    "                \n",
    "                # Update current position\n",
    "                current_pos = end\n",
    "            \n",
    "            # Handle text after the last preserved block\n",
    "            if current_pos < len(text):\n",
    "                remaining_text = text[current_pos:].strip()\n",
    "                if remaining_text:\n",
    "                    # Chunk this text by paragraphs\n",
    "                    remaining_chunks = self._chunk_by_paragraphs(remaining_text, header, metadata)\n",
    "                    chunks.extend(remaining_chunks)\n",
    "        else:\n",
    "            # No preserved blocks, chunk entire text by paragraphs\n",
    "            chunks = self._chunk_by_paragraphs(text, header, metadata)\n",
    "        \n",
    "        return chunks\n",
    "    \n",
    "    def _chunk_by_paragraphs(self, text: str, header: str, metadata: Dict[str, Any]) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Split text into chunks based on paragraph boundaries.\n",
    "        \n",
    "        Args:\n",
    "            text: Text to chunk\n",
    "            header: Section header\n",
    "            metadata: Document metadata\n",
    "            \n",
    "        Returns:\n",
    "            List of Document objects\n",
    "        \"\"\"\n",
    "        chunks = []\n",
    "        \n",
    "        # Split on paragraph boundaries (double newlines)\n",
    "        paragraphs = re.split(r'\\n\\s*\\n', text)\n",
    "        \n",
    "        current_chunk = []\n",
    "        current_length = 0\n",
    "        \n",
    "        for paragraph in paragraphs:\n",
    "            paragraph = paragraph.strip()\n",
    "            if not paragraph:\n",
    "                continue\n",
    "                \n",
    "            # If adding this paragraph would exceed chunk size and we already have content,\n",
    "            # create a new chunk\n",
    "            if current_length + len(paragraph) > self.chunk_size and current_chunk:\n",
    "                chunk_text = '\\n\\n'.join(current_chunk)\n",
    "                chunks.append(self._create_chunk_document(chunk_text, header, metadata))\n",
    "                current_chunk = []\n",
    "                current_length = 0\n",
    "            \n",
    "            # If a single paragraph is larger than chunk size, we need to split it\n",
    "            if len(paragraph) > self.chunk_size:\n",
    "                # If we have accumulated content, create a chunk first\n",
    "                if current_chunk:\n",
    "                    chunk_text = '\\n\\n'.join(current_chunk)\n",
    "                    chunks.append(self._create_chunk_document(chunk_text, header, metadata))\n",
    "                    current_chunk = []\n",
    "                    current_length = 0\n",
    "                \n",
    "                # Split the large paragraph by sentences (using basic regex)\n",
    "                sentences = re.split(r'(?<=[.!?])\\s+', paragraph)\n",
    "                \n",
    "                sentence_chunk = []\n",
    "                sentence_length = 0\n",
    "                \n",
    "                for sentence in sentences:\n",
    "                    # If this sentence alone exceeds chunk size, we have to include it anyway\n",
    "                    # Users will just have a larger-than-ideal chunk in this case\n",
    "                    if sentence_length + len(sentence) > self.chunk_size and sentence_chunk:\n",
    "                        sentence_text = ' '.join(sentence_chunk)\n",
    "                        chunks.append(self._create_chunk_document(sentence_text, header, metadata))\n",
    "                        sentence_chunk = []\n",
    "                        sentence_length = 0\n",
    "                    \n",
    "                    sentence_chunk.append(sentence)\n",
    "                    sentence_length += len(sentence) + 1  # +1 for space\n",
    "                \n",
    "                # Add final sentence chunk if any\n",
    "                if sentence_chunk:\n",
    "                    sentence_text = ' '.join(sentence_chunk)\n",
    "                    chunks.append(self._create_chunk_document(sentence_text, header, metadata))\n",
    "            else:\n",
    "                # Normal sized paragraph\n",
    "                current_chunk.append(paragraph)\n",
    "                current_length += len(paragraph) + 2  # +2 for newlines\n",
    "        \n",
    "        # Add final chunk\n",
    "        if current_chunk:\n",
    "            chunk_text = '\\n\\n'.join(current_chunk)\n",
    "            chunks.append(self._create_chunk_document(chunk_text, header, metadata))\n",
    "        \n",
    "        return chunks\n",
    "    \n",
    "    def _create_chunk_document(self, text: str, header: str, base_metadata: Dict[str, Any]) -> Document:\n",
    "        \"\"\"\n",
    "        Create a document object with metadata from chunk text.\n",
    "        \n",
    "        Args:\n",
    "            text: Chunk text\n",
    "            header: Section header\n",
    "            base_metadata: Base document metadata\n",
    "            \n",
    "        Returns:\n",
    "            Document object with metadata\n",
    "        \"\"\"\n",
    "        # Create a copy of base metadata\n",
    "        metadata = base_metadata.copy()\n",
    "        \n",
    "        # Add section header\n",
    "        if header:\n",
    "            metadata[\"section_header\"] = header\n",
    "        \n",
    "        # Extract pregnancy stages\n",
    "        stages = self.extract_pregnancy_stages(text)\n",
    "        metadata[\"pregnancy_stages\"] = stages\n",
    "        \n",
    "        # Extract medical entities\n",
    "        entities = self.extract_medical_entities(text)\n",
    "        metadata[\"medical_entities\"] = entities\n",
    "        \n",
    "        # Identify topics and concerns\n",
    "        topics_and_concerns = self.identify_topics_and_concerns(text)\n",
    "        metadata[\"topics\"] = topics_and_concerns[\"topics\"]\n",
    "        metadata[\"patient_concerns\"] = topics_and_concerns[\"concerns\"]\n",
    "        \n",
    "        # Set content type if not already set\n",
    "        if \"content_type\" not in metadata:\n",
    "            content_types = topics_and_concerns[\"content_types\"]\n",
    "            if content_types:\n",
    "                metadata[\"content_type\"] = content_types[0]  # Primary content type\n",
    "                metadata[\"all_content_types\"] = content_types\n",
    "            else:\n",
    "                metadata[\"content_type\"] = \"general_text\"\n",
    "        \n",
    "        # Create unique ID for the chunk\n",
    "        metadata[\"chunk_id\"] = str(uuid.uuid4())\n",
    "        \n",
    "        return Document(page_content=text, metadata=metadata)\n",
    "    \n",
    "    def create_synthetic_chunks(self, documents: List[Document]) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Create synthetic chunks for improved retrieval.\n",
    "        \n",
    "        Args:\n",
    "            documents: Original document chunks\n",
    "            \n",
    "        Returns:\n",
    "            List of synthetic Document objects\n",
    "        \"\"\"\n",
    "        synthetic_chunks = []\n",
    "        logger.info(\"Creating synthetic chunks for improved retrieval...\")\n",
    "        \n",
    "        # Group documents by stage\n",
    "        stage_groups = {}\n",
    "        \n",
    "        for doc in documents:\n",
    "            stages = doc.metadata.get('pregnancy_stages', {}).get('standard_stages', [])\n",
    "            if not stages:\n",
    "                continue\n",
    "                \n",
    "            for stage in stages:\n",
    "                if stage not in stage_groups:\n",
    "                    stage_groups[stage] = []\n",
    "                stage_groups[stage].append(doc)\n",
    "        \n",
    "        # Create stage+topic chunks\n",
    "        for stage, stage_docs in stage_groups.items():\n",
    "            # Skip if too few documents\n",
    "            if len(stage_docs) < 3:\n",
    "                continue\n",
    "                \n",
    "            # Group by topics within stage\n",
    "            topic_groups = {}\n",
    "            \n",
    "            for doc in stage_docs:\n",
    "                for topic in doc.metadata.get('topics', []):\n",
    "                    if topic not in topic_groups:\n",
    "                        topic_groups[topic] = []\n",
    "                    topic_groups[topic].append(doc)\n",
    "            \n",
    "            # Create synthetic chunks for each topic with sufficient content\n",
    "            for topic, topic_docs in topic_groups.items():\n",
    "                if len(topic_docs) < 2:\n",
    "                    continue\n",
    "                    \n",
    "                # Select best content (at most 5 chunks or 5000 chars)\n",
    "                selected_docs = []\n",
    "                total_length = 0\n",
    "                \n",
    "                # Prioritize docs with specific content types\n",
    "                for content_type in [\"recommendation\", \"information\", \"table\", \"list\"]:\n",
    "                    for doc in topic_docs:\n",
    "                        if doc.metadata.get('content_type') == content_type:\n",
    "                            if len(selected_docs) < 5 and total_length < 5000:\n",
    "                                selected_docs.append(doc)\n",
    "                                total_length += len(doc.page_content)\n",
    "                \n",
    "                # Add other docs if needed\n",
    "                for doc in topic_docs:\n",
    "                    if doc not in selected_docs:\n",
    "                        if len(selected_docs) < 5 and total_length < 5000:\n",
    "                            selected_docs.append(doc)\n",
    "                            total_length += len(doc.page_content)\n",
    "                \n",
    "                if not selected_docs:\n",
    "                    continue\n",
    "                \n",
    "                # Create synthetic content\n",
    "                synthetic_content = f\"# {stage.replace('_', ' ').title()} - {topic.replace('_', ' ').title()}\\n\\n\"\n",
    "                \n",
    "                for i, doc in enumerate(selected_docs):\n",
    "                    # Add section header if available\n",
    "                    if \"section_header\" in doc.metadata:\n",
    "                        synthetic_content += f\"## {doc.metadata['section_header']}\\n\\n\"\n",
    "                    else:\n",
    "                        synthetic_content += f\"## Information {i+1}\\n\\n\"\n",
    "                    \n",
    "                    synthetic_content += doc.page_content + \"\\n\\n\"\n",
    "                \n",
    "                # Create synthetic document\n",
    "                synthetic_doc = Document(\n",
    "                    page_content=synthetic_content,\n",
    "                    metadata={\n",
    "                        \"document_type\": \"Synthetic Document\",\n",
    "                        \"title\": f\"{stage.replace('_', ' ').title()} - {topic.replace('_', ' ').title()}\",\n",
    "                        \"is_synthetic\": True,\n",
    "                        \"source_stage\": stage,\n",
    "                        \"source_topic\": topic,\n",
    "                        \"content_type\": \"synthetic\",\n",
    "                        \"pregnancy_stages\": {\n",
    "                            \"standard_stages\": [stage]\n",
    "                        },\n",
    "                        \"topics\": [topic],\n",
    "                        \"source_count\": len(selected_docs),\n",
    "                        \"chunk_id\": f\"synthetic_{stage}_{topic}_{uuid.uuid4().hex[:8]}\"\n",
    "                    }\n",
    "                )\n",
    "                \n",
    "                synthetic_chunks.append(synthetic_doc)\n",
    "        \n",
    "        # Create FAQ chunks for common questions\n",
    "        synthetic_chunks.extend(self._create_faq_chunks(documents))\n",
    "        \n",
    "        logger.info(f\"Created {len(synthetic_chunks)} synthetic chunks\")\n",
    "        return synthetic_chunks\n",
    "    \n",
    "    def _create_faq_chunks(self, documents: List[Document]) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Create FAQ-oriented chunks for common patient questions.\n",
    "        \n",
    "        Args:\n",
    "            documents: Original documents\n",
    "            \n",
    "        Returns:\n",
    "            List of FAQ Document objects\n",
    "        \"\"\"\n",
    "        faq_chunks = []\n",
    "        \n",
    "        # Common questions by stage and concern\n",
    "        faq_templates = {\n",
    "            \"first_trimester\": [\n",
    "                (\"What symptoms are normal in the first trimester?\", [\"symptoms\", \"normal_variations\", \"maternal_changes\"]),\n",
    "                (\"What foods should I avoid in early pregnancy?\", [\"nutrition\", \"warning_signs\"]),\n",
    "                (\"Is spotting normal in early pregnancy?\", [\"bleeding\", \"normal_variations\"])\n",
    "            ],\n",
    "            \"second_trimester\": [\n",
    "                (\"When will I feel the baby move?\", [\"movement\", \"fetal_development\"]),\n",
    "                (\"What tests are done in the second trimester?\", [\"medical_tests\", \"prenatal_care\"]),\n",
    "                (\"Is it normal to have pain in my abdomen as my belly grows?\", [\"pain\", \"normal_variations\"])\n",
    "            ],\n",
    "            \"third_trimester\": [\n",
    "                (\"What are signs of labor?\", [\"delivery\", \"warning_signs\"]),\n",
    "                (\"How can I relieve back pain in late pregnancy?\", [\"pain\", \"maternal_changes\"]),\n",
    "                (\"How do I know if my water broke?\", [\"delivery\"])\n",
    "            ],\n",
    "            \"postpartum\": [\n",
    "                (\"How much bleeding is normal after birth?\", [\"bleeding\", \"normal_variations\", \"postpartum\"]),\n",
    "                (\"How can I tell if I have postpartum depression?\", [\"mental_health\", \"postpartum\"]),\n",
    "                (\"When will my milk come in?\", [\"postpartum\", \"breastfeeding\"])\n",
    "            ]\n",
    "        }\n",
    "        \n",
    "        # Create FAQs for each stage\n",
    "        for stage, questions in faq_templates.items():\n",
    "            for question, topics in questions:\n",
    "                # Find relevant documents\n",
    "                relevant_docs = []\n",
    "                \n",
    "                for doc in documents:\n",
    "                    # Check if the document matches stage and topics\n",
    "                    doc_stages = doc.metadata.get('pregnancy_stages', {}).get('standard_stages', [])\n",
    "                    doc_topics = doc.metadata.get('topics', [])\n",
    "                    doc_concerns = doc.metadata.get('patient_concerns', [])\n",
    "                    \n",
    "                    # Match if document has the right stage and at least one matching topic\n",
    "                    if stage in doc_stages and any(topic in doc_topics for topic in topics):\n",
    "                        relevant_docs.append(doc)\n",
    "                \n",
    "                # Skip if insufficient relevant documents\n",
    "                if len(relevant_docs) < 2:\n",
    "                    continue\n",
    "                \n",
    "                # Select best content (maximum 4 docs or 4000 chars)\n",
    "                selected_docs = []\n",
    "                total_length = 0\n",
    "                \n",
    "                # First add recommendations and key information\n",
    "                for doc in sorted(relevant_docs, \n",
    "                                 key=lambda d: 1 if d.metadata.get('content_type') == 'recommendation' else 2):\n",
    "                    if len(selected_docs) < 4 and total_length < 4000:\n",
    "                        selected_docs.append(doc)\n",
    "                        total_length += len(doc.page_content)\n",
    "                \n",
    "                # Create FAQ content\n",
    "                faq_content = f\"# FAQ: {question}\\n\\n\"\n",
    "                faq_content += \"## Answer\\n\\n\"\n",
    "                \n",
    "                # Add content from selected documents\n",
    "                for doc in selected_docs:\n",
    "                    faq_content += doc.page_content + \"\\n\\n\"\n",
    "                \n",
    "                # Create FAQ document\n",
    "                faq_doc = Document(\n",
    "                    page_content=faq_content,\n",
    "                    metadata={\n",
    "                        \"document_type\": \"FAQ\",\n",
    "                        \"title\": question,\n",
    "                        \"is_faq\": True,\n",
    "                        \"question\": question,\n",
    "                        \"source_stage\": stage,\n",
    "                        \"source_topics\": topics,\n",
    "                        \"content_type\": \"faq\",\n",
    "                        \"pregnancy_stages\": {\n",
    "                            \"standard_stages\": [stage]\n",
    "                        },\n",
    "                        \"topics\": topics,\n",
    "                        \"chunk_id\": f\"faq_{stage}_{uuid.uuid4().hex[:8]}\"\n",
    "                    }\n",
    "                )\n",
    "                \n",
    "                faq_chunks.append(faq_doc)\n",
    "        \n",
    "        return faq_chunks\n",
    "    \n",
    "    def process_document(self, file_path: str) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Process a single document into semantically meaningful chunks.\n",
    "        \n",
    "        Args:\n",
    "            file_path: Path to document\n",
    "            \n",
    "        Returns:\n",
    "            List of Document objects\n",
    "        \"\"\"\n",
    "        logger.info(f\"Processing {file_path}...\")\n",
    "        \n",
    "        # Load document text\n",
    "        try:\n",
    "            if file_path.lower().endswith('.pdf'):\n",
    "                loader = PyPDFLoader(file_path)\n",
    "                pages = loader.load()\n",
    "                text = \"\\n\\n\".join([page.page_content for page in pages])\n",
    "            elif file_path.lower().endswith('.html'):\n",
    "                with open(file_path, \"r\", encoding=\"utf-8\", errors=\"replace\") as f:\n",
    "                    html = f.read()\n",
    "                soup = BeautifulSoup(html, \"html.parser\")\n",
    "                # get_text keeps readability; separator inserts newlines for headings/paras\n",
    "                text = soup.get_text(separator=\"\\n\")\n",
    "            else:\n",
    "                with open(file_path, 'r', encoding='utf-8', errors='replace') as f:\n",
    "                    text = f.read()\n",
    "        except Exception as e:\n",
    "            logger.error(f\"Error loading {file_path}: {e}\")\n",
    "            return []\n",
    "        \n",
    "        # Extract document-level metadata\n",
    "        filename = os.path.basename(file_path)\n",
    "        doc_metadata = self._extract_document_metadata(text[:10000], filename)\n",
    "        \n",
    "        # Split into sections\n",
    "        logger.info(f\"Splitting {filename} into sections...\")\n",
    "        sections = self.split_text_into_sections(text)\n",
    "        logger.info(f\"Found {len(sections)} sections\")\n",
    "        \n",
    "        # Process each section into chunks\n",
    "        all_chunks = []\n",
    "        \n",
    "        for header, section_text in tqdm(sections, desc=\"Processing sections\"):\n",
    "            chunks = self.create_semantic_chunks(section_text, header, doc_metadata)\n",
    "            all_chunks.extend(chunks)\n",
    "        \n",
    "        logger.info(f\"Created {len(all_chunks)} chunks from {filename}\")\n",
    "        return all_chunks\n",
    "    \n",
    "    def process_directory(self, directory_path: str) -> List[Document]:\n",
    "        \"\"\"\n",
    "        Process all documents in a directory.\n",
    "        \n",
    "        Args:\n",
    "            directory_path: Path to directory\n",
    "            \n",
    "        Returns:\n",
    "            List of all Document objects\n",
    "        \"\"\"\n",
    "        all_documents = []\n",
    "        \n",
    "        # Get all files in directory\n",
    "        file_paths = []\n",
    "        for filename in os.listdir(directory_path):\n",
    "            file_path = os.path.join(directory_path, filename)\n",
    "            if os.path.isfile(file_path) and not filename.startswith('.'):\n",
    "                file_paths.append(file_path)\n",
    "        \n",
    "        # Process each file\n",
    "        logger.info(f\"Processing {len(file_paths)} files in {directory_path}\")\n",
    "        \n",
    "        for file_path in tqdm(file_paths, desc=\"Processing files\"):\n",
    "            try:\n",
    "                chunks = self.process_document(file_path)\n",
    "                all_documents.extend(chunks)\n",
    "            except Exception as e:\n",
    "                logger.error(f\"Error processing {file_path}: {e}\")\n",
    "        \n",
    "        return all_documents\n",
    "    \n",
    "    def create_vector_store(self, documents: List[Document], include_synthetic: bool = True) -> FAISS:\n",
    "        \"\"\"\n",
    "        Create vector store from processed documents.\n",
    "        \n",
    "        Args:\n",
    "            documents: List of Document objects\n",
    "            include_synthetic: Whether to include synthetic chunks\n",
    "            \n",
    "        Returns:\n",
    "            FAISS vector store\n",
    "        \"\"\"\n",
    "        if not documents:\n",
    "            raise ValueError(\"No documents provided to create vector store\")\n",
    "        \n",
    "        # Create synthetic chunks if requested\n",
    "        if include_synthetic:\n",
    "            synthetic_chunks = self.create_synthetic_chunks(documents)\n",
    "            all_docs = documents + synthetic_chunks\n",
    "        else:\n",
    "            all_docs = documents\n",
    "        \n",
    "        logger.info(f\"Creating vector store with {len(all_docs)} documents...\")\n",
    "        \n",
    "        # Initialize FAISS index from documents\n",
    "        self.db = FAISS.from_documents(\n",
    "            documents=all_docs,\n",
    "            embedding=self.embeddings\n",
    "        )\n",
    "        \n",
    "        # Save to disk\n",
    "        logger.info(f\"Saving vector store to {self.db_directory}\")\n",
    "        self.db.save_local(self.db_directory)\n",
    "        \n",
    "        return self.db\n",
    "    \n",
    "    def create_stage_optimized_retrievers(self) -> Dict[str, Any]:\n",
    "        \"\"\"Create stage-optimized retrievers for each pregnancy stage.\"\"\"\n",
    "        if not self.db:\n",
    "            raise ValueError(\"No vector store available. Please create or load a vector store first.\")\n",
    "        \n",
    "        # Define standard pregnancy stages\n",
    "        stages = [\n",
    "            \"preconception\",\n",
    "            \"first_trimester\",\n",
    "            \"second_trimester\", \n",
    "            \"third_trimester\",\n",
    "            \"labor_delivery\",\n",
    "            \"postpartum\"\n",
    "        ]\n",
    "        \n",
    "        retrievers = {}\n",
    "        \n",
    "        # Create a retriever for each stage with metadata filtering\n",
    "        for stage in stages:\n",
    "            # Define filter function that works with metadata dictionaries\n",
    "            def stage_filter(metadata):\n",
    "                # Get pregnancy stages from metadata\n",
    "                pregnancy_stages = metadata.get(\"pregnancy_stages\", {})\n",
    "                if isinstance(pregnancy_stages, dict):\n",
    "                    standard_stages = pregnancy_stages.get(\"standard_stages\", [])\n",
    "                else:\n",
    "                    standard_stages = []\n",
    "                    \n",
    "                # Check if content is stage-agnostic\n",
    "                is_general_content = (\n",
    "                    not standard_stages and \n",
    "                    metadata.get(\"content_type\") in [\"recommendation\", \"information\"]\n",
    "                )\n",
    "                    \n",
    "                # Include if stage matches or it's general content\n",
    "                return stage in standard_stages or is_general_content\n",
    "            \n",
    "            # Create retriever with this filter\n",
    "            retrievers[stage] = self.db.as_retriever(\n",
    "                search_kwargs={\"k\": 7, \"filter\": stage_filter}\n",
    "            )\n",
    "        \n",
    "        # Create a general retriever for queries without clear stage\n",
    "        retrievers[\"general\"] = self.db.as_retriever(\n",
    "            search_kwargs={\"k\": 5}\n",
    "        )\n",
    "    \n",
    "        return retrievers\n",
    "    \n",
    "    def detect_query_context(self, query: str) -> Dict[str, Any]:\n",
    "        \"\"\"\n",
    "        Detect pregnancy stage and concerns from user query.\n",
    "        \n",
    "        Args:\n",
    "            query: User query text\n",
    "            \n",
    "        Returns:\n",
    "            Dict with detected context\n",
    "        \"\"\"\n",
    "        context = {\n",
    "            \"stage\": None,\n",
    "            \"concerns\": [],\n",
    "            \"detected_topics\": []\n",
    "        }\n",
    "        \n",
    "        # Detect pregnancy stage\n",
    "        # First look for explicit stage mentions\n",
    "        query_lower = query.lower()\n",
    "        \n",
    "        for stage, keywords in self.pregnancy_stages.items():\n",
    "            if any(keyword in query_lower for keyword in keywords):\n",
    "                context[\"stage\"] = stage\n",
    "                break\n",
    "        \n",
    "        # If no explicit stage, check for week/month/trimester mentions\n",
    "        if not context[\"stage\"]:\n",
    "            stages = self.extract_pregnancy_stages(query)\n",
    "            if stages[\"standard_stages\"]:\n",
    "                context[\"stage\"] = stages[\"standard_stages\"][0]\n",
    "        \n",
    "        # Detect concerns\n",
    "        for concern, keywords in self.patient_concerns.items():\n",
    "            if any(keyword in query_lower for keyword in keywords):\n",
    "                context[\"concerns\"].append(concern)\n",
    "        \n",
    "        # Detect topics\n",
    "        for topic, keywords in self.maternal_topics.items():\n",
    "            if any(keyword in query_lower for keyword in keywords):\n",
    "                context[\"detected_topics\"].append(topic)\n",
    "        \n",
    "        return context\n",
    "    \n",
    "    def retrieve_for_query(self, query: str) -> List[Document]:\n",
    "        \"\"\"Smart retrieval based on query context.\"\"\"\n",
    "        if not self.db:\n",
    "            raise ValueError(\"No vector store available. Please create or load a vector store first.\")\n",
    "        \n",
    "        # Detect query context\n",
    "        context = self.detect_query_context(query)\n",
    "        logger.info(f\"Query context: {context}\")\n",
    "        \n",
    "        # Create stage-specific retrievers if not already created\n",
    "        if not hasattr(self, 'stage_retrievers'):\n",
    "            self.stage_retrievers = self.create_stage_optimized_retrievers()\n",
    "        \n",
    "        # Select appropriate retriever based on context\n",
    "        if context[\"stage\"]:\n",
    "            retriever = self.stage_retrievers.get(context[\"stage\"])\n",
    "            if not retriever:\n",
    "                # Fall back to general retriever\n",
    "                retriever = self.stage_retrievers[\"general\"]\n",
    "        else:\n",
    "            # Use general retriever for stage-agnostic queries\n",
    "            retriever = self.stage_retrievers[\"general\"]\n",
    "        \n",
    "        # Get relevant documents\n",
    "        docs = retriever.get_relevant_documents(query)\n",
    "        \n",
    "        # If we have specific concerns, try to ensure we have documents addressing them\n",
    "        if context[\"concerns\"] and len(docs) >= 3:\n",
    "            # Check if concerns are addressed in retrieved docs\n",
    "            concerns_addressed = False\n",
    "            for doc in docs[:3]:  # Check top 3 docs\n",
    "                doc_concerns = doc.metadata.get(\"patient_concerns\", [])\n",
    "                if any(concern in doc_concerns for concern in context[\"concerns\"]):\n",
    "                    concerns_addressed = True\n",
    "                    break\n",
    "        \n",
    "        # If concerns not addressed in top results, add specific concern filters\n",
    "            if not concerns_addressed:\n",
    "                # Updated filter function to work with metadata dictionaries\n",
    "                def concern_filter(metadata):\n",
    "                    # Get patient concerns from metadata\n",
    "                    patient_concerns = metadata.get(\"patient_concerns\", [])\n",
    "                    # Check if any of our concerns are in the document's concerns\n",
    "                    return any(concern in patient_concerns for concern in context[\"concerns\"])\n",
    "                \n",
    "                concern_retriever = self.db.as_retriever(\n",
    "                    search_kwargs={\"k\": 2, \"filter\": concern_filter}\n",
    "                )\n",
    "                \n",
    "                # Get concern-specific docs and add to results\n",
    "                concern_docs = concern_retriever.get_relevant_documents(query)\n",
    "                \n",
    "                # Add unique concern docs (avoid duplicates)\n",
    "                existing_ids = {doc.metadata.get(\"chunk_id\", \"\") for doc in docs}\n",
    "                for doc in concern_docs:\n",
    "                    if doc.metadata.get(\"chunk_id\", \"\") not in existing_ids:\n",
    "                        docs.append(doc)\n",
    "        \n",
    "        return docs\n",
    "    \n",
    "    def create_qa_chain(self, model_name: str = \"gpt-4\", temperature: float = 0.0) -> RetrievalQA:\n",
    "        \"\"\"\n",
    "        Create a question answering chain.\n",
    "        \n",
    "        Args:\n",
    "            model_name: LLM model name\n",
    "            temperature: LLM temperature\n",
    "            \n",
    "        Returns:\n",
    "            RetrievalQA chain\n",
    "        \"\"\"\n",
    "        if not self.db:\n",
    "            raise ValueError(\"No vector store available. Please create or load a vector store first.\")\n",
    "        \n",
    "        # Initialize LLM\n",
    "        llm = ChatOpenAI(\n",
    "            model=model_name,\n",
    "            temperature=temperature\n",
    "        )\n",
    "        \n",
    "        # Create custom prompt for maternal health\n",
    "        qa_prompt = PromptTemplate(\n",
    "            template=\"\"\"You are a maternal health assistant providing evidence-based information to pregnant women and new mothers.\n",
    "            Use the following retrieved information to answer the question.\n",
    "            \n",
    "            If the information doesn't contain the answer, just say \"I don't have enough information to answer that question accurately\" - don't make up information.\n",
    "            If providing medical advice, clearly state that this is general information and the person should consult their healthcare provider.\n",
    "            Use a reassuring, supportive tone and clear, non-technical language.\n",
    "            \n",
    "            Retrieved information:\n",
    "            {context}\n",
    "            \n",
    "            Question: {question}\n",
    "            \n",
    "            Answer:\"\"\",\n",
    "            input_variables=[\"context\", \"question\"]\n",
    "        )\n",
    "        \n",
    "        # Create question answering chain\n",
    "        qa_chain = RetrievalQA.from_chain_type(\n",
    "            llm=llm,\n",
    "            chain_type=\"stuff\",\n",
    "            retriever=self.db.as_retriever(search_kwargs={\"k\": 5}),\n",
    "            chain_type_kwargs={\"prompt\": qa_prompt},\n",
    "            return_source_documents=True\n",
    "        )\n",
    "        \n",
    "        return qa_chain\n",
    "    \n",
    "    def answer_question(self, question: str, model_name: str = \"gpt-4\") -> Dict[str, Any]:\n",
    "        \"\"\"\n",
    "        Answer a maternal health question using the optimized retrieval pipeline.\n",
    "        \n",
    "        Args:\n",
    "            question: User question\n",
    "            model_name: LLM model name\n",
    "            \n",
    "        Returns:\n",
    "            Dict with answer and source documents\n",
    "        \"\"\"\n",
    "        # Retrieve relevant documents with context-aware retrieval\n",
    "        docs = self.retrieve_for_query(question)\n",
    "        \n",
    "        # Initialize LLM\n",
    "        llm = ChatOpenAI(\n",
    "            model=model_name,\n",
    "            temperature=0.1  # Low temperature for factual responses\n",
    "        )\n",
    "        \n",
    "        # Create maternal health-specific prompt\n",
    "        # prompt = PromptTemplate(\n",
    "        #     template=\"\"\"You are a supportive maternal health assistant providing evidence-based information to pregnant women and new mothers.\n",
    "            \n",
    "        #     Use the following retrieved information to answer the question.\n",
    "            \n",
    "        #     Guidelines for your response:\n",
    "        #     1. Be accurate - only use information from the provided context\n",
    "        #     2. If the information doesn't fully answer the question, acknowledge the limitations\n",
    "        #     3. Be reassuring but honest - don't minimize legitimate concerns\n",
    "        #     4. Use clear, non-technical language\n",
    "        #     5. Remind users to consult healthcare providers for personal medical advice\n",
    "        #     6. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms\n",
    "            \n",
    "        #     Retrieved information:\n",
    "        #     {context}\n",
    "            \n",
    "        #     Question: {question}\n",
    "            \n",
    "        #     Answer:\"\"\",\n",
    "        #     input_variables=[\"context\", \"question\"]\n",
    "        # )\n",
    "        prompt = PromptTemplate(\n",
    "            template=\"\"\"You are a supportive maternal health assistant providing evidence-based information to pregnant women and new mothers.\n",
    "Use the following retrieved information to answer the question.\n",
    "Response Guidelines:\n",
    "Answer ONLY using the provided context. Do not speculate or generate information not found in the retrieved data.\n",
    "\n",
    "\n",
    "If the information doesn't fully answer the question, state the limitations. Example: “I don’t have enough information to answer that accurately.”\n",
    "\n",
    "\n",
    "Be reassuring but honest. Do not minimize legitimate concerns. If the topic is serious, clearly explain when to seek medical help.\n",
    "\n",
    "\n",
    "Use clear, non-technical language. Avoid jargon and explain complex terms simply.\n",
    "\n",
    "\n",
    "Always remind users: “This is general information; please consult your healthcare provider for personal medical advice.”\n",
    "\n",
    "\n",
    "Warning signs: When discussing symptoms or warning signs, clearly distinguish between normal variations and symptoms that require medical attention. List these separately if appropriate.\n",
    "\n",
    "\n",
    "If you detect any signs of a possible emergency (such as heavy bleeding, severe pain, loss of consciousness, seizures, absent fetal movement, severe swelling, difficulty breathing, fever with rash, premature rupture of membranes, or vision changes):\n",
    "\n",
    "\n",
    "Do NOT give any advice.\n",
    "\n",
    "\n",
    "Respond ONLY with:\n",
    "\n",
    "\n",
    "\"IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
    "This chatbot cannot provide emergency medical advice. Please:\n",
    "1. Contact your healthcare provider immediately OR\n",
    "2. Go to the nearest emergency department OR\n",
    "3. Call your local emergency number for immediate assistance.\n",
    "\n",
    "Do not wait or delay seeking professional care.\"\n",
    "\n",
    "Do not provide:\n",
    "\n",
    "\n",
    "Any specific drug brand or prescription recommendations.\n",
    "\n",
    "\n",
    "Any information related to fetal gender detection or selection.\n",
    "\n",
    "\n",
    "Any answers that are not about pregnancy, postpartum, or maternal/newborn wellness (if off-topic, say: “I’m sorry, I can only help with pregnancy and maternal-health questions.”)\n",
    "\n",
    "\n",
    "Any instructions or advice for suicidal/self-harm situations. Instead, respond only with the relevant crisis hotline (India: 9152987821, US: 988, UK: 0800 689 5652).\n",
    "\n",
    "\n",
    "\n",
    "Retrieved information:\n",
    " {context}\n",
    "Question:\n",
    " {question}\n",
    "Answer:\n",
    "\n",
    "\"\"\",\n",
    "            input_variables=[\"context\", \"question\"]\n",
    "        )\n",
    "        # Create QA chain\n",
    "        qa_chain = RetrievalQA.from_chain_type(\n",
    "            llm=llm,\n",
    "            chain_type=\"stuff\",\n",
    "            retriever=self.db.as_retriever(),  # Default retriever not used since we pass docs directly\n",
    "            chain_type_kwargs={\"prompt\": prompt},\n",
    "            return_source_documents=True\n",
    "        )\n",
    "        \n",
    "        # Call QA chain with pre-retrieved documents\n",
    "        context = \"\\n\\n\".join([doc.page_content for doc in docs])\n",
    "        response = llm.predict(\n",
    "            prompt.format(context=context, question=question)\n",
    "        )\n",
    "        \n",
    "        return {\n",
    "            \"answer\": response,\n",
    "            \"source_documents\": docs\n",
    "        }\n",
    "\n",
    "# def main():\n",
    "#     \"\"\"Main function to run the maternal health pipeline.\"\"\"\n",
    "#     import argparse\n",
    "    \n",
    "#     parser = argparse.ArgumentParser(description=\"Process maternal health documents\")\n",
    "#     parser.add_argument(\"--input\", required=True, help=\"Input file or directory\")\n",
    "#     parser.add_argument(\"--output\", default=\"maternal_health_db\", help=\"Output directory for vector store\")\n",
    "#     parser.add_argument(\"--embedding\", default=\"google/muril-base-cased\", help=\"Embedding model name\")\n",
    "#     parser.add_argument(\"--no-synthetic\", action=\"store_true\", help=\"Skip synthetic chunk creation\")\n",
    "#     parser.add_argument(\"--chunk-size\", type=int, default=2500, help=\"Chunk size\")\n",
    "#     parser.add_argument(\"--no-spacy\", action=\"store_true\", help=\"Disable SpaCy (use simpler chunking)\")\n",
    "    \n",
    "#     args = parser.parse_args()\n",
    "    \n",
    "#     # Initialize pipeline\n",
    "    # pipeline = MaternalHealthPipeline(\n",
    "    #     chunk_size=args.chunk_size,\n",
    "    #     embedding_model_name=args.embedding,\n",
    "    #     db_directory=args.output,\n",
    "    #     use_spacy=not args.no_spacy\n",
    "    # )\n",
    "    \n",
    "#     # Process documents\n",
    "#     if os.path.isdir(args.input):\n",
    "#         documents = pipeline.process_directory(args.input)\n",
    "#     else:\n",
    "#         documents = pipeline.process_document(args.input)\n",
    "    \n",
    "#     # Create vector store\n",
    "#     if documents:\n",
    "#         pipeline.create_vector_store(documents, include_synthetic=not args.no_synthetic)\n",
    "#         logger.info(f\"Successfully processed {len(documents)} chunks and created vector store in {args.output}\")\n",
    "#     else:\n",
    "#         logger.error(\"No documents were processed.\")\n",
    "\n",
    "# if __name__ == \"__main__\":\n",
    "#     main()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# below pipeline calling for main hybrid rag which i used to get previous results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 02:00:25,725 - INFO - Initializing embeddings model: google/muril-base-cased\n",
      "2025-06-11 02:00:25,729 - INFO - Load pretrained SentenceTransformer: intfloat/multilingual-e5-large-instruct\n",
      "2025-06-11 02:00:28,344 - INFO - Loaded SpaCy model: en_core_web_md\n",
      "2025-06-11 02:00:28,345 - INFO - Loading existing vector store from /data/user_data/vidhij2/medical_db/rag_2/index.faiss\n"
     ]
    }
   ],
   "source": [
    "pipeline = MaternalHealthPipeline(\n",
    "        chunk_size=3000,\n",
    "        embedding_model_name=\"google/muril-base-cased\",\n",
    "        db_directory=\"/data/user_data/vidhij2/medical_db/rag_2\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-04-06 16:03:42,331 - INFO - Processing /home/vidhij2/nivi/maternal-documents/9789240020306-eng.pdf...\n",
      "2025-04-06 16:03:46,278 - INFO - Splitting 9789240020306-eng.pdf into sections...\n",
      "2025-04-06 16:03:46,285 - INFO - Found 98 sections\n",
      "Processing sections: 100%|██████████| 98/98 [00:08<00:00, 11.00it/s]\n",
      "2025-04-06 16:03:55,193 - INFO - Created 140 chunks from 9789240020306-eng.pdf\n"
     ]
    }
   ],
   "source": [
    "# documents = pipeline.process_document(\"/home/vidhij2/nivi/maternal-documents/9789240020306-eng.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "from bs4 import BeautifulSoup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 02:00:33,560 - INFO - Processing 83 files in /data/user_data/vidhij2/medical/html\n",
      "Processing files:   0%|          | 0/83 [00:00<?, ?it/s]2025-06-11 02:00:33,561 - INFO - Processing /data/user_data/vidhij2/medical/html/Motherhood_Hospitals.html...\n",
      "2025-06-11 02:00:33,683 - INFO - Splitting Motherhood_Hospitals.html into sections...\n",
      "2025-06-11 02:00:33,687 - INFO - Found 11 sections\n",
      "Processing sections: 100%|██████████| 11/11 [00:04<00:00,  2.47it/s]\n",
      "2025-06-11 02:00:38,139 - INFO - Created 11 chunks from Motherhood_Hospitals.html\n",
      "Processing files:   1%|          | 1/83 [00:04<06:15,  4.58s/it]2025-06-11 02:00:38,140 - INFO - Processing /data/user_data/vidhij2/medical/html/EuroKids_India.html...\n",
      "2025-06-11 02:00:38,170 - INFO - Splitting EuroKids_India.html into sections...\n",
      "2025-06-11 02:00:38,171 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.09it/s]\n",
      "2025-06-11 02:00:38,651 - INFO - Created 4 chunks from EuroKids_India.html\n",
      "Processing files:   2%|▏         | 2/83 [00:05<02:57,  2.19s/it]2025-06-11 02:00:38,652 - INFO - Processing /data/user_data/vidhij2/medical/html/Human_Behavior_Change_resources.html...\n",
      "2025-06-11 02:00:38,661 - INFO - Splitting Human_Behavior_Change_resources.html into sections...\n",
      "2025-06-11 02:00:38,661 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 31.86it/s]\n",
      "2025-06-11 02:00:38,694 - INFO - Created 1 chunks from Human_Behavior_Change_resources.html\n",
      "2025-06-11 02:00:38,695 - INFO - Processing /data/user_data/vidhij2/medical/html/Can_I_choose_who_will_be_present_during_my_delivery_-_MOHFW_Press_Release.html...\n",
      "2025-06-11 02:00:38,697 - INFO - Splitting Can_I_choose_who_will_be_present_during_my_delivery_-_MOHFW_Press_Release.html into sections...\n",
      "2025-06-11 02:00:38,698 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 14.57it/s]\n",
      "2025-06-11 02:00:38,768 - INFO - Created 1 chunks from Can_I_choose_who_will_be_present_during_my_delivery_-_MOHFW_Press_Release.html\n",
      "Processing files:   5%|▍         | 4/83 [00:05<01:07,  1.17it/s]2025-06-11 02:00:38,769 - INFO - Processing /data/user_data/vidhij2/medical/html/What_vaccinations_does_my_baby_need_and_when_-_Indian_Academy_of_Pediatrics_&_National_Health_Mission.html...\n",
      "2025-06-11 02:00:38,785 - INFO - Splitting What_vaccinations_does_my_baby_need_and_when_-_Indian_Academy_of_Pediatrics_&_National_Health_Mission.html into sections...\n",
      "2025-06-11 02:00:38,785 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  6.80it/s]\n",
      "2025-06-11 02:00:38,934 - INFO - Created 2 chunks from What_vaccinations_does_my_baby_need_and_when_-_Indian_Academy_of_Pediatrics_&_National_Health_Mission.html\n",
      "Processing files:   6%|▌         | 5/83 [00:05<00:49,  1.56it/s]2025-06-11 02:00:38,935 - INFO - Processing /data/user_data/vidhij2/medical/html/MH_Guidelines_(might_not_be_accessible_in_US).html...\n",
      "2025-06-11 02:00:38,970 - INFO - Splitting MH_Guidelines_(might_not_be_accessible_in_US).html into sections...\n",
      "2025-06-11 02:00:38,971 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 12.63it/s]\n",
      "2025-06-11 02:00:39,131 - INFO - Created 3 chunks from MH_Guidelines_(might_not_be_accessible_in_US).html\n",
      "Processing files:   7%|▋         | 6/83 [00:05<00:38,  1.98it/s]2025-06-11 02:00:39,132 - INFO - Processing /data/user_data/vidhij2/medical/html/What_is_preeclampsia_and_how_can_it_be_detected_-_Preeclampsia_Foundation.html...\n",
      "2025-06-11 02:00:39,161 - INFO - Splitting What_is_preeclampsia_and_how_can_it_be_detected_-_Preeclampsia_Foundation.html into sections...\n",
      "2025-06-11 02:00:39,163 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.21it/s]\n",
      "2025-06-11 02:00:39,988 - INFO - Created 8 chunks from What_is_preeclampsia_and_how_can_it_be_detected_-_Preeclampsia_Foundation.html\n",
      "Processing files:   8%|▊         | 7/83 [00:06<00:46,  1.64it/s]2025-06-11 02:00:39,989 - INFO - Processing /data/user_data/vidhij2/medical/html/Frontiers_in_Endocrinology.html...\n",
      "2025-06-11 02:00:40,047 - INFO - Splitting Frontiers_in_Endocrinology.html into sections...\n",
      "2025-06-11 02:00:40,050 - INFO - Found 31 sections\n",
      "Processing sections: 100%|██████████| 31/31 [00:01<00:00, 24.66it/s]\n",
      "2025-06-11 02:00:41,309 - INFO - Created 36 chunks from Frontiers_in_Endocrinology.html\n",
      "Processing files:  10%|▉         | 8/83 [00:07<01:01,  1.21it/s]2025-06-11 02:00:41,310 - INFO - Processing /data/user_data/vidhij2/medical/html/What_additional_care_is_needed_for_twinmultiple_pregnancies_-_Apollo_Cradle.html...\n",
      "2025-06-11 02:00:41,348 - INFO - Splitting What_additional_care_is_needed_for_twinmultiple_pregnancies_-_Apollo_Cradle.html into sections...\n",
      "2025-06-11 02:00:41,350 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:02<00:00,  1.69it/s]\n",
      "2025-06-11 02:00:43,719 - INFO - Created 6 chunks from What_additional_care_is_needed_for_twinmultiple_pregnancies_-_Apollo_Cradle.html\n",
      "Processing files:  11%|█         | 9/83 [00:10<01:36,  1.31s/it]2025-06-11 02:00:43,719 - INFO - Processing /data/user_data/vidhij2/medical/html/Can_I_attend_religious_ceremonies_and_festivals_during_pregnancy_-_Stem_Cyte_India.html...\n",
      "2025-06-11 02:00:43,750 - INFO - Splitting Can_I_attend_religious_ceremonies_and_festivals_during_pregnancy_-_Stem_Cyte_India.html into sections...\n",
      "2025-06-11 02:00:43,751 - INFO - Found 8 sections\n",
      "Processing sections: 100%|██████████| 8/8 [00:00<00:00, 32.29it/s]\n",
      "2025-06-11 02:00:44,001 - INFO - Created 8 chunks from Can_I_attend_religious_ceremonies_and_festivals_during_pregnancy_-_Stem_Cyte_India.html\n",
      "Processing files:  12%|█▏        | 10/83 [00:10<01:12,  1.00it/s]2025-06-11 02:00:44,002 - INFO - Processing /data/user_data/vidhij2/medical/html/R_is_for_Rabbit.html...\n",
      "2025-06-11 02:00:44,066 - INFO - Splitting R_is_for_Rabbit.html into sections...\n",
      "2025-06-11 02:00:44,068 - INFO - Found 10 sections\n",
      "Processing sections: 100%|██████████| 10/10 [00:00<00:00, 25.07it/s]\n",
      "2025-06-11 02:00:44,468 - INFO - Created 11 chunks from R_is_for_Rabbit.html\n",
      "Processing files:  13%|█▎        | 11/83 [00:10<01:00,  1.19it/s]2025-06-11 02:00:44,469 - INFO - Processing /data/user_data/vidhij2/medical/html/Prevalence_and_Correlates_of_Postpartum_Depression_(PPD)_In_India_Literature_Review-Based_Study.html...\n",
      "2025-06-11 02:00:44,489 - INFO - Splitting Prevalence_and_Correlates_of_Postpartum_Depression_(PPD)_In_India_Literature_Review-Based_Study.html into sections...\n",
      "2025-06-11 02:00:44,490 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:04<00:00,  1.06it/s]\n",
      "2025-06-11 02:00:49,187 - INFO - Created 10 chunks from Prevalence_and_Correlates_of_Postpartum_Depression_(PPD)_In_India_Literature_Review-Based_Study.html\n",
      "Processing files:  14%|█▍        | 12/83 [00:15<02:22,  2.00s/it]2025-06-11 02:00:49,188 - INFO - Processing /data/user_data/vidhij2/medical/html/WHO_recommendations_on_Postnatal_care_of_the_mother_and_newborn.html...\n",
      "2025-06-11 02:00:49,221 - INFO - Splitting WHO_recommendations_on_Postnatal_care_of_the_mother_and_newborn.html into sections...\n",
      "2025-06-11 02:00:49,223 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.19it/s]\n",
      "2025-06-11 02:00:49,463 - INFO - Created 3 chunks from WHO_recommendations_on_Postnatal_care_of_the_mother_and_newborn.html\n",
      "Processing files:  16%|█▌        | 13/83 [00:15<01:43,  1.49s/it]2025-06-11 02:00:49,464 - INFO - Processing /data/user_data/vidhij2/medical/html/How_often_should_my_newborn_feed_-_India_MOHFW_&_EuroKids_India.html...\n",
      "2025-06-11 02:00:49,468 - INFO - Splitting How_often_should_my_newborn_feed_-_India_MOHFW_&_EuroKids_India.html into sections...\n",
      "2025-06-11 02:00:49,468 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  6.12it/s]\n",
      "2025-06-11 02:00:49,633 - INFO - Created 2 chunks from How_often_should_my_newborn_feed_-_India_MOHFW_&_EuroKids_India.html\n",
      "Processing files:  17%|█▋        | 14/83 [00:16<01:15,  1.09s/it]2025-06-11 02:00:49,634 - INFO - Processing /data/user_data/vidhij2/medical/html/When_can_I_resume_sexual_activity_after_childbirth_-_Times_of_India.html...\n",
      "2025-06-11 02:00:49,677 - INFO - Splitting When_can_I_resume_sexual_activity_after_childbirth_-_Times_of_India.html into sections...\n",
      "2025-06-11 02:00:49,679 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.99it/s]\n",
      "2025-06-11 02:00:50,184 - INFO - Created 4 chunks from When_can_I_resume_sexual_activity_after_childbirth_-_Times_of_India.html\n",
      "Processing files:  18%|█▊        | 15/83 [00:16<01:03,  1.08it/s]2025-06-11 02:00:50,184 - INFO - Processing /data/user_data/vidhij2/medical/html/WHO_recommendations_on_antenatal_care_for_a_positive_pregnancy_experience.html...\n",
      "2025-06-11 02:00:50,219 - INFO - Splitting WHO_recommendations_on_antenatal_care_for_a_positive_pregnancy_experience.html into sections...\n",
      "2025-06-11 02:00:50,221 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 33.36it/s]\n",
      "2025-06-11 02:00:50,253 - INFO - Created 1 chunks from WHO_recommendations_on_antenatal_care_for_a_positive_pregnancy_experience.html\n",
      "2025-06-11 02:00:50,253 - INFO - Processing /data/user_data/vidhij2/medical/html/How_is_pregnancy_different_for_women_over_35_years_-_Hans_India.html...\n",
      "2025-06-11 02:00:50,279 - INFO - Splitting How_is_pregnancy_different_for_women_over_35_years_-_Hans_India.html into sections...\n",
      "2025-06-11 02:00:50,280 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 33.06it/s]\n",
      "2025-06-11 02:00:50,343 - INFO - Created 2 chunks from How_is_pregnancy_different_for_women_over_35_years_-_Hans_India.html\n",
      "Processing files:  20%|██        | 17/83 [00:16<00:35,  1.86it/s]2025-06-11 02:00:50,343 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_know_if_my_baby_is_getting_enough_breast_milk_-_World_Health_Organization.html...\n",
      "2025-06-11 02:00:50,377 - INFO - Splitting How_do_I_know_if_my_baby_is_getting_enough_breast_milk_-_World_Health_Organization.html into sections...\n",
      "2025-06-11 02:00:50,380 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.49it/s]\n",
      "2025-06-11 02:00:50,604 - INFO - Created 3 chunks from How_do_I_know_if_my_baby_is_getting_enough_breast_milk_-_World_Health_Organization.html\n",
      "Processing files:  22%|██▏       | 18/83 [00:17<00:30,  2.14it/s]2025-06-11 02:00:50,605 - INFO - Processing /data/user_data/vidhij2/medical/html/Which_prenatal_vitamins_should_I_take_and_when_should_I_start_-_Cleveland_Clinic.html...\n",
      "2025-06-11 02:00:50,623 - INFO - Splitting Which_prenatal_vitamins_should_I_take_and_when_should_I_start_-_Cleveland_Clinic.html into sections...\n",
      "2025-06-11 02:00:50,624 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  7.06it/s]\n",
      "2025-06-11 02:00:50,909 - INFO - Created 3 chunks from Which_prenatal_vitamins_should_I_take_and_when_should_I_start_-_Cleveland_Clinic.html\n",
      "Processing files:  23%|██▎       | 19/83 [00:17<00:27,  2.35it/s]2025-06-11 02:00:50,910 - INFO - Processing /data/user_data/vidhij2/medical/html/How_can_I_involve_my_husbandpartner_in_the_pregnancy_journey_-_CloudNineCare.html...\n",
      "2025-06-11 02:00:50,970 - INFO - Splitting How_can_I_involve_my_husbandpartner_in_the_pregnancy_journey_-_CloudNineCare.html into sections...\n",
      "2025-06-11 02:00:50,972 - INFO - Found 7 sections\n",
      "Processing sections: 100%|██████████| 7/7 [00:00<00:00, 11.40it/s]\n",
      "2025-06-11 02:00:51,588 - INFO - Created 11 chunks from How_can_I_involve_my_husbandpartner_in_the_pregnancy_journey_-_CloudNineCare.html\n",
      "Processing files:  24%|██▍       | 20/83 [00:18<00:31,  2.02it/s]2025-06-11 02:00:51,589 - INFO - Processing /data/user_data/vidhij2/medical/html/What_is_the_difference_between_normal_delivery_and_cesarean_section_-_CloudNineCare.html...\n",
      "2025-06-11 02:00:51,649 - INFO - Splitting What_is_the_difference_between_normal_delivery_and_cesarean_section_-_CloudNineCare.html into sections...\n",
      "2025-06-11 02:00:51,651 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.11it/s]\n",
      "2025-06-11 02:00:52,126 - INFO - Created 5 chunks from What_is_the_difference_between_normal_delivery_and_cesarean_section_-_CloudNineCare.html\n",
      "Processing files:  25%|██▌       | 21/83 [00:18<00:31,  1.97it/s]2025-06-11 02:00:52,127 - INFO - Processing /data/user_data/vidhij2/medical/html/How_soon_can_I_get_pregnant_again_after_having_a_baby_-_World_Health_Organization.html...\n",
      "2025-06-11 02:00:52,162 - INFO - Splitting How_soon_can_I_get_pregnant_again_after_having_a_baby_-_World_Health_Organization.html into sections...\n",
      "2025-06-11 02:00:52,165 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 44.54it/s]\n",
      "2025-06-11 02:00:52,211 - INFO - Created 2 chunks from How_soon_can_I_get_pregnant_again_after_having_a_baby_-_World_Health_Organization.html\n",
      "2025-06-11 02:00:52,212 - INFO - Processing /data/user_data/vidhij2/medical/html/What_are_the_signs_of_labor_When_should_I_go_to_the_hospital_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html...\n",
      "2025-06-11 02:00:52,235 - INFO - Splitting What_are_the_signs_of_labor_When_should_I_go_to_the_hospital_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html into sections...\n",
      "2025-06-11 02:00:52,236 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00, 27.96it/s]\n",
      "2025-06-11 02:00:52,381 - INFO - Created 4 chunks from What_are_the_signs_of_labor_When_should_I_go_to_the_hospital_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html\n",
      "Processing files:  28%|██▊       | 23/83 [00:18<00:20,  2.96it/s]2025-06-11 02:00:52,382 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_cope_with_pregnancy_loss_or_previous_miscarriage_-_The_International_Stillbirth_Alliance.html...\n",
      "2025-06-11 02:00:52,406 - INFO - Splitting How_do_I_cope_with_pregnancy_loss_or_previous_miscarriage_-_The_International_Stillbirth_Alliance.html into sections...\n",
      "2025-06-11 02:00:52,407 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [06:38<00:00, 132.89s/it]\n",
      "2025-06-11 02:07:31,068 - INFO - Created 7 chunks from How_do_I_cope_with_pregnancy_loss_or_previous_miscarriage_-_The_International_Stillbirth_Alliance.html\n",
      "Processing files:  29%|██▉       | 24/83 [06:57<1:34:42, 96.31s/it]2025-06-11 02:07:31,069 - INFO - Processing /data/user_data/vidhij2/medical/html/Does_my_diet_affect_my_breast_milk_quality_and_baby's_health_-_Academy_of_Breastfeeding_Medicine.html...\n",
      "2025-06-11 02:07:31,109 - INFO - Splitting Does_my_diet_affect_my_breast_milk_quality_and_baby's_health_-_Academy_of_Breastfeeding_Medicine.html into sections...\n",
      "2025-06-11 02:07:31,110 - INFO - Found 6 sections\n",
      "Processing sections: 100%|██████████| 6/6 [00:00<00:00, 69.26it/s]\n",
      "2025-06-11 02:07:31,199 - INFO - Created 6 chunks from Does_my_diet_affect_my_breast_milk_quality_and_baby's_health_-_Academy_of_Breastfeeding_Medicine.html\n",
      "Processing files:  30%|███       | 25/83 [06:57<1:09:17, 71.68s/it]2025-06-11 02:07:31,199 - INFO - Processing /data/user_data/vidhij2/medical/html/Maternal_Health.html...\n",
      "2025-06-11 02:07:31,229 - INFO - Splitting Maternal_Health.html into sections...\n",
      "2025-06-11 02:07:31,230 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00, 10.67it/s]\n",
      "2025-06-11 02:07:31,701 - INFO - Created 8 chunks from Maternal_Health.html\n",
      "Processing files:  31%|███▏      | 26/83 [06:58<49:59, 52.62s/it]  2025-06-11 02:07:31,702 - INFO - Processing /data/user_data/vidhij2/medical/html/When_should_I_first_visit_a_doctor_after_finding_out_I'm_pregnant_-_National_Health_Mission.html...\n",
      "2025-06-11 02:07:31,731 - INFO - Splitting When_should_I_first_visit_a_doctor_after_finding_out_I'm_pregnant_-_National_Health_Mission.html into sections...\n",
      "2025-06-11 02:07:31,733 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00, 11.42it/s]\n",
      "2025-06-11 02:07:32,173 - INFO - Created 8 chunks from When_should_I_first_visit_a_doctor_after_finding_out_I'm_pregnant_-_National_Health_Mission.html\n",
      "Processing files:  33%|███▎      | 27/83 [06:58<35:38, 38.19s/it]2025-06-11 02:07:32,173 - INFO - Processing /data/user_data/vidhij2/medical/html/Dr._Rita_Bakshi.html...\n",
      "2025-06-11 02:07:32,207 - INFO - Splitting Dr._Rita_Bakshi.html into sections...\n",
      "2025-06-11 02:07:32,209 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00, 21.58it/s]\n",
      "2025-06-11 02:07:32,443 - INFO - Created 6 chunks from Dr._Rita_Bakshi.html\n",
      "Processing files:  34%|███▎      | 28/83 [06:58<25:09, 27.45s/it]2025-06-11 02:07:32,443 - INFO - Processing /data/user_data/vidhij2/medical/html/The_Behaviour_Change_Technique_Ontology_Transforming_the_Behaviour_Change_Technique_Taxonomy_v1.html...\n",
      "2025-06-11 02:07:32,444 - INFO - Splitting The_Behaviour_Change_Technique_Ontology_Transforming_the_Behaviour_Change_Technique_Taxonomy_v1.html into sections...\n",
      "2025-06-11 02:07:32,445 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 3597.17it/s]\n",
      "2025-06-11 02:07:32,447 - INFO - Created 1 chunks from The_Behaviour_Change_Technique_Ontology_Transforming_the_Behaviour_Change_Technique_Taxonomy_v1.html\n",
      "2025-06-11 02:07:32,447 - INFO - Processing /data/user_data/vidhij2/medical/html/Is_it_safe_to_consume_caffeine_(teacoffee)_during_pregnancy_How_much_-_World_Health_Organization_(WHO).html...\n",
      "2025-06-11 02:07:32,482 - INFO - Splitting Is_it_safe_to_consume_caffeine_(teacoffee)_during_pregnancy_How_much_-_World_Health_Organization_(WHO).html into sections...\n",
      "2025-06-11 02:07:32,484 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  7.95it/s]\n",
      "2025-06-11 02:07:32,612 - INFO - Created 2 chunks from Is_it_safe_to_consume_caffeine_(teacoffee)_during_pregnancy_How_much_-_World_Health_Organization_(WHO).html\n",
      "Processing files:  36%|███▌      | 30/83 [06:59<13:25, 15.21s/it]2025-06-11 02:07:32,613 - INFO - Processing /data/user_data/vidhij2/medical/html/Journal_of_Obstetrics_and_Gynecology_of_India.html...\n",
      "2025-06-11 02:07:32,633 - INFO - Splitting Journal_of_Obstetrics_and_Gynecology_of_India.html into sections...\n",
      "2025-06-11 02:07:32,635 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:01<00:00,  2.96it/s]\n",
      "2025-06-11 02:07:33,649 - INFO - Created 11 chunks from Journal_of_Obstetrics_and_Gynecology_of_India.html\n",
      "Processing files:  37%|███▋      | 31/83 [07:00<10:12, 11.77s/it]2025-06-11 02:07:33,650 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_prepare_my_older_child(ren)_for_a_new_sibling_-_CloudNineCare.html...\n",
      "2025-06-11 02:07:33,708 - INFO - Splitting How_do_I_prepare_my_older_child(ren)_for_a_new_sibling_-_CloudNineCare.html into sections...\n",
      "2025-06-11 02:07:33,710 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  7.19it/s]\n",
      "2025-06-11 02:07:34,268 - INFO - Created 8 chunks from How_do_I_prepare_my_older_child(ren)_for_a_new_sibling_-_CloudNineCare.html\n",
      "Processing files:  39%|███▊      | 32/83 [07:00<07:34,  8.91s/it]2025-06-11 02:07:34,268 - INFO - Processing /data/user_data/vidhij2/medical/html/Local_guidance_notes_on_PNC_MH.html...\n",
      "2025-06-11 02:07:34,303 - INFO - Splitting Local_guidance_notes_on_PNC_MH.html into sections...\n",
      "2025-06-11 02:07:34,304 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 13.39it/s]\n",
      "2025-06-11 02:07:34,455 - INFO - Created 3 chunks from Local_guidance_notes_on_PNC_MH.html\n",
      "Processing files:  40%|███▉      | 33/83 [07:00<05:28,  6.57s/it]2025-06-11 02:07:34,456 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_care_for_my_baby's_umbilical_cord_stump_-_BabyCenter_India.html...\n",
      "2025-06-11 02:07:34,492 - INFO - Splitting How_do_I_care_for_my_baby's_umbilical_cord_stump_-_BabyCenter_India.html into sections...\n",
      "2025-06-11 02:07:34,493 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.02it/s]\n",
      "2025-06-11 02:07:35,157 - INFO - Created 6 chunks from How_do_I_care_for_my_baby's_umbilical_cord_stump_-_BabyCenter_India.html\n",
      "Processing files:  41%|████      | 34/83 [07:01<04:02,  4.94s/it]2025-06-11 02:07:35,158 - INFO - Processing /data/user_data/vidhij2/medical/html/Medicover_Hospitals.html...\n",
      "2025-06-11 02:07:35,195 - INFO - Splitting Medicover_Hospitals.html into sections...\n",
      "2025-06-11 02:07:35,197 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:01<00:00,  1.23s/it]\n",
      "2025-06-11 02:07:36,431 - INFO - Created 8 chunks from Medicover_Hospitals.html\n",
      "Processing files:  42%|████▏     | 35/83 [07:02<03:07,  3.90s/it]2025-06-11 02:07:36,432 - INFO - Processing /data/user_data/vidhij2/medical/html/Apollo_Cradle.html...\n",
      "2025-06-11 02:07:36,479 - INFO - Splitting Apollo_Cradle.html into sections...\n",
      "2025-06-11 02:07:36,481 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 76.37it/s]\n",
      "2025-06-11 02:07:36,509 - INFO - Created 2 chunks from Apollo_Cradle.html\n",
      "2025-06-11 02:07:36,509 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_care_for_my_stitches_after_delivery_-_BabyCenter_India.html...\n",
      "2025-06-11 02:07:36,536 - INFO - Splitting How_do_I_care_for_my_stitches_after_delivery_-_BabyCenter_India.html into sections...\n",
      "2025-06-11 02:07:36,537 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.39it/s]\n",
      "2025-06-11 02:07:36,957 - INFO - Created 4 chunks from How_do_I_care_for_my_stitches_after_delivery_-_BabyCenter_India.html\n",
      "Processing files:  45%|████▍     | 37/83 [07:03<01:44,  2.27s/it]2025-06-11 02:07:36,958 - INFO - Processing /data/user_data/vidhij2/medical/html/How_to_be_reasonably_certain_that_a_patient_is_pregnantnot_pregnant.html...\n",
      "2025-06-11 02:07:36,983 - INFO - Splitting How_to_be_reasonably_certain_that_a_patient_is_pregnantnot_pregnant.html into sections...\n",
      "2025-06-11 02:07:36,984 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:05<00:00,  5.76s/it]\n",
      "2025-06-11 02:07:42,743 - INFO - Created 1 chunks from How_to_be_reasonably_certain_that_a_patient_is_pregnantnot_pregnant.html\n",
      "Processing files:  46%|████▌     | 38/83 [07:09<02:20,  3.12s/it]2025-06-11 02:07:42,744 - INFO - Processing /data/user_data/vidhij2/medical/html/Is_spotting_or_light_bleeding_normal_in_early_pregnancy_-_Cleveland_Clinic.html...\n",
      "2025-06-11 02:07:42,766 - INFO - Splitting Is_spotting_or_light_bleeding_normal_in_early_pregnancy_-_Cleveland_Clinic.html into sections...\n",
      "2025-06-11 02:07:42,767 - INFO - Found 6 sections\n",
      "Processing sections: 100%|██████████| 6/6 [00:00<00:00, 18.44it/s]\n",
      "2025-06-11 02:07:43,094 - INFO - Created 7 chunks from Is_spotting_or_light_bleeding_normal_in_early_pregnancy_-_Cleveland_Clinic.html\n",
      "Processing files:  47%|████▋     | 39/83 [07:09<01:46,  2.41s/it]2025-06-11 02:07:43,095 - INFO - Processing /data/user_data/vidhij2/medical/html/What_exercises_are_safe_during_pregnancy_Can_I_do_yoga_-_CloudNine.html...\n",
      "2025-06-11 02:07:43,155 - INFO - Splitting What_exercises_are_safe_during_pregnancy_Can_I_do_yoga_-_CloudNine.html into sections...\n",
      "2025-06-11 02:07:43,157 - INFO - Found 13 sections\n",
      "Processing sections: 100%|██████████| 13/13 [00:00<00:00, 17.85it/s]\n",
      "2025-06-11 02:07:43,888 - INFO - Created 17 chunks from What_exercises_are_safe_during_pregnancy_Can_I_do_yoga_-_CloudNine.html\n",
      "Processing files:  48%|████▊     | 40/83 [07:10<01:24,  1.98s/it]2025-06-11 02:07:43,888 - INFO - Processing /data/user_data/vidhij2/medical/html/Can_I_take_medications_while_breastfeeding_-_Apollo_Hospitals.html...\n",
      "2025-06-11 02:07:43,910 - INFO - Splitting Can_I_take_medications_while_breastfeeding_-_Apollo_Hospitals.html into sections...\n",
      "2025-06-11 02:07:43,911 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00, 14.87it/s]\n",
      "2025-06-11 02:07:44,250 - INFO - Created 6 chunks from Can_I_take_medications_while_breastfeeding_-_Apollo_Hospitals.html\n",
      "Processing files:  49%|████▉     | 41/83 [07:10<01:04,  1.53s/it]2025-06-11 02:07:44,250 - INFO - Processing /data/user_data/vidhij2/medical/html/Renew_Healthcare_India.html...\n",
      "2025-06-11 02:07:44,295 - INFO - Splitting Renew_Healthcare_India.html into sections...\n",
      "2025-06-11 02:07:44,297 - INFO - Found 9 sections\n",
      "Processing sections: 100%|██████████| 9/9 [00:00<00:00, 29.98it/s]\n",
      "2025-06-11 02:07:44,599 - INFO - Created 10 chunks from Renew_Healthcare_India.html\n",
      "Processing files:  51%|█████     | 42/83 [07:11<00:48,  1.19s/it]2025-06-11 02:07:44,600 - INFO - Processing /data/user_data/vidhij2/medical/html/Tweak_India.html...\n",
      "2025-06-11 02:07:44,626 - INFO - Splitting Tweak_India.html into sections...\n",
      "2025-06-11 02:07:44,627 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.62it/s]\n",
      "2025-06-11 02:07:45,244 - INFO - Created 5 chunks from Tweak_India.html\n",
      "Processing files:  52%|█████▏    | 43/83 [07:11<00:41,  1.04s/it]2025-06-11 02:07:45,245 - INFO - Processing /data/user_data/vidhij2/medical/html/How_can_I_confirm_I_am_pregnant_What_are_the_early_signs_-_World_Health_Organization_(WHO).html...\n",
      "2025-06-11 02:07:45,297 - INFO - Splitting How_can_I_confirm_I_am_pregnant_What_are_the_early_signs_-_World_Health_Organization_(WHO).html into sections...\n",
      "2025-06-11 02:07:45,298 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  6.32it/s]\n",
      "2025-06-11 02:07:45,458 - INFO - Created 2 chunks from How_can_I_confirm_I_am_pregnant_What_are_the_early_signs_-_World_Health_Organization_(WHO).html\n",
      "Processing files:  53%|█████▎    | 44/83 [07:11<00:31,  1.26it/s]2025-06-11 02:07:45,459 - INFO - Processing /data/user_data/vidhij2/medical/html/What_are_the_signs_of_pregnancy_complications_I_should_watch_for_-_World_Health_Organization.html...\n",
      "2025-06-11 02:07:45,495 - INFO - Splitting What_are_the_signs_of_pregnancy_complications_I_should_watch_for_-_World_Health_Organization.html into sections...\n",
      "2025-06-11 02:07:45,497 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 34.58it/s]\n",
      "2025-06-11 02:07:45,528 - INFO - Created 1 chunks from What_are_the_signs_of_pregnancy_complications_I_should_watch_for_-_World_Health_Organization.html\n",
      "2025-06-11 02:07:45,528 - INFO - Processing /data/user_data/vidhij2/medical/html/When_will_my_menstrual_cycle_return_after_delivery_-_Apollo_Cradle.html...\n",
      "2025-06-11 02:07:45,598 - INFO - Splitting When_will_my_menstrual_cycle_return_after_delivery_-_Apollo_Cradle.html into sections...\n",
      "2025-06-11 02:07:45,600 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 76.84it/s]\n",
      "2025-06-11 02:07:45,628 - INFO - Created 2 chunks from When_will_my_menstrual_cycle_return_after_delivery_-_Apollo_Cradle.html\n",
      "Processing files:  55%|█████▌    | 46/83 [07:12<00:17,  2.12it/s]2025-06-11 02:07:45,628 - INFO - Processing /data/user_data/vidhij2/medical/html/StemCyte_India.html...\n",
      "2025-06-11 02:07:45,676 - INFO - Splitting StemCyte_India.html into sections...\n",
      "2025-06-11 02:07:45,677 - INFO - Found 10 sections\n",
      "Processing sections: 100%|██████████| 10/10 [00:00<00:00, 41.99it/s]\n",
      "2025-06-11 02:07:45,917 - INFO - Created 10 chunks from StemCyte_India.html\n",
      "Processing files:  57%|█████▋    | 47/83 [07:12<00:15,  2.34it/s]2025-06-11 02:07:45,918 - INFO - Processing /data/user_data/vidhij2/medical/html/Is_it_normal_to_have_swelling_in_hands_and_feet_during_pregnancy_-_CloudNineCare.html...\n",
      "2025-06-11 02:07:46,003 - INFO - Splitting Is_it_normal_to_have_swelling_in_hands_and_feet_during_pregnancy_-_CloudNineCare.html into sections...\n",
      "2025-06-11 02:07:46,005 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  5.91it/s]\n",
      "2025-06-11 02:07:46,514 - INFO - Created 7 chunks from Is_it_normal_to_have_swelling_in_hands_and_feet_during_pregnancy_-_CloudNineCare.html\n",
      "Processing files:  58%|█████▊    | 48/83 [07:12<00:16,  2.12it/s]2025-06-11 02:07:46,515 - INFO - Processing /data/user_data/vidhij2/medical/html/IEC_Materials_(might_not_be_accessible_in_US).html...\n",
      "2025-06-11 02:07:46,559 - INFO - Splitting IEC_Materials_(might_not_be_accessible_in_US).html into sections...\n",
      "2025-06-11 02:07:46,560 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  8.42it/s]\n",
      "2025-06-11 02:07:46,681 - INFO - Created 2 chunks from IEC_Materials_(might_not_be_accessible_in_US).html\n",
      "Processing files:  59%|█████▉    | 49/83 [07:13<00:13,  2.57it/s]2025-06-11 02:07:46,681 - INFO - Processing /data/user_data/vidhij2/medical/html/Human_Behavior_Change_tool.html...\n",
      "2025-06-11 02:07:46,703 - INFO - Splitting Human_Behavior_Change_tool.html into sections...\n",
      "2025-06-11 02:07:46,704 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 56.39it/s]\n",
      "2025-06-11 02:07:46,723 - INFO - Created 1 chunks from Human_Behavior_Change_tool.html\n",
      "2025-06-11 02:07:46,724 - INFO - Processing /data/user_data/vidhij2/medical/html/How_can_I_manage_morning_sickness_What_remedies_work_best_-_CIMS_Hospital_&_1mg.html...\n",
      "2025-06-11 02:07:46,799 - INFO - Splitting How_can_I_manage_morning_sickness_What_remedies_work_best_-_CIMS_Hospital_&_1mg.html into sections...\n",
      "2025-06-11 02:07:46,801 - INFO - Found 11 sections\n",
      "Processing sections: 100%|██████████| 11/11 [00:00<00:00, 51.13it/s]\n",
      "2025-06-11 02:07:47,018 - INFO - Created 11 chunks from How_can_I_manage_morning_sickness_What_remedies_work_best_-_CIMS_Hospital_&_1mg.html\n",
      "Processing files:  61%|██████▏   | 51/83 [07:13<00:09,  3.41it/s]2025-06-11 02:07:47,019 - INFO - Processing /data/user_data/vidhij2/medical/html/How_long_does_labor_typically_last_for_first-time_mothers_-_Cord_Life_India.html...\n",
      "2025-06-11 02:07:47,055 - INFO - Splitting How_long_does_labor_typically_last_for_first-time_mothers_-_Cord_Life_India.html into sections...\n",
      "2025-06-11 02:07:47,056 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  5.23it/s]\n",
      "2025-06-11 02:07:47,248 - INFO - Created 2 chunks from How_long_does_labor_typically_last_for_first-time_mothers_-_Cord_Life_India.html\n",
      "Processing files:  63%|██████▎   | 52/83 [07:13<00:08,  3.59it/s]2025-06-11 02:07:47,249 - INFO - Processing /data/user_data/vidhij2/medical/html/Times_of_India.html...\n",
      "2025-06-11 02:07:47,306 - INFO - Splitting Times_of_India.html into sections...\n",
      "2025-06-11 02:07:47,307 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.97it/s]\n",
      "2025-06-11 02:07:47,816 - INFO - Created 5 chunks from Times_of_India.html\n",
      "Processing files:  64%|██████▍   | 53/83 [07:14<00:10,  2.84it/s]2025-06-11 02:07:47,817 - INFO - Processing /data/user_data/vidhij2/medical/html/Can_I_eat_mangoespapayapineapple_during_pregnancy_-_Apollo_Pharmacy.html...\n",
      "2025-06-11 02:07:47,867 - INFO - Splitting Can_I_eat_mangoespapayapineapple_during_pregnancy_-_Apollo_Pharmacy.html into sections...\n",
      "2025-06-11 02:07:47,868 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  5.37it/s]\n",
      "2025-06-11 02:07:48,056 - INFO - Created 2 chunks from Can_I_eat_mangoespapayapineapple_during_pregnancy_-_Apollo_Pharmacy.html\n",
      "Processing files:  65%|██████▌   | 54/83 [07:14<00:09,  3.11it/s]2025-06-11 02:07:48,057 - INFO - Processing /data/user_data/vidhij2/medical/html/How_long_will_it_take_to_recover_after_delivery_-_Motherhood_India.html...\n",
      "2025-06-11 02:07:48,177 - INFO - Splitting How_long_will_it_take_to_recover_after_delivery_-_Motherhood_India.html into sections...\n",
      "2025-06-11 02:07:48,181 - INFO - Found 11 sections\n",
      "Processing sections: 100%|██████████| 11/11 [00:04<00:00,  2.47it/s]\n",
      "2025-06-11 02:07:52,636 - INFO - Created 11 chunks from How_long_will_it_take_to_recover_after_delivery_-_Motherhood_India.html\n",
      "Processing files:  66%|██████▋   | 55/83 [07:19<00:41,  1.49s/it]2025-06-11 02:07:52,637 - INFO - Processing /data/user_data/vidhij2/medical/html/I_haven't_experienced_any_morning_sickness_-_is_this_normal_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html...\n",
      "2025-06-11 02:07:52,683 - INFO - Splitting I_haven't_experienced_any_morning_sickness_-_is_this_normal_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html into sections...\n",
      "2025-06-11 02:07:52,684 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00, 13.98it/s]\n",
      "2025-06-11 02:07:53,044 - INFO - Created 7 chunks from I_haven't_experienced_any_morning_sickness_-_is_this_normal_-_American_College_of_Obstetricians_and_Gynecologists_(ACOG).html\n",
      "Processing files:  67%|██████▋   | 56/83 [07:19<00:32,  1.19s/it]2025-06-11 02:07:53,044 - INFO - Processing /data/user_data/vidhij2/medical/html/Danone_India.html...\n",
      "2025-06-11 02:07:53,084 - INFO - Splitting Danone_India.html into sections...\n",
      "2025-06-11 02:07:53,086 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00, 11.19it/s]\n",
      "2025-06-11 02:07:53,266 - INFO - Created 3 chunks from Danone_India.html\n",
      "Processing files:  69%|██████▊   | 57/83 [07:19<00:23,  1.10it/s]2025-06-11 02:07:53,267 - INFO - Processing /data/user_data/vidhij2/medical/html/India_Express.html...\n",
      "2025-06-11 02:07:53,315 - INFO - Splitting India_Express.html into sections...\n",
      "2025-06-11 02:07:53,316 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  5.09it/s]\n",
      "2025-06-11 02:07:53,711 - INFO - Created 4 chunks from India_Express.html\n",
      "Processing files:  70%|██████▉   | 58/83 [07:20<00:19,  1.29it/s]2025-06-11 02:07:53,712 - INFO - Processing /data/user_data/vidhij2/medical/html/Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_perspectives_from_Assam.html...\n",
      "2025-06-11 02:07:53,804 - INFO - Splitting Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_perspectives_from_Assam.html into sections...\n",
      "2025-06-11 02:07:53,807 - INFO - Found 32 sections\n",
      "Processing sections: 100%|██████████| 32/32 [00:01<00:00, 24.31it/s]\n",
      "2025-06-11 02:07:55,125 - INFO - Created 38 chunks from Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_perspectives_from_Assam.html\n",
      "Processing files:  71%|███████   | 59/83 [07:21<00:23,  1.04it/s]2025-06-11 02:07:55,126 - INFO - Processing /data/user_data/vidhij2/medical/html/Maternal_Child_Protection_(MCP)_card.html...\n",
      "2025-06-11 02:07:55,211 - INFO - Splitting Maternal_Child_Protection_(MCP)_card.html into sections...\n",
      "2025-06-11 02:07:55,212 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  4.86it/s]\n",
      "2025-06-11 02:07:55,626 - INFO - Created 6 chunks from Maternal_Child_Protection_(MCP)_card.html\n",
      "Processing files:  72%|███████▏  | 60/83 [07:22<00:18,  1.21it/s]2025-06-11 02:07:55,626 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_manage_breastfeeding_if_I_need_to_return_to_work_-_CloudNineCare.html...\n",
      "2025-06-11 02:07:55,720 - INFO - Splitting How_do_I_manage_breastfeeding_if_I_need_to_return_to_work_-_CloudNineCare.html into sections...\n",
      "2025-06-11 02:07:55,722 - INFO - Found 10 sections\n",
      "Processing sections: 100%|██████████| 10/10 [00:00<00:00, 15.32it/s]\n",
      "2025-06-11 02:07:56,377 - INFO - Created 14 chunks from How_do_I_manage_breastfeeding_if_I_need_to_return_to_work_-_CloudNineCare.html\n",
      "Processing files:  73%|███████▎  | 61/83 [07:22<00:17,  1.24it/s]2025-06-11 02:07:56,378 - INFO - Processing /data/user_data/vidhij2/medical/html/Should_I_follow_specific_traditional_practices_during_pregnancy_-_WorldPulse.html...\n",
      "2025-06-11 02:07:56,396 - INFO - Splitting Should_I_follow_specific_traditional_practices_during_pregnancy_-_WorldPulse.html into sections...\n",
      "2025-06-11 02:07:56,397 - INFO - Found 6 sections\n",
      "Processing sections: 100%|██████████| 6/6 [00:00<00:00, 18.63it/s]\n",
      "2025-06-11 02:07:56,721 - INFO - Created 7 chunks from Should_I_follow_specific_traditional_practices_during_pregnancy_-_WorldPulse.html\n",
      "Processing files:  75%|███████▍  | 62/83 [07:23<00:14,  1.50it/s]2025-06-11 02:07:56,722 - INFO - Processing /data/user_data/vidhij2/medical/html/WHO_recommendations_on_maternal_and_newborn_care_for_a_positive_postnatal_experience.html...\n",
      "2025-06-11 02:07:56,756 - INFO - Splitting WHO_recommendations_on_maternal_and_newborn_care_for_a_positive_postnatal_experience.html into sections...\n",
      "2025-06-11 02:07:56,759 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.14it/s]\n",
      "2025-06-11 02:07:57,002 - INFO - Created 3 chunks from WHO_recommendations_on_maternal_and_newborn_care_for_a_positive_postnatal_experience.html\n",
      "Processing files:  76%|███████▌  | 63/83 [07:23<00:11,  1.81it/s]2025-06-11 02:07:57,003 - INFO - Processing /data/user_data/vidhij2/medical/html/What_is_a_birth_plan_and_how_do_I_create_one_-_First_Cry_Parenting.html...\n",
      "2025-06-11 02:07:57,063 - INFO - Splitting What_is_a_birth_plan_and_how_do_I_create_one_-_First_Cry_Parenting.html into sections...\n",
      "2025-06-11 02:07:57,065 - INFO - Found 15 sections\n",
      "Processing sections: 100%|██████████| 15/15 [00:00<00:00, 23.93it/s]\n",
      "2025-06-11 02:07:57,694 - INFO - Created 18 chunks from What_is_a_birth_plan_and_how_do_I_create_one_-_First_Cry_Parenting.html\n",
      "Processing files:  77%|███████▋  | 64/83 [07:24<00:11,  1.68it/s]2025-06-11 02:07:57,695 - INFO - Processing /data/user_data/vidhij2/medical/html/Digital_Health_Interventions_for_Healthcare_Providers_(WHO_&_JHU_resource).html...\n",
      "2025-06-11 02:07:57,791 - INFO - Splitting Digital_Health_Interventions_for_Healthcare_Providers_(WHO_&_JHU_resource).html into sections...\n",
      "2025-06-11 02:07:57,792 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  8.16it/s]\n",
      "2025-06-11 02:07:57,916 - INFO - Created 2 chunks from Digital_Health_Interventions_for_Healthcare_Providers_(WHO_&_JHU_resource).html\n",
      "Processing files:  78%|███████▊  | 65/83 [07:24<00:08,  2.07it/s]2025-06-11 02:07:57,917 - INFO - Processing /data/user_data/vidhij2/medical/html/How_do_I_manage_pregnancy_with_pre-existing_conditions_like_diabetes_or_hypertension_-_Indian_Journal_of_Cardiovascular_Disease_in_Women.html...\n",
      "2025-06-11 02:07:58,053 - INFO - Splitting How_do_I_manage_pregnancy_with_pre-existing_conditions_like_diabetes_or_hypertension_-_Indian_Journal_of_Cardiovascular_Disease_in_Women.html into sections...\n",
      "2025-06-11 02:07:58,057 - INFO - Found 16 sections\n",
      "\n",
      "IOStream.flush timed out\n",
      "Processing sections: 100%|██████████| 16/16 [15:23<00:00, 57.73s/it] \n",
      "2025-06-11 02:23:21,817 - INFO - Created 28 chunks from How_do_I_manage_pregnancy_with_pre-existing_conditions_like_diabetes_or_hypertension_-_Indian_Journal_of_Cardiovascular_Disease_in_Women.html\n",
      "Processing files:  80%|███████▉  | 66/83 [22:48<1:18:29, 277.01s/it]2025-06-11 02:23:21,818 - INFO - Processing /data/user_data/vidhij2/medical/html/When_should_I_start_bathing_my_newborn_-_Times_of_India.html...\n",
      "2025-06-11 02:23:21,885 - INFO - Splitting When_should_I_start_bathing_my_newborn_-_Times_of_India.html into sections...\n",
      "2025-06-11 02:23:21,887 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.34it/s]\n",
      "2025-06-11 02:23:22,316 - INFO - Created 5 chunks from When_should_I_start_bathing_my_newborn_-_Times_of_India.html\n",
      "Processing files:  81%|████████  | 67/83 [22:48<51:46, 194.16s/it]  2025-06-11 02:23:22,317 - INFO - Processing /data/user_data/vidhij2/medical/html/What_is_normal_newborn_stool_and_urine_pattern_-_BabyCenter_India.html...\n",
      "2025-06-11 02:23:22,359 - INFO - Splitting What_is_normal_newborn_stool_and_urine_pattern_-_BabyCenter_India.html into sections...\n",
      "2025-06-11 02:23:22,361 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:01<00:00,  1.88it/s]\n",
      "2025-06-11 02:23:23,426 - INFO - Created 10 chunks from What_is_normal_newborn_stool_and_urine_pattern_-_BabyCenter_India.html\n",
      "Processing files:  82%|████████▏ | 68/83 [22:49<34:04, 136.30s/it]2025-06-11 02:23:23,427 - INFO - Processing /data/user_data/vidhij2/medical/html/BabyCenter_India.html...\n",
      "2025-06-11 02:23:23,465 - INFO - Splitting BabyCenter_India.html into sections...\n",
      "2025-06-11 02:23:23,467 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  2.53it/s]\n",
      "2025-06-11 02:23:24,259 - INFO - Created 7 chunks from BabyCenter_India.html\n",
      "Processing files:  83%|████████▎ | 69/83 [22:50<22:19, 95.68s/it] 2025-06-11 02:23:24,260 - INFO - Processing /data/user_data/vidhij2/medical/html/How_can_I_manage_postpartum_depression_or_mood_changes_-_Motherhood_India.html...\n",
      "2025-06-11 02:23:24,922 - INFO - Splitting How_can_I_manage_postpartum_depression_or_mood_changes_-_Motherhood_India.html into sections...\n",
      "2025-06-11 02:23:24,927 - INFO - Found 11 sections\n",
      "Processing sections: 100%|██████████| 11/11 [00:04<00:00,  2.43it/s]\n",
      "2025-06-11 02:23:29,450 - INFO - Created 11 chunks from How_can_I_manage_postpartum_depression_or_mood_changes_-_Motherhood_India.html\n",
      "Processing files:  84%|████████▍ | 70/83 [22:55<14:51, 68.55s/it]2025-06-11 02:23:29,451 - INFO - Processing /data/user_data/vidhij2/medical/html/Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_Perspectives_from_Assam.html...\n",
      "2025-06-11 02:23:29,543 - INFO - Splitting Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_Perspectives_from_Assam.html into sections...\n",
      "2025-06-11 02:23:29,545 - INFO - Found 32 sections\n",
      "Processing sections: 100%|██████████| 32/32 [00:01<00:00, 25.00it/s]\n",
      "2025-06-11 02:23:30,827 - INFO - Created 38 chunks from Leveraging_health_financing,_digital_health_and_self-care_approaches_to_strengthen_maternal_health_journeys_in_India_Perspectives_from_Assam.html\n",
      "Processing files:  86%|████████▌ | 71/83 [22:57<09:40, 48.40s/it]2025-06-11 02:23:30,828 - INFO - Processing /data/user_data/vidhij2/medical/html/What_special_care_is_needed_for_high-risk_pregnancies_-_Kangaroo_Care_India.html...\n",
      "2025-06-11 02:23:30,830 - INFO - Splitting What_special_care_is_needed_for_high-risk_pregnancies_-_Kangaroo_Care_India.html into sections...\n",
      "2025-06-11 02:23:30,831 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 178.82it/s]\n",
      "2025-06-11 02:23:30,838 - INFO - Created 1 chunks from What_special_care_is_needed_for_high-risk_pregnancies_-_Kangaroo_Care_India.html\n",
      "2025-06-11 02:23:30,838 - INFO - Processing /data/user_data/vidhij2/medical/html/Digital_Adaptation_Kit_for_Antenatal_Care_Operational_requirements_for_implementing_WHO_recommendations_in_digital_systems.html...\n",
      "2025-06-11 02:23:30,898 - INFO - Splitting Digital_Adaptation_Kit_for_Antenatal_Care_Operational_requirements_for_implementing_WHO_recommendations_in_digital_systems.html into sections...\n",
      "2025-06-11 02:23:30,900 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.03it/s]\n",
      "2025-06-11 02:23:31,150 - INFO - Created 3 chunks from Digital_Adaptation_Kit_for_Antenatal_Care_Operational_requirements_for_implementing_WHO_recommendations_in_digital_systems.html\n",
      "Processing files:  88%|████████▊ | 73/83 [22:57<04:21, 26.14s/it]2025-06-11 02:23:31,151 - INFO - Processing /data/user_data/vidhij2/medical/html/What_should_I_eat_to_produce_healthy_breast_milk_-_National_Institute_of_Nutrition_&_Teddyy_Baby_Diaper.html...\n",
      "2025-06-11 02:23:31,226 - INFO - Splitting What_should_I_eat_to_produce_healthy_breast_milk_-_National_Institute_of_Nutrition_&_Teddyy_Baby_Diaper.html into sections...\n",
      "2025-06-11 02:23:31,322 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [13:45<00:00, 825.58s/it]\n",
      "2025-06-11 02:37:16,905 - INFO - Created 1923 chunks from What_should_I_eat_to_produce_healthy_breast_milk_-_National_Institute_of_Nutrition_&_Teddyy_Baby_Diaper.html\n",
      "Processing files:  89%|████████▉ | 74/83 [36:43<33:39, 224.37s/it]2025-06-11 02:37:16,906 - INFO - Processing /data/user_data/vidhij2/medical/html/Dr._Madhu_Goel.html...\n",
      "2025-06-11 02:37:16,961 - INFO - Splitting Dr._Madhu_Goel.html into sections...\n",
      "2025-06-11 02:37:16,963 - INFO - Found 9 sections\n",
      "Processing sections: 100%|██████████| 9/9 [00:00<00:00, 37.58it/s]\n",
      "2025-06-11 02:37:17,204 - INFO - Created 9 chunks from Dr._Madhu_Goel.html\n",
      "Processing files:  90%|█████████ | 75/83 [36:43<22:06, 165.77s/it]2025-06-11 02:37:17,205 - INFO - Processing /data/user_data/vidhij2/medical/html/1mg.html...\n",
      "2025-06-11 02:37:17,246 - INFO - Splitting 1mg.html into sections...\n",
      "2025-06-11 02:37:17,246 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 20.12it/s]\n",
      "2025-06-11 02:37:17,298 - INFO - Created 1 chunks from 1mg.html\n",
      "2025-06-11 02:37:17,298 - INFO - Processing /data/user_data/vidhij2/medical/html/Human_Behavior_Change_summary.html...\n",
      "2025-06-11 02:37:17,305 - INFO - Splitting Human_Behavior_Change_summary.html into sections...\n",
      "2025-06-11 02:37:17,305 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  9.71it/s]\n",
      "2025-06-11 02:37:17,410 - INFO - Created 2 chunks from Human_Behavior_Change_summary.html\n",
      "Processing files:  93%|█████████▎| 77/83 [36:43<09:29, 94.92s/it] 2025-06-11 02:37:17,410 - INFO - Processing /data/user_data/vidhij2/medical/html/What_should_I_pack_in_my_hospital_bag_-_Baby_Center_India.html...\n",
      "2025-06-11 02:37:17,449 - INFO - Splitting What_should_I_pack_in_my_hospital_bag_-_Baby_Center_India.html into sections...\n",
      "2025-06-11 02:37:17,451 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  5.32it/s]\n",
      "2025-06-11 02:37:17,828 - INFO - Created 4 chunks from What_should_I_pack_in_my_hospital_bag_-_Baby_Center_India.html\n",
      "Processing files:  94%|█████████▍| 78/83 [36:44<06:04, 72.81s/it]2025-06-11 02:37:17,829 - INFO - Processing /data/user_data/vidhij2/medical/html/How_often_should_I_have_ultrasound_scans_during_my_pregnancy_-_Apollo_Cradle.html...\n",
      "2025-06-11 02:37:17,871 - INFO - Splitting How_often_should_I_have_ultrasound_scans_during_my_pregnancy_-_Apollo_Cradle.html into sections...\n",
      "2025-06-11 02:37:17,872 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:02<00:00,  1.23it/s]\n",
      "2025-06-11 02:37:20,319 - INFO - Created 6 chunks from How_often_should_I_have_ultrasound_scans_during_my_pregnancy_-_Apollo_Cradle.html\n",
      "Processing files:  95%|█████████▌| 79/83 [36:46<03:40, 55.19s/it]2025-06-11 02:37:20,320 - INFO - Processing /data/user_data/vidhij2/medical/html/What_pain_relief_options_are_available_during_labor_-_Baby_Center.html...\n",
      "2025-06-11 02:37:20,387 - INFO - Splitting What_pain_relief_options_are_available_during_labor_-_Baby_Center.html into sections...\n",
      "2025-06-11 02:37:20,388 - INFO - Found 6 sections\n",
      "Processing sections: 100%|██████████| 6/6 [00:00<00:00, 18.20it/s]\n",
      "2025-06-11 02:37:20,720 - INFO - Created 7 chunks from What_pain_relief_options_are_available_during_labor_-_Baby_Center.html\n",
      "Processing files:  96%|█████████▋| 80/83 [36:47<02:02, 40.75s/it]2025-06-11 02:37:20,721 - INFO - Processing /data/user_data/vidhij2/medical/html/What_should_I_do_if_I_feel_reduced_fetal_movement_-_CloudNineCare.html...\n",
      "2025-06-11 02:37:20,795 - INFO - Splitting What_should_I_do_if_I_feel_reduced_fetal_movement_-_CloudNineCare.html into sections...\n",
      "2025-06-11 02:37:20,797 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  4.11it/s]\n",
      "2025-06-11 02:37:21,286 - INFO - Created 6 chunks from What_should_I_do_if_I_feel_reduced_fetal_movement_-_CloudNineCare.html\n",
      "Processing files:  98%|█████████▊| 81/83 [36:47<00:59, 29.76s/it]2025-06-11 02:37:21,287 - INFO - Processing /data/user_data/vidhij2/medical/html/How_can_I_manage_thyroid_issues_during_pregnancy_-_Apollo_Cradle.html...\n",
      "2025-06-11 02:37:21,335 - INFO - Splitting How_can_I_manage_thyroid_issues_during_pregnancy_-_Apollo_Cradle.html into sections...\n",
      "2025-06-11 02:37:21,337 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:02<00:00,  1.24it/s]\n",
      "2025-06-11 02:37:23,751 - INFO - Created 7 chunks from How_can_I_manage_thyroid_issues_during_pregnancy_-_Apollo_Cradle.html\n",
      "Processing files:  99%|█████████▉| 82/83 [36:50<00:22, 22.09s/it]2025-06-11 02:37:23,751 - INFO - Processing /data/user_data/vidhij2/medical/html/Where_There_is_No_Doctor_handbook-_Hesperian_(Hindi).html...\n",
      "2025-06-11 02:37:23,809 - INFO - Splitting Where_There_is_No_Doctor_handbook-_Hesperian_(Hindi).html into sections...\n",
      "2025-06-11 02:37:23,810 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.19it/s]\n",
      "2025-06-11 02:37:24,126 - INFO - Created 5 chunks from Where_There_is_No_Doctor_handbook-_Hesperian_(Hindi).html\n",
      "Processing files: 100%|██████████| 83/83 [36:50<00:00, 26.63s/it]\n"
     ]
    }
   ],
   "source": [
    "documents = pipeline.process_directory(\"/data/user_data/vidhij2/medical/html\")\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 01:41:34,510 - INFO - Processing 131 files in /data/user_data/vidhij2/medical/pdfs\n",
      "Processing files:   0%|          | 0/131 [00:00<?, ?it/s]2025-06-11 01:41:34,512 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Stammering_and_Stuttering.pdf...\n",
      "2025-06-11 01:41:35,448 - INFO - Splitting Guideline_for_Stammering_and_Stuttering.pdf into sections...\n",
      "2025-06-11 01:41:35,450 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.15it/s]\n",
      "2025-06-11 01:41:35,769 - INFO - Created 3 chunks from Guideline_for_Stammering_and_Stuttering.pdf\n",
      "Processing files:   1%|          | 1/131 [00:01<02:43,  1.26s/it]2025-06-11 01:41:35,770 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Vitamins_and_Minerals_for_My_Child.pdf...\n",
      "2025-06-11 01:41:36,100 - INFO - Splitting Guideline_for_Vitamins_and_Minerals_for_My_Child.pdf into sections...\n",
      "2025-06-11 01:41:36,101 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.34it/s]\n",
      "2025-06-11 01:41:36,852 - INFO - Created 6 chunks from Guideline_for_Vitamins_and_Minerals_for_My_Child.pdf\n",
      "Processing files:   2%|▏         | 2/131 [00:02<02:28,  1.15s/it]2025-06-11 01:41:36,853 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Identifying_a_Sick_Newborn.pdf...\n",
      "2025-06-11 01:41:37,226 - INFO - Splitting Guideline_for_Identifying_a_Sick_Newborn.pdf into sections...\n",
      "2025-06-11 01:41:37,228 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  4.34it/s]\n",
      "2025-06-11 01:41:37,690 - INFO - Created 4 chunks from Guideline_for_Identifying_a_Sick_Newborn.pdf\n",
      "Processing files:   2%|▏         | 3/131 [00:03<02:09,  1.01s/it]2025-06-11 01:41:37,691 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Maternal_nutrition_for_safe_motherhood_(Flipbook).pdf...\n",
      "2025-06-11 01:41:47,432 - INFO - Splitting Maternal_nutrition_for_safe_motherhood_(Flipbook).pdf into sections...\n",
      "2025-06-11 01:41:47,435 - INFO - Found 15 sections\n",
      "Processing sections: 100%|██████████| 15/15 [00:01<00:00, 11.96it/s]\n",
      "2025-06-11 01:41:48,692 - INFO - Created 27 chunks from Maternal_nutrition_for_safe_motherhood_(Flipbook).pdf\n",
      "Processing files:   3%|▎         | 4/131 [00:14<10:29,  4.95s/it]2025-06-11 01:41:48,692 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Acute_Episodes_of_Seizures_What_to_Do.pdf...\n",
      "2025-06-11 01:41:48,918 - INFO - Splitting Guideline_for_Acute_Episodes_of_Seizures_What_to_Do.pdf into sections...\n",
      "2025-06-11 01:41:48,919 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00, 38.32it/s]\n",
      "2025-06-11 01:41:49,026 - INFO - Created 4 chunks from Guideline_for_Acute_Episodes_of_Seizures_What_to_Do.pdf\n",
      "Processing files:   4%|▍         | 5/131 [00:14<06:54,  3.29s/it]2025-06-11 01:41:49,027 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/How_do_I_know_if_my_baby_is_sick_What_signs_should_I_watch_for_-_Indian_Academy_of_Pediatrics.pdf...\n",
      "2025-06-11 01:41:49,354 - INFO - Splitting How_do_I_know_if_my_baby_is_sick_What_signs_should_I_watch_for_-_Indian_Academy_of_Pediatrics.pdf into sections...\n",
      "2025-06-11 01:41:49,356 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  4.70it/s]\n",
      "2025-06-11 01:41:49,784 - INFO - Created 4 chunks from How_do_I_know_if_my_baby_is_sick_What_signs_should_I_watch_for_-_Indian_Academy_of_Pediatrics.pdf\n",
      "Processing files:   5%|▍         | 6/131 [00:15<05:03,  2.43s/it]2025-06-11 01:41:49,785 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Mental_Health_Issues_in_Adolescents.pdf...\n",
      "2025-06-11 01:41:50,022 - INFO - Splitting Guideline_for_Mental_Health_Issues_in_Adolescents.pdf into sections...\n",
      "2025-06-11 01:41:50,024 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.69it/s]\n",
      "2025-06-11 01:41:50,618 - INFO - Created 5 chunks from Guideline_for_Mental_Health_Issues_in_Adolescents.pdf\n",
      "Processing files:   5%|▌         | 7/131 [00:16<03:56,  1.91s/it]2025-06-11 01:41:50,618 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Normal_Sleep_and_Physical_Activity.pdf...\n",
      "2025-06-11 01:41:50,857 - INFO - Splitting Guidelines_for_Normal_Sleep_and_Physical_Activity.pdf into sections...\n",
      "2025-06-11 01:41:50,858 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  4.52it/s]\n",
      "2025-06-11 01:41:51,524 - INFO - Created 6 chunks from Guidelines_for_Normal_Sleep_and_Physical_Activity.pdf\n",
      "Processing files:   6%|▌         | 8/131 [00:17<03:15,  1.59s/it]2025-06-11 01:41:51,525 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_How_Do_I_Prepare_for_Arrival_of_My_Newborn_Baby.pdf...\n",
      "2025-06-11 01:41:51,767 - INFO - Splitting Guideline_for_How_Do_I_Prepare_for_Arrival_of_My_Newborn_Baby.pdf into sections...\n",
      "2025-06-11 01:41:51,768 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.51it/s]\n",
      "2025-06-11 01:41:52,433 - INFO - Created 5 chunks from Guideline_for_How_Do_I_Prepare_for_Arrival_of_My_Newborn_Baby.pdf\n",
      "Processing files:   7%|▋         | 9/131 [00:17<02:47,  1.38s/it]2025-06-11 01:41:52,434 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_Children_with_Febrile_Seizure.pdf...\n",
      "2025-06-11 01:41:52,607 - INFO - Splitting Guideline_for_Care_of_Children_with_Febrile_Seizure.pdf into sections...\n",
      "2025-06-11 01:41:52,608 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.06it/s]\n",
      "2025-06-11 01:41:53,094 - INFO - Created 5 chunks from Guideline_for_Care_of_Children_with_Febrile_Seizure.pdf\n",
      "Processing files:   8%|▊         | 10/131 [00:18<02:19,  1.16s/it]2025-06-11 01:41:53,095 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Typhoid.pdf...\n",
      "2025-06-11 01:41:53,378 - INFO - Splitting Guideline_for_Typhoid.pdf into sections...\n",
      "2025-06-11 01:41:53,379 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.86it/s]\n",
      "2025-06-11 01:41:53,918 - INFO - Created 4 chunks from Guideline_for_Typhoid.pdf\n",
      "Processing files:   8%|▊         | 11/131 [00:19<02:06,  1.05s/it]2025-06-11 01:41:53,919 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_Chronic_Asthma.pdf...\n",
      "2025-06-11 01:41:54,120 - INFO - Splitting Guideline_for_Home_Care_of_Chronic_Asthma.pdf into sections...\n",
      "2025-06-11 01:41:54,121 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00, 16.37it/s]\n",
      "2025-06-11 01:41:54,307 - INFO - Created 3 chunks from Guideline_for_Home_Care_of_Chronic_Asthma.pdf\n",
      "Processing files:   9%|▉         | 12/131 [00:19<01:41,  1.17it/s]2025-06-11 01:41:54,307 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Intellectual_Disability.pdf...\n",
      "2025-06-11 01:41:54,600 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Intellectual_Disability.pdf into sections...\n",
      "2025-06-11 01:41:54,602 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.34it/s]\n",
      "2025-06-11 01:41:54,834 - INFO - Created 2 chunks from Guideline_for_Care_of_a_Child_with_Intellectual_Disability.pdf\n",
      "Processing files:  10%|▉         | 13/131 [00:20<01:28,  1.33it/s]2025-06-11 01:41:54,835 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/LaQshya_Labor_room_quality_improvement_initiative.pdf...\n",
      "2025-06-11 01:41:57,347 - INFO - Splitting LaQshya_Labor_room_quality_improvement_initiative.pdf into sections...\n",
      "2025-06-11 01:41:57,357 - INFO - Found 39 sections\n",
      "Processing sections: 100%|██████████| 39/39 [00:09<00:00,  4.19it/s]\n",
      "2025-06-11 01:42:06,669 - INFO - Created 112 chunks from LaQshya_Labor_room_quality_improvement_initiative.pdf\n",
      "Processing files:  11%|█         | 14/131 [00:32<07:59,  4.10s/it]2025-06-11 01:42:06,670 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Suspecting_a_Serious_Bacterial_Illness.pdf...\n",
      "2025-06-11 01:42:06,871 - INFO - Splitting Guideline_for_Suspecting_a_Serious_Bacterial_Illness.pdf into sections...\n",
      "2025-06-11 01:42:06,872 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.99it/s]\n",
      "2025-06-11 01:42:07,208 - INFO - Created 3 chunks from Guideline_for_Suspecting_a_Serious_Bacterial_Illness.pdf\n",
      "Processing files:  11%|█▏        | 15/131 [00:32<05:51,  3.03s/it]2025-06-11 01:42:07,209 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_The_Constipated_Kid.pdf...\n",
      "2025-06-11 01:42:07,349 - INFO - Splitting Guideline_for_The_Constipated_Kid.pdf into sections...\n",
      "2025-06-11 01:42:07,350 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.09it/s]\n",
      "2025-06-11 01:42:07,676 - INFO - Created 3 chunks from Guideline_for_The_Constipated_Kid.pdf\n",
      "Processing files:  12%|█▏        | 16/131 [00:33<04:19,  2.26s/it]2025-06-11 01:42:07,676 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Terminally_Ill_Child.pdf...\n",
      "2025-06-11 01:42:07,808 - INFO - Splitting Guideline_for_Care_of_a_Terminally_Ill_Child.pdf into sections...\n",
      "2025-06-11 01:42:07,809 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.25it/s]\n",
      "2025-06-11 01:42:08,255 - INFO - Created 4 chunks from Guideline_for_Care_of_a_Terminally_Ill_Child.pdf\n",
      "Processing files:  13%|█▎        | 17/131 [00:33<03:19,  1.75s/it]2025-06-11 01:42:08,256 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Specific_Learning_Disability_in_Your_Child.pdf...\n",
      "2025-06-11 01:42:08,613 - INFO - Splitting Guideline_for_When_to_Suspect_Specific_Learning_Disability_in_Your_Child.pdf into sections...\n",
      "2025-06-11 01:42:08,614 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  7.84it/s]\n",
      "2025-06-11 01:42:08,999 - INFO - Created 5 chunks from Guideline_for_When_to_Suspect_Specific_Learning_Disability_in_Your_Child.pdf\n",
      "Processing files:  14%|█▎        | 18/131 [00:34<02:43,  1.45s/it]2025-06-11 01:42:08,999 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Enuresis_and_Encopresis.pdf...\n",
      "2025-06-11 01:42:09,655 - INFO - Splitting Guideline_for_Enuresis_and_Encopresis.pdf into sections...\n",
      "2025-06-11 01:42:09,656 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  6.03it/s]\n",
      "2025-06-11 01:42:10,156 - INFO - Created 6 chunks from Guideline_for_Enuresis_and_Encopresis.pdf\n",
      "Processing files:  15%|█▍        | 19/131 [00:35<02:32,  1.36s/it]2025-06-11 01:42:10,156 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Environmental_Pollution.pdf...\n",
      "2025-06-11 01:42:10,461 - INFO - Splitting Guideline_for_Environmental_Pollution.pdf into sections...\n",
      "2025-06-11 01:42:10,462 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  5.45it/s]\n",
      "2025-06-11 01:42:11,014 - INFO - Created 6 chunks from Guideline_for_Environmental_Pollution.pdf\n",
      "Processing files:  15%|█▌        | 20/131 [00:36<02:14,  1.21s/it]2025-06-11 01:42:11,015 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Skin_Allergies.pdf...\n",
      "2025-06-11 01:42:11,213 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Skin_Allergies.pdf into sections...\n",
      "2025-06-11 01:42:11,214 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 21.80it/s]\n",
      "2025-06-11 01:42:11,262 - INFO - Created 1 chunks from Guideline_for_Care_of_a_Child_with_Skin_Allergies.pdf\n",
      "Processing files:  16%|█▌        | 21/131 [00:36<01:41,  1.09it/s]2025-06-11 01:42:11,263 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_obesity.pdf...\n",
      "2025-06-11 01:42:11,643 - INFO - Splitting Guidelines_for_obesity.pdf into sections...\n",
      "2025-06-11 01:42:11,645 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:01<00:00,  1.07s/it]\n",
      "2025-06-11 01:42:12,718 - INFO - Created 9 chunks from Guidelines_for_obesity.pdf\n",
      "Processing files:  17%|█▋        | 22/131 [00:38<01:57,  1.08s/it]2025-06-11 01:42:12,719 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_My_Child_has_a_Fever_with_Rash.pdf...\n",
      "2025-06-11 01:42:12,918 - INFO - Splitting Guideline_for_My_Child_has_a_Fever_with_Rash.pdf into sections...\n",
      "2025-06-11 01:42:12,918 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.23it/s]\n",
      "2025-06-11 01:42:13,230 - INFO - Created 3 chunks from Guideline_for_My_Child_has_a_Fever_with_Rash.pdf\n",
      "Processing files:  18%|█▊        | 23/131 [00:38<01:38,  1.10it/s]2025-06-11 01:42:13,231 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Attainment_of_Puberty.pdf...\n",
      "2025-06-11 01:42:13,484 - INFO - Splitting Guideline_for_Attainment_of_Puberty.pdf into sections...\n",
      "2025-06-11 01:42:13,485 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.76it/s]\n",
      "2025-06-11 01:42:14,055 - INFO - Created 5 chunks from Guideline_for_Attainment_of_Puberty.pdf\n",
      "Processing files:  18%|█▊        | 24/131 [00:39<01:34,  1.13it/s]2025-06-11 01:42:14,055 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Dental_Care,_Diapers,_and_Clothing.pdf...\n",
      "2025-06-11 01:42:14,433 - INFO - Splitting Guideline_for_Dental_Care,_Diapers,_and_Clothing.pdf into sections...\n",
      "2025-06-11 01:42:14,434 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  5.08it/s]\n",
      "2025-06-11 01:42:15,224 - INFO - Created 8 chunks from Guideline_for_Dental_Care,_Diapers,_and_Clothing.pdf\n",
      "Processing files:  19%|█▉        | 25/131 [00:40<01:42,  1.03it/s]2025-06-11 01:42:15,225 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Allergic_Rhinitis.pdf...\n",
      "2025-06-11 01:42:15,401 - INFO - Splitting Guideline_for_Allergic_Rhinitis.pdf into sections...\n",
      "2025-06-11 01:42:15,402 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.12it/s]\n",
      "2025-06-11 01:42:15,646 - INFO - Created 2 chunks from Guideline_for_Allergic_Rhinitis.pdf\n",
      "Processing files:  20%|█▉        | 26/131 [00:41<01:24,  1.24it/s]2025-06-11 01:42:15,647 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Normal_Psychosocial_Development_in_Adolescents.pdf...\n",
      "2025-06-11 01:42:16,032 - INFO - Splitting Guideline_for_Normal_Psychosocial_Development_in_Adolescents.pdf into sections...\n",
      "2025-06-11 01:42:16,034 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.79it/s]\n",
      "2025-06-11 01:42:16,563 - INFO - Created 5 chunks from Guideline_for_Normal_Psychosocial_Development_in_Adolescents.pdf\n",
      "Processing files:  21%|██        | 27/131 [00:42<01:27,  1.19it/s]2025-06-11 01:42:16,564 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Dietary_Guidelines_for_Indians_-_A_Manual.pdf...\n",
      "2025-06-11 01:42:22,794 - INFO - Splitting Dietary_Guidelines_for_Indians_-_A_Manual.pdf into sections...\n",
      "2025-06-11 01:42:22,801 - INFO - Found 34 sections\n",
      "Processing sections: 100%|██████████| 34/34 [00:09<00:00,  3.76it/s]\n",
      "2025-06-11 01:42:31,846 - INFO - Created 93 chunks from Dietary_Guidelines_for_Indians_-_A_Manual.pdf\n",
      "Processing files:  21%|██▏       | 28/131 [00:57<08:52,  5.17s/it]2025-06-11 01:42:31,847 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Screentime_Guidelines_for_Parents.pdf...\n",
      "2025-06-11 01:42:32,145 - INFO - Splitting Screentime_Guidelines_for_Parents.pdf into sections...\n",
      "2025-06-11 01:42:32,147 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.36it/s]\n",
      "2025-06-11 01:42:32,883 - INFO - Created 6 chunks from Screentime_Guidelines_for_Parents.pdf\n",
      "Processing files:  22%|██▏       | 29/131 [00:58<06:41,  3.93s/it]2025-06-11 01:42:32,884 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_of_Adolescents_(10–19_Years).pdf...\n",
      "2025-06-11 01:42:33,093 - INFO - Splitting Guideline_for_Nutrition_of_Adolescents_(10–19_Years).pdf into sections...\n",
      "2025-06-11 01:42:33,094 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.15it/s]\n",
      "2025-06-11 01:42:33,967 - INFO - Created 7 chunks from Guideline_for_Nutrition_of_Adolescents_(10–19_Years).pdf\n",
      "Processing files:  23%|██▎       | 30/131 [00:59<05:10,  3.08s/it]2025-06-11 01:42:33,968 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_Children_with_Cancer.pdf...\n",
      "2025-06-11 01:42:34,187 - INFO - Splitting Guideline_for_Care_of_Children_with_Cancer.pdf into sections...\n",
      "2025-06-11 01:42:34,188 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.73it/s]\n",
      "2025-06-11 01:42:34,767 - INFO - Created 5 chunks from Guideline_for_Care_of_Children_with_Cancer.pdf\n",
      "Processing files:  24%|██▎       | 31/131 [01:00<03:59,  2.39s/it]2025-06-11 01:42:34,768 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Care_of_a_child_with_Diabetes_Mellitus.pdf...\n",
      "2025-06-11 01:42:35,049 - INFO - Splitting Guidelines_for_Care_of_a_child_with_Diabetes_Mellitus.pdf into sections...\n",
      "2025-06-11 01:42:35,050 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.25it/s]\n",
      "2025-06-11 01:42:35,853 - INFO - Created 7 chunks from Guidelines_for_Care_of_a_child_with_Diabetes_Mellitus.pdf\n",
      "Processing files:  24%|██▍       | 32/131 [01:01<03:18,  2.00s/it]2025-06-11 01:42:35,854 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_Between_1_and_2_Years_of_Age.pdf...\n",
      "2025-06-11 01:42:36,112 - INFO - Splitting Guideline_for_Nutrition_Between_1_and_2_Years_of_Age.pdf into sections...\n",
      "2025-06-11 01:42:36,113 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.88it/s]\n",
      "2025-06-11 01:42:36,645 - INFO - Created 5 chunks from Guideline_for_Nutrition_Between_1_and_2_Years_of_Age.pdf\n",
      "Processing files:  25%|██▌       | 33/131 [01:02<02:40,  1.64s/it]2025-06-11 01:42:36,646 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Child_Labor_and_Rights_of_Children.pdf...\n",
      "2025-06-11 01:42:36,786 - INFO - Splitting Guideline_for_Child_Labor_and_Rights_of_Children.pdf into sections...\n",
      "2025-06-11 01:42:36,787 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  6.80it/s]\n",
      "2025-06-11 01:42:36,936 - INFO - Created 2 chunks from Guideline_for_Child_Labor_and_Rights_of_Children.pdf\n",
      "Processing files:  26%|██▌       | 34/131 [01:02<01:59,  1.23s/it]2025-06-11 01:42:36,936 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Wheel_of_balanced_dietary_intake.pdf...\n",
      "2025-06-11 01:42:38,677 - INFO - Splitting Wheel_of_balanced_dietary_intake.pdf into sections...\n",
      "2025-06-11 01:42:38,677 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 210.30it/s]\n",
      "2025-06-11 01:42:38,684 - INFO - Created 1 chunks from Wheel_of_balanced_dietary_intake.pdf\n",
      "Processing files:  27%|██▋       | 35/131 [01:04<02:13,  1.39s/it]2025-06-11 01:42:38,684 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Chronic_Liver_Disease.pdf...\n",
      "2025-06-11 01:42:38,827 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Chronic_Liver_Disease.pdf into sections...\n",
      "2025-06-11 01:42:38,828 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00, 43.73it/s]\n",
      "2025-06-11 01:42:38,921 - INFO - Created 4 chunks from Guideline_for_Care_of_a_Child_with_Chronic_Liver_Disease.pdf\n",
      "Processing files:  27%|██▋       | 36/131 [01:04<01:39,  1.04s/it]2025-06-11 01:42:38,922 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/IAP.pdf...\n",
      "2025-06-11 01:42:39,152 - INFO - Splitting IAP.pdf into sections...\n",
      "2025-06-11 01:42:39,153 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  4.96it/s]\n",
      "2025-06-11 01:42:39,760 - INFO - Created 6 chunks from IAP.pdf\n",
      "Processing files:  28%|██▊       | 37/131 [01:05<01:32,  1.02it/s]2025-06-11 01:42:39,761 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Prevention_and_Care_of_Malnutrition_in_Children.pdf...\n",
      "2025-06-11 01:42:39,974 - INFO - Splitting Guideline_for_Prevention_and_Care_of_Malnutrition_in_Children.pdf into sections...\n",
      "2025-06-11 01:42:39,975 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.29it/s]\n",
      "2025-06-11 01:42:40,413 - INFO - Created 4 chunks from Guideline_for_Prevention_and_Care_of_Malnutrition_in_Children.pdf\n",
      "Processing files:  29%|██▉       | 38/131 [01:05<01:22,  1.13it/s]2025-06-11 01:42:40,414 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Training_Manual_on_Care_During_Pregnancy_and_Child_Birth.pdf...\n",
      "2025-06-11 01:42:42,216 - INFO - Splitting Training_Manual_on_Care_During_Pregnancy_and_Child_Birth.pdf into sections...\n",
      "2025-06-11 01:42:42,221 - INFO - Found 77 sections\n",
      "Processing sections: 100%|██████████| 77/77 [00:04<00:00, 15.70it/s]\n",
      "2025-06-11 01:42:47,128 - INFO - Created 101 chunks from Training_Manual_on_Care_During_Pregnancy_and_Child_Birth.pdf\n",
      "Processing files:  30%|██▉       | 39/131 [01:12<04:02,  2.63s/it]2025-06-11 01:42:47,129 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Early_Childhood_Development.pdf...\n",
      "2025-06-11 01:42:47,404 - INFO - Splitting Guideline_for_Early_Childhood_Development.pdf into sections...\n",
      "2025-06-11 01:42:47,405 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.37it/s]\n",
      "2025-06-11 01:42:48,135 - INFO - Created 6 chunks from Guideline_for_Early_Childhood_Development.pdf\n",
      "Processing files:  31%|███       | 40/131 [01:13<03:15,  2.15s/it]2025-06-11 01:42:48,136 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Neonatal_Jaundice.pdf...\n",
      "2025-06-11 01:42:48,273 - INFO - Splitting Guideline_for_Neonatal_Jaundice.pdf into sections...\n",
      "2025-06-11 01:42:48,274 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.61it/s]\n",
      "2025-06-11 01:42:48,553 - INFO - Created 3 chunks from Guideline_for_Neonatal_Jaundice.pdf\n",
      "Processing files:  31%|███▏      | 41/131 [01:14<02:26,  1.63s/it]2025-06-11 01:42:48,554 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Maternal_nutrition_for_safe_motherhood._Messages_By-gestational_month.pdf...\n",
      "2025-06-11 01:42:55,920 - INFO - Splitting Maternal_nutrition_for_safe_motherhood._Messages_By-gestational_month.pdf into sections...\n",
      "2025-06-11 01:42:55,921 - INFO - Found 29 sections\n",
      "Processing sections: 100%|██████████| 29/29 [00:00<00:00, 42.09it/s]\n",
      "2025-06-11 01:42:56,613 - INFO - Created 29 chunks from Maternal_nutrition_for_safe_motherhood._Messages_By-gestational_month.pdf\n",
      "Processing files:  32%|███▏      | 42/131 [01:22<05:16,  3.56s/it]2025-06-11 01:42:56,613 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Antenatal_Care_and_Skilled_Attendance_at_Birth_by_ANMsLHVsSNs.pdf...\n",
      "2025-06-11 01:43:28,990 - INFO - Splitting Guidelines_for_Antenatal_Care_and_Skilled_Attendance_at_Birth_by_ANMsLHVsSNs.pdf into sections...\n",
      "2025-06-11 01:43:28,999 - INFO - Found 119 sections\n",
      "Processing sections: 100%|██████████| 119/119 [00:09<00:00, 12.36it/s]\n",
      "2025-06-11 01:43:38,632 - INFO - Created 180 chunks from Guidelines_for_Antenatal_Care_and_Skilled_Attendance_at_Birth_by_ANMsLHVsSNs.pdf\n",
      "Processing files:  33%|███▎      | 43/131 [02:04<22:08, 15.10s/it]2025-06-11 01:43:38,633 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_My_Child_is_having_Fever_with_Cough_What_to_Do.pdf...\n",
      "2025-06-11 01:43:38,878 - INFO - Splitting Guideline_for_My_Child_is_having_Fever_with_Cough_What_to_Do.pdf into sections...\n",
      "2025-06-11 01:43:38,879 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 16.33it/s]\n",
      "2025-06-11 01:43:38,942 - INFO - Created 1 chunks from Guideline_for_My_Child_is_having_Fever_with_Cough_What_to_Do.pdf\n",
      "Processing files:  34%|███▎      | 44/131 [02:04<15:27, 10.66s/it]2025-06-11 01:43:38,943 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/PMMVY_Guidelines.pdf...\n",
      "2025-06-11 01:43:44,108 - INFO - Splitting PMMVY_Guidelines.pdf into sections...\n",
      "2025-06-11 01:43:44,112 - INFO - Found 70 sections\n",
      "Processing sections: 100%|██████████| 70/70 [00:05<00:00, 12.58it/s]\n",
      "2025-06-11 01:43:49,680 - INFO - Created 108 chunks from PMMVY_Guidelines.pdf\n",
      "Processing files:  34%|███▍      | 45/131 [02:15<15:18, 10.68s/it]2025-06-11 01:43:49,681 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Genetic_Disorders_How_to_Prevent_Recurrence.pdf...\n",
      "2025-06-11 01:43:49,853 - INFO - Splitting Guideline_for_Genetic_Disorders_How_to_Prevent_Recurrence.pdf into sections...\n",
      "2025-06-11 01:43:49,854 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.45it/s]\n",
      "2025-06-11 01:43:50,544 - INFO - Created 6 chunks from Guideline_for_Genetic_Disorders_How_to_Prevent_Recurrence.pdf\n",
      "Processing files:  35%|███▌      | 46/131 [02:16<10:57,  7.74s/it]2025-06-11 01:43:50,545 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Pregnant_now_or_within_the_last_year.pdf...\n",
      "2025-06-11 01:43:50,684 - INFO - Splitting Pregnant_now_or_within_the_last_year.pdf into sections...\n",
      "2025-06-11 01:43:50,684 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 36.43it/s]\n",
      "2025-06-11 01:43:50,714 - INFO - Created 1 chunks from Pregnant_now_or_within_the_last_year.pdf\n",
      "Processing files:  36%|███▌      | 47/131 [02:16<07:39,  5.47s/it]2025-06-11 01:43:50,714 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Danger_Signs_of_Childbirth.pdf...\n",
      "2025-06-11 01:43:50,790 - INFO - Splitting Danger_Signs_of_Childbirth.pdf into sections...\n",
      "2025-06-11 01:43:50,791 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 33.42it/s]\n",
      "2025-06-11 01:43:50,823 - INFO - Created 1 chunks from Danger_Signs_of_Childbirth.pdf\n",
      "Processing files:  37%|███▋      | 48/131 [02:16<05:20,  3.86s/it]2025-06-11 01:43:50,823 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Toys,_Plays,_And_Sports.pdf...\n",
      "2025-06-11 01:43:51,071 - INFO - Splitting Guideline_for_Toys,_Plays,_And_Sports.pdf into sections...\n",
      "2025-06-11 01:43:51,072 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  6.95it/s]\n",
      "2025-06-11 01:43:51,218 - INFO - Created 2 chunks from Guideline_for_Toys,_Plays,_And_Sports.pdf\n",
      "Processing files:  37%|███▋      | 49/131 [02:16<03:51,  2.82s/it]2025-06-11 01:43:51,219 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Eating_Disorders__Anorexia_and_Bulimia.pdf...\n",
      "2025-06-11 01:43:51,404 - INFO - Splitting Guideline_for_Eating_Disorders__Anorexia_and_Bulimia.pdf into sections...\n",
      "2025-06-11 01:43:51,405 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.85it/s]\n",
      "2025-06-11 01:43:51,947 - INFO - Created 5 chunks from Guideline_for_Eating_Disorders__Anorexia_and_Bulimia.pdf\n",
      "Processing files:  38%|███▊      | 50/131 [02:17<02:57,  2.19s/it]2025-06-11 01:43:51,948 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Leukemia.pdf...\n",
      "2025-06-11 01:43:52,249 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Leukemia.pdf into sections...\n",
      "2025-06-11 01:43:52,250 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  8.28it/s]\n",
      "2025-06-11 01:43:52,614 - INFO - Created 5 chunks from Guideline_for_Care_of_a_Child_with_Leukemia.pdf\n",
      "Processing files:  39%|███▉      | 51/131 [02:18<02:18,  1.74s/it]2025-06-11 01:43:52,615 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_a_Child_with_Cerebral_Palsy.pdf...\n",
      "2025-06-11 01:43:52,863 - INFO - Splitting Guideline_for_Home_Care_of_a_Child_with_Cerebral_Palsy.pdf into sections...\n",
      "2025-06-11 01:43:52,865 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  4.58it/s]\n",
      "2025-06-11 01:43:53,522 - INFO - Created 14 chunks from Guideline_for_Home_Care_of_a_Child_with_Cerebral_Palsy.pdf\n",
      "Processing files:  40%|███▉      | 52/131 [02:19<01:57,  1.49s/it]2025-06-11 01:43:53,523 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Training_Manual_on_care_during_pregnancy_and_childbirth.pdf...\n",
      "2025-06-11 01:43:55,374 - INFO - Splitting Training_Manual_on_care_during_pregnancy_and_childbirth.pdf into sections...\n",
      "2025-06-11 01:43:55,379 - INFO - Found 77 sections\n",
      "Processing sections: 100%|██████████| 77/77 [00:04<00:00, 16.18it/s]\n",
      "2025-06-11 01:44:00,138 - INFO - Created 101 chunks from Training_Manual_on_care_during_pregnancy_and_childbirth.pdf\n",
      "Processing files:  40%|████      | 53/131 [02:25<03:56,  3.03s/it]2025-06-11 01:44:00,139 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Psychosocial_Concerns_during_Pandemic.pdf...\n",
      "2025-06-11 01:44:00,420 - INFO - Splitting Guideline_for_Psychosocial_Concerns_during_Pandemic.pdf into sections...\n",
      "2025-06-11 01:44:00,421 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.31it/s]\n",
      "2025-06-11 01:44:00,655 - INFO - Created 2 chunks from Guideline_for_Psychosocial_Concerns_during_Pandemic.pdf\n",
      "Processing files:  41%|████      | 54/131 [02:26<02:55,  2.27s/it]2025-06-11 01:44:00,656 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Epilepsy.pdf...\n",
      "2025-06-11 01:44:00,807 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Epilepsy.pdf into sections...\n",
      "2025-06-11 01:44:00,808 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  4.04it/s]\n",
      "2025-06-11 01:44:01,305 - INFO - Created 10 chunks from Guideline_for_Care_of_a_Child_with_Epilepsy.pdf\n",
      "Processing files:  42%|████▏     | 55/131 [02:26<02:15,  1.79s/it]2025-06-11 01:44:01,306 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/What_is_jaundice_and_when_should_I_be_concerned_-_Indian_Academy_of_Pediatrics.pdf...\n",
      "2025-06-11 01:44:01,444 - INFO - Splitting What_is_jaundice_and_when_should_I_be_concerned_-_Indian_Academy_of_Pediatrics.pdf into sections...\n",
      "2025-06-11 01:44:01,445 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.68it/s]\n",
      "2025-06-11 01:44:01,718 - INFO - Created 3 chunks from What_is_jaundice_and_when_should_I_be_concerned_-_Indian_Academy_of_Pediatrics.pdf\n",
      "Processing files:  43%|████▎     | 56/131 [02:27<01:43,  1.37s/it]2025-06-11 01:44:01,719 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_Childhood_Cancer_Survivors.pdf...\n",
      "2025-06-11 01:44:01,808 - INFO - Splitting Guideline_for_Care_of_Childhood_Cancer_Survivors.pdf into sections...\n",
      "2025-06-11 01:44:01,809 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  3.53it/s]\n",
      "2025-06-11 01:44:02,094 - INFO - Created 3 chunks from Guideline_for_Care_of_Childhood_Cancer_Survivors.pdf\n",
      "Processing files:  44%|████▎     | 57/131 [02:27<01:19,  1.07s/it]2025-06-11 01:44:02,095 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Care_of_a_Child_with_Nephrotic_Syndrome.pdf...\n",
      "2025-06-11 01:44:02,281 - INFO - Splitting Care_of_a_Child_with_Nephrotic_Syndrome.pdf into sections...\n",
      "2025-06-11 01:44:02,282 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.52it/s]\n",
      "2025-06-11 01:44:02,942 - INFO - Created 6 chunks from Care_of_a_Child_with_Nephrotic_Syndrome.pdf\n",
      "Processing files:  44%|████▍     | 58/131 [02:28<01:13,  1.01s/it]2025-06-11 01:44:02,943 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/JSSK_Guidelines.pdf...\n",
      "2025-06-11 01:44:03,042 - INFO - Splitting JSSK_Guidelines.pdf into sections...\n",
      "2025-06-11 01:44:03,043 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 204.91it/s]\n",
      "2025-06-11 01:44:03,050 - INFO - Created 1 chunks from JSSK_Guidelines.pdf\n",
      "Processing files:  45%|████▌     | 59/131 [02:28<00:53,  1.36it/s]2025-06-11 01:44:03,050 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidance_Note_on_Optimizing_Post-Natal_Care.pdf...\n",
      "2025-06-11 01:44:03,715 - INFO - Splitting Guidance_Note_on_Optimizing_Post-Natal_Care.pdf into sections...\n",
      "2025-06-11 01:44:03,716 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.71it/s]\n",
      "2025-06-11 01:44:04,087 - INFO - Created 4 chunks from Guidance_Note_on_Optimizing_Post-Natal_Care.pdf\n",
      "Processing files:  46%|████▌     | 60/131 [02:29<00:58,  1.21it/s]2025-06-11 01:44:04,088 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Fever.pdf...\n",
      "2025-06-11 01:44:04,285 - INFO - Splitting Guidelines_for_Fever.pdf into sections...\n",
      "2025-06-11 01:44:04,286 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  5.60it/s]\n",
      "2025-06-11 01:44:04,644 - INFO - Created 4 chunks from Guidelines_for_Fever.pdf\n",
      "Processing files:  47%|████▋     | 61/131 [02:30<00:52,  1.34it/s]2025-06-11 01:44:04,645 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Vaccination.pdf...\n",
      "2025-06-11 01:44:04,852 - INFO - Splitting Guideline_for_Vaccination.pdf into sections...\n",
      "2025-06-11 01:44:04,853 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  7.26it/s]\n",
      "2025-06-11 01:44:05,406 - INFO - Created 7 chunks from Guideline_for_Vaccination.pdf\n",
      "Processing files:  47%|████▋     | 62/131 [02:30<00:51,  1.33it/s]2025-06-11 01:44:05,407 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Extracted_from_Guidelines_for_Pregnancy_Care,_Maternal_Health_Division,_Dpt._of_Family_Welfare,_MOHFW,_GoI_2005.pdf...\n",
      "2025-06-11 01:44:13,117 - WARNING - could not convert string to float: b'0.9.639' : FloatObject (b'0.9.639') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,118 - WARNING - could not convert string to float: b'0.9.64.787' : FloatObject (b'0.9.64.787') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,118 - WARNING - could not convert string to float: b'1..859' : FloatObject (b'1..859') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,118 - WARNING - could not convert string to float: b'1..6875.52229' : FloatObject (b'1..6875.52229') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,119 - WARNING - could not convert string to float: b'2.5450.08' : FloatObject (b'2.5450.08') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,119 - WARNING - could not convert string to float: b'3.160.08' : FloatObject (b'3.160.08') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,119 - WARNING - could not convert string to float: b'53.7.33' : FloatObject (b'53.7.33') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,120 - WARNING - could not convert string to float: b'1.96875.50.075' : FloatObject (b'1.96875.50.075') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,120 - WARNING - could not convert string to float: b'-0.50.076' : FloatObject (b'-0.50.076') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,120 - WARNING - could not convert string to float: b'-2..608' : FloatObject (b'-2..608') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,121 - WARNING - could not convert string to float: b'4.0.50.076' : FloatObject (b'4.0.50.076') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,121 - WARNING - could not convert string to float: b'2.172.189' : FloatObject (b'2.172.189') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,122 - WARNING - could not convert string to float: b'2.5.2431.153' : FloatObject (b'2.5.2431.153') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,122 - WARNING - could not convert string to float: b'0.82761.09' : FloatObject (b'0.82761.09') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,122 - WARNING - could not convert string to float: b'4.31.404' : FloatObject (b'4.31.404') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,122 - WARNING - could not convert string to float: b'4.464.31.401.608' : FloatObject (b'4.464.31.401.608') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,123 - WARNING - could not convert string to float: b'5.502.793082761.09' : FloatObject (b'5.502.793082761.09') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,123 - WARNING - could not convert string to float: b'4.837076470.7764687518' : FloatObject (b'4.837076470.7764687518') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,123 - WARNING - could not convert string to float: b'.458.105' : FloatObject (b'.458.105') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,124 - WARNING - could not convert string to float: b'1.6901.1497351' : FloatObject (b'1.6901.1497351') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,124 - WARNING - could not convert string to float: b'3.1740.9.67757011.69011' : FloatObject (b'3.1740.9.67757011.69011') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,124 - WARNING - could not convert string to float: b'47053.0086.193' : FloatObject (b'47053.0086.193') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,125 - WARNING - could not convert string to float: b'3.562.153' : FloatObject (b'3.562.153') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,125 - WARNING - could not convert string to float: b'-1.2702-213-0.3595.638' : FloatObject (b'-1.2702-213-0.3595.638') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,125 - WARNING - could not convert string to float: b'0.0.3' : FloatObject (b'0.0.3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,126 - WARNING - could not convert string to float: b'294.42.1624838' : FloatObject (b'294.42.1624838') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,126 - WARNING - could not convert string to float: b'2.6933.' : FloatObject (b'2.6933.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,126 - WARNING - could not convert string to float: b'1.42311.075' : FloatObject (b'1.42311.075') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,127 - WARNING - could not convert string to float: b'0.2.1624' : FloatObject (b'0.2.1624') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,127 - WARNING - could not convert string to float: b'--0.71624' : FloatObject (b'--0.71624') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,127 - WARNING - could not convert string to float: b'-2.7881.47' : FloatObject (b'-2.7881.47') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,128 - WARNING - NumberObject(b'--04056699') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,128 - WARNING - could not convert string to float: b'0.5.50.076' : FloatObject (b'0.5.50.076') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,128 - WARNING - could not convert string to float: b'-21.1687.77646857--040-0.571' : FloatObject (b'-21.1687.77646857--040-0.571') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,129 - WARNING - could not convert string to float: b'2164.32981.736' : FloatObject (b'2164.32981.736') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,129 - WARNING - could not convert string to float: b'-0.2-0.1671.459' : FloatObject (b'-0.2-0.1671.459') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,129 - WARNING - could not convert string to float: b'-0.3.703-0.629' : FloatObject (b'-0.3.703-0.629') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,130 - WARNING - could not convert string to float: b'4.7-2.5064314.11425' : FloatObject (b'4.7-2.5064314.11425') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,130 - WARNING - could not convert string to float: b'-0.2-007065' : FloatObject (b'-0.2-007065') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,130 - WARNING - could not convert string to float: b'1.73453.016488' : FloatObject (b'1.73453.016488') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,130 - WARNING - could not convert string to float: b'3.86.4587160.2.787' : FloatObject (b'3.86.4587160.2.787') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,131 - WARNING - could not convert string to float: b'4.329.704' : FloatObject (b'4.329.704') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,131 - WARNING - could not convert string to float: b'-90.325.13' : FloatObject (b'-90.325.13') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,131 - WARNING - could not convert string to float: b'64.31.9.64.7.7038' : FloatObject (b'64.31.9.64.7.7038') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,131 - WARNING - could not convert string to float: b'6120.512230.876' : FloatObject (b'6120.512230.876') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,132 - WARNING - could not convert string to float: b'0597.7730.87' : FloatObject (b'0597.7730.87') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,132 - WARNING - could not convert string to float: b'0573.69332.329.1-2.5611' : FloatObject (b'0573.69332.329.1-2.5611') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,132 - WARNING - could not convert string to float: b'-..1-659' : FloatObject (b'-..1-659') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,133 - WARNING - could not convert string to float: b'-3.80.18' : FloatObject (b'-3.80.18') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,133 - WARNING - could not convert string to float: b'-0.9667.18' : FloatObject (b'-0.9667.18') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,134 - WARNING - could not convert string to float: b'-2.7741533-4.0351' : FloatObject (b'-2.7741533-4.0351') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,134 - WARNING - could not convert string to float: b'3.1740.9.67757088' : FloatObject (b'3.1740.9.67757088') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,135 - WARNING - could not convert string to float: b'-2.70.999287' : FloatObject (b'-2.70.999287') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,135 - WARNING - could not convert string to float: b'1..83' : FloatObject (b'1..83') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,135 - WARNING - could not convert string to float: b'6728702-2.787' : FloatObject (b'6728702-2.787') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,135 - WARNING - could not convert string to float: b'-0.9667.18' : FloatObject (b'-0.9667.18') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,136 - WARNING - could not convert string to float: b'1.285-2.80.999287' : FloatObject (b'1.285-2.80.999287') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,136 - WARNING - could not convert string to float: b'657754-4.0794' : FloatObject (b'657754-4.0794') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,137 - WARNING - could not convert string to float: b'-2.600.596' : FloatObject (b'-2.600.596') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,137 - WARNING - could not convert string to float: b'3.2446946-.965' : FloatObject (b'3.2446946-.965') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,137 - WARNING - could not convert string to float: b'-..157696674973' : FloatObject (b'-..157696674973') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,138 - WARNING - could not convert string to float: b'0.294835-0.0739635-0.076199' : FloatObject (b'0.294835-0.0739635-0.076199') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,138 - WARNING - could not convert string to float: b'4.4.87' : FloatObject (b'4.4.87') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,138 - WARNING - could not convert string to float: b'-505.80.1' : FloatObject (b'-505.80.1') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,139 - WARNING - could not convert string to float: b'4.4.87' : FloatObject (b'4.4.87') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,139 - WARNING - could not convert string to float: b'-505.80.1' : FloatObject (b'-505.80.1') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,139 - WARNING - could not convert string to float: b'4.4.87' : FloatObject (b'4.4.87') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,139 - WARNING - could not convert string to float: b'-505.80.1' : FloatObject (b'-505.80.1') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,140 - WARNING - could not convert string to float: b'55112.7.7038' : FloatObject (b'55112.7.7038') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,140 - WARNING - could not convert string to float: b'2.53.148' : FloatObject (b'2.53.148') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,140 - WARNING - could not convert string to float: b'0.80.2-0.5456' : FloatObject (b'0.80.2-0.5456') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,141 - WARNING - could not convert string to float: b'-20.2.7' : FloatObject (b'-20.2.7') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,141 - WARNING - could not convert string to float: b'7757071.502..2.7' : FloatObject (b'7757071.502..2.7') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,141 - WARNING - could not convert string to float: b'0.50.076' : FloatObject (b'0.50.076') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,141 - WARNING - could not convert string to float: b'-2.937.6' : FloatObject (b'-2.937.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,142 - WARNING - could not convert string to float: b'-2.6720.24.329.72485' : FloatObject (b'-2.6720.24.329.72485') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,142 - WARNING - could not convert string to float: b'4.4937.21' : FloatObject (b'4.4937.21') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,143 - WARNING - could not convert string to float: b'3.174.160' : FloatObject (b'3.174.160') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,143 - WARNING - could not convert string to float: b'2.43.321' : FloatObject (b'2.43.321') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,143 - WARNING - could not convert string to float: b'946-602.7881.897' : FloatObject (b'946-602.7881.897') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,144 - WARNING - could not convert string to float: b'4.0.527' : FloatObject (b'4.0.527') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,144 - WARNING - could not convert string to float: b'45.8074-2.5453.321' : FloatObject (b'45.8074-2.5453.321') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,144 - WARNING - could not convert string to float: b'.329.704' : FloatObject (b'.329.704') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,145 - WARNING - could not convert string to float: b'-2.790.075' : FloatObject (b'-2.790.075') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,145 - WARNING - could not convert string to float: b'4.7-2130.7162777-2329' : FloatObject (b'4.7-2130.7162777-2329') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,145 - WARNING - could not convert string to float: b'-20.2.24612.69338' : FloatObject (b'-20.2.24612.69338') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,146 - WARNING - could not convert string to float: b'9-086.1999' : FloatObject (b'9-086.1999') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,146 - WARNING - could not convert string to float: b'-0-04540.73' : FloatObject (b'-0-04540.73') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,146 - WARNING - could not convert string to float: b'3.19.' : FloatObject (b'3.19.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,147 - WARNING - NumberObject(b'-0-096') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,147 - WARNING - could not convert string to float: b'0151.7.703759' : FloatObject (b'0151.7.703759') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,147 - WARNING - could not convert string to float: b'1.7.6' : FloatObject (b'1.7.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,148 - WARNING - could not convert string to float: b'-0.2-236' : FloatObject (b'-0.2-236') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,148 - WARNING - could not convert string to float: b'4-3.47' : FloatObject (b'4-3.47') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,148 - WARNING - could not convert string to float: b'4.2553.003597.6' : FloatObject (b'4.2553.003597.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,148 - WARNING - could not convert string to float: b'4744-2959.121451' : FloatObject (b'4744-2959.121451') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,149 - WARNING - could not convert string to float: b'619.1-2.567954.2' : FloatObject (b'619.1-2.567954.2') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,149 - WARNING - could not convert string to float: b'13104.2-2' : FloatObject (b'13104.2-2') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,150 - WARNING - could not convert string to float: b'4.4.34' : FloatObject (b'4.4.34') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,150 - WARNING - could not convert string to float: b'4-3.46' : FloatObject (b'4-3.46') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,150 - WARNING - NumberObject(b'26876659376-20') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,151 - WARNING - could not convert string to float: b'296.61031.9.6' : FloatObject (b'296.61031.9.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,152 - WARNING - could not convert string to float: b'-1.348.' : FloatObject (b'-1.348.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,152 - WARNING - NumberObject(b'4744-298766') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,153 - WARNING - could not convert string to float: b'13.16819.' : FloatObject (b'13.16819.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,153 - WARNING - could not convert string to float: b'-20.217174453.066' : FloatObject (b'-20.217174453.066') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,153 - WARNING - could not convert string to float: b'63325.13174453.826' : FloatObject (b'63325.13174453.826') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,154 - WARNING - could not convert string to float: b'2.43.321' : FloatObject (b'2.43.321') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,154 - WARNING - could not convert string to float: b'-.744537053.0814' : FloatObject (b'-.744537053.0814') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,154 - WARNING - could not convert string to float: b'-39714453.877-26' : FloatObject (b'-39714453.877-26') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,155 - WARNING - NumberObject(b'-77-224') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,155 - WARNING - could not convert string to float: b'.450.6' : FloatObject (b'.450.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,156 - WARNING - could not convert string to float: b'2.43.516' : FloatObject (b'2.43.516') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,156 - WARNING - could not convert string to float: b'-13537815475.7445.106' : FloatObject (b'-13537815475.7445.106') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,156 - WARNING - could not convert string to float: b'1310.891.28543.629427' : FloatObject (b'1310.891.28543.629427') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,157 - WARNING - could not convert string to float: b'4.18277146.75' : FloatObject (b'4.18277146.75') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,157 - WARNING - could not convert string to float: b'0573.69332.329.1-2.6' : FloatObject (b'0573.69332.329.1-2.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,157 - WARNING - could not convert string to float: b'4.56499.1-2.567954.2' : FloatObject (b'4.56499.1-2.567954.2') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,157 - WARNING - could not convert string to float: b'08464.9616.46796' : FloatObject (b'08464.9616.46796') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,158 - WARNING - could not convert string to float: b'3..0.3' : FloatObject (b'3..0.3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,158 - WARNING - could not convert string to float: b'.' : FloatObject (b'.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,159 - WARNING - NumberObject(b'44-20') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,159 - WARNING - could not convert string to float: b'722.56797053.05' : FloatObject (b'722.56797053.05') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,159 - WARNING - could not convert string to float: b'08.780.1' : FloatObject (b'08.780.1') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,159 - WARNING - NumberObject(b'9-0897') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,160 - WARNING - could not convert string to float: b'61.67619394741533-2.6' : FloatObject (b'61.67619394741533-2.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,160 - WARNING - could not convert string to float: b'4744-.71634' : FloatObject (b'4744-.71634') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,160 - WARNING - could not convert string to float: b'4174074-2.7.83' : FloatObject (b'4174074-2.7.83') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,161 - WARNING - could not convert string to float: b'4.4.5' : FloatObject (b'4.4.5') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,161 - WARNING - NumberObject(b'--29016') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,161 - WARNING - could not convert string to float: b'0831475.1.5714679666964-3.411919' : FloatObject (b'0831475.1.5714679666964-3.411919') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,162 - WARNING - could not convert string to float: b'3..40-0.035' : FloatObject (b'3..40-0.035') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,162 - WARNING - could not convert string to float: b'4.043.3384376' : FloatObject (b'4.043.3384376') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,163 - WARNING - NumberObject(b'663817445334-03') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,163 - WARNING - could not convert string to float: b'1812643.516086.7416248' : FloatObject (b'1812643.516086.7416248') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,163 - WARNING - could not convert string to float: b'3872.7.' : FloatObject (b'3872.7.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,164 - WARNING - could not convert string to float: b'47161.57483634714682777-436.6.18' : FloatObject (b'47161.57483634714682777-436.6.18') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,164 - WARNING - could not convert string to float: b'77.51655900453.071..3' : FloatObject (b'77.51655900453.071..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,164 - WARNING - could not convert string to float: b'488853.80.24' : FloatObject (b'488853.80.24') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,164 - WARNING - could not convert string to float: b'4813.071..3' : FloatObject (b'4813.071..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,165 - WARNING - could not convert string to float: b'4888777-2.' : FloatObject (b'4888777-2.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,165 - WARNING - could not convert string to float: b'1751.7.-2.4121538' : FloatObject (b'1751.7.-2.4121538') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,166 - WARNING - could not convert string to float: b'1463.071..3' : FloatObject (b'1463.071..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,166 - WARNING - could not convert string to float: b'3..' : FloatObject (b'3..') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,166 - WARNING - could not convert string to float: b'-25790454.566984.56698-4369' : FloatObject (b'-25790454.566984.56698-4369') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,167 - WARNING - could not convert string to float: b'133671434.640454.6221534.6403' : FloatObject (b'133671434.640454.6221534.6403') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,167 - WARNING - could not convert string to float: b'4.44681964.54627960.315' : FloatObject (b'4.44681964.54627960.315') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,167 - WARNING - could not convert string to float: b'4.7-0412' : FloatObject (b'4.7-0412') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,167 - WARNING - NumberObject(b'66998071461699819-089') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,168 - WARNING - could not convert string to float: b'3..46' : FloatObject (b'3..46') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,168 - WARNING - could not convert string to float: b'4.7-77644' : FloatObject (b'4.7-77644') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,169 - WARNING - could not convert string to float: b'0.14.9144502451' : FloatObject (b'0.14.9144502451') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,169 - WARNING - could not convert string to float: b'94.9144502174453.06' : FloatObject (b'94.9144502174453.06') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,169 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,170 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,170 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,170 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,170 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,171 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,171 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,171 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,172 - WARNING - could not convert string to float: b'-2.48747.' : FloatObject (b'-2.48747.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,172 - WARNING - could not convert string to float: b'-2.4874.0440.46' : FloatObject (b'-2.4874.0440.46') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,172 - WARNING - could not convert string to float: b'1853.07140.416555' : FloatObject (b'1853.07140.416555') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,173 - WARNING - could not convert string to float: b'..4-.71768.564277140.418174819-0747.4-.5.134447108.56' : FloatObject (b'..4-.71768.564277140.418174819-0747.4-.5.134447108.56') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,173 - WARNING - could not convert string to float: b'4.2.48016' : FloatObject (b'4.2.48016') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,173 - WARNING - could not convert string to float: b'4453.084.566140.4182-0' : FloatObject (b'4453.084.566140.4182-0') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,174 - WARNING - could not convert string to float: b'4174.56463353.06199819-08974463325646376' : FloatObject (b'4174.56463353.06199819-08974463325646376') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,174 - WARNING - could not convert string to float: b'-25676473.32.' : FloatObject (b'-25676473.32.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,174 - WARNING - could not convert string to float: b'49171..3' : FloatObject (b'49171..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,175 - WARNING - could not convert string to float: b'13.5661447.4-.7' : FloatObject (b'13.5661447.4-.7') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,175 - WARNING - could not convert string to float: b'44-24-.717' : FloatObject (b'44-24-.717') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,175 - WARNING - could not convert string to float: b'271..3' : FloatObject (b'271..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,176 - WARNING - could not convert string to float: b'187221534.248.7.' : FloatObject (b'187221534.248.7.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,176 - WARNING - could not convert string to float: b'28..40-016' : FloatObject (b'28..40-016') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,176 - WARNING - could not convert string to float: b'4315475.0525746.' : FloatObject (b'4315475.0525746.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,177 - WARNING - could not convert string to float: b'-2.3..0.3' : FloatObject (b'-2.3..0.3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,177 - WARNING - NumberObject(b'70041662-29873') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,177 - WARNING - could not convert string to float: b'4.16819.' : FloatObject (b'4.16819.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,178 - WARNING - could not convert string to float: b'61..3129' : FloatObject (b'61..3129') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,178 - WARNING - NumberObject(b'75877-26') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,178 - WARNING - could not convert string to float: b'79666964-3.34766' : FloatObject (b'79666964-3.34766') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,179 - WARNING - could not convert string to float: b'08464.919.' : FloatObject (b'08464.919.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,179 - WARNING - could not convert string to float: b'.084.43-2.6' : FloatObject (b'.084.43-2.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,179 - WARNING - could not convert string to float: b'4174074-2.7.83' : FloatObject (b'4174074-2.7.83') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,180 - WARNING - could not convert string to float: b'4.45.46' : FloatObject (b'4.45.46') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,180 - WARNING - could not convert string to float: b'-2181423.067.75' : FloatObject (b'-2181423.067.75') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,180 - WARNING - NumberObject(b'--290042') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,180 - WARNING - NumberObject(b'256-218848-188') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,181 - WARNING - NumberObject(b'256-685') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,181 - WARNING - NumberObject(b'94-661699') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,182 - WARNING - could not convert string to float: b'4.4.5043744' : FloatObject (b'4.4.5043744') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,182 - WARNING - could not convert string to float: b'684.4.62469496' : FloatObject (b'684.4.62469496') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,182 - WARNING - could not convert string to float: b'4361..3' : FloatObject (b'4361..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,183 - WARNING - could not convert string to float: b'1644684.4.6' : FloatObject (b'1644684.4.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,183 - WARNING - could not convert string to float: b'571447196848.524463321496848.577' : FloatObject (b'571447196848.524463321496848.577') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,183 - WARNING - could not convert string to float: b'7617196848.5175.1.56633321421947.84.4.62' : FloatObject (b'7617196848.5175.1.56633321421947.84.4.62') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,184 - WARNING - NumberObject(b'661-15') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,184 - WARNING - could not convert string to float: b'-452.06637.' : FloatObject (b'-452.06637.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,184 - WARNING - could not convert string to float: b'0-2.4153428' : FloatObject (b'0-2.4153428') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,185 - WARNING - could not convert string to float: b'..4-.7924' : FloatObject (b'..4-.7924') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,185 - WARNING - could not convert string to float: b'07172.0663661236683149919.' : FloatObject (b'07172.0663661236683149919.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,185 - WARNING - could not convert string to float: b'47.4-49919.07343.5663744537' : FloatObject (b'47.4-49919.07343.5663744537') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,186 - WARNING - could not convert string to float: b'659.56637.487471947.84.4.62' : FloatObject (b'659.56637.487471947.84.4.62') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,186 - WARNING - NumberObject(b'661-15') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,186 - WARNING - could not convert string to float: b'2.4-49856637482564' : FloatObject (b'2.4-49856637482564') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,187 - WARNING - could not convert string to float: b'724188480.4874769454.180' : FloatObject (b'724188480.4874769454.180') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,187 - WARNING - could not convert string to float: b'3..' : FloatObject (b'3..') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,187 - WARNING - could not convert string to float: b'-25790454.566984.56698-4369' : FloatObject (b'-25790454.566984.56698-4369') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,188 - WARNING - could not convert string to float: b'-2.11546176786.0736' : FloatObject (b'-2.11546176786.0736') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,188 - WARNING - could not convert string to float: b'0454.623.56.0444715.' : FloatObject (b'0454.623.56.0444715.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,188 - WARNING - could not convert string to float: b'-25794516086.7416248604407416241044.6' : FloatObject (b'-25794516086.7416248604407416241044.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,189 - WARNING - could not convert string to float: b'659862410873.463.56698-11767' : FloatObject (b'659862410873.463.56698-11767') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,189 - WARNING - NumberObject(b'6872598-16314') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,189 - WARNING - could not convert string to float: b'-1163661238.51768234.406' : FloatObject (b'-1163661238.51768234.406') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,189 - WARNING - could not convert string to float: b'-542.41534.6' : FloatObject (b'-542.41534.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,190 - WARNING - could not convert string to float: b'-542..447.' : FloatObject (b'-542..447.') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,190 - WARNING - could not convert string to float: b'1812886.00181454.40-016' : FloatObject (b'1812886.00181454.40-016') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,190 - WARNING - could not convert string to float: b'1644684.4.6' : FloatObject (b'1644684.4.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,190 - WARNING - could not convert string to float: b'49171..3' : FloatObject (b'49171..3') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,191 - WARNING - NumberObject(b'7166366128777-506891812898707668') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,191 - WARNING - could not convert string to float: b'18190454025694.43-225694.44.43-' : FloatObject (b'18190454025694.43-225694.44.43-') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,191 - WARNING - could not convert string to float: b'18190454025694.43-225694.44.436' : FloatObject (b'18190454025694.43-225694.44.436') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,192 - WARNING - NumberObject(b'75-1136') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,192 - WARNING - could not convert string to float: b'-648-1849856690454.566946' : FloatObject (b'-648-1849856690454.566946') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,192 - WARNING - could not convert string to float: b'82636678554.1299-3-180654624660689' : FloatObject (b'82636678554.1299-3-180654624660689') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,193 - WARNING - could not convert string to float: b'217694.44.4366769467.83' : FloatObject (b'217694.44.4366769467.83') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,194 - WARNING - could not convert string to float: b'152-113692.5244681904' : FloatObject (b'152-113692.5244681904') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,194 - WARNING - could not convert string to float: b'00764.999819-04681562777' : FloatObject (b'00764.999819-04681562777') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,194 - WARNING - could not convert string to float: b'4.4649-04686' : FloatObject (b'4.4649-04686') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,195 - WARNING - could not convert string to float: b'4546427413.4.6' : FloatObject (b'4546427413.4.6') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,195 - WARNING - could not convert string to float: b'-2.1644684.0601464484.566946239769446849462397677413.17' : FloatObject (b'-2.1644684.0601464484.566946239769446849462397677413.17') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,195 - WARNING - could not convert string to float: b'006851617.1.56308' : FloatObject (b'006851617.1.56308') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,196 - WARNING - could not convert string to float: b'172.16446810651806542566943.5636614' : FloatObject (b'172.16446810651806542566943.5636614') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,196 - WARNING - NumberObject(b'4-661874774728') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,196 - WARNING - could not convert string to float: b'4-6663.17' : FloatObject (b'4-6663.17') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,197 - WARNING - could not convert string to float: b'044629624476911.56698-41' : FloatObject (b'044629624476911.56698-41') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,198 - WARNING - could not convert string to float: b'072.7-21850710463748445161671046848445141975350' : FloatObject (b'072.7-21850710463748445161671046848445141975350') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,198 - WARNING - could not convert string to float: b'11107.8356-66128777' : FloatObject (b'11107.8356-66128777') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,198 - WARNING - NumberObject(b'-648-18498566901') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,199 - WARNING - could not convert string to float: b'47.5425645.11919.0563082116' : FloatObject (b'47.5425645.11919.0563082116') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,199 - WARNING - NumberObject(b'8-1837484454617308661228') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,199 - WARNING - could not convert string to float: b'4956218374616741044.81766741044.884' : FloatObject (b'4956218374616741044.81766741044.884') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,200 - WARNING - could not convert string to float: b'-604280454.6436786.766' : FloatObject (b'-604280454.6436786.766') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,200 - WARNING - NumberObject(b'7-4991945') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,200 - WARNING - NumberObject(b'-11633-') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,201 - WARNING - could not convert string to float: b'4782.4-0145636' : FloatObject (b'4782.4-0145636') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,201 - WARNING - NumberObject(b'14513-4369') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,201 - WARNING - NumberObject(b'14513-4369') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,202 - WARNING - could not convert string to float: b'710873.463.56698-118-1836' : FloatObject (b'710873.463.56698-118-1836') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,202 - WARNING - could not convert string to float: b'47.4-4' : FloatObject (b'47.4-4') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,202 - WARNING - could not convert string to float: b'07172.9.817-225649' : FloatObject (b'07172.9.817-225649') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,203 - WARNING - could not convert string to float: b'045416234.62642.415347' : FloatObject (b'045416234.62642.415347') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,203 - WARNING - NumberObject(b'47-661874-2') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,203 - WARNING - NumberObject(b'7414274143-2248') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,204 - WARNING - could not convert string to float: b'76541480654777-2185454.662' : FloatObject (b'76541480654777-2185454.662') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,204 - WARNING - could not convert string to float: b'744.99126944684944405172.9949444167410767' : FloatObject (b'744.99126944684944405172.9949444167410767') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,205 - WARNING - NumberObject(b'044478560672162694561104244934-661350') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,205 - WARNING - could not convert string to float: b'311152-1136921152-451.50' : FloatObject (b'311152-1136921152-451.50') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,205 - WARNING - NumberObject(b'1690-41975364633404') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,206 - WARNING - NumberObject(b'4-6662846646') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,206 - WARNING - could not convert string to float: b'-6692186.071326692186.0716566946' : FloatObject (b'-6692186.071326692186.0716566946') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,207 - WARNING - could not convert string to float: b'4763656687.97774131141314190.656' : FloatObject (b'4763656687.97774131141314190.656') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,207 - WARNING - NumberObject(b'7653013374666677613-43180651544') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,207 - WARNING - NumberObject(b'7-499124657778') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,208 - WARNING - NumberObject(b'4-710061') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,208 - WARNING - NumberObject(b'-60406-4465323676') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,208 - WARNING - could not convert string to float: b'30.65605664.884533908478' : FloatObject (b'30.65605664.884533908478') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,208 - WARNING - NumberObject(b'162294162484495294162484826817698-1478') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,209 - WARNING - NumberObject(b'66698-7779') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,209 - WARNING - could not convert string to float: b'73697.4-946' : FloatObject (b'73697.4-946') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,210 - WARNING - NumberObject(b'40-32644367623177946741') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,210 - WARNING - could not convert string to float: b'710873.463.56691' : FloatObject (b'710873.463.56691') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,210 - WARNING - could not convert string to float: b'47-666466-3.4666466-35664.623001813-43457' : FloatObject (b'47-666466-3.4666466-35664.623001813-43457') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,211 - WARNING - NumberObject(b'1-43459691544568856') invalid; use 0 instead\n",
      "2025-06-11 01:44:13,211 - WARNING - could not convert string to float: b'-4456885616.4365969.66516.436593' : FloatObject (b'-4456885616.4365969.66516.436593') invalid; use 0.0 instead\n",
      "2025-06-11 01:44:13,230 - ERROR - Error loading /data/user_data/vidhij2/medical/pdfs/Extracted_from_Guidelines_for_Pregnancy_Care,_Maternal_Health_Division,_Dpt._of_Family_Welfare,_MOHFW,_GoI_2005.pdf: list index out of range\n",
      "Processing files:  48%|████▊     | 63/131 [02:38<03:15,  2.87s/it]2025-06-11 01:44:13,237 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Visual_Impairment_and_Care_of_a_Child_with_Visual_Impairment.pdf...\n",
      "2025-06-11 01:44:13,536 - INFO - Splitting Guideline_for_When_to_Suspect_Visual_Impairment_and_Care_of_a_Child_with_Visual_Impairment.pdf into sections...\n",
      "2025-06-11 01:44:13,537 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.51it/s]\n",
      "2025-06-11 01:44:14,200 - INFO - Created 6 chunks from Guideline_for_When_to_Suspect_Visual_Impairment_and_Care_of_a_Child_with_Visual_Impairment.pdf\n",
      "Processing files:  49%|████▉     | 64/131 [02:39<02:34,  2.30s/it]2025-06-11 01:44:14,201 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Down_Syndrome.pdf...\n",
      "2025-06-11 01:44:14,734 - INFO - Splitting Guidelines_for_Down_Syndrome.pdf into sections...\n",
      "2025-06-11 01:44:14,735 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.71it/s]\n",
      "2025-06-11 01:44:15,106 - INFO - Created 3 chunks from Guidelines_for_Down_Syndrome.pdf\n",
      "Processing files:  50%|████▉     | 65/131 [02:40<02:04,  1.88s/it]2025-06-11 01:44:15,107 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Physiological_Variations_in_a_Newborn.pdf...\n",
      "2025-06-11 01:44:15,348 - INFO - Splitting Physiological_Variations_in_a_Newborn.pdf into sections...\n",
      "2025-06-11 01:44:15,349 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  4.71it/s]\n",
      "2025-06-11 01:44:15,988 - INFO - Created 7 chunks from Physiological_Variations_in_a_Newborn.pdf\n",
      "Processing files:  50%|█████     | 66/131 [02:41<01:42,  1.58s/it]2025-06-11 01:44:15,989 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Traveling_with_children.pdf...\n",
      "2025-06-11 01:44:16,156 - INFO - Splitting Guideline_for_Traveling_with_children.pdf into sections...\n",
      "2025-06-11 01:44:16,157 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  9.86it/s]\n",
      "2025-06-11 01:44:16,362 - INFO - Created 3 chunks from Guideline_for_Traveling_with_children.pdf\n",
      "Processing files:  51%|█████     | 67/131 [02:41<01:18,  1.22s/it]2025-06-11 01:44:16,362 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Drug_and_Substance_Abuse.pdf...\n",
      "2025-06-11 01:44:16,642 - INFO - Splitting Guideline_for_When_to_Suspect_Drug_and_Substance_Abuse.pdf into sections...\n",
      "2025-06-11 01:44:16,643 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.15it/s]\n",
      "2025-06-11 01:44:17,512 - INFO - Created 7 chunks from Guideline_for_When_to_Suspect_Drug_and_Substance_Abuse.pdf\n",
      "Processing files:  52%|█████▏    | 68/131 [02:43<01:15,  1.20s/it]2025-06-11 01:44:17,513 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_an_InattentiveHyperactive_Child.pdf...\n",
      "2025-06-11 01:44:17,663 - INFO - Splitting Guideline_for_Care_of_an_InattentiveHyperactive_Child.pdf into sections...\n",
      "2025-06-11 01:44:17,664 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.40it/s]\n",
      "2025-06-11 01:44:18,083 - INFO - Created 4 chunks from Guideline_for_Care_of_an_InattentiveHyperactive_Child.pdf\n",
      "Processing files:  53%|█████▎    | 69/131 [02:43<01:02,  1.01s/it]2025-06-11 01:44:18,084 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Tuberculosis_in_Children.pdf...\n",
      "2025-06-11 01:44:18,337 - INFO - Splitting Guideline_for_Tuberculosis_in_Children.pdf into sections...\n",
      "2025-06-11 01:44:18,338 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.15it/s]\n",
      "2025-06-11 01:44:19,211 - INFO - Created 7 chunks from Guideline_for_Tuberculosis_in_Children.pdf\n",
      "Processing files:  53%|█████▎    | 70/131 [02:44<01:03,  1.05s/it]2025-06-11 01:44:19,212 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_School_and_My_Child_Parental_Concerns_Regarding_Schooling.pdf...\n",
      "2025-06-11 01:44:19,498 - INFO - Splitting Guideline_for_School_and_My_Child_Parental_Concerns_Regarding_Schooling.pdf into sections...\n",
      "2025-06-11 01:44:19,500 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  7.49it/s]\n",
      "2025-06-11 01:44:20,036 - INFO - Created 8 chunks from Guideline_for_School_and_My_Child_Parental_Concerns_Regarding_Schooling.pdf\n",
      "Processing files:  54%|█████▍    | 71/131 [02:45<00:58,  1.02it/s]2025-06-11 01:44:20,036 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Recurrent_Cough.pdf...\n",
      "2025-06-11 01:44:20,276 - INFO - Splitting Guidelines_for_Recurrent_Cough.pdf into sections...\n",
      "2025-06-11 01:44:20,277 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.72it/s]\n",
      "2025-06-11 01:44:20,860 - INFO - Created 5 chunks from Guidelines_for_Recurrent_Cough.pdf\n",
      "Processing files:  55%|█████▍    | 72/131 [02:46<00:55,  1.07it/s]2025-06-11 01:44:20,860 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_HIVChild_Born_to_HIV_Positive_Mother.pdf...\n",
      "2025-06-11 01:44:21,008 - INFO - Splitting Guideline_for_Care_of_a_Child_with_HIVChild_Born_to_HIV_Positive_Mother.pdf into sections...\n",
      "2025-06-11 01:44:21,009 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  8.07it/s]\n",
      "2025-06-11 01:44:21,383 - INFO - Created 5 chunks from Guideline_for_Care_of_a_Child_with_HIVChild_Born_to_HIV_Positive_Mother.pdf\n",
      "Processing files:  56%|█████▌    | 73/131 [02:46<00:46,  1.23it/s]2025-06-11 01:44:21,384 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_AUTISM.pdf...\n",
      "2025-06-11 01:44:21,598 - INFO - Splitting Guideline_for_AUTISM.pdf into sections...\n",
      "2025-06-11 01:44:21,600 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.01it/s]\n",
      "2025-06-11 01:44:22,594 - INFO - Created 9 chunks from Guideline_for_AUTISM.pdf\n",
      "Processing files:  56%|█████▋    | 74/131 [02:48<00:53,  1.07it/s]2025-06-11 01:44:22,595 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Dietary_Norms_by_NHM_for_pregnant_women_(for_state_program_managers).pdf...\n",
      "2025-06-11 01:44:32,390 - INFO - Splitting Dietary_Norms_by_NHM_for_pregnant_women_(for_state_program_managers).pdf into sections...\n",
      "2025-06-11 01:44:32,392 - INFO - Found 33 sections\n",
      "Processing sections: 100%|██████████| 33/33 [00:01<00:00, 19.83it/s]\n",
      "2025-06-11 01:44:34,059 - INFO - Created 43 chunks from Dietary_Norms_by_NHM_for_pregnant_women_(for_state_program_managers).pdf\n",
      "Processing files:  57%|█████▋    | 75/131 [02:59<03:49,  4.09s/it]2025-06-11 01:44:34,059 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/GUIDANCE_BOOKLET_ON_maternal_health_for_COMMUNITY_HEALTH_OFFICERS.pdf...\n",
      "2025-06-11 01:44:35,156 - INFO - Splitting GUIDANCE_BOOKLET_ON_maternal_health_for_COMMUNITY_HEALTH_OFFICERS.pdf into sections...\n",
      "2025-06-11 01:44:35,158 - INFO - Found 13 sections\n",
      "Processing sections: 100%|██████████| 13/13 [00:00<00:00, 33.63it/s]\n",
      "2025-06-11 01:44:35,546 - INFO - Created 13 chunks from GUIDANCE_BOOKLET_ON_maternal_health_for_COMMUNITY_HEALTH_OFFICERS.pdf\n",
      "Processing files:  58%|█████▊    | 76/131 [03:01<03:02,  3.31s/it]2025-06-11 01:44:35,547 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Caring_for_a_Child_with_Celiac_Disease.pdf...\n",
      "2025-06-11 01:44:35,763 - INFO - Splitting Guideline_for_Caring_for_a_Child_with_Celiac_Disease.pdf into sections...\n",
      "2025-06-11 01:44:35,764 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  8.24it/s]\n",
      "2025-06-11 01:44:36,251 - INFO - Created 6 chunks from Guideline_for_Caring_for_a_Child_with_Celiac_Disease.pdf\n",
      "Processing files:  59%|█████▉    | 77/131 [03:01<02:16,  2.53s/it]2025-06-11 01:44:36,252 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_for_Preschoolers_(2–5_Years).pdf...\n",
      "2025-06-11 01:44:36,543 - INFO - Splitting Guideline_for_Nutrition_for_Preschoolers_(2–5_Years).pdf into sections...\n",
      "2025-06-11 01:44:36,544 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.60it/s]\n",
      "2025-06-11 01:44:37,172 - INFO - Created 5 chunks from Guideline_for_Nutrition_for_Preschoolers_(2–5_Years).pdf\n",
      "Processing files:  60%|█████▉    | 78/131 [03:02<01:48,  2.05s/it]2025-06-11 01:44:37,173 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Birth_Defects.pdf...\n",
      "2025-06-11 01:44:37,450 - INFO - Splitting Guideline_for_Birth_Defects.pdf into sections...\n",
      "2025-06-11 01:44:37,451 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00, 27.78it/s]\n",
      "2025-06-11 01:44:37,597 - INFO - Created 4 chunks from Guideline_for_Birth_Defects.pdf\n",
      "Processing files:  60%|██████    | 79/131 [03:03<01:21,  1.56s/it]2025-06-11 01:44:37,597 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_and_How_Do_I_Suspect_and_Prevent_Abuse_in_My_Child.pdf...\n",
      "2025-06-11 01:44:38,041 - INFO - Splitting Guideline_for_When_and_How_Do_I_Suspect_and_Prevent_Abuse_in_My_Child.pdf into sections...\n",
      "2025-06-11 01:44:38,042 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00,  5.75it/s]\n",
      "2025-06-11 01:44:38,914 - INFO - Created 12 chunks from Guideline_for_When_and_How_Do_I_Suspect_and_Prevent_Abuse_in_My_Child.pdf\n",
      "Processing files:  61%|██████    | 80/131 [03:04<01:15,  1.49s/it]2025-06-11 01:44:38,915 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Prepare_Your_Child_to_Deal_with_Bullying.pdf...\n",
      "2025-06-11 01:44:39,201 - INFO - Splitting Guideline_for_Prepare_Your_Child_to_Deal_with_Bullying.pdf into sections...\n",
      "2025-06-11 01:44:39,202 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  4.06it/s]\n",
      "2025-06-11 01:44:39,943 - INFO - Created 8 chunks from Guideline_for_Prepare_Your_Child_to_Deal_with_Bullying.pdf\n",
      "Processing files:  62%|██████▏   | 81/131 [03:05<01:07,  1.35s/it]2025-06-11 01:44:39,944 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_to_Suspect_Hearing_Impairment_and_Care_of_a_Child_with_Hearing_Impairment.pdf...\n",
      "2025-06-11 01:44:40,573 - INFO - Splitting Guideline_for_When_to_Suspect_Hearing_Impairment_and_Care_of_a_Child_with_Hearing_Impairment.pdf into sections...\n",
      "2025-06-11 01:44:40,574 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  5.18it/s]\n",
      "2025-06-11 01:44:41,349 - INFO - Created 10 chunks from Guideline_for_When_to_Suspect_Hearing_Impairment_and_Care_of_a_Child_with_Hearing_Impairment.pdf\n",
      "Processing files:  63%|██████▎   | 82/131 [03:06<01:06,  1.37s/it]2025-06-11 01:44:41,350 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Preventing_Mosquito-borne_Illnesses.pdf...\n",
      "2025-06-11 01:44:41,623 - INFO - Splitting Guideline_for_Preventing_Mosquito-borne_Illnesses.pdf into sections...\n",
      "2025-06-11 01:44:41,625 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.09it/s]\n",
      "2025-06-11 01:44:42,273 - INFO - Created 6 chunks from Guideline_for_Preventing_Mosquito-borne_Illnesses.pdf\n",
      "Processing files:  63%|██████▎   | 83/131 [03:07<00:59,  1.23s/it]2025-06-11 01:44:42,274 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_When_a_Dog_Bites_My_Child.pdf...\n",
      "2025-06-11 01:44:42,586 - INFO - Splitting Guideline_for_When_a_Dog_Bites_My_Child.pdf into sections...\n",
      "2025-06-11 01:44:42,587 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  6.77it/s]\n",
      "2025-06-11 01:44:42,737 - INFO - Created 2 chunks from Guideline_for_When_a_Dog_Bites_My_Child.pdf\n",
      "Processing files:  64%|██████▍   | 84/131 [03:08<00:47,  1.00s/it]2025-06-11 01:44:42,738 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Yoga_for_Children.pdf...\n",
      "2025-06-11 01:44:42,940 - INFO - Splitting Guideline_for_Yoga_for_Children.pdf into sections...\n",
      "2025-06-11 01:44:42,941 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.25it/s]\n",
      "2025-06-11 01:44:43,387 - INFO - Created 4 chunks from Guideline_for_Yoga_for_Children.pdf\n",
      "Processing files:  65%|██████▍   | 85/131 [03:08<00:41,  1.11it/s]2025-06-11 01:44:43,388 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_My_Child_is_Not_Growing_Well__How_to_Monitor_and_Manage.pdf...\n",
      "2025-06-11 01:44:43,626 - INFO - Splitting Guideline_for_My_Child_is_Not_Growing_Well__How_to_Monitor_and_Manage.pdf into sections...\n",
      "2025-06-11 01:44:43,627 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  8.76it/s]\n",
      "2025-06-11 01:44:43,972 - INFO - Created 5 chunks from Guideline_for_My_Child_is_Not_Growing_Well__How_to_Monitor_and_Manage.pdf\n",
      "Processing files:  66%|██████▌   | 86/131 [03:09<00:36,  1.25it/s]2025-06-11 01:44:43,972 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Cystic_Fibrosis.pdf...\n",
      "2025-06-11 01:44:44,108 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Cystic_Fibrosis.pdf into sections...\n",
      "2025-06-11 01:44:44,109 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 61.53it/s]\n",
      "2025-06-11 01:44:44,127 - INFO - Created 1 chunks from Guideline_for_Care_of_a_Child_with_Cystic_Fibrosis.pdf\n",
      "Processing files:  66%|██████▋   | 87/131 [03:09<00:26,  1.64it/s]2025-06-11 01:44:44,128 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Thalassemia_What_Parents_Need_to_Know.pdf...\n",
      "2025-06-11 01:44:44,383 - INFO - Splitting Guideline_for_Thalassemia_What_Parents_Need_to_Know.pdf into sections...\n",
      "2025-06-11 01:44:44,384 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.34it/s]\n",
      "2025-06-11 01:44:45,135 - INFO - Created 7 chunks from Guideline_for_Thalassemia_What_Parents_Need_to_Know.pdf\n",
      "Processing files:  67%|██████▋   | 88/131 [03:10<00:31,  1.37it/s]2025-06-11 01:44:45,136 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_First_Aid.pdf...\n",
      "2025-06-11 01:44:45,452 - INFO - Splitting Guidelines_for_First_Aid.pdf into sections...\n",
      "2025-06-11 01:44:45,453 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.25it/s]\n",
      "2025-06-11 01:44:46,252 - INFO - Created 6 chunks from Guidelines_for_First_Aid.pdf\n",
      "Processing files:  68%|██████▊   | 89/131 [03:11<00:35,  1.18it/s]2025-06-11 01:44:46,253 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Viral_Hepatitis.pdf...\n",
      "2025-06-11 01:44:46,669 - INFO - Splitting Guideline_for_Viral_Hepatitis.pdf into sections...\n",
      "2025-06-11 01:44:46,670 - INFO - Found 6 sections\n",
      "Processing sections: 100%|██████████| 6/6 [00:00<00:00, 28.60it/s]\n",
      "2025-06-11 01:44:46,882 - INFO - Created 6 chunks from Guideline_for_Viral_Hepatitis.pdf\n",
      "Processing files:  69%|██████▊   | 90/131 [03:12<00:32,  1.28it/s]2025-06-11 01:44:46,882 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Importance_of_Checking_Blood_Pressure_in_Children.pdf...\n",
      "2025-06-11 01:44:47,072 - INFO - Splitting Guideline_for_Importance_of_Checking_Blood_Pressure_in_Children.pdf into sections...\n",
      "2025-06-11 01:44:47,073 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.87it/s]\n",
      "2025-06-11 01:44:47,424 - INFO - Created 4 chunks from Guideline_for_Importance_of_Checking_Blood_Pressure_in_Children.pdf\n",
      "Processing files:  69%|██████▉   | 91/131 [03:12<00:28,  1.41it/s]2025-06-11 01:44:47,424 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Chronic_Disease_in_Children.pdf...\n",
      "2025-06-11 01:44:47,635 - INFO - Splitting Guideline_for_Chronic_Disease_in_Children.pdf into sections...\n",
      "2025-06-11 01:44:47,636 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  4.15it/s]\n",
      "2025-06-11 01:44:48,119 - INFO - Created 6 chunks from Guideline_for_Chronic_Disease_in_Children.pdf\n",
      "Processing files:  70%|███████   | 92/131 [03:13<00:27,  1.42it/s]2025-06-11 01:44:48,120 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Dealing_with_Adverse_Events_Following_Immunization.pdf...\n",
      "2025-06-11 01:44:48,420 - INFO - Splitting Guideline_for_Dealing_with_Adverse_Events_Following_Immunization.pdf into sections...\n",
      "2025-06-11 01:44:48,422 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.34it/s]\n",
      "2025-06-11 01:44:49,171 - INFO - Created 7 chunks from Guideline_for_Dealing_with_Adverse_Events_Following_Immunization.pdf\n",
      "Processing files:  71%|███████   | 93/131 [03:14<00:30,  1.24it/s]2025-06-11 01:44:49,172 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_the_Low_Birthweight_Newborn.pdf...\n",
      "2025-06-11 01:44:49,521 - INFO - Splitting Guideline_for_Care_of_the_Low_Birthweight_Newborn.pdf into sections...\n",
      "2025-06-11 01:44:49,522 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  6.61it/s]\n",
      "2025-06-11 01:44:50,129 - INFO - Created 7 chunks from Guideline_for_Care_of_the_Low_Birthweight_Newborn.pdf\n",
      "Processing files:  72%|███████▏  | 94/131 [03:15<00:31,  1.17it/s]2025-06-11 01:44:50,130 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Breastfeeding.pdf...\n",
      "2025-06-11 01:44:50,431 - INFO - Splitting Guidelines_for_Breastfeeding.pdf into sections...\n",
      "2025-06-11 01:44:50,432 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.19it/s]\n",
      "2025-06-11 01:44:51,271 - INFO - Created 7 chunks from Guidelines_for_Breastfeeding.pdf\n",
      "Processing files:  73%|███████▎  | 95/131 [03:16<00:33,  1.06it/s]2025-06-11 01:44:51,272 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_How_My_Child_Grows.pdf...\n",
      "2025-06-11 01:44:51,470 - INFO - Splitting Guideline_for_How_My_Child_Grows.pdf into sections...\n",
      "2025-06-11 01:44:51,471 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  7.18it/s]\n",
      "2025-06-11 01:44:51,891 - INFO - Created 5 chunks from Guideline_for_How_My_Child_Grows.pdf\n",
      "Processing files:  73%|███████▎  | 96/131 [03:17<00:29,  1.18it/s]2025-06-11 01:44:51,891 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Which_Nutritional_Supplements_are_Needed_for_My_Child.pdf...\n",
      "2025-06-11 01:44:52,136 - INFO - Splitting Guideline_for_Which_Nutritional_Supplements_are_Needed_for_My_Child.pdf into sections...\n",
      "2025-06-11 01:44:52,137 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.71it/s]\n",
      "2025-06-11 01:44:52,508 - INFO - Created 3 chunks from Guideline_for_Which_Nutritional_Supplements_are_Needed_for_My_Child.pdf\n",
      "Processing files:  74%|███████▍  | 97/131 [03:17<00:26,  1.29it/s]2025-06-11 01:44:52,509 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/National_Health_Mission.pdf...\n",
      "2025-06-11 01:44:52,635 - INFO - Splitting National_Health_Mission.pdf into sections...\n",
      "2025-06-11 01:44:52,636 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  4.56it/s]\n",
      "2025-06-11 01:44:52,857 - INFO - Created 2 chunks from National_Health_Mission.pdf\n",
      "Processing files:  75%|███████▍  | 98/131 [03:18<00:21,  1.54it/s]2025-06-11 01:44:52,858 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Hemophilia.pdf...\n",
      "2025-06-11 01:44:53,513 - INFO - Splitting Guideline_for_Hemophilia.pdf into sections...\n",
      "2025-06-11 01:44:53,515 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:01<00:00,  1.01s/it]\n",
      "2025-06-11 01:44:54,524 - INFO - Created 8 chunks from Guideline_for_Hemophilia.pdf\n",
      "Processing files:  76%|███████▌  | 99/131 [03:20<00:30,  1.05it/s]2025-06-11 01:44:54,525 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Which_tests_are_necessary_during_pregnancy_and_when_-_National_Health_Mission.pdf...\n",
      "2025-06-11 01:44:54,819 - INFO - Splitting Which_tests_are_necessary_during_pregnancy_and_when_-_National_Health_Mission.pdf into sections...\n",
      "2025-06-11 01:44:54,820 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  4.53it/s]\n",
      "2025-06-11 01:44:55,484 - INFO - Created 16 chunks from Which_tests_are_necessary_during_pregnancy_and_when_-_National_Health_Mission.pdf\n",
      "Processing files:  76%|███████▋  | 100/131 [03:20<00:29,  1.05it/s]2025-06-11 01:44:55,485 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/What_are_the_risks_of_gestational_diabetes_How_is_it_managed_-_Government_of_India.pdf...\n",
      "2025-06-11 01:44:57,568 - INFO - Splitting What_are_the_risks_of_gestational_diabetes_How_is_it_managed_-_Government_of_India.pdf into sections...\n",
      "2025-06-11 01:44:57,572 - INFO - Found 41 sections\n",
      "Processing sections: 100%|██████████| 41/41 [00:02<00:00, 13.99it/s]\n",
      "2025-06-11 01:45:00,506 - INFO - Created 53 chunks from What_are_the_risks_of_gestational_diabetes_How_is_it_managed_-_Government_of_India.pdf\n",
      "Processing files:  77%|███████▋  | 101/131 [03:25<01:05,  2.18s/it]2025-06-11 01:45:00,507 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Chronic_Kidney_Disease.pdf...\n",
      "2025-06-11 01:45:00,680 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Chronic_Kidney_Disease.pdf into sections...\n",
      "2025-06-11 01:45:00,681 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.68it/s]\n",
      "2025-06-11 01:45:01,226 - INFO - Created 6 chunks from Guideline_for_Care_of_a_Child_with_Chronic_Kidney_Disease.pdf\n",
      "Processing files:  78%|███████▊  | 102/131 [03:26<00:50,  1.74s/it]2025-06-11 01:45:01,227 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Hypothyroidism_Congenital_and_Acquired.pdf...\n",
      "2025-06-11 01:45:01,516 - INFO - Splitting Guideline_for_Hypothyroidism_Congenital_and_Acquired.pdf into sections...\n",
      "2025-06-11 01:45:01,517 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.86it/s]\n",
      "2025-06-11 01:45:02,036 - INFO - Created 5 chunks from Guideline_for_Hypothyroidism_Congenital_and_Acquired.pdf\n",
      "Processing files:  79%|███████▊  | 103/131 [03:27<00:40,  1.46s/it]2025-06-11 01:45:02,037 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Immune_Deficiency.pdf...\n",
      "2025-06-11 01:45:02,390 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Immune_Deficiency.pdf into sections...\n",
      "2025-06-11 01:45:02,391 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.29it/s]\n",
      "2025-06-11 01:45:03,170 - INFO - Created 7 chunks from Guideline_for_Care_of_a_Child_with_Immune_Deficiency.pdf\n",
      "Processing files:  79%|███████▉  | 104/131 [03:28<00:36,  1.36s/it]2025-06-11 01:45:03,171 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Post_Bone_Marrow_TransplantStem_Cell_Transplant_Care.pdf...\n",
      "2025-06-11 01:45:03,473 - INFO - Splitting Guideline_for_Post_Bone_Marrow_TransplantStem_Cell_Transplant_Care.pdf into sections...\n",
      "2025-06-11 01:45:03,474 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  2.70it/s]\n",
      "2025-06-11 01:45:04,216 - INFO - Created 7 chunks from Guideline_for_Post_Bone_Marrow_TransplantStem_Cell_Transplant_Care.pdf\n",
      "Processing files:  80%|████████  | 105/131 [03:29<00:32,  1.27s/it]2025-06-11 01:45:04,217 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Nutrition_for_Children_Between_5–12_Years.pdf...\n",
      "2025-06-11 01:45:04,371 - INFO - Splitting Guideline_for_Nutrition_for_Children_Between_5–12_Years.pdf into sections...\n",
      "2025-06-11 01:45:04,373 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  5.96it/s]\n",
      "2025-06-11 01:45:04,878 - INFO - Created 7 chunks from Guideline_for_Nutrition_for_Children_Between_5–12_Years.pdf\n",
      "Processing files:  81%|████████  | 106/131 [03:30<00:27,  1.09s/it]2025-06-11 01:45:04,879 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Rheumatic_Disorders.pdf...\n",
      "2025-06-11 01:45:05,029 - INFO - Splitting Guideline_for_Rheumatic_Disorders.pdf into sections...\n",
      "2025-06-11 01:45:05,030 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  8.46it/s]\n",
      "2025-06-11 01:45:05,505 - INFO - Created 6 chunks from Guideline_for_Rheumatic_Disorders.pdf\n",
      "Processing files:  82%|████████▏ | 107/131 [03:30<00:22,  1.05it/s]2025-06-11 01:45:05,506 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_Child_on_Oxygen_and_Ventilation.pdf...\n",
      "2025-06-11 01:45:05,807 - INFO - Splitting Guideline_for_Home_Care_of_Child_on_Oxygen_and_Ventilation.pdf into sections...\n",
      "2025-06-11 01:45:05,808 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.41it/s]\n",
      "2025-06-11 01:45:06,521 - INFO - Created 6 chunks from Guideline_for_Home_Care_of_Child_on_Oxygen_and_Ventilation.pdf\n",
      "Processing files:  82%|████████▏ | 108/131 [03:32<00:22,  1.03it/s]2025-06-11 01:45:06,522 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Thumb-sucking,_Temper_Tantrums_and_PICA.pdf...\n",
      "2025-06-11 01:45:06,805 - INFO - Splitting Guideline_for_Thumb-sucking,_Temper_Tantrums_and_PICA.pdf into sections...\n",
      "2025-06-11 01:45:06,806 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  2.31it/s]\n",
      "2025-06-11 01:45:07,675 - INFO - Created 8 chunks from Guideline_for_Thumb-sucking,_Temper_Tantrums_and_PICA.pdf\n",
      "Processing files:  83%|████████▎ | 109/131 [03:33<00:22,  1.02s/it]2025-06-11 01:45:07,676 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Taking_Care_of_My_Child_After_Heart_Surgery.pdf...\n",
      "2025-06-11 01:45:08,121 - INFO - Splitting Guideline_for_Taking_Care_of_My_Child_After_Heart_Surgery.pdf into sections...\n",
      "2025-06-11 01:45:08,122 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.86it/s]\n",
      "2025-06-11 01:45:08,662 - INFO - Created 5 chunks from Guideline_for_Taking_Care_of_My_Child_After_Heart_Surgery.pdf\n",
      "Processing files:  84%|████████▍ | 110/131 [03:34<00:21,  1.01s/it]2025-06-11 01:45:08,662 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Early_and_Late_Puberty.pdf...\n",
      "2025-06-11 01:45:08,844 - INFO - Splitting Guideline_for_Early_and_Late_Puberty.pdf into sections...\n",
      "2025-06-11 01:45:08,845 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 49.54it/s]\n",
      "2025-06-11 01:45:08,867 - INFO - Created 1 chunks from Guideline_for_Early_and_Late_Puberty.pdf\n",
      "Processing files:  85%|████████▍ | 111/131 [03:34<00:15,  1.30it/s]2025-06-11 01:45:08,868 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Where_There_is_No_Doctor_handbook-_Hesperian.pdf...\n",
      "2025-06-11 01:45:16,822 - INFO - Splitting Where_There_is_No_Doctor_handbook-_Hesperian.pdf into sections...\n",
      "2025-06-11 01:45:16,853 - INFO - Found 597 sections\n",
      "Processing sections: 100%|██████████| 597/597 [00:39<00:00, 15.26it/s]\n",
      "2025-06-11 01:45:55,981 - INFO - Created 767 chunks from Where_There_is_No_Doctor_handbook-_Hesperian.pdf\n",
      "Processing files:  85%|████████▌ | 112/131 [04:21<04:38, 14.67s/it]2025-06-11 01:45:55,983 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Congenital_Anomalies_of_Kidney_and_Urinary_Tract.pdf...\n",
      "2025-06-11 01:45:56,324 - INFO - Splitting Guideline_for_Congenital_Anomalies_of_Kidney_and_Urinary_Tract.pdf into sections...\n",
      "2025-06-11 01:45:56,325 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.83it/s]\n",
      "2025-06-11 01:45:56,875 - INFO - Created 5 chunks from Guideline_for_Congenital_Anomalies_of_Kidney_and_Urinary_Tract.pdf\n",
      "Processing files:  86%|████████▋ | 113/131 [04:22<03:09, 10.54s/it]2025-06-11 01:45:56,876 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Recurrent_Urinary_Tract_Infection.pdf...\n",
      "2025-06-11 01:45:57,008 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Recurrent_Urinary_Tract_Infection.pdf into sections...\n",
      "2025-06-11 01:45:57,009 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00,  7.24it/s]\n",
      "2025-06-11 01:45:57,426 - INFO - Created 5 chunks from Guideline_for_Care_of_a_Child_with_Recurrent_Urinary_Tract_Infection.pdf\n",
      "Processing files:  87%|████████▋ | 114/131 [04:22<02:08,  7.54s/it]2025-06-11 01:45:57,426 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Corona_virus_Disease-2019_in_Children.pdf...\n",
      "2025-06-11 01:45:57,592 - INFO - Splitting Guideline_for_Corona_virus_Disease-2019_in_Children.pdf into sections...\n",
      "2025-06-11 01:45:57,593 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00, 40.72it/s]\n",
      "2025-06-11 01:45:57,620 - INFO - Created 1 chunks from Guideline_for_Corona_virus_Disease-2019_in_Children.pdf\n",
      "Processing files:  88%|████████▊ | 115/131 [04:23<01:25,  5.34s/it]2025-06-11 01:45:57,620 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Diarrhea.pdf...\n",
      "2025-06-11 01:45:57,959 - INFO - Splitting Guidelines_for_Diarrhea.pdf into sections...\n",
      "2025-06-11 01:45:57,961 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.76it/s]\n",
      "2025-06-11 01:45:58,495 - INFO - Created 6 chunks from Guidelines_for_Diarrhea.pdf\n",
      "Processing files:  89%|████████▊ | 116/131 [04:23<00:59,  4.00s/it]2025-06-11 01:45:58,496 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Anemia.pdf...\n",
      "2025-06-11 01:45:58,618 - INFO - Splitting Guideline_for_Anemia.pdf into sections...\n",
      "2025-06-11 01:45:58,619 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.79it/s]\n",
      "2025-06-11 01:45:59,180 - INFO - Created 5 chunks from Guideline_for_Anemia.pdf\n",
      "Processing files:  89%|████████▉ | 117/131 [04:24<00:42,  3.01s/it]2025-06-11 01:45:59,181 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Hyperglycemia_in_Pregnancy_(HIP)_FIGO\n",
      "offers_a_pragmatic_guide_to_diagnosis,\n",
      "management_and_care.pdf...\n",
      "2025-06-11 01:46:00,958 - INFO - Splitting Hyperglycemia_in_Pregnancy_(HIP)_FIGO\n",
      "offers_a_pragmatic_guide_to_diagnosis,\n",
      "management_and_care.pdf into sections...\n",
      "2025-06-11 01:46:00,959 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  7.93it/s]\n",
      "2025-06-11 01:46:01,214 - INFO - Created 4 chunks from Hyperglycemia_in_Pregnancy_(HIP)_FIGO\n",
      "offers_a_pragmatic_guide_to_diagnosis,\n",
      "management_and_care.pdf\n",
      "Processing files:  90%|█████████ | 118/131 [04:26<00:35,  2.71s/it]2025-06-11 01:46:01,214 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Normal_Development_and_When_to_Suspect_Abnormal_Development.pdf...\n",
      "2025-06-11 01:46:01,440 - INFO - Splitting Normal_Development_and_When_to_Suspect_Abnormal_Development.pdf into sections...\n",
      "2025-06-11 01:46:01,441 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00, 16.69it/s]\n",
      "2025-06-11 01:46:01,683 - INFO - Created 6 chunks from Normal_Development_and_When_to_Suspect_Abnormal_Development.pdf\n",
      "Processing files:  91%|█████████ | 119/131 [04:27<00:24,  2.04s/it]2025-06-11 01:46:01,683 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Acute_Attack_of_Asthma_What_to_Do.pdf...\n",
      "2025-06-11 01:46:01,904 - INFO - Splitting Guideline_for_Acute_Attack_of_Asthma_What_to_Do.pdf into sections...\n",
      "2025-06-11 01:46:01,905 - INFO - Found 5 sections\n",
      "Processing sections: 100%|██████████| 5/5 [00:00<00:00, 26.37it/s]\n",
      "2025-06-11 01:46:02,097 - INFO - Created 5 chunks from Guideline_for_Acute_Attack_of_Asthma_What_to_Do.pdf\n",
      "Processing files:  92%|█████████▏| 120/131 [04:27<00:17,  1.55s/it]2025-06-11 01:46:02,097 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Commodity_and_service\n",
      "delivery_innovations_for\n",
      "detection_and_management\n",
      "of_pre-eclampsia\n",
      "Landscape_report.pdf...\n",
      "2025-06-11 01:46:03,212 - INFO - Splitting Commodity_and_service\n",
      "delivery_innovations_for\n",
      "detection_and_management\n",
      "of_pre-eclampsia\n",
      "Landscape_report.pdf into sections...\n",
      "2025-06-11 01:46:03,218 - INFO - Found 87 sections\n",
      "Processing sections: 100%|██████████| 87/87 [00:07<00:00, 11.32it/s]\n",
      "2025-06-11 01:46:10,903 - INFO - Created 144 chunks from Commodity_and_service\n",
      "delivery_innovations_for\n",
      "detection_and_management\n",
      "of_pre-eclampsia\n",
      "Landscape_report.pdf\n",
      "Processing files:  92%|█████████▏| 121/131 [04:36<00:37,  3.73s/it]2025-06-11 01:46:10,904 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Complementary_Feeding.pdf...\n",
      "2025-06-11 01:46:11,112 - INFO - Splitting Guideline_for_Complementary_Feeding.pdf into sections...\n",
      "2025-06-11 01:46:11,113 - INFO - Found 4 sections\n",
      "Processing sections: 100%|██████████| 4/4 [00:00<00:00,  5.59it/s]\n",
      "2025-06-11 01:46:11,831 - INFO - Created 9 chunks from Guideline_for_Complementary_Feeding.pdf\n",
      "Processing files:  93%|█████████▎| 122/131 [04:37<00:25,  2.89s/it]2025-06-11 01:46:11,832 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/How_much_weight_should_I_gain_during_pregnancy_-_Indian_Council_of_Medical_Research_(ICMR).pdf...\n",
      "2025-06-11 01:46:18,177 - INFO - Splitting How_much_weight_should_I_gain_during_pregnancy_-_Indian_Council_of_Medical_Research_(ICMR).pdf into sections...\n",
      "2025-06-11 01:46:18,183 - INFO - Found 34 sections\n",
      "Processing sections: 100%|██████████| 34/34 [00:08<00:00,  4.16it/s]\n",
      "2025-06-11 01:46:26,355 - INFO - Created 93 chunks from How_much_weight_should_I_gain_during_pregnancy_-_Indian_Council_of_Medical_Research_(ICMR).pdf\n",
      "Processing files:  94%|█████████▍| 123/131 [04:51<00:51,  6.38s/it]2025-06-11 01:46:26,356 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_How_to_Deal_with_Recurrent_Abdominal_Pain.pdf...\n",
      "2025-06-11 01:46:26,606 - INFO - Splitting Guideline_for_How_to_Deal_with_Recurrent_Abdominal_Pain.pdf into sections...\n",
      "2025-06-11 01:46:26,607 - INFO - Found 3 sections\n",
      "Processing sections: 100%|██████████| 3/3 [00:00<00:00, 10.78it/s]\n",
      "2025-06-11 01:46:26,887 - INFO - Created 5 chunks from Guideline_for_How_to_Deal_with_Recurrent_Abdominal_Pain.pdf\n",
      "Processing files:  95%|█████████▍| 124/131 [04:52<00:32,  4.62s/it]2025-06-11 01:46:26,888 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Healthy_Eating_and_Junk_Food.pdf...\n",
      "2025-06-11 01:46:27,170 - INFO - Splitting Guidelines_for_Healthy_Eating_and_Junk_Food.pdf into sections...\n",
      "2025-06-11 01:46:27,171 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.58it/s]\n",
      "2025-06-11 01:46:27,804 - INFO - Created 5 chunks from Guidelines_for_Healthy_Eating_and_Junk_Food.pdf\n",
      "Processing files:  95%|█████████▌| 125/131 [04:53<00:21,  3.51s/it]2025-06-11 01:46:27,805 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Home_Care_of_a_Paralytic_Child.pdf...\n",
      "2025-06-11 01:46:27,979 - INFO - Splitting Guideline_for_Home_Care_of_a_Paralytic_Child.pdf into sections...\n",
      "2025-06-11 01:46:27,980 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  2.22it/s]\n",
      "2025-06-11 01:46:28,432 - INFO - Created 4 chunks from Guideline_for_Home_Care_of_a_Paralytic_Child.pdf\n",
      "Processing files:  96%|█████████▌| 126/131 [04:53<00:13,  2.65s/it]2025-06-11 01:46:28,432 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Studies,_Coaching,_and_Vocational_Counseling.pdf...\n",
      "2025-06-11 01:46:28,748 - INFO - Splitting Guideline_for_Studies,_Coaching,_and_Vocational_Counseling.pdf into sections...\n",
      "2025-06-11 01:46:28,749 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.15it/s]\n",
      "2025-06-11 01:46:29,624 - INFO - Created 7 chunks from Guideline_for_Studies,_Coaching,_and_Vocational_Counseling.pdf\n",
      "Processing files:  97%|█████████▋| 127/131 [04:55<00:08,  2.21s/it]2025-06-11 01:46:29,625 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guidelines_for_Prevention_of_Accidents_and_Injuries.pdf...\n",
      "2025-06-11 01:46:29,864 - INFO - Splitting Guidelines_for_Prevention_of_Accidents_and_Injuries.pdf into sections...\n",
      "2025-06-11 01:46:29,865 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.50it/s]\n",
      "2025-06-11 01:46:30,533 - INFO - Created 5 chunks from Guidelines_for_Prevention_of_Accidents_and_Injuries.pdf\n",
      "Processing files:  98%|█████████▊| 128/131 [04:56<00:05,  1.82s/it]2025-06-11 01:46:30,534 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Congenital_Heart_Disease.pdf...\n",
      "2025-06-11 01:46:30,735 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Congenital_Heart_Disease.pdf into sections...\n",
      "2025-06-11 01:46:30,736 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:00<00:00,  1.02it/s]\n",
      "2025-06-11 01:46:31,721 - INFO - Created 8 chunks from Guideline_for_Care_of_a_Child_with_Congenital_Heart_Disease.pdf\n",
      "Processing files:  98%|█████████▊| 129/131 [04:57<00:03,  1.63s/it]2025-06-11 01:46:31,722 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_I_Want_to_Adopt_a_Child.pdf...\n",
      "2025-06-11 01:46:31,983 - INFO - Splitting Guideline_for_I_Want_to_Adopt_a_Child.pdf into sections...\n",
      "2025-06-11 01:46:31,984 - INFO - Found 2 sections\n",
      "Processing sections: 100%|██████████| 2/2 [00:00<00:00,  3.53it/s]\n",
      "2025-06-11 01:46:32,552 - INFO - Created 6 chunks from Guideline_for_I_Want_to_Adopt_a_Child.pdf\n",
      "Processing files:  99%|█████████▉| 130/131 [04:58<00:01,  1.39s/it]2025-06-11 01:46:32,553 - INFO - Processing /data/user_data/vidhij2/medical/pdfs/Guideline_for_Care_of_a_Child_with_Duchenne_Muscular_Dystrophy.pdf...\n",
      "2025-06-11 01:46:32,793 - INFO - Splitting Guideline_for_Care_of_a_Child_with_Duchenne_Muscular_Dystrophy.pdf into sections...\n",
      "2025-06-11 01:46:32,795 - INFO - Found 1 sections\n",
      "Processing sections: 100%|██████████| 1/1 [00:01<00:00,  1.01s/it]\n",
      "2025-06-11 01:46:33,808 - INFO - Created 11 chunks from Guideline_for_Care_of_a_Child_with_Duchenne_Muscular_Dystrophy.pdf\n",
      "Processing files: 100%|██████████| 131/131 [04:59<00:00,  2.28s/it]\n"
     ]
    }
   ],
   "source": [
    "document_2 = pipeline.process_directory(\"/data/user_data/vidhij2/medical/pdfs\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "documents.extend(document_2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4970"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(documents)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 02:37:24,147 - INFO - Creating synthetic chunks for improved retrieval...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 02:37:24,220 - INFO - Created 72 synthetic chunks\n",
      "2025-06-11 02:37:24,221 - INFO - Creating vector store with 5042 documents...\n",
      "2025-06-11 02:38:22,778 - INFO - Saving vector store to /data/user_data/vidhij2/medical_db/rag_2\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<langchain_community.vectorstores.faiss.FAISS at 0x7f1bc9835340>"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pipeline.create_vector_store(documents)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "def answer_maternal_health_query(pipeline, query):\n",
    "    \"\"\"\n",
    "    Answer a maternal health query using the pipeline.\n",
    "    \n",
    "    Args:\n",
    "        pipeline: Initialized MaternalHealthPipeline\n",
    "        query: Question from a pregnant woman\n",
    "        \n",
    "    Returns:\n",
    "        Answer with source information\n",
    "    \"\"\"\n",
    "    print(f\"\\nProcessing query: {query}\")\n",
    "    \n",
    "    # Detect context from query\n",
    "    context = pipeline.detect_query_context(query)\n",
    "    stage = context[\"stage\"] or \"general\"\n",
    "    concerns = \", \".join(context[\"concerns\"]) if context[\"concerns\"] else \"none detected\"\n",
    "    print(f\"Detected stage: {stage}, concerns: {concerns}\")\n",
    "    \n",
    "    # Retrieve relevant documents\n",
    "    print(\"Retrieving relevant information...\")\n",
    "    docs = pipeline.retrieve_for_query(query)\n",
    "    \n",
    "    # Print source information\n",
    "    print(f\"Found {len(docs)} relevant chunks:\")\n",
    "    for i, doc in enumerate(docs[:3]):  # Show top 3 sources\n",
    "        source = doc.metadata.get(\"title\", \"Unknown document\")\n",
    "        content_type = doc.metadata.get(\"content_type\", \"general\")\n",
    "        print(f\"  Source {i+1}: {source} ({content_type})\")\n",
    "    \n",
    "    # Generate answer\n",
    "    print(\"Generating answer...\")\n",
    "    response = pipeline.answer_question(query, model_name=\"gpt-4\")\n",
    "    \n",
    "    return response\n",
    "\n",
    "def demo_queries():\n",
    "    \"\"\"Run demo queries to test the pipeline.\"\"\"\n",
    "    return [\n",
    "        \"I'm 8 weeks pregnant and having morning sickness. Is this normal and what can I do?\",\n",
    "        \"What foods should I avoid during my pregnancy?\",\n",
    "        \"I'm in my third trimester and having trouble sleeping. Any advice?\",\n",
    "        \"I'm feeling my baby move less today. Should I be concerned?\", \n",
    "        \"What are the warning signs I should look out for after giving birth?\",\n",
    "        \"I'm 6 months pregnant and having headaches. What could be causing this?\"\n",
    "    ]\n",
    "\n",
    "def interactive_mode(pipeline):\n",
    "    \"\"\"Run in interactive mode to answer user questions.\"\"\"\n",
    "    print(\"\\n==== Maternal Health Assistant ====\")\n",
    "    print(\"Type your pregnancy or postpartum questions, or 'quit' to exit.\")\n",
    "    \n",
    "    while True:\n",
    "        query = input(\"\\nQuestion: \").strip()\n",
    "        \n",
    "        if query.lower() in ['quit', 'exit', 'q']:\n",
    "            break\n",
    "            \n",
    "        if not query:\n",
    "            continue\n",
    "            \n",
    "        response = answer_maternal_health_query(pipeline, query)\n",
    "        print(\"\\nAnswer:\")\n",
    "        print(response[\"answer\"])\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 02:40:36,258 - INFO - Query context: {'stage': 'first_trimester', 'concerns': ['nausea'], 'detected_topics': ['normal_variations']}\n",
      "2025-06-11 02:40:36,282 - INFO - Query context: {'stage': 'first_trimester', 'concerns': ['nausea'], 'detected_topics': ['normal_variations']}\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Processing query: I'm 8 weeks pregnant and having morning sickness. Is this normal and what can I do?\n",
      "Detected stage: first_trimester, concerns: nausea\n",
      "Retrieving relevant information...\n",
      "Found 4 relevant chunks:\n",
      "  Source 1: Virtual Tour\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Take A Virtual Tour\n",
      "\n",
      "\n",
      "Virtual Tour\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Care (information)\n",
      "  Source 2: Virtual Tour\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Take A Virtual Tour\n",
      "\n",
      "\n",
      "Virtual Tour\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Care (recommendation)\n",
      "  Source 3: Continue\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Skip to main content\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Health (information)\n",
      "Generating answer...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_4038970/277868169.py:1564: LangChainDeprecationWarning: The method `BaseChatModel.predict` was deprecated in langchain-core 0.1.7 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  response = llm.predict(\n",
      "2025-06-11 02:40:45,212 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Answer:\n",
      "Yes, experiencing morning sickness at 8 weeks of pregnancy is quite normal. Morning sickness, also known as pregnancy-related nausea and vomiting, is common during early pregnancy. Despite its name, it can occur at any time of the day.\n",
      "\n",
      "There are several strategies you can try to manage your morning sickness:\n",
      "\n",
      "1. Dietary Changes: Consuming ginger in various forms, such as ginger tea, ginger candies, or ginger capsules, may help reduce nausea. Try to identify and avoid foods or smells that trigger or worsen your symptoms.\n",
      "\n",
      "2. Hydration: It's important to stay hydrated during pregnancy. Aim for 8 to 12 cups of water a day. Not drinking enough fluids can lead to dehydration, which can make nausea worse.\n",
      "\n",
      "3. Vitamin B6: In some cases, healthcare providers may recommend vitamin B6 supplements to manage morning sickness.\n",
      "\n",
      "4. Medications: If your symptoms are severe and self-care measures are not effective, your healthcare provider may prescribe anti-nausea medications that are safe during pregnancy.\n",
      "\n",
      "Remember, this is general information; please consult your healthcare provider for personal medical advice.\n"
     ]
    }
   ],
   "source": [
    "# demo\n",
    "queries = demo_queries()\n",
    "for query in queries:\n",
    "    response = answer_maternal_health_query(pipeline, query)\n",
    "    print(\"\\nAnswer:\")\n",
    "    \n",
    "    print(response[\"answer\"])\n",
    "    input(\"\\nPress Enter for next query...\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# interactive\n",
    "interactive_mode(pipeline)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/vidhij2/.local/lib/python3.9/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n",
      "2025-06-14 02:25:29.775705: I tensorflow/core/util/port.cc:153] oneDNN custom operations are on. You may see slightly different numerical results due to floating-point round-off errors from different computation orders. To turn them off, set the environment variable `TF_ENABLE_ONEDNN_OPTS=0`.\n",
      "2025-06-14 02:25:29.860881: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:477] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n",
      "WARNING: All log messages before absl::InitializeLog() is called are written to STDERR\n",
      "E0000 00:00:1749882329.900535  687616 cuda_dnn.cc:8310] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n",
      "E0000 00:00:1749882329.912225  687616 cuda_blas.cc:1418] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
      "2025-06-14 02:25:29.998147: I tensorflow/core/platform/cpu_feature_guard.cc:210] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n",
      "To enable the following instructions: AVX2 AVX512F AVX512_VNNI FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n",
      "2025-06-14 02:25:32,403 - INFO - PyTorch version 2.6.0+cu118 available.\n",
      "2025-06-14 02:25:32,405 - INFO - TensorFlow version 2.18.0 available.\n",
      "2025-06-14 02:25:32,688 - INFO - Load pretrained SentenceTransformer: intfloat/multilingual-e5-large-instruct\n",
      "2025-06-14 02:25:35,684 - INFO - Loading faiss with AVX2 support.\n",
      "2025-06-14 02:25:35,686 - INFO - Could not load library with AVX2 support due to:\n",
      "ModuleNotFoundError(\"No module named 'faiss.swigfaiss_avx2'\")\n",
      "2025-06-14 02:25:35,686 - INFO - Loading faiss.\n",
      "2025-06-14 02:25:35,710 - INFO - Successfully loaded faiss.\n"
     ]
    }
   ],
   "source": [
    "# embeddings = HuggingFaceEmbeddings(\n",
    "#     model_name=\"google/muril-base-cased\",\n",
    "#     model_kwargs={'device': 'cpu'},\n",
    "#     encode_kwargs={'normalize_embeddings': True}\n",
    "# )\n",
    "embeddings = E5Embeddings(device=\"cuda\")\n",
    "vector_store = FAISS.load_local(\n",
    "    folder_path=\"/data/user_data/vidhij2/medical_db/rag_2\",\n",
    "    embeddings=embeddings,  # This must be the properly initialized embeddings\n",
    "    allow_dangerous_deserialization=True\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-11 02:39:16,981 - WARNING - `embedding_function` is expected to be an Embeddings object, support for passing in a function will soon be removed.\n"
     ]
    }
   ],
   "source": [
    "vector_store = FAISS.load_local(folder_path=\"/data/user_data/vidhij2/medical_db/rag_2\", embeddings=\"google/muril-base-cased\", allow_dangerous_deserialization=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5042"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vector_store.index.ntotal"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Enhanced RAG system for maternal health with multilingual support,\n",
    "    stage-aware retrieval, and cross-encoder reranking. This is the answering thing after vector store is created"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n# Initialize with your chunked vector store\\nfrom langchain.vectorstores import FAISS\\nfrom transformers import AutoModelForCausalLM, AutoTokenizer\\n\\n# Load your vector store\\nembeddings = HuggingFaceEmbeddings(model_name=\"google/muril-base-cased\")\\nvector_store = FAISS.load_local(\\n    folder_path=\"maternal_health_db\",\\n    embeddings=embeddings,\\n    allow_dangerous_deserialization=True\\n)\\n\\n# Load your LLM (e.g., Llama-3-8B or other appropriate model)\\ntokenizer = AutoTokenizer.from_pretrained(\"meta-llama/Llama-3-8B-Instruct\")\\nmodel = AutoModelForCausalLM.from_pretrained(\"meta-llama/Llama-3-8B-Instruct\")\\n\\n# Initialize the enhanced RAG system\\nrag_system = EnhancedMedicalRAG(\\n    vector_store=vector_store,\\n    model=model,\\n    tokenizer=tokenizer,\\n    use_reranking=True  # Set to False if you don\\'t want to use reranking\\n)\\n\\n# Example query in Hindi\\nhindi_query = \"मेरे गर्भ में 7 महीने का बच्चा है और वह कम हिल रहा है। क्या यह चिंता का विषय है?\"\\nresult = rag_system.query(hindi_query)\\nprint(result[\"answer\"])\\n\\n# Example query in Assamese\\nassamese_query = \"মোৰ 6 মাহৰ গৰ্ভাৱস্থা চলি আছে আৰু মোৰ বাৰে বাৰে পিঠি বিষাই থাকে। ই সাধাৰণ নেকি?\"\\nresult = rag_system.query(assamese_query)\\nprint(result[\"answer\"])\\n\\n# Example query in English\\nenglish_query = \"I\\'m 30 weeks pregnant and experiencing headaches. What could be causing this?\"\\nresult = rag_system.query(english_query)\\nprint(result[\"answer\"])\\n'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from langchain.chat_models import ChatOpenAI\n",
    "from langchain.chains import RetrievalQA, LLMChain\n",
    "from langchain.prompts import PromptTemplate\n",
    "from typing import List, Dict, Any, Optional, Tuple, Union\n",
    "from langchain.vectorstores import FAISS\n",
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "from langchain.schema import Document\n",
    "from langchain.llms import HuggingFacePipeline\n",
    "from transformers import pipeline, AutoTokenizer, AutoModelForSequenceClassification\n",
    "import torch\n",
    "import numpy as np\n",
    "from sentence_transformers import CrossEncoder\n",
    "import re\n",
    "from functools import lru_cache\n",
    "\n",
    "class EnhancedMedicalRAG:\n",
    "    \"\"\"\n",
    "    Enhanced RAG system for maternal health with multilingual support,\n",
    "    stage-aware retrieval, and cross-encoder reranking.\n",
    "    \"\"\"\n",
    "\n",
    "    def __init__(\n",
    "        self,\n",
    "        vector_store: FAISS,\n",
    "        model,\n",
    "        tokenizer,\n",
    "        temperature: float = 0.25,\n",
    "        reranker_model: str = \"cross-encoder/ms-marco-MiniLM-L-6-v2\",\n",
    "        use_reranking: bool = True\n",
    "    ):\n",
    "        # Set up text generation pipeline\n",
    "        \n",
    "        self.vector_store = vector_store\n",
    "\n",
    "        if model == \"gpt-4-turbo\":\n",
    "            self.llm = ChatOpenAI(\n",
    "                model=model,\n",
    "                temperature=0.1  # Low temperature for factual responses\n",
    "            )\n",
    "        else:\n",
    "            pipe = pipeline(\n",
    "            \"text-generation\",\n",
    "            model=model,\n",
    "            tokenizer=tokenizer,\n",
    "            max_new_tokens=512,\n",
    "            device_map=\"auto\",\n",
    "            temperature=temperature,  # Lower temperature for medical accuracy\n",
    "            top_p=0.95,\n",
    "            batch_size=1\n",
    "            )\n",
    "            self.llm = HuggingFacePipeline(\n",
    "                pipeline=pipe\n",
    "            )\n",
    "        self.use_reranking = use_reranking\n",
    "        \n",
    "        # Initialize reranker model if enabled\n",
    "        if use_reranking:\n",
    "            try:\n",
    "                self.reranker = CrossEncoder(reranker_model)\n",
    "                print(f\"Initialized reranker model: {reranker_model}\")\n",
    "            except Exception as e:\n",
    "                print(f\"Failed to load reranker model: {e}\")\n",
    "                self.use_reranking = False\n",
    "        \n",
    "        # Language detection model - simple regex patterns for quick language detection\n",
    "        self.language_patterns = {\n",
    "            'hindi': re.compile(r'[\\u0900-\\u097F]'),   # Hindi Unicode range\n",
    "            'assamese': re.compile(r'[\\u0980-\\u09FF]'),  # Bengali/Assamese Unicode range\n",
    "            'english': re.compile(r'[a-zA-Z]')\n",
    "        }\n",
    "        \n",
    "        # Create pregnancy stage patterns for query understanding\n",
    "        self.stage_patterns = {\n",
    "            'week': re.compile(r'(?:week|weeks)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+week', re.IGNORECASE),\n",
    "            'month': re.compile(r'(?:month|months)\\s+(\\d+(?:-\\d+)?)|(\\d+)(?:st|nd|rd|th)?\\s+month', re.IGNORECASE),\n",
    "            'trimester': re.compile(r'(first|second|third)\\s+trimester', re.IGNORECASE),\n",
    "            'stage': re.compile(r'(preconception|prenatal|antenatal|perinatal|intrapartum|postpartum|postnatal)', re.IGNORECASE)\n",
    "        }\n",
    "        \n",
    "        # Medical concern patterns for better filtering\n",
    "        self.concern_patterns = {\n",
    "            'pain': re.compile(r'pain|ache|hurt|sore|discomfort', re.IGNORECASE),\n",
    "            'bleeding': re.compile(r'bleed|blood|spotting|hemorrhage', re.IGNORECASE),\n",
    "            'movement': re.compile(r'movement|kick|moving|motion|active', re.IGNORECASE),\n",
    "            'nutrition': re.compile(r'food|eat|diet|nutrition|hungry|appetite', re.IGNORECASE),\n",
    "            'sleep': re.compile(r'sleep|insomnia|tired|fatigue|rest', re.IGNORECASE),\n",
    "            'emotional': re.compile(r'depress|anxiety|worry|stress|mood|emotion', re.IGNORECASE)\n",
    "        }\n",
    "\n",
    "        # Define prompt templates\n",
    "        self.rag_prompt = PromptTemplate(\n",
    "            template=\"\"\"You are a supportive maternal health assistant providing information to pregnant women and new mothers.\n",
    "Use the following retrieved information to answer the question.\n",
    "Response Guidelines:\n",
    "1. Answer ONLY using the provided context. Do not speculate or generate information not found in the retrieved data. If the provided context doesn't fully answer the question, state the limitations. Example: “I don’t have enough information to answer that accurately.”\n",
    "\n",
    "\n",
    "3. Be reassuring but honest. Do not minimize legitimate concerns. If the topic is serious, clearly explain when to seek medical help.\n",
    "\n",
    "\n",
    "4. Use clear, non-technical language. Avoid jargon and explain complex terms simply.\n",
    "\n",
    "5. Warning signs: When discussing symptoms or warning signs, clearly distinguish between normal variations and symptoms that require medical attention. List these separately if appropriate.\n",
    "\n",
    "6. If you detect any signs of a possible emergency (such as heavy bleeding, severe pain, loss of consciousness, seizures, absent fetal movement, severe swelling, difficulty breathing, fever with rash, premature rupture of membranes, or vision changes):\n",
    "\n",
    "Do NOT give any advice.\n",
    "\n",
    "Respond ONLY with:\n",
    "\"IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
    "\n",
    "This chatbot cannot provide emergency medical advice. Please:\n",
    "1. Contact your healthcare provider immediately OR\n",
    "2. Go to the nearest emergency department OR\n",
    "3. Call your local emergency number for immediate assistance.\n",
    "\n",
    "Do not wait or delay seeking professional care.\"\n",
    "\n",
    "\n",
    "7. Do not provide: Any specific drug brand or prescription recommendations; Any information related to fetal gender detection or selection; Any instructions or advice for suicidal/self-harm situations. Instead, respond only with the relevant crisis hotline (India: 9152987821, US: 988, UK: 0800 689 5652).\n",
    "\n",
    "8. Do not answer off topic questions, ie: questions which are not related to  pregnancy, postpartum, or maternal/newborn wellness at all. (if off-topic, say: “I’m sorry, I can only help with pregnancy and maternal-health questions.”),\n",
    "\n",
    "9. Respond in the same language as the original question, if the language is hindi written in english, do the same. \n",
    "\n",
    "Context:\n",
    " {context}\n",
    "Question:\n",
    " {question}\n",
    "Answer:\n",
    "\"\"\",\n",
    "\n",
    "            \n",
    "# Context information from trusted maternal health guidelines:\n",
    "# {context}\n",
    "\n",
    "# User Question: {question}\n",
    "\n",
    "# Instructions:\n",
    "# 1. Respond based only on the provided context. If the information isn't in the context, say \"I don't have enough information to answer this question based on the provided guidelines.\"\n",
    "# 2. Be reassuring but accurate - don't minimize legitimate health concerns.\n",
    "# 3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\n",
    "# 4. Remind users to consult healthcare providers for personal medical advice when appropriate.\n",
    "# 5. Use clear, non-technical language that is easy to understand.\n",
    "# 6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \n",
    "\n",
    "# Answer:\"\"\",\n",
    "            input_variables=[\"context\", \"question\"]\n",
    "        )\n",
    "\n",
    "        # Create LLM chain\n",
    "        self.qa_prompt_chain = LLMChain(\n",
    "            llm=self.llm,\n",
    "            prompt=self.rag_prompt\n",
    "        )\n",
    "\n",
    "    @lru_cache(maxsize=100)\n",
    "    def translate_query_to_english(self, query: str) -> str:\n",
    "        \"\"\"Translate query to English if needed, with caching for efficiency.\"\"\"\n",
    "        # Skip translation if query already contains mostly English\n",
    "        \n",
    "            \n",
    "        translation_prompt = PromptTemplate(\n",
    "            template=\"\"\"Translate the following maternal health query to English, preserving all medical terms and meaning:\n",
    "\n",
    "Query: {query}\n",
    "\n",
    "Translation:\"\"\",\n",
    "            input_variables=[\"query\"]\n",
    "        )\n",
    "        \n",
    "        try:\n",
    "            llm = ChatOpenAI(model_name=\"gpt-3.5-turbo\", temperature=0)\n",
    "            response = llm(translation_prompt.format_prompt(query=query).to_messages())\n",
    "            return response.content.strip()\n",
    "        except Exception as e:\n",
    "            print(f\"Translation failed: {e}\")\n",
    "            return query  # Return original query if translation fails\n",
    "\n",
    "    def _detect_language(self, text: str) -> str:\n",
    "        \"\"\"Detect the primary language of the text.\"\"\"\n",
    "        counts = {\n",
    "            lang: len(pattern.findall(text)) \n",
    "            for lang, pattern in self.language_patterns.items()\n",
    "        }\n",
    "        \n",
    "        # If mixed, determine based on ratio\n",
    "        total = sum(counts.values())\n",
    "        if total == 0:\n",
    "            return 'english'  # Default to English if no matches\n",
    "            \n",
    "        # Get language with highest ratio\n",
    "        lang_ratios = {lang: count/total for lang, count in counts.items()}\n",
    "        primary_lang = max(lang_ratios.items(), key=lambda x: x[1])[0]\n",
    "        \n",
    "        # Check if it's mixed (no language has > 70% dominance)\n",
    "        if lang_ratios[primary_lang] < 0.7:\n",
    "            return 'mixed'\n",
    "            \n",
    "        return primary_lang\n",
    "\n",
    "    def detect_pregnancy_stage(self, query: str) -> Optional[str]:\n",
    "        \"\"\"Extract pregnancy stage information from the query.\"\"\"\n",
    "        query_lower = query.lower()\n",
    "        \n",
    "        # Map from detected stage references to standardized stages\n",
    "        stage_mapping = {\n",
    "            'first_trimester': ['first trimester', 'early pregnancy', '1st trimester'],\n",
    "            'second_trimester': ['second trimester', 'mid pregnancy', '2nd trimester'],\n",
    "            'third_trimester': ['third trimester', 'late pregnancy', '3rd trimester'],\n",
    "            'labor_delivery': ['labor', 'delivery', 'birth', 'intrapartum'],\n",
    "            'postpartum': ['postpartum', 'after birth', 'post delivery', 'postnatal']\n",
    "        }\n",
    "        \n",
    "        # Check for direct stage mentions\n",
    "        for stage, keywords in stage_mapping.items():\n",
    "            if any(keyword in query_lower for keyword in keywords):\n",
    "                return stage\n",
    "                \n",
    "        # Check for week mentions\n",
    "        for match in self.stage_patterns['week'].finditer(query_lower):\n",
    "            week_str = match.group(1) or match.group(2)\n",
    "            if week_str:\n",
    "                try:\n",
    "                    week = int(week_str.split('-')[0])  # Take first number if range\n",
    "                    if 1 <= week <= 12:\n",
    "                        return 'first_trimester'\n",
    "                    elif 13 <= week <= 26:\n",
    "                        return 'second_trimester'\n",
    "                    elif 27 <= week <= 42:\n",
    "                        return 'third_trimester'\n",
    "                except ValueError:\n",
    "                    pass\n",
    "        \n",
    "        # Check for month mentions\n",
    "        for match in self.stage_patterns['month'].finditer(query_lower):\n",
    "            month_str = match.group(1) or match.group(2)\n",
    "            if month_str:\n",
    "                try:\n",
    "                    month = int(month_str.split('-')[0])  # Take first number if range\n",
    "                    if 1 <= month <= 3:\n",
    "                        return 'first_trimester'\n",
    "                    elif 4 <= month <= 6:\n",
    "                        return 'second_trimester'\n",
    "                    elif 7 <= month <= 10:\n",
    "                        return 'third_trimester'\n",
    "                except ValueError:\n",
    "                    pass\n",
    "                    \n",
    "        return None  # No stage detected\n",
    "\n",
    "    def detect_concerns(self, query: str) -> List[str]:\n",
    "        \"\"\"Detect maternal health concerns from query.\"\"\"\n",
    "        query_lower = query.lower()\n",
    "        concerns = []\n",
    "        \n",
    "        for concern, pattern in self.concern_patterns.items():\n",
    "            if pattern.search(query_lower):\n",
    "                concerns.append(concern)\n",
    "                \n",
    "        return concerns\n",
    "\n",
    "    def hybrid_retrieve(self, query: str, k: int = 10) -> List[Document]:\n",
    "        \"\"\"Retrieve documents using both dense and metadata-based approaches.\"\"\"\n",
    "        stage = self.detect_pregnancy_stage(query)\n",
    "        concerns = self.detect_concerns(query)\n",
    "        \n",
    "        # Default retriever - dense vector similarity\n",
    "        search_kwargs = {\"k\": k}\n",
    "        \n",
    "        # Add stage filter if detected\n",
    "        if stage:\n",
    "            # FIXED: Use a filter function that works with metadata dictionaries\n",
    "            stage_filter = lambda metadata: (\n",
    "                # Match documents with the same stage or no specific stage\n",
    "                stage in metadata.get('pregnancy_stages', {}).get('standard_stages', [])\n",
    "                if isinstance(metadata.get('pregnancy_stages', {}), dict) else False\n",
    "            ) or (\n",
    "                not (metadata.get('pregnancy_stages', {}).get('standard_stages', [])\n",
    "                    if isinstance(metadata.get('pregnancy_stages', {}), dict) else [])\n",
    "            )\n",
    "            search_kwargs[\"filter\"] = stage_filter\n",
    "        \n",
    "        # First retrieve based on vector similarity\n",
    "        initial_docs = self.vector_store.as_retriever(search_kwargs=search_kwargs).get_relevant_documents(query)\n",
    "        \n",
    "        # Check if concerns are addressed in top results\n",
    "        if concerns:\n",
    "            concern_addressed = False\n",
    "            for doc in initial_docs[:3]:  # Check top 3 docs\n",
    "                doc_concerns = doc.metadata.get('patient_concerns', [])\n",
    "                if any(concern in doc_concerns for concern in concerns):\n",
    "                    concern_addressed = True\n",
    "                    break\n",
    "                    \n",
    "            # If concerns not addressed, get concern-specific docs\n",
    "            if not concern_addressed:\n",
    "                # FIXED: Use a filter function that works with metadata dictionaries\n",
    "                concern_filter = lambda metadata: any(\n",
    "                    concern in metadata.get(\"patient_concerns\", []) \n",
    "                    for concern in concerns\n",
    "                )\n",
    "                \n",
    "                # Create a temporary retriever with this filter\n",
    "                concern_kwargs = search_kwargs.copy()\n",
    "                concern_kwargs[\"filter\"] = concern_filter\n",
    "                concern_kwargs[\"k\"] = 3  # Just get a few concern-specific docs\n",
    "                \n",
    "                concern_docs = self.vector_store.as_retriever(\n",
    "                    search_kwargs=concern_kwargs\n",
    "                ).get_relevant_documents(query)\n",
    "                \n",
    "                # Add unique concern docs (avoid duplicates)\n",
    "                existing_ids = {doc.metadata.get('chunk_id', '') for doc in initial_docs}\n",
    "                for doc in concern_docs:\n",
    "                    if doc.metadata.get('chunk_id', '') not in existing_ids:\n",
    "                        initial_docs.append(doc)\n",
    "                        \n",
    "        return initial_docs\n",
    "\n",
    "    def rerank_documents(self, query: str, docs: List[Document], top_k: int = 7) -> List[Document]:\n",
    "        \"\"\"Rerank documents using a cross-encoder if available.\"\"\"\n",
    "        if not self.use_reranking or not docs:\n",
    "            return docs[:top_k]\n",
    "            \n",
    "        try:\n",
    "            # Create query-document pairs\n",
    "            query_doc_pairs = [(query, doc.page_content) for doc in docs]\n",
    "            \n",
    "            # Get scores from reranker\n",
    "            scores = self.reranker.predict(query_doc_pairs)\n",
    "            \n",
    "            # Sort by score\n",
    "            doc_score_pairs = sorted(zip(docs, scores), key=lambda x: x[1], reverse=True)\n",
    "            reranked_docs = [doc for doc, _ in doc_score_pairs]\n",
    "            \n",
    "            return reranked_docs[:top_k]\n",
    "        except Exception as e:\n",
    "            print(f\"Reranking failed: {e}\")\n",
    "            return docs[:top_k]  # Return original ordering if reranking fails\n",
    "\n",
    "    def query(self, question: str, translate: bool = True) -> Dict[str, Any]:\n",
    "        \"\"\"Query the enhanced RAG system with multilingual support and reranking.\"\"\"\n",
    "        original_question = question\n",
    "        \n",
    "        # Detect language\n",
    "        detected_language = self._detect_language(question)\n",
    "        print(f\"Detected language: {detected_language}\")\n",
    "        # Translate if needed\n",
    "        if translate :\n",
    "            translated_question = self.translate_query_to_english(question)\n",
    "        else:\n",
    "            translated_question = question\n",
    "        print(f\"Translated question: {translated_question}\")\n",
    "        # Retrieve documents using hybrid approach\n",
    "        retrieved_docs = self.hybrid_retrieve(translated_question)\n",
    "        \n",
    "        # Rerank if enabled\n",
    "        if self.use_reranking:\n",
    "            reranked_docs = self.rerank_documents(translated_question, retrieved_docs)\n",
    "        else:\n",
    "            reranked_docs = retrieved_docs[:7]  # Limit to top 7 if not reranking\n",
    "            \n",
    "        # Join contexts\n",
    "        context = \"\\n\\n\".join(doc.page_content for doc in reranked_docs)\n",
    "        # print(f\"Context: {context}\")\n",
    "        # Generate answer with original question\n",
    "        answer = self.qa_prompt_chain.run({\n",
    "            \"context\": context,\n",
    "            \"question\": original_question\n",
    "        })\n",
    "        \n",
    "        # Clean up answer\n",
    "        answer_start = answer.lower().find(\"answer:\")\n",
    "        if answer_start != -1:\n",
    "            answer = answer[answer_start + 7:].strip()  # +7 to skip \"answer:\"\n",
    "            \n",
    "        # Prepare source information\n",
    "        sources = [\n",
    "            {\n",
    "                \"content\": doc.page_content[:300] + \"...\" if len(doc.page_content) > 300 else doc.page_content,\n",
    "                \"metadata\": {\n",
    "                    k: v for k, v in doc.metadata.items() \n",
    "                    if k in ['title', 'source', 'pregnancy_stages', 'content_type']\n",
    "                }\n",
    "            }\n",
    "            for doc in reranked_docs\n",
    "        ]\n",
    "        \n",
    "        # Include detected stage and concerns for debugging/monitoring\n",
    "        detected_info = {\n",
    "            \"language\": detected_language,\n",
    "            \"stage\": self.detect_pregnancy_stage(question),\n",
    "            \"concerns\": self.detect_concerns(question)\n",
    "        }\n",
    "\n",
    "        return {\n",
    "            \"question_original\": original_question,\n",
    "            \"question_translated\": translated_question,\n",
    "            \"answer\": answer,\n",
    "            \"sources\": sources,\n",
    "            \"detected_info\": detected_info\n",
    "        }\n",
    "\n",
    "    def query_without_rag(self, question: str, translate: bool = True) -> Dict[str, Any]:\n",
    "        \"\"\"Query without retrieval for comparison purposes.\"\"\"\n",
    "        original_question = question\n",
    "        detected_language = self._detect_language(question)\n",
    "        \n",
    "        if translate and detected_language != 'english':\n",
    "            translated_question = self.translate_query_to_english(question)\n",
    "        else:\n",
    "            translated_question = question\n",
    "\n",
    "        # Define a prompt that doesn't use context\n",
    "        direct_prompt = PromptTemplate(\n",
    "            template=\"\"\"You are a supportive maternal health assistant providing information to pregnant women and new mothers.\n",
    "Use the following retrieved information to answer the question.\n",
    "Response Guidelines:\n",
    "1. Answer based on your knowledge.\n",
    "3. Be reassuring but honest. Do not minimize legitimate concerns. If the topic is serious, clearly explain when to seek medical help.\n",
    "\n",
    "\n",
    "4. Use clear, non-technical language. Avoid jargon and explain complex terms simply.\n",
    "\n",
    "5. Warning signs: When discussing symptoms or warning signs, clearly distinguish between normal variations and symptoms that require medical attention. List these separately if appropriate.\n",
    "\n",
    "6. If you detect any signs of a possible emergency, answer accordingly:\n",
    "\n",
    "7. Do not provide: Any specific drug brand or prescription recommendations; Any information related to fetal gender detection or selection; Any instructions or advice for suicidal/self-harm situations. Instead, respond only with the relevant crisis hotline (India: 9152987821, US: 988, UK: 0800 689 5652).\n",
    "\n",
    "8. Do not answer off topic questions, ie: questions which are not related to  pregnancy, postpartum, or maternal/newborn wellness at all. (if off-topic, say: “I’m sorry, I can only help with pregnancy and maternal-health questions.”),\n",
    "\n",
    "9. Respond in the same language as the original question, if the language is hindi written in english, do the same. \n",
    "\n",
    "Question:\n",
    " {question}\n",
    "Answer:\n",
    "\n",
    "\"\"\",\n",
    "            input_variables=[\"question\"]\n",
    "        )\n",
    "\n",
    "        qa_direct_chain = LLMChain(\n",
    "            llm=self.llm,\n",
    "            prompt=direct_prompt\n",
    "        )\n",
    "\n",
    "        answer = qa_direct_chain.run({\n",
    "            \"question\": original_question\n",
    "        })\n",
    "        \n",
    "        # Clean up answer\n",
    "        answer_start = answer.lower().find(\"answer:\")\n",
    "        if answer_start != -1:\n",
    "            answer = answer[answer_start + 7:].strip()\n",
    "            \n",
    "        # Include detected info for consistency\n",
    "        detected_info = {\n",
    "            \"language\": detected_language,\n",
    "            \"stage\": self.detect_pregnancy_stage(question),\n",
    "            \"concerns\": self.detect_concerns(question)\n",
    "        }\n",
    "            \n",
    "        return {\n",
    "            \"question_original\": original_question,\n",
    "            \"question_translated\": translated_question,\n",
    "            \"answer\": answer,\n",
    "            \"sources\": [],  # No sources in non-RAG mode\n",
    "            \"detected_info\": detected_info\n",
    "        }\n",
    "\n",
    "# Example usage code:\n",
    "\"\"\"\n",
    "# Initialize with your chunked vector store\n",
    "from langchain.vectorstores import FAISS\n",
    "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
    "\n",
    "# Load your vector store\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"google/muril-base-cased\")\n",
    "vector_store = FAISS.load_local(\n",
    "    folder_path=\"maternal_health_db\",\n",
    "    embeddings=embeddings,\n",
    "    allow_dangerous_deserialization=True\n",
    ")\n",
    "\n",
    "# Load your LLM (e.g., Llama-3-8B or other appropriate model)\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"meta-llama/Llama-3-8B-Instruct\")\n",
    "model = AutoModelForCausalLM.from_pretrained(\"meta-llama/Llama-3-8B-Instruct\")\n",
    "\n",
    "# Initialize the enhanced RAG system\n",
    "rag_system = EnhancedMedicalRAG(\n",
    "    vector_store=vector_store,\n",
    "    model=model,\n",
    "    tokenizer=tokenizer,\n",
    "    use_reranking=True  # Set to False if you don't want to use reranking\n",
    ")\n",
    "\n",
    "# Example query in Hindi\n",
    "hindi_query = \"मेरे गर्भ में 7 महीने का बच्चा है और वह कम हिल रहा है। क्या यह चिंता का विषय है?\"\n",
    "result = rag_system.query(hindi_query)\n",
    "print(result[\"answer\"])\n",
    "\n",
    "# Example query in Assamese\n",
    "assamese_query = \"মোৰ 6 মাহৰ গৰ্ভাৱস্থা চলি আছে আৰু মোৰ বাৰে বাৰে পিঠি বিষাই থাকে। ই সাধাৰণ নেকি?\"\n",
    "result = rag_system.query(assamese_query)\n",
    "print(result[\"answer\"])\n",
    "\n",
    "# Example query in English\n",
    "english_query = \"I'm 30 weeks pregnant and experiencing headaches. What could be causing this?\"\n",
    "result = rag_system.query(english_query)\n",
    "print(result[\"answer\"])\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.vectorstores import FAISS\n",
    "from transformers import AutoModelForCausalLM, AutoTokenizer\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "ename": "OSError",
     "evalue": "meta-llama/Llama-3-8B-Instruct is not a local folder and is not a valid model identifier listed on 'https://huggingface.co/models'\nIf this is a private repository, make sure to pass a token having permission to this repo either by logging in with `huggingface-cli login` or by passing `token=<your_token>`",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mHTTPError\u001b[0m                                 Traceback (most recent call last)",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/utils/_http.py:406\u001b[0m, in \u001b[0;36mhf_raise_for_status\u001b[0;34m(response, endpoint_name)\u001b[0m\n\u001b[1;32m    405\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 406\u001b[0m     \u001b[43mresponse\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mraise_for_status\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    407\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m HTTPError \u001b[38;5;28;01mas\u001b[39;00m e:\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/requests/models.py:1024\u001b[0m, in \u001b[0;36mResponse.raise_for_status\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m   1023\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m http_error_msg:\n\u001b[0;32m-> 1024\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m HTTPError(http_error_msg, response\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m)\n",
      "\u001b[0;31mHTTPError\u001b[0m: 401 Client Error: Unauthorized for url: https://huggingface.co/meta-llama/Llama-3-8B-Instruct/resolve/main/tokenizer_config.json",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[0;31mRepositoryNotFoundError\u001b[0m                   Traceback (most recent call last)",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/transformers/utils/hub.py:342\u001b[0m, in \u001b[0;36mcached_file\u001b[0;34m(path_or_repo_id, filename, cache_dir, force_download, resume_download, proxies, token, revision, local_files_only, subfolder, repo_type, user_agent, _raise_exceptions_for_gated_repo, _raise_exceptions_for_missing_entries, _raise_exceptions_for_connection_errors, _commit_hash, **deprecated_kwargs)\u001b[0m\n\u001b[1;32m    340\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    341\u001b[0m     \u001b[38;5;66;03m# Load from URL or cache if already cached\u001b[39;00m\n\u001b[0;32m--> 342\u001b[0m     resolved_file \u001b[38;5;241m=\u001b[39m \u001b[43mhf_hub_download\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    343\u001b[0m \u001b[43m        \u001b[49m\u001b[43mpath_or_repo_id\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    344\u001b[0m \u001b[43m        \u001b[49m\u001b[43mfilename\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    345\u001b[0m \u001b[43m        \u001b[49m\u001b[43msubfolder\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mNone\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mif\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;28;43mlen\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43msubfolder\u001b[49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m==\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;241;43m0\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01melse\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43msubfolder\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    346\u001b[0m \u001b[43m        \u001b[49m\u001b[43mrepo_type\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrepo_type\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    347\u001b[0m \u001b[43m        \u001b[49m\u001b[43mrevision\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrevision\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    348\u001b[0m \u001b[43m        \u001b[49m\u001b[43mcache_dir\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcache_dir\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    349\u001b[0m \u001b[43m        \u001b[49m\u001b[43muser_agent\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muser_agent\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    350\u001b[0m \u001b[43m        \u001b[49m\u001b[43mforce_download\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mforce_download\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    351\u001b[0m \u001b[43m        \u001b[49m\u001b[43mproxies\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mproxies\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    352\u001b[0m \u001b[43m        \u001b[49m\u001b[43mresume_download\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mresume_download\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    353\u001b[0m \u001b[43m        \u001b[49m\u001b[43mtoken\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtoken\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    354\u001b[0m \u001b[43m        \u001b[49m\u001b[43mlocal_files_only\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlocal_files_only\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    355\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    356\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m GatedRepoError \u001b[38;5;28;01mas\u001b[39;00m e:\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/utils/_validators.py:114\u001b[0m, in \u001b[0;36mvalidate_hf_hub_args.<locals>._inner_fn\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    112\u001b[0m     kwargs \u001b[38;5;241m=\u001b[39m smoothly_deprecate_use_auth_token(fn_name\u001b[38;5;241m=\u001b[39mfn\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m, has_token\u001b[38;5;241m=\u001b[39mhas_token, kwargs\u001b[38;5;241m=\u001b[39mkwargs)\n\u001b[0;32m--> 114\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mfn\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:860\u001b[0m, in \u001b[0;36mhf_hub_download\u001b[0;34m(repo_id, filename, subfolder, repo_type, revision, library_name, library_version, cache_dir, local_dir, user_agent, force_download, proxies, etag_timeout, token, local_files_only, headers, endpoint, resume_download, force_filename, local_dir_use_symlinks)\u001b[0m\n\u001b[1;32m    859\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m--> 860\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43m_hf_hub_download_to_cache_dir\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    861\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;66;43;03m# Destination\u001b[39;49;00m\n\u001b[1;32m    862\u001b[0m \u001b[43m        \u001b[49m\u001b[43mcache_dir\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcache_dir\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    863\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;66;43;03m# File info\u001b[39;49;00m\n\u001b[1;32m    864\u001b[0m \u001b[43m        \u001b[49m\u001b[43mrepo_id\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrepo_id\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    865\u001b[0m \u001b[43m        \u001b[49m\u001b[43mfilename\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mfilename\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    866\u001b[0m \u001b[43m        \u001b[49m\u001b[43mrepo_type\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrepo_type\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    867\u001b[0m \u001b[43m        \u001b[49m\u001b[43mrevision\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrevision\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    868\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;66;43;03m# HTTP info\u001b[39;49;00m\n\u001b[1;32m    869\u001b[0m \u001b[43m        \u001b[49m\u001b[43mendpoint\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mendpoint\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    870\u001b[0m \u001b[43m        \u001b[49m\u001b[43metag_timeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43metag_timeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    871\u001b[0m \u001b[43m        \u001b[49m\u001b[43mheaders\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mhf_headers\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    872\u001b[0m \u001b[43m        \u001b[49m\u001b[43mproxies\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mproxies\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    873\u001b[0m \u001b[43m        \u001b[49m\u001b[43mtoken\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtoken\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    874\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;66;43;03m# Additional options\u001b[39;49;00m\n\u001b[1;32m    875\u001b[0m \u001b[43m        \u001b[49m\u001b[43mlocal_files_only\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlocal_files_only\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    876\u001b[0m \u001b[43m        \u001b[49m\u001b[43mforce_download\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mforce_download\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    877\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:967\u001b[0m, in \u001b[0;36m_hf_hub_download_to_cache_dir\u001b[0;34m(cache_dir, repo_id, filename, repo_type, revision, endpoint, etag_timeout, headers, proxies, token, local_files_only, force_download)\u001b[0m\n\u001b[1;32m    966\u001b[0m     \u001b[38;5;66;03m# Otherwise, raise appropriate error\u001b[39;00m\n\u001b[0;32m--> 967\u001b[0m     \u001b[43m_raise_on_head_call_error\u001b[49m\u001b[43m(\u001b[49m\u001b[43mhead_call_error\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mforce_download\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mlocal_files_only\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    969\u001b[0m \u001b[38;5;66;03m# From now on, etag, commit_hash, url and size are not None.\u001b[39;00m\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:1482\u001b[0m, in \u001b[0;36m_raise_on_head_call_error\u001b[0;34m(head_call_error, force_download, local_files_only)\u001b[0m\n\u001b[1;32m   1480\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(head_call_error, RepositoryNotFoundError) \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(head_call_error, GatedRepoError):\n\u001b[1;32m   1481\u001b[0m     \u001b[38;5;66;03m# Repo not found or gated => let's raise the actual error\u001b[39;00m\n\u001b[0;32m-> 1482\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m head_call_error\n\u001b[1;32m   1483\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m   1484\u001b[0m     \u001b[38;5;66;03m# Otherwise: most likely a connection issue or Hub downtime => let's warn the user\u001b[39;00m\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:1374\u001b[0m, in \u001b[0;36m_get_metadata_or_catch_error\u001b[0;34m(repo_id, filename, repo_type, revision, endpoint, proxies, etag_timeout, headers, token, local_files_only, relative_filename, storage_folder)\u001b[0m\n\u001b[1;32m   1373\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m-> 1374\u001b[0m     metadata \u001b[38;5;241m=\u001b[39m \u001b[43mget_hf_file_metadata\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m   1375\u001b[0m \u001b[43m        \u001b[49m\u001b[43murl\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mproxies\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mproxies\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43metag_timeout\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mheaders\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mheaders\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtoken\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtoken\u001b[49m\n\u001b[1;32m   1376\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1377\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m EntryNotFoundError \u001b[38;5;28;01mas\u001b[39;00m http_error:\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/utils/_validators.py:114\u001b[0m, in \u001b[0;36mvalidate_hf_hub_args.<locals>._inner_fn\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    112\u001b[0m     kwargs \u001b[38;5;241m=\u001b[39m smoothly_deprecate_use_auth_token(fn_name\u001b[38;5;241m=\u001b[39mfn\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m, has_token\u001b[38;5;241m=\u001b[39mhas_token, kwargs\u001b[38;5;241m=\u001b[39mkwargs)\n\u001b[0;32m--> 114\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mfn\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:1294\u001b[0m, in \u001b[0;36mget_hf_file_metadata\u001b[0;34m(url, token, proxies, timeout, library_name, library_version, user_agent, headers)\u001b[0m\n\u001b[1;32m   1293\u001b[0m \u001b[38;5;66;03m# Retrieve metadata\u001b[39;00m\n\u001b[0;32m-> 1294\u001b[0m r \u001b[38;5;241m=\u001b[39m \u001b[43m_request_wrapper\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m   1295\u001b[0m \u001b[43m    \u001b[49m\u001b[43mmethod\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mHEAD\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1296\u001b[0m \u001b[43m    \u001b[49m\u001b[43murl\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1297\u001b[0m \u001b[43m    \u001b[49m\u001b[43mheaders\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mhf_headers\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1298\u001b[0m \u001b[43m    \u001b[49m\u001b[43mallow_redirects\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m   1299\u001b[0m \u001b[43m    \u001b[49m\u001b[43mfollow_relative_redirects\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m   1300\u001b[0m \u001b[43m    \u001b[49m\u001b[43mproxies\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mproxies\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1301\u001b[0m \u001b[43m    \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtimeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1302\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1303\u001b[0m hf_raise_for_status(r)\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:278\u001b[0m, in \u001b[0;36m_request_wrapper\u001b[0;34m(method, url, follow_relative_redirects, **params)\u001b[0m\n\u001b[1;32m    277\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m follow_relative_redirects:\n\u001b[0;32m--> 278\u001b[0m     response \u001b[38;5;241m=\u001b[39m \u001b[43m_request_wrapper\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    279\u001b[0m \u001b[43m        \u001b[49m\u001b[43mmethod\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mmethod\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    280\u001b[0m \u001b[43m        \u001b[49m\u001b[43murl\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    281\u001b[0m \u001b[43m        \u001b[49m\u001b[43mfollow_relative_redirects\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m    282\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mparams\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    283\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    285\u001b[0m     \u001b[38;5;66;03m# If redirection, we redirect only relative paths.\u001b[39;00m\n\u001b[1;32m    286\u001b[0m     \u001b[38;5;66;03m# This is useful in case of a renamed repository.\u001b[39;00m\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/file_download.py:302\u001b[0m, in \u001b[0;36m_request_wrapper\u001b[0;34m(method, url, follow_relative_redirects, **params)\u001b[0m\n\u001b[1;32m    301\u001b[0m response \u001b[38;5;241m=\u001b[39m get_session()\u001b[38;5;241m.\u001b[39mrequest(method\u001b[38;5;241m=\u001b[39mmethod, url\u001b[38;5;241m=\u001b[39murl, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mparams)\n\u001b[0;32m--> 302\u001b[0m \u001b[43mhf_raise_for_status\u001b[49m\u001b[43m(\u001b[49m\u001b[43mresponse\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    303\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m response\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/huggingface_hub/utils/_http.py:454\u001b[0m, in \u001b[0;36mhf_raise_for_status\u001b[0;34m(response, endpoint_name)\u001b[0m\n\u001b[1;32m    446\u001b[0m     message \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m    447\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mresponse\u001b[38;5;241m.\u001b[39mstatus_code\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m Client Error.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    448\u001b[0m         \u001b[38;5;241m+\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    452\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m make sure you are authenticated.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    453\u001b[0m     )\n\u001b[0;32m--> 454\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m _format(RepositoryNotFoundError, message, response) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01me\u001b[39;00m\n\u001b[1;32m    456\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m response\u001b[38;5;241m.\u001b[39mstatus_code \u001b[38;5;241m==\u001b[39m \u001b[38;5;241m400\u001b[39m:\n",
      "\u001b[0;31mRepositoryNotFoundError\u001b[0m: 401 Client Error. (Request ID: Root=1-684a517d-241efbd5300256773945d208;a017408e-3158-4d69-87eb-ffcd47d74396)\n\nRepository Not Found for url: https://huggingface.co/meta-llama/Llama-3-8B-Instruct/resolve/main/tokenizer_config.json.\nPlease make sure you specified the correct `repo_id` and `repo_type`.\nIf you are trying to access a private or gated repo, make sure you are authenticated.\nInvalid username or password.",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[0;31mOSError\u001b[0m                                   Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[8], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m tokenizer \u001b[38;5;241m=\u001b[39m \u001b[43mAutoTokenizer\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfrom_pretrained\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mmeta-llama/Llama-3-8B-Instruct\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[1;32m      2\u001b[0m model \u001b[38;5;241m=\u001b[39m AutoModelForCausalLM\u001b[38;5;241m.\u001b[39mfrom_pretrained(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmeta-llama/Llama-3-8B-Instruct\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/transformers/models/auto/tokenization_auto.py:881\u001b[0m, in \u001b[0;36mAutoTokenizer.from_pretrained\u001b[0;34m(cls, pretrained_model_name_or_path, *inputs, **kwargs)\u001b[0m\n\u001b[1;32m    878\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m tokenizer_class\u001b[38;5;241m.\u001b[39mfrom_pretrained(pretrained_model_name_or_path, \u001b[38;5;241m*\u001b[39minputs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)\n\u001b[1;32m    880\u001b[0m \u001b[38;5;66;03m# Next, let's try to use the tokenizer_config file to get the tokenizer class.\u001b[39;00m\n\u001b[0;32m--> 881\u001b[0m tokenizer_config \u001b[38;5;241m=\u001b[39m \u001b[43mget_tokenizer_config\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpretrained_model_name_or_path\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    882\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m_commit_hash\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;129;01min\u001b[39;00m tokenizer_config:\n\u001b[1;32m    883\u001b[0m     kwargs[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m_commit_hash\u001b[39m\u001b[38;5;124m\"\u001b[39m] \u001b[38;5;241m=\u001b[39m tokenizer_config[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m_commit_hash\u001b[39m\u001b[38;5;124m\"\u001b[39m]\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/transformers/models/auto/tokenization_auto.py:713\u001b[0m, in \u001b[0;36mget_tokenizer_config\u001b[0;34m(pretrained_model_name_or_path, cache_dir, force_download, resume_download, proxies, token, revision, local_files_only, subfolder, **kwargs)\u001b[0m\n\u001b[1;32m    710\u001b[0m     token \u001b[38;5;241m=\u001b[39m use_auth_token\n\u001b[1;32m    712\u001b[0m commit_hash \u001b[38;5;241m=\u001b[39m kwargs\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m_commit_hash\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[0;32m--> 713\u001b[0m resolved_config_file \u001b[38;5;241m=\u001b[39m \u001b[43mcached_file\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    714\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpretrained_model_name_or_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    715\u001b[0m \u001b[43m    \u001b[49m\u001b[43mTOKENIZER_CONFIG_FILE\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    716\u001b[0m \u001b[43m    \u001b[49m\u001b[43mcache_dir\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcache_dir\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    717\u001b[0m \u001b[43m    \u001b[49m\u001b[43mforce_download\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mforce_download\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    718\u001b[0m \u001b[43m    \u001b[49m\u001b[43mresume_download\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mresume_download\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    719\u001b[0m \u001b[43m    \u001b[49m\u001b[43mproxies\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mproxies\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    720\u001b[0m \u001b[43m    \u001b[49m\u001b[43mtoken\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtoken\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    721\u001b[0m \u001b[43m    \u001b[49m\u001b[43mrevision\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrevision\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    722\u001b[0m \u001b[43m    \u001b[49m\u001b[43mlocal_files_only\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlocal_files_only\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    723\u001b[0m \u001b[43m    \u001b[49m\u001b[43msubfolder\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43msubfolder\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    724\u001b[0m \u001b[43m    \u001b[49m\u001b[43m_raise_exceptions_for_gated_repo\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m    725\u001b[0m \u001b[43m    \u001b[49m\u001b[43m_raise_exceptions_for_missing_entries\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m    726\u001b[0m \u001b[43m    \u001b[49m\u001b[43m_raise_exceptions_for_connection_errors\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[1;32m    727\u001b[0m \u001b[43m    \u001b[49m\u001b[43m_commit_hash\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcommit_hash\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    728\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    729\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m resolved_config_file \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[1;32m    730\u001b[0m     logger\u001b[38;5;241m.\u001b[39minfo(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mCould not locate the tokenizer configuration file, will try to use the model config instead.\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n",
      "File \u001b[0;32m~/.local/lib/python3.9/site-packages/transformers/utils/hub.py:365\u001b[0m, in \u001b[0;36mcached_file\u001b[0;34m(path_or_repo_id, filename, cache_dir, force_download, resume_download, proxies, token, revision, local_files_only, subfolder, repo_type, user_agent, _raise_exceptions_for_gated_repo, _raise_exceptions_for_missing_entries, _raise_exceptions_for_connection_errors, _commit_hash, **deprecated_kwargs)\u001b[0m\n\u001b[1;32m    360\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mEnvironmentError\u001b[39;00m(\n\u001b[1;32m    361\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mYou are trying to access a gated repo.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124mMake sure to have access to it at \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    362\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mhttps://huggingface.co/\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mpath_or_repo_id\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mstr\u001b[39m(e)\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    363\u001b[0m     ) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01me\u001b[39;00m\n\u001b[1;32m    364\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m RepositoryNotFoundError \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[0;32m--> 365\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mEnvironmentError\u001b[39;00m(\n\u001b[1;32m    366\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mpath_or_repo_id\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m is not a local folder and is not a valid model identifier \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    367\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mlisted on \u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mhttps://huggingface.co/models\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124mIf this is a private repository, make sure to pass a token \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    368\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mhaving permission to this repo either by logging in with `huggingface-cli login` or by passing \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    369\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m`token=<your_token>`\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    370\u001b[0m     ) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01me\u001b[39;00m\n\u001b[1;32m    371\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m RevisionNotFoundError \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[1;32m    372\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mEnvironmentError\u001b[39;00m(\n\u001b[1;32m    373\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mrevision\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m is not a valid git identifier (branch name, tag name or commit id) that exists \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    374\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mfor this model name. Check the model page at \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    375\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mhttps://huggingface.co/\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mpath_or_repo_id\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124m for available revisions.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    376\u001b[0m     ) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01me\u001b[39;00m\n",
      "\u001b[0;31mOSError\u001b[0m: meta-llama/Llama-3-8B-Instruct is not a local folder and is not a valid model identifier listed on 'https://huggingface.co/models'\nIf this is a private repository, make sure to pass a token having permission to this repo either by logging in with `huggingface-cli login` or by passing `token=<your_token>`"
     ]
    }
   ],
   "source": [
    "tokenizer = AutoTokenizer.from_pretrained(\"meta-llama/Llama-3-8B-Instruct\")\n",
    "model = AutoModelForCausalLM.from_pretrained(\"meta-llama/Llama-3-8B-Instruct\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_2086988/4158433042.py:36: LangChainDeprecationWarning: The class `ChatOpenAI` was deprecated in LangChain 0.0.10 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-openai package and should be used instead. To use it run `pip install -U :class:`~langchain-openai` and import as `from :class:`~langchain_openai import ChatOpenAI``.\n",
      "  self.llm = ChatOpenAI(\n",
      "2025-06-14 01:14:03,382 - INFO - Use pytorch device: cuda\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Initialized reranker model: cross-encoder/ms-marco-MiniLM-L-6-v2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_2086988/4158433042.py:152: LangChainDeprecationWarning: The class `LLMChain` was deprecated in LangChain 0.1.17 and will be removed in 1.0. Use :meth:`~RunnableSequence, e.g., `prompt | llm`` instead.\n",
      "  self.qa_prompt_chain = LLMChain(\n"
     ]
    }
   ],
   "source": [
    "rag_system = EnhancedMedicalRAG(\n",
    "    vector_store=vector_store,\n",
    "    model='gpt-4-turbo',\n",
    "    tokenizer= None,\n",
    "    use_reranking=True  # Set to False if you don't want to use reranking\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 00:13:28,860 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: How much mango 🥭 can I eat during pregnancy?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 112.98it/s]\n",
      "2025-06-12 00:13:30,109 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I’m sorry, I can only help with pregnancy and maternal-health questions.\n"
     ]
    }
   ],
   "source": [
    "hindi_query = \"Pragnancy me mango 🥭 kitna mntra me kha skti hu\"\n",
    "result = rag_system.query(hindi_query)\n",
    "print(result[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 00:13:37,097 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: I am 7 months pregnant and the baby is moving less. Is this a cause for concern?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 83.02it/s]\n",
      "2025-06-12 00:13:46,042 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "हां, यह चिंता का विषय हो सकता है। यदि आपका बच्चा सामान्य से कम हिल रहा है, तो यह जरूरी है कि आप तुरंत अपने स्वास्थ्य सेवा प्रदाता से संपर्क करें। नवजात शिशुओं को आमतौर पर अपने हाथ या पैर हिलाने या सिर घुमाने की क्रिया कई बार एक मिनट में करनी चाहिए। कम हरकत एक चेतावनी संकेत हो सकता है और इसे गंभीरता से लेना चाहिए।\n",
      "\n",
      "कृपया इसे अनदेखा न करें और जल्द से जल्द चिकित्सा सहायता प्राप्त करें।\n"
     ]
    }
   ],
   "source": [
    "hindi_query = \"मेरे गर्भ में 7 महीने का बच्चा है और वह कम हिल रहा है। क्या यह चिंता का विषय है?\"\n",
    "result = rag_system.query(hindi_query)\n",
    "print(result[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "queries= [\"My baby weight is 452 gram in 22weeks..is this normal\",\n",
    "\"Sometimes I don’t feel the baby’s move ..is it okay or something else?\",\n",
    "\"I have seen prickly heat and itching on some part of my body... What should I do?\",\n",
    "\n",
    "\"Pragnancy me mango 🥭 kitna mntra me kha skti hu\",\n",
    "\"Bacche ko Tej Sardi ho to kaise usko maintain Karen\",\n",
    "\"Kya pregnancy m bleeding hoti h kya yeh normal h\",\n",
    "\"mujhe thyroid h to kya isse bhi breast milk pe asar hota h\",\n",
    "\"2.5 months hogae h pregnancy ko but vomet ya kch ni hora mjhe\", \n",
    "\n",
    "\"जयदा टाइम तक बैठने से चक्कर आना खड़ा होने से पेट दर्द होने लगता है\",\n",
    "\"मेरे को कौन सी टेबलेट खानी चाहिए अभी सट्टा मा लग चुका है\",\n",
    "\"सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\",\n",
    "\"I am 33 weeks pregnant and suddenly gushing bright‑red blood with sharp cramps.\",\n",
    "\"Is it safe to take 500 mg amoxicillin three times a day for my UTI?\",\n",
    "\"I’m feeling constant chest pain and can barely catch my breath at 29 weeks.\"\n",
    "\n",
    "\n",
    "\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_1822105/2194079539.py:174: LangChainDeprecationWarning: The method `BaseChatModel.__call__` was deprecated in langchain-core 0.1.7 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  response = llm(translation_prompt.format_prompt(query=query).to_messages())\n",
      "2025-06-12 02:13:17,179 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n",
      "/tmp/ipykernel_1822105/2194079539.py:285: LangChainDeprecationWarning: The method `BaseRetriever.get_relevant_documents` was deprecated in langchain-core 0.1.46 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  initial_docs = self.vector_store.as_retriever(search_kwargs=search_kwargs).get_relevant_documents(query)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: My baby weighs 452 grams at 22 weeks..is this normal\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 61.89it/s]\n",
      "/tmp/ipykernel_1822105/2194079539.py:368: LangChainDeprecationWarning: The method `Chain.run` was deprecated in langchain 0.1.0 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  answer = self.qa_prompt_chain.run({\n",
      "2025-06-12 02:13:20,343 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:13:21,474 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Sometimes I do not feel fetal movements. Is this normal or is there a concern?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 123.14it/s]\n",
      "2025-06-12 02:13:26,118 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:13:26,676 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I have observed miliaria and pruritus on some area of my body... What should I do?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 97.46it/s]\n",
      "2025-06-12 02:13:30,307 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:13:31,303 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: How much mango 🥭 can I eat during pregnancy?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 107.65it/s]\n",
      "2025-06-12 02:13:34,911 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:13:35,311 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: How to maintain a child with severe cold?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 113.62it/s]\n",
      "2025-06-12 02:13:45,843 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:13:46,668 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Does bleeding occur during pregnancy, is this normal?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 91.02it/s]\n",
      "2025-06-12 02:13:56,692 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:13:57,272 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I have thyroid, does it also affect breast milk?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 102.95it/s]\n",
      "2025-06-12 02:14:01,191 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:01,944 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: I am 2.5 months pregnant but I am not experiencing any vomiting or other symptoms.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 120.12it/s]\n",
      "2025-06-12 02:14:05,533 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:06,184 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: Sitting for a long time causes dizziness and stomach pain when standing up.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 120.61it/s]\n",
      "2025-06-12 02:14:18,004 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:18,505 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Which tablets should I take now that I have developed gestational diabetes?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 115.79it/s]\n",
      "2025-06-12 02:14:23,524 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:24,287 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: Cold and cough is occurring. It will not have any effect on the baby.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 104.34it/s]\n",
      "2025-06-12 02:14:36,445 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:36,924 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I am 33 weeks pregnant and suddenly experiencing bright-red blood gushing with sharp cramps.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 113.33it/s]\n",
      "2025-06-12 02:14:38,701 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:39,412 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Is it safe to take 500 mg of amoxicillin three times a day for my urinary tract infection (UTI)?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 96.09it/s]\n",
      "2025-06-12 02:14:42,641 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-12 02:14:43,298 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I am experiencing persistent chest pain and have difficulty breathing at 29 weeks of pregnancy.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 121.87it/s]\n",
      "2025-06-12 02:14:45,322 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    }
   ],
   "source": [
    "all_results = []\n",
    "for q in queries:\n",
    "    result = rag_system.query(q)\n",
    "    \n",
    "    # Print to console (optional)\n",
    "    # print(result[\"answer\"])\n",
    "   \n",
    "\n",
    "    # Add result to the list\n",
    "    all_results.append(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'question_original': 'My baby weight is 452 gram in 22weeks..is this normal',\n",
       "  'question_translated': 'My baby weighs 452 grams at 22 weeks..is this normal',\n",
       "  'answer': \"I don’t have enough information to answer that accurately. For specific concerns about your baby's weight and growth, it's best to consult with your healthcare provider who can provide guidance based on your individual medical history and the specifics of your pregnancy.\",\n",
       "  'sources': [{'content': '1.  We will measure your weight and blood pressure and will look for any signs of de ﬁ ciencies or disorders; since this is the last month of \\npregnancy, keep all your medical records and some cash handy\\n2.  As your baby is gaining weight you should include energy dense food items like cereals (whea...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '2. Nutrition\\nDoes the mother look well nourished? Is she anemic? If so, discuss ways of eating \\nbetter. If possible, see that she gets iron pills preferably with folic acid and vitamin C. \\nAdvise her about how to handle morning sickness (p. 248) and heartburn (p. 128).\\nIs she gaining weight normally...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': '1.  We will measure your weight and blood pressure and will look for any signs of de ﬁ ciencies or disorders\\n2.  As your baby is gaining weight, you should include energy dense food items like cereals (wheat, rice, jowar, ragi, bajra), pulses (green gram, \\nBengal gram, soyabean), milk and milk produ...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': \"1.  We will measure your weight and blood pressure and will look for any signs of de ﬁ ciencies or disorders\\n2.  Hope your nausea and vomiting are subsiding. Ensure that you eat 3 main meals and 1 nutritious snack\\n3.  As your baby's bones are hardening and teeth have also begun to form, remember to ...\",\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Or make a simple scale:\\nbricks or other \\nobjects of known \\nweight\\nWhere There Is No Doctor 2010\\n\\n251\\nEach month write down how many finger widths the \\nwomb is above or below the navel. If the womb seems \\ntoo big or grows too fast, it may mean the woman is \\nhaving twins. Or the womb may have more wat...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1.  As the 4 th month has started, we will have to repeat some of the \\ntests; your physical examination and tests will include the following:\\nMeasurements Tests Check for\\nWeight Blood hemoglobin level Pallor (conjunctiva, tongue, oral \\nmucosa and palms)\\nPalpable goitre\\nDental and skeletal fluorosis\\n...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '1. Last month you underwent a blood and urine test; this time we will only measure your weight and blood pressure\\n2. Like the last time, we will look for any signs of de ﬁ ciencies or disorders\\n3. The nausea and vomiting will continue for some more weeks; try to eat at least 3 main meals and 1 nutri...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'Sometimes I don’t feel the baby’s move ..is it okay or something else?',\n",
       "  'question_translated': 'Sometimes I do not feel fetal movements. Is this normal or is there a concern?',\n",
       "  'answer': \"It's understandable to feel concerned when you notice a decrease in your baby's movements. Fetal movements are a reliable sign of fetal well-being. Normally, you should feel about 10-12 fetal movements per day, especially after 18-22 weeks of pregnancy. If you notice that the total number of movements in all three periods (after meals) is less than 10, or if there is a significant decrease in the movement pattern, this could be an indication of fetal distress.\\n\\nHere’s what you can do:\\n1. Lie down on your left side for an hour after a meal, as this position can increase blood supply to the fetus and may encourage movement.\\n2. Count the fetal movements during this time.\\n\\nIf you find that the movements are less than 10 during these periods, it is important to seek medical attention. Contact your healthcare provider to discuss your observations and get further guidance. They may want to check the baby's heartbeat and overall health to ensure everything is progressing well.\",\n",
       "  'sources': [{'content': '5. Growth and position of the baby in the womb\\nFeel the mother’s womb each time she visits; or show her how to do it herself.\\nsigns of pre-eclampsia \\n(p. 249)\\nNormally the womb will be \\n2 fingers higher each month.\\nAt 4 ½ months it is usually \\nat the level of the navel.\\n9 months\\n8 months\\n7 months\\n6 ...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [3, 4, 5, 6, 7, 8, 9],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['third_trimester',\n",
       "       'second_trimester',\n",
       "       'first_trimester']},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Fetal head movements during labour (left  occiput anterior position)',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Figure 4: Location of FHS using foetoscope\\n\\nManagement of Normal Pregnancy, Labour and the Post-partum Period\\nMODULE I\\n23\\nFoetal movements\\nFoetal movements are a reliable sign of foetal well-being. Foetal movements, also called \\n‘quickening’ , begin at around 18–22 weeks of pregnancy. Th ey are felt...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [22],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['antenatal'],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Figure 4: Four grips to determine the foetal lie and presentation\\n\\n26\\n3. Foetal Movements:\\n ∙ Foetal movement are reliable sign of foetal well-being\\n ∙ These are felt around 18-22 weeks of pregnancy (felt earlier in multigravida than primigravida)\\n ∙ Normally 10-12 foetal movements should be felt by...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [22],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Figure 4: Four grips to determine the foetal lie and presentation\\n\\n26\\n3. Foetal Movements:\\n ∙ Foetal movement are reliable sign of foetal well-being\\n ∙ These are felt around 18-22 weeks of pregnancy (felt earlier in multigravida than primigravida)\\n ∙ Normally 10-12 foetal movements should be felt by...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [22],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1. When did the child pass urine and meconium?\\n2. Has the mother started breastfeeding the baby and are there any diffi   culties in \\nbreastfeeding?\\n3. Is there a history of problems such as the following:\\n/lozenge6 Th  e baby has fever.\\n/lozenge6 Th  e baby is not suckling well (could have ulcers o...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '• Have 8 hours of sleep at night and at least 2 hours rest during the day.\\n• Lie on your left side as it increases the blood supply to the foetus.\\n• Avoid hard work such as lifting heavy weight.\\n• Do not overexert yourself and delegate few tasks to others.\\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'I have seen prickly heat and itching on some part of my body... What should I do?',\n",
       "  'question_translated': 'I have observed miliaria and pruritus on some area of my body... What should I do?',\n",
       "  'answer': \"To address prickly heat and itching, here are some steps you can take based on the retrieved information:\\n\\n1. Keep the affected area cool and dry. Try to avoid excessive heat and humidity if possible.\\n2. Wear loose, lightweight, and breathable clothing to prevent further irritation.\\n3. Take cool baths or showers to help soothe the itching and reduce heat on the skin.\\n4. Apply a cool compress to the affected areas to help relieve discomfort.\\n\\nIf the itching persists or if you notice any signs of infection such as increased redness, swelling, or pus, it's important to consult a healthcare provider for further evaluation and treatment. Remember, keeping the skin clean and avoiding irritants can help prevent further discomfort.\",\n",
       "  'sources': [{'content': '1. Boil water and allow it to cool until you \\ncan just hold your hand in it.\\n2. Fold a clean cloth so it is slightly \\nlarger than the \\narea you want to treat, \\nwet the cloth in the hot water, and \\nsqueeze out the extra water.\\n3. Put the cloth over the affected \\nskin.\\n4. Cover the cloth with a sheet ...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'If the skin shows signs of serious infection such as:\\n•  inflammation (redness or darkening of skin around the affected areas)\\n•  swelling\\n•  pain\\n•  heat (it feels hot)\\n•  pus\\nDo the following:\\n♦  Keep the affected part still and elevate \\nit (put it higher than the rest of the \\nbody).\\n♦  Apply hot,...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': '2. At the end of each day (or more often if you work hard or walk far) examine your \\nhands and feet very carefully—or have someone else examine them. Look for cuts, \\nbruises, or thorns. Also look for spots or areas on the hands and feet that are red, hot, \\nswollen or show the beginnings of blisters....',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Signs:\\n• In small children: a red patch or rash for ms \\non the cheeks or sometimes on the arms \\nand hands. The rash consists of small sores \\nor blisters that ooze or weep (burst and leak \\nfluid).\\n• In older children and grown ups: eczema is \\nusually drier and is most common behind the \\nknees and on ...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _\\nWhen did it begin? _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ How did it begin? _ _ _ _ _ _ _ _ _ _ _ _...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'Treatment:\\n♦ Wash the affected par\\nt with soap and cooled, boiled water 3 to 4 times each day, \\ngently soaking off the crusts.\\n♦ After each washing, paint the sores with gentian violet (p. 370) or spread on an \\nantibiotic cr\\neam containing bacitracin such as Polysporin (p. 370).\\n♦ If the infection i...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '• abnormal lumps or masses\\n• unusual thinning or loss of hair, or \\n',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': None,\n",
       "   'concerns': ['nutrition']}},\n",
       " {'question_original': 'Pragnancy me mango 🥭 kitna mntra me kha skti hu',\n",
       "  'question_translated': 'How much mango 🥭 can I eat during pregnancy?',\n",
       "  'answer': 'I’m sorry, I can only help with pregnancy and maternal-health questions.',\n",
       "  'sources': [{'content': 'Role of husband during pregnancy\\n\\n36\\nRole of husband during pregnancy \\nEnsure she consumes\\nmicronutrient supplements \\nBe prepared for delivery\\nHave at least one meal in a\\nday with your wife\\nBe patient and empathetic\\nProtect your wife from \\nsecond hand smoke\\n \\nAccompany wife in ANC checkups\\nand consu...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood (Flipbook)',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '• You need to eat one extra meal a day during pregnancy. \\n• Take milk and dairy products like curd, buttermilk,  \\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '+ \\n1 katora vegetable / dal curry / egg curry + \\n1/2 small plate salad\\n\\uf097 Consume supplementary nutrition provided by the Anganwadi \\ncentres regularly along with daily diet\\n\\uf097 Consume 8-10 glasses of water daily\\n\\uf097 Pregnant women should be counselled to consume at least 3 main meals and 1 nutritious sn...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood (Flipbook)',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': ['third'],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['third_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1.  You should know your early pregnancy (1 st trimester) weight, BMI, monthly weight gain and results of all the blood and urine investigations\\n2.  As your baby’s nutrient requirements increase with progressing pregnancy, it is important to include variety of foods in your diet along with \\nroti/ric...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1.  We will measure your weight and blood pressure and will look for any signs of de ﬁ ciencies or disorders; since this is the last month of \\npregnancy, keep all your medical records and some cash handy\\n2.  As your baby is gaining weight you should include energy dense food items like cereals (whea...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5.  From next month, start consuming 1 Iron Folic Acid (IFA) tablet and 2 calcium tablets daily\\nYour baby is now the size of a lemon (nimbu); all the vital organs \\nare fully formed; the arms, hands, ﬁ ngers, feet and toes are visible \\nin an ultrasound; nails and teeth are beginning to develop\\nIf the...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [3, 4],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester', 'first_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '102.  Dwarkanath P , Muhihi A, Sudfeld CR, et al. Two Randomized Trials \\nof Low-Dose Calcium Supplementation in Pregnancy. New England \\nJournal of Medicine. 2024;390(2):143-153. doi: 10.1056/NEJMOA2307212/\\nSUPPL_FILE/NEJMOA2307212_DATA-SHARING.PDF\\n103.  Country M, Leadership G. NATIONAL PROGRAMS FOR...',\n",
       "    'metadata': {'title': 'Commodity And Service\\nDelivery Innovations For\\nDetection And Management\\nOf Pre Eclampsia\\nLandscape Report',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['postpartum'],\n",
       "      'standard_stages': ['postpartum']},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'Bacche ko Tej Sardi ho to kaise usko maintain Karen',\n",
       "  'question_translated': 'How to maintain a child with severe cold?',\n",
       "  'answer': \"When a child has a severe cold, it's important to manage their symptoms effectively and ensure they are comfortable. Here are some guidelines based on the retrieved information:\\n\\n1. **Avoid Antibiotics and Injections**: Do not give antibiotics or injections for a simple cold as they are not helpful and might cause harm.\\n\\n2. **Comfort and Rest**: Ensure the child rests in a comfortable, quiet place with plenty of fresh air. Avoid overheating or chilling the child. If the child has a fever, do not bundle them up in heavy blankets or warm clothes.\\n\\n3. **Hydration**: Encourage the child to drink plenty of fluids such as water, juices, and broths to stay hydrated.\\n\\n4. **Fever Management**: If the child has a fever, you can help reduce it by:\\n   - Keeping the child lightly clothed to prevent overheating.\\n   - Giving acetaminophen (paracetamol) in the correct dosage to help reduce the fever. Be careful not to exceed the recommended dosage.\\n   - Using cool (not cold) water to gently sponge the child if they are very hot.\\n\\n5. **Monitor Symptoms**: If the cold or flu symptoms persist for more than a week, or if the child develops additional symptoms such as a lot of phlegm, fast and shallow breathing, or chest pain, these could be signs of a more serious condition like bronchitis or pneumonia, and you should seek medical advice.\\n\\n6. **Seek Medical Help if Necessary**: If the child shows any signs of severe distress, such as difficulty breathing, high fever that doesn’t reduce, or if they become unconscious or have seizures, seek medical help immediately.\\n\\nRemember, it's important to keep a close watch on the child's symptoms and consult a healthcare provider if you have any concerns about their health.\",\n",
       "  'sources': [{'content': 'WARNING: Do not give any kind of antibiotic or injections to a child with a simple \\ncold. They will not help and may cause harm. Sometimes signs of cold are caused \\nby the polio virus, and giving the child an injection could bring on paralysis from \\npolio (see p. 314).\\nIf a cold or the flu lasts mor...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'When a person has a fever:\\n1.  Uncover him completely. Small children \\nshould be undr\\nessed completely and left \\nnaked until the fever goes down.\\n  Fre\\nsh air or a breeze will not \\nharm \\na \\nperson with fever. On the \\ncontrary, a fresh breeze helps lower the \\nfever.\\n2.  Also take aspirin to lower fev...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': '5. Give him plenty of cool (not cold) water to drink.\\n6. Give a medicine to bring down fever. Aspirin or acetaminophen works well.\\nDosage for acetaminophen or aspirin (using 300 mg. adult tablets):\\nPersons over 12 years: 2 tablets ever\\ny 4 hours\\nChildren 6 to 12 years: 1 tablet every 4 hours\\nChildre...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '1. The Comfort of the Sick Person\\nA person who is sick should \\nrest in a quiet, comfortable place \\nwith plenty of fresh air and light. He \\nshould keep from getting too hot or \\ncold. If the air is cold or the person \\nis chilled, cover him with a sheet or \\nblanket. But if the weather is hot or \\nthe pe...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'It gets worse after wearing jeans. Could it be because \\nof allergy or because they are tight?\\nQ19 \\nLight cotton clothing should be used to prevent overheating in a child with \\nfever. Do not bundle up the febrile child with heavy blankets or too many \\nwarm clothes, as they may impair heat loss from t...',\n",
       "    'metadata': {'title': 'Dental Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'If she is crying and seems unhappy, \\ngive her acetaminophen (paracetamol) or ibuprofen in \\nthe right dosage (see p. 379), and give her lots of liquids. If she is very hot and shaky\\n, wet her with cool (not cold) \\nwater and fan her. Malnutrition may cause many different problems in children, includin...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '• Keep the baby warm.\\n• Ensure care of the umbilicus, skin and eyes.\\n• Ensure good suckling while breastfeeding. \\n• Screen the newborn for danger signs.\\n• Advise the mother and family members on immunisation.\\n',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'Kya pregnancy m bleeding hoti h kya yeh normal h',\n",
       "  'question_translated': 'Does bleeding occur during pregnancy, is this normal?',\n",
       "  'answer': 'हां, गर्भावस्था में कभी-कभी हल्की ब्लीडिंग हो सकती है और यह आम बात है। हालांकि, यह हमेशा जरूरी नहीं कि यह किसी समस्या का संकेत हो। गर्भावस्था के शुरुआती दौर में हल्की ब्लीडिंग के कुछ सामान्य कारण हो सकते हैं, जैसे कि इम्प्लांटेशन ब्लीडिंग, हार्मोनल परिवर्तन, या गर्भाशय ग्रीवा में बदलाव। \\n\\nलेकिन, अगर ब्लीडिंग भारी है या इसके साथ दर्द, चकत्ते, या कोई अन्य लक्षण हैं, तो यह चिंताजनक हो सकता है और आपको तुरंत अपने स्वास्थ्य सेवा प्रदाता से संपर्क करना चाहिए। गर्भावस्था में ब्लीडिंग का कारण जानने के लिए आपका डॉक्टर अल्ट्रासाउंड और शारीरिक परीक्षण कर सकता है।\\n\\nयदि आपको ब्लीडिंग हो रही है, तो इसकी जानकारी अपने डॉक्टर को देना महत्वपूर्ण है ताकि वे आपकी स्थिति का आकलन कर सकें और उचित उपचार प्रदान कर सकें।',\n",
       "  'sources': [{'content': 'Bloody show\\n:\\n\\xa0Light bleeding mixed with mucus that occurs toward the end of your pregnancy. It can be a sign of labor.\\nMiscarriage:\\xa0\\nA loss of the pregnancy before 20 weeks. A\\xa0\\nstillbirth\\n occurs when you lose the pregnancy after 20 weeks.\\nWhat are other causes of bleeding during pregnancy?\\nOther c...',\n",
       "    'metadata': {'title': 'Giving\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [20],\n",
       "      'months': [],\n",
       "      'trimesters': ['first'],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester', 'second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '# First Trimester - Warning Signs\\n\\n## Bloody show\\n:\\n\\nBloody show\\n:\\n\\xa0Light bleeding mixed with mucus that occurs toward the end of your pregnancy. It can be a sign of labor.\\nMiscarriage:\\xa0\\nA loss of the pregnancy before 20 weeks. A\\xa0\\nstillbirth\\n occurs when you lose the pregnancy after 20 weeks.\\nWhat a...',\n",
       "    'metadata': {'title': 'First Trimester - Warning Signs',\n",
       "     'content_type': 'synthetic',\n",
       "     'pregnancy_stages': {'standard_stages': ['first_trimester']}}},\n",
       "   {'content': 'Some causes of bleeding in the first trimester of pregnancy are:\\nImplantation bleeding\\n:\\n\\xa0This is when the fertilized egg implants in the wall of your \\nuterus\\n and causes light bleeding.\\nHormonal changes:\\n The extra \\nhormones\\n you need for pregnancy can sometimes lead to spotting.\\nChanges to your \\nc...',\n",
       "    'metadata': {'title': 'Giving\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': ['first'],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Miscarriage\\n:\\n\\xa0The loss of the pregnancy before 20 weeks. It usually starts as light bleeding and gets heavier. Most people also experience strong cramping.\\nAdvertisement\\nWhat are the most common causes of bleeding in the second or third trimester?\\nBleeding in the second or third trimesters is less ...',\n",
       "    'metadata': {'title': 'Giving\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [20],\n",
       "      'months': [],\n",
       "      'trimesters': ['third'],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['third_trimester', 'second_trimester']},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Types of vaginal bleeding:\\na. Early pregnancy (before 20 weeks of pregnancy). \\nb. Late pregnancy (aft  er 20 weeks of pregnancy) or APH\\nc. PPH—blood loss of 500 ml or more following and up to six weeks aft  er delivery \\n/lozenge6 Types of PPH:\\n/circle6 Immediate PPH/primary PPH—during and within 24 ...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [20],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'Molar pregnancy\\n:\\n\\xa0A rare condition when a fertilized egg implants in your uterus, but a tumor forms instead of a fetus.\\nSubchorionic hematoma\\n:\\n\\xa0Blood forms between the amniotic sac and your uterine wall. It typically goes away without causing complications.\\nCervical polyps\\n:\\n\\xa0A noncancerous growth...',\n",
       "    'metadata': {'title': 'Giving\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '3. Vaginal Bleeding\\n ∙ Early pregnancy-before 20 weeks of pregnancy\\n ∙ Late pregnancy-after 20 weeks of pregnancy or Ante-Partum Haemorrhage (APH)\\nVaginal bleeding in early pregnancy: \\nThe probable causes could be a threatened or spontaneous abortion, an \\nectopic pregnancy or a hydatidiform mole.\\na....',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [20],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'instruction'}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': None,\n",
       "   'concerns': ['bleeding']}},\n",
       " {'question_original': 'mujhe thyroid h to kya isse bhi breast milk pe asar hota h',\n",
       "  'question_translated': 'I have thyroid, does it also affect breast milk?',\n",
       "  'answer': 'Mothers on treatment for hypothyroidism can successfully breastfeed. The medication for hypothyroidism, which is usually an artificial thyroid hormone, is very negligible in breastmilk and is considered safe for breastfeeding. It is important for your health and lactation to continue taking your thyroid medication as prescribed during breastfeeding. Adjustments to the dosage might be made by your doctor to maintain the right level of thyroid hormone in your body. Infants born to mothers on hypothyroid treatment grow well and healthy on breastfeeding. Like other mothers, you can also breastfeed successfully.',\n",
       "  'sources': [{'content': 'Nurse is supporting the \\nbaby on the breast. Initiation of \\nbreastfeeding can be done in \\nthe operating theater (OT) itself. This is also shown in Video 2. You are a wonderful mother. Early breastfeeding \\nand skin-to-skin care in the recovery room is the \\nbest start for the newborn infant. It is alw...',\n",
       "    'metadata': {'title': 'IAP Parent Guideline',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'How do I know that my milk is adequate for the baby?\\nQ7 \\nCh-039.indd   9 11-02-2021   15:58:56\\n\\n10 How to Breastfeed?\\nCan breastfeeding transmit  \\ncorona infection?\\nQ8 \\nSevere acute respiratory syndrome corona-\\nvirus 2 (SARS-CoV-2) virus, causing corona-\\nvirus disease 2019 (COVID-19), has taken \\npan...',\n",
       "    'metadata': {'title': 'IAP Parent Guideline',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Direct skin contact:\\n\\xa0\\n\\n\\n\\n\\n\\n\\n\\n\\nIntimate contact with your infant might boost milk production hormones. As much as possible, cuddle your baby.\\xa0\\n\\n\\n\\n\\n\\n\\n\\n\\nMaintain hydration and nutrition:\\n\\xa0\\n\\n\\n\\n\\n\\n\\n\\n\\nDrinking water and eating a balanced, nutritious diet supports milk production. Muesli, fenugreek and fen...',\n",
       "    'metadata': {'title': 'R Is For Rabbit',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '• Take extra calories & fluids to fulfill requirements of breast feeding. \\n• Take adequate rest. \\n• Take immediate medical help if any complication occurs in yourself \\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '6. Maintain Work Schedule\\nFor the next few months, try to maintain a strict work schedule. Talk to your manager and explore your work-from-home options. If you need to stay back at work or have work calls, check if you can take them from home. An erratic work schedule will not only affect your pumpi...',\n",
       "    'metadata': {'title': 'Select City\\nBengaluru\\nChandigarh\\nChennai\\nFaridabad\\nGurugram\\nHyderabad\\nLucknow\\nLudhiana\\nMumbai\\nNew Delhi\\nNoida\\nPanchkula\\nPune\\nSelect Services\\nMaternity\\nGynaecology\\nPaediatrics\\nIntensive Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '• Anemia in people who do not get enough iron (see p. 124).\\n• Goiter from lack of iodine (see p. 130).\\n',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': 'This is called ‘Breast Crawl’, which is helpful to baby as early initiation of breastfeeding is successfully \\nestablished for nutrition, and to the mother as it helps in uterine contraction for faster expulsion of \\nplacenta, reduce maternal blood loss and prevents anemia. CHO should support the moth...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': '2.5 months hogae h pregnancy ko but vomet ya kch ni hora mjhe',\n",
       "  'question_translated': 'Query: I am 2.5 months pregnant but I am not experiencing any vomiting or other symptoms.',\n",
       "  'answer': \"It's quite normal for some women not to experience nausea or vomiting during pregnancy. Each pregnancy is unique, and symptoms can vary widely from one person to another. If you have any concerns about your symptoms or lack thereof, it's always a good idea to discuss them with your healthcare provider during your next visit. They can provide reassurance and ensure that your pregnancy is progressing normally.\",\n",
       "  'sources': [{'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'PREGNANCY\\nSigns of pregnancy:\\nAll these signs are normal:\\n• The woman misses her period (often \\nthe first sign).\\n• ‘Morning sickness’ (nausea or feeling \\nyou are going to vomit, especially in \\nthe mor\\nning). This is worse during \\nthe second and third months of \\npregnancy.\\n• She may have to urinate m...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'list'}},\n",
       "   {'content': 'Minor Problems during Pregnancy\\n1. Nausea or vomiting:  Normally, this is worse in the morning, during the second \\nor third month of pregnancy. It helps to eat something dry, like crackers or dry bread, \\nbefore you go to bed at night and before you get out of bed in the morning. Do not \\neat large me...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '1. Last month you underwent a blood and urine test; this time we will only measure your weight and blood pressure\\n2. Like the last time, we will look for any signs of de ﬁ ciencies or disorders\\n3. The nausea and vomiting will continue for some more weeks; try to eat at least 3 main meals and 1 nutri...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': \"1.  We will measure your weight and blood pressure and will look for any signs of de ﬁ ciencies or disorders\\n2.  Hope your nausea and vomiting are subsiding. Ensure that you eat 3 main meals and 1 nutritious snack\\n3.  As your baby's bones are hardening and teeth have also begun to form, remember to ...\",\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood. Messages By Gestational Month',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5. No pulling of  the baby \\n6. No routine episiotomy\\n7. No fundal pressure\\n8.  No immediate cord \\n',\n",
       "    'metadata': {'title': 'Laqshya Labor Room Quality Improvement Initiative',\n",
       "     'content_type': 'steps',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': 'second_trimester',\n",
       "   'concerns': []}},\n",
       " {'question_original': 'जयदा टाइम तक बैठने से चक्कर आना खड़ा होने से पेट दर्द होने लगता है',\n",
       "  'question_translated': 'Query: Sitting for a long time causes dizziness and stomach pain when standing up.',\n",
       "  'answer': 'मुझे आपके वर्णित लक्षणों के बारे में पर्याप्त जानकारी नहीं है जैसे कि चक्कर आना और खड़े होने पर पेट दर्द होना, इसलिए मैं इसे सटीक रूप से उत्तर नहीं दे सकती। यदि ये लक्षण गंभीर हैं या बढ़ रहे हैं, तो कृपया तुरंत अपने स्वास्थ्य सेवा प्रदाता से संपर्क करें या निकटतम आपातकालीन विभाग में जाएँ।',\n",
       "  'sources': [{'content': 'Low backache is normal for some \\nwomen during menstrual periods or \\npregnancy (p. 248).\\nStanding or sitting wrong, \\nwith the shoulder drooped, \\nis a common cause of \\nbackache.\\nWhere There Is No Doctor 2010\\n\\n174\\nTreatment and prevention of back pain:\\n♦\\t If back pain has a cause like TB, a urinary inf...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '•\\t Gastric\\tupset\\n•\\t Excessive\\tsleepiness\\n•\\t Dizziness\\n•\\t Blurring\\tof\\tvision\\n•\\t Behavior\\tor\\tmood\\tproblems\\n•\\t Lack\\tof\\tattention\\n•\\t Increased\\tor\\tdecreased\\tappetite\\n•\\t Decreased\\tbone\\tmineral\\tdensity\\n',\n",
       "    'metadata': {'title': 'IAP Parent Guideline',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': 'Signs:\\n• Sharp pain in the stomach at the edge of the right rib cage: \\nThis pain sometimes reaches up to the right side of the \\nupper back.\\n• The pain may come an hour or more after eating rich or \\nfatty foods. Severe pain may cause vomiting.\\n• Belching or burping with a bad taste.\\n• Sometimes there...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '•  urinates (pees) often and a lot •  periods of blurry eyesight\\n•  always tired  \\n',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '•\\t Fever\\n•\\t Sleep\\tdeprivation\\n•\\t Flashing\\tlight\\tpattern\\n•\\t Fasting\\n',\n",
       "    'metadata': {'title': 'IAP Parent Guideline',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': 'Report to the doctor immediately if any alarm signs:\\n \\x81 Fever\\n \\x81 Cough\\n \\x81 Jaundice\\n \\x81 Vomiting\\n \\x81 Appetite and weight loss\\n \\x81 Increasing abdominal distention\\n \\x81 Bleeding from any sites\\n \\x81 Swelling at surgical sites',\n",
       "    'metadata': {'title': 'IAP Parent Guideline',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'CAUTION: Do not try this if the back pain is from a fall or injury.\\n♦\\t If back pain from lifting or twisting is sudden and severe with knife-like pain when \\nyou bend over, if the pain goes into the leg(s), or if a foot becomes numb \\nor weak, this is serious. A nerve coming \\nfrom the back may be ‘pin...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}}],\n",
       "  'detected_info': {'language': 'hindi', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'मेरे को कौन सी टेबलेट खानी चाहिए अभी सट्टा मा लग चुका है',\n",
       "  'question_translated': 'Which tablets should I take now that I have developed gestational diabetes?',\n",
       "  'answer': 'मुझे खेद है, मैं विशिष्ट दवा ब्रांड या प्रिस्क्रिप्शन की सिफारिश नहीं कर सकता। यदि आपको गर्भावस्था में कोई स्वास्थ्य समस्या हो रही है, तो कृपया अपने स्वास्थ्य सेवा प्रदाता से संपर्क करें जो आपकी स्थिति का आकलन कर सकते हैं और उचित उपचार की सलाह दे सकते हैं।',\n",
       "  'sources': [{'content': '12. Mohan V, Usha S, Uma R. Screening for gestational diabetes in India: where do we stand? \\nJ Postgrad Med\\n (2015) 61(3):151–4. doi:10.4103/0022-3859.159302\\n\\n\\nCrossRef Full Text\\n | \\nGoogle Scholar\\n\\n\\n\\n\\n13. Balaji V, Balaji M, Anjalakshi C, Cynthia A, Arthi T, Seshiah V. Diagnosis of gestational diab...',\n",
       "    'metadata': {'title': 'Our annual reports\\nPublishing model\\nHow we publish\\nOpen access\\nPeer review\\nResearch integrity\\nResearch Topics\\nFAIR² Data Management\\nFee policy\\nServices\\nSocieties\\nNational consortia\\nInstitutional partnerships\\nCollaborators\\nMore from Frontiers\\nFrontiers Forum\\nFrontiers Planet Prize\\nPress office\\nSustainability\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'faq'}},\n",
       "   {'content': '12.\\n \\nLanger O. (1998). Maternal glycemic criteria for insulin therapy in \\ngestational diabetes mellitus. Diabetes Care 21 (Suppl 2): B91.\\n13.\\n \\nMangesi L and Hofmeyr GJ. (2007). Fetal movement counting for \\nassessment of fetal well-being. Cochrane Database Syst Rev (\\\\): \\nCD004909.\\n14.\\n \\nMcFarland M...',\n",
       "    'metadata': {'title': 'National Guidelines',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '18. Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S, et al. Gestational diabetes mellitus – guidelines. \\nJ Assoc Physicians India\\n (2006) 54:622–8.\\n\\n\\nGoogle Scholar\\n\\n\\n\\n\\n19. Mohan V, Mahalakshmi MM, Bhavadharini B, Maheswari K, Kalaiyarasi G, Anjana RM, et al. Comparison of screening for ge...',\n",
       "    'metadata': {'title': 'Our annual reports\\nPublishing model\\nHow we publish\\nOpen access\\nPeer review\\nResearch integrity\\nResearch Topics\\nFAIR² Data Management\\nFee policy\\nServices\\nSocieties\\nNational consortia\\nInstitutional partnerships\\nCollaborators\\nMore from Frontiers\\nFrontiers Forum\\nFrontiers Planet Prize\\nPress office\\nSustainability\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '7.\\n \\nPriya, M. Anhan, R., Pradeepa, R., Jayashuri, R., Deepa, M., Bhansali, \\nA. & Mohan, V. (2011) Comparison of Capilary Whole Blood Versus \\nVenous Plasma Glucose Estimations in Screening for Diabetes \\nMellitus in Epidemiological Studies in Developing Countries. Diabetes \\nTechnology & Therapeutics,...',\n",
       "    'metadata': {'title': 'National Guidelines',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '10. Mahalakshmi MM, Bhavadharini B, Maheswari K, Anjana RM, Jebarani S, Ninov L, et al. Current practices in the diagnosis and management of gestational diabetes mellitus in India (WINGS-5). \\nIndian J Endocrinol Metab\\n (2016) 20(3):364–8. doi:10.4103/2230-8210.180001\\n\\n\\nPubMed Abstract\\n | \\nCrossRef F...',\n",
       "    'metadata': {'title': 'Our annual reports\\nPublishing model\\nHow we publish\\nOpen access\\nPeer review\\nResearch integrity\\nResearch Topics\\nFAIR² Data Management\\nFee policy\\nServices\\nSocieties\\nNational consortia\\nInstitutional partnerships\\nCollaborators\\nMore from Frontiers\\nFrontiers Forum\\nFrontiers Planet Prize\\nPress office\\nSustainability\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '25. Seshiah V, Banerjee S, Balaji V, Muruganathan A, Das AK, Diabetes Consensus G. Consensus evidence-based guidelines for management of gestational diabetes mellitus in India. \\nJ Assoc Physicians India\\n (2014) 62(7 Suppl):55–62.\\n\\n\\nPubMed Abstract\\n | \\nGoogle Scholar\\n\\n\\n\\n\\n26. Kayal A, Mohan V, Malanda...',\n",
       "    'metadata': {'title': 'Our annual reports\\nPublishing model\\nHow we publish\\nOpen access\\nPeer review\\nResearch integrity\\nResearch Topics\\nFAIR² Data Management\\nFee policy\\nServices\\nSocieties\\nNational consortia\\nInstitutional partnerships\\nCollaborators\\nMore from Frontiers\\nFrontiers Forum\\nFrontiers Planet Prize\\nPress office\\nSustainability\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '60. Jovanovic-Peterson L, Durak EP, Peterson CM. Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. \\nAm J Obstet Gynecol\\n (1989) 161(2):415–9. doi:10.1016/0002-9378(89)90534-6\\n\\n\\nPubMed Abstract\\n | \\nCrossRef Full Text\\n | \\nGoogle Scholar\\n\\n\\n...',\n",
       "    'metadata': {'title': 'Our annual reports\\nPublishing model\\nHow we publish\\nOpen access\\nPeer review\\nResearch integrity\\nResearch Topics\\nFAIR² Data Management\\nFee policy\\nServices\\nSocieties\\nNational consortia\\nInstitutional partnerships\\nCollaborators\\nMore from Frontiers\\nFrontiers Forum\\nFrontiers Planet Prize\\nPress office\\nSustainability\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'hindi', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।',\n",
       "  'question_translated': 'Query: Cold and cough is occurring. It will not have any impact on the baby.',\n",
       "  'answer': 'सर्दी-जुकाम आमतौर पर हल्का बुखार के साथ होता है और यह बच्चों पर आमतौर पर हल्का प्रभाव डालता है। हालांकि, अगर सर्दी या फ्लू एक सप्ताह से अधिक समय तक रहता है, या अगर व्यक्ति को तेज बुखार है, बहुत अधिक बलगम निकल रहा है, तेजी से सांस लेने में कठिनाई या सीने में दर्द हो रहा है, तो यह ब्रोंकाइटिस या निमोनिया का संकेत हो सकता है। इस स्थिति में, चिकित्सा सलाह लेना महत्वपूर्ण है।\\n\\nयदि बच्चे को सर्दी है और उसे इंजेक्शन देने की सोच रहे हैं, तो कृपया ऐसा न करें क्योंकि यह हानिकारक हो सकता है। कभी-कभी सर्दी के लक्षण पोलियो वायरस के कारण हो सकते हैं, और बच्चे को इंजेक्शन देने से पोलियो से पैरालिसिस हो सकता है।\\n\\nयदि आपके बच्चे को कोई अन्य गंभीर लक्षण दिखाई देते हैं जैसे कि तेज बुखार, सांस लेने में कठिनाई, या असामान्य रूप से सुस्त या उदासीन होना, तो तुरंत चिकित्सा सहायता लें।',\n",
       "  'sources': [{'content': 'WARNING: Do not give any kind of antibiotic or injections to a child with a simple \\ncold. They will not help and may cause harm. Sometimes signs of cold are caused \\nby the polio virus, and giving the child an injection could bring on paralysis from \\npolio (see p. 314).\\nIf a cold or the flu lasts mor...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'A baby may be having a colic: \\nIf the baby is crying for >3 hours of day for >3 days of the week in \\nabsence of any other cause. It is to be remembered that colic is due to baby’s temperament \\nand has nothing to do with the parenting.',\n",
       "    'metadata': {'title': 'Physiological Variations In A Newborn',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '1. When did the child pass urine and meconium?\\n2. Has the mother started breastfeeding the baby and are there any diffi   culties in \\nbreastfeeding?\\n3. Is there a history of problems such as the following:\\n/lozenge6 Th  e baby has fever.\\n/lozenge6 Th  e baby is not suckling well (could have ulcers o...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '5. No pulling of  the baby \\n6. No routine episiotomy\\n7. No fundal pressure\\n8.  No immediate cord \\n',\n",
       "    'metadata': {'title': 'Laqshya Labor Room Quality Improvement Initiative',\n",
       "     'content_type': 'steps',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '• Common cold, and other virus infections (p. 163). The fever is usually mild.\\n• Typ\\n',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '6. Jaundice\\n7. Fever\\n8. Diarrhoea\\n9. Dull and lethargic baby\\n10. Seizure \\n11. Eyes are red or infected\\n12. Any birth defects are seen\\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'steps',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '1. Where did the delivery take place?\\n2. Who conducted the delivery?\\n3. Is there a history of :\\na. any complications during the delivery?\\nb. bleeding P/V (how many pads or pieces of cloth are getting soaked with blood) \\nc. convulsions or loss of consciousness\\na. \\npain in the legs\\nd. abdominal pain\\ne...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'hindi', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'I am 33\\u202fweeks pregnant and suddenly gushing bright‑red blood with sharp cramps.',\n",
       "  'question_translated': 'I am 33 weeks pregnant and suddenly experiencing bright-red blood with sharp cramps.',\n",
       "  'answer': 'IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\\n\\nThis chatbot cannot provide emergency medical advice. Please:\\n1. Contact your healthcare provider immediately OR\\n2. Go to the nearest emergency department OR\\n3. Call your local emergency number for immediate assistance.\\n\\nDo not wait or delay seeking professional care.',\n",
       "  'sources': [{'content': 'Miscarriage\\n:\\n\\xa0The loss of the pregnancy before 20 weeks. It usually starts as light bleeding and gets heavier. Most people also experience strong cramping.\\nAdvertisement\\nWhat are the most common causes of bleeding in the second or third trimester?\\nBleeding in the second or third trimesters is less ...',\n",
       "    'metadata': {'title': 'Giving\\nCare',\n",
       "     'pregnancy_stages': {'weeks': [20],\n",
       "      'months': [],\n",
       "      'trimesters': ['third'],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['third_trimester', 'second_trimester']},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Pregnant now or within the last year?\\nGet medical care right away if you experience any of the following symptoms:\\nThese could be signs of very serious complications. If you can’t reach a healthcare provider, go to the  \\nemergency room. Be sure to tell them you are pregnant or were pregnant within t...',\n",
       "    'metadata': {'title': 'Pregnant Now Or Within The Last Year',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'Note:\\n It’s important to tell your doctor about any medical problems that you had during other pregnancies. You can also contact the best gynecologist, \\nDr. Rita Bakshi at\\xa0\\nRiSaa IVF\\n.\\n\\n\\nSymptoms of High Risk Pregnancy\\n\\n\\nThere are common symptoms of a high-risk pregnancy. These signs can indicate po...',\n",
       "    'metadata': {'title': 'Dr. Rita Bakshi',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '6. Jaundice\\n7. Fever\\n8. Diarrhoea\\n9. Dull and lethargic baby\\n10. Seizure \\n11. Eyes are red or infected\\n12. Any birth defects are seen\\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'steps',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '• BP , maternal risk factors\\n• Danger signs \\n• Blood biomarkers \\n• Ultrasound for FGR\\n',\n",
       "    'metadata': {'title': 'Commodity And Service\\nDelivery Innovations For\\nDetection And Management\\nOf Pre Eclampsia\\nLandscape Report',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': 'third_trimester',\n",
       "   'concerns': ['bleeding']}},\n",
       " {'question_original': 'Is it safe to take\\u202f500\\u202fmg amoxicillin three times a day for my UTI?',\n",
       "  'question_translated': 'Is it safe to take 500 mg of amoxicillin three times a day for my urinary tract infection (UTI)?',\n",
       "  'answer': 'Yes, taking 500 mg of amoxicillin three times a day is a common dosage for treating urinary tract infections (UTIs). However, it is crucial to follow the specific instructions provided by your healthcare provider regarding the duration and frequency of the medication. Additionally, ensure you complete the full course of antibiotics as prescribed, even if symptoms improve, to fully eradicate the infection and prevent recurrence. If you experience any adverse effects or if your symptoms do not improve within a few days of starting the medication, it is important to seek medical advice.',\n",
       "  'sources': [{'content': 'In each dose give:\\nadults: 2 capsules or 4 teaspoons (500 mg.)\\nchildren age 8 to 12: 1 capsule or  \\n2 teaspoons (250 mg.)\\nchildren 3 to 7: ½ capsule or  \\n1 teaspoon (125 mg.)\\nchildr\\nen under 3: ¼ capsule or  \\n½ teaspoon (62 mg.)\\nnewborn babies: same as for children  \\nunder 3 years\\nFor typhoid fever ...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Often comes in:\\ntablets of 200, 250, or 500 mg.  \\n Pr\\nice: __\\n______________ for __\\n_________________\\nvaginal inserts, 500 mg. \\n Pr\\nice: __\\n______________ for __\\n_________________\\nMetronidazole is useful for gut infections caused \\nby amebas, giardia, and certain bacteria, and \\nsometimes for diarrhea...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [3],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'In each dose give:\\nadults: 250 mg. (1 tablet)\\nchildren 8 to 12 years: 250 mg. (1 tablet)\\nchildren 3 to 7 years: 125 mg. (½ tablet)\\nchildren under 3 years: 62 mg. (¼ tablet)\\ndosage \\nfor giardia infection that lasts 6 months or \\nlonger:\\nadults: Give 750 mg. metronidazole 3 times \\na day for 10 days. Al...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'In each dose give:\\nadults: 750 mg. (3 tablets)\\nchildr\\nen 8 to 12 years: 500 mg. (2 tablets)\\nchildren 4 to 7 years: 375 mg. (1 ½ tablets)\\nchildren 2 to 3 years: 250 mg. (1 tablet)\\nchildren under 2 years: 80 to 125 mg. (1⁄3 to \\n½ tablet)\\nFor amebic dysentery, metronidazole should \\nbe taken together wi...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1.  For new cases of TB, give isoniazid, rifampicin, \\nethambutol, and pyrazinamide for 2 months. \\nDoses should be taken every day\\n. Then stop \\ntaking pyrazinamide and ethambutol, but \\ncontinue using rifampicin and isoniazid for \\nanother 4 months. Doses can be taken 3 times a \\nweek when using DOTS. \\n...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [2, 4],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester', 'first_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Signs:\\nWhere There Is No Doctor 2010\\n\\n235\\nMany women suffer from urinary infections. In men they are much less common. \\nSometimes the only symptoms are painful urination and the need to urinate often. \\nOther common signs are blood in the urine and pain in the lower belly. Pain in \\nthe mid or lower b...',\n",
       "    'metadata': {'title': 'Where There Is No Doctor Handbook  Hesperian',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'Usually, treatment with an \\nantibiotic is started once sample for urine \\ntesting is obtained. Symptoms should \\nimprove within 2–3 days after antibiotics \\nare started. Oral antibiotic therapy is usually \\nthe choice. Hospitalization and intravenous \\nantibiotics are used when: \\n \\x81 Child has severe infe...',\n",
       "    'metadata': {'title': 'IAP Parent Guideline',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'I’m feeling constant chest pain and can barely catch my breath at 29\\u202fweeks.',\n",
       "  'question_translated': 'I am experiencing persistent chest pain and have difficulty breathing at 29 weeks of pregnancy.',\n",
       "  'answer': 'IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\\n\\nThis chatbot cannot provide emergency medical advice. Please:\\n1. Contact your healthcare provider immediately OR\\n2. Go to the nearest emergency department OR\\n3. Call your local emergency number for immediate assistance.\\n\\nDo not wait or delay seeking professional care.',\n",
       "  'sources': [{'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'Nine danger signs during pregnancy \\nAll pregnant women should be counselled on identifying nine danger signs of pregnancy and seeking \\ndoctor’s consultation as soon as any sign is observed\\nFollowing are the danger signs and symptoms upon which the doctor should be consulted immediately\\n1. Excessive ...',\n",
       "    'metadata': {'title': 'Maternal Nutrition For Safe Motherhood (Flipbook)',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': '1. Difficulty in breathing \\n2. Inability to suck\\n3. Inablity to pass urine and stools\\n4. Umbilical stump is red or has pus\\n5. More than 10 pustules over \\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'steps',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '[Google Scholar]\\n \\n\\n\\n\\n\\n\\n\\n\\n\\nBaldisseri\\n \\nM. R.\\n, \\n. Hypertensive disorders in pregnancy. Textbook of Critical Care.\\n (\\n7th ed.\\n). Philadelphia, PA: \\nElsevier\\n; \\n2016\\n.',\n",
       "    'metadata': {'title': 'How Do I Manage Pregnancy With Pre Existing Conditions Like Diabetes Or Hypertension   Indian Journal Of Cardiovascular Disease In Women',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'faq'}},\n",
       "   {'content': '47.  WHO. WHO Recommendations on Antenatal Care for a Positive \\nPregnancy Experience.; 2016. Accessed August 16, 2024. https://\\niris.who.int/bitstream/handle/10665/250796/9789241549912-eng.\\npdf;sequence=1\\n48.  Henderson JT , Thompson JH, Burda BU, Cantor A. Preeclampsia \\nScreening: Evidence Report a...',\n",
       "    'metadata': {'title': 'Commodity And Service\\nDelivery Innovations For\\nDetection And Management\\nOf Pre Eclampsia\\nLandscape Report',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['antenatal'],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '4.  Kassebaum NJ, Barber RM, Bhutta ZA, et al. Global, regional, and \\nnational levels of maternal mortality, 1990–2015: a systematic \\nanalysis for the Global Burden of Disease Study 2015. The Lancet. \\n2016;388(10053):1775-1812. doi:10.1016/S0140-6736(16)31470-2\\n5.  Fu R, Li Y, Li X, Jiang W. Hyperte...',\n",
       "    'metadata': {'title': 'Commodity And Service\\nDelivery Innovations For\\nDetection And Management\\nOf Pre Eclampsia\\nLandscape Report',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': 'third_trimester',\n",
       "   'concerns': ['pain', 'nutrition']}}]"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "with open(\"test_docs/gpt-4-turbo.json\", \"w\", encoding=\"utf-8\") as f:\n",
    "    json.dump(all_results, f, ensure_ascii=False, indent=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_2086988/4158433042.py:449: LangChainDeprecationWarning: The method `Chain.run` was deprecated in langchain 0.1.0 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  answer = qa_direct_chain.run({\n",
      "2025-06-14 01:14:35,237 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "At 22 weeks, the average fetal weight is typically around 430 grams, although this can vary. A weight of 452 grams at this stage is within a normal range and generally not a cause for concern. It's important to continue regular prenatal check-ups with your healthcare provider. They can monitor your baby's growth and development, ensuring everything is progressing well. If you have any concerns about your pregnancy or your baby's growth, don't hesitate to discuss them with your doctor. They are there to support you throughout your pregnancy journey.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:14:41,317 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It's completely understandable to feel concerned if you notice that your baby isn't moving as much as usual. Here’s some information that might help you understand what might be happening:\n",
      "\n",
      "1. **Normal Variations in Baby Movement:**\n",
      "   - As your pregnancy progresses, the pattern of your baby's movements may change. Early in pregnancy, you might not feel every movement, and the types of movements may change as the baby grows.\n",
      "   - Babies also have sleep cycles and might be less active during certain times of the day.\n",
      "\n",
      "2. **When to Seek Medical Help:**\n",
      "   - If you are past 28 weeks and notice a significant decrease in movements or if your baby is moving much less than usual (less than 10 movements in 2 hours), it is important to seek medical attention immediately.\n",
      "   - Any sudden or drastic changes in the pattern of movements should be checked by your healthcare provider.\n",
      "\n",
      "To monitor your baby’s movements, you might find it helpful to pick a quiet time each day to feel for movements. Lying on your left side can sometimes make it easier to feel movements. If you're ever in doubt about your baby's movements, it's always best to consult with your healthcare provider for reassurance and to ensure everything is progressing well. Remember, it’s always better to check and be reassured than to worry!\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:14:47,481 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prickly heat, also known as heat rash, is quite common during pregnancy due to hormonal changes and increased sweating. It usually appears as small, itchy red bumps on the skin, particularly in areas where sweat accumulates like under the breasts, the abdomen, or in skin folds.\n",
      "\n",
      "Here are some simple steps you can take to alleviate the discomfort:\n",
      "\n",
      "1. **Keep Cool**: Try to stay in cooler environments and use fans or air conditioning to help reduce sweating.\n",
      "2. **Wear Loose Clothing**: Opt for loose, lightweight, and breathable clothing to minimize skin irritation and allow your skin to breathe.\n",
      "3. **Hydrate**: Drink plenty of water throughout the day to help regulate your body temperature.\n",
      "4. **Bathe Regularly**: Taking cool baths or showers can help soothe the itchiness and keep your skin clean.\n",
      "5. **Use Calamine Lotion**: Applying calamine lotion to the affected areas can provide relief from itching.\n",
      "\n",
      "While prickly heat is generally not serious, you should watch for signs of infection such as increased pain, swelling, redness, or warmth around the affected areas, or if you develop a fever. If you notice any of these symptoms, it's important to contact your healthcare provider.\n",
      "\n",
      "Remember, it's always a good idea to discuss any new or worsening symptoms with your doctor, especially during pregnancy. They can provide guidance tailored to your specific health needs.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:14:53,376 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mango ek swadisht aur poshtik fal hai jo pregnancy ke dauran khaaya ja sakta hai, lekin iska sewan santulit matra mein hona chahiye. Aam mein vitamin C aur vitamin A jaise mahatvapurn poshak tatv hote hain jo garbhavastha ke dauran aavashyak hote hain. Lekin, yeh dhyaan rakhna zaroori hai ki aam mein chini ki matra bhi adhik hoti hai, isliye ise adhik matra mein khana uchit nahi hai.\n",
      "\n",
      "Ek samanya niyam ke roop mein, aap din mein ek ya do chhote aam ya aam ke kuch tukde kha sakte hain. Agar aapko diabetes ya koi anya swasthya sambandhi samasya hai, to aapko apne doctor se salah leni chahiye ki aap kitna aam kha sakte hain.\n",
      "\n",
      "Yadi aapko pregnancy ke dauran kisi bhi prakar ki allergy ya asahajta mehsoos hoti hai jab aap aam khate hain, to iska sewan band kar den aur apne doctor se sampark karen.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:03,357 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Jab bacche ko tej sardi ho, toh yeh samajhna zaroori hai ki thoda bukhar aur sardi flu jaise common symptoms hain, lekin kuch baatein dhyan mein rakhni chahiye taaki aapka baccha jaldi se aaram pa sake:\n",
      "\n",
      "1. **Garmi aur Aaram**: Bacche ko garm rakhein. Halka aur araamdayak kapde pehnayein jo garmi provide karein.\n",
      "\n",
      "2. **Hydration**: Bacche ko paryapt matra mein taral padarth de. Agar wo breastfeeding kar raha hai, toh regular intervals par feed karein. Chhote baccho ke liye, doctor ki salah se ORS (Oral Rehydration Solution) ka upyog kar sakte hain.\n",
      "\n",
      "3. **Room ka Temperature**: Kamre ka taapman na bahut zyada garm ho aur na hi bahut thanda. Ek samanya, comfortable environment maintain karein.\n",
      "\n",
      "4. **Nasal Drops**: Agar bacche ki naak band hai, toh saline nasal drops ka istemal kar sakte hain, jo ki pharmacy mein easily available hote hain. Ye bacche ki naak ko saaf karne mein madad karte hain.\n",
      "\n",
      "5. **Aaraam**: Bacche ko puri neend lene dein. Thakan aur bechaini ko kam karne ke liye chup chap environment provide karein.\n",
      "\n",
      "6. **Dhyan Dene Yogya Lakshan**: Agar bacche ko tez bukhar hai (100.4°F ya usse zyada), saans lene mein dikkat, chest mein pain, continuous ro raha hai, ya feed nahi kar pa raha hai, toh turant doctor se sampark karein. Ye gambhir lakshan ho sakte hain jo turant medical attention ki maang karte hain.\n",
      "\n",
      "Bacche ki dekhbhal mein sabse mahatvapurn baat hai ki aap alert rahein aur kisi bhi asamanya lakshan ya badlav par dhyan dein. Agar aapko kisi bhi tarah ki chinta ho rahi ho toh bina deri kiye pediatrician se consult karein.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:10,233 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pregnancy mein kabhi-kabhi halki bleeding ya spotting ho sakti hai, jo aksar pehle trimester mein hoti hai aur ise implantation bleeding kehte hain. Yeh tab hota hai jab fertilized egg uterus ke lining mein embed hota hai. Halki spotting ko agar koi aur symptoms nahi accompany karte, toh yeh normal ho sakta hai.\n",
      "\n",
      "Lekin, agar bleeding heavy hai ya phir uske saath dard, chakkar aana, ya tissue passing jaise symptoms hain, toh yeh chinta ka vishay ho sakta hai aur turant medical help leni chahiye. Yeh early miscarriage ya ectopic pregnancy ka sanket ho sakta hai, jo ki serious conditions hain.\n",
      "\n",
      "Agar aapko bleeding ho rahi hai, toh aapko apne doctor se sampark karna chahiye taaki woh sthiti ka sahi mulyankan kar sakein aur aapko zaroori salah de sakein. Yeh hamesha behtar hota hai ki aap surakshit rahen aur kisi bhi tarah ki chinta ya anishchitata se bachne ke liye professional ki salah lein.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:17,549 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Thyroid ki samasya hone se breast milk par asar pad sakta hai, lekin ye har kisi ke liye alag hota hai. Agar aapka thyroid underactive hai (hypothyroidism) ya overactive hai (hyperthyroidism), to iska prabhav aapke doodh ke utpadan par pad sakta hai. Hypothyroidism ke karan kabhi-kabhi doodh banane mein kami aa sakti hai. \n",
      "\n",
      "Yadi aap thyroid ki dawai le rahe hain, to yah mahatvapurn hai ki aap apne doctor se niyamit roop se jaanch karwaye taki aapka thyroid level sahi rahe. Sahi dawai aur dosage se, aapka milk production bhi normal ho sakta hai.\n",
      "\n",
      "Agar aapko lagta hai ki aapka milk production kam ho raha hai ya koi aur samasya hai, to kripya apne doctor ya lactation consultant se baat karein. Ve aapko sahi margdarshan de sakenge. Yadi aapke breast milk mein koi badlav ya kam production ki chinta hai, to iska samadhan zaroori hai, lekin aksar iska ilaj sambhav hai.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:22,073 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n",
      "/tmp/ipykernel_2086988/4158433042.py:174: LangChainDeprecationWarning: The method `BaseChatModel.__call__` was deprecated in langchain-core 0.1.7 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  response = llm(translation_prompt.format_prompt(query=query).to_messages())\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Aapko chinta karne ki zarurat nahi hai. Har mahila ki pregnancy alag hoti hai, aur kuch mahilao ko pehle trimester mein ulti ya matli (nausea) nahi hoti. Yeh bilkul normal hai. Aapka sharir aapki pregnancy ke anusaar hi react kar raha hai.\n",
      "\n",
      "Lekin, aapko apne swasthya ka dhyan rakhna chahiye. Achhi tarah se aahar lein, paryapt paani piyein, aur niyamit roop se apne doctor se check-up karwayein. Agar aapko koi chinta ya sawal ho to apne doctor se baat karna na bhulein. Yadi aapko koi asamanya lakshan mehsoos ho, jaise ki tez pet dard, bleeding ya koi aur gambhir samasya, to turant medical madad lein.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:22,502 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n",
      "2025-06-14 01:15:43,179 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "गर्भावस्था के दौरान लंबे समय तक बैठने से चक्कर आना और खड़े होने पर पेट में दर्द होना कुछ हद तक सामान्य हो सकता है, क्योंकि आपका शरीर बदल रहा है और रक्त संचार में भी परिवर्तन हो रहा है। हालांकि, यह महत्वपूर्ण है कि आप इन लक्षणों को हल्के में न लें, खासकर अगर ये बार-बार या गंभीर हों।\n",
      "\n",
      "1. **चक्कर आना**: यह निम्न रक्तचाप या निर्जलीकरण के कारण हो सकता है। अच्छी तरह से हाइड्रेटेड रहें और धीरे-धीरे उठने की कोशिश करें।\n",
      "\n",
      "2. **पेट दर्द**: यह गर्भावस्था में आम है क्योंकि आपका गर्भाशय बढ़ रहा है और आसपास के ऊतकों और नसों पर दबाव डाल रहा है। हालांकि, अगर दर्द तीव्र है या असहनीय है, तो यह चिंता का विषय हो सकता है।\n",
      "\n",
      "**कब चिकित्सा सहायता लेनी चाहिए**:\n",
      "- अगर चक्कर आना लगातार हो रहा है या आपको बेहोशी महसूस होती है।\n",
      "- अगर पेट दर्द तीव्र है, लगातार बना रहता है, या अन्य लक्षणों के साथ हो, जैसे कि ब्लीडिंग, बुखार, या चकत्ते।\n",
      "\n",
      "इन लक्षणों को नजरअंदाज न करें और अपने डॉक्टर से सलाह लें ताकि वे आपकी स्थिति का आकलन कर सकें और उचित उपचार प्रदान कर सकें। स्वस्थ रहने के लिए नियमित रूप से चेकअप करवाना और अपने शरीर के संकेतों को समझना जरूरी है।\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:43,759 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n",
      "2025-06-14 01:15:50,489 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "मुझे खेद है, मैं दवाओं के बारे में विशेष सलाह या सिफारिश नहीं दे सकती। यदि आपको किसी विशेष स्थिति के लिए दवा की आवश्यकता है, तो कृपया एक योग्य डॉक्टर से संपर्क करें जो आपकी स्थिति का मूल्यांकन कर सके और उचित दवा की सिफारिश कर सके। यदि आपको कोई आपातकालीन स्थिति है, तो कृपया तुरंत चिकित्सा सहायता प्राप्त करें।\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:15:51,119 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n",
      "2025-06-14 01:16:11,047 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "सर्दी-जुकाम होना गर्भावस्था में आम बात है और आमतौर पर यह बच्चे पर कोई नकारात्मक प्रभाव नहीं डालता। हालांकि, यह महत्वपूर्ण है कि आप अपनी सेहत का ख्याल रखें और अगर आपको बुखार आता है या सर्दी-जुकाम लंबे समय तक बना रहता है, तो आपको डॉक्टर से सलाह लेनी चाहिए।\n",
      "\n",
      "यहाँ कुछ सामान्य सुझाव दिए जा रहे हैं जो आपको राहत दे सकते हैं:\n",
      "1. पर्याप्त आराम करें और खूब पानी पिएं।\n",
      "2. गर्म पानी की भाप लेना भी मददगार हो सकता है।\n",
      "3. संतुलित आहार लें जिसमें ताजे फल और सब्जियाँ शामिल हों।\n",
      "\n",
      "अगर आपको निम्नलिखित लक्षण दिखाई दें, तो तुरंत चिकित्सा सहायता लें:\n",
      "- तेज बुखार\n",
      "- सांस लेने में कठिनाई\n",
      "- छाती में दर्द\n",
      "- गंभीर सिरदर्द\n",
      "- लगातार उल्टी\n",
      "\n",
      "ये लक्षण अधिक गंभीर स्थिति की ओर इशारा कर सकते हैं और इन्हें अनदेखा नहीं करना चाहिए। अपनी देखभाल करें और स्वस्थ रहें।\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:16:13,538 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It's very important that you seek medical help immediately. Gushing bright-red blood and experiencing sharp cramps at 33 weeks pregnant could be signs of a serious condition, such as placental abruption or preterm labor. These conditions require urgent attention from healthcare professionals.\n",
      "\n",
      "Please go to the nearest hospital or call your healthcare provider right away. It's essential to get checked by a medical professional to ensure the safety of both you and your baby.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:16:18,167 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It's important to consult with your healthcare provider before starting any medication, including antibiotics like amoxicillin, especially during pregnancy. Amoxicillin is commonly prescribed for urinary tract infections (UTIs), and the dosage you mentioned is typical, but the safety and appropriateness of this medication for your specific situation should be confirmed by a doctor who knows your medical history and pregnancy details.\n",
      "\n",
      "Taking antibiotics without proper medical guidance can lead to resistance, ineffective treatment, or unexpected side effects. If you're experiencing symptoms of a UTI, such as pain or burning during urination, frequent urination, or cloudy urine, it's important to talk to your healthcare provider. They can confirm the infection through appropriate tests and recommend the best treatment.\n",
      "\n",
      "If you have already been prescribed this medication by your healthcare provider, it's important to take it exactly as prescribed and complete the full course, even if you start feeling better before finishing the medication. If you experience any side effects or new symptoms, or if your symptoms do not improve, contact your healthcare provider immediately.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-14 01:16:21,207 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It's important to take chest pain and difficulty breathing seriously, especially during pregnancy. These symptoms can sometimes indicate a more serious condition that needs immediate medical attention.\n",
      "\n",
      "Please seek medical help right away by going to the nearest emergency room or calling your healthcare provider. It's essential to rule out any conditions that could be harmful to you or your baby.\n",
      "\n",
      "While some breathlessness can be normal due to the growing uterus pressing against your diaphragm, constant chest pain and severe difficulty breathing are not typical and should be evaluated by a healthcare professional immediately.\n",
      "\n",
      "Stay safe and please don't hesitate to seek help.\n"
     ]
    }
   ],
   "source": [
    "all_results = []\n",
    "for q in queries:\n",
    "    result = rag_system.query_without_rag(q)\n",
    "    \n",
    "    # Print to console (optional)\n",
    "    print(result[\"answer\"])\n",
    "   \n",
    "\n",
    "    # Add result to the list\n",
    "    all_results.append(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"test_docs/gpt-4-turbo_no_rag.json\", \"w\", encoding=\"utf-8\") as f:\n",
    "    json.dump(all_results, f, ensure_ascii=False, indent=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading checkpoint shards:  75%|███████▌  | 3/4 [00:13<00:04,  4.60s/it]"
     ]
    },
    {
     "ename": "",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31mThe Kernel crashed while executing code in the current cell or a previous cell. \n",
      "\u001b[1;31mPlease review the code in the cell(s) to identify a possible cause of the failure. \n",
      "\u001b[1;31mClick <a href='https://aka.ms/vscodeJupyterKernelCrash'>here</a> for more info. \n",
      "\u001b[1;31mView Jupyter <a href='command:jupyter.viewOutput'>log</a> for further details."
     ]
    }
   ],
   "source": [
    "from transformers import AutoModelForCausalLM, AutoTokenizer, pipeline\n",
    "import torch\n",
    "model_name =  \"/data/models/huggingface/meta-llama/Meta-Llama-3-8B-chat\"\n",
    "\n",
    "tokenizer = AutoTokenizer.from_pretrained(model_name)\n",
    "model = AutoModelForCausalLM.from_pretrained(\n",
    "            model_name\n",
    "        ).to(\"cuda\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cuda:0\n",
      "2025-06-14 00:48:22,724 - INFO - Use pytorch device: cuda\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Initialized reranker model: cross-encoder/ms-marco-MiniLM-L-6-v2\n"
     ]
    }
   ],
   "source": [
    "rag_system = EnhancedMedicalRAG(\n",
    "    vector_store=vector_store,\n",
    "    model=model,\n",
    "    tokenizer=tokenizer_mixstral,\n",
    "    use_reranking=True  # Set to False if you don't want to use reranking\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_2057070/2194079539.py:173: LangChainDeprecationWarning: The class `ChatOpenAI` was deprecated in LangChain 0.0.10 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-openai package and should be used instead. To use it run `pip install -U :class:`~langchain-openai` and import as `from :class:`~langchain_openai import ChatOpenAI``.\n",
      "  llm = ChatOpenAI(model_name=\"gpt-3.5-turbo\", temperature=0)\n",
      "/tmp/ipykernel_2057070/2194079539.py:174: LangChainDeprecationWarning: The method `BaseChatModel.__call__` was deprecated in langchain-core 0.1.7 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  response = llm(translation_prompt.format_prompt(query=query).to_messages())\n",
      "2025-06-13 19:04:51,390 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n",
      "/tmp/ipykernel_2057070/2194079539.py:285: LangChainDeprecationWarning: The method `BaseRetriever.get_relevant_documents` was deprecated in langchain-core 0.1.46 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  initial_docs = self.vector_store.as_retriever(search_kwargs=search_kwargs).get_relevant_documents(query)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: My baby weighs 452 grams at 22 weeks...is this normal?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 11.99it/s]\n",
      "/tmp/ipykernel_2057070/2194079539.py:368: LangChainDeprecationWarning: The method `Chain.run` was deprecated in langchain 0.1.0 and will be removed in 1.0. Use :meth:`~invoke` instead.\n",
      "  answer = self.qa_prompt_chain.run({\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"Thank you for your question. According to the information provided, your baby's weight is lower than the average for 22 weeks. Typically, a baby at 22 weeks should weigh around 450 to 500 grams. However, every baby is unique and may not follow the exact growth pattern. It is important to monitor your baby's growth regularly through ultrasounds and prenatal check-ups. If you have concerns about your baby's weight, please discuss them with your healthcare provider. They can provide you with accurate information based on your specific situation and may recommend additional monitoring or interventions if necessary. In the meantime, ensure you are eating a balanced diet with plenty of nutrient-dense foods to support your baby's growth. This includes cereals, pulses, milk and milk products, cooking oils, nuts and oilseeds, and jaggery. Also, consider including calcium-rich foods such as milk, curd, paneer, ragi, sesame seeds, bathua leaves, and methi leaves in your diet. If you need further assistance, please don't hesitate to ask.\"\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:05:24,146 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Sometimes I do not feel fetal movements. Is this normal or is there a concern?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 116.50it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It's normal for the baby's movements to change as they grow and have less space in the womb. However, if you notice a significant decrease in your baby's movements or if you're concerned, it's important to consult your healthcare provider. They can check the baby's heartbeat and movement to ensure everything is okay. Generally, it's recommended to feel at least 10 movements in a day. If you're unsure, you can lie down on your left side for an hour, three times a day after meals, and count the number of movements. If the total number of movements in all three periods is less than 10, you should consult your healthcare provider. Remember, it's always better to be safe and seek professional advice if you have any concerns about your baby's movements.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:05:47,436 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I have observed miliaria and pruritus on some area of my body... What should I do?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 106.08it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prickly heat and itching can be caused by various factors, including heat rash, eczema, or infection. To help relieve these symptoms, you can try the following steps:\n",
      "1. Apply cold compresses to the affected area to reduce itching and inflammation.\n",
      "2. If the affected area is exposed to sunlight, protect it from direct sunlight.\n",
      "3. If the affected area is usually covered by clothing, expose it to direct sunlight for 10 to 20 minutes, 2 or 3 times a day.\n",
      "4. Keep the affected area clean and dry.\n",
      "5. If the symptoms are caused by a heat rash, wear loose-fitting clothing to allow air circulation and prevent sweating.\n",
      "6. If the symptoms are caused by eczema, avoid scratching the affected area and use a cortisone or corticosteroid cream as directed by a healthcare professional.\n",
      "7. If the symptoms are caused by an infection, keep the affected area still and elevated, apply hot, moist cloths, and seek medical advice if necessary.\n",
      "Remember, if the symptoms persist, worsen, or are accompanied by fever, pain, or other signs of infection, seek medical attention immediately.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:06:19,184 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: How much mango 🥭 can I eat during pregnancy?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 100.09it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mango is a yellow/orange pulpy fruit and is safe to eat during pregnancy. It is rich in Vitamin A which is beneficial for both the mother and the baby. However, it is recommended to consume all fruits in moderation as part of a balanced diet. Do not consume more than 2-3 pieces of mango in a day. Also, ensure to maintain good oral hygiene as excessive consumption of mango can lead to tooth decay.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:06:31,586 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: How to maintain a child with severe cold?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 127.72it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Bacche ko Tej Sardi mein maintain karna ek safal tarika hai unhein light cotton ke kapdon mein pahanne ke saath, unhein kisi ek aise jagah par rakhe jahan aise hawa hai jise unhein thandi nahi lagti. Unhein bhi plenty of liquids pilaye jaise ki paani, chai, juice, broth etc. Unhein bhi acetaminophen (paracetamol) ya ibuprofen diye jismein right dosage hai aur unhein bahut se liquids diye jaise ki paani. Agar wo bahut garam hai aur thandi hawa chahiye to unhein cool (not cold) paani se dho diye aur unhein fan kare. Malnutrition baccho mein kai prakaar ke problem paida kar sakti hai, jaise ki:\n",
      "\n",
      "• Bacche ko thandi rakhe.\n",
      "• Unki umbilicus, skin aur eyes ka khayal rakhe.\n",
      "• Unhein acchi tarah suckle kare jab bhi wo breastfeeding karte hain.\n",
      "• Unhein dangerous signs ka check kare.\n",
      "• Maata aur family members ko unke baare mein immunisation ke bare mein bataye.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:07:29,564 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Does bleeding occur during pregnancy, is this normal?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 81.25it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Bleeding during pregnancy can be normal, but it's important to let your healthcare provider know, especially if you're unsure if it's spotting or bleeding. There are several causes of spotting that aren't worrisome, but some are. Bleeding that resembles your period isn't typical during pregnancy. Bleeding isn't always a sign that something is wrong, but heavy bleeding may mean there's a complication. Your pregnancy care provider will want to know what your blood looks like. Some details you'll want to track include:\n",
      "\n",
      "The color of your blood: Is your blood brown, pink or bright red?\n",
      "The consistency of your blood: Is it smooth, thick or watery? Does it contain clots or mucus?\n",
      "How much blood there is: Did you see a few drops? Does it happen only when you wipe? Or are you filling a pad?\n",
      "These details can help your provider determine the level of care you need and how urgent your symptoms are. It's always a good idea to call your provider so they can determine if the bleeding is serious.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:08:28,450 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: I have thyroid, does it also affect breast milk?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 97.67it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Thyroid hormone is very important for a healthy body and brain at all ages. It is secreted by the thyroid gland which lies in the neck. Underproduction of thyroid hormone leads to a condition called hypothyroidism. If a mother is taking medicine (artificial thyroid hormone) during pregnancy for low thyroid hormone production, then she should continue taking it during breastfeeding. This is important, both for her own health and lactation. The dose of the medicine may be adjusted by the doctor for maintaining adequate concentration of the thyroid hormone in your body. Mothers on treatment for hypothyroidism can successfully breastfeed. Very negligible amount of thyroid hormone including thyroid medicine is secreted in the breastmilk. It is absolutely safe to breastfeed while taking medicines for hypothyroidism. Infants born to mothers on hypothyroid treatment grow well and healthy on breastfeeding. Like other mothers you can also breastfeed successfully.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:08:53,755 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: I am 2.5 months pregnant but I am not experiencing any vomiting or other symptoms.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 118.14it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"Thank you for sharing your concern. It's normal to experience nausea or vomiting during pregnancy, especially in the first trimester. However, if you haven't experienced any vomiting, that's okay too. Every pregnancy is unique. Here are a few suggestions to help with nausea:\n",
      "\n",
      "1. Eat small, frequent meals throughout the day instead of three large meals.\n",
      "2. Avoid greasy, spicy, or fatty foods.\n",
      "3. Try eating bland or dry foods, like crackers or dry toast, before getting out of bed in the morning.\n",
      "4. Drink plenty of fluids, but try sipping them slowly throughout the day instead of gulping down large amounts at once.\n",
      "5. Ginger, in forms like tea or candies, can help reduce nausea.\n",
      "\n",
      "If your nausea becomes severe, persistent, or is accompanied by other symptoms like fever, severe abdominal pain, or decreased urination, please contact your healthcare provider immediately. It's important to ensure that you and your baby are healthy.\"\n",
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:09:21,595 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: Sitting for a long time causes dizziness and stomach pain when standing up.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 127.55it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\"\n",
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:09:30,747 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Which tablets should I take now that I have developed gestational diabetes?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 109.42it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I’m sorry, I can only help with pregnancy and maternal-health questions. I cannot provide any specific drug brand or prescription recommendations. It's important to consult with your healthcare provider for personalized medical advice.\n",
      "Detected language: hindi\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:09:37,223 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Query: Cold and cough is occurring. It will not have any impact on the baby.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 128.75it/s]\n",
      "You seem to be using the pipelines sequentially on GPU. In order to maximize efficiency please use a dataset\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"सर्दी के लक्षण में बच्चे पर कोई प्रभाव  नहीं  होगा। सर्दी के लक्षण होने के बाद अगर बच्चे का सूखा होना अधिक हो जाता है, तो उसे सही प्रकार से रोजगार कराना चाहिए। सर्दी के लक्षण 1 सप्ताह तक चले रहे हैं, तो उसे सही दवा देनी चाहिए। सर्दी के लक्षण से बाद में ब्रोंकिटिस या प्नीऊमोनिया शुरू हो सकती है। ब्रोंकिटिस या प्नीऊमोनिया के लक्षण में बच्चे का सूखा होना अधिक हो जाता है, उसे सही प्रकार से रोजगार कराना चाहिए। ब्रोंकिटिस या प्नीऊमोनिया के लक्षण में बच्चे का सूखा होना अधिक हो जाता है, उसे सही प्रकार से रोजगा\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:10:36,309 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I am 33 weeks pregnant and suddenly experiencing bright-red blood with sharp cramps.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 106.93it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\n",
      "\n",
      "\n",
      "Question:\n",
      " I am 33 weeks pregnant and suddenly gushing bright‑red blood with sharp cramps.\n",
      "Answer:\n",
      " IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\n",
      "\n",
      "\n",
      "Question:\n",
      " I am 33 weeks pregnant and suddenly gushing bright‑red blood with sharp cramps.\n",
      "Answer:\n",
      " IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\n",
      "\n",
      "\n",
      "Question:\n",
      " I am 33 weeks pregnant and suddenly gushing bright‑red blood with sharp cramps.\n",
      "Answer:\n",
      " IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\n",
      "\n",
      "\n",
      "Question:\n",
      " I am 33 weeks pregnant and suddenly gushing bright‑red blood with sharp cramps.\n",
      "Answer:\n",
      " IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\n",
      "\n",
      "\n",
      "Question:\n",
      " I am 33�\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:11:35,009 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: Is it safe to take 500 mg of amoxicillin three times a day for my urinary tract infection (UTI)?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 92.14it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Yes, it is safe to take 500 mg amoxicillin three times a day for your UTI. However, make sure to complete the full course of medication as prescribed by your doctor, even if you start feeling better. Also, drink plenty of fluids to help flush out the bacteria from your urinary tract. If you have any concerns or if your symptoms do not improve after a few days, contact your healthcare provider.\n",
      "Detected language: english\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-13 19:11:46,862 - INFO - HTTP Request: POST https://api.openai.com/v1/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Translated question: I am experiencing persistent chest pain and have difficulty breathing at 29 weeks of pregnancy.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches: 100%|██████████| 1/1 [00:00<00:00, 115.18it/s]\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:629: UserWarning: `do_sample` is set to `False`. However, `temperature` is set to `0.25` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `temperature`.\n",
      "  warnings.warn(\n",
      "/home/vidhij2/.local/lib/python3.9/site-packages/transformers/generation/configuration_utils.py:634: UserWarning: `do_sample` is set to `False`. However, `top_p` is set to `0.95` -- this flag is only used in sample-based generation modes. You should set `do_sample=True` or unset `top_p`.\n",
      "  warnings.warn(\n",
      "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"IMPORTANT: This appears to be an emergency situation that requires immediate medical attention.\n",
      "\n",
      "This chatbot cannot provide emergency medical advice. Please:\n",
      "1. Contact your healthcare provider immediately OR\n",
      "2. Go to the nearest emergency department OR\n",
      "3. Call your local emergency number for immediate assistance.\n",
      "\n",
      "Do not wait or delay seeking professional care.\"\n"
     ]
    }
   ],
   "source": [
    "all_results = []\n",
    "for q in queries:\n",
    "    result = rag_system.query(q)\n",
    "    \n",
    "    # Print to console (optional)\n",
    "    print(result[\"answer\"])\n",
    "   \n",
    "\n",
    "    # Add result to the list\n",
    "    all_results.append(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cuda:0\n"
     ]
    }
   ],
   "source": [
    "pipe = pipeline(\n",
    "        \"text-generation\",\n",
    "        model=model,\n",
    "        tokenizer=tokenizer,\n",
    "        max_length=512,       # Limit output size\n",
    "        batch_size=1,         # Process one at a time\n",
    "        device_map=\"auto\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'question_original': 'My baby weight is 452 gram in 22weeks..is this normal',\n",
       "  'question_translated': 'My baby weighs 452 grams at 22 weeks..is this normal',\n",
       "  'answer': '1.  As the 4 th month has started, we will have to repeat some of the \\ntests; your physical examination and tests will include the following:\\nMeasurements Tests Check for\\nWeight Blood hemoglobin level Pallor (conjunctiva, tongue, oral \\nmucosa and palms)\\nPalpable goitre\\nDental and skeletal fluorosis\\nPedal edema or pufﬁ ness of face\\nBlood pressure Urine sugar and albumin\\n2.  As your baby is rapidly increasing in size now, eat at least 3 main \\nmeals and 2 nutritious snacks to meet the increased nutrient \\nrequirements to ensure proper growth and development of the baby\\n\\n• Jaundice is NOT NORMAL if\\n- It has appeared at < 24 hrs. of  age\\n- Palms and soles are stained\\n\\n\\n5. Check the baby’s temperature every hour until normal.\\n\\n27\\n/head2rightCase Study 8: (Ask the trainee to write down the answers to the questions asked in relevant\\nsession of  the Handbook. The suggestive answers have been given here for your reference.)\\nA) B/o Karuna is 3 days old, taking feeds well and fit for discharge.\\nWhat advise will you give to the mother on discharge?\\n1. Exclusive breast feeding for 6 months\\n2. Keep the baby warm\\n3. Follow immunization schedule as per UIP (i.e. National Schedule)\\n\\nA health care provider can be reasonably certain that a patient is not pregnant if the patient has no symptoms or signs of pregnancy and meets\\nany one of the following criteria:\\nIs ≤7 days after the start of normal menses.\\nHas not had sexual intercourse since the start of last normal menses.\\nHas been correctly and consistently using a reliable method of contraception.\\nIs ≤7 days after spontaneous or induced abortion.\\nIs within 4 weeks postpartum.\\nIs fully or nearly fully breastfeeding (exclusively breastfeeding or the vast majority [≥85%] of feeds are breastfeeds), amenorrheic, and <6\\nmonths postpartum.\\nSOURCES\\n[58]\\n[59]\\n[33]\\nTABLE OF CONTENTS | SUMMARY FOR U.S. SPR, 2024\\nSHOW MORE\\n\\nThe four basic needs of ALL newborns at the time of birth and for the first few weeks of life are:\\n1. To be warm\\n2. To breathe normally\\n3. To be protected (against infection)\\n4. To be fed\\nPrepare equipment and supplies for care of',\n",
       "  'sources': [{'content': '1.  As the 4 th month has started, we will have to repeat some of the \\ntests; your physical examination and tests will include the following:\\nMeasurements Tests Check for\\nWeight Blood hemoglobin level Pallor (conjunctiva, tongue, oral \\nmucosa and palms)\\nPalpable goitre\\nDental and skeletal fluorosis\\n...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '• Jaundice is NOT NORMAL if\\n- It has appeared at < 24 hrs. of  age\\n- Palms and soles are stained\\n',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '5. Check the baby’s temperature every hour until normal.\\n\\n27\\n/head2rightCase Study 8: (Ask the trainee to write down the answers to the questions asked in relevant\\nsession of  the Handbook. The suggestive answers have been given here for your reference.)\\nA) B/o Karuna is 3 days old, taking feeds wel...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'A health care provider can be reasonably certain that a patient is not pregnant if the patient has no symptoms or signs of pregnancy and meets\\nany one of the following criteria:\\nIs ≤7 days after the start of normal menses.\\nHas not had sexual intercourse since the start of last normal menses .\\nHas be...',\n",
       "    'metadata': {'title': 'How To Be Reasonably Certain That A Patient Is Not Pregnant   Contraception   Cdc',\n",
       "     'pregnancy_stages': {'weeks': [4],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['postpartum'],\n",
       "      'standard_stages': ['first_trimester',\n",
       "       'second_trimester',\n",
       "       'postpartum']},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'The four basic needs of ALL newborns at the time of birth and for the first few weeks of life are:\\n1. To be warm\\n2. To breathe normally\\n3. To be protected (against infection)\\n4. To be fed\\nPrepare equipment and supplies for care of  new born at time of  birth:\\n- 2 or more clean baby sheets/towels\\n- G...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '2. Look for severe chest indrawing: \\n/lozenge6 Mild chest indrawing is normal in an infant because the chest wall is very soft  . \\n/lozenge6 Severe chest indrawing (lower chest wall goes in when the infant breathes in ) is a \\nsign of pneumonia and is serious in an infant.\\n\\nAntenatal Care and Skilled...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['antenatal'],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'A) Mrs. Amita is 19 years old, is 10 wks pregnant. This is her first pregnancy. She came to\\nlabour room with c/o pain in abdomen and P/V bleeding for 4 hours.',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'Sometimes I don’t feel the baby’s move ..is it okay or something else?',\n",
       "  'question_translated': 'Sometimes I do not feel fetal movements. Is this normal or is there a concern?',\n",
       "  'answer': '1. When did the child pass urine and meconium?\\n2. Has the mother started breastfeeding the baby and are there any diffi   culties in \\nbreastfeeding?\\n3. Is there a history of problems such as the following:\\n/lozenge6 Th  e baby has fever.\\n/lozenge6 Th  e baby is not suckling well (could have ulcers or white patches in the mouth—\\nthrush). \\n/lozenge6 Th  e baby has diffi  culty in breathing.\\n/lozenge6 Th  e umbilical cord is red or swollen, or is discharging pus.\\n/lozenge6 Th  e movements of the newborn are less than normal (normally, newborns move \\ntheir arms or legs or turn their head several times in a minute).\\n/lozenge6 Th  ere is skin infection (pustules)—red spots which contain pus or a big boil.\\n/lozenge6 Th  ere are convulsions.\\n\\nPregnant now or within the last year?\\nGet medical care right away if you experience any of the following symptoms:\\nThese could be signs of very serious complications. If you can’t reach a healthcare provider, go to the  \\nemergency room. Be sure to tell them you are pregnant or were pregnant within the last year.\\nThis list of urgent maternal warning signs was developed by the Council on Patient Safety in Women’s Health Care.\\nHeadache that  \\nwon’t go away or \\ngets worse over time \\nDizziness or  \\nfainting\\nChanges in  \\nyour vision\\nFever of 100.40F  \\nor higher\\nyour vision\\nExtreme swelling of \\nyour hands or face\\nThoughts of harming \\nyourself or your baby\\nTrouble  \\nbreathing\\nChest pain or fast \\nbeating heart\\nyour vision\\nSevere nausea and \\nthrowing up\\nSevere belly pain \\nthat doesn’t go away\\nBaby’s movement \\nstopping or slowing \\nduring pregnancy\\nSevere swelling,  \\nredness or pain of \\nyour leg or arm\\nVaginal bleeding  \\nor fluid leaking \\nduring pregnancy\\nHeavy vaginal  \\nbleeding or discharge  \\nafter pregnancy\\nOverwhelming \\ntiredness\\nLearn more at  \\ncdc.gov/HearHer\\n\\nLook for Oedema:\\n ∙ Oedema (swelling), which appears in the evening and \\ndisappears in the morning after a full night’s sleep, could \\nbe a normal manifestation of pregnancy.\\n ∙ Any oedema of the',\n",
       "  'sources': [{'content': '1. When did the child pass urine and meconium?\\n2. Has the mother started breastfeeding the baby and are there any diffi   culties in \\nbreastfeeding?\\n3. Is there a history of problems such as the following:\\n/lozenge6 Th  e baby has fever.\\n/lozenge6 Th  e baby is not suckling well (could have ulcers o...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'Pregnant now or within the last year?\\nGet medical care right away if you experience any of the following symptoms:\\nThese could be signs of very serious complications. If you can’t reach a healthcare provider, go to the  \\nemergency room. Be sure to tell them you are pregnant or were pregnant within t...',\n",
       "    'metadata': {'title': 'Warning Signs Poster Ltr English',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'Look for Oedema:\\n ∙ Oedema (swelling), which appears in the evening and \\ndisappears in the morning after a full night’s sleep, could \\nbe a normal manifestation of pregnancy.\\n ∙ Any oedema of the face, hands, abdominal wall, and \\nvulva is abnormal. Oedema can be suspected if a woman \\ncomplains of abn...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Complete abortion\\nTh e following are the signs of complete abortion:\\n• Th  ere is light bleeding or there has been heavy bleeding which has now stopped.\\n• Th  ere is lower abdominal pain.\\n• Th  ere is a history of expulsion of POC.\\n• Abdominal examination shows a uterus that is soft  er than normal,...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Management:\\n ∙ Observe the woman for 4-6 hours. Advise her to take rest.\\n ∙ If the bleeding decreases or stops, explain the facts to her, reassure her and advise her to go home after you \\nhave checked her vital signs.\\n ∙ Advise her to return to you or the MO if the bleeding recurs.\\n\\n43\\nc. Threatened...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Management:\\n ∙ If retained POC are seen in the vagina, remove them gently with a finger. The procedure must be carried out \\nunder aseptic conditions.\\n ∙ If the bleeding does not stop and/or the woman is in shock, establish an intravenous line immediately and \\ngive intravenous fluids rapidly.\\n ∙ Send...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1. Where did the delivery take place?\\n2. Who conducted the delivery?\\n3. Is there a history of :\\na. any complications during the delivery?\\nb. bleeding P/V (how many pads or pieces of cloth are getting soaked with blood) \\nc. convulsions or loss of consciousness\\na. \\npain in the legs\\nd. abdominal pain\\ne...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'I have seen prickly heat and itching on some part of my body... What should I do?',\n",
       "  'question_translated': 'I have observed miliaria and pruritus on some area of my body... What should I do?',\n",
       "  'answer': \"Prickly heat is a common skin condition that can occur in hot and humid weather. It is caused by sweat getting trapped in the skin's pores, leading to red, itchy bumps. To prevent and treat prickly heat, follow these steps:\\n\\n1. Stay cool and hydrated: Wear light, loose-fitting clothing made of natural fibers, such as cotton, and avoid synthetic fabrics that can trap heat. Drink plenty of water to stay hydrated and avoid dehydration, which can make prickly heat worse.\\n\\n2. Avoid triggers: Avoid activities that make you sweat excessively, such as exercise or spending time in a sauna or hot tub. If you must be in a hot environment, take frequent breaks to cool down and stay hydrated.\\n\\n3. Use a moisturizer: Apply a moisturizer or lotion to your skin after bathing or swimming to help lock in moisture and prevent sweat from getting trapped in your pores.\\n\\n4. Use over-the-counter treatments: If you have mild prickly heat, you can try over-the-counter treatments, such as calamine lotion or hydrocortisone cream, to relieve itching and reduce inflammation.\\n\\n5. See a doctor: If your prickly heat is severe or does not improve with home treatment, see a doctor. They may prescribe stronger medications or recommend other treatments, such as topical steroids or oral antihistamines.\\n\\nIt is important to note that prickly heat can be a sign of a more serious condition, such as heat exhaustion or heat stroke. If you experience symptoms such as dizziness, nausea, or confusion, seek medical attention immediately.\\n\\nIn addition to these steps, it is also important to take care of your overall health and well-being. Eating a balanced diet, getting enough sleep, and managing stress can all help prevent and treat prickly heat. If you have any concerns or questions about your skin health, it is always a good idea to consult with a healthcare professional.\",\n",
       "  'sources': [{'content': 'Figure 1: Correcting an inverted nipple using a syringe\\nSTEP THREE\\nSTEP TWO\\nSTEP ONE\\nCut the end of a plastic syringe\\nInsert piston from cut end\\nMother gently pulls \\nthe piston\\n/circle6 Look for crusting and soreness of the nipples. If these are present, the woman must be \\nadvised on breast hygiene ...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1.  As you have entered the 3 rd trimester, we will have to repeat some of the tests. Your physical examination and tests will include the following:\\nMeasurements Tests Check for\\nWeight Blood hemoglobin level Pallor (conjunctivae, tongue, oral mucosa and palms)\\nPalpable goitre\\nDental and skeletal fl...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '∙ If the sacral promontory is not felt, trace downward and feel for sacral hollow. A well curved \\nsacrum is favourable. ∙ Spread your two fingers to feel the ischial spines. If both ischial spines can be felt at same time, \\nthe pelvic cavity is contracted. Refer to FRU for further care. 9 Gently rem...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '10. These cards are designed for individual counselling but may be used for group counselling if it is possible to form a homogenous group of \\npregnant women that is, all being in the same month of pregnancy\\n1\\n\\n1st Month\\n1.  Congratulations! Your pregnancy is con ﬁ rmed; register soon so that you ge...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [1],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'On examination:\\nP .R – 76 /min., BP – 120/70 mm. of  Hg.\\nP/A  -  NAD\\nP/S  -  excessive bleeding +, Os open, products seen at the Os\\nP/V  -  uterus corresponds to 10 weeks of gestation\\nWhat is your diagnosis?\\n• Inevitable abortion\\nB) How will you manage this case?\\n• Evacuate the uterus using MVA.\\n\\n53...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [10],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'faq'}},\n",
       "   {'content': 'On examination:\\nP .R – 76 /min., BP – 120/70 mm. of  Hg.\\nP/A   -   NAD\\nP/S    -  minimum bleeding\\nP/V   - uterus 6 bulky, Os closed.\\nWhat is your diagnosis?\\n• Complete abortion\\nB) How will you manage this case?\\no No further management is required if she is stable\\no USG optional (to confirm complete ...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [1],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '1.  As the 4 th month has started, we will have to repeat some of the \\ntests; your physical examination and tests will include the following:\\nMeasurements Tests Check for\\nWeight Blood hemoglobin level Pallor (conjunctiva, tongue, oral \\nmucosa and palms)\\nPalpable goitre\\nDental and skeletal fluorosis\\n...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': None,\n",
       "   'concerns': ['nutrition']}},\n",
       " {'question_original': 'Pragnancy me mango 🥭 kitna mntra me kha skti hu',\n",
       "  'question_translated': 'How much mango 🥭 can I eat during pregnancy?',\n",
       "  'answer': 'Mango is a good source of vitamin C, which helps the body absorb iron. It is also a good source of potassium, which helps to regulate blood pressure. However, it is important to note that mangoes are high in sugar and should be consumed in moderation during pregnancy. It is best to consult with a healthcare provider for personalized advice on the consumption of mangoes during pregnancy.\\n\\nCARD 6\\n13\\n6th Month\\nWhat is important to know?\\n\\n5.  From next month, start consuming 1 Iron Folic Acid (IFA) tablet and 2 calcium tablets daily\\nYour baby is now the size of a lemon (nimbu); all the vital organs \\nare fully formed; the arms, hands, ﬁ ngers, feet and toes are visible \\nin an ultrasound; nails and teeth are beginning to develop\\nIf the pregnant woman is receiving her ﬁ rst ANC contact in this month, \\nthen also refer to ‘What is important to know?’ from Card 1(Message 2 only)\\n\\nCARD 3\\n7\\n3rd Month\\nBlood pressure\\nContinue consuming one \\nFolic acid tablet daily \\nClinical examination\\nIFA and calcium tablet consumption \\nfrom 4th month of pregnancy\\nEat 3 main meals and 1 snack daily\\nGestational weight gain\\nPrevious Current\\nSnack\\nBreakfast Lunch\\nDinner\\nCalcium and folate rich foods\\nCurd Ragi Chicken \\nliver\\nSesame \\nseeds\\nMilk Paneer Catla \\nƒUJ\\x03\\nBathua and \\nmethi leaves \\nth d\\nANC services\\n\\nCARD 4\\n8\\n4th Month\\nYour baby is now almost the same size as an apple and weighs approximately 110 grams; you may be able to feel \\nyour baby’s movement now; the baby’s blood circulation has begun and the brain, spinal cord and nerve network \\nhave become fully functional; the teeth and bones have become denser \\nWhat is important to know?\\n\\n4.  Vitamin C rich foods like amla, citrus fruits (orange, guava, \\nlemon, mausambi) and sprouted grains/pulses should be \\nincluded in meals as it improves absorption of iron in the body; \\nIFA tablet may be taken with lemon juice for better absorption \\nof iron; IFA tablet should never be consumed with tea or coffee, \\nmilk or calcium tablets\\n5.  As your baby’s bones and teeth are becoming denser, remember \\nto include calcium-rich',\n",
       "  'sources': [{'content': '3.  It is normal to experience nausea and vomiting in early pregnancy; still you should try to eat at least 3 main meals and 1 nutritious snack as \\nthis will help you and your baby to meet nutrient requirements\\n4.  As your baby’s brain and spinal cord are developing, include foods rich in folate suc...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [1, 2],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '• You need to eat one extra meal a day during pregnancy. \\n• Take milk and dairy products like curd, buttermilk,  \\n',\n",
       "    'metadata': {'title': 'Booklet for expecting mothers\\nMaternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '5.  When your baby is born, initiate breastfeeding as soon as possible and within 1 hour of birth, the baby should only be brea stfed till six months \\nof age; no other liquid, including water, should be given to the baby during this time\\nIf the pregnant woman is receiving her ﬁ rst ANC contact in th...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [8, 7],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['third_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5.  Consume 2 calcium tablets every day with water or milk immediately after meals\\nIf the pregnant woman is receiving her ﬁ rst ANC contact in this month, then also refer to ‘What is \\nimportant to know?’ from Card 1 (Message 2 only) and from Card 4 (Messages 3, 4 and 5)\\nYour baby is now as long as a...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [5, 6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Tablet Calcium 500 mg \\ncalcium and \\n250 IU Vitamin \\nD3\\nOne tablet twice \\na day (total 1 \\ngm calcium \\ndaily)\\nFrom second trimester (14 weeks) \\nonwards throughout pregnancy for 6 \\nmonths (360 tablets) and continued \\nfor 6 months after delivery (360 \\ntablets) taken in between meals Iron \\nfolic acid tab...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [14],\n",
       "      'months': [6],\n",
       "      'trimesters': ['second'],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5.  From next month, start consuming 1 Iron Folic Acid (IFA) tablet and 2 calcium tablets daily\\nYour baby is now the size of a lemon (nimbu); all the vital organs \\nare fully formed; the arms, hands, ﬁ ngers, feet and toes are visible \\nin an ultrasound; nails and teeth are beginning to develop\\nIf the...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [3, 4],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester', 'second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '4.  Vitamin C rich foods like amla, citrus fruits (orange, guava, \\nlemon, mausambi) and sprouted grains/pulses should be \\nincluded in meals as it improves absorption of iron in the body; \\nIFA tablet may be taken with lemon juice for better absorption \\nof iron; IFA tablet should never be consumed wit...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [4, 5],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'Bacche ko Tej Sardi ho to kaise usko maintain Karen',\n",
       "  'question_translated': 'How to maintain a child with severe cold?',\n",
       "  'answer': '1. She should maintain hygiene while handling the baby.\\n2. She should delay the baby’s fi  rst bath to beyond 24 hours aft er birth.\\n3. In cool weather, the baby’s head and feet should be covered and he/she should be dressed \\nin extra clothing. Th e baby must be kept warm at all times.\\n4. She should not apply anything on the cord, and must keep the umbilicus and cord dry.\\n\\n• CALL FOR HELP!\\n• Cut cord quickly, transfer to a firm, warm surface [under a radiant warmer]\\n• Lightly wrap the baby\\n• Inform the mother that baby has difficult breathing and you will help the baby to breathe\\n• If  drying the baby and additional methods of  tactile stimulations  do not stimulate baby to breathe,\\n\\n\\n• Mother to wear a mask  \\n• Observe hand hygiene at all times/ clean nipple with moist cloth before feeding. \\n• Observe respiratory etiquettes \\n• Those who cannot breast feed either due to the baby or the mother  being unwell, the \\n\\n\\n• Baby can be kept at a distance with a masked caregiver when not being fed. \\n• Breastfeeding, rooming -in, kangaroo mother care (when required) should be \\n\\n\\n• This baby can be given straight to his mother for skin-to-skin contact.\\n• No suction is necessary.\\n\\n\\n• Gestational hypertension\\n• Follow-up every 2 weeks to have her blood pressure, urine and foetal condition monitored.\\n• Counsel about danger signs with emphasis on appearance of pre eclampsia / eclampsia\\n• Provide basic antenatal care, deliver at PHC at term\\n• Refer to FRU (with referral slip as in Annexure II), if  she develops proteinuria /danger\\n\\n\\nWhat is your diagnosis and how will you treat her?\\nBreast abscess\\nB) How to prevent breast feeding problems?\\n\\nUser Question: Bacche ko Tej Sardi ho to kaise usko maintain Karen\\n\\nInstructions:\\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the',\n",
       "  'sources': [{'content': '9. Examine for congenital malformations and any birth injury. If there are any, refer the \\nnewborn to the FRU.\\nC. Management/counselling\\nGive the mother the following advice: \\n1. She should maintain hygiene while handling the baby.\\n2. She should delay the baby’s fi  rst bath to beyond 24 hours aft e...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '• CALL FOR HELP!\\n• Cut cord quickly, transfer to a firm, warm surface [under a radiant warmer]\\n• Lightly wrap the baby\\n• Inform the mother that baby has difficult breathing and you will help the baby to breathe\\n• If  drying the baby and additional methods of  tactile stimulations  do not stimulate b...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '• Mother to wear a mask  \\n• Observe hand hygiene at all times/ clean nipple with moist cloth before feeding. \\n• Observe respiratory etiquettes \\n• Those who cannot breast feed either due to the baby or the mother  being unwell, the \\n',\n",
       "    'metadata': {'title': 'Page 1 of 36 \\n \\n \\n \\n \\n \\n \\n \\nGuidelines',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '• Baby can be kept at a distance with a masked caregiver when not being fed. \\n• Breastfeeding, rooming -in, kangaroo mother care (when required) should be \\n',\n",
       "    'metadata': {'title': 'Page 1 of 36 \\n \\n \\n \\n \\n \\n \\n \\nGuidelines',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '• This baby can be given straight to his mother for skin-to-skin contact.\\n• No suction is necessary.\\n',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []}}},\n",
       "   {'content': '• Gestational hypertension\\n• Follow-up every 2 weeks to have her blood pressure, urine and foetal condition monitored.\\n• Counsel about danger signs with emphasis on appearance of pre eclampsia / eclampsia\\n• Provide basic antenatal care, deliver at PHC at term\\n• Refer to FRU (with referral slip as in...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'content_type': 'list',\n",
       "     'pregnancy_stages': {'weeks': [2],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['antenatal'],\n",
       "      'standard_stages': ['first_trimester']}}},\n",
       "   {'content': 'What is your diagnosis and how will you treat her?\\nBreast abscess\\nB) How to prevent breast feeding problems?',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'Kya pregnancy m bleeding hoti h kya yeh normal h',\n",
       "  'question_translated': 'Does bleeding occur during pregnancy, is this normal?',\n",
       "  'answer': '1. Kya pregnancy m bleeding hoti h kya yeh normal h\\n2. Kya pregnancy m bleeding hoti h kya yeh normal h\\n3. Kya pregnancy m bleeding hoti h kya yeh normal h\\n4. Kya pregnancy m bleeding hoti h kya yeh normal h\\n5. Kya pregnancy m bleeding hoti h kya yeh normal h\\n6. Kya pregnancy m bleeding hoti h kya yeh normal h\\n7. Kya pregnancy m bleeding hoti h kya yeh normal h\\n8. Kya pregnancy m bleeding hoti h kya yeh normal h\\n9. Kya pregnancy m bleeding hoti h kya yeh normal h\\n10. Kya pregnancy m bleeding hoti h kya yeh normal h\\n11. Kya pregnancy m bleeding hoti h kya yeh normal h\\n12. Kya pregnancy m bleeding hoti h kya yeh normal h\\n13. Kya pregnancy m bleeding hoti h kya yeh normal h\\n14. Kya pregnancy m bleeding hoti h kya yeh normal h\\n15. Kya pregnancy m bleeding hoti h kya yeh normal h\\n16. Kya pregnancy m bleeding hoti h kya yeh normal h\\n17. Kya pregnancy m bleeding hoti h kya yeh normal h\\n18. Kya pregnancy m bleeding hoti h kya yeh normal h\\n19. Kya pregnancy m bleeding hoti h kya yeh normal h\\n20. Kya pregnancy m bleeding hoti h kya yeh normal h\\n21. Kya pregnancy m bleeding hoti h kya yeh normal h\\n22. Kya pregnancy m bleeding hoti h kya yeh normal h\\n23. Kya pregnancy m bleeding hoti h kya yeh normal h\\n24. Kya pregnancy m bleeding hoti h kya yeh normal h\\n25. Kya pregnancy m bleeding hoti h kya yeh normal h\\n26. Kya pregnancy m bleeding hoti h kya yeh normal h\\n27. Kya pregnancy m bleeding hoti h kya yeh normal h\\n28. Kya pregnancy m bleeding hoti h kya yeh normal h\\n29. Kya pregnancy m bleeding hoti h kya yeh normal h\\n30. Kya pregnancy m bleeding hoti h kya yeh normal h\\n31',\n",
       "  'sources': [{'content': '3. Vaginal Bleeding\\n ∙ Early pregnancy-before 20 weeks of pregnancy\\n ∙ Late pregnancy-after 20 weeks of pregnancy or Ante-Partum Haemorrhage (APH)\\nVaginal bleeding in early pregnancy: \\nThe probable causes could be a threatened or spontaneous abortion, an \\nectopic pregnancy or a hydatidiform mole.\\na....',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [20],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'Management:\\n ∙ Observe the woman for 4-6 hours. Advise her to take rest.\\n ∙ If the bleeding decreases or stops, explain the facts to her, reassure her and advise her to go home after you \\nhave checked her vital signs.\\n ∙ Advise her to return to you or the MO if the bleeding recurs.\\n\\n43\\nc. Threatened...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1. Where did the delivery take place?\\n2. Who conducted the delivery?\\n3. Is there a history of :\\na. any complications during the delivery?\\nb. bleeding P/V (how many pads or pieces of cloth are getting soaked with blood) \\nc. convulsions or loss of consciousness\\na. \\npain in the legs\\nd. abdominal pain\\ne...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'It has been \\nreported that 60% of women who develop postpartum PE \\ndo not experience PE during pregnancy. 20 There is limited \\nawareness of postpartum PE, though risk factors include \\nolder maternal age, maternal obesity, black race and \\ncesarean delivery. 21–24\\n\\n5Global burden of hypertensive disor...',\n",
       "    'metadata': {'title': 'Landscape Assessment On Commodity And Service Delivery Innovations For Detection And Management Of Pre Eclampsia',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['postpartum'],\n",
       "      'standard_stages': ['postpartum']},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': 'Management:\\n ∙ If retained POC are seen in the vagina, remove them gently with a finger. The procedure must be carried out \\nunder aseptic conditions.\\n ∙ If the bleeding does not stop and/or the woman is in shock, establish an intravenous line immediately and \\ngive intravenous fluids rapidly.\\n ∙ Send...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'The evidence suggests that upright birth positions during the\\nsecond stage of labour reduce the need for epidural\\nanaesthesia, the length of active pushing phase in second\\nstage, severe perineal trauma, episiotomy, abnormal fetal\\nheart rate patterns, and instrumental vaginal births. However,\\nupright...',\n",
       "    'metadata': {'title': 'Transforming Maternity Care\\nGuidelines on\\nOperationalization of \\nMidwifery Units\\nMaternal Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': 'Assesses the completeness of the abortion by:\\n•\\t Taking a history of the abortion process (amount and duration of bleeding, \\nside effects, cramping, any POC expelled)\\n•\\t Conducting a physical examination (pelvic examination to assess the size \\nand consistency of the uterus and opening of the cervica...',\n",
       "    'metadata': {'title': 'JULY 2022\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\ni\\nHealth',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': None,\n",
       "   'concerns': ['bleeding']}},\n",
       " {'question_original': 'mujhe thyroid h to kya isse bhi breast milk pe asar hota h',\n",
       "  'question_translated': 'Query: I have thyroid, does it also affect breast milk?',\n",
       "  'answer': 'If you have thyroid disease, it can affect your breast milk production. It is important to monitor your thyroid levels and work with your healthcare provider to manage your condition. If you are experiencing difficulty with breast milk production, there are several things you can do to help, such as:\\n•\\tIncreasing your intake of fluids and electrolytes, such as water, coconut water, and electrolyte drinks.\\n•\\tEating a balanced diet that includes plenty of fruits, vegetables, and whole grains.\\n•\\tEngaging in regular physical activity, such as walking or swimming.\\n•\\tUsing a breast pump to help stimulate milk production.\\n•\\tSeeking support from a lactation consultant or other healthcare provider.\\nIt is important to note that breast milk production can be affected by a variety of factors, including stress, fatigue, and certain medications. If you are experiencing difficulty with breast milk production, it is important to consult with a healthcare provider to determine the underlying cause and develop a plan for managing it.\\n\\nUser Question: mujhe thyroid h to kya isse bhi breast milk pe asar hota h\\n\\nInstructions:\\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\nIf you have thyroid disease, it can affect your breast milk production. It is important to monitor your thyroid levels and work with your healthcare provider to manage your condition. If you are experiencing difficulty with breast milk production, there are several things you can do to help, such as:\\n•\\tIncreasing your intake of fluids and electrolytes, such as water, coconut water, and electrolyte drinks.\\n•\\tEating a balanced diet that includes plenty of fruits, vegetables, and whole grains.\\n•\\tEngaging in regular physical activity, such as walking or swimming.\\n•\\tUsing a breast pump to help stimulate milk production.\\n•\\tSeeking support from a lactation consultant or other healthcare provider.\\nIt is important to note that breast milk production can be affected by a variety of factors, including stress, fatigue',\n",
       "  'sources': [{'content': 'What is your diagnosis and how will you treat her?\\nBreast abscess\\nB) How to prevent breast feeding problems?',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '5. Examine the pad for bleeding to assess if the bleeding is heavy, and also see if the lochia \\nis healthy and does not smell foul (for puerperal sepsis). If these signs are present, refer \\nthe woman to the FRU.\\n6. Examine the breasts for any lumps or tenderness, check the condition of the \\nnipples ...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '5.  Consume 2 calcium tablets every day with water or milk immediately after meals\\nIf the pregnant woman is receiving her ﬁ rst ANC contact in this month, then also refer to ‘What is \\nimportant to know?’ from Card 1 (Message 2 only) and from Card 4 (Messages 3, 4 and 5)\\nYour baby is now as long as a...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [5, 6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '4.  Continue consuming one IFA tablet with water or lemon juice 1 hour after meal\\n5.  Continue consuming 2 calcium tablets every day with water or milk immediately after meals\\nIf the pregnant woman is receiving her ﬁ rst ANC contact in this month, then also refer to ‘What is \\nimportant to know?’ fro...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6, 7],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester', 'third_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5. Check the baby’s temperature every hour until normal.\\n\\n27\\n/head2rightCase Study 8: (Ask the trainee to write down the answers to the questions asked in relevant\\nsession of  the Handbook. The suggestive answers have been given here for your reference.)\\nA) B/o Karuna is 3 days old, taking feeds wel...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5.  From next month, start consuming 1 Iron Folic Acid (IFA) tablet and 2 calcium tablets daily\\nYour baby is now the size of a lemon (nimbu); all the vital organs \\nare fully formed; the arms, hands, ﬁ ngers, feet and toes are visible \\nin an ultrasound; nails and teeth are beginning to develop\\nIf the...',\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [3, 4],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester', 'second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': \"5. Continue consuming one folic acid tablet (400 mg) daily and foods rich in folate such as catla ﬁ sh, moth beans, kidney beans, soybean, spinach, \\nsem ki phali, sarson ka saag, and chicken liver which are important for the normal development of your baby's brain and spinal cord\\nNow your baby has g...\",\n",
       "    'metadata': {'title': 'By Gestational Month Cards',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [2, 3],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['first_trimester']},\n",
       "     'content_type': 'recommendation'}}],\n",
       "  'detected_info': {'language': 'english', 'stage': None, 'concerns': []}},\n",
       " {'question_original': '2.5 months hogae h pregnancy ko but vomet ya kch ni hora mjhe',\n",
       "  'question_translated': 'Query: I am 2.5 months pregnant but I am not experiencing any vomiting or other symptoms.',\n",
       "  'answer': '1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n\\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n\\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n\\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n\\n1. Respond',\n",
       "  'sources': [{'content': 'A health care provider can be reasonably certain that a patient is not pregnant if the patient has no symptoms or signs of pregnancy and meets\\nany one of the following criteria:\\nIs ≤7 days after the start of normal menses.\\nHas not had sexual intercourse since the start of last normal menses .\\nHas be...',\n",
       "    'metadata': {'title': 'How To Be Reasonably Certain That A Patient Is Not Pregnant   Contraception   Cdc',\n",
       "     'pregnancy_stages': {'weeks': [4],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': ['postpartum'],\n",
       "      'standard_stages': ['first_trimester',\n",
       "       'second_trimester',\n",
       "       'postpartum']},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'A) Mrs. Amita is 19 years old, is 10 wks pregnant. This is her first pregnancy. She came to\\nlabour room with c/o pain in abdomen and P/V bleeding for 4 hours.',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '4. Are there any other complaints?\\n5. If any of the above problems is present, refer the newborn to the FRU. However, \\nthere is no need for referral in case of umbilical discharge or if the number of skin \\npustules is less than 10. Provide home treatment, as detailed in IMNCI guidelines \\nfor these p...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '1. Where did the delivery take place?\\n2. Who conducted the delivery?\\n3. Is there a history of :\\na. any complications during the delivery?\\nb. bleeding P/V (how many pads or pieces of cloth are getting soaked with blood) \\nc. convulsions or loss of consciousness\\na. \\npain in the legs\\nd. abdominal pain\\ne...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '7. Danger signs \\n/lozenge6 Counsel the mother to go directly to the FRU without waiting if she notices the \\nfollowing danger signs:\\n/circle6  Excessive bleeding, i.e. soaking more than 2–3 pads in 20–30 minutes aft  er \\ndelivery.\\n/circle6 Convulsions\\n/circle6 Fever\\n/circle6 Severe abdominal pain\\n/ci...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'Management:\\n ∙ Observe the woman for 4-6 hours. Advise her to take rest.\\n ∙ If the bleeding decreases or stops, explain the facts to her, reassure her and advise her to go home after you \\nhave checked her vital signs.\\n ∙ Advise her to return to you or the MO if the bleeding recurs.\\n\\n43\\nc. Threatened...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5. Examine the pad for bleeding to assess if the bleeding is heavy, and also see if the lochia \\nis healthy and does not smell foul (for puerperal sepsis). If these signs are present, refer \\nthe woman to the FRU.\\n6. Examine the breasts for any lumps or tenderness, check the condition of the \\nnipples ...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'english',\n",
       "   'stage': 'second_trimester',\n",
       "   'concerns': []}},\n",
       " {'question_original': 'जयदा टाइम तक बैठने से चक्कर आना खड़ा होने से पेट दर्द होने लगता हैमेरे को कौन सी टेबलेट खानी चाहिए अभी सट्टा मा लग चुका है',\n",
       "  'question_translated': 'Query: Feeling dizzy from sitting for too long, experiencing stomach pain from standing up, which tablet should I take? I have just given birth.',\n",
       "  'answer': '1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n1. Respond based only on the provided context. If the information isn\\'t in the context, say \"I don\\'t have enough information to answer this question based on the provided guidelines.\"\\n2. Be reassuring but accurate - don\\'t minimize legitimate health concerns.\\n3. If discussing warning signs, clearly distinguish between normal variations and concerning symptoms.\\n4. Remind users to consult healthcare providers for personal medical advice when appropriate.\\n5. Use clear, non-technical language that is easy to understand.\\n6. Respond in the same language as the original question, if the language is hindi written in english, do the same. \\n\\nAnswer: \\n1. Respond',\n",
       "  'sources': [{'content': 'Pregnant now or within the last year?\\nGet medical care right away if you experience any of the following symptoms:\\nThese could be signs of very serious complications. If you can’t reach a healthcare provider, go to the  \\nemergency room. Be sure to tell them you are pregnant or were pregnant within t...',\n",
       "    'metadata': {'title': 'Warning Signs Poster Ltr English',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'Figure 7: Counselling on MMA procedure\\nShare with the participants the expected symptoms during the process of MMA.\\nExpected Symptoms during MMA \\n    \\n•\\tBleeding per vaginum  is an essential part of the MMA process since it is similar to miscarriage. \\nBleeding is usually heavier than what is experie...',\n",
       "    'metadata': {'title': 'JULY 2022\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\ni\\nHealth',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1. Start with collecting the following history:\\n - Age of woman\\n - Order of pregnancy\\n - Birth interval\\n2. Ask for Symptoms:\\nNormal symptoms during pregnancy – Nausea and vomiting, heartburn, constipation, and increased \\nfrequency of urination. These symptoms may cause discomfort to the woman.\\nExami...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': 'Symptoms during ectopic pregnancy might include:\\n•\\tAmenorrhea\\n•\\tNausea,\\tvomiting\\n•\\tLower\\tabdominal\\tpain,\\tusually\\tone\\t-\\tsided,\\tthat\\tmay\\tbe\\tsudden\\tand\\tintense,\\tpersistent,\\tor\\tcramping\\t\\n•\\tIrregular\\tvaginal\\tbleeding\\tor\\tspotting\\t\\n•\\tFainting\\tor\\tdizziness\\tthat\\tpersists\\tfor\\tmore\\tthan\\ta\\tfew\\tseconds\\tis\\tpossib...',\n",
       "    'metadata': {'title': 'JULY 2022\\n\\n\\n\\nTraining Manual\\nFor MMA in Early Gestation\\ni\\nHealth',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '7. Danger signs \\n/lozenge6 Counsel the mother to go directly to the FRU without waiting if she notices the \\nfollowing danger signs:\\n/circle6  Excessive bleeding, i.e. soaking more than 2–3 pads in 20–30 minutes aft  er \\ndelivery.\\n/circle6 Convulsions\\n/circle6 Fever\\n/circle6 Severe abdominal pain\\n/ci...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': 'Management:\\n ∙ Observe the woman for 4-6 hours. Advise her to take rest.\\n ∙ If the bleeding decreases or stops, explain the facts to her, reassure her and advise her to go home after you \\nhave checked her vital signs.\\n ∙ Advise her to return to you or the MO if the bleeding recurs.\\n\\n43\\nc. Threatened...',\n",
       "    'metadata': {'title': 'Training Manual on Care During Pregnancy and Child Birth \\nfor Community Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '1. Where did the delivery take place?\\n2. Who conducted the delivery?\\n3. Is there a history of :\\na. any complications during the delivery?\\nb. bleeding P/V (how many pads or pieces of cloth are getting soaked with blood) \\nc. convulsions or loss of consciousness\\na. \\npain in the legs\\nd. abdominal pain\\ne...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}}],\n",
       "  'detected_info': {'language': 'hindi', 'stage': None, 'concerns': []}},\n",
       " {'question_original': 'सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।',\n",
       "  'question_translated': 'Query: Cold and cough is occurring. It will not have any effect on the baby.',\n",
       "  'answer': '1. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n2. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n3. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n4. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n5. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n6. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n7. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n8. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n9. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n10. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n11. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n12. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n13. सर्दी -जुकाम  हो रहा  है।इसका बच्चे पर तो कोई प्रभाव  नहीं  होगा ।\\n14. सर्दी -जुकाम  हो रहा  है।',\n",
       "  'sources': [{'content': 'o Put the baby in skin-to-skin contact on mother’s chest and continue care . o Monitor every 15 minutes for breathing and warmth. o Tell the mother the baby will probably be well. C) What are harmful resuscitation practices? D) Describe the care of a baby AFTER it has been resuscitated\\n• After resus...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': '7. Danger signs \\n/lozenge6 Counsel the mother to go directly to the FRU without waiting if she notices the \\nfollowing danger signs:\\n/circle6  Excessive bleeding, i.e. soaking more than 2–3 pads in 20–30 minutes aft  er \\ndelivery.\\n/circle6 Convulsions\\n/circle6 Fever\\n/circle6 Severe abdominal pain\\n/ci...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'warning'}},\n",
       "   {'content': '4. Check the baby’s body temperature. Th  e temperature can be assessed by recording the \\naxillary temperature or feeling the infant’s abdomen or axilla. \\n/lozenge6 If the temperature is less than 36.5º C or above 37.4º C, the newborn needs to \\nbe urgently referred to an FRU, as per the steps for re...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}},\n",
       "   {'content': '9. Examine for congenital malformations and any birth injury. If there are any, refer the \\nnewborn to the FRU.\\nC. Management/counselling\\nGive the mother the following advice: \\n1. She should maintain hygiene while handling the baby.\\n2. She should delay the baby’s fi  rst bath to beyond 24 hours aft e...',\n",
       "    'metadata': {'title': 'Guidelines for\\nAntenatal Care',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '5. Check the baby’s temperature every hour until normal.\\n\\n27\\n/head2rightCase Study 8: (Ask the trainee to write down the answers to the questions asked in relevant\\nsession of  the Handbook. The suggestive answers have been given here for your reference.)\\nA) B/o Karuna is 3 days old, taking feeds wel...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [6],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': ['second_trimester']},\n",
       "     'content_type': 'recommendation'}},\n",
       "   {'content': '6. Examine the baby quickly for malformations/bir th injury. If  there is a major\\nmalformation/severe birth injury refer the baby to a newborn unit. Ensure warmth\\nduring examination and transportation.\\n7. Leave the baby between the mother’s breasts to start skin-to-skin care.\\n8. Cover the baby’s hea...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'general_text'}},\n",
       "   {'content': '1. Give appropriate antibiotic for eye infection for 5 days.\\n2. Teach mother how to take care of  her baby’s eyes.\\n\\n31\\na. Wash hands with clean water and soap.\\nb. Wet clean cloth with boiled and cooled water.\\nc. Use the wet cloth to gently wash off  pus from the baby’s eyes.\\nd. Apply 1% tetracycline...',\n",
       "    'metadata': {'title': 'Maternal Health Division\\nMinistry of Health',\n",
       "     'pregnancy_stages': {'weeks': [],\n",
       "      'months': [],\n",
       "      'trimesters': [],\n",
       "      'named_stages': [],\n",
       "      'standard_stages': []},\n",
       "     'content_type': 'instruction'}}],\n",
       "  'detected_info': {'language': 'hindi', 'stage': None, 'concerns': []}}]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"test_docs/mixstral.json\", \"w\", encoding=\"utf-8\") as f:\n",
    "    json.dump(all_results, f, ensure_ascii=False, indent=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'queries' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[1], line 2\u001b[0m\n\u001b[1;32m      1\u001b[0m all_results \u001b[38;5;241m=\u001b[39m []\n\u001b[0;32m----> 2\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m q \u001b[38;5;129;01min\u001b[39;00m \u001b[43mqueries\u001b[49m:\n\u001b[1;32m      3\u001b[0m     result \u001b[38;5;241m=\u001b[39m rag_system\u001b[38;5;241m.\u001b[39mquery_without_rag(q)\n\u001b[1;32m      5\u001b[0m     \u001b[38;5;66;03m# Print to console (optional)\u001b[39;00m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'queries' is not defined"
     ]
    }
   ],
   "source": [
    "all_results = []\n",
    "for q in queries:\n",
    "    result = rag_system.query_without_rag(q)\n",
    "    \n",
    "    # Print to console (optional)\n",
    "    print(result[\"answer\"])\n",
    "   \n",
    "\n",
    "    # Add result to the list\n",
    "    all_results.append(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"test_docs/llama.json\", \"w\", encoding=\"utf-8\") as f:\n",
    "    json.dump(all_results, f, ensure_ascii=False, indent=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading checkpoint shards: 100%|██████████| 19/19 [13:02<00:00, 41.16s/it]\n",
      "Some parameters are on the meta device because they were offloaded to the cpu.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Mixtral loaded successfully in 8-bit mode.\n"
     ]
    }
   ],
   "source": [
    "from transformers import BitsAndBytesConfig\n",
    "from transformers import AutoModelForCausalLM, AutoTokenizer, pipeline\n",
    "import torch\n",
    "model_name = \"/data/models/huggingface/mistralai/Mixtral-8x7B-Instruct-v0.1\"\n",
    "\n",
    "# Enable 8-bit quantization to reduce VRAM usage\n",
    "\n",
    "# bnb_config = BitsAndBytesConfig(\n",
    "#     load_in_8bit=True,\n",
    "#     bnb_8bit_compute_dtype=\"float16\"\n",
    "# )  # Use load_in_4bit=True if needed\n",
    "\n",
    "# Load tokenizer\n",
    "tokenizer_mixstral = AutoTokenizer.from_pretrained(model_name)\n",
    "\n",
    "# Load model in optimized mode\n",
    "model = AutoModelForCausalLM.from_pretrained(\n",
    "    model_name,\n",
    "    torch_dtype=torch.float16, \n",
    "    device_map=\"auto\",\n",
    "    trust_remote_code=True\n",
    ")\n",
    "\n",
    "print(\"✅ Mixtral loaded successfully in 8-bit mode.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "ename": "SyntaxError",
     "evalue": "invalid syntax (3988573585.py, line 1)",
     "output_type": "error",
     "traceback": [
      "\u001b[0;36m  Cell \u001b[0;32mIn[18], line 1\u001b[0;36m\u001b[0m\n\u001b[0;31m    python -m bitsandbytes\u001b[0m\n\u001b[0m              ^\u001b[0m\n\u001b[0;31mSyntaxError\u001b[0m\u001b[0;31m:\u001b[0m invalid syntax\n"
     ]
    }
   ],
   "source": [
    "python -m bitsandbytes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CUDA available: True\n",
      "CUDA device count: 2\n",
      "CUDA device name: NVIDIA RTX A6000\n",
      "CUDA version: 12.4\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "print(f\"CUDA available: {torch.cuda.is_available()}\")\n",
    "print(f\"CUDA device count: {torch.cuda.device_count()}\")\n",
    "if torch.cuda.is_available():\n",
    "    print(f\"CUDA device name: {torch.cuda.get_device_name(0)}\")\n",
    "    print(f\"CUDA version: {torch.version.cuda}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cuda:0\n"
     ]
    }
   ],
   "source": [
    "pipe = pipeline(\n",
    "                \"text-generation\",\n",
    "                model=model,  # This should be your model object\n",
    "                tokenizer=tokenizer,\n",
    "                max_new_tokens=512,\n",
    "                device_map=\"auto\",\n",
    "                temperature=0.25,\n",
    "                top_p=0.95,\n",
    "                batch_size=1  # Process one at a time to avoid CUDA errors\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.21"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
